PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	PG	WC	SC	GA	UT	PM
J	Abe, Y; Isoyama, T; Saito, I; Inoue, Y; Ishii, K; Sato, M; Hara, S; Yurimoto, T; Li, XY; Murakami, H; Ariyoshi, K; Kawase, Y; Ono, T; Fukazawa, K; Ishihara, K				Abe, Yusuke; Isoyama, Takashi; Saito, Itsuro; Inoue, Yusuke; Ishii, Kohei; Sato, Masami; Hara, Shintaro; Yurimoto, Terumi; Li, Xinyang; Murakami, Haruka; Ariyoshi, Koki; Kawase, Yukino; Ono, Toshiya; Fukazawa, Kyoko; Ishihara, Kazuhiko			Animal Experiments of the Helical Flow Total Artificial Heart	ARTIFICIAL ORGANS			English	Article						Total artificial heart; Animal experiment; Helical flow pump; 1; R control; P control	VENTRICULAR ASSIST DEVICE; PUMP; TRANSPLANTATION; SURVIVAL; PRESSURE; FAILURE; CALF	Severe cardiac failure patients require a total artificial heart (TAH) to save life. To realize a TAH that can fit a body of small stature and has high performance, high durability, good anatomical fitting, good blood compatibility, and physiological control, we have been developing the helical flow TAH (HFTAH) with two helical flow pumps with hydrodynamic levitation impeller. Animal experiments of the HFTAH were conducted to perform in vivo studies. The HFTAH was implanted in 13 adult female goats weighing 45.0-64.0kg. After surgery, neither anti-coagulant nor anti-platelet medication was given systemically. The HFTAH was usually driven with a quasi-pulsatile mode. The 1/R control or P control was applied to control the circulation. The P control is a new method using simplified equation of the 1/R control. The HFTAH could be implanted in all goats with good anatomical fitting. Two goats survived for a long time (100 and 68 days). Major causes of termination were device failure and surgical complications. In the device failure, trouble with hydrodynamic bearing was conspicuous. In the two long-term survived goats, experiments were terminated with bearing instability that was probably caused by the suction effect. In these goats, hemolysis occurred on postoperative day 88 and 44, which was considered to be relevant to the bearing trouble. Thrombus was found at the broken right bearing of the 100-day survived goat. However, antithrombogenicity of the pump is expected to be good unless bearing trouble occurs. In two long-term survived goats, the 1/R control or P control worked appropriately to prevent the elevation of right atrial pressure. In both goats, hemodynamic parameters changed with the condition of the animals, liver and kidney functions remained almost normal except when recovering from surgery and during hemolysis, and total protein recovered 2 weeks after surgery. Although instability of the hydrodynamic bearing should be improved, performance of the HFTAH with physiological control could be demonstrated.	[Abe, Yusuke; Isoyama, Takashi; Saito, Itsuro; Sato, Masami; Hara, Shintaro; Yurimoto, Terumi; Li, Xinyang; Murakami, Haruka; Ariyoshi, Koki; Ono, Toshiya] Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Tokyo 1130033, Japan; [Inoue, Yusuke] Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Tokyo 1130033, Japan; [Fukazawa, Kyoko; Ishihara, Kazuhiko] Univ Tokyo, Sch Engn, Dept Mat Engn, Tokyo 1130033, Japan; [Ishii, Kohei] Kagawa Natl Coll Technol, Dept Electromech Syst Engn, Kagawa, Japan; [Kawase, Yukino] Kitasato Univ, Grad Sch Med Sci, Sagamihara, Kanagawa 228, Japan	Abe, Y (reprint author), Univ Tokyo, Grad Sch Med, Dept Biomed Engn, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	abe@bme.gr.jp			JSPS KAKENHI [22249053, 26240054, 26253071]	This study was supported in part by the JSPS KAKENHI Grant Numbers 22249053, 26240054, and 26253071.	Abe Y, 1997, ARTIF ORGANS, V21, P665, DOI 10.1111/j.1525-1594.1997.tb03719.x; Abe Y, 1998, J APPL PHYSIOL, V84, P868; Abe Y, 2008, J ARTIF ORGANS, V11, P191, DOI 10.1007/s10047-008-0434-3; Abe Y, 1998, HEART REPLACMENT ART, V4, P34; Abe Y, 2013, IEEE ENG MED BIO, P2720, DOI 10.1109/EMBC.2013.6610102; Abe Y, 2012, J ARTIF ORGANS, V15, P331, DOI 10.1007/s10047-012-0659-z; Kobayashi M, 2012, ARTIF ORGANS, V36, P705, DOI 10.1111/j.1525-1594.2012.01489.x; Copeland JG, 2004, NEW ENGL J MED, V351, P859, DOI 10.1056/NEJMoa040186; Frazier OH, 2004, CARDIOLOGY, V101, P111, DOI 10.1159/000075991; Snyder A J, 1992, ASAIO J, V38, pM707, DOI 10.1097/00002480-199207000-00130; Cohn WE, 2014, ASAIO J, V60, P15, DOI 10.1097/MAT.0000000000000026; Nojiri C, 2001, ARTIF ORGANS, V25, P411, DOI 10.1046/j.1525-1594.2001.025005411.x; Abe Y, 2011, ARTIF ORGANS, V35, P781, DOI 10.1111/j.1525-1594.2011.01318.x; Furukawa K, 2005, ARTIF ORGANS, V29, P369, DOI 10.1111/j.1525-1594.2005.29063.x; Kyomoto M, 2010, BIOMATERIALS, V31, P658, DOI 10.1016/j.biomaterials.2009.09.083; Fujimasa I, 1986, PROGR ARTIFICIAL ORG, P345; Fukamachi K, 2008, ASAIO J, V54, P589, DOI 10.1097/MAT.0b013e31818a30f1; Guan YL, 2010, ARTIF ORGANS, V34, P529, DOI 10.1111/j.1525-1594.2010.00996.x; HENNIG E, 1978, T AM SOC ART INT ORG, V24, P616; James KK, 2012, J HEART LUNG TRANSPL, V31, P117; Jeffrey LA, 2010, ASAIO J, V56, P285; Kleinheyer M, 2014, P 36 IEEE EMBC, P5659; Kormos RL, 2001, ANN THORAC SURG S, V71, pS116; Shi W, 2011, J ARTIF ORGANS, V14, P81, DOI 10.1007/s10047-011-0556-x; TAKATANI S, 1982, T AM SOC ART INT ORG, V28, P148; Vasku J., 1998, HEART REPLACMENT ART, V4, P161; Yamazaki Kenji, 2002, Jpn J Thorac Cardiovasc Surg, V50, P461, DOI 10.1007/BF02919636	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	AUG	2015	39	8					670	680		10.1111/aor.12543		11	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CO1WW	WOS:000358947800010		
J	Okamoto, E; Yano, T; Shiraishi, Y; Miura, H; Yambe, T; Mitamura, Y				Okamoto, Eiji; Yano, Tetsuya; Shiraishi, Yasuyuki; Miura, Hidekazu; Yambe, Tomoyuki; Mitamura, Yoshinori			Initial Acute Animal Experiment Using a New Miniature Axial Flow Pump in Series With the Natural Heart	ARTIFICIAL ORGANS			English	Article						Artificial heart; Ventricular assist device; Axial flow pump; Pulsatility		We have advocated an axial flow blood pump called valvo pump that is implanted at the aortic valve position, and we have developed axial flow blood pumps to realize the concept of the valvo pump. The latest model of the axial flow blood pump mainly consists of a stator, a directly driven impeller, and a hydrodynamic bearing. The axial flow blood pump has a diameter of 33mm and length of 74mm, and the length of anatomical occupation is 33mm. The axial flow blood pump is anastomosed to the aorta with polytetrafluoroethylene (PTFE) cuffs worn on the inflow and outflow ports. Dp-Q curves of the axial flow blood pump are flatter than those of ordinary axial flow pumps, and pump outflow of 5L/min was obtained against a pressure difference of 50mmHg at a rotational speed of 9000rpm in vitro. The axial flow blood pump was installed in a goat by anastomosing with the thoracic descending aorta using PTFE cuffs, and it was rotated at a rotational speed of 8000rpm. Unlike in case of the ventricular assistance in parallel with the natural heart, pulsatilities of aortic pressure and aortic flow were preserved even when the pump was on, and mean aortic flow was increased by 1.5L/min with increase in mean aortic pressure of 30mmHg. In conclusion, circulatory assistance in series with the natural heart using the axial flow blood pump was able to improve hemodynamic pulsatility, and it would contribute to improvement of end-organ circulation.	[Okamoto, Eiji] Tokai Univ, Grad Sch Sci & Engn, Sapporo, Hokkaido 0058601, Japan; [Mitamura, Yoshinori] Hokkaido Univ, Sapporo, Hokkaido, Japan; [Yano, Tetsuya] Akita Prefectural Univ, Fac Syst Sci & Technol, Yuri Honjo, Japan; [Shiraishi, Yasuyuki; Miura, Hidekazu; Yambe, Tomoyuki] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 980, Japan	Okamoto, E (reprint author), Tokai Univ, Grad Sch Sci & Engn, Minami Ku, Minami Sawa 5-1-1-1, Sapporo, Hokkaido 0058601, Japan.	okamoto29@tsc.u-tokai.ac.jp			KAKENHI [25350539]; Institute of Development, Aging and Cancer, Tohoku University [2013_25]	This study was supported by KAKENHI (Grant-in-Aid for Scientific Research-C [No. 25350539]) and by a research program of Institute of Development, Aging and Cancer, Tohoku University (No. 2013_25).	Kirklin JK, 2013, J HEART LUNG TRANSPL, V32, P141, DOI 10.1016/j.healun.2012.12.004; GRADEL FO, 1966, ANN SURG, V163, P347; Gradel FO, 1966, T ASAIO, V11, P277; Hsu PL, 2009, P IEEE IEMDC 09, P1023; Hsu PL, 2010, ARTIF ORGANS, V35, P282; Mitamura Y, 1991, ASAIO Trans, V37, pM510; Mitamura Y, 1999, ARTIF ORGANS, V23, P566, DOI 10.1046/j.1525-1594.1999.06404.x; Okamoto E, 2015, J ARTIF ORGANS, V18, P181, DOI 10.1007/s10047-014-0806-9; Qian KX, 2005, ASAIO J, V51, P736, DOI 10.1097/01.mat.0000185914.88497.9e; Rezaienia MA, 2013, ARTIF ORGANS, V38, P800; Yozu R, 1991, U.S. Patent, Patent No. 4994917	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	AUG	2015	39	8					701	704		10.1111/aor.12558		4	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CO1WW	WOS:000358947800013		
J	Murashige, T; Kosaka, R; Sakota, D; Nishida, M; Kawaguchi, Y; Yamane, T; Maruyama, O				Murashige, Tomotaka; Kosaka, Ryo; Sakota, Daisuke; Nishida, Masahiro; Kawaguchi, Yasuo; Yamane, Takashi; Maruyama, Osamu			Evaluation of a Spiral Groove Geometry for Improvement of Hemolysis Level in a Hydrodynamically Levitated Centrifugal Blood Pump	ARTIFICIAL ORGANS			English	Article						Bearing gap; Centrifugal blood pump; Hemolysis; Hydrodynamic bearing; Spiral groove	VENTRICULAR ASSIST DEVICE; DECISION; BRIDGE; FAILURE	The purpose of this study is to evaluate a spiral groove geometry for a thrust bearing to improve the hemolysis level in a hydrodynamically levitated centrifugal blood pump. We compared three geometric models: (i) the groove width is the same as the ridge width at any given polar coordinate (conventional model); (ii) the groove width contracts inward from 9.7 to 0.5mm (contraction model); and (iii) the groove width expands inward from 0.5 to 4.2mm (expansion model). To evaluate the hemolysis level, an impeller levitation performance test and in vitro hemolysis test were conducted using a mock circulation loop. In these tests, the driving conditions were set at a pressure head of 200mmHg and a flow rate of 4.0L/min. As a result of the impeller levitation performance test, the bottom bearing gaps of the contraction and conventional models were 88 and 25m, respectively. The impeller of the expansion model touched the bottom housing. In the hemolysis test, the relative normalized index of hemolysis (NIH) ratios of the contraction model in comparison with BPX-80 and HPM-15 were 0.6 and 0.9, respectively. In contrast, the relative NIH ratios of the conventional model in comparison with BPX-80 and HPM-15 were 9.6 and 13.7, respectively. We confirmed that the contraction model achieved a large bearing gap and improved the hemolysis level in a hydrodynamically levitated centrifugal blood pump.	[Murashige, Tomotaka] Tokyo Univ Sci, Grad Sch Sci & Technol, Noda, Chiba 278, Japan; [Kawaguchi, Yasuo] Tokyo Univ Sci, Noda, Chiba 278, Japan; [Kosaka, Ryo; Sakota, Daisuke; Nishida, Masahiro; Yamane, Takashi; Maruyama, Osamu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058564, Japan; [Yamane, Takashi] Kobe Univ, Kobe, Hyogo 657, Japan	Kosaka, R (reprint author), Natl Inst Adv Ind Sci & Technol, 1-2-1 Namiki, Tsukuba, Ibaraki 3058564, Japan.	ryo.kosaka@aist.go.jp			KAKENHI [24700468]	The present study was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI, 24700468).	Hoshi H, 2006, ARTIF ORGANS, V30, P324, DOI 10.1111/j.1525-1594.2006.00222.x; GIERSIEPEN M, 1990, INT J ARTIF ORGANS, V13, P300; Birks EJ, 2010, HEART, V96, P63, DOI 10.1136/hrt.2007.130740; De Robertis F, 2008, J HEART LUNG TRANSPL, V27, P474, DOI 10.1016/j.healun.2008.01.027; Hijikata W, 2008, ARTIF ORGANS, V32, P531, DOI 10.1111/j.1525-1594.2008.00576.x; Hori Y., 2006, HYDRODYNAMIC LUBRICA, P11; Kosaka R, 2014, ARTIF ORGANS, V38, P818, DOI 10.1111/aor.12383; MIZUGUCHI K, 1994, ARTIF ORGANS, V18, P650, DOI 10.1111/j.1525-1594.1994.tb03394.x; Neragi-Miandoab S, 2012, SURG TODAY, V42, P917, DOI 10.1007/s00595-012-0256-z; Nishida M, 2002, JSME INT J C-MECH SY, V45, P981, DOI 10.1299/jsmec.45.981; Pagani Francis D, 2008, Semin Thorac Cardiovasc Surg, V20, P255, DOI 10.1053/j.semtcvs.2008.08.002; Slaughter MS, 2009, NEW ENGL J MED, V361, P2241, DOI 10.1056/NEJMoa0909938; Yamane T, 2007, J ARTIF ORGANS, V10, P71, DOI 10.1007/s10047-006-0370-z; Ziemba EA, 2010, J CARDIAC SURG, V25, P425, DOI 10.1111/j.1540-8191.2010.01038.x	14	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	AUG	2015	39	8					710	714		10.1111/aor.12546		5	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CO1WW	WOS:000358947800015		
J	Sakota, D; Murashige, T; Kosaka, R; Fujiwara, T; Nishida, M; Maruyama, O				Sakota, Daisuke; Murashige, Tomotaka; Kosaka, Ryo; Fujiwara, Tatsuki; Nishida, Masahiro; Maruyama, Osamu			Real-Time Observation of Thrombus Growth Process in an Impeller of a Hydrodynamically Levitated Centrifugal Blood Pump by Near-Infrared Hyperspectral Imaging	ARTIFICIAL ORGANS			English	Article						Hemocompatibility; Hyperspectral imaging; Near-infrared light; Rotary blood pump; Thrombus	EMBOLI	Understanding the thrombus formation in cardiovascular devices such as rotary blood pumps is the most important issue in developing more hemocompatible devices. The objective of this study was to develop a hyperspectral imaging (HSI) method to visualize the thrombus growth process within a rotary blood pump and investigate the optical properties of the thrombus. An in vitro thrombogenic test was conducted using fresh porcine blood and a specially designed hydrodynamically levitated centrifugal blood pump with a transparent bottom. The pump rotating at 3000rpm circulated the blood at 1.0L/min. The bottom surface of the pump was illuminated with white light pulsed at the same frequency as the pump rotation, and the backward-scattered light was imaged using the HSI system. Using stroboscopic HSI and an image construction algorithm, dynamic spectral imaging at wavelengths ranging from 608 to 752nm within the rotating pump was achieved. After completing the experiment, we collected the red thrombus formed in the pump impeller and quantified the thrombus hemoglobin concentration (Hb(thrombus)). The spectrum changed around the center of the impeller, and the area of change expanded toward the impeller flow path. The shape corresponded approximately to the shape of the thrombus. The spectrum change indicated that the light scattering derived from red blood cells decreased. The Hb(thrombus) was 4.7 +/- 1.3g/dL versus a total hemoglobin of 13 +/- 0.87g/dL. The study revealed that Hb(thrombus) was reduced by the surrounding blood flow.	[Sakota, Daisuke; Kosaka, Ryo; Nishida, Masahiro; Maruyama, Osamu] Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Tsukuba, Ibaraki 3058564, Japan; [Murashige, Tomotaka] Tokyo Univ Sci, Grad Sch Sci & Technol, Noda, Chiba 278, Japan; [Fujiwara, Tatsuki] Tokyo Med & Dent Univ, Dept Cardiovasc Surg, Bunkyo Ku, Tokyo, Japan	Sakota, D (reprint author), Natl Inst Adv Ind Sci & Technol, Human Technol Res Inst, Artificial Organ Grp, Namiki 1-2-1, Tsukuba, Ibaraki 3058564, Japan.	sakota.ao@aist.go.jp			Japan Society for the Promotion of Science [26870902]	This work was supported by a Grant-in-Aid for Young Scientists (B) (#26870902, recipient Daisuke Sakota, April 2014 to present) from the Japan Society for the Promotion of Science.	Roggan A, 1999, J BIOMED OPT, V4, P36, DOI 10.1117/1.429919; Barbut D, 1997, ANN THORAC SURG, V63, P1262; Giller CA, 1998, NEUROSURGERY, V42, P490, DOI 10.1097/00006123-199803000-00010; Lennard N, 1999, EUR J VASC ENDOVASC, V17, P301, DOI 10.1053/ejvs.1998.0738; Maruyama O, 2009, ASAIO J, V55, P314, DOI 10.1097/MAT.0b013e3181a7b540; RAMPLING MW, 1989, STUD BIOPHYS, V134, P91; Sakota D, 2014, ARTIF ORGANS, V38, P733, DOI 10.1111/aor.12377; Shvertsman LD, 2003, IEEE T BIOMED ENG, V50, P1026; Yasui K, 2013, ARTIF ORGANS, V37, P768, DOI 10.1111/aor.12163	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0160-564X	1525-1594		ARTIF ORGANS	Artif. Organs	AUG	2015	39	8					714	719		10.1111/aor.12560		6	Engineering, Biomedical; Transplantation	Engineering; Transplantation	CO1WW	WOS:000358947800016		
J	Nakajima, T; Tsuji, T; Takeda, Y				Nakajima, T.; Tsuji, T.; Takeda, Y.			PHYSICAL PROPERTIES OF GLIESE 229B BASED ON NEWLY DETERMINED CARBON AND OXYGEN ABUNDANCES OF GLIESE 229A	ASTRONOMICAL JOURNAL			English	Article						brown dwarfs; stars: abundances; stars: individual (Gl 229A, Gl 229B); stars: low-mass	COOL BROWN DWARF; NEAR-INFRARED SPECTROSCOPY; EXTRASOLAR GIANT PLANETS; DIGITAL SKY SURVEY; T-DWARF; PHOTOSPHERIC ENVIRONMENT; ULTRACOOL DWARFS; MONOXIDE; METHANE; DUST	Recently Tsuji & Nakajima and Tsuji et al. have developed a method of molecular line spectroscopy of M dwarfs with which carbon and oxygen abundances are derived respectively from CO and H2O lines in the K band. They applied this method to Gliese 229A(Gl 229A), the primary star of the brown dwarf companion, Gliese 229B(Gl 229B). The derived abundances of Gl 229A are log A(C) = -3.27. +/- 0.07 and log A(O) = -3.10. +/- 0.02, which are close to the classical values of the solar abundances of carbon and oxygen. We generate model spectra of Gl 229B for the metallicity of Gl 229A as well as for the classical solar metallicity (log A(C) = -3.40 and log A(O) = -3.08). We find that the differences in the resulting spectra are not so large for differences in metallicity of 0.1 dex or so, but we now discuss the spectrum of Gl 229B on the basis of reliable metallicity. From the literature, the lower limit to the age of Gl 229A is found to be 0.3 Gyr. From the kinematics of Gl 229A, we evaluate the upper limit to the age of Gl 229A to be 3.0 Gyr. The observed and model spectra are compared and the goodness of fit is obtained in the range of model parameters 750 <= T-eff <= 1000 K and 4.5 <= log g <= 5.5. Among the candidates that satisfy the age constraint, the best combinations of model parameters are (T-eff, log g) = (800 K, 4.75) and (850 K, 5.0), while acceptable combinations are (750 K, 4.75), (850 K, 4.75) and (900 K, 5.0).	[Nakajima, T.; Takeda, Y.] Natl Astron Observ Japan, Mitaka, Tokyo 1818588, Japan; [Tsuji, T.] Univ Tokyo, Sch Sci, Inst Astron, Mitaka, Tokyo 1810015, Japan	Nakajima, T (reprint author), Natl Astron Observ Japan, 2-21-1 Osawa, Mitaka, Tokyo 1818588, Japan.	tadashi.nakajima@nao.ac.jp; ttsuji@ioa.s.u-tokyo.ac.jp; takeda.yoichi@nao.ac.jp					Allard F, 1996, ASTROPHYS J, V465, pL123, DOI 10.1086/310143; Burrows A, 2001, REV MOD PHYS, V73, P719, DOI 10.1103/RevModPhys.73.719; Rothman LS, 2010, J QUANT SPECTROSC RA, V111, P2139, DOI 10.1016/j.jqsrt.2010.05.001; Dehnen W, 1998, MON NOT R ASTRON SOC, V298, P387, DOI 10.1046/j.1365-8711.1998.01600.x; OPPENHEIMER BR, 1995, SCIENCE, V270, P1478, DOI 10.1126/science.270.5241.1478; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Leggett SK, 2002, MON NOT R ASTRON SOC, V332, P78, DOI 10.1046/j.1365-8711.2002.05273.x; Burrows A, 1997, ASTROPHYS J, V491, P856, DOI 10.1086/305002; York DG, 2000, ASTRON J, V120, P1579, DOI 10.1086/301513; Warren SJ, 2007, MON NOT R ASTRON SOC, V381, P1400, DOI 10.1111/j.1365-2966.2007.12348.x; Barber RJ, 2006, MON NOT R ASTRON SOC, V368, P1087, DOI [10.1111/j.1365-2966.2006.10184.x, 10.1111/j.1365-2966.10184.x]; Allard F, 2001, ASTROPHYS J, V556, P357, DOI 10.1086/321547; Wright EL, 2010, ASTRON J, V140, P1868, DOI 10.1088/0004-6256/140/6/1868; Lawrence A, 2007, MON NOT R ASTRON SOC, V379, P1599, DOI 10.1111/j.1365-2966.2007.12040.x; Burgasser AJ, 2006, ASTROPHYS J, V637, P1067, DOI 10.1086/498563; Strauss MA, 1999, ASTROPHYS J, V522, pL61, DOI 10.1086/312218; Kobayashi N, 2000, PROC SPIE, V4008, P1056, DOI 10.1117/12.395423; Gizis JE, 2002, ASTRON J, V123, P3356, DOI 10.1086/340465; Burgasser AJ, 1999, ASTROPHYS J, V522, pL65, DOI 10.1086/312221; Marley MS, 1996, SCIENCE, V272, P1919, DOI 10.1126/science.272.5270.1919; Golimowski DA, 2004, ASTRON J, V127, P3516, DOI 10.1086/420709; Boyajian TS, 2012, ASTROPHYS J, V757, DOI 10.1088/0004-637X/757/2/112; BYRNE PB, 1985, MON NOT R ASTRON SOC, V214, P119; Geballe TR, 1996, ASTROPHYS J, V467, pL101, DOI 10.1086/310203; Gilmore G. F., 2000, ALLENS ASTROPHYSICAL, P471; Golimowski DA, 1998, ASTRON J, V115, P2579, DOI 10.1086/300370; Griffith CA, 1999, ASTROPHYS J, V519, pL85, DOI 10.1086/312103; Hawley SL, 2000, CAM CONTEMP ASTROPHY, P109, DOI 10.1017/CBO9780511564758.012; LEGGETT SK, 1992, ASTROPHYS J SUPPL S, V82, P351, DOI 10.1086/191720; Leggett SK, 1999, ASTROPHYS J, V517, pL139, DOI 10.1086/312049; Mace GN, 2013, ASTROPHYS J SUPPL S, V205, DOI 10.1088/0067-0049/205/1/6; Matthews K, 1996, ASTRON J, V112, P1678, DOI 10.1086/118133; MOULD JR, 1978, ASTROPHYS J, V226, P923, DOI 10.1086/156673; NAKAJIMA T, 1995, NATURE, V378, P463, DOI 10.1038/378463a0; Noll KS, 1997, ASTROPHYS J, V489, pL87, DOI 10.1086/310954; Oppenheimer BR, 1998, ASTROPHYS J, V502, P932, DOI 10.1086/305928; Partridge H., 1997, JCHPH, V106, P4681; Saumon D, 2000, ASTROPHYS J, V541, P374, DOI 10.1086/309410; Schiavon RP, 1997, ASTROPHYS J, V484, P499, DOI 10.1086/304332; Schultz AB, 1998, ASTROPHYS J, V492, pL181, DOI 10.1086/311103; Tsuji T, 2005, ASTROPHYS J, V621, P1033, DOI 10.1086/427747; Tsuji T, 2002, ASTROPHYS J, V575, P264, DOI 10.1086/341262; Tsuji T, 2014, PUBL ASTRON SOC JPN, V66, DOI 10.1093/pasj/psu078; Tsuji T, 2015, PUBL ASTRON SOC JPN, V67, DOI 10.1093/pasj/psu160; Tsuji T, 1996, ASTRON ASTROPHYS, V308, pL29; Visscher C, 2011, ASTROPHYS J, V738, DOI 10.1088/0004-637X/738/1/72; Zahnle KJ, 2014, ASTROPHYS J, V797, DOI 10.1088/0004-637X/797/1/41	47	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0004-6256	1538-3881		ASTRON J	Astron. J.	AUG	2015	150	2							53	10.1088/0004-6256/150/2/53		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CO0QL	WOS:000358856900014		
J	Kaneda, K; Misawa, H; Iwai, K; Tsuchiya, F; Obara, T				Kaneda, Kazutaka; Misawa, H.; Iwai, K.; Tsuchiya, F.; Obara, T.			FREQUENCY DEPENDENCE OF POLARIZATION OF ZEBRA PATTERN IN TYPE-IV SOLAR RADIO BURSTS	ASTROPHYSICAL JOURNAL LETTERS			English	Article						polarization; Sun: corona; Sun: radio radiation	FINE-STRUCTURES; EMISSION; CORONA; MECHANISM	We investigated the polarization characteristics of a zebra pattern (ZP) in a type-IV solar radio burst observed with AMATERAS on 2011 June 21 for the purpose of evaluating the generation processes of ZPs. Analyzing highly resolved spectral and polarization data revealed the frequency dependence of the degree of circular polarization and the delay between two polarized components for the first time. The degree of circular polarization was 50%-70% right-handed and it varied little as a function of frequency. Cross-correlation analysis determined that the left-handed circularly polarized component was delayed by 50-70 ms relative to the right-handed component over the entire frequency range of the ZP and this delay increased with the frequency. We examined the obtained polarization characteristics by using pre-existing ZP models and concluded that the ZP was generated by the double-plasma-resonance process. Our results suggest that the ZP emission was originally generated in a completely polarized state in the O-mode and was partly converted into the X-mode near the source. Subsequently, the difference between the group velocities of the O-mode and X-mode caused the temporal delay.	[Kaneda, Kazutaka; Misawa, H.; Tsuchiya, F.; Obara, T.] Tohoku Univ, Planetary Plasma & Atmospher Res Ctr, Sendai, Miyagi 9808578, Japan; [Iwai, K.] Natl Inst Informat & Commun Technol, Koganei, Tokyo 1848795, Japan	Kaneda, K (reprint author), Tohoku Univ, Planetary Plasma & Atmospher Res Ctr, Sendai, Miyagi 9808578, Japan.	k.kaneda@pparc.gp.tohoku.ac.jp					ALLEN CW, 1947, MON NOT R ASTRON SOC, V107, P426; DULK GA, 1978, SOL PHYS, V57, P279, DOI 10.1007/BF00160102; CHERNOV GP, 1990, SOL PHYS, V130, P75, DOI 10.1007/BF00156780; ZHELEZNYAKOV VV, 1975, SOL PHYS, V44, P461, DOI 10.1007/BF00153225; Benz AO, 1997, ASTRON ASTROPHYS, V323, P250; Chen B., 2011, APJ, V734, P64; CHERNOV GP, 1975, SOL PHYS, V44, P435, DOI 10.1007/BF00153223; CHERNOV GP, 1995, SOL PHYS, V160, P79, DOI 10.1007/BF00679097; Chernov GP, 2006, SPACE SCI REV, V127, P195, DOI 10.1007/s11214-006-9141-7; COHEN MH, 1960, ASTROPHYS J, V131, P664, DOI 10.1086/146878; Iwai K., 2012, SOPH, V227, P447; Iwai K, 2013, ASTROPHYS J LETT, V768, DOI 10.1088/2041-8205/768/1/L2; Iwai K, 2014, ASTROPHYS J, V789, DOI 10.1088/0004-637X/789/1/4; Katoh Y, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/1/45; Kuijpers J., 1980, P IAU S, P341; Kuznetsov AA, 2008, SOL PHYS, V253, P103, DOI 10.1007/s11207-008-9179-7; Ledenev V. G., 2006, SOPH, V202, P129; Mclean D. J., 1985, SOLAR RADIOPHYSICS; Nakajima H., 1994, IEEE P, V82, P705; ROSENBER.H, 1972, SOL PHYS, V25, P188, DOI 10.1007/BF00155756; ZHELEZNYAKOV VV, 1964, SOV ASTRON, V7, P485; Zlotnik EY, 2014, SOL PHYS, V289, P233, DOI 10.1007/s11207-013-0327-3	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	AUG 1	2015	808	2							L45	10.1088/2041-8205/808/2/L45		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CO1TS	WOS:000358938800013		
J	Komiya, Y; Suda, T; Fujimoto, MY				Komiya, Yutaka; Suda, Takuma; Fujimoto, Masayuki Y.			THE MOST IRON-DEFICIENT STARS AS THE POLLUTED POPULATION III STARS	ASTROPHYSICAL JOURNAL LETTERS			English	Article						early universe; stars: abundances; stars: Population III	METAL-POOR STARS; INITIAL MASS FUNCTION; 1ST STARS; GALACTIC-HALO; MILKY-WAY; CHEMICAL ENRICHMENT; INTERSTELLAR MATTER; STELLAR ABUNDANCES; RADIATIVE FEEDBACK; FORMING CLOUDS	We investigate the origin of the most iron-poor stars including SMSS J031300.36-670839.3 with [Fe/H] < -7.52. We compute the change of surface metallicity of stars with the of interstellar matter (ISM) after their birth using the chemical evolution model within the framework of the hierarchical galaxy formation. The predicted metallicity distribution function agrees very well with that observed from extremely metal-poor stars. In particular, the lowest metallicity tail is well reproduced by the Population III stars whose surfaces are polluted with metals through ISM accretion. This suggests that the origin of iron group elements is explained by ISM accretion for the stars with [Fe/H]less than or similar to -5. The present results give new insights into the nature of the most metal-poor stars and the search for Population III stars with pristine abundances.	[Komiya, Yutaka; Suda, Takuma] Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo, Japan; [Fujimoto, Masayuki Y.] Hokkaido Univ, Dept Cosmosci, Sapporo, Hokkaido 0600810, Japan; [Fujimoto, Masayuki Y.] Hokkai Gakuen Univ, Dept Engn, Sapporo, Hokkaido 0628605, Japan	Komiya, Y (reprint author), Univ Tokyo, Res Ctr Early Universe, Bunkyo Ku, Tokyo, Japan.				 [23224004];  [25400233];  [25800115]	This work is partially supported by Grant-in-Aid for Scientific Research (23224004, 25400233, 25800115).	Ahn K, 2007, MON NOT R ASTRON SOC, V375, P881, DOI 10.1111/j.1365-2966.2006.11332.x; Somerville RS, 1999, MON NOT R ASTRON SOC, V305, P1, DOI 10.1046/j.1365-8711.1999.02154.x; Keller SC, 2014, NATURE, V506, P463, DOI 10.1038/nature12990; Beers TC, 2005, ANNU REV ASTRON ASTR, V43, P531, DOI 10.1146/annurev.astro.42.053102.134057; Caffau E, 2011, NATURE, V477, P67, DOI 10.1038/nature10377; Johnson JL, 2011, MON NOT R ASTRON SOC, V413, P1184, DOI 10.1111/j.1365-2966.2011.18215.x; LACEY C, 1993, MON NOT R ASTRON SOC, V262, P627; Clark PC, 2008, ASTROPHYS J, V672, P757, DOI 10.1086/524187; Bromm V, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/11/112901; Frebel A, 2005, NATURE, V434, P871, DOI 10.1038/nature03455; Suda T, 2011, MON NOT R ASTRON SOC, V412, P843, DOI 10.1111/j.1365-2966.2011.17943.x; Smith RJ, 2011, MON NOT R ASTRON SOC, V414, P3633, DOI 10.1111/j.1365-2966.2011.18659.x; Omukai K, 2005, ASTROPHYS J, V626, P627, DOI 10.1086/429955; Suda T, 2004, ASTROPHYS J, V611, P476, DOI 10.1086/422135; Li YS, 2008, MON NOT R ASTRON SOC, V384, P1459, DOI 10.1111/j.1365-2966.2007.12748.x; Tegmark M, 1997, ASTROPHYS J, V474, P1, DOI 10.1086/303434; Schneider R, 2006, MON NOT R ASTRON SOC, V369, P1437, DOI [10.1111/j.1365-2966.2006.10391.x, 10.1111/j.1365-2966.10391.x]; Komiya Y, 2010, ASTROPHYS J, V717, P542, DOI 10.1088/0004-637X/717/1/542; Norris JE, 2007, ASTROPHYS J, V670, P774, DOI 10.1086/521919; Yoshida N, 2003, ASTROPHYS J, V592, P645, DOI 10.1086/375810; Komiya Y, 2007, ASTROPHYS J, V658, P367, DOI 10.1086/510826; Christlieb N, 2002, NATURE, V419, P904, DOI 10.1038/nature01142; Umeda H, 2003, NATURE, V422, P871, DOI 10.1038/nature01571; Suda T, 2013, MON NOT R ASTRON SOC, V432, pL46, DOI 10.1093/mnrasl/slt033; Suda T, 2008, PUBL ASTRON SOC JPN, V60, P1159; Iwamoto N, 2005, SCIENCE, V309, P451, DOI 10.1126/science.1112997; Bessell M., 2015, ARXIV150503756; BOND HE, 1981, ASTROPHYS J, V248, P606, DOI 10.1086/159186; Boylan-Kolchin M, 2013, ASTROPHYS J, V768, DOI 10.1088/0004-637X/768/2/140; Dopcke G, 2013, ASTROPHYS J, V766, DOI 10.1088/0004-637X/766/2/103; Frebel A., 2009, MNRAS, V392, P50; FUJIMOTO MY, 1995, ASTROPHYS J, V444, P175, DOI 10.1086/175592; Greif TH, 2011, ASTROPHYS J, V737, DOI 10.1088/0004-637X/737/2/75; Hansen T, 2014, ASTROPHYS J, V787, DOI 10.1088/0004-637X/787/2/162; Hattori K, 2014, ASTROPHYS J, V784, DOI 10.1088/0004-637X/784/2/153; Iben I., 1983, MEM SOC ASTRON ITAL, V54, P321; Ishigaki MN, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/2/L32; Komiya Y, 2014, ASTROPHYS J, V783, DOI 10.1088/0004-637X/783/2/132; Komiya Y, 2009, ASTROPHYS J LETT, V696, pL79, DOI 10.1088/0004-637X/696/1/L79; Komiya Y, 2009, ASTROPHYS J, V694, P1577, DOI 10.1088/0004-637X/694/2/1577; Marassi S, 2014, ASTROPHYS J, V794, DOI 10.1088/0004-637X/794/2/100; Nishimura T., 2008, PASJ, V61, P909; Ricotti M, 2002, ASTROPHYS J, V575, P49, DOI 10.1086/341256; Schorck T, 2009, ASTRON ASTROPHYS, V507, P817, DOI 10.1051/0004-6361/200810925; Shigeyama T, 2003, ASTROPHYS J, V586, pL57, DOI 10.1086/374635; Stacy A, 2014, ASTROPHYS J, V785, DOI 10.1088/0004-637X/785/1/73; Uehara HY, 2000, ASTROPHYS J, V531, pL91, DOI 10.1086/312529; YOSHII Y, 1981, ASTRON ASTROPHYS, V97, P280	48	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	AUG 1	2015	808	2							L47	10.1088/2041-8205/808/2/L47		5	Astronomy & Astrophysics	Astronomy & Astrophysics	CO1TS	WOS:000358938800015		
J	Pignatari, M; Zinner, E; Hoppe, P; Jordan, CJ; Gibson, BK; Trappitsch, R; Herwig, F; Fryer, C; Hirschi, R; Timmes, FX				Pignatari, M.; Zinner, E.; Hoppe, P.; Jordan, C. J.; Gibson, B. K.; Trappitsch, R.; Herwig, F.; Fryer, C.; Hirschi, R.; Timmes, F. X.		NuGrid Collaboration; BRIDGCE UK Network	CARBON-RICH PRESOLAR GRAINS FROM MASSIVE STARS: SUBSOLAR C-12/C-13 AND N-14/N-15 RATIOS AND THE MYSTERY OF N-15	ASTROPHYSICAL JOURNAL LETTERS			English	Article						nuclear reactions, nucleosynthesis, abundances; stars: abundances; stars: evolution; stars: interiors; supernovae: general	SILICON-CARBIDE GRAINS; GALACTIC EVOLUTION; ISOTOPIC COMPOSITIONS; GRAPHITE GRAINS; SUPERNOVA GAS; SOLAR-SYSTEM; NUCLEOSYNTHESIS; CONDENSATION; METALLICITY; SIMULATIONS	Carbon-rich grains with isotopic anomalies compared to the Sun are found in primitive meteorites. They were made by stars, and carry the original stellar nucleosynthesis signature. Silicon carbide grains of Type X and C and low-density (LD) graphites condensed in the ejecta of core-collapse supernovae. We present a new set of models for the explosive He shell and compare them with the grains showing C-12/C-13 and N-14/N-15 ratios lower than solar. In the stellar progenitor H was ingested into the He shell and not fully destroyed before the explosion. Different explosion energies and H concentrations are considered. If the supernova shock hits the He-shell region with some H still present, the models can reproduce the C and N isotopic signatures in C-rich grains. Hot-CNO cycle isotopic signatures are obtained, including a large production of C-13 and N-15. The short-lived radionuclides Na-22 and Al-26 are increased by orders of magnitude. The production of radiogenic Ne-22 from the decay of Na-22 in the He shell might solve the puzzle of the Ne-E(L) component in LD graphite grains. This scenario is attractive for the SiC grains of type AB with N-14/N-15 ratios lower than solar, and provides an alternative solution for SiC grains originally classified as nova grains. Finally, this process may contribute to the production of N-14 and N-15 in the Galaxy, helping to produce the N-14/N-15 ratio in the solar system.	[Pignatari, M.] Hungarian Acad Sci, Res Ctr Astron & Earth Sci, Konkoly Observ, H-1121 Budapest, Hungary; [Pignatari, M.] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland; [Zinner, E.] Washington Univ, Space Sci Lab, St Louis, MO 63130 USA; [Zinner, E.] Washington Univ, Dept Phys, St Louis, MO 63130 USA; [Hoppe, P.] Max Planck Inst Chem, D-55128 Mainz, Germany; [Jordan, C. J.; Gibson, B. K.] Univ Hull, Dept Math & Phys, EA Milne Ctr Astrophys, Kingston Upon Hull HU6 7RX, N Humberside, England; [Trappitsch, R.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Trappitsch, R.] Chicago Ctr Cosmochem, Chicago, IL 60637 USA; [Herwig, F.] Univ Victoria, Dept Phys & Astron, Victoria, BC V8P5C2, Canada; [Herwig, F.; Timmes, F. X.] Joint Inst Nucl Astrophys, Notre Dame, IN 46556 USA; [Fryer, C.] LANL, Computat Phys & Methods CCS 2, Los Alamos, NM 87545 USA; [Hirschi, R.] Keele Univ, Keele ST5 5BG, Staffs, England; [Hirschi, R.] Univ Tokyo, Inst Phys & Math Universe WPI, Kashiwa, Chiba 2778583, Japan; [Timmes, F. X.] ASU, Tempe, AZ 85287 USA	Pignatari, M (reprint author), Hungarian Acad Sci, Res Ctr Astron & Earth Sci, Konkoly Observ, Konkoly Thege Miklos Ut 15-17, H-1121 Budapest, Hungary.		Gibson, Brad/M-3592-2015; Hoppe, Peter/B-3032-2015	Gibson, Brad/0000-0003-4446-3130; Hoppe, Peter/0000-0003-3681-050X	NSF [PHY 02-16783, PHY 09-22648, PHY-1430152]; EU [MIRG-CT-2006-046520]; STFC; EU-FP7-ERC-St Grant [306901]; NSERC; SNSF; "Lendulet" Programme of the Hungarian Academy of Sciences; SNF (Switzerland); NASA [NNX11AH14G]; UK's Science & Technology Facilities Council [ST/J001341/1]; NASA Headquarters under the NASA Earth and Planetary Science Fellowship Program [NNX12AL85H]; NASA Cosmochemistry Program [NNX09AG39G]	NuGrid acknowledges significant support from NSF grants PHY 02-16783 and PHY 09-22648 (Joint Institute for Nuclear Astrophysics, JINA), NSF grant PHY-1430152 (JINA Center for the Evolution of the Elements) and EU MIRG-CT-2006-046520. The continued work on codes and in disseminating data is made possible through funding from STFC and EU-FP7-ERC-2012-St Grant 306901 (RH, UK), and NSERC Discovery grant (FH, Canada), and an Ambizione grant of the SNSF (MP, Switzerland). M.P. acknowledges support from the "Lendulet-2014" Programme of the Hungarian Academy of Sciences and from SNF (Switzerland). NuGrid data are served by Canfar/CADC. E.Z. acknowledges support from NASA grant NNX11AH14G. B.K.G. acknowledges the support of the UK's Science & Technology Facilities Council (ST/J001341/1). R.T. is supported by NASA Headquarters under the NASA Earth and Planetary Science Fellowship Program through grant NNX12AL85H and was partially supported by the NASA Cosmochemistry Program through grant NNX09AG39G (to A. M. Davis).	Lin YT, 2010, ASTROPHYS J, V709, P1157, DOI 10.1088/0004-637X/709/2/1157; Jose J, 2007, J PHYS G NUCL PARTIC, V34, pR431, DOI 10.1088/0954-3899/34/12/R01; Marty B, 2011, SCIENCE, V332, P1533, DOI 10.1126/science.1204656; Clayton DD, 1999, SCIENCE, V283, P1290, DOI 10.1126/science.283.5406.1290; LEWIS RS, 1987, NATURE, V326, P160, DOI 10.1038/326160a0; Spite M, 2005, ASTRON ASTROPHYS, V430, P655, DOI 10.1051/0004-6361:20041274; AMARI S, 1990, NATURE, V345, P238, DOI 10.1038/345238a0; Amari S, 2001, ASTROPHYS J, V559, P463, DOI 10.1086/322397; Hughes GL, 2008, MON NOT R ASTRON SOC, V390, P1710, DOI 10.1111/j.1365-2966.2008.13870.x; Karakas AI, 2010, ASTROPHYS J, V713, P374, DOI 10.1088/0004-637X/713/1/374; Israelian G, 2004, ASTRON ASTROPHYS, V421, P649, DOI 10.1051/0004-6361:20047132; JONES AP, 1994, ASTROPHYS J, V433, P797, DOI 10.1086/174689; Muller S, 2006, ASTRON ASTROPHYS, V458, P417, DOI 10.1051/0004-6361:20065187; Kobayashi C, 2011, MON NOT R ASTRON SOC, V414, P3231, DOI 10.1111/j.1365-2966.2011.18621.x; Besmehn A, 2003, GEOCHIM COSMOCHIM AC, V67, P4693, DOI 10.1016/S0016-7037(03)00239-4; Bojazi MJ, 2014, PHYS REV C, V89, DOI 10.1103/PhysRevC.89.025807; Chiappini CC, 2006, ASTRON ASTROPHYS, V449, pL27, DOI 10.1051/0004-6361:20064866; Diehl R, 2006, NEW ASTRON REV, V50, P534, DOI 10.1016/j.newar.2006.06.082; Ebel DS, 2001, GEOCHIM COSMOCHIM AC, V65, P469, DOI 10.1016/S0016-7037(00)00550-0; Fenner Y, 2003, PUBL ASTRON SOC AUST, V20, P189, DOI 10.1071/AS02047; Fryer CL, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/91; Groopman E, 2012, ASTROPHYS J LETT, V754, DOI 10.1088/2041-8205/754/1/L8; Herwig F, 2014, ASTROPHYS J LETT, V792, DOI 10.1088/2041-8205/792/1/L3; Huss GR, 1997, GEOCHIM COSMOCHIM AC, V61, P5117, DOI 10.1016/S0016-7037(97)00299-8; Hynes K.M., 2009, LUNAR PLANET SCI, V40, P1198; Meyer BS, 2000, ASTROPHYS J, V540, pL49, DOI 10.1086/312865; Meyner G, 2006, ASTRON ASTROPHYS, V447, P623, DOI 10.1051/0004-6361:20053070; Nittler LR, 2005, ASTROPHYS J, V631, pL89, DOI 10.1086/497029; Palmerini S, 2011, ASTROPHYS J, V729, DOI 10.1088/0004-637X/729/1/3; Pignatari M, 2013, ASTROPHYS J LETT, V771, DOI 10.1088/2041-8205/771/1/L7; Pignatari M, 2013, ASTROPHYS J LETT, V767, DOI 10.1088/2041-8205/767/2/L22; Pignatari M, 2013, ASTROPHYS J, V762, DOI 10.1088/0004-637X/762/1/31; Romano D, 2003, MON NOT R ASTRON SOC, V342, P185, DOI 10.1046/j.1365-8711.2003.06526.x; Travaglio C, 1999, ASTROPHYS J, V510, P325, DOI 10.1086/306551; Wongwathanarat A, 2015, ASTRON ASTROPHYS, V577, DOI 10.1051/0004-6361/201425025; WOOSLEY SE, 1995, ASTROPHYS J SUPPL S, V101, P181, DOI 10.1086/192237; Yoshida T, 2007, ASTROPHYS J, V666, P1048, DOI 10.1086/520631; Zinner E., 2014, TREATISE GEOCHEMISTR, V1, P181	38	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	2041-8205	2041-8213		ASTROPHYS J LETT	Astrophys. J. Lett.	AUG 1	2015	808	2							L43	10.1088/2041-8205/808/2/L43		6	Astronomy & Astrophysics	Astronomy & Astrophysics	CO1TS	WOS:000358938800011		
J	Kawabata, K				Kawabata, Kiyoshi			A fast iterative method for Chandrasekhar's H-functions for general laws of scattering	ASTROPHYSICS AND SPACE SCIENCE			English	Article						Radiative transfer: general-multiple scattering; H-function; Numerical solution		This work shows that notable acceleration of the speed of calculating Chandrasekhar's H-functions for general laws of scattering with an iterative method can be realized by supplying a starting approximation produced by the following procedure: (i) in the cases of azimuth-angle independent Fourier components, values of the isotropic scattering H-function given by an accurate yet simple-to-apply formula, in particular, the one by Kawabata and Limaye (Astrophys. Space Sci. 332: 365, 2011), and (ii) for azimuth-angle dependent Fourier components, an already obtained solution of the next lower order term.	Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan	Kawabata, K (reprint author), Tokyo Univ Sci, Dept Phys, Shinjuku Ku, Tokyo 1628601, Japan.	kawabata@rs.kagu.tus.ac.jp					Jablonski A, 2012, COMPUT PHYS COMMUN, V183, P1773, DOI 10.1016/j.cpc.2012.02.022; Kawabata K, 2011, ASTROPHYS SPACE SCI, V332, P365, DOI 10.1007/s10509-010-0512-x; BOSMA PB, 1983, ASTRON ASTROPHYS, V126, P283; HIROI T, 1994, ICARUS, V109, P313, DOI 10.1006/icar.1994.1096; Davidovic DA, 2008, ICARUS, V194, P389, DOI 10.1016/j.icarus.2007.09.024; Chandrasekhar S., 1960, RAD TRANSFER; Hapke B, 1993, THEORY REFLECTANCE E; Kawabata K, 2013, ASTROPHYS SPACE SCI, V348, P601, DOI 10.1007/s10509-013-1589-9; KAWABATA K, 1991, ASTROPHYS SPACE SCI, V182, P249, DOI 10.1007/BF00645005; KOLESOV AK, 1972, SOV ASTRON, V15, P802; Sobolev V.V., 1975, LIGHT SCATTERING PLA; Van de Hulst H. C., 1980, MULTIPLE LIGHT SCATT, VII; Van de Hulst H. C., 1980, MULTIPLE LIGHT SCATT, V1	13	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0004-640X	1572-946X		ASTROPHYS SPACE SCI	Astrophys. Space Sci.	AUG	2015	358	2							32	10.1007/s10509-015-2434-0		7	Astronomy & Astrophysics	Astronomy & Astrophysics	CO2WB	WOS:000359016500009		
J	Tyagi, P; Ishimura, Y; Kawamura, K				Tyagi, Poonam; Ishimura, Yutaka; Kawamura, Kimitaka			Hydroxy fatty acids in marine aerosols as microbial tracers: 4-year study on beta- and omega-hydroxy fatty acids from remote Chichijima Island in the western North Pacific	ATMOSPHERIC ENVIRONMENT			English	Article						beta- and omega-hydroxy fatty acids; Terrestrial biomarkers; Marine aerosols; North Pacific; East-Asian outflow; Gram-negative bacteria	RANGE ATMOSPHERIC TRANSPORT; ACE-ASIA CAMPAIGN; ORGANIC-MATTER; EAST-ASIA; BACTERIAL ABUNDANCE; EARLY DIAGENESIS; YELLOW SAND; SOIL DUST; SEDIMENT; OCEAN	To better understand the long-range atmospheric transport of microbial aerosols from Asia to the western North Pacific, marine aerosols were collected from Chichijima Island (27 degrees 04'N; 142 degrees 13'E) on a biweekly basis during 1990-1993. These samples were investigated for beta- and omega-hydroxy fatty acids (FM) as terrestrial biomarkers of Gram-negative bacteria (GNB) and higher plants, respectively. The average concentrations of beta-hydroxy (C-8-C-31) and omega-hydroxy (C-11-C-28) FAs show pronounced seasonal variability with maxima in spring (300 +/- 70 pg m(-3)) and winter (650 +/- 330 pg m(-3)), respectively. Airmass back trajectories clearly indicate the continental outflow from Asia during winter to spring, whereas maritime airmasses dominate in summer to autumn over Chichijima. It is noteworthy that atmospheric abundances of beta-hydroxy FM and, thus, the estimated mass concentration of GNB have not been significantly varied between polluted (continental) and pristine (oceanic) airmasses during the study period. However, the relative source strength observed from cluster analysis of beta-hydroxy FAs in the polluted continental airmassess vary significantly among seasons (winter: 98%, spring: 63%, summer; 11%, autumn: 26%). In addition, there were distinguishable differences between polluted continental and pristine maritime airmasses with regard to C-number predominance. The even C-number predominance of beta- and omega-hydroxy FAs (similar to 80 and 98% of total mass concentration, respectively) in marine aerosols could be due to their significant contribution from GNB, terrestrial plants and soil microorganisms. These results have implications towards assessing the atmospheric transport of bacterial and plant lipids in the continental outflow over the open ocean. (C) 2015 Elsevier Ltd. All rights reserved.	[Tyagi, Poonam; Ishimura, Yutaka] Hokkaido Univ, Grad Sch Environm Sci, Sapporo, Hokkaido 060, Japan; [Tyagi, Poonam; Ishimura, Yutaka; Kawamura, Kimitaka] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan	Kawamura, K (reprint author), Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan.	kawamura@lowtem.hokudai.ac.jp	Kawamura, Kimitaka/B-3839-2011		Japan Society for the Promotion of Science [24221001]; Japanese Ministry of Education, Science and Culture (MEXT)	The authors thank S. Ogishima for his help in the aerosol sampling and the Japan Aerospace Exploration Agency (JAXA) for the courtesy to use the facility in the Satellite Tracking Center at Chichijima. Authors are also thankful to S. Bikkina for his help in the statistical analysis of the data. This study is in part supported by Japan Society for the Promotion of Science (Grant-in-aid No. 24221001). PT is thankful to Japanese Ministry of Education, Science and Culture (MEXT) for the Monbukagakusho Scholarship.	UEMATSU M, 1983, J GEOPHYS RES-OC ATM, V88, P5343, DOI 10.1029/JC088iC09p05343; CARDOSO JN, 1983, GEOCHIM COSMOCHIM AC, V47, P723, DOI 10.1016/0016-7037(83)90106-0; KAWAMURA K, 1984, GEOCHIM COSMOCHIM AC, V48, P251, DOI 10.1016/0016-7037(84)90249-7; Saraf A, 1997, APPL ENVIRON MICROB, V63, P2554; Yamamoto S, 2011, ATMOS ENVIRON, V45, P3553, DOI 10.1016/j.atmosenv.2011.03.071; Graca J, 2006, CHEM PHYS LIPIDS, V144, P96, DOI 10.1016/j.chemphyslip.2006.08.001; GAGOSIAN RB, 1986, ORG GEOCHEM, V10, P661, DOI 10.1016/S0146-6380(86)80002-X; Griffin DW, 2006, AEROBIOLOGIA, V22, P211, DOI 10.1007/s10453-006-9033-z; KAWAMURA K, 1987, ORG GEOCHEM, V11, P251, DOI 10.1016/0146-6380(87)90036-2; Pollard M, 2008, TRENDS PLANT SCI, V13, P236, DOI 10.1016/j.tplants.2008.03.003; EGLINTON G, 1968, TETRAHEDRON, V24, P5929, DOI 10.1016/S0040-4020(01)90979-2; CHO BC, 1990, MAR ECOL PROG SER, V63, P253, DOI 10.3354/meps063253; DUCE RA, 1980, SCIENCE, V209, P1522, DOI 10.1126/science.209.4464.1522; Wang ZF, 2000, J GEOPHYS RES-ATMOS, V105, P26947, DOI 10.1029/2000JD900370; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Wakeham SG, 2003, ORG GEOCHEM, V34, P857, DOI 10.1016/S0146-6380(02)00189-4; ROGGE WF, 1993, ATMOS ENVIRON A-GEN, V27, P1309, DOI 10.1016/0960-1686(93)90257-Y; Hines CJ, 2003, INDOOR AIR, V13, P166, DOI 10.1034/j.1600-0668.2003.00175.x; Molina I, 2006, PHYTOCHEMISTRY, V67, P2597, DOI 10.1016/j.phytochem.2006.09.011; Prospero JM, 2005, AEROBIOLOGIA, V21, P1, DOI 10.1007/s10453-004-5872-7; Lin TH, 2001, ATMOS ENVIRON, V35, P5873, DOI 10.1016/S1352-2310(01)00392-2; BIRD DF, 1984, CAN J FISH AQUAT SCI, V41, P1015, DOI 10.1139/f84-118; Blokker P, 1998, PHYTOCHEMISTRY, V49, P691, DOI 10.1016/S0031-9422(98)00229-5; Chen J, 2013, ATMOS ENVIRON, V67, P448, DOI 10.1016/j.atmosenv.2012.11.014; Chun YS, 2001, J GEOPHYS RES-ATMOS, V106, P18461, DOI 10.1029/2001JD900184; DOWNING DT, 1961, REV PURE APPL CHEM, V11, P196; Draxler R.R., 2014, HYSPLIT HYBRID SINGL; Gelin F, 1997, PHYTOCHEMISTRY, V45, P641, DOI 10.1016/S0031-9422(97)00068-X; Giovannoni S.J., 2000, MICROBIAL ECOLOGY OC, P47; Harrison RM, 2005, INT J BIOMETEOROL, V49, P167, DOI 10.1007/s00484-004-0225-3; Hartigan J. A., 1979, Applied Statistics, V28, DOI 10.2307/2346830; Kawamura K, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2001GB001810; Kawamura K., 1984, ORG GEOCHEM, V7, P121, DOI 10.1016/0146-6380(84)90125-6; Kawamura K, 1995, BIOGEOCHEMICAL PROCE, P31; KAWAMURA K, 1982, NATURE, V297, P144, DOI 10.1038/297144a0; Laitinen S, 2001, ANN AGR ENV MED, V8, P213; Lee A.K.Y., 2004, ATMOS ENVIRON, V56, P124; Li WKW, 2004, DEEP-SEA RES PT I, V51, P1529, DOI 10.1016/j.dsr.2004.06.012; LINLEY EAS, 1983, MAR ECOL PROG SER, V12, P77, DOI 10.3354/meps012077; Matsumoto K, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002744; Mochida M, 2003, J GEOPHYS RES-ATMOS, V108, DOI [10.1029/2002JD002355, 10.1029/2002JD003249]; Mochida M., 2002, J GEOPHYS RES, V107, P1; Murayama T, 2001, J GEOPHYS RES-ATMOS, V106, P18345, DOI 10.1029/2000JD900554; SIMONEIT BRT, 1989, J ATMOS CHEM, V8, P251, DOI 10.1007/BF00051497; SKERRATT JH, 1992, ORG GEOCHEM, V18, P189, DOI 10.1016/0146-6380(92)90129-L; Wilkinson S.G., 1988, MICROBIAL LIPIDS, V1, P199	46	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	AUG	2015	115						89	100		10.1016/j.atmosenv.2015.05.038		12	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CN9ZL	WOS:000358809600011		
J	Yagishita, M; Kageyama, S; Ohshima, S; Matsumoto, M; Aoki, Y; Goto, S; Nakajima, D				Yagishita, Mayuko; Kageyama, Shiho; Ohshima, Shigeru; Matsumoto, Michi; Aoki, Yasunobu; Goto, Sumio; Nakajima, Daisuke			Atmospheric concentration and carcinogenic risk of polycyclic aromatic hydrocarbons including benzo[c]fluorene, cyclopenta[c,d] pyrene, and benzo[j]fluoranthene in Japan	ATMOSPHERIC ENVIRONMENT			English	Article						Benzo[c]fluorene; Benzo[a]pyrene; Gaseous PAHs; Particulate PAHs; Carcinogenic risk	AIRBORNE PARTICULATE MATTER; TOXIC EQUIVALENCY FACTORS; AMBIENT-TEMPERATURE; PAHS; IDENTIFICATION; COMBUSTION; EMISSIONS; COAL	The atmospheric concentrations of both gas-phase and particulate-phase polycyclic aromatic hydrocarbons (PAHs) including 16 US Environmental Protection Agency priority PAHs (16 PAHs) were measured in eleven cities across Japan. Using the measured average concentrations and toxic equivalency factors (TEF) of the 16 PAHs, the benzo[alpyrene (BaP)-toxic equivalent for eight major PAHs was obtained: the ratio of BaP to the eight major PAR toxicities ranged from 0.23 to 0.47. Among the target PAHs, from the viewpoint of carcinogenicity, we focused on benzo[c]fluorene (BcFE), which was detected in both the gas and particulate phase in contrast to BaP. The relative potency factor (RPF) of BcFE was evaluated as 6.46 based on its cancer slope factor relative to that of BaP determined in the benchmark dose calculations for mice. The relative carcinogenic risk of BcFE to BaP was obtained by multiplying the averaged concentrations of BaP and BcFE by the RPF value: the risk of BcFE was 6.8 and 5.1 times higher than that of BaP in summer and winter, respectively. These results show that the collection of atmospheric samples including the gas phase is important when assessing the carcinogenic risk of atmospheric PAHs. (C) 2015 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).	[Yagishita, Mayuko; Ohshima, Shigeru] Toho Univ, Fac Sci, Dept Environm Sci, Funabashi, Chiba 274, Japan; [Yagishita, Mayuko; Matsumoto, Michi; Aoki, Yasunobu; Nakajima, Daisuke] Natl Inst Environm Studies, Tsukuba, Ibaraki, Japan; [Kageyama, Shiho] Koriyama Womens Univ & Coll, Fac Home Econ, Dept Food & Nutr, Koriyama, Fukushima, Japan; [Goto, Sumio] Azabu Univ, Coll Environm Hlth, Sagamihara, Kanagawa, Japan	Yagishita, M (reprint author), Toho Univ, Fac Sci, Dept Environm Sci, 2-2-1 Miyama, Funabashi, Chiba 274, Japan.	7612002y@nc.toho-u.ac.jp					YAMASAKI H, 1982, ENVIRON SCI TECHNOL, V16, P189, DOI 10.1021/es00098a003; Tobiszewski M, 2012, ENVIRON POLLUT, V162, P110, DOI 10.1016/j.envpol.2011.10.025; Barrado AI, 2012, ATMOS ENVIRON, V49, P224, DOI 10.1016/j.atmosenv.2011.11.056; Petry T, 1996, CHEMOSPHERE, V32, P639, DOI 10.1016/0045-6535(95)00348-7; Galarneau E, 2008, ATMOS ENVIRON, V42, P8139, DOI 10.1016/j.atmosenv.2008.07.025; Lim LH, 1999, ENVIRON SCI TECHNOL, V33, P3538, DOI 10.1021/es990392d; Hecht SS, 1999, J NATL CANCER I, V91, P1194, DOI 10.1093/jnci/91.14.1194; Ravindra K, 2008, ATMOS ENVIRON, V42, P2895, DOI 10.1016/j.atmosenv.2007.12.010; Fraser MP, 1998, ENVIRON SCI TECHNOL, V32, P1760, DOI 10.1021/es970349v; ATSDR (Agency for Toxic Substances and Disease Registry), 1995, TOX PROF POL AR HYDR; Augusto S, 2009, ENVIRON SCI TECHNOL, V43, P7762, DOI 10.1021/es901024w; Dejean S, 2009, ENVIRON MONIT ASSESS, V148, P27, DOI 10.1007/s10661-007-0136-y; EUD (European Union Directive), 2004, OFFICIAL J EUROPEA L, V23, P3; Garrido A, 2014, ATMOS ENVIRON, V99, P474, DOI 10.1016/j.atmosenv.2014.10.011; GRIMMER G, 1991, FRESEN J ANAL CHEM, V339, P792, DOI 10.1007/BF00321747; HABS M, 1980, ARCH GESCHWULSTFORSC, V50, P266; Integrated Risk Information System (IRIS), 2010, DEV REL POT FACT RPF; Kirso U, 2006, POLYCYCL AROMAT COMP, V26, P111, DOI 10.1080/10406630600642337; Mastral AM, 2001, ENVIRON SCI TECHNOL, V35, P2645, DOI 10.1021/es0015850; Mastral AM, 1996, POLYCYCL AROMAT COMP, V9, P37, DOI 10.1080/10406639608031199; Mineki S., 2008, J ENV CHEM, V18, P43; NISBET ICT, 1992, REGUL TOXICOL PHARM, V16, P290, DOI 10.1016/0273-2300(92)90009-X; ROUSSEL R, 1992, J AIR WASTE MANAGE, V42, P1609; SONNEFELD WJ, 1983, ANAL CHEM, V55, P275, DOI 10.1021/ac00253a022; Takahashi Y., 1998, J ENV CHEM, V8, P71; U.S. Environmental Protection Agency (US EPA), 2013, BENCHM DOS SOFTW VER; WENZELHARTUNG R, 1990, EXP PATHOL-JENA, V40, P221; Weyand EH, 2004, POLYCYCL AROMAT COMP, V24, P1, DOI 10.1080/10406630490426942; WISLOCKI PG, 1986, CARCINOGENESIS, V7, P1317, DOI 10.1093/carcin/7.8.1317; WOOD AW, 1980, CANCER RES, V40, P642	30	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1352-2310	1873-2844		ATMOS ENVIRON	Atmos. Environ.	AUG	2015	115						263	268		10.1016/j.atmosenv.2015.05.050		6	Environmental Sciences; Meteorology & Atmospheric Sciences	Environmental Sciences & Ecology; Meteorology & Atmospheric Sciences	CN9ZL	WOS:000358809600029		
J	Mine, C; Saiki, J				Mine, Chisato; Saiki, Jun			Task-irrelevant stimulus-reward association induces value-driven attentional capture	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Attentional capture; Flanker task; Incentive salience; Reward learning; Task-irrelevant stimuli	VISUAL SELECTIVE ATTENTION; PERCEPTUAL SELECTIVITY; BOTTOM-UP; PRIORITY; SEARCH; MOTIVATION; VOLUNTARY; EMOTION; CORTEX; BRAIN	Rewards affect the deployment of visual attention in various situations. Evidence suggests that the stimulus associated with reward involuntary captures attention (value-driven attentional capture; VDAC). Recent studies report VDAC even when the reward-associated feature does not define the target (i.e., task-irrelevant). However, these studies did not conduct the test phase without reward, thus the effect may be qualitatively different from those in the previous studies. In the current study, we tested if task-irrelevant features induce VDAC even in the test phase with no reward. We used a flanker task during reward learning to create color-reward associations (training phase), and then tested the effect of color during visual search (test phase). Reward learning with no spatial uncertainty in the flanker task induced VDAC, even when reward signaling color was associated with both target and distractor (Experiments 1 and 2). In Experiment 3, a significant VDAC with a color for all letters indicated that target-distractor discrimination is not necessary for VDAC. Finally, a significant VDAC (Experiment 4) with color rectangular frames around the letters indicated binding reward-associated features to task-relevant letters is not necessary for VDAC. All these effects were obtained in the test phase without reward, thus VDAC in the current study is comparable to previous studies using target-defining features. These findings indicate that task-relevance is not a necessary condition for VDAC from reward-associated features, suggesting that reward-associated learning in VDAC is more indirect.	[Mine, Chisato; Saiki, Jun] Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ward, Kyoto 6065801, Japan	Mine, C (reprint author), Kyoto Univ, Grad Sch Human & Environm Studies, Sakyo Ward, Kyoto 6065801, Japan.	mine.chisato.68m@st.kyoto-u.ac.jp; saiki.jun.8e@kyoto-u.ac.jp			JSPS KAKENHI [24240041]	This research was supported by JSPS KAKENHI Grant 24240041. We thank Takeshi Sugio and Takemasa Yokoyama for helpful comments and suggestions on this article.	Ahissar M, 2001, P NATL ACAD SCI USA, V98, P11842, DOI 10.1073/pnas.221461598; Anderson BA, 2015, VIS COGN, V23, P67, DOI 10.1080/13506285.2014.956851; Anderson B. A., 2013, J VISION, V13, P1, DOI 10.1167/13.3.7; Anderson BA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00262; Anderson BA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027926; Anderson BA, 2015, PSYCHON B REV, V22, P750, DOI 10.3758/s13423-014-0724-0; Serences JT, 2005, PSYCHOL SCI, V16, P114, DOI 10.1111/j.0956-7976.2005.00791.x; Kiss M, 2009, PSYCHOL SCI, V20, P245, DOI 10.1111/j.1467-9280.2009.02281.x; Della Libera C, 2006, PSYCHOL SCI, V17, P222; Tseng YC, 2013, ATTEN PERCEPT PSYCHO, V75, P287, DOI 10.3758/s13414-012-0400-2; Lee J, 2014, PSYCHOL SCI, V25, P466, DOI 10.1177/0956797613509284; Anderson BA, 2013, J EXP PSYCHOL HUMAN, V39, P6, DOI 10.1037/a0030860; Most SB, 2007, COGNITION EMOTION, V21, P964, DOI 10.1080/0269993060959340; SHIU LP, 1992, PERCEPT PSYCHOPHYS, V52, P582, DOI 10.3758/BF03206720; Qi SQ, 2013, BRAIN RES, V1532, P32, DOI 10.1016/j.brainres.2013.07.044; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Rutherford HJV, 2010, PSYCHON B REV, V17, P536, DOI 10.3758/PBR.17.4.536; Engelmann JB, 2007, EMOTION, V7, P668, DOI 10.1037/1528-3542.7.3.668; Seitz AR, 2009, NEURON, V61, P700, DOI 10.1016/j.neuron.2009.01.016; Krebs RM, 2010, COGNITION, V117, P341, DOI 10.1016/j.cognition.2010.08.018; Serences JT, 2007, CEREB CORTEX, V17, P284, DOI 10.1093/cercor/bhj146; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Anderson BA, 2011, P NATL ACAD SCI USA, V108, P10367, DOI 10.1073/pnas.1104047108; Anderson BA, 2014, BRAIN RES, V1587, P88, DOI 10.1016/j.brainres.2014.08.062; Anderson BA, 2012, VIS COGN, V20, P647, DOI 10.1080/13506285.2012.679711; Hickey C, 2010, J NEUROSCI, V30, P11096, DOI 10.1523/JNEUROSCI.1026-10.2010; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.neuro.18.1.193; Sasaki Y, 2010, NAT REV NEUROSCI, V11, P53, DOI 10.1038/nrn2737; Della Libera C, 2009, PSYCHOL SCI, V20, P778, DOI 10.1111/j.1467-9280.2009.02360.x; Chelazzi L, 2013, VISION RES, V85, P58, DOI 10.1016/j.visres.2012.12.005; Raymond JE, 2009, PSYCHOL SCI, V20, P981, DOI 10.1111/j.1467-9280.2009.02391.x; Navalpakkam V, 2010, P NATL ACAD SCI USA, V107, P5232, DOI 10.1073/pnas.0911972107; Chelazzi L, 2014, J NEUROSCI, V34, P8594, DOI 10.1523/JNEUROSCI.0277-14.2014; Most SB, 2005, PSYCHON B REV, V12, P654, DOI 10.3758/BF03196754; Hodsoll S, 2011, EMOTION, V11, P346, DOI 10.1037/a0022771; Bucker B., 2015, VISUAL COGNITION; ERIKSEN BA, 1974, PERCEPT PSYCHOPHYS, V16, P143, DOI 10.3758/BF03203267; Failing MF, 2014, J VISION, V14, DOI 10.1167/14.5.6; Hickey C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014087; Hubner R, 2010, PSYCHON B REV, V17, P821, DOI [10.3758/PBR.17.6.821, 10.3758/PBR.17.6821]; Kristjansson A, 2010, ATTEN PERCEPT PSYCHO, V72, P1229, DOI 10.3758/APP.72.5.1229; Laurent PA, 2015, VIS COGN, V23, P133, DOI 10.1080/13506285.2014.965242; Le Pelley M. E., 2015, J EXPT PSYC IN PRESS; Della Libera C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019460; Sali AW, 2014, J EXP PSYCHOL HUMAN, V40, P1654, DOI 10.1037/a0037267; Stormer V., 2014, COGN AFFECT BEHAV NE, V14, P659, DOI [10.3758/s13415-014-0273-z, DOI 10.3758/S13415-014-0273-Z]; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V50, P184, DOI 10.3758/BF03212219; Wang L, 2013, J VISION, V13, P1; Wei P, 2006, BRAIN RES, V1114, P113, DOI 10.1016/j.brainres.2006.07.071; Williams MA, 2005, VIS COGN, V12, P29, DOI 10.1080/13506280444000193; Yokoyama T, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00269; Yokoyama T, 2011, PERCEPTION, V40, P785, DOI 10.1068/p7003	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	AUG	2015	77	6					1896	1907		10.3758/s13414-015-0894-5		12	Psychology; Psychology, Experimental	Psychology	CN9CA	WOS:000358742500008		
J	Sasada, M; Nakamoto, H; Ikudome, S; Unenaka, S; Mori, S				Sasada, Manami; Nakamoto, Hiroki; Ikudome, Sachi; Unenaka, Satoshi; Mori, Shiro			Color perception is impaired in baseball batters while performing an interceptive action	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Dual visual systems; Sport expertise; Visuo-motor control	ANTICIPATORY PERFORMANCE; VISUAL-SEARCH; BALL; INFORMATION; EXPERTISE; MOVEMENTS; EYE; SPECIFICITY; PATHWAYS; SYSTEMS	In order to test the theoretical idea that experts rely more on the dorsal stream than the ventral stream during interceptive action for the interception of a moving target, the present study investigates the perception of color (dominant in ventral processing) during interceptive action in fast-ball sports. Twelve college baseball players and 12 non-baseball players performed a coincident-timing task with target color changes (from white to red, blue, or white) at various time points (at 100, 200, or 300 ms before target arrival). In this task, participants swung a bat and/or pressed a button in response to the target's arrival at a prespecified location. Participants were then asked to state the final color of the target. Baseball players, but not non-baseball players, were significantly less proficient at identifying color changes during the bat-swing condition relative to the button-press condition, irrespective of the time points of color change. These results are consistent with the idea that baseball players rely more on the dorsal stream during bat swinging for the interception of a moving target than do novices.	[Sasada, Manami] Natl Inst Fitness & Sports Kanoya, Undergrad Sch Phys Educ, Kanoya, Kagoshima 8912393, Japan; [Nakamoto, Hiroki; Ikudome, Sachi; Mori, Shiro] Natl Inst Fitness & Sports Kanoya, Fac Phys Educ, Kanoya, Kagoshima 8912393, Japan; [Unenaka, Satoshi] Natl Inst Fitness & Sports Kanoya, Grad Sch Phys Educ, Kanoya, Kagoshima 8912393, Japan	Nakamoto, H (reprint author), Natl Inst Fitness & Sports Kanoya, Fac Phys Educ, 1 Shiromizu, Kanoya, Kagoshima 8912393, Japan.	nakamoto@nifs-k.ac.jp					ABERNETHY B, 1987, HUM MOVEMENT SCI, V6, P283, DOI 10.1016/0167-9457(87)90001-7; SHIPP S, 1985, NATURE, V315, P322, DOI 10.1038/315322a0; Rossetti Y, 1998, CONSCIOUS COGN, V7, P520, DOI 10.1006/ccog.1998.0370; GOODALE MA, 1991, NATURE, V349, P154, DOI 10.1038/349154a0; Van der Kamp J, 2008, INT J SPORT PSYCHOL, V39, P100; SCHILLER PH, 1978, J NEUROPHYSIOL, V41, P788; Singer RN, 1998, RES Q EXERCISE SPORT, V69, P290; GOODALE MA, 1992, TRENDS NEUROSCI, V15, P20, DOI 10.1016/0166-2236(92)90344-8; Westwood DA, 2000, EXP BRAIN RES, V130, P545, DOI 10.1007/s002219900287; Williams AM, 2005, HUM MOVEMENT SCI, V24, P283, DOI 10.1016/j.humov.2005.06.002; Milner AD, 2008, NEUROPSYCHOLOGIA, V46, P774, DOI 10.1016/j.neuropsychologia.2007.10.005; GOODALE MA, 1994, NEUROPSYCHOLOGIA, V32, P1159, DOI 10.1016/0028-3932(94)90100-7; Mann DL, 2010, ACTA PSYCHOL, V135, P17, DOI 10.1016/j.actpsy.2010.04.006; BOUSSAOUD D, 1991, J COMP NEUROL, V306, P554, DOI 10.1002/cne.903060403; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Land MF, 2000, NAT NEUROSCI, V3, P1340, DOI 10.1038/81887; Farrow D, 2003, PERCEPTION, V32, P1127, DOI 10.1068/p3323; Croft JL, 2010, HUM MOVEMENT SCI, V29, P751, DOI 10.1016/j.humov.2009.10.004; Land MF, 1997, PHILOS T ROY SOC B, V352, P1231; CAMPBELL FW, 1978, VISION RES, V18, P1297; VOLKMANN FC, 1968, J OPT SOC AM, V58, P562, DOI 10.1364/JOSA.58.000562; BAHILL AT, 1984, AM SCI, V72, P249; Bear M. F., 2007, NEUROSCIENCE EXPLORI; DELUCIA PR, 1985, PERCEPT MOTOR SKILL, V61, P143; FROHLICH C, 1984, AM J PHYS, V52, P325, DOI 10.1119/1.13883; Hubbard AW, 1954, RES QUART, V25, P42; JONES C M, 1978, Journal of Human Movement Studies, V4, P231; Mann DL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058289; Mann DL, 2010, ATTEN PERCEPT PSYCHO, V72, P1317, DOI 10.3758/APP.72.5.1317; Mann DL, 2010, HUM MOVEMENT SCI, V29, P386, DOI 10.1016/j.humov.2010.02.007; Milner A. D., 1995, VISUAL BRAIN ACTION; Muller S, 2006, J SCI MED SPORT, V9, P446, DOI 10.1016/j.jsams.2006.03.029; RIPOLL H, 1988, ERGONOMICS, V31, P1647, DOI 10.1080/00140138808966814; Rossetti Y, 2002, ATTENTION PERFORM, V19, P62; SELIN C, 1959, RES QUART, V30, P232; Ungerleider L. G., 1982, ANAL VISUAL BEHAV, P549; Whiting H. T. A., 1973, INT J SPORT PSYCHOL, V46, P420; WHITING HTA, 1970, ERGONOMICS, V13, P265, DOI 10.1080/00140137008931141; Williams A. M., 1999, VISUAL PERCEPTION AC; Williams T., 1986, SCI HITTING; Wright M., 1974, NEUROSCIENCES 3RD ST, P115	41	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	AUG	2015	77	6					2074	2081		10.3758/s13414-015-0906-5		8	Psychology; Psychology, Experimental	Psychology	CN9CA	WOS:000358742500021		
J	Kawashima, T; Sato, T				Kawashima, Takayuki; Sato, Takao			Perceptual limits in a simulated "Cocktail party"	ATTENTION PERCEPTION & PSYCHOPHYSICS			English	Article						Auditory organization; Numerosity perception; Response times; Counting	SOUND SOURCES; SPATIAL SEPARATION; SPEECH; ATTENTION; DISCRIMINATION; NUMEROSITY; PATTERNS; NUMBER	Numerosity judgments of simultaneous talkers were examined. Listeners were required to report the number of talkers heard when this number varied (1 to 13). Spatial location of talkers (1 or 6 locations), duration of talker voices (0.8 s, 5.0 s, and 15.0 s), and gender arrangement of talkers also were manipulated in four experiments. In all experiments, the proportion of correct numerosity judgments monotonically decreased as talker numbers increased. Perceptual limits, defined as talker numbers with proportion correct scores of 0.5, varied between 3 to 5 talkers, on average, depending on listening conditions, and were significantly higher for spatially separated talkers, for the longer voices, and for the mixed gender voices (Experiments 1, 2, and 3). In addition, Experiment 4 found that average numerosity response times increased monotonically over a range of one to four talkers. These results support the idea that, before counting talkers, listeners perceptually segregate talkers to render numerosity judgments. They also suggest that our functional auditory world for simultaneous voices may consist of, at most, three to five talkers depending on listening situations. In light of these results, possible causes for such perceptual limits are discussed.	[Kawashima, Takayuki] Teikyo Heisei Univ, Fac Hlth & Med Sci, Toshima Ku, Tokyo 1708445, Japan; [Sato, Takao] Univ Tokyo, Grad Sch Humanities & Sociol, Tokyo, Japan	Kawashima, T (reprint author), Teikyo Heisei Univ, Fac Hlth & Med Sci, Toshima Ku, 2-51-4 Higashi Ikebukuro, Tokyo 1708445, Japan.	takayuki.kawashima@thu.ac.jp					KAUFMAN EL, 1949, AM J PSYCHOL, V62, P498, DOI 10.2307/1418556; Carlyon RP, 2001, J EXP PSYCHOL HUMAN, V27, P115, DOI 10.1037//0096-1523.27.1.115; CHERRY EC, 1953, J ACOUST SOC AM, V25, P975, DOI 10.1121/1.1907229; Piazza M, 2006, BRAIN RES, V1106, P177, DOI 10.1016/j.brainres.2006.05.104; Brungart DS, 2001, J ACOUST SOC AM, V110, P2527, DOI 10.1121/1.1408946; MANDLER G, 1982, J EXP PSYCHOL GEN, V111, P1, DOI 10.1037/0096-3445.111.1.1; Halberda J, 2008, NATURE, V455, P665, DOI 10.1038/nature07246; Freyman RL, 1999, J ACOUST SOC AM, V106, P3578, DOI 10.1121/1.428211; Cowan N, 2005, COGNITIVE PSYCHOL, V51, P42, DOI 10.1016/j.cogpsych.2004.12.001; Vuokko E, 2013, BRAIN RES, V1497, P40, DOI 10.1016/j.brainres.2012.12.019; LIBERMAN AM, 1967, PSYCHOL REV, V74, P431, DOI 10.1037/h0020279; Yost WA, 1996, PERCEPT PSYCHOPHYS, V58, P1026, DOI 10.3758/BF03206830; BRONKHORST AW, 1992, J ACOUST SOC AM, V92, P3132, DOI 10.1121/1.404209; Pylyshyn ZW, 2001, COGNITION, V80, P127, DOI 10.1016/S0010-0277(00)00156-6; Bronkhorst AW, 2000, ACUSTICA, V86, P117; Best V, 2006, J ACOUST SOC AM, V120, P1506, DOI 10.1121/1.2234849; Bregman A.S., 1994, AUDITORY SCENE ANAL; DARWIN CJ, 1995, HDB PERCEPTION COGNI, P387; Kahneman D., 1973, ATTENTION EFFORT; Kashino M., 1996, J ACOUST SOC AM, V99, P2596, DOI 10.1121/1.415287; Kawashima T., 2005, THESIS U TOKYO TOKYO; Kobayashi T., 1992, J ACOUST SOC JPN, V48, P888; MASSARO DW, 1976, J EXP PSYCHOL HUMAN, V2, P337, DOI 10.1037//0096-1523.2.3.337; Nagaoka University of Technology, 2002, HEAD REL TRANSF FUNC; PYLYSHYN Z W, 1988, Spatial Vision, V3, P179, DOI 10.1163/156856888X00122; Repp BH, 2007, PERCEPT PSYCHOPHYS, V69, P529, DOI 10.3758/BF03193910; Santala O, 2011, J ACOUST SOC AM, V129, P1522, DOI 10.1121/1.3533727; Stern RM, 2005, SPEECH SEPARATION BY HUMANS AND MACHINES, P135, DOI 10.1007/0-387-22794-6_9; Tohoku University, 2001, HEAD REL TRANSF FUNC; Turgeon M, 2005, J EXP PSYCHOL HUMAN, V31, P939, DOI 10.1037/0096-1523.31.5.939; WATSON CS, 1976, J ACOUST SOC AM, V60, P1176, DOI 10.1121/1.381220; Yost William A., 2008, V29, P1	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1943-3921	1943-393X		ATTEN PERCEPT PSYCHO	Atten. Percept. Psychophys.	AUG	2015	77	6					2108	2120		10.3758/s13414-015-0910-9		13	Psychology; Psychology, Experimental	Psychology	CN9CA	WOS:000358742500024		
J	Lam, LM				Lam, Lai Ming			Environment, livelihood and household: The ethno-history of Rana Tharus Badaghar households	AUSTRALIAN JOURNAL OF ANTHROPOLOGY			English	Article						Rana Tharus; Nepal; livelihood; household; environment	FAMILY	This paper focuses on the changes occurring in households in the indigenous Rana Tharus community. I discuss the household not in terms of physical structure but instead on the social aspects: how people relate to each other through the lens of the household context. I argue that the fluid nature of households makes its flexible to different ecological environments and socio-economic scenarios. My ethnography of Rana households clearly illustrated that the formation, structure and management of Rana households was fundamentally linked to people's livelihoods. Before 1950s, abundant land resources allowed Ranas to live in joint-type households. This particular household arrangement not only fulfilled labour needs but also secured the mutual security for every household member. Gradually, undivided and big households (known in Rana as Badaghar) became the ideal model for Ranas as soon as such establishments did not become divided or separated. This household structure also served as an important safety net for most Ranas and fundamental to other social relationships especially Mukhiya (household head system) and Kurmaa (patrilineal kin). However, since the 1950s, new socio-economic landscapes have significantly challenged the maintenance of traditional Rana households. Within the lifetime of most Ranas, they first experienced household fission and the disappearance of the Mukhiya system. The dynamic relationships between Rana household and new ecological, social and economic landscapes are explored here. It is concluded that the household is a critical institution allowing anthropologists to better understand the long-term social impacts caused by state policies and ecological changes. This is because people often practice their new household relations in their everyday life as a response to environmental and livelihood changes.	Osaka Univ, Suita, Osaka 565, Japan	Lam, LM (reprint author), Osaka Univ, Suita, Osaka 565, Japan.	your_laiming@yahoo.com					YANAGISAKO SJ, 1979, ANNU REV ANTHROPOL, V8, P161, DOI 10.1146/annurev.an.08.100179.001113; Bhattarai A. M., 2001, DISPLACEMENT REHABIL; CALDWELL JC, 1984, J MARRIAGE FAM, V46, P215, DOI 10.2307/351879; Caplan L., 1970, LAND SOCIAL CHANGE E; Carsten Janet, 1995, HOUSE LEVISTRAUSS; Fricke T., 1984, HIMALAYAN HOUSEHOLDS; GOLDSCHM.W, 1971, AM ANTHROPOL, V73, P1058, DOI 10.1525/aa.1971.73.5.02a00060; Goody J., 1972, HOUSEHOLD FAMILY PAS, P103, DOI 10.1017/CBO9780511561207.005; Gray J. N., 1995, HOUSEHOLDERS WORLD P; Guneratne A, 2002, MANY TONGUES ONE PEO; Gurung G. M., 1996, KATHMANDU OCCASIONAL, V5, P78; Guyer J., 1981, AFR STUD REV, V24, P87, DOI 10.2307/523903; Krauskopff G., 2002, POLITICS BELONGING H, P25; Lam L. M., 2015, EUROPEAN B IN PRESS; Levi-Strauss Claude, 1983, WAY MASKS; Levi-Strauss Claude, 1987, ANTHR MYTH LECT 1951; McDonaugh C, 1985, J ANTHR SOC OXFORD, V15, P1; Netting Robert, 1984, HOUSEHOLDS COMP HIST; Pandey S. B., 2003, RESETTLEMENT HIST RO; PASTERNAK B, 1976, J ANTHROPOL RES, V32, P109; Rankin K, 1999, NEPAL THARU TARAI NE, P27; Regmi M. C., 1999, LANDOWNERSHIP NEPAL; Regmi M. C., 1963, LAND TENURE TAXATION; Sahlins Marshall, 1981, HIST METAPHORS MYTHI; Turner R. L., 1931, COMP ETYMOLOGICAL DI; WHEATON R, 1975, J INTERDISCIPL HIST, V5, P601, DOI 10.2307/202861; Wilk R. R., 1997, HOUSEHOLD ECOLOGY EC; Wolf Eric, 1966, PEASANTS	28	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1035-8811	1757-6547		AUST J ANTHROPOL	Aust. J. Anthropol.	AUG	2015	26	2					293	312		10.1111/taja.12136		20	Anthropology	Anthropology	CN8ND	WOS:000358697000008		
J	Gilbert, B; Ahmad, K; Roos, J; Lehmann, C; Chiba, T; Ulrich-Ruckert, S; Smeenk, L; van Heeringen, S; Maier, TJ; Groner, B; Steinhilber, D				Gilbert, Bianca; Ahmad, Khalil; Roos, Jessica; Lehmann, Christoph; Chiba, Tomohiro; Ulrich-Rueckert, Sandra; Smeenk, Leonie; van Heeringen, Simon; Maier, Thorsten J.; Groner, Bernd; Steinhilber, Dieter			5-Lipoxygenase is a direct p53 target gene in humans	BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS			English	Article						p53; 5-Lipoxygenase; p21; Leukotriene; Leukemia; Chromatin immunoprecipitation	FACTOR-BINDING-SITES; GROWTH-FACTOR-BETA; ARACHIDONATE 5-LIPOXYGENASE; LEUKOTRIENE-A4 SYNTHASE; SV40-TRANSFORMED CELLS; INDUCED APOPTOSIS; PROMOTER ACTIVITY; MYELOID-LEUKEMIA; TRICHOSTATIN-A; BREAST-CANCER	The p53 tumor suppressor plays a critical role in cancer, and more than 50% of human tumors contain mutations or deletions of the TP53 gene. p53 can transactivate or repress target genes in response to diverse stress signals, such as transient growth arrest DNA repair, cellular differentiation, senescence and apoptosis. Through an unbiased genome-wide ChIP-seq analysis, we have found that 5-lipoxygenase (ALOX5, 5-LO) which is a key enzyme of leukotriene (LT) biosynthesis, is a direct target gene of p53 and its expression is induced by genotoxic stress via actinomycin D (Act.D) or etoposide (Eto) treatment. 5-LO and LTs play a role in immunological diseases as well as in tumorigenesis and tumor growth. p53 binds to a specific binding site consisting of a complete p53 consensus-binding motif in ALOX5 intron G which is located about 64 kbp downstream of the transcriptional start site. We confirmed the strong binding of p53 to the 5-LO target site in ChIP-qPCR experiments. Expression analyses by qRT-PCR and immunoblot further revealed that genotoxic stress induces the ALOX5 mRNA and protein expression in a p53-dependent manner. Knockdown of p53 in U2OS cells leads to a downregulation of 5-LO mRNA and protein expression. In addition, immunofluorescence and immunoprecipitation assays indicate the direct binding of 5-LO to p53 protein. Furthermore, we found that 5-LO can inhibit the transcriptional activity of p53 suggesting that 5-LO acts in a negative feedback loop to limit induction of p53 target genes. (C) 2015 Elsevier B.V. All rights reserved.	[Gilbert, Bianca; Ahmad, Khalil; Roos, Jessica; Ulrich-Rueckert, Sandra; Maier, Thorsten J.; Steinhilber, Dieter] Goethe Univ Frankfurt, Inst Pharmaceut Chem, D-60438 Frankfurt, Germany; [Chiba, Tomohiro] Kyorin Univ, Sch Med, Dept Pathol, Tokyo, Japan; [Groner, Bernd] Georg Speyer Haus, Inst Biomed Res, Frankfurt, Germany; [van Heeringen, Simon] Radboud Univ Nijmegen, Nijmegen Ctr Mol Life Sci, Fac Sci, Dept Mol Biol, NL-6525 ED Nijmegen, Netherlands; [Smeenk, Leonie] IMP Res Inst Mol Pathol, Vienna, Austria; [Lehmann, Christoph] Fraunhofer Inst Mol Biol & Appl Ecol IME, Project Grp Translat Med & Pharmacol, Frankfurt, Germany; [Maier, Thorsten J.] Aarhus Univ, DK-8000 Aarhus C, Denmark	Steinhilber, D (reprint author), Goethe Univ Frankfurt, Inst Pharmaceut Chem, Max von Laue Str 9, D-60438 Frankfurt, Germany.	steinhilber@em.uni-frankfurt.de			Else Kroner-Fresenius Stiftung	This study was supported by the Else Kroner-Fresenius Stiftung (Dr. Hans Kroner Graduiertenkolleg).	ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1073/jbc.M110629200; BRUNGS M, 1995, P NATL ACAD SCI USA, V92, P107, DOI 10.1073/pnas.92.1.107; Choong ML, 2009, CELL CYCLE, V8, P2810; HOSHIKO S, 1990, P NATL ACAD SCI USA, V87, P9073, DOI 10.1073/pnas.87.23.9073; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Ohd JF, 2003, GASTROENTEROLOGY, V124, P57, DOI 10.1053/gast.2003.50011; Melo CA, 2013, MOL CELL, V49, P524, DOI 10.1016/j.molcel.2012.11.021; Jiang WG, 2003, PROSTAG LEUKOTR ESS, V69, P275, DOI 10.1016/S0952-3278(03)00110-8; Chipuk JE, 2009, CELL CYCLE, V8, P2692; Denissov S, 2007, EMBO J, V26, P944, DOI 10.1038/sj.emboj.7601550; Brazdova M, 2009, NUCLEIC ACIDS RES, V37, P1486, DOI 10.1093/nar/gkn1085; BOADO RJ, 1992, P NATL ACAD SCI USA, V89, P9044, DOI 10.1073/pnas.89.19.9044; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Seuter S, 2007, BBA-MOL CELL BIOL L, V1771, P864, DOI 10.1016/j.bbalip.2007.04.007; Cawley S, 2004, CELL, V116, P499, DOI 10.1016/S0092-8674(04)00127-8; de Vries A, 2002, P NATL ACAD SCI USA, V99, P2948, DOI 10.1073/pnas.052713099; FUNK CD, 1989, P NATL ACAD SCI USA, V86, P2587, DOI 10.1073/pnas.86.8.2587; Smeenk L, 2008, NUCLEIC ACIDS RES, V36, P3639, DOI 10.1093/nar/gkn232; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; Klan N, 2003, BIOL CHEM, V384, P777, DOI 10.1515/BC.2003.086; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Uhl J, 2002, J BIOL CHEM, V277, P4374, DOI 10.1074/jbc.M107665200; MIYASHITA T, 1995, CELL, V80, P293; Ko LJ, 1996, GENE DEV, V10, P1054, DOI 10.1101/gad.10.9.1054; Hennig R, 2002, AM J PATHOL, V161, P421, DOI 10.1016/S0002-9440(10)64198-3; Stoffers KL, 2010, J MOL BIOL, V395, P884, DOI 10.1016/j.jmb.2009.10.022; Radmark O, 2007, TRENDS BIOCHEM SCI, V32, P332, DOI 10.1016/j.tibs.2007.06.002; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Hermeking H, 1997, MOL CELL, V1, P3, DOI 10.1016/S1097-2765(00)80002-7; LINZER DIH, 1979, CELL, V17, P43, DOI 10.1016/0092-8674(79)90293-9; Schnur N, 2007, BBA-MOL CELL BIOL L, V1771, P1271, DOI 10.1016/j.bbalip.2007.08.003; ELDEIRY WS, 1992, NAT GENET, V1, P45, DOI 10.1038/ng0492-45; Espinosa JM, 2008, ONCOGENE, V27, P4013, DOI 10.1038/onc.2008.37; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; Smeenk L, 2010, INT J ONCOL, V37, P1061, DOI 10.3892/ijo_00000757; STEINHILBER D, 1993, P NATL ACAD SCI USA, V90, P5984, DOI 10.1073/pnas.90.13.5984; Menendez D, 2009, NAT REV CANCER, V9, P724, DOI 10.1038/nrc2730; Hong SH, 1999, CANCER RES, V59, P2223; Chen YY, 2009, NAT GENET, V41, P783, DOI 10.1038/ng.389; Avis IM, 1996, J CLIN INVEST, V97, P806, DOI 10.1172/JCI118480; BARGONETTI J, 1993, GENE DEV, V7, P2565, DOI 10.1101/gad.7.12b.2565; Catalano A, 2004, FASEB J, V18, P1740, DOI 10.1096/fj.04-2258fje; Ghosh J, 1998, P NATL ACAD SCI USA, V95, P13182, DOI 10.1073/pnas.95.22.13182; Gupta S, 2001, CANCER, V91, P737, DOI 10.1002/1097-0142(20010215)91:4<737::AID-CNCR1059>3.0.CO;2-F; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; In KH, 1999, CLIN REV ALLERG IMMU, V17, P59, DOI 10.1007/BF02737597; Jiang WG, 2006, PROSTAG LEUKOTR ESS, V74, P125, DOI 10.1016/j.plefa.2005.10.005; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; Roos J, 2014, CANCER RES, V74, P5244, DOI 10.1158/0008-5472.CAN-13-3012; ROUZER CA, 1986, P NATL ACAD SCI USA, V83, P857, DOI 10.1073/pnas.83.4.857; Sambrook J., 2001, MOL CLONING, V2; Sambrook J., 2001, MOL CLONING, V3-1; Sambrook J., 2001, MOL CLONING, V1; SHIMIZU T, 1986, P NATL ACAD SCI USA, V83, P4175, DOI 10.1073/pnas.83.12.4175; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316; Smeenk L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017574; Steinhilber D, 2010, FRONT PHARMACOL, V1, DOI 10.3389/fphar.2010.00143; THUKRAL SK, 1995, MOL CELL BIOL, V15, P5196; Werz Oliver, 2002, Current Drug Targets - Inflammation and Allergy, V1, P23, DOI 10.2174/1568010023344959	60	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1874-9399	0006-3002		BBA-GENE REGUL MECH	Biochim. Biophys. Acta-Gene Regul. Mech.	AUG	2015	1849	8					1003	1016		10.1016/j.bbagrm.2015.06.004		14	Biochemistry & Molecular Biology; Biophysics	Biochemistry & Molecular Biology; Biophysics	CO2EN	WOS:000358969000009		
J	Hamada, M; Ono, Y; Fujimaki, R; Asai, K				Hamada, Michiaki; Ono, Yukiteru; Fujimaki, Ryohei; Asai, Kiyoshi			Learning chromatin states with factorized information criteria	BIOINFORMATICS			English	Article							HIDDEN MARKOV MODEL; HUMAN CELL-TYPES; HISTONE MODIFICATIONS; HUMAN GENOME; ANNOTATION; COMPLEXITY; DISCOVERY; REGULATOR; ELEMENTS; BINDING	Motivation: Recent studies have suggested that both the genome and the genome with epigenetic modifications, the so-called epigenome, play important roles in various biological functions, such as transcription and DNA replication, repair, and recombination. It is well known that specific combinations of histone modifications (e.g. methylations and acetylations) of nucleosomes induce chromatin states that correspond to specific functions of chromatin. Although the advent of next-generation sequencing (NGS) technologies enables measurement of epigenetic information for entire genomes at high-resolution, the variety of chromatin states has not been completely characterized. Results: In this study, we propose a method to estimate the chromatin states indicated by genome-wide chromatin marks identified by NGS technologies. The proposed method automatically estimates the number of chromatin states and characterize each state on the basis of a hidden Markov model (HMM) in combination with a recently proposed model selection technique, factorized information criteria. The method is expected to provide an unbiased model because it relies on only two adjustable parameters and avoids heuristic procedures as much as possible. Computational experiments with simulated datasets show that our method automatically learns an appropriate model, even in cases where methods that rely on Bayesian information criteria fail to learn the model structures. In addition, we comprehensively compare our method to ChromHMM on three real datasets and show that our method estimates more chromatin states than ChromHMM for those datasets.	[Hamada, Michiaki] Waseda Univ, Dept Elect Engn & Biosci, Fac Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Hamada, Michiaki; Asai, Kiyoshi] Natl Inst Adv Ind Sci & Technol, Computat Biol Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Ono, Yukiteru] Informat & Math Sci & Bioinformat Co Ltd, Toshima Ku, Tokyo 1700013, Japan; [Fujimaki, Ryohei] NEC Labs Amer, Dept Media Analyt, Cupertino, CA 95014 USA; [Asai, Kiyoshi] Univ Tokyo, Grad Sch Frontier Sci, Kashiwa, Chiba 2778562, Japan	Hamada, M (reprint author), Waseda Univ, Dept Elect Engn & Biosci, Fac Sci & Engn, Shinjuku Ku, 55N-06-10,3-4-1 Okubo, Tokyo 1698555, Japan.	mhamada@waseda.jp			MEXT KAKENHI [24680031]	This work was supported in part by a MEXT KAKENHI Grant-in-Aid for Young Scientists (A) (24680031) to MH and a Grant-in-Aid for Scientific Research on Innovative Areas to MH and KA.	Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Baker M, 2011, NAT METHODS, V8, P717, DOI 10.1038/nmeth.1673; Voigt P, 2013, GENE DEV, V27, P1318, DOI 10.1101/gad.219626.113; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Strahl BD, 2000, NATURE, V403, P41; Hoffman MM, 2013, NUCLEIC ACIDS RES, V41, P827, DOI 10.1093/nar/gks1284; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2013, GENOME RES, V23, P1142, DOI 10.1101/gr.144840.112; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Rando OJ, 2012, CURR OPIN GENET DEV, V22, P148, DOI 10.1016/j.gde.2012.02.013; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Watanabe S, 2013, J MACH LEARN RES, V14, P867; Zhou VW, 2011, NAT REV GENET, V12, P7, DOI 10.1038/nrg2905; Attias H, 1999, UNCERTAINTY IN ARTIFICIAL INTELLIGENCE, PROCEEDINGS, P21; Watanabe S, 2010, J MACH LEARN RES, V11, P3571; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Biesinger J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S5-S4; Bishop C. M., 2006, PATTERN RECOGNITION; Cielik M., 2014, BMC GENOMICS, V15, P76; Durbin R., 1998, BIOL SEQUENCE ANAL P; Fujimaki R., 2012, P 29 INT C MACH LEAR; Konishi S., 2007, INFORM CRITERIA STAT; Lai WKM, 2013, BIOINFORMATICS, V29, P2231, DOI 10.1093/bioinformatics/btt382; Laplace PS, 1986, STAT SCI, V1, p[364, 621], DOI DOI 10.1214/SS/1177013621; Larson JL, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-557; Roh Tae-Young, 2008, V387, P95; Teh Y W, 2010, ENCY MACHINE LEARNIN; Yamazaki K, 2005, NEUROCOMPUTING, V69, P62, DOI 10.1016/j.neucom.2005.02.014	30	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	AUG 1	2015	31	15					2426	2433		10.1093/bioinformatics/btv163		8	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CO7BL	WOS:000359312400002		
J	Gunawardana, Y; Fujiwara, S; Takeda, A; Woo, J; Woelk, C; Niranjan, M				Gunawardana, Yawwani; Fujiwara, Shuhei; Takeda, Akiko; Woo, Jeongmin; Woelk, Christopher; Niranjan, Mahesan			Outlier detection at the transcriptome-proteome interface	BIOINFORMATICS			English	Article							YEAST; PREDICTION; QUANTILES; ABUNDANCE; SETS	Background: In high-throughput experimental biology, it is widely acknowledged that while expression levels measured at the levels of transcriptome and the corresponding proteome do not, in general, correlate well, messenger RNA levels are used as convenient proxies for protein levels. Our interest is in developing data-driven computational models that can bridge the gap between these two levels of measurement at which different mechanisms of regulation may act on different molecular species causing any observed lack of correlations. To this end, we build data-driven predictors of protein levels using mRNA levels and known proxies of translation efficiencies as covariates. Previous work showed that in such a setting, outliers with respect to the model are reliable candidates for post-translational regulation. Results: Here, we present and compare two novel formulations of deriving a protein concentration predictor from which outliers may be extracted in a systematic manner. The first approach, outlier rejecting regression, allows explicit specification of a certain fraction of the data as outliers. In a regression setting, this is a non-convex optimization problem which we solve by deriving a difference of convex functions algorithm (DCA). With post-translationally regulated proteins, one expects their concentrations to be affected primarily by disruption of protein stability. Our second algorithm exploits this observation by minimizing an asymmetric loss using quantile regression and extracts outlier proteins whose measured concentrations are lower than what a genome-wide regression would predict. We validate the two approaches on a dataset of yeast transcriptome and proteome. Functional annotation check on detected outliers demonstrate that the methods are able to identify post-translationally regulated genes with high statistical confidence.	[Gunawardana, Yawwani; Niranjan, Mahesan] Univ Southampton, Sch Elect & Comp Sci, Southampton, Hants, England; [Fujiwara, Shuhei; Takeda, Akiko] Univ Tokyo, Grad Sch Informat Sci & Technol, Dept Math Informat, Tokyo, Japan; [Woo, Jeongmin; Woelk, Christopher] Univ Southampton, Fac Med, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England	Niranjan, M (reprint author), Univ Southampton, Sch Elect & Comp Sci, Southampton, Hants, England.	mn@ecs.soton.ac.uk					Andrew G., 2007, P 24 INT C MACH LEAR, P33, DOI DOI 10.1145/1273496.1273501; Gygi SP, 1999, MOL CELL BIOL, V19, P1720; BURNETT G, 1954, J BIOL CHEM, V211, P969; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Heagerty PJ, 1999, J ROY STAT SOC C-APP, V48, P533, DOI 10.1111/1467-9876.00170; HENDRICKS W, 1992, J AM STAT ASSOC, V87, P58, DOI 10.2307/2290452; Greenbaum D, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-117; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Koenker R, 2001, J AM STAT ASSOC, V96, P458, DOI 10.1198/016214501753168172; Futcher B, 1999, MOL CELL BIOL, V19, P7357; Wu YC, 2007, J AM STAT ASSOC, V102, P974, DOI 10.1198/016214507000000617; Kiemer L, 2005, BIOINFORMATICS, V21, P1269, DOI 10.1093/bioinformatics/bti130; Arava Y, 2003, P NATL ACAD SCI USA, V100, P3889, DOI 10.1073/pnas.0635171100; Wall DP, 2005, P NATL ACAD SCI USA, V102, P5483, DOI 10.1073/pnas.0501761102; Gunawardana Y, 2013, BIOINFORMATICS, V29, P3060, DOI 10.1093/bioinformatics/btt537; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; HAWKINS DM, 1984, TECHNOMETRICS, V26, P197, DOI 10.2307/1267545; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Carroll AJ, 2008, MOL CELL PROTEOMICS, V7, P347, DOI 10.1074/mcp.M700052-MCP200; COLE TJ, 1992, STAT MED, V11, P1305, DOI 10.1002/sim.4780111005; Collobert R., 2006, INT C MACH LEARN, P129; Copic A, 2009, GENETICS, V182, P757, DOI 10.1534/genetics.109.101105; Koenker R., 2005, QUANTILE REGRESSION, V38; Lichman M., 2013, UCI MACHINE LEARNING, P901; Liu ZX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034370; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Pham Dinh T., 1997, ACTA MATH VIETNAMICA, V22, P289; Shin YJ, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-83; Smardova J, 2005, DIFFERENTIATION, V73, P261, DOI 10.1111/j.1432-0436.2005.00028.x; Tuller T, 2007, PLOS COMPUT BIOL, V3, P2510, DOI 10.1371/journal.pcbi.0030248; Warde-Farley D, 2010, NUCLEIC ACIDS RES, V38, pW214, DOI 10.1093/nar/gkq537; Xu L., 2006, P 21 NATL C ART INT, V1, P536; Yang M., 2010, NEURAL INFORM PROCES, P2532	37	0	0	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1367-4803	1460-2059		BIOINFORMATICS	Bioinformatics	AUG 1	2015	31	15					2530	2536		10.1093/bioinformatics/btv182		7	Biochemical Research Methods; Biotechnology & Applied Microbiology; Computer Science, Interdisciplinary Applications; Mathematical & Computational Biology; Statistics & Probability	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Computer Science; Mathematical & Computational Biology; Mathematics	CO7BL	WOS:000359312400015		
J	Sanbe, A				Sanbe, Atsushi			Cell Death in Neuromuscular Diseases Foreword	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Editorial Material									Iwate Med Univ, Sch Pharm, Dept Pharmacotherapeut, Yahaba, Iwate 0283694, Japan	Sanbe, A (reprint author), Iwate Med Univ, Sch Pharm, Dept Pharmacotherapeut, 2-1-1 Nishitokuda, Yahaba, Iwate 0283694, Japan.						MAJNO G, 1995, AM J PATHOL, V146, P3; Clarke PGH, 1996, ANAT EMBRYOL, V193, P81	2	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1093	1093				1	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000001		
J	Marunouchi, T; Tanonaka, K				Marunouchi, Tetsuro; Tanonaka, Kouichi			Cell Death in the Cardiac Myocyte	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						cardiac myocyte; cell death; neuromuscular disease; apoptosis; necrosis	BCL-2 PROTEIN FAMILY; FAILING HUMAN HEART; APOPTOSIS; CARDIOMYOCYTES; MECHANISMS; AUTOPHAGY; CARDIOMYOPATHY; EXPRESSION; FAILURE; RECEPTORS	Loss of cardiac myocytes plays a critical role in the pathogenesis of cardiovascular disorders. A decrease in the number of cardiac myocytes in cardiac diseases results in sustained, irreversible contractile failure of myocardium. Therefore prevention of cardiac cell death is a potential therapeutic strategy for various heart diseases. It is well accepted that three types of phenomena such as apoptosis, necrosis, and autophagy may be involved in myocardial cell death. Apoptosis is a highly regulated process that is promoted via death receptor pathway in the plasma membrane or via mitochondrial pathway. Necrosis is induced via mitochondrial swelling, cell rupture, and subsequent inflammation. Autophagy is a cell survival mechanism that involves degradation and recycling of cytoplasmic components. As compared with the other two mechanisms, autophagy may mediate cell death under specific conditions. These three types of cell death in the myocardium are discussed in this article.	[Marunouchi, Tetsuro; Tanonaka, Kouichi] Tokyo Univ Pharm & Life Sci, Dept Mol & Cellular Pharmacol, Hachioji, Tokyo 1920392, Japan	Marunouchi, T (reprint author), Tokyo Univ Pharm & Life Sci, Dept Mol & Cellular Pharmacol, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	tetsurom@toyaku.ac.jp					Hein S, 2003, CIRCULATION, V107, P984, DOI 10.1161/01.CIR.0000051865.66123.B7; Kumar D, 1999, ANN NY ACAD SCI, V874, P156, DOI 10.1111/j.1749-6632.1999.tb09233.x; Edinger AL, 2004, CURR OPIN CELL BIOL, V16, P663, DOI 10.1016/j.ceb.2004.09.011; TorreAmione G, 1996, CIRCULATION, V93, P704; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; Di Lisa F, 1998, MOL CELL BIOCHEM, V184, P379, DOI 10.1023/A:1006810523586; Adams JM, 1998, SCIENCE, V281, P1322, DOI 10.1126/science.281.5381.1322; Selcen D, 2011, NEUROMUSCULAR DISORD, V21, P161, DOI 10.1016/j.nmd.2010.12.007; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; Iwai T, 2002, CARDIOVASC RES, V55, P141, DOI 10.1016/S0008-6363(02)00282-1; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; TANAKA M, 1994, CIRC RES, V75, P426; Kostin S, 2003, CIRC RES, V92, P715, DOI 10.1161/01.RES.0000067471.95890.5C; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Bernardi P, 2012, CELL CALCIUM, V52, P22, DOI 10.1016/j.ceca.2012.03.004; Yan L, 2005, P NATL ACAD SCI USA, V102, P13807, DOI 10.1073/pnas.0506843102; Wang XJ, 2001, CIRC RES, V89, P84, DOI 10.1161/hh1301.092688; Youle RJ, 2008, NAT REV MOL CELL BIO, V9, P47, DOI 10.1038/nrm2308; Jiang XJ, 2000, J BIOL CHEM, V275, P31199, DOI 10.1074/jbc.C000405200; van Empel VPM, 2005, CARDIOVASC RES, V67, P21, DOI 10.1016/j.cardiores.2005.04.012; CHENG W, 1995, J CLIN INVEST, V96, P2247, DOI 10.1172/JCI118280; Chiong M, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.130; He A, 2007, FOLIA HISTOCHEM CYTO, V45, P397; Kostin S, 2005, ADV CLIN CHEM, V40, P37, DOI 10.1016/S0065-2423(05)4002-5; Mallat Z, 1996, NEW ENGL J MED, V335, P1190, DOI 10.1056/NEJM199610173351604; Maloyan A, 2010, CIRC RES, V106, P1524, DOI 10.1161/CIRCRESAHA.109.212639; Nakano S, 1997, J NEUROPATH EXP NEUR, V56, P850, DOI 10.1097/00005072-199708000-00002; Narula J, 1996, NEW ENGL J MED, V335, P1182, DOI 10.1056/NEJM199610173351603; Olivetti G, 1997, NEW ENGL J MED, V336, P1131, DOI 10.1056/NEJM199704173361603; Sanbe A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005351; Shimomura H, 2001, JPN CIRC J, V65, P965, DOI 10.1253/jcj.65.965; Sui X, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.350	34	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1094	1097				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000002		
J	Hayashi, H; Takagi, N				Hayashi, Hideki; Takagi, Norio			Endogenous Neuroprotective Molecules and Their Mechanisms in the Central Nervous System	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						neuroprotectant; central nervous system; neuronal damage	HEPATOCYTE GROWTH-FACTOR; CYCLASE-ACTIVATING POLYPEPTIDE; TRAUMATIC BRAIN-INJURY; VASOACTIVE-INTESTINAL-PEPTIDE; RECEPTOR-RELATED PROTEIN-1; E-CONTAINING LIPOPROTEINS; HIPPOCAMPAL-NEURONS; NEUROTROPHIC FACTOR; ADENYLATE-CYCLASE; TISSUE INHIBITOR	Functions of the central nervous system (CNS) are based on a complex neural network. It is believed that the CNS has several neuroprotective mechanisms operated by neurons, glia and other types of cells against various types of neuronal damage. Since mature, differentiated neurons are not able to divide, it is important to protect neurons from damage prior to death. The neuroprotective effects of a number of pharmaceutical agents and natural products against necrosis and apoptosis of the CNS neurons have been reported, thus this review will mainly discuss several endogenous neuroprotectants and their mechanisms.	[Hayashi, Hideki; Takagi, Norio] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Appl Biochem, Hachioji, Tokyo 1920392, Japan	Hayashi, H (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Appl Biochem, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	hhayashi@toyaku.ac.jp			Japan Society for the Promotion of Science (JSPS) [15K06781]; Takeda Science Foundation	This work was supported by Grantin-Aid for Scientific Research C (No. 15K06781) from Japan Society for the Promotion of Science (JSPS) and the Takeda Science Foundation.	Stroth N, 2011, ANN NY ACAD SCI, V1220, P49, DOI 10.1111/j.1749-6632.2011.05904.x; Fujita R, 2007, CELL DEATH DIFFER, V14, P1839, DOI 10.1038/sj.cdd.4402189; Nguyen TLX, 2010, EXP MOL MED, V42, P583, DOI 10.3858/emm.2010.42.8.060; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Frechilla D, 2001, NEUROREPORT, V12, P919, DOI 10.1097/00001756-200104170-00011; Ueda H, 2007, J CELL BIOL, V176, P853, DOI 10.1083/jcb.200608022; McConeghy KW, 2012, CNS DRUGS, V26, P613, DOI 10.2165/11634020-000000000-00000; Kabadi SV, 2014, INT J MOL SCI, V15, P1216, DOI 10.3390/ijms15011216; Baydyuk M, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00254; Anderson KD, 1996, P NATL ACAD SCI USA, V93, P7346, DOI 10.1073/pnas.93.14.7346; Harmar AJ, 2012, BRIT J PHARMACOL, V166, P4, DOI 10.1111/j.1476-5381.2012.01871.x; Morishita E, 1997, NEUROSCIENCE, V76, P105; Kumral A, 2011, BRAIN DEV-JPN, V33, P632, DOI 10.1016/j.braindev.2010.10.014; Chen Y, 2006, REGUL PEPTIDES, V137, P4, DOI 10.1016/j.regpep.2006.06.016; MIYATA A, 1989, BIOCHEM BIOPH RES CO, V164, P567, DOI 10.1016/0006-291X(89)91757-9; Sakanaka M, 1998, P NATL ACAD SCI USA, V95, P4635, DOI 10.1073/pnas.95.8.4635; Hayashi H, 2007, J NEUROSCI, V27, P1933, DOI 10.1523/JNEUROSCI.5471-06.2007; Brenneman DE, 2007, PEPTIDES, V28, P1720, DOI 10.1016/j.peptides.2007.04.002; Devi L, 2012, NEUROPSYCHOPHARMACOL, V37, P434, DOI 10.1038/npp.2011.191; Ohtaki H, 2006, P NATL ACAD SCI USA, V103, P7488, DOI 10.1073/pnas.0600375103; Bartesaghi S, 2005, NEUROTOXICOLOGY, V26, P923, DOI 10.1016/j.neuro.2005.01.016; Allen SJ, 2013, PHARMACOL THERAPEUT, V138, P155, DOI 10.1016/j.pharmthera.2013.01.004; Hayashi H, 2009, J BIOL CHEM, V284, P29605, DOI 10.1074/jbc.M109.039560; Waschek JA, 2013, BRIT J PHARMACOL, V169, P512, DOI 10.1111/bph.12181; Souvenir R, 2011, NEUROBIOL DIS, V44, P28, DOI 10.1016/j.nbd.2011.05.020; JELKMANN W, 1992, PHYSIOL REV, V72, P449; Bode W, 1999, ANN NY ACAD SCI, V878, P73, DOI 10.1111/j.1749-6632.1999.tb07675.x; Sytkowski AJ, 2011, CELL MOL NEUROBIOL, V31, P931, DOI 10.1007/s10571-011-9695-0; NAKAMURA T, 1984, BIOCHEM BIOPH RES CO, V122, P1450, DOI 10.1016/0006-291X(84)91253-1; Hayashi H, 2011, BIOL PHARM BULL, V34, P453; Schapira AHV, 2014, LANCET, V384, P545, DOI 10.1016/S0140-6736(14)61010-2; UEHARA Y, 1995, NATURE, V373, P702, DOI 10.1038/373702a0; Ohtaki H, 2008, J MOL NEUROSCI, V36, P16, DOI 10.1007/s12031-008-9077-3; Hayashi H, 2012, J BIOL CHEM, V287, P25395, DOI 10.1074/jbc.M112.370130; Lu J, 2013, P NATL ACAD SCI USA, V110, P10747, DOI 10.1073/pnas.1308950110; NAKAMURA T, 1989, NATURE, V342, P440, DOI 10.1038/342440a0; Ichim G, 2012, EXP CELL RES, V318, P1221, DOI 10.1016/j.yexcr.2012.03.006; Chateauvieux S, 2011, BIOCHEM PHARMACOL, V82, P1291, DOI 10.1016/j.bcp.2011.06.045; Viviani B, 2005, J NEUROCHEM, V93, P412, DOI 10.1111/j.1471-4159.2005.03033.x; Jang SW, 2010, P NATL ACAD SCI USA, V107, P2687, DOI 10.1073/pnas.0913572107; Kells AP, 2004, MOL THER, V9, P682, DOI 10.1016/j.ymthe.2004.02.016; Niimura M, 2006, J CEREBR BLOOD F MET, V26, P1354, DOI 10.1038/sj.jcbfm.9600287; Ji JZ, 2004, EUR J NEUROSCI, V19, P265, DOI 10.1111/j.1460-9568.2003.03107.x; Ashutosh, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.54; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bond WS, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00523; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Dicicco-Bloom E, 1998, ANN NY ACAD SCI, V865, P274, DOI 10.1111/j.1749-6632.1998.tb11188.x; Du SW, 2015, NEUROSCI LETT, V584, P56, DOI 10.1016/j.neulet.2014.09.045; Gene S, 2004, BRAIN RES, V1000, P19; Grupke S, 2015, CLIN NEUROL NEUROSUR, V129, P1, DOI 10.1016/j.clineuro.2014.11.013; Haider S.K., 2013, J NEUROCHEM, V125, P713; HARITOS AA, 1984, P NATL ACAD SCI-BIOL, V81, P1008, DOI 10.1073/pnas.81.4.1008; Ishihara N, 2005, J NEUROCHEM, V95, P1277, DOI 10.1111/j.1471-4159.2005.03446.x; Jang SW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011528; Kaur H, 2013, PHARMACOLOGY, V92, P324, DOI 10.1159/000356320; Lorente L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094370; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; MATTSON MP, 1995, J NEUROCHEM, V65, P1740; Miyazawa T, 1998, J CEREBR BLOOD F MET, V18, P345; Rege SD, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00218; Ren ZH, 2013, SCI REP-UK, V3, DOI 10.1038/srep02786; Sargin Derya, 2010, Best Pract Res Clin Anaesthesiol, V24, P573, DOI 10.1016/j.bpa.2010.10.005; Segade F, 1999, INT J BIOCHEM CELL B, V31, P1243, DOI 10.1016/S1357-2725(99)00094-1; Shi Y, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000188; Tejima E, 2009, J NEUROTRAUM, V26, P1935, DOI 10.1089/neu.2009-0959; Uren RT, 2014, FRONT MOL NEUROSCI, V7, DOI [10.3389/fnmol.2014.00039, 10.3389/fnmo1.2014.00039]; Wang XK, 1998, J CEREBR BLOOD F MET, V18, P1173; Yamauchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075497	69	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1104	1108				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000004		
J	Aung, KH; Tsukahara, S; Maekawa, F; Nohara, K; Nakamura, K; Tanoue, A				Aung, Kyaw Htet; Tsukahara, Shinji; Maekawa, Fumihiko; Nohara, Keiko; Nakamura, Kazuaki; Tanoue, Akito			Role of Environmental Chemical Insult in Neuronal Cell Death and Cytoskeleton Damage	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						neurodegeneration; arsenic; neurite outgrowth; cytoskeleton; neuronal death	AMYOTROPHIC-LATERAL-SCLEROSIS; ARSENIC EXPOSURE; NEURODEGENERATIVE DISEASES; NEURITE OUTGROWTH; SODIUM ARSENITE; NERVOUS-SYSTEM; TEST EST; TAU; INHIBITION; APOPTOSIS	Environmental influences, such as chemical exposure, have long been considered potential risk factors for neurodegenerative disorders, including neuromuscular diseases. However, no definitive links between environmental chemical exposure and a pathogenic mechanism of neurodegenerative disease has yet been established. In this study, we describe that exposure to arsenic, an environmental pollutant naturally found in drinking water, induces neuronal cell death and alteration of morphology, particularly neurite outgrowth and in the cytoskeleton of neurons. Since progressive cell loss accompanied by the alteration of neuronal structures and cytoskeleton is considered the major pathologic feature of neurodegenerative disorders, arsenic-induced neurotoxicity might contribute to an etiologic mechanism of some neurodegenerative diseases. Further, we discuss the importance of in vitro assay, particularly an embryonic toxicity test, for assessing the neurotoxicity of chemicals, because most of chemicals found in our environment remain to be evaluated regarding their neurotoxicity risk for neurodegenerative diseases.	[Aung, Kyaw Htet; Nakamura, Kazuaki; Tanoue, Akito] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, Tokyo 1578535, Japan; [Aung, Kyaw Htet; Tsukahara, Shinji] Saitama Univ, Grad Sch Sci & Engn, Div Life Sci, Sakura Ku, Saitama 3388570, Japan; [Maekawa, Fumihiko; Nohara, Keiko] Natl Inst Environm Studies, Ctr Environm Hlth Sci, Mol Toxicol Sect, Tsukuba, Ibaraki 3058506, Japan	Nakamura, K (reprint author), Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Setagaya Ku, 2-10-1 Okura, Tokyo 1578535, Japan.	nakamura-kz@ncchd.go.jp					Hei TK, 1998, P NATL ACAD SCI USA, V95, P8103, DOI 10.1073/pnas.95.14.8103; Sutedja NA, 2009, AMYOTROPH LATERAL SC, V10, P302, DOI 10.3109/17482960802455416; Johnson FO, 2009, NEUROTOXICOLOGY, V30, P761, DOI 10.1016/j.neuro.2009.07.010; Bolin CM, 2006, FASEB J, V20, P788, DOI 10.1096/fj.05-5091fje; BROOKS BR, 1994, J NEUROL SCI, V124, P96, DOI 10.1016/0022-510X(94)90191-0; EYER J, 1994, NEURON, V12, P389, DOI 10.1016/0896-6273(94)90280-1; Basha R, 2010, INDIAN J EXP BIOL, V48, P636; Lu TH, 2014, TOXICOL LETT, V224, P130, DOI 10.1016/j.toxlet.2013.10.013; Baek DH, 2012, J APPL TOXICOL, V32, P617, DOI 10.1002/jat.1747; Martinez-Finley EJ, 2009, PHARMACOL BIOCHEM BE, V94, P271, DOI 10.1016/j.pbb.2009.09.006; Przedborski S, 2003, J CLIN INVEST, V111, P3, DOI 10.1172/JCI200317522; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; DeFuria J, 2007, BRAIN RES, V1181, P74, DOI 10.1016/j.brainres.2007.04.019; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Liu SX, 2001, P NATL ACAD SCI USA, V98, P1643, DOI 10.1073/pnas.031482998; ITOH T, 1990, TOXICOL LETT, V54, P345; McGuire V, 1997, AM J EPIDEMIOL, V145, P1076; Xi SH, 2009, ARCH TOXICOL, V83, P549, DOI 10.1007/s00204-009-0403-5; Dwivedi N, 2011, TOXICOL APPL PHARM, V256, P241, DOI 10.1016/j.taap.2011.04.004; Liu JT, 2014, TOXICOL APPL PHARM, V281, P243, DOI 10.1016/j.taap.2014.10.007; Rodriguez VM, 2003, TOXICOL LETT, V145, P1, DOI 10.1016/S0378-4274(03)00262-5; Pulido MD, 2003, MUTAT RES-FUND MOL M, V533, P227, DOI 10.1016/j.mrfmmm.2003.07.015; Spielmann Horst, 1997, In Vitro Toxicology, V10, P119; Wolfe MS, 2009, J BIOL CHEM, V284, P6021, DOI 10.1074/jbc.R800013200; O'Bryant SE, 2011, INT J ENV RES PUB HE, V8, P861, DOI 10.3390/ijerph8030861; Genschow E, 2004, ATLA-ALTERN LAB ANIM, V32, P209; Chattopadhyay S, 2002, TOXICOL LETT, V136, P65, DOI 10.1016/S0378-4274(02)00282-5; SHEA TB, 1994, MOL BIOL CELL, V5, P863; Cannon JR, 2011, TOXICOL SCI, V124, P225, DOI 10.1093/toxsci/kfr239; Young-Wolff KC, 2014, ALCOHOL CLIN EXP RES, V38, P241, DOI 10.1111/acer.12226; Marx-Stoelting P, 2009, ATLA-ALTERN LAB ANIM, V37, P313; Aung KH, 2013, NEUROTOXICOLOGY, V34, P226, DOI 10.1016/j.neuro.2012.09.008; ARMON C, 1991, NEUROLOGY, V41, P1077; Buesen R, 2004, ALTEX-ALTERN TIEREXP, V21, P15; CIDARREGUI A, 1995, NEUROBIOL AGING, V16, P239, DOI 10.1016/0197-4580(94)00190-C; Coque E, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00271; FRIEDRICH P, 1990, NEUROSCIENCE, V35, P1, DOI 10.1016/0306-4522(90)90115-K; Goddard M J, 1992, Electromyogr Clin Neurophysiol, V32, P419; Kamel F, 2002, EPIDEMIOLOGY, V13, P311, DOI 10.1097/00001648-200205000-00012; Nakamura K, 2011, METHODOLOGICAL ADV C, P413; Nelson L M, 1995, Clin Neurosci, V3, P327; Rodriguez VM, 2002, NEUROTOXICOL TERATOL, V24, P743, DOI 10.1016/S0892-0362(02)00313-6; SNOW ET, 1992, PHARMACOL THERAPEUT, V53, P31, DOI 10.1016/0163-7258(92)90043-Y; Wang X, 2010, ENVIRON HEALTH PERSP, V118, P627, DOI 10.1289/ehp.0901510; XU ZS, 1993, CELL, V73, P23, DOI 10.1016/0092-8674(93)90157-L	45	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1109	1112				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000005		
J	Ueda, K; Hosokawa, M; Iwakawa, S				Ueda, Kumiko; Hosokawa, Mika; Iwakawa, Seigo			Cellular Uptake of Decitabine by Equilibrative Nucleoside Transporters in HCT116 Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						equilibrative nucleoside transporter; decitabine; uridine	HMLH1 PROMOTER HYPERMETHYLATION; COLON-CANCER; COLORECTAL-CANCER; DRUG-RESISTANCE; DNA METHYLATION; SUPPRESSOR GENE; TUMOR; LINES; 5-AZA-2'-DEOXYCYTIDINE; IRINOTECAN	DNA hypermethylation, an epigenetic change that silences gene expression without altering nucleotide sequences, plays a critical role in the formation and progression of colorectal cancers as well as in the acquisition of drug resistance. Decitabine (DAC), a DNA methyltransferase 1 inhibitor of nucleoside analogues, has been shown to restore gene expression silenced by hypermethylation. In the present study, the mechanisms underlying both uridine and DAC uptake were examined in the human colon cancer cell line HCT116. Real-time polymerase chain reaction analysis revealed that ENT1 mRNA was the most abundant among the nucleoside transporters examined in HCT116 cells. The ENT1 protein was detected in the membrane fraction, as determined by Western blotting. The uptake of uridine or DAC was time- and concentration-dependent, but also Na+-independent. The uptake of these agents was inhibited by S-(4-nitrobenzyl)-6-thioinosine (NBMPR), an inhibitor of equilibrative nucleoside transporters (ENTs), and was also decreased in cells treated with ENT1 small interfering RNA. The uptake of both uridine and DAC was inhibited by uridine, cytidine, adenosine, or inosine, while that of DAC was also inhibited by thymidine. The expression of MAGEA1 mRNA, the DNA of which was methylated in HCT116 cells, was increased by DAC treatment, and this increment was attenuated by concomitant treatment with NBMPR. The IC50 value of DAC was also increased in the presence of NBMPR. These results suggest that DAC is mainly taken up by ENT1 and that this uptake is one of the key determinants of the activity of DAC in HCT116 cells.	[Ueda, Kumiko; Hosokawa, Mika; Iwakawa, Seigo] Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, Kobe, Hyogo 6588558, Japan	Ueda, K (reprint author), Kobe Pharmaceut Univ, Dept Pharmaceut, Higashinada Ku, 4-19-1 Motoyamakita Machi, Kobe, Hyogo 6588558, Japan.	ueda@kobepharma-u.ac.jp					Al-Salihi M, 2011, EPIGENETICS-US, V6, P1021, DOI 10.4161/epi.6.8.16064; YOSHIURA K, 1995, P NATL ACAD SCI USA, V92, P7416, DOI 10.1073/pnas.92.16.7416; Jabbour E, 2008, CANCER, V112, P2341, DOI 10.1002/cncr.23463; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Podgorska M, 2005, ACTA BIOCHIM POL, V52, P749; Huang Y, 2004, CANCER RES, V64, P4294, DOI 10.1158/0008-5472.CAN-03-3884; Ikehata M, 2012, BIOL PHARM BULL, V35, P301; Stresemann C, 2008, INT J CANCER, V123, P8, DOI 10.1002/ijc.23607; Karpf AR, 2004, MOL PHARMACOL, V65, P18, DOI 10.1124/mol.65.1.18; Mackey JR, 1998, CANCER RES, V58, P4349; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Bender CM, 1998, CANCER RES, V58, P95; Arnold CN, 2003, INT J CANCER, V106, P66, DOI 10.1002/ijc.11176; GONZALEZZULUETA M, 1995, CANCER RES, V55, P4531; Plumb JA, 2000, CANCER RES, V60, P6039; Ward JL, 2000, J BIOL CHEM, V275, P8375, DOI 10.1074/jbc.275.12.8375; Goel A, 2012, GASTROENTEROLOGY, V143, P1442, DOI 10.1053/j.gastro.2012.09.032; Choi JS, 2012, FUTURE MED CHEM, V4, P1461, DOI [10.4155/fmc.12.79, 10.4155/FMC.12.79]; Damaraju VL, 2012, NUCLEOS NUCLEOT NUCL, V31, P236, DOI 10.1080/15257770.2011.652330; Hummel-Eisenbeiss J, 2013, MOL PHARMACOL, V84, P438, DOI 10.1124/mol.113.086801; Iikura M, 2012, ANTIMICROB AGENTS CH, V56, P1407, DOI 10.1128/AAC.05762-11; Ishiguro M, 2007, ANN SURG ONCOL, V14, P1752, DOI 10.1245/s10434-006-9285-4; Matsuda A, 2013, JPN J CLIN ONCOL, V43, P328, DOI 10.1093/jjco/hys233; Miyaki Y, 2012, INT J ONCOL, V40, P217, DOI 10.3892/ijo.2011.1189; Roy S, 2012, J STEM CELL RES T S7, VS7, P006; Schneider-Stock R, 2005, J PHARMACOL EXP THER, V312, P525, DOI 10.1124/jpet.104.074195; WILEY JS, 1982, J CLIN INVEST, V69, P479, DOI 10.1172/JCI110472	27	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1113	1119				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000006		
J	Yoshida, Y; Mikami, N; Matsushima, Y; Otani, F; Miyawaki, M; Takatsuji, M; Banno, R; Tsuji, T; Fujita, T; Tsujikawa, K; Kohno, T				Yoshida, Yuya; Mikami, Norihisa; Matsushima, Yuki; Otani, Fumiya; Miyawaki, Mai; Takatsuji, Miku; Banno, Rie; Tsuji, Takumi; Fujita, Tetsuro; Tsujikawa, Kazutake; Kohno, Takeyuki			Functional Mechanism(s) of the Inhibition of Disease Progression by Combination Treatment with Fingolimod Plus Pathogenic Antigen in a Glucose-6-phosphate Isomerase Peptide-Induced Arthritis Mouse Modelle	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						fingolimod; FTY720; rheumatoid arthritis; pathogenic antigen; immune tolerance	T-CELL FUNCTION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOMODULATOR FTY720 FINGOLIMOD; CIRCULATING MATURE LYMPHOCYTES; NONOBESE DIABETIC MICE; IN-VIVO; IMMUNOSUPPRESSIVE ACTIVITY; THERAPEUTIC APPROACH; TOLERANCE; CTLA-4	We previously reported that combination treatment with fingolimod (FTY720) plus antigenic peptide of glucose-6-phosphate isomerase (residues 325-339) (GPI(325-339)) from the onset of symptoms significantly inhibited disease progression in a mouse model of GPI(325-339)-induced arthritis. In this study, we investigated the mechanism(s) involved. The model mice were treated from arthritis onset with FTY720 alone, GPI(325-339) alone, or the combination of FTY720 plus GPI(325-339). At the end of treatment, inguinal lymph nodes (LNs) were excised and examined histologically and in flow cytometry. Levels of apoptotic cells, programmed death-l-expressing CD4(+)forkhead box P3(-) nonregulatory T cells (non-Tregs), and cytotoxic T-lymphocyte antigen 4-expressing non-Tregs in inguinal LNs were markedly increased in the combination treatment group mice. Regulatory T cells (Tregs) were also increased. These results indicate that combination treatment with FTY720 plus GPI(325-339) inhibits the progression of arthritis by inducing clonal deletion and anergy of pathogenic T cells and also by immune suppression via Tregs.	[Yoshida, Yuya; Matsushima, Yuki; Otani, Fumiya; Miyawaki, Mai; Banno, Rie; Tsuji, Takumi; Kohno, Takeyuki] Setsunan Univ, Fac Pharmaceut Sci, Dept Pathol Biochem, Hirakata, Osaka 5730101, Japan; [Mikami, Norihisa; Takatsuji, Miku; Tsujikawa, Kazutake] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Mol & Cellular Physiol, Suita, Osaka 5650871, Japan; [Fujita, Tetsuro; Kohno, Takeyuki] Res Inst Prod & Dev, Sakyo Ku, Kyoto 6060805, Japan	Kohno, T (reprint author), Setsunan Univ, Fac Pharmaceut Sci, Dept Pathol Biochem, 45-1 Nagaotoge Cho, Hirakata, Osaka 5730101, Japan.	kohno@pharm.setsunan.ac.jp			Watanabe Memorial Foundation for Advancement of New Technology	This work was supported in part by Watanabe Memorial Foundation for the Advancement of New Technology.	Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C220176200; Fife BT, 2006, J EXP MED, V203, P2737, DOI 10.1084/jem.20061577; Agata Y, 1996, INT IMMUNOL, V8, P765, DOI 10.1093/intimm/8.5.765; Yoshida Y, 2011, BIOL PHARM BULL, V34, P933; Yamazaki T, 2002, J IMMUNOL, V169, P5538; Yoshida Y, 2013, BIOL PHARM BULL, V36, P1739; Tsuji T, 2012, BIOL PHARM BULL, V35, P1314; Keir ME, 2008, ANNU REV IMMUNOL, V26, P677, DOI 10.1146/annurev.immunol.26.021607.090331; Yanagawa Y, 1998, J IMMUNOL, V160, P5493; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Chiba K, 1998, J IMMUNOL, V160, P5037; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Liu GW, 2010, NAT IMMUNOL, V11, P1047, DOI 10.1038/ni.1939; FUJITA T, 1994, J ANTIBIOT, V47, P208; Scott DL, 2010, LANCET, V376, P1094, DOI 10.1016/S0140-6736(10)60826-4; Kiuchi M, 2000, J MED CHEM, V43, P2946, DOI 10.1021/jm000173z; Wu YQ, 2006, CELL, V126, P375, DOI 10.1016/j.cell.2006.05.042; Freeman GJ, 2000, J EXP MED, V192, P1027, DOI 10.1084/jem.192.7.1027; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; KEARNEY ER, 1994, IMMUNITY, V1, P327, DOI 10.1016/1074-7613(94)90084-1; Tsuji T, 2012, J DIABETES INVEST, V3, P441, DOI 10.1111/j.2040-1124.2012.00218.x; Auchincloss H, 2011, J IMMUNOL, V187, P3457, DOI 10.4049/jimmunol.1102316; Brinkmann V, 2001, TRANSPLANT P, V33, P530, DOI 10.1016/S0041-1345(00)02126-6; Brinkmann V, 2000, TRENDS PHARMACOL SCI, V21, P49, DOI 10.1016/S0165-6147(99)01419-4; Gumanovskaya ML, 1999, IMMUNOLOGY, V97, P466; Iwanami K, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2545; Jiang ZL, 2009, EUR J IMMUNOL, V39, P789, DOI 10.1002/eji.200838427; Kohno T, 2005, BIOL PHARM BULL, V28, P736, DOI 10.1248/bpb.28.736; Kohno T, 2004, BIOL PHARM BULL, V27, P1392, DOI 10.1248/bpb.27.1392; Li HM, 2009, J NEUROIMMUNOL, V208, P54, DOI 10.1016/j.jneuroim.2009.01.002; Perez VL, 1997, IMMUNITY, V6, P411, DOI 10.1016/S1074-7613(00)80284-8; Tsuji T, 2012, J DIABETES INVEST, V3, P132, DOI 10.1111/j.2040-1124.2011.00160.x; Zhang GX, 1999, AUTOIMMUNITY, V31, P219	34	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1120	1125				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000007		
J	Miyajima, C; Itoh, Y; Inoue, Y; Hayashi, H				Miyajima, Chiharu; Itoh, Yuka; Inoue, Yasumichi; Hayashi, Hidetoshi			Positive Regulation of Interleukin-2 Expression by a Pseudokinase, Tribbles 1, in Activated T Cells	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						Tribbles 1 (TRB1); interleukin-2 (IL-2); histone deacetylase (HDAC); nuclear factor of activated T cells (NFAT)	GENE-EXPRESSION; MYELOID LEUKEMOGENESIS; CO-STIMULATION; C/EBP-ALPHA; TRIB1; TRB3; DROSOPHILA; FAMILY; TRANSCRIPTION; DEGRADATION	Tribbles 1 (TRB1), a member of the Tribbles family, is a pseudokinase that is conserved among species and implicated in various human diseases including leukemia, cardiovascular diseases, and metabolic disorders. However, the role of TRB1 in the immune response is not understood. To evaluate this role, we examined regulation of TRB1 expression and the function of TRB1 in interleukin-2 (IL-2) induction in Jurkat cells, a human acute T cell leukemia cell line. We found that TRB1 was strongly induced by phorbol 12-myristate 13-acetate (PMA) and ionomycin in these cells. IL-2 expression was induced in Jurkat cells activated by PMA and ionomycin; however, knockdown of TRB1 resulted in decreased induction of IL-2. TRB1 null Jurkat cells established using the CRISPR/Cas9 system also showed reduction of IL-2 expression on PMA/ionomycin stimulation. TRB1 knockdown also markedly inhibited IL-2 promoter activation. To determine the mechanism of the stimulatory effect on IL-2 induction, we focused on histone deacetylases (HDACs), and found that HDAC1 preferentially interacts with TRB1. TRB1 suppressed the interaction of HDAC1 with nuclear factor of activated T cells 2 (NFAT2), which is a crucial transcription factor for IL-2 induction. These results indicate that TRB1 is a positive regulator of IL-2 induction in activated T cells.	[Miyajima, Chiharu; Itoh, Yuka; Inoue, Yasumichi; Hayashi, Hidetoshi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cell Signaling, Mizuho Ku, Nagoya, Aichi 4678603, Japan	Hayashi, H (reprint author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Cell Signaling, Mizuho Ku, 3-1 Tanabedori, Nagoya, Aichi 4678603, Japan.	hhayashi@phar.nagoya-cu.ac.jp			Japan Society for the Promotion of Science (JSPS) [21590067, 24590085]; Nagoya City University	We thank Dr. Hiroshi Takayanagi, Dr. Eric Verdin, and Dr. Edward Seto for generously providing expression plasmids, and Dr. Satoshi Sakai for discussion of the work. This study was supported by a Grant-in-Aid for Scientific Research (C) (Nos. 21590067, 24590085) from the Japan Society for the Promotion of Science (JSPS), and a Grant-in-Aid for Research in Nagoya City University.	Liang KL, 2013, BLOOD, V121, P4265, DOI 10.1182/blood-2012-12-471300; Kiss-Toth E, 2004, J BIOL CHEM, V279, P42703, DOI 10.1074/jbc.M407732200; Imajo M, 2010, GENES CELLS, V15, P1089, DOI 10.1111/j.1365-2443.2010.01445.x; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Yoshida A, 2013, BLOOD, V122, P1750, DOI 10.1182/blood-2012-12-476101; Yang WM, 1997, J BIOL CHEM, V272, P28001, DOI 10.1074/jbc.272.44.28001; Crispin JC, 2009, AUTOIMMUN REV, V8, P190, DOI 10.1016/j.autrev.2008.07.042; Yamamoto M, 2007, J EXP MED, V204, P2233, DOI 10.1084/jem.20070183; Halterman MW, 2010, J BIOL CHEM, V285, P21329, DOI 10.1074/jbc.M109.095299; Jousse C, 2007, J BIOL CHEM, V282, P15851, DOI 10.1074/jbc.M611723200; Burkhardt R, 2010, J CLIN INVEST, V120, P4410, DOI [10.1172/JCI44213, 10.1172/JC144213]; Rorth P, 2000, MOL CELL, V6, P23; Ishikawa F, 2009, J BIOCHEM, V146, P123, DOI 10.1093/jb/mvp052; Fischle W, 2001, J BIOL CHEM, V276, P35826, DOI 10.1074/jbc.M104935200; ROONEY JW, 1995, MOL CELL BIOL, V15, P6299; Powell JD, 1998, IMMUNOL REV, V165, P287, DOI 10.1111/j.1600-065X.1998.tb01246.x; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Ord D, 2005, BIOCHEM BIOPH RES CO, V330, P210, DOI 10.1016/j.bbrc.2005.02.149; Dugast E, 2013, J BIOL CHEM, V288, P10051, DOI 10.1074/jbc.M112.448654; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Yokoyama T, 2010, BLOOD, V116, P2768, DOI 10.1182/blood-2009-10-246264; Johnstone RW, 2002, NAT REV DRUG DISCOV, V1, P287, DOI 10.1038/nrd772; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Macian F, 2001, ONCOGENE, V20, P2476, DOI 10.1038/sj.onc.1204386; Du KY, 2009, MOL ENDOCRINOL, V23, P475, DOI 10.1210/me.2008-0284; Sung HY, 2007, J BIOL CHEM, V282, P18379, DOI 10.1074/jbc.M610792200; Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Glozak MA, 2005, GENE, V363, P15, DOI 10.1016/j.gene.2005.09.010; Ostertag A, 2010, DIABETES, V59, P1991, DOI 10.2337/db09-1537; Jin GA, 2007, BLOOD, V109, P3998, DOI 10.1182/blood-2006-08-041202; Ashton-Chess J, 2008, J AM SOC NEPHROL, V19, P1116, DOI 10.1681/ASN.2007101056; Meissner JD, 2011, NUCLEIC ACIDS RES, V39, P5907, DOI 10.1093/nar/gkr162; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Dedhia PH, 2010, BLOOD, V116, P1321, DOI 10.1182/blood-2009-07-229450; Satoh T, 2013, NATURE, V495, P524, DOI 10.1038/nature11930; Liao W, 2013, IMMUNITY, V38, P13, DOI 10.1016/j.immuni.2013.01.004; Boyman O, 2012, NAT REV IMMUNOL, V12, P180, DOI 10.1038/nri3156; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Ding JX, 2008, EXP CELL RES, V314, P1566, DOI 10.1016/j.yexcr.2008.01.026; CHEN C, 1987, MOL CELL BIOL, V7, P2745; NAU GJ, 1988, J IMMUNOL, V141, P3557; Soubeyrand S, 2013, BBA-MOL CELL RES, V1833, P3405, DOI 10.1016/j.bbamcr.2013.10.001; Troppmair J, 1994, J BIOL CHEM, V269, P7530	46	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1126	1133				8	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000008		
J	Ito, K; Saito, Y; Ashida, K; Yamaji, T; Itoh, H; Oda, M				Ito, Kentaro; Saito, Yuri; Ashida, Kinya; Yamaji, Taketo; Itoh, Hiroyuki; Oda, Munehiro			Increased Milk Protein Concentration in a Rehydration Drink Enhances Fluid Retention Caused by Water Reabsorption in Rats	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						milk protein; milk protein-enriched drink (MPD); fluid retention; water reabsorption; insulin	COLLECTING DUCT; EXERCISE; DEHYDRATION; INSULIN; RESTORATION; ABSORPTION; BALANCE; PLASMA; CELLS; ACIDS	A fluid-retention effect is required for beverages that are designed to prevent dehydration. That is, fluid absorbed from the intestines should not be excreted quickly; long-term retention is desirable. Here, we focused on the effect of milk protein on fluid retention, and propose a new effective oral rehydration method that can be used daily for preventing dehydration. We first evaluated the effects of different concentrations of milk protein on fluid retention by measuring the urinary volumes of rats fed fluid containing milk protein at concentrations of 1, 5, and 10%. We next compared the fluid-retention effect of milk protein-enriched drink (MPD) with those of distilled water (DW) and a sports drink (SD) by the same method. Third, to investigate the mechanism of fluid retention, we measured plasma insulin changes in rats after ingesting these three drinks. We found that the addition of milk protein at 5 or 10% reduced urinary volume in a dose-dependent manner. Ingestion of the MPD containing 4.6% milk protein resulted in lower urinary volumes than DW and SD. MPD also showed a higher water reabsorption rate in the kidneys and higher concentrations of plasma insulin than DW and SD. These results suggest that increasing milk protein concentration in a beverage enhances fluid retention, which may allow the possibility to develop rehydration beverages that are more effective than SDs. In addition, insulin-modifying renal water reabsorption may contribute to the fluid-retention effect of MPD.	[Ito, Kentaro; Saito, Yuri; Ashida, Kinya; Yamaji, Taketo; Itoh, Hiroyuki] Meiji Co Ltd, R&D Div, Food Sci Res Labs, Odawara, Kanagawa 2500862, Japan; [Oda, Munehiro] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Ito, K (reprint author), Meiji Co Ltd, R&D Div, Food Sci Res Labs, 540 Naruda, Odawara, Kanagawa 2500862, Japan.	kentarou.itou@meiji.com					Nilsson M, 2004, AM J CLIN NUTR, V80, P1246; NADEL ER, 1980, J APPL PHYSIOL, V49, P715; Holliday MA, 1999, PEDIATR NEPHROL, V13, P989; DILL DB, 1974, J APPL PHYSIOL, V37, P247; Maughan RJ, 1997, BRIT J SPORT MED, V31, P175; Osterberg KL, 2010, J APPL PHYSIOL, V108, P245, DOI 10.1152/japplphysiol.91275.2008; MENSINK RP, 1992, ARTERIOSCLER THROMB, V12, P911; BAUM M, 1987, J CLIN INVEST, V79, P1104, DOI 10.1172/JCI112925; DURKOT MJ, 1986, J APPL PHYSIOL, V61, P1031; Shirreffs SM, 2007, BRIT J NUTR, V98, P173, DOI 10.1017/S0007114507695543; Watson P, 2008, EUR J APPL PHYSIOL, V104, P633, DOI 10.1007/s00421-008-0809-4; Bustamante M, 2005, AM J PHYSIOL-RENAL, V288, pF334, DOI 10.1152/ajprenal.00180.2004; CHATTERJEE A, 1978, ARCH DIS CHILD, V53, P284; Intersalt Cooperative Research Group, 1988, BMJ-BRIT MED J, V297, P319, DOI DOI 10.1136/BMJ.297.66; Ishihara Kengo, 2013, J Nutr Sci, V2, pe8, DOI 10.1017/jns.2012.24; James LJ, 2011, BRIT J NUTR, V105, P393, DOI 10.1017/S0007114510003545; LIFSHITZ F, 1985, J PEDIATR-US, V106, P383, DOI 10.1016/S0022-3476(85)80661-2; MAGALDI AJ, 1994, AM J PHYSIOL, V266, pF394; NAGASHIMA K, 1994, JPN J PHARMACOL, V64, P9, DOI 10.1254/jjp.64.9; SUZUKI Y, 1977, FOLIA PHARMACOL JPN, V73, P321, DOI 10.1254/fpj.73.321	20	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1169	1174				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000013		
J	Liu, N; Shi, JF; Xiao, Y; Yasue, M; Takei, Y; Sanefuji, H; Tsujimoto, G; Hirasawa, A				Liu, Ning; Shi, Junfeng; Xiao, Ying; Yasue, Misato; Takei, Yoshinori; Sanefuji, Hayato; Tsujimoto, Gozoh; Hirasawa, Akira			Effects of a Tricaprylin Emulsion on Anti-glomerular Basement Membrane Glomerulonephritis in Rats: In Vivo and in Silico Studies	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						tricaprylin; crescentic glomerulonephritis; microarray; gene ontology	FACTOR-V EXPRESSION; PROTEIN-KINASE CK2; INFILTRATING CELLS; LUPUS NEPHRITIS; GENE ONTOLOGY; FATTY-ACID; DYSFUNCTION; INHIBITOR; SOFTWARE; BIOLOGY	Glomerulonephritis (GN) is a set of pathological conditions that result in the destruction of glomeruli and loss of renal function, commonly leading to the development of end-stage renal disease. Current pharmacotherapy is limited to immunosuppressive therapy. In the present study, we found a novel antinephritic effect of a tricaprylin emulsion in the anti-glomerular basement membrane (anti-GBM) GN rat model. We evaluated the treatment in vivo by comparing administration of the emulsion with administration of a casein kinase II (CK2) inhibitor in this rat model, and performed a gene ontology-based microarray analysis to reveal in silico the detailed mechanism of action. Our results showed that administration of the tricaprylin emulsion, or even tricaprylin alone, significantly ameliorated the anti-GBM antibody-induced renal dysfunction in these rats. We believe that tricaprylin is the key active antinephritic component of the emulsion and might be a promising drug for the effective treatment of nephritis. Moreover, with respect to microarray analysis, we developed a generally applicable and rapid method to compare gene expression profile data for multiple models of nephritis and clinical samples from a public domain microarray database.	[Liu, Ning; Shi, Junfeng; Xiao, Ying; Yasue, Misato; Tsujimoto, Gozoh; Hirasawa, Akira] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto 6068501, Japan; [Takei, Yoshinori] Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Nanobio Drug Discovery, Kyoto 6068501, Japan; [Sanefuji, Hayato] Okamura Isshindow Hosp, Dept Internal Med, Okayama 7048117, Japan; [Hirasawa, Akira] Tokyo Womens Med Univ, Inst Integrated Med Sci, Tokyo 1628666, Japan	Hirasawa, A (reprint author), Kyoto Univ, Grad Sch Pharmaceut Sci, Dept Genom Drug Discovery Sci, Kyoto 6068501, Japan.	akira_h@pharm.kyoto-u.ac.jp			Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO); Targeted Protein Research Program from Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT); Scientific Fund of the MEXT	This study was supported by Fundamental Studies in Health Sciences of the National Institute of Biomedical Innovation (NIBIO; to G.T.), Grants-in-Aid for Scientific Research and Targeted Protein Research Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) (to G.T.) and a Research Grant from the Scientific Fund of the MEXT (to A.H.) Thanks to Dr. Yoshinobu Takakura, Dr. Makiya Nishikawa & Dr. Yuki Takahashi for the emulsion preparation, Ms. Keiko Iida for microarray processing, Mr. Naoya Umeda and Mr. Naoi Okada for microarray data analysis and Ms. Ayako Hirata for the manuscript preparation.	Fu YY, 2007, CLIN IMMUNOL, V124, P109, DOI 10.1016/j.clim.2007.05.007; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Yamada M, 2005, P NATL ACAD SCI USA, V102, P7736, DOI 10.1073/pnas.0409818102; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Scholzen T, 2000, J CELL PHYSIOL, V182, P311, DOI 10.1002/(SICI)1097-4652(200003)182:3<311::AID-JCP1>3.0.CO;2-9; Bartek J, 2003, CANCER CELL, V3, P421, DOI 10.1016/S1535-6108(03)00110-7; Hara T, 2014, BBA-MOL CELL BIOL L, V1841, P1292, DOI 10.1016/j.bbalip.2014.06.002; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Kastantin M, 2010, J PHYS CHEM B, V114, P12632, DOI 10.1021/jp1001786; YOSHIMURA T, 1989, J IMMUNOL, V142, P1956; Grabsch H, 2003, J PATHOL, V200, P16, DOI 10.1002/path.1324; Fassett RG, 2010, AM J KIDNEY DIS, V56, P728, DOI 10.1053/j.ajkd.2010.03.009; Ashburner M, 2000, NAT GENET, V25, P25; Kanehisa M, 2002, NUCLEIC ACIDS RES, V30, P42, DOI 10.1093/nar/30.1.42; Liu K, 2009, J CLIN INVEST, V119, P911, DOI 10.1172/JCI36728; Battistutta R, 2000, J BIOL CHEM, V275, P29618, DOI 10.1074/jbc.M004257200; DIJKSTRA CD, 1985, IMMUNOLOGY, V54, P589; Berthier CC, 2012, J IMMUNOL, V189, P988, DOI 10.4049/jimmunol.1103031; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Chin HJ, 2010, NEPHROL DIAL TRANSPL, V25, P1450, DOI 10.1093/ndt/gfp695; Durvasula RV, 2003, METH MOLEC MED, V86, P47; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; HARBECK RJ, 1986, AM J PATHOL, V123, P204; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; KRAKOWER CA, 1978, P SOC EXP BIOL MED, V159, P324; Li X, 2013, CONTRIB NEPHROL, V181, P229, DOI 10.1159/000348479; Liberato MV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036297; Liu N, 2000, KIDNEY INT, V58, P598, DOI 10.1046/j.1523-1755.2000.00206.x; Liu N, 2004, AM J PHYSIOL-RENAL, V287, pF612, DOI 10.1152/ajprenal.00322.2003; Nakaniwa T, 2009, ACTA CRYSTALLOGR F, V65, P75, DOI 10.1107/S1744309108043194; Ophascharoensuk V, 1998, KIDNEY INT, V54, P416, DOI 10.1046/j.1523-1755.1998.00003.x; Oshida K, 2011, J APPL TOXICOL, V31, P790, DOI 10.1002/jat.1637; Pemberton HN, 2007, J CELL PHYSIOL, V213, P45, DOI 10.1002/jcp.21086; Tipping PG, 2008, NEPHROL DIAL TRANSPL, V23, P3065, DOI 10.1093/ndt/gfn402	35	1	2	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1175	1184				10	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000014		
J	Sakurai, Y; Matsuda, T; Hada, T; Harashima, H				Sakurai, Yu; Matsuda, Takashi; Hada, Tomoya; Harashima, Hideyoshi			Efficient Packaging of Plasmid DNA Using a pH Sensitive Cationic Lipid for Delivery to Hepatocytes	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						plasmid DNA; pH-sensitive lipid; liposome; hepatic delivery	GENE DELIVERY; LIPOSOMAL-SIRNA; SKELETAL-MUSCLE; SYSTEM; LIVER; NANOPARTICLES; TRANSFECTION; MEND; CGAS; RNAI	Plasmid DNA (pDNA) is expected to be a new class of medicine for treating currently incurable diseases. To deliver these nucleic acids, we developed a liposomal delivery system we have called a multifunctional envelope-type nano device (MEND). In this report, we demonstrate that a MEND containing a pH-sensitive cationic lipid, YSK05 (YSK-MEND), efficiently delivered pDNA via systemic injection, and that its expression was highly dependent on the encapsulation state of the pDNA. In the preparation, the pH, ionic strength, and sodium chloride (NaCl) concentration of the lipid/pDNA mixture strongly affected the encapsulation efficiency of pDNA. Additionally, the transgene expression of luciferase in the liver by the injected YSK-MEND was dependent on the encapsulation state of pDNA rather than the nature of the YSK-MEND. Confocal laser scanning microscopy findings revealed that injection of the YSK-MEND led to homogenous gene expression in the liver compared to injection via the hydrodynamic tail vein (HTV). Concerning the safety of the YSK-MEND, a transient increase in the activity of liver enzymes was observed. However, no significant adverse events were observed. Taken together, the YSK-MEND represents a potentially attractive therapy for the treatment of various hepatic diseases.	[Sakurai, Yu; Matsuda, Takashi; Hada, Tomoya; Harashima, Hideyoshi] Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Sapporo, Hokkaido 0600812, Japan	Harashima, H (reprint author), Hokkaido Univ, Fac Pharmaceut Sci, Kita Ku, Kita 12,Nishi 6, Sapporo, Hokkaido 0600812, Japan.	harasima@pharm.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) [25893001]; Ministry of Health, Labour and Welfare (MHLW) of Japan	This study was supported in part by Grant-in-Aid for Young Scientists (Start-up) from Japan Society for the Promotion of Science (JSPS) (Grant No. 25893001) and a Grant-in-Aid for Research on Medical Device Development from the Ministry of Health, Labour and Welfare (MHLW) of Japan. We thank Dr. Milton S. Feather for his helpful advice in writing the English manuscript.	Akinc A, 2014, MOL THER, V18, P1357; Suda T, 2007, MOL THER, V15, P2063, DOI 10.1038/sj.mt.6300314; Wasungu L, 2006, J CONTROL RELEASE, V116, P255, DOI 10.1016/j.jconrel.2006.06.024; Sakurai Y, 2013, MOL THER, V21, P1195, DOI 10.1038/mt.2013.57; Yasuzaki Y, 2013, J CONTROL RELEASE, V172, P805, DOI 10.1016/j.jconrel.2013.09.029; Harvie P, 2000, J PHARM SCI, V89, P652, DOI 10.1002/(SICI)1520-6017(200005)89:5<652::AID-JPS11>3.3.CO;2-8; Cai X, 2014, MOL CELL, V54, P289, DOI 10.1016/j.molcel.2014.03.040; Jacobs F, 2010, AM J PATHOL, V176, P14, DOI 10.2353/ajpath.2010.090136; Liu F, 1999, GENE THER, V6, P1258, DOI 10.1038/sj.gt.3300947; Civril F, 2013, NATURE, V498, P332, DOI 10.1038/nature12305; Johansson HO, 2012, J CHROMATOGR A, V1233, P30, DOI 10.1016/j.chroma.2012.02.028; Sakurai Y, 2014, J CONTROL RELEASE, V173, P110, DOI 10.1016/j.jconrel.2013.10.003; Sato Y, 2012, J CONTROL RELEASE, V163, P267, DOI 10.1016/j.jconrel.2012.09.009; Akinc A, 2009, MOL THER, V17, P872, DOI 10.1038/mt.2009.36; Hatakeyama H, 2011, ADV DRUG DELIVER REV, V63, P152, DOI 10.1016/j.addr.2010.09.001; Park HJ, 2012, ADV DRUG DELIVER REV, V64, P40, DOI 10.1016/j.addr.2011.09.005; SCHLICK T, 1994, BIOPHYS J, V67, P2146; Jeffs LB, 2005, PHARM RES, V22, P362, DOI 10.1007/s11095-004-1873-z; Sakurai Y, 2014, MOL PHARMACEUT, V11, P2713, DOI 10.1021/mp500245z; Hayashi Y, 2014, MOL THER-NUCL ACIDS, V3, pe154; Jacobs F, 2008, GENE THER, V15, P594, DOI 10.1038/sj.gt.3303096; Khalil IA, 2011, J CONTROL RELEASE, V156, P374, DOI 10.1016/j.jconrel.2011.08.012; Mui BL, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.66; Sato S, 2015, IMMUNITY, V42, P123, DOI 10.1016/j.immuni.2014.12.016; Ukawa M, 2014, ADV HEALTHC MATER, V3, P1222, DOI 10.1002/adhm.201300629; Wells DJ, 2004, MOL THER, V10, P207, DOI 10.1016/mthe.2004.2382	26	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1185	1191				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000015		
J	Ikesue, H; Watanabe, H; Hirano, M; Chikamori, A; Suetsugu, K; Ryokai, Y; Egashira, N; Yamada, T; Ikeda, M; Iwama, E; Harada, T; Takayama, K; Nakanishi, Y; Masuda, S				Ikesue, Hiroaki; Watanabe, Hiroyuki; Hirano, Megumi; Chikamori, Ayako; Suetsugu, Kimitaka; Ryokai, Yuriko; Egashira, Nobuaki; Yamada, Tsuyoshi; Ikeda, Munehiko; Iwama, Eiji; Harada, Taishi; Takayama, Koichi; Nakanishi, Yoichi; Masuda, Satohiro			Risk Factors for Predicting Severe Neutropenia Induced by Pemetrexed Plus Carboplatin Therapy in Patients with Advanced Non-small Cell Lung Cancer	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						pemetrexed; carboplatin; neutropenia; risk factor; neutrophil; hemoglobin	FEBRILE NEUTROPENIA; PHASE-III; HEMATOLOGICAL TOXICITY; 1ST-LINE CHEMOTHERAPY; GEMCITABINE; INTERLEUKIN-6; BEVACIZUMAB; COMBINATION; PACLITAXEL; CISPLATIN	Pemetrexed plus carboplatin therapy is widely administered to patients with non-squamous non-small cell lung cancer. Although severe neutropenia is often observed during this combination therapy, its predictive factors are unknown. Therefore, we investigated the predictive factors for severe neutropenia in 77 patients treated with this combination therapy at the Department of Respiratory Medicine, Kyushu University Hospital, between September 2009 and September 2013. All data were retrospectively collected from the electronic medical record system, and univariate and multivariate logistic regression analyses were performed to identify risk factors for grade 3 or 4 neutropenia. Among the 77 patients, 34 (44%) developed grade 3 or 4 neutropenia. Multivariate analysis revealed that lower baseline hemoglobin values (odds ratio [OR], 1.97 per 1 g/dL decrease; 95% confidence interval [CI], 1.39-2.99, p<0.01) and lower baseline neutrophil counts (OR, 1.71 per 1000/mm(3) decrease; 95% CI, 1.14-2.71, p=0.01) were significantly associated with grade 3 or 4 neutropenia. During 4 courses of pemetrexed plus carboplatin therapy, the incidence of grade 3 or 4 neutropenia in patients with baseline hemoglobin values of <11.6 g/dL was significantly higher than that in patients with values of >= 11.6g/dL [84% (16/19) vs. 31% (18/58), p<0.001]. In conclusion, patients with lower baseline neutrophil counts or lower baseline hemoglobin values, especially those with baseline hemoglobin values of <11.6 g/dL, should be monitored more carefully during pemetrexed plus carboplatin therapy.	[Ikesue, Hiroaki; Watanabe, Hiroyuki; Hirano, Megumi; Chikamori, Ayako; Suetsugu, Kimitaka; Ryokai, Yuriko; Egashira, Nobuaki; Masuda, Satohiro] Kyushu Univ Hosp, Dept Pharm, Higashi Ku, Fukuoka 8128582, Japan; [Egashira, Nobuaki; Masuda, Satohiro] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Clin Pharmacol & Biopharmaceut, Higashi Ku, Fukuoka 8128582, Japan; [Yamada, Tsuyoshi] Oita Prefectural Hosp, Dept Pharm, Oita 8708511, Japan; [Ikeda, Munehiko] Saiseikai Fukuoka Gen Hosp, Dept Pharm, Chuo Ku, Fukuoka 8100001, Japan; [Iwama, Eiji] Kyushu Univ, Fac Med Sci, Dept Comprehens Clin Oncol, Higashi Ku, Fukuoka 8128582, Japan; [Iwama, Eiji; Harada, Taishi; Takayama, Koichi; Nakanishi, Yoichi] Kyushu Univ, Grad Sch Med Sci, Res Inst Dis Chest, Higashi Ku, Fukuoka 8128582, Japan	Ikesue, H (reprint author), Kyushu Univ Hosp, Dept Pharm, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ikesue@pharm.med.kyushu-u.ac.jp	Masuda, Satohiro/E-6691-2010	Masuda, Satohiro/0000-0002-3589-5989	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; Japan Research Foundation for Clinical Pharmacology	This study was supported in part by a Grant-in-Aid for Scientific Research (KAKENHI) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan and a Grant-in-Aid from the Japan Research Foundation for Clinical Pharmacology.	Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; [Anonymous], 2014, PROD INF AL PEM INJ; Ramalingam SS, 2008, J CLIN ONCOL, V26, P60, DOI 10.1200/JCO.2007.13.1144; Gronberg BH, 2009, J CLIN ONCOL, V27, P3217, DOI 10.1200/JCO.2008.20.9114; Phippen NT, 2011, GYNECOL ONCOL, V123, P360, DOI 10.1016/j.ygyno.2011.07.093; Patel JD, 2013, J CLIN ONCOL, V31, P4349, DOI 10.1200/JCO.2012.47.9626; Alexandre J, 2003, ANN ONCOL, V14, P36, DOI 10.1093/annonc/mdg013; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Go RS, 1999, J CLIN ONCOL, V17, P409; Kuroda K, 2007, UROLOGY, V69, P113, DOI 10.1016/j.urology.2006.09.039; Matsubara J, 2009, J CLIN ONCOL, V27, P2261, DOI 10.1200/JCO.2008.19.9745; Center for Cancer Control and Information Service. National Cancer Center Japan, CANC STAT JAP 2013; Chan A, 2013, SUPPORT CARE CANCER, V21, P2137, DOI 10.1007/s00520-013-1768-9; Chan A, 2014, SUPPORT CARE CANCER, V22, P1105, DOI 10.1007/s00520-013-2067-1; Jenkins P, 2009, ANN ONCOL, V20, P34, DOI 10.1093/annonc/mdn560; Kanazawa K, 2014, CANCER CHEMOTH PHARM, V74, P1149, DOI 10.1007/s00280-014-2589-3; Kao SCH, 2010, CURR DRUG TARGETS, V11, P48; Kim YH, 2012, CANCER CHEMOTH PHARM, V70, P271, DOI 10.1007/s00280-012-1910-2; Kurata T, 2014, DRUG METAB PHARMACOK, V29, P148, DOI 10.2133/dmpk.DMPK-13-RG-042; Maccio A, 2005, BLOOD, V106, P362, DOI 10.1182/blood-2005-01-0160; National Comprehensive Cancer Network (NCCN), NCCN CLIN PRACT GUID; Okamoto I, 2013, INVEST NEW DRUG, V31, P1275, DOI 10.1007/s10637-013-9941-z; Okubo Sumiko, 2014, Gan To Kagaku Ryoho, V41, P475; Sakata Y, 2013, YAKUGAKU ZASSHI, V133, P1209; Salar A, 2012, LEUKEMIA RES, V36, P548, DOI 10.1016/j.leukres.2012.02.002; Sweeney CJ, 2006, CLIN CANCER RES, V12, P536, DOI 10.1158/1078-0432.CCR-05-1834; The Japan Lung Cancer Society, 2015, 1 LIN TREATM STAG 4; Watanabe H, 2012, CHEMOTHERAPY, V58, P419, DOI 10.1159/000345617; Yokoi T, 2014, ONCOL LETT, V8, P2453, DOI 10.3892/ol.2014.2552	29	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1192	1198				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000016		
J	Takahashi, T; Takano, M; Kurebayashi, Y; Agarikuchi, T; Suzuki, C; Fukushima, K; Takahashi, S; Otsubo, T; Ikeda, K; Minami, A; Suzuki, T				Takahashi, Tadanobu; Takano, Maiko; Kurebayashi, Yuuki; Agarikuchi, Takashi; Suzuki, Chihiro; Fukushima, Keijo; Takahashi, Shunsaku; Otsubo, Tadamune; Ikeda, Kiyoshi; Minami, Akira; Suzuki, Takashi			Rapid Fluorescent Detection Assay for Human Parainfluenza Viruses	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						human parainfluenza virus (hPIV); sialidase activity; fluorescent visualization; histochemical staining; 2-(benzothiazol-2-yl)-4-bromophenyl 5-acetamido-3,5-dideoxy-alpha-D-glycero-D-galacto-2-nonulopyranosidonic acid (BTP3-Neu5A)	HEMAGGLUTININ-NEURAMINIDASE; SENDAI VIRUS; SIALIDASE SUBSTRATE; PLAQUE-FORMATION; TYPE-1; CELLS; ACID; INHIBITION; KIDNEY; MONKEY	Human parainfluenza virus type 1 (hPIV1) does not form clear plaque by the conventional plaque formation assay because of slightly a cytopathic effects in many cell lines infected with hPIV1, thus making in virus titration, isolation and inhibitor evaluation difficult. We have succeeded in fluorescent histochemical visualization of sialidase activities of influenza A and B viruses, Newcastle disease virus and Sendai virus by using a novel fluorescent sialidase substrate, 2-(benzothiazol-2-yl)-4-bromophenyl 5-acetamido-3,5-dideoxy-alpha-D-glycero-D-galacto-2-nonulopyranosidonic acid (BTP3-Neu5Ac). In this study, we applied the BTP3-Neu5Ac assay for rapid detection of hPIV1 and hPIV type 3. The BTP3-Neu5Ac assay could histochemically visualize dot-blotted hPIVs on a membrane and hPIV-infected cells as local fluorescence under UV irradiation. We succeeded in distinct fluorescent visualization of hPIV1-infected cells in only 3d using the BTP3Neu5Ac assay. Due to there being no fixation, hPIV1 was isolated directly from fluorescent stained focus cells by the BTP3-Neu5Ac assay. Establishment of a sensitive, easy, and rapid fluorescent focus detection assay for hPIV, hPIV1 in particular will contribute greatly to progress in hPIV studies.	[Takahashi, Tadanobu; Takano, Maiko; Kurebayashi, Yuuki; Agarikuchi, Takashi; Suzuki, Chihiro; Fukushima, Keijo; Takahashi, Shunsaku; Minami, Akira; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan; [Otsubo, Tadamune; Ikeda, Kiyoshi] Hiroshima Int Univ, Sch Pharmaceut Sci, Dept Organ Chem, Kure, Hiroshima 7370112, Japan	Suzuki, T (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp			Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering; Kurata Memorial Hitachi Science and Technology Foundation; Futaba Electronics Memorial Foundation; Tokai Foundation for Technology; Takahashi Industrial and Economic Research Foundation; Izumi Science and Technology Foundation; Shimabara Science Promotion Foundation; Research Foundation for the Electrotechnology of Chubu; Tokyo Biomarker Innovation Research Association (TOBIRA); Japan Foundation for Aging and Health; Pharmacological Research Foundation, Tokyo; University of Shizuoka; JSPS KAKENHI Grant Numbers Challenging Exploratory Research [26670064]; Young Scientists (A) [15H05644]	We thank Dr. Allen Portner (St. Jude Children's Research Hospital) for providing virus strains. This work was in part supported by a Grant from Nakatani Foundation for Advancement of Measuring Technologies in Biomedical Engineering, the Kurata Memorial Hitachi Science and Technology Foundation, the Futaba Electronics Memorial Foundation, Tokai Foundation for Technology, Takahashi Industrial and Economic Research Foundation, Izumi Science and Technology Foundation, The Shimabara Science Promotion Foundation, Research Foundation for the Electrotechnology of Chubu, Tokyo Biomarker Innovation Research Association (TOBIRA), Japan Foundation for Aging and Health, The Pharmacological Research Foundation, Tokyo, University of Shizuoka, and JSPS KAKENHI Grant Numbers Challenging Exploratory Research 26670064 and Young Scientists (A) 15H05644. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	McKimm-Breschkin JL, 2004, J VIROL METHODS, V120, P113, DOI 10.1016/j.jviromet.2004.02.020; Takahashi T, 2014, J VIROL METHODS, V209, P136, DOI 10.1016/j.jviromet.2014.09.010; Otsubo T, 2013, BIOORG MED CHEM LETT, V23, P2245, DOI 10.1016/j.bmcl.2013.01.043; Henrickson KJ, 2003, CLIN MICROBIOL REV, V16, P242, DOI 10.1128/CMR.16.2.242-264.2003; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Takano M, 2014, VIROLOGY, V464, P206, DOI 10.1016/j.virol.2014.04.005; Fukushima K, 2011, BIOL PHARM BULL, V34, P996; Fukushima K, 2014, VIROLOGY, V464, P424, DOI 10.1016/j.virol.2014.07.033; Kurebayashi Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep04877; MERZ DC, 1981, VIROLOGY, V112, P296, DOI 10.1016/0042-6822(81)90635-8; Minami A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0081941; MOSCONA A, 1993, J VIROL, V67, P6463; Sato K, 2007, TETRAHEDRON, V63, P7571, DOI 10.1016/j.tet.2007.05.049; SCHEID A, 1976, VIROLOGY, V69, P265, DOI 10.1016/0042-6822(76)90213-0; SHIBUTA H, 1971, JPN J MICROBIOL, V15, P175; Sinaniotis C A, 2004, Paediatr Respir Rev, V5 Suppl A, pS197, DOI 10.1016/S1526-0542(04)90037-1; SUGITA K, 1974, JPN J MICROBIOL, V18, P262; Suzuki T, 2001, GLYCOCONJUGATE J, V18, P331, DOI 10.1023/A:1013617232576; Takahashi T, 2014, BIOL PHARM BULL, V37, P1668; Tao T, 1998, J VIROL, V72, P2955; Tappert MM, 2011, J VIROL, V85, P12146, DOI 10.1128/JVI.05537-11; Wang ZM, 2001, J VIROL METHODS, V98, P53, DOI 10.1016/S0166-0934(01)00355-X	22	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1214	1219				6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000019		
J	Takahashi, T; Kawagishi, S; Funahashi, H; Hayashi, N; Suzuki, T				Takahashi, Tadanobu; Kawagishi, Sawako; Funahashi, Hiroki; Hayashi, Nonoka; Suzuki, Takashi			Production and Purification of Secretory Simian Cytidine Monophosphate-N-acetylneuraminic Acid Hydroxylase Using Baculovirus-Protein Expression System	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						N-glycolylneuraminic acid; N-acetylneuraminic acid (Neu5Ac); baculovirus; cytidine monophosphate N-acetylneuraminic acid hydroxylase (CMAH); secretory protein	INFLUENZA-A VIRUS; GLYCOLYLNEURAMINIC ACID; SIALIC-ACID; GLYCOPROTEINS; SULFATIDE	Cytidine monophosphate (CMP) N-acetylneuraminic acid (Neu5Ac) hydroxylase (CMAH) is an essential enzyme for N-glycolylneuraminic acid (Neu5Gc) synthesis. In humans, Neu5Gc cannot be synthesized because of a deletion in the CMAH gene. Since Neu5Gc research has not been actively performed in comparison with Neu5Ac research, little is known about the function of Neu5Gc. Possible reasons are that CMAH for controlling Neu5Gc synthesis is not understood well at the molecular level, that commercial Neu5Gc is expensive, and that addition of exogenous Neu5Gc to glycoconjugates is not a general method because of the difficulty in obtaining CMAH. One solution to these problems is to achieve large-scale production of CMAH with enzymatic activity. To produce and purify CMAH as simply as possible, we generated simian CMAH as a secretory protein with a histidine tag using a baculovirus protein expression system. After culture of baculovirus-infected cells in serum-free medium, secretory simian CMAH (approximately 180 mu g) was highly purified from the supernatant (150 mL) of cell culture. HPLC analysis showed conversion of CMP-Neu5Ac to CMP-Neu5Gc by the secretory CMAH. We succeeded in producing secretory CMAH with enzymatic activity that is easy to purify. In addition, peptide-N-glycosidase F treatment of CMAH indicated that secretory CMAH was a glycoprotein with N-glycan. It will also contribute to research on Neu5Gc function by easy-to-use methods for controlling Neu5Gc synthesis, for exogenous addition of Neu5Gc to glycoconjugates and by application to industrial Neu5Gc synthesis.	[Takahashi, Tadanobu; Kawagishi, Sawako; Funahashi, Hiroki; Hayashi, Nonoka; Suzuki, Takashi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan	Suzuki, T (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Biochem, Shizuoka 4228526, Japan.	suzukit@u-shizuoka-ken.ac.jp			Global COE Program from the Japan Society for the Promotion of Science; JSPS KAKENHI [23590549, 26670064, 15H05644]; Hokuto Foundation for Bioscience; Showa University Medical Foundation; Uehara Memorial Foundation; Foundation for Promotion of Material Science and Technology of Japan; Waksman Foundation of Japan; Research Foundation for Pharmaceutical Sciences; Takeda Science Foundation; Tokyo Biochemical Research Foundation; Hamamatsu Scientific Research Foundation; Japan Science Society; Adaptable and Seamless Technology Transfer Program (Astep) through Target-driven RD; JST	This work was supported in part by the Global COE Program from the Japan Society for the Promotion of Science and by JSPS KAKENHI Grant Number (Scientific Research C, 23590549; Challenging Exploratory Research, 26670064; Young Scientists A, 15H05644), Grantsin-Aid from Hokuto Foundation for Bioscience, Showa University Medical Foundation, the Uehara Memorial Foundation, Foundation for Promotion of Material Science and Technology of Japan, The Waksman Foundation of Japan, the Research Foundation for Pharmaceutical Sciences, Takeda Science Foundation, the Tokyo Biochemical Research Foundation, the Hamamatsu Scientific Research Foundation, the Sasakawa Scientific Research Grant from The Japan Science Society and Adaptable and Seamless Technology Transfer Program (Astep) through Target-driven R&D, JST.	Byres E, 2008, NATURE, V456, P648, DOI 10.1038/nature07428; Hedlund M, 2007, MOL CELL BIOL, V27, P4340, DOI 10.1128/MCB.00379-07; Naito Y, 2007, MOL CELL BIOL, V27, P3008, DOI 10.1128/MCB.02047-06; Malykh YN, 2001, BIOCHIMIE, V83, P623, DOI 10.1016/S0300-9084(01)01303-7; Takahashi T, 2008, J VIROL, V82, P5940, DOI 10.1128/JVI.02496-07; Suzuki Y, 2000, J VIROL, V74, P11825, DOI 10.1128/JVI.74.24.11825-11831.2000; Irie A, 1998, J BIOL CHEM, V273, P15866, DOI 10.1074/jbc.273.25.15866; Hedlund M, 2008, P NATL ACAD SCI USA, V105, P18936, DOI 10.1073/pnas.0803943105; Ghaderi D, 2010, NAT BIOTECHNOL, V28, P863, DOI 10.1038/nbt.1651; HARA S, 1987, ANAL BIOCHEM, V164, P138, DOI 10.1016/0003-2697(87)90377-0; Chou HH, 1998, P NATL ACAD SCI USA, V95, P11751, DOI 10.1073/pnas.95.20.11751; Ito T, 2000, VIROL J, V74, P9300; Suzuki T, 1997, FEBS LETT, V404, P192, DOI 10.1016/S0014-5793(97)00127-0; Takahashi T, 2010, J BIOCHEM, V147, P459, DOI 10.1093/jb/mvq013; Takahashi T, 2009, FEBS LETT, V583, P3171, DOI 10.1016/j.febslet.2009.08.037; Tangvoranuntakul P, 2003, P NATL ACAD SCI USA, V100, P12045, DOI 10.1073/pnas.2131556100; Varki A, 2001, Am J Phys Anthropol, VSuppl 33, P54	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1220	1226				7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000020		
J	Koizumi, N; Yamagishi, Y; Hirai, T; Fujii, M; Mizuguchi, H; Watanabe, Y				Koizumi, Naoya; Yamagishi, Yoshiaki; Hirai, Takamasa; Fujii, Makiko; Mizuguchi, Hiroyuki; Watanabe, Yoshiteru			Efficient Adenovirus Gene Transfer Methods in Human Colonic Caco-2 Epithelial Cells Using Capric Acid	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						gene transfer; adenovirus vector; coxsackievirus and adenovirus receptor; Caco-2 monolayer; capric acid	TIGHT JUNCTION; RECEPTOR; VECTORS; INTEGRIN; BINDING; COXSACKIEVIRUS	Adenovirus (Ad) vectors are widely used in gene therapy and in vitro/in vivo gene transfer. However, Ad-mediated gene transfer in epithelial cells shows low efficiency, because Ad fiber cannot bind to the primary receptor, the coxsackievirus and adenovirus receptor (CAR), present in tight junctions. Caco-2 monolayer cells cultured on Transwell-chamber plates for approximately 2 weeks are widely used for drug membrane permeation studies, but Ad-mediated gene transfer is difficult in Caco-2 monolayer cells. First, we examined the efficiency of gene transfer into Caco-2 monolayer cells. Luciferase production in cultured Caco-2 cells transduced with Ad vectors was 20-fold lower on day 12 than on day 1. In contrast, the expression of CAR protein in Caco-2 cells gradually increased along with the duration of culture. For efficient gene transfer into Caco-2 monolayer cells, the binding ability of Ad vectors with CAR was found to be important. Capric acid (C10), a medium-chain fatty acid is a tight-junction modulator used as a pharmaceutical agent. We found that a novel gene transfer method using transduction with Ad vectors in the presence of C10 led more efficiently to LacZ expression in Caco-2 monolayer cells than Ad vectors alone. The results of the present study indicate that C10 could be very useful for Ad-mediated gene transfer in human colonic Caco-2 epithelial cells.	[Koizumi, Naoya; Yamagishi, Yoshiaki; Hirai, Takamasa; Fujii, Makiko; Watanabe, Yoshiteru] Showa Pharmaceut Univ, Dept Pharmaceut & Biopharmaceut, Machida, Tokyo 1948543, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, Lab Biochem & Mol Biol, Suita, Osaka 5650871, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Grad Sch Pharmaceut Sci, iPS Cell Based Res Project Hepat Tox & Metab, Suita, Osaka 5650871, Japan; [Mizuguchi, Hiroyuki] Osaka Univ, Ctr Adv Med Engn & Informat, Suita, Osaka 5650871, Japan	Koizumi, N (reprint author), Showa Pharmaceut Univ, Dept Pharmaceut & Biopharmaceut, 3-3165 Higashitamagawagakuen, Machida, Tokyo 1948543, Japan.	koizumi@ac.shoyaku.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21590178, 19790135]	This work was partly supported by a Grant-in-Aid for Scientific Research C (21590178) and Grant-in-Aid for Young Scientists B (19790135) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Koizumi N, 2003, J VIROL, V77, P13062, DOI 10.1128/JVI.77.24.13062-13072.2003; Bergelson JM, 1997, SCIENCE, V275, P1320, DOI 10.1126/science.275.5304.1320; Cohen CJ, 2001, P NATL ACAD SCI USA, V98, P15191, DOI 10.1073/pnas.261452898; MAIZEL JV, 1968, VIROLOGY, V36, P115, DOI 10.1016/0042-6822(68)90121-9; Grotz N, 1998, P NATL ACAD SCI USA, V95, P7220, DOI 10.1073/pnas.95.12.7220; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Lindmark T, 1998, J PHARMACOL EXP THER, V284, P362; BAI M, 1993, J VIROL, V67, P5198; Coyne CB, 2000, AM J RESP CELL MOL, V23, P602; Kesisoglou F, 2006, J GENE MED, V8, P1379, DOI 10.1002/jgm.981; Koizumi N, 2006, HUM GENE THER, V17, P264, DOI 10.1089/hum.2006.17.264; Mizuguchi H, 2002, GENE THER, V9, P769, DOI 10.1038/sj/gt/3301701; Pickles RJ, 1998, J VIROL, V72, P6014; Walter E, 1997, PHARMACEUT RES, V14, P1216, DOI 10.1023/A:1012163025455; Zabner J, 1997, J CLIN INVEST, V100, P1144, DOI 10.1172/JCI119625	15	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1240	1244				5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000023		
J	El Hamd, MA; Wada, M; Ikeda, R; Kawakami, S; Nakashima, K				El Hamd, Mohamed Abo; Wada, Mitsuhiro; Ikeda, Rie; Kawakami, Shigeru; Nakashima, Kenichiro			Validation of an LC-MS/MS Method for the Determination of Propofol, Midazolam, and Carbamazepine in Rat Plasma: Application to Monitor Their Concentrations Following Co-administration	BIOLOGICAL & PHARMACEUTICAL BULLETIN			English	Article						propofol (PRO); midazolam (MDZ); carbamazepine (CBZ); pharmacokinetic interaction; rat plasma	PHARMACOKINETICS; METABOLISM	Propofol (PRO) is a hypnotic used to induce and maintain general anesthesia. A risk of drug drug interactions exists in cases of clinical co-administration of PRO and midazolam (MDZ) or carbamazepine (CBZ). Therefore a sensitive and rapid assay is needed to monitor these drugs. In this study, a sensitive and selective liquid chromatography-tandem mass spectrometry technique was developed for simultaneous determination of PRO, MDZ, and CBZ in plasma. Simultaneous selected reaction monitoring in the positive and negative ionization modes was used for mass detection. Analytes were isolated from plasma samples by a simple, economic, and rapid solid-phase extraction method. Chromatographic separations were achieved using a Chromolith Performance RP-18e analytical column (100x4.6mm i.d.) with a mixture of acetonitrile ammonium acetate buffer (10 111114, pH 3.5) (90:10, v/v) as the mobile phase. The method was fully validated for PRO, MDZ, and CBZ over concentrations ranging at 1-100, 2-100, and 7-1000 ng/mL, respectively, with acceptable validation parameters. Furthermore, the method was applied to monitor PRO and MDZ or CBZ following co-administration in rats.	[El Hamd, Mohamed Abo; Ikeda, Rie; Kawakami, Shigeru] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528131, Japan; [Wada, Mitsuhiro] Kyushu Univ Hlth & Welf, Fac Pharmaceut Sci, Nobeoka, Miyazaki 8828508, Japan; [Nakashima, Kenichiro] Nagasaki Int Univ, Fac Pharmaceut Sci, Sasebo, Nagasaki 8593298, Japan	Wada, M (reprint author), Kyushu Univ Hlth & Welf, Fac Pharmaceut Sci, 1714-1 Yoshino Cho, Nobeoka, Miyazaki 8828508, Japan.	m-wada@phoenix.ac.jp					Anderson J, 2010, CLIN MED, V10, P54; Miekisch W, 2008, CLIN CHIM ACTA, V395, P32, DOI 10.1016/j.cca.2008.04.021; Albani F, 1995, PHARMACOPSYCHIATRY, V28, P235, DOI 10.1055/s-2007-979609; Bernus I, 1996, EPILEPSY RES, V24, P163, DOI 10.1016/0920-1211(96)00011-3; Deleu D, 2001, EUR J CLIN PHARMACOL, V57, P243, DOI 10.1007/s002280100300; El Hamd MA, 2015, BIOMED CHROMATOGR, V29, P325, DOI 10.1002/bmc.3281; Food and Drug Administration (FDA), 2013, GUID IND EF POL REG, P1; GHONEIM MM, 1977, CLIN PHARMACOKINET, V2, P344, DOI 10.2165/00003088-197702050-00003; Gratrix A P, 2005, CONTIN ED ANAESTH CR, V5, P118, DOI 10.1093/bjaceaccp/mki032; Guitton J, 1998, BRIT J ANAESTH, V80, P788; Hamaoka N, 1999, CLIN PHARMACOL THER, V66, P110, DOI 10.1053/cp.1999.v66.100038001; Johannessen L.C., 2010, EXPERT REV NEUROTHER, V10, P119; John R, 2014, CARBAMAZEPINE WATCH; Medhi B, 2011, INDIAN J PHARMACOL, V43, P73, DOI 10.4103/0253-7613.75675; Nordt Sean Patrick, 1997, Journal of Emergency Medicine, V15, P357, DOI 10.1016/S0736-4679(97)00022-X; Ragno G, 1997, J PHARMACEUT BIOMED, V15, P1633, DOI 10.1016/S0731-7085(96)01946-2; Vuyk J, 2009, ANESTH ANALG, V108, P1522, DOI 10.1213/ane.0b013e31819e4058	17	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0918-6158			BIOL PHARM BULL	Biol. Pharm. Bull.	AUG	2015	38	8					1250	1253				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO0DJ	WOS:000358820000025		
J	Choi, HJ; Lee, HC; Kang, KS; Lee, HG; Ono, T; Nagai, H; Sheng, G; Han, JY				Choi, Hee Jung; Lee, Hyung Chul; Kang, Kyung Soo; Lee, Hyo Gun; Ono, Tamao; Nagai, Hiroki; Sheng, Guojun; Han, Jae Yong			Production of Interspecific Germline Chimeras via Embryo Replacement	BIOLOGY OF REPRODUCTION			English	Article						chicken; embryo replacement; interspecies germline chimera; primordial germ cell; quail	AVIAN YOLK-SAC; STEM-CELLS; IN-VITRO; RECIPIENT EMBRYOS; LINE CHIMERA; CHICKEN; QUAIL; TRANSPLANTATION; TRANSMISSION; MIGRATION	In avian species, primordial germ cells (PGCs) use the vascular system to reach their destination, the genital ridge. Because of this unique migratory route of avian germ cells, germline chimera production can be achieved via germ cell transfer into a blood vessel. This study was performed to establish an alternative germ cell-transfer system for producing germline chimeras by replacing an original host embryo with a donor embryo, while retaining the host extraembryonic tissue and yolk, before circulation. First, to test the migratory capacity of PGCs after embryo replacement, Korean Oge (KO) chick embryos were used to replace GFP transgenic chick embryos. Four days after replacement, GFP-positive cells were detected in the replaced KO embryonic gonads, and genomic DNA PCR analysis with the embryonic gonads demonstrated the presence of the GFP transgene. To produce an interspecific germline chimera, the original chick embryo proper was replaced with a quail embryo onto the chick yolk. To detect the gonadal PGCs in the 5.5-day-old embryonic gonads, immunohistochemistry was performed with monoclonal antibodies specific to either quail or chick PGCs, i.e., QCR1 and anti-stage-specific embryonic antigen-1 (SSEA-1), respectively. Both the QCR1-positive and SSEA-1-positive cells were detected in the gonads of replaced quail embryos. Forty percent of the PGC population in the quail embryos was occupied by chick extraembryonically derived PGCs. In conclusion, replacement of an embryo onto the host yolk before circulation can be applied to produce interspecies germline chimeras, and this germ cell-transfer technology is potentially applicable for reproduction of wild or endangered bird species.	[Choi, Hee Jung; Lee, Hyung Chul; Kang, Kyung Soo; Lee, Hyo Gun; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, Seoul 151921, South Korea; [Choi, Hee Jung; Lee, Hyung Chul; Kang, Kyung Soo; Lee, Hyo Gun; Han, Jae Yong] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul 151921, South Korea; [Ono, Tamao] Shinshu Univ, Fac Agr, Div Anim Sci, Nagano, Japan; [Nagai, Hiroki; Sheng, Guojun] RIKEN, Ctr Dev Biol, Lab Early Embryogenesis, Kobe, Hyogo, Japan; [Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Nagano, Japan	Han, JY (reprint author), Seoul Natl Univ, Coll Agr & Life Sci, Dept Agr Biotechnol, San 56-1, Seoul 151921, South Korea.	jaehan@snu.ac.kr			Cooperative Research Program for Agriculture Science & Technology Development from the Rural Development Administration, Republic of Korea [PJ01039001, PJ01053301]	Supported by grants from Cooperative Research Program for Agriculture Science & Technology Development (PJ01039001 and PJ01053301) from the Rural Development Administration, Republic of Korea.	Park TS, 2014, P NATL ACAD SCI USA, V111, P12716, DOI 10.1073/pnas.1410555111; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Park TS, 2003, BIOL REPROD, V68, P1657, DOI 10.1095/biolreprod.102.006825; Lee YM, 2006, BIOL REPROD, V75, P380, DOI 10.1095/biolreprod.106.052084; PETITTE JN, 1990, DEVELOPMENT, V108, P185; Park TS, 2012, P NATL ACAD SCI USA, V109, P9337, DOI 10.1073/pnas.1203823109; EYALGILADI H, 1981, J EMBRYOL EXP MORPH, V65, P139; Li P, 2008, CELL, V135, P1299, DOI 10.1016/j.cell.2008.12.006; TAJIMA A, 1993, THERIOGENOLOGY, V40, P509, DOI 10.1016/0093-691X(93)90404-S; FUJIMOTO T, 1976, ANAT REC, V185, P139, DOI 10.1002/ar.1091850203; NAITO M, 1994, MOL REPROD DEV, V39, P153, DOI 10.1002/mrd.1080390206; Han JY, 2002, THERIOGENOLOGY, V58, P1531, DOI 10.1016/S0093-691X(02)01061-0; Dzierzak E, 2008, DEVELOPMENT, V135, P2343, DOI 10.1242/dev.021279; Pain B, 1996, DEVELOPMENT, V122, P2339; Nakamura Y, 2010, BIOL REPROD, V83, P130, DOI 10.1095/biolreprod.110.083923; Nakamura Y, 2007, POULTRY SCI, V86, P2182; AOYAMA H, 1992, J HISTOCHEM CYTOCHEM, V40, P1769; CHANG IK, 1995, CELL BIOL INT, V19, P569, DOI 10.1006/cbir.1995.1103; Choi JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012968; De Melo Bernardo Ana, 2012, Biol Open, V1, P1146, DOI 10.1242/bio.20122592; DIETERLENLIEVRE F, 1975, J EMBRYOL EXP MORPH, V33, P607; Françoise-Lièvre Francoise, 2005, Int J Dev Biol, V49, P125; GINSBURG M, 1994, CIBA F SYMP, V182, P52; Kang SJ, 2008, BIOL REPROD, V79, P931, DOI 10.1095/biolreprod.108.069989; KENNY D, 1992, J ZOO WILDLIFE MED, V23, P55; Kim MA, 2005, THERIOGENOLOGY, V63, P774, DOI 10.1016/j.theriogenology.2004.04.014; LASSILA O, 1982, BLOOD, V59, P377; Lee HC, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt347; Li Hai-Chang, 2001, Journal of Poultry Science, V38, P308; Macdonald J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015518; Martin C, 1972, CR SOC BIOL, V116, P283; MARTIN C, 1978, CELL DIFFER DEV, V7, P115, DOI 10.1016/0045-6039(78)90012-X; Nagai H, 2014, METHODS, V66, P441, DOI 10.1016/j.ymeth.2013.05.005; Naito M, 2004, BRIT POULTRY SCI, V45, P762, DOI 10.1080/00071660400014325; Ono T, 1996, EXP ANIM TOKYO, V45, P347, DOI 10.1538/expanim.45.347; Ono Tamao, 1998, Animal Science and Technology, V69, P911; Ono Tamao, 1998, Animal Science and Technology, V69, P546; Park TS, 2008, MOL REPROD DEV, V75, P274, DOI 10.1002/mrd.20821; Park TS, 2013, GEN COMP ENDOCR, V190, P144, DOI 10.1016/j.ygcen.2012.11.020; Tanaka J, 2010, DEV GROWTH DIFFER, V52, P629, DOI 10.1111/j.1440-169X.2010.01198.x; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; van de Lavoir MC, 2006, NATURE, V441, P766, DOI 10.1038/nature04831; Wernery U, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015824	43	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	AUG 1	2015	93	2							36	10.1095/biolreprod.114.127365		7	Reproductive Biology	Reproductive Biology	CO8UT	WOS:000359448300011		
J	Ichimura, R; Takahashi, M; Morikawa, T; Inoue, K; Kuwata, K; Usuda, K; Yokosuka, M; Watanabe, G; Yoshida, M				Ichimura, Ryohei; Takahashi, Miwa; Morikawa, Tomomi; Inoue, Kaoru; Kuwata, Kazunori; Usuda, Kento; Yokosuka, Makoto; Watanabe, Gen; Yoshida, Midori			The Critical Hormone-Sensitive Window for the Development of Delayed Effects Extends to 10 Days after Birth in Female Rats Postnatally Exposed to 17alpha-Ethynylestradiol	BIOLOGY OF REPRODUCTION			English	Article						AVPV; critical window; delayed effects; estrous cycle; ethynylestradiol; KiSS1; postnatal day; sexual differentiation	CENTRAL-NERVOUS-SYSTEM; EARLY-LIFE EXPOSURE; NEONATAL EXPOSURE; SYMPATHETIC INNERVATION; NEUROENDOCRINE SYSTEMS; INTRAUTERINE EXPOSURE; ESTROUS-CYCLE; DIETHYLSTILBESTROL; ESTRADIOL; KISSPEPTIN	Neonatal exposure to estrogens is known to cause delayed effects, a late-occurring adverse effect on adult female reproductive functions, such as early onset of age-matched abnormal estrous cycling. However, the critical period in which neonates are sensitive to delayed effects inducible by exogenous estrogen exposure has not been clearly identified. To clarify this window, we examined the intensity and timing of delayed effects using rats exposed to ethynylestradiol (EE) at various postnatal ages. After subcutaneous administration of a single dose of EE (20 mu g/kg, which induces delayed effects) on Postnatal Day (PND) 0, 5, 10, or 14 in Wistar rats, hypothalamic and hormonal alterations in young adults and long-term estrous cycling status were investigated as indicators of delayed effects. In young adults, peak luteinizing hormone concentrations at the time of the luteinizing hormone surge showed a decreasing trend, and KiSS1 mRNA expression of the anterior hypothalamus and number of KiSS1-positive cells in the anteroventral periventricular nucleus were significantly decreased in the PND 0, 5, and 10 groups. The reduction in KiSS1 mRNA and KiSS1-postive cells was inversely correlated with age at time of exposure. These groups also exhibited early onset of abnormal estrous cycling, starting from 17 wk of age in the PND0 group and 19 wk of age in the PND5 and 10 groups. These indicators were not apparent in the PND14 group. Our results suggest that PND0-PND10 is the critical window of susceptibility for delayed effects, and PND14 is presumed to be the provisional endpoint of the window.	[Ichimura, Ryohei; Takahashi, Miwa; Morikawa, Tomomi; Inoue, Kaoru; Kuwata, Kazunori; Yoshida, Midori] Natl Inst Hlth Sci, Div Pathol, Tokyo 1588501, Japan; [Ichimura, Ryohei; Usuda, Kento; Watanabe, Gen] Tokyo Univ Agr & Technol, Dept Vet Med, Vet Physiol Lab, Tokyo, Japan; [Ichimura, Ryohei] Mochida Pharmaceut Co Ltd, Pharmaceut Res Ctr, Dev Res, Shizuoka, Japan; [Kuwata, Kazunori] Tokyo Univ Agr & Technol, Dept Vet Med, Lab Vet Pathol, Tokyo, Japan; [Kuwata, Kazunori] Mitsubishi Tanabe Pharma Corp, Div Res, Chiba, Japan; [Yokosuka, Makoto] Nippon Vet & Life Sci Univ, Grad Sch Vet Med, Behav Neurosci Lab, Tokyo, Japan	Yoshida, M (reprint author), Natl Inst Hlth Sci, Div Pathol, Setagaya Ku, 1-18-1 Kamiyoga, Tokyo 1588501, Japan.	midoriy@nihs.go.jp			Health and Labor Sciences Research Grants, Research on Risk of Chemical Substances, Ministry of Health, Labor and Welfare, Japan [H25-Toxicol-003]	This work was supported by the Health and Labor Sciences Research Grants, Research on Risk of Chemical Substances, Ministry of Health, Labor and Welfare, Japan [H25-Toxicol-003].	Grumbach MM, 2002, HORM RES, V57, P2, DOI 10.1159/000058094; Khan AR, 2012, J NEUROENDOCRINOL, V24, P131, DOI 10.1111/j.1365-2826.2011.02162.x; Losa SM, 2011, REPROD TOXICOL, V31, P280, DOI 10.1016/j.reprotox.2010.10.002; Rice D, 2000, ENVIRON HEALTH PERSP, V108, P511, DOI 10.2307/3454543; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Rosa-E-Silva A, 2003, ENDOCRINOLOGY, V144, P4289, DOI 10.1210/en.2003-0146; Gore AC, 2011, MOL ENDOCRINOL, V25, P2157, DOI 10.1210/me.2011-1210; Smith JT, 2006, REPRODUCTION, V131, P623, DOI 10.1530/rep.1.00368; Dungan HM, 2006, ENDOCRINOLOGY, V147, P1154, DOI 10.1210/en.2005-1282; Maeda KI, 2007, REV ENDOCR METAB DIS, V8, P21, DOI 10.1007/s11154-007-9032-6; Gore AC, 2008, FRONT NEUROENDOCRIN, V29, P358, DOI 10.1016/j.yfrne.2008.02.002; Adewale HB, 2009, BIOL REPROD, V81, P690, DOI 10.1095/biolreprod.109.078261; Cruz G, 2012, FERTIL STERIL, V98, P1283, DOI 10.1016/j.fertnstert.2012.07.1060; Ohta R, 2012, REPROD TOXICOL, V34, P323, DOI 10.1016/j.reprotox.2012.04.014; Dickerson SM, 2011, ENDOCRINOLOGY, V152, P581, DOI 10.1210/en.2010-1103; Ichimura R, 2015, REPROD TOXICOL, V51, P145, DOI 10.1016/j.reprotox.2015.01.004; Swan SH, 2000, APMIS, V108, P793, DOI 10.1111/j.1600-0463.2000.tb00001.x; Kauffman AS, 2007, TRENDS NEUROSCI, V30, P504, DOI 10.1016/j.tins.2007.08.001; ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Takahashi M, 2013, REPROD TOXICOL, V40, P16, DOI 10.1016/j.reprotox.2013.05.005; Takahashi M, 2014, J TOXICOL SCI, V39, P775; Robertson JL, 2009, ENDOCRINOLOGY, V150, P3664, DOI 10.1210/en.2009-0247; CHRISTENSEN LW, 1978, BRAIN RES, V146, P325, DOI 10.1016/0006-8993(78)90977-0; DUSTERBERG B, 1986, ARZNEIMITTEL-FORSCH, V36-2, P1187; GIBORI G, 1981, BIOL REPROD, V24, P249, DOI 10.1095/biolreprod24.2.249; HERBST AL, 1990, SEMIN SURG ONCOL, V6, P343, DOI 10.1002/ssu.2980060609; Katsuda S, 2000, TOXICOL APPL PHARM, V165, P217, DOI 10.1006/taap.2000.8940; Lederman MA, 2010, NEUROPHARMACOLOGY, V58, P314, DOI 10.1016/j.neuropharm.2009.06.015; MCLACHLAN JA, 1982, FERTIL STERIL, V38, P364; Neal-Perry G, 2009, ENDOCRINOLOGY, V150, P3699, DOI 10.1210/en.2008-1667; Shiorta M, 2012, J TOXICOL SCI, V37, P681; Sotomayor-Zarate R, 2008, BIOL REPROD, V78, P673, DOI 10.1095/biolreprod.107.063974; TAYA K, 1983, J REPROD FERTIL, V69, P265; Watson C, 2007, RAT BRAIN STEREOTAXI; Yoshida M, 2011, TOXICOL PATHOL, V39, P823, DOI 10.1177/0192623311413785; Yoshida M, 2002, CARCINOGENESIS, V23, P1745, DOI 10.1093/carcin/23.10.1745	36	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	AUG 1	2015	93	2							32	10.1095/biolreprod.115.129650		11	Reproductive Biology	Reproductive Biology	CO8UT	WOS:000359448300007		
J	Ono, M; Kajitani, T; Uchida, H; Arase, T; Oda, H; Uchida, S; Ota, K; Nagashima, T; Masuda, H; Miyazaki, K; Asada, H; Hida, N; Mabuchi, Y; Morikawa, S; Ito, M; Bulun, SE; Okano, H; Matsuzaki, Y; Yoshimura, Y; Maruyama, T				Ono, Masanori; Kajitani, Takashi; Uchida, Hiroshi; Arase, Toru; Oda, Hideyuki; Uchida, Sayaka; Ota, Kuniaki; Nagashima, Takashi; Masuda, Hirotaka; Miyazaki, Kaoru; Asada, Hironori; Hida, Naoko; Mabuchi, Yo; Morikawa, Satoru; Ito, Mamoru; Bulun, Serdar E.; Okano, Hideyuki; Matsuzaki, Yumi; Yoshimura, Yasunori; Maruyama, Tetsuo			CD34 and CD49f Double-Positive and Lineage Marker-Negative Cells Isolated from Human Myometrium Exhibit Stem Cell-Like Properties Involved in Pregnancy-Induced Uterine Remodeling	BIOLOGY OF REPRODUCTION			English	Article						CD34; CD49f; myometrium; pregnancy; stem cells; uterus	CAJAL-LIKE CELLS; TUMOR-INITIATING CELLS; SIDE POPULATION; STEM/PROGENITOR CELLS; FUNCTIONAL-CHARACTERISTICS; LEIOMYOMA; IDENTIFICATION; PROGENITORS; ACTIVATION; TELOCYTES	Repeated and dramatic pregnancy-induced uterine enlargement and remodeling throughout reproductive life suggests the existence of uterine smooth muscle stem/progenitor cells. The aim of this study was to isolate and characterize stem/progenitor-like cells from human myometrium through identification of specific surface markers. We here identify CD49f and CD34 as markers to permit selection of the stem/progenitor cell-like population from human myometrium and show that human CD45(-) CD31(-) glycophorin A(-) and CD49f(+) CD34(+) myometrial cells exhibit stem cell-like properties. These include side population phenotypes, an undifferentiated status, high colony-forming ability, multilineage differentiation into smooth muscle cells, osteoblasts, adipocytes, and chondrocytes, and in vivo myometrial tissue reconstitution following xenotransplantation. Furthermore, CD45(-) CD31(-) glycophorin A(-) and CD49f(+) CD34(+) myometrial cells proliferate under hypoxic conditions in vitro and, compared with the untreated nonpregnant myometrium, show greater expansion in the estrogen-treated nonpregnant myometrium and further in the pregnant myometrium in mice upon xenotransplantation. These results suggest that the newly identified myometrial stem/progenitor-like cells influenced by hypoxia and sex steroids may participate in pregnancy-induced uterine enlargement and remodeling, providing novel insights into human myometrial physiology.	[Ono, Masanori; Kajitani, Takashi; Uchida, Hiroshi; Arase, Toru; Oda, Hideyuki; Uchida, Sayaka; Ota, Kuniaki; Nagashima, Takashi; Masuda, Hirotaka; Miyazaki, Kaoru; Asada, Hironori; Hida, Naoko; Yoshimura, Yasunori; Maruyama, Tetsuo] Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, Tokyo 1608582, Japan; [Mabuchi, Yo; Morikawa, Satoru; Okano, Hideyuki; Matsuzaki, Yumi] Keio Univ, Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan; [Ito, Mamoru] Cent Inst Expt Anim, Kawasaki, Kanagawa, Japan; [Bulun, Serdar E.] Northwestern Univ, Feinberg Sch Med, Dept Obstet & Gynecol, Chicago, IL 60611 USA	Maruyama, T (reprint author), Keio Univ, Sch Med, Dept Obstet & Gynecol, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	tetsuo@keio.jp	Okano, Hideyuki/J-5973-2013; Mabuchi, Yo/L-1535-2013	Mabuchi, Yo/0000-0001-8008-3966	Japan Society for the Promotion of Science; Keio University Sakaguchi-Memorial Medical Science Fund; Japan Medical Association; Uehara Memorial Foundation; Ministry of Education, Science, and Culture of Japan (MEXT); Project for the Realization of Regenerative Medicine from the MEXT	This study was supported, in part, by Grant-in-Aids from the Japan Society for the Promotion of Science (to T.M., Y.Y., and M.O.), a Grant-in-Aid from Keio University Sakaguchi-Memorial Medical Science Fund (to T.M.), a Grant-in-Aid from the Japan Medical Association (to T.M.), a Grant-in-Aid from the Uehara Memorial Foundation (to T.M.), and a Grant-in-Aid from the 21st Century and Global COE programs of the Ministry of Education, Science, and Culture of Japan (MEXT) to Keio University and the Project for the Realization of Regenerative Medicine from the MEXT.	Notta F, 2011, SCIENCE, V333, P218, DOI 10.1126/science.1201219; Ono M, 2013, P NATL ACAD SCI USA, V110, P17053, DOI 10.1073/pnas.1313650110; Maruyama T, 2010, REPRODUCTION, V140, P11, DOI 10.1530/REP-09-0438; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Zheng YH, 2012, J CELL PHYSIOL, V227, P2311, DOI 10.1002/jcp.23022; Sidney LE, 2014, STEM CELLS, V32, P1380, DOI 10.1002/stem.1661; Mas A, 2012, FERTIL STERIL, V98, P741, DOI 10.1016/j.fertnstert.2012.04.044; Popescu LM, 2009, J CELL MOL MED, V13, P866, DOI 10.1111/j.1582-4934.2009.00758.x; Golebiewska A, 2011, CELL STEM CELL, V8, P136, DOI 10.1016/j.stem.2011.01.007; Redvers RP, 2006, P NATL ACAD SCI USA, V103, P13168, DOI 10.1073/pnas.0602579103; Chang HL, 2010, REPROD SCI, V17, P158, DOI 10.1177/1933719109348924; Mou YC, 2013, J CELL MOL MED, V17, P65, DOI 10.1111/j.1582-4934.2012.01646.x; Daley GQ, 2010, J CLIN INVEST, V120, P8, DOI 10.1172/JCI41801; Kostin S, 2009, J CELL MOL MED, V13, P295, DOI 10.1111/j.1582-4934.2008.00668.x; Yin P, 2015, J CLIN ENDOCR METAB, V100, pE601, DOI 10.1210/jc.2014-2134; Corradi LS, 2013, J CELL MOL MED, V17, P398, DOI 10.1111/jcmm.12021; Shynlova O, 2006, BIOL REPROD, V74, P839, DOI 10.1095/biolreprod.105.048124; Gargett CE, 2007, HUM REPROD UPDATE, V13, P87, DOI 10.1093/humupd/dml045; Gimpl G, 2001, PHYSIOL REV, V81, P629; Wang L, 2011, MOL CANCER THER, V10, P2276, DOI 10.1158/1535-7163.MCT-11-0487; Cretoiu SM, 2011, ACTA PHYSIOL HUNG, V98, P329, DOI 10.1556/APhysiol.98.2011.3.10; Ono M, 2010, HUM REPROD, V25, P2059, DOI 10.1093/humrep/deq163; Ono M, 2014, FERTIL STERIL, V101, P1441, DOI 10.1016/j.fertnstert.2014.01.017; Walker CL, 2005, SCIENCE, V308, P1589, DOI 10.1126/science.1112063; Ono M, 2007, P NATL ACAD SCI USA, V104, P18700, DOI 10.1073/pnas.0704472104; Nystedt J, 2013, STEM CELLS, V31, P317, DOI 10.1002/stem.1271; Challen GA, 2006, STEM CELLS, V24, P3, DOI 10.1634/stemcells.2005.0116; Clay MM, 1989, QUADRUPLETS HIGHER M, P95; Cretoiu SM, 2015, HISTOCHEM CELL BIOL, V143, P83, DOI 10.1007/s00418-014-1268-0; Deschaseaux F, 2000, J CELL PHYSIOL, V184, P319, DOI 10.1002/1097-4652(200009)184:3<319::AID-JCP5>3.0.CO;2-N; Masuda H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010387; Miyazaki K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050749; Ono M, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.123794; Ono M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036935; Popescu LM, 2007, ANN NY ACAD SCI, V1101, P139, DOI 10.1196/annals.1389.022; Ramsey EM, 1994, THE UTERUS, P18; Thulke Stefanie, 2003, Haematologica, V88, pELT18	38	0	0	SOC STUDY REPRODUCTION	MADISON	1691 MONROE ST,SUITE # 3, MADISON, WI 53711-2021 USA	0006-3363	1529-7268		BIOL REPROD	Biol. Reprod.	AUG 1	2015	93	2							37	10.1095/biolreprod.114.127126		9	Reproductive Biology	Reproductive Biology	CO8UT	WOS:000359448300012		
J	Masuda, Y; Nawa, Y; Inami, W; Kawata, Y				Masuda, Yuriko; Nawa, Yasunori; Inami, Wataru; Kawata, Yoshimasa			Carboxylic monolayer formation for observation of intracellular structures in HeLa cells with direct electron beam excitation-assisted fluorescence microscopy	BIOMEDICAL OPTICS EXPRESS			English	Article							HIGH-RESOLUTION; SILICON	Intracellular structures of HeLa cells are observed using a direct electron beam excitation-assisted fluorescence (D-EXA) microscope. In this microscope, a silicon nitride membrane is used as a culture plate, which typically has a low biocompatibility between the sample and the silicon nitride surface to prevent the HeLa cells from adhering strongly to the surface. In this work, the surface of silicon nitride is modified to allow strong cell attachment, which enables high-resolution observation of intracellular structures and an increased signal-to-noise ratio. In addition, the penetration depth of the electron beam is evaluated using Monte Carlo simulations. We can conclude from the results of the observations and simulations that the surface modification technique is promising for the observation of intracellular structures using the D-EXA microscope. (C) 2015 Optical Society of America	[Masuda, Yuriko] Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Nawa, Yasunori; Inami, Wataru; Kawata, Yoshimasa] Shizuoka Univ, Elect Res Inst, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Nawa, Yasunori; Inami, Wataru; Kawata, Yoshimasa] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Masuda, Y (reprint author), Shizuoka Univ, Grad Sch Sci & Technol, Naka Ku, 3-5-1 Johoku, Hamamatsu, Shizuoka 4328561, Japan.	kawata@eng.shizuoka.ac.jp			JST-CREST (Japan Science and Technology Agency, Core Research for Evolutionary Science and Technology)	This work has been supported by JST-CREST (Japan Science and Technology Agency, Core Research for Evolutionary Science and Technology).	Ogura T, 2010, BIOCHEM BIOPH RES CO, V391, P198, DOI 10.1016/j.bbrc.2009.11.031; Inami W, 2010, OPT EXPRESS, V18, P12897, DOI 10.1364/OE.18.012897; Cattaruzza F, 2004, J MATER CHEM, V14, P1461, DOI 10.1039/b312273e; Nawa Y, 2014, BIOMED OPT EXPRESS, V5, P378, DOI 10.1364/BOE.5.000378; de Jonge N, 2009, P NATL ACAD SCI USA, V106, P2159, DOI 10.1073/pnas.0809567106; Nishiyama H, 2010, J STRUCT BIOL, V169, P438, DOI 10.1016/j.jsb.2010.01.005; Nawa Y, 2012, OPT EXPRESS, V20, P5629, DOI 10.1364/OE.20.005629; HOUGH PVC, 1976, P NATL ACAD SCI USA, V73, P317, DOI 10.1073/pnas.73.2.317; Masuda Y., WORLD J MIC IN PRESS; Nichols G, 2012, EUR J PHARM SCI, V45, P19, DOI 10.1016/j.ejps.2011.10.017	10	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	AUG 1	2015	6	8					3128	3133		10.1364/BOE.6.003128		6	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CO2SD	WOS:000359006000034		
J	Tashima, T				Tashima, Toshihiko			Intriguing possibilities and beneficial aspects of transporter-conscious drug design	BIOORGANIC & MEDICINAL CHEMISTRY			English	Review						Transporter-conscious drug design; Drug design; Transporter; Drug delivery; BBB; ADMET	BLOOD-BRAIN-BARRIER; CENTRAL-NERVOUS-SYSTEM; MAJOR FACILITATOR SUPERFAMILY; ORGANIC CATION TRANSPORTERS; RENAL PEPTIDE TRANSPORTERS; ESCHERICHIA-COLI; GLYCEROL-3-PHOSPHATE TRANSPORTER; MOLECULAR-MECHANISM; PARKINSONS-DISEASE; PRODRUG APPROACH	It has been revealed that many types of drugs interact with transporter proteins within an organism. Transporter proteins absorb or excrete materials, including drugs and nutrients, across the cell membrane. Some hydrophobic drugs are excreted from the cell as xenobiotics by ATP-binding cassette (ABC) transporters. However, solute carrier (SLC) transporters are tissue-specifically expressed and have substrate specificities. Thus, transporter-conscious drug design is an excellent method of delivering drugs to pharmaceutical target organs and provides advantages in absorption, distribution, excretion, and toxicity of drugs (ADMET) due to transport systems. In fact, based on this strategy, the bioavailability of prodrugs designed as peptide transporter 1 (PEPT1) substrates was better than that of the corresponding parent compounds due to the transport system in the small intestine. Furthermore, in central nervous system (CNS) drug developing, drug delivery into brain across the blood-brain barrier (BBB) is a serious problem. However, this problem can be also solved by the use of the transport systems at the BBB. Therefore, transporter-consciously designed drugs not only may effectively elicit activity but also may control adverse side effects caused by off-targets and drug-drug interactions and, consequently, may show good performance in clinical trials. In this review, I introduce possibilities and advantages of transporter-conscious drug designs. (C) 2015 Elsevier Ltd. All rights reserved.	Nippon Pharmaceut Chem Co Ltd, Higashiosaka, Osaka 5770056, Japan	Tashima, T (reprint author), Nippon Pharmaceut Chem Co Ltd, 2-8-18 Chodo, Higashiosaka, Osaka 5770056, Japan.	t-tashima@nichiri.co.jp					Alper J, 2002, SCIENCE, V296, P838, DOI 10.1126/science.296.5569.838; Jonker JW, 2004, J PHARMACOL EXP THER, V308, P2, DOI 10.1124/jpet.103.053298; Dresser MJ, 2001, J PHARM SCI, V90, P397, DOI 10.1002/1520-6017(200104)90:4<397::AID-JPS1000>3.3.CO;2-4; Ninomiya M, 2011, J MED CHEM, V54, P1529, DOI 10.1021/jm1015457; Tamai I, 1998, J PHARM SCI, V87, P1542, DOI 10.1021/js980186o; Brodney MA, 2012, J MED CHEM, V55, P9240, DOI 10.1021/jm300953p; Kotthaus J, 2011, BIOORGAN MED CHEM, V19, P1907, DOI 10.1016/j.bmc.2011.01.066; Peura L, 2013, PHARM RES-DORDR, V30, P2523, DOI 10.1007/s11095-012-0966-3; Peura L, 2011, MOL PHARMACEUT, V8, P1857, DOI 10.1021/mp2001878; Li YP, 2014, MOL PHARMACEUT, V11, P3174, DOI 10.1021/mp500352p; Kouodom MN, 2012, J MED CHEM, V55, P2212, DOI 10.1021/jm201480u; Nirogi R, 2012, J MED CHEM, V55, P9255, DOI 10.1021/jm300955x; Pardridge WM, 2012, J CEREBR BLOOD F MET, V32, P1959, DOI 10.1038/jcbfm.2012.126; Andre P, 2009, J CEREBR BLOOD F MET, V29, P1293, DOI 10.1038/jcbfm.2009.54; GANAPATHY ME, 1995, J BIOL CHEM, V270, P25672; Law CJ, 2008, ANNU REV MICROBIOL, V62, P289, DOI 10.1146/annurev.micro.61.080706.093329; Ganapathy ME, 1998, BIOCHEM BIOPH RES CO, V246, P470, DOI 10.1006/bbrc.1998.8628; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Kikuchi R, 2006, MOL PHARMACOL, V70, P887, DOI 10.1124/mol.106.025494; Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196; Hewawasam P, 2002, BIOORG MED CHEM LETT, V12, P1023, DOI 10.1016/S0960-894X(02)00101-4; Shugarts S, 2009, PHARM RES-DORDR, V26, P2039, DOI 10.1007/s11095-009-9924-0; Shao LM, 2011, J MED CHEM, V54, P5283, DOI 10.1021/jm101312a; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Hitchcock SA, 2006, J MED CHEM, V49, P7559, DOI 10.1021/jm060642i; Hilgendorf C, 2007, DRUG METAB DISPOS, V35, P1333, DOI 10.1124/dmd.107.014902; Pavan B, 2008, MOLECULES, V13, P1035, DOI 10.3390/molecules13051035; Stockwell J, 2014, CHEM BIOL DRUG DES, V83, P507, DOI 10.1111/cbdd.12268; Gynther M, 2008, J MED CHEM, V51, P932, DOI 10.1021/jm701175d; Tamai I, 2000, J PHARM SCI, V89, P1371, DOI 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D; Kimura Y, 2007, CANCER SCI, V98, P1303, DOI 10.1111/j.1349-7006.2007.00538.x; Yamazaki M, 1997, DRUG METAB DISPOS, V25, P1123; Fang L, 2014, J MED CHEM, V57, P1116, DOI 10.1021/jm401634d; Brand S, 2014, J MED CHEM, V57, P9855, DOI 10.1021/jm500809c; Ohtsuki S, 2007, PHARM RES, V24, P1745, DOI 10.1007/s11095-007-9374-5; Huang YF, 2003, SCIENCE, V301, P616, DOI 10.1126/science.1087619; Hirota T, 2008, CURR DRUG METAB, V9, P34; Pedregal C, 2012, J MED CHEM, V55, P4955, DOI 10.1021/jm201629q; Dalpiaz A, 2007, INT J PHARM, V336, P133, DOI 10.1016/j.ijpharm.2006.11.051; Storer RI, 2014, J MED CHEM, V57, P5258, DOI 10.1021/jm5003292; Poller B, 2008, J NEUROCHEM, V107, P1358, DOI 10.1111/j.1471-4159.2008.05730.x; Bailey P. D., 2006, CHEM COMMUN, P323; Begley D. J., 2004, J PHARM, V104, P29; Border N., 1981, SCIENCE, V214, P1370; BORGMAN RJ, 1973, J MED CHEM, V16, P630, DOI 10.1021/jm00264a011; Cheung YY, 2012, J MED CHEM, V55, P6975, DOI 10.1021/jm300700v; Deguchi Y, 2011, DRUG METAB PHARMACOK, V26, P219, DOI 10.2133/dmpk.DMPK-11-PF-903; Fabio R. D., 2011, J MED CHEM, V54, P1071; Farag H., 1983, J MED CHEM, V26, P313; Goodfellow VS, 2013, J MED CHEM, V56, P8032, DOI 10.1021/jm401094t; Gynther M, 2009, J MED CHEM, V52, P3348, DOI 10.1021/jm8015409; Hewawasam P, 2002, BIOORG MED CHEM LETT, V12, P1779, DOI 10.1016/S0960-894X(02)00240-8; Hirai T, 2004, BIOPHYS J, V87, P3600, DOI 10.1529/biophysj.104.049320; Hodgetts KJ, 2011, J MED CHEM, V54, P4187, DOI 10.1021/jm200365y; Hunt KW, 2013, J MED CHEM, V56, P3379, DOI 10.1021/jm4002154; Inano Akihiro, 2004, Drug Metab Pharmacokinet, V19, P180, DOI 10.2133/dmpk.19.180; Kanner BI, 2002, BBA-BIOENERGETICS, V1555, P92, DOI 10.1016/S0005-2728(02)00260-8; Kato Y, 2006, MOL PHARMACOL, V70, P829, DOI 10.1124/mol.106.024158; Lavieri RR, 2010, J MED CHEM, V53, P6706, DOI 10.1021/jm100814g; Lemieux MJ, 2004, CURR OPIN STRUC BIOL, V14, P405, DOI 10.1016/j.sbi.2004.06.003; Lipinski Christopher A, 2004, Drug Discov Today Technol, V1, P337, DOI 10.1016/j.ddtec.2004.11.007; McCoull W, 2014, J MED CHEM, V57, P6128, DOI 10.1021/jm500610n; Mehta DC, 2013, MOL PHARMACEUT, V10, P4491, DOI 10.1021/mp400316e; Nakanishi T, 2011, J PHARM SCI-US, V100, P3731, DOI 10.1002/jps.22576; Nozaki Y, 2007, J PHARMACOL EXP THER, V321, P362, DOI 10.1124/jpet.106.113076; Ratni H, 2015, J MED CHEM, V58, P2275, DOI 10.1021/jm501745f; Sheha M, 2003, BIOORGAN MED CHEM, V11, P1865, DOI 10.1016/S0968-0896(03)00038-5; Shimomura Keita, 2013, Fluids Barriers CNS, V10, P8, DOI 10.1186/2045-8118-10-8; Slotboom DJ, 2014, NAT REV MICROBIOL, V12, P79, DOI 10.1038/nrmicro3175; Sonders MS, 2005, CURR OPIN NEUROBIOL, V15, P296, DOI 10.1016/j.conb.2005.05.009; Sun J, 2010, J MED CHEM, V53, P624, DOI 10.1021/jm9011559; SWAAN PW, 1995, BBA-BIOMEMBRANES, V1236, P31, DOI 10.1016/0005-2736(95)00030-7; Tashima T., 2014, DRUG DES, V3, P116; TEDJAMULIA ML, 1985, J MED CHEM, V28, P1574, DOI 10.1021/jm00149a006; Tsuji Akira, 2002, Drug Metab Pharmacokinet, V17, P253, DOI 10.2133/dmpk.17.253; ULLRICH KJ, 1993, PFLUG ARCH EUR J PHY, V425, P280, DOI 10.1007/BF00374179; ULLRICH KJ, 1992, PFLUG ARCH EUR J PHY, V420, P29, DOI 10.1007/BF00378638; Wang XY, 2014, BIOCONJUGATE CHEM, V25, P2046, DOI 10.1021/bc5004108; Yamazaki M., 1993, AM J PHYSIOL, V264, P36	82	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4119	4131		10.1016/j.bmc.2015.06.022		13	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000001		
J	Demizu, Y; Misawa, T; Nagakubo, T; Kanda, Y; Okuhira, K; Sekino, Y; Naito, M; Kurihara, M				Demizu, Yosuke; Misawa, Takashi; Nagakubo, Takaya; Kanda, Yasunari; Okuhira, Keiichiro; Sekino, Yuko; Naito, Mikihiko; Kurihara, Masaaki			Structural development of stabilized helical peptides as inhibitors of estrogen receptor (ER)-mediated transcription	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Estrogen receptor; Protein-protein interaction; Transcriptional inhibitor; Helical peptide	PROTEIN-PROTEIN INTERACTIONS; CELL-CYCLE PROGRESSION; BREAST-CANCER CELLS; VITAMIN-D-RECEPTOR; MODULATORS; COACTIVATORS; METATHESIS; REGULATORS; THERAPY; BINDING	Three types of stabilized helical peptides containing disulfide bonds, C-C cross-linked side chains, or alpha, alpha-disubstituted amino acids (2-aminoisobutyric acid (Aib)) were designed and synthesized as inhibitors of estrogen receptor (ER)-coactivator interactions. Furthermore, heptaarginine (R7)-conjugated versions of the peptides were prepared, and their effects on ER-mediated transcription were evaluated at the cellular level (in ER-positive T47D cells). Among them, the R7-conjugated peptides 11 and 12 downregulated the mRNA expression of pS2 (an ER-mediated gene whose expression is upregulated by 17 beta-estradiol) by 95% (at a dose of 10 mu M) and 87% (at a dose of 3 mu M), respectively. (C) 2015 Elsevier Ltd. All rights reserved.	[Demizu, Yosuke; Misawa, Takashi; Nagakubo, Takaya; Kurihara, Masaaki] Natl Inst Hlth Sci, Div Organ Chem, Tokyo, Tokyo 1588501, Japan; [Nagakubo, Takaya; Kurihara, Masaaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Kanda, Yasunari; Sekino, Yuko] Natl Inst Hlth Sci, Div Pharmacol, Tokyo, Tokyo 1588501, Japan; [Okuhira, Keiichiro; Naito, Mikihiko] Natl Inst Hlth Sci, Div Mol Target & Gene Therapy Prod, Tokyo, Tokyo 1588501, Japan	Demizu, Y (reprint author), Natl Inst Hlth Sci, Div Organ Chem, 1-18-1 Kamiyoga, Tokyo, Tokyo 1588501, Japan.	demizu@nihs.go.jp; masaaki@nihs.go.jp			JSPS KAKENHI [26460169, 26670041]; Research Foundation for Pharmaceutical Sciences	This study was supported, in part, by JSPS KAKENHI Grant Numbers 26460169 (Y.D.) and 26670041 (Y.K.) and a Grant-in-Aid from the Research Foundation for Pharmaceutical Sciences (Y.D.).	Mita Y, 2013, BIOORGAN MED CHEM, V21, P993, DOI 10.1016/j.bmc.2012.11.042; Doisneau-Sixou SF, 2003, ENDOCR-RELAT CANCER, V10, P179, DOI 10.1677/erc.0.0100179; Nomura W, 2013, ACS CHEM BIOL, V8, P2235, DOI 10.1021/cb400495h; Demizu Y, 2015, ORG BIOMOL CHEM, V13, P5617, DOI 10.1039/c5ob00389j; Bernstein L, 1999, J NATL CANCER I, V91, P1654, DOI 10.1093/jnci/91.19.1654; Phan T, 2010, CHEM COMMUN, V46, P8207, DOI 10.1039/c0cc02727h; Kim YW, 2011, NAT PROTOC, V6, P761, DOI 10.1038/nprot.2011.324; Toniolo C, 1996, J AM CHEM SOC, V118, P2744, DOI 10.1021/ja9537383; Heery DM, 1997, NATURE, V387, P733; Hall JM, 2005, MOL INTERV, V5, P343, DOI 10.1124/mi.5.6.7; Milroy LG, 2014, CHEM REV, V114, P4695, DOI 10.1021/cr400698c; Moellering RE, 2009, NATURE, V462, P182, DOI 10.1038/nature08543; Tints K, 2014, INT J MOL SCI, V15, P5680, DOI 10.3390/ijms15045680; Karle IL, 2001, BIOPOLYMERS, V60, P351, DOI 10.1002/bip.10174; Li XD, 2004, MOL CELL BIOL, V24, P7681, DOI 10.1128/MCB.24.17.4681-7689.2004; Demizu Y, 2011, ORG BIOMOL CHEM, V9, P3303, DOI 10.1039/c0ob01146k; Thomas C, 2011, NAT REV CANCER, V11, P597, DOI 10.1038/nrc3093; Leduc AM, 2003, P NATL ACAD SCI USA, V100, P11273, DOI 10.1073/pnas.1934759100; Yamashita H, 2014, BIOORGAN MED CHEM, V22, P2403, DOI 10.1016/j.bmc.2014.03.005; Azzarito V, 2013, NAT CHEM, V5, P161, DOI [10.1038/nchem.1568, 10.1038/NCHEM.1568]; Demizu Y, 2011, TETRAHEDRON, V67, P6155, DOI 10.1016/j.tet.2011.06.075; Holst F, 2007, NAT GENET, V39, P655, DOI 10.1038/ng2006; Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537; Blackwell HE, 2001, J ORG CHEM, V66, P5291, DOI 10.1021/jo015533k; Baumann CK, 2007, DRUGS, V67, P2335; Benedetti E, 1996, BIOPOLYMERS, V40, P3, DOI 10.1002/(SICI)1097-0282(1996)40:1<3::AID-BIP2>3.0.CO;2-#; Carraz M, 2009, CHEM BIOL, V16, P702, DOI 10.1016/j.chembiol.2009.06.009; Demizu Y, 2013, J ORG CHEM, V78, P12106, DOI 10.1021/jo402133e; Foster JS, 2001, MOL CELL BIOL, V21, P794, DOI 10.1128/MCB.21.3.794-810.2001; Galande AK, 2005, CHEMBIOCHEM, V6, P1991, DOI 10.1002/cbic.200500083; Howell SJ, 2004, BEST PRACT RES CL EN, V18, P47, DOI 10.1016/j.beem.2003.08.002; Misawa T, 2015, BIOORGAN MED CHEM, V23, P1055, DOI 10.1016/j.bmc.2015.01.007; Nagakubo T., 1921, BIOCONJUGATE CHEM, V25, P1921; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; PATERSON Y, 1981, J AM CHEM SOC, V103, P2947, DOI 10.1021/ja00401a007; Pengo P, 2003, ANGEW CHEM INT EDIT, V42, P3388, DOI 10.1002/anie.200351015; Teft WA, 2011, DRUG METAB DISPOS, V39, P558, DOI 10.1124/dmd.110.036160	37	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4132	4138		10.1016/j.bmc.2015.06.067		7	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000002		
J	Arai, MA; Uchida, K; Sadhu, SK; Ahmed, F; Koyano, T; Kowithayakorn, T; Ishibashi, M				Arai, Midori A.; Uchida, Kyoko; Sadhu, Samir K.; Ahmed, Firoj; Koyano, Takashi; Kowithayakorn, Thaworn; Ishibashi, Masami			Hedgehog inhibitors from Artocarpus communis and Hyptis suaveolens	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Natural products; Inhibitor; Hedgehog signal; Artocarpus communis; Hyptis suaveolens	MEDIATED TRANSCRIPTIONAL INHIBITORS; SMALL-MOLECULE INHIBITORS; SIGNALING PATHWAY; FLAVONOIDS; LEAVES; DITERPENOIDS; CYCLOPAMINE; BLOCKS	The hedgehog (Hh) signaling pathway plays crucial roles in cell maintenance and proliferation during embryonic development. Naturally occurring Hh inhibitors were isolated from Artocarpus communis and Hyptis suaveolens using our previously constructed cell-based assay system. Bioactivity guided fractionation led to the isolation of 15 compounds, including seven new compounds (4, 5, 6, 7, and 9-11). The isolated compounds showed cytotoxicity against a cancer cell line (PANC1) in which Hh signaling was abnormally activated. Several compounds (12-14; GLI1 transcriptional inhibition IC50 = 7.6, 4.7, and 4.0 mu M, respectively) inhibited Hh related protein (BCL2) expression. Moreover, compounds 1, 12, and 13 disrupted GLI1 and DNA complex formation. (C) 2015 Elsevier Ltd. All rights reserved.	[Arai, Midori A.; Uchida, Kyoko; Ishibashi, Masami] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Sadhu, Samir K.] Khulna Univ, Sch Life Sci, Pharm Discipline, Khulna 9208, Bangladesh; [Ahmed, Firoj] Univ Dhaka, Dept Pharmaceut Chem, Dhaka 1000, Bangladesh; [Koyano, Takashi] Temko Corp, Nakano, Tokyo 1640012, Japan; [Kowithayakorn, Thaworn] Khon Kaen Univ, Fac Agr, Khon Kaen 40002, Thailand	Arai, MA (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	midori_arai@chiba-u.jp; mish@chiba-u.jp	Ishibashi, Masami /E-5328-2015; Arai, Midori/O-4613-2015	Ishibashi, Masami /0000-0002-2839-1045; 	Japan Society for the Promotion of Science (JSPS); Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT); Terumo Life Science Foundation; Tokyo Biochemical Research Foundation (TBRF)	This study was supported by a Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS), a Grant-in-Aid for Scientific Research on Innovative Areas 'Chemical Biology of Natural Products' from The Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT), Terumo Life Science Foundation and the Tokyo Biochemical Research Foundation (TBRF).	Atwood SX, 2012, J CELL BIOL, V199, P193, DOI 10.1083/jcb.201207140; Arai MA, 2013, MOL BIOSYST, V9, P1012, DOI 10.1039/c3mb25567k; Chen JK, 2002, P NATL ACAD SCI USA, V99, P14071, DOI 10.1073/pnas.182542899; Stanton BZ, 2009, NAT CHEM BIOL, V5, P154, DOI 10.1038/nchembio.142; Williams JA, 2003, P NATL ACAD SCI USA, V100, P4616, DOI 10.1073/pnas.0732813100; Arai MA, 2008, BIOORGAN MED CHEM, V16, P9420, DOI 10.1016/j.bmc.2008.09.053; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Incardona JP, 1998, DEVELOPMENT, V125, P3553; Petrova E, 2013, NAT CHEM BIOL, V9, P247, DOI [10.1038/nchembio.1184, 10.1038/NCHEMBIO.1184]; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Rifai Y, 2010, J NAT PROD, V73, P995, DOI 10.1021/np1000818; Firestone AJ, 2012, NATURE, V484, P125, DOI 10.1038/nature10936; Arai MA, 2011, ORG BIOMOL CHEM, V9, P1133, DOI 10.1039/c0ob00677g; Chen YL, 2008, J NAT PROD, V71, P1207, DOI 10.1021/np800147z; Rifai Y, 2011, BIOORG MED CHEM LETT, V21, P718, DOI 10.1016/j.bmcl.2010.11.126; Bigelow RLH, 2004, J BIOL CHEM, V279, P1197, DOI 10.1074/jbc.M310589200; Hosoya T, 2008, CHEMBIOCHEM, V9, P1082, DOI 10.1002/cbic.200700511; Arai MA, 2014, BEILSTEIN J ORG CHEM, V10, P134, DOI 10.3762/bjoc.10.10; di Magliano MP, 2003, NAT REV CANCER, V3, P903, DOI 10.1038/nrc1229; Huang YC, 2009, J NAT PROD, V72, P1273, DOI 10.1021/np900148a; LARSSON R, 1993, BRIT J CANCER, V67, P969, DOI 10.1038/bjc.1993.178; Li YW, 2012, EXPERT OPIN THER TAR, V16, P49, DOI 10.1517/14728222.2011.617367; MANCHAND PS, 1977, J ORG CHEM, V42, P3824, DOI 10.1021/jo00444a007; McCall TD, 2007, CANCER RES, V67, P5179, DOI 10.1158/0008-5472.CAN-06-4177; McLean S, 1996, MAGN RESON CHEM, V34, P719; SHIRATAKI Y, 1983, CHEM PHARM BULL, V31, P2859; Trinh TN, 2014, MEDCHEMCOMM, V5, P117, DOI 10.1039/c3md00334e; Uzawa J., 1987, TENNEN YUKI KAGOBUTS, V29, P721; Wang Y, 2007, PHYTOCHEMISTRY, V68, P1300, DOI 10.1016/j.phytochem.2007.01.009; Wang YQ, 2001, J NAT PROD, V64, P196, DOI 10.1021/np0001124	31	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4150	4154		10.1016/j.bmc.2015.06.058		5	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000004		
J	Nguyen, VH; Kikuchi, H; Kubohara, Y; Takahashi, K; Katou, Y; Oshima, Y				Nguyen, Van Hai; Kikuchi, Haruhisa; Kubohara, Yuzuru; Takahashi, Katsunori; Katou, Yasuhiro; Oshima, Yoshiteru			Development of novel DIF-1 derivatives that selectively suppress innate immune responses	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Innate immunity; Drosophila; Immunosuppressor; Cellular slime mold; Structure-activity relationship	DIFFERENTIATION-INDUCING FACTORS; DICTYOSTELIUM-DISCOIDEUM; CELL-DIFFERENTIATION; JURKAT CELLS; DROSOPHILA; MORPHOGEN; VIVO	The multiple pharmacological activities of differentiation-inducing factor-1 (DIF-1) of the cellular slime mold Dictyostelium discoideum led us to examine the use of DIF-1 as a 'drug template' to develop promising seed compounds for drug discovery. DIF-1 and its derivatives were synthesized and evaluated for their regulatory activities in innate immune responses. We found two new derivatives (4d and 5e) with highly selective inhibitory activities against production of the antimicrobial peptide attacin in Drosophila S2 cells and against production of interleukin-2 in Jurkat cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Nguyen, Van Hai; Kikuchi, Haruhisa; Katou, Yasuhiro; Oshima, Yoshiteru] Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan; [Kubohara, Yuzuru] Gunma Univ, IMCR, Dept Mol & Cellular Biol, Maebashi, Gumma 3718512, Japan; [Kubohara, Yuzuru] Juntendo Univ, Grad Sch Hlth & Sports Sci, Inzai, Chiba 2701695, Japan; [Takahashi, Katsunori] Gunma Paz Coll, Fac Hlth Sci, Dept Med Technol, Takasaki, Gumma 3700006, Japan	Kikuchi, H (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Aoba Ku, Sendai, Miyagi 9808578, Japan.	hal@mail.pharm.tohoku.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23710247, 24590110, 25350959]; Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Kobayashi International Scholarship Foundation; Suntory Institute for Bioorganic Research; Astellas Foundation for Research on Metabolic Disorders	We thank Dr. J.L. Imler for att-luc reporter construct. This work was supported in part by Grant-in-Aid for Scientific Research (Nos. 23710247, 24590110 and 25350959) from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Drug Discovery, Informatics, and Structural Life Science from the Ministry of Education, Culture, Sports, Science, and Technology, Japan; Kobayashi International Scholarship Foundation; the SUNBOR GRANT from the Suntory Institute for Bioorganic Research; and the Astellas Foundation for Research on Metabolic Disorders.	Aherne SA, 2008, MOL NUTR FOOD RES, V52, P664, DOI 10.1002/mnfr.200700385; Kikuchi H, 2011, ORG LETT, V13, P4624, DOI 10.1021/ol2018449; Janeway CA, 2001, P NATL ACAD SCI USA, V98, P7461, DOI 10.1073/pnas.131202998; Goto A, 2008, NAT IMMUNOL, V9, P97, DOI 10.1038/ni1543; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; MORRIS HR, 1987, NATURE, V328, P811, DOI 10.1038/328811a0; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Tanaka S, 2005, BIOCHEM BIOPH RES CO, V335, P162, DOI 10.1016/j.bbrc.2005.07.059; Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Gaffen SL, 2004, CYTOKINE, V28, P109, DOI 10.1016/j.cyto.2004.06.010; Gokan N, 2005, BIOCHEM PHARMACOL, V70, P676, DOI 10.1016/j.bcp.2005.06.002; KAY RR, 1989, DEVELOPMENT, V107, P81; Kubohara Y, 1999, EUR J PHARMACOL, V381, P57, DOI 10.1016/S0014-2999(99)00548-8; Kubohara Y, 1997, BIOCHEM BIOPH RES CO, V236, P418, DOI 10.1006/bbrc.1997.6964; Maeda Y, 1997, DICTYOSTELIUM MODEL; Nakajima-Shimada J, 2013, BIOCHEM PHARMACOL, V85, P1603, DOI 10.1016/j.bcp.2013.03.007; Omata W, 2007, FEBS J, V274, P3392, DOI 10.1111/j.1742-4658.2007.05872.x; RAO JA, 1987, CAN J CHEM, V65, P31, DOI 10.1139/v87-007; Sekiya M, 2008, BIOCHEM PHARMACOL, V75, P2165, DOI 10.1016/j.bcp.2007.12.020; Sekiya M, 2006, LIFE SCI, V80, P113, DOI 10.1016/j.lfs.2006.08.026; Seya K, 2012, BRIT J PHARMACOL, V165, P870, DOI 10.1111/j.1476-5381.2011.01541.x; Takahashi K, 2009, LIFE SCI, V85, P438, DOI 10.1016/j.lfs.2009.07.008; TOWN CD, 1976, NATURE, V262, P717, DOI 10.1038/262717a0	23	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4311	4315		10.1016/j.bmc.2015.06.027		5	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000020		
J	Mizuguchi, T; Ohashi, N; Nomura, W; Komoriya, M; Hashimoto, C; Yamamoto, N; Murakami, T; Tamamura, H				Mizuguchi, Takaaki; Ohashi, Nami; Nomura, Wataru; Komoriya, Mao; Hashimoto, Chie; Yamamoto, Naoki; Murakami, Tsutomu; Tamamura, Hirokazu			Anti-HIV screening for cell-penetrating peptides using chloroquine and identification of anti-HIV peptides derived from matrix proteins	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Matrix protein; Octa-arginyl group; Chloroquine; Anti-HIV	HUMAN-IMMUNODEFICIENCY-VIRUS; INTEGRASE INHIBITORS; GENE-PRODUCTS; CD4 MIMICS; CRYSTAL-STRUCTURES; ENTRY INHIBITORS; LIFE-CYCLE; POTENT; CXCR4; ANTAGONIST	Previously, compounds which inhibit the HIV-1 replication cycle were found in overlapping peptide libraries covering the whole sequence of an HIV-1 matrix (MA) protein constructed with the addition of an octa-arginyl group. The two top lead compounds are sequential fragments MA-8L and MA-9L. In the present study, the addition of chloroquine in cell-based anti-HIV assays was proven to be an efficient method with which to find anti-HIV compounds among several peptides conjugated by cell-penetrating signals such as an octa-arginyl group: the conjugation of an octa-arginyl group to individual peptides contained in whole proteins in combination with the addition of chloroquine in cells is a useful assay method to search active peptides. To find more potent fragment peptides, individual peptides between MA-8L and MA-9L, having the same peptide chain length but with sequences shifted by one amino acid residue, were synthesized in this paper and their anti-HIV activity was evaluated with an anti-HIV assay using chloroquine. As a result, the peptides in the C-terminal side of the series, which are relatively close to MA-9L, showed more potent inhibitory activity against both X4-HIV-1 and R5-HIV-1 than the peptides in the N-terminal side. (C) 2015 Published by Elsevier Ltd.	[Mizuguchi, Takaaki; Ohashi, Nami; Nomura, Wataru; Komoriya, Mao; Hashimoto, Chie; Tamamura, Hirokazu] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Chiyoda Ku, Tokyo 1010062, Japan; [Yamamoto, Naoki] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117597, Singapore; [Murakami, Tsutomu] Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan	Murakami, T (reprint author), Natl Inst Infect Dis, AIDS Res Ctr, Shinjuku Ku, Tokyo 1628640, Japan.	tmura@nih.go.jp; tamamura.mr@tmd.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan; Japanese Ministry of Health, Labor, and Welfare; JSPS; MEXT, Japan	This work was supported in part by Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan, and Health and Labour Sciences Research Grants from Japanese Ministry of Health, Labor, and Welfare. This work was supported in part by JSPS Core-to-Core Program, A and the Platform for Drug Discovery, Informatics, and Structural Life Science of MEXT, Japan. The authors thank Ms. M. Kawamata, and Mr. H. Wu, National Institute of Infectious Diseases, for their assistance in the cytotoxicity and anti-HIV assays. We also thank Dr. Y. Maeda, Kumamoto University, for providing PM1/CCR5 cells, and Mr. S. Kumakura, Kureha Corporation, for providing SCH-D, respectively.	Ghosh AK, 2007, BIOORGAN MED CHEM, V15, P7576, DOI 10.1016/j.bmc.2007.09.010; Erbacher P, 1996, EXP CELL RES, V225, P186, DOI 10.1006/excr.1996.0169; Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200; Grinsztejn B, 2007, LANCET, V369, P1261, DOI 10.1016/S0140-6736(07)60597-2; Nomura W, 2013, ACS CHEM BIOL, V8, P2235, DOI 10.1021/cb400495h; MITSUYA H, 1985, P NATL ACAD SCI USA, V82, P7096, DOI 10.1073/pnas.82.20.7096; Fujii N, 2003, ANGEW CHEM INT EDIT, V42, P3251, DOI 10.1002/anie.200351024; NIEDRIG M, 1994, J GEN VIROL, V75, P1469, DOI 10.1099/0022-1317-75-6-1469; DE CLERCQ E, 1994, ANTIMICROB AGENTS CH, V38, P668; El-Sayed A, 2008, J BIOL CHEM, V283, P23450, DOI 10.1074/jbc.M709387200; Cahn P, 2007, LANCET, V369, P1235, DOI 10.1016/S0140-6736(07)60571-6; Tamamura H, 1998, BIOCHEM BIOPH RES CO, V253, P877, DOI 10.1006/bbrc.1998.9871; Yamada Y, 2010, BIOORG MED CHEM LETT, V20, P354, DOI 10.1016/j.bmcl.2009.10.098; Tanaka T, 2010, J AM CHEM SOC, V132, P15899, DOI 10.1021/ja107447w; Narumi T, 2013, BIOORGAN MED CHEM, V21, P2518, DOI 10.1016/j.bmc.2013.02.041; Hill CP, 1996, P NATL ACAD SCI USA, V93, P3099, DOI 10.1073/pnas.93.7.3099; El-Sayed A, 2009, AAPS J, V11, P13, DOI 10.1208/s12248-008-9071-2; Freed EO, 1998, VIROLOGY, V251, P1, DOI 10.1006/viro.1998.9398; Narumi T, 2010, BIOORG MED CHEM LETT, V20, P5853, DOI 10.1016/j.bmcl.2010.07.106; Narumi T, 2011, BIOORGAN MED CHEM, V19, P6735, DOI 10.1016/j.bmc.2011.09.045; Tanaka T, 2011, CHEMMEDCHEM, V6, P834, DOI 10.1002/cmdc.201000548; Tamamura H, 2003, ORG BIOMOL CHEM, V1, P3663, DOI 10.1039/b306613b; Bukrinskaya A, 2007, VIRUS RES, V124, P1, DOI 10.1016/j.virusres.2006.07.001; Cannon PM, 1997, J VIROL, V71, P3474; Ciftci K, 2001, INT J PHARM, V218, P81, DOI 10.1016/S0378-5173(01)00623-8; Cordier C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104999; Kelly BN, 2006, BIOCHEMISTRY-US, V45, P11257, DOI 10.1021/bi060927x; Otaka Akira, 2002, Angew Chem Int Ed Engl, V41, P2937, DOI 10.1002/1521-3773(20020816)41:16<2937::AID-ANIE2937>3.0.CO;2-J; Mitsuya H., 1999, TXB AIDS MED, P751; MORIKAWA Y, 1995, J VIROL, V69, P4519; Narumi T, 2012, BIOORGAN MED CHEM, V20, P1468, DOI 10.1016/j.bmc.2011.12.055; Nomura W, 2013, BIOORGAN MED CHEM, V21, P4452, DOI 10.1016/j.bmc.2013.05.060; Nomura W, 2012, CHEMMEDCHEM, V7, P205, DOI 10.1002/cmdc.201100542; RAO ZH, 1995, NATURE, V378, P743, DOI 10.1038/378743a0; Suzuki S, 2010, J MED CHEM, V53, P5356, DOI 10.1021/jm1003528; Suzuki S, 2010, BIOORGAN MED CHEM, V18, P6771, DOI 10.1016/j.bmc.2010.07.050; Tagat JR, 2004, J MED CHEM, V47, P2405, DOI 10.1021/jm0304515; Yoshimura K, 2010, J VIROL, V84, P7558, DOI 10.1128/JVI.00227-10; Zentner I, 2013, BIOORG MED CHEM LETT, V23, P1132, DOI 10.1016/j.bmcl.2012.11.041	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4423	4427		10.1016/j.bmc.2015.06.020		5	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000032		
J	Masaki, S; Kii, I; Sumida, Y; Kato-Sumida, T; Ogawa, Y; Ito, N; Nakamura, M; Sonamoto, R; Kataoka, N; Hosoya, T; Hagiwara, M				Masaki, So; Kii, Isao; Sumida, Yuto; Kato-Sumida, Tomoe; Ogawa, Yasushi; Ito, Nobutoshi; Nakamura, Mitsuhiro; Sonamoto, Rie; Kataoka, Naoyuki; Hosoya, Takamitsu; Hagiwara, Masatoshi			Design and synthesis of a potent inhibitor of class 1 DYRK kinases as a suppressor of adipogenesis	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						DYRK1; Kinase inhibitor; Structural modification; Docking model; Dibenzofuran; Adipogenesis	PANCREATIC-CANCER CELLS; PROTEIN-KINASE; MIRK/DYRK1B KINASE; OVARIAN-CANCER; GAMMA EXPRESSION; DOWNS-SYNDROME; MURINE MODEL; PPAR-GAMMA; SURVIVAL; PHOSPHORYLATION	Dysregulation of dual-specificity tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) has been demonstrated in several pathological conditions, including Alzheimer's disease and cancer progression. It has been recently reported that a gain of function-mutation in the human DYRK1B gene exacerbates metabolic syndrome by enhancing obesity. In the previous study, we developed an inhibitor of DYRK family kinases (INDY) and demonstrated that INDY suppresses the pathological phenotypes induced by overexpression of DYRK1A or DYRK1B in cellular and animal models. In this study, we designed and synthesized a novel inhibitor of DYRK family kinases based on the crystal structure of the DYRK1A/INDY complex by replacing the phenol group of INDY with dibenzofuran to produce a derivative, named BINDY. This compound exhibited potent and selective inhibitory activity toward DYRK family kinases in an in vitro assay. Furthermore, treatment of 3T3-L1 pre-adipocytes with BINDY hampered adipogenesis by suppressing gene expression of the critical transcription factors PPARc and C/EBPa. This study indicates the possibility of BINDY as a potential drug for metabolic syndrome. (C) 2015 Elsevier Ltd. All rights reserved.	[Masaki, So; Kataoka, Naoyuki] Kyoto Univ, Grad Sch Med, Med Innovat Ctr, Lab Malignancy Control Res,Sakyo Ku, Kyoto 6068507, Japan; [Kii, Isao; Sonamoto, Rie; Kataoka, Naoyuki; Hagiwara, Masatoshi] Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Sakyo Ku, Kyoto 6068501, Japan; [Sumida, Yuto; Kato-Sumida, Tomoe; Hosoya, Takamitsu] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Lab Chem Biosci, Chiyoda Ku, Tokyo 1010062, Japan; [Ogawa, Yasushi] Nagoya Univ, Grad Sch Med, Dept Dermatol, Showa Ku, Nagoya, Aichi 4668550, Japan; [Ito, Nobutoshi] Tokyo Med & Dent Univ, Med Res Inst, Dept Biol Struct, Bunkyo Ku, Tokyo 1138510, Japan; [Nakamura, Mitsuhiro] Univ Tokushima, Grad Sch Integrated Arts & Sci, Div Nat Sci, Tokushima 7708502, Japan	Hagiwara, M (reprint author), Kyoto Univ, Grad Sch Med, Dept Anat & Dev Biol, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	hagiwara.masatoshi.8c@kyoto-u.ac.jp	OGAWA, Yasushi/M-8900-2014		Japan Science and Technology Agency (J-AMP) [10103930]; Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI) [24241076]; Platform for Drug Discovery, Informatics, and Structural Life Science of MEXT, Japan	We thank Ayako Hosoya (Tokyo Medical and Dental University, Tokyo, Japan) for HRMS analyses, and Yuka Koike (Kyoto University, Kyoto, Japan) for technical assistance. Illustration was reproduced courtesy of Cell Signaling Technology, Inc. (www.cellsignal.com). This work was supported by Grants-in-Aid from the Japan Science and Technology Agency (J-AMP Grant number 10103930, M.H.), Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan (KAKENHI Grant number 24241076, M.H.), and by the Platform for Drug Discovery, Informatics, and Structural Life Science of MEXT, Japan (M.H. and T.H.).	Anderson K, 2013, BIOORG MED CHEM LETT, V23, P6610, DOI 10.1016/j.bmcl.2013.10.055; Wegiel J, 2011, FEBS J, V278, P236, DOI 10.1111/j.1742-4658.2010.07955.x; Marshall NF, 1996, J BIOL CHEM, V271, P27176; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; Keramati AR, 2014, NEW ENGL J MED, V370, P1909, DOI 10.1056/NEJMoa1301824; Saltiel AR, 1996, DIABETES, V45, P1661, DOI 10.2337/diabetes.45.12.1661; Friedman E, 2013, INT J MOL SCI, V14, P5560, DOI 10.3390/ijms14035560; O'Roak BJ, 2012, SCIENCE, V338, P1619, DOI 10.1126/science.1227764; Moller RS, 2008, AM J HUM GENET, V82, P1165, DOI 10.1016/j.ajhg.2008.03.001; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Ghoreschi K, 2009, NAT IMMUNOL, V10, P356, DOI 10.1038/ni.1701; Altafaj X, 2001, HUM MOL GENET, V10, P1915, DOI 10.1093/hmg/10.18.1915; Siersbaek R, 2012, TRENDS ENDOCRIN MET, V23, P56, DOI 10.1016/j.tem.2011.10.001; Tahtouh T, 2012, J MED CHEM, V55, P9312, DOI 10.1021/jm301034u; Wang P, 2015, NAT MED, V21, P383, DOI 10.1038/nm.3820; Deng XB, 2006, CANCER RES, V66, P4149, DOI 10.1158/0008-5472.CAN-05-9089; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Liu J, 2008, J ORG CHEM, V73, P2951, DOI 10.1021/jo8000595; Gockler N, 2009, FEBS J, V276, P6324, DOI 10.1111/j.1742-4658.2009.07346.x; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Hong JY, 2012, J CELL SCI, V125, P561, DOI 10.1242/jcs.086173; Lahiry P, 2010, NAT REV GENET, V11, P60, DOI 10.1038/nrg2707; Malinge S, 2012, J CLIN INVEST, V122, P948, DOI 10.1172/JCI60455; Lapenna S, 2009, NAT REV DRUG DISCOV, V8, P547, DOI 10.1038/nrd2907; Yang C, 2010, CARCINOGENESIS, V31, P552, DOI 10.1093/carcin/bgp330; Raghav SK, 2012, MOL CELL, V46, P335, DOI 10.1016/j.molcel.2012.03.017; Rosenthal AS, 2011, BIOORG MED CHEM LETT, V21, P3152, DOI 10.1016/j.bmcl.2011.02.114; O'Roak BJ, 2012, NATURE, V485, P246, DOI 10.1038/nature10989; Grabher P, 2012, PLANTA MED, V78, P951, DOI 10.1055/s-0031-1298625; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Gao JC, 2012, INT J ONCOL, V40, P1203, DOI 10.3892/ijo.2011.1293; Lee K, 2000, CANCER RES, V60, P3631; Chartier M, 2013, PEERJ, V1, DOI 10.7717/peerj.126; Coombs TC, 2013, BIOORG MED CHEM LETT, V23, P3654, DOI 10.1016/j.bmcl.2013.02.096; Deng Xiaobing, 2014, Genes Cancer, V5, P337; Deng Xiaobing, 2014, Genes Cancer, V5, P22; Deng Xiaobing, 2014, Genes Cancer, V5, P201; Deng XB, 2009, CANCER RES, V69, P3317, DOI 10.1158/0008-5472.CAN-08-2903; Di Vona C, 2015, MOL CELL, V57, P506, DOI 10.1016/j.molcel.2014.12.026; Ewton DZ, 2011, MOL CANCER THER, V10, P2104, DOI 10.1158/1535-7163.MCT-11-0498; Fabbro D., 2014, MOL PHARM; Friedman E, 2007, J CELL BIOCHEM, V102, P274, DOI 10.1002/jcb.21451; Gao J., 2014, CANCER BIOL THER, V8, P1671; Gao J., 2013, CANC CELL INT, V13; Hu J., 2010, GENES CANC, V1, P803; Hu J, 2013, INT J CANCER, V132, P2258, DOI 10.1002/ijc.27917; Jin K, 2009, J BIOL CHEM, V284, P22916, DOI 10.1074/jbc.M109.035519; Jin K, 2007, CANCER RES, V67, P7247, DOI 10.1158/0008-5472.can-06-4099; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; Li LW, 2014, ACS CHEM BIOL, V9, P731, DOI 10.1021/cb4005589; Mercer SE, 2006, CANCER RES, V66, P5143, DOI 10.1158/0008-5472.CAN-05-1539; Ogawa Y, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1090; Song WJ, 2015, J BIOL CHEM, V290, P2321, DOI 10.1074/jbc.M114.594952; Tsioras K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082172	56	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4434	4441		10.1016/j.bmc.2015.06.018		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000034		
J	Sato, K; Takahagi, H; Kubo, O; Hidaka, K; Yoshikawa, T; Kamaura, M; Nakakariya, M; Amano, N; Adachi, R; Maki, T; Take, K; Takekawa, S; Kitazaki, T; Maekawa, T				Sato, Kenjiro; Takahagi, Hiroki; Kubo, Osamu; Hidaka, Kousuke; Yoshikawa, Takeshi; Kamaura, Masahiro; Nakakariya, Masanori; Amano, Nobuyuki; Adachi, Ryutaro; Maki, Toshiyuki; Take, Kazumi; Takekawa, Shiro; Kitazaki, Tomoyuki; Maekawa, Tsuyoshi			Optimization of a novel series of N-phenylindoline-5-sulfonamide-based acyl CoA: monoacylglycerol acyltransferase-2 inhibitors: Mitigation of CYP3A4 time-dependent inhibition and phototoxic liabilities	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						MGAT2 inhibitor; Acyltransferase; Triacylglycerol; Obesity; Metabolic disease; Indoline; Time-dependent inhibition; CYP3A4; Phototoxicity	MGAT2 INHIBITORS; MICE; DEFICIENCY; DISCOVERY; DISEASE; CLONING; RISK; TRIGLYCERIDES; COENZYME; ANILINES	Acyl CoA: monoacylglycerol acyltransferase-2 (MGAT2) has emerged as a potential peripheral target for the treatment of obesity and metabolic disorders. We previously identified a novel series of N-phenylin-doline-5-sulfonamide derivatives exemplified by 2 as potent and orally bioavailable MGAT2 inhibitors. Despite its attractive potency, further assessment revealed that this compound exhibited time-dependent inhibition (TDI) of cytochrome P450 3A4 (CYP3A4). To remove the undesirable CYP3A4 TDI activity, structural modification was focused on the 2,4-difluoroaniline moiety on the basis of the assumption that this moiety would be involved in mechanism-based inhibition of CYP3A4 via oxidative metabolism. This led to the finding that the introduction of 4-chloro-2,6-difluoroaniline significantly improved CYP3A4 TDI risk. Further optimization resulted in the discovery of N-(4-chloro-2,6-difluorophenyl)-1-{5-[1-methyl-3-(trifluoromethyl)-1H-pyrazol-5-yl]pyrimidin-2-yl}-7-(2-oxopyrrolidin-1-yl)-2,3-dihydro-1H-indole-5-sulfonamide (27c) with potent MGAT2 inhibitory activity (IC50 = 7.8 nM) and excellent ADME-Tox profiles including metabolic stability, oral bioavailability, and CYP3A4 TDI. In a mouse oral fat tolerance test, compound 27c effectively and dose-dependently suppressed the elevation of plasma triacylglycerol levels after oral administration at doses of 1 and 3 mg/kg. We also discuss mitigation of the phototoxic liability of biaryl derivatives on the basis of the HOMO-LUMO gap hypothesis during the course of optimization efforts. (C) 2015 Elsevier Ltd. All rights reserved.	[Sato, Kenjiro; Takahagi, Hiroki; Kubo, Osamu; Hidaka, Kousuke; Yoshikawa, Takeshi; Kamaura, Masahiro; Nakakariya, Masanori; Amano, Nobuyuki; Adachi, Ryutaro; Maki, Toshiyuki; Take, Kazumi; Takekawa, Shiro; Kitazaki, Tomoyuki; Maekawa, Tsuyoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan	Sato, K (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	kenjirou.satou@takeda.com					Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963; Sato K, 2015, J MED CHEM, V58, P3892, DOI 10.1021/acs.jmedchem.5b00178; Scott JS, 2013, MEDCHEMCOMM, V4, P1305, DOI 10.1039/c3md00156c; Millar JS, 2005, J LIPID RES, V46, P2023, DOI 10.1194/jlr.D500019-JLR200; Maiti D, 2011, CHEM SCI, V2, P57, DOI 10.1039/c0sc00330a; Boullart ACI, 2012, BBA-MOL CELL BIOL L, V1821, P867, DOI 10.1016/j.bbalip.2011.10.002; Cao JS, 2007, J LIPID RES, V48, P583, DOI 10.1194/jlr.M600331-JLR200; Leeson PD, 2007, NAT REV DRUG DISCOV, V6, P881, DOI 10.1038/nrd2445; CHANG CCY, 1993, J BIOL CHEM, V268, P20747; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; DEWAR MJS, 1985, J AM CHEM SOC, V107, P3902, DOI 10.1021/ja00299a024; Li XH, 2009, CHEM RES TOXICOL, V22, P1736, DOI 10.1021/tx900256y; Yen CLE, 2003, J BIOL CHEM, V278, P18532, DOI 10.1074/jbc.M301633200; Cao JS, 2003, J BIOL CHEM, V278, P13860, DOI 10.1074/jbc.M300139200; Yen CLE, 2009, NAT MED, V15, P442, DOI 10.1038/nm.1937; Barlind JG, 2013, BIOORG MED CHEM LETT, V23, P2721, DOI 10.1016/j.bmcl.2013.02.084; Orr STM, 2012, J MED CHEM, V55, P4896, DOI 10.1021/jm300065h; Cases S, 2001, J BIOL CHEM, V276, P38870, DOI 10.1074/jbc.M106219200; Biscoe MR, 2008, J AM CHEM SOC, V130, P6686, DOI 10.1021/ja801137k; RIETJENS IMCM, 1989, XENOBIOTICA, V19, P1297; Oelkers P, 1998, J BIOL CHEM, V273, P26765, DOI 10.1074/jbc.273.41.26765; CNUBBEN NHP, 1995, BIOCHEM PHARMACOL, V49, P1235, DOI 10.1016/0006-2952(95)00043-Y; Goldberg IJ, 2012, BBA-MOL CELL BIOL L, V1821, P719, DOI 10.1016/j.bbalip.2012.02.005; Harchaoui K E L, 2009, Curr Cardiol Rev, V5, P216, DOI 10.2174/157340309788970315; MASUMOTO K, 1995, YAKUGAKU ZASSHI, V115, P213; Nakashima S, 2013, CHEM PHARM BULL, V61, P1228; Nelson DW, 2011, J LIPID RES, V52, P1723, DOI 10.1194/jlr.M016840; Peukert S, 2011, MEDCHEMCOMM, V2, P973, DOI 10.1039/c1md00144b; RIETJENS IMCM, 1991, CHEM-BIOL INTERACT, V77, P263, DOI 10.1016/0009-2797(91)90036-7; Ringeissen S, 2011, TOXICOL IN VITRO, V25, P324, DOI 10.1016/j.tiv.2010.09.017; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Stein KR, 2007, EXPERT OPIN DRUG SAF, V6, P431, DOI 10.1517/14740338.6.4.431; Tsuchida T, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-75	33	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4544	4560		10.1016/j.bmc.2015.06.003		17	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000046		
J	Koda, H; Brazier, JA; Onishi, I; Sasaki, S				Koda, Hironori; Brazier, John Alan; Onishi, Ippei; Sasaki, Shigeki			Strong positive cooperativity in binding to the A(3)T(3) repeat by Hoechst 33258 derivatives attaching the quinoline units at the end of a branched linker	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Cooperative binding; DNA repeat; Hoechst; Fluorescence titration; McGhee-von Hippel equation	DIMENSIONAL HOMOGENEOUS LATTICE; CALF THYMUS DNA; NONCOOPERATIVE BINDING; LARGE LIGANDS; G-QUADRUPLEX; BASE; RECOGNITION; COMPLEX; SITES; MODES	Hoechst 33258 derivatives with additional interacting moieties attached at the ends of branched linkers were synthesized, and their DNA binding properties were investigated with regard to the A3T3 repeat by measuring fluorescence spectra. The binding property of the ligand was investigated by fluorescence titration, and the titration data were analyzed using the McGhee-von Hippel method. Ligand 6Q with the quinolin-6-yloxyacetyl group and Ligand IQ with isoquinolin-6-yloxyacetyl group at the ends of the branched linkers exhibit highly positive cooperativity for the DNA having 5 A3T3 sites with 3 base-insertions between them with sequence selectivity. The strategy developed in this study may be generally applicable for designing ligands for repetitive DNA sequences. (C) 2015 Elsevier Ltd. All rights reserved.	[Koda, Hironori; Onishi, Ippei; Sasaki, Shigeki] Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, Fukuoka 8128582, Japan; [Brazier, John Alan] Univ Reading, Sch Pharm, Reading RG6 6AD, Berks, England	Sasaki, S (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	sasaki@phar.kyushu-u.ac.jp	Brazier, John/A-6403-2009		Japan Society for the Promotion of Science (JSPS) [21229002, 18 06231]	We are grateful for support provided by a Grant-in-Aid for Scientific Research (S) (Grant number 21229002) and Restart Postdoctoral Fellowship to JB (Grant number 18 06231) from the Japan Society for the Promotion of Science (JSPS).	McMurray CT, 2010, NAT REV GENET, V11, P786, DOI 10.1038/nrg2828; Haq I, 1997, J MOL BIOL, V271, P244, DOI 10.1006/jmbi.1997.1170; Tessmer I, 2012, NUCLEIC ACIDS RES, V40, P8296, DOI 10.1093/nar/gks574; Tanada M, 2006, ORG LETT, V8, P2475, DOI 10.1021/ol060632b; STOKKE T, 1985, J HISTOCHEM CYTOCHEM, V33, P333; Mitra A, 1998, TETRAHEDRON, V54, P15489, DOI 10.1016/S0040-4020(98)01015-1; LOONTIENS FG, 1990, BIOCHEMISTRY-US, V29, P9029, DOI 10.1021/bi00490a021; Zhang J, 2013, SCIENCE, V342, P611, DOI 10.1126/science.1242603; Breusegem SY, 2002, J MOL BIOL, V315, P1049, DOI 10.1006/jmbi.2001.5301; Shapiro JA, 2005, BIOL REV, V80, P227, DOI 10.1017/S1464793104006657; Liu Y, 2012, J AM CHEM SOC, V134, P5290, DOI 10.1021/ja211628j; WILCOX CS, 1986, TETRAHEDRON LETT, V27, P5563, DOI 10.1016/S0040-4039(00)85266-1; Mirkin SM, 2006, CURR OPIN STRUC BIOL, V16, P351, DOI 10.1016/j.sbi.2006.05.004; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Guan Y, 2007, J PHYS CHEM B, V111, P7336, DOI 10.1021/jp066344e; Brooks TA, 2010, FEBS J, V277, P3459, DOI 10.1111/j.1742-4658.2010.07759.x; Casabianca LB, 2004, J PHYS CHEM A, V108, P8505, DOI 10.1021/jp047361b; BUJALOWSKI W, 1989, BIOPOLYMERS, V28, P1637, DOI 10.1002/bip.360280912; Di Prospero NA, 2005, NAT REV GENET, V6, P756, DOI 10.1038/nrg1690; GAUGAIN B, 1978, BIOCHEMISTRY-US, V17, P5078, DOI 10.1021/bi00617a002; Gavathiotis E, 2000, NUCLEIC ACIDS RES, V28, P728, DOI 10.1093/nar/28.3.728; Ghosh K, 2008, BEILSTEIN J ORG CHEM, V4, DOI 10.3762/bjoc.4.52; Gomes LR, 2013, ACTA CRYSTALLOGR C, V69, P191, DOI 10.1107/S0108270113001510; Hadadzadeh H, 2013, INORG CHIM ACTA, V400, P82, DOI 10.1016/j.ica.2013.02.010; KOWALCZYKOWSKI SC, 1986, BIOCHEMISTRY-US, V25, P1226, DOI 10.1021/bi00354a006; Maiti S, 2003, BIOCHEM BIOPH RES CO, V310, P505, DOI 10.1016/j.bbrc.2003.09.052; Mckay SL, 2001, J AM CHEM SOC, V123, P1244, DOI 10.1021/ja003256d; Rao SR, 2010, J CELL MOL BIOL, V7, P1; Tanada M, 2006, J ORG CHEM, V71, P125, DOI 10.1021/jo051836t; Wang M, 2007, BIOPHYS J, V93, P2477, DOI 10.1529/biophysj.106.102624	30	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4583	4590		10.1016/j.bmc.2015.05.056		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000050		
J	Ogiyama, T; Yonezawa, K; Inoue, M; Watanabe, T; Sugano, Y; Gotoh, T; Kiso, T; Koakutsu, A; Kakimoto, S; Shishikura, J				Ogiyama, Takashi; Yonezawa, Koichi; Inoue, Makoto; Watanabe, Toshihiro; Sugano, Yukihito; Gotoh, Takayasu; Kiso, Tetsuo; Koakutsu, Akiko; Kakimoto, Shuichiro; Shishikura, Jun-ichi			Discovery of a 1-isopropyltetrahydroisoquinoline derivative as an orally active N-type calcium channel blocker for neuropathic pain	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						N-type calcium channel; CaV 2.2; Pain; CYP2D6; CYP3A4	REUPTAKE INHIBITORS SNRI; IN-VITRO; LIVER-MICROSOMES; DRUG DISCOVERY; MICE LACKING; SAR; ANTIDEPRESSANTS; MECHANISM; SUBUNIT; RAT	N-type calcium channel blockade is a promising therapeutic approach for the treatment of neuropathic pain. Starting from lead compound (S)-1, we focused our optimization efforts on potency for N-type calcium channel inhibition and improvement of CYP inhibition profile. 2-{[(1-Hydroxycyclohexyl) methyl] amino}-(1R)-(1-isopropyl-6-methoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethanone oxalate ((R)-5r) was identified as a novel orally active small-molecule N-type calcium channel inhibitor with reduced CYP inhibition liability. Oral administration of (R)-5r improved mechanical allodynia in a spinal nerve ligation model of neuropathic pain in rats with an ED50 value of 2.5 mg/kg. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogiyama, Takashi; Yonezawa, Koichi; Inoue, Makoto; Watanabe, Toshihiro; Sugano, Yukihito; Gotoh, Takayasu; Kiso, Tetsuo; Kakimoto, Shuichiro; Shishikura, Jun-ichi] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Koakutsu, Akiko] Astellas Pharma Inc, Drug Discovery Res, Yodogawa Ku, Osaka 5328514, Japan	Ogiyama, T (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	takashi.ogiyama@astellas.com					Yamamoto T, 2009, CURR TOP MED CHEM, V9, P377; Hatakeyama S, 2001, NEUROREPORT, V12, P2423, DOI 10.1097/00001756-200108080-00027; McGivern JG, 2006, DRUG DISCOV TODAY, V11, P245, DOI 10.1016/S1359-6446(05)03662-7; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; Scott DA, 2002, EUR J PHARMACOL, V451, P279, DOI 10.1016/S0014-2999(02)02247-1; Bockbrader HN, 2010, CLIN PHARMACOKINET, V49, P661, DOI 10.2165/11536200-000000000-00000; Pajouhesh H, 2012, BIOORG MED CHEM LETT, V22, P4153, DOI 10.1016/j.bmcl.2012.04.054; Lee MS, 2014, PROGR MED CHEM, V53, P147, DOI 10.1016/B978-0-444-63380-4.00004-4; de Groot MJ, 2009, DRUG DISCOV TODAY, V14, P964, DOI 10.1016/j.drudis.2009.07.005; Zhou SF, 2009, CURR MED CHEM, V16, P2661; KIM SH, 1992, PAIN, V50, P355; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Kim C, 2001, MOL CELL NEUROSCI, V18, P235, DOI 10.1006/mcne.2001.1013; Zamponi GW, 2009, BIOORG MED CHEM LETT, V19, P6467, DOI 10.1016/j.bmcl.2009.09.008; Saegusa H, 2001, EMBO J, V20, P2349, DOI 10.1093/emboj/20.10.2349; Spina E, 2012, CNS DRUGS, V26, P39, DOI 10.2165/11594710-000000000-00000; LARSEN RD, 1991, J ORG CHEM, V56, P6034, DOI 10.1021/jo00021a014; Watabiki T, 2011, J PHARMACOL EXP THER, V336, P743, DOI 10.1124/jpet.110.175570; Winters MP, 2014, BIOORG MED CHEM LETT, V24, P2053, DOI 10.1016/j.bmcl.2014.03.062; Di L, 2007, INT J PHARM, V335, P1, DOI 10.1016/j.ijpharm.2006.10.039; Beebe X, 2013, BIOORG MED CHEM LETT, V23, P4857, DOI 10.1016/j.bmcl.2013.06.074; Barrow JC, 2010, ANNU REP MED CHEM, V45, P3, DOI 10.1016/S0065-7743(10)45001-0; Fish PV, 2007, BIOORG MED CHEM LETT, V17, P2022, DOI 10.1016/j.bmcl.2007.01.020; Fray MJ, 2006, BIOORG MED CHEM LETT, V16, P4349, DOI 10.1016/j.bmcl.2006.05.049; Hudson S, 2008, BIOORG MED CHEM LETT, V18, P4491, DOI 10.1016/j.bmcl.2008.07.049; Ishichi Y, 2013, BIOORGAN MED CHEM, V21, P4600, DOI 10.1016/j.bmc.2013.05.025; Kitabatake M, 2009, EUR J MED CHEM, V44, P4034, DOI 10.1016/j.ejmech.2009.04.035; Kumar S, 2012, CURR MED CHEM, V19, P3605; Leister L., 2009, CURR MED CHEM, V16, P3093; Watanuki S, 2011, CHEM PHARM BULL, V59, P1029; McGivern Joseph G., 2004, Current Drug Targets - CNS and Neurological Disorders, V3, P457, DOI 10.2174/1568007043336743; Naritomi Y, 2001, DRUG METAB DISPOS, V29, P1316; Ogiyama T, 2015, BIOORGAN MED CHEM, V23, P4638, DOI 10.1016/j.bmc.2015.05.053; Ogiyama T, 2014, BIOORGAN MED CHEM, V22, P6899, DOI 10.1016/j.bmc.2014.10.020; Pontillo J, 2008, BIOORG MED CHEM LETT, V18, P6151, DOI 10.1016/j.bmcl.2008.10.013; SEEBACH D, 1983, TETRAHEDRON, V39, P1963, DOI 10.1016/S0040-4020(01)91914-3; Shao P. P., 2013, ACS MED CHEM LETT, V1064, P4; Shin JG, 2002, DRUG METAB DISPOS, V30, P1102, DOI 10.1124/dmd.30.10.1102; Wernicke Joachim F, 2005, Expert Opin Drug Saf, V4, P987, DOI 10.1517/14740338.4.6.987; Winters MP, 2014, BIOORG MED CHEM LETT, V24, P2057, DOI 10.1016/j.bmcl.2014.03.063; Zhou SF, 2008, CURR PHARM DESIGN, V14, P990, DOI 10.2174/138161208784139738	41	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4624	4637		10.1016/j.bmc.2015.05.030		14	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000053		
J	Ogiyama, T; Yonezawa, K; Inoue, M; Katayama, N; Watanabe, T; Yoshimura, S; Gotoh, T; Kiso, T; Koakutsu, A; Kakimoto, S; Shishikura, J				Ogiyama, Takashi; Yonezawa, Koichi; Inoue, Makoto; Katayama, Naoko; Watanabe, Toshihiro; Yoshimura, Seiji; Gotoh, Takayasu; Kiso, Tetsuo; Koakutsu, Akiko; Kakimoto, Shuichiro; Shishikura, Jun-ichi			Discovery of an 8-methoxytetrahydroisoquinoline derivative as an orally active N-type calcium channel blocker for neuropathic pain without CYP inhibition liability	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						N-type calcium channel; CaV2.2; Pain; CYP2D6; CYP3A4	DRUG DISCOVERY; SAR	In lead optimization efforts starting from the tetrahydroisoquinoline (S)-1, we identified 2-{[(2R)-2-hydroxypropyl]amino}-1-[(1S)-8-methoxy-1-phenyl-3,4-dihydroisoquinolin-2(1H)-yl]ethanone((1S)-8t) as a novel orally active small-molecule N-type calcium channel blocker without CYP inhibition liability. CYP3A4 inhibition profile was improved by reducing the lipophilicity of compound (S)-1. Moreover, introduction of a methoxy group to the C-8 position of tetrahydroisoquinoline led to identification of (1S)-8t, which eliminated CYP2D6 inhibition liability. Oral administration of (1S)-8t exerted efficacy in a rat spinal nerve ligation (SNL) model of neuropathic pain with an ED50 value of 2.8 mg/kg. (C) 2015 Elsevier Ltd. All rights reserved.	[Ogiyama, Takashi; Yonezawa, Koichi; Inoue, Makoto; Katayama, Naoko; Watanabe, Toshihiro; Yoshimura, Seiji; Gotoh, Takayasu; Kiso, Tetsuo; Kakimoto, Shuichiro; Shishikura, Jun-ichi] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan; [Koakutsu, Akiko] Astellas Pharma Inc, Drug Discovery Res, Yodogawa Ku, Osaka 5328514, Japan	Ogiyama, T (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	takashi.ogiyama@astellas.com					Yamamoto T, 2009, CURR TOP MED CHEM, V9, P377; Stephens PJ, 2008, CHIRALITY, V20, P643, DOI 10.1002/chir.20477; McGivern JG, 2006, DRUG DISCOV TODAY, V11, P245, DOI 10.1016/S1359-6446(05)03662-7; HUNSKAAR S, 1985, J NEUROSCI METH, V14, P69, DOI 10.1016/0165-0270(85)90116-5; Li CQ, 2008, J AM CHEM SOC, V130, P13208, DOI 10.1021/ja8050958; Stoll F, 2011, DRUG DISCOV TODAY, V16, P530, DOI 10.1016/j.drudis.2011.04.008; Lee MS, 2014, PROGR MED CHEM, V53, P147, DOI 10.1016/B978-0-444-63380-4.00004-4; de Groot MJ, 2009, DRUG DISCOV TODAY, V14, P964, DOI 10.1016/j.drudis.2009.07.005; Moroy G, 2012, DRUG DISCOV TODAY, V17, P44, DOI 10.1016/j.drudis.2011.10.023; Zhou SF, 2009, CURR MED CHEM, V16, P2661; KIM SH, 1992, PAIN, V50, P355; Miljanich GP, 2004, CURR MED CHEM, V11, P3029; Branden G, 2014, DRUG DISCOV TODAY, V19, P905, DOI 10.1016/j.drudis.2014.03.012; Schmidtko A, 2010, LANCET, V375, P1569, DOI 10.1016/S0140-6736(10)60354-6; Watabiki T, 2011, J PHARMACOL EXP THER, V336, P743, DOI 10.1124/jpet.110.175570; Winters MP, 2014, BIOORG MED CHEM LETT, V24, P2053, DOI 10.1016/j.bmcl.2014.03.062; Beebe X, 2013, BIOORG MED CHEM LETT, V23, P4857, DOI 10.1016/j.bmcl.2013.06.074; Barrow JC, 2010, ANNU REP MED CHEM, V45, P3, DOI 10.1016/S0065-7743(10)45001-0; Guner OF, 2013, CURR TOP MED CHEM, V13, P1327; Kumar S, 2012, CURR MED CHEM, V19, P3605; Leister L., 2009, CURR MED CHEM, V16, P3093; McGivern Joseph G., 2004, Current Drug Targets - CNS and Neurological Disorders, V3, P457, DOI 10.2174/1568007043336743; Nafie L. A., 2000, CIRCULAR DICHROISM P, P97; Ogiyama T., 2015, J BIOORG ME IN PRESS; Ogiyama T., 2014, J BIOORG MED CHEM, V22, P6899; Shao PCP, 2013, ACS MED CHEM LETT, V4, P1064, DOI 10.1021/ml4002612; Winters MP, 2014, BIOORG MED CHEM LETT, V24, P2057, DOI 10.1016/j.bmcl.2014.03.063; Zhou SF, 2008, CURR PHARM DESIGN, V14, P990, DOI 10.2174/138161208784139738	28	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4638	4648		10.1016/j.bmc.2015.05.053		11	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000054		
J	Karmakar, UK; Ishikawa, N; Toume, K; Arai, MA; Sadhu, SK; Ahmed, F; Ishibashi, M				Karmakar, Utpal K.; Ishikawa, Naoki; Toume, Kazufumi; Arai, Midori A.; Sadhu, Samir K.; Ahmed, Firoj; Ishibashi, Masami			Sesquiterpenes with TRAIL-resistance overcoming activity from Xanthium strumarium	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						TRAIL-resistance; Xanthium strumarium; Asteraceae; Sesquiterpenes	OCCURRING TERPENE DERIVATIVES; INDUCED APOPTOSIS; LIGAND TRAIL; CANCER-CELLS; IN-VITRO; XANTHANOLIDES; LACTONES; EXPRESSION; MECHANISM; PATHWAY	The ability of TRAIL to selectively induce apoptosis in cancer cells while sparing normal cells makes it an attractive target for the development of new cancer therapy. In search of bioactive natural products for overcoming TRAIL-resistance from natural resources, we previously reported a number of active compounds. In our screening program on natural resources targeting overcoming TRAIL-resistance, activity-guided fractionations of the extract of Xanthium strumarium led to the isolation of five sesquiterpene compounds (1-5). 11 alpha, 13-dihydroxanthinin (2) and 11 alpha, 13-dihydroxanthuminol (3) were first isolated from natural resources and xanthinosin (1), desacetylxanthanol (4), and lasidiol p-methoxybenzoate (5) were known compounds. All compounds (1-5) showed potent TRAIL-resistance overcoming activity at 8, 20, 20, 16, and 16 mu M, respectively, in TRAIL-resistant AGS cells. Compounds 1 and 5 enhanced the levels of apoptosis inducing proteins DR4, DR5, p53, CHOP, Bax, cleaved caspase-3, cleaved caspase-8, and cleaved caspase-9 and also decreased the levels of cell survival protein Bcl-2 in TRAIL-resistant AGS cells in a dose-dependent manner. Compound 1 also enhanced the levels of DR4 and DR5 proteins in a time-dependent manner. Thus, compounds 1 and 5 were found to induce both extrinsic and intrinsic apoptotic cell death. Compound 1 also exhibit TRAIL-resistance overcoming activity in DLD1, DU145, HeLa, and MCF7 cells but did not decrease viability in non-cancer HEK293 cells up to 8 mu M. (C) 2015 Elsevier Ltd. All rights reserved.	[Karmakar, Utpal K.; Ishikawa, Naoki; Toume, Kazufumi; Arai, Midori A.; Ishibashi, Masami] Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, Chiba 2608675, Japan; [Karmakar, Utpal K.; Sadhu, Samir K.] Khulna Univ, Sch Life Sci, Pharm Discipline, Khulna 9208, Bangladesh; [Ahmed, Firoj] Univ Dhaka, Dept Pharmaceut Chem, Dhaka 1000, Bangladesh	Ishibashi, M (reprint author), Chiba Univ, Grad Sch Pharmaceut Sci, Chuo Ku, 1-8-1 Inohana, Chiba 2608675, Japan.	mish@chiba-u.jp	Ishibashi, Masami /E-5328-2015; Arai, Midori/O-4613-2015; Toume, Kazufumi/A-2632-2012	Ishibashi, Masami /0000-0002-2839-1045; Toume, Kazufumi/0000-0002-3315-145X	MEXT [23102008]; JSPS [26305001, 25670045, 25870128]; Uehara Memorial Foundation; Tokyo Biochemical Research Foundation (TBRF)	This study was supported by KAKENHI Grants Number 23102008 from MEXT, 26305001, 25670045, and 25870128 from JSPS, the Uehara Memorial Foundation, and the Tokyo Biochemical Research Foundation (TBRF).	AGATA I, 1993, PHYTOCHEMISTRY, V33, P508, DOI 10.1016/0031-9422(93)85551-2; Ahmed F, 2010, ORG BIOMOL CHEM, V8, P3696, DOI 10.1039/c004927a; Ishibashi M, 2008, MED RES REV, V28, P688, DOI 10.1002/med.20123; Zhao J, 2012, CANCER LETT, V314, P8, DOI 10.1016/j.canlet.2011.09.040; Prasad S, 2011, CANCER RES, V71, P538, DOI 10.1158/0008-5472.CAN-10-3121; Wu GS, 1997, NAT GENET, V17, P141, DOI 10.1038/ng1097-141; Zhang LD, 2005, CANCER GENE THER, V12, P228, DOI 10.1038/sj.cgt.7700792; Wu GS, 2009, CANCER LETT, V285, P1, DOI 10.1016/j.canlet.2009.02.029; MOLINATORRES J, 1991, NEW PHYTOL, V118, P95, DOI 10.1111/j.1469-8137.1991.tb00569.x; MARCO JA, 1993, PHYTOCHEMISTRY, V34, P1569, DOI 10.1016/S0031-9422(00)90847-1; Yoon JH, 2008, BIOORG MED CHEM LETT, V18, P2179, DOI 10.1016/j.bmcl.2007.12.076; Cheng XR, 2011, EUR J MED CHEM, V46, P5408, DOI 10.1016/j.ejmech.2011.08.047; Gupta SC, 2013, J BIOL CHEM, V288, P32343, DOI 10.1074/jbc.M113.455188; Lindhagen E, 2008, NAT PROTOC, V3, P1364, DOI 10.1038/nprot.2008.114; Lavault M, 2005, FITOTERAPIA, V76, P363, DOI 10.1016/j.fitote.2005.03.019; Shiraishi T, 2005, CANCER RES, V65, P6364, DOI 10.1158/0008-5472.CAN-05-0312; BOHLMANN F, 1978, PHYTOCHEMISTRY, V17, P1165, DOI 10.1016/S0031-9422(00)94308-5; BOHLMANN F, 1979, PHYTOCHEMISTRY, V18, P885, DOI 10.1016/0031-9422(79)80041-2; BOHLMANN F, 1979, PHYTOCHEMISTRY, V18, P1231; CUMANDA J, 1991, J NAT PROD, V54, P460, DOI 10.1021/np50074a017; Favier LS, 2005, J ETHNOPHARMACOL, V100, P260, DOI 10.1016/j.jep.2005.02.042; Hasegawa H, 2007, BLOOD, V110, P1664, DOI 10.1182/blood-2007-01-068981; Joshi Swati P., 1997, Journal of Medicinal and Aromatic Plant Sciences, V19, P366; Jung E. M., 1905, CARCINOGENESIS, V2005, P26; LANZETTA R, 1991, PHYTOCHEMISTRY, V30, P1121, DOI 10.1016/S0031-9422(00)95185-9; Miyagawa T, 2009, TETRAHEDRON LETT, V50, P4658, DOI 10.1016/j.tetlet.2009.05.113; Ohtsuki T, 2008, BIOORGAN MED CHEM, V16, P1756, DOI 10.1016/j.bmc.2007.11.022; Park EH, 2014, J GINSENG RES, V38, P22, DOI 10.1016/j.jgr.2013.11.007; Passreiter CM, 1999, PLANTA MED, V65, P153, DOI 10.1055/s-1999-13978; Pinel B, 2010, J ENZYM INHIB MED CH, V25, P172, DOI 10.3109/14756360903169592; Ramirez-Erosa I, 2007, CAN J PHYSIOL PHARM, V85, P1160, DOI 10.1139/Y07-104; Rojas-Silva P, 2014, PHARM BIOL, V52, P398, DOI 10.3109/13880209.2013.837077; Talakal TS, 1995, J ETHNOPHARMACOL, V49, P141, DOI 10.1016/0378-8741(95)01313-X; Thorburn A, 2007, J THORAC ONCOL, V2, P461, DOI 10.1097/JTO.0b013e31805fea64; Yang JF, 2012, CANCER CHEMOTH PHARM, V69, P195, DOI 10.1007/s00280-011-1686-9	35	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4746	4754		10.1016/j.bmc.2015.05.044		9	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000065		
J	Islam, MM; Fujii, S; Sato, S; Okauchi, T; Takenaka, S				Islam, Md. Monirul; Fujii, Satoshi; Sato, Shinobu; Okauchi, Tatsuo; Takenaka, Shigeori			Thermodynamics and kinetic studies in the binding interaction of cyclic naphthalene diimide derivatives with double stranded DNAs	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Cyclic naphthalene diimide derivatives; Double-stranded DNA; Bis-intercalative binding; Entropy-dependence binding; Hydrophobic interaction	THREADING TETRA-INTERCALATOR; CIRCULAR-DICHROISM; NUCLEIC-ACIDS; LIGANDS; SEQUENCE; DESIGN; MODE; BISINTERCALATOR; EQUILIBRIUM; MOLECULES	Previously, we reported our investigations of the interaction between a cyclic naphthalene diimide derivative (cNDI 1) and double stranded DNA (dsDNA) (Bioorg. Med. Chem. 2014, 22, 2593). Here, we report the synthesis of the novel cNDI 2, which has shorter linker chains than cNDI 1. We performed comparative investigations of the interactions of both cNDI 1 and cNDI 2 with different types of dsDNA, including analysis of their thermodynamics and kinetics. Interactions between the cNDIs and calf thymus DNA (CT-DNA), poly[d(A-T)](2), or poly[d(G-C)](2) were explored by physicochemical and biochemical methods, including UV-Vis spectroscopy, circular dichroism (CD) spectroscopy, stopped-flow kinetics, and a topoisomerase I assay. Upon addition of cNDIs to CT-DNA, the existence of an induced CD signal at approximately the wavelength of the naphthalene diimide chromophore and unwinding of the DNA duplex, as detected by the topoisomerase I assay, revealed that cNDIs bound to the DNA duplex. As indicated by the steric constraint in the formation of the complex, bis-threading intercalation was the more favorable binding mode. UV-Vis spectroscopic titration of the cNDIs with DNA duplexes showed affinities on the order of 10(5)-10(6) M-1, with a stoichiometry of one cNDI molecule per four DNA base pairs. Thermodynamic parameters (Delta G, Delta H, and Delta S) based on the van't Hoff equation indicated that exothermic and entropy-dependent hydrophobic interactions played a major role in the reaction. Stopped-flow association and dissociation analysis showed that cNDI interactions with poly[d(G-C)](2) were more stable and had a slower dissociation rate than their interactions with poly[d(A-T)](2) and CT-DNA. Measurement of ionic strength indicated that electrostatic attraction is also an important component of the interaction between cNDIs and CT-DNA. Because of its longer linker chain, cNDI 1 showed higher binding selectivity, a more entropically favorable interaction, and much slower dissociation from dsDNA than cNDI 2. (C) 2015 Elsevier Ltd. All rights reserved.	[Islam, Md. Monirul; Sato, Shinobu; Okauchi, Tatsuo; Takenaka, Shigeori] Kyushu Inst Technol, Dept Appl Chem, Kitakyushu, Fukuoka 8048550, Japan; [Fujii, Satoshi] Kyushu Inst Technol, Dept Biosci & Bioinformat, Iizuka, Fukuoka 8208502, Japan	Takenaka, S (reprint author), Kyushu Inst Technol, Dept Appl Chem, Kitakyushu, Fukuoka 8048550, Japan.	shige@che.kyutech.ac.jp			Japan Society for the Promotion of Science [15K13748]	This work was supported in part by Japan Society for the Promotion of Science KAKENHI, Grant-in-Aid for Exploratory Research Grant Number 15K13748.	Haq I, 1997, J MOL BIOL, V271, P244, DOI 10.1006/jmbi.1997.1170; Huang N, 2003, P NATL ACAD SCI USA, V100, P68, DOI 10.1073/pnas.0135427100; Sato Y, 2009, NUCLEIC ACIDS RES, V37, P1411, DOI 10.1093/nar/gkn1079; Smith AR, 2013, J AM CHEM SOC, V135, P12783, DOI 10.1021/ja4057344; Hampel SM, 2010, BIOORG MED CHEM LETT, V20, P6459, DOI 10.1016/j.bmcl.2010.09.066; Leng FF, 2003, NUCLEIC ACIDS RES, V31, P6191, DOI 10.1093/nar/gkg826; SPOLAR RS, 1994, SCIENCE, V263, P777, DOI 10.1126/science.8303294; Holman GG, 2011, NAT CHEM, V3, P875, DOI [10.1038/nchem.1151, 10.1038/NCHEM.1151]; Shahabadi N, 2010, J MOL STRUCT, V970, P90, DOI 10.1016/j.molstruc.2010.02.048; MCGHEE JD, 1974, J MOL BIOL, V86, P469, DOI 10.1016/0022-2836(74)90031-X; Peixoto P, 2010, METHODS MOL BIOL, V613, P235, DOI 10.1007/978-1-60327-418-0_15; Chaires JB, 2006, ARCH BIOCHEM BIOPHYS, V453, P26, DOI 10.1016/j.abb.2006.03.027; RECORD MT, 1978, Q REV BIOPHYS, V11, P103; Milelli A, 2012, EUR J MED CHEM, V57, P417, DOI 10.1016/j.ejmech.2012.06.045; Haq I, 2002, ARCH BIOCHEM BIOPHYS, V403, P1, DOI 10.1016/S0003-9861(02)00202-3; Banavali NK, 2013, J AM CHEM SOC, V135, P8274, DOI 10.1021/ja401573j; Becker HC, 1997, J AM CHEM SOC, V119, P5798, DOI 10.1021/ja963919k; Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, P1, DOI 10.1039/9781847555380; Chaires JB, 1998, CURR OPIN STRUC BIOL, V8, P314, DOI 10.1016/S0959-440X(98)80064-X; Chaires JB, 1997, J MED CHEM, V40, P261, DOI 10.1021/jm9607414; Chu YJ, 2007, J AM CHEM SOC, V129, P1304, DOI 10.1021/ja066480x; Chu YJ, 2009, J AM CHEM SOC, V131, P3499, DOI 10.1021/ja805676w; Czerwinska I, 2014, BIOORGAN MED CHEM, V22, P2593, DOI 10.1016/j.bmc.2014.03.034; Elkordy A. A., 2013, APPL CALORIMETRY WID, P129; Esaki Y, 2014, CHEM COMMUN, V50, P5967, DOI 10.1039/c4cc01005a; Guelev VM, 2001, METHOD ENZYMOL, V340, P556; Hu GG, 1997, BIOCHEMISTRY-US, V36, P5940, DOI 10.1021/bi9705218; JONES RL, 1980, NUCLEIC ACIDS RES, V8, P1613, DOI 10.1093/nar/8.7.1613; Lee J, 2004, J AM CHEM SOC, V126, P14036, DOI 10.1021/ja046335o; Liu ZR, 1996, J BIOMOL STRUCT DYN, V14, P331; Lokey RS, 1997, J AM CHEM SOC, V119, P7202, DOI 10.1021/ja9706108; MONNOT M, 1992, EUR J BIOCHEM, V204, P1035, DOI 10.1111/j.1432-1033.1992.tb16725.x; Nakatani K, 2005, NAT CHEM BIOL, V1, P39, DOI 10.1038/nchembio708; TANIOUS FA, 1991, BIOCHEMISTRY-US, V30, P1813, DOI 10.1021/bi00221a013; TANIOUS FA, 1992, BIOCHEMISTRY-US, V31, P11632, DOI 10.1021/bi00161a050; Tse WC, 2004, CHEM BIOL, V11, P1607, DOI 10.1016/j.chembiol.2003.08.012; von Hippel PH, 2013, BIOPOLYMERS, V99, P923, DOI 10.1002/bip.22347; Wilson W. D., 1994, MOL ASPECTS ANTICANC, V2, P243; WILSON WD, 1985, BIOPOLYMERS, V24, P1941, DOI 10.1002/bip.360241008	39	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4769	4776		10.1016/j.bmc.2015.05.046		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000068		
J	Ohashi, T; Tanaka, Y; Shiokawa, Z; Banno, H; Tanaka, T; Shibata, S; Satoh, Y; Yamakawa, H; Yamamoto, Y; Hattori, H; Kondo, S; Miyamoto, M; Tojo, H; Baba, A; Sasaki, S				Ohashi, Tomohiro; Tanaka, Yuta; Shiokawa, Zenyu; Banno, Hiroshi; Tanaka, Toshio; Shibata, Sachio; Satoh, Yoshihiko; Yamakawa, Hiroko; Yamamoto, Yukiko; Hattori, Harumi; Kondo, Shigeru; Miyamoto, Maki; Tojo, Hideaki; Baba, Atsuo; Sasaki, Satoshi			Synthesis and evaluation of hedgehog signaling inhibitor with novel core system	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Hedgehog; Hh signaling inhibitor; X-ray single crystal structure; Benzamide; Dihedral angle; TAK-441	DISCOVERY; POTENT; DERIVATIVES	As we previously reported, N-methylpyrrolo[3,2-c] pyridine derivatives 1 (TAK-441) was discovered as a clinical candidate of hedgehog (Hh) signaling inhibitor by modification of the upper part. We next focused on modification of the lower part including core skeletons to discover new Hh signaling inhibitors with novel core rings. Efforts to find novel chemotypes by using X-ray single crystal structure analysis led to some potent Hh signaling inhibitors (2c, 2d, 2e, 2f) with novel core ring systems, which had benzamide moiety at the 5-position as a key component for potent activity. The suppression of Gli1 expression with these new Hh signaling inhibitors were weaker than that of compound 1 (TAK-441) because of low pharmacokinetic property. We recognized again TAK-441 is a good compound as clinical candidate with good structural and pharmacokinetic advantages. (C) 2015 Elsevier Ltd. All rights reserved.	[Ohashi, Tomohiro; Tanaka, Yuta; Shiokawa, Zenyu; Banno, Hiroshi; Tanaka, Toshio; Shibata, Sachio; Satoh, Yoshihiko; Yamakawa, Hiroko; Yamamoto, Yukiko; Hattori, Harumi; Kondo, Shigeru; Miyamoto, Maki; Tojo, Hideaki; Baba, Atsuo; Sasaki, Satoshi] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan	Ohashi, T (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1 Muraoka Higashi,2 Chome, Fujisawa, Kanagawa 2518555, Japan.	tomohiro.oohashi@takeda.com; satoshi.sasaki@takeda.com					Ohashi T, 2012, BIOORGAN MED CHEM, V20, P5507, DOI 10.1016/j.bmc.2012.07.034; Munchhof MJ, 2012, ACS MED CHEM LETT, V3, P106, DOI 10.1021/ml2002423; Tremblay MR, 2009, J MED CHEM, V52, P4400, DOI 10.1021/jm900305z; Peukert S, 2013, CHEMMEDCHEM, V8, P1261, DOI 10.1002/cmdc.201300217; Ohashi T, 2012, BIOORGAN MED CHEM, V20, P5496, DOI 10.1016/j.bmc.2012.07.039; Thayer SP, 2003, NATURE, V425, P851, DOI 10.1038/nature02009; Mazumdar T, 2011, CANCER RES, V71, P1092, DOI 10.1158/0008-5472.CAN-10-2315; Shaw A, 2007, J UROLOGY, V177, P832, DOI 10.1016/j.juro.2006.10.061; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Wang C, 2013, NATURE, V497, P338, DOI 10.1038/nature12167; Chang C. A., 2007, PNAS, V104, P1540; Dropinski D. F., 2005, BIOORG MED CHEM LETT, V15, P5035; Epstein H. E., 2008, NAT REV CANCER, V8, P743; Gao J, 2007, TETRAHEDRON LETT, V48, P7395, DOI 10.1016/j.tetlet.2007.08.003; LIU H, 1995, TETRAHEDRON LETT, V36, P8917, DOI 10.1016/0040-4039(95)01917-7; Marshall D., 2009, BIOORG MED CHEM LETT, V19, P5576; Marshall GR, 2012, J COMPUT AID MOL DES, V26, P3, DOI 10.1007/s10822-011-9494-1; Pan S., 2010, ACS MED CHEM LETT, V3, P130; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Zaidi AH, 2013, CANCER INVEST, V31, P480, DOI 10.3109/07357907.2013.820317; Zhu YF, 2002, BIOORG MED CHEM LETT, V12, P403, DOI 10.1016/S0960-894X(01)00780-6	21	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4777	4791		10.1016/j.bmc.2015.05.036		15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000069		
J	Takahashi, B; Funami, H; Iwaki, T; Maruoka, H; Shibata, M; Koyama, M; Nagahira, A; Kamiide, Y; Kanki, S; Igawa, Y; Muto, T				Takahashi, Bitoku; Funami, Hideaki; Iwaki, Takehiko; Maruoka, Hiroshi; Shibata, Makoto; Koyama, Makoto; Nagahira, Asako; Kamiide, Yoshiyuki; Kanki, Satomi; Igawa, Yoshiyuki; Muto, Tsuyoshi			Orally active ghrelin receptor inverse agonists and their actions on a rat obesity model	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						GhrelinR; Inverse agonist; 2-Aminoalkyl nicotinamide; Obesity	GROWTH-HORMONE SECRETION; IDENTIFICATION; POTENT; ANTAGONISTS; PEPTIDE	A series of 2-alkylamino nicotinamide analogs was prepared as orally active ghrelin receptor (ghrelinR) inverse agonists. Starting from compound 1, oral bioavailability was improved by modifying metabolically unstable sites and reducing molecular weight. Brain-permeable compound 33 and compound 24 with low brain permeability were tested in rat models of obesity; 30 mg/kg of compound 33 suppressed weight gain. PK/PD analysis revealed that the anti-obesity effect of ghrelinR inverse agonists depends on their brain concentrations. (C) 2015 Elsevier Ltd. All rights reserved.	[Takahashi, Bitoku; Funami, Hideaki; Iwaki, Takehiko; Maruoka, Hiroshi; Shibata, Makoto; Koyama, Makoto; Nagahira, Asako; Kamiide, Yoshiyuki; Kanki, Satomi; Igawa, Yoshiyuki; Muto, Tsuyoshi] Asubio Pharma Co Ltd, Chuo Ku, Kobe, Hyogo 6500047, Japan	Takahashi, B (reprint author), Asubio Pharma Co Ltd, Chuo Ku, 6-4-3 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	takahashi.bitoku.cz@asubio.co.jp					Al Massadi O, 2014, CURR DRUG METAB, V15, P398; Date Y, 2002, GASTROENTEROLOGY, V123, P1120, DOI 10.1053/gast.2002.35954; Korbonits M, 2004, FRONT NEUROENDOCRIN, V25, P27, DOI 10.1016/j.yfrne.2004.03.002; Mason BL, 2014, ANNU REV PHYSIOL, V76, P519, DOI 10.1146/annurev-physiol-021113-170310; McCoull W, 2013, MEDCHEMCOMM, V4, P456, DOI 10.1039/c2md20340e; Kojima M, 2005, PHYSIOL REV, V85, P495, DOI 10.1152/physrev.00012.2004; Tschop M, 2000, NATURE, V407, P908, DOI 10.1038/35038090; Arnold M, 2006, J NEUROSCI, V26, P11052, DOI 10.1523/JNEUROSCI.2606-06.2006; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Holst B, 2003, MOL ENDOCRINOL, V17, P2201, DOI 10.1210/me.2003-0069; Bhattacharya SK, 2014, ACS MED CHEM LETT, V5, P474, DOI 10.1021/ml400473x; Cameron KO, 2014, J MED CHEM, V57, P8671, DOI 10.1021/jm5003183; Cheng K, 1997, J ENDOCRINOL, V152, P155, DOI 10.1677/joe.0.1520155; DELGADO A, 1988, TETRAHEDRON LETT, V29, P3671, DOI 10.1016/S0040-4039(00)82150-4; Depoortere I., 2012, WORLD J GASTROENTERO, V18, P3183; Ghosh S, 2006, CAN J CHEM, V84, P555, DOI 10.1139/V06-045; Koopmann A, 2012, PSYCHONEUROENDOCRINO, V37, P980, DOI 10.1016/j.psyneuen.2011.11.005; LaPlante S. R., 2011, J MED CHEM, V54, P70005; le Roux CW, 2005, J CLIN ENDOCR METAB, V90, P4521, DOI 10.1210/jc.2004-2537; McClure KF, 2013, BIOORG MED CHEM LETT, V23, P5410, DOI 10.1016/j.bmcl.2013.07.044; Mertinell P. M., PCT INT APPL, pA1; Pasternak A, 2009, BIOORG MED CHEM LETT, V19, P6237, DOI 10.1016/j.bmcl.2009.08.076; Paulino G, 2009, AM J PHYSIOL-ENDOC M, V296, pE898, DOI 10.1152/ajpendo.90796.2008; Takahashi B, 2015, BIOORG MED CHEM LETT, V25, P2707, DOI 10.1016/j.bmcl.2015.04.040; Yamazaki M, 2002, J NEUROENDOCRINOL, V14, P156, DOI 10.1046/j.0007-1331.2001.00757.x	25	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4792	4803		10.1016/j.bmc.2015.05.047		12	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000070		
J	Yamagishi, H; Shirakami, S; Nakajima, Y; Tanaka, A; Takahashi, F; Hamaguchi, H; Hatanaka, K; Moritomo, A; Inami, M; Higashi, Y; Inoue, T				Yamagishi, Hiroaki; Shirakami, Shohei; Nakajima, Yutaka; Tanaka, Akira; Takahashi, Fumie; Hamaguchi, Hisao; Hatanaka, Keiko; Moritomo, Ayako; Inami, Masamichi; Higashi, Yasuyuki; Inoue, Takayuki			Discovery of 3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2(1H)-one derivatives as novel JAK inhibitors	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Janus kinase inhibitor; IL-2; Organ transplant rejection; Autoimmune diseases; Immunomodulator	LIGAND-BINDING; POTENT; IMIDAZOPYRROLOPYRIDINES; IDENTIFICATION; SELECTIVITY; REJECTION; DISEASES; PATHWAY; PATENTS; DESIGN	Because Janus kinases (JAKs) play a crucial role in cytokine-mediated signal transduction, JAKs are an attractive target for the treatment of organ transplant rejection and autoimmune diseases such as rheumatoid arthritis (RA). To identify JAK inhibitors, we focused on the 1H-pyrrolo[2,3-b]pyridine derivative 3, which exhibited moderate JAK3 and JAK1 inhibitory activities. Optimization of 3 identified the tricyclic imidazo-pyrrolopyridinone derivative 19, which exhibited potent JAK3 and JAK1 inhibitory activities (IC50 = 1.1 nM, 1.5 nM, respectively) with favorable metabolic stability. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamagishi, Hiroaki; Shirakami, Shohei; Nakajima, Yutaka; Tanaka, Akira; Takahashi, Fumie; Hamaguchi, Hisao; Hatanaka, Keiko; Moritomo, Ayako; Inami, Masamichi; Higashi, Yasuyuki; Inoue, Takayuki] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Yamagishi, H (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	hiroaki.yamagishi@astellas.com; inoue_eck@mii.maruho.co.jp					Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; Gummert JF, 1999, J AM SOC NEPHROL, V10, P1366; Flanagan ME, 2010, J MED CHEM, V53, P8468, DOI 10.1021/jm1004286; Zak M, 2013, J MED CHEM, V56, P4764, DOI 10.1021/jm4004895; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Zak M, 2012, J MED CHEM, V55, P6176, DOI 10.1021/jm300628c; Kulagowski JJ, 2012, J MED CHEM, V55, P5901, DOI 10.1021/jm300438j; Ho S, 1996, CLIN IMMUNOL IMMUNOP, V80, pS40, DOI 10.1006/clin.1996.0140; Naesens M, 2009, CLIN J AM SOC NEPHRO, V4, P481, DOI 10.2215/CJN.04800908; Norman P, 2012, EXPERT OPIN THER PAT, V22, P1233, DOI 10.1517/13543776.2012.723693; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; Clark JD, 2014, J MED CHEM, V57, P5023, DOI 10.1021/jm401490p; Dymock BW, 2013, EXPERT OPIN THER PAT, V23, P449, DOI 10.1517/13543776.2013.765862; Van Epps S, 2013, BIOORG MED CHEM LETT, V23, P693, DOI 10.1016/j.bmcl.2012.11.108; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Fridman JS, 2010, J IMMUNOL, V184, P5298, DOI 10.4049/jimmunol.0902819; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; [Anonymous], 2012, MOL DOCK STUD HUM JA; Abel R, 2008, J AM CHEM SOC, V130, P2817, DOI 10.1021/ja0771033; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Gehringer M, 2014, CHEMMEDCHEM, V9, P277, DOI 10.1002/cmdc.201300520; Inoue T., 2007, PCT INT APPL; Kiss R, 2010, EXPERT OPIN THER PAT, V20, P471, DOI 10.1517/13543771003639436; Mele TS, 2000, IMMUNOPHARMACOLOGY, V47, P215, DOI 10.1016/S0162-3109(00)00190-9; Nakajima Y, 2015, CHEM PHARM BULL, V63, P341, DOI 10.1248/cpb.c15-00036; SHIRAGA T, 1994, BIOCHEM PHARMACOL, V47, P727, DOI 10.1016/0006-2952(94)90136-8; Wilson LJ, 2010, EXPERT OPIN THER PAT, V20, P609, DOI 10.1517/13543771003709767; Wishart N., 2011, PCT INT APPL; Wishart N., 2009, PCT INT APPL; Yang Y, 2013, EXPERT OPIN DRUG DIS, V8, P277, DOI 10.1517/17460441.2013.749853	31	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4846	4859		10.1016/j.bmc.2015.05.028		14	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000076		
J	Nakajima, Y; Inoue, T; Nakai, K; Mukoyoshi, K; Hamaguchi, H; Hatanaka, K; Sasaki, H; Tanaka, A; Takahashi, F; Kunikawa, S; Usuda, H; Moritomo, A; Higashi, Y; Inami, M; Shirakami, S				Nakajima, Yutaka; Inoue, Takayuki; Nakai, Kazuo; Mukoyoshi, Koichiro; Hamaguchi, Hisao; Hatanaka, Keiko; Sasaki, Hiroshi; Tanaka, Akira; Takahashi, Fumie; Kunikawa, Shigeki; Usuda, Hiroyuki; Moritomo, Ayako; Higashi, Yasuyuki; Inami, Masamichi; Shirakami, Shohei			Synthesis and evaluation of novel 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives as potent and orally efficacious immunomodulators targeting JAK3	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						JAK (Janus kinase); JAK3 inhibitor; Immunomodulator; Transplant rejection; Docking calculation; hERG (human ether-a-go-go-related gene)	JANUS KINASE 3; CALCINEURIN INHIBITORS; KIDNEY-TRANSPLANTATION; LYMPHOID DEVELOPMENT; DISCOVERY; REJECTION; IMMUNOSUPPRESSION; INTERLEUKIN-2; CP-690550; PATHWAY	Janus kinases (JAKs) regulate various inflammatory and immune responses and are targets for the treatment of inflammatory and immune diseases. As a novel class of immunomodulators targeting JAK3, 1H-pyrrolo[2,3-b]pyridine-5-carboxamide derivatives are promising candidates for treating such diseases. In chemical modification of lead compound 2, the substitution of a cycloalkyl ring for an N-cyanopy-ridylpiperidine in C4-position was effective for increasing JAK3 inhibitory activity. In addition, modulation of physical properties such as molecular lipophilicity and basicity was important for reducing human ether-a-go-go-related gene (hERG) inhibitory activity. Our optimization study gave compound 31, which exhibited potent JAK3 inhibitory activity as well as weak hERG inhibitory activity. In cellular assay, 31 exhibited potent immunomodulating effect on IL-2-stimulated T cell proliferation. In a pharmacokinetic study, good metabolic stability and oral bioavailability of 31 were achieved in rats, dogs, and monkeys. Further, 31 prolonged graft survival in an in vivo rat heterotopic cardiac transplant model. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakajima, Yutaka; Inoue, Takayuki; Nakai, Kazuo; Mukoyoshi, Koichiro; Hamaguchi, Hisao; Hatanaka, Keiko; Sasaki, Hiroshi; Tanaka, Akira; Takahashi, Fumie; Kunikawa, Shigeki; Usuda, Hiroyuki; Moritomo, Ayako; Higashi, Yasuyuki; Inami, Masamichi; Shirakami, Shohei] Astellas Pharma Inc, Drug Discovery Res, Tsukuba, Ibaraki 3058585, Japan	Nakajima, Y (reprint author), Astellas Pharma Inc, Drug Discovery Res, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	yutaka.nakajima@astellas.com; shohei.shirakami@astellas.com					Leonard WJ, 2000, J ALLERGY CLIN IMMUN, V105, P877, DOI 10.1067/mai.2000.106899; [Anonymous], 2012, GLID VERS 5 8; Borie DC, 2005, TRANSPLANTATION, V79, P791, DOI 10.1097/01.TP.0000157117.30290.6F; [Anonymous], 2012, CONFG VERS 2 3; Safa K, 2013, CURR OPIN NEPHROL HY, V22, P689, DOI 10.1097/MNH.0b013e328365b3e6; Park SY, 1995, IMMUNITY, V3, P771, DOI 10.1016/1074-7613(95)90066-7; NOSAKA T, 1995, SCIENCE, V270, P800, DOI 10.1126/science.270.5237.800; Changelian PS, 2003, SCIENCE, V302, P875, DOI 10.1126/science.1087061; West K, 2009, CURR OPIN INVEST DR, V10, P491; Thoma G, 2011, J MED CHEM, V54, P284, DOI 10.1021/jm101157q; Imada K, 2000, MOL IMMUNOL, V37, P1, DOI 10.1016/S0161-5890(00)00018-3; Bechstein WO, 2000, TRANSPLANT INT, V13, P313, DOI 10.1111/j.1432-2277.2000.tb01004.x; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225; Pesu M, 2008, IMMUNOL REV, V223, P132, DOI 10.1111/j.1600-065X.2008.00644.x; RUSSELL SM, 1995, SCIENCE, V270, P797, DOI 10.1126/science.270.5237.797; Norman P, 2012, EXPERT OPIN THER PAT, V22, P1233, DOI 10.1517/13543776.2012.723693; Ghoreschi K, 2009, IMMUNOL REV, V228, P273, DOI 10.1111/j.1600-065X.2008.00754.x; MACCHI P, 1995, NATURE, V377, P65, DOI 10.1038/377065a0; Clark MP, 2007, BIOORG MED CHEM LETT, V17, P1250, DOI 10.1016/j.bmcl.2006.12.018; Dymock BW, 2013, EXPERT OPIN THER PAT, V23, P449, DOI 10.1517/13543776.2013.765862; O'Shea JJ, 2012, IMMUNITY, V36, P542, DOI 10.1016/j.immuni.2012.03.014; Chrencik JE, 2010, J MOL BIOL, V400, P413, DOI 10.1016/j.jmb.2010.05.020; Jaime-Figueroa S, 2013, BIOORG MED CHEM LETT, V23, P2522, DOI 10.1016/j.bmcl.2013.03.015; Neubauer H, 1998, CELL, V93, P397, DOI 10.1016/S0092-8674(00)81168-X; Denton MD, 1999, LANCET, V353, P1083, DOI 10.1016/S0140-6736(98)07493-5; Sherer BA, 2011, BIOORG MED CHEM LETT, V21, P7416, DOI 10.1016/j.bmcl.2011.10.010; Cox CD, 2008, J MED CHEM, V51, P4239, DOI 10.1021/jm800386y; [Anonymous], 2012, LIGPREP VERS 2 5; [Anonymous], 2012, MAESTR VERS 9 3; O'Shea JJ, 2004, NAT REV DRUG DISCOV, V3, P555, DOI 10.1038/nrd1441; Liptak P, 2006, NAT CLIN PRACT NEPHR, V2, P398, DOI 10.1038/ncpneph0225; Aronov Alex M, 2005, Drug Discov Today, V10, P149, DOI 10.1016/S1359-6446(04)03278-7; Aronov AM, 2008, CURR TOP MED CHEM, V8, P1113, DOI 10.2174/156802608785700061; Basarab G., 2006, BASARAB G; Gehringer M, 2014, CHEMMEDCHEM, V9, P277, DOI 10.1002/cmdc.201300520; JOHNSTON JA, 1994, NATURE, V370, P151, DOI 10.1038/370151a0; Nakajima Y, 2015, CHEM PHARM BULL, V63, P341, DOI 10.1248/cpb.c15-00036; Nakanishi T, 2010, INT IMMUNOPHARMACOL, V10, P91, DOI 10.1016/j.intimp.2009.09.026; O'Shea J. J., 2013, ANN RHEUM DIS, V72, P1; Podder H, 2004, EXPERT OPIN THER TAR, V8, P613, DOI 10.1517/14728222.8.6.613; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; Wilson LJ, 2010, EXPERT OPIN THER PAT, V20, P609, DOI 10.1517/13543771003709767; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Wojciechowski D, 2011, CURR OPIN ORGAN TRAN, V16, P614, DOI 10.1097/MOT.0b013e32834c23ce; Yang ZQ, 2008, J MED CHEM, V51, P6471, DOI 10.1021/jm800830n	45	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4871	4883		10.1016/j.bmc.2015.05.034		13	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000079		
J	Oba, M; Demizu, Y; Yamashita, H; Kurihara, M; Tanaka, M				Oba, Makoto; Demizu, Yosuke; Yamashita, Hiroko; Kurihara, Masaaki; Tanaka, Masakazu			Plasmid DNA delivery using fluorescein-labeled arginine-rich peptides	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Cell-penetrating peptide; Arginine; Gene transfer; Drug delivery system	POLYPLEX MICELLES; GENE DELIVERY; INTERNALIZATION MECHANISMS; INTRACELLULAR TRAFFICKING; CELLULAR UPTAKE; TRANSFECTION; PATHWAYS; ACIDS	Arginine (Arg)-rich peptides exhibit an effective cell-penetrating ability and deliver membrane-impermeable compounds into cells. In the present study, three types of Arg-rich peptides, R9 containing nine Arg residues, (RRG)3 containing six Arg and three glycine (Gly) residues, and (RRU)3 containing six Arg and three alpha-aminoisobutyric acid (Aib) residues, were evaluated for their plasmid DNA (pDNA) delivery and cell-penetrating abilities. The transfection efficiency of R9/pDNA complexes was much higher than those of (RRG) 3 and (RRU)3/pDNA complexes, and was derived from the enhanced cellular uptake of R9/pDNA complexes. The replacement of three Arg residues with the neutral amino acid Gly and hydrophobic amino acid Aib drastically changed the cell-penetrating ability and physicochemical properties of peptide/pDNA complexes, resulting in markedly reduced transfection efficiency. A comparison of the R9 peptide administration forms between a peptide alone and peptide/pDNA complex revealed that the uptake of R9 peptides was more efficient for the complex than the peptide alone, but occurred through the same internalization mechanism. The results of the present study will contribute to the design of novel Arg-rich cell-penetrating peptides for pDNA delivery. (C) 2015 Elsevier Ltd. All rights reserved.	[Oba, Makoto; Tanaka, Masakazu] Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan; [Demizu, Yosuke; Yamashita, Hiroko; Kurihara, Masaaki] Natl Inst Hlth Sci, Div Organ Chem, Tokyo 1588501, Japan; [Yamashita, Hiroko; Kurihara, Masaaki] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan	Oba, M (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Nagasaki 8528521, Japan.	moba@nagasaki-u.ac.jp			JSPS KAKENHI [25713008, 26460169]; Kurata Memorial Hitachi Science and Technology Foundation; Shoshisha Foundation	This work was financially supported in part by JSPS KAKENHI Grant Number 25713008 (M.O.) and 26460169 (Y.D.), by the Kurata Grant awarded by the Kurata Memorial Hitachi Science and Technology Foundation (M.O.), and scholarship support from the Shoshisha Foundation (H.Y.).	Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l; Wada S, 2011, BIOORG MED CHEM LETT, V21, P5688, DOI 10.1016/j.bmcl.2011.08.030; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; Nakase I, 2008, ADV DRUG DELIVER REV, V60, P598, DOI 10.1016/j.addr.2007.10.006; Gruber HJ, 2000, BIOCONJUGATE CHEM, V11, P696, DOI 10.1021/bc000015m; Wender PA, 2008, ADV DRUG DELIVER REV, V60, P452, DOI 10.1016/j.addr.2007.10.016; Umezawa N, 2002, J AM CHEM SOC, V124, P368, DOI 10.1021/ja017283v; Veldhoen S, 2008, INT J MOL SCI, V9, P1276, DOI 10.3390/ijms9071276; Christie RJ, 2011, BIOMACROMOLECULES, V12, P3174, DOI 10.1021/bm2006714; Oba M, 2008, MOL PHARMACEUT, V5, P1080, DOI 10.1021/mp800070s; Ge ZS, 2014, BIOMATERIALS, V35, P3416, DOI 10.1016/j.biomaterials.2013.12.086; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Yamashita H, 2014, BIOORGAN MED CHEM, V22, P2403, DOI 10.1016/j.bmc.2014.03.005; Schmidt N, 2010, FEBS LETT, V584, P1806, DOI 10.1016/j.febslet.2009.11.046; Hoyer J, 2012, ACCOUNTS CHEM RES, V45, P1048, DOI 10.1021/ar2002304; von Gersdorff K, 2006, MOL THER, V14, P745, DOI 10.1016/j.ymthe.2006.07.006; El-Sayed A., 2008, AAPS J, V11, P13; Kato T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082876; Kato T, 2014, BIOCONJUGATE CHEM, V25, P1761, DOI 10.1021/bc5003949; Nagahara H, 1998, NAT MED, V4, P1449, DOI 10.1038/4042; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Nidome T., 1999, BIOCONJUGATE CHEM, V10, P773; Oba M, 2011, BIOMATERIALS, V32, P652, DOI 10.1016/j.biomaterials.2010.09.022; Oba M, 2012, BIOL PHARM BULL, V35, P1064	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4911	4918		10.1016/j.bmc.2015.05.025		8	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000083		
J	Nakao, A; Suzuki, H; Ueno, H; Iwasaki, H; Setsuta, T; Kashima, A; Sunada, S				Nakao, Akira; Suzuki, Hiroko; Ueno, Hiroaki; Iwasaki, Hiroshi; Setsuta, Tomofumi; Kashima, Akiko; Sunada, Shinji			Discovery and structural analyses of S-adenosyl-L-homocysteine hydrolase inhibitors based on non-adenosine analogs	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Homocysteine; S-Adenosyl-L-homocysteine hydrolase; cis-Amide; X-ray crystal structure; Intramolecular eight-membered ring hydrogen bond interaction	SITE-DIRECTED MUTAGENESIS; ADENOSYLHOMOCYSTEINE HYDROLASE; CRYSTAL-STRUCTURE; BIOLOGICAL RECOGNITION; PLASMA HOMOCYSTEINE; CATALYTIC MECHANISM; ALZHEIMERS-DISEASE; PI INTERACTIONS; AROMATIC RINGS; RAT-LIVER	Optimization of a new series of S-adenosyl-L-homocysteine hydrolase (AdoHcyase) inhibitors based on non-adenosine analogs led to very potent compounds 14n, 18a, and 18b with IC50 values of 13 +/- 3, 5.0 +/- 2.0, and 8.5 +/- 3.1 nM, respectively. An X-ray crystal structure of AdoHcyase with NAD(+) and 18a showed a novel open form co-crystal structure. 18a in the co-crystals formed intramolecular eight membered ring hydrogen bond formations. A single crystal X-ray structure of 14n also showed an intramolecular eight-membered ring hydrogen bond interaction. (C) 2015 Elsevier Ltd. All rights reserved.	[Nakao, Akira; Suzuki, Hiroko; Ueno, Hiroaki; Iwasaki, Hiroshi; Setsuta, Tomofumi; Kashima, Akiko; Sunada, Shinji] Mitsubishi Tanabe Pharma Corp, Div Res, Aoba Ku, Yokohama, Kanagawa 2270033, Japan	Nakao, A (reprint author), Mitsubishi Tanabe Pharma Corp, Div Res, 2-2-50 Kawagishi, Toda, Saitama 3358505, Japan.	Nakao.Akira@mc.mt-pharma.co.jp					Abele S, 2000, EUR J ORG CHEM, P1; GELLMAN SH, 1991, J AM CHEM SOC, V113, P1164, DOI 10.1021/ja00004a016; Yamada T, 2007, BIOCHEM PHARMACOL, V73, P981, DOI 10.1016/j.bcp.2006.12.014; NYGARD O, 1995, JAMA-J AM MED ASSOC, V274, P1526, DOI 10.1001/jama.274.19.1526; Yang XD, 2003, BIOCHEMISTRY-US, V42, P1900, DOI 10.1021/bi0262350; Van Dam F, 2009, ARCH GERONTOL GERIAT, V48, P425, DOI 10.1016/j.archger.2008.03.009; Stanger O, 2009, EXPERT REV NEUROTHER, V9, P1393, DOI [10.1586/ern.09.75, 10.1586/ERN.09.75]; Hu YB, 1999, BIOCHEMISTRY-US, V38, P8323, DOI 10.1021/bi990332k; MCCULLY KS, 1969, AM J PATHOL, V56, P111; ALTOMARE A, 1994, J APPL CRYSTALLOGR, V27, P435, DOI 10.1107/S002188989400021X; Seshadri S, 2002, NEW ENGL J MED, V346, P476, DOI 10.1056/NEJMoa011613; McGaughey GB, 1998, J BIOL CHEM, V273, P15458, DOI 10.1074/jbc.273.25.15458; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Langheinrich AC, 2003, ATHEROSCLEROSIS, V171, P181, DOI 10.1016/j.atherosclerosis.2003.08.028; Laursen JS, 2013, J AM CHEM SOC, V135, P2835, DOI 10.1021/ja312532x; Takata Y, 2002, J BIOL CHEM, V277, P22670, DOI 10.1074/jbc.M201116200; Meyer EA, 2003, ANGEW CHEM INT EDIT, V42, P1210, DOI 10.1002/anie.200390319; RICHARDS HH, 1978, J BIOL CHEM, V253, P4476; Lee KM, 2011, J MED CHEM, V54, P930, DOI 10.1021/jm1010836; Clarke R, 2002, JAMA-J AM MED ASSOC, V288, P2015; Gallivan JP, 1999, P NATL ACAD SCI USA, V96, P9459, DOI 10.1073/pnas.96.17.9459; Ma JC, 1997, CHEM REV, V97, P1303, DOI 10.1021/cr9603744; Kuhn B, 2010, J MED CHEM, V53, P2601, DOI 10.1021/jm100087s; Annis DA, 2004, INT J MASS SPECTROM, V238, P77, DOI 10.1016/j.ijms.2003.11.022; Salonen LM, 2011, ANGEW CHEM INT EDIT, V50, P4808, DOI 10.1002/anie.201007560; Komoto J, 2000, J BIOL CHEM, V275, P32147, DOI 10.1074/jbc.M003725200; Huang YF, 2002, J BIOL CHEM, V277, P7477, DOI 10.1074/jbc.M109187200; Annis DA, 2007, CURR OPIN CHEM BIOL, V11, P518, DOI 10.1016/j.cbpa.2007.07.011; HUNTER CA, 1990, J AM CHEM SOC, V112, P5525, DOI 10.1021/ja00170a016; [Anonymous], 2000, CRYSTALSTRUCTURE 4 0; Turner MA, 1998, NAT STRUCT BIOL, V5, P369, DOI 10.1038/nsb0598-369; Yamada T, 2005, INT J BIOCHEM CELL B, V37, P2417, DOI 10.1016/j.biocel.2005.06.009; Wu QL, 2005, J PHARMACOL EXP THER, V313, P705, DOI 10.1124/jpet.104.080416; BATES RB, 1979, ACTA CRYSTALLOGR B, V35, P188, DOI 10.1107/S056774087900296X; BIEL JH, 1960, J AM CHEM SOC, V82, P2204, DOI 10.1021/ja01494a028; CANNON JG, 1980, J MED CHEM, V23, P745, DOI 10.1021/jm00181a009; Colbert J. C., 1926, J AM CHEM SOC, V48, P2654; Converso A, 2014, BIOORG MED CHEM LETT, V24, P2737, DOI 10.1016/j.bmcl.2014.04.034; Gibbs C. G., 1981, U. S. Patent, Patent No. [4,272,284, 4272284]; ITAI A, 1992, J AM CHEM SOC, V114, P10649, DOI 10.1021/ja00052a078; Johannes C. J., 2004, BIOORG MED CHEM LETT, V14, P1741; Kim BG, 2009, BIOORGAN MED CHEM, V17, P6707, DOI 10.1016/j.bmc.2009.07.061; McCombie H, 1931, J CHEM SOC, P529, DOI 10.1039/jr9310000529; METZ HJ, 1982, CHEM BER-RECL, V115, P2807, DOI 10.1002/cber.19821150812; Nakao A, 2014, BIOORG MED CHEM LETT, V24, P4336, DOI 10.1016/j.bmcl.2014.06.008; Nakao A., 2009, [No title captured], V2, P125, Patent No. 2009125853; Rollett J. S., 1999, CRYSTALS; Schulz G.E., 1979, PRINCIPLES PROTEIN S; Tan XD, 2014, CHEM PHARM BULL, V62, P112; Yamada T., 2007, BIOCHEM PHARMACOL, V37, P981; Yang D, 1996, J AM CHEM SOC, V118, P9794, DOI 10.1021/ja960515j; Yuan CS, 1999, EXPERT OPIN THER PAT, V9, P1197, DOI 10.1517/13543776.9.9.1197; YUAN CS, 1993, J BIOL CHEM, V268, P17030; Zhang YM, 2008, BIOORGAN MED CHEM, V16, P9212, DOI 10.1016/j.bmc.2008.09.017; Zhaohai Z., 1996, TETRAHEDRON LETT, V37, P2189	55	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					4952	4969		10.1016/j.bmc.2015.05.018		18	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000087		
J	Fujimori, I; Yukawa, T; Kamei, T; Nakada, Y; Sakauchi, N; Yamada, M; Ohba, Y; Takiguchi, M; Kuno, M; Kamo, I; Nakagawa, H; Hamada, T; Igari, T; Okuda, T; Yamamoto, S; Tsukamoto, T; Ishichi, Y; Ueno, H				Fujimori, Ikuo; Yukawa, Tomoya; Kamei, Taku; Nakada, Yoshihisa; Sakauchi, Nobuki; Yamada, Masami; Ohba, Yusuke; Takiguchi, Maiko; Kuno, Masako; Kamo, Izumi; Nakagawa, Hideyuki; Hamada, Teruki; Igari, Tomoko; Okuda, Teruaki; Yamamoto, Satoshi; Tsukamoto, Tetsuya; Ishichi, Yuji; Ueno, Hiroyuki			Design, synthesis and biological evaluation of a novel series of peripheral-selective noradrenaline reuptake inhibitor	BIOORGANIC & MEDICINAL CHEMISTRY			English	Article						Peripheral-selective noradrenaline reuptake inhibitor; Stress urinary incontinence; 7-Aryl-1,4-oxazepane derivatives	URINARY-INCONTINENCE; RISK; PREVALENCE; URETHRA	Centrally acting noradrenaline reuptake inhibitor (NRI) is reportedly effective for patients with stress urinary incontinence (SUI) by increasing urethral closure in the clinical Phase IIa study with esreboxetine. Noradrenaline transporters are expressed in both central and peripheral nervous systems and the contribution of each site to efficacy has not been clarified. This report describes the development of a series of peripheral-selective 7-phenyl-1,4-oxazepane NRIs to investigate the contribution of the peripheral site to increasing urethral resistance in rats. (6S,7R)-1,4-Oxazepane derivative 7 exhibited noradrenaline transporter inhibition with high selectivity against inhibitions of serotonin and dopamine transporters. A replacement of hydroxyl with acetamide group contributed to enhancement of peripheral selectivity by increasing molecular polarity. Compound 12, N-{[(6S,7R)-7-(3,4-dichlorophenyl)-1,4-oxazepan-6-yl]methyl}acetamide 0.5 fumarate, which showed effectively no brain penetration in rats, increased urethral resistance in a dose-dependent manner and exhibited a maximal effect on par with esreboxetine. These results demonstrate that the urethral resistance-increasing effects of NRI in rats are mainly caused by the inhibition of noradrenaline transporters in the peripheral sites. (C) 2015 Elsevier Ltd. All rights reserved.	[Fujimori, Ikuo; Yukawa, Tomoya; Kamei, Taku; Nakada, Yoshihisa; Sakauchi, Nobuki; Yamada, Masami; Ohba, Yusuke; Takiguchi, Maiko; Kuno, Masako; Kamo, Izumi; Nakagawa, Hideyuki; Hamada, Teruki; Igari, Tomoko; Okuda, Teruaki; Yamamoto, Satoshi; Tsukamoto, Tetsuya; Ishichi, Yuji; Ueno, Hiroyuki] Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, Fujisawa, Kanagawa 2518555, Japan	Yukawa, T (reprint author), Takeda Pharmaceut Co Ltd, Div Pharmaceut Res, 26-1,Muraokahigashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	tomoya.yukawa@takeda.com					FLACK HD, 1983, ACTA CRYSTALLOGR A, V39, P876, DOI 10.1107/S0108767383001762; Netzer R, 2001, DRUG DISCOV TODAY, V6, P78, DOI 10.1016/S1359-6446(00)01602-0; Rover S, 2013, J MED CHEM, V56, P9874, DOI 10.1021/jm4010708; Hannestad YS, 2000, J CLIN EPIDEMIOL, V53, P1150, DOI 10.1016/S0895-4356(00)00232-8; DIOKNO AC, 1986, J UROLOGY, V136, P1022; Ueda T, 2000, INT J UROL, V7, P95, DOI 10.1046/j.1442-2042.2000.00147.x; Bridgland-Taylor M. H., 2006, Journal of Pharmacological and Toxicological Methods, V54, P189, DOI 10.1016/j.vascn.2006.02.003; Bae JH, 2001, BJU INT, V88, P771, DOI 10.1046/j.1464-4096.2001.02389.x; Silvestri C, 2012, EXPERT OPIN INV DRUG, V21, P1309, DOI 10.1517/13543784.2012.704019; Burla MC, 2007, J APPL CRYSTALLOGR, V40, P609, DOI 10.1107/S0021889807010941; Cannon Tracy W, 2003, Int Urogynecol J Pelvic Floor Dysfunct, V14, P367, DOI 10.1007/s00192-003-1093-9; Cao X., 2011, J PHARMACOL TOX MET, V64, P8; Sweeney Danielle D, 2005, Rev Urol, V7, P81; Friedman RA, 2007, NEW ENGL J MED, V356, P2343, DOI 10.1056/NEJMp078015; Honda E, 2014, BIOORG MED CHEM LETT, V24, P3898, DOI 10.1016/j.bmcl.2014.06.046; Ishichi Y, 2013, BIOORGAN MED CHEM, V21, P4600, DOI 10.1016/j.bmc.2013.05.025; Kihara K, 1997, J AUTONOM NERV SYST, V62, P134, DOI 10.1016/S0165-1838(96)00117-8; Klarskov N, 2009, J UROLOGY, V181, P2628, DOI 10.1016/j.juro.2009.01.114; Mahaney PE, 2008, J MED CHEM, V51, P4038, DOI 10.1021/jm8002262; Miyazato M., 2008, AM J PHYSIOL-RENAL, V295, P264; Shao LM, 2014, EXPERT OPIN THER PAT, V24, P131, DOI 10.1517/13543776.2014.859676; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Thor K. B., 2004, INT J GYNECOL OBS S1, V86, P38; THOR KB, 1995, J PHARMACOL EXP THER, V274, P1014; Zinner N., 2008, 2008 ANN M AM UR ASS	25	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					5000	5014		10.1016/j.bmc.2015.05.017		15	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000091		
J	Hoque, MA; Islam, MN; Islam, MS; Kato, T; Nishino, N; Ito, A; Yoshida, M				Hoque, Md Ashraful; Islam, Md Nurul; Islam, Md Shahidul; Kato, Tamaki; Nishino, Norikazu; Ito, Akihiro; Yoshida, Minoru			Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors (Retraction of vol 22, pg 3850, 2014)	BIOORGANIC & MEDICINAL CHEMISTRY			English	Correction									[Hoque, Md Ashraful; Islam, Md Nurul; Islam, Md Shahidul; Kato, Tamaki; Nishino, Norikazu] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan; [Hoque, Md Ashraful] Rajshahi Univ, Fac Sci, Dept Biochem & Mol Biol, Rajshahi 6205, Bangladesh; [Islam, Md Nurul; Islam, Md Shahidul] Rajshahi Univ, Fac Sci, Dept Chem, Rajshahi 6205, Bangladesh; [Ito, Akihiro; Yoshida, Minoru] RIKEN Adv Sci Inst, Chem Genom Res Grp, Chem Genet Lab, Saitama 3510198, Japan	Hoque, MA (reprint author), Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Kitakyushu, Fukuoka 8080196, Japan.						HOQUE A, 2014, BIOORGAN MED CHEM, V22, P3850, DOI DOI 10.1016/J.BMC.2014.06.029	1	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0968-0896	1464-3391		BIOORGAN MED CHEM	Bioorg. Med. Chem.	AUG 1	2015	23	15					5078	5078		10.1016/j.bmc.2015.06.057		1	Biochemistry & Molecular Biology; Chemistry, Medicinal; Chemistry, Organic	Biochemistry & Molecular Biology; Pharmacology & Pharmacy; Chemistry	CN4ZV	WOS:000358440000101		
J	Kato, T; Fujita, K; Kashimori, Y				Kato, Takayuki; Fujita, Kazuhisa; Kashimori, Yoshiki			A neural mechanism of phase-locked responses to sinusoidally amplitude-modulated signals in the inferior colliculus	BIOSYSTEMS			English	Article						Phase-locking; Sinusoidal amplitude modulation; Inferior colliculus; Neuronal model; Inhibitory effect	DORSAL COCHLEAR NUCLEUS; CHINCHILLA AUDITORY-NERVE; SUPERIOR OLIVARY COMPLEX; BIG BROWN BAT; STOCHASTIC RESONANCE; LATERAL LEMNISCUS; TIME DIFFERENCE; INHIBITORY INPUTS; EPTESICUS-FUSCUS; BACKGROUND-NOISE	The central nucleus of the inferior colliculus (ICc) is an auditory region that receives convergent inputs from a large number of lower auditory nuclei. ICc neurons phase-lock to low frequencies of sinusoidally amplitude-modulated (SAM) signals but have a different mechanism in the phase-locking from that in neurons of lower nuclei. In the mustached bat, the phase-locking ability in lower nuclei is created by the coincidence of phase-locked excitatory and inhibitory inputs that have slightly different latencies. In contrast, the phase-locking property of ICc neurons is little influenced by the blocking of inhibitory synapses. Moreover, ICc neurons exhibit different characteristics in the spike patterns and synchronicity, classified here by three types of ICc neurons, or sustained, onset, and non-onset phase-locking neurons. However it remains unclear how ICc neurons create the phase-locking ability and the different characteristics. To address this issue, we developed a model of ICc neuronal population. Using this model, we show that the phase-locking ability of ICc neurons to low SAM frequencies is created by an intrinsic membrane property of ICc neuron, limited by inhibitory ion channels. We also show that response characteristics of the three types of neurons arise from the difference in an inhibitory effect sensitive to SAM frequencies. Our model reproduces well the experimental results observed in the mustached bat. These findings provide necessary conditions of how ICc neurons can give rise to the phase-locking ability and characteristic responses to low SAM frequencies. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Kato, Takayuki; Kashimori, Yoshiki] Univ Electrocommun, Grad Sch Informat Syst, Chofu, Tokyo 1828585, Japan; [Fujita, Kazuhisa; Kashimori, Yoshiki] Univ Electrocommun, Dept Engn Sci, Chofu, Tokyo 1828585, Japan; [Fujita, Kazuhisa] Tsuyama Coll, Natl Inst Technol, Tsuyama, Okayama 7088506, Japan	Fujita, K (reprint author), Tsuyama Coll, Natl Inst Technol, Dept Comp & Informat Engn, Numa 624-1, Tsuyama, Okayama 7088509, Japan.	kazu@spikingneuron.net					Hu GN, 2004, IEEE T NEURAL NETWOR, V15, P1135, DOI 10.1109/TNN.2004.832812; SHANNON RV, 1995, SCIENCE, V270, P303, DOI 10.1126/science.270.5234.303; Tan ML, 2007, J NEUROPHYSIOL, V98, P443, DOI 10.1152/jn.01273.2006; Nelken I, 1999, NATURE, V397, P154, DOI 10.1038/16456; JORIS PX, 1992, J ACOUST SOC AM, V91, P215, DOI 10.1121/1.402757; ADAMS JC, 1979, J COMP NEUROL, V183, P519, DOI 10.1002/cne.901830305; Walton JP, 2002, J NEUROPHYSIOL, V88, P565, DOI 10.1152/jn.00945.2001; Russell DF, 1999, NATURE, V402, P291; Moore DR, 1998, J NEUROPHYSIOL, V80, P2229; Frisina RD, 1996, J ACOUST SOC AM, V99, P475, DOI 10.1121/1.414559; RHODE WS, 1994, J NEUROPHYSIOL, V71, P1797; Oertel D, 2000, P NATL ACAD SCI USA, V97, P11773, DOI 10.1073/pnas.97.22.11773; DRULLMAN R, 1994, J ACOUST SOC AM, V95, P2670, DOI 10.1121/1.409836; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613; SAINTMARIE RL, 1990, BRAIN RES, V524, P244, DOI 10.1016/0006-8993(90)90698-B; Fubara BM, 1996, J COMP NEUROL, V369, P83; Krishna BS, 2000, J NEUROPHYSIOL, V84, P255; Collins JJ, 1996, J NEUROPHYSIOL, V76, P642; Fullgrabe C, 2009, J ACOUST SOC AM, V125, P1277, DOI 10.1121/1.3075591; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; JAVEL E, 1980, J ACOUST SOC AM, V68, P133, DOI 10.1121/1.384639; Steinschneider M, 1998, J ACOUST SOC AM, V104, P2935, DOI 10.1121/1.423877; Yang LC, 1997, J NEUROPHYSIOL, V77, P324; Bregman AS., 1990, AUDITORY SCENE ANAL; BRUNSOBECHTOLD JK, 1981, J COMP NEUROL, V197, P705, DOI 10.1002/cne.901970410; Burger RM, 1998, J NEUROPHYSIOL, V80, P1686; Cai HM, 1998, J ACOUST SOC AM, V103, P494, DOI 10.1121/1.421130; Cai HM, 1998, J ACOUST SOC AM, V103, P475, DOI 10.1121/1.421100; Cai YD, 2000, J NEUROPHYSIOL, V83, P301; DOUGLASS JK, 1993, NATURE, V365, P337, DOI 10.1038/365337a0; Fenton M.B., 1995, HEARING BATS, P37; FRISINA RD, 1990, HEARING RES, V44, P99, DOI 10.1016/0378-5955(90)90074-Y; Frisina RD, 2001, HEARING RES, V158, P1, DOI 10.1016/S0378-5955(01)00296-9; Frisina RD, 1997, ACOUSTICAL SIGNAL PROCESSING IN THE CENTRAL AUDITORY SYSTEM, P109, DOI 10.1007/978-1-4419-8712-9_11; FRISINA RD, 1990, HEARING RES, V44, P123, DOI 10.1016/0378-5955(90)90075-Z; FRISINA RD, 1994, EXP BRAIN RES, V102, P160; Glendenning K.K., 1988, J COMP NEUROL, V275, P261; GonzalezHernandez T, 1996, J COMP NEUROL, V372, P309, DOI 10.1002/(SICI)1096-9861(19960819)372:2<309::AID-CNE11>3.0.CO;2-E; GROTHE B, 1994, J NEUROPHYSIOL, V71, P706; Guerin A, 2006, HEARING RES, V211, P54, DOI 10.1016/j.heares.2005.10.001; HEWITT MJ, 1994, J ACOUST SOC AM, V95, P2145, DOI 10.1121/1.408676; Huffman RF, 1998, HEARING RES, V126, P181, DOI 10.1016/S0378-5955(98)00166-X; Joris PX, 1998, J NEUROPHYSIOL, V79, P253; Kamata E, 2004, BIOSYSTEMS, V76, P55, DOI 10.1016/j.biosystems.2004.05.006; Kashimori Y, 2000, NEUROCOMPUTING, V32, P855, DOI 10.1016/S0925-2312(00)00253-8; Kashimori Y, 1998, BIOPHYS J, V75, P1700; Kelly JB, 2005, INFERIOR COLLICULUS, P248, DOI 10.1007/0-387-27083-3_9; Koch U, 2003, J NEUROPHYSIOL, V90, P3679, DOI 10.1152/jn.00375.2003; LANGNER G, 1992, HEARING RES, V60, P115, DOI 10.1016/0378-5955(92)90015-F; SCHREINER CE, 1988, J NEUROPHYSIOL, V60, P1823; LANGNER G, 1988, J NEUROPHYSIOL, V60, P1799; Levin JE, 1996, NATURE, V380, P165, DOI 10.1038/380165a0; Malmierca MS, 2005, NEUROSCIENCE, V136, P883, DOI 10.1016/j.neuroscience.2005.04.040; Moss CF, 1995, HEARING BATS, P87; Nagtegaal AP, 2010, J NEUROPHYSIOL, V104, P940, DOI 10.1152/jn.00264.2010; Nelson PC, 2004, J ACOUST SOC AM, V116, P2173, DOI 10.1121/1.1784442; Oliver D.L., 1991, MAMMALIAN AUDITORY P, V1, P168; Oliver D.L., 2000, INFERIOR COLLICULUS, P69; Pollak G.D., 1995, HEARING BATS, P296; Rabang CF, 2012, FRONT NEURAL CIRCUIT, V6, DOI 10.3389/fncir.2012.00077; REES A, 1983, HEARING RES, V10, P301, DOI 10.1016/0378-5955(83)90095-3; Schnerderman A., 1988, J COMP NEUROL, V276, P188; SEMPLE MN, 1980, EXP BRAIN RES, V41, P19; Sirvaramakrishnan S., 2001, J NEUROSCI, V21, P2861; Stebbins W.C., 1994, COMP HEARING MAMMALS, P97; Suga N., 1988, AUDITORY FUNCTION NE, P679; Tan ML, 2007, J NEUROPHYSIOL, V98, P454, DOI 10.1152/jn.00174.2007; VATER M, 1992, J COMP NEUROL, V325, P183, DOI 10.1002/cne.903250205; WINER JA, 1995, J COMP NEUROL, V355, P317, DOI 10.1002/cne.903550302; Wu SH, 2004, J NEUROSCI, V24, P4625, DOI 10.1523/JNEUROSCI.0318-04.2004; Yost W.A., 1992, HEARING RES, V56, P8; Zhang HM, 2003, J NEUROPHYSIOL, V90, P477, DOI 10.1152/jn.01084.2002	72	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0303-2647	1872-8324		BIOSYSTEMS	Biosystems	AUG	2015	134						24	36		10.1016/j.biosystems.2015.05.007		13	Biology; Mathematical & Computational Biology	Life Sciences & Biomedicine - Other Topics; Mathematical & Computational Biology	CO5AC	WOS:000359171000003		
J	Urita, A; Funakoshi, T; Suenaga, N; Oizumi, N; Iwasaki, N				Urita, A.; Funakoshi, T.; Suenaga, N.; Oizumi, N.; Iwasaki, N.			A combination of subscapularis tendon transfer and small-head hemiarthroplasty for cuff tear arthropathy A PILOT STUDY	BONE & JOINT JOURNAL			English	Article							TOTAL SHOULDER ARTHROPLASTY; ROTATOR CUFF; GLENOHUMERAL OSTEOARTHRITIS; FOLLOW-UP; PROSTHESIS; ARTHRITIS; DEGENERATION; MULTICENTER; SURGERY; REPAIR	This pilot study reports the clinical outcomes of a combination of partial subscapularis tendon transfer and small-head hemiarthroplasty in patients with rotatator cuff arthropathy. A total of 30 patients (30 shoulders; eight men and 22 women) with a mean age of 74 years (55 to 84) were assessed at a mean follow-up of 31 months (24 to 60). The inclusion criteria were painful cuff tear arthropathy with normal deltoid function and a non-degenerative subscapularis muscle and tendon and a preserved teres minor. Outcome was assessed using the University of California Los Angeles score, the Japanese Orthopaedic Association score, and the Oxford Shoulder Score. Radiographic measurements included the centre of rotation distance and the length of the deltoid. All clinical scores were significantly improved post-operatively. The active flexion and external rotation improved significantly at the most recent follow-up (p < 0.035). Although the mean centre of rotation distance changed significantly (p < 0.001), the mean length of the deltoid did not change significantly from the pre-operative value (p = 0.29). The change in the length of the deltoid with < 100 degrees flexion was significantly less than that with > 100 degrees (p < 0.001). Progressive erosion of the glenoid was seen in four patients. No patient required revision or further surgery. A combination of partial subscapularis tendon transfer and small-head hemiarthroplasty effectively restored function and relieved pain in patients with rotator cuff arthropathy.	[Urita, A.; Funakoshi, T.; Iwasaki, N.] Hokkaido Univ, Dept Orthopaed Surg, Grad Sch Med, Sapporo, Hokkaido, Japan; [Suenaga, N.; Oizumi, N.] Hokkaido Univ, Grad Sch Med, Sapporo, Hokkaido, Japan	Funakoshi, T (reprint author), Hokkaido Univ, Dept Orthopaed Surg, Grad Sch Med, Kita 15 Nishi 5, Sapporo, Hokkaido, Japan.	tfunakoshi@gmail.com					Visotsky JL, 2004, J BONE JOINT SURG AM, V86A, P35; Fuchs B, 1999, J SHOULDER ELB SURG, V8, P599, DOI 10.1016/S1058-2746(99)90097-6; Boileau P, 2009, J SHOULDER ELB SURG, V18, P600, DOI 10.1016/j.jse.2009.03.011; COFIELD RH, 1982, SURG GYNECOL OBSTET, V154, P667; Young AA, 2012, J BONE JOINT SURG AM, V94A, P685, DOI [10.2106/JBJS.J.00727, 10.2106/JBJSJ.00727]; ELLMAN H, 1986, J BONE JOINT SURG AM, V68A, P1136; Goldberg SS, 2008, J BONE JOINT SURG AM, V90A, P554, DOI 10.2106/JBJS.F.01029; Jobin CM, 2012, J SHOULDER ELB SURG, V21, P1269, DOI 10.1016/j.jse.2011.08.049; Sanchez-Sotelo J, 2001, J BONE JOINT SURG AM, V83A, P1814; Frankle M, 2005, J BONE JOINT SURG AM, V87A, P1697, DOI 10.2106/JBJS.D.02813; Sirveaux F, 2004, J BONE JOINT SURG BR, V86B, P388, DOI 10.1302/0301-620X.86B3.14024; Boileau P, 2006, J SHOULDER ELB SURG, V15, P527, DOI 10.1016/j.jse.2006.01.003; NEER CS, 1983, J BONE JOINT SURG AM, V65, P1232; Ide J, 2004, J SHOULDER ELB SURG, V13, P174, DOI 10.1016/j.jse.2003.11.001; Favard L, 2011, CLIN ORTHOP RELAT R, V469, P2469, DOI 10.1007/s11999-011-1833-y; Boileau P, 2005, J SHOULDER ELB SURG, V14, p147S, DOI 10.1016/j.jse.2004.10.006; Dawson J, 1996, J BONE JOINT SURG BR, V78B, P593; De Wilde L, 2002, CLIN BIOMECH, V17, P499, DOI 10.1016/S0268-0033(02)00065-7; Frankle Mark, 2006, J Bone Joint Surg Am, V88 Suppl 1 Pt 2, P178, DOI 10.2106/JBJS.F.00123; GOUTALLIER D, 1994, CLIN ORTHOP RELAT R, P78; Hsu JE, 2011, J ORTHOP RES, V29, P1028, DOI 10.1002/jor.21361; Mackenzie DB, 1993, ORTHOP TRAUMATOL, V2, P71, DOI 10.1007/BF02620461; Nam D, 2012, J BONE JOINT SURG AM, V94-A, P34; Neer CS, 1990, SHOULDER RECONSTRUCT, P262; NEVIASER JS, 1973, CLIN ORTHOP RELAT R, P34; Pape G, 2013, J SHOULDER ELB SURG, V22, P1	26	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	AUG	2015	97B	8					1090	1095		10.1302/0301-620X.97B8.34029		6	Orthopedics; Surgery	Orthopedics; Surgery	CO3WY	WOS:000359093100014		
J	Oizumi, N; Suenaga, N; Yoshioka, C; Yamane, S				Oizumi, N.; Suenaga, N.; Yoshioka, C.; Yamane, S.			Triceps-sparing ulnar approach for total elbow arthroplasty	BONE & JOINT JOURNAL			English	Article							FOLLOW-UP; HUMERAL COMPONENT; PROXIMAL ULNA; REPLACEMENT; INSUFFICIENCY; ALIGNMENT; 5-YEAR	To prevent insufficiency of the triceps after total elbow arthroplasty, we have, since 2008, used a triceps-sparing ulnar approach. This study evaluates the clinical results and post-operative alignment of the prosthesis using this approach. We reviewed 25 elbows in 23 patients. There were five men and 18 women with a mean age of 69 years (54 to 83). There were 18 elbows with rheumatoid arthritis, six with a fracture or pseudoarthrosis and one elbow with osteoarthritis. Post-operative complications included one intra-operative fracture, one elbow with heterotopic ossification, one transient ulnar nerve palsy, and one elbow with skin necrosis, but no elbow was affected by insufficiency of the triceps. Patients were followed for a mean of 42 months (24 to 77). The mean post-operative Japanese Orthopaedic Association Elbow Score was 90.8 (51 to 100) and the mean Mayo Elbow Performance score 93.8 (65 to 100). The mean post-operative flexion/extension of the elbow was 135 degrees/-8 degrees. The Manual Muscle Testing score of the triceps was 5 in 23 elbows and 2 in two elbows (one patient). The mean alignment of the implants examined by 3D-CT was 2.8 degrees pronation (standard deviation (SD) 5.5), 0.3 degrees valgus (SD 2.7), and 0.7 degrees extension (SD 3.2) for the humeral component, and 9.3 degrees pronation (SD 9.7), 0.3 degrees valgus (SD 4.0), and 8.6 degrees extension (SD 3.1) for the ulnar component. There was no radiolucent line or loosening of the implants on the final radiographs. The triceps-sparing ulnar approach allows satisfactory alignment of the implants, is effective in preventing post-operative triceps insufficiency, and gives satisfactory short-term results.	[Oizumi, N.; Suenaga, N.] Hokushin Orthopaed Hosp, Shiroishi Ku, Sapporo, Hokkaido 0030823, Japan; [Yoshioka, C.; Yamane, S.] Hokushin Orthopaed Hosp, Sapporo, Hokkaido 0030823, Japan	Oizumi, N (reprint author), Hokushin Orthopaed Hosp, Shiroishi Ku, 1-18 Kikusuimotomachi 3jo 3chome, Sapporo, Hokkaido 0030823, Japan.	nao9877@gmail.com					Duquin TR, 2014, BONE JOINT J, V96B, P82, DOI 10.1302/0301-620X.96B1.31127; Duggal N, 2004, J SHOULDER ELB SURG, V13, P206, DOI 10.1016/j.jse.2003.11.003; McDonald CP, 2010, J SHOULDER ELB SURG, V19, P533, DOI 10.1016/j.jse.2009.10.010; INGLIS AE, 1980, J BONE JOINT SURG AM, V62, P1252; Brownhill JR, 2012, J SHOULDER ELB SURG, V21, P1032, DOI 10.1016/j.jse.2011.05.024; MORREY BF, 1981, J BONE JOINT SURG AM, V63, P1050; Gill DRJ, 1998, J BONE JOINT SURG AM, V80A, P1327; Hildebrand KA, 2000, J BONE JOINT SURG AM, V82A, P1379; BRYAN RS, 1982, CLIN ORTHOP RELAT R, P188; Brownhill JR, 2009, J SHOULDER ELB SURG, V18, P27, DOI 10.1016/j.jse.2008.03.008; Campbell WC, 1932, AM J SURG, V15, P65; Celli A, 2005, J BONE JOINT SURG AM, V87A, P1957, DOI 10.2106/JBJS.D.02423; Crenshaw AH, 1992, CAMPBELLS OPERATIVE, P98; FRESE E, 1987, PHYS THER, V67, P1072; Ishii S., 1992, J JPN ORTHOP ASS JAP, V66, P591; ITOI E, 1994, J ORTHOPAED RES, V12, P665, DOI 10.1002/jor.1100120509; Kelly EW, 2004, J SHOULDER ELB SURG, V13, P434, DOI 10.1016/j.jse.2004.01.028; Large R, 2014, BONE JOINT J, V96B, P1359, DOI 10.1302/0301-620X.96B10.33815; Morrey BF, 1993, ELBOW ITS DISORDERS, VSecond, P95; Pierce TD, 1998, CLIN ORTHOP RELAT RE; Prokopis PM, 2008, J SHOULDER ELB SURG, V17, P454, DOI 10.1016/j.jse.2008.02.002; Schneeberger AG, 2007, J SHOULDER ELB SURG, V16, p47S, DOI 10.1016/j.jse.2006.01.013; Schneeberger AG, 2000, J SHOULDER ELB SURG, V9, P135; SCHUIND F, 1995, J ARTHROPLASTY, V10, P670, DOI 10.1016/S0883-5403(05)80214-1; Van Gorder GW, 1940, J BONE JOINT SURG, V22, P278; WOLFE SW, 1990, J BONE JOINT SURG AM, V72A, P684	26	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	AUG	2015	97B	8					1096	1101		10.1302/0301-620X.97B8.34956		6	Orthopedics; Surgery	Orthopedics; Surgery	CO3WY	WOS:000359093100015		
J	Waki, T; Lee, SY; Niikura, T; Iwakura, T; Dogaki, Y; Okumachi, E; Kuroda, R; Kurosaka, M				Waki, T.; Lee, S. Y.; Niikura, T.; Iwakura, T.; Dogaki, Y.; Okumachi, E.; Kuroda, R.; Kurosaka, M.			Profiling microRNA expression in fracture nonunions POTENTIAL ROLE OF MICRORNAS IN NONUNION FORMATION STUDIED IN A RAT MODEL	BONE & JOINT JOURNAL			English	Article							MESENCHYMAL STEM-CELLS; GENE-EXPRESSION; BONE-MARROW; OSTEOGENIC DIFFERENTIATION; ATROPHIC NONUNION; STROMAL CELLS; REPAIR; MIR-31; INFECTION; REVEALS	MicroRNAs (miRNAs) are small non-coding RNAs that regulate gene expression. We hypothesised that the functions of certain miRNAs and changes to their patterns of expression may be crucial in the pathogenesis of nonunion. Healing fractures and atrophic nonunions produced by periosteal cauterisation were created in the femora of 94 rats, with 1: 1 group allocation. At post-fracture days three, seven, ten, 14, 21 and 28, miRNAs were extracted from the newly generated tissue at the fracture site. Microarray and real-time polymerase chain reaction (PCR) analyses of day 14 samples revealed that five miRNAs, miR-31a-3p, miR-31a-5p, miR-146a-5p, miR-146b-5p and miR-223-3p, were highly upregulated in nonunion. Real-time PCR analysis further revealed that, in nonunion, the expression levels of all five of these miRNAs peaked on day 14 and declined thereafter. Our results suggest that miR-31a-3p, miR-31a-5p, miR-146a-5p, miR-146b-5p and miR-223-3p may play an important role in the development of nonunion. These findings add to the understanding of the molecular mechanism for nonunion formation and may lead to the development of novel therapeutic strategies for its treatment.	[Waki, T.; Lee, S. Y.; Niikura, T.; Iwakura, T.; Dogaki, Y.; Okumachi, E.; Kuroda, R.; Kurosaka, M.] Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, Kobe, Hyogo 657, Japan	Lee, SY (reprint author), Kobe Univ, Grad Sch Med, Dept Orthopaed Surg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 657, Japan.	sangyang@beige.plala.or.jp			Japan Society for the Promotion of Science [24791544]	This study was supported by a Grant-in-Aid for Young Scientists (B) from the Japan Society for the Promotion of Science (24791544 to S.Y.L.).	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Kitaori T, 2009, ARTHRITIS RHEUM-US, V60, P813, DOI 10.1002/art.24330; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Yamagishi M, 2012, CANCER CELL, V21, P121, DOI 10.1016/j.ccr.2011.12.015; Reed AAC, 2002, J ORTHOPAED RES, V20, P593, DOI 10.1016/S0736-0266(01)00142-5; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Baglio SR, 2013, GENE, V527, P321, DOI 10.1016/j.gene.2013.06.021; Einhorn TA, 1998, CLIN ORTHOP RELAT R, pS7; Gao J, 2011, J CELL BIOCHEM, V112, P1844, DOI 10.1002/jcb.23106; Haneklaus M, 2013, J INTERN MED, V274, P215, DOI 10.1111/joim.12099; David NB, 2002, DEVELOPMENT, V129, P4457; Seeliger C, 2014, J BONE MINER RES, V29, P1718, DOI 10.1002/jbmr.2175; Mills LA, 2012, J BONE JOINT SURG BR, V94B, P865, DOI 10.1302/0301-620X.94B7.27370; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Wang XG, 2013, NAT MED, V19, P93, DOI 10.1038/nm.3026; Hsieh JY, 2013, NUCLEIC ACIDS RES, V41, P9753, DOI 10.1093/nar/gkt666; Dar A, 2005, NAT IMMUNOL, V6, P1038, DOI 10.1038/ni1251; Xie Q, 2014, BIOCHEM BIOPH RES CO, V446, P98, DOI 10.1016/j.bbrc.2014.02.058; Patil S, 2006, J BONE JOINT SURG BR, V88B, P928, DOI 10.1302/0301-620X.88B7.17639; Gaston MS, 2007, J BONE JOINT SURG BR, V89B, P1553, DOI 10.1302/0301-620X.89B12; Janssen HLA, 2013, NEW ENGL J MED, V369, P878, DOI 10.1056/NEJMc1307787; Kokubu T, 2003, J ORTHOPAED RES, V21, P503, DOI 10.1016/S0736-0266(02)00209-7; Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Soifer HS, 2007, MOL THER, V15, P2070, DOI 10.1038/sj.mt.6300311; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Chen QY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037149; Gerstenfeld LC, 2001, CELLS TISSUES ORGANS, V169, P285, DOI 10.1159/000047893; Ismail HD, 2013, BONE JOINT RES, V2, P112, DOI 10.1302/2046-3758.26.2000165; Kanegae Y, 1998, NATURE, V392, P611; Meyer RA, 2003, J BONE JOINT SURG AM, V85A, P1243; Niikura T, 2006, J ORTHOP RES, V24, P1463, DOI 10.1002/jor.20182; van Wijnen AJ, 2013, CURR OSTEOPOROS REP, V11, P72, DOI 10.1007/s11914-013-0143-6; Xiao W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038648	35	0	0	BRITISH EDITORIAL SOC BONE JOINT SURGERY	LONDON	22 BUCKINGHAM STREET, LONDON WC2N 6ET, ENGLAND	2049-4394			BONE JOINT J	Bone Joint J.	AUG	2015	97B	8					1144	1151		10.1302/0301-620X.97B8.34966		8	Orthopedics; Surgery	Orthopedics; Surgery	CO3WY	WOS:000359093100023		
J	Ihori, N; Kashiwagi, A; Kashiwagi, T				Ihori, Nami; Kashiwagi, Asako; Kashiwagi, Toshihiro			Right unilateral spatial neglect in aphasic patients	BRAIN AND LANGUAGE			English	Article						Leftward deviation; Aphasic patients; Language task; Directional attention; Left brain damage; Right unilateral spatial neglect; Severe aphasia; Moderate aphasia; Mild aphasia	LEFT-HEMISPHERE STROKE; HEMISPATIAL NEGLECT; SELECTIVE ATTENTION; DOMINANCE; ASYMMETRIES; INFARCTION; NETWORK	To investigate spatial responses by aphasic patients during language tasks, 63 aphasics (21 severe, 21 moderate, and 21 mild) were administered two kinds of auditory pointing tasks word tasks and sentence tasks in which the spatial conditions of the stimuli were controlled. There were significantly fewer correct responses on the right side of a space than on the left side in both the word and sentence tasks, but the left deviation of correct responses was more prominent in the sentence task than in the word task. Additionally, the severe aphasics exhibited a prominent leftward deviation that may have been the result of deficits in rightward attention controlled by the left hemisphere. This phenomenon also seems to reflect the directional attention that is subserved by the right hemisphere, which attends to the left side of a space and, less predominantly, the right side of a space. (C) 2015 Elsevier Inc. All rights reserved.	[Ihori, Nami] Kawasaki Cooperat Hosp, Dept Rehabil, Kawasaki Ku, Kawasaki, Kanagawa 2100833, Japan; [Kashiwagi, Asako] Kyoritsu Rehabil Hosp, Dept Rehabil, Kawanishi 6660121, Japan; [Kashiwagi, Toshihiro] Nakaya Hosp, Dept Rehabil, Wakayama 6408303, Japan	Ihori, N (reprint author), 23-20 Honmokuwada,Naka Ku, Yokohama, Kanagawa 2310827, Japan.	ihorinami@aol.com					Coslett HB, 1999, NEUROPSYCHOLOGIA, V37, P695, DOI 10.1016/S0028-3932(98)00116-X; Hillis AE, 2002, BRAIN, V125, P1094, DOI 10.1093/brain/awf113; Kleinman JT, 2007, BRAIN COGNITION, V64, P50, DOI 10.1016/j.bandc.2006.10.005; HEILMAN KM, 1980, NEUROLOGY, V30, P327; WEINTRAUB S, 1987, ARCH NEUROL-CHICAGO, V44, P621; Kinsbourne M, 1977, Adv Neurol, V18, P41; Duecker F, 2013, J COGNITIVE NEUROSCI, V25, P1332, DOI 10.1162/jocn_a_00402; RAPCSAK SZ, 1989, ARCH NEUROL-CHICAGO, V46, P178; Suchan J, 2011, BRAIN, V134, P3059, DOI 10.1093/brain/awr120; Urbanski M, 2008, J NEUROL NEUROSUR PS, V79, P598, DOI 10.1136/jnnp.2007.126276; Mesulam MM, 1999, PHILOS T ROY SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; MAESHIMA S, 1992, ACTA NEUROL SCAND, V85, P418; Urbanski M, 2011, EXP BRAIN RES, V208, P491, DOI 10.1007/s00221-010-2496-8; PETRY MC, 1994, NEUROPSYCHOLOGIA, V32, P1397, DOI 10.1016/0028-3932(94)00072-7; Gitelman DR, 1999, BRAIN, V122, P1093, DOI 10.1093/brain/122.6.1093; Floel A, 2005, BEHAV BRAIN RES, V158, P269, DOI 10.1016/j.bbr.2004.09.016; POSNER MI, 1987, PSYCHOBIOLOGY, V15, P107; Verdon V, 2010, BRAIN, V133, P880, DOI 10.1093/brain/awp305; Benson D. F., 1979, APHASIA ALEXIA AGRAP, P161; Bisiach E., 2000, HDB NEUROPSYCHOLOGY, V1, P459; CORBETTA M, 1993, J NEUROSCI, V13, P1202; COSLETT HB, 1993, BRAIN, V116, P527; Damasio A. R., 1989, LESION ANAL NEUROPSY; Darley F. L, 1982, APHASIA, P75; Halligan P. W., 1993, UNILATERAL NEGLECT C, P3; Hasegawa T., 1977, STANDARD LANGUAGE TE; Heilman K. M., 1985, HDB CLIN NEUROLOGY, V1, P153; Heilman K. M., 1979, CLIN NEUROPSYCHOLOGY, P268; HIER DB, 1983, NEUROLOGY, V33, P337; Hillis AE, 2006, NEUROSCIENTIST, V12, P153, DOI 10.1177/1073858405284257; KAPLAN RF, 1991, ARCH NEUROL-CHICAGO, V48, P1263; KASHIWAGI A, 1990, BRAIN, V113, P1005, DOI 10.1093/brain/113.4.1005; Kinsbourne M, 1993, UNILATERAL NEGLECT C, P63; Kinsbourne M, 1987, NEUROPHYSIOLOGICAL N, P69; LECOURS AR, 1987, BRAIN COGNITION, V6, P243, DOI 10.1016/0278-2626(87)90126-6; LEVINE DN, 1986, NEUROLOGY, V36, P362; Mesulam M. M., 2000, PRINCIPLES BEHAV COG, P174; MESULAM MM, 1981, ANN NEUROL, V10, P309, DOI 10.1002/ana.410100402; Mesulam M. M., 1985, PRINCIPLES BEHAV NEU, P125; POSNER MI, 1988, ARCH GEN PSYCHIAT, V45, P814; Shewan C. M., 1986, TREATMENT APHASIA LA, P78; Wilson B., 1987, BEHAV INATTENTION TE	42	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0093-934X	1090-2155		BRAIN LANG	Brain Lang.	AUG	2015	147						21	29		10.1016/j.bandl.2015.05.001		9	Audiology & Speech-Language Pathology; Linguistics; Neurosciences; Psychology, Experimental	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Psychology	CO3DD	WOS:000359035900003		
J	Aho, AJ; Kamata, K; Jantti, V; Kulkas, A; Hagihira, S; Huhtala, H; Yli-Hankala, A				Aho, A. J.; Kamata, K.; Jantti, V.; Kulkas, A.; Hagihira, S.; Huhtala, H.; Yli-Hankala, A.			Comparison of Bispectral Index and Entropy values with electroencephalogram during surgical anaesthesia with sevoflurane	BRITISH JOURNAL OF ANAESTHESIA			English	Article						anaesthetics inhalation, sevoflurane; EEG; electromyography; monitoring, intraoperative	SPECTRAL ENTROPY; CEREBRAL STATE; TIME-DELAY; INTRAOPERATIVE AWARENESS; NARCOTREND INDEXES; HYPNOTIC COMPONENT; CONSCIOUSNESS; POPULATION; PREVENTION; RESPONSES	Background: Concomitantly recorded Bispectral Index (R) (BIS) and Entropy (TM) values sometimes show discordant trends during general anaesthesia. Previously, no attempt had been made to discover which EEG characteristics cause discrepancies between BIS and Entropy. We compared BIS and Entropy values, and analysed the changes in the raw EEG signal during surgical anaesthesia with sevoflurane. Methods: In this prospective, open-label study, 65 patients receiving general anaesthesia with sevoflurane were enrolled. BIS, Entropy and multichannel digital EEG were recorded. Concurrent BIS and State Entropy (SE) values were selected. Whenever BIS and SE values showed >= 10-unit disagreement for >= 60 s, the raw EEG signal was analysed both in time and frequency domain. Results: A >= 10-unit disagreement >= 60 s was detected 428 times in 51 patients. These 428 episodes accounted for 5158 (11%) out of 45 918 analysed index pairs. During EEG burst suppression, SE was higher than BIS in 35 out of 49 episodes. During delta-theta dominance, BIS was higher than SE in 141 out of 157 episodes. During alpha or beta activity, SE was higher than BIS in all 49 episodes. During electrocautery, both BIS and SE changed, sometimes in the opposite direction, but returned to baseline values after electrocautery. Electromyography caused index disagreement four times (BIS > SE). Conclusions: Certain specific EEG patterns, and artifacts, are associated with discrepancies between BIS and SE. Time and frequency domain analyses of the original EEG improve the interpretation of studies involving BIS, Entropy and other EEG-based indices.	[Aho, A. J.] Hosp Joint Replacement, Coxa Ltd, Dept Anaesthesia, Tampere 33101, Finland; [Aho, A. J.; Kamata, K.; Yli-Hankala, A.] Tampere Univ Hosp, Dept Anaesthesia, Tampere, Finland; [Aho, A. J.; Kamata, K.; Yli-Hankala, A.] Univ Tampere, Sch Med, FIN-33101 Tampere, Finland; [Jantti, V.; Kulkas, A.] Seinajoki Cent Hosp, Dept Clin Neurophysiol, Seinajoki, Finland; [Jantti, V.] Tampere Univ Technol, Dept Elect & Commun Engn, FIN-33101 Tampere, Finland; [Hagihira, S.] Osaka Univ, Grad Sch Med, Dept Anaesthesia & Intens Care, Osaka, Japan; [Huhtala, H.] Univ Tampere, Sch Hlth Sci, FIN-33101 Tampere, Finland	Aho, AJ (reprint author), Hosp Joint Replacement, Coxa Ltd, Dept Anaesthesia, POB 652, Tampere 33101, Finland.	antti.j.aho@uta.fi					Hans P, 2006, BRIT J ANAESTH, V97, P842, DOI 10.1093/bja/ael253; Avidan MS, 2008, NEW ENGL J MED, V358, P1097, DOI 10.1056/NEJMoa0707361; Aime I, 2012, BRIT J ANAESTH, V108, P638, DOI 10.1093/bja/aer457; Aho AJ, 2011, BRIT J ANAESTH, V106, P69, DOI 10.1093/bja/aeq300; Johansen JW, 2000, ANESTHESIOLOGY, V93, P1336, DOI 10.1097/00000542-200011000-00029; Avidan MS, 2011, NEW ENGL J MED, V365, P591, DOI 10.1056/NEJMoa1100403; MARTIN JT, 1959, ANESTHESIOLOGY, V20, P359, DOI 10.1097/00000542-195905000-00017; Mashour GA, 2012, ANESTHESIOLOGY, V117, P717, DOI 10.1097/ALN.0b013e31826904a6; Viertio-Oja H, 2004, ACTA ANAESTH SCAND, V48, P154, DOI 10.1111/j.0001-5172.2004.00322.x; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; Pilge S, 2006, ANESTHESIOLOGY, V104, P488, DOI 10.1097/00000542-200603000-00016; Schmidt GN, 2004, ANESTHESIOLOGY, V101, P1283; Chan MTV, 2012, J NEUROSURG ANESTH, V24, P9, DOI 10.1097/ANA.0b013e31823058bf; Cortinez LI, 2008, ANESTH ANALG, V107, P1566, DOI 10.1213/ane.0b013e318181f013; Dahaba AA, 2005, ANESTH ANALG, V101, P165; Ellerkmann RK, 2004, ANESTHESIOLOGY, V101, P1275; Hart SM, 2009, ANAESTH INTENS CARE, V37, P1002; Jantti V, 2008, HDB CLIN NEUROPHYSIO, V8, P77; Jantti V, 2002, ANESTHESIOLOGY, V97, P756; Kreuzer M, 2012, ANESTH ANALG, V115, P315, DOI [10.1213/ANE.0b013e31825801ea, 10.1213/ANE.0b01301825801ca]; Lefoll-Masson Cécile, 2007, Anesth Analg, V105, P1319; Lysakowski C, 2009, BRIT J ANAESTH, V103, P387, DOI 10.1093/bja/aep162; Mahon Padraig, 2008, J Clin Monit Comput, V22, P87, DOI 10.1007/s10877-008-9109-0; Pilge S, 2012, MINERVA ANESTESIOL, V78, P636; Schultz Arthur, 2008, J Clin Monit Comput, V22, P103, DOI 10.1007/s10877-008-9111-6; Vanluchene ALG, 2004, ANESTHESIOLOGY, V101, P34, DOI 10.1097/00000542-200407000-00008; Wennervirta J, 2007, INTENS CARE MED, V33, P133, DOI 10.1007/s00134-006-0429-6; Yli-Hankala A, 1999, ANESTHESIOLOGY, V91, P1596, DOI 10.1097/00000542-199912000-00009; Zanner R, 2009, BRIT J ANAESTH, V103, P394, DOI 10.1093/bja/aep198	29	1	1	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0007-0912	1471-6771		BRIT J ANAESTH	Br. J. Anaesth.	AUG	2015	115	2					258	266		10.1093/bja/aev206		9	Anesthesiology	Anesthesiology	CN9YW	WOS:000358808100016		
J	Yasumi, T; Hori, M; Hiejima, E; Shibata, H; Izawa, K; Oda, H; Yoshioka, K; Nakagawa, K; Kawai, T; Nishikomori, R; Ohara, O; Heike, T				Yasumi, Takahiro; Hori, Masayuki; Hiejima, Eitaro; Shibata, Hirofumi; Izawa, Kazushi; Oda, Hirotsugu; Yoshioka, Kouhei; Nakagawa, Kenji; Kawai, Tomoki; Nishikomori, Ryuta; Ohara, Osamu; Heike, Toshio			Laboratory parameters identify familial haemophagocytic lymphohistiocytosis from other forms of paediatric haemophagocytosis	BRITISH JOURNAL OF HAEMATOLOGY			English	Article						haemophagocytic lymphohistiocytosis; common laboratory parameters; differential diagnosis; innate and adaptive immunity	MACROPHAGE ACTIVATION SYNDROME; JUVENILE IDIOPATHIC ARTHRITIS; FLOW-CYTOMETRY; DIAGNOSIS; GUIDELINES; INFECTION; PATHOGENESIS; DYSFUNCTION; MARKER; EBV	Haemophagocytic lymphohistiocytosis (HLH) is a life-threatening syndrome of immune dysregulation and is classified as primary or secondary according to the underlying aetiology. The treatment strategies recommended for these two groups differ substantially; however, it is thought to be impossible to predict the underlying causes of HLH using conventional laboratory tests. Recent studies show that serum levels of soluble interleukin-2 receptor (sIL2R) and ferritin are useful for differentiating some forms of HLH. The present study reports that combinations of common laboratory parameters, such as the percentage of total lymphocytes within the peripheral blood leucocyte population, serum levels of lactate dehydrogenase and the sIL2R/ferritin ratio, are useful for identifying patients with familial haemophagocytic lymphohistiocytosis and for differentiating the underlying aetiology of paediatric HLH during the early course of the disease. These findings suggest that the pathogenesis of HLH differs greatly in terms of innate and adaptive immunity depending on the aetiology and may provide a new approach to unravelling the complex pathophysiology underlying this syndrome.	[Yasumi, Takahiro; Hori, Masayuki; Hiejima, Eitaro; Shibata, Hirofumi; Izawa, Kazushi; Oda, Hirotsugu; Yoshioka, Kouhei; Nakagawa, Kenji; Kawai, Tomoki; Nishikomori, Ryuta; Heike, Toshio] Kyoto Univ, Grad Sch Med, Dept Paediat, Kyoto 6068507, Japan; [Oda, Hirotsugu; Ohara, Osamu] RIKEN, Ctr Integrat Med Sci, Lab Integrat Genom, Yokohama, Kanagawa, Japan; [Ohara, Osamu] KAZUSA DNA Res Inst, Dept Human Genome Res, Kisarazu, Japan	Yasumi, T (reprint author), Kyoto Univ, Grad Sch Med, Dept Paediat, Sakyo Ku, 54 Kawahara Cho, Kyoto 6068507, Japan.	yasumi@kuhp.kyoto-u.ac.jp			JSPS KAKENHI [26461582, 25670475]; Japanese Ministry of Health, Labour and Welfare	This work was supported by JSPS KAKENHI (Grant Number 26461582 and 25670475); and by grants from 'Research on Measures for Intractable Diseases' Project: matching fund subsidy from the Japanese Ministry of Health, Labour and Welfare.	Yang X, 2012, J CLIN IMMUNOL, V32, P411, DOI 10.1007/s10875-011-9638-z; Shimizu M, 2010, RHEUMATOLOGY, V49, P1645, DOI 10.1093/rheumatology/keq133; Tabata C, 2012, ANN HEMATOL, V91, P63, DOI 10.1007/s00277-011-1239-7; Norvell JP, 2007, LIVER TRANSPLANT, V13, P1428, DOI 10.1002/lt.21250; Villanueva J, 2005, ARTHRITIS RES THER, V7, pR30, DOI 10.1186/ar1453; Veillette A, 2013, CURR OPIN ALLERGY CL, V13, P614, DOI 10.1097/ACI.0000000000000008; Zhao M, 2011, CYTOM PART B-CLIN CY, V80B, P8, DOI 10.1002/cyto.b.20552; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Tacke F, 2009, CLIN REV ALLERG IMMU, V36, P4, DOI 10.1007/s12016-008-8091-0; Bleesing J, 2007, ARTHRITIS RHEUM, V56, P965, DOI 10.1002/art.22416; Janka GE, 2012, ANNU REV MED, V63, P233, DOI 10.1146/annurev-med-041610-134208; Behrens EM, 2007, J RHEUMATOL, V34, P1133; Suzuki N, 2009, J PEDIATR-US, V155, P235, DOI 10.1016/j.jpeds.2009.02.050; Tsuji T, 2014, ANN HEMATOL, V93, P821, DOI 10.1007/s00277-013-1925-8; Marsh RA, 2010, J IMMUNOL METHODS, V362, P1, DOI 10.1016/j.jim.2010.08.010; Kimura H, 2012, BLOOD, V119, P673, DOI 10.1182/blood-2011-10-381921; Wittkowski H, 2008, ARTHRITIS RHEUM, V58, P3924, DOI 10.1002/art.24137; Ravelli A, 2005, J PEDIATR-US, V146, P598, DOI 10.1016/j.jpeds.2004.12.016; RUBIN LA, 1990, ANN INTERN MED, V113, P619; Henter JI, 2007, PEDIATR BLOOD CANCER, V48, P124, DOI 10.1002/pbc.21039; Vastert SJ, 2009, BEST PRACT RES CL RH, V23, P655, DOI 10.1016/j.berh.2009.08.003; Rosado FGN, 2013, AM J CLIN PATHOL, V139, P713, DOI 10.1309/AJCP4ZDKJ4ICOUAT; Murata Y, 2011, BLOOD, V118, P1225, DOI 10.1182/blood-2011-01-329540; Jordan MB, 2004, BLOOD, V104, P735, DOI 10.1182/blood-2003-10-3413; Kasahara Y, 2002, CRIT REV ONCOL HEMAT, V44, P283, DOI 10.1016/S1040-8428(02)00119-1; Bode SFN, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3843; Davi S, 2014, ARTHRITIS RHEUMATOL, V66, P2871, DOI 10.1002/art.38769; desSaint Basile G., 2011, ANN NY ACAD SCI, V1246, P64; Kawada J, 2004, J INFECT DIS, V190, P494, DOI 10.1086/422325; Kurt-Jones EA, 2005, J INFECT DIS, V191, P746, DOI 10.1086/427339; Lehmberg K, 2013, J PEDIATR-US, V162, P1245, DOI 10.1016/j.jpeds.2012.11.081; Luo Y. B., 2014, BIOCHIM BIOPHYS ACTA, V1852, P622; Papathanassoglou EDE, 2000, CRIT CARE MED, V28, P537, DOI 10.1097/00003246-200002000-00042; Zhang MC, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0439-2	34	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0007-1048	1365-2141		BRIT J HAEMATOL	Br. J. Haematol.	AUG	2015	170	4					532	538		10.1111/bjh.13461		7	Hematology	Hematology	CO6IH	WOS:000359259900012		
J	Kwak, DY; Brandenberg, SJ; Mikami, A; Stewart, JP				Kwak, Dong Youp; Brandenberg, Scott J.; Mikami, Atsushi; Stewart, Jonathan P.			Prediction Equations for Estimating Shear-Wave Velocity from Combined Geotechnical and Geomorphic Indexes Based on Japanese Data Set	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							SEISMIC SITE CONDITIONS; PENETRATION RESISTANCE; CALIFORNIA; MAP; V-S30; PROXY; VS30	We develop empirical predictive equations for shear-wave velocity (V-S) conditional on standard penetration test resistance (N-value) and other explanatory variables using data sets from Japan. The V-S and N data sets are from the Kyoshin network (K-NET), which include 16,845 collocated measurements of V-S and N at 1102 sites. We begin with baseline equations considering soil type and overburden pressure in addition to N. For coarse-grained soils, V-S is more sensitive to overburden pressure than to N, whereas for fine-grained soils, V-S is more sensitive to N. We find that residuals (difference between data and model) for a given borehole tend to be correlated (e.g., samples within a boring are consistently high or low); hence, we use mixed-effects regression to compute a quantity akin to an average borehole residual referred to as the between-boring residual. Sites associated with older (pre-Holocene, > 10,000 yrs) geology tend to have null to slightly positive between-boring residuals, whereas these residuals are negative for more recent materials. Accordingly, we provide adjustments to the baseline equations conditional on geologic condition. Between-boring residuals exhibit spatial correlations; however, due to lack of knowledge as to the cause of these correlations, we do not recommend such effects for inclusion in the model. When applied to predict the time-averaged V-S in the upper 30 m (V-S30) in the absence of direct measurement, the proposed equations provide significantly better accuracy than widely used local geomorphology-based proxies (0.26 versus 0.42 of standard deviation of the natural log of residuals). This suggests that penetration resistance data can improve predictions of V-S30 compared with geomorphology-based proxies alone, when site-specific V-S measurements are unavailable.	[Kwak, Dong Youp; Brandenberg, Scott J.; Stewart, Jonathan P.] Univ Calif Los Angeles, Dept Civil & Environm Engn, Los Angeles, CA 90095 USA; [Mikami, Atsushi] Univ Tokushima, Dept Civil & Environm Engn, Tokushima 7708506, Japan	Kwak, DY (reprint author), Univ Calif Los Angeles, Dept Civil & Environm Engn, 5731 Boelter Hall, Los Angeles, CA 90095 USA.	kwakdongyoup@gmail.com		Brandenberg, Scott/0000-0003-2493-592X	California Department of Water and Resource (CDWR) [4600008849]	This work was supported by the California Department of Water and Resource (CDWR) under Contract Number 4600008849. This funding source is gratefully acknowledged. Any opinions, findings, and conclusions or recommendations expressed in this article are those of the authors and do not necessarily reflect those of CDWR. We also acknowledge data providers, that is, National Research Institute for Earth Science and Disaster Prevention (NIED), Port and Airport Research Institute (PARI), and U.S. Geological Survey (USGS). Constructive comments by two anonymous reviewers strengthened this article.	Dikmen U, 2009, J GEOPHYS ENG, V6, P61, DOI 10.1088/1742-2132/6/1/007; Allen TI, 2009, B SEISMOL SOC AM, V99, P935, DOI 10.1785/0120080255; Hasancebi N, 2007, B ENG GEOL ENVIRON, V66, P203, DOI 10.1007/s10064-006-0063-0; Wald DJ, 2007, B SEISMOL SOC AM, V97, P1379, DOI 10.1785/0120060267; OHTA Y, 1978, EARTHQUAKE ENG STRUC, V6, P167, DOI 10.1002/eqe.4290060205; Thompson EM, 2014, B SEISMOL SOC AM, V104, P2313, DOI 10.1785/0120130312; Andrus RD, 2004, SOIL DYN EARTHQ ENG, V24, P713, DOI 10.1016/j.soildyn.2004.06.001; Yong A, 2012, B SEISMOL SOC AM, V102, P114, DOI 10.1785/0120100262; Wills CJ, 2006, B SEISMOL SOC AM, V96, P1483, DOI 10.1785/0120050179; SKEMPTON AW, 1986, GEOTECHNIQUE, V36, P425; Rollins KM, 1998, J GEOTECH GEOENVIRON, V124, P396, DOI 10.1061/(ASCE)1090-0241(1998)124:5(396); Boore DM, 2004, B SEISMOL SOC AM, V94, P591, DOI 10.1785/0120030105; Boore DM, 2011, B SEISMOL SOC AM, V101, P3046, DOI 10.1785/0120110071; Brandenberg SJ, 2010, SOIL DYN EARTHQ ENG, V30, P1026, DOI 10.1016/j.soildyn.2010.04.014; Danielson J.J., 2011, 20111073 US GEOL SUR; HORN BKP, 1981, P IEEE, V69, P14, DOI 10.1109/PROC.1981.11918; Kinoshita S, 1998, SEISMOL RES LETT, V69, P309; Kwak D. Y., 2014, THESIS U CALIFORNIA; Lee S H-H, 1992, SOILS FOUND, V32, P205; Lodge A. L., 1994, THESIS U CALIFORNIA; Matsuoka M., 2006, STRUCT ENG EARTHQ EN, V23, P57; Montgomery D. C., 2014, APPL STAT PROBABILIT; Nath SK, 2004, NAT HAZARDS, V31, P319; Ohno M., 2007, JPN GEOTECH J, V2, P319, DOI 10.3208/jgs.2.319; Oliver M. A., 1990, International Journal of Geographical Information Systems, V4, DOI 10.1080/02693799008941549; Pinheiro H., 2013, NLME LINEAR NONLINEA, P108; Piratheepan P., 2002, THESIS CLEMSON U CLE; SEED HB, 1985, J GEOTECH ENG-ASCE, V111, P1425; Seed HB, 1986, GEOTECHNICAL ENG ASC, V112, P1016; Seyhan E, 2014, EARTHQ SPECTRA, V30, P1007, DOI 10.1193/062913EQS180M; Stewart JP, 2014, B SEISMOL SOC AM, V104, P2827, DOI 10.1785/0120130331; Sykora D.E., 1983, SOIL DYN EARTHQ ENG, V20, P125; Sykora DW, 1988, EARTHQUAKE ENG SOIL, V2, P389; Wair B. R., 2012, 201208 PEER; Wakamatsu K., 2011, EARTHQ RESIST ENG ST, VVIII, P101; Wills C. J., 2008, INVESTIGATION GEOGRA; Yoshida Y., 1988, P PEN TEST 1988 ISOP, V2, P381	37	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	AUG	2015	105	4					1919	1930		10.1785/0120140326		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CN9MN	WOS:000358773100007		
J	Yagoda-Biran, G; Anderson, JG; Miyake, H; Koketsu, K				Yagoda-Biran, Gony; Anderson, John G.; Miyake, Hiroe; Koketsu, Kazuki			Between-Event Variance for Large Repeating Earthquakes	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							2004 PARKFIELD EARTHQUAKE; GROUND-MOTION PREDICTION; 1979 IMPERIAL-VALLEY; TOKACHI-OKI EARTHQUAKE; TECTONIC STRESS; HORIZONTAL COMPONENTS; SOUTHERN CALIFORNIA; SLIP DISTRIBUTION; SOURCE PARAMETERS; HAZARD ASSESSMENT	We estimate the variance in ground motions related to repeated large earthquakes occurring on the same fault segment with similar magnitudes. We find eight earthquake pairs for which suitable strong-motion records exist. Two are crustal strike-slip earthquakes from California and six are subduction zone earthquakes from Japan. We consider only large earthquakes and deal with frequencies greater than the earthquake corner frequency, so the variability that is considered here is related to smaller scale differences in the rupture process, particularly on the part of the fault nearest the station. We find that the variance of the 5% damped spectral accelerations of these pairs, termed tau(2)(F), averages to about 45% and 80% of tau(2) for the crustal and subduction zone earthquakes, respectively, in which tau(2) is the contribution of source variability to the total variability of ground motion estimated by some recent ground-motion prediction equations. We suggest that tau(2)(F) is lower than tau(2), for the frequencies at which tau(2)(F) is estimated, because it depends primarily on only local physical properties of a fault that are the same in repeated earthquakes. We therefore suggest that at sites where the hazard is controlled by a single rerupturing source, one could potentially use a between-event variance that is smaller than tau(2) in seismic-hazard calculations. Thus, these results may help to resolve the inconsistencies that are now present between the national hazard maps and some precariously balanced rocks in southern California.	[Yagoda-Biran, Gony; Anderson, John G.] Univ Nevada, Nevada Seismol Lab, Reno, NV 89557 USA; [Miyake, Hiroe; Koketsu, Kazuki] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan	Yagoda-Biran, G (reprint author), Geol Survey Israel, 30 Malkhe Israel St, IL-95501 Jerusalem, Israel.	gonyb@gsi.gov.il			Geological Survey at the Earth Science Research Administration within the Government of the State of Israel; Southern California Earthquake Center (SCEC); National Science Foundation [EAR-1033462]; U.S. Geological Survey [G12AC20038]	We thank the editor and two anonymous reviewers for their critical comments, which have greatly improved the quality of this article. Sanaz Rezaeian is thanked for a last minute correction. This research has been supported by the Geological Survey at the Earth Science Research Administration within the Government of the State of Israel. Gony Yagoda-Biran thanks the Nevada Seismological Laboratory, University of Nevada, Reno, for logistical support, as the major part of this research was performed while she was there as a visiting scholar. A portion of this research was supported by the Southern California Earthquake Center (SCEC). SCEC is funded by National Science Foundation Cooperative Agreement EAR-1033462 and U.S. Geological Survey Cooperative Agreement G12AC20038. The SCEC contribution number for this article is 2086.	Abrahamson NA, 2014, EARTHQ SPECTRA, V30, P1025, DOI [10.1193/062913EQS198M, 10.1193/070913EQS198M]; AKI K, 1968, J GEOPHYS RES, V73, P5359, DOI 10.1029/JB073i016p05359; Anderson J. G., 1999, SEISMOL RES LETT, V70, P19, DOI DOI 10.1785/GSSRL.70.1.19; Anderson J. G., 2014, EARTHQUAKE HAZARD RI, P377; Anderson JG, 2015, SEISMOL RES LETT, V86, P68, DOI 10.1785/0220140098; Anderson J.G., 2011, SEISMOL RES LETT, V82, P431, DOI DOI 10.1785/GSSRL.82.3.431; ANDERSON JG, 1985, GEOPHYS RES LETT, V12, P349, DOI 10.1029/GL012i006p00349; ANDERSON JG, 1987, B SEISMOL SOC AM, V77, P562; Miyake H, 2003, B SEISMOL SOC AM, V93, P2531, DOI 10.1785/0120020183; HARTZELL SH, 1983, B SEISMOL SOC AM, V73, P1553; JOYNER WB, 1981, B SEISMOL SOC AM, V71, P2011; Rockwell TK, 2013, B SEISMOL SOC AM, V103, P629, DOI 10.1785/0120120192; Nadeau RM, 1998, B SEISMOL SOC AM, V88, P790; ABRAHAMSON NA, 1992, B SEISMOL SOC AM, V82, P505; Yamanaka Y, 2003, EARTH PLANETS SPACE, V55, pE21; Mochizuki K, 2008, SCIENCE, V321, P1194, DOI 10.1126/science.1160250; Wesnousky SG, 2008, B SEISMOL SOC AM, V98, P1609, DOI 10.1785/0120070111; Morikawa N, 2008, J SEISMOL, V12, P529, DOI 10.1007/s10950-008-9106-2; Kanno T, 2006, B SEISMOL SOC AM, V96, P879, DOI 10.1785/0120050138; HANKS TC, 1979, J GEOPHYS RES, V84, P2235, DOI 10.1029/JB084iB05p02235; Ameri G, 2011, B SEISMOL SOC AM, V101, P1136, DOI 10.1785/0120100231; Douglas J, 2013, B SEISMOL SOC AM, V103, P1875, DOI 10.1785/0120120197; Bakun WH, 2005, NATURE, V437, P969, DOI 10.1038/nature04067; Boore DM, 2010, B SEISMOL SOC AM, V100, P1830, DOI 10.1785/0120090400; Rodriguez-Marek A, 2011, B SEISMOL SOC AM, V101, P1242, DOI 10.1785/0120100252; Baltay AS, 2013, B SEISMOL SOC AM, V103, P211, DOI 10.1785/0120120161; BRUNE JN, 1970, J GEOPHYS RES, V75, P4997, DOI 10.1029/JB075i026p04997; Atkinson GM, 2006, B SEISMOL SOC AM, V96, P446, DOI 10.1785/0120050137; Ripperger J, 2008, B SEISMOL SOC AM, V98, P1207, DOI 10.1785/0120070076; Kanamori H, 2006, EARTH PLANETS SPACE, V58, P1533; Custodio S, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2006JB004617; Al Atik L, 2010, SEISMOL RES LETT, V81, P794, DOI 10.1785/gssrl.81.5.794; Hirata K, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB001976; ARCHULETA RJ, 1982, B SEISMOL SOC AM, V72, P1927; Boore DM, 2014, EARTHQ SPECTRA, V30, P1057, DOI 10.1193/070113EQS184M; Borcherdt RD, 2006, B SEISMOL SOC AM, V96, pS73, DOI 10.1785/0120050827; Brune J. N., 1999, SEISMOL RES LETT, V70, P29; Brune JN, 1996, B SEISMOL SOC AM, V86, P43; Campbell KW, 2014, EARTHQ SPECTRA, V30, P1087, DOI 10.1193/062913EQS175M; Chiou BSJ, 2014, EARTHQ SPECTRA, V30, P1117, DOI 10.1193/072813EQS219M; CROUSE CB, 1983, B SEISMOL SOC AM, V73, P1187; DOSER DI, 1990, B SEISMOL SOC AM, V80, P1099; Douglas J, 2006, J SEISMOL, V10, P271, DOI 10.1007/s10950-006-9016-0; Hudson D.E., 1963, Bulletin of the Seismological Society of America, V53; Iai S., 1978, 286 MIN TRANSP; Japan Meteorological Agency (JMA), 2011, 11 MARCH IW OK EARTH; Kim A, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005115; Kimura T, 2010, J GEOPHYS RES-SOL EA, V115, DOI 10.1029/2009JB006758; Kinoshita S, 1998, SEISMOL RES LETT, V69, P309; Kobayashi H., 2013, JAP GEOSC UN M MAK C; Lienkaemper JJ, 2006, B SEISMOL SOC AM, V96, pS239, DOI 10.1785/0120050806; Mena B, 2006, B SEISMOL SOC AM, V96, pS183, DOI 10.1785/0120050814; Nagai R., 2001, ZISIN, V54, P267; Petersen M. D., 2014, 20141091 US GEOL SUR; Petersen M. D., 2008, 20081128 US GEOL SUR; Restrepo-Velez LF, 2003, J EARTHQUAKE ENG, V7, P171, DOI 10.1142/S1363246903001000; Robinson DP, 2010, GEOPHYS J INT, V181, P334, DOI 10.1111/j.1365-246X.2010.04513.x; Sharp R. V., 1982, US GEOL SURV PROF PA, V1254, P213; Sharp R. V., 1982, 1254 US GEOL SURV, V1254, P119; Shimamura K, 2011, B SEISMOL SOC AM, V101, P2355, DOI 10.1785/0120100295; SMITH SW, 1968, B SEISMOL SOC AM, V58, P1955; Stepp J. C., 2001, EARTHQ SPECTRA, V17, P113, DOI 10.1193/1.1586169; Strasser FO, 2008, J SEISMOL, V12, P79, DOI 10.1007/s10950-007-9073-z; Suzuki W., 2012, SEISM SOC JAP FALL M; Takiguchi M, 2011, J SEISMOL SOC JPN, V63, P223; TRIFUNAC MD, 1970, B SEISMOL SOC AM, V60, P137; TRIFUNAC MD, 1972, B SEISMOL SOC AM, V62, P1283; Uchida N, 2012, GEOPHYS J INT, V189, P999, DOI 10.1111/j.1365-246X.2012.05377.x; WONG HL, 1979, EARTHQUAKE ENG STRUC, V7, P75, DOI 10.1002/eqe.4290070107; Wu C, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005189; Wu CJ, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2009JB006419; Yamanaka Y, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002683; Yamanaka Y., 2008, NGY SEISMOLOGICAL NO	73	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	AUG	2015	105	4					2023	2040		10.1785/0120140196		18	Geochemistry & Geophysics	Geochemistry & Geophysics	CN9MN	WOS:000358773100013		
J	Kuge, K				Kuge, Keiko			Teleseismic Peak Ground Accelerations from the 24 May 2013 Sea of Okhotsk Deep Earthquake	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							BOLIVIA EARTHQUAKE; TRAVEL-TIME; JUNE 9; WAVE; SLAB; CONSTRAINTS; SIMULATION; RUPTURE; MOTIONS; MODELS	The 2013 Sea of Okhotsk deep earthquake (M-w 8.3), which was recorded by many global seismic stations with adequate coverage of azimuth and distance, provided an opportunity to understand the global characteristics of ground shaking. Peak ground accelerations (PGAs) from the Sea of Okhotsk earthquake decreased with distance up to 120 degrees and peaked at a distance of 140 degrees-150 degrees. The variation as a function of distance is similar to that of the 1994 Bolivia earthquake. PGA values at distances between 40 degrees and 85 degrees are associated with vertical components of direct P waves, and the values are in a range from 10(-4) to 10(-2) m/s. The average decay with distance agrees with that of the P-wave amplitude predicted by the ray theory using lower-mantle attenuation in a range of previously obtained models. Frequencies characterizing the PGA decay are between 0.8 and 1.8 Hz. In agreement with observations from other deep earthquakes, the P-wave radiation pattern can affect the decay curves of PGA with distance by changing the amplitude of P waves in the frequency range. Spatial variations in PGA can depend on the tectonic setting; large values of PGA are observed in stable continents and old seas, whereas small values are observed in tectonically active regions. Considering observations from the Sea of Okhotsk deep earthquakes, it is likely that PGA values have a positive correlation with shear-velocity variations at depths of around 100-150 km below the stations.	Kyoto Univ, Dept Geophys, Kyoto 6068502, Japan	Kuge, K (reprint author), Kyoto Univ, Dept Geophys, Kyoto 6068502, Japan.	keiko@kugi.kyoto-u.ac.jp					ANDERSON JG, 1995, GEOPHYS RES LETT, V22, P2293, DOI 10.1029/95GL01808; KENNETT BLN, 1995, GEOPHYS J INT, V122, P108, DOI 10.1111/j.1365-246X.1995.tb03540.x; KIKUCHI M, 1994, GEOPHYS RES LETT, V21, P2341, DOI 10.1029/94GL02483; Zhan ZW, 2014, EARTH PLANET SC LETT, V385, P89, DOI 10.1016/j.epsl.2013.10.028; Ritsema J, 2011, GEOPHYS J INT, V184, P1223, DOI 10.1111/j.1365-246X.2010.04884.x; Boore DM, 2003, PURE APPL GEOPHYS, V160, P635, DOI 10.1007/PL00012553; Montagner JP, 1996, GEOPHYS J INT, V125, P229, DOI 10.1111/j.1365-246X.1996.tb06548.x; Meng LS, 2014, GEOPHYS RES LETT, V41, P3779, DOI 10.1002/2014GL059968; Ye LL, 2013, SCIENCE, V341, P1380, DOI 10.1126/science.1242032; Hwang YK, 2011, EARTH PLANET SC LETT, V303, P369, DOI 10.1016/j.epsl.2011.01.023; WEBER M, 1990, GEOPHYS J INT, V101, P529, DOI 10.1111/j.1365-246X.1990.tb05568.x; Chen Y, 2014, J GEOPHYS RES-SOL EA, V119, P3035, DOI 10.1002/2013JB010926; Fukao Y, 2013, J GEOPHYS RES-SOL EA, V118, P5920, DOI 10.1002/2013JB010466; BOORE DM, 1983, B SEISMOL SOC AM, V73, P1865; Chen Y, 2014, J SEISMOL, V18, P457, DOI 10.1007/s10950-014-9419-2; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Frohlich C., 2006, DEEP EARTHQUAKES, P4; Goldstein P., 2005, INC I SEISMOL DATA M, V7, P1; Pankow KL, 2002, J GEOPHYS RES-SOL EA, V107, DOI 10.1029/2001JB000594; SUETSUGU D, 1989, J PHYS EARTH, V37, P265; Venkataraman A, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002548; WESSEL P, 1998, EOS T AGU, V0079	22	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	AUG	2015	105	4					2058	2069		10.1785/0120140315		12	Geochemistry & Geophysics	Geochemistry & Geophysics	CN9MN	WOS:000358773100015		
J	Kim, A; Iida, S				Kim, Ahyi; Iida, Shuhei			Low Apparent Stress Observed for M-w <-0.6 Microearthquakes Recorded during Hydraulic-Fracturing Stimulation in the Carthage Cotton Valley Gas Field	BULLETIN OF THE SEISMOLOGICAL SOCIETY OF AMERICA			English	Article							SOURCE PARAMETERS; INJECTION EXPERIMENT; INDUCED EARTHQUAKES; FLUID INJECTION; SEISMIC EVENTS; UNITED-STATES; KM DEPTH; SITE; GERMANY; MOMENT	Understanding the source characteristics of hydraulic-fracturing-induced microearthquakes is expected to provide better understanding of both the fracturing process and the influence of pre-existing structures on the distribution of events. However, details of the source characteristics of microearthquakes remain largely unknown. One controversial issue is whether the mechanism of such events differs from natural tectonic events, that is, whether significant reductions of effective stress and/or volumetric change occur because of the stimulation. Herein, to address this question, we estimated the apparent stress of the 61 M-w <-0.6 microearthquakes observed during the hydraulic fracturing in the Carthage Cotton Valley gas field. We first obtained the apparent stress by estimating the radiated seismic energy from the duration of the relative moment rate function and then adjusted the values, considering the possibility of seismic energy underestimation. The initial value range of 0.001-0.02 MPa is consistent with other past studies of hydraulic-fracturing-induced microearthquakes. Although the adjustment increases the original value by a factor of 10, it is still within the lower bound of the range of constant apparent stress commonly observed for natural tectonic events. Furthermore, relatively lower apparent stress was observed for the events striking sub-parallel to the maximum horizontal compressional stress axis. This implies the mechanism of these events could be different from that of events optimally oriented for failure, although the uncertainty of their measurements was expected to be large compared with other events because of their small magnitude.	[Kim, Ahyi; Iida, Shuhei] Yokohama City Univ, Kanazawa Ku, Yokohama, Kanagawa 2360027, Japan	Kim, A (reprint author), Yokohama City Univ, Kanazawa Ku, 22-2 Seto, Yokohama, Kanagawa 2360027, Japan.	ahyik@yokohama-cu.ac.jp; n145203c@yokohama-cu.ac.jp			Japan Society for the Promotion of Science [25870600]	We thank James Rutledge for providing seismic waveform data and helpful advice. We are grateful to the two anonymous reviewers for their insightful reviews that improved the manuscript. We also thank Diane Doser and Delphine Fitzenz for their editorial stewardship of the journal. This work was supported by the Japan Society for the Promotion of Science Grant-in-Aid for Scientific Research (KAKENHI) Grant Number 25870600. Figures were created using Generic Mapping Tool (Wessel and Smith, 1995).	Abercrombie RE, 1995, J GEOPHYS RES-SOL EA, V100, P24015, DOI 10.1029/95JB02397; Andrews DJ, 1986, GEOPHYS MONOGR SER, V37, P259, DOI DOI 10.1029/GM037P0259; Mandal P, 1998, B SEISMOL SOC AM, V88, P833; BOATWRIGHT J, 1984, B SEISMOL SOC AM, V74, P361; Rutledge JT, 2003, GEOPHYSICS, V68, P441, DOI 10.1190/1.1567214; Rutledge JT, 2004, B SEISMOL SOC AM, V94, P1817, DOI 10.1785/012003257; MORI J, 1990, B SEISMOL SOC AM, V80, P278; Harrington RM, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028714; Bertero M, 1997, INVERSE PROBL, V13, P465, DOI 10.1088/0266-5611/13/2/017; Sileny J, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB005987; Vavrycuk V, 2007, GEOPHYS PROSPECT, V55, P381, DOI 10.1111/j.1365-2478.2007.00624.x; Jost ML, 1998, B SEISMOL SOC AM, V88, P815; Ide S, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001617; Horalek J, 2010, GEOPHYS J INT, V181, P1547, DOI 10.1111/j.1365-246X.2010.04506.x; Tomic J, 2009, GEOPHYS J INT, V179, P1013, DOI 10.1111/j.1365-246X.2009.04233.x; Lanza V, 1999, GEOPHYS J INT, V137, P651, DOI 10.1046/j.1365-246x.1999.00809.x; ABERCROMBIE R, 1993, GEOPHYS RES LETT, V20, P1511, DOI 10.1029/93GL00367; Ide S, 2001, GEOPHYS RES LETT, V28, P3349, DOI 10.1029/2001GL013106; Hough SE, 2014, B SEISMOL SOC AM, V104, P2619, DOI 10.1785/0120140099; McGarr A, 1999, J GEOPHYS RES-SOL EA, V104, P3003, DOI 10.1029/1998JB900083; Baig A., 2012, TLE, V31, P1470; Baig Adam, 2010, Leading Edge, V29, DOI 10.1190/1.3353729; BOATWRIGHT J, 1978, B SEISMOL SOC AM, V68, P1117; Fischer T, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045447; GIBOWICZ SJ, 1990, B SEISMOL SOC AM, V80, P88; GIBOWICZ SJ, 1991, B SEISMOL SOC AM, V81, P1157; Kim A., 2011, SEG TECHN PROGR EXP, V30, P1509; Laubach S., 1988, SPE ANN TECHN C EXH; Maxwell S., 2007, 2007 SEG ANN M SAN A; Mayeda K, 1996, J GEOPHYS RES-SOL EA, V101, P11195, DOI 10.1029/96JB00112; Rutledge J., 2013, 2013 SEG ANN M HOUST; Rutledge J., 1998, GRI990269; SAVAGE JC, 1971, B SEISMOL SOC AM, V61, P1381; Snoke J. A., 2003, FOCMEC FOCAL MECH DE, P1629; Talebi S., 1999, PURE APPL GEOPHYS, V153, P113; Urbancic T., 1999, VAIL ROCKS 1999 37 U; VASSILIOU MS, 1982, B SEISMOL SOC AM, V72, P371; Vavrycuk V, 2008, TECTONOPHYSICS, V456, P74, DOI 10.1016/j.tecto.2007.08.019; Walker R. N., 1997, SPE ANN TECHN C SAN, P131; Wessel P., 1995, EOS T AM GEOPHYS UN, V76, P329, DOI DOI 10.1029/95EO00198	40	0	0	SEISMOLOGICAL SOC AMER	ALBANY	400 EVELYN AVE, SUITE 201, ALBANY, CA 94706-1375 USA	0037-1106	1943-3573		B SEISMOL SOC AM	Bull. Seismol. Soc. Amer.	AUG	2015	105	4					2313	2320		10.1785/0120140319		8	Geochemistry & Geophysics	Geochemistry & Geophysics	CN9MN	WOS:000358773100034		
J	Uchida, T; Nagayama, M; Yamazaki, K; Gohara, K; Sum, AK				Uchida, Tsutomu; Nagayama, Masafumi; Yamazaki, Kenji; Gohara, Kazutoshi; Sum, Amadeu K.			Raman spectra measurements on DEPC liposome and cell membrane of living neuron under xenon pressure	CANADIAN JOURNAL OF CHEMISTRY			English	Article						liposome; neuron; Raman shift; phase transition; xenon	METHYL-D-ASPARTATE; ACTIVATED MICROGLIA; SYNCHRONIZED BURSTS; PHASE-TRANSITION; INHIBITION; RECEPTOR; METHANE; WATER; TRANSMISSION; SPECTROSCOPY	The Raman spectra of liposomes were measured under xenon pressures and low temperatures to observe the spectra changes accompanying the gel to liquid crystalline phase transition of the liposomes. C-H stretching bonds of the lipids in the liposome were slightly red shifted at approximately 285 K and atmospheric pressure, which coincided well with the phase transition condition. This Raman peak shift was observed at lower temperatures and related linearly to the xenon pressures. The xenon pressure dependence on the phase transition temperature was in good agreement with the DSC measurements, and the red shifts of Raman peaks supported the molecular mechanism of interaction between xenon and phospholipid bilayers suggested by the MD simulations. The phase transition measurements under xenon pressure with the microscopic Raman spectroscopy were applied to cultured neuronal networks to observe the interaction of dissolved xenon with the cell membrane and the surrounding water.	[Uchida, Tsutomu; Nagayama, Masafumi; Yamazaki, Kenji; Gohara, Kazutoshi] Hokkaido Univ, Fac Engn, Div Appl Phys, Kita Ku, Sapporo, Hokkaido 0608628, Japan; [Nagayama, Masafumi] Hokkaido Univ, Asahikawa, Hokkaido 0700825, Japan; [Sum, Amadeu K.] Colorado Sch Mines, Dept Chem & Biol Engn, Ctr Hydrate Res, Golden, CO 80401 USA	Uchida, T (reprint author), Hokkaido Univ, Fac Engn, Div Appl Phys, Kita Ku, N13 W8, Sapporo, Hokkaido 0608628, Japan.	t-uchida@eng.hokudai.ac.jp			Japan Society for the Promotion of Science [23350001, 25600035]; Nanotechnology Platform program	This work was partly supported financially by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (Grant Nos. 23350001 and 25600035). Raman spectroscopic measurements were performed with Renishaw inVia Reflex micro-Raman system at the OPEN FACILITY, Hokkaido University Sousei Hall. FEG-TEM observations were financially supported by the Nanotechnology Platform program and technically supported by Dr. N. Sakaguchi and Dr. T. Shibayama (Hokkaido Univ.). We thank D. Ito (Hokkaido Univ.) for his technical support on the neuron culture preparations.	Ajito K, 2002, LAB CHIP, V2, P11, DOI 10.1039/b108744b; Ito D, 2010, NEUROSCIENCE, V171, P50, DOI 10.1016/j.neuroscience.2010.08.038; Uchida T, 2002, J PHYS CHEM B, V106, P820, DOI 10.1021/jp012823w; Uchida T, 1999, J PHYS CHEM B, V103, P3659, DOI 10.1021/jp984559l; Dinse A, 2005, BRIT J ANAESTH, V94, P479, DOI 10.1093/bja/aei080; Takeuchi H, 2005, J BIOL CHEM, V280, P10444, DOI 10.1074/jbc.M413863200; Banno M, 2005, NEUROPHARMACOLOGY, V48, P283, DOI 10.1016/j.neuropharm.2004.10.002; BATENJANY MM, 1994, BBA-BIOMEMBRANES, V1192, P205, DOI 10.1016/0005-2736(94)90120-1; Nagele P, 2005, ANESTHESIOLOGY, V103, P508, DOI 10.1097/00000542-200509000-00013; Wang H, 2011, J TRAUMA, V71, P1246, DOI 10.1097/TA.0b013e31822503a7; Booker RD, 2013, BBA-BIOMEMBRANES, V1828, P1347, DOI 10.1016/j.bbamem.2013.01.016; Franks NP, 1998, NATURE, V396, P324, DOI 10.1038/24525; Janko M, 2010, OPT LETT, V35, P2765, DOI 10.1364/OL.35.002765; Preckel B, 2006, ANESTHESIOLOGY, V105, P187, DOI 10.1097/00000542-200607000-00029; EWING GJ, 1974, J CHEM ENG DATA, V19, P367, DOI 10.1021/je60063a006; Dickinson R, 2007, ANESTHESIOLOGY, V107, P756; Hamada K, 2008, J BIOMED OPT, V13, DOI 10.1117/1.2952192; Plested AJR, 2004, ANESTHESIOLOGY, V100, P347, DOI 10.1097/00000542-200402000-00025; Haseneder R, 2008, ANESTHESIOLOGY, V109, P998, DOI 10.1097/ALN.0b013e31818d6aee; Maeda Y, 1996, J RAMAN SPECTROSC, V27, P425; de Sousa SLM, 2000, ANESTHESIOLOGY, V92, P1055, DOI 10.1097/00000542-200004000-00024; [Anonymous], 2002, BRIT J ANAESTH; Uchida T, 2004, J GEOPHYS RES-SOL EA, V109, DOI 10.1029/2003JB002771; FRANKS NP, 1984, NATURE, V310, P599, DOI 10.1038/310599a0; Uchida T, 2012, NEUROSCIENCE, V214, P149, DOI 10.1016/j.neuroscience.2012.03.063; Mizuno T, 2004, NEUROPHARMACOLOGY, V46, P404, DOI 10.1016/j.neuropharm.2003.09.009; Fox CB, 2007, J PHYS CHEM B, V111, P11428, DOI 10.1021/jp0735886; Georgiev SK, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-25; GREEN JL, 1986, J PHYS CHEM-US, V90, P3958, DOI 10.1021/j100408a027; Mayer H., 1899, NAUNYUN SCHMIEDEBERG, V42, P109, DOI [10.1007/BF01834479, DOI 10.1007/BF01834479]; MILLER STANLEY L., 1961, PROC NATL ACAD USA, V47, P1515, DOI 10.1073/pnas.47.9.1515; Overton C.E., 1901, STUDIEN NARKOSE ZUGL; PAULING L, 1961, SCIENCE, V134, P15, DOI 10.1126/science.134.3471.15; Silvius J., 1982, THERMOTROPIC PHASE T; SRINIVAS.KR, 1974, BIOCHEMISTRY-US, V13, P3494, DOI 10.1021/bi00714a012; Tanaka S., 1992, J SCCJ, V25, P232; Uchida T, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-295; Uchida T., 2013, LOW TEMP SCI, V71, P105	38	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	AUG	2015	93	8	1		SI		831	838		10.1139/cjc-2014-0542		8	Chemistry, Multidisciplinary	Chemistry	CO3OI	WOS:000359067400008		
J	Imasato, K; Murayama, K; Takeya, S; Alavi, S; Ohmura, R				Imasato, Kazuki; Murayama, Kotaro; Takeya, Satoshi; Alavi, Saman; Ohmura, Ryo			Effect of nitrogen atom substitution in cyclic guests on properties of structure H clathrate hydrates	CANADIAN JOURNAL OF CHEMISTRY			English	Article						clathrate hydrates; powder X-ray diffraction; molecular dynamics; lattice parameter; guest-host interactions; methylcyclohexane; 1-methylpiperidine	PHASE-EQUILIBRIUM; METHANE; STABILITY; SYSTEM; SIMULATION; HYDROGEN; ETHANOL; FORM; CONFIRMATION; DIFFRACTION	The effect of substituting nitrogen heteroatoms in the cyclohexane ring of methylcyclohexane on the structure and guest dynamics of structure H (sH) clathrate hydrates with methane help gases are studied through experimental synthesis, powder X-ray diffraction (PXRD) measurements, and classical molecular dynamics simulation of methylcyclohexane and 1-methylpiperidine. The PXRD measurements were performed for temperatures in the range of 138 to 183 K, and the a axis and c axis lattice constants were determined in this temperature range. The PXRD results show the different thermal expansivity of lattice constants in both sH hydrate cages. Simulations on methylcyclohexane and 1-methylpiperidine are performed, and the effects of methane cage occupancy on the lattice constants were studied by simulations with 100% and 80% of the small and medium cages occupied by methane. The sH phases do not expand isotropically, and the a and c lattice constants can vary over a range of 0.015 angstrom and 0.06 angstrom, respectively, depending on the large cage guest and methane occupancy. Hydrogen bonding between the 1-methylpiperidine nitrogen atom and cage water in the sH hydrate are not observed in the simulations, and differences in behavior of the two sH hydrates are likely related to the differences in geometry of the large guests and occupancies of methane in the small and medium sH cages.	[Imasato, Kazuki; Murayama, Kotaro; Alavi, Saman; Ohmura, Ryo] Keio Univ, Dept Mech Engn, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan; [Takeya, Satoshi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan; [Alavi, Saman] Univ Ottawa, Dept Chem, Ottawa, ON K1N 6N5, Canada	Ohmura, R (reprint author), Keio Univ, Dept Mech Engn, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	rohmura@mech.keio.ac.jp			JKA Foundation; JSPS KAKENHI [25289045]	This study was supported by a Keirin-Racing-based research promotion fund from the JKA Foundation and by JSPS KAKENHI (Grant No. 25289045).	Alavi S, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3548868; Allen M. P., 1987, COMPUTER SIMULATION; Ohmura R, 2004, IND ENG CHEM RES, V43, P4964, DOI 10.1021/ie0498089; Anderson R, 2009, J PHYS CHEM C, V113, P12602, DOI 10.1021/jp9021536; Lee JW, 2011, J PHYS CHEM A, V115, P1650, DOI 10.1021/jp1118184; Alavi S, 2010, J CHEM PHYS, V133, DOI 10.1063/1.3469776; Tezuka K, 2013, J PHYS CHEM C, V117, P10473, DOI 10.1021/jp4005899; BRENEMAN CM, 1990, J COMPUT CHEM, V11, P361, DOI 10.1002/jcc.540110311; Ostergaard KK, 2002, IND ENG CHEM RES, V41, P2064, DOI 10.1021/ie010833d; Yasuda K, 2009, J PHYS CHEM C, V113, P12598, DOI 10.1021/jp901685t; Lee JW, 2012, J PHYS CHEM B, V116, P332, DOI 10.1021/jp210223r; Chapoy A, 2008, IND ENG CHEM RES, V47, P1689, DOI 10.1021/ie071019e; Alavi S, 2010, CHEM-EUR J, V16, P1017, DOI 10.1002/chem.200902351; Makiya T, 2010, PHYS CHEM CHEM PHYS, V12, P9927, DOI 10.1039/c002187c; Kulig W, 2011, J PHYS CHEM A, V115, P6149, DOI 10.1021/jp111245z; Mao WL, 2004, P NATL ACAD SCI USA, V101, P708, DOI 10.1073/pnas.0307449100; Nakamura T, 2003, CHEM ENG SCI, V58, P269, DOI 10.1016/S0009-2509(02)00518-3; Yasuda K, 2009, IND ENG CHEM RES, V48, P9335, DOI 10.1021/ie900954w; Takeya S, 2006, J PHYS CHEM B, V110, P12943, DOI 10.1021/jp060198v; Izumi F, 2007, SOL ST PHEN, V130, P15; Alavi S, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4739928; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Shin W, 2011, J PHYS CHEM C, V115, P18885, DOI 10.1021/jp205433j; Ogawa T, 2006, APPL THERM ENG, V26, P2157, DOI 10.1016/j.applthermaleng.2006.04.003; Tezuka K, 2013, CHEM COMMUN, V49, P505, DOI 10.1039/c2cc37717a; GUILLOT B, 1993, J CHEM PHYS, V99, P8075, DOI 10.1063/1.465634; Kondo W, 2014, APPL ENERG, V113, P864, DOI 10.1016/j.apenergy.2013.08.033; RIPMEESTER JA, 1987, NATURE, V325, P135, DOI 10.1038/325135a0; Park Y, 2008, J PHYS CHEM B, V112, P8443, DOI 10.1021/jp804447r; Hester KC, 2007, J PHYS CHEM B, V111, P8830, DOI 10.1021/jp0715880; Abascal JLF, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1931662; Zhurko FV, 2010, CHEM ENG SCI, V65, P900, DOI 10.1016/j.ces.2009.09.040; Brewer PG, 1999, SCIENCE, V284, P943, DOI 10.1126/science.284.5416.943; Duarte ARC, 2008, J PHYS CHEM B, V112, P1888, DOI 10.1021/jp7110605; Forester T. R., 2008, DL POLY 2 20; Frenkel D., 2000, UNDERSTANDING MOL SI; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Maekawa T, 2008, FLUID PHASE EQUILIBR, V267, P1, DOI 10.1016/j.fluid.2008.02.006; Murayama K, 2014, J PHYS CHEM C, V118, P21323, DOI 10.1021/jp5058786; Murayama K, 2014, FLUID PHASE EQUILIBR, V365, P64, DOI 10.1016/j.fluid.2013.12.011; Nagao T., 1993, HAKODATE KOGYO KOTO, V27, P111; Okano Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2150430; Sloan ED, 2008, CHEM IND-SER, V119, pXIX; Tezuka K, 2012, ENERGIES, V5, P459, DOI 10.3390/en5020459; Udachin KA, 1997, SUPRAMOL CHEM, V8, P173, DOI 10.1080/10610279708034933; Udachin KA, 2008, ANGEW CHEM INT EDIT, V47, P9704, DOI 10.1002/anie.200801694	46	1	1	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	AUG	2015	93	8	1		SI		906	912		10.1139/cjc-2014-0553		7	Chemistry, Multidisciplinary	Chemistry	CO3OI	WOS:000359067400018		
J	Yamada, J; Nishikiori, S				Yamada, Junpei; Nishikiori, Shin-ichi			New structure, reconstruction, and behaviour of the coordination polymer framework [CuZn(CN)(4)](-) towards hydrated alkali metal ions	CANADIAN JOURNAL OF CHEMISTRY			English	Article						cyanide complex; coordination polymer; inclusion compound; reconstructive conversion; hydration structure	CADMIUM CYANIDE HOST; MINERALOMIMETIC CHEMISTRY; STRUCTURE VALIDATION; SINGLE-CRYSTAL; HIGH-PRESSURES; CLATHRATE; GUEST; ALUMINOPHOSPHATE; POLYMORPHISM; ZN(CN)(2)	A new framework structure of the coordination polymer [CuZn(CN)(4)](-) has been discovered in the newly synthesized [Na(H2O)n][CuZn(CN)(4)] (n = 12.7; 1). X-ray crystal structure analysis revealed a 3D framework comprised of tetrahedral Cu(I) and Zn(II) centres with bridging cyanide ligands containing both octagonal and square channel cavities; these channels contain hydrated Na+ ions as guests. In open air, complex 1 is extremely unstable and loses water molecules to form [Na(H2O)(n)][CuZn(CN)(4)] (n = 5.2-6.8; 2) within 30 min. Powder X-ray diffraction patterns showed that this change results in the conversion of the framework of complex 1 to the same framework observed in [K(H2O)(n)][CuZn(CN)(4)]. The [CuZn(CN)(4)]-framework of [K(H2O)(n)][CuZn(CN)(4)] has a tridymite structure with hexagonal channel cavities occupied by hydrated K+ ions. Like 1, 2 is also unstable under atmospheric conditions, yielding [Na(H2O)(n)][CuZn(CN)(4)] (n = 3), which has an unknown structure. While the framework of [K(H2O)(n)][CuZn(CN)(4)] is structurally flexible and robust, the framework of 2 is unstable and fragile. This contrast comes from the difference between the nature of the hydrated K+ and Na+ ions present in the frameworks.	[Yamada, Junpei; Nishikiori, Shin-ichi] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan	Nishikiori, S (reprint author), Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Meguro Ku, 3-8-1 Komaba, Tokyo 1538902, Japan.	cnskor@mail.ecc.u-tokyo.ac.jp					ABRAHAMS BF, 1992, J AM CHEM SOC, V114, P10641, DOI 10.1021/ja00052a073; Marcus Y, 2009, CHEM REV, V109, P1346, DOI 10.1021/cr8003828; Spek AL, 2009, ACTA CRYSTALLOGR D, V65, P148, DOI 10.1107/S090744490804362X; Spek AL, 2003, J APPL CRYSTALLOGR, V36, P7, DOI 10.1107/S0021889802022112; Mahler J, 2012, INORG CHEM, V51, P425, DOI 10.1021/ic2018693; Dan H, 2011, DALTON T, V40, P1168, DOI 10.1039/c0dt01201g; SMITH JV, 1988, CHEM REV, V88, P149, DOI 10.1021/cr00083a008; HOSKINS BF, 1990, J AM CHEM SOC, V112, P1546, DOI 10.1021/ja00160a038; ENDERBY JE, 1995, CHEM SOC REV, V24, P159, DOI 10.1039/cs9952400159; Mancinelli R, 2007, J PHYS CHEM B, V111, P13570, DOI 10.1021/jp075913v; Poswal HK, 2009, J SOLID STATE CHEM, V182, P136, DOI 10.1016/j.jssc.2008.09.026; Lapidus SH, 2013, J AM CHEM SOC, V135, P7621, DOI 10.1021/ja4012707; WERNER PE, 1985, J APPL CRYSTALLOGR, V18, P367, DOI 10.1107/S0021889885010512; SMITH DW, 1977, J CHEM EDUC, V54, P540; OHTAKI H, 1993, CHEM REV, V93, P1157, DOI 10.1021/cr00019a014; Galamba N, 2009, J PHYS CHEM B, V113, P16151, DOI 10.1021/jp904901b; Iwamoto T, 1997, J CHEM SOC DALTON, P4127, DOI 10.1039/a702539d; Iwamoto T, 1995, SUPRAMOL CHEM, V6, P179, DOI 10.1080/10610279508032534; KIM J, 1993, J CHEM SOC CHEM COMM, P1400, DOI 10.1039/c39930001400; Kitazawa T, 1999, J STRUCT CHEM+, V40, P721, DOI 10.1007/BF02903448; Kitazawa T, 1998, J MATER CHEM, V8, P671, DOI 10.1039/a707250c; Kitazawa T, 1996, J INCLUS PHENOM MOL, V26, P153, DOI 10.1007/BF01029939; KITAZAWA T, 1992, J CHEM SOC CHEM COMM, P413, DOI 10.1039/c39920000413; KITAZAWA T, 1994, J CHEM SOC DALTON, P1029, DOI 10.1039/dt9940001029; Kitazawa T, 1999, CHEM COMMUN, P891, DOI 10.1039/a901613i; KITAZAWA T, 1988, CHEM LETT, P1729, DOI 10.1246/cl.1988.1729; KITAZAWA T, 1995, J CHEM SOC DALTON, P3715, DOI 10.1039/dt9950003715; Nishikiori S, 2014, CRYSTENGCOMM, V16, P10173, DOI 10.1039/c4ce01435a; PLUTH JJ, 1986, ACTA CRYSTALLOGR C, V42, P1118, DOI 10.1107/S0108270186093198; PLUTH JJ, 1985, NATURE, V318, P165, DOI 10.1038/318165a0; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; VANDERSLUIS P, 1990, ACTA CRYSTALLOGR C, V46, P883, DOI 10.1107/S0108270189010061; VANDERSLUIS P, 1990, ACTA CRYSTALLOGR A, V46, P194, DOI 10.1107/S0108767389011189	33	0	0	CANADIAN SCIENCE PUBLISHING, NRC RESEARCH PRESS	OTTAWA	65 AURIGA DR, SUITE 203, OTTAWA, ON K2E 7W6, CANADA	0008-4042	1480-3291		CAN J CHEM	Can. J. Chem.	AUG	2015	93	8	1		SI		913	919		10.1139/cjc-2014-0533		7	Chemistry, Multidisciplinary	Chemistry	CO3OI	WOS:000359067400019		
J	Hikita, H; Kodama, T; Tanaka, S; Saito, Y; Nozaki, Y; Nakabori, T; Shimizu, S; Hayashi, Y; Li, W; Shigekawa, M; Sakamori, R; Miyagi, T; Hiramatsu, N; Tatsumi, T; Takehara, T				Hikita, Hayato; Kodama, Takahiro; Tanaka, Satoshi; Saito, Yoshinobu; Nozaki, Yasutoshi; Nakabori, Tasuku; Shimizu, Satoshi; Hayashi, Yoshito; Li, Wei; Shigekawa, Minoru; Sakamori, Ryotaro; Miyagi, Takuya; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo			Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damagein Hepatocytes That Contribute to Liver Tumorigenesis	CANCER PREVENTION RESEARCH			English	Article							CHRONIC HEPATITIS-C; HEPATOCELLULAR-CARCINOMA; NONALCOHOLIC STEATOHEPATITIS; RECURRENT MUTATIONS; SOMATIC MUTATIONS; DEFICIENT MICE; PROTEIN; DEATH; EXPRESSION; GENOME	Chronic hepatitis, including viral hepatitis and steatihepatitis, is a well-known high-risk condition for hepatocellular carcinoma. We previously reported that continuous hepatocyte apoptosis drives liver tumors in hepatocyte-specific Bcl-xL or Mcl-1 knockout mice. In this study, we further examine the underlying cellular mechanisms of generating tumors in apoptosis-prone liver. In cultured hepatocytes, the administration of ABT-737, a Bcl-xL/-2/-w inhibitor, led to production of reactive oxygen species (ROS) as well as activation of caspases. Mitochondria isolated from murine liver, upon administration of truncated-Bid, a proapoptotic Bcl-2 family protein, released cytochrome c and produced ROS, which was dependent on mitochondrial respiration. Hepatic apoptosis, regeneration, accumulation of oxidative damages, and tumorigenesis observed in hepatocyte-specific Mcl-1 knockout mice were substantially attenuated by further deficiency of Bax or Bid, suggesting that a balance of mitochondrial Bcl-2 family proteins governs generation of oxidative stress and other pathologies. Whole-exome sequencing clarified that C> A/G> T transversion, which is often caused by oxidative DNA damage in proliferating cells, was a frequently observed mutation pattern in liver tumors of Mcl-1 knockout mice. The administration of antioxidant L-N-acetylcysteine did not affect apoptosis, compensatory regeneration, or fibrotic responses but significantly reduced oxidative DNA damage and incidence and multiplicity of live tumors in Mcl-1 knockout mice. In conclusion, activation of the mitochondrial apoptotic pathway in hepatocytes accumulates intracellular oxidative damages, leading to liver tumorigenesis, independently of liver regeneration or fibrosis. This study supports a concept that antioxidant therapy may be useful for suppressing liver carcinogenesis in patients with chronic liver disease. (C) 2015 AACR.	[Hikita, Hayato; Kodama, Takahiro; Tanaka, Satoshi; Saito, Yoshinobu; Nozaki, Yasutoshi; Nakabori, Tasuku; Shimizu, Satoshi; Hayashi, Yoshito; Li, Wei; Shigekawa, Minoru; Sakamori, Ryotaro; Miyagi, Takuya; Hiramatsu, Naoki; Tatsumi, Tomohide; Takehara, Tetsuo] Osaka Univ, Grad Sch Med, Dept Gastroenterol & Hepatol, Suita, Osaka 5650871, Japan	Takehara, T (reprint author), Osaka Univ, Grad Sch Med, 2-2 Yamada Oka, Suita, Osaka 5650871, Japan.	takehara@gh.med.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan; Ministry of Health, Labour and Welfare of Japan	This work was partly supported by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (to T. Takehara and H. Hikita) and a Grant-in-Aid for Research on Hepatitis from the Ministry of Health, Labour and Welfare of Japan (to T. Takehara).	Kan ZY, 2013, GENOME RES, V23, P1422, DOI 10.1101/gr.154492.113; Totoki Y, 2014, NAT GENET, V46, P1267, DOI 10.1038/ng.3126; Yin XM, 1999, NATURE, V400, P886; Shimizu S, 2010, J HEPATOL, V52, P698, DOI 10.1016/j.jhep.2009.12.024; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Okuda M, 2002, GASTROENTEROLOGY, V122, P366, DOI 10.1053/gast.2002.30983; Guichard C, 2012, NAT GENET, V44, P694, DOI 10.1038/ng.2256; Hoofnagle JH, 2013, ALIMENT PHARM THER, V38, P134, DOI 10.1111/apt.12352; Dionisio N, 2009, J HEPATOL, V50, P872, DOI 10.1016/j.jhep.2008.12.026; Hikita H, 2012, J HEPATOL, V57, P92, DOI 10.1016/j.jhep.2012.01.027; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Kasahara A, 1998, HEPATOLOGY, V27, P1394, DOI 10.1002/hep.510270529; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Tsujimoto Y, 2003, J CELL PHYSIOL, V195, P158, DOI 10.1002/jcp.10254; Ratziu V, 2012, HEPATOLOGY, V55, P419, DOI 10.1002/hep.24747; Hikita H, 2011, HEPATOLOGY, V54, P240, DOI 10.1002/hep.24305; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; David SS, 2007, NATURE, V447, P941, DOI 10.1038/nature05978; Hikita H, 2010, HEPATOLOGY, V52, P1310, DOI 10.1002/hep.23836; van Loon B, 2010, DNA REPAIR, V9, P604, DOI 10.1016/j.dnarep.2010.03.004; Kodama T, 2011, J CLIN INVEST, V121, P3343, DOI 10.1172/JCI44957; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Takehara T, 2004, GASTROENTEROLOGY, V127, P1189, DOI 10.1053/j.gastro.2004.07.019; Ding WX, 2004, HEPATOLOGY, V40, P403, DOI 10.1002/hep.20310; Hikita H, 2009, HEPATOLOGY, V50, P1217, DOI 10.1002/hep.23126; Totoki Y, 2011, NAT GENET, V43, P464, DOI 10.1038/ng.804; Lee MH, 2013, HEPATOLOGY, V58, P546, DOI 10.1002/hep.26385; Oze T, 2014, CLIN GASTROENTEROL H, V12, P1186, DOI 10.1016/j.cgh.2013.11.033; Weber A, 2010, HEPATOLOGY, V51, P1226, DOI 10.1002/hep.23479; Dhanasekaran Renumathy, 2012, Hepat Med, V4, P19, DOI 10.2147/HMER.S16316; Hikita H, 2009, HEPATOLOGY, V50, P1972, DOI 10.1002/hep.23207; Kim S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-8-r90; Koike K, 2009, CANCER LETT, V286, P60, DOI 10.1016/j.canlet.2009.04.010; Schulze K, 2015, NAT GENET, V47, P505, DOI 10.1038/ng.3252; Shiffman ML, 2010, ALIMENT PHARM THER, V31, P969, DOI 10.1111/j.1365-2036.2010.04264.x; Takehara T, 1999, GASTROENTEROLOGY, V117, P661, DOI 10.1016/S0016-5085(99)70460-9	36	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1940-6207	1940-6215		CANCER PREV RES	Cancer Prev. Res.	AUG	2015	8	8					693	701		10.1158/1940-6207.CAPR-15-0022-T		9	Oncology	Oncology	CO7DM	WOS:000359318600005		
J	Ichimura, N; Shinjo, K; An, B; Shimizu, Y; Yamao, K; Ohka, F; Katsushima, K; Hatanaka, A; Tojo, M; Yamamoto, E; Suzuki, H; Ueda, M; Kondo, Y				Ichimura, Norihisa; Shinjo, Keiko; An, Byonggu; Shimizu, Yasuhiro; Yamao, Kenji; Ohka, Fumiharu; Katsushima, Keisuke; Hatanaka, Akira; Tojo, Masayuki; Yamamoto, Eiichiro; Suzuki, Hiromu; Ueda, Minoru; Kondo, Yutaka			Aberrant TET1 Methylation Closely Associated with CpG Island Methylator Phenotype in Colorectal Cancer	CANCER PREVENTION RESEARCH			English	Article							DNA METHYLATION; COLON-CANCER; HYPERMETHYLATION; CIMP; 5-HYDROXYMETHYLCYTOSINE; EPIGENOTYPES; CONTRIBUTE; MUTATIONS; PROTEINS; IDH1	Inactivation of methylcytosine dioxygenase, ten-eleven translocation (TET) is known to be associated with aberrant DNA methylation in cancers. Tumors with a CpG island methylator phenotype (CIMP), a distinct subgroup with extensive DNA methylation, show characteristic features in the case of colorectal cancer. The relationship between TET inactivation and CIMP in colorectal cancers is not well understood. The expression level of TET family genes was compared between CIMP-positive (CIMPP) and CIMP-negative (CIMP-N) colorectal cancers. Furthermore, DNA methylation profiling, including assessment of the TET1 gene, was assessed in colorectal cancers, as well as colon polyps. The TET1 was silenced by DNA methylation in a subset of colorectal cancers as well as cell lines, expression of which was reactivated by demethylating agent. TET1 methylation was more frequent in CIMP-P (23/55, 42%) than CIMP-N (2/113, 2%, P < 0.0001) colorectal cancers. This trend was also observed in colon polyps (CIMP-P, 16/40, 40%; CIMP-N, 2/24, 8%; P = 0.002), suggesting that TET1 methylation is an early event in CIMP tumorigenesis. TET1 methylation was significantly associated with BRAF mutation but not with hMLH1 methylation in the CIMP-P colorectal cancers. Colorectal cancers with TET1 methylation have a significantly greater number of DNA methylated genes and less pathological metastasis compared to those without TET1 methylation (P = 0.007 and 0.045, respectively). Our data suggest that TET1 methylation may contribute to the establishment of a unique pathway in respect to CIMP-mediated tumorigenesis, which may be incidental to hMLH1 methylation. In addition, our findings provide evidence that TET1 methylation may be a good biomarker for the prediction of metastasis in colorectal cancer. (C) 2015 AACR.	[Ichimura, Norihisa; Shinjo, Keiko; Ohka, Fumiharu; Katsushima, Keisuke; Hatanaka, Akira; Tojo, Masayuki; Kondo, Yutaka] Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Nagoya, Aichi 4678601, Japan; [Ichimura, Norihisa; Ueda, Minoru] Nagoya Univ, Sch Med, Dept Oral & Maxillofacial Surg, Nagoya, Aichi 466, Japan; [An, Byonggu] Ako City Hosp, Dept Surg, Ako, Japan; [Shimizu, Yasuhiro] Aichi Canc Ctr, Dept Gastrointestinal Surg, Nagoya, Aichi 464, Japan; [Yamao, Kenji] Aichi Canc Ctr, Dept Gastroenterol, Nagoya, Aichi 464, Japan; [Yamamoto, Eiichiro; Suzuki, Hiromu] Sapporo Med Univ, Dept Mol Biol, Sapporo, Hokkaido, Japan	Kondo, Y (reprint author), Nagoya City Univ, Grad Sch Med Sci, Dept Epigen, Mizuho Ku, 1 Kawasumi,Mizuho Cho, Nagoya, Aichi 4678601, Japan.	ykondo@med.nagoya-cu.ac.jp			Japan Society for the Promotion of Science [25290048]; PRESTO of JST; P-Direct of Ministry of Education, Culture, Sports, Science and Technology; Takeda Science Foundation	This work is supported by Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (25290048, Y. Kondo), PRESTO of JST (Y. Kondo), P-Direct of Ministry of Education, Culture, Sports, Science and Technology (Y. Kondo), and Takeda Science Foundation (Y. Kondo).	Ahmed D, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.35; An B, 2010, INT J CANCER, V127, P2095, DOI 10.1002/ijc.25225; Yang H, 2013, ONCOGENE, V32, P663, DOI 10.1038/onc.2012.67; Schuebel K, 2006, NAT GENET, V38, P738, DOI 10.1038/ng0706-738; Ogino S, 2006, J MOL DIAGN, V8, P582, DOI 10.2353/j.moldx.2006.060082; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Issa JP, 2008, CLIN CANCER RES, V14, P5939, DOI 10.1158/1078-0432.CCR-08-1596; Estecio MRH, 2007, GENOME RES, V17, P1529, DOI 10.1101/gr.6417007; Ogino S, 2006, GUT, V55, P1000, DOI 10.1136/gut.2005.082933; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Yamamoto E, 2012, AM J PATHOL, V181, P1847, DOI 10.1016/j.ajpath.2012.08.007; Robert MF, 2003, NAT GENET, V33, P61, DOI 10.1038/ng1068; Kudo Y, 2012, CANCER SCI, V103, P670, DOI 10.1111/j.1349-7006.2012.02213.x; Eads CA, 1999, CANCER RES, V59, P2302; Dawson MA, 2012, CELL, V150, P12, DOI 10.1016/j.cell.2012.06.013; Yagi K, 2010, CLIN CANCER RES, V16, P21, DOI 10.1158/1078-0432.CCR-09-2006; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Nosho K, 2009, CLIN CANCER RES, V15, P3663, DOI 10.1158/1078-0432.CCR-08-2383; Lorsbach RB, 2003, LEUKEMIA, V17, P637, DOI 10.1038/sj.leu.2402834; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Karpinski P, 2013, CANCER EPIDEM BIOMAR, V22, P201, DOI 10.1158/1055-9965.EPI-12-0157; Kondo Y, 2007, HEPATOL RES, V37, P974, DOI 10.1111/j.1872-034X.2007.00141.x; Williams K, 2012, EMBO REP, V13, P28, DOI 10.1038/embor.2011.233; Leggett B, 2010, GASTROENTEROLOGY, V138, P2088, DOI 10.1053/j.gastro.2009.12.066; Turcan S, 2012, NATURE, V483, P479, DOI 10.1038/nature10866; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Hsu CH, 2012, CELL REPORTS, V2, P568, DOI 10.1016/j.celrep.2012.08.030; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Ju HX, 2011, AM J PATHOL, V178, P1835, DOI 10.1016/j.ajpath.2010.12.045; Liu Chunhua, 2013, P 2013 IEEE INT S IN, V1, P1, DOI DOI 10.1016/J.TMP.2012.09.004	34	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1940-6207	1940-6215		CANCER PREV RES	Cancer Prev. Res.	AUG	2015	8	8					702	711		10.1158/1940-6207.CAPR-14-0306		10	Oncology	Oncology	CO7DM	WOS:000359318600006		
J	Mutoh, M; Ishikawa, H				Mutoh, Michihiro; Ishikawa, Hideki			Metformin Use and Lung Cancer Risk-Letter	CANCER PREVENTION RESEARCH			English	Letter							BETA-CAROTENE; ASPIRIN; TRIAL		[Mutoh, Michihiro] Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Epidemiol & Prevent Div, Tokyo 1040045, Japan; [Ishikawa, Hideki] Kyoto Prefectural Univ Med, Dept Mol Targeting Canc Prevent, Kyoto, Japan	Mutoh, M (reprint author), Natl Canc Ctr, Res Ctr Canc Prevent & Screening, Chuo Ku, 5-1-1 Tsukiji, Tokyo 1040045, Japan.	mimutoh@ncc.go.jp					Albanes D, 1996, J NATL CANCER I, V88, P1560, DOI 10.1093/jnci/88.21.1560; Ishikawa H, 2014, GUT, V63, P1755, DOI 10.1136/gutjnl-2013-305827; Ishikawa H, 2013, CANCER MED-US, V2, P50, DOI 10.1002/cam4.46; Omenn GS, 1996, NEW ENGL J MED, V334, P1150, DOI 10.1056/NEJM199605023341802; Sakoda LC, 2015, CANCER PREV RES, V8, P174, DOI 10.1158/1940-6207.CAPR-14-0291; Sasazuki S, 2008, CANCER EPIDEM BIOMAR, V17, P343, DOI 10.1158/1055-9965.EPI-07-0428	6	0	0	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	1940-6207	1940-6215		CANCER PREV RES	Cancer Prev. Res.	AUG	2015	8	8					760	760		10.1158/1940-6207.CAPR-15-0075		1	Oncology	Oncology	CO7DM	WOS:000359318600013		
J	Kang, JM; Park, S; Kim, SJ; Kim, H; Lee, B; Kim, J; Park, J; Kim, ST; Yang, HK; Kim, WH; Kim, SJ				Kang, Jin Muk; Park, Sujin; Kim, Staci Jakyong; Kim, Hyojung; Lee, Bona; Kim, Junil; Park, Jinah; Kim, Shin Tae; Yang, Han-Kwang; Kim, Woo Ho; Kim, Seong-Jin			KIAA1324 Suppresses Gastric Cancer Progression by Inhibiting the Oncoprotein GRP78	CANCER RESEARCH			English	Article							ENDOPLASMIC-RETICULUM CHAPERONE; GLUCOSE-REGULATED PROTEINS; IN-VITRO; TRANSMEMBRANE PROTEIN; COLORECTAL-CANCER; INDUCED APOPTOSIS; CELL GROWTH; ATP BINDING; GENE; EXPRESSION	Recent advances in genome and transcriptome analysis have contributed to the identification of many potential cancer-related genes. Furthermore, biological and clinical investigations of the candidate genes provide us with a better understanding of carcinogenesis and development of cancer treatment. Here, we report a novel role of KIAA1324 as a tumor suppressor in gastric cancer. We observed that KIAA1324 was downregulated in most gastric cancers from transcriptome sequencing data and found that histone deacetylase was involved in the suppression of KIAA1324. Low KIAA1324 levels were associated with poor prognosis in gastric cancer patients. In the xenograft model, KIAA1324 significantly reduced tumor formation of gastric cancer cells and decreased development of preformed tumors. KIAA1324 also suppressed proliferation, invasion, and drug resistance and induced apoptosis in gastric cancer cells. Through protein interaction analysis, we identified GRP78 (glucose-regulated protein 78 kDa) as a KIAA1324-binding partner. KIAA1324 blocked oncogenic activities of GRP78 by inhibiting GRP78-caspase-7 interaction and suppressing GRP78-mediated AKT activation, thereby inducing apoptosis. In conclusion, our study reveals a tumor suppressive role of KIAA1324 via inhibition of GRP78 oncoprotein activities and provides new insight into the diagnosis and treatment of gastric cancer. (C) 2015 AACR.	[Kang, Jin Muk; Park, Sujin; Kim, Staci Jakyong; Kim, Hyojung; Lee, Bona; Kim, Junil; Park, Jinah; Kim, Shin Tae; Kim, Seong-Jin] CHA Univ, CHA Canc Inst, Coll Life Sci, Songnam 463400, Kyunggi Do, South Korea; [Kim, Staci Jakyong] Univ Tsukuba, Int Inst Integrat Sleep Med WPI IIIS, Tsukuba, Ibaraki, Japan; [Kim, Staci Jakyong] Univ Tsukuba, Sch Integrat & Global Majors, Tsukuba, Ibaraki, Japan; [Lee, Bona] Sookmyung Womens Univ, Coll Pharm, Seoul, South Korea; [Park, Jinah] CHA Univ, Coll Pharm, Songnam 463400, Kyunggi Do, South Korea; [Kim, Shin Tae] CHA Univ, CHA Gangnam Med Ctr, Coll Med, Div Pulm Med,Dept Internal Med, Songnam 463400, Kyunggi Do, South Korea; [Yang, Han-Kwang; Kim, Woo Ho] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Yang, Han-Kwang] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea; [Kim, Woo Ho] Seoul Natl Univ, Coll Med, Dept Pathol, Seoul 151, South Korea; [Kim, Seong-Jin] CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam 463400, Kyunggi Do, South Korea	Kim, SJ (reprint author), CHA Univ, CHA Canc Inst, 335 Pangyo Ro, Songnam 463400, Kyunggi Do, South Korea.	kimsj@cha.ac.kr			Basic Science Research Program [2011-0014281, 2014R1A6A3A01058338]; Bio-Synergy Research Project of Ministry of Science, ICT, and Future Planning through the National Research Foundation, Korea [NRF-2012M3A9C4048735]	This work was supported by the Basic Science Research Program (2011-0014281 to S. Park and 2014R1A6A3A01058338 to J.M. Kang) and the Bio-Synergy Research Project (NRF-2012M3A9C4048735 to S.-J. Kim) of Ministry of Science, ICT, and Future Planning through the National Research Foundation, Korea.	Davidson DJ, 2005, CANCER RES, V65, P4663, DOI 10.1158/0008-5472.CAN-04-3426; Kang JM, 2012, ONCOGENE, V31, P5123, DOI 10.1038/onc.2012.18; Kelber JA, 2009, ONCOGENE, V28, P2324, DOI 10.1038/onc.2009.97; Yu L, 2006, P NATL ACAD SCI USA, V103, P4952, DOI 10.1073/pnas.0511288103; Cho JY, 2011, CLIN CANCER RES, V17, P1850, DOI 10.1158/1078-0432.CCR-10-2180; Fu Y, 2008, P NATL ACAD SCI USA, V105, P19444, DOI 10.1073/pnas.0807691105; Fu Y, 2007, CANCER RES, V67, P3734, DOI 10.1158/0008-5472.CAN-06-4594; Khanna A, 2009, J NATL CANCER I, V101, P793, DOI 10.1093/jnci/djp103; Thornton M, 2013, INT J CANCER, V133, P1408, DOI 10.1002/ijc.28137; Lee AS, 2014, NAT REV CANCER, V14, P263, DOI 10.1038/nrc3701; Lee HK, 2008, NEURO-ONCOLOGY, V10, P236, DOI 10.1215/15228517-2008-006; Burikhanov R, 2009, CELL, V138, P377, DOI 10.1016/j.cell.2009.05.022; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Kang JQ, 2013, CANCER LETT, V339, P247, DOI 10.1016/j.canlet.2013.06.016; Gonzalez-Gronow M, 2006, CANCER RES, V66, P11424, DOI 10.1158/0008-5472.CAN-06-1721; WEI JY, 1995, J BIOL CHEM, V270, P26677; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Klockenbusch C, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/927585; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Liang H, 2013, CANCER LETT, V340, P241, DOI 10.1016/j.canlet.2012.11.029; Yoon K, 2013, GENOME RES, V23, P1109, DOI 10.1101/gr.145706.112; Wang K, 2014, NAT GENET, V46, P573, DOI 10.1038/ng.2983; Reddy RK, 2003, J BIOL CHEM, V278, P20915, DOI 10.1074/jbc.M212328200; Zheng HC, 2008, HUM PATHOL, V39, P1042, DOI 10.1016/j.humpath.2007.11.009; Arap MA, 2004, CANCER CELL, V6, P275, DOI 10.1016/j.ccr.2004.08.018; Cheng CC, 2012, PROTEOMICS, V12, P2584, DOI 10.1002/pmic.201100602; Cameron EE, 1999, NAT GENET, V21, P103, DOI 10.1038/5047; Li C, 2013, J BIOL CHEM, V288, P17908, DOI 10.1074/jbc.M113.458836; Wu JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084158; Fernandez PM, 2000, BREAST CANCER RES TR, V59, P15, DOI 10.1023/A:1006332011207; Li ZW, 2013, INT J BIOCHEM CELL B, V45, P987, DOI 10.1016/j.biocel.2013.02.002; Zhang XX, 2013, BIOMED RES INT, DOI 10.1155/2013/917296; Hartgrink HH, 2009, LANCET, V374, P477, DOI 10.1016/S0140-6736(09)60617-6; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Liu J, 2014, BIOTECHNOL ADV, V32, P693, DOI 10.1016/j.biotechadv.2013.11.009; Zhang Y, 2010, J BIOL CHEM, V285, P15065, DOI 10.1074/jbc.M109.087445; Chang Y, 2013, CANCER LETT, V328, P126, DOI 10.1016/j.canlet.2012.08.032; Deng L, 2005, CLIN CANCER RES, V11, P8258, DOI 10.1158/1078-0432.CCR-05-1189; Deng L, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.9; Estrella JS, 2014, PANCREAS, V43, P996, DOI 10.1097/MPA.0000000000000203; Kasala D, 2014, EXPERT OPIN DRUG DEL, V11, P379, DOI 10.1517/17425247.2014.874414; Little Edward, 1994, Critical Reviews in Eukaryotic Gene Expression, V4, P1; Nagase Takahiro, 2006, Briefings in Functional Genomics & Proteomics, V5, P4, DOI 10.1093/bfgp/ell005; Schlumbrecht MP, 2011, MODERN PATHOL, V24, P453, DOI 10.1038/modpathol.2010.211; Tsutsumi S, 2006, ONCOGENE, V25, P1018, DOI 10.1038/sj.onc.1209139; Wang L, 2007, APOPTOSIS, V12, P1489, DOI 10.1007/s10495-007-0073-9; Xu D, 2013, APPL IMMUNOHISTO M M, V21, P543, DOI 10.1097/PAI.0b013e31824e93d1; Zhang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080071; Zhao Q, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-11-r114	49	1	1	AMER ASSOC CANCER RESEARCH	PHILADELPHIA	615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, PA 19106-4404 USA	0008-5472	1538-7445		CANCER RES	Cancer Res.	AUG 1	2015	75	15					3087	3097		10.1158/0008-5472.CAN-14-3751		11	Oncology	Oncology	CO7EU	WOS:000359323200013		
J	Miyazaki, T; Baba, TT; Mori, M; Moriishi, T; Komori, T				Miyazaki, Toshihiro; Baba, Tomomi T.; Mori, Masako; Moriishi, Takeshi; Komori, Toshihisa			Microtubule-associated protein tau (Mapt) is expressed in terminally differentiated odontoblasts and severely down-regulated in morphologically disturbed odontoblasts of Runx2 transgenic mice	CELL AND TISSUE RESEARCH			English	Article						Microtubule-associated protein tau (Mapt); Odontoblast; Cytoskeleton; alpha-Tubulin; Runx2	DENTIN SIALOPROTEIN; NESTIN EXPRESSION; BONE-DEVELOPMENT; CELLS; CBFA1; TOOTH; ORGANIZATION; OSTEOBLASTS; DYNAMICS; PATTERNS	Runx2 is an essential transcription factor for osteoblast and odontoblast differentiation and the terminal differentiation of chondrocytes. We have previously shown that the terminal differentiation of odontoblasts is inhibited in Runx2 transgenic {Tg(Col1a1-Runx2)} mice under the control of the 2.3-kb Col1a1 promoter, which directs the transgene expression to osteoblasts and odontoblasts. Odontoblasts show severe reductions in Dspp and nestin expression and lose their characteristic polarized morphology, including a long process extending to dentin, in Tg(Col1a1-Runx2) mice. We study the molecular mechanism of odontoblast morphogenesis by comparing gene expression in the molars of wild-type and Tg(Col1a1-Runx2) mice, focusing on cytoskeleton-related genes. Using microarray, we found that the gene expression of microtubule-associated protein tau (Mapt), a neuronal phosphoprotein with important roles in neuronal biology and microtubule dynamics and assembly, was high in wild-type molars but severely reduced in Tg(Col1a1-Runx2) molars. Immunohistochemical analysis revealed that Mapt was specifically expressed in terminally differentiated odontoblasts including their processes in wild-type molars but its expression was barely detectable in Tg(Col1a1-Runx2) molars. Doublestaining of Mapt and Runx2 showed their reciprocal expression in odontoblasts. Mapt and tubulin co-localized in odontoblasts in wild-type molars. Immunoelectron microscopic analysis demonstrated Mapt lying around alpha-tubulin-positive filamentous structures in odontoblast processes. Thus, Mapt is a useful marker for terminally differentiated odontoblasts and might play an important role in odontoblast morphogenesis.	[Miyazaki, Toshihiro; Mori, Masako; Moriishi, Takeshi; Komori, Toshihisa] Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Dept Cell Biol, Nagasaki 8528588, Japan; [Baba, Tomomi T.] Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Dept Oral Mol Biol, Nagasaki 8528588, Japan	Komori, T (reprint author), Nagasaki Univ, Grad Sch Biomed Sci, Unit Basic Med Sci, Dept Cell Biol, 1-7-1 Sakamoto, Nagasaki 8528588, Japan.	komorit@nagasaki-u.ac.jp			Japan Society for the Promotion of Science [24592771, 26221310]	This work was supported by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (#24592771 and #26221310).	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; KNOPS J, 1991, J CELL BIOL, V114, P725, DOI 10.1083/jcb.114.4.725; Goldberg M, 2004, CRIT REV ORAL BIOL M, V15, P13; Miyazaki T, 2008, ARCH HISTOL CYTOL, V71, P131, DOI 10.1679/aohc.71.131; Magloire H, 2009, J EXP ZOOL PART B, V312B, P416, DOI 10.1002/jez.b.21264; Bleicher F, 2014, EXP CELL RES, V325, P65, DOI 10.1016/j.yexcr.2013.12.012; Quackenbush J, 2002, NAT GENET, V32, P496, DOI 10.1038/ng1032; Takei Y, 2000, J CELL BIOL, V150, P989, DOI 10.1083/jcb.150.5.989; Yoshida CA, 2004, GENE DEV, V18, P952, DOI 10.1101/gad.1174704; Arana-Chavez VE, 2004, INT J BIOCHEM CELL B, V36, P1367, DOI 10.1016/j.biocel.2004.01.006; Chen S, 2005, J BIOL CHEM, V280, P29717, DOI 10.1074/jbc.M502929200; Feinstein SC, 2005, BBA-MOL BASIS DIS, V1739, P268, DOI 10.1016/j.bbadis.2004.07.002; CACERES A, 1990, NATURE, V343, P461, DOI 10.1038/343461a0; Li ST, 2011, BIOCHEM BIOPH RES CO, V410, P698, DOI 10.1016/j.bbrc.2011.06.065; Michalczyk K, 2005, HISTOL HISTOPATHOL, V20, P665; Begue-Kirn C, 1998, EUR J ORAL SCI, V106, P963, DOI 10.1046/j.0909-8836.1998.eos106510.x; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Iqbal K, 2005, BBA-MOL BASIS DIS, V1739, P198, DOI 10.1016/j.bbadis.2004.09.008; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; SIGAL MJ, 1985, J DENT RES, V64, P1348, DOI 10.1177/00220345850640120401; HIROKAWA N, 1988, J CELL BIOL, V107, P1449, DOI 10.1083/jcb.107.4.1449; Kawagishi E, 2006, CELL TISSUE RES, V326, P111, DOI 10.1007/s00441-006-0230-4; Liu WG, 2001, J CELL BIOL, V155, P157, DOI 10.1083/jcb.200105052; Carda C, 2006, TISSUE CELL, V38, P141, DOI 10.1016/j.tice.2006.01.002; Kempf M, 1996, J NEUROSCI, V16, P5583; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; RUCH JV, 1995, INT J DEV BIOL, V39, P51; CHEN J, 1992, NATURE, V360, P674, DOI 10.1038/360674a0; About I, 2000, AM J PATHOL, V157, P287, DOI 10.1016/S0002-9440(10)64539-7; Aberg T, 2004, DEV BIOL, V270, P76, DOI 10.1016/j.ydbio.2004.02.012; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Baba TT, 2013, CELL BIOCHEM FUNCT, V31, P652, DOI 10.1002/cbf.2951; Black MM, 1996, J NEUROSCI, V16, P3601; Bleicher F, 2001, Adv Dent Res, V15, P30; Bronckers ALJJ, 2001, MECH DEVELOP, V101, P255, DOI 10.1016/S0925-4773(00)00562-1; Buchaille R, 2000, MATRIX BIOL, V19, P421, DOI 10.1016/S0945-053X(00)00091-3; Dehmelt L, 2005, GENOME BIOL, V6; DiTella MC, 1996, J CELL SCI, V109, P467; D'Souza RN, 1999, DEVELOPMENT, V126, P2911; GARANT PR, 1972, ARCH ORAL BIOL, V17, P1047, DOI 10.1016/0003-9969(72)90179-3; Hall GF, 2012, CYTOSKELETON HUMAN D, P285; Huang W da, 2009, NAT PROTOC, V4, P44, DOI [10.1038/nprot.2008.211, DOI 10.1038/NPROT.2008.211]; Kobayashi N, 1998, CELL TISSUE RES, V291, P163, DOI 10.1007/s004410050988; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Lee Y, 2012, INT ENDOD J, V45, P652, DOI 10.1111/j.1365-2591.2012.02024.x; Linde Anders, 1993, Critical Reviews in Oral Biology and Medicine, V4, P679; Maurin JC, 2009, J ENDODONT, V35, P992, DOI 10.1016/j.joen.2009.04.009; NISHIKAWA S, 1987, ANAT REC, V219, P144, DOI 10.1002/ar.1092190206; Quispe-Salcedo A, 2012, BIOMED RES-TOKYO, V33, P119; Sasaki T, 1996, ANAT REC, V245, P235, DOI 10.1002/(SICI)1097-0185(199606)245:2<235::AID-AR10>3.0.CO;2-Q; Tint I, 1998, J NEUROSCI, V18, P8660; Yamashiro T, 2002, MECH DEVELOP, V119, pS107, DOI 10.1016/S0925-4773(03)00101-1; Yan Y, 2001, NEUROSCI LETT, V302, P89, DOI 10.1016/S0304-3940(01)01664-0	53	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	AUG	2015	361	2					457	466		10.1007/s00441-015-2135-6		10	Cell Biology	Cell Biology	CO6KK	WOS:000359265400005		
J	Higuchi, M; Kato, T; Yoshida, S; Ueharu, H; Nishimura, N; Kato, Y				Higuchi, Masashi; Kato, Takako; Yoshida, Saishu; Ueharu, Hiroki; Nishimura, Naoto; Kato, Yukio			PRRX1-and PRRX2-positive mesenchymal stem/progenitor cells are involved in vasculogenesis during rat embryonic pituitary development	CELL AND TISSUE RESEARCH			English	Article						PRRX1; PRRX2; NESTIN-positive dividing mesenchymal stem/progenitor cell; Vasculogenesis; Embryonic pituitary development; Rat	HOMEODOMAIN PROTEINS; GLAND; PRX1; MORPHOGENESIS; EXPRESSION; GENE; DIFFERENTIATION; POPULATION; PERICYTES; NETWORKS	We have recently shown that cells positive for the paired-related homeobox transcription factors PRRX1 and PRRX2 occur in the rat pituitary, and that they are derived from two different origins: pituitary-derived cells positive for stem cell marker SOX2 and extra-pituitary-derived cells negative for SOX2. In this study, we have further characterized the PRRX1- and PRRX2-positive cells that originate from extra-pituitary cells. Immunohistochemical analyses were performed with specific antibodies against PRRX1 and PRRX2 in order to clarify their roles in pituitary vasculogenesis. PRRX1-and PRRX2-positive cells were found in Atwell's recess and at the periphery of the pituitary on embryonic day 15.5 (E15.5). Several PRRX1-positive cells then invaded the anterior lobe, together with a few PRRX2-positive cells, on E16.5. Some PRRX1-positive cells were also positive for mesenchymal stem cell marker NESTIN. Moreover, some PRRX1/NESTIN double-positive cells showed characteristics of vascular endothelial cells with an Isolectin-B4-binding capacity. PRRX1 co-localized with vascular smooth muscle cell/pericyte marker alpha-smooth muscle actin in the deep area of Atwell's recess. We confirmed the presence of PRRX2/NESTIN double-positive cells at an entry area in Atwell's recess and at the periphery of the pituitary, but PRRX2 did not co-localize with Isolectin B4 or alpha-smooth muscle actin. These data suggest that PRRX1- and PRRX2-positive mesenchymal stem/progenitor cells are present at the periphery of the embryonic pituitary and at the entry from Atwell's recess and participate in pituitary vasculogenesis by differentiation into vascular endothelial cells and pericytes, whereas the presence of PRRX2 indicates much higher stemness than PRRX1.	[Higuchi, Masashi; Kato, Takako] Meiji Univ, Org Strateg Coordinat Res & Intellectual Property, Kanagawa 2148571, Japan; [Higuchi, Masashi; Kato, Takako; Kato, Yukio] Meiji Univ, Inst Reprod & Endocrinol, Kanagawa 2148571, Japan; [Yoshida, Saishu; Ueharu, Hiroki; Nishimura, Naoto] Meiji Univ, Grad Sch Agr, Div Life Sci, Kanagawa 2148571, Japan; [Kato, Yukio] Meiji Univ, Sch Agr, Dept Life Sci, Kanagawa 2148571, Japan	Kato, Y (reprint author), Meiji Univ, Inst Reprod & Endocrinol, Kanagawa 2148571, Japan.	yukato@isc.meiji.ac.jp			JSPS KAKENHI [21380184, 24580435]; MEXT-Supported Program for the Strategic Research Foundation at Private Universities; Institute of Science and Technology, Meiji University; Meiji University International Institute for BioResource Research (MUIIR)	This work was partially supported by JSPS KAKENHI Grants nos. 21380184 to Y.K. and 24580435 to T.K., by a MEXT-Supported Program for the Strategic Research Foundation at Private Universities, 2014-2018, and by a research grant (A) to Y.K. from the Institute of Science and Technology, Meiji University. This study was also supported by the Meiji University International Institute for BioResource Research (MUIIR).	Mendez-Ferrer S, 2010, NATURE, V466, P829, DOI 10.1038/nature09262; SKALLI O, 1989, J HISTOCHEM CYTOCHEM, V37, P315; Susa T, 2012, J NEUROENDOCRINOL, V24, P1201, DOI 10.1111/j.1365-2826.2012.02336.x; Zhu XY, 2004, CURR OPIN GENET DEV, V14, P567, DOI 10.1016/j.gde.2004.08.006; Hunziker E, 2000, BIOCHEM BIOPH RES CO, V271, P116, DOI 10.1006/bbrc.2000.2611; Watkins-Chow DE, 1998, TRENDS GENET, V14, P284, DOI 10.1016/S0168-9525(98)01476-0; Fauquier T, 2008, P NATL ACAD SCI USA, V105, P2907, DOI 10.1073/pnas.0707886105; Vankelecom H, 2010, GEN COMP ENDOCR, V166, P478, DOI 10.1016/j.ygcen.2009.11.007; Boyd NL, 2007, EXP BIOL MED, V232, P833; Brinkmeier ML, 2009, GENOMICS, V93, P449, DOI 10.1016/j.ygeno.2008.11.010; Chen JH, 2009, STEM CELLS, V27, P1182, DOI 10.1002/stem.51; Suga H, 2011, NATURE, V480, P57, DOI 10.1038/nature10637; Zhu XY, 2007, PHYSIOL REV, V87, P933, DOI 10.1152/physrev.00006.2006; Balic A, 2009, DEV DYNAM, V238, P2599, DOI 10.1002/dvdy.22092; DAIKOKU S, 1981, ARCH HISTOL JAPON, V44, P103; Douville JM, 2007, CAN J PHYSIOL PHARM, V85, P55, DOI 10.1139/Y06-091; HERMAN IM, 1985, J CELL BIOL, V101, P43, DOI 10.1083/jcb.101.1.43; Higuchi M, 2014, CELL TISSUE RES, V357, P323, DOI 10.1007/s00441-014-1861-5; Higuchi M, 2013, CELL TISSUE RES, V353, P27, DOI 10.1007/s00441-013-1632-8; Meijlink F, 1999, INT J DEV BIOL, V43, P651; Mitchell JM, 2006, J DENT RES, V85, P888; Mitsuishi H, 2013, CELL TISSUE RES, V354, P563, DOI 10.1007/s00441-013-1686-7; Shih CC, 2001, BLOOD, V98, P2412, DOI 10.1182/blood.V98.8.2412; Sunabori T, 2008, J CELL SCI, V121, P1204, DOI 10.1242/jcs.025064; SZABO K, 1982, CELL TISSUE RES, V224, P563; Ueharu H, 2014, J REPROD DEVELOP, V60, P304, DOI 10.1262/jrd.2014-037; Vankelecom H, 2010, EUR J NEUROSCI, V32, P2063, DOI 10.1111/j.1460-9568.2010.07523.x; Yako H, 2013, CELL TISSUE RES, V354, P837, DOI 10.1007/s00441-013-1717-4; Yoshida S, 2013, J NEUROENDOCRINOL, V25, P779, DOI 10.1111/jne.12077; Yoshida S, 2014, J REPROD DEVELOP, V60, P295, DOI 10.1262/jrd.2014-031; Yoshida S, 2009, BIOCHEM BIOPH RES CO, V385, P11, DOI 10.1016/j.bbrc.2009.05.027	31	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0302-766X	1432-0878		CELL TISSUE RES	Cell Tissue Res.	AUG	2015	361	2					557	565		10.1007/s00441-015-2128-5		9	Cell Biology	Cell Biology	CO6KK	WOS:000359265400012		
J	Sviridova, N; Sakai, K				Sviridova, Nina; Sakai, Kenshi			Human photoplethysmogram: new insight into chaotic characteristics	CHAOS SOLITONS & FRACTALS			English	Article							TIME-SERIES; DETERMINISM; DYNAMICS; FINGER	The photoplethysmogram is widely used in medical settings and sports equipment to measure biological signals. The photoplethysmogram, which is measured noninvasively, can provide valuable information about cardiovascular system performance. The present study sought to investigate the underlying dynamics of photoplethysmographic signals from healthy young human subjects. In previous studies the photoplethysmogram was claimed to be driven by deterministic chaos [Tsuda 1992, Sumida 20001; however, the methods applied for chaos detection were noise sensitive and inconclusive. Therefore, to reach a consistent conclusion it is important to employ additional nonlinear time series analysis tools that can test different features of the signal's underlying dynamics. In this paper, methods of nonlinear time series analysis, including time delay embedding, largest Lyapunov exponent, deterministic nonlinear prediction, Poincare section, the Wayland test and method of surrogate data were applied to photoplethysmogram time series to identify the unique characteristics of the photoplethysmogram as a dynamical system. Results demonstrated that photoplethysmogram dynamics is consistent with the definition of chaotic movement, and its chaotic properties showed some similarity to Rossler's single band chaos with induced dynamical noise. Additionally it was found that deterministic nonlinear prediction, Poincare section and the Wayland test can reveal important characteristics of photoplethysmographic signals that will be important tools for theoretical and applied studies on the photoplethysmogram. (C) 2015 The Authors. Published by Elsevier Ltd.	[Sviridova, Nina] Tokyo Univ Agr & Technol, United Grad Sch Agr, Fuchu, Tokyo 1838509, Japan; [Sakai, Kenshi] Tokyo Univ Agr & Technol, Environm & Agr Engn Dept, Fuchu, Tokyo 1838509, Japan	Sakai, K (reprint author), Tokyo Univ Agr & Technol, Environm & Agr Engn Dept, 3-5-8 Saiwai Cho, Fuchu, Tokyo 1838509, Japan.	nina_svr@mail.ru; ken@cc.tuat.ac.jp	Sakai, Kenshi/F-9248-2013		JSPS [25660204, 15H04572]; TUAT intensive study abroad program; MEXT scholarship	This work was supported by JSPS Grant-in-Aid No. 25660204 and No. 15H04572, TUAT intensive study abroad program and MEXT scholarship.	Allen J, 2007, PHYSIOL MEAS, V28, P1; Mascaro SA, 2001, IEEE T ROBOTIC AUTOM, V17, P698, DOI 10.1109/70.964669; WAYLAND R, 1993, PHYS REV LETT, V70, P580, DOI 10.1103/PhysRevLett.70.580; ABARBANEL HDI, 1993, REV MOD PHYS, V65, P1331, DOI 10.1103/RevModPhys.65.1331; Poon CS, 1997, NATURE, V389, P492, DOI 10.1038/39043; Millasseau SC, 2006, J HYPERTENS, V24, P1449, DOI 10.1097/01.hjh.0000239277.05068.87; THEILER J, 1992, PHYSICA D, V58, P77, DOI 10.1016/0167-2789(92)90102-S; Ivanov PC, 1999, NATURE, V399, P461, DOI 10.1038/20924; Berardesca E., 1995, BIOENGINEERING SKIN; Bezruchko BP, 2010, SPRINGER SER SYNERG, P1, DOI 10.1007/978-3-642-12601-7; Glass L, 2009, CHAOS, V19, DOI 10.1063/1.3156832; Kantz H., 1998, NONLINEAR ANAL PHYSL; McClintock PVE, 2002, PHYSICA A, V314, P69, DOI 10.1016/S0378-4371(02)01165-2; Miao T, 2012, INT J COMPUT AIDED E, V4, P557; Pham TD, 2013, CHAOS SOLITON FRACT, V51, P64, DOI 10.1016/j.chaos.2013.03.010; Sakai K., 2001, NONLINEAR DYNAMICS C; Shelhamer M, 2007, NONLINEAR DYNAMICS IN PHYSIOLOGY: A STATE-SPACE APPROACH, P1; Small M, 2001, PHYS REV LETT, V87, P1; Small M, 2005, P 2005 EUR C, V2, P169, DOI 10.1109/ECCTD.2005.1523020; Sumida T, 2000, INT J BIFURCAT CHAOS, V10, P2245, DOI 10.1142/S0218127400001407; Tamura Toshiyo, 2014, Electronics, V3, DOI 10.3390/electronics3020282; Thompson JMT, 1991, NONLINEAR DYNAMICS C; Tsuda I., 1992, International Journal of Bifurcation and Chaos in Applied Sciences and Engineering, V2, DOI 10.1142/S0218127492000318; WOLF A, 1985, PHYSICA D, V16, P285, DOI 10.1016/0167-2789(85)90011-9	24	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779	1873-2887		CHAOS SOLITON FRACT	Chaos Solitons Fractals	AUG	2015	77						53	63		10.1016/j.chaos.2015.05.005		11	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CO2FC	WOS:000358970500007		
J	Miino, Y; Ito, D; Ueta, T				Miino, Yuu; Ito, Daisuke; Ueta, Tetsushi			A computation method for non-autonomous systems with discontinuous characteristics	CHAOS SOLITONS & FRACTALS			English	Article						Bifurcation phenomena; Numerical analysis; Nonlinear non-autonomous system; Discontinuity	BIFURCATION; MODEL; CIRCUITS	We propose a computation method to obtain bifurcation sets of periodic solutions in non-autonomous systems with discontinuous properties. If the system has discontinuity for the states and/or the vector field, conventional methods cannot be applied. We have developed a method for autonomous systems with discontinuity by taking the Poincare mapping on the switching point in the preceded study, however, this idea does not work well for some non-autonomous systems with discontinuity. We overcome this difficulty by extending the system to an autonomous system. As a result, bifurcation sets of periodic solutions are solved accurately with a shooting method. We show two numerical examples and demonstrate the corresponding laboratory experiment. (C) 2015 Elsevier Ltd. All rights reserved.	[Miino, Yuu] Univ Tokushima, Adv Technol & Sci, Syst Innovat Engn, Tokushima 7708506, Japan; [Ito, Daisuke] Univ Shiga Prefecture, Sch Engn, Dept Elect Syst Engn, Hikone, Shiga 5228533, Japan; [Ueta, Tetsushi] Univ Tokushima, Ctr Adm Informat Technol, Tokushima 7708506, Japan	Miino, Y (reprint author), Univ Tokushima, Adv Technol & Sci, Syst Innovat Engn, 2-1 Minami Josanjima, Tokushima 7708506, Japan.	c501437041@tokushima-u.ac.jp; ito.d@e.usp.ac.jp; ueta@tokushima-u.ac.jp			JSPS KAKENHI [25420373]	This research is partially supported by JSPS KAKENHI 25420373.	KAWAKAMI H, 1984, IEEE T CIRCUITS SYST, V31, P248, DOI 10.1109/TCS.1984.1085495; Piiroinen PT, 2004, J NONLINEAR SCI, V14, P383, DOI 10.1007/s00332-004-0616-y; Izhikevich EM, 2003, IEEE T NEURAL NETWOR, V14, P1569, DOI 10.1109/TNN.2003.820440; Banerjee S, 2000, IEEE T CIRCUITS-I, V47, P633, DOI 10.1109/81.847870; Bernardo MD, 1999, CHAOS SOLITON FRACT, V10, P1881, DOI DOI 10.1016/S0960-0779(98)00317-8; di Bernardo M, 2001, PHYS REV LETT, V86, P2553, DOI 10.1103/PhysRevLett.86.2553; Doole SH, 1996, DYNAM STABIL SYST, V11, P19, DOI 10.1080/02681119608806215; Ito D, 2010, P NOLTA2010 POL, P627; Ito D, 2014, INT J BIFURCAT CHAOS, V24, DOI 10.1142/S0218127414501259; Kawakami H, 1979, P ISCAS, V79, P44; Kawakami H, 1992, P RIMS C STRUCT BIF, P39; Kousaka T, 1999, IEEE T CIRCUITS-II, V46, P878, DOI 10.1109/82.775383; TAMURA A, 2009, DYNAM CONT DIS SER A, V16, P849; UETA T, 1995, IEICE T FUND ELECTR, VE78A, P1269; Ueta T, 1999, P ISCAS 1999, V5, P503	15	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0779	1873-2887		CHAOS SOLITON FRACT	Chaos Solitons Fractals	AUG	2015	77						277	285		10.1016/j.chaos.2015.06.014		9	Mathematics, Interdisciplinary Applications; Physics, Multidisciplinary; Physics, Mathematical	Mathematics; Physics	CO2FC	WOS:000358970500030		
J	Urabe, D				Urabe, Daisuke			Radical-Mediated Three-Component Reaction: A Study toward the Total Synthesis of Resiniferatoxin	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Review						total synthesis; diterpene; radical reaction; three-component reaction; stereoselective reaction	TIGLIANE RING-SYSTEM; DAPHNANE-TYPE; POLYFUNCTIONAL DITERPENES; ASYMMETRIC-SYNTHESIS; BRIDGEHEAD RADICALS; TUMOR PROMOTERS; ALDOL REACTION; PHORBOL; CONSTRUCTION; CHEMISTRY	This review summarizes the efforts to develop a radical-mediated three-component reaction and its application to a convergent approach to synthesize the 5/7/6-tricyclic framework (ABC-rings) of the densely functionalized dephnane diterpene, resiniferatoxin. The alpha-alkoxy bridgehead radical species, which was designed as the radical donor of the three-component reaction, was generated from O, Se- and O,Te-acetals under two different conditions. The generated alpha -alkoxy bridgehead radical effectively underwent the three-component reaction with alpha, beta-unsaturated ketones and allyltributyltin/aldehyde under each of the conditions, giving rise to a wide variety of multiply functionalized 2,3-trans disubstituted cyclopentenone moieties. One of the established reactions was utilized as the key assembling reaction of the ABC-tricyclic framework of resiniferatoxin. The reaction of the bridgehead radical of the highly functionalized 6-membered C-ring, the 5-membered A-ring, and an allyltributyltin derivative effectively produced the C4-branched AC-rings. The last B-ring was constructed from the coupling adduct in two steps through the 7-endo cyclization, delivering the tricyclic framework possessing the correct C8 and 9-stereocenters of resiniferatoxin. The present methods demonstrate the power of the three-component reaction using an alpha-alkoxy bridgehead radical in a convergent approach to the complex architectures of daphnane diterpenes.	Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan	Urabe, D (reprint author), Univ Tokyo, Grad Sch Pharmaceut Sci, Bunkyo Ku, Tokyo 1130033, Japan.	d-urabe@mol.f.u-tokyo.ac.jp			JSPS; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan	I express my profound gratitude to Prof. Masayuki Inoue at the University of Tokyo for his direction, continuous support, and encouragement. I sincerely thank my highly talented co-workers whose names appear in the reference section of this review. The work described in this review was financially supported by a Grant-in-Aid for Start-up, Young Scientists (B) and Scientific Research (C) from the JSPS, and a Grant-in-Aid for Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan.	ADOLF W, 1982, J NAT PROD, V45, P347, DOI 10.1021/np50021a018; ADOLF W, 1977, ISRAEL J CHEM, V16, P75; PAQUETTE LA, 1994, TETRAHEDRON, V50, P4071, DOI 10.1016/S0040-4020(01)86705-3; DAUBEN WG, 1993, J ORG CHEM, V58, P7635, DOI 10.1021/jo00079a004; Nagatomo M, 2014, J AM CHEM SOC, V136, P5916, DOI 10.1021/ja502770n; Wender PA, 2007, ORG LETT, V9, P1829, DOI 10.1021/ol0705649; Vidal V, 2012, J NAT PROD, V75, P414, DOI 10.1021/np200855d; Saraiva MF, 2009, TETRAHEDRON, V65, P3563, DOI 10.1016/j.tet.2009.01.103; HUDLICKY T, 1990, J ORG CHEM, V55, P4683, DOI 10.1021/jo00302a037; Wong GY, 2009, BRAIN RES REV, V60, P267, DOI 10.1016/j.brainresrev.2008.12.006; Wender PA, 1997, J AM CHEM SOC, V119, P7897, DOI 10.1021/ja9706256; Urabe D, 2011, ORG LETT, V13, P4778, DOI 10.1021/ol201758a; Krasovskiy A, 2006, ANGEW CHEM INT EDIT, V45, P497, DOI 10.1002/anie.200502485; BARTON DHR, 1983, J CHEM SOC CHEM COMM, P939, DOI 10.1039/c39830000939; Stewart C, 2011, ORG LETT, V13, P720, DOI 10.1021/ol102953s; Liao SG, 2009, CHEM REV, V109, P1092, DOI 10.1021/cr0782832; Mukai K, 2013, ANGEW CHEM INT EDIT, V52, P5300, DOI 10.1002/anie.201302067; Marson CM, 2003, J ORG CHEM, V68, P792, DOI 10.1021/jo0205816; Urabe D, 2012, ORG LETT, V14, P3842, DOI 10.1021/ol301482f; Godineau E, 2009, CHEM-EUR J, V15, P3044, DOI 10.1002/chem.200802415; Vasas A, 2014, CHEM REV, V114, P8579, DOI 10.1021/cr400541j; Maimone TJ, 2007, NAT CHEM BIOL, V3, P396, DOI 10.1038/nchembio.2007.1; Dong SH, 2011, J NAT PROD, V74, P1255, DOI 10.1021/np200231u; Jackson SR, 2001, ANGEW CHEM INT EDIT, V40, P2694, DOI 10.1002/1521-3773(20010716)40:14<2694::AID-ANIE2694>3.0.CO;2-D; Wender PA, 1997, J AM CHEM SOC, V119, P12976, DOI 10.1021/ja972279y; EVANS DA, 1981, J AM CHEM SOC, V103, P3099, DOI 10.1021/ja00401a031; CRICH D, 1989, CHEM REV, V89, P1413, DOI 10.1021/cr00097a001; Wender PA, 2006, ORG LETT, V8, P5373, DOI 10.1021/ol062234e; He WD, 2002, MINI-REV MED CHEM, V2, P185, DOI 10.2174/1389557024605492; BORRIS RP, 1988, J ETHNOPHARMACOL, V24, P41, DOI 10.1016/0378-8741(88)90138-9; Ollivier C, 2001, CHEM REV, V101, P3415, DOI 10.1021/cr010001p; Nicolaou KC, 2000, ANGEW CHEM INT EDIT, V39, P44; Murai K, 2013, CHEM SCI, V4, P2364, DOI 10.1039/c3sc50329a; Barton D. H. R., 1975, J CHEM SOC P1, V1975, P1574; Barton D. H. R., 1981, PURE APPL CHEM, V53; BARTON DHR, 1988, TETRAHEDRON LETT, V29, P6581, DOI 10.1016/S0040-4039(00)82402-8; Bloomfield G. C., 1992, J CHEM SOC P1, V1992, P1229; BUCHI G, 1979, J ORG CHEM, V44, P546; Chatgilialoglu C, 1996, TETRAHEDRON LETT, V37, P6387, DOI 10.1016/0040-4039(96)01354-8; Cowden C. J., 1997, ORG REACTIONS, V51, P1; Fenzl W., 1975, LIEBIGS ANN CHEM, V1975, P1322; HARWOOD LM, 1991, J CHEM SOC CHEM COMM, P527, DOI 10.1039/c39910000527; HATAKEYAMA S, 1994, J AM CHEM SOC, V116, P4081, DOI 10.1021/ja00088a055; He W., 1998, J CHEM SOC P1, V1998, P2425; HERGENHAHN M, 1975, TETRAHEDRON LETT, P1595; INOUE T, 1980, B CHEM SOC JPN, V53, P174, DOI 10.1246/bcsj.53.174; Kamimura D, 2013, ORG LETT, V15, P5122, DOI 10.1021/ol402563v; Kissin I, 2011, CURR TOP MED CHEM, V11, P2159; Kotsuki H., 1991, TETRAHEDRON LETT, V32, P4504; KRAUS GA, 1994, SYNLETT, P237; KRAUS GA, 1995, SYNLETT, P201; KRAUS GA, 1993, TETRAHEDRON LETT, V34, P1741, DOI 10.1016/S0040-4039(00)60766-9; Lee K, 2001, J AM CHEM SOC, V123, P5590, DOI 10.1021/ja010643u; Metzger A, 2009, SYNLETT, P1433, DOI 10.1055/s-0029-1217169; Mukai K., 2015, CHEM SCI, V26, P3383; MUKAIYAMA T, 1982, ORG REACTIONS, V28, P203; Murphy J. A., 2001, RADICALS ORGANIC SYN, V1, P298; NOZAKI K, 1991, B CHEM SOC JPN, V64, P403, DOI 10.1246/bcsj.64.403; NOZAKI K, 1987, J AM CHEM SOC, V109, P2547, DOI 10.1021/ja00242a068; OHNO M, 1988, J ORG CHEM, V53, P1285, DOI 10.1021/jo00241a030; Ovaska TV, 2001, ORG LETT, V3, P115, DOI 10.1021/ol006823a; Page PCB, 2002, SYNLETT, P583; RIGBY JH, 1989, TETRAHEDRON LETT, V30, P5073, DOI 10.1016/S0040-4039(01)93450-1; Ryu I, 2002, CHEM REC, V2, P249, DOI 10.1002/tcr.10026; SHIGENO K, 1992, TETRAHEDRON LETT, V33, P4937, DOI 10.1016/S0040-4039(00)61239-X; Stanoeva E, 2004, TETRAHEDRON, V60, P5077, DOI 10.1016/j.tet.2004.04.046; Stanoeva E, 2005, BIOORGAN MED CHEM, V13, P17, DOI 10.1016/j.bmc.2004.07.070; Stout GH, 1970, J AM CHEM SOC, V92, P1070, DOI 10.1021/ja00707a058; SUGITA K, 1995, TETRAHEDRON LETT, V36, P1067, DOI 10.1016/0040-4039(94)02455-K; Tsukano C, 2007, ANGEW CHEM INT EDIT, V46, P8840, DOI 10.1002/anie.200703886; Urabe D, 2013, CHEM SCI, V4, P1615, DOI 10.1039/c3sc00023k; Urabe D, 2015, CHEM REV, V115, P9207, DOI 10.1021/cr500716f; WALTON JC, 1992, CHEM SOC REV, V21, P105, DOI 10.1039/cs9922100105; WENDER PA, 1989, J AM CHEM SOC, V111, P8957, DOI 10.1021/ja00206a050; Wender PA, 2011, NAT CHEM, V3, P615, DOI [10.1038/nchem.1074, 10.1038/NCHEM.1074]; WENDER PA, 1990, J AM CHEM SOC, V112, P4956, DOI 10.1021/ja00168a050; Zard S. Z., 2003, RADICAL REACTIONS OR	77	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	AUG	2015	63	8					565	572				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CO0DL	WOS:000358820200001		
J	Shibata, Y; Kagechika, K; Ota, M; Yamaguchi, M; Setoguchi, M; Kubo, H; Chiba, K; Takano, H; Akiyama, C; Ono, M; Nishi, M; Usui, H				Shibata, Yoshihiro; Kagechika, Katsuji; Ota, Masahiro; Yamaguchi, Mitsuhiro; Setoguchi, Masaki; Kubo, Hideo; Chiba, Kiyoshi; Takano, Hiromichi; Akiyama, Chiyuki; Ono, Mayumi; Nishi, Mina; Usui, Hiroyuki			Synthesis and Structure-Activity Relationships of 2-Aminoacetamide Derivatives as Peroxisome Proliferator-Activated Receptor alpha/gamma Dual Agonists	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						peroxisome proliferator-activated receptor; type 2 diabetes; bioisostere	ZWITTERIONIC COMPOUNDS; INHIBITION; DESIGN	We describe the design, syntheses, and structure activity relationships of novel zwitterionic compounds as nonthiazolidinedion-based peroxisome proliferator-activated receptor (PPAR) alpha/gamma dual agonists. In our previous report, we obtained compound 1 showing potent PPAR alpha/gamma dual agonistic activities, together with a sufficient glucose-lowering effect in db/db mice. However, this compound possessed an issue, i.e., the 1,3,4-oxadiazole ring was not stable in acidic conditions. Thus, we carried out further optimization to improve the stability while maintaining the other favorable profile features including potent PPAR alpha/gamma dual agonistic activity. We addressed the issue by changing the oxadiazole ring to a bioisostere amide group. These amide derivatives were stable in acidic conditions and decreased plasma glucose and plasma triglyceride levels significantly without marked weight gain.	[Shibata, Yoshihiro; Kagechika, Katsuji; Ota, Masahiro; Yamaguchi, Mitsuhiro; Setoguchi, Masaki; Chiba, Kiyoshi; Takano, Hiromichi; Akiyama, Chiyuki; Ono, Mayumi; Nishi, Mina; Usui, Hiroyuki] Daiichi Sankyo Co Ltd, R&D Div, Shinagawa Ku, Tokyo 1408710, Japan; [Kubo, Hideo] Daiichi Sankyo RD Novare Co Ltd, Dept Biol Res, Edogawa Ku, Tokyo 1348630, Japan	Shibata, Y (reprint author), Daiichi Sankyo Co Ltd, R&D Div, Shinagawa Ku, 1-2-58 Hiromachi, Tokyo 1408710, Japan.	shibata.yoshihiro.da@daiichisankyo.co.jp					Watanabe A, 2007, DRUG METAB DISPOS, V35, P1232, DOI 10.1124/dmd.107.015016; Guerre-Millo M, 2000, J BIOL CHEM, V275, P16638, DOI 10.1074/jbc.275.22.16638; Chen R, 2010, INT HEART J, V51, P199; Crespi CL, 1997, ANAL BIOCHEM, V248, P188, DOI 10.1006/abio.1997.2145; Onitilo AA, 2012, CANCER CAUSE CONTROL, V23, P991, DOI 10.1007/s10552-012-9971-4; Devasthale PV, 2005, J MED CHEM, V48, P2248, DOI 10.1021/jm0496436; Hulin B, 1996, CURR PHARM DESIGN, V2, P85; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953; International Diabetes Federation, IDF DIABETES ATLAS; MANNERS CN, 1989, XENOBIOTICA, V19, P1387; Shah P, 2010, EXPERT OPIN DRUG SAF, V9, P347, DOI 10.1517/14740331003623218; Shibata Y, 2012, BIOORG MED CHEM LETT, V22, P7075, DOI 10.1016/j.bmcl.2012.09.092; Shibata Y, 2013, CHEM PHARM BULL, V61, P1248; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; Zimmet P, 2002, TRENDS CARDIOVAS MED, V12, P354, DOI 10.1016/S1050-1738(02)00187-1	15	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	AUG	2015	63	8					591	602				12	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CO0DL	WOS:000358820200005		
J	Uemura, Y; Iwami, M; Kawakami, S; Sugimoto, S; Matsunami, K; Otsuka, H; Shinzato, T; Kawahata, M; Yamaguchi, K				Uemura, Yuka; Iwami, Mio; Kawakami, Susumu; Sugimoto, Sachiko; Matsunami, Katsuyoshi; Otsuka, Hideaki; Shinzato, Takakazu; Kawahata, Masatoshi; Yamaguchi, Kentaro			Megastigmane Glucosides and Megastigmanes from the Leaves of Meliosma lepidota ssp squamulata	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						Meliosma lepidota ssp squamulata; Sabiaceae; megastigmane glucoside; megastigmane		From the leaves of Meliosma lepidota ssp. squamulata, megastigmane glucosides with spiro-structures and megastigmanes were isolated. Their structures were determined by X-ray crystallographic analyses and spectroscopic investigation. The absolute structures of the megastigmanes were determined by the modified Mosher's method.	[Uemura, Yuka; Iwami, Mio; Sugimoto, Sachiko; Matsunami, Katsuyoshi; Otsuka, Hideaki] Hiroshima Univ, Grad Sch Biomed Sci, Minami Ku, Hiroshima 7348553, Japan; [Kawakami, Susumu; Otsuka, Hideaki] Yasuda Womens Univ, Fac Pharm, Asaminami Ku, Hiroshima 7310153, Japan; [Shinzato, Takakazu] Univ Ryukyus, Fac Agr, Subtrop Field Sci Ctr, Nishihara, Okinawa 9030213, Japan; [Kawahata, Masatoshi; Yamaguchi, Kentaro] Tokushima Bunri Univ, Fac Pharmaceut Sci, Sanuki, Kagawa 7692193, Japan	Otsuka, H (reprint author), Hiroshima Univ, Grad Sch Biomed Sci, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	hotsuka@hiroshima-u.ac.jp			Ministry of Education, Sports, Culture, Science and Technology of Japan; Japan Society for the Promotion of Science [22590006, 23590130, 15H04651]; Takeda Science Foundation	The authors are grateful for access to the superconducting NMR instrument and the HR-ESI-MS at the Analytical Center of Molecular Medicine and the Analysis Center of Life Science, respectively, of the Graduate School of Biomedical Sciences, Hiroshima University. This work was supported in part by Grants-in-Aid from the Ministry of Education, Sports, Culture, Science and Technology of Japan, and the Japan Society for the Promotion of Science (Nos. 22590006, 23590130 and 15H04651) Thanks are also due to the Takeda Science Foundation for the financial support.	ABE F, 1993, PHYTOCHEMISTRY, V33, P1499, DOI 10.1016/0031-9422(93)85120-G; [Anonymous], PLANT NAM QUER MEL; Dong LP, 2006, CHEM BIODIVERS, V3, P791, DOI 10.1002/cbdv.200690081; MIZUTANI K, 1988, CHEM PHARM BULL, V36, P2689; UMEHARA K, 1988, CHEM PHARM BULL, V36, P5004; OHTANI I, 1991, J AM CHEM SOC, V113, P4092, DOI 10.1021/ja00011a006; Farrugia LJ, 1997, J APPL CRYSTALLOGR, V30, P565, DOI DOI 10.1107/S0021889897003117; Greca M. D., 1998, Phytochemistry, V49, P1299, DOI 10.1016/S0031-9422(98)00092-2; Hatusima S., 1975, FLORA RYUKYUS INCLUD, P389; Ohba H., 2009, SYLLABUS VASCULAR PL, P90; Otsuka H, 2003, PHYTOCHEMISTRY, V62, P763, DOI 10.1016/S0031-9422(02)00614-3; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sheldrick G.M., 1996, PROGRAM EMPIRICAL AB	13	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	AUG	2015	63	8					608	616				9	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CO0DL	WOS:000358820200007		
J	Katsura, S; Yamada, N; Nakashima, A; Shiraishi, S; Furuishi, T; Ueda, H				Katsura, Shinji; Yamada, Nobuo; Nakashima, Atsushi; Shiraishi, Sumihiro; Furuishi, Takayuki; Ueda, Haruhisa			Identification of Furosemide Photodegradation Products in Water-Acetonitrile Mixture	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						furosemide; photodegradation; water-acetonitrile mixture; identification; Japanese Pharmacopoeia	LIQUID-CHROMATOGRAPHIC METHOD; ASSAY-METHOD; HYDROLYSIS; STABILITY; DEGRADATION; FRUSEMIDE	The aim of this study was to identify the chemical structure of the photodegradation products of furosemide in a water acetonitrile mixture (1 :1). Furosemide solution was irradiated with a D65 fluorescent lamp and the products were isolated by preparative HPLC. The fractions were evaporated to dryness in vacuo. The purity of the photodegradation products was measured by HPLC. The purity of products 1, 3, and 4 was greater than 90%, whereas that of product 2 was 13%, therefore, photodegradation product 2 was unstable. We identified photodegradation products 1 and 3 as 4-chloro-5-sulfamoylanthranilic acid and 4-hydroxy-N-furfuryl-5-sulfamoylanthranilic acid, respectively, by LC/MS and NMR. Additionally, we assumed that photodegradation product 4 was methyl 2-((furan-2-ylmethyl)amino)-4-hydroxy-3-(methyleneamino)-5-sulfamoylbenzoate by LC/MS and NMR. This showed that furosemide underwent hydrolysis and substitution, and reacted with the acetonitrile under the light of a D65 fluorescent lamp. We were furthermore able to determine the elution times of the photodegradation products of furosemide by applying the Japanese Pharmacopoeia chromatographic method for related substances to the isolated products.	[Katsura, Shinji; Yamada, Nobuo; Nakashima, Atsushi; Shiraishi, Sumihiro] Teva Pharma Japan Inc, Div Res & Dev, Nakamura Ku, Nagoya, Aichi 4530801, Japan; [Katsura, Shinji; Furuishi, Takayuki] Hoshi Univ, Dept Phys Chem, Shinagawa Ku, Tokyo 1428501, Japan; [Ueda, Haruhisa] Nihon Pharmaceut Univ, Dept Pharmaceut Sci, Ina, Saitama 3620806, Japan	Furuishi, T (reprint author), Hoshi Univ, Dept Phys Chem, Shinagawa Ku, 2-4-41 Ebara, Tokyo 1428501, Japan.	t-furuishi@hoshi.ac.jp					ABOULENEIN HY, 1979, SPECTROSC LETT, V12, P323, DOI 10.1080/00387017908069159; Ram VR, 2012, J CHROMATOGR SCI, V50, P721, DOI 10.1093/chromsci/bms062; Carda-Broch S, 2000, J PHARMACEUT BIOMED, V23, P803, DOI 10.1016/S0731-7085(00)00378-2; Asker A F, 1996, PDA J Pharm Sci Technol, V50, P158; BUNDGAARD H, 1988, INT J PHARM, V42, P217, DOI 10.1016/0378-5173(88)90178-0; CRUZ JE, 1979, INT J PHARM, V2, P275, DOI 10.1016/0378-5173(79)90034-6; HANNA GM, 1993, J AOAC INT, V76, P526; KOVAR KA, 1974, ARCH PHARM, V307, P657, DOI 10.1002/ardp.19743070902; MILLER JHM, 1993, J PHARMACEUT BIOMED, V11, P257, DOI 10.1016/0731-7085(93)80206-G; Mizuma T, 1998, J CHROMATOGR B, V718, P153, DOI 10.1016/S0378-4347(98)00357-0; MOORE DE, 1983, J PHARM PHARMACOL, V35, P489; RAPAKA RS, 1982, INT J PHARM, V11, P237, DOI 10.1016/0378-5173(82)90042-4; ROWBOTHAM PC, 1976, PHARM ACTA HELV, V51, P304; YAGI N, 1991, CHEM PHARM BULL, V39, P454	14	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	AUG	2015	63	8					617	627				11	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CO0DL	WOS:000358820200008		
J	Ono, M; Takigawa, A; Muto, H; Kabata, K; Okawa, M; Kinjo, J; Yokomizo, K; Yoshimitsu, H; Nohara, T				Ono, Masateru; Takigawa, Ayako; Muto, Haruka; Kabata, Kiyotaka; Okawa, Masafumi; Kinjo, Junei; Yokomizo, Kazumi; Yoshimitsu, Hitoshi; Nohara, Toshihiro			Antiviral Activity of Four New Resin Glycosides Calysolins XIV-XVII from Calystegia soldanella against Herpes Simplex Virus	CHEMICAL & PHARMACEUTICAL BULLETIN			English	Article						resin glycoside; Calystegia soldanella; Convolvulaceae; calysolin; antiviral activity	ESTER-TYPE DIMERS; IPOMOEA-BATATAS; SWEET-POTATO; PURGA; IV	Four new resin glycosides, named calysolins XIV (1), XV (2), XVI (3), and XVII (4) were isolated from the leaves, stems, and roots of Calystegia soldanella ROEM. et SCHULT. (Convolvulaceae). Their structures were determined based on spectroscopic and chemical evidence, and consisted of two different types: those (1) with a macrolactone structure and those (2-4) with a non-macrolactone structure. Their sugar moieties were partially acylated by specific organic acids, including tiglic, 2S-methylbutyric, and 2S,3S-nilic acids. Additionally, evaluation of the antiviral activity of 1-4 revealed effects against the herpes simplex virus type 1.	[Ono, Masateru; Takigawa, Ayako; Muto, Haruka; Kabata, Kiyotaka] Tokai Univ, Sch Agr, Aso, Kumamoto 8691404, Japan; [Okawa, Masafumi; Kinjo, Junei] Fukuoka Univ, Fac Pharmaceut Sci, Jonan Ku, Fukuoka 8140180, Japan; [Yokomizo, Kazumi; Yoshimitsu, Hitoshi; Nohara, Toshihiro] Sojo Univ, Fac Pharmaceut Sci, Nishi Ku, Kumamoto 8600082, Japan	Ono, M (reprint author), Tokai Univ, Sch Agr, 5435 Minamiaso, Aso, Kumamoto 8691404, Japan.	mono@agri.u-tokai.ac.jp					Leon-Rivera I, 2014, J NAT MED-TOKYO, V68, P655, DOI 10.1007/s11418-014-0844-x; Ono M, 2014, CHEM PHARM BULL, V62, P97, DOI 10.1248/cpb.c13-00610; SCHINAZI RF, 1982, ANTIMICROB AGENTS CH, V22, P499; Bah M, 1997, TETRAHEDRON, V53, P9007, DOI 10.1016/S0040-4020(97)00607-8; Castaneda-Gomez J, 2013, J NAT PROD, V76, P64, DOI 10.1021/np300739y; Castaneda-Gomez J, 2011, J NAT PROD, V74, P1148, DOI 10.1021/np200080k; Escalante-Sanchez E, 2007, J NAT PROD, V70, P1029, DOI 10.1021/np070093z; Escobedo-Martinez C, 2007, J NAT PROD, V70, P974, DOI 10.1021/np070040h; Hotta M., 1989, USEFUL PLANTS WORLD, P197; Mayer W., 1955, LIEBIGS ANN CHEM, V95, P129; NODA N, 1995, CHEM PHARM BULL, V43, P1061; NODA N, 1987, TETRAHEDRON, V43, P3889, DOI 10.1016/S0040-4020(01)81671-9; Ono M, 2014, CHEM PHARM BULL, V62, P839, DOI 10.1248/cpb.c14-00356; Rosas-Ramirez D, 2013, J AGR FOOD CHEM, V61, P9488, DOI 10.1021/jf402952d; Rosas-Ramirez D, 2011, PHYTOCHEMISTRY, V72, P773, DOI 10.1016/j.phytochem.2011.03.002; Shellard E. J., 1961, PLANTA MED, V9, P102; Takigawa A, 2011, J NAT PROD, V74, P2414, DOI 10.1021/np2006378; Takigawa A, 2011, CHEM PHARM BULL, V59, P1163, DOI 10.1248/cpb.59.1163	18	0	0	PHARMACEUTICAL SOC JAPAN	TOKYO	2-12-15 SHIBUYA, SHIBUYA-KU, TOKYO, 150-0002, JAPAN	0009-2363			CHEM PHARM BULL	Chem. Pharm. Bull.	AUG	2015	63	8					641	648				8	Chemistry, Medicinal; Chemistry, Multidisciplinary; Pharmacology & Pharmacy	Pharmacology & Pharmacy; Chemistry	CO0DL	WOS:000358820200011		
J	Namekawa, A; Katoh, R				Namekawa, Akihiro; Katoh, Ryuzi			Improvement of light-harvesting and electron injection efficiencies by lithium ion in D149-sensitized nanocrystalline TiO2 films	CHEMICAL PHYSICS LETTERS			English	Article							SENSITIZED SOLAR-CELLS; CHARGE SEPARATION; INDOLINE DYES; THIN-FILMS; ABSORPTION; D149; SPECTROSCOPY; CONVERSION; DYNAMICS	The effect of Li ion on the light-harvesting and electron injection efficiencies of D149-sensitized nanocrystalline TiO2 films was studied. Absorption spectra shifted toward the long-wavelength region when films were immersed in a Li ion solution, indicating that Li ion enhanced light-harvesting efficiency. We also found that electron injection efficiency was dramatically enhanced by Li ion. These observations indicate that it is essential to incorporate Li ion in the electrolyte of D149-sensitized solar cell devices to improve their performance. (C) 2015 Elsevier B.V. All rights reserved.	[Namekawa, Akihiro; Katoh, Ryuzi] Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 9638642, Japan	Katoh, R (reprint author), Nihon Univ, Coll Engn, Dept Chem Biol & Appl Chem, Koriyama, Fukushima 9638642, Japan.	rkatoh@chem.ce.nihon-u.ac.jp			SENTAN, JST	This research was supported by SENTAN, JST.	Katoh R, 2014, J PHOTOCH PHOTOBIO C, V20, P1, DOI 10.1016/j.jphotochemrev.2014.02.001; Asbury JB, 2001, J PHYS CHEM B, V105, P4545, DOI 10.1021/jp003485m; Juozapavicius M, 2013, J PHYS CHEM C, V117, P116, DOI 10.1021/jp309732z; Hagfeldt A, 2010, CHEM REV, V110, P6595, DOI 10.1021/cr900356p; Rajh T, 2002, J PHYS CHEM B, V106, P10543, DOI 10.1021/jp021235v; Oum K, 2012, PHYS CHEM CHEM PHYS, V14, P15429, DOI 10.1039/c2cp42961f; Horiuchi T, 2004, J AM CHEM SOC, V126, P12218, DOI 10.1021/ja0488277; Howie WH, 2008, J AM CHEM SOC, V130, P1367, DOI 10.1021/ja076525+; Ardo S, 2009, CHEM SOC REV, V38, P115, DOI 10.1039/b804321n; Sobus J, 2015, DYES PIGMENTS, V113, P692, DOI 10.1016/j.dyepig.2014.10.008; Kroeze JE, 2004, J AM CHEM SOC, V126, P7608, DOI 10.1021/ja039303u; Katoh R, 2007, J PHYS CHEM C, V111, P10741, DOI 10.1021/jp072585q; Katoh R, 2009, J PHYS CHEM C, V113, P20738, DOI 10.1021/jp906190a; Cappel UB, 2010, J AM CHEM SOC, V132, P9096, DOI 10.1021/ja102334h; Katoh R, 2010, J PHYS CHEM LETT, V1, P3261, DOI 10.1021/jz1011548; Haque SA, 2005, J AM CHEM SOC, V127, P3456, DOI 10.1021/ja0460357; Kelly CA, 2001, COORDIN CHEM REV, V211, P295, DOI 10.1016/S0010-8545(00)00285-X; Fakis M, 2013, DYES PIGMENTS, V96, P304, DOI 10.1016/j.dyepig.2012.07.025; Furube A, 2005, J PHYS CHEM B, V109, P16406, DOI 10.1021/jp0513263; Durrant JR, 2006, CHEM COMMUN, P3279, DOI 10.1039/b601785c; El-Zohry A, 2012, J PHYS CHEM C, V116, P26144, DOI 10.1021/jp306636w; Ito S, 2008, CHEM COMMUN, P5194, DOI 10.1039/b809093a; Kalyanasundaram K., 2010, DYE SENSITIZED SOLAR; Pastore M., 2009, ACS NANO, V4, P556, DOI DOI 10.1021/NN901518S; Sakuragi Y, 2010, J PHOTOCH PHOTOBIO A, V216, P1, DOI 10.1016/j.jphotochem.2010.08.015; Yaguchi K, 2012, CHEM PHYS LETT, V551, P96, DOI 10.1016/j.cplett.2012.09.003	26	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						37	41		10.1016/j.cptet.2015.05.054		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100007		
J	Oba, Y; Watanabe, N; Osamura, Y; Kouchi, A				Oba, Yasuhiro; Watanabe, Naoki; Osamura, Yoshihiro; Kouchi, Akira			Chiral glycine formation on cold interstellar grains by quantum tunneling hydrogen-deuterium substitution reactions	CHEMICAL PHYSICS LETTERS			English	Article							AMINO-ACIDS; ICE ANALOGS; SURFACE-REACTIONS; LOW-TEMPERATURES; HOMOCHIRALITY; IRRADIATION; ENRICHMENT; MOLECULES; METEORITE; CLOUDS	We report experimental evidence that chiral glycine (NH2CHDCOOH) is formed by the surface reaction of normal glycine (NH2CH2COOH) solid with deuterium (D) atom at 12K under the simulative conditions of interstellar molecular clouds. Chiral glycine formation is most likely initiated by the tunneling abstraction reaction of H atom by D atom followed by the addition of D atom to the glycine radical (NH2CHCOOH). Given that chiral glycine can form in such a primordial low-temperature environment, it might source molecular chirality as molecular clouds evolve into planetary systems. (C) 2015 Elsevier B.V. All rights reserved.	[Oba, Yasuhiro; Watanabe, Naoki; Kouchi, Akira] Hokkaido Univ, Inst Low Temp Sci, Kita Ku, Sapporo, Hokkaido 0600819, Japan; [Osamura, Yoshihiro] Kanagawa Inst Technol, Atsugi, Kanagawa 2430292, Japan	Oba, Y (reprint author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19W8, Sapporo, Hokkaido 0600819, Japan.	oba@lowtem.hokudai.ac.jp	Oba, Yasuhiro/E-2851-2012; WATANABE, Naoki/A-7451-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Society for the Promotion of Science	We would like to thank Dr. Hiroshi Hidaka for constructing the present experimental setup, Drs. Hirokazu Ueta and Tetsuya Hama for discussion on the behaviour of atoms on the surface, Drs. Yoshito Chikaraishi and Yoshinori Takano for discussion on the analytical method of glycine, and Mr. Tomohiro Hirose for his technical advice on the analysis of samples by high-resolution mass spectrometer. This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan and the Japan Society for the Promotion of Science.	Glavin DP, 2009, P NATL ACAD SCI USA, V106, P5487, DOI 10.1073/pnas.0811618106; Blagojevic V, 2003, MON NOT R ASTRON SOC, V339, pL7, DOI 10.1046/j.1365-8711.2003.06351.x; Saito Y, 2013, REV MOD PHYS, V85, P603, DOI 10.1103/RevModPhys.85.603; Rose RJ, 2012, NAT METHODS, V9, P1084, DOI [10.1038/nmeth.2208, 10.1038/NMETH.2208]; Herbst E, 2009, ANNU REV ASTRON ASTR, V47, P427, DOI 10.1146/annurev-astro-082708-101654; Roberts H, 2003, ASTROPHYS J, V591, pL41, DOI 10.1086/376962; Kerkeni B, 2004, J PHYS CHEM A, V108, P8966, DOI 10.1021/jp048440q; Linsky JL, 2003, SPACE SCI REV, V106, P49, DOI 10.1023/A:1024673217736; Snyder LE, 2005, ASTROPHYS J, V619, P914, DOI 10.1086/426677; Pilling S, 2011, ASTROBIOLOGY, V11, P883, DOI 10.1089/ast.2011.0650; Caro GMM, 2002, NATURE, V416, P403; Ehrenfreund P, 2001, ASTROPHYS J, V550, pL95, DOI 10.1086/319491; BRIGGS R, 1992, ORIGINS LIFE EVOL B, V22, P287, DOI 10.1007/BF01810858; Nagaoka A, 2005, ASTROPHYS J, V624, pL29, DOI 10.1086/430304; Hama T, 2013, CHEM REV, V113, P8783, DOI 10.1021/cr4000978; Watanabe N, 2008, PROG SURF SCI, V83, P439, DOI 10.1016/j.progsurf.2008.10.001; Ernst KH, 2013, SURF SCI, V613, P1, DOI 10.1016/j.susc.2013.03.014; Ehrenfreund P, 2000, ANNU REV ASTRON ASTR, V38, P427, DOI 10.1146/annurev.astro.38.1.427; BADA JL, 1995, NATURE, V374, P594, DOI 10.1038/374594a0; Hidaka H, 2009, ASTROPHYS J, V702, P291, DOI 10.1088/0004-637X/702/1/291; Elsila JE, 2009, METEORIT PLANET SCI, V44, P1323, DOI 10.1111/j.1945-5100.2009.tb01224.x; Pizzarello S, 2008, P NATL ACAD SCI USA, V105, P3700, DOI 10.1073/pnas.0709909105; Tielens AGGM, 2013, REV MOD PHYS, V85, P1021, DOI 10.1103/RevModPhys.85.1021; Woon DE, 2002, ASTROPHYS J, V571, pL177, DOI 10.1086/341227; DUNNING TH, 1989, J CHEM PHYS, V90, P1007, DOI 10.1063/1.456153; Bernstein MP, 2002, NATURE, V416, P401, DOI 10.1038/416401a; Ceccarelli C, 2000, ASTRON ASTROPHYS, V362, P1122; Duvernay F, 2010, ASTRON ASTROPHYS, V523, DOI 10.1051/0004-6361/201015342; Frisch M. J., 2004, GAUSSIAN 03 REVISION; Kawasaki T., 2009, CHEM COMMUN, V2009, P4396; Kobayashi K., 1995, ADV SPACE RES, V16, P21; Lee CW, 2009, ASTROPHYS J, V697, P428, DOI 10.1088/0004-637X/697/1/428; Lu W., 2010, ANAL CHEM, V82, P3212; Nuevo M, 2008, ORIGINS LIFE EVOL B, V38, P37, DOI [10.1007/s11084-007-9117-y, 10.1007/sll084-007-9117-y]; Oba Y, 2012, ASTROPHYS J, V749, DOI 10.1088/0004-637X/749/1/67; Oba Y, 2014, FARADAY DISCUSS, V168, P185, DOI 10.1039/c3fd00112a; Oba Y, 2014, METEORIT PLANET SCI, V49, P117, DOI 10.1111/maps.12096; WILLIAMS RM, 1986, J ORG CHEM, V51, P5021, DOI 10.1021/jo00375a055	38	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						53	59		10.1016/j.cplett.2015.05.070		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100010		
J	Kobayashi, K; Yasuda, H				Kobayashi, Keita; Yasuda, Hidehiro			Structural transition of tellurium encapsulated in confined one-dimensional nanospaces depending on the diameter	CHEMICAL PHYSICS LETTERS			English	Article							WALL CARBON NANOTUBES; PHASE-TRANSITION; METAL NANOWIRES; RAMAN-SPECTRA; CRYSTAL; SULFUR; STABILITY; IODINE; ATOMS	Transmission electron microscopy (TEM) showed that Te in the inner space of carbon nanotubes (CNTs) with inner diameters of less than 1.7-2.0 nm adopted an atomic chain structure that formed double helices near the CNT wall. In contrast, crystalline Te consisting of spiral chain molecules with a ternary screw axis was observed in CNTs with inner diameters greater than 1.7-2.0 nm. The structural transformation related to the inner diameter can be attributed to different interactions between Te and the CNT wall depending on the inner diameter. (C) 2015 Elsevier B.V. All rights reserved.	[Kobayashi, Keita; Yasuda, Hidehiro] Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, Osaka 5670047, Japan; [Yasuda, Hidehiro] Osaka Univ, Grad Sch Engn, Div Mat & Mfg Sci, Suita, Osaka 5650871, Japan	Kobayashi, K (reprint author), Osaka Univ, Res Ctr Ultra High Voltage Electron Microscopy, 7-1 Mihogaoka, Osaka 5670047, Japan.	kobayashi-z@uhvem.osaka-u.ac.jp	Kobayashi, Keita/P-6513-2015		JSPS (KAKENHI) [25790003]	K.K. thanks Prof. J. Yamasaki (Osaka University) for guidance with the TEM image simulation, and JSPS for financial support (KAKENHI #25790003).	AKAHAMA Y, 1993, PHYS REV B, V48, P6862, DOI 10.1103/PhysRevB.48.6862; Dresselhaus MS, 2000, ADV PHYS, V49, P705, DOI 10.1080/000187300413184; Momma K, 2011, J APPL CRYSTALLOGR, V44, P1272, DOI 10.1107/S0021889811038970; Khlobystov AN, 2005, ACCOUNTS CHEM RES, V38, P901, DOI 10.1021/ar040287v; Sloan J, 2003, CR PHYS, V4, P1063, DOI 10.1016/S1631-0705(03)00102-6; DUTTON WA, 1966, CHEM REV, V66, P657, DOI 10.1021/cr60244a003; [Anonymous], 2002, VAC HDB; Kitaura R, 2008, NANO LETT, V8, P693, DOI 10.1021/nl073070d; ALLRED AL, 1958, J INORG NUCL CHEM, V5, P264, DOI 10.1016/0022-1902(58)80003-2; Muramatsu H, 2008, NANO LETT, V8, P237, DOI 10.1021/nl0725188; Ando Y, 2000, CHEM PHYS LETT, V323, P580, DOI 10.1016/S0009-2614(00)00556-X; Guan LH, 2008, NANO LETT, V8, P459, DOI 10.1021/nl072396j; Fan X, 2000, PHYS REV LETT, V84, P4621, DOI 10.1103/PhysRevLett.84.4621; Liang HW, 2013, ACCOUNTS CHEM RES, V46, P1450, DOI 10.1021/ar300272m; Kitaura R, 2009, ANGEW CHEM INT EDIT, V48, P8298, DOI 10.1002/anie.200902615; Jorio A, 2001, PHYS REV LETT, V86, P1118, DOI 10.1103/PhysRevLett.86.1118; BONDI A, 1964, J PHYS CHEM-US, V68, P441, DOI 10.1021/j100785a001; Bose SM, 2004, PHYSICA B, V351, P129, DOI [10.1016/j.physb.2004.05.021, 10.1016/j.physb.2004.058.021]; Chernysheva MV, 2008, PHYSICA E, V40, P2283, DOI 10.1016/j.physe.2007.10.070; Colomer JF, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.125425; Fujimori T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3162; Fujimori T, 2013, ACS NANO, V7, P5607, DOI 10.1021/nn4019703; Guan L., 2010, J AM CHEM SOC, V130, P2162; Guan LH, 2007, NANO LETT, V7, P1532, DOI 10.1021/nl070313t; Hirahara K, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.115420; HODAK M, 2003, PHYS REV B, V67; Liu JW, 2012, ANGEW CHEM INT EDIT, V51, P7420, DOI 10.1002/anie.201201608; LUO H, 1991, PHYS REV LETT, V67, P2998, DOI 10.1103/PhysRevLett.67.2998; Ning GQ, 2007, J PHYS CHEM C, V111, P14652, DOI 10.1021/jp074047j; PINE AS, 1971, PHYS REV B-SOLID ST, V4, P356, DOI 10.1103/PhysRevB.4.356; Sendova M, 2008, J APPL PHYS, V103, DOI 10.1063/1.2832757; Sloan J, 2002, CHEM COMMUN, P1319, DOI 10.1039/b200537a; STEELE WA, 1978, J PHYS CHEM-US, V82, P817, DOI 10.1021/j100496a011; Sugai T., 2014, 47 FULL NAN GRAPH GE, P57; TORRIE BH, 1970, SOLID STATE COMMUN, V8, P1899, DOI 10.1016/0038-1098(70)90343-1; Wilson M, 2002, CHEM PHYS LETT, V366, P504, DOI 10.1016/S0009-2614(02)01613-5; Zhao X, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.125502	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						60	65		10.1016/j.cplett.2015.05.047		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100011		
J	Shimazaki, T; Nakajima, T				Shimazaki, Tomomi; Nakajima, Takahito			Gaussian-based cutoff scheme on Hartree-Fock exchange term of dielectric-dependent potential	CHEMICAL PHYSICS LETTERS			English	Article							DENSITY-FUNCTIONAL THEORY; ENERGIES; APPROXIMATION; OPERATORS	A Gaussian-based cutoff scheme in the dielectric-dependent Hartree-Fock (HF) exchange potential under periodic boundary conditions is discussed. The scheme is applied to HF and hybrid density functional theory methods. For comparison, we examine short-range potentials based on the complementary error function. To investigate the behaviors of these short-range exchange potentials, we study several polymers, such as polyethylene and polytetrafluoroethylene. (C) 2015 Elsevier B.V. All rights reserved.	[Shimazaki, Tomomi; Nakajima, Takahito] RIKEN, Adv Inst Computat Sci, Chuo Ku, Kobe, Hyogo 6500047, Japan	Shimazaki, T (reprint author), RIKEN, Adv Inst Computat Sci, Chuo Ku, 7-1-26 Minatojima Minami Machi, Kobe, Hyogo 6500047, Japan.	t-shimazaki@riken.jp; nakajima@riken.jp			FOCUS Establishing Super computing Center of Excellence	This work was partially supported by FOCUS Establishing Super computing Center of Excellence.	Adamson RD, 1996, CHEM PHYS LETT, V254, P329, DOI 10.1016/0009-2614(96)00280-1; Shimazaki T, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3119259; Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; Prendergast D, 2001, J CHEM PHYS, V115, P1626, DOI 10.1063/1.1383585; Song JW, 2013, J CHEM PHYS, V138, DOI 10.1063/1.4811775; BECKE AD, 1993, J CHEM PHYS, V98, P5648, DOI 10.1063/1.464913; VOSKO SH, 1980, CAN J PHYS, V58, P1200; ROBINSON JE, 1962, PHYS REV LETT, V9, P215, DOI 10.1103/PhysRevLett.9.215; Tawada Y, 2004, J CHEM PHYS, V120, P8425, DOI 10.1063/1.1688752; OBARA S, 1986, J CHEM PHYS, V84, P3963, DOI 10.1063/1.450106; Yanai T, 2004, CHEM PHYS LETT, V393, P51, DOI 10.1016/j.cplett.2004.06.011; Akinaga Y, 2008, CHEM PHYS LETT, V462, P348, DOI 10.1016/j.cplett.2008.07.103; Akinaga Y, 2009, INT J QUANTUM CHEM, V109, P1905, DOI 10.1002/qua.22012; Iikura H, 2001, J CHEM PHYS, V115, P3540, DOI 10.1063/1.1383587; Tran F, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.235118; Lippert G, 1997, MOL PHYS, V92, P477, DOI 10.1080/002689797170220; Gill PMW, 1996, CHEM PHYS LETT, V261, P105, DOI 10.1016/0009-2614(96)00931-1; Kamiya M, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1935514; BECKE AD, 1988, PHYS REV A, V38, P3098, DOI 10.1103/PhysRevA.38.3098; Chai JD, 2008, CHEM PHYS LETT, V467, P176, DOI 10.1016/j.cplett.2008.10.070; LEE CT, 1988, PHYS REV B, V37, P785, DOI 10.1103/PhysRevB.37.785; Song JW, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2790017; BECHSTEDT F, 1992, SOLID STATE COMMUN, V84, P765, DOI 10.1016/0038-1098(92)90476-P; D'Amore M, 2006, J AM CHEM SOC, V128, P1099, DOI 10.1021/ja0527929; Dombroski JP, 1996, J PHYS CHEM-US, V100, P6272, DOI 10.1021/jp952841b; Grosso G., 2000, SOLID STATE PHYS; Jensen F., 1999, INTRO COMPUTATIONAL; Leininger T., 1997, CHEM PHYS LETT, V275; Oda K, 1996, MOL SIMULAT, V16, P167, DOI 10.1080/08927029608024070; Pollet R, 2002, J CHEM PHYS, V116, P1250, DOI 10.1063/1.1430739; Savin A., 1996, RECENT DEV APPL MODE; Shimazaki T, 2014, J PHYS SOC JPN, V83, DOI 10.7566/JPSJ.83.054702; Shimazaki T, 2009, J CHEM THEORY COMPUT, V5, P136, DOI 10.1021/ct800329m; Shimazaki T, 2015, J CHEM PHYS, V142, DOI 10.1063/1.4908061; Shimazaki T, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3431293; Shimazaki T, 2009, INT J QUANTUM CHEM, V109, P2953, DOI 10.1002/qua.22176; Shimazaki T, 2008, CHEM PHYS LETT, V466, P91, DOI 10.1016/j.cplett.2008.10.012; Shimazaki T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4895623; Toulouse J, 2004, PHYS REV A, V70, DOI 10.1103/PhysRevA.70.062505	39	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						83	87		10.1016/j.cplett.2015.06.001		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100015		
J	Yagi, H; Miyazaki, T; Okita, S; Zaima, T; Okimoto, H; Izumi, N; Nakanishi, Y; Shinohara, H; Hino, S				Yagi, Hajime; Miyazaki, Takafumi; Okita, Sosuke; Zaima, Takeyuki; Okimoto, Haruya; Izumi, Noriko; Nakanishi, Yusuke; Shinohara, Hisanori; Hino, Shojun			Ultraviolet photoelectron spectra of Sc3C2@C-80	CHEMICAL PHYSICS LETTERS			English	Article							LA-2-AT-C-80; C-60	Sc3C2@C-80 is one of the well studied endohedral fullerenes. Recent band calculation suggests the possibility of its semimetallic behavior due to the small band gap (0.07 eV). We measured the Ultraviolet Photoelectron Spectra (UPS) of Sc3C2@C-80 and estimated the lower limit of the band gap to be 0.2 eV. A simulated spectrum obtained by averaging the results of DFT calculations on two stable Sc3C2 geometries reproduces the UPS well. In conclusion, Sc3C2@C-80 thin film is not a semimetal but a semiconductor. The discrepancy between the experimental and previously calculated results might be attributed to the coexistence of two Sc3C2 geometries. (C) 2015 Elsevier B.V. All rights reserved.	[Yagi, Hajime; Miyazaki, Takafumi; Okita, Sosuke; Zaima, Takeyuki; Hino, Shojun] Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan; [Okimoto, Haruya; Izumi, Noriko; Nakanishi, Yusuke; Shinohara, Hisanori] Nagoya Univ, Dept Chem, Chikusa Ku, Nagoya, Aichi 4648602, Japan	Yagi, H (reprint author), Ehime Univ, Grad Sch Sci & Engn, Matsuyama, Ehime 7908577, Japan.	yagi.hajime@ehime-u.ac.jp; hino@gakushikai.jp			JSPS KAKENHI Grant [15K05477, 24550026]	This study was conducted as part of a Joint Research Program of UVSOR, Institute for Molecular Science. This work was supported by JSPS KAKENHI Grant Number 15K05477 and 24550026.	Alvarez L, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.035107; Sato S, 2012, J AM CHEM SOC, V134, P11681, DOI 10.1021/ja303660g; Shiraishi M, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.235414; Xu YB, 1996, PHYS REV LETT, V76, P3538, DOI 10.1103/PhysRevLett.76.3538; CHAI Y, 1991, J PHYS CHEM-US, V95, P7564, DOI 10.1021/j100173a002; Tan K, 2006, J PHYS CHEM A, V110, P1171, DOI 10.1021/jp056145f; Yang SF, 2011, CHEM COMMUN, V47, P11822, DOI 10.1039/c1cc12318a; Frisch M. J., 2003, GAUSSIAN 03; Hasegawa S, 1998, J ELECTRON SPECTROSC, V88, P891, DOI 10.1016/S0368-2048(97)00208-9; Miyazaki T, 2015, CHEM PHYS, V447, P71, DOI 10.1016/j.chemphys.2014.12.004; Noro T, 2000, THEOR CHEM ACC, V104, P146, DOI 10.1007/s002140000126; SHINOHARA H, 1992, NATURE, V357, P52, DOI 10.1038/357052a0; SHINOHARA H, 1994, J PHYS CHEM-US, V98, P8597, DOI 10.1021/j100086a001; Ton-That C, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.205406; Ton-That C, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.165429	15	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						98	100		10.1016/j.cplett.2015.06.021		3	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100018		
J	Narita, K; Okada, S				Narita, Kohei; Okada, Susumu			Radical spin interaction in one-dimensional chains of decamethyl C-60	CHEMICAL PHYSICS LETTERS			English	Article							FULLERENE APEX; GROUND-STATE; ELECTRON-GAS; ISOMERS; SUPERCONDUCTIVITY; COMPLEXES; CARBON; MOLECULES; STACKING; C84	Based on density functional theory, we examine the energetics and electronic structure of chains of decamethyl C-60 with two stacking conformations. The decamethyl C-60 chains possess various spin configurations arising from the combinations of intramolecular and intermolecular spin interactions. The antiparallel spin arrangement within and between molecules is the ground state, and the intramolecular spin interaction is four times larger than the intermolecular interaction. These decamethyl C-60 chains possess small dispersion bands near the Fermi level arising from the pi states distributed on pentagonal rings, which are well separated from each other because of segmentation by the attached methyl groups. (C) 2015 Elsevier B.V. All rights reserved.	[Narita, Kohei; Okada, Susumu] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan	Narita, K (reprint author), Univ Tsukuba, Grad Sch Pure & Appl Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058571, Japan.	knarita@comas.frsc.tsukuba.ac.jp; sokada@comas.frsc.tsukuba.ac.jp	Okada, Susumu/D-7461-2012		CREST, from the Japan Science and Technology Agency; Ministry of Education, Culture, Sports, Science and Technology of Japan	This work was supported by CREST, from the Japan Science and Technology Agency, and a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan. A part of the calculations were performed on NEC SX-9 at the Cybermedia Center at Osaka University and on NEC SX-9 at the Institute of Solid State Physics, The University of Tokyo.	Achiba Y., 1995, P MAT RES SOC, V359, P3; Akasaka T., 2010, CHEM NANOCARBONS; YOSIDA K, 1957, PHYS REV, V106, P893, DOI 10.1103/PhysRev.106.893; KASUYA T, 1956, PROG THEOR PHYS, V16, P45, DOI 10.1143/PTP.16.45; Wang CR, 2001, ANGEW CHEM INT EDIT, V40, P397, DOI 10.1002/1521-3773(20010119)40:2<397::AID-ANIE397>3.0.CO;2-3; Matsuo Y, 2004, J AM CHEM SOC, V126, P432, DOI 10.1021/ja038816y; KROTO HW, 1985, NATURE, V318, P162, DOI 10.1038/318162a0; TANIGAKI K, 1991, NATURE, V352, P222, DOI 10.1038/352222a0; SAITO S, 1991, PHYS REV LETT, V66, P2637, DOI 10.1103/PhysRevLett.66.2637; HEBARD AF, 1991, NATURE, V350, P600, DOI 10.1038/350600a0; RUDERMAN MA, 1954, PHYS REV, V96, P99, DOI 10.1103/PhysRev.96.99; Stevenson S, 1999, NATURE, V401, P55; ROSSEINSKY MJ, 1991, PHYS REV LETT, V66, P2830, DOI 10.1103/PhysRevLett.66.2830; Sawamura M, 2002, NATURE, V419, P702, DOI 10.1038/nature01110; CHAI Y, 1991, J PHYS CHEM-US, V95, P7564, DOI 10.1021/j100173a002; Ran J, 2006, J PHYS CHEM A, V110, P9702, DOI 10.1021/jp0555403; RAGHAVACHARI K, 1992, CHEM PHYS LETT, V190, P397, DOI 10.1016/0009-2614(92)85162-4; HEATH JR, 1985, J AM CHEM SOC, V107, P7779, DOI 10.1021/ja00311a102; Nakamura E, 2003, J AM CHEM SOC, V125, P2834, DOI 10.1021/ja029915z; PERDEW JP, 1981, PHYS REV B, V23, P5048, DOI 10.1103/PhysRevB.23.5048; CEPERLEY DM, 1980, PHYS REV LETT, V45, P566, DOI 10.1103/PhysRevLett.45.566; STEPHENS PW, 1991, NATURE, V351, P632, DOI 10.1038/351632a0; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Matsuo Y, 2008, CHEM REV, V108, P3016, DOI 10.1021/cr0684218; HOHENBERG P, 1964, PHYS REV B, V136, pB864, DOI 10.1103/PhysRev.136.B864; Morikawa Y, 2001, APPL SURF SCI, V169, P11, DOI 10.1016/S0169-4332(00)00631-0; Okada S, 2001, PHYS REV LETT, V86, P3835, DOI 10.1103/PhysRevLett.86.3835; BAKOWIES D, 1992, CHEM PHYS LETT, V200, P411, DOI 10.1016/0009-2614(92)87013-F; DIEDERICH F, 1991, SCIENCE, V254, P1768, DOI 10.1126/science.254.5039.1768; Dresselhaus M. S., 1996, SCI FULLERENES CARBO; Fowler P.W., 1995, ATLAS FULLERENES; Kamiya K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CN07; KIKUCHI K, 1992, NATURE, V357, P142, DOI 10.1038/357142a0; KOHN W, 1965, PHYS REV, V140, P1133, DOI 10.1103/PhysRev.140.A1133; KRATSCHMER W, 1990, NATURE, V347, P354, DOI 10.1038/347354a0; Matsuo Y, 2005, J AM CHEM SOC, V127, P8457, DOI 10.1021/ja050318x; Nitta H, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.045102; Okada S, 2004, CHEM PHYS LETT, V399, P157, DOI 10.1016/j.cplett.2004.09.152; Otani M, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.153413; SAUNDERS M, 1995, J AM CHEM SOC, V117, P9305, DOI 10.1021/ja00141a023; SHINOHARA H, 1992, NATURE, V357, P52, DOI 10.1038/357052a0	41	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						129	133		10.1016/j.cplett.2015.05.075		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100024		
J	Yoshida, T; Tokizaki, C; Takayanagi, T				Yoshida, Takahiko; Tokizaki, Chihiro; Takayanagi, Toshiyuki			Theoretical analysis of the transition-state spectrum of the cyclooctatetraene unimolecular reaction: Three degree-of-freedom model calculations	CHEMICAL PHYSICS LETTERS			English	Article							BIMOLECULAR CHEMICAL-REACTIONS; NEGATIVE-ION PHOTODETACHMENT; PHOTOELECTRON-SPECTROSCOPY; QUANTUM-THEORY; RING; ANTIAROMATICITY; PRECURSORS; GEOMETRY; SINGLET; REGION	A three degree-of-freedom potential energy surface of the cyclooctatetraene (COT) unimolecular reaction that can describe both ring-inversion (D-2d <-> D-2d) and double bond-alternation (D-4h <-> D-4h) processes was constructed using complete active space self-consistent field calculations. The potential energy surface was used to simulate the experimentally measured transition-state spectrum by calculating the photodetachment spectrum of the COT anion with time-dependent wave packet formalism. The calculated spectrum reproduces the experimental result well. We also analyzed wavefunction properties at spectral peak positions to understand the COT unimolecular reaction dynamics. (C) 2015 Elsevier B.V. All rights reserved.	[Yoshida, Takahiko; Tokizaki, Chihiro; Takayanagi, Toshiyuki] Saitama Univ, Dept Chem, Sakura Ku, Saitama 3388570, Japan	Takayanagi, T (reprint author), Saitama Univ, Dept Chem, Sakura Ku, 255 Shimo Okubo, Saitama 3388570, Japan.	tako@mail.saitama-u.ac.jp					Andres JL, 1998, J CHEM PHYS, V108, P203, DOI 10.1063/1.475388; Bearpark MJ, 2002, MOL PHYS, V100, P1735, DOI 10.1080/00268970110105442; Wenthold PG, 1996, SCIENCE, V272, P1456, DOI 10.1126/science.272.5267.1456; NEUMARK DM, 1992, ANNU REV PHYS CHEM, V43, P153; Kummli DS, 2008, J PHYS CHEM A, V112, P9134, DOI 10.1021/jp803523y; Blancafort L, 2006, MOL PHYS, V104, P2007, DOI 10.1080/00268970600665427; Neumark DM, 2005, PHYS CHEM CHEM PHYS, V7, P433, DOI 10.1039/b417886f; Nyman G, 2000, REP PROG PHYS, V63, P1001, DOI 10.1088/0034-4885/63/7/201; LIGHT JC, 1985, J CHEM PHYS, V82, P1400, DOI 10.1063/1.448462; Lineberger WC, 2011, PHYS CHEM CHEM PHYS, V13, P11792, DOI 10.1039/c0cp02786c; Hege HC, 2010, CHEM PHYS, V376, P46, DOI 10.1016/j.chemphys.2010.07.033; POLANYI JC, 1995, ACCOUNTS CHEM RES, V28, P119, DOI 10.1021/ar00051a005; METZ RB, 1990, J PHYS CHEM-US, V94, P1377, DOI 10.1021/j100367a034; Russell CL, 1996, CHEM PHYS LETT, V256, P465, DOI 10.1016/0009-2614(96)00445-9; Garavelli M, 2002, J AM CHEM SOC, V124, P13770, DOI 10.1021/ja020741v; Wu JI, 2012, J CHEM THEORY COMPUT, V8, P1280, DOI 10.1021/ct3000553; Karadakov PB, 2008, J PHYS CHEM A, V112, P12707, DOI 10.1021/jp8067365; Baik MH, 2002, J AM CHEM SOC, V124, P11167, DOI 10.1021/ja016905+; Becke AD, 2013, J CHEM PHYS, V139, DOI 10.1063/1.4812926; BROOKS PR, 1988, CHEM REV, V88, P407, DOI 10.1021/cr00084a004; Castano O, 2002, J COMPUT CHEM, V23, P732, DOI 10.1002/jcc.10013; Conesa C., 1998, J CHEM SOC PERK T, V2, P857; Frutos LM, 2003, J PHYS CHEM A, V107, P5472, DOI 10.1021/jp030193n; Garavelli M, 2001, ANGEW CHEM INT EDIT, V40, P1466, DOI 10.1002/1521-3773(20010417)40:8<1466::AID-ANIE1466>3.0.CO;2-R; Gomez H, 2003, J CHEM PHYS, V119, P872, DOI 10.1063/1.1577331; Hrovat DA, 1997, J AM CHEM SOC, V119, P9523, DOI 10.1021/ja9714144; HROVAT DA, 1992, J AM CHEM SOC, V114, P5879, DOI 10.1021/ja00040a071; Klarner FG, 2001, ANGEW CHEM INT EDIT, V40, P3977, DOI 10.1002/1521-3773(20011105)40:21<3977::AID-ANIE3977>3.0.CO;2-N; Liu Z, 2000, CHEM PHYS LETT, V332, P65, DOI 10.1016/S0009-2614(00)01243-4; METZ RB, 1992, J CHEM PHYS, V97, P962, DOI 10.1063/1.463199; METZ RB, 1992, ADV CHEM PHYS, V81, P1; Neumark DM, 2002, PHYSCHEMCOMM, V5, P76, DOI 10.1039/b202218d; Neumark D.M., 1993, ACC CHEM RES, V26, P33; Paik DH, 2004, ANGEW CHEM INT EDIT, V43, P2830, DOI 10.1002/anie.200453962; Schaad LJ, 1998, J AM CHEM SOC, V120, P1571, DOI 10.1021/ja973394b; SCHATZ GC, 1990, J PHYS CHEM-US, V94, P6157, DOI 10.1021/j100379a005; Schild A, 2013, J COMPUT CHEM, V34, P1393, DOI 10.1002/jcc.23273; Schinke R., 1993, PHOTODISSOCIATION DY; TRINDLE C, 1991, J ORG CHEM, V56, P5426, DOI 10.1021/jo00018a043; WALLER IM, 1990, J PHYS CHEM-US, V94, P2240, DOI 10.1021/j100369a009; WEAVER A, 1988, J PHYS CHEM-US, V92, P5558, DOI 10.1021/j100331a004; Werner H., MOLPRO VERSION 2010; ZHOU XF, 1993, SPECTROCHIM ACTA A, V49, P953, DOI 10.1016/0584-8539(93)80214-U	43	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						134	139		10.1016/j.cplett.2015.06.018		6	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100025		
J	Kawatsu, T; Miura, S				Kawatsu, Tsutomu; Miura, Shinichi			Isotope effects of ammonia umbrella flip using semiclassical instanton calculations based on discretized path integrals	CHEMICAL PHYSICS LETTERS			English	Article							BOUND-CONSTRAINED OPTIMIZATION; MOLECULAR-ORBITAL METHODS; TRANSITION-STATE THEORY; TUNNELING SPLITTINGS; POLYATOMIC-MOLECULES; GROUND-STATE; INVERSION SPECTRUM; QUANTUM DYNAMICS; MONTE-CARLO; BASIS-SETS	We have recently developed a new algorithm to calculate tunneling splittings for molecular systems using the discretized path integral instanton method Kawatsu and Miura (2014) [29]. Compared with the standard method, the new algorithm enables us to reduce the computational cost without decreasing the numerical accuracy. The algorithm has been combined with ab initio electronic structure calculations on the fly. In this Letter, we apply our method to ammonia umbrella flips with five different isotopologues: ND3, NT3, (NH3)-N-15, (ND3)-N-15, NH2D and NHD2. The calculated tunneling splittings are found to be in quantitative agreement with experimental data in all of these calculations as well as for NH3. The method provides a useful tool for evaluating tunneling splittings for such rigid molecular systems. (C) 2015 Elsevier B.V. All rights reserved.	[Kawatsu, Tsutomu] Univ Tokyo, Grad Sch Arts & Sci, Dept Basic Sci, Tokyo 1538902, Japan; [Kawatsu, Tsutomu] Yokohama City Univ, Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan; [Miura, Shinichi] Kanazawa Univ, Fac Math & Phys, Kanazawa, Ishikawa 9201192, Japan	Kawatsu, T (reprint author), Grad Sch Nanobiosci, Yokohama, Kanagawa 2360027, Japan.	kawatsu@fukui.kyoto-u.ac.jp; smiura@mail.kanazawa-u.ac.jp			Japan Society for the Promotion of Science [23550011]; Strategic Programs for Innovative Research (SPIRE), MEXT; Computational Materials Science Initiative (CMSI), Japan	This work was partially supported by a Grant-in-Aid for Scientific Research (C) (No. 23550011) from the Japan Society for the Promotion of Science and by the Strategic Programs for Innovative Research (SPIRE), MEXT, and the Computational Materials Science Initiative (CMSI), Japan. A portion of the computations were performed at the Research Center for Computational Science, Okazaki, Japan.	Mil'nikov G, 2008, PHYS CHEM CHEM PHYS, V10, P1374, DOI 10.1039/b712988b; KRISHNAN R, 1980, J CHEM PHYS, V72, P650, DOI 10.1063/1.438955; Andersson S, 2009, J PHYS CHEM A, V113, P4468, DOI 10.1021/jp811070w; FRISCH MJ, 1984, J CHEM PHYS, V80, P3265, DOI 10.1063/1.447079; Zhu CY, 1997, ACM T MATH SOFTWARE, V23, P550, DOI 10.1145/279232.279236; MAKRI N, 1989, J CHEM PHYS, V91, P4026, DOI 10.1063/1.456833; Rajamaki T, 2003, J CHEM PHYS, V118, P10929, DOI 10.1063/1.1574784; Yagi K, 2001, J CHEM PHYS, V115, P10647, DOI 10.1063/1.1418436; Kawatsu T, 2014, J CHEM PHYS, V141, DOI 10.1063/1.4885437; SCHMIDT MW, 1993, J COMPUT CHEM, V14, P1347, DOI 10.1002/jcc.540141112; BENDERSKII VA, 1993, PHYS REP, V233, P195, DOI 10.1016/0370-1573(93)90136-2; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; MILLER WH, 1975, J CHEM PHYS, V62, P1899, DOI 10.1063/1.430676; Rommel JB, 2011, J CHEM THEORY COMPUT, V7, P690, DOI 10.1021/ct100658y; CHANDLER D, 1981, J CHEM PHYS, V74, P4078, DOI 10.1063/1.441588; CALLAN CG, 1977, PHYS REV D, V16, P1762, DOI 10.1103/PhysRevD.16.1762; CLARK T, 1983, J COMPUT CHEM, V4, P294, DOI 10.1002/jcc.540040303; Richardson JO, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3640429; Benderskii VA, 1997, CHEM PHYS, V219, P119, DOI 10.1016/S0301-0104(97)00118-3; BENEDICT WS, 1957, CAN J PHYS, V35, P1235; BYRD RH, 1995, SIAM J SCI COMPUT, V16, P1190, DOI 10.1137/0916069; Callomon J.H., 1976, LANDOLTBORNSTEIN NUM, P84; Cao JS, 1996, J CHEM PHYS, V105, P6856, DOI 10.1063/1.471980; CEPERLEY DM, 1987, PHYS REV LETT, V58, P1648, DOI 10.1103/PhysRevLett.58.1648; Coleman S., 1985, ASPECTS SYMMETRY; COUDERT L, 1986, J MOL SPECTROSC, V120, P185, DOI 10.1016/0022-2852(86)90081-0; FUSINA L, 1988, J MOL SPECTROSC, V127, P240, DOI 10.1016/0022-2852(88)90023-9; FUSINA L, 1991, J MOL SPECTROSC, V147, P71, DOI 10.1016/0022-2852(91)90169-B; GREGORY JK, 1995, J CHEM PHYS, V102, P7817, DOI 10.1063/1.468982; HARIHARA.PC, 1973, THEOR CHIM ACTA, V28, P213, DOI 10.1007/BF00533485; HELMINGE.P, 1974, PHYS REV A, V9, P12, DOI 10.1103/PhysRevA.9.12; Iroshnikov GS, 2004, OPT SPECTROSC+, V97, P714, DOI 10.1134/1.1828620; Katsnelson MI, 1996, PHYS REV A, V54, P4802, DOI 10.1103/PhysRevA.54.4802; Kawatsu T, 2013, J PHYS CONF SER, V454, DOI 10.1088/1742-6596/454/1/012030; DEVI VM, 1981, J MOL SPECTROSC, V88, P293; Meana-Paneda R, 2010, J CHEM THEORY COMPUT, V6, P6, DOI 10.1021/ct900420e; Nakamura H., 2014, QUANTUM MECH TUNNELI; Ootani Y, 2012, J COMPUT CHEM, V33, P60, DOI 10.1002/jcc.21943; Rajamaki T, 2004, MOL PHYS, V102, P2297, DOI 10.1080/00268970412331292759; Neff M, 2014, SPECTROCHIM ACTA A, V119, P100, DOI 10.1016/j.saa.2013.02.033; Richardson JO, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3530589; SASADA H, 1980, J MOL SPECTROSC, V83, P15, DOI 10.1016/0022-2852(80)90307-0; SCHNABEL E, 1965, Z PHYS, V188, P167, DOI 10.1007/BF01339404; Siebrand W, 1999, INT REV PHYS CHEM, V18, P5, DOI 10.1080/014423599229992; Simons B., 2006, CONDENSED MATTER FIE; Smedarchina Z, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769198; SMEDARCHINA Z, 1995, J CHEM PHYS, V103, P5326, DOI 10.1063/1.470567; SPIRKO V, 1983, J MOL SPECTROSC, V101, P30, DOI 10.1016/0022-2852(83)90004-8; Tautermann CS, 2002, J CHEM PHYS, V117, P1967, DOI 10.1063/1.1488925; TRUHLAR DG, 1971, J AM CHEM SOC, V93, P1840	50	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						146	150		10.1016/j.cplett.2015.05.072		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100027		
J	Shoji, M; Kayanuma, M; Umeda, H; Shigeta, Y				Shoji, Mitsuo; Kayanuma, Megumi; Umeda, Hiroaki; Shigeta, Yasuteru			Performance of the divide-and-conquer approach used as an initial guess	CHEMICAL PHYSICS LETTERS			English	Article							ELECTRONIC-STRUCTURE CALCULATIONS; MOLECULAR-ORBITAL METHOD; OPEN-SHELL SYSTEMS; FMO-MO METHOD; SCF CALCULATION; DENSITY; IMPLEMENTATION	Computational costs with the use of the initial guesses formed by the divide-and-conquer approach are examined. For conventional density functional theory calculations, their computational costs rapidly increase as the system sizes increase, therefore, an efficient methodologies to construct a fine initial molecular orbital guess or a fine density matrix (DM) is quite variable in order to enhance the fast convergence. We examined the DM construction approaches by changing the subsystem buffer sizes and number of divisions, and their computational costs were numerically investigated in order to clarify their characteristic features. (C) 2015 Elsevier B.V. All rights reserved.	[Shoji, Mitsuo; Umeda, Hiroaki; Shigeta, Yasuteru] Univ Tsukuba, Ctr Computat Sci, Tsukuba, Ibaraki 3058577, Japan; [Shoji, Mitsuo; Shigeta, Yasuteru] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan; [Kayanuma, Megumi] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki 3058573, Japan	Shoji, M (reprint author), Univ Tsukuba, Ctr Computat Sci, 1-1-1 Tennodai, Tsukuba, Ibaraki 3058577, Japan.	mshoji@ccs.tsukuba.ac.jp			Japan Society for the Promotion of Science [24000018, 26410002]	The numerical calculations for the present study have been carried out under the 'Interdisciplinary Computational Science Program' at the Center for computational Sciences, University of Tsukuba. This research has been supported by Grants-in-Aid from Japan Society for the Promotion of Science (1) for Specially Promoted Research (No. 24000018), (2) for Scientific Research (C; No. 26410002) and (3) for scientific research on innovative areas '3D active-site science'.	Valiev M, 2010, COMPUT PHYS COMMUN, V181, P1477, DOI 10.1016/j.cpc.2010.04.018; Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253; YANG WT, 1995, J CHEM PHYS, V103, P5674, DOI 10.1063/1.470549; Kobayashi M, 2012, PHYS CHEM CHEM PHYS, V14, P7629, DOI 10.1039/c2cp40153c; Honda S, 2004, STRUCTURE, V12, P1507, DOI 10.1016/j.str.2004.05.022; Inadomi Y, 2002, CHEM PHYS LETT, V364, P139, DOI 10.1016/S0009-2614(02)01291-5; Kitaura K, 1999, CHEM PHYS LETT, V313, P701, DOI 10.1016/S0009-2614(99)00874-X; Inaba T, 2005, J COMPUT CHEM, V26, P987, DOI 10.1002/jcc.20239; Kashiwagi H, 2003, MOL PHYS, V101, P81, DOI 10.1080/0026897021000026854; Kobayashi M, 2010, CHEM PHYS LETT, V500, P172, DOI 10.1016/j.cplett.2010.10.005; Lee TS, 1998, COMP MATER SCI, V12, P259, DOI 10.1016/S0927-0256(98)00029-9; Pan W, 1998, J COMPUT CHEM, V19, P1101, DOI 10.1002/(SICI)1096-987X(19980715)19:9<1101::AID-JCC10>3.0.CO;2-8; Parr R. G., 1989, DENSITY FUNCTIONAL T; Szekeres Z, 2006, CHEM PHYS LETT, V424, P420, DOI 10.1016/j.cplett.2006.04.089; Tamura K, 2008, B CHEM SOC JPN, V81, P254, DOI 10.1246/bcsj.81.254; Umeda H, 2010, J COMPUT CHEM, V31, P2381, DOI 10.1002/jcc.21531; Watanabe T, 2009, J COMPUT THEOR NANOS, V6, P1328, DOI 10.1166/jctn.2009.1182; Wolfram research, MATHEMATICA, V9; YANG WT, 1991, PHYS REV LETT, V66, P1438, DOI 10.1103/PhysRevLett.66.1438	19	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						181	187		10.1016/j.cplett.2015.06.011		7	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100034		
J	Nishi, K; Inoue, S; Matsumura, Y				Nishi, Kazuki; Inoue, Shuhei; Matsumura, Yukihiko			Molecular dynamic simulation for the evaluation of free energy distribution along the reaction coordinates at the initial stage of carbon nanotube nucleation	CHEMICAL PHYSICS LETTERS			English	Editorial Material							DIAMETER CONTROL; LASER-ABLATION; GROWTH; DISSOCIATION; CATALYSTS; MECHANISM; METALS	In order to evaluate the free energy associated with supplying an additional carbon atom to a catalyst cluster, we performed umbrella sampling and used the weighted histogram analysis in our classical molecular dynamic simulation. We assumed a one-dimensional reaction coordinate and derived the free energy. The derived free energy distribution was consistent with the observed phenomena and we found a reaction barrier of 0.6 eV near the cluster surface. Beyond the reaction barrier, the free energy increased with increasing density of the carbon atoms, and this indicated that the saturation started from the cluster center. (C) 2015 Elsevier B.V. All rights reserved.	[Nishi, Kazuki] Hiroshima Univ, Dept Mech Sci & Engn, Higashihiroshima 7398527, Japan; [Inoue, Shuhei; Matsumura, Yukihiko] Hiroshima Univ, Div Energy & Environm Engn, Higashihiroshima 7398527, Japan	Inoue, S (reprint author), Hiroshima Univ, Div Energy & Environm Engn, 1-4-1 Kagamiyama, Higashihiroshima 7398527, Japan.	shu18@hiroshima-u.ac.jp					Ding F, 2004, J CHEM PHYS, V121, P2775, DOI 10.1063/1.1770424; Yudasaka M, 1999, J PHYS CHEM B, V103, P6224, DOI 10.1021/jp9908451; IIJIMA S, 1991, NATURE, V354, P56, DOI 10.1038/354056a0; Tang DM, 2014, ACS NANO, V8, P292, DOI 10.1021/nn403927y; Kataura H, 2000, CARBON, V38, P1691, DOI 10.1016/S0008-6223(00)00090-7; ROUX B, 1995, COMPUT PHYS COMMUN, V91, P275, DOI 10.1016/0010-4655(95)00053-I; BRENNER DW, 1990, PHYS REV B, V42, P9458, DOI 10.1103/PhysRevB.42.9458; Inoue S, 2005, CHEM PHYS LETT, V410, P209, DOI 10.1016/j.cplett.2005.05.082; Shibuta Y, 2003, CHEM PHYS LETT, V382, P381, DOI 10.1016/j.cplett.2003.10.080; Shibuta Y, 2013, CHEM PHYS LETT, V565, P92, DOI 10.1016/j.cplett.2013.02.038; FINNIS MW, 1984, PHILOS MAG A, V50, P45; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; Oguri T, 2013, J PHYS CHEM C, V117, P9983, DOI 10.1021/jp403006m; Dai H., 1996, Chemical Physics Letters, V260, DOI 10.1016/0009-2614(96)00862-7; IIJIMA S, 1993, NATURE, V363, P603, DOI 10.1038/363603a0; Nishi K, 2014, CHEM PHYS LETT, V604, P1, DOI 10.1016/j.cplett.2014.04.041; Scott CD, 2001, APPL PHYS A-MATER, V72, P573, DOI 10.1007/s003390100761; Yudasaka M, 2002, APPL PHYS A-MATER, V74, P377, DOI 10.1007/s003390101070	18	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						194	197		10.1016/j.cplett.2015.06.009		4	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100036		
J	Hirakawa, K; Yoshioka, T				Hirakawa, Kazutaka; Yoshioka, Takuto			Photoexcited riboflavin induces oxidative damage to human serum albumin	CHEMICAL PHYSICS LETTERS			English	Article							(STZ)-INDUCED DIABETIC-RATS; PHOTOSENSITIZED DNA-DAMAGE; XANTHONE DERIVATIVES; ELECTRON-TRANSFER; UV-RADIATION; FOLIC-ACID; PHOTODEGRADATION; CARCINOGENESIS; BELLIDIFOLIN; SWERCHIRIN	Photoexcited riboflavin induced damage of human serum albumin (HSA), a water soluble protein, resulting in the diminishment of fluorescence from the tryptophan residue. Because riboflavin hardly photosensitized singlet oxygen generation and sodium azide, a singlet oxygen quencher, did not inhibit protein damage, electron transfer-mediated oxidation of HSA was speculated. Fluorescence lifetime of riboflavin was not affected by HSA, suggesting that the excited triplet state of riboflavin is responsible for protein damage through electron transfer. In addition, the preventive effect of xanthone derivatives, triplet quenchers, on photosensitized protein damage could be evaluated using this photosensitized reaction system of riboflavin and HSA. (C) 2015 Elsevier B.V. All rights reserved.	[Hirakawa, Kazutaka; Yoshioka, Takuto] Shizuoka Univ, Grad Sch Integrated Sci & Technol, Appl Chem & Biochem Engn Course, Dept Engn,Naka Ku, Hamamatsu, Shizuoka 4328561, Japan; [Hirakawa, Kazutaka] Shizuoka Univ, Grad Sch Sci & Technol, Dept Optoelect & Nanostruct Sci, Naka Ku, Hamamatsu, Shizuoka 4328561, Japan	Hirakawa, K (reprint author), Shizuoka Univ, Grad Sch Integrated Sci & Technol, Appl Chem & Biochem Engn Course, Dept Engn,Naka Ku, Johoku 3-5-1, Hamamatsu, Shizuoka 4328561, Japan.	hirakawa.kazutaka@shizuoka.ac.jp			JSPS KAKENHI [23750186]	This work was supported by JSPS KAKENHI Grant Number 23750186.	Li MY, 2001, PHOTOCHEM PHOTOBIOL, V74, P760, DOI 10.1562/0031-8655(2001)074<0760:QOSMOO>2.0.CO;2; Hirakawa K, 2012, J PHYS CHEM B, V116, P3037, DOI 10.1021/jp300142e; Kumar V, 2004, PHOTOCHEM PHOTOBIOL, V80, P15, DOI 10.1562/2003-12-23-RA-036.1; Cadet J, 2014, INT J RADIAT BIOL, V90, P423, DOI 10.3109/09553002.2013.877176; Burrows CJ, 1998, CHEM REV, V98, P1109, DOI 10.1021/cr960421s; Wondrak GT, 2006, PHOTOCH PHOTOBIO SCI, V5, P215, DOI 10.1039/b504573h; BASNET P, 1994, PLANTA MED, V60, P507, DOI 10.1055/s-2006-959560; Islam SDM, 2003, CHEM PHYS, V291, P97, DOI 10.1016/S0301-0104(03)00187-3; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Akhtar MJ, 1997, J PHARMACEUT BIOMED, V16, P95, DOI 10.1016/S0731-7085(96)02028-6; Kawanishi S, 2001, MUTAT RES-REV MUTAT, V488, P65, DOI 10.1016/S1383-5742(00)00059-4; HE XM, 1992, NATURE, V358, P209, DOI 10.1038/358209a0; Hirakawa K, 2013, J PHYS CHEM B, V117, P13490, DOI 10.1021/jp4072444; ITO K, 1993, J BIOL CHEM, V268, P13221; Kino K, 2009, BIOORG MED CHEM LETT, V19, P2070, DOI 10.1016/j.bmcl.2009.01.112; Hirakawa K, 2014, CHEM RES TOXICOL, V27, P649, DOI 10.1021/tx400475c; Hirakawa K, 2015, CHEM RES TOXICOL, V28, P262, DOI 10.1021/tx500492w; Ravanat JL, 2001, J PHOTOCH PHOTOBIO B, V63, P88, DOI 10.1016/S1011-1344(01)00206-8; Thomas AH, 2013, FREE RADICAL BIO MED, V63, P467, DOI 10.1016/j.freeradbiomed.2013.05.044; Tan SLJ, 2012, J AM CHEM SOC, V134, P5954, DOI 10.1021/ja300191u; BAJPAI MB, 1991, PLANTA MED, V57, P102, DOI 10.1055/s-2006-960041; BASNET P, 1995, PLANTA MED, V61, P402, DOI 10.1055/s-2006-958124; Hirakawa K, 2005, PHOTOCHEM PHOTOBIOL, V81, P314, DOI 10.1562/2004-07-29-RA-252.1; Hirakawa K, 2013, BIOORG MED CHEM LETT, V23, P2704, DOI 10.1016/j.bmcl.2013.02.081; Hiraku Y, 2007, PHOTOCHEM PHOTOBIOL, V83, P205, DOI 10.1562/2006-03-09-IR-840; International Agency for Research on Cancer (IARC) Working Group, 1992, IARC MON EV CARC RIS, V55, P43; Lewis F. D., 2001, J PHOTOCH PHOTOBIO C, V2, P1, DOI 10.1016/S1389-5567(01)00008-9; Massad W, 2004, CHEMOSPHERE, V57, P455, DOI 10.1016/j.chemosphere.2004.06.021; Menkovic N, 2002, PHYTOCHEMISTRY, V61, P415, DOI 10.1016/S0031-9422(02)00231-5; Nan CG, 2002, ANAL CHIM ACTA, V452, P245, DOI 10.1016/S0003-2670(01)01470-2; Santos WG, 2014, J PHOTOCH PHOTOBIO A, V293, P32, DOI 10.1016/j.jphotochem.2014.07.010; Shen L, 2008, J MOL STRUC-THEOCHEM, V854, P106, DOI 10.1016/j.theochem.2007.12.010; Ya BQ, 1999, PHYTOMEDICINE, V6, P85	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						221	224		10.1016/j.cpleu.2015.06.026		4	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100041		
J	Miyajima, K; Sobhan, MA; Hardy, RA; Metha, GF; Mafune, F				Miyajima, Ken; Sobhan, Mushtaq Ahmed; Hardy, Robert A.; Metha, Gregory F.; Mafune, Fumitaka			Structural rearrangement in gas phase niobium carbide clusters, NbnC3 and NbnC6	CHEMICAL PHYSICS LETTERS			English	Article						Laser ablation; Photoionization; Mass spectrometry; Graphite	SMALL CARBON CLUSTERS; PHOTOELECTRON-SPECTROSCOPY; THRESHOLD PHOTOIONIZATION; ELECTRONIC-STRUCTURE; LASER VAPORIZATION; NEUTRAL FRAGMENT; OXIDE CLUSTERS; MET-CARS; IONS; IONIZATION	Niobium carbide clusters were formed in the gas phase by mixing vapors of niobium and carbon. When a carbon trimer, C3, was richly formed in the vapor, clusters with compositions NbnC3k' (n= 2-10, k= 0-4) were abundantly observed after photoionization at 215 nm, enabling the presumption that a C3 unit could be a building block of the observed clusters. Contrary to this presumption, photoionization efficiency spectra in 215-286 nm suggest that the clusters should be assigned to atomically mixed niobium carbide. Structural rearrangement of the clusters into the atomically mixed form is consistent with the results of DFT calculations. (C) 2015 Elsevier B.V. All rights reserved.	[Miyajima, Ken; Sobhan, Mushtaq Ahmed; Mafune, Fumitaka] Univ Tokyo, Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan; [Hardy, Robert A.; Metha, Gregory F.] Univ Adelaide, Dept Chem, Adelaide, SA 5005, Australia	Mafune, F (reprint author), Univ Tokyo, Sch Arts & Sci, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan.	mafune@cluster.c.u-tokyo.ac.jp			JSPS KAKENHI [25248004, 24550010]; Genesis Research Institute, Inc.; RACI Travel Award	This work was supported by JSPS KAKENHI Grant Numbers 25248004 and 24550010, and additional funding for cluster research was provided by the Genesis Research Institute, Inc. Computing resources were provided by the Australian National Computational Infrastructure (NCI) Facility and eResearch SA. R.H. acknowledges support from a RACI Travel Award.	Addicoat MA, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3122542; GUO BC, 1992, SCIENCE, V255, P1411, DOI 10.1126/science.255.5050.1411; Van Orden A, 1998, CHEM REV, V98, P2313, DOI 10.1021/cr970086n; GUO BC, 1992, SCIENCE, V256, P515, DOI 10.1126/science.256.5056.515; Miyajima K, 2008, J PHYS CHEM A, V112, P5774, DOI 10.1021/jp803247h; Sakuma K, 2013, J PHYS CHEM A, V117, P3260, DOI 10.1021/jp400850u; Diaz-Tendero S, 2005, PHYS REV A, V71, DOI 10.1103/PhysRevA.71.033202; Belau L, 2007, J AM CHEM SOC, V129, P10229, DOI 10.1021/ja072526q; Bae CH, 2002, J CHEM PHYS, V117, P5347, DOI 10.1063/1.1500356; Beroff K, 2009, NUCL INSTRUM METH B, V267, P866, DOI 10.1016/j.nimb.2009.02.043; Brock LR, 1996, J PHYS CHEM-US, V100, P5654, DOI 10.1021/jp953421p; Byun YG, 1996, J PHYS CHEM-US, V100, P6336, DOI 10.1021/jp9531974; Byun YG, 1996, J PHYS CHEM-US, V100, P14281, DOI 10.1021/jp961166i; Cartier SF, 1996, J CHEM PHYS, V104, P3423, DOI 10.1063/1.471535; Deng H, 1998, CROAT CHEM ACTA, V71, P1105; DENG HT, 1994, J PHYS CHEM-US, V98, P13373, DOI 10.1021/j100101a042; Dryza V, 2008, J PHYS CHEM A, V112, P5582, DOI 10.1021/jp800691s; Dryza V, 2009, PHYS CHEM CHEM PHYS, V11, P1060, DOI 10.1039/b813359j; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fukushima N, 2009, J PHYS CHEM A, V113, P2309, DOI 10.1021/jp809915c; GAUMET JJ, 1993, J CHEM SOC FARADAY T, V89, P1667, DOI 10.1039/ft9938901667; GEUSIC ME, 1987, J CHEM PHYS, V86, P3862, DOI 10.1063/1.451946; GEUSIC ME, 1986, J CHEM PHYS, V84, P2421, DOI 10.1063/1.450354; Harris H, 2001, J PHYS CHEM A, V105, P3340, DOI 10.1021/jp0035535; Knappenberger KL, 2007, ACS NANO, V1, P319, DOI 10.1021/nn700167c; Kokai F, 1997, NUCL INSTRUM METH B, V121, P387, DOI 10.1016/S0168-583X(96)00395-3; LEIDER HR, 1973, CARBON, V11, P555, DOI 10.1016/0008-6223(73)90316-3; Li S, 1997, J AM CHEM SOC, V119, P7417, DOI 10.1021/ja9710159; PILGRIM JS, 1995, J PHYS CHEM-US, V99, P544, DOI 10.1021/j100002a016; PRADEL P, 1989, CHEM PHYS LETT, V158, P412, DOI 10.1016/0009-2614(89)87362-2; RADI PP, 1988, J CHEM PHYS, V88, P2809, DOI 10.1063/1.454015; Wakabayashi T, 1999, J CHEM PHYS, V111, P6260, DOI 10.1063/1.479931; Wang LS, 1996, J PHYS CHEM-US, V100, P19211, DOI 10.1021/jp9630683; WEI S, 1994, J AM CHEM SOC, V116, P4475, DOI 10.1021/ja00089a046; Yamada A, 2012, PHYS CHEM CHEM PHYS, V14, P4188, DOI 10.1039/c2cp24036j; Yang DS, 1996, J CHEM PHYS, V105, P10663, DOI 10.1063/1.472873; YEH CS, 1995, J AM CHEM SOC, V117, P4042, DOI 10.1021/ja00119a020	37	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0009-2614	1873-4448		CHEM PHYS LETT	Chem. Phys. Lett.	AUG 1	2015	634						261	265		10.1016/j.cplett.2015.06.031		5	Chemistry, Physical; Physics, Atomic, Molecular & Chemical	Chemistry; Physics	CO4RA	WOS:000359147100048		
J	Morita, T; Kobayashi, D; Matsumura, K; Johmoto, K; Uekusa, H; Fuse, S; Takahashi, T				Morita, Taiki; Kobayashi, Daisuke; Matsumura, Keisuke; Johmoto, Kohei; Uekusa, Hidehiro; Fuse, Shinichiro; Takahashi, Takashi			Sequential SNAr Reaction/Suzuki-Miyaura Coupling/C-H Direct Arylations Approach for the Rapid Synthesis of Tetraaryl-Substituted Pyrazoles	CHEMISTRY-AN ASIAN JOURNAL			English	Article						C-H activation; cross-coupling; heterocycles; palladium; synthetic methods	CATALYZED DIRECT ARYLATION; ONE-POT; ARYL BROMIDES; PROGRAMMED SYNTHESIS; PALLADIUM; CHLORIDES; LIGANDS; HALIDES; HETEROCYCLES; DERIVATIVES	A rapid synthesis of 1,3,4,5-tetraaryl-substituted pyrazoles has been achieved through a sequence of SNAr reaction/Suzuki-Miyaura coupling/Pd-catalyzed direct arylations that used 3-iodo-1H-pyrazole as a scaffold. Pyrazoles with four different aryl groups were synthesized in a straightforward manner with no extra synthetic steps, such as protection/deprotection or the introduction of activating/directing groups, using readily available substrates and reagents. The developed synthetic approach enabled the structurally diverse synthesis of multiaryl-substituted pyrazoles without using a glovebox technique.	[Morita, Taiki; Kobayashi, Daisuke; Matsumura, Keisuke; Fuse, Shinichiro] Tokyo Inst Technol, Dept Appl Chem, Meguro Ku, Tokyo 1528552, Japan; [Johmoto, Kohei; Uekusa, Hidehiro] Tokyo Inst Technol, Dept Chem & Mat Sci, Meguro Ku, Tokyo 1528551, Japan; [Takahashi, Takashi] Yokohama Coll Pharm, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan	Fuse, S (reprint author), Tokyo Inst Technol, Dept Appl Chem, Meguro Ku, 2-12-1 Ookayama, Tokyo 1528552, Japan.	sfuse@res.titech.ac.jp	Fuse, Shinichiro/B-9396-2015	Fuse, Shinichiro/0000-0002-6836-4180			Yanagisawa S, 2009, J AM CHEM SOC, V131, P14622, DOI 10.1021/ja906215b; Takfaoui A, 2014, TETRAHEDRON LETT, V55, P1697, DOI 10.1016/j.tetlet.2014.01.079; Willy B, 2011, ORG LETT, V13, P2082, DOI 10.1021/ol2004947; Kumar S, 2009, J ORG CHEM, V74, P7046, DOI 10.1021/jo901309t; Goikhman R, 2009, J AM CHEM SOC, V131, P3042, DOI 10.1021/ja8096114; Fuse S, 2010, CHEM-ASIAN J, V5, P2459, DOI 10.1002/asia.201000534; KRANENBURG M, 1995, ORGANOMETALLICS, V14, P3081, DOI 10.1021/om00006a057; Pinto DJP, 2007, J MED CHEM, V50, P5339, DOI 10.1021/jm070245n; Matsumura K, 2015, CHEM-EUR J, V21, P9742, DOI 10.1002/chem.201500979; Campeau LC, 2008, J AM CHEM SOC, V130, P3276, DOI 10.1021/ja7107068; Mateos C, 2010, ORG LETT, V12, P4924, DOI 10.1021/ol1020898; Shibahara F, 2011, J ORG CHEM, V76, P2680, DOI 10.1021/jo200067y; Rene O, 2010, ADV SYNTH CATAL, V352, P2116, DOI 10.1002/adsc.201000397; Gowrisankar S, 2012, CHEM-EUR J, V18, P2498, DOI 10.1002/chem.201103347; Bellina F, 2013, EUR J ORG CHEM, V2013, P5621, DOI 10.1002/ejoc.201300704; Do HO, 2008, J AM CHEM SOC, V130, P15185, DOI 10.1021/ja805688p; Heller ST, 2006, ORG LETT, V8, P2675, DOI 10.1021/ol060570p; Haas D, 2013, ORG LETT, V15, P6162, DOI 10.1021/ol403019c; Gaulier SM, 2011, TETRAHEDRON LETT, V52, P6000, DOI 10.1016/j.tetlet.2011.08.174; Yan T, 2012, J ORG CHEM, V77, P7659, DOI 10.1021/jo301047v; Naoum F, 2007, MOLECULES, V12, P1259, DOI 10.3390/12071259; Fuse S, 2014, EUR J MED CHEM, V85, P228, DOI 10.1016/j.ejmech.2014.07.095; Fulp A, 2012, J MED CHEM, V55, P2820, DOI 10.1021/jm201731z; Zapf A, 2000, ANGEW CHEM INT EDIT, V39, P4153, DOI 10.1002/1521-3773(20001117)39:22<4153::AID-ANIE4153>3.0.CO;2-T; Kudo N, 2006, ANGEW CHEM INT EDIT, V45, P1282, DOI 10.1002/anie.200503479; Wolfe JP, 1999, ANGEW CHEM INT EDIT, V38, P2413, DOI 10.1002/(SICI)1521-3773(19990816)38:16<2413::AID-ANIE2413>3.0.CO;2-H; Doebelin C, 2014, J ORG CHEM, V79, P908, DOI 10.1021/jo402200q; Netherton MR, 2001, ORG LETT, V3, P4295, DOI 10.1021/ol016971g; McLaughlin M, 2008, J ORG CHEM, V73, P4309, DOI 10.1021/jo800321p; Fuse S, 2014, ACS COMB SCI, V16, P494, DOI 10.1021/co500071x; Fuse S, 2014, TETRAHEDRON, V70, P8690, DOI 10.1016/j.tet.2014.09.039; Brnardic EJ, 2007, BIOORG MED CHEM LETT, V17, P5989, DOI 10.1016/j.bmcl.2007.07.051; Lee SH, 2009, BIOORG MED CHEM LETT, V19, P6632, DOI 10.1016/j.bmcl.2009.10.015; Fustero S, 2011, CHEM REV, V111, P6984, DOI 10.1021/cr2000459; Xu ZL, 2011, TETRAHEDRON, V67, P5282, DOI 10.1016/j.tet.2011.05.025; Derridj F, 2012, ADV SYNTH CATAL, V354, P747, DOI 10.1002/adsc.201100726; Stauffer SR, 2000, J MED CHEM, V43, P4934, DOI 10.1021/jm000170m; MIYAURA N, 1979, TETRAHEDRON LETT, V20, P3437, DOI 10.1016/S0040-4039(01)95429-2; Ye MC, 2013, CHEM SCI, V4, P2374, DOI 10.1039/c3sc50184a; Tani S, 2014, CHEM SCI, V5, P123, DOI 10.1039/c3sc52199k; Fuse S, 2014, CHEM-EUR J, V20, P10685, DOI 10.1002/chem.201402093; Smari I, 2014, EUR J ORG CHEM, V2014, P1778, DOI 10.1002/ejoc.201301593; Fuse S, 2012, ACS COMB SCI, V14, P545, DOI 10.1021/co3000665; Bagley M. C., 2007, SYNLETT, P0704; Beladhria A, 2011, SYNTHESIS-STUTTGART, P2553, DOI 10.1055/s-0030-1260076; Brennfuhrer A., 2009, ANGEW CHEM, V121, P4176; Fall Y, 2010, SYNTHESIS-STUTTGART, P127, DOI 10.1055/s-0029-1217075; Gorelsky SI, 2013, COORDIN CHEM REV, V257, P153, DOI 10.1016/j.ccr.2012.06.016; Hartwig J. F., 1998, ANGEW CHEM, V37, P2046, DOI 10.1002/(SICI)1521-3757(19980803)110:15<2154::AID-ANGE2154>3.0.CO;2-C; Hartwig JF, 1998, ANGEW CHEM INT EDIT, V37, P2046, DOI 10.1002/(SICI)1521-3773(19980817)37:15<2046::AID-ANIE2046>3.0.CO;2-L; Iaroshenko Viktor O, 2014, J Org Chem, V79, P2906, DOI 10.1021/jo4025418; Ikegami H., 2007, [No title captured], Patent No. [WO 2007043677, 2007043677]; Kudo N., 2006, ANGEW CHEM, V118, P1304, DOI 10.1002/ange.200503479; MIYAURA N, 1979, J CHEM SOC CHEM COMM, P866, DOI 10.1039/c39790000866; Brennfuhrer A, 2009, ANGEW CHEM INT EDIT, V48, P4114, DOI 10.1002/anie.200900013; Sasse K., 1988, [No title captured], Patent No. [US-A 4772608, 4772608]; Sugiyama S, 2011, TETRAHEDRON, V67, P6654, DOI 10.1016/j.tet.2011.05.023; Suzuki S, 2015, NAT CHEM, V7, P227, DOI [10.1038/nchem.2174, 10.1038/NCHEM.2174]; TAKAHASH.Y, 1970, J CHEM SOC CHEM COMM, P1065, DOI 10.1039/c29700001065; Thaher B. A., 2012, J MED CHEM, V55, P961; Willy B, 2008, EUR J ORG CHEM, P4157, DOI 10.1002/ejoc.200800444; Wolfe J. P., 1999, ANGEW CHEM, V111, P2570, DOI 10.1002/(SICI)1521-3757(19990816)111:16<2570::AID-ANGE2570>3.0.CO;2-S; Wolfe JP, 1998, ACCOUNTS CHEM RES, V31, P805, DOI 10.1021/ar9600650; Yang YW, 2011, BEILSTEIN J ORG CHEM, V7, P1656, DOI 10.3762/bjoc.7.195; Zapf A., 2000, ANGEW CHEM, V112, P4315, DOI 10.1002/1521-3757(20001117)112:22<4315::AID-ANGE4315>3.0.CO;2-L	65	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	AUG	2015	10	8					1626	1630		10.1002/asia.201500362		5	Chemistry, Multidisciplinary	Chemistry	CN9TV	WOS:000358793000004		
J	Kato, K; Segawa, Y; Scott, LT; Itami, K				Kato, Kenta; Segawa, Yasutomo; Scott, Lawrence T.; Itami, Kenichiro			Synthesis, Properties, and Packing Structures of Corannulene-Based -Systems Containing Heptagons	CHEMISTRY-AN ASIAN JOURNAL			English	Article						fused ring systems; negative curvature; polycyclic aromatic hydrocarbons; Scholl reaction; warped nanographene	POLYCYCLIC AROMATIC-HYDROCARBONS; C-H ACTIVATION; MOLECULAR-STRUCTURE; CARBON NANOTUBES; ARYLATION; ARENES; NANOGRAPHENE; CYCLOPHANES; CURVATURE; GROWTH	Introduction of heptagons into hexagonal carbon lattices can generate negatively curved polycyclic aromatic hydrocarbons, which are of significant interest in the field of exotic molecular nanocarbons. We have successfully synthesized and characterized corannulene-based -systems containing heptagons (4 and 5) as new negatively curved polycyclic aromatic hydrocarbons as well as possible intermediates in the synthesis of warped nanographene 1. The formation of 4 and 5 represents the first example for which a heptagon is formed under Scholl reaction conditions before all hexagons are formed. Even more interestingly, we discovered that the mode and degree of solid-phase intermolecular - interaction can be altered significantly by the degree of ring closure.	[Kato, Kenta; Segawa, Yasutomo; Scott, Lawrence T.; Itami, Kenichiro] Nagoya Univ, Grad Sch Sci, Nagoya, Aichi 4648602, Japan; [Segawa, Yasutomo; Scott, Lawrence T.; Itami, Kenichiro] Nagoya Univ, Itami Mol Nanocarbon Project, Chikusa Ku, JST,ERATO, Nagoya, Aichi 4648602, Japan; [Scott, Lawrence T.] Boston Coll, Merkert Chem Ctr, Chestnut Hill, MA 02167 USA; [Itami, Kenichiro] Nagoya Univ, Inst Transformat Biomol WPI ITbM, Nagoya, Aichi 4648602, Japan	Segawa, Y (reprint author), Nagoya Univ, Itami Mol Nanocarbon Project, Chikusa Ku, JST,ERATO, Nagoya, Aichi 4648602, Japan.	ysegawa@nagoya-u.jp; itami@chem.nagoya-u.ac.jp	Itami, Kenichiro/B-5110-2011; Segawa, Yasutomo/F-4889-2010		ERATO program from JST; Integrative Graduate Education and Research Program in Green Natural Sciences; World Premier International Research Center (WPI) Initiative, Japan	This work was supported by the ERATO program from JST (K.I.). K.K. thanks the Integrative Graduate Education and Research Program in Green Natural Sciences for support. ITbM is supported by the World Premier International Research Center (WPI) Initiative, Japan. Calculations were performed using the resources of the Research Center for Computational Science, Okazaki, Japan.	Kawasumi K, 2013, NAT CHEM, V5, P739, DOI [10.1038/nchem.1704, 10.1038/NCHEM.1704]; Mochida K, 2011, J AM CHEM SOC, V133, P10716, DOI 10.1021/ja202975w; Pradhan A, 2013, J ORG CHEM, V78, P2266, DOI 10.1021/jo3027752; Sakurai H, 2003, SCIENCE, V301, P1878, DOI 10.1126/science.1088290; IVANOV V, 1994, CHEM PHYS LETT, V223, P329, DOI 10.1016/0009-2614(94)00467-6; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Steinberg BD, 2009, J AM CHEM SOC, V131, P10537, DOI 10.1021/ja9031852; [Anonymous], 1991, ANGEW CHEM, V103, P1202; Grzybowski M, 2013, ANGEW CHEM INT EDIT, V52, P9900, DOI 10.1002/anie.201210238; [Anonymous], 2013, ANGEW CHEM, V125, P10084; Scott LT, 2012, J AM CHEM SOC, V134, P107, DOI 10.1021/ja209461g; YAMAMOTO K, 1988, J AM CHEM SOC, V110, P3578, DOI 10.1021/ja00219a036; Maekawa T, 2013, CHEM SCI, V4, P2369, DOI 10.1039/c3sc50585e; Zhang QY, 2012, J AM CHEM SOC, V134, P15664, DOI 10.1021/ja306992k; Eliseeva MN, 2012, J AM CHEM SOC, V134, P15169, DOI 10.1021/ja307547j; IIJIMA S, 1992, PHYS REV LETT, V69, P3100, DOI 10.1103/PhysRevLett.69.3100; Kawasumi K, 2013, TETRAHEDRON, V69, P4371, DOI 10.1016/j.tet.2013.01.037; Cheung KY, 2015, J AM CHEM SOC, V137, P3910, DOI 10.1021/jacs.5b00403; Kawasumi K, 2012, ORG LETT, V14, P418, DOI 10.1021/ol203235w; Luo J, 2012, J AM CHEM SOC, V134, P13796, DOI 10.1021/ja3054354; YAMAMOTO K, 1983, J AM CHEM SOC, V105, P7171, DOI 10.1021/ja00362a025; IIJIMA S, 1992, NATURE, V356, P776; [Anonymous], 1996, ANGEW CHEM, V108, P69; Tsefrikas VM, 2006, CHEM REV, V106, P4868, DOI 10.1021/cr050553y; BARTH WE, 1966, J AM CHEM SOC, V88, P380, DOI 10.1021/ja00954a049; Baldridge KK, 1997, THEOR CHEM ACC, V97, P67, DOI 10.1007/s002140050238; DOPPER JH, 1975, J ORG CHEM, V40, P3398, DOI 10.1021/jo00911a020; Dresselhaus M, 2001, CARBON NANOTUBES SYN; HANSON JC, 1976, ACTA CRYSTALLOGR B, V32, P1147, DOI 10.1107/S0567740876012430; Hirsch A., 2005, FULLERENES; JESSUP PJ, 1975, TETRAHEDRON LETT, P1453; JESSUP PJ, 1976, AUST J CHEM, V29, P173; Mughal U., 2014, EUR J ORG CHEM, P7469; Ozaki K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7251; Sarkar P, 2012, ASIAN J ORG CHEM, V1, P366, DOI 10.1002/ajoc.201200098; Takashima A, 2012, J PHYS D APPL PHYS, V45, DOI 10.1088/0022-3727/45/48/485302; WELDON DN, 1995, CHEM PHYS LETT, V241, P365, DOI 10.1016/0009-2614(95)00634-G; YAMAMOTO K, 1991, ANGEW CHEM INT EDIT, V30, P1173, DOI 10.1002/anie.199111731; YAMAMOTO K, 1993, PURE APPL CHEM, V65, P157, DOI 10.1351/pac199365010157; Yamamoto K, 1996, ANGEW CHEM INT EDIT, V35, P69, DOI 10.1002/anie.199600691	40	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	AUG	2015	10	8					1635	1639		10.1002/asia.201500560		5	Chemistry, Multidisciplinary	Chemistry	CN9TV	WOS:000358793000006		
J	Imoto, H; Kizaki, K; Naka, K				Imoto, Hiroaki; Kizaki, Kohei; Naka, Kensuke			A Mechanochromic Luminescent Dye Exhibiting On/Off Switching by Crystalline-Amorphous Transitions	CHEMISTRY-AN ASIAN JOURNAL			English	Article						dyes; pigments; luminescence; maleimides; mechanochromism; X-ray diffraction	MOLECULAR ASSEMBLIES; SECURITY PROTECTION; EMISSION; FLUORESCENCE; STIMULI	A mechanochromic luminescent dye based on a simple aminomaleimide skeleton was readily synthesized in a one-pot process. It exhibited an on/off mechanochromic luminescent switching property dependent on external stimuli, unlike a traditional mechanochromic color change. The green emission was turned on by grinding in a mortar and turned off by heating or treatment with dichloromethane. In the crystalline state, two molecules were stacked by cofacial - interactions, which caused concentration self-quenching. The crystalline-to-amorphous transition induced by grinding removed cofacial - stacking, which led to intensive emission. Crystallizing processes recovered the cofacial - stacking, resulting in elimination of the emission. Theoretical calculations and X-ray diffraction analyses revealed that the dye molecule was distorted in the crystalline state; thus even a mechanical stimulus caused the crystalline-to-amorphous transition.	[Imoto, Hiroaki; Kizaki, Kohei; Naka, Kensuke] Kyoto Inst Technol, Fac Mol Chem & Engn, Grad Sch Sci & Technol, Sakyo Ku, Matsugasaki, Kyoto 6068585, Japan	Naka, K (reprint author), Kyoto Inst Technol, Fac Mol Chem & Engn, Grad Sch Sci & Technol, Sakyo Ku, Goshokaido Cho, Matsugasaki, Kyoto 6068585, Japan.	kenaka@kit.ac.jp					Lim SJ, 2004, ANGEW CHEM INT EDIT, V43, P6346, DOI 10.1002/anie.200461172; HEINDEL ND, 1968, J ORG CHEM, V33, P3997, DOI 10.1021/jo01275a001; Kato T, 2012, CHEM LETT, V41, P1445, DOI 10.1246/cl.2012.1445; Kizaki K, 2015, TETRAHEDRON, V71, P643, DOI 10.1016/j.tet.2014.12.023; HEINDEL ND, 1970, J ORG CHEM, V35, P3138, DOI 10.1021/jo00834a061; Teng MJ, 2012, ADV MATER, V24, P1255, DOI 10.1002/adma.201104592; Hong YN, 2009, CHEM COMMUN, P4332, DOI 10.1039/b904665h; Hu R, 2014, CHEM SOC REV, V43, P4494, DOI 10.1039/c4cs00044g; [Anonymous], 2000, CRYSTALSTRUCTURE 3 8; Hirata S, 2006, ADV MATER, V18, P2725, DOI 10.1002/adma.200600209; Park DH, 2014, ADV FUNCT MATER, V24, P5186, DOI 10.1002/adfm.201400779; Luo XL, 2011, ADV MATER, V23, P3261, DOI 10.1002/adma.201101059; Sagara Y, 2009, NAT CHEM, V1, P605, DOI [10.1038/nchem.411, 10.1038/NCHEM.411]; Chi ZG, 2012, CHEM SOC REV, V41, P3878, DOI 10.1039/c2cs35016e; Gierschner J, 2005, J CHEM PHYS, V123, DOI 10.1063/1.2062028; Zhang XQ, 2013, J MATER CHEM C, V1, P3376, DOI 10.1039/c3tc30316k; Irie M, 2002, NATURE, V420, P759, DOI 10.1038/420759a; Olson CE, 2002, NAT MATER, V1, P225, DOI 10.1038/nmat766; Ding D, 2013, ACCOUNTS CHEM RES, V46, P2441, DOI 10.1021/ar3003464; Zhu XL, 2014, CHEM COMMUN, V50, P12951, DOI 10.1039/c4cc05913a; Kwon MS, 2012, ADV MATER, V24, P5487, DOI 10.1002/adma.201202409; Mei J, 2014, ADV MATER, V26, P5429, DOI 10.1002/adma.201401356; Luo J, 2011, CHEM-EUR J, V17, P10515, DOI 10.1002/chem.201101284; Beurskens P. T., 1992, PATTY DIRDIF PROGRAM; Beurskens P.T., 1999, DIRDIF 99 PROGRAM SY; Carruthers J. R., 1999, CRYSTALS; Cellini F, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4893010; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hemmer JR, 2014, J POLYM SCI POL PHYS, V52, P1347, DOI 10.1002/polb.23569; Higashi T., 1995, FA ABSCOR PROGRAM AB; Larson A. C., 1970, CRYSTALLOGRAPHIC COM, P291; Lim S. J., 2004, ANGEW CHEM, V116, P6506, DOI 10.1002/ange.200461172; PROCESS-AUTO, 1996, PROCESS AUTO RAXIS D; Sun HB, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4601; Sun JK, 2014, CHEM COMMUN, V50, P15956, DOI 10.1039/c4cc08316d	35	1	1	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	AUG	2015	10	8					1698	1702		10.1002/asia.201500499		5	Chemistry, Multidisciplinary	Chemistry	CN9TV	WOS:000358793000014		
J	Li, RJ; Nakashima, T; Galangau, O; Iijima, S; Kanazawa, R; Kawai, T				Li, Ruiji; Nakashima, Takuya; Galangau, Olivier; Iijima, Shunsuke; Kanazawa, Rui; Kawai, Tsuyoshi			Photon-Quantitative 6-Electrocyclization of a Diarylbenzo[b]thiophene in Polar Medium	CHEMISTRY-AN ASIAN JOURNAL			English	Article						crystals; noncovalent interactions; photochromism; quantum yield	QUANTUM YIELDS; DIARYLETHENES; PHOTOCHROMISM; SWITCHES; TERARYLENES; DERIVATIVES; REACTIVITY; MOLECULES; THIAZOLE; MEMORIES	The high reactivity of 6-electrocyclization in polar solvents has remained one of the important challenges for diarylethenes because of the emergence of a twisted intramolecular charge transfer (TICT) state at the excited state in such polar media, which usually quenches the photocyclization reaction. Herein we report on the preparation and highly efficient photocyclization of 2,3-diarylbenzo[b]thiophenes with nonsymmetric side-aryl units in a polar solvent. While the dithiazolylbenzo[b]thiophene showed a suppressed quantum yield of 6-electrocyclization of 54% in methanol, the replacement of a thiazole unit with a thiophene ring led to a photon-quantitative 6-cyclization reaction. The nonsymmetrical modification into the side-aryl units was considered to enhance the CH/ interactions between side-aryl units to support a photoreactive conformation in methanol. The stabilization of the photochromic reactive conformation is expected to suppress the formation of the TICT state at the excited state, leading to highly efficient photoreactivity.	[Li, Ruiji; Nakashima, Takuya; Galangau, Olivier; Iijima, Shunsuke; Kanazawa, Rui; Kawai, Tsuyoshi] Nara Inst Sci & Technol, Grad Sch Mat Sci, Ikoma, Nara 6300192, Japan; [Galangau, Olivier; Kawai, Tsuyoshi] Ctr Elaborat Mat & Etud Struct, NAIST CEMES Int Collaborat Lab Supraphotoact Syst, F-31055 Toulouse, France	Nakashima, T (reprint author), Nara Inst Sci & Technol, Grad Sch Mat Sci, NAIST 8916-5 Takayama, Ikoma, Nara 6300192, Japan.	ntaku@ms.naist.jp; tkawai@ms.naist.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; NAIST Green-Photonics Project; Mazda Foundation	The authors thank Mr. F. Asanoma, Mr. S. Katao and Ms. Y. Nishikawa at NAIST for their assistance with VT-NMR, X-ray crystallography and mass spectra, respectively. This work was partly supported by Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan under Green Photonics Project at NAIST and the Grand-in-Aid for on Innovative Areas of "PhotoSynergetics", NAIST Green-Photonics Project and the Mazda Foundation.	Aloise S, 2010, J AM CHEM SOC, V132, P7379, DOI 10.1021/ja910813x; Aloise S, 2013, PHYS CHEM CHEM PHYS, V15, P6226, DOI 10.1039/c3cp43806f; [Anonymous], 2007, CHEM COMMUN, DOI DOI 10.1039/B610004J; Gostl R, 2014, CHEM SOC REV, V43, P1982, DOI 10.1039/c3cs60383k; Gostl R, 2012, CHEM-EUR J, V18, P14282, DOI 10.1002/chem.201203111; Morinaka K, 2009, ORG LETT, V11, P3890, DOI 10.1021/ol901497t; IRIE M, 1992, J PHYS CHEM-US, V96, P7671, DOI 10.1021/j100198a035; Tian H, 2004, CHEM SOC REV, V33, P85, DOI 10.1039/b302356g; Tsuzuki S, 2000, J AM CHEM SOC, V122, P3746, DOI 10.1021/ja993972j; Nakashima T, 2007, EUR J ORG CHEM, P3212, DOI 10.1002/ejoc.200700074; Asadirad AM, 2014, J AM CHEM SOC, V136, P3024, DOI 10.1021/ja500496n; Tomasi J, 2005, CHEM REV, V105, P2999, DOI 10.1021/cr9904009; Sumi T, 2014, CHEM COMMUN, V50, P3928, DOI 10.1039/c4cc00396a; Ogawa H, 2012, CHEM COMMUN, V48, P11838, DOI 10.1039/c2cc35793c; Fukumoto S, 2011, ANGEW CHEM INT EDIT, V50, P1565, DOI 10.1002/anie.201006844; Galangau O, 2015, CHEM-EUR J, V21, P8471, DOI 10.1002/chem.201500647; Yildiz I, 2009, CHEM SOC REV, V38, P1859, DOI 10.1039/b804151m; Irie M, 2000, CHEM REV, V100, P1685, DOI 10.1021/cr980069d; Li WL, 2014, ANGEW CHEM INT EDIT, V53, P4603, DOI 10.1002/anie.201310438; Guichard G, 2011, CHEM COMMUN, V47, P5933, DOI 10.1039/c1cc11137j; Irie M, 2014, CHEM REV, V114, P12174, DOI 10.1021/cr500249p; Chai JD, 2008, PHYS CHEM CHEM PHYS, V10, P6615, DOI 10.1039/b810189b; Pu SZ, 2013, CHEM COMMUN, V49, P8036, DOI 10.1039/c3cc44348e; Kawai S, 2007, CHEM MATER, V19, P3479, DOI 10.1021/cm0630340; Goodman AJ, 2001, ORG LETT, V3, P1531, DOI 10.1021/ol015838l; Durr H., 2003, PHOTOCHROMISM MOL SY; Feringa B. L., 2001, MOL SWITCHES; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Fukumoto S, 2011, EUR J ORG CHEM, P5047, DOI 10.1002/ejoc.201100676; Galangau O, 2014, EUR J ORG CHEM, P7165, DOI 10.1002/ejoc.201402774; Guerin J, 2014, CHEM-EUR J, V20, P12279, DOI 10.1002/chem.201402448; Kawai S, 2009, J MATER CHEM, V19, P3606, DOI 10.1039/b823354c; Kobatake S, 2002, CHEM COMMUN, P2804, DOI 10.1039/b208419h; Li W., 2015, SCI REP, V5, P9186; Mutoh K, 2015, PURE APPL CHEM, V87, P511, DOI 10.1515/pac-2014-0910; Nakashima T, 2013, CHEM-EUR J, V19, P16972, DOI 10.1002/chem.201302564; Nakashima T, 2011, CHEM-EUR J, V17, P10951, DOI 10.1002/chem.201101495; Nakashima T, 2014, CHEM-EUR J, V20, P13722, DOI 10.1002/chem.201403791; Nishio M., 1998, CH PI INTERACTION; Ohsumi M, 2008, CHEM COMMUN, P3281, DOI 10.1039/b802780c; Suezawa H, 2002, EUR J INORG CHEM, P3148	41	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	AUG	2015	10	8					1725	1730		10.1002/asia.201500328		6	Chemistry, Multidisciplinary	Chemistry	CN9TV	WOS:000358793000018		
J	Kitagishi, H; Kawasaki, H; Kano, K				Kitagishi, Hiroaki; Kawasaki, Hiroki; Kano, Koji			Bioconjugation of Serum Albumin to a Maleimide-appended Porphyrin/Cyclodextrin Supramolecular Complex as an Artificial Oxygen Carrier in the Bloodstream	CHEMISTRY-AN ASIAN JOURNAL			English	Article						cyclodextrins; oxygen; porphyrinoids; protein modifications; supramolecular chemistry	DIATOMIC MOLECULE RECEPTOR; AQUEOUS-SOLUTION; CIRCULATION TIME; DIOXYGEN BINDING; FREE HEMOGLOBIN; HALF-LIFE; O-2; CYCLODEXTRIN; MYOGLOBIN; IRON	HemoCD is an inclusion complex of per-O-methylated -cyclodextrin dimer and an iron(II) porphyrin, which forms a stable O-2 complex in water. Therefore, hemoCD has the potential for use as a synthetic O-2 carrier in mammalian blood. In this study, a hemoCD derivative having a maleimide group (Mal-hemoCD) was conjugated to a Cys residue of serum albumin via a Michael addition reaction in order to increase the circulation time of the O-2 carrier. The O-2-binding affinities (P-1/2 [Torr]) and half-lives (t(1/2) [h]) of the O-2 adducts at pH7.4 and 25 degrees C were determined to be 9Torr and 23h for Mal-hemoCD, and 10Torr and 14h for albumin-conjugated hemoCD (Alb-hemoCD). Our pharmacokinetic study revealed that renal excretion of Alb-hemoCD was effectively suppressed and that half of injected Alb-hemoCD remained in blood at 3h after injection. It is noteworthy that Mal-hemoCD also had a long circulation time because of the bioconjugation reaction that occurred during circulation in the bloodstream.	[Kitagishi, Hiroaki; Kawasaki, Hiroki; Kano, Koji] Doshisha Univ, Fac Sci & Engn, Dept Mol Chem & Biochem, Kyotanabe, Kyoto 6100321, Japan	Kitagishi, H (reprint author), Doshisha Univ, Fac Sci & Engn, Dept Mol Chem & Biochem, 1-3 Tatara Miyakodani, Kyotanabe, Kyoto 6100321, Japan.	hkitagis@mail.doshisha.ac.jp			Japan Society for the Promotion Science (JSPS) [26870704]	This work was financially supported by Grants-in-Aid for Young Scientists (B) (No. 26870704) from Japan Society for the Promotion Science (JSPS).	Eyer P, 2003, ANAL BIOCHEM, V312, P224, DOI 10.1016/S0003-2697(02)00506-7; Vinodh M, 2012, MOLECULES, V17, P11763, DOI 10.3390/molecules171011763; Kano K, 2005, ANGEW CHEM INT EDIT, V44, P435, DOI 10.1002/anie.200461609; Armstrong JK, 2004, BIOPHYS J, V87, P4259, DOI 10.1529/biophysj.104.047746; Riess JG, 2001, CHEM REV, V101, P2797, DOI 10.1021/cr970143c; COLLMAN JP, 1994, J AM CHEM SOC, V116, P6245, DOI 10.1021/ja00093a026; Li YJ, 2006, J PHYS CHEM B, V110, P8499, DOI 10.1021/jp060532n; BRETON J, 1995, EUR J BIOCHEM, V231, P563, DOI 10.1111/j.1432-1033.1995.0563d.x; Zhao M, 2013, CHEM SOC REV, V42, P8360, DOI 10.1039/c3cs60162e; Tomita D, 2013, BIOMACROMOLECULES, V14, P1816, DOI 10.1021/bm400204y; De P, 2008, J AM CHEM SOC, V130, P11288, DOI 10.1021/ja804495v; Geng J, 2007, J AM CHEM SOC, V129, P15156, DOI 10.1021/ja072999x; Tsuchida E, 2009, BIOCONJUGATE CHEM, V20, P1419, DOI 10.1021/bc800431d; Vandegriff KD, 2003, TRANSFUSION, V43, P509, DOI 10.1046/j.1537-2995.2003.00341.x; Natanson C, 2008, JAMA-J AM MED ASSOC, V299, P2304, DOI 10.1001/jama.299.19.jrv80007; Mantovani G, 2005, J AM CHEM SOC, V127, P2966, DOI 10.1021/ja0430999; Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2; Daijima Y, 2014, CHEM COMMUN, V50, P14716, DOI 10.1039/c4cc06076h; Fox ME, 2009, ACCOUNTS CHEM RES, V42, P1141, DOI 10.1021/ar900035f; Gould SA, 1996, WORLD J SURG, V20, P1200; Kano K, 2006, INORG CHEM, V45, P4448, DOI 10.1021/ic060137b; Kano K, 2012, DALTON T, V41, P453, DOI 10.1039/c1dt11596k; Kano K, 2011, CHEM-ASIAN J, V6, P2946, DOI 10.1002/asia.201100354; Kano K., 2005, ANGEW CHEM, V117, P439, DOI 10.1002/ange.200461609; Karasugi K, 2011, CHEM-ASIAN J, V6, P825, DOI 10.1002/asia.201000756; Karasugi K, 2012, BIOCONJUGATE CHEM, V23, P2365, DOI 10.1021/bc300303z; Karasugi K, 2013, CHEM LETT, V42, P115, DOI 10.1246/cl.2013.115; Karim N., 2009, CAN J PURE APPL SCI, V3, P929; Kawaguchi AT, 2012, ARTIF ORGANS, V36, P127, DOI 10.1111/j.1525-1594.2011.01357.x; Kawaguchi AT, 2014, ARTIF ORGANS, V38, P617, DOI 10.1111/aor.12372; Kettisen K, 2015, BIOCONJUGATE CHEM, V26, P746, DOI 10.1021/acs.bioconjchem.5b00076; Kitagishi H, 2010, ANGEW CHEM INT EDIT, V49, P1312, DOI 10.1002/anie.200906149; Kitagishi H., 2010, ANGEW CHEM, V122, P1334; Kitagishi H, 2012, BIOPOLYMERS, V97, P11, DOI 10.1002/bip.21695; Modery-Pawlowski CL, 2013, BIOMACROMOLECULES, V14, P939, DOI 10.1021/bm400074t; PETERS TH, 1975, THE PLASMA PROTEINS, V1; REED RG, 1988, CLIN CHEM, V34, P1992; Sakai H, 2014, BIOCONJUGATE CHEM, V25, P1301, DOI 10.1021/bc500153x; Sakai H., 2007, J INTERN MED, V263, P4; SAVITSKY JP, 1978, CLIN PHARMACOL THER, V23, P73; Shikama K, 1998, CHEM REV, V98, P1357, DOI 10.1021/cr970042e; Sloan EP, 2010, J TRAUMA, V68, P1158, DOI 10.1097/TA.0b013e3181bbfaac; Tominaga TT, 1997, J INORG BIOCHEM, V65, P235, DOI 10.1016/S0162-0134(96)00137-7; Tsuchida E, 2000, BIOCONJUGATE CHEM, V11, P46, DOI 10.1021/bc990065v; Ueda T, 2012, ORG BIOMOL CHEM, V10, P4337, DOI 10.1039/c2ob07044h; Watanabe K., 2013, ANGEW CHEM, V125, P7032; Watanabe K, 2013, ANGEW CHEM INT EDIT, V52, P6894, DOI 10.1002/anie.201302470; Zingg A, 2002, HELV CHIM ACTA, V85, P333, DOI 10.1002/1522-2675(200201)85:1<333::AID-HLCA333>3.0.CO;2-H	48	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1861-4728	1861-471X		CHEM-ASIAN J	Chem.-Asian J.	AUG	2015	10	8					1768	1775		10.1002/asia.201500451		8	Chemistry, Multidisciplinary	Chemistry	CN9TV	WOS:000358793000024		
J	Pal, T; Kambe, T; Kusamoto, T; Foo, ML; Matsuoka, R; Sakamoto, R; Nishihara, H				Pal, Tigmansu; Kambe, Tetsuya; Kusamoto, Tetsuro; Foo, Maw Lin; Matsuoka, Ryota; Sakamoto, Ryota; Nishihara, Hiroshi			Interfacial Synthesis of Electrically Conducting Palladium Bis(dithiolene) Complex Nanosheet	CHEMPLUSCHEM			English	Article						electrochemistry; nanostructures; thin films; transition metals; synthesis design	ELECTROCATALYTIC REDUCTION; TOPOLOGICAL INSULATOR; SILICON NANOSHEETS; OPTICAL-PROPERTIES; ULTRATHIN FILMS; GRAPHENE; PROTONS; FIELD; OXIDE; NI	The synthesis of palladium bis(dithiolene) complex nanosheets (PdDt) possessing a kagome-type lattice structure was performed via interfacial reaction between metal salt in aqueous phase and dithiolato ligand in organic phase. The PdDt nanosheets were characterised by AFM, STM, TEM revealing flat and sheet-like morphology; IR, UV spectroscopy show the corresponding coordination connectivity between metal and ligand, followed by powder X-ray diffraction and SAED, which determined nanosheets to be structurally similar to previously reported nickel bis(dithiolene) complex nanosheets NiDt.	[Pal, Tigmansu; Kambe, Tetsuya; Kusamoto, Tetsuro; Foo, Maw Lin; Matsuoka, Ryota; Sakamoto, Ryota; Nishihara, Hiroshi] Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, Tokyo 1130033, Japan	Nishihara, H (reprint author), Univ Tokyo, Grad Sch Sci, Dept Chem, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	nisihara@chem.s.u-tokyo.ac.jp	Nishihara, Hiroshi/B-4755-2012; Kambe, Tetsuya/D-2937-2015	Kambe, Tetsuya/0000-0002-9216-2693	MEXT of Japan [24750054, 25107510, 26110505, 26220801, 26708005, 26107510, 26620039, 15H00862, 15K13654, areas 2406, 2506, 2509]; Ogasawara Foundation for the Promotion of Science Engineering; Noguchi Institute; Tokuyama Science Foundation; Asahi Glass Foundation; Murata Science Foundation; Iketani Science and Technology Foundation; Japan Prize Foundation; Kao Foundation for Arts and Sciences; Japan Association for Chemical Innovation; MIKIYA Science and Technology Foundation; Yazaki Memorial Foundation for Science and Technology; Shorai Foundation for Science and Technology; Kurata Memorial Hitachi Science and Technology Foundation; Kumagai Foundation for Science and Technology	We acknowledge Grants-in-Aid from MEXT of Japan (nos. 24750054, 25107510, 26110505, 26220801, 26708005, 26107510, 26620039, 15H00862, 15K13654, areas 2406 (All Nippon Artificial Photosynthesis Project for Living Earth), 2506 (Science of Atomic Layers), 2509 (Molecular Architectonics)). R.S. is grateful to the Ogasawara Foundation for the Promotion of Science & Engineering, the Noguchi Institute, the Tokuyama Science Foundation, the Asahi Glass Foundation, the Murata Science Foundation, the Iketani Science and Technology Foundation, the Japan Prize Foundation, the Kao Foundation for Arts and Sciences, the Japan Association for Chemical Innovation, the MIKIYA Science and Technology Foundation, the Yazaki Memorial Foundation for Science and Technology, the Shorai Foundation for Science and Technology, the Kurata Memorial Hitachi Science and Technology Foundation and the Kumagai Foundation for Science and Technology for financial support. R.M. acknowledges a JSPS fellowship for young scientists. T.P. acknowledges the Todai-IIT Graduate Student Scholarship program.	Matsuoka R, 2014, CHEM COMMUN, V50, P8137, DOI 10.1039/c4cc02022g; Geim AK, 2007, NAT MATER, V6, P183, DOI 10.1038/nmat1849; Das A, 2015, ACS CATAL, V5, P1397, DOI 10.1021/acscatal.5b00045; Kim U, 2011, ACS NANO, V5, P2176, DOI 10.1021/nn103385p; Kambe T, 2013, J AM CHEM SOC, V135, P2462, DOI 10.1021/ja312380b; Li BW, 2010, ACS NANO, V4, P6673, DOI 10.1021/nn102144s; Novoselov KS, 2005, P NATL ACAD SCI USA, V102, P10451, DOI 10.1073/pnas.0502848102; Huang XY, 2009, ANGEW CHEM INT EDIT, V48, P7871, DOI 10.1002/anie.200903234; Okamoto H, 2010, J AM CHEM SOC, V132, P2710, DOI 10.1021/ja908827z; Sheberla D, 2014, J AM CHEM SOC, V136, P8859, DOI 10.1021/ja502765n; Yan DP, 2011, ANGEW CHEM INT EDIT, V50, P720, DOI 10.1002/anie.201003015; Campbell MG, 2015, ANGEW CHEM INT EDIT, V54, P4349, DOI 10.1002/anie.201411854; Lin CC, 2013, NANO LETT, V13, P5177, DOI 10.1021/nl402547m; Novoselov KS, 2004, SCIENCE, V306, P666, DOI 10.1126/science.1102896; Lu ZY, 2011, CHEM MATER, V23, P5293, DOI 10.1021/cm202891p; Xu YH, 2013, CHEM COMMUN, V49, P1591, DOI 10.1039/c2cc38211c; Watanabe K, 2004, NAT MATER, V3, P404, DOI 10.1038/nmat1134; Ida S, 2008, J AM CHEM SOC, V130, P14038, DOI 10.1021/ja804397n; Umar A, 2006, NANOTECHNOLOGY, V17, P2174, DOI 10.1088/0957-4484/17/9/016; McNamara WR, 2011, J AM CHEM SOC, V133, P15368, DOI 10.1021/ja207842r; Mak KF, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.136805; Sasaki T, 1996, J AM CHEM SOC, V118, P8329, DOI 10.1021/ja960073b; Yan DP, 2009, ANGEW CHEM INT EDIT, V48, P3073, DOI 10.1002/anie.200900178; Clough AJ, 2015, J AM CHEM SOC, V137, P118, DOI 10.1021/ja5116937; Kong DS, 2010, NANO LETT, V10, P2245, DOI 10.1021/nl101260j; Takada K, 2015, J AM CHEM SOC, V137, P4681, DOI 10.1021/ja510788b; Kambe T, 2014, J AM CHEM SOC, V136, P14357, DOI 10.1021/ja507619d; Lee HS, 2012, SMALL, V8, P3111, DOI 10.1002/smll.201200752; Muramatsu M, 2005, LANGMUIR, V21, P6590, DOI 10.1021/la050293f; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Ray K, 2005, INORG CHEM, V44, P5345, DOI 10.1021/ic0507565; Song L, 2010, NANO LETT, V10, P3209, DOI 10.1021/nl1022139; Wang ZF, 2013, NANO LETT, V13, P2842, DOI 10.1021/nl401147u; McNamara WR, 2012, P NATL ACAD SCI USA, V109, P15594, DOI 10.1073/pnas.1120757109; Sakai N, 2004, J AM CHEM SOC, V126, P5851, DOI 10.1021/ja0394582; Aragoni MC, 2002, INORG CHEM COMMUN, V5, P869, DOI 10.1016/S1387-7003(02)00582-8; Campbell M. G., 2015, ANGEW CHEM, V127, P4423; Hamoudi H, 2015, J MATER CHEM C, V3, P3636, DOI 10.1039/c5tc00228a; Haynes W. M., 2014, CRC HDB CHEM PHYS, P12; Huang X., 2009, ANGEW CHEM, V121, P8011, DOI DOI 10.1021/JA0343611; Liu XH, 2014, ADV MATER, V26, P6912, DOI 10.1002/adma.201305317; Ma R., 2006, MATER CHEM, V16, P3809; Sakamoto R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7713; Yan D., 2009, ANGEW CHEM, V121, P3119; Yan D. P., 2011, ANGEW CHEM, V123, P746, DOI 10.1002/ange.201003015	45	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	2192-6506			CHEMPLUSCHEM	ChemPlusChem	AUG	2015	80	8			SI		1255	1258		10.1002/cplu.201500206		4	Chemistry, Multidisciplinary	Chemistry	CO3UV	WOS:000359086900011		
J	Kataoka, K; Taniguchi, H; Kondoh, Y; Nishiyama, O; Kimura, T; Matsuda, T; Yokoyama, T; Sakamoto, K; Ando, M				Kataoka, Kensuke; Taniguchi, Hiroyuki; Kondoh, Yasuhiro; Nishiyama, Osamu; Kimura, Tomoki; Matsuda, Toshiaki; Yokoyama, Toshiki; Sakamoto, Koji; Ando, Masahiko			Recombinant Human Thrombomodulin in Acute Exacerbation of Idiopathic Pulmonary Fibrosis	CHEST			English	Article							HUMAN SOLUBLE THROMBOMODULIN; ACUTE LUNG INJURY; DISSEMINATED INTRAVASCULAR COAGULATION; LECTIN-LIKE DOMAIN; CLINICAL-COURSE; CYCLOSPORINE-A; SEVERE SEPSIS; PROTEIN-C; MORTALITY; INFLAMMATION	BACKGROUND: Acute exacerbation (AE) of idiopathic pulmonary fibrosis (IPF) presents as episodes of acute respiratory worsening closely associated with endothelial damage and disordered coagulopathy. Recombinant human soluble thrombomodulin (rhTM) regulates the coagulation pathway mainly by reducing thrombin-mediated clotting and enhancing protein C activation. We investigated the efficacy of rhTM for the treatment of patients with AE-IPF. METHODS: This historical control study comprised 40 patients with AE-IPF. Twenty patients treated with rhTM (0.06 mg/kg/d) for about 6 days (rhTM group) and 20 patients treated without rhTM (control group) were evaluated. The predictors of 3-month mortality (logistic regression model) were evaluated. RESULTS: There was no difference in baseline characteristics between the control group and the rhTM group. Three-month mortality of the rhTM group and control group was 30.0% and 65.0%, respectively. In univariate analysis, C-reactive protein and rhTM therapy were significant determinants for 3-month survival. In multivariate analysis, rhTM therapy (OR, 0.219; 95% CI, 0.049-0.978; P = 0.047) was an independent significant determinant for 3-month survival. CONCLUSIONS: We found that rhTM therapy improved 3-month survival of AE-IPF. The results observed here warrant further investigation of rhTM in randomized control trials.	[Kataoka, Kensuke; Taniguchi, Hiroyuki; Kondoh, Yasuhiro; Kimura, Tomoki; Matsuda, Toshiaki; Yokoyama, Toshiki] Tosei Gen Hosp, Dept Resp Med & Allergy, Seto, Aichi 4898642, Japan; [Nishiyama, Osamu] Kinki Univ, Fac Med, Dept Resp Med & Allergol, Osaka, Japan; [Sakamoto, Koji] Nagoya Univ, Grad Sch Med, Dept Resp Med, Nagoya, Aichi 4648601, Japan; [Ando, Masahiko] Nagoya Univ Hosp, Ctr Adv Med & Clin Res, Nagoya, Aichi, Japan	Taniguchi, H (reprint author), Tosei Gen Hosp, Dept Resp Med & Allergy, 160 Nishioiwake Cho, Seto, Aichi 4898642, Japan.	taniguchi@tosei.or.jp			Ministry of Health, Labor and Welfare, Japan; NPO Respiratory Disease Conference	This study was partially supported by a grant to the Diffuse Lung Disease Research Group from the Ministry of Health, Labor and Welfare, Japan, and the NPO Respiratory Disease Conference.	Homma S, 2005, INTERNAL MED, V44, P1144, DOI 10.2169/internalmedicine.44.1144; Yokoyama T, 2010, INTERNAL MED, V49, P1509, DOI 10.2169/internalmedicine.49.3222; Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Sakamoto S, 2010, INTERNAL MED, V49, P109, DOI 10.2169/internalmedicine.49.2359; Noth I, 2012, AM J RESP CRIT CARE, V186, P88, DOI 10.1164/rccm.201202-0314OC; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Collard HR, 2010, AM J PHYSIOL-LUNG C, V299, pL3, DOI 10.1152/ajplung.90637.2008; Martinez FJ, 2005, ANN INTERN MED, V142, P963; Gunther A, 2000, THROMB HAEMOSTASIS, V83, P853; Ito T, 2011, J THROMB HAEMOST, V9, P168, DOI 10.1111/j.1538-7836.2011.04319.x; KONDOH Y, 1993, CHEST, V103, P1808, DOI 10.1378/chest.103.6.1808; Collard HR, 2007, AM J RESP CRIT CARE, V176, P636, DOI 10.1164/rccm.200703-463PP; Song JW, 2011, EUR RESPIR J, V37, P356, DOI 10.1183/09031936.00159709; Kubo H, 2005, CHEST, V128, P1475, DOI 10.1378/chest.128.3.1475; Maruyama I, 1999, THROMB HAEMOSTASIS, V82, P718; Van de Wouwer M, 2006, J THROMB HAEMOST, V4, P1813, DOI 10.1111/j.1538-7836.2006.02033.x; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Shi CS, 2008, BLOOD, V112, P3661, DOI 10.1182/blood-2008-03-142760; Ley B, 2011, AM J RESP CRIT CARE, V183, P431, DOI 10.1164/rccm.201006-0894CI; Ogawa Y, 2012, J TRAUMA ACUTE CARE, V72, P1150, DOI 10.1097/TA.0b013e3182516ab5; Inase N, 2003, INTERNAL MED, V42, P565, DOI 10.2169/internalmedicine.42.565; Ebina M, 2011, PULM MED, V2011, DOI DOI 10.1155/2011/916486; Gaggar A, 2006, CLIN CHIM ACTA, V372, P24, DOI 10.1016/j.cca.2006.04.019; Olman MA, 2003, ACUTE RESP DISTRESS, P313; Prabhakaran P, 2003, AM J PHYSIOL-LUNG C, V285, pL20, DOI 10.1152/ajplung.00312.2002; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Ware LB, 2003, AM J PHYSIOL-LUNG C, V285, pL514, DOI 10.1152/ajplung.00442.2002; Yamakawa K, 2011, CRIT CARE, V15, DOI 10.1186/cc10228	28	0	0	AMER COLL CHEST PHYSICIANS	GLENVIEW	2595 PATRIOT BLVD, GLENVIEW, IL 60026 USA	0012-3692			CHEST	Chest	AUG	2015	148	2					436	443		10.1378/chest.14-2746		8	Critical Care Medicine; Respiratory System	General & Internal Medicine; Respiratory System	CO2SA	WOS:000359005700043		
J	Tahara, T; Shibata, T; Okubo, M; Kawamura, T; Sumi, K; Ishizuka, T; Nakamura, M; Nagasaka, M; Nakagawa, Y; Ohmiya, N; Arisawa, T; Hirata, I				Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Kawamura, Tomohiko; Sumi, Kazuya; Ishizuka, Takamitsu; Nakamura, Masakatsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Arisawa, Tomiyasu; Hirata, Ichiro			Telomere length in non-neoplastic colonic mucosa in ulcerative colitis (UC) and its relationship to the severe clinical phenotypes	CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Telomere length; Colonic mucosa; Ulcerative colitis; Clinical phenotypes	CHROMOSOMAL INSTABILITY; 5-AMINOSALICYLIC ACID; CIGARETTE-SMOKING; OXIDATIVE STRESS; CANCER; DISEASE; CARCINOGENESIS; SENESCENCE; DAMAGE; WOMEN	Telomere shortening occurs with human aging in many organs and tissues and is accelerated by rapid cell turnover and oxidative injury. To clarify the clinical importance of telomere shortening in colonic mucosa in ulcerative colitis (UC), we measured average telomere length using quantitative real-time PCR in non-neoplastic colonic mucosa in UC patients and assessed its relationship to various clinical subtypes. Relative telomere length in genomic DNA was measured in colonic biopsies obtained from rectal inflammatory mucosa from 86 UC patients as well as paired non-inflammatory proximal colonic mucosae from 10 patients. Data were correlated with various clinical phenotypes. In paired samples, average relative telomere length of rectal inflammatory mucosa was shortened compared to normal appearing proximal colon in eight out of ten cases (p = 0.01). Telomere length shortening was significantly associated with more severe Mayo endoscopic subscore (p < 0.0001) and cases needing surgery due to toxic megacolon or cancer occurrence (p = 0.043). When the severe clinical phenotype was defined as having at least one of following phenotypes, more than two times of hospitalization, highest Mayo endoscopic subscore, steroid dependent, refractory, or needing operation, average relative telomere length was significantly shortened in the same phenotypes than the others (p = 0.003). Telomere shortening is associated with more severe clinical phenotypes of UC, reflecting severe inflammatory state in the colonic mucosa.	[Tahara, Tomomitsu; Shibata, Tomoyuki; Okubo, Masaaki; Kawamura, Tomohiko; Sumi, Kazuya; Ishizuka, Takamitsu; Nagasaka, Mitsuo; Nakagawa, Yoshihito; Ohmiya, Naoki; Hirata, Ichiro] Fujita Hlth Univ, Sch Med, Dept Gastroenterol, Toyoake, Aichi 4701192, Japan; [Nakamura, Masakatsu; Arisawa, Tomiyasu] Kanazawa Med Univ, Dept Gastroenterol, Kanazawa, Ishikawa, Japan	Tahara, T (reprint author), Fujita Hlth Univ, Sch Med, Dept Gastroenterol, 1-98 Dengakugakubo Kutsukake Cho, Toyoake, Aichi 4701192, Japan.	tomomiccyu@yahoo.co.jp					Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Issa JPJ, 2001, CANCER RES, V61, P3573; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Chang S, 2005, MUTAT RES-FUND MOL M, V576, P39, DOI 10.1016/j.mrfmmm.2004.08.020; Rabinovitch PS, 1999, CANCER RES, V59, P5148; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Wu XF, 2003, J NATL CANCER I, V95, P1211, DOI 10.1093/jnci/djg011; Hande MP, 1999, J CELL BIOL, V144, P589, DOI 10.1083/jcb.144.4.589; Jennings BJ, 2000, MOL GENET METAB, V71, P32, DOI 10.1006/mgme.2000.3077; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Aida J, 2007, HUM PATHOL, V38, P1192, DOI 10.1016/j.humpath.2006.11.023; Blasco MA, 2005, NAT REV GENET, V6, P611, DOI 10.1038/nrg1656; Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Kinouchi Y, 1998, J GASTROENTEROL, V33, P343, DOI 10.1007/s005350050094; Roessner A, 2008, PATHOL RES PRACT, V204, P511, DOI 10.1016/j.prp.2008.04.011; Cheng Y, 2005, WORLD J GASTROENTERO, V11, P309; Da-Silva N, 2010, DIGEST LIVER DIS, V42, P544, DOI 10.1016/j.dld.2009.12.005; Head Kathleen A, 2003, Altern Med Rev, V8, P247; Lakatos László, 2003, Orv Hetil, V144, P1853; Risques RA, 2011, CANCER RES, V71, P1669, DOI 10.1158/0008-5472.CAN-10-1966; Risques RA, 2008, GASTROENTEROLOGY, V135, P410, DOI 10.1053/j.gastro.2008.04.008; Schonland SO, 2003, P NATL ACAD SCI USA, V100, P13471, DOI 10.1073/pnas.2233561100; Tahara T, 2009, CLIN EXP MED, V9, P125, DOI 10.1007/s10238-008-0025-x; Tahara T, 2011, VIRCHOWS ARCH, V458, P205, DOI 10.1007/s00428-010-1038-x	28	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1591-8890	1591-9528		CLIN EXP MED	Clin. Exper. Med.	AUG	2015	15	3					327	332		10.1007/s10238-014-0295-4		6	Medicine, Research & Experimental	Research & Experimental Medicine	CN9NN	WOS:000358775900012		
J	Nakarai, C; Osawa, K; Akiyama, M; Matsubara, N; Ikeuchi, H; Yamano, T; Hirota, S; Tomita, N; Usami, M; Kido, Y				Nakarai, Chiaki; Osawa, Kayo; Akiyama, Minami; Matsubara, Nagahide; Ikeuchi, Hiroki; Yamano, Tomoki; Hirota, Seiichi; Tomita, Naohiro; Usami, Makoto; Kido, Yoshiaki			Expression of AKR1C3 and CNN3 as markers for detection of lymph node metastases in colorectal cancer	CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						AKR1C3; CNN3; Lymph node metastasis; Colorectal cancer; Real-time quantitative PCR	MESSENGER-RNA EXPRESSION; TREFOIL FACTOR-3; RECTAL-CANCER; COLON-CANCER; CARCINOMA; REDUCTASE; SURVIVAL; S100P; PROSTATE; 17-BETA-HYDROXYSTEROID-DEHYDROGENASE	The aim of the study was to identify a set of discriminating genes that could be used for the prediction of Lymph node (LN) metastasis in human colorectal cancer (CRC), and for this, we compared the whole genome profiles of two CRC cell lines (the primary cell line SW480 and its LN metastatic variant, SW620) and identified eight genes [S100 calcium-binding protein P; aldo-keto reductase family 1(AKR1), member B1 (aldose reductase; AKR1B1); AKR1, member C3 (AKR1C3); calponin 3, acidic; metastasis associated in colon cancer 1; hemoglobin, epsilon 1; trefoil factor 3; and FGGY carbohydrate kinase domain containing]. These genes were examined by quantitative RT-PCR in tissues and LNs in 14 CRC patients and 11 control patients. The level of AKR1C3 mRNA expression was significantly different between the Dukes' stage A, B, and C groups and the control group (p < 0.05, p < 0.001, and p < 0.001) and was also significantly different between Dukes' stage C and A or B groups (p < 0.05 and p < 0.001, respectively). The expression of CNN3 was significantly different between the Dukes' stage C and B or control groups (p < 0.001 and p < 0.01, respectively). There were significant correlations between the expression levels of AKR1C3 and CNN3. AKR1C3 and CNN3 expressions are more accurate and suitable markers for the diagnosis of LN metastasis than the other six genes examined in this study.	[Nakarai, Chiaki; Osawa, Kayo; Akiyama, Minami; Usami, Makoto; Kido, Yoshiaki] Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Suma Ku, Kobe, Hyogo 6540142, Japan; [Matsubara, Nagahide; Ikeuchi, Hiroki; Yamano, Tomoki; Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Hirota, Seiichi] Hyogo Coll Med, Dept Surg Pathol, Nishinomiya, Hyogo 6638501, Japan; [Kido, Yoshiaki] Kobe Univ, Grad Sch Med, Dept Internal Med, Div Diabet & Endocrinol, Kobe, Hyogo 6540142, Japan	Osawa, K (reprint author), Kobe Univ, Grad Sch Hlth Sci, Dept Biophys, Suma Ku, 7-10-2 Tomogaoka, Kobe, Hyogo 6540142, Japan.	osawakysr@gmail.com					Ueno H, 2007, AM J CLIN PATHOL, V127, P287, DOI 10.1309/903UT10VQ3LC7B8L; Wang GZ, 2006, CANCER RES, V66, P1199, DOI 10.1158/0008-5472.CAN-05-2605; Jiang Z, 2010, MOL BIOL REP, V37, P3029, DOI 10.1007/s11033-009-9873-z; Yoshino K, 2011, BIOCHEM BIOPH RES CO, V404, P1070, DOI 10.1016/j.bbrc.2010.12.115; Daoud H, 2010, AMYOTROPH LATERAL SC, V11, P389, DOI 10.3109/17482960903358857; Stein U, 2009, NAT MED, V15, P59, DOI 10.1038/nm.1889; Rosenberg R, 2002, J CLIN ONCOL, V20, P1049, DOI 10.1200/JCO.20.4.1049; Casado E, 2012, INT J RADIAT ONCOL, V84, P1151, DOI 10.1016/j.ijrobp.2012.01.083; DUKES CE, 1958, BRIT J CANCER, V12, P309, DOI 10.1038/bjc.1958.37; Greiner M, 2000, PREV VET MED, V45, P23, DOI 10.1016/S0167-5877(00)00115-X; Rizner TL, 2006, MOL CELL ENDOCRINOL, V248, P126, DOI 10.1016/j.mce.2005.10.009; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Yabe-Nishimura C, 1998, PHARMACOL REV, V50, P21; Fung KM, 2006, ENDOCR-RELAT CANCER, V13, P169, DOI 10.1677/erc.1.01048; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Ashley RA, 2010, UROLOGY, V76, P67, DOI 10.1016/j.urology.2009.09.046; Azzarello J, 2008, J HISTOCHEM CYTOCHEM, V56, P853, DOI 10.1369/jhc.2008.951384; BECKER T, 1992, EUR J BIOCHEM, V207, P541, DOI 10.1111/j.1432-1033.1992.tb17080.x; Bilchik AJ, 2007, ANN SURG, V246, P568, DOI 10.1097/S1A.0b013e318155a9c7; Blumenthal RD, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-2; Dozmorov MG, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-672; Hamid AR, 2013, MOL MED, V18, P1449; Hatairaktham S, 2013, ANN HEMATOL, V92, P365, DOI 10.1007/s00277-012-1629-5; Huang YG, 2013, J CANCER RES THER, V9, P376, DOI 10.4103/0973-1482.119308; Lin HK, 2004, STEROIDS, V69, P795, DOI 10.1016/j.steroids.2004.09.014; Liu JH, 2009, RECENT PAT ANTI-CANC, V4, P246; Miller VL, 2012, INT J CLIN EXP PATHO, V5, P278; Miyake Y, 2001, CLIN CANCER RES, V7, P1350; Nakarai C, 2012, ANTICANCER RES, V32, P3753; Ohlsson L, 2006, BRIT J CANCER, V95, P218, DOI 10.1038/sj.bjc.6603206; Parkkila Seppo, 2008, BMC Clin Pathol, V8, P2, DOI 10.1186/1472-6890-8-2; Shibukawa Y, 2010, MOL BIOL CELL, V21, P3973, DOI 10.1091/mbc.E10-03-0261; Shirahata A, 2010, ANTICANCER RES, V30, P2689; Shrout J, 2008, BRIT J CANCER, V98, P1999, DOI 10.1038/sj.bjc.6604399; Urzua U, 2006, J CELL PHYSIOL, V206, P594, DOI 10.1002/jcp.20522; Vinatzer U, 2008, CLIN CANCER RES, V14, P6426, DOI 10.1158/1078-0432.CCR-08-0702; Wang Q, 2012, ONCOL REP, V28, P303, DOI 10.3892/or.2012.1794; Zhang Y, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002318	38	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1591-8890	1591-9528		CLIN EXP MED	Clin. Exper. Med.	AUG	2015	15	3					333	341		10.1007/s10238-014-0298-1		9	Medicine, Research & Experimental	Research & Experimental Medicine	CN9NN	WOS:000358775900013		
J	Ojima, E; Fujimura, T; Oyama, K; Tsukada, T; Kinoshita, J; Miyashita, T; Tajima, H; Fushida, S; Harada, S; Mukaisho, K; Hattori, T; Ohta, T				Ojima, Eisuke; Fujimura, Takashi; Oyama, Katsunobu; Tsukada, Tomoya; Kinoshita, Jun; Miyashita, Tomoharu; Tajima, Hidehiro; Fushida, Sachio; Harada, Shin-ichi; Mukaisho, Ken-ichi; Hattori, Takanori; Ohta, Tetsuo			Chemoprevention of esophageal adenocarcinoma in a rat model by ursodeoxycholic acid	CLINICAL AND EXPERIMENTAL MEDICINE			English	Article						Gastroesophageal reflux disease; Barrett's esophagus; Esophageal adenocarcinoma; Caudal-type homeobox 2; Ursodeoxycholic acid; Chemoprevention	FACTOR-KAPPA-B; BARRETTS-ESOPHAGUS; BILE-ACIDS; GASTROESOPHAGEAL-REFLUX; CDX2 EXPRESSION; CELLS; CARCINOGENESIS; METAPLASIA; PH; EPITHELIUM	Reflux of bile acid into the esophagus induces esophagitis, inflammation-stimulated hyperplasia, metaplasia such as Barrett's esophagus (BE), and esophageal adenocarcinoma (EAC). Caudal-type homeobox 2 (Cdx2) via nuclear factor (NF)-kappa B induced by bile acid is an important factor in the development of BE and EAC. In colorectal cancer, experimental data suggest a chemopreventive effect of ursodeoxycholic acid (UDCA). We hypothesized that UDCA may protect against the esophageal inflammation-metaplasia-carcinoma sequence by decreasing the overall proportion of the toxic bile acids. Wistar male rats that underwent a duodenoesophageal reflux procedure were divided into two groups. One group was given commercial chow (control group), and the other was given experimental chow containing UDCA (UDCA group). The animals were killed at 40 weeks after surgery, and their bile and esophagus were examined. In the UDCA group, the esophagitis was milder and the incidence of BE was significantly lower (p < 0.05) than in the control group, and EAC was not observed (p < 0.05). In analysis of the compartment of bile acid, UDCA was markedly increased in the UDCA group compared with the control group (32.7 +/- A 11.4 vs. 0.82 +/- A 0.33 mmol/L, p < 0.05) and cholic acid was decreased (32.7 +/- A 4.05 vs. 60.9 +/- A 8.26 mmol/L, p < 0.05). Expression intensity of Cdx2 and NF-kappa B was greater in the control group than in the UDCA group (p < 0.05). UDCA may be a chemopreventive agent against EAC by varying the bile acid composition.	[Ojima, Eisuke; Fujimura, Takashi; Oyama, Katsunobu; Tsukada, Tomoya; Kinoshita, Jun; Miyashita, Tomoharu; Tajima, Hidehiro; Fushida, Sachio; Ohta, Tetsuo] Kanazawa Univ, Dept Surg Gastroenterol, Kanazawa, Ishikawa 9208641, Japan; [Harada, Shin-ichi] Kanazawa Univ, Ctr Biomed Res, Kanazawa, Ishikawa 9208641, Japan; [Mukaisho, Ken-ichi; Hattori, Takanori] Shiga Univ Med Sci, Dept Pathol, Otsu, Shiga 5202192, Japan	Fujimura, T (reprint author), Kanazawa Univ, Dept Surg Gastroenterol, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	tphuji@staff.kanazawa-u.ac.jp					Cronin J, 2010, BIOCHEM SOC T, V38, P337, DOI 10.1042/BST0380337; EARNEST DL, 1994, CANCER RES, V54, P5071; Paumgartner G, 2002, HEPATOLOGY, V36, P525, DOI 10.1053/jhep.2002.36088; Moons LMG, 2004, J CLIN PATHOL, V57, P1063, DOI 10.1136/jcp.2003.015727; Tamagawa Y, 2012, LAB INVEST, V92, P896, DOI 10.1038/labinvest.2012.56; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Miwa K, 1996, INT J CANCER, V67, P269, DOI 10.1002/(SICI)1097-0215(19960717)67:2<269::AID-IJC19>3.0.CO;2-6; Oyama K, 2005, CARCINOGENESIS, V26, P565, DOI 10.1093/carcin/bgh340; Alberts DS, 2005, J NATL CANCER I, V97, P846, DOI 10.1093/jnci/dji144; Miura T, 2001, J BIOL CHEM, V276, P47371, DOI 10.1074/jbc.M107098200; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Kazumori H, 2006, GUT, V55, P16, DOI 10.1136/gut.2005.066209; O'Riordan JM, 2005, AM J GASTROENTEROL, V100, P1257, DOI 10.1111/j.1572-0241.2005.41338.x; Rost D, 2004, HEPATOLOGY, V40, P693, DOI 10.1002/hep.20370; Jankowski JA, 2000, LANCET, V356, P2079, DOI 10.1016/S0140-6736(00)03411-5; Phillips RW, 2003, AM J SURG PATHOL, V27, P1442, DOI 10.1097/00000478-200311000-00006; Jenkins GJS, 2004, CARCINOGENESIS, V25, P317, DOI 10.1093/carcin/bgh032; Rayet B, 1999, ONCOGENE, V18, P6938, DOI 10.1038/sj.onc.1203221; CHAMPION G, 1994, GASTROENTEROLOGY, V107, P747; STEIN HJ, 1994, AM J SURG, V167, P163, DOI 10.1016/0002-9610(94)90068-X; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Nehra D, 1999, GUT, V44, P598; Debruyne PR, 2006, GASTROENTEROLOGY, V130, P1191, DOI 10.1053/j.gastro.2005.12.032; Eda A, 2003, J GASTROENTEROL, V38, P14, DOI 10.1007/s005350300001; Bozikas A, 2008, DIS ESOPHAGUS, V21, P346, DOI 10.1111/j.1442-2050.2007.00782.x; Burnat G, 2010, J PHYSIOL PHARMACOL, V61, P185; Chen KH, 2007, CANCER SCI, V98, P1683, DOI 10.1111/j.1349-7006.2007.00605.x; Fujimura Takashi, 2011, Cancers (Basel), V3, P3206, DOI 10.3390/cancers3033206; GILLEN P, 1988, BRIT J SURG, V75, P540, DOI 10.1002/bjs.1800750612; Goldman A, 2010, DIS ESOPHAGUS, V23, P83, DOI 10.1111/j.1442-2050.2009.00993.x; IFTIKHAR SY, 1993, ANN ROY COLL SURG, V75, P411; Liu T, 2007, CARCINOGENESIS, V28, P488, DOI 10.1093/carcin/bgl176; Loddenkemper C, 2006, INT J CANCER, V118, P2750, DOI 10.1002/ijc.21729; Pera M, 2000, Recent Results Cancer Res, V155, P1	34	0	0	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1591-8890	1591-9528		CLIN EXP MED	Clin. Exper. Med.	AUG	2015	15	3					343	350		10.1007/s10238-014-0301-x		8	Medicine, Research & Experimental	Research & Experimental Medicine	CN9NN	WOS:000358775900014		
J	Korzun, WJ; Nilsson, G; Bachmann, LM; Myers, GL; Sakurabayashi, I; Nakajima, K; Nakamura, M; Shamburek, RD; Remaley, AT; Miller, WG				Korzun, William J.; Nilsson, Goeran; Bachmann, Lorin M.; Myers, Gary L.; Sakurabayashi, Ikunosuke; Nakajima, Katsuyuki; Nakamura, Masakazu; Shamburek, Robert D.; Remaley, Alan T.; Miller, W. Greg			Difference in Bias Approach for Commutability Assessment: Application to Frozen Pools of Human Serum Measured by 8 Direct Methods for HDL and LDL Cholesterol	CLINICAL CHEMISTRY			English	Article								BACKGROUND: We used a difference in bias approach to evaluate the commutability of 4 frozen serum pools for 8 direct methods for measurement of HDL and LDL cholesterol (HDLC and LDLC). METHODS: Freshly collected nonfrozen sera from 138 diseased and 37 nondiseased patients and 4 frozen pools from the CDC Lipid Standardization Program were measured by direct methods and by the beta-quantification reference measurement procedure of the CDC. We used an error components model to estimate the difference in the bias component of error plus its uncertainty for frozen pools vs patient samples between the direct method and the reference procedure. Frozen pools with bias differences less than a critical value determined by either medical requirements for bias or the random error components of the measurement procedures were considered commutable. RESULTS: On the basis of medical requirement criteria, 1 of the 4 frozen pools was commutable for most of the HDLC methods for both diseased and nondiseased patients, and none was commutable for LDLC methods. On the basis of random error criteria, all of the frozen pools were generally commutable for all of the HDLC methods for both diseased and nondiseased patients, and 1 of the 4 frozen pools was generally commutable for most of the LDLC methods for both diseased and nondiseased patients. CONCLUSIONS: Commutability was assessed as the closeness of agreement of the difference in bias between a reference material and a set of patient samples. Criteria for commutability could be based on fixed medical requirements for bias or on random error components. (C) 2015 American Association for Clinical Chemistry	[Korzun, William J.; Bachmann, Lorin M.; Miller, W. Greg] Virginia Commonwealth Univ, Richmond, VA USA; [Myers, Gary L.] Amer Assoc Clin Chem, Washington, DC USA; [Sakurabayashi, Ikunosuke] Jichi Med Univ, Shimotsuke, Tochigi, Japan; [Nakajima, Katsuyuki] Otsuka Pharmaceut Co Ltd, Tokyo, Japan; [Nakamura, Masakazu] Osaka Med Ctr Hlth Sci & Promot, Osaka, Japan; [Shamburek, Robert D.; Remaley, Alan T.] NIH, Bethesda, MD 20892 USA	Miller, WG (reprint author), POB 980286, Richmond, VA 23298 USA.	gmiller@vcu.edu					Bachmann LM, 2014, CLIN CHEM, V60, P471, DOI 10.1373/clinchem.2013.210302; Miller WG, 2010, CLIN CHEM, V56, P977, DOI 10.1373/clinchem.2009.142810; [Anonymous], 2008, INT VOC METR BAS GEN; CLSI, 1999, C37A CLSI; CLSI, 2014, EP14A3 CLSI; CLSI, 2010, EP30A CLSI; Cobbaert C, 2002, CLIN CHEM, V48, P1526; Miller WG, 2013, CLIN CHEM, V59, P1291, DOI 10.1373/clinchem.2013.208785; National Cholesterol Education Program, 1995, NIH PUB	9	2	2	AMER ASSOC CLINICAL CHEMISTRY	WASHINGTON	2101 L STREET NW, SUITE 202, WASHINGTON, DC 20037-1526 USA	0009-9147	1530-8561		CLIN CHEM	Clin. Chem.	AUG	2015	61	8					1107	1113		10.1373/clinchem.2015.240861		7	Medical Laboratory Technology	Medical Laboratory Technology	CO0BO	WOS:000358815300015		
J	Tomori, K; Nagayama, H; Ohno, K; Nagatani, R; Saito, Y; Takahashi, K; Sawada, T; Higashi, T				Tomori, Kounosuke; Nagayama, Hirofumi; Ohno, Kanta; Nagatani, Ryutaro; Saito, Yuki; Takahashi, Kayoko; Sawada, Tatsunori; Higashi, Toshio			Comparison of occupation-based and impairment-based occupational therapy for subacute stroke: a randomized controlled feasibility study	CLINICAL REHABILITATION			English	Article						Occupational therapy; occupation-based; impairment-based; activities; Aid for Decision-Making in Occupation Choice	SF-36 HEALTH SURVEY; DECISION-MAKING; REHABILITATION; INTERVENTION; JAPAN; RELIABILITY; VALIDITY; CHOICE; TRIAL; AID	Objective: To compare occupation-based and impairment-based approaches in occupational therapy and determine the feasibility of patient recruitment and retention. Design: A multicenter, randomized, controlled pilot trial with a single blind assessor. Setting: Ten subacute rehabilitation units in Japan. Participants: Fifty-four patients with subacute stroke. Interventions: The experimental group used the iPad application, Aid for Decision-making in Occupation Choice, to establish occupation-based goals, and evaluation and intervention were conducted mainly through real occupations. The control group was evaluated according to patients' generic abilities and activities of daily living (ADL), and the intervention mainly involved the impairment-based approach. Main outcome measures: Short Form-36, Functional Independence Measure, Brunnstrom recovery stages, The Client Satisfaction Questionnaire, and length of hospital stay. Results: Of the 1465 potential participants, 54 (3%) subacute stroke patients were enrolled over 16 months and 68% (n = 36) were retained to the 2-month assessment: experimental group (n = 16); control group (n = 21). Although there was no significant intergroup difference for any outcomes, the experimental group had a small effect size advantage on the Short Form-36 ''General health'' (d = 0.42) and ''Role emotional'' (d = 0.43) subscales relative to the control group. A sample of 118 subacute stroke patients per group would be required for a lager study. Conclusions: Results suggest that the occupation-based approach has more potential to improve ''General health'' and ''Role emotional'' scores on the Short Form-36 than the impairment-based approach. Further investigation of study protocol with interventions and recruiting is needed prior to a larger trial.	[Tomori, Kounosuke; Nagayama, Hirofumi; Nagatani, Ryutaro] Kanagawa Univ Human Serv, Dept Occupat Therapy, Yokosuka, Kanagawa 2388522, Japan; [Ohno, Kanta] Kanagawa Univ Human Serv, Grad Course Hlth & Social Care, Yokosuka, Kanagawa 2388522, Japan; [Saito, Yuki] Koriyama Inst Hlth Sci, Dept Occupat Therapy, Koriyama, Fukushima, Japan; [Takahashi, Kayoko] Kitasato Univ, Dept Occupat Therapy, Sagamihara, Kanagawa 228, Japan; [Sawada, Tatsunori] IMS Itabashi Rehabil Hosp, Tokyo, Tokyo, Japan; [Higashi, Toshio] Nagasaki Univ, Grad Sch Biomed Sci, Unit Rehabil Sci, Dept Community Based Rehabil Sci, Nagasaki 852, Japan	Tomori, K (reprint author), Kanagawa Univ Human Serv, Occupat Therapy, Yokosuka, Kanagawa 2388522, Japan.	adoc.project@gmail.com			Japan Society for the Promotion of Science [24531257, 23590610]	This work was supported in part by a Grant-in-Aid for Scientific Research (C) (project no. 24531257 to K Tomori and project no. 23590610 to R Nagatani) from the Japan Society for the Promotion of Science.	KIRESUK TJ, 1968, COMMUNITY MENT HLT J, V4, P443, DOI 10.1007/BF01530764; Gustafsson L, 2012, SCAND J OCCUP THER, V19, P132, DOI 10.3109/11038128.2011.562915; Egan M, 2007, TOP STROKE REHABIL, V14, P37, DOI 10.1310/tsr1405-37; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1045, DOI 10.1016/S0895-4356(98)00096-1; Polatajko HJ, 2012, CAN J OCCUP THER, V79, P259, DOI 10.2182/cjot.2012.79.5.1; Fukuhara S, 1998, J CLIN EPIDEMIOL, V51, P1037, DOI 10.1016/S0895-4356(98)00095-X; Legg L, 2007, BRIT MED J, V335, P922, DOI 10.1136/bmj.39343.466863.55; Miyai I, 2011, NEUROREHAB NEURAL RE, V25, P540, DOI 10.1177/1545968311402696; Naghdi S, 2010, BRAIN INJURY, V24, P1372, DOI 10.3109/02699052.2010.506860; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Fisher AG, 2013, SCAND J OCCUP THER, V20, P162, DOI 10.3109/11038128.2012.754492; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Hopman WM, 2003, STROKE, V34, P801, DOI 10.1161/01.STR.0000057978.15397.6F; Attkisson C C, 1982, Eval Program Plann, V5, P233, DOI 10.1016/0149-7189(82)90074-X; Baum CM, 2005, OCCUPATIONAL THERAPY, V3rd; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; Cohen J., 1988, STAT POWER ANAL BEHA; Estes J, 2012, SCAND J OCCUP THER, V19, P17, DOI 10.3109/11038128.2010.547598; Fisher TF, 2010, OCCUPATIONAL THERAPY ESSENTIALS FOR CLINICAL COMPETENCE, P485; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gotoh F, 2001, STROKE, V32, P1800; Guidetti S, 2010, SCAND J OCCUP THER, V17, P276, DOI 10.3109/11038120903281169; Latham NK, 2006, AM J OCCUP THER, V60, P369; Law M., 2005, CANADIAN OCCUPATIONA; Richards L. G., 2005, ARCH PHYS MED REHAB, V86, P51, DOI DOI 10.1016/J.APMR.2005.08.127; Saito Y, 2013, JPN J OCCUP THER, V32, P55; Saito Y, 2012, JPN J OCCUP THER, V31, P22; Shinohara K, 2012, HONG KONG J OCCUP TH, V22, P60, DOI 10.1016/j.hkjot.2012.09.001; Smallfield S, 2009, AM J OCCUP THER, V63, P408; The American Occupational Therapy Association, 2014, AM J OCCUP THER, V68, pS1; Tomori K, 2013, DISABIL REHABIL, V35, P113, DOI 10.3109/09638288.2012.689919; Tomori K, 2012, OCCUP THER INT, V19, P88, DOI 10.1002/oti.325; Tomori K, 2013, DISABIL REHABIL ASSI, P1; Townsend EA, 2007, ENABLING OCCUPATION; World Federation of Occupational Therapists, 2014, DEF OCC THER; World Health Organization, 2001, INT CLASS FUNCT DIS; Zemke R., 2012, JAP OCC SCI S 16 SAP	37	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	AUG	2015	29	8					752	762		10.1177/0269215514555876		11	Rehabilitation	Rehabilitation	CO0YN	WOS:000358880000003		
J	Fushiki, R; Mayahara, K; Ogawa, M; Takahashi, Y; Karasawa, Y; Tsurumachi, N; Tamura, T; Shimizu, N				Fushiki, Rena; Mayahara, Kotoe; Ogawa, Mai; Takahashi, Yasuyo; Karasawa, Yoko; Tsurumachi, Niina; Tamura, Takahiko; Shimizu, Noriyoshi			High-magnitude mechanical strain inhibits the differentiation of bone-forming rat calvarial progenitor cells	CONNECTIVE TISSUE RESEARCH			English	Article						BMP-2; bone nodule; differentiation; mechanical strain; osteoblast	OSTEOBLAST DIFFERENTIATION; MORPHOGENETIC PROTEINS; OSTEOGENIC DIFFERENTIATION; GENE-EXPRESSION; CBFA1; INDUCTION; FORCE; MSX2; ANTAGONISTS; PROMOTER	Purpose: Orthodontic tooth movement occurs during the bone remodeling induced by therapeutic mechanical strain. It is important to investigate the relation between the strength of mechanical stress and bone formation activity. The aim of this study was to determine the effect of high-magnitude mechanical strain on bone formation in detail. Materials and methods: Osteoblast-like cells isolated from fetal rat calvariae were loaded with 18% cyclic tension force (TF) for 48 h. To phenotypically investigate the effect of TF, we measured the number and the size of bone nodules stained by von Kossa technique on day 21 after cell seeding and determined the calcium content of bone nodules on day 14. Furthermore, we examined the gene expression of BMP-2, Runx2 and Msx2, which are important factors for bone nodule formation, on days 1, 4 and 7 after TF loading. Results: The maximum bone nodule size in the control group was 1620 and 719 mu m in the TF group. Furthermore, the mean number of bone nodules sized over 360 mu m in the TF group was significantly decreased compared to the control group. The calcium content was also significantly decreased to 42% by TF loading. The mRNA expression of BMP-2, Runx2 and Msx2 was decreased 1 and 4 days after TF loading. Conclusion: The differentiation of bone forming progenitor cells into bone nodule forming cells was inhibited by TF due to the decreased expression of bone formation related factors such as BMP-2, Runx2 and Msx2.	[Fushiki, Rena; Mayahara, Kotoe; Ogawa, Mai; Tamura, Takahiko; Shimizu, Noriyoshi] Nihon Univ, Sch Dent, Dept Orthodont, Tokyo 1018310, Japan; [Mayahara, Kotoe; Tamura, Takahiko; Shimizu, Noriyoshi] Nihon Univ, Sch Dent, Div Clin Res, Dent Res Ctr, Tokyo 1018310, Japan; [Takahashi, Yasuyo; Karasawa, Yoko; Tsurumachi, Niina] Nihon Univ, Sch Dent, Tokyo 1018310, Japan	Shimizu, N (reprint author), Nihon Univ, Sch Dent, Dept Orthodont, Chiyoda Ku, 1-8-13 Kanda Surugadai, Tokyo 1018310, Japan.	shimizu.noriyoshi@nihon-u.ac.jp			Dental Research Center at Nihon University School of Dentistry; Nihon University School of Dentistry; Ministry of Education, Culture, Sports, Science, and Technology Japan (MEXT) [24792311, S1001024]	This study was supported by a grant from the Dental Research Center at Nihon University School of Dentistry, the Sato Fund of Nihon University School of Dentistry. This study was also supported in part by a Grant-in-Aid for Young Scientists (B) (24792311), a Grant of Strategic Research Base Development "Program for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology Japan" (MEXT) (S1001024).	Agarwal S, 2003, FASEB J, V17, P899, DOI 10.1096/fj.02-0901fjc; Cheng SL, 2003, J BIOL CHEM, V278, P45969, DOI 10.1074/jbc.M306972200; Hanai J, 1999, J BIOL CHEM, V274, P31577, DOI 10.1074/jbc.274.44.31577; Gazzerro E, 2006, REV ENDOCR METAB DIS, V7, P51, DOI 10.1007/s11154-006-9000-6; Miron RJ, 2013, CLIN ORAL INVEST, V17, P981, DOI 10.1007/s00784-012-0764-7; ROBERTS WE, 1981, DENT CLIN N AM, V25, P3; Ichida F, 2004, J BIOL CHEM, V279, P34015, DOI 10.1074/jbc.M403621200; Nishimura R, 2002, BONE, V31, P303, DOI 10.1016/S8756-3282(02)00826-8; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1; Mitsui N, 2006, LIFE SCI, V78, P2697, DOI 10.1016/j.lfs.2005.10.024; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Katagiri T, 2002, ORAL DIS, V8, P147, DOI 10.1034/j.1601-0825.2002.01829.x; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Chen D, 1997, CALCIFIED TISSUE INT, V60, P283, DOI 10.1007/s002239900230; BELLOWS CG, 1986, CALCIFIED TISSUE INT, V38, P143, DOI 10.1007/BF02556874; Fujimoto K, 2010, LASER SURG MED, V42, P519, DOI 10.1002/lsm.20880; Jacobs C, 2013, ARCH ORAL BIOL, V58, P896, DOI 10.1016/j.archoralbio.2013.01.009; Kiyosaki T, 2010, PHOTOMED LASER SURG, V28, pS167, DOI 10.1089/pho.2009.2693; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; Cao Xu, 2005, Gene, V357, P1, DOI 10.1016/j.gene.2005.06.017; Frost HM, 1998, CALCIFIED TISSUE INT, V62, P89, DOI 10.1007/s002239900399; Huang H, 2014, AM J ORTHOD DENTOFAC, V146, P620, DOI 10.1016/j.ajodo.2014.07.007; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Mirzayans F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049095; Newberry EP, 1997, J BIOL CHEM, V272, P29607, DOI 10.1074/jbc.272.47.29607; Robubi A, 2014, BONE JOINT RES, V3, P236, DOI 10.1302/2046-3758.37.2000231; Xue H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068926; Yanagisawa M, 2008, ARCH ORAL BIOL, V53, P214, DOI 10.1016/j.archoralbio.2007.08.012	29	1	1	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	0300-8207	1607-8438		CONNECT TISSUE RES	Connect. Tissue Res.	AUG	2015	56	4					336	341		10.3109/03008207.2015.1040878		6	Cell Biology; Orthopedics	Cell Biology; Orthopedics	CO3BQ	WOS:000359032000009		
J	Heerdt, PM; Sunaga, H; Savarese, JJ				Heerdt, Paul M.; Sunaga, Hiroshi; Savarese, John J.			Novel neuromuscular blocking drugs and antagonists	CURRENT OPINION IN ANESTHESIOLOGY			English	Review							N-ACETYLCYSTEINE; MOLECULAR CONTAINERS; GW280430A AV430A; AGENTS; CYSTEINE; PHARMACOLOGY; CW002; PHARMACODYNAMICS; REVERSAL; DOGS	Purpose of review This review summarizes recent progress in the development of new muscle relaxants that are inactivated by cysteine, and considers the evolving paradigm of selective relaxant binding or degrading agents that can reverse neuromuscular blockade at any time. Recent findings The benzylisoquinoline compound gantacurium is a nondepolarizing muscle relaxant with an ultrashort duration largely determined by the rapid rate at which endogenous l-cysteine binds to, and permanently inactivates, the molecule. Although the clinical development of gantacurium has been hampered by modest histamine release, preclinical studies demonstrating that the drug can be rapidly reversed by injecting l-cysteine led to the development of CW002, an intermediate duration molecule that can also be reversed at any time by l-cysteine injection. Clinical trials with CW002 are now underway. The ability to reverse complete paralysis with cysteine dovetails with the established selective aminosteroid binding agent sugammadex, and the recently described universal relaxant binding agent calabadion. Taken together, the concept of rapid reversal at any time raises the question of whether an ultrashort nondepolarizing drug is needed if safe and cost-effective relaxant binding agents are available. The gantacurium derivative CW002 is an intermediate duration, nondepolarizing, cysteine-inactivated, neuromuscular blocking drug currently in clinical trials. Like sugammadex reversal of rocuronium, CW002 can be reversed at any time by cysteine injection.	[Heerdt, Paul M.] Cornell Univ, Weill Med Coll, Dept Anesthesiol, Ithaca, NY 14853 USA; [Heerdt, Paul M.] Mem Sloan Kettering Canc Ctr, Dept Anesthesiol Crit Care Med, New York, NY USA; [Sunaga, Hiroshi] Jikei Univ, Sch Med, Tokyo, Japan; [Savarese, John J.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Heerdt, PM (reprint author), 525 East 68th St,Ladson 2,Box 50, New York, NY 10021 USA.	pmheerd@med.cornell.edu			Department of Anesthesiology, Weill Cornell Medical College; CB Starr Foundation; Nancy Paduano IRA	The Department of Anesthesiology, Weill Cornell Medical College, The CB Starr Foundation, and Nancy Paduano IRA.	Abrishami Amir, 2010, Anesth Analg, V110, P1239, DOI 10.1213/ANE.0b013e3181ce8d5e; Adam JM, 2002, J MED CHEM, V45, P1806, DOI 10.1021/jm011107f; Karila L, 2008, INT J NEUROPSYCHOPH, V11, P425, DOI 10.1017/S1461145707008097; Samano V, 1999, ORG LETT, V1, P1993, DOI 10.1021/ol9911573; Ng F, 2008, INT J NEUROPSYCHOPH, V11, P851, DOI 10.1017/S1461145707008401; [Anonymous], 2014, CURR ANESTHESIOL REP; Kortsalioudaki C, 2008, LIVER TRANSPLANT, V14, P25, DOI 10.1002/lt.21246; Janaky R, 2000, NEUROCHEM RES, V25, P1397, DOI 10.1023/A:1007616817499; Macartney DH, 2013, FUTURE MED CHEM, V5, P2075, DOI 10.4155/fmc.13.164; Wang Y, 2014, CHEM COMMUN, V50, P9390, DOI 10.1039/c4cc03978e; Ma D, 2012, ANGEW CHEM INT EDIT, V51, P11358, DOI 10.1002/anie.201206031; Belmont MR, 2004, ANESTHESIOLOGY, V100, P768, DOI 10.1097/00000542-200404000-00004; Boros EE, 1999, J MED CHEM, V42, P1114, DOI 10.1021/jm990060j; Boros EE, 2003, J MED CHEM, V46, P2502, DOI 10.1021/jm020574+; Diaz LL, 2014, J AM ASSOC LAB ANIM, V53, P283; Gyermek L, 2005, MED RES REV, V25, P610, DOI 10.1002/med.20036; Gyermek L, 2009, J CRIT CARE, V24, P58, DOI 10.1016/j.jcrc.2008.08.005; Heerdt PM, 2004, ANESTHESIOLOGY, V100, P846, DOI 10.1097/00000542-200404000-00014; Heerdt PM, 2010, ANESTHESIOLOGY, V112, P910, DOI 10.1097/ALN.0b013e3181d31f71; Hoffmann U, 2013, ANESTHESIOLOGY, V119, P317, DOI 10.1097/ALN.0b013e3182910213; Isaacs L, 2014, ACCOUNTS CHEM RES, V47, P2052, DOI 10.1021/ar500075g; Kaldor I, 2001, J ORG CHEM, V66, P3495, DOI 10.1021/jo010032k; Ledowski T, 2015, ANAESTH INTENS CARE, V43, P14; Lien CA, 2011, BRIT J ANAESTH, V107, P60, DOI 10.1093/bja/aer341; Lien CA, 2009, J CRIT CARE, V24, P50, DOI 10.1016/j.jcrc.2008.11.001; Marshall R J, 1995, Eur J Anaesthesiol Suppl, V11, P5; Murrell MT, ASA 2013; Naguib M, 2009, CURR OPIN ANESTHESIO, V22, P483, DOI 10.1097/ACO.0b013e32832b8cff; Owens JS, 2014, AAPS ANN M; Savarese JJ, 2010, ANESTHESIOLOGY, V113, P58, DOI 10.1097/ALN.0b013e3181dc1b5b; Savarese JJ, 2004, ANESTHESIOLOGY, V100, P835, DOI 10.1097/00000542-200404000-00013; Savarese JJ, ASA 2013; SAVARESE JJ, 1995, ACTA ANAESTH SCAND, V39, P18; Savarese JJ, ASA 2014; Sawamoto O, 2004, EXP TOXICOL PATHOL, V56, P45, DOI 10.1016/j.etp.2004.05.003; Schaller G, 2007, CRIT CARE MED, V35, P1869, DOI 10.1097/01.CCM.0000275385.45557.25; Schepens Tom, 2014, Acta Anaesthesiol Belg, V65, P151; Sharpe LG, 1975, PHARM BIOCH BEHAV, V3, P291; Sunaga H, 2010, ANESTHESIOLOGY, V112, P900, DOI 10.1097/ALN.0b013e3181d31f8c; Sunaga H, 2010, ANESTHESIOLOGY, V112, P892, DOI 10.1097/ALN.0b013e3181d32016; Sunaga H, 2013, ASA 2013; White PF, 2002, BRIT J ANAESTH, V88, P163, DOI 10.1093/bja/88.2.163; ZLOTKIN SH, 1981, AM J CLIN NUTR, V34, P914; Zuin R, 2005, CLIN DRUG INVEST, V25, P401, DOI 10.2165/00044011-200525060-00005	44	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0952-7907	1473-6500		CURR OPIN ANESTHESIO	Curr. Opin. Anesthesiol.	AUG	2015	28	4					403	410		10.1097/ACO.0000000000000209		8	Anesthesiology	Anesthesiology	CN2YH	WOS:000358288700003		
J	Hong, KY; Bae, H; Park, I; Park, DY; Kim, KH; Kubota, Y; Cho, ES; Kim, H; Adams, RH; Yoo, OJ; Koh, GY				Hong, Ki Yong; Bae, Hosung; Park, Intae; Park, Dae-Young; Kim, Kyun Hoo; Kubota, Yoshiaki; Cho, Eui-Sic; Kim, Hail; Adams, Ralf H.; Yoo, Ook-Joon; Koh, Gou Young			Perilipin(+) embryonic preadipocytes actively proliferate along growing vasculatures for adipose expansion	DEVELOPMENT			English	Article						Adipogenesis; Adipose tissue; Angiogenesis; Preadipocytes	ADIPOCYTE DIFFERENTIATION; TISSUE DEVELOPMENT; STEM-CELLS; IN-VIVO; OBESITY; WHITE; FAT; ADIPOGENESIS; ANGIOGENESIS; EXPRESSION	Despite the growing interest in adipose tissue as a therapeutic target of metabolic diseases, the identity of adipocyte precursor cells (preadipocytes) and the formation of adipose tissue during embryonic development are still poorly understood. Here, we clarified the identity and dynamic processes of preadipocytes in mouse white adipose tissue during embryogenesis through direct examination, lineage tracing and culture systems. Surprisingly, we found that lipid-lacking but perilipin(+) or adiponectin(+) proliferating preadipocytes started to emerge at embryonic day 16.5, and these cells underwent active proliferation until birth. Moreover, these preadipocytes resided as clusters and were distributed along growing adipose vasculatures. Importantly, the embryonic preadipocytes exhibited considerable coexpression of stem cell markers, such as CD24, CD29 and PDGFR alpha, and a small portion of preadipocytes were derived from PDGFR beta(+) mural cells, in contrast to the adult preadipocytes present in the stromal vascular fraction. Further analyses with in vitro and ex vivo culture systems revealed a stepwise but dynamic regulation of preadipocyte formation and differentiation during prenatal adipogenesis. To conclude, we unraveled the identity and characteristics of embryonic preadipocytes, which are crucial for the formation and expansion of adipose tissue during embryogenesis.	[Hong, Ki Yong; Bae, Hosung; Park, Intae; Park, Dae-Young; Kim, Kyun Hoo; Kim, Hail; Yoo, Ook-Joon; Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 305701, South Korea; [Kubota, Yoshiaki] Keio Univ, Lab Vasc Biol, Tokyo 1608582, Japan; [Cho, Eui-Sic] Chonbuk Natl Univ, Sch Dent, Lab Craniofacial Biol, Cluster Craniofacial Dev & Regenerat Res, Jeonju 561756, South Korea; [Adams, Ralf H.] Univ Munster, Fac Med, Dept Tissue Morphogenesis, Max Planck Inst Mol Biomed, D-48149 Munster, Germany	Koh, GY (reprint author), Korea Adv Inst Sci & Technol, Grad Sch Med Sci & Engn, Daejeon 305701, South Korea.	ojyoo@kaist.ac.kr; gykoh@kaist.ac.kr	Yoo, Ook Joon/C-1860-2011; Koh, Gou Young /C-1615-2011		Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Korea [A120275]; National Research Foundation (NRF) of Korea - Ministry of Science, ICT & Future Planning, Korea [2013-036-003]	This research was supported by a grant from the Korean Healthcare Technology R&D Project, Ministry of Health and Welfare, Korea [A120275 to G.Y.K.]; and by the National Research Foundation (NRF) of Korea funded by the Ministry of Science, ICT & Future Planning, Korea [2013-036-003 to G.Y.K.].	Feil R, 1997, BIOCHEM BIOPH RES CO, V237, P752, DOI 10.1006/bbrc.1997.7124; Chau YY, 2014, NAT CELL BIOL, V16, P367, DOI 10.1038/ncb2922; Rudolph MC, 2007, J MAMMARY GLAND BIOL, V12, P269, DOI 10.1007/s10911-007-9061-5; Tang QQ, 2003, P NATL ACAD SCI USA, V100, P44, DOI 10.1073/pnas.0137044100; Li FYL, 2011, ACTA PHYSIOL, V203, P167, DOI 10.1111/j.1748-1716.2010.02216.x; Liu J, 2005, CELL METAB, V2, P165, DOI 10.1016/j.cmet.2005.08.006; Rupnick MA, 2002, P NATL ACAD SCI USA, V99, P10730, DOI 10.1073/pnas.162349799; Cawthorn WP, 2012, J LIPID RES, V53, P227, DOI 10.1194/jlr.R021089; Prins JB, 1997, CLIN SCI, V92, P3; Muzumdar MD, 2007, GENESIS, V45, P593, DOI 10.1002/dvg.20335; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816f1; Han J, 2011, DEVELOPMENT, V138, P5027, DOI 10.1242/dev.067686; Wang YD, 2010, NATURE, V465, P483, DOI 10.1038/nature09002; Nedergaard J, 2014, CELL METAB, V20, P396, DOI 10.1016/j.cmet.2014.07.005; Hoshiba T, 2010, ADV MATER, V22, P3042, DOI 10.1002/adma.201000038; Birsoy K, 2011, DEVELOPMENT, V138, P4709, DOI 10.1242/dev.067710; Tansey JT, 2001, P NATL ACAD SCI USA, V98, P6494, DOI 10.1073/pnas.101042998; Christiaens V, 2010, MOL CELL ENDOCRINOL, V318, P2, DOI 10.1016/j.mce.2009.08.006; Cao YH, 2013, CELL METAB, V18, P478, DOI 10.1016/j.cmet.2013.08.008; Albuquerque RJC, 2009, NAT MED, V15, P1023, DOI 10.1038/nm.2018; Cao YH, 2010, NAT REV DRUG DISCOV, V9, P107, DOI 10.1038/nrd3055; Macotela Y, 2012, DIABETES, V61, P1691, DOI 10.2337/db11-1753; Lee YH, 2012, CELL METAB, V15, P480, DOI 10.1016/j.cmet.2012.03.009; Yamamoto Y, 2010, OBESITY, V18, P872, DOI 10.1038/oby.2009.512; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Wang QA, 2013, NAT MED, V19, P1338, DOI 10.1038/nm.3324; Rosenwald M, 2013, NAT CELL BIOL, V15, P659, DOI 10.1038/ncb2740; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Berry R, 2013, NAT CELL BIOL, V15, P302, DOI 10.1038/ncb2696; Gregoire FM, 1998, PHYSIOL REV, V78, P783; Tran KV, 2012, CELL METAB, V15, P222, DOI 10.1016/j.cmet.2012.01.008; Sun K, 2011, J CLIN INVEST, V121, P2094, DOI 10.1172/JCI45887; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; Cao Y, 2007, J CLIN INVEST, V117, P2362, DOI 10.1172/JC132239; GREENBERG AS, 1991, J BIOL CHEM, V266, P11341; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Gupta RK, 2012, CELL METAB, V15, P230, DOI 10.1016/j.cmet.2012.01.010; Nishimura S, 2007, DIABETES, V56, P1517, DOI 10.2337/db06-1749; Crandall DL, 1997, MICROCIRCULATION-LON, V4, P211, DOI 10.3109/10739689709146786; Cho CH, 2007, CIRC RES, V100, pE47, DOI 10.1161/01.RES.0000259564.92792.93; Jiang YW, 2014, CELL REP, V9, P1007, DOI 10.1016/j.celrep.2014.09.049; Lee J.-M., 2013, BIOMED RES INT, V2013, P1, DOI DOI 10.7780/KJRS.2013.29.1.14; Rigamonti A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017637; Stanczuk L., 2015, CELL REP	45	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0950-1991	1477-9129		DEVELOPMENT	Development	AUG 1	2015	142	15					2623	U150		10.1242/dev.125336		21	Developmental Biology	Developmental Biology	CO1VF	WOS:000358943200009		
J	Komori, T; Tanaka, M; Furuta, H; Akamizu, T; Miyajima, A; Morikawa, Y				Komori, Tadasuke; Tanaka, Minoru; Furuta, Hiroto; Akamizu, Takashi; Miyajima, Atsushi; Morikawa, Yoshihiro			Oncostatin M is a potential agent for the treatment of obesity and related metabolic disorders: a study in mice	DIABETOLOGIA			English	Article						Adipose tissue inflammation; Hepatic steatosis; High-fat diet; Insulin resistance; Lipid absorption; Metabolic disorders; Obesity; Therapeutic agent	INSULIN-RESISTANCE; ENERGY-EXPENDITURE; ADIPOSE-TISSUE; PEPTIDE YY3-36; M EXPRESSION; FOOD-INTAKE; BETA; INFLAMMATION; SENSITIVITY; RECEPTOR	Aims/hypothesis Obesity and insulin resistance are closely associated with adipose tissue dysfunction caused by the abnormal recruitment of inflammatory cells, including macrophages. Oncostatin M (OSM), a member of the IL-6 family of cytokines, plays important roles in a variety of biological functions including the regulation of inflammatory responses. In previous reports, we have demonstrated that mice deficient in the OSM receptor beta subunit show obesity, adipose tissue inflammation, insulin resistance and hepatic steatosis, all of which are exacerbated by feeding the mice a high-fat diet. These results prompted us to test the therapeutic effects of OSM on obesity-induced metabolic disorders using mouse models of obesity. Methods In diet-induced obese and ob/ob mice, metabolic variables were assessed physiologically, histologically and biochemically after the intraperitoneal injection of recombinant mouse OSM twice a day for 1 week. Results Treatment with OSM improved obesity, adipose tissue inflammation, insulin resistance and hepatic steatosis in both mouse models. Although OSM reduced food intake, such therapeutic effects of OSM were observed even under pair-feeding conditions. Functionally, OSM directly changed the phenotype of adipose tissue macrophages from M1 type (inflammatory) to M2 type (anti-inflammatory). In the liver, OSM suppressed the expression of genes related to fatty acid synthesis and increased the expression of genes related to fatty acid oxidation. Furthermore, OSM decreased lipid absorption and increased the expression of active glucagon-like peptide-1 in the intestine. Conclusions/interpretation We showed that OSM is a novel candidate to act as a powerful therapeutic agent for the treatment of obesity-induced metabolic disorders.	[Komori, Tadasuke; Morikawa, Yoshihiro] Wakayama Med Univ, Dept Anat & Neurobiol, Wakayama 6418509, Japan; [Tanaka, Minoru] Natl Ctr Global Hlth & Med, Dept Regenerat Med, Res Inst, Tokyo, Japan; [Furuta, Hiroto; Akamizu, Takashi] Wakayama Med Univ, Dept Med 1, Wakayama, Japan; [Miyajima, Atsushi] Univ Tokyo, Lab Cell Growth & Differentiat, Inst Mol & Cellular Biosci, Tokyo, Japan	Morikawa, Y (reprint author), Wakayama Med Univ, Dept Anat & Neurobiol, 811-1 Kimiidera, Wakayama 6418509, Japan.	yoshim@wakayama-med.ac.jp			Japan Society for the Promotion of Science [26282195]; Research Grant on Priority Areas from Wakayama Medical University	This work was supported by a Grant-in-Aid for Scientific Research (B) (JSPS KAKENHI Grant Number 26282195) from the Japan Society for the Promotion of Science and Research Grant on Priority Areas from Wakayama Medical University.	Repovic P, 2002, J NEUROSCI, V22, P5334; Goren I, 2006, J INVEST DERMATOL, V126, P628, DOI 10.1038/sj.jid.5700136; Komori T, 2013, J BIOL CHEM, V288, DOI 10.1074/jbc.M113.461905; Park EJ, 2010, CELL, V140, P197, DOI 10.1016/j.cell.2009.12.052; Lin ZF, 2013, CELL METAB, V17, P779, DOI 10.1016/j.cmet.2013.04.005; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Fisher FM, 2010, DIABETES, V59, P2781, DOI 10.2337/db10-0193; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Xu J, 2009, DIABETES, V58, P250, DOI 10.2337/db08-0392; Holland WL, 2013, CELL METAB, V17, P790, DOI 10.1016/j.cmet.2013.03.019; Yuan MS, 2001, SCIENCE, V293, P1673, DOI 10.1126/science.1061620; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Zhou Y, 2007, ARTERIOSCL THROM VAS, V27, P2198, DOI 10.1161/ATVBAHA.107.148429; Despres JP, 2006, NATURE, V444, P881, DOI 10.1038/nature05488; Komori T, 2014, J BIOL CHEM, V289, P13821, DOI 10.1074/jbc.M113.542399; Tanaka M, 1999, BLOOD, V93, P804; Lindberg RA, 1998, MOL CELL BIOL, V18, P3357; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Abbott CR, 2005, BRAIN RES, V1044, P127, DOI 10.1016/j.brainres.2005.03.011; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu AM, 2003, J CLIN INVEST, V112, P91, DOI 10.1172/JCI200317797; Kang HW, 2012, FASEB J, V26, P2209, DOI 10.1096/fj.11-202853; Tamura S, 2002, DEV DYNAM, V225, P327, DOI 10.1002/dvdy.10156; Tanaka M, 2003, Rev Physiol Biochem Pharmacol, V149, P39	28	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0012-186X	1432-0428		DIABETOLOGIA	Diabetologia	AUG	2015	58	8					1868	1876		10.1007/s00125-015-3613-9		9	Endocrinology & Metabolism	Endocrinology & Metabolism	CO0XN	WOS:000358877300026		
J	Doki, K; Sekiguchi, Y; Kuga, K; Aonuma, K; Homma, M				Doki, Kosuke; Sekiguchi, Yukio; Kuga, Keisuke; Aonuma, Kazutaka; Homma, Masato			Serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Flecainide; S/R ratio; CYP2D6; Genotype; CYP2D6 inhibitor	LIQUID-CHROMATOGRAPHY; PSYCHIATRIC-PATIENTS; CLINICAL-PRACTICE; METABOLIC RATIO; DISPOSITION; PHENOTYPE; PHARMACOKINETICS; TACHYARRHYTHMIA; MISMATCH; ACETATE	The aims of this study were to clarify whether the ratio of S-to R-flecainide (S/R ratio) in the serum flecainide concentration was associated with the stereoselectivity of flecainide metabolism, and to investigate the effects of the cytochrome P450 (CYP) 2D6 (CYP2D6) genotype and CYP2D6 inhibitor on the serum flecainide S/R ratio. In vitro studies using human liver microsomes and cDNA-expressed CYP isoforms suggested that variability in the serum flecainide S/R ratio was associated with the stereoselectivity of CYP2D6-mediated flecainide metabolism. We examined the serum flecainide S/R ratio in 143 patients with supraventricular tachyarrhythmia. The S/R ratio was significantly lower in intermediate metabolizers and poor metabolizers (IMs/PMs) than in extensive metabolizers (EMs) identified by the CYP2D6 genotype. The cut-off value for the S/R ratio to allow the discrimination between CYP2D6 EMs and IMs/PMs was 0.99. The S/R ratio in patients with co-administration of bepridil, a potent CYP2D6 inhibitor, was lower than 0.99, regardless of the CYP2D6 genotype status. Other factors, including age, sex, body weight, and renal function, did not affect the serum flecainide S/R ratio. This study suggests that the serum flecainide S/R ratio reflects the CYP2D6 genotype and changes in CYP2D6 activity on co-administration of a CYP2D6 inhibitor. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Doki, Kosuke; Homma, Masato] Univ Tsukuba, Fac Med, Dept Pharmaceut Sci, Tsukuba, Ibaraki 3058575, Japan; [Sekiguchi, Yukio; Kuga, Keisuke; Aonuma, Kazutaka] Univ Tsukuba, Fac Med, Dept Internal Med, Tsukuba, Ibaraki 3058575, Japan	Homma, M (reprint author), Univ Tsukuba, Fac Med, Dept Pharmaceut Sci, Tennodai 1-1-1, Tsukuba, Ibaraki 3058575, Japan.	k-doki@mail.hosp.tsukuba.ac.jp; yseki@md.tsukuba.ac.jp; kuga@md.tsukuba.ac.jp; kaonuma@md.tsukuba.ac.jp; masatoh@md.tsukuba.ac.jp					Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Zineh I, 2004, CLIN PHARMACOL THER, V76, P536, DOI 10.1016/j.clpt.2004.08.020; CROZIER IG, 1987, AM J CARDIOL, V59, P607, DOI 10.1016/0002-9149(87)91178-7; Gardiner SJ, 2006, PHARMACOL REV, V58, P521, DOI 10.1124/pr.58.3.6; Zhou SF, 2009, CLIN PHARMACOKINET, V48, P689, DOI 10.2165/11318030-000000000-00000; BIRGERSDOTTER UM, 1992, BRIT J CLIN PHARMACO, V33, P275; BORIANI G, 1991, EUR J CLIN PHARMACOL, V41, P57, DOI 10.1007/BF00280107; CONARD GJ, 1984, AM J CARDIOL, V53, pB41, DOI 10.1016/0002-9149(84)90501-0; Crespi Charles L, 2006, Methods Mol Biol, V320, P121; Doki K, 2013, PHARMACOGENET GENOM, V23, P349, DOI 10.1097/FPC.0b013e328361fb8d; Doki K, 2009, BRIT J CLIN PHARMACO, V68, P89, DOI 10.1111/j.1365-2125.2009.03435.x; Doki K, 2012, PHARMACOGENET GENOM, V22, P777, DOI 10.1097/FPC.0b013e3283588fe5; Doki K, 2006, EUR J CLIN PHARMACOL, V62, P919, DOI 10.1007/s00228-006-0188-x; Doki K, 2014, BIOMED CHROMATOGR, V28, P1193, DOI 10.1002/bmc.3143; Doki K, 2004, J PHARMACEUT BIOMED, V35, P1307, DOI 10.1016/j.jpba.2004.04.009; GROSS AS, 1991, EUR J CLIN PHARMACOL, V40, P155; GROSS AS, 1989, BRIT J CLIN PHARMACO, V28, P555; Homma M, 2005, J PHARM PHARMACOL, V57, P47, DOI 10.1211/0022357055128; Ieiri I, 2003, PHARMACOPSYCHIATRY, V36, P192; Ishiguro A, 2005, ANAL BIOCHEM, V337, P256, DOI 10.1016/j.ab.2004.11.038; Jurica J, 2012, J CLIN PHARM THER, V37, P486, DOI 10.1111/j.1365-2710.2012.01333.x; KREEGER RW, 1987, MAYO CLIN PROC, V62, P1033; Lohmann PL, 2001, EUR J CLIN PHARMACOL, V57, P289, DOI 10.1007/s002280100299; MCQUINN RL, 1984, DRUG METAB DISPOS, V12, P414; MIKUS G, 1989, CLIN PHARMACOL THER, V45, P562	25	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	AUG	2015	30	4					257	262		10.1016/j.dmpk.2015.04.001		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO4XL	WOS:000359164100001		
J	Hosono, H; Kumondai, M; Arai, T; Sugimura, H; Sasaki, T; Hirasawa, N; Hiratsuka, M				Hosono, Hiroki; Kumondai, Masaki; Arai, Tomio; Sugimura, Haruhiko; Sasaki, Takamitsu; Hirasawa, Noriyasu; Hiratsuka, Masahiro			CYP2A6 genetic polymorphism is associated with decreased susceptibility to squamous cell lung cancer in Japanese smokers	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Squamous cell lung cancer; CYP2A6; Genetic polymorphism; Activity score; Smoker	SLOW NICOTINE METABOLISM; IN-VIVO; CYTOCHROME-P450 2A6; CHINESE POPULATION; RISK; DELETION; SMOKING; VARIANTS; 4-(METHYLNITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; METAANALYSIS	Cytochrome P450 2A6 (CYP2A6) is an enzyme involved in the metabolism of tobacco carcinogens, which are important risk factors in lung cancer. We and others have previously reported that CYP2A6*4, a whole-gene deletion polymorphism, is associated with lower risk of lung cancer than the wild-type allele. However, the genotyping method used in these previous studies considered only the CYP2A6*4 allele; this lead to insufficient classification of the CYP2A6 genotype, thereby underestimating the frequencies of the deficient alleles. In this study, CYP2A6 genotypes of Japanese smokers (110 individuals with squamous cell lung cancer (SQCC) and 132 sex-matched cancer-free controls) were determined using a sequencing-based approach to determine CYP2A6 haplotypes. The risk of SQCC was evaluated using the activity score (AS) system to predict CYP2A6 phenotype from its genotype. The risk of developing SQCC was significantly lower in the poor metabolizers assigned as AS 0.5 (adjusted odds ratio [OR] = 0.13, 95% CI = 0.04-0.45, P = 0.001) and AS 0 (adjusted OR = 0.15, 95% CI = 0.03-0.82, P = 0.028) than in the extensive metabolizers assigned as AS 2.0. In conclusion, CYP2A6 genetic polymorphisms may play important roles in the development of SQCC in Japanese smokers. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Hosono, Hiroki; Kumondai, Masaki; Hirasawa, Noriyasu; Hiratsuka, Masahiro] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan; [Arai, Tomio] Tokyo Metropolitan Geriatr Hosp, Dept Pathol, Tokyo 173, Japan; [Arai, Tomio] Inst Gerontol, Tokyo, Japan; [Sugimura, Haruhiko] Hamamatsu Univ Sch Med, Dept Tumor Pathol, Hamamatsu, Shizuoka 4313192, Japan; [Sasaki, Takamitsu] Tohoku Pharmaceut Univ, Dept Environm & Hlth Sci, Sendai, Miyagi, Japan	Hiratsuka, M (reprint author), Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Pharmacotherapy Life Style Related Dis, Sendai, Miyagi 980, Japan.	mhira@m.tohoku.ac.jp			Smoking Research Foundation; Japan Research Foundation for Clinical Pharmacology	This study was supported by grants from Smoking Research Foundation and Japan Research Foundation for Clinical Pharmacology.	Parkin DM, 2001, EUR J CANCER, V37, pS4; Oscarson M, 1999, FEBS LETT, V448, P105, DOI 10.1016/S0014-5793(99)00359-2; Nakajima M, 1996, DRUG METAB DISPOS, V24, P1212; Fujieda M, 2004, CARCINOGENESIS, V25, P2451, DOI 10.1093/carcin/bgh258; Loriot MA, 2001, PHARMACOGENETICS, V11, P39, DOI 10.1097/00008571-200102000-00005; Gaedigk A, 2008, CLIN PHARMACOL THER, V83, P234, DOI 10.1038/sj.clpt.6100406; Oscarson M, 1999, FEBS LETT, V460, P321, DOI 10.1016/S0014-5793(99)01364-2; Wassenaar CA, 2011, J NATL CANCER I, V103, P1342, DOI 10.1093/jnci/djr237; Ariyoshi N, 2002, CANCER EPIDEM BIOMAR, V11, P890; Schoedel KA, 2004, PHARMACOGENETICS, V14, P615, DOI 10.1097/00008571-200409000-00006; Islam MS, 2013, CLIN CHIM ACTA, V416, P11, DOI 10.1016/j.cca.2012.11.011; CRESPI CL, 1991, CARCINOGENESIS, V12, P1197, DOI 10.1093/carcin/12.7.1197; Haberl M, 2005, PHARMACOGENET GENOM, V15, P609; Liu T, 2013, ENVIRON MOL MUTAGEN, V54, P133, DOI 10.1002/em.21751; Nakajima M, 2006, CLIN PHARMACOL THER, V80, P282, DOI 10.1016/j.clpt.2006.05.012; Xu C, 2002, BIOCHEM BIOPH RES CO, V290, P318, DOI 10.1006/bbrc.2001.6209; Nunoya K, 1999, J PHARMACOL EXP THER, V289, P437; Tan W, 2001, INT J CANCER, V95, P96, DOI 10.1002/1097-0215(20010320)95:2<96::AID-IJC1017>3.0.CO;2-2; Fujita K, 2001, ENVIRON MOL MUTAGEN, V38, P339, DOI 10.1002/em.10036; Ariyoshi N, 2001, BIOCHEM BIOPH RES CO, V281, P810, DOI 10.1006/bbrc.2001.4422; Goodz SD, 2002, METHOD ENZYMOL, V357, P59; Gu Yanfei, 2005, Zhongguo Fei Ai Za Zhi, V8, P297, DOI 10.3779/j.issn.1009-3419.2005.04.09; ISCAN M, 1994, EUR J CLIN PHARMACOL, V47, P315; Kiyohara C, 2005, J HEALTH SCI, V51, P658, DOI 10.1248/jhs.51.658; Kiyotani Kazuma, 2002, Drug Metab Pharmacokinet, V17, P482, DOI 10.2133/dmpk.17.482; Kiyotani Kazuma, 2003, Pharmacogenetics, V13, P689, DOI 10.1097/00008571-200311000-00005; Kumasaka N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044507; Liu ZB, 2013, MOL BIOL REP, V40, P5255, DOI 10.1007/s11033-013-2625-0; Miyamoto M, 1999, BIOCHEM BIOPH RES CO, V261, P658, DOI 10.1006/bbrc.1999.1089; Piliguian M, 2014, PHARMACOGENET GENOM, V24, P118, DOI 10.1097/FPC.0000000000000026; Sobue T, 2002, INT J CANCER, V99, P245, DOI 10.1002/ijc.10308; Takeuchi H, 2003, CANCER RES, V63, P7581; Tamaki Y, 2011, DRUG METAB PHARMACOK, V26, P516, DOI 10.2133/dmpk.DMPK-11-RG-046; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028844; Wang LS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059556; Wassenaar CA, 2015, CARCINOGENESIS, V36, P99, DOI 10.1093/carcin/bgu235	36	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	AUG	2015	30	4					263	268		10.1016/j.dmpk.2015.04.002		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO4XL	WOS:000359164100002		
J	Sakamoto, M; Itoh, T; Tukey, RH; Fujiwara, R				Sakamoto, Masaya; Itoh, Tomoo; Tukey, Robert H.; Fujiwara, Ryoichi			Nicotine regulates the expression of UDP-glucuronosyltransferase (UGT) in humanized UGT1 mouse brain	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						UDP-glucuronosyltransferase (UGT); Nicotine; Brain; Tissue-specific regulation; Humanized animal model	RAT-BRAIN; N-GLUCURONIDATION; MASS-SPECTROMETRY; MESSENGER-RNA; BILE-ACIDS; IN-VITRO; MICE; METABOLISM; MORPHINE; TISSUES	UDP-glucuronosyltransferase (UGT) is a family of enzymes that catalyze the glucuronidation of various compounds, and thereby has an important role in metabolism and detoxification of a large number of xenobiotic and endogenous compounds. UGTs are present highly in the liver and small intestine, while several investigations on quantification of UGT mRNA reported that UGTs were also expressed in the brain. However, reported expression patterns of UGT isoforms in human brain were often incongruous with each other. In the present study, therefore, we investigated UGT mRNA expressions in brains of humanized UGT1 (hUGT1) mice. We found that among the human UGT1 members, UGT1A1, 1A3, and 1A6 were expressed in the brain. We further observed that nicotine (3 mg/kg) induced the expression of UGT1A3 mRNA in the brain, but not liver. While it was not statistically significant, the nicotine treatment resulted in an increase in the chenodeoxycholic acid glucuronide-formation activity in the brain microsomes. UGT1A3 is involved in metabolism of various antidepressants and non-steroidal antiinflammatory drugs, which exhibit their pharmacological effects in the brain. Therefore, nicotine-treated hUGT1 mice might be useful to investigate the role of brain UGT1A3 in the regulation of local levels of these drugs and their response. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Sakamoto, Masaya; Itoh, Tomoo; Fujiwara, Ryoichi] Kitasato Univ, Grad Sch Pharmaceut Sci, Minato Ku, Tokyo 1088641, Japan; [Itoh, Tomoo; Fujiwara, Ryoichi] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan; [Tukey, Robert H.] Univ Calif San Diego, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA	Fujiwara, R (reprint author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	fujiwarar@pharm.kitasato-u.ac.jp			National Institutes of Health National Institute of Environmental Health Sciences [P42-ES010337]; National Institute of General Medical Sciences [R01-GM100481];  [26870562]	This work was supported by a Grant-in-Aid for Encouragement of Young Scientists B [26870562] (R.F.). This work was also supported in part by the National Institutes of Health National Institute of Environmental Health Sciences [Grant P42-ES010337] and National Institute of General Medical Sciences [Grant R01-GM100481].	Altomare C, 2003, EUR J PHARM SCI, V20, P17, DOI 10.1016/S0928-0987(03)00161-1; Griffiths WJ, 2003, MASS SPECTROM REV, V22, P81, DOI 10.1002/mas.10046; Miksys S, 2000, BIOCHEM PHARMACOL, V59, P1501, DOI 10.1016/S0006-2952(00)00281-1; Jones NR, 2014, DRUG METAB DISPOS, V42, P529, DOI 10.1124/dmd.113.054718; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Stone AN, 2003, DRUG METAB DISPOS, V31, P1086, DOI 10.1124/dmd.31.9.1086; Buckley DB, 2007, DRUG METAB DISPOS, V35, P121, DOI 10.1124/dmd.106.012070; Ohno S, 2009, DRUG METAB DISPOS, V37, P32, DOI 10.1124/dmd.108.023598; Court MH, 2012, XENOBIOTICA, V42, P266, DOI 10.3109/00498254.2011.618954; Miksys S, 2003, NEUROPHARMACOLOGY, V45, P122, DOI 10.1016/S0028-3908(03)00136-9; Fujiwara R, 2010, P NATL ACAD SCI USA, V107, P5024, DOI 10.1073/pnas.0913290107; Court MH, 2002, DRUG METAB DISPOS, V30, P1257, DOI 10.1124/dmd.30.11.1257; Trottier J, 2006, HEPATOLOGY, V44, P1158, DOI 10.1002/hep.21362; Izukawa T, 2009, DRUG METAB DISPOS, V37, P1759, DOI 10.1124/dmd.109.027227; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Gong QH, 2001, PHARMACOGENETICS, V11, P357, DOI 10.1097/00008571-200106000-00011; SULTATOS LG, 1994, J TOXICOL ENV HEALTH, V43, P271; King CD, 1999, ARCH BIOCHEM BIOPHYS, V365, P156, DOI 10.1006/abbi.1999.1155; Fujiwara R, 2012, GASTROENTEROLOGY, V142, P109, DOI 10.1053/j.gastro.2011.09.045; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1006/abio.1976.9999; Caron P, 2006, MOL PHARMACEUT, V3, P293, DOI 10.1021/mp060021l; Court MH, 2001, ANESTHESIOLOGY, V94, P110, DOI 10.1097/00000542-200101000-00021; Ferguson CS, 2012, J PHARMACOL EXP THER, V343, P628, DOI 10.1124/jpet.112.198564; Guillemette C, 2010, DRUG METAB REV, V42, P24, DOI 10.3109/03602530903210682; Kallonen SE, 2009, ANAL CHIM ACTA, V651, P69, DOI 10.1016/j.aca.2009.07.059; Kato Y, 2013, DRUG METAB DISPOS, V41, P1389, DOI 10.1124/dmd.113.051565; Khokhar JY, 2012, TOXICOL SCI, V126, P325, DOI 10.1093/toxsci/kfs029; Kutsuno Y., 2013, PHARM RES PERSPECT, V1, DOI DOI 10.1002/PRP2.225505556; Kyerematen GA, DRUG METAB DISPOS, V198, P823; Mano N, 2004, J LIPID RES, V45, P295, DOI 10.1194/jlr.M300369-JLR200; Miksys SL, 2002, J PSYCHIATR NEUROSCI, V27, P406; Nagano E, 2000, LIFE SCI, V67, P2453, DOI 10.1016/S0024-3205(00)00825-0; Perreault M, 2013, DRUG METAB DISPOS, V41, P1616, DOI 10.1124/dmd.113.052613; PETERSEN DR, 1984, DRUG METAB DISPOS, V12, P725; Sakaguchi K, 2004, ARCH BIOCHEM BIOPHYS, V424, P219, DOI 10.1016/j.abb.2004.02.004; SEATON M, 1991, DRUG METAB DISPOS, V19, P946; Suominen T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068007; Togna AR, 2013, NEUROPHARMACOLOGY, V75, P391, DOI 10.1016/j.neuropharm.2013.08.019; TYCE GM, 1986, FASEB J, V45, P2247; Tyndale RF, 2010, NEUROPSYCHOPHARMACOL, V36, P692; Uchaipichat V, 2013, DRUG METAB DISPOS, V41, P1273, DOI 10.1124/dmd.113.051656; Uutela P, 2009, ANAL CHEM, V81, P8417, DOI 10.1021/ac901320z; Yamada Hideyuki, 2003, J Toxicol Sci, V28, P395, DOI 10.2131/jts.28.395; Zhou DS, 2010, DRUG METAB DISPOS, V38, P863, DOI 10.1124/dmd.109.030981; Zhou K, 2013, BIOCHEM PHARMACOL, V85, P1848, DOI 10.1016/j.bcp.2013.04.014	46	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	AUG	2015	30	4					269	275		10.1016/j.dmpk.2015.04.004		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO4XL	WOS:000359164100003		
J	Kawami, M; Miyamoto, M; Yumoto, R; Takano, M				Kawami, Masashi; Miyamoto, Mioka; Yumoto, Ryoko; Takano, Mikihisa			Methotrexate influx via folate transporters into alveolar epithelial cell line A549	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Alveolar epithelial cells; Folic acid; Methotrexate; Proton-coupled folate transporter; Reduced folate carrier	L1210 LEUKEMIA-CELLS; CARRIER-MEDIATED TRANSPORT; RHEUMATOID-ARTHRITIS; MAMMALIAN-CELLS; INTESTINAL-ABSORPTION; MOLECULAR-BASIS; PH-DEPENDENCE; FOLIC-ACID; IDENTIFICATION; RECEPTOR	Methotrexate (MTX), a drug used for the treatment of certain cancers as well as rheumatoid arthritis, sometimes induces serious interstitial lung injury. Although lung toxicity of MTX is related to its accumulation, the information concerning MTX transport in the lungs is lacking. In this study, we investigated the mechanisms underlying MTX influx into human alveolar epithelial cell line A549. MTX influx into A549 cells was time-, pH-, and temperature-dependent and showed saturation kinetics. The influx was inhibited by folic acid with IC50 values of 256.1 mu M at pH 7.4 and 1.6 mu M at pH 5.5, indicating that the mechanisms underlying MTX influx would be different at these pHs. We then examined the role of two folate transporters in MTX influx, reduced folate carrier (RFC) and proton-coupled folate transporter (PCFT). The expression of RFC and PCFT mRNAs in A549 cells was confirmed by reverse transcription polymerase chain reaction. In addition, MTX influx was inhibited by thiamine monophosphate, an RFC inhibitor, at pH 7.4, and by sulfasalazine, a PCFT inhibitor, at pH 5.5. These results indicated that RFC and PCFT are predominantly involved in MTX influx into A549 cells at pH 7.4 and pH 5.5, respectively. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Kawami, Masashi; Miyamoto, Mioka; Yumoto, Ryoko; Takano, Mikihisa] Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmaceut & Therapeut, Minami Ku, Hiroshima 7348553, Japan	Takano, M (reprint author), Hiroshima Univ, Grad Sch Biomed & Hlth Sci, Dept Pharmaceut & Therapeut, Minami Ku, 1-2-3 Kasumi, Hiroshima 7348553, Japan.	takanom@hiroshima-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [22390031]	This work was supported in part by a Grant-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (JSPS, No. 22390031).	SPINELLA MJ, 1995, J BIOL CHEM, V270, P7842; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; Roenigk HH, 1998, J AM ACAD DERMATOL, V38, P478, DOI 10.1016/S0190-9622(98)70508-0; van de Steeg E, 2013, CLIN CANCER RES, V19, P821, DOI 10.1158/1078-0432.CCR-12-2080; Endter S, 2009, J PHARM PHARMACOL, V61, P583, DOI 10.1211/jpp/61.05.0006; Badagnani I, 2006, J PHARMACOL EXP THER, V318, P521, DOI 10.1124/jpet.106.104364; Takeda M, 2002, J PHARMACOL EXP THER, V302, P666, DOI 10.1124/jpet.102.034330; Imokawa S, 2000, EUR RESPIR J, V15, P373, DOI 10.1034/j.1399-3003.2000.15b25.x; [Anonymous], 1969, JAMA, V207, P923; Cronstein BN, 2005, PHARMACOL REV, V57, P163, DOI 10.1124/pr.57.2.3; Yuasa H, 2009, J PHARM SCI-US, V98, P1608, DOI 10.1002/jps.21515; Nakai Y, 2007, J PHARMACOL EXP THER, V322, P469, DOI 10.1124/jpet.107.122606; Wang YH, 2004, CLIN CANCER RES, V10, P6256, DOI 10.1158/1078-0432.CCR-04-0645; Ohbayashi M, 2013, J TOXICOL SCI, V38, P103; Zhao RB, 2008, MOL PHARMACOL, V74, P854, DOI 10.1124/mol.108.045443; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Inoue K, 2014, DRUG METAB PHARMACOK, V29, P12, DOI 10.2133/dmpk.DMPK-13-RV-119; Araujo JR, 2010, BIOFACTORS, V36, P201, DOI 10.1002/biof.82; BARRERA P, 1994, ANN RHEUM DIS, V53, P434, DOI 10.1136/ard.53.7.434; Blanco Alonso R, 2011, REUMATOL CLIN, V6S3, pS29; Furst DE, 1997, BRIT J RHEUMATOL, V36, P1196; GOLDMAN ID, 1968, J BIOL CHEM, V243, P5007; GOLDMAN ID, 1985, PHARMACOL THERAPEUT, V28, P77, DOI 10.1016/0163-7258(85)90083-X; HORNE DW, 1990, BIOCHIM BIOPHYS ACTA, V1023, P47, DOI 10.1016/0005-2736(90)90008-C; Jansen G, 2004, ARTHRITIS RHEUM, V50, P2130, DOI 10.1002/art.20375; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Roubille C, 2014, SEMIN ARTHRITIS RHEU, V43, P613, DOI 10.1016/j.semarthrit.2013.09.005; SIERRA EE, 1995, BIOCHEM PHARMACOL, V50, P1287, DOI 10.1016/0006-2952(95)94097-Y; Sierra EE, 1997, BIOCHEM PHARMACOL, V53, P223, DOI 10.1016/S0006-2952(96)00730-7; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Takano M, 2010, DRUG METAB PHARMACOK, V25, P351; Tomaru A, 2013, DRUG METAB PHARMACOK, V28, P71, DOI 10.2133/dmpk.DMPK-12-NT-024; Urquhart BL, 2010, AM J PHYSIOL-GASTR L, V298, pG248, DOI 10.1152/ajpgi.00224.2009; Wani NA, 2012, J PHYSIOL SCI, V62, P461, DOI 10.1007/s12576-012-0223-x; Wells AF, 2011, J RHEUMATOL, V38, P2362, DOI 10.3899/jrheum.110054; Whetstine JR, 2002, BIOCHEM J, V367, P629, DOI 10.1042/BJ20020512; YUN CH, 1995, J PHYSIOL-LONDON, V482P, pS1; Zhao RB, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000969; Zhao RB, 2002, AM J PHYSIOL-CELL PH, V282, pC1512, DOI 10.1152/ajpcell.00547.2001	39	1	1	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	AUG	2015	30	4					276	281		10.1016/j.dmpk.2015.04.005		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO4XL	WOS:000359164100004		
J	Takagi, M; Sakamoto, M; Itoh, T; Fujiwara, R				Takagi, Motoi; Sakamoto, Masaya; Itoh, Tomoo; Fujiwara, Ryoichi			Underlying mechanism of drug-drug interaction between pioglitazone and gemfibrozil: Gemfibrozil acyl-glucuronide is a mechanism-based inhibitor of CYP2C8	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Gemfibrozil; Pioglitazone; Mechanism-based inhibition; Acyl-glucuronide; CYP2C8	HUMAN UDP-GLUCURONOSYLTRANSFERASES; PROTEIN-PROTEIN INTERACTIONS; HUMAN LIVER-MICROSOMES; IN-VITRO; PLASMA-CONCENTRATIONS; METABOLIZING-ENZYMES; GRAPEFRUIT JUICE; CYTOCHROMES P450; PHARMACOKINETICS; UGT	While co-administered gemfibrozil can increase the area under the concentration/time curve (AUC) of pioglitazone more than 3-fold, the underlying mechanism of the drug-drug interaction between gemfibrozil and pioglitazone has not been fully understood. In the present study, gemfibrozil preincubation time-dependently inhibited the metabolism of pioglitazone in the cytochrome P450 (CYP)- and UDP-glucuronosyltransferase (UGT)-activated human liver microsomes. We estimated the k(inact) and K'(app) values, which are the maximum inactivation rate constant and the apparent dissociation constant, of gemfibrozil to be 0.071 min(-1) and 57.3 mu M, respectively. In this study, the k(obs, in vivo) value was defined as a parameter that indicates the potency of the mechanism-based inhibitory effect at the blood drug concentration in vivo. The kobs, in vivo values of potent mechanism-based inhibitors, clarithromycin and erythromycin, were estimated to be 0.0096 min(-1) and 0.0051 min(-1), respectively. The kobs, in vivo value of gemfibrozil was 0.0060 min(-1), which was comparable to those of clarithromycin and erythromycin, suggesting that gemfibrozil could be a mechanism-based inhibitor as potent as clarithromycin and erythromycin in vivo. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Takagi, Motoi; Sakamoto, Masaya; Itoh, Tomoo; Fujiwara, Ryoichi] Kitasato Univ, Sch Pharm, Minato Ku, Tokyo 1088641, Japan	Fujiwara, R (reprint author), Kitasato Univ, Sch Pharm, Minato Ku, 5-9-1 Shirokane, Tokyo 1088641, Japan.	fujiwarar@pharm.kitasato-u.ac.jp					TODD PA, 1988, DRUGS, V36, P314, DOI 10.2165/00003495-198836030-00004; Bailey MJ, 2003, CHEM-BIOL INTERACT, V145, P117, DOI 10.1016/S0009-2797(03)00020-6; Mackenzie PI, 2005, PHARMACOGENET GENOM, V15, P677, DOI 10.1097/01.fpc.0000173483.13689.56; Niemi M, 2003, DIABETOLOGIA, V46, P1319, DOI 10.1007/s00125-003-1181-x; Hsu A, 1997, ANTIMICROB AGENTS CH, V41, P898; Muschler E, 2009, BASIC CLIN PHARMACOL, V105, P374, DOI 10.1111/j.1742-7843.2009.00457.x; Ishii Y, 2007, DRUG METAB PHARMACOK, V22, P367, DOI 10.2133/dmpk.22.367; Jaakkola T, 2005, CLIN PHARMACOL THER, V77, P404, DOI 10.1016/j.clpt.2004.12.266; Wen X, 2001, DRUG METAB DISPOS, V29, P1359; Ernest CS, 2005, J PHARMACOL EXP THER, V312, P583, DOI 10.1124/jpet.104.075416; Mano Y, 2007, DRUG METAB DISPOS, V35, P2040, DOI 10.1124/dmd.107.017269; Backman JT, 2002, CLIN PHARMACOL THER, V72, P685, DOI 10.1067/mcp.2002.128469; Kanamitsu S, 2000, PHARMACEUT RES, V17, P419, DOI 10.1023/A:1007572803027; Lewis DFV, 2004, PHARMACOGENOMICS, V5, P305, DOI 10.1517/phgs.5.3.305.29827; Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581; Fujiwara R, 2014, DRUG METAB PHARMACOK, V29, P259, DOI 10.2133/dmpk.DMPK-13-RG-096; Shitara Y, 2004, J PHARMACOL EXP THER, V311, P228, DOI 10.1124/jpet.104.068536; Lin JH, 2002, CURR DRUG METAB, V3, P623, DOI 10.2174/1389200023336992; Nakamura A, 2008, DRUG METAB DISPOS, V36, P1461, DOI 10.1124/dmd.108.021428; Meech R, 2010, DRUG METAB REV, V42, P45, DOI 10.3109/03602530903205823; Ogilvie BW, 2006, DRUG METAB DISPOS, V34, P191, DOI 10.1124/dmd.105.007633; Aquilante CL, 2013, BRIT J CLIN PHARMACO, V75, P217, DOI 10.1111/j.1365-2125.2012.04343.x; Azie NE, 1998, CLIN PHARMACOL THER, V64, P369, DOI 10.1016/S0009-9236(98)90067-4; Baer BR, 2009, CHEM RES TOXICOL, V22, P1298, DOI 10.1021/tx900105n; Bailey DG, 1996, CLIN PHARMACOL THER, V60, P25, DOI 10.1016/S0009-9236(96)90163-0; CHUN AHC, 1977, INFECTION, V5, P14, DOI 10.1007/BF01639131; Culm-Merdek KE, 2006, CLIN PHARMACOL THER, V79, P243, DOI 10.1016/j.clpt.2005.11.009; Deng LJ, 2005, EUR J CLIN PHARMACOL, V61, P831, DOI 10.1007/s00228-005-0042-6; Eckland D.A., 2000, EXP CLIN ENDOCR S2, V108, P234, DOI 10.1055/s-2000-8525; Fujiwara R., 2014, PHARM RES PERSPECT, V2; Guillemette C, 2010, DRUG METAB REV, V42, P24, DOI 10.3109/03602530903210682; Ikushiro S, 2004, BBA-GEN SUBJECTS, V1672, P86, DOI 10.1016/j.bbagen.2004.02.012; Ishii Y, 2014, DRUG METAB DISPOS, V42, P229, DOI 10.1124/dmd.113.054833; Jaakkola T, 2006, BASIC CLIN PHARMACOL, V99, P44, DOI 10.1111/j.1742-7843.2006.pto_437.x; Jenkins SM, 2011, DRUG METAB DISPOS, V39, P2421, DOI 10.1124/dmd.111.041947; Kirch W, 1984, Arch Toxicol Suppl, V7, P256; Kivisto KT, 1999, PHARMACOL TOXICOL, V84, P94; Nakajima Miki, 2005, Drug Metab Pharmacokinet, V20, P227, DOI 10.2133/dmpk.20.227; Ouellet D, 1998, CLIN PHARMACOL THER, V64, P355, DOI 10.1016/S0009-9236(98)90065-0; Parkinson A, 2010, DRUG METAB PHARMACOK, V25, P16; PUMFORD NR, 1993, CHEM RES TOXICOL, V6, P147, DOI 10.1021/tx00032a002; Silverman RB, 1988, CHEM ENZYMOLOGY, V1, P3; Taura K, 2000, BIOCHEM BIOPH RES CO, V273, P1048, DOI 10.1006/bbrc.2000.3076; Tornio A, 2008, CLIN PHARMACOL THER, V84, P403, DOI 10.1038/clpt.2008.34; Xu L, 2009, DRUG METAB DISPOS, V37, P2330, DOI 10.1124/dmd.108.025494; Zhang HB, 2012, TOXICOL IN VITRO, V26, P1286, DOI 10.1016/j.tiv.2012.01.005; Zheng Y, 2007, DRUG METAB DISPOS, V35, P1942, DOI 10.1124/dmd.107.016279	47	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	AUG	2015	30	4					288	294		10.1016/j.dmpk.2015.05.001		7	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO4XL	WOS:000359164100006		
J	Akiyoshi, T; Ishiuchi, M; Imaoka, A; Ohtani, H				Akiyoshi, Takeshi; Ishiuchi, Miho; Imaoka, Ayuko; Ohtani, Hisakazu			Variation in the inhibitory potency of terbinafine among genetic variants of CYP2D6	DRUG METABOLISM AND PHARMACOKINETICS			English	Article						Drug interactions; Time-dependent inhibition; Interindividual variation; Personalized medication	PROFILES	Cytochrome P450 2D6 (CYP2D6) is a highly polymorphic enzyme that is involved in the metabolism of many drugs. Terbinafine (TER) is a CYP2D6 inhibitor and causes persistent drug interactions in the clinical setting; however, its inhibitory mechanism and the differences in its inhibitory potency among genetic variants of CYP2D6 remain to be investigated. This study aimed to investigate the inhibitory mechanism of TER and the differences in its inhibitory potency among three CYP2D6 variants, CYP2D6.1, CYP2D6.2, and CYP2D6.10. In a competitive inhibition study, the metabolic activity of the CYP2D6 was assessed based on their demethylation of dextromethorphan in the presence or absence of TER, and the time-dependency of the inhibitory effects were examined by preincubating the enzymes with TER. TER had weaker inhibitory effects on CYP2D6.2 and CYP2D6.10 than on CYP2D6.1; i.e., TER exhibited K-i values (the concentration of inhibitor that results in half-maximal inhibition) of 0.0525, 0.355, and 1.85 mu M for CYP2D6.1, CYP2D6.2, and CYP2D6.10, respectively. The inhibitory effects of TER were not time-dependent. Since TER's K-i value for CYP2D6.10 was 35.2-fold higher than its K-i value for CYP2D6.1, the CYP2D6 genotype of subjects should be taken into account when estimating the severity of drug interactions involving TER. Copyright (C) 2015, The Japanese Society for the Study of Xenobiotics. Published by Elsevier Ltd. All rights reserved.	[Akiyoshi, Takeshi; Ishiuchi, Miho; Imaoka, Ayuko; Ohtani, Hisakazu] Keio Univ, Fac Pharm, Tokyo 1058512, Japan	Ohtani, H (reprint author), Keio Univ, Fac Pharm, Minato Ku, 1-5-30 Shibakoen, Tokyo 1058512, Japan.	ohtani-tky@umin.net			Japan Research Foundation for Clinical Pharmacology; JSPS Kakenhi [24590668]	This work was supported in part by the Japan Research Foundation for Clinical Pharmacology [to T, A] and JSPS Kakenhi Grant Number 24590668 [to H, O].	Abdel-Rahman SM, 1999, DRUG METAB DISPOS, V27, P770; Akiyoshi T, 2013, DRUG METAB PHARMACOK, V28, P411, DOI 10.2133/dmpk.DMPK-12-RG-134; Akiyoshi T, 2011, DRUG METAB DISPOS, V39, P724, DOI 10.1124/dmd.110.036780; Vickers AEM, 1999, DRUG METAB DISPOS, V27, P1029; Shen HW, 2007, DRUG METAB DISPOS, V35, P1292, DOI 10.1124/dmd.107.015354; KOVARIK JM, 1995, ANTIMICROB AGENTS CH, V39, P2738; Madeira M, 2004, DRUG METAB DISPOS, V32, P460, DOI 10.1124/dmd.32.4.460; Park YM, 2012, PSYCHIAT INVEST, V9, P422, DOI 10.4306/pi.2012.9.4.422; Ramamoorthy Y, 2001, PHARMACOGENETICS, V11, P477, DOI 10.1097/00008571-200108000-00003; YAMAOKA K, 1981, J PHARMACOBIO-DYNAM, V4, P879	10	0	0	JAPANESE SOC STUDY XENOBIOTICS	TOKYO	INT MED INF CENTER SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI SHINJUKU-KU, TOKYO, 160-0016, JAPAN	1347-4367	1880-0920		DRUG METAB PHARMACOK	Drug Metab. Pharmacokinet.	AUG	2015	30	4					321	324		10.1016/j.dmpk.2015.04.003		4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO4XL	WOS:000359164100010		
J	Park, HR; Uno, A				Park, Hyun-Rin; Uno, Akira			Cognitive Abilities Underlying Reading Accuracy, Fluency and Spelling Acquisition in Korean Hangul Learners from Grades 1 to 4: A Cross-Sectional Study	DYSLEXIA			English	Article						Reading; Spelling; Vocabulary; Visual processing; Phonological Awareness	PHONOLOGICAL AWARENESS; POOR READERS; NAMING-SPEED; DEVELOPMENTAL DYSLEXIA; DEFICIT HYPOTHESIS; PROCESSING SPEED; SKILLS; VOCABULARY; ENGLISH; COMPREHENSION	The purpose of this cross-sectional study was to examine the cognitive abilities that predict reading and spelling performance in Korean children in Grades 1 to 4, depending on expertise and reading experience. As a result, visual cognition, phonological awareness, naming speed and receptive vocabulary significantly predicted reading accuracy in children in Grades 1 and 2, whereas visual cognition, phonological awareness and rapid naming speed did not predict reading accuracy in children in higher grades. For reading, fluency, phonological awareness, rapid naming speed and receptive vocabulary were crucial abilities in children in Grades 1 to 3, whereas phonological awareness was not a significant predictor in children in Grade 4. In spelling, reading ability and receptive vocabulary were the most important abilities for accurate Hangul spelling. The results suggested that the degree of cognitive abilities required for reading and spelling changed depending on expertise and reading experience. Copyright (c) 2015 John Wiley & Sons, Ltd.	[Park, Hyun-Rin] Gwangju Univ, Gwangju, South Korea; [Uno, Akira] Univ Tsukuba, Tsukuba, Ibaraki 3058577, Japan	Uno, A (reprint author), Univ Tsukuba, D217,1-1-1,Tennohdai, Tsukuba, Ibaraki 3058577, Japan.	uno@human.tsukuba.ac.jp			Gwangju University; Japan Society for the Promotion of Science (JSPS)	This study was conducted by research funds from Gwangju University in 2014. A Grant-in-Aid for a Research Fellow from the Japan Society for the Promotion of Science (JSPS) Fellows also supported the research in this paper.	Ziegler JC, 2010, PSYCHOL SCI, V21, P551, DOI 10.1177/0956797610363406; HUANG HS, 1995, COGNITION, V54, P73, DOI 10.1016/0010-0277(94)00641-W; Kail R, 1999, APPL PSYCHOLINGUIST, V20, P303; Cho JR, 2005, SCI STUD READ, V9, P3, DOI 10.1207/s1532799xssr0901_2; Uno A, 2009, READ WRIT, V22, P755, DOI 10.1007/s11145-008-9128-8; Nikolopoulos D, 2006, J EXP CHILD PSYCHOL, V94, P1, DOI 10.1016/j.jecp.2005.11.006; Share DL, 2008, PSYCHOL BULL, V134, P584, DOI 10.1037/0033-2909.134.4.584; Furnes B, 2011, LEARN INDIVID DIFFER, V21, P85, DOI 10.1016/j.lindif.2010.10.005; JUEL C, 1988, J EDUC PSYCHOL, V80, P437, DOI 10.1037/0022-0663.80.4.437; Wang M, 2009, CONTEMP EDUC PSYCHOL, V34, P132, DOI 10.1016/j.cedpsych.2008.12.002; Nation K, 1998, CHILD DEV, V69, P996, DOI 10.1111/j.1467-8624.1998.tb06157.x; KAIL R, 1994, DEV PSYCHOL, V30, P949, DOI 10.1037/0012-1649.30.6.949; Wolf M, 1999, J EDUC PSYCHOL, V91, P415, DOI 10.1037//0022-0663.91.3.415; Talcott JB, 2003, BRAIN LANG, V87, P259, DOI 10.1016/S0093-934X(03)00105-6; Treiman R, 1998, CHILD DEV, V69, P1524, DOI 10.1111/j.1467-8624.1998.tb06175.x; Nation K, 1997, READ RES QUART, V32, P154, DOI 10.1598/RRQ.32.2.2; Muter V, 2004, DEV PSYCHOL, V40, P665, DOI 10.1037/0012-1649.40.5.665; Ricketts J, 2007, SCI STUD READ, V11, P235; Vaessen A, 2010, J EXP CHILD PSYCHOL, V105, P213, DOI 10.1016/j.jecp.2009.11.005; Cho JR, 2008, READ WRIT, V21, P255, DOI 10.1007/s11145-007-9072-z; Schatschneider C, 2004, J EDUC PSYCHOL, V96, P265, DOI 10.1037/0022-0663.96.2.265; Parrila R, 2004, SCI STUD READ, V8, P3, DOI 10.1207/s1532799xssr0801_2; Wolf M, 2000, J LEARN DISABIL-US, V33, P387, DOI 10.1177/002221940003300409; Ziegler JC, 2005, PSYCHOL BULL, V131, P3, DOI 10.1037/0033-2909.131.1.3; Ouellette GP, 2006, J EDUC PSYCHOL, V98, P554, DOI 10.1037/0022-0663.98.3.554; Cho JR, 2011, DYSLEXIA, V17, P312, DOI 10.1002/dys.439; Cho JR, 2005, J PSYCHOLINGUIST RES, V34, P401, DOI 10.1007/s10936-005-6140-x; Choi E. H., 2000, THESIS SEOUL NATL U; desLuca M., 2010, MED SCI MONITOR, V16, P1; Ehri L, 1995, J RES READ, V18, P116, DOI DOI 10.1111/J.1467-9817.1995.TB00077.X; Frith U., 1985, SURFACE DYSLEXIA, V32, P301; Georgiou GK, 2006, SCI STUD READ, V10, P199, DOI 10.1207/s1532799xssr1002_4; Georgiou GK, 2012, READ WRIT, V25, P321, DOI 10.1007/s11145-010-9271-x; Georgiou K. G., 2008, J EDUC PSYCHOL, V100, P566; Goswami U., 1990, J CHILD PSYCHOL PSYC, V32, P1173; GOSWAMI U, 1992, READ RES QUART, V27, P152, DOI 10.2307/747684; Haruhara N., 2011, JAPANESE J LOGOPEDIC, V52, P263; Kaneko M, 2004, ONSEI GENGO IGAKU, V45, P30; Katzir T, 2006, READ WRIT, V19, P845, DOI 10.1007/s11145-006-9013-2; Kim J., 2004, READ WRIT, V17, P153, DOI 10.1023/B:READ.0000013804.76677.a9; Kim J, 2004, BRAIN LANG, V91, P326, DOI 10.1016/j.bandl.2004.05.001; Kim Y. S., 2010, CONTEMP EDUC PSYCHOL, V36, P177; Kim Y. T., 2009, RECEPTIVE EXPRESS VO; Kim YS, 2009, READ WRIT, V22, P907, DOI 10.1007/s11145-008-9131-0; Kirby J. R., 2003, J EDUC PSYCHOL, V95, P452; Landerl K, 1997, COGNITION, V63, P315, DOI 10.1016/S0010-0277(97)00005-X; McBride-Chang C, 2011, J EXP CHILD PSYCHOL, V109, P256, DOI 10.1016/j.jecp.2010.12.003; Muter V, 1998, J Exp Child Psychol, V71, P3, DOI 10.1006/jecp.1998.2453; Papadopoulos TC, 2001, EUR J PSYCHOL EDUC, V16, P549; Park H. R., 2010, JAPANESE J LOGOPEDIC, V51, P235; Park HR, 2012, DYSLEXIA, V18, P199, DOI 10.1002/dys.1443; Raven J. C., 1995, COLOURED PROGR MATRI; Seo J. H., 1999, LEXICAL ANAL STUDIES; Sprenger-Charolles L, 1998, J EXP CHILD PSYCHOL, V68, P134, DOI 10.1006/jecp.1997.2422; Strauss E, 2006, COMPENDIUM NEUROPSYC; Taylor I, 1997, COGNITIVE PROCESSING OF CHINESE AND RELATED ASIAN LANGUAGES, P299; Thurlow M., 2003, LIT EARLY LITERACY I, V21; Tunmer W. E., 2012, J LEARNING DISABILIT, V31, P1; Uno A, 2005, JAPAN J LOGOPEDICS P, V46, P185; WIMMER H, 1993, APPL PSYCHOLINGUIST, V14, P1, DOI 10.1017/S0142716400010122; WOLF M, 1992, BRAIN LANG, V42, P219, DOI 10.1016/0093-934X(92)90099-Z; Wydell TN, 1999, COGNITION, V70, P273, DOI 10.1016/S0010-0277(99)00016-5; Yoon K, 2006, COMPUT SPEECH LANG, V20, P357, DOI 10.1016/j.csl.2005.03.002	63	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1076-9242	1099-0909		DYSLEXIA	Dyslexia	AUG	2015	21	3			SI		235	253		10.1002/dys.1500		19	Education, Special; Psychology, Educational; Rehabilitation	Education & Educational Research; Psychology; Rehabilitation	CO1XV	WOS:000358950500004		
J	Enami, N; Itaya-Hironaka, A; Yamauchi, A; Sakuramoto-Tsuchida, S; Takasawa, S; Takahashi, Y				Enami, Nobuko; Itaya-Hironaka, Asako; Yamauchi, Akiyo; Sakuramoto-Tsuchida, Sumiyo; Takasawa, Shin; Takahashi, Yukihiro			The CD38 genotype (rs1800561 (4693C > T): R140W) is associated with an increased risk of admission to the neonatal intensive care unit	EARLY HUMAN DEVELOPMENT			English	Article						CD38; Preterm birth; OXTR; SNP	CYCLIC-ADP-RIBOSE; LEUKOCYTE ANTIGEN CD38; PRETERM BIRTH; INSULIN-SECRETION; RECEPTOR GENE; POLYMORPHISMS; HYDROLASE; MYOMETRIUM; CELLS	Backgrounds: Preterm birth (PTB)/admission to the neonatal intensive care unit (NICU) is a complex disorder associated with significant neonatal mortality and morbidity and long-term adverse health consequences. Multiple lines of evidence suggest that genetic factors play an important role in its etiology. Aim: Given the role of CD38 in term delivery through oxytocin (OXT) release, we hypothesized that OXF signaling may play a role in the etiology of PTB/admission to the NICU. This study was designed to identify genetic variation in the CD38-oxytocin pathway associated with PTB/admission to the NICU. Methods: To identify common genetic variants predisposing individuals to PTB/admission to the NICU, we genotyped two single nucleotide polymorphisms (SNPs) in the CD38-oxytocin pathway in 63 case mothers, 55 control mothers, and 188 female volunteers in Nara Medical University Hospital, Japan. Results: Maternal genetic effect analysis of the SNP genotype data revealed a significant association between an SNP in CD38 (rs1800561 (4693C>T): R140W), which was reported to be correlated with diabetes and autism, and the risk of NICU admission. On the other hand, an SNP in the oxytocin receptor (OXTR) (rs2254298) showed no correlation with the risk of NICU admission. Conclusion: Our study points to an association between maternal common polymorphisms in the CD38 (rs1800561) gene in Japanese women and susceptibility to PTB/admission to the NICU. Future studies with larger sample sizes are needed to confirm the findings of this study. (C) 2015 Elsevier Ireland Ltd. All rights reserved.	[Enami, Nobuko; Takahashi, Yukihiro] Nara Med Univ Hosp, Perinatal Ctr, Div Neonatal Intens Care, Kashihara, Nara 6348522, Japan; [Itaya-Hironaka, Asako; Yamauchi, Akiyo; Sakuramoto-Tsuchida, Sumiyo; Takasawa, Shin] Nara Med Univ, Dept Biochem, Kashihara, Nara 6348521, Japan	Takasawa, S (reprint author), Nara Med Univ, Dept Biochem, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	shintksw@naramed-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan	We are grateful to the families who participated in this study and, the nurses and our colleagues at Nara Medical University Hospital. We thank T. Miyaoka, K. Yoshimoto, M. Takeda, H. Ota, C. Tsuchida, H. Tsujinaka, and T. Fujimura at Nara Medical University for useful discussions. This work was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. This work is in partial fulfillment by N. E. of the degree of Doctor of Medical Science at Nara Medical University.	Beck S, 2010, B WORLD HEALTH ORGAN, V88, P31, DOI 10.2471/BLT.08.062554; Jin D, 2007, NATURE, V446, P41, DOI 10.1038/nature05526; Thompson RJ, 2011, PSYCHONEUROENDOCRINO, V36, P144, DOI 10.1016/j.psyneuen.2010.07.003; TAKASAWA S, 1993, SCIENCE, V259, P370, DOI 10.1126/science.8420005; Nata K, 1997, GENE, V186, P285, DOI 10.1016/S0378-1119(96)00723-8; Gimpl G, 2001, PHYSIOL REV, V81, P629; NAKAGAWARA K, 1995, CYTOGENET CELL GENET, V69, P38, DOI 10.1159/000133933; Munesue T, 2010, NEUROSCI RES, V67, P181, DOI 10.1016/j.neures.2010.03.004; Antonelli A, 2001, CLIN EXP IMMUNOL, V126, P426, DOI 10.1046/j.1365-2249.2001.01683.x; Barata H, 2004, ENDOCRINOLOGY, V145, P881, DOI 10.1210/en.2003-0774; de Heus Roel, 2010, Int J Womens Health, V2, P137; Di Napoli A, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-48; Dogan S, 2006, MOL CELL ENDOCRINOL, V246, P101, DOI 10.1016/j.mce.2005.11.014; Gotsch F, 2009, J MATERN-FETAL NEO M, V22, P5, DOI 10.1080/14767050902860690; Harmon QE, 2013, AM J EPIDEMIOL, V178, P1208, DOI 10.1093/aje/kwt108; Ikehata F, 1998, J CLIN INVEST, V102, P395, DOI 10.1172/JCI1656; Jafarzadeh Lobat, 2013, Int J Prev Med, V4, P896; Jamroziak K, 2009, CANCER EPIDEM BIOMAR, V18, P945, DOI 10.1158/1055-9965.EPI-08-0683; Kuessel L, 2013, DIS MARKERS, V34, P51, DOI 10.3233/DMA-2012-00936; LEE HC, 1989, J BIOL CHEM, V264, P1608; Mallone R, 2001, DIABETES, V50, P752, DOI 10.2337/diabetes.50.4.752; Martin Joyce A, 2015, Natl Vital Stat Rep, V64, P1; Montag C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051882; Okamoto H, 2014, MESSENGER, V3, P27; TAKASAWA S, 1993, J BIOL CHEM, V268, P26052; Takasawa S, 2010, BIOCHEM BIOPH RES CO, V397, P140, DOI 10.1016/j.bbrc.2010.05.051; Terzidou Vasso, 2007, Best Pract Res Clin Obstet Gynaecol, V21, P729, DOI 10.1016/j.bpobgyn.2007.05.001; Wang Y, 2015, MOL GENET GENOMICS, V290, P289, DOI 10.1007/s00438-014-0921-6; Wu W, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-30; Yagui K, 1998, DIABETOLOGIA, V41, P1024, DOI 10.1007/s001250051026	30	0	0	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0378-3782	1872-6232		EARLY HUM DEV	Early Hum. Dev.	AUG	2015	91	8					467	470		10.1016/j.earlhumdev.2015.05.002		4	Obstetrics & Gynecology; Pediatrics	Obstetrics & Gynecology; Pediatrics	CO0DQ	WOS:000358820700006		
J	Hellgren, O; Atkinson, CT; Bensch, S; Albayrak, T; Dimitrov, D; Ewen, JG; Kim, KS; Lima, MR; Martin, L; Palinauskas, V; Ricklefs, R; Sehgal, RNM; Valkiunas, G; Tsuda, Y; Marzal, A				Hellgren, Olof; Atkinson, Carter T.; Bensch, Staffan; Albayrak, Tamer; Dimitrov, Dimitar; Ewen, John G.; Kim, Kyeong Soon; Lima, Marcos R.; Martin, Lynn; Palinauskas, Vaidas; Ricklefs, Robert; Sehgal, Ravinder N. M.; Valkiunas, Gediminas; Tsuda, Yoshio; Marzal, Alfonso			Global phylogeography of the avian malaria pathogen Plasmodium relictum based on MSP1 allelic diversity	ECOGRAPHY			English	Article							MEROZOITE SURFACE PROTEIN-1; VACCINE-CANDIDATE ANTIGENS; BLOOD PARASITES; CYANISTES-CAERULEUS; SPOROGONIC DEVELOPMENT; GENETIC DIVERSITY; HOST-SPECIFICITY; PASSERINE BIRD; BLUE TITS; POPULATION	Knowing the genetic variation that occurs in pathogen populations and how it is distributed across geographical areas is essential to understand parasite epidemiology, local patterns of virulence, and evolution of host-resistance. In addition, it is important to identify populations of pathogens that are evolutionarily independent and thus free' to adapt to hosts and environments. Here, we investigated genetic variation in the globally distributed, highly invasive avian malaria parasite Plasmodium relictum, which has several distinctive mitochondrial haplotyps (cyt b lineages, SGS1, GRW11 and GRW4). The phylogeography of P. relictum was accessed using the highly variable nuclear gene merozoite surface protein 1 (MSP1), a gene linked to the invasion biology of the parasite. We show that the lineage GRW4 is evolutionarily independent of GRW11 and SGS1 whereas GRW11 and SGS1 share MSP1 alleles and thus suggesting the presence of two distinct species (GRW4 versus SGS1 and GRW11). Further, there were significant differences in the global distribution of MSP1 alleles with differences between GRW4 alleles in the New and the Old World. For SGS1, a lineage formerly believed to have both tropical and temperate transmission, there were clear differences in MSP1 alleles transmitted in tropical Africa compared to the temperate regions of Europe and Asia. Further, we highlight the occurrence of multiple MSP1 alleles in GRW4 isolates from the Hawaiian Islands, where the parasite has contributed to declines and extinctions of endemic forest birds since it was introduced. This study stresses the importance of multiple independent loci for understanding patterns of transmission and evolutionary independence across avian malaria parasites.	[Hellgren, Olof; Bensch, Staffan; Marzal, Alfonso] Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, SE-22362 Lund, Sweden; [Marzal, Alfonso] Univ Extremadura, Anat Biol Celular & Zool, ES-06071 Badajoz, Spain; [Atkinson, Carter T.] US Geol Survey, Pacific Isl Ecosyst Res Ctr, Hawaii Natl Pk, HI 96718 USA; [Albayrak, Tamer] Mehmet Akif Ersoy Univ, Dept Biol, Ornithol Lab, Burdur, Turkey; [Dimitrov, Dimitar; Palinauskas, Vaidas; Valkiunas, Gediminas] Nat Res Ctr, Inst Ecol, LT-08412 Vilnius 21, Lithuania; [Dimitrov, Dimitar] Bulgarian Acad Sci, Inst Biodivers & Ecosyst Res, BG-1113 Sofia, Bulgaria; [Ewen, John G.] Zool Soc London, Inst Zool, London, England; [Kim, Kyeong Soon] Tottori Univ, Fac Agr, Joint Dept Vet Med, Tottori, Japan; [Lima, Marcos R.] Univ Estadual Londrina, Posgrad Ciencias Biol, Depto Biol Anim & Vegetal, Londrina, PR, Brazil; [Martin, Lynn] Univ S Florida, Dept Integrat Biol, Tampa, FL 33620 USA; [Ricklefs, Robert] Univ Missouri, Dept Biol, St Louis, MO 63121 USA; [Sehgal, Ravinder N. M.] San Francisco State Univ, Dept Biol, San Francisco, CA 94132 USA; [Tsuda, Yoshio] Natl Inst Infect Dis, Dept Med Entomol, Shinjuku Ku, Tokyo 1628640, Japan	Hellgren, O (reprint author), Lund Univ, Dept Biol, Mol Ecol & Evolut Lab, SE-22362 Lund, Sweden.	olof.hellgren@biol.lu.se	Marzal, Alfonso/J-6677-2012; Hellgren, Olof/C-7420-2014	Marzal, Alfonso/0000-0001-5872-1060; SEHGAL, Ravinder/0000-0002-5255-4641; Hellgren, Olof/0000-0002-4062-7276	Swedish Research Council (Svenska Vetenskapsradet); Crafoord Foundation; U.S. Geological Survey Wildlife and Terrestrial Resources Program; NSF-IOS [0920475]	This work was supported in part by the Swedish Research Council (Svenska Vetenskapsradet) and the Crafoord Foundation (OH), the U.S. Geological Survey Wildlife and Terrestrial Resources Program (CA). Any use of trade, product, or firm names in this publication is for descriptive purposes only and does not imply endorsement by the U.S. Government. Sample collection by LBM was supported by NSF-IOS 0920475.	Kadekoppala M, 2010, INT J PARASITOL, V40, P1155, DOI 10.1016/j.ijpara.2010.04.008; Bensch S, 2004, EVOLUTION, V58, P1617, DOI 10.1554/04-026; Atkinson CT, 2013, ECOHEALTH, V10, P366, DOI 10.1007/s10393-013-0899-2; Wood MJ, 2007, MOL ECOL, V16, P3263, DOI 10.1111/j.1365-294X.2007.03362.x; Remarque EJ, 2008, TRENDS PARASITOL, V24, P74, DOI 10.1016/j.pt.2007.12.002; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Palinauskas V, 2011, EXP PARASITOL, V127, P527, DOI 10.1016/j.exppara.2010.10.007; Samuel MD, 2011, ECOL APPL, V21, P2960, DOI 10.1890/10-1311.1; Hellgren O, 2009, ECOLOGY, V90, P2840, DOI 10.1890/08-1059.1; Cosgrove CL, 2008, J ANIM ECOL, V77, P540, DOI 10.1111/j.1365-2656.2008.01370.x; WARNER RE, 1968, CONDOR, V70, P101, DOI 10.2307/1365954; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Bensch S, 2000, P ROY SOC B-BIOL SCI, V267, P1583, DOI 10.1098/rspb.2000.1181; Ferrer ES, 2012, PARASITOL RES, V111, P2137, DOI 10.1007/s00436-012-3062-z; Bensch S, 2007, J ANIM ECOL, V76, P112, DOI 10.1111/j.1365-2656.2006.01176.x; Lachish S, 2011, J ANIM ECOL, V80, P1196, DOI 10.1111/j.1365-2656.2011.01836.x; Marzal A, 2005, OECOLOGIA, V142, P541, DOI 10.1007/s00442-004-1757-2; Loiseau C, 2012, MOL ECOL, V21, P431, DOI 10.1111/j.1365-294X.2011.05341.x; Beadell JS, 2006, P ROY SOC B-BIOL SCI, V273, P2935, DOI 10.1098/rspb.2006.3671; Reullier J, 2006, MOL ECOL, V15, P753, DOI 10.1111/j.1365-294X.2005.02826.x; Bensch S, 2009, MOL ECOL RESOUR, V9, P1353, DOI 10.1111/j.1755-0998.2009.02692.x; Beadell JS, 2004, MOL ECOL, V13, P3829, DOI 10.1111/j.1365-294X.2004.02363.x; Baldwin P. H., 1941, HAWAII NATL PARK NAT; Barry AE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008497; Bensch S, 2014, MOL ECOL RESOUR, V14, P218, DOI 10.1111/1755-0998.12166; Billker O., 1997, PARASITOLOGY, V111, P539; Bishop MA, 1992, MEMORIAL U NEWFOUNDL, V15, P1; Bruce MC, 2002, CURR OPIN MICROBIOL, V5, P431, DOI 10.1016/S1369-5274(02)00348-X; Bueno MG, 2010, VET PARASITOL, V173, P123, DOI 10.1016/j.vetpar.2010.06.026; Farias MEM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-305; Gerold P, 1996, MOL BIOCHEM PARASIT, V75, P131, DOI 10.1016/0166-6851(95)02518-9; Hellgren O, 2007, MOL ECOL, V16, P1281, DOI 10.1111/j.1365-294X.2007.03277.x; Hellgren O, 2013, J EVOLUTION BIOL, V26, P1047, DOI 10.1111/jeb.12129; Hellgren O, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-381; Hui G, 2007, VACCINE, V25, P948, DOI 10.1016/j.vaccine.2006.08.041; Jarvi SI, 2013, PARASITOLOGY, V140, P1741, DOI 10.1017/S0031182013000905; Kang JM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-206; Lowe S, 2000, 100 WORLDS WORST INV; Marzal A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021905; Marzal A., 2014, BIOL INVASIONS, DOI [10.1007/s10530-014-0718, DOI 10.1007/S10530-014-0718]; Moulton MP, 2001, STUD AVIAN BIOL-SER, P31; Ngoundou-Landji J, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-287; Noranate N, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-219; Pacheco MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034990; Palinauskas V, 2008, EXP PARASITOL, V120, P372, DOI 10.1016/j.exppara.2008.09.001; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Perez-Tris J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000235; Pyle RL, 2009, BIRDS HAWAIIAN ISLAN; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Tanabe K, 2013, VACCINE, V31, P1334, DOI 10.1016/j.vaccine.2012.12.039; Valkiunas G, 2005, AVIAN MALARIA PARASI; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; VANDERBE.JP, 1966, J PARASITOL, V52, P559, DOI 10.2307/3276326; Waldenstrom J, 2004, J PARASITOL, V90, P191, DOI 10.1645/GE-3221RN; Wright GJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003943	55	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-7590	1600-0587		ECOGRAPHY	Ecography	AUG	2015	38	8					842	850		10.1111/ecog.01158		9	Biodiversity Conservation; Ecology	Biodiversity & Conservation; Environmental Sciences & Ecology	CO7AU	WOS:000359310700010		
J	Jin, Y; Zhang, J; Yuan, Q; Manabe, T; Tan, W				Jin, Ya; Zhang, Jun; Yuan, Qi; Manabe, Takashi; Tan, Wen			Proteomic analysis of cellular soluble proteins from human bronchial smooth muscle cells by combining nondenaturing micro 2DE and quantitative LC-MS/MS. 1. Preparation of more than 4000 native protein maps	ELECTROPHORESIS			English	Article						Cellular proteins; LC-MS; MS; Native protein map; Nondenaturing micro 2DE; Quantitative protein-protein interaction	MALDI-MS-PMF; GEL-ELECTROPHORESIS; 2-DIMENSIONAL ELECTROPHORESIS; IDENTIFICATION TECHNOLOGY; MASS-SPECTROMETRY; PLASMA-PROTEINS; SEPARATION; ACQUISITION; PERFORMANCE; ASSIGNMENT	Soluble proteins of human bronchial smooth muscle cells (HBSMC) were separated by nondenaturing micro 2DE and a 30 mm x 40 mm area of the CBB-stained slab gel (1.0 mm thick) was cut into 1.1 mm x 1.1 mm squares, then the proteins in the 972 gel pieces (squares) were applied to quantitative LC-MS/MS. Grid-cutting of the gel was employed to; (i) ensure the total analysis of the proteins in the area, (ii) standardize the conditions of analysis by LC-MS/MS, (iii) reconstruct the protein distribution patterns from the quantity data [1]. Totally 4323 proteins were identified in successfully analyzed 967 squares and the quantity distribution of each was reconstructed as a color density pattern (a native protein map). The quantity of the proteins distributed from 3.6% to 1 x 10(-5)% of the total protein quantity in the grid area. Each protein map was characterized by several features, including the position of quantity peak square, number of detected squares, and degree of concentration (focused or dispersed). About 4% of the proteins were detected in 100 or more squares, suggesting that they might be ubiquitous and interacting with other proteins. In contrast, many proteins showed more concentrated quantity distribution and the quantity peak positions of 565 proteins with a defined degree of concentration were summarized into a quantity peak map. These results for the first time visualized the distribution patterns of cellular proteins on a nondenaturing 2D gel.	[Jin, Ya; Zhang, Jun; Yuan, Qi; Tan, Wen] S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China; [Jin, Ya] S China Univ Technol, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China; [Jin, Ya; Tan, Wen] S China Univ Technol, Guangdong Higher Educ Inst, Key Lab Ind Biotechnol, Guangzhou 510006, Guangdong, Peoples R China; [Manabe, Takashi] Ehime Univ, Fac Sci, Matsuyama, Ehime 790, Japan	Tan, W (reprint author), S China Univ Technol, Sch Biosci & Bioengn, Guangzhou 510006, Guangdong, Peoples R China.	went@scut.edu.cn			National Natural Science Foundation of China [31400798]; Science and Technology Program of Guangzhou, China [2014J4100022]; Fundamental Research Funds for the Central Universities [2013ZM0048]; Guangdong Province Key Laboratory of Fermentation and Enzyme Engineering Open Fund, China [FJ2013002]; Ministry of Science and Technology of Guangdong Province, China [2012A080204001]	This work is financially supported by "National Natural Science Foundation of China 31400798," "Science and Technology Program of Guangzhou, China 2014J4100022," "The Fundamental Research Funds for the Central Universities 2013ZM0048," "Guangdong Province Key Laboratory of Fermentation and Enzyme Engineering Open Fund, China FJ2013002," and "Ministry of Science and Technology of Guangdong Province, China 2012A080204001."	Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686; Bond NJ, 2013, J PROTEOME RES, V12, P2340, DOI 10.1021/pr300776t; Shliaha PV, 2013, J PROTEOME RES, V12, P2323, DOI 10.1021/pr300775k; Wu CG, 2013, METHODS, V62, P151, DOI 10.1016/j.ymeth.2013.02.002; Manabe T, 2010, ELECTROPHORESIS, V31, P2740, DOI 10.1002/elps.201000165; Link AJ, 1999, NAT BIOTECHNOL, V17, P676; Lasserre JP, 2006, ELECTROPHORESIS, V27, P3306, DOI 10.1002/elps.200500912; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Unlu M, 1997, ELECTROPHORESIS, V18, P2071, DOI 10.1002/elps.1150181133; Wang H, 2010, J PROTEOME RES, V9, P1032, DOI 10.1021/pr900927y; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Burkard TR, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-17; Geiger T, 2012, MOL CELL PROTEOMICS, V11, pM111, DOI DOI 10.1074/MCP.M111.014050; Jin Y, 2009, ELECTROPHORESIS, V30, P939, DOI 10.1002/elps.200800539; Jin Y, 2014, ELECTROPHORESIS, V35, P2055, DOI 10.1002/elps.201300628; Jin Y., ELECTROPHOR IN PRESS, DOI [10.1002/elps.201400574, DOI 10.1002/ELPS.201400574]; Jin Y, 2009, ELECTROPHORESIS, V30, P931, DOI 10.1002/elps.200800663; Karsani SA, 2014, PROTEOME SCI, V12, DOI 10.1186/1477-5956-12-3; Manabe T, 2008, ELECTROPHORESIS, V29, P2672, DOI 10.1002/elps.200700893; Manabe T, 2011, ELECTROPHORESIS, V32, P300, DOI 10.1002/elps.201000443; Manabe T, 2007, ELECTROPHORESIS, V28, P843, DOI 10.1002/elps.200600389; Nagaraj N, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.81; OFARRELL PH, 1975, J BIOL CHEM, V250, P4007; Shimazaki Y, 2003, PROTEOMICS, V3, P2002, DOI 10.1002/pmic.200300467; Vizcaino J. A., 2014, NAT BIOTECHNOL, V30, P223, DOI [10.1038/nbt.2839, DOI 10.1038/NBT.2839]; Wolters DA, 2001, ANAL CHEM, V73, P5683, DOI 10.1021/ac010617e	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	AUG	2015	36	15			SI		1711	1723		10.1002/elps.201400573		13	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CO3LB	WOS:000359057600007		
J	Tanaka, S; Suzuki, H; Sadamoto, S; Imachi, M; Bui, TQ				Tanaka, Satoyuki; Suzuki, Hirotaka; Sadamoto, Shota; Imachi, Michiya; Tinh Quoc Bui			Analysis of cracked shear deformable plates by an effective meshfree plate formulation	ENGINEERING FRACTURE MECHANICS			English	Article						Fracture; Meshfree methods; Mindlin-Reissner plates; J-integral; Stabilized conforming nodal integration	CONFORMING NODAL INTEGRATION; STRESS INTENSITY FACTORS; FREE GALERKIN METHODS; THIN PLATES; NUMERICAL-SIMULATION; FRACTURE-MECHANICS; ELEMENT METHODS; PROPAGATION; SHELLS	A novel technique to evaluate the path-independent integral using nodal integration is developed for cracked plate problems. The formulation is based on the Mindlin-Reissner plate theory, and the reproducing kernel is used as a meshfree interpolant. A visibility criterion, diffraction method, and enriched basis are included. To integrate the stiffness matrix, the stabilized conforming nodal integration and the sub-domain conforming integration are adopted. A moment intensity factor is also evaluated employing the J-integral based on the nodal integration. Convergence and numerical results derived from regular and irregular discretizations, node density, and other aspect ratios are analyzed. (C) 2015 Elsevier Ltd. All rights reserved.	[Tanaka, Satoyuki; Suzuki, Hirotaka; Sadamoto, Shota; Imachi, Michiya] Hiroshima Univ, Grad Sch Engn, Hiroshima 730, Japan; [Tinh Quoc Bui] Tokyo Inst Technol, Dept Mech & Environm Informat, Tokyo, Japan	Tanaka, S (reprint author), Hiroshima Univ, Grad Sch Engn, Hiroshima 730, Japan.	satoyuki@hiroshima-u.ac.jp; m140825@hiroshima-u.ac.jp; shota.sadamoto@gmail.com; m155994@hiroshima-u.ac.jp; tinh.buiquoc@gmail.com	Bui, Tinh Quoc/H-6752-2014	Bui, Tinh Quoc/0000-0002-6426-6639	JSPS KAKENHI [15H02328, 15H04212, 15K06632]; JSPS [26-04055]	This research was partially supported by JSPS KAKENHI Grant-in-Aid for Scientific Research (A) (15H02328), (B) (15H04212) and (C) (15K06632). This work was performed under the Cooperative Research Program of the Joining and Welding Research Institute, Osaka University. Tinh Quoc Bui gratefully acknowledges the support from the Grant-in-Aid for Scientific Research (No. 26-04055) - JSPS.	Aliabadi MH, 1997, INT J FRACTURE, V86, P91, DOI 10.1023/A:1007381025099; Anderson TL, 2005, FRACTURE MECH FUNDAM; Dolbow J, 2000, INT J SOLIDS STRUCT, V37, P7161, DOI 10.1016/S0020-7683(00)00194-3; Wang DD, 2004, COMPUT METHOD APPL M, V193, P1065, DOI 10.1016/j.cma.2003.12.006; Krysl P, 1997, COMPUT METHOD APPL M, V148, P257, DOI 10.1016/S0045-7825(96)00007-2; BELYTSCHKO T, 1994, INT J NUMER METH ENG, V37, P229, DOI 10.1002/nme.1620370205; Rabczuk T, 2008, INT J NUMER METH ENG, V75, P577, DOI 10.1002/nme.2273; Rabczuk T, 2007, INT J NUMER METH ENG, V72, P524, DOI 10.1002/nme.2013; Nguyen VP, 2008, MATH COMPUT SIMULAT, V79, P763, DOI 10.1016/j.matcom.2008.01.003; Chau-Dinh T, 2012, COMPUT STRUCT, V92-93, P242, DOI 10.1016/j.compstruc.2011.10.021; De Luycker E, 2011, INT J NUMER METH ENG, V87, P541, DOI 10.1002/nme.3121; Atluri SN, 1998, COMPUT MECH, V22, P117, DOI 10.1007/s004660050346; LIU WK, 1995, INT J NUMER METH FL, V20, P1081, DOI 10.1002/fld.1650200824; Wang DD, 2013, COMPUT MECH, V51, P1013, DOI 10.1007/s00466-012-0784-9; Organ D, 1996, COMPUT MECH, V18, P225; Sadamoto S, 2013, COMPUT MECH, V52, P1313, DOI 10.1007/s00466-013-0878-z; Chen JS, 2001, INT J NUMER METH ENG, V50, P435, DOI 10.1002/1097-0207(20010120)50:2<435::AID-NME32>3.0.CO;2-A; Bhardwaj G, 2015, COMPOS STRUCT, V126, P347, DOI 10.1016/j.compstruct.2015.02.066; Wang DD, 2011, COMPUT MECH, V48, P47, DOI 10.1007/s00466-011-0580-y; Wang DD, 2014, COMPUT MECH, V54, P689, DOI 10.1007/s00466-014-1022-4; Wang DD, 2010, COMPUT MECH, V46, P703, DOI 10.1007/s00466-010-0511-3; Fleming M, 1997, INT J NUMER METH ENG, V40, P1483, DOI 10.1002/(SICI)1097-0207(19970430)40:8<1483::AID-NME123>3.0.CO;2-6; Areias PMA, 2006, COMPUT METHOD APPL M, V195, P5343, DOI 10.1016/j.cma.2005.10.024; Liu P, 2015, COMPOS PART B-ENG, V77, P179, DOI 10.1016/j.compositesb.2015.03.036; BODUROGLU H, 1983, J APPL MECH-T ASME, V50, P621; Bui Q.T., 2011, ENG STRUCT, V33, P3364; Bui QT, 2011, ENG ANAL BOUND ELEM, V35, P1038; Dirgantara T, 2002, ENG FRACT MECH, V69, P1465, DOI 10.1016/S0013-7944(01)00136-9; Dirgantara T, 2001, INT J SOLIDS STRUCT, V38, P7769, DOI 10.1016/S0020-7683(01)00097-X; Gotoh K, 2015, MAR STRUCT, V42, P53, DOI 10.1016/j.marstruc.2015.03.003; He WT, 2014, MAR STRUCT, V35, P45, DOI 10.1016/j.marstruc.2013.12.001; Joyot P, 2005, LECT NOTES COMPUT SC, V43, P93; Lasry J, 2010, INT J NUMER METH ENG, V84, P1115, DOI 10.1002/nme.2939; Mohammad M, 2011, CMES-COMP MODEL ENG, V76, P19; Mos N, 1999, INT J NUMER METH ENG, V46, P131; Qiao WF, 2014, MAR STRUCT, V39, P373, DOI 10.1016/j.marstruc.2014.10.003; Sih G. C., 1997, MECH FRACTURE, V3; SOSA H, 1989, INT J FRACTURE, V40, P111, DOI 10.1007/BF00963970; SOSA HA, 1986, ENG FRACT MECH, V25, P451, DOI 10.1016/0013-7944(86)90259-6; Tanaka S, 2012, INT J COMP METH-SING, V9, DOI 10.1142/S0219876212400129; Tanaka S, 2014, MAR STRUCT, V39, P315, DOI 10.1016/j.marstruc.2014.08.001; Wang DD, 2008, INT J NUMER METH ENG, V74, P368, DOI 10.1002/nme.2175; Wang DD, 2011, INT J COMP METH-SING, V8, P685, DOI 10.1142/S0219876211002769; Yu TT, INT J MECH MAT DES; Zhender AT, 2005, APPL MECH REV, V58, P37	45	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0013-7944	1873-7315		ENG FRACT MECH	Eng. Fract. Mech.	AUG	2015	144						142	157		10.1016/j.engfracmech.2015.06.084		16	Mechanics	Mechanics	CO7DR	WOS:000359319300010		
J	Sabrekov, AF; Glagolev, MV; Fastovets, IA; Smolentsev, BA; Il'yasov, DV; Maksyutov, SS				Sabrekov, A. F.; Glagolev, M. V.; Fastovets, I. A.; Smolentsev, B. A.; Il'yasov, D. V.; Maksyutov, Sh. Sh.			Relationship of methane consumption with the respiration of soil and grass-moss layers in forest ecosystems of the southern taiga in Western Siberia	EURASIAN SOIL SCIENCE			English	Article						rhizospheric methanotrophs; total soil and plant respiration; greenhouse gases; Fluvisol; Luvisol; Gleysol	NITROUS-OXIDE FLUXES; ATMOSPHERIC METHANE; METHANOTROPHIC BACTERIA; SEASONAL DYNAMICS; MIXING RATIOS; PEAT SOILS; OXIDATION; EMISSION; CH4; CO2	The consumption of methane by some soils in the southern taiga of Western Siberia was studied by the static chamber method in the summer of 2013. The median of the specific CH4 flux through the soil was -0.05 mg C/(m(2) h) for the entire set of measurements (the negative flux indicates the consumption of methane by the soil). A statistically significant (R (2) = 0.81) linear relationship has been found between the specific CH4 flux to the soil and the total respiration of the soil and the grass-moss layers in the studied forest ecosystems. The quantitative theoretical explanation of this relationship is based on the plant-associated and free methanotrophy.	[Sabrekov, A. F.; Glagolev, M. V.; Fastovets, I. A.] Moscow MV Lomonosov State Univ, Fac Soil Sci, Moscow 119991, Russia; [Sabrekov, A. F.; Glagolev, M. V.; Maksyutov, Sh. Sh.] Tomsk State Univ, Tomsk 643050, Russia; [Sabrekov, A. F.; Glagolev, M. V.] Yugra State Univ, Khanty Mansiisk 628012, Russia; [Sabrekov, A. F.; Glagolev, M. V.; Il'yasov, D. V.] Russian Acad Sci, Inst Forest Sci, Moscow 143030, Moscow Oblast, Russia; [Smolentsev, B. A.] Russian Acad Sci, Inst Soil Sci & Agrochem, Siberian Branch, Novosibirsk 630099, Russia; [Maksyutov, Sh. Sh.] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan	Sabrekov, AF (reprint author), Moscow MV Lomonosov State Univ, Fac Soil Sci, Moscow 119991, Russia.	sabrekovaf@gmail.com; m_glagolev@mail.ru	Maksyutov, Shamil/G-6494-2011	Maksyutov, Shamil/0000-0002-1200-9577			ANDRONOVA NG, 1993, CHEMOSPHERE, V26, P111, DOI 10.1016/0045-6535(93)90416-3; Knief C, 2003, APPL ENVIRON MICROB, V69, P6703, DOI 10.1128/AEM.69.11.6703-6714.2003; Heimann M, 2011, NATURE, V476, P157, DOI 10.1038/476157a; Semenov MV, 2010, EURASIAN SOIL SCI+, V43, P541, DOI 10.1134/S1064229310050078; ADAMSEN APS, 1993, APPL ENVIRON MICROB, V59, P485; HUTCHINSON GL, 1981, SOIL SCI SOC AM J, V45, P311; Conrad R, 2007, ADV AGRON, V96, P1, DOI 10.1016/S0065-2113(07)96005-8; KING GM, 1994, APPL ENVIRON MICROB, V60, P3220; Knief C, 2005, ENVIRON MICROBIOL, V7, P1307, DOI 10.1111/j.1462-2920.2005.00814.x; CASTRO MS, 1995, GLOBAL BIOGEOCHEM CY, V9, P1, DOI 10.1029/94GB02651; Conrad R, 1996, MICROBIOL REV, V60, P609; Kolb S, 2005, ENVIRON MICROBIOL, V7, P1150, DOI 10.1111/j.1462-2920.2005.00791.x; Kruger M, 2001, GLOBAL CHANGE BIOL, V7, P49, DOI 10.1046/j.1365-2486.2001.00395.x; [Anonymous], 2004, CLASSIFICATION DIAGN; Repo ME, 2007, TELLUS B, V59, P788, DOI 10.1111/j.1600-0889.2007.00301.x; Reich PB, 1998, FUNCT ECOL, V12, P395, DOI 10.1046/j.1365-2435.1998.00209.x; BENDER M, 1992, FEMS MICROBIOL ECOL, V101, P261, DOI 10.1111/j.1574-6968.1992.tb05783.x; Shipley B, 2002, FUNCT ECOL, V16, P326, DOI 10.1046/j.1365-2435.2002.00626.x; RODHE H, 1990, SCIENCE, V248, P1217, DOI 10.1126/science.248.4960.1217; Collier DE, 1996, CAN J BOT, V74, P317; CRILL P M, 1991, Global Biogeochemical Cycles, V5, P319, DOI 10.1029/91GB02466; Efremova T. T., 1998, SIBIRSKY EKOL ZH, P563; GARNIER E, 1992, J ECOL, V80, P665, DOI 10.2307/2260858; GERARD G, 1993, BIOGEOCHEMISTRY, V23, P79, DOI 10.1007/BF00000444; Glagolev M, 2011, ENVIRON RES LETT, V6, DOI 10.1088/1748-9326/6/4/045214; Glagolev M. V., 2010, PHYS CHEM BIOL PEAT; Glagolev M. V., 2011, DYN OKRUZH SREDY GLO, V2; Glagolev MV, 2008, CONTEMP PROBL ECOL, V1, P136, DOI 10.1134/S1995425508010165; Glagolev MV, 2012, EURASIAN SOIL SCI+, V45, P947, DOI 10.1134/S106422931210002X; Golovatskaya E. A., 2005, BOT PRINCIPLES PHYTO; Ivanova E. G., 2006, T I MIKROBIOL IM SN, P263; Kondrat'ev K. Ya., 2004, MODELING GLOBAL CARB; KOSCHORRECK M, 1993, GLOBAL BIOGEOCHEM CY, V7, P109, DOI 10.1029/92GB02814; Kravchenko IK, 2005, MICROBIOLOGY+, V74, P216, DOI 10.1007/s11021-005-0054-3; Krivenko L. A., 2013, DIN OKRUZH SREDY GLO, V4; Kudeyarov VN, 2005, EURASIAN SOIL SCI+, V38, P808; Kurganova I, 2003, TELLUS B, V55, P338, DOI 10.1034/j.1600-0889.2003.00047.x; Naumov A. V., 2003, 2 INT C EM FLOW GREE, P86; Naumov A. V., 2002, SIB EKOL ZH, P313; Novikov VV, 2005, EURASIAN SOIL SCI+, V38, P745; Novikov VV, 2004, EURASIAN SOIL SCI+, V37, P755; Rayment MB, 1997, J GEOPHYS RES-ATMOS, V102, P28779, DOI 10.1029/97JD01103; Semenov VM, 2004, MICROBIOLOGY+, V73, P356, DOI 10.1023/B:MICI.0000032249.72956.9f; Sirin A. A., 2012, DYN OKRUZH SREDY GLO, V3; World Reference Base for Soil Resources, 2014, WORLD SOIL RES REP, V106; Zhu XD, 2013, GLOBAL BIOGEOCHEM CY, V27, P592, DOI 10.1002/gbc.20052	46	0	0	MAIK NAUKA/INTERPERIODICA/SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013-1578 USA	1064-2293	1556-195X		EURASIAN SOIL SCI+	Eurasian Soil Sci.	AUG	2015	48	8					841	851		10.1134/S1064229315080062		11	Soil Science	Agriculture	CN9QA	WOS:000358782700007		
J	Tani, Y; Asakura, K; Sasaki, S; Hirota, N; Notsu, A; Todoriki, H; Miura, A; Fukui, M; Date, C				Tani, Y.; Asakura, K.; Sasaki, S.; Hirota, N.; Notsu, A.; Todoriki, H.; Miura, A.; Fukui, M.; Date, C.			The influence of season and air temperature on water intake by food groups in a sample of free-living Japanese adults	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article							ENERGY-INTAKE; FLUID INTAKE; RELATIVE VALIDITY; PHYSICAL-ACTIVITY; CONSUMPTION; POPULATION; BEVERAGE; PATTERNS; ADOLESCENTS; CHILDREN	BACKGROUND/OBJECTIVES: To examine the influence of season and climate (air temperature and humidity) on water intake by the food group in a sample of free-living Japanese adults. SUBJECTS/METHODS: Four-nonconsecutive-day, semi-weighed dietary records were collected from each of the four seasons in a single 12-month period (16 days in total). The influence of season and climate on individual water intake by the food group was analyzed using a mixed linear model. Participants were 242 healthy adults (121 women aged 30-69 years and 121 men aged 30-76 years) from four areas in Japan. RESULTS: For women and men together, the mean total water intake was 2230 g/day (highest in summer: 2331 g/day; lowest in winter: 2134 g/day). Fifty-one percent of water was derived from foods and the rest from beverages. In a mixed linear model adjusted for sex, age and body mass index, intake of water from foods decreased by 3.1 g/day and that from beverages increased by 8.4 g/day, with an increase in the mean outdoor air temperature on the survey day of 1 degrees C (both P < 0.0001). The influence of humidity was nonsignificant. CONCLUSIONS: In contrast to previous findings in Western countries, half of water intake in Japanese adults was derived from foods. Water intake from beverages was positively associated with air temperature, whereas that from foods was inversely associated with air temperature.	[Tani, Y.; Asakura, K.; Sasaki, S.] Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Tokyo 1130033, Japan; [Asakura, K.] Univ Tokyo, Grad Sch Interdisciplinary Informat Studies, Interfac Initiat Informat Studies, Tokyo 1130033, Japan; [Hirota, N.] Matsumoto Univ, Grad Sch Hlth Sci, Matsumoto, Nagano, Japan; [Notsu, A.] Tottori Coll, Dept Food Sci & Nutr, Tottori, Japan; [Todoriki, H.] Univ Ryukyus, Sch Med, Dept Publ Hlth & Hyg, Nishihara, Okinawa 90301, Japan; [Miura, A.] Tokoha Univ, Fac Hlth Promot Sci, Dept Hlth & Nutr Sci, Hamamatsu, Shizuoka, Japan; [Fukui, M.] Osaka City Univ, Sch Med, Dept Stat, Osaka 545, Japan; [Date, C.] Univ Hyogo, Sch Human Sci & Environm, Dept Food Sci & Nutr, Himeji, Hyogo 6712201, Japan	Sasaki, S (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Social & Prevent Epidemiol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	stssasak@m.u-tokyo.ac.jp			Japanese Ministry of Health, Labour and Welfare	The present study was supported by grants from the Japanese Ministry of Health, Labour and Welfare. The authors are grateful to all participants and local staff for their participation in this study.	Manz F, 2012, BRIT J NUTR, V107, P1673, DOI 10.1017/S0007114511004776; Ishigaki A, 2013, TOHOKU J EXP MED, V229, P287, DOI 10.1620/tjem.229.287; Kleiner SM, 1999, J AM DIET ASSOC, V99, P200, DOI 10.1016/S0002-8223(99)00048-6; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Popkin BM, 2010, PHYSIOL BEHAV, V100, P4, DOI 10.1016/j.physbeh.2009.12.022; Levallois P, 1998, SCI TOTAL ENVIRON, V209, P233, DOI 10.1016/S0048-9697(97)00320-3; Rennie KL, 2007, BRIT J NUTR, V97, P1169, DOI 10.1017/S0007114507433086; Bellisle F, 2010, EUR J CLIN NUTR, V64, P350, DOI 10.1038/ejcn.2010.4; Malisova O, 2013, J HUM NUTR DIET, V26, P90, DOI 10.1111/jhn.12077; Ng SW, 2012, BRIT J NUTR, V108, P536, DOI 10.1017/S0007114511006465; Turrini A, 2001, EUR J CLIN NUTR, V55, P571, DOI 10.1038/sj.ejcn.1601185; Kant AK, 2009, AM J CLIN NUTR, V90, P655, DOI 10.3945/ajcn.2009.27749; Nissensohn M, 2013, INT J FOOD SCI NUTR, V64, P801, DOI 10.3109/09637486.2013.801406; Ma GS, 2012, NUTR REV, V70, pS105, DOI 10.1111/j.1753-4887.2012.00520.x; Popkin BM, 2010, NUTR REV, V68, P439, DOI 10.1111/j.1753-4887.2010.00304.x; Armstrong VC, 1981, TAP WATER CONSUMPTIO; Becker W, 2002, RIKSM 1997 98 DIET H; EFSA Panel on Dietetic Products Nutrition and Allergies (NDA), 2010, EFSA J, V8, P1459, DOI [DOI 10.2903/J.EFSA.2010.1459, 10.2903/j.efsa.2010.1459]; Ershow AG, 1989, TOTAL WATER TAPWATER; GALAGAN DJ, 1957, PUBLIC HEALTH REP, V72, P484, DOI 10.2307/4589806; Garriguet Didier, 2008, Health Rep, V19, P23; Gibson S, 2013, NUTR J, V12, DOI 10.1186/1475-2891-12-9; Heller KE, 1999, J PUBLIC HLTH DENT, V59, P3; Henderson L., 2002, NATL DIET NUTR SURVE, V1; Hoare J, 2004, NATL DIET NUTR SURVV, V5; Institute of Medicine, 2005, DIET REF INT WAT POT; Ji K, 2010, SCI TOTAL ENVIRON, V408, P734, DOI 10.1016/j.scitotenv.2009.10.076; Ministry of Health. Labour and welfare, 2009, DIET REF INT JAP 201; Ministry of Public Management Home Affairs, 2000, POSTS TEL JAP NAT CE; Murakami K, 2008, BRIT J NUTR, V99, P639, DOI 10.1017/S0007114507812086; Park S, 2011, J AM DIET ASSOC, V111, P1211, DOI 10.1016/j.jada.2011.05.006; Sawka MN, 2005, NUTR REV, V63, pS30, DOI 10.1301/nr.2005.jun.S30-S39; Science and Technology Agency, 2010, STAND TABL FOOD COMP; Sohn W, 2001, J PUBLIC HEALTH DENT, V61, P99, DOI 10.1111/j.1752-7325.2001.tb03373.x; Westerterp KR, 2005, BRIT J NUTR, V93, P199, DOI 10.1079/BJN20041310	35	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0954-3007	1476-5640		EUR J CLIN NUTR	Eur. J. Clin. Nutr.	AUG	2015	69	8					907	913		10.1038/ejcn.2014.290		7	Nutrition & Dietetics	Nutrition & Dietetics	CO6JX	WOS:000359264100008		
J	Sato, S; Demura, S; Nakai, M				Sato, S.; Demura, S.; Nakai, M.			Storage capacity of subcutaneous fat in Japanese adults	EUROPEAN JOURNAL OF CLINICAL NUTRITION			English	Article							CORONARY-HEART-DISEASE; METABOLIC RISK-FACTORS; ADIPOSE-TISSUE; ABDOMINAL FAT; CELL SIZE; OBESITY; LIPOSUCTION; NUMBER; INDIVIDUALS; PROPORTION	BACKGROUND: On the basis of our previous study, which examined the nonlinear relationship between visceral fat area (VFA) and percent regional fat mass in the trunk, we hypothesise the presence of some storage capacity of subcutaneous fat. This study aimed to examine the storage capacity of subcutaneous fat on the basis of subcutaneous fat area (SFA) and VFA in 791 Japanese adult males and 563 females. METHODS: Regression analyses by using SFA as a dependent variable and VFA as an independent variable were performed for each group classified by visceral fat obesity (VO): VO (VFA >= 100 cm(2)) and the no-VO (NVO) groups. To statistically identify an optimal critical point for subcutaneous fat accumulation, we changed the cutoff point for the VO group from 50-150 cm(2) in 10-cm(2) increments and confirmed the significance of the correlation between SFA and VFA for each obesity group, the statistical difference in correlations between NVO and VO groups, and the goodness of fit for the two regression lines using the standard error of estimation values. These analyses were conducted for each sex and age (<65 and >= 65 years) group. RESULTS: The critical point for subcutaneous fat accumulation appears at the following cutoff points of VFA: 130 cm(2) in <65-year-old males, 110 cm(2) in >= 65-year-old males and 100 cm(2) in both female groups. CONCLUSIONS: These results suggest the presence of some storage capacity of subcutaneous fat. As a further application, these findings may serve to improve the risk assessment of obesity-related diseases.	[Sato, S.] Kanazawa Inst Technol, Nonoichi, Ishikawa 921, Japan; [Demura, S.] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa, Japan; [Nakai, M.] Warani Med Corp, Houju Mem Hosp, Nomi, Ishikawa, Japan	Sato, S (reprint author), Kanazawa Inst Technol, Ohgigaoka 7-1, Nonoichi, Ishikawa 921, Japan.	sssato@neptune.kanazawa-it.ac.jp			JSPS [23700847]; Warani Medical Corporation, Hoju Memorial Hospital (Midorigaoka, Nomi, Ishikawa, Japan)	This research was supported by JSPS KAKENHI Grant Number 23700847 and by Warani Medical Corporation, Hoju Memorial Hospital (Midorigaoka, Nomi, Ishikawa, Japan, URL http://www.houju.or.jp). The authors would like to thank Enago (www.enago.jp) for the English language review.	Klein S, 2004, NEW ENGL J MED, V350, P2549, DOI 10.1056/NEJMoa033179; Yoshizumi T, 1999, RADIOLOGY, V211, P283; SALANS LB, 1973, J CLIN INVEST, V52, P929, DOI 10.1172/JCI107258; Danforth E, 2000, NAT GENET, V26, P13, DOI 10.1038/79111; Kim JY, 2007, J CLIN INVEST, V117, P2621, DOI 10.1172/JCI31021; Sniderman AD, 2007, INT J EPIDEMIOL, V36, P220, DOI 10.1093/ije/dyl245; Tchernof A, 2006, DIABETES, V55, P1353, DOI 10.2337/db05-1439; Mohammed BS, 2008, OBESITY, V16, P2648, DOI 10.1038/oby.2008.418; Huffman DM, 2009, BBA-GEN SUBJECTS, V1790, P1117, DOI 10.1016/j.bbagen.2009.01.008; BJORNTOR.P, 1971, ACTA MED SCAND, V190, P363; BJORNTOR.P, 1971, METABOLISM, V20, P703, DOI 10.1016/0026-0495(71)90084-9; Busetto L, 2008, NUTR METAB CARDIOVAS, V18, P112, DOI 10.1016/j.numecd.2006.09.009; Demura S, 2008, EUR J CLIN NUTR, V62, P1395, DOI 10.1038/sj.ejcn.1602887; EGUSA G, 1993, ATHEROSCLEROSIS, V100, P249, DOI 10.1016/0021-9150(93)90211-C; FUJIMOTO WY, 1995, OBES RES, V3, pS179; Huffman DM, 2010, INTERD TOP GERONTOL, V37, P1, DOI 10.1159/000319991; Imbeault P, 1999, METABOLISM, V48, P355, DOI 10.1016/S0026-0495(99)90085-9; McLaugblin T, 2007, DIABETOLOGIA, V50, P1707, DOI 10.1007/s00125-007-0708-y; McLaughlin TM, 2010, OBESITY, V18, P926, DOI 10.1038/oby.2009.380; Rolfe Ede L, 2010, AM J CLIN NUTR, V92, P347; Tchoukalova YD, 2008, AM J CLIN NUTR, V87, P56; Matsuzawa Y, 2002, CIRC J, V66, P987; YANO K, 1988, AM J EPIDEMIOL, V127, P476; Ybarra J, 2008, OBES SURG, V18, P408, DOI 10.1007/s11695-007-9261-5	24	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0954-3007	1476-5640		EUR J CLIN NUTR	Eur. J. Clin. Nutr.	AUG	2015	69	8					933	938		10.1038/ejcn.2014.292		6	Nutrition & Dietetics	Nutrition & Dietetics	CO6JX	WOS:000359264100012		
J	Murakami, M; Yoshimoto, T; Nakabayashi, K; Tsuchiya, K; Minami, I; Bouchi, R; Izumiyama, H; Fujii, Y; Abe, K; Tayama, C; Hashimoto, K; Suganami, T; Hata, K; Kihara, K; Ogawa, Y				Murakami, Masanori; Yoshimoto, Takanobu; Nakabayashi, Kazuhiko; Tsuchiya, Kyoichiro; Minami, Isao; Bouchi, Ryotaro; Izumiyama, Hajime; Fujii, Yasuhisa; Abe, Kosei; Tayama, Chiharu; Hashimoto, Koshi; Suganami, Takayoshi; Hata, Ken-ichiro; Kihara, Kazunori; Ogawa, Yoshihiro			Integration of transcriptome and methylome analysis of aldosterone-producing adenomas	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							FIBROBLAST ACTIVATION PROTEIN; ADRENOCORTICAL TUMORS; GENE-EXPRESSION; DNA METHYLATION; EPIGENETIC REGULATION; SOMATIC MUTATIONS; CHANNEL MUTATIONS; KCNJ5 MUTATIONS; POOR-PROGNOSIS; MESSENGER-RNA	Objective: The pathophysiology of aldosterone-producing adenomas (APA) has been investigated intensively through genetic and genomic approaches. However, the role of epigenetics in APA is not fully understood. In the present study, we explored the relationship between gene expression and DNA methylation status in APA. Methods: We conducted an integrated analysis of transcriptome and methylome data of paired APA-adjacent adrenal gland (AAG) samples from the same patient. The adrenal specimens were obtained from seven Japanese patients with APA who underwent adrenalectomy. Gene expression and genome-wide CpG methylation profiles were obtained from RNA and DNA samples that were extracted from those seven paired tissues. Results: Methylome analysis showed global CpG hypomethylation in APA relative to AAG. The integration of gene expression and methylation status showed that 34 genes were up-regulated with CpG hypomethylation in APA. Of these, three genes (CYP11B2, MC2R, and HPX) may be related to aldosterone production, and five genes (PRRX1, RAB38, FAP, GCNT2, and ASB4) are potentially involved in tumorigenesis. Conclusion: The present study is the first methylome analysis to compare APA with AAG in the same patients. Our integrated analysis of transcriptome and methylome revealed DNA hypomethylation in APA and identified several up-regulated genes with DNA hypomethylation that may be involved in aldosterone production and tumorigenesis.	[Murakami, Masanori; Yoshimoto, Takanobu; Tsuchiya, Kyoichiro; Minami, Isao; Bouchi, Ryotaro; Izumiyama, Hajime; Hashimoto, Koshi; Ogawa, Yoshihiro] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, Tokyo 1138510, Japan; [Nakabayashi, Kazuhiko; Abe, Kosei; Tayama, Chiharu; Hata, Ken-ichiro] Natl Res Inst Child Hlth & Dev, Dept Maternal Fetal Biol, Tokyo 1578535, Japan; [Izumiyama, Hajime] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Ctr Med Welf & Liaison Serv, Tokyo 1138510, Japan; [Fujii, Yasuhisa; Kihara, Kazunori] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Urol, Tokyo 1138510, Japan; [Hashimoto, Koshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Preempt Med & Metab, Tokyo 1138510, Japan; [Suganami, Takayoshi] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Organ Network & Metab, Tokyo 1138510, Japan; [Suganami, Takayoshi] Japan Sci & Technol Agcy, PRESTO, Tokyo 1020076, Japan; [Ogawa, Yoshihiro] Japan Sci & Technol Agcy, CREST, Tokyo 1020076, Japan	Yoshimoto, T (reprint author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Mol Endocrinol & Metab, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138510, Japan.	tyoshimoto.mem@tmd.ac.jp			Ministry of Education, Science, Sports and Culture of Japan [24591110]; "Advancing Care of Primary Aldosteronism in Japan Study" - Japan Primary Aldosteronism Study (JPAS) - from Japan Agency for Medical Research and development, AMED	This study was supported in part by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Sports and Culture of Japan (grant number 24591110 to T Yoshimoto). This study was partially supported by "Advancing Care of Primary Aldosteronism in Japan Study" - Japan Primary Aldosteronism Study (JPAS) - from Japan Agency for Medical Research and development, AMED.	Akerstrom T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041926; Choi M, 2011, SCIENCE, V331, P768, DOI 10.1126/science.1198785; Itoh M, 2007, ARTERIOSCL THROM VAS, V27, P1918, DOI 10.1161/ATVBAHA.106.136853; Ding LX, 2014, ONCOL LETT, V7, P699, DOI 10.3892/ol.2014.1788; Rechache NS, 2012, J CLIN ENDOCR METAB, V97, pE1004, DOI 10.1210/jc.2011-3298; Lerario AM, 2014, MOL CELL ENDOCRINOL, V386, P67, DOI 10.1016/j.mce.2013.10.028; Azizan EAB, 2012, J CLIN ENDOCR METAB, V97, pE819, DOI 10.1210/jc.2011-2965; Plouin PF, 2004, NEPHROL DIAL TRANSPL, V19, P774, DOI 10.1093/ndt/gfh112; Azizan EAB, 2013, NAT GENET, V45, P1055, DOI 10.1038/ng.2716; Wikberg ML, 2013, TUMOR BIOL, V34, P1013, DOI 10.1007/s13277-012-0638-2; Ye P, 2007, J ENDOCRINOL, V195, P39, DOI 10.1677/JOE-07-0037; Hardin H, 2014, AM J PATHOL, V184, P2342, DOI 10.1016/j.ajpath.2014.04.011; Au V, 2014, BIOSCI TRENDS, V8, P101, DOI 10.5582/bst.8.101; Taguchi R, 2012, J CLIN ENDOCR METAB, V97, P1311, DOI 10.1210/jc.2011-2885; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Zennaro MC, 2012, HYPERTENSION, V60, P580, DOI 10.1161/HYPERTENSIONAHA.111.188250; Mulatero P, 2012, HYPERTENSION, V59, P235, DOI 10.1161/HYPERTENSIONAHA.111.183996; Wang T, 2011, EUR J ENDOCRINOL, V164, P613, DOI 10.1530/EJE-10-1085; Fonseca AL, 2012, GENE CHROMOSOME CANC, V51, P949, DOI 10.1002/gcc.21978; Hannemann A, 2012, HORM METAB RES, V44, P157, DOI 10.1055/s-0031-1295438; Young WF, 2004, SURGERY, V136, P1227, DOI 10.1016/j.surg.2004.06.051; Boulkroun S, 2012, HYPERTENSION, V59, P592, DOI 10.1161/HYPERTENSIONAHA.111.186478; Boulkroun S, 2011, ENDOCRINOLOGY, V152, P4753, DOI 10.1210/en.2011-1205; Howard B, 2014, J CLIN ENDOCR METAB, V99, pE536, DOI 10.1210/jc.2013-3495; Milliez P, 2005, J AM COLL CARDIOL, V45, P1243, DOI 10.1016/j.jacc.2005.01.015; Das PM, 2004, J CLIN ONCOL, V22, P4632, DOI 10.1200/JCO.2004.07.151; Zhang HJ, 2011, CANCER RES, V71, P4846, DOI 10.1158/0008-5472.CAN-11-0414; Hammoud SS, 2013, CURR OPIN CELL BIOL, V25, P177, DOI 10.1016/j.ceb.2013.01.007; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Beuschlein F, 2013, NAT GENET, V45, P440, DOI 10.1038/ng.2550; Krikken JA, 2013, J HYPERTENS, V31, P537, DOI 10.1097/HJH.0b013e32835c1727; Murthy M, 2012, J HYPERTENS, V30, P1827, DOI 10.1097/HJH.0b013e328356139f; Scholl UI, 2013, NAT GENET, V45, P1050, DOI 10.1038/ng.2695; Nishikawa T, 2011, ENDOCR J, V58, P711; Arnaldi G, 1998, ENDOCR RES, V24, P845; Barreau O, 2013, J CLIN ENDOCR METAB, V98, pE174, DOI 10.1210/jc.2012-2993; Bennett RD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062347; Berthon A, 2014, HUM MOL GENET, V23, P889, DOI 10.1093/hmg/ddt484; Brooks MD, 2013, INT J DENT, V2013, DOI [10.1155/2013/592843, DOI 10.1155/2013/592843]; Dennis Glynn Jr, 2003, Genome Biol, V4, pP3, DOI 10.1186/gb-2003-4-5-p3; Haria D, 2013, CANC HALLMARK, V1, P67, DOI DOI 10.1166/CH.2013.1007); Kitamoto T, 2015, J ATHEROSCLER THROMB, V22, P191, DOI 10.5551/jat.24455; Neville SE, 2002, ENDOCR RES, V28, P669, DOI 10.1081/ERC-120016984; STOWASSER M, 1995, CLIN EXP PHARMACOL P, V22, P460, DOI 10.1111/j.1440-1681.1995.tb02044.x; Takahashi Y, 2013, BRIT J CANCER, V109, P307, DOI 10.1038/bjc.2013.339; Wang HJ, 2013, ONCOL REP, V30, P2350, DOI 10.3892/or.2013.2730; WISGERHOF M, 1981, J CLIN ENDOCR METAB, V52, P195	47	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	AUG	2015	173	2					185	195		10.1530/EJE-15-0148		11	Endocrinology & Metabolism	Endocrinology & Metabolism	CO1XH	WOS:000358949000016		
J	Hirata, Y; Fukuoka, H; Iguchi, G; Iwahashi, Y; Fujita, Y; Hari, Y; Iga, M; Nakajima, S; Nishimoto, Y; Mukai, M; Hirota, Y; Sakaguchi, K; Ogawa, W; Takahashi, Y				Hirata, Yu; Fukuoka, Hidenori; Iguchi, Genzo; Iwahashi, Yasuyuki; Fujita, Yasunori; Hari, Yusuke; Iga, Makiko; Nakajima, Shinsuke; Nishimoto, Yuki; Mukai, Miki; Hirota, Yushi; Sakaguchi, Kazuhiko; Ogawa, Wataru; Takahashi, Yutaka			Median-lower normal levels of serum thyroxine are associated with low triiodothyronine levels and body temperature in patients with central hypothyroidism	EUROPEAN JOURNAL OF ENDOCRINOLOGY			English	Article							THYROID-HORMONE REPLACEMENT; RANDOMIZED CONTROLLED-TRIAL; BROWN ADIPOSE-TISSUE; LEVOTHYROXINE; THERAPY; THERMOGENESIS; COMBINATION; DEIODINASE; DEFICIENCY; CONVERSION	Objective: Although it has been recommended that serum free thyroxine (FT4) levels should be targeted to middle-upper normal levels during levothyroxine (L-T-4) replacement therapy in patients with central hypothyroidism (CeH), the rationale has not been clarified. Methods: A retrospective single-center study enrolled 116 patients with hypothyroidism (CeH, n=32; total thyroidectomy (Tx), n=22; primary hypothyroidism (PH), n=33; and control benign thyroid nodule (C), n=29). The patients had received L-T-4 therapy at the Kobe University Hospital between 2003 and 2013. They were stratified according to serum FT4 level (>= 1.10 or <1.10 ng/dl), and body temperature (BT), serum free triiodothyronine (FT3) levels, FT3/FT4 ratio, and lipid profiles were compared. The effect of GH replacement therapy on thyroid function was also analyzed. Results: FT3 levels and FT3/FT4 ratios were significantly lower in patients with CeH than in patients with PH (P<0.05) or C (P<0.05). In patients with FT4 < 1.10 ng/dl, BT was significantly lower in patients with CeH (P=0.002) and Tx (P=0.005) than in patients with PH, whereas no differences were found in patients with FT4 >= 1.10 ng/dl. In patients with CeH, FT3 levels were higher in those with GH replacement therapy (P=0.018). Conclusion: In CeH, patients with median-lower normal levels of serum FT4 exhibited lower serum FT3 levels and lower BT. These results support the target levels of serum FT4 as middle-upper normal levels during L-T-4 replacement therapy in patients with CeH.	[Hirata, Yu; Fukuoka, Hidenori; Iguchi, Genzo; Iwahashi, Yasuyuki; Fujita, Yasunori; Hari, Yusuke; Iga, Makiko; Nakajima, Shinsuke; Nishimoto, Yuki; Mukai, Miki; Hirota, Yushi] Kobe Univ Hosp, Div Diabet & Endocrinol, Chuo Ku, Kobe, Hyogo 6500017, Japan; [Sakaguchi, Kazuhiko; Ogawa, Wataru; Takahashi, Yutaka] Kobe Univ, Grad Sch Med, Div Diabet & Endocrinol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Fukuoka, H (reprint author), Kobe Univ Hosp, Div Diabet & Endocrinol, Chuo Ku, 7-5-2 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	fukuokah@med.kobe-u.ac.jp			Japanese Ministry of Education Science, Culture, Sports, Science, and Technology [24790945, 23659477, 23591354, 22591012]; Ministry of Health, Labor and Welfare of Japan; Novo Nordisk; Daiichi-Sankyo Foundation of Life Science; Naito Foundation	This work was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education Science, Culture, Sports, Science, and Technology (numbers 24790945, 23659477, 23591354, and 22591012), and Grants-in-Aid for Scientific Research (research on hypothalamic-hypophyseal disorders) from the Ministry of Health, Labor and Welfare of Japan, Novo Nordisk, the Daiichi-Sankyo Foundation of Life Science, and the Naito Foundation.	Agnihothri RV, 2014, THYROID, V24, P19, DOI 10.1089/thy.2013.0055; Alcantara MRS, 2006, J CLIN ENDOCR METAB, V91, P860, DOI 10.1210/jc.2005-2555; Alexopoulou O, 2004, EUR J ENDOCRINOL, V150, P1, DOI 10.1530/eje.0.1500001; Shimon I, 2002, THYROID, V12, P823, DOI 10.1089/105072502760339406; Slawik M, 2007, J CLIN ENDOCR METAB, V92, P4115, DOI 10.1210/jc.2007-0297; Ito M, 2012, EUR J ENDOCRINOL, V167, P373, DOI 10.1530/EJE-11-1029; JORGENSEN JOL, 1994, CLIN ENDOCRINOL, V41, P609, DOI 10.1111/j.1365-2265.1994.tb01826.x; Lee JY, 2012, AM J PHYSIOL-CELL PH, V302, pC463, DOI 10.1152/ajpcell.00010.2011; FISH LH, 1987, NEW ENGL J MED, V316, P764, DOI 10.1056/NEJM198703263161302; Silva JE, 2003, ANN INTERN MED, V139, P205; Clyde PW, 2003, JAMA-J AM MED ASSOC, V290, P2952, DOI 10.1001/jama.290.22.2952; MANDEL SJ, 1993, ANN INTERN MED, V119, P492; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Butler PW, 2010, THYROID, V20, P1407, DOI 10.1089/thy.2010.0244; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Portes ES, 2000, CLIN ENDOCRINOL, V53, P183, DOI 10.1046/j.1365-2265.2000.01071.x; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Tomlinson JW, 2001, LANCET, V357, P425, DOI 10.1016/S0140-6736(00)04006-X; Bunevicius R, 1999, NEW ENGL J MED, V340, P424, DOI 10.1056/NEJM199902113400603; DUICK DS, 1974, J CLIN ENDOCR METAB, V39, P1151; ENGLER D, 1984, ENDOCR REV, V5, P151; Ferretti E, 1999, J CLIN ENDOCR METAB, V84, P924, DOI 10.1210/jc.84.3.924; Grozinsky-Glasberg S, 2006, J CLIN ENDOCR METAB, V91, P2592, DOI 10.1210/jc.2006-0448; Gullo D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022552; Howlett TA, 2010, OXFORD TXB ENDOCRINO, P145; Landsberg L, 2009, METABOLISM, V58, P871, DOI 10.1016/j.metabol.2009.02.017; de Morentin PBM, 2014, CELL METAB, V20, P41, DOI 10.1016/j.cmet.2014.03.031; Persani L, 2012, J CLIN ENDOCR METAB, V97, P3068, DOI 10.1210/jc.2012-1616; ROSIN AJ, 1964, BRIT MED J, V1, P16; Sesmilo G, 2001, J CLIN ENDOCR METAB, V86, P1518, DOI 10.1210/jc.86.4.1518; Sesmilo Gemma, 2011, Endocrinol Nutr, V58, P9, DOI 10.1016/j.endonu.2010.09.006; Van der GS, 2005, J ENDOCRINOL, V185, P327, DOI [10.1677/joe.1.05974, DOI 10.1677/JOE.1.05974]; Wiersinga WM, 2014, NAT REV ENDOCRINOL, V10, P164, DOI 10.1038/nrendo.2013.258	33	0	0	BIOSCIENTIFICA LTD	BRISTOL	EURO HOUSE, 22 APEX COURT WOODLANDS, BRADLEY STOKE, BRISTOL BS32 4JT, ENGLAND	0804-4643	1479-683X		EUR J ENDOCRINOL	Eur. J. Endocrinol.	AUG	2015	173	2					247	256		10.1530/EJE-15-0130		10	Endocrinology & Metabolism	Endocrinology & Metabolism	CO1XH	WOS:000358949000022		
J	Uetsuka, S; Ogata, G; Nagamori, S; Isozumi, N; Nin, F; Yoshida, T; Komune, S; Kitahara, T; Kikkawa, Y; Inohara, H; Kanai, Y; Hibino, H				Uetsuka, Satoru; Ogata, Genki; Nagamori, Shushi; Isozumi, Noriyoshi; Nin, Fumiaki; Yoshida, Takamasa; Komune, Shizuo; Kitahara, Tadashi; Kikkawa, Yoshiaki; Inohara, Hidenori; Kanai, Yoshikatsu; Hibino, Hiroshi			Molecular architecture of the stria vascularis membrane transport system, which is essential for physiological functions of the mammalian cochlea	EUROPEAN JOURNAL OF NEUROSCIENCE			English	Article						ion channel; mass spectrometry; proteomics; rat; transporter	AMINO-ACID TRANSPORTER; K-CL COTRANSPORTER; PROTEIN-KINASE-II; GERBIL INNER-EAR; PLATINUM-INDUCED OTOTOXICITY; BETA-SUBUNIT ISOFORMS; VESTIBULAR DARK CELLS; OUTER HAIR-CELLS; RAT COCHLEA; IMMUNOHISTOCHEMICAL LOCALIZATION	Stria vascularis of the mammalian cochlea transports K+ to establish the electrochemical property in the endolymph crucial for hearing. This epithelial tissue also transports various small molecules. To clarify the profile of proteins participating in the transport system in the stria vascularis, membrane components purified from the stria of adult rats were analysed by liquid chromatography tandem mass spectrometry. Of the 3236 proteins detected in the analysis, 1807 were membrane proteins. Ingenuity Knowledge Base and literature data identified 513 proteins as being expressed on the plasma membrane', these included 25 ion channels and 79 transporters. Sixteen of the former and 62 of the latter had not yet been identified in the stria. Unexpectedly, many Cl- and Ca2+ transport systems were found, suggesting that the dynamics of these ions play multiple roles. Several transporters for organic substances were also detected. Network analysis demonstrated that a few kinases, including protein kinase A, and Ca2+ were key regulators for the strial transports. In the library of channels and transporters, 19 new candidates for uncloned deafness-related genes were identified. These resources provide a platform for understanding the molecular mechanisms underlying the epithelial transport essential for cochlear function and the pathophysiological processes involved in hearing disorders.	[Uetsuka, Satoru; Ogata, Genki; Nin, Fumiaki; Yoshida, Takamasa; Hibino, Hiroshi] Niigata Univ, Sch Med, Dept Mol Physiol, Niigata 9518510, Japan; [Uetsuka, Satoru; Ogata, Genki; Nin, Fumiaki; Yoshida, Takamasa; Hibino, Hiroshi] Niigata Univ, Ctr Transdisciplinary Res, Niigata 9518510, Japan; [Uetsuka, Satoru; Kitahara, Tadashi; Inohara, Hidenori] Osaka Univ, Grad Sch Med, Dept Otorhinolaryngol Head & Neck Surg, Osaka, Japan; [Nagamori, Shushi; Isozumi, Noriyoshi; Kanai, Yoshikatsu] Osaka Univ, Grad Sch Med, Dept Pharmacol, Div Biosyst Pharmacol, Osaka, Japan; [Yoshida, Takamasa; Komune, Shizuo] Kyushu Univ, Grad Sch Med Sci, Dept Otorhinolaryngol, Fukuoka 812, Japan; [Kitahara, Tadashi] Nara Med Univ, Dept Otorhinolaryngol Head & Neck Surg, Nara, Japan; [Kikkawa, Yoshiaki] Tokyo Metropolitan Inst Med Sci, Mammalian Genet Project, Tokyo 113, Japan	Hibino, H (reprint author), Niigata Univ, Sch Med, Dept Mol Physiol, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	nagamori@pharma1.med.osaka-u.ac.jp; hibinoh@med.niigata-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [25293058, 25870248, 26870210, 25893075, 25136704, 25136714]; Niigata University [24A006]; Salt Science Research Foundation [1318]; Takeda Science Foundation; Uehara Memorial Foundation	The authors thank Dr Shinichi Uchida (Tokyo Medical and Dental University) for providing the antibody against Barttin; Pattama Wiriyasermkul for her advice on biochemical experiments; and Karin Hori, Takanori Kobayashi, Seisei Sou and Yumi Nakamura for technical assistance. This work was partially supported by the following research grants and funds: Grant-in-Aid for Scientific Research B 25293058 (to H.H.); Grants-in-Aid for Young Scientists B 25870248 (to F.N.) and 26870210 (to G.O.); Grant-in-Aid for Research Activity Start-up 25893075 (to G.O.); Grants-in-Aid for Scientific Research on Innovative Areas 'HD Physiology' 25136704 (to F.N.) and 25136714 (to S.N.) from the Ministry of Education, Culture, Sports, Science and Technology of Japan; a Grant for Promotion of Niigata University Research Projects 24A006 (to H.H.); and grants from the Salt Science Research Foundation 1318 (to F.N.), Takeda Science Foundation (to F.N.) and Uehara Memorial Foundation (to F.N.).	Vlajkovic SM, 2010, J NEUROSCI RES, V88, P2598, DOI 10.1002/jnr.22421; Brock PR, 2012, J CLIN ONCOL, V30, P2408, DOI 10.1200/JCO.2011.39.1110; Nomura N, 2011, AM J PHYSIOL-RENAL, V301, pF297, DOI 10.1152/ajprenal.00604.2010; Goodyear RJ, 2002, J NEUROBIOL, V53, P212, DOI 10.1002/neu.10097; Hess A, 2006, EUR ARCH OTO-RHINO-L, V263, P75, DOI 10.1007/s00405-005-0953-y; Ding DL, 2011, HEARING RES, V282, P196, DOI 10.1016/j.heares.2011.08.002; Kodawara T, 2002, PHARMACEUT RES, V19, P738, DOI 10.1023/A:1016184211491; STEEL KP, 1989, DEVELOPMENT, V107, P453; Dean M, 2001, GENOME RES, V11, P1156, DOI 10.1101/gr.GR-1649R; Ose A, 2010, DRUG METAB DISPOS, V38, P168, DOI 10.1124/dmd.109.029454; Grifa A, 1999, NAT GENET, V23, P16; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Takeuchi S, 2001, HEARING RES, V155, P103, DOI 10.1016/S0378-5955(01)00252-0; Jespersen T, 2005, PHYSIOLOGY, V20, P408, DOI 10.1152/physiol.00031.2005; HUDSPETH AJ, 1989, NATURE, V341, P397, DOI 10.1038/341397a0; Masuda T, 2008, J PROTEOME RES, V7, P731, DOI 10.1021/pr700658q; Kubisch C, 1999, CELL, V96, P437, DOI 10.1016/S0092-8674(00)80556-5; Jentsch TJ, 2008, CRIT REV BIOCHEM MOL, V43, P3, DOI 10.1080/10409230701829110 ; Abiria SA, 2010, J NEUROCHEM, V112, P150, DOI 10.1111/j.1471-4159.2009.06436.x; Liedtke W, 2000, CELL, V103, P525, DOI 10.1016/S0092-8674(00)00143-4; Shibata T, 2006, AM J PHYSIOL-CELL PH, V291, pC1038, DOI 10.1152/ajpcell.00266.2006; Hibino H, 2004, J BIOL CHEM, V279, P44065, DOI 10.1074/jbc.M405985200; Hibino H, 2010, PFLUG ARCH EUR J PHY, V459, P521, DOI 10.1007/s00424-009-0754-z; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Cohen-Salmon M, 2007, P NATL ACAD SCI USA, V104, P6229, DOI 10.1073/pnas.0605108104; Priller C, 2006, J NEUROSCI, V26, P7212, DOI 10.1523/JNEUROSCI.1450-06.2006; Weyer SW, 2011, EMBO J, V30, P2266, DOI 10.1038/emboj.2011.119; ITO M, 1993, HEARING RES, V71, P230, DOI 10.1016/0378-5955(93)90039-4; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Kelsell DP, 1997, NATURE, V387, P80, DOI 10.1038/387080a0; Sharlin DS, 2011, ENDOCRINOLOGY, V152, P5053, DOI 10.1210/en.2011-1372; Magupalli VG, 2013, J BIOL CHEM, V288, P4637, DOI 10.1074/jbc.M112.369058; Birkenhager R, 2001, NAT GENET, V29, P310, DOI 10.1038/ng752; Noe B, 1997, P NATL ACAD SCI USA, V94, P10346, DOI 10.1073/pnas.94.19.10346; Hibino H, 2006, PHYSIOLOGY, V21, P336, DOI 10.1152/physiol.00023.2006; Gow A, 2004, J NEUROSCI, V24, P7051, DOI 10.1523/JNEUROSCI.1640-04.2004; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Hibino H, 1997, J NEUROSCI, V17, P4711; TAKEUCHI S, 1995, HEARING RES, V83, P89, DOI 10.1016/0378-5955(94)00191-R; Segawa H, 1999, J BIOL CHEM, V274, P19745, DOI 10.1074/jbc.274.28.19745; Savas JN, 2011, TRENDS BIOCHEM SCI, V36, P388, DOI 10.1016/j.tibs.2011.04.005; Giacomini KM, 2010, NAT REV DRUG DISCOV, V9, P215, DOI 10.1038/nrd3028; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lautermann J, 1998, CELL TISSUE RES, V294, P415, DOI 10.1007/s004410051192; KIKUCHI T, 1995, ANAT EMBRYOL, V191, P101, DOI 10.1007/BF00186783; Voss FK, 2014, SCIENCE, V344, P634, DOI 10.1126/science.1252826; Samuel Y, 2005, J ACOUST SOC AM, V117, P1465, DOI 10.1121/1.1847993; THALMANN R, 1972, LARYNGOSCOPE, V82, P2249, DOI 10.1288/00005537-197212000-00013; Kitajiri SI, 2004, J CELL SCI, V117, P5087, DOI 10.1242/jcs.01393; More SS, 2010, J NEUROSCI, V30, P9500, DOI 10.1523/JNEUROSCI.1544-10.2010; Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Kim D, 2002, BBA-BIOMEMBRANES, V1565, P112, DOI 10.1016/S0005-2736(02)00516-3; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Zdebik AA, 2009, PHYSIOLOGY, V24, P307, DOI 10.1152/physiol.00018.2009; Pelis RM, 2011, COMPR PHYSIOL, V1, P1795, DOI 10.1002/cphy.c100084; Nin F, 2008, P NATL ACAD SCI USA, V105, P1751, DOI 10.1073/pnas.0711463105; Jeon JH, 2011, CELL TISSUE RES, V345, P223, DOI 10.1007/s00441-011-1206-6; Uchino H, 2002, MOL PHARMACOL, V61, P729, DOI 10.1124/mol.61.4.729; Boettger T, 2003, EMBO J, V22, P5422, DOI 10.1093/emboj/cdg519; Wangemann P, 2002, HEARING RES, V165, P1, DOI 10.1016/S0378-5955(02)00279-4; Wangemann P, 2006, J PHYSIOL-LONDON, V576, P11, DOI 10.1113/jphysiol.2006.112888; Sage CL, 2001, HEARING RES, V160, P1, DOI 10.1016/S0378-5955(01)00308-2; Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610; HASSON T, 1995, P NATL ACAD SCI USA, V92, P9815, DOI 10.1073/pnas.92.21.9815; Zheng J, 2000, NATURE, V405, P149, DOI 10.1038/35012009; Neyroud N, 1997, NAT GENET, V15, P186, DOI 10.1038/ng0297-186; Schlingmann KP, 2004, NEW ENGL J MED, V350, P1314, DOI 10.1056/NEJMoa032843; Minowa O, 1999, SCIENCE, V285, P1408, DOI 10.1126/science.285.5432.1408; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Jamesdaniel S, 2009, J PROTEOME RES, V8, P3520, DOI 10.1021/pr900222c; Bond BR, 1998, HEARING RES, V123, P1, DOI 10.1016/S0378-5955(98)00089-6; Chandra P, 2004, PHARM RES, V21, P719, DOI 10.1023/B:PHAM.0000026420.79421.8f; Chen QG, 2011, INT J PEDIATR OTORHI, V75, P196, DOI 10.1016/j.ijporl.2010.10.033; Ciarimboli G, 2014, ANTICANCER RES, V34, P547; Crouch JJ, 1997, J HISTOCHEM CYTOCHEM, V45, P773; Crouch JJ, 1995, HEARING RES, V92, P112, DOI 10.1016/0378-5955(95)00201-4; delsAmo E. M., 2008, EUR J PHARM SCI, V35, P161; delsCastillo I., 2002, NEW ENGL J MED, V346, P243; DOI K, 1990, EUR ARCH OTO-RHINO-L, V247, P16; Doroudi M, 2015, J STEROID BIOCHEM, V145, P65, DOI 10.1016/j.jsbmb.2014.09.019; dusPlessis L., 2011, BRIEF BIOINFORM, V12, P723; Furuta H, 1998, HEARING RES, V123, P10, DOI 10.1016/S0378-5955(98)00091-4; Goto S, 1997, BRAIN RES, V765, P324, DOI 10.1016/S0006-8993(97)00679-3; Gritli-Linde A, 2009, GENE EXPR PATTERNS, V9, P178, DOI 10.1016/j.gep.2008.11.002; HINOJOSA R, 1966, AM J ANAT, V118, P631, DOI 10.1002/aja.1001180218; Ingenuity systems, 2005, IPA NETW GEN ALG; Kanai Y, 2001, CURR DRUG METAB, V2, P339, DOI 10.2174/1389200013338324; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; Khunweeraphong N, 2012, J PHARMACOL SCI, V119, P368, DOI 10.1254/jphs.12124FP; Kikuchi Toshihiko, 2000, Medical Electron Microscopy, V33, P51, DOI 10.1007/s007950070001; Kim DK, 2004, NEUROSCI RES, V50, P437, DOI 10.1016/j.neures.2004.08.003; Kwun YS, 2003, HEARING RES, V183, P84, DOI 10.1016/S0378-5955(03)00218-1; Li HZ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00159; MCGUIRT JP, 1994, J HISTOCHEM CYTOCHEM, V42, P843; Mizuta K, 1997, HEARING RES, V106, P154, DOI 10.1016/S0378-5955(97)00010-5; Muthalif MM, 1996, J BIOL CHEM, V271, P30149; Rosker C, 2009, J BIOL CHEM, V284, P5186, DOI 10.1074/jbc.M805587200; Sage CL, 2002, J MEMBRANE BIOL, V185, P103, DOI 10.1007/s00232-001-0116-z; Saito T, 1997, BRAIN RES, V767, P388, DOI 10.1016/S0006-8993(97)00821-4; Saito T, 2001, BRAIN RES, V895, P253, DOI 10.1016/S0006-8993(01)02020-0; SAKAGAMI M, 1991, HEARING RES, V56, P168, DOI 10.1016/0378-5955(91)90166-7; Sakuraba M, 2014, J NEUROSCI RES, V92, P1409, DOI 10.1002/jnr.23410; Sawada S, 2003, HEARING RES, V181, P15, DOI 10.1016/S0378-5955(03)00131-X; SCHULTE BA, 1994, HEARING RES, V78, P65, DOI 10.1016/0378-5955(94)90045-0; Schultz JM, 2005, NEW ENGL J MED, V352, P1557, DOI 10.1056/NEJMoa043899; Shen ZJ, 1998, HEARING RES, V123, P157, DOI 10.1016/S0378-5955(98)00110-5; Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121; SUNOSE H, 1993, AM J PHYSIOL, V265, pC72; TAKEUCHI S, 1992, HEARING RES, V61, P86, DOI 10.1016/0378-5955(92)90039-P; Takumida M, 2005, ACTA OTO-LARYNGOL, V125, P929, DOI 10.1080/00016480510038572; Takumida M, 2009, ACTA OTO-LARYNGOL, V129, P1050, DOI 10.1080/00016480802570545; Takumida M, 2010, ACTA OTO-LARYNGOL, V130, P196, DOI 10.3109/00016480903013593; Thalhammer A, 2006, EMBO J, V25, P5873, DOI 10.1038/sj.emboj.7601420; Wangemann P., 1996, COCHLEA, P130; Wu MH, 2014, PFLUG ARCH EUR J PHY, V466, P937, DOI 10.1007/s00424-013-1352-7; Yang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016547; Yoshihara T, 1999, ACTA OTO-LARYNGOL, V119, P336; ZAJIC G, 1983, HEARING RES, V10, P249, DOI 10.1016/0378-5955(83)90090-4	120	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0953-816X	1460-9568		EUR J NEUROSCI	Eur. J. Neurosci.	AUG	2015	42	3					1984	2002		10.1111/ejn.12973		19	Neurosciences	Neurosciences & Neurology	CO1XF	WOS:000358948800012		
J	Imataka, G; Tsuboi, Y; Kano, Y; Ogino, K; Tsuchioka, T; Ohnishi, T; Kaji, Y; Wake, K; Ichikawa, G; Suzumura, H; Arisaka, O				Imataka, G.; Tsuboi, Y.; Kano, Y.; Ogino, K.; Tsuchioka, T.; Ohnishi, T.; Kaji, Y.; Wake, K.; Ichikawa, G.; Suzumura, H.; Arisaka, O.			Treatment with mild brain hypothermia for cardiopulmonary resuscitation after myoclonic seizures in infant with robertsonian type of trisomy 13	EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES			English	Article						Patau syndrome; Epilepsy; Steroid pulse; Intensive care unit; Spectral karyotyping	MONOSOMY 5P; THERAPY	Congenital chromosomal abnormality with trisomy 13 is known to be associated with poor life prognosis and lethal. Therefore, physician advice the patients be kept in intensive treatment with resuscitation and state of the art intensive care when sudden change in the general condition with this trisomy is observed. We report herein, the treatment with mild brain hypothermia therapy for cardiopulmonary resuscitation after myoclonic seizures in infant with Robertsonian type of trisomy 13 in intensive care unit. Our study indicated that brain hypothermia therapy and steroid pulse therapy on an infant who was believed to have post-resuscitation hypoxic encephalopathy was highly effective as the patient's general condition recovered to the original state after four months.	[Imataka, G.; Tsuboi, Y.; Kano, Y.; Ichikawa, G.; Suzumura, H.; Arisaka, O.] Dokkyo Med Univ, Sch Med, Dept Pediat, Shimotsuga, Tochigi, Japan; [Ogino, K.; Tsuchioka, T.] Dokkyo Med Univ, Sch Med, Dept Surg 1, Shimotsuga, Tochigi, Japan; [Ohnishi, T.; Kaji, Y.; Wake, K.] Dokkyo Med Univ, Sch Med, Dept Emergency & Crit Care & Med, Shimotsuga, Tochigi, Japan	Imataka, G (reprint author), Dokkyo Med Univ, Sch Med, Dept Pediat, Shimotsuga, Tochigi, Japan.	geo@dokkyomed.ac.jp					Imataka G, 2014, EUR REV MED PHARMACO, V18, P1883; Rasmussen SA, 2003, PEDIATRICS, V111, P777, DOI 10.1542/peds.111.4.777; Ding L, 2014, CELL BIOCHEM BIOPHYS, V70, P1519, DOI 10.1007/s12013-014-0087-1; Graham EM, 2004, AM J CARDIOL, V93, P801, DOI 10.1016/j.amjcard.2003.12.012; Sayre MR, 2009, PREHOSP EMERG CARE, V13, P469, DOI 10.1080/10903120903144965; Imataka G, 2012, CELL BIOCHEM BIOPHYS, V62, P13, DOI 10.1007/s12013-011-9285-2; Imataka G, 2013, GENET COUNSEL, V24, P435; Imataka G, 2013, GENET COUNSEL, V24, P399; Imataka G, 2013, GENET COUNSEL, V24, P445; Imataka G, 2013, CELL BIOCHEM BIOPHYS, V67, P813, DOI 10.1007/s12013-013-9567-y; Kaneko Y, 2008, AM J MED GENET A, V146A, P1372, DOI 10.1002/ajmg.a.32311; Miyamoto K, 2014, J CHILD NEUROL, V29, pNP69, DOI 10.1177/0883073813501874; Petit P., 1994, Genetic Counseling, V5, P311; Prempunpong C, 2013, ACTA PAEDIATR, V102, pE507, DOI 10.1111/apa.12362	14	2	2	VERDUCI PUBLISHER	ROME	VIA GREGORIO VII, ROME, 186-00165, ITALY	1128-3602			EUR REV MED PHARMACO	Eur. Rev. Med. Pharmacol. Sci.	AUG	2015	19	15					2852	2855				4	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO6YS	WOS:000359304500015		
J	Hotta, S; Nakatani, Y; Kambe, T; Abe, K; Masuda, Y; Utsumomiya, I; Taguchi, K				Hotta, Sayako; Nakatani, Yoshihiko; Kambe, Toshie; Abe, Kenji; Masuda, Yutaka; Utsumomiya, Iku; Taguchi, Kyoji			Effects of IgG anti-GM1 monoclonal antibodies on neuromuscular transmission and calcium channel binding in rat neuromuscular junctions	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						Guillain-Barre syndrome; IgG anti-GM1 monoclonal antibody; muscle action potential; calcium channel; neuromuscular junctions	GUILLAIN-BARRE-SYNDROME; DEPENDENT CA2+ CHANNEL; SYNAPTIC-TRANSMISSION; RELEASE; GANGLIOSIDES; HOMEOSTASIS; CA(V)2.1; INFLUX; MOUSE; CELLS	Guillain-Barre syndrome is a type of acute inflammatory neuropathy that causes ataxia and is associated with the IgG anti-GM1 antibody. However, the pathogenic role of the IgG anti-GM1 antibody and calcium channels in neuromuscular junctions (NMJs) remains unclear. Thus, the aim of the present study was to investigate the effects of the IgG anti-GM1 monoclonal antibody (mAb) on spontaneous muscle action potentials (SMAPs), and the effects of calcium channel blockers, in a rat spinal cord-muscle co-culture system. In addition, the binding of IgG anti-GM1 mAb to calcium channels was investigated in the rat hemidiaphragm. The frequency of SMAPs in the innervated muscle cells was acutely inhibited by the IgG anti-GM1 mAb; however, this effect was blocked by the N-type calcium channel blocker, omega-conotoxin GVIA (30 nM). Furthermore, the P/Q-type calcium channel blocker, omega-agatoxin IVA (10 nM), was found to partially block the IgG anti-GM1 mAb-induced inhibitory effect in the spinal cord-muscle co-culture system. Immunohistochemical analysis of the rat hemidiaphragm indicated that IgG anti-GM1 mAb binding overlapped with anti-Ca(v)2.2 (alpha(1B)) antibody binding in the nerve terminal. In addition, IgG anti-GM1 mAb binding partially overlapped with anti-Ca(v)2.1 (alpha(1A)) antibody binding. Thus, the results demonstrated that the IgG anti-GM1 mAb binds to calcium channels in the nerve terminals of NMJs. Therefore, the inhibitory effect of IgG anti-GM1 mAb on SMAPs may involve N-type and P/Q-type calcium channels in motor nerve terminals at the NMJ.	[Hotta, Sayako; Nakatani, Yoshihiko; Taguchi, Kyoji] Showa Pharmaceut Univ, Dept Med Pharmacol, Machida, Tokyo 1948543, Japan; [Kambe, Toshie] Showa Pharmaceut Univ, Dept Pharmacol, Machida, Tokyo 1948543, Japan; [Abe, Kenji] Ohu Univ, Sch Pharmaceut Sci, Dept Pharmacol, Koriyama, Fukushima 9638611, Japan; [Masuda, Yutaka] Showa Pharmaceut Univ, Lab Clin Pharm, Machida, Tokyo 1948543, Japan; [Utsumomiya, Iku] Showa Pharmaceut Univ, Dept Dev Educ, Machida, Tokyo 1948543, Japan	Taguchi, K (reprint author), Showa Pharmaceut Univ, Dept Med Pharmacol, 3-3165 Higashi Tamagawagakuen, Machida, Tokyo 1948543, Japan.	taguchi@ac.shoyaku.ac.jp			Japan Society for the Promotion of Science [22590087]	This study was supported in part by a grant from the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (no. 22590087).	Fewou SN, 2012, J CLIN INVEST, V122, P1037, DOI 10.1172/JCI59110; Iwasaki S, 2000, J NEUROSCI, V20, P59; Pagani R, 2004, NEUROSCIENCE, V123, P75, DOI 10.1016/j.neuroscience.2003.09.019; Ledeen RW, 2002, NEUROCHEM RES, V27, P637, DOI 10.1023/A:1020224016830; Davies A, 2006, J NEUROSCI, V26, P8748, DOI 10.1523/JNEUROSCI.2764-06.2006; Buchwald B, 2007, NEUROBIOL DIS, V28, P113, DOI 10.1016/j.nbd.2007.07.008; Buchwald B, 1998, ANN NEUROL, V44, P913, DOI 10.1002/ana.410440610; Fewou SN, 2014, J ANAT, V224, P36, DOI 10.1111/joa.12088; Hotta S, 2014, NEUROL SCI, V35, P205, DOI 10.1007/s10072-013-1480-z; Nakatani Y, 2009, NEUROCHEM RES, V34, P149, DOI 10.1007/s11064-008-9735-4; Nakatani Y, 2007, EXP NEUROL, V204, P380, DOI 10.1016/j.expneurol.2006.11.015; O'Hanlon GM, 2002, NEUROCHEM RES, V27, P697, DOI 10.1023/A:1020284302718; Ortiz N, 2001, J NEUROIMMUNOL, V119, P114, DOI 10.1016/S0165-5728(01)00373-3; Quattrini A, 2001, J NEUROIMMUNOL, V114, P213, DOI 10.1016/S0165-5728(00)00452-5; Taguchi K, 2005, BRAIN RES, V1034, P62, DOI 10.1016/j.brainres.2004.11.057; Taguchi K, 2004, J NEUROL SCI, V225, P91, DOI 10.1016/j.jns.2004.07.011; Tanaka Y, 1997, NEUROREPORT, V8, P2203, DOI 10.1097/00001756-199707070-00023; Taverna E, 2004, J BIOL CHEM, V279, P5127, DOI 10.1074/jbc.M308798200; Urbano FJ, 2008, J NEUROIMMUNOL, V201, P136, DOI 10.1016/j.jneuroim.2008.06.031	19	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	AUG	2015	10	2					535	540		10.3892/etm.2015.2575		6	Medicine, Research & Experimental	Research & Experimental Medicine	CN8GZ	WOS:000358679400024		
J	Hamadate, N; Matsumoto, Y; Seto, K; Yamamoto, T; Yamaguchi, H; Nakagawa, T; Yamamoto, E; Fukagawa, M; Yazawa, K				Hamadate, Naobumi; Matsumoto, Yoshiyuki; Seto, Kayoko; Yamamoto, Tetsuro; Yamaguchi, Hideyo; Nakagawa, Takashi; Yamamoto, Etsushi; Fukagawa, Mitsuhiko; Yazawa, Kazunaga			Vascular effects and safety of supplementation with shark liver oil in middle-aged and elderly males	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						shark liver oil; blood flow; cardio-ankle vascular index; laser Doppler perfusion imaging; arterial stiffness	PULSE-WAVE VELOCITY; ESSENTIAL HYPERTENSIVE PATIENTS; ARTERIAL STIFFNESS; INDEX CAVI; VITAMIN-E; CARDIOVASCULAR EVENTS; ENDOTHELIAL FUNCTION; SKIN TEMPERATURE; BLOOD-FLOW; SQUALENE	Shark liver oil (SLO) has long been used as a traditional health food, with a particular benefit for vascular health, in Japan. The aim of this study was to assess the effect of dietary supplementation with SLO on arterial stiffness and peripheral microvascular function in otherwise healthy middle-aged and older males with slightly increased arterial stiffness. A randomized, double-blind, placebo-controlled, parallel study design was used to assign 41 healthy males with a mean age of 59.0+/-4.0 years (range, 45-69 years) to either SLO (n=21) or placebo (n=20) treatment for eight weeks. The effects on arterial stiffness and peripheral microvascular function were assessed by the cardio-ankle vascular index (CAVI) and by measurement of hand blood flow to cutaneous tissues using a laser Doppler perfusion imaging (LDPI) technique, respectively. Although the magnitude of the changes in the CAVI value during the eight-week intervention for the SLO group did not significantly differ from that for the placebo group, the changes in the CAVI value for the former group were significantly associated (r=0.575, P<0.01) with age. It was also found that the LDPI values at week 8 were significantly lowered (P<0.05) compared with the baseline values in the placebo group, while no change was observed in the SLO group, resulting in a significant difference in the changes between the two groups (P=0.002). Neither SLO supplementation-related adverse side-effects nor any abnormal changes in routine laboratory tests, including lipid profiles and anthropometric and haemodynamic parameters, were observed throughout the intervention. SLO may have the potential to safely improve vascular health in middle-aged and elderly males.	[Hamadate, Naobumi; Matsumoto, Yoshiyuki; Seto, Kayoko] Egao Co Ltd, Dept Res & Dev, Kumamoto, Kumamoto 8620902, Japan; [Yamamoto, Tetsuro; Yamaguchi, Hideyo; Nakagawa, Takashi; Yamamoto, Etsushi] TTC Co Ltd, Res Ctr, Shibuya Ku, Tokyo 1130021, Japan; [Fukagawa, Mitsuhiko] Shinyokohama Shinoharaguchi Orthopaed Surg Dermat, Yokohama, Kanagawa 2220026, Japan; [Yazawa, Kazunaga] Tokyo Univ Marine Sci & Technol, Lab Nutraceut & Funct Foods Sci, Minato Ku, Tokyo 1088477, Japan	Hamadate, N (reprint author), Egao Co Ltd, Dept Res & Dev, Higashi Ku, 1-47 Higashihonmachi, Kumamoto, Kumamoto 8620902, Japan.	hamadate@241241.jp					Siasos G, 2013, INT J CARDIOL, V166, P340, DOI 10.1016/j.ijcard.2011.10.081; Sutton-Tyrrell K, 2005, CIRCULATION, V111, P3384, DOI 10.1161/CIRCULATIONAHA.104.483628; Reddy LH, 2009, ADV DRUG DELIVER REV, V61, P1412, DOI 10.1016/j.addr.2009.09.005; Yambe T, 2004, BIOMED PHARMACOTHER, V58, pS95, DOI 10.1016/S0753-3322(04)80015-5; Fahs CA, 2010, APPL PHYSIOL NUTR ME, V35, P294, DOI 10.1139/H10-020; Matsui Y, 2004, HYPERTENS RES, V27, P851, DOI 10.1291/hypres.27.851; Okura T, 2007, HYPERTENS RES, V30, P335, DOI 10.1291/hypres.30.335; Plantinga Y, 2007, AM J HYPERTENS, V20, P392, DOI 10.1016/j.amjhyper.2006.09.021; Mottram P, 1999, ATHEROSCLEROSIS, V145, P399, DOI 10.1016/S0021-9150(99)00073-8; Kadota K, 2008, CIRC J, V72, P304, DOI 10.1253/circj.72.304; Nakamura K, 2008, CIRC J, V72, P598; Smith TJ, 2000, EXPERT OPIN INV DRUG, V9, P1841, DOI 10.1517/13543784.9.8.1841; Shirai K, 2006, J ATHEROSCLER THROMB, V13, P101; Vlachopoulos C, 2010, J AM COLL CARDIOL, V55, P1318, DOI 10.1016/j.jacc.2009.10.061; Sawada M, 2001, EUR J PHARMACOL, V431, P11, DOI 10.1016/S0014-2999(01)01411-X; Takaki A, 2007, CIRC J, V71, P1710, DOI 10.1253/circj.71.1710; Kubozono T, 2007, CIRC J, V71, P89, DOI 10.1253/circj.71.89; Newmark HL, 1999, ANN NY ACAD SCI, V889, P193, DOI 10.1111/j.1749-6632.1999.tb08735.x; Deniau AL, 2010, MAR DRUGS, V8, P2175, DOI 10.3390/md8072175; Bornmyr S, 1997, CLIN PHYSIOL, V17, P71, DOI 10.1046/j.1365-2281.1997.01313.x; Collins EG, 2003, MED SCI SPORT EXER, V35, P384, DOI 10.1249/01.MSS.0000053658.82687.FF; Gatzka CD, 1998, HYPERTENSION, V32, P575; GYLLING H, 1994, ATHEROSCLEROSIS, V106, P169, DOI 10.1016/0021-9150(94)90122-8; HALLGREN B, 1974, ACTA CHEM SCAND B, VB 28, P1029, DOI 10.3891/acta.chem.scand.28b-1029; JORNESKOG G, 1995, DIABETOLOGIA, V38, P474; KAMIMURA H, 1989, Fukuoka Acta Medica, V80, P269; KOHNO Y, 1995, BBA-LIPID LIPID MET, V1256, P52, DOI 10.1016/0005-2760(95)00005-W; MIETTINEN TA, 1994, AM J CLIN NUTR, V59, P356; Mirbod SM, 1998, IND HEALTH, V36, P171, DOI 10.2486/indhealth.36.171; Motoyama T, 1998, J AM COLL CARDIOL, V32, P1672, DOI 10.1016/S0735-1097(98)00447-1; Mozaffarian D, 2012, J NUTR, V142, p614S, DOI 10.3945/jn.111.149633; Nilsson L, 1998, EUR J VASC ENDOVASC, V15, P331, DOI 10.1016/S1078-5884(98)80037-3; Farvin K. H. S., 2009, Asian Journal of Biochemistry, V4, P133; Farvin KHS, 2007, FOOD CHEM, V105, P1390, DOI 10.1016/j.foodchem.2007.05.034; Farvin KHS, 2004, PHARMACOL RES, V50, P231, DOI 10.1016/j.phrs.2004.03.004; SAINTLEGER D, 1986, BRIT J DERMATOL, V114, P535, DOI 10.1111/j.1365-2133.1986.tb04060.x; Sakane Kosuke, 2008, J Atheroscler Thromb, V15, P261; Sotiroudis TG, 2008, EUR J NUTR S2, V47, P69; STRANDBERG TE, 1990, J LIPID RES, V31, P1637; Suzuki H, 2009, BENCH BEDSIDE CAVI N, P34; Tsujimoto M, 1916, IND ENG CHEM, V8, P889, DOI 10.1021/i500010a005; Wadell K, 1993, IEEE T BIOMED ENG, V40, P309; Wang S, 2008, EUR J CLIN NUTR, V62, P1426, DOI 10.1038/sj.ejcn.1602886	43	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	AUG	2015	10	2					641	646		10.3892/etm.2015.2568		6	Medicine, Research & Experimental	Research & Experimental Medicine	CN8GZ	WOS:000358679400042		
J	Matsumoto, T; Otsuka, K; Kato, R; Shimizu, R; Otoshi, T; Fujimoto, D; Kawamura, T; Tamai, K; Nagata, K; Otsuka, K; Nakagawa, A; Tomii, K				Matsumoto, Takeshi; Otsuka, Kojiro; Kato, Ryoji; Shimizu, Ryoko; Otoshi, Takehiro; Fujimoto, Daichi; Kawamura, Takahisa; Tamai, Koji; Nagata, Kazuma; Otsuka, Kyoko; Nakagawa, Atsushi; Tomii, Keisuke			Evaluation of discomfort and tolerability to bronchoscopy according to different sedation procedures with midazolam	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						discomfort; tolerability; bronchoscopy; sedation; midazolam	FLEXIBLE BRONCHOSCOPY; FIBEROPTIC BRONCHOSCOPY; RESPIRATORY ENDOSCOPY; UNITED-KINGDOM; JAPAN SOCIETY; ADULTS	Patients frequently experience great discomfort during a bronchoscopy for the diagnosis of lung neoplasms. Sedation is generally recommended during bronchoscopy; however, few studies have evaluated the discomfort and tolerability of patients to a bronchoscopy with regard to the administration procedures. The aim of the present study was to evaluate the discomfort and tolerability of patients undergoing a bronchoscopy using different sedation procedures with midazolam. The retrospective survey of sedation during bronchoscopy involved the comparison of two periods: January-March 2012 (first period) and July-September 2012 (second period). A numerical rating score, which ranged between 1 (best) and 5 (worst) according to the subjective view of the patients, was used to rate patient discomfort, pain, sensation, time and tolerability to the bronchoscopy. In the first period, 2.5 mg midazolam was administered prior to the initiation of surgery, and additional doses of midazolam was added in 2.5-mg increments whenever the patient deviated from the target sedation level. In the second period, 2.0 or 3.0 mg midazolam was administered prior to the initiation of surgery, and additional midazolam doses were administered in 1.0-mg increments until the patients were sedated to the target sedation level. In total, 60 and 68 valid responses were obtained in the first and second periods, respectively. The patients in the second period exhibited significantly improved discomfort and pain scores during the bronchoscopy and higher rates of consent to re-exam-ination, as compared with the patients in the first period (1.89+/-1.40 vs. 2.78+/-1.52, P<0.001; 1.48+/-1.13 vs. 2.00+/-1.37, P=0.005; 2.45+/-1.62 vs. 3.13+/-1.47, P=0.013, respectively). The amount of midazolam administered was significantly higher in the second period. There were no fatal complications during the bronchoscopy in either period. In conclusion, the present study observed that the administration of additional midazolam in small doses, until the target sedation level is achieved, is a safe procedure that is associated with significantly less discomfort and pain during bronchoscopy and a greater consent to re-examination when compared with the administration of a fixed dose of midazolam.	[Matsumoto, Takeshi; Otsuka, Kojiro; Kato, Ryoji; Shimizu, Ryoko; Otoshi, Takehiro; Fujimoto, Daichi; Kawamura, Takahisa; Tamai, Koji; Nagata, Kazuma; Otsuka, Kyoko; Nakagawa, Atsushi; Tomii, Keisuke] Kobe City Med Ctr Gen Hosp, Dept Resp Med, Kobe, Hyogo 6500047, Japan	Matsumoto, T (reprint author), Kobe City Med Ctr Gen Hosp, Dept Resp Med, Chuo Ku, 2-1-1 Minatojima Minamimachi, Kobe, Hyogo 6500047, Japan.	fu_rinkazan0202@yahoo.co.jp					Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Du Rand IA, 2013, THORAX, V68, P1, DOI 10.1136/thoraxjnl-2013-203618; Wahidi MM, 2011, CHEST, V140, P1342, DOI 10.1378/chest.10-3361; Asano F, 2012, RESPIROLOGY, V17, P478, DOI 10.1111/j.1440-1843.2011.02123.x; Asano F, 2013, RESPIROLOGY, V18, P284, DOI 10.1111/j.1440-1843.2012.02273.x; Dreher M, 2010, RESPIRATION, V79, P307, DOI 10.1159/000267227; Fujisawa T, 2011, KIKANSHIGAKU, V33, P3; HATTON MQF, 1994, BRIT MED J, V309, P1206; Honeybourne D, 1997, THORAX, V52, P709; Jones DR, 2011, NEW ENGL J MED, V364, pE54, DOI 10.1056/NEJMvcm0800732; José Ricardo J, 2013, Eur Respir Rev, V22, P106, DOI 10.1183/09059180.00006412; Morgan GE, 2001, CLIN ANAESTHESIOL, V3rd, P160; Ogawa Tomomi, 2014, Respir Investig, V52, P153, DOI 10.1016/j.resinv.2013.09.003; PRAKASH UBS, 1991, CHEST, V100, P1668, DOI 10.1378/chest.100.6.1668; Smyth CM, 2002, EUR RESPIR J, V19, P458, DOI 10.1183/09031936.02.00103702	15	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	AUG	2015	10	2					659	664		10.3892/etm.2015.2547		6	Medicine, Research & Experimental	Research & Experimental Medicine	CN8GZ	WOS:000358679400045		
J	Osaki, K; Shimizu, Y; Yamamoto, T; Miyake, F; Kondo, S; Yamaguchi, H				Osaki, Kenji; Shimizu, Yoshio; Yamamoto, Tetsuro; Miyake, Fumiharu; Kondo, Sumio; Yamaguchi, Hideyo			Improvement of liver function by the administration of oyster extract as a dietary supplement to habitual alcohol drinkers: A pilot study	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						liver function; oyster extract; habitual alcohol drinking; feeding trial; taurine; gamma-glutamyltransferase	GAMMA-GLUTAMYL-TRANSFERASE; ALDEHYDE DEHYDROGENASE; HEPATIC STEATOSIS; TAURINE; RATS; DISEASE; CONSUMPTION; JAPANESE; BURDEN; INJURY	Alcoholic liver disease (ALD) is characterized by elevated serum.-glutamyltransferase (GGT) activity with hepatic steatosis, hepatitis or occasionally fibrosis that may progress to cirrhosis. The potential therapeutic role of oyster extract (OE) or OE-containing dietary supplements (OE supplement) in ALD has seldom been evaluated. In the present study, 84 adults who had an alcohol-drinking habit and marginally high serum GGT levels were enrolled in a randomized, double-blind, placebo-controlled feeding trial to study the effect on alcohol-impaired liver function as reflected by an increased serum level of GGT, as well as the safety, of an OE supplement. The subjects were randomized to receive either an OE supplement (OE group) or placebo (placebo group). There were 42 subjects (31 males and 11 females) in each group, and all the enrolled subjects entered the study. Four individuals (5%) dropped out for reasons unassociated with the study and 6 other subjects were excluded from the efficacy analysis because they did not maintain the required frequency of alcohol intake. As a result, 38 subjects in the placebo group and 36 in the OE group underwent efficacy assessment. Assays of GGT and other liver enzymes were performed at baseline (week 0) and at weeks 4, 8 and 12 of the intervention period. The mean serum levels of GGT in the placebo group gradually increased, while those in the OE group tended to decrease, although no significant within-group differences were observed for either group. A significant between-group difference in the change of mean GGT from baseline was, however, found at week 12 (P=0.049). No OE supplement-associated untoward side-effects nor any abnormal changes in routine laboratory tests and anthropometric parameters were observed throughout the 12-week intervention. An OE supplement shows promise in reducing risk factors associated with ALD in adults with an alcohol intake habit.	[Osaki, Kenji] Bizen Chem Co Ltd, Tokyo Branch, Tokyo 1030023, Japan; [Shimizu, Yoshio] Bizen Chem Co Ltd, Okayama Head Off, Okayama 7090716, Japan; [Yamamoto, Tetsuro; Yamaguchi, Hideyo] TTC Co Ltd, Res Ctr, Tokyo 1130021, Japan; [Miyake, Fumiharu] Bizen Chem Co Ltd, Prod Formulat Div, Okayama 7090716, Japan; [Kondo, Sumio] Med Corp Kenshokai, Fukushima Healthcare Ctr, Osaka 5530004, Japan	Osaki, K (reprint author), Bizen Chem Co Ltd, Tokyo Branch, Kdc Nihonbashi Bldg,1-5-11 Nihonbashi Honcho, Tokyo 1030023, Japan.	kenji-os@bizen-c.co.jp					HUXTABLE RJ, 1992, PHYSIOL REV, V72, P101; Kerai MDJ, 1998, AMINO ACIDS, V15, P53, DOI 10.1007/BF01345280; Conigrave KM, 2003, ADDICTION, V98, P31, DOI 10.1046/j.1359-6357.2003.00581.x; Devi SL, 2010, EUR J PHARMACOL, V647, P161, DOI 10.1016/j.ejphar.2010.08.011; Wu GF, 2009, AMINO ACIDS, V36, P457, DOI 10.1007/s00726-008-0101-2; Chen XC, 2009, HEPATOLOGY, V49, P1554, DOI 10.1002/hep.22811; Anton RF, 2002, ALCOHOL CLIN EXP RES, V26, P1215, DOI 10.1097/01.ALC.0000023986.42254.F5; Yang LL, 2010, J BIOL CHEM, V285, P22211, DOI 10.1074/jbc.M110.119982; Wojcik OP, 2010, ATHEROSCLEROSIS, V208, P19, DOI 10.1016/j.atherosclerosis.2009.06.002; Lucey MR, 2009, NEW ENGL J MED, V360, P2758, DOI 10.1056/NEJMra0805786; Chang YY, 2011, J AGR FOOD CHEM, V59, P450, DOI 10.1021/jf103167u; Barve A, 2008, ANN HEPATOL, V7, P5; GOEDDE HW, 1983, AM J HUM GENET, V35, P769; BELL H, 1987, BRIT J ADDICT, V82, P1021; Chesney R W, 1985, Adv Pediatr, V32, P1; Fujisawa H, 2012, TRACE NUTR RES, V29, P13; HARADA S, 1980, AM J HUM GENET, V32, P8; Horie Yoshinori, 2004, Nihon Arukoru Yakubutsu Igakkai Zasshi, V39, P505; Kim Kyung-Ah, 2009, Korean J Hepatol, V15 Suppl 6, pS29, DOI 10.3350/kjhep.2009.15.S6.S29; Lakshman M. Raj, 2004, Alcohol, V34, P45, DOI 10.1016/j.alcohol.2004.08.004; Latchoumycandane C, 2014, FREE RADICAL BIO MED, V69, P403, DOI 10.1016/j.freeradbiomed.2014.01.001; Lu XL, 2002, ZHONGHUA GAN ZANG BI, V6, P467; Madhotra R, 2003, QJM-INT J MED, V96, P391, DOI 10.1093/qjmed/hcg076; Matsuda Y, 1995, TRACE NUTR RES, V12, P91; Matsuda Y, 1993, ALCOHOL ALCOHOL B S, P27; Matsuka Y, 2003, ACTA MED OKAYAMA, V57, P171; Ming Z, 2013, JPN PHARMACOL THER, V41, P319; Nishihori Y, 2011, TRACE NUTR RES, V28, P40; Park SH, 2011, SUBST USE MISUSE, V46, P1755, DOI 10.3109/10826084.2011.620053; Pirmohamed M, 2000, J ROY COLL PHYS LOND, V34, P161; Pirmohamed M, 2000, QJM-MON J ASSOC PHYS, V93, P291, DOI 10.1093/qjmed/93.5.291; Steffensen FH, 1997, INT J EPIDEMIOL, V26, P92, DOI 10.1093/ije/26.1.92; TAKADA A, 1995, J GASTROEN HEPATOL, V10, P509, DOI 10.1111/j.1440-1746.1995.tb01339.x; Tanaka K, 2006, BIOSCI BIOTECH BIOCH, V70, P462, DOI 10.1271/bbb.70.462; World Health Organisation, 2011, GLOB STAT REP ALC HL; Yoshikawa T, 1997, BIOMED PHARMACOTHER, V51, P328, DOI 10.1016/S0753-3322(97)88050-X; Zhang CP, 2014, J OCEAN U CHINA, V13, P262, DOI 10.1007/s11802-014-2449-0	37	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	AUG	2015	10	2					705	710		10.3892/etm.2015.2563		6	Medicine, Research & Experimental	Research & Experimental Medicine	CN8GZ	WOS:000358679400053		
J	Iguchi, K; Ishibashi, O; Kondo, T; Kagohashi, K; Takayashiki, N; Satoh, H				Iguchi, Kesato; Ishibashi, Osamu; Kondo, Tadashi; Kagohashi, Katsunori; Takayashiki, Norio; Satoh, Hiroaki			Isolated spleen recurrence in a patient with lung adenocarcinoma: A case report	EXPERIMENTAL AND THERAPEUTIC MEDICINE			English	Article						fluorodeoxyglucose-positon emission tomography; spleen metastasis; lung cancer	ISOLATED SPLENIC METASTASIS; CANCER; DIAGNOSIS; TUMORS	Spleen metastasis is extremely rare in patients with lung cancer. However, recent improvements in imaging modalities may enable the antemortem diagnosis of spleen metastasis. The present study reports the case of a female patient with lung adenocarcinoma and spleen metastasis. The patient developed isolated spleen metastasis in the postoperative course. This rare metastasis was detected in a follow-up abdominal computed tomography (CT) scan without any symptoms, and was confirmed by fluorodeoxyglucose positron emission tomography (FDG-PET)/CT scan. Although very rare, chest physicians and thoracic surgeons should be alert to the possibility of spleen metastasis development when evaluating the follow-up abdominal CT scan. FDG-PET/CT scanning and an interventional approach should be considered to clarify the possibility of spleen metastasis.	[Iguchi, Kesato; Ishibashi, Osamu; Kondo, Tadashi] Univ Tsukuba, Mito Med Ctr, Div Surg, Mito, Ibaraki 3100015, Japan; [Kagohashi, Katsunori; Satoh, Hiroaki] Univ Tsukuba, Mito Med Ctr, Div Resp Med, Mito, Ibaraki 3100015, Japan; [Takayashiki, Norio] Univ Tsukuba, Mito Med Ctr, Div Pathol, Mito, Ibaraki 3100015, Japan	Satoh, H (reprint author), Univ Tsukuba, Mito Med Ctr, Div Resp Med, Miya Machi 3-2-7, Mito, Ibaraki 3100015, Japan.	hirosato@md.tsukuba.ac.jp					Ando Katsutoshi, 2009, Nihon Kokyuki Gakkai Zasshi, V47, P581; Comperat E, 2007, ARCH PATHOL LAB MED, V131, P965; ABRAMS HL, 1950, CANCER, V3, P74, DOI 10.1002/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7; KRAEMER BB, 1984, CANCER, V54, P1606, DOI 10.1002/1097-0142(19841015)54:8<1606::AID-CNCR2820540823>3.0.CO;2-5; Assouline P, 2006, Rev Mal Respir, V23, P265, DOI 10.1016/S0761-8425(06)71576-5; AUERBACH O, 1975, CHEST, V67, P382, DOI 10.1378/chest.67.4.382; Chloros Diamantis, 2009, Cases J, V2, P9091, DOI 10.1186/1757-1626-2-9091; DENSERT O, 1965, ACTA PATHOL MIC SC, V64, P477; Dias AR, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-24; EDELMAN AS, 1990, AM J CLIN PATHOL, V94, P326; Fujii Masaru, 2008, Nihon Kokyuki Gakkai Zasshi, V46, P950; HIRST AE, 1952, AM J MED SCI, V223, P414, DOI 10.1097/00000441-195204000-00008; IMADA H, 1991, Nippon Acta Radiologica, V51, P498; Kinoshita A, 1995, NETH J MED, V47, P219, DOI 10.1016/0300-2977(95)00011-8; KLEIN B, 1987, CANCER, V60, P100, DOI 10.1002/1097-0142(19870701)60:1<100::AID-CNCR2820600118>3.0.CO;2-9; Lachachi F, 2004, ANN CHIR, V129, P521, DOI 10.1016/j.anchir.2004.09.001; MORGENSTERN L, 1985, WORLD J SURG, V9, P468; Oussama Baraket, 2013, Tunis Med, V91, P484; Pramesh C S, 2004, Ann Thorac Cardiovasc Surg, V10, P247; Sánchez-Romero Ana, 2006, Clin Transl Oncol, V8, P294, DOI 10.1007/BF02664942; Sardenberg RAS, 2013, ANN THORAC SURG, V95, P1432, DOI 10.1016/j.athoracsur.2012.08.086; Satoh H, 2001, ONCOL REP, V8, P1239; Schmidt BJ, 2004, SOUTH MED J, V97, P298, DOI 10.1097/01.SMJ.0000053457.57534.E3; Scintu F, 1991, Minerva Chir, V46, P1277; SHARPE RW, 1993, CANCER, V71, P2222, DOI 10.1002/1097-0142(19930401)71:7<2222::AID-CNCR2820710710>3.0.CO;2-B; Soussan M, 2011, CLIN NUCL MED, V36, P707, DOI 10.1097/RLU.0b013e318217ae45; Tang H, 2010, Eur Respir Rev, V19, P253, DOI 10.1183/09059180.00004110; Tomaszewski Dariusz, 2003, Pneumonol Alergol Pol, V71, P533; Van Hul I, 2008, ACTA CHIR BELG, V108, P462; WARREN S, 1964, ARCH PATHOL, V78, P467; Yen RF, 2005, J FORMOS MED ASSOC, V104, P674	31	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-0981	1792-1015		EXP THER MED	Exp. Ther. Med.	AUG	2015	10	2					733	736		10.3892/etm.2015.2524		4	Medicine, Research & Experimental	Research & Experimental Medicine	CN8GZ	WOS:000358679400058		
J	Sakisaka, Y; Tsuchiya, M; Nakamura, T; Tamura, M; Shimauchi, H; Nemoto, E				Sakisaka, Yukihiko; Tsuchiya, Masahiro; Nakamura, Takashi; Tamura, Masato; Shimauchi, Hidetoshi; Nemoto, Eiji			Wnt5a attenuates Wnt3a-induced alkaline phosphatase expression in dental follicle cells	EXPERIMENTAL CELL RESEARCH			English	Article						Wnt5a; Wnt3a; Dental follicle cells; Alkaline phosphatase; Cell differentiation	TOOTH ROOT DEVELOPMENT; BETA-CATENIN; SIGNALING PATHWAY; OSTEOBLAST DIFFERENTIATION; BONE MASS; IN-VITRO; CEMENTUM; ODONTOBLASTS; ACTIVATION; GROWTH	Wnt signaling regulates multiple cellular events such as cell proliferation, differentiation, and apoptosis through beta-catenin-dependent canonical and beta-catenin-independent noncanonical pathways. Canonical Wnt/beta-catenin signaling can promote the differentiation of dental follicle cells, putative progenitor cells for cementoblasts, osteoblasts, and periodontal ligament cells, toward a cementoblast/osteoblast phenotype during root formation, but little is known about the biological significance of noncanonical Wnt signaling in this process. We identified the expression of Wnt5a, a representative noncanonical Wnt ligand, in tooth root lining cells (i.e. precementoblasts/cementoblasts) and dental follicle cells during mouse tooth root development, as assessed by immunohistochemistry. Silencing expression of the Wnt5a gene in a dental follicle cell line resulted in enhancement of the Wnt3a (a representative canonical Wnt ligand)-mediated increase in alkaline phosphatase (ALP) expression. Conversely, treatment with recombinant Wnt5a inhibited the increase in ALP expression, suggesting that Wnt5a signaling functions as a negative regulator of canonical Wnt-mediated ALP expression of dental follicle cells. Wnt5a did not affect the nuclear translocation of beta-catenin as well as beta-catenin-mediated transcriptional activation of T-cell factor (Tcf) triggered by Wnt3a, suggesting that Wnt5a inhibits the downstream part of the beta-catenin-Tcf pathway. These findings suggest the existence of a feedback mechanism between canonical and noncanonical Wnt signaling during the differentiation of dental follicle cells. (C) 2015 Elsevier Inc. All rights reserved.	[Sakisaka, Yukihiko; Shimauchi, Hidetoshi; Nemoto, Eiji] Tohoku Univ, Grad Sch Dent, Dept Periodontol & Endodontol, Sendai, Miyagi 9808575, Japan; [Tsuchiya, Masahiro] Tohoku Univ, Grad Sch Dent, Dept Oral Diag, Sendai, Miyagi 9808575, Japan; [Tsuchiya, Masahiro] Tohoku Fukushi Univ, Sendai, Miyagi 9893201, Japan; [Nakamura, Takashi] Tohoku Univ, Grad Sch Dent, Dept Pediat Dent, Sendai, Miyagi 9808575, Japan; [Nakamura, Takashi] Tohoku Univ, Grad Sch Dent, Liason Ctr Innovat Dent, Sendai, Miyagi 9808575, Japan; [Tamura, Masato] Hokkaido Univ, Grad Sch Dent, Dept Biochem & Mol Biol, Sapporo, Hokkaido 0608586, Japan	Nemoto, E (reprint author), Tohoku Univ, Grad Sch Dent, Dept Periodontol & Endodontol, Sendai, Miyagi 9808575, Japan.	e-nemoto@dent.tohoku.ac.jp	TAMURA, MASATO/B-7304-2009; 	TAMURA, MASATO/0000-0003-3700-5203; Nakamura, Takashi/0000-0001-9904-1037	Japan Society for the Promotion of Science (Japan) [25670805];  [22390346];  [23390475]	We are grateful to Dr. Martha J. Somerman (NIH/NIDCR) for providing immortalized murine cell lines (OCCM30 and SVF4). We thank S. Kanaya and M. Suto for excellent technical assistance. We also thank T. Yamamoto and Y. Sasano for helpful discussions. This study was supported by Grant-in-Aid for Scientific Research (22390346 and 23390475) and Grant-in-Aid for Challenging Exploratory Research (25670805) from the Japan Society for the Promotion of Science (Japan).	Huang XF, 2010, J BONE MINER RES, V25, P1167, DOI 10.1359/jbmr.091103; Bain G, 2003, BIOCHEM BIOPH RES CO, V301, P84, DOI 10.1016/S0006-291X(02)02951-0; Pukrop T, 2008, J MOL MED-JMM, V86, P259, DOI 10.1007/s00109-007-0266-2; Bae CH, 2013, J PERIODONTAL RES, V48, P405, DOI 10.1111/jre.12018; Ishitani T, 2003, MOL CELL BIOL, V23, P131, DOI 10.1128/MCB.23.1.131-139.2003; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Zhao M, 2002, J BONE MINER RES, V17, P1441, DOI 10.1359/jbmr.2002.17.8.1441; Hedgepeth CM, 1997, DEV BIOL, V185, P82, DOI 10.1006/dbio.1997.8552; Sarkar L, 1999, MECH DEVELOP, V85, P197, DOI 10.1016/S0925-4773(99)00095-7; Yamada A, 2013, BIOMATERIALS, V34, P3270, DOI 10.1016/j.biomaterials.2013.01.066; Kim TH, 2011, BIOCHEM BIOPH RES CO, V412, P549, DOI 10.1016/j.bbrc.2011.07.116; Veeman MT, 2003, DEV CELL, V5, P367, DOI 10.1016/S1534-5807(03)00266-1; Nemoto E, 2009, BONE, V44, P805, DOI 10.1016/j.bone.2008.12.029; Foster BL, 2007, CURR TOP DEV BIOL, V78, P47, DOI 10.1016/S0070-2153(06)78003-6; Gaur T, 2005, J BIOL CHEM, V280, P33132, DOI 10.1074/jbc.M500608200; Guo J, 2008, BONE, V43, P961, DOI 10.1016/j.bone.2008.06.011; Bennett CN, 2005, P NATL ACAD SCI USA, V102, P3324, DOI 10.1073/pnas.0408742102; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Topol L, 2003, J CELL BIOL, V162, P899, DOI 10.1083/job.200303158; Rawadi G, 2003, J BONE MINER RES, V18, P1842, DOI 10.1359/jbmr.2003.18.10.1842; D'Errico JA, 2000, J PERIODONTOL, V71, P63, DOI 10.1902/jop.2000.71.1.63; Chen RH, 2000, J BIOL CHEM, V275, P17894, DOI 10.1074/jbc.M905336199; Takada I, 2007, NAT CELL BIOL, V9, P1273, DOI 10.1038/ncb1647; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Nemoto E, 2012, BIOCHEM BIOPH RES CO, V422, P627, DOI 10.1016/j.bbrc.2012.05.039; Sato S, 2009, HISTOCHEM CELL BIOL, V131, P583, DOI 10.1007/s00418-009-0556-6; Bosshardt DD, 1996, ANAT RECORD, V245, P267; DErrico JA, 1997, BONE, V20, P117, DOI 10.1016/S8756-3282(96)00348-1; Zhang R, 2013, INT J BIOL SCI, V9, P228, DOI 10.7150/ijbs.5476; Du Y, 2012, CONNECT TISSUE RES, V53, P390, DOI 10.3109/03008207.2012.668980; Eijken M, 2008, J CELL BIOCHEM, V104, P568, DOI 10.1002/jcb.21651; Jung HS, 2011, J MOL HISTOL, V42, P227, DOI 10.1007/s10735-011-9327-5; Kagayama M, 1997, J PERIODONTAL RES, V32, P273, DOI 10.1111/j.1600-0765.1997.tb00534.x; Lin MK, 2011, DEV DYNAM, V240, P432, DOI 10.1002/dvdy.22550; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; Miller JR, 2001, GENOME BIOL, V3; Nemoto E., 2015, J PERIODONT IN PRESS; Peng L, 2010, INT ENDOD J, V43, P404, DOI 10.1111/j.1365-2591.2010.01693.x; Zeichner-David M, 2003, DEV DYNAM, V228, P651, DOI 10.1002/dvdy.10404	40	0	0	ELSEVIER INC	SAN DIEGO	525 B STREET, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4827	1090-2422		EXP CELL RES	Exp. Cell Res.	AUG 1	2015	336	1					85	93		10.1016/j.yexcr.2015.06.013		9	Oncology; Cell Biology	Oncology; Cell Biology	CO0EA	WOS:000358821700009		
J	Kato, A; Yutani, M; Terao, M; Kimura, A; Itoi, S; Murota, H; Miyoshi, E; Katayama, I				Kato, Arisa; Yutani, Mizuki; Terao, Mika; Kimura, Akihiro; Itoi, Saori; Murota, Hiroyuki; Miyoshi, Eiji; Katayama, Ichiro			Oligosaccharide modification by N-acetylglucosaminyltransferase-V in macrophages are involved in pathogenesis of bleomycin-induced scleroderma	EXPERIMENTAL DERMATOLOGY			English	Article						bleomycin; localized scleroderma; macrophages; N-acetylglucosaminyltransferase-V; systemic sclerosis	ALLERGIC AIRWAY INFLAMMATION; SYSTEMIC-SCLEROSIS; SKIN FIBROSIS; UP-REGULATION; MURINE MODEL; T-CELLS; GLYCOSYLATION; EXPRESSION; CANCER; MICE	Oligosaccharide modification by N-acetylglucosaminyltransferase-V (GnT-V), which catalyses the formation of 1,6 GlcNAc (N-acetylglucosamine) branches on N-glycans, is associated with various pathologies, such as cancer metastasis, multiple sclerosis and liver fibrosis. In this study, we demonstrated the involvement of GnT-V in the pathophysiology of scleroderma. High expression of GnT-V was observed in infiltrating cells in skin section samples from systemic and localized patients with scleroderma. Most of the infiltrating cells were T cells and macrophages, most of which were CD163(+) M2 macrophages. To determine the role of GnT-V in scleroderma, we next investigated skin sclerosis in GnT-V knockout (MGAT5(-/-)) mice. Expression of GnT-V was also elevated in bleomycin (BLM)-injected sclerotic skin, and MGAT5(-/-) mice were resistant to BLM-induced skin sclerosis with reduced collagen type 1 1 content, suggesting the biological significance of GnT-V in skin sclerosis. Furthermore, the number of CD163(+) M2 macrophages and CD3-positive T cells in BLM-induced skin sclerosis was significantly fewer in MGAT5(-/-) mice. In bone marrow-derived macrophages (BMDMs), IL-4-induced expressions of Fizz1 and Ym1 were significantly reduced in MGAT5(-/-) mice-derived BMDMs. Taken together, these results suggest the induction of GnT-V in skin sclerosis progression is possibly dependent on increased numbers of M2 macrophages in the skin, which are important for tissue fibrosis and remodelling.	[Kato, Arisa; Yutani, Mizuki; Terao, Mika; Kimura, Akihiro; Itoi, Saori; Murota, Hiroyuki; Katayama, Ichiro] Osaka Univ, Grad Sch Med, Dept Dermatol, Suita, Osaka 5650871, Japan; [Kato, Arisa; Yutani, Mizuki; Kimura, Akihiro; Miyoshi, Eiji] Osaka Univ, Grad Sch Med, Dept Mol Biochem & Clin Invest, Suita, Osaka, Japan	Terao, M (reprint author), Osaka Univ, Grad Sch Med, Dept Dermatol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	mterao@derma.med.osaka-u.ac.jp			Japan Society for the Promotion of Science;  [24689045]	This work was supported in part by a Grant-in-Aid for Young Scientists (A) (No. 24689045) and grants from the Japan Society for the Promotion of Science. The authors thank Mr. Kenju Nishida, Mr. Hironobu Fujii, Ms. Sayaka Matsumura, Ms. Eriko Nobuyoshi and Ms. Yumiko Fujii for research assistance.	Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Morgan R, 2004, J IMMUNOL, V173, P7200; Greenblatt MB, 2012, AM J PATHOL, V180, P1080, DOI 10.1016/j.ajpath.2011.11.024; Matsushita M, 2004, INT ARCH ALLERGY IMM, V135, P348, DOI 10.1159/000082331; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Brynedal B, 2010, J NEUROIMMUNOL, V220, P120, DOI 10.1016/j.jneuroim.2010.01.003; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Miyoshi E, 1995, HEPATOLOGY, V22, P1847, DOI 10.1016/0270-9139(95)90214-7; ISHIKAWA O, 1992, J RHEUMATOL, V19, P1202; Fuschiotti P, 2009, ARTHRITIS RHEUM, V60, P1119, DOI 10.1002/art.24432; Granovsky M, 2000, NAT MED, V6, P306; Kamada Y, 2012, GLYCOBIOLOGY, V22, P778, DOI 10.1093/glycob/cws012; Murata K, 2000, CLIN CANCER RES, V6, P1772; Higashi-Kuwata N, 2009, EXP DERMATOL, V18, P727, DOI 10.1111/j.1600-0625.2008.00828.x; Ohgo S, 2013, EXP DERMATOL, V22, P769, DOI 10.1111/exd.12256; Dennis JW, 1999, BBA-GEN SUBJECTS, V1473, P21, DOI 10.1016/S0304-4165(99)00167-1; Bahaie NS, 2011, J BIOL CHEM, V286, P38231, DOI 10.1074/jbc.M111.279554; Bohm M, 2014, EXP DERMATOL, V23, P431, DOI 10.1111/exd.12409; CUMMINGS RD, 1982, J BIOL CHEM, V257, P1230; Esposito F, 2011, J NEUROIMMUNOL, V230, P143, DOI 10.1016/j.jneuroim.2010.10.026; Greenblatt MB, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-012-0297-8; Kimura A, 2012, EXP DERMATOL, V21, P515, DOI 10.1111/j.1600-0625.2012.01515.x; KRIEG T, 1988, J AM ACAD DERMATOL, V18, P457, DOI 10.1016/S0190-9622(88)70070-5; Maier C, 2014, EXP DERMATOL, V23, P99, DOI 10.1111/exd.12237; Miyoshi E, 2012, BMB REP, V45, P554, DOI 10.5483/BMBRep.2012.45.10.190; Mkhikian H, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1333; Nakayama W, 2012, RHEUMATOL INT, V32, P403, DOI 10.1007/s00296-010-1691-z; RADEMACHER TW, 1988, ANNU REV BIOCHEM, V57, P785; Shibui Akiko, 2011, Allergology International, V60, P345, DOI 10.2332/allergolint.10-OA-0283; Shimizu K, 2012, CLIN RHEUMATOL, V31, P1059, DOI 10.1007/s10067-012-1972-x; Terao M, 2010, EXP DERMATOL, V19, P38, DOI 10.1111/j.1600-0625.2009.00973.x; Terao M, 2011, J BIOL CHEM, V286, P28303, DOI 10.1074/jbc.M111.220376; Tian H, 2008, PATHOBIOLOGY, V75, P288, DOI 10.1159/000151709	33	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	AUG	2015	24	8					585	590		10.1111/exd.12730		6	Dermatology	Dermatology	CN8FV	WOS:000358676000007		
J	Ono, S; Kabashima, K				Ono, Sachiko; Kabashima, Kenji			Proposal of inducible skin-associated lymphoid tissue (iSALT)	EXPERIMENTAL DERMATOLOGY			English	Article						iSALT; dDC clustering; T cell activation	CELLS	In the 1980s, Streilein etal. introduced the term skinassociated lymphoid tissue (SALT)' based on observations that revealed the existence of T cells and dendritic cells (DCs) in the skin and that T cells are activated in the skin draining lymph nodes. However, in the perspective of SALT, it remains still unclear whether and how cellular components in the skin interact with each other. In addition, whether the T-cell activation occurs in the skin insitu has also been unrevealed. With the close observation of a skin specimen obtained from a patient with contact dermatitis, we discovered that dermal DCs (dDCs) clustered and closely attached to T cells. Thus, we hypothesized that this clustering might be essential for the establishment of the dermatitis and the T-cell activation insitu. Through the detailed examination of the elicitation phase of contact hypersensitivity as a murine model of contact dermatitis, we demonstrated the formation of sequential leukocyte clusters at the postcapillary venules. The clusters include perivascular macrophages that are activated by IL-1a produced by keratinocytes and dDCs that are attracted by these macrophages through CXCL2 signalling, both of which are essential for the efficient activation of memory T cells insitu. The structure does not exist in the steady state, but is induced' in response to local inflammatory conditions. Herein, we propose that this structure to be termed as inducible SALT (iSALT)'.	[Ono, Sachiko; Kabashima, Kenji] Kyoto Univ, Grad Sch Med, Dept Dermatol, Kyoto 6068507, Japan	Kabashima, K (reprint author), Kyoto Univ, Grad Sch Med, Dept Dermatol, 54 Shogoin Kawara, Kyoto 6068507, Japan.	kaba@kuhp.kyoto-u.ac.jp					Moyron-Quiroz JE, 2004, NAT MED, V10, P927, DOI 10.1038/nm1091; Bagabir R, 2012, BRIT J DERMATOL, V167, P1053, DOI 10.1111/j.1365-2133.2012.11190.x; Abtin A, 2014, NAT IMMUNOL, V15, P45, DOI 10.1038/ni.2769; Honda T, 2013, J INVEST DERMATOL, V133, P303, DOI 10.1038/jid.2012.284; Brandtzaeg P, 2004, TRENDS IMMUNOL, V25, P570, DOI 10.1016/j.it.2004.09.005; Egawa G, 2011, J INVEST DERMATOL, V131, P2178, DOI 10.1038/jid.2011.198; Natsuaki Y, 2014, NAT IMMUNOL, V15, P1064, DOI 10.1038/ni.2992; Streilein JW, 1983, J INVEST DERMATOL S, V80, P12; TOEWS GB, 1980, J INVEST DERMATOL, V75, P78, DOI 10.1111/1523-1747.ep12521270	9	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0906-6705	1600-0625		EXP DERMATOL	Exp. Dermatol.	AUG	2015	24	8					630	631		10.1111/exd.12716		2	Dermatology	Dermatology	CN8FV	WOS:000358676000014		
J	Kojima, C				Kojima, Chie			Preclinical studies of dendrimer prodrugs	EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY			English	Review						anti-inflammatory; cancer therapy; dendrimer; ligand; prodrug; theranostics	DRUG-DELIVERY; IN-VIVO; CANCER-THERAPY; ANIMAL-MODEL; RETINAL DEGENERATION; PEGYLATED DENDRIMERS; GOLD NANOPARTICLES; ANTITUMOR EFFICACY; HYBRID GELS; MOUSE MODEL	Introduction: Dendrimers are synthetic macromolecules with well-defined structures bearing a wide variety of functional groups on their periphery. These groups can be used to conjugate bioactive molecules such as drugs, ligands and imaging agents. Dendrimer prodrugs can be used to improve the water solubility and pharmacokinetic properties of the corresponding free drugs. Areas covered: This article summarizes preclinical studies pertaining to the use of drug-dendrimer conjugates as dendrimer prodrugs for the treatments of various diseases, including cancer and inflammatory diseases. A wide range of anticancer drugs have been conjugated to dendrimers via biodegradable linkers. The side effects of the parent drugs can be markedly reduced using dendrimer prodrugs, with some drugs showing improved efficacy. Antiinflammatory agents have also been conjugated to dendrimers and used to treat a number of inflammatory diseases. Expert opinion: Drug-dendrimer conjugates are preferable to drug-dendrimer complexes, where the use of degradable linkers is critical to the release of the drug. Polyethylene glycol and/or ligands can be added to a dendrimer prodrug, which is useful for the targeting of affected tissues. Imaging probes can also be incorporated into dendrimer prodrugs for the simultaneous delivery of therapeutic and diagnostic agents as 'theranostics.'	[Kojima, Chie] Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, Naka Ku, Sakai, Osaka 5998531, Japan	Kojima, C (reprint author), Osaka Prefecture Univ, Grad Sch Engn, Dept Appl Chem, 1-1 Gakuen Cho, Sakai, Osaka 5998531, Japan.	kojima@chem.osakafu-u.ac.jp			Japan Society for the Promotion of Science (JSPS) [26410227]	The author was supported by a grant-in-aid from the Japan Society for the Promotion of Science (JSPS) (No. 26410227). The author has no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	Kaminskas LM, 2012, NANOMED-NANOTECHNOL, V8, P103, DOI 10.1016/j.nano.2011.05.013; TOMALIA DA, 1985, POLYM J, V17, P117, DOI 10.1295/polymj.17.117; Khandare J, 2006, PROG POLYM SCI, V31, P359, DOI 10.1016/j.progpolymsci.2005.09.004; She WC, 2013, BIOMATERIALS, V34, P1613, DOI 10.1016/j.biomaterials.2012.11.007; Thomas TP, 2011, ARTHRITIS RHEUM-US, V63, P2671, DOI 10.1002/art.30459; Xie J, 2010, ADV DRUG DELIVER REV, V62, P1064, DOI 10.1016/j.addr.2010.07.009; Tekade RK, 2009, CHEM REV, V109, P49, DOI 10.1021/cr068212n; Pissuwan D, 2006, TRENDS BIOTECHNOL, V24, P62, DOI 10.1016/j.tibtech.2005.12.004; Calderon M, 2011, J CONTROL RELEASE, V151, P295, DOI 10.1016/j.jconrel.2011.01.017; Zhu JY, 2014, BIOMATERIALS, V35, P7635, DOI 10.1016/j.biomaterials.2014.05.046; Kojima C, 2013, ACTA BIOMATER, V9, P5673, DOI 10.1016/j.actbio.2012.11.013; Benchaala I, 2014, INT J PHARMACEUT, V466, P258, DOI 10.1016/j.ijpharm.2014.03.018; Maeda H, 2000, J CONTROL RELEASE, V65, P271, DOI 10.1016/S0168-3659(99)00248-5; Kukowska-Latallo JF, 2005, CANCER RES, V65, P5317, DOI 10.1158/0008-5472.CAN-04-3921; Duncan R, 2006, NAT REV CANCER, V6, P688, DOI 10.1038/nrc1958; Ward BB, 2011, J ORAL MAXIL SURG, V69, P2452, DOI 10.1016/j.joms.2010.12.041; Tomalia DA, 2005, PROG POLYM SCI, V30, P294, DOI 10.1016/j.progpolymsci.2005.01.007; D'Emanuele A, 2005, ADV DRUG DELIVER REV, V57, P2147, DOI 10.1016/j.addr.2005.09.012; Astruc D, 2010, CHEM REV, V110, P1857, DOI 10.1021/cr900327d; Thoma CR, 2014, ADV DRUG DELIVER REV, V69, P29, DOI 10.1016/j.addr.2014.03.001; Wolinsky JB, 2008, ADV DRUG DELIVER REV, V60, P1037, DOI 10.1016/j.addr.2008.02.012; Haag R, 2006, ANGEW CHEM INT EDIT, V45, P1198, DOI 10.1002/anie.200502113; Etrych T, 2011, J CONTROL RELEASE, V154, P241, DOI 10.1016/j.jconrel.2011.06.015; Mignani S, 2013, ADV DRUG DELIVER REV, V65, P1316, DOI 10.1016/j.addr.2013.01.001; Najlah M, 2006, INT J PHARM, V308, P175, DOI 10.1016/ijpharm.2005.10.033; Li XJ, 2014, BIOMATERIALS, V35, P6576, DOI 10.1016/j.biomaterials.2014.04.043; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Wu XM, 2014, ACS NANO, V8, P153, DOI 10.1021/nn4054107; Medina SH, 2009, CHEM REV, V109, P3141, DOI 10.1021/cr900174j; Kaminskas LM, 2014, J CONTROL RELEASE, V183, P18, DOI 10.1016/j.jconrel.2014.03.012; Boisselier E, 2009, CHEM SOC REV, V38, P1759, DOI 10.1039/b806051g; Kaminskas LM, 2012, MOL PHARMACEUT, V9, P422, DOI 10.1021/mp200522d; Inapagolla R, 2010, INT J PHARMACEUT, V399, P140, DOI 10.1016/j.ijpharm.2010.07.030; Zhu SJ, 2010, BIOMATERIALS, V31, P1360, DOI 10.1016/j.biomaterials.2009.10.044; Mishra MK, 2014, ACS NANO, V8, P2134, DOI 10.1021/nn404872e; Pan DY, 2014, BIOMATERIALS, V35, P10080, DOI 10.1016/j.biomaterials.2014.09.006; Iezzi R, 2012, BIOMATERIALS, V33, P979, DOI 10.1016/j.biomaterials.2011.10.010; Govorov AO, 2007, NANO TODAY, V2, P30, DOI 10.1016/S1748-0132(07)70017-8; Kojima C, 2010, EXPERT OPIN DRUG DEL, V7, P307, DOI 10.1517/17425240903530651; Jain PK, 2007, NANO TODAY, V2, P18, DOI 10.1016/S1748-0132(07)70016-6; Wu D, 2013, BIOMATERIALS, V34, P5036, DOI 10.1016/j.biomaterials.2013.03.053; Chang YL, 2013, POLYM CHEM-UK, V4, P789, DOI 10.1039/c2py20740k; Moscicki AB, 2012, JAIDS-J ACQ IMM DEF, V59, P134, DOI 10.1097/QAI.0b013e31823f2aeb; Zhang LH, 2011, EUR J PHARM BIOPHARM, V79, P232, DOI 10.1016/j.ejpb.2011.03.025; Lammers T, 2010, MOL PHARMACEUT, V7, P1899, DOI 10.1021/mp100228v; Satsangi A, 2014, MOL PHARMACEUT, V11, P1906, DOI 10.1021/mp500128k; TOMALIA DA, 1990, ANGEW CHEM INT EDIT, V29, P138, DOI 10.1002/anie.199001381; Cheng YY, 2011, CHEM SOC REV, V40, P2673, DOI 10.1039/c0cs00097c; Wang K, 2014, BIOMATERIALS, V35, P8735, DOI 10.1016/j.biomaterials.2014.06.042; Gomes CM, 2011, ADV DRUG DELIVER REV, V63, P547, DOI 10.1016/j.addr.2010.09.015; Kaminskas LM, 2011, MOL PHARMACEUT, V8, P338, DOI 10.1021/mp1001872; Pu YJ, 2013, BIOMATERIALS, V34, P3658, DOI 10.1016/j.biomaterials.2013.01.082; Lee CC, 2006, P NATL ACAD SCI USA, V103, P16649, DOI 10.1073/pnas.0607705103; Chang YL, 2012, J MATER CHEM, V22, P9594, DOI 10.1039/c2jm16792a; Bhatia SN, 2014, NAT BIOTECHNOL, V32, P760, DOI 10.1038/nbt.2989; Burd I, 2014, NANOMED-NANOTECHNOL, V10, P1343, DOI 10.1016/j.nano.2014.03.008; Etrych T, 2011, J DRUG TARGET, V19, P874, DOI 10.3109/1061186X.2011.622402; Etrych T, 2015, POLYM CHEM-UK, V6, P160, DOI 10.1039/c4py01120a; Gajbhiye V, 2007, CURR PHARM DESIGN, V13, P415, DOI 10.2174/138161207780162999; Greenwald RB, 2000, CRIT REV THER DRUG, V17, P101; Huang J, 2010, POLYM INT, V59, P1390, DOI 10.1002/pi.2880; JANSEN JFGA, 1994, SCIENCE, V266, P1226, DOI 10.1126/science.266.5188.1226; Jiang YY, 2010, J DRUG TARGET, V18, P389, DOI 10.3109/10611860903494203; Kaminskas LM, 2011, J CONTROL RELEASE, V152, P241, DOI 10.1016/j.jconrel.2011.02.005; Kojima C, 2013, NANOMED-NANOTECHNOL, V9, P767, DOI 10.1016/j.nano.2013.01.004; Kojima C, 2014, INT J PHARMACEUT, V476, P164, DOI 10.1016/j.ijpharm.2014.09.053; Lee CC, 2005, NAT BIOTECHNOL, V23, P1517, DOI 10.1038/nbt1171; LEE SM, 2013, BIOMED MAT RES A, V101, P2306, DOI DOI 10.1002/JBM.A.34529; Lim J, 2012, MOL PHARMACEUT, V9, P404, DOI 10.1021/mp2005017; MAEDA H, 1989, CRIT REV THER DRUG, V6, P193; Myc A, 2010, ANTI-CANCER DRUG, V21, P186, DOI 10.1097/CAD.0b013e328334560f; Oerlemans C, 2010, PHARM RES-DORDR, V27, P2569, DOI 10.1007/s11095-010-0233-4; Sakuma S, 2010, EUR J PHARM BIOPHARM, V75, P366, DOI 10.1016/j.ejpb.2010.04.003; Sato K, 2014, ADV DRUG DELIVER REV, V74, P115, DOI 10.1016/j.addr.2013.08.009; Shabat D, 2006, J POLYM SCI POL CHEM, V44, P1569, DOI 10.1002/pola.21258; Shrivastava PK, 2010, CHEM PAP, V64, P592, DOI 10.2478/s11696-010-0042-6; Svenson S, 2005, ADV DRUG DELIVER REV, V57, P2106, DOI 10.1016/j.addr.2005.09.018; Wei JB, 2013, BIOORGAN MED CHEM, V21, P4192, DOI 10.1016/j.bmc.2013.05.006; Wu G, 2006, MOL CANCER THER, V5, P52, DOI 10.1158/1535-7163.MCT-05-0325; Zhou ZX, 2014, ANGEW CHEM INT EDIT, V53, P10949, DOI 10.1002/anie.201406442	80	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1742-5255	1744-7607		EXPERT OPIN DRUG MET	Expert Opin. Drug Metab. Toxicol.	AUG	2015	11	8					1303	1315		10.1517/17425255.2015.1052404		13	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	CO2HN	WOS:000358976900009		
J	Galling, B; Garcia, MA; Osuchukwu, U; Hagi, K; Correll, CU				Galling, Britta; Garcia, Maryam A.; Osuchukwu, Uzoma; Hagi, Katsuhiko; Correll, Christoph U.			Safety and tolerability of antipsychotic-mood stabilizer co-treatment in the management of acute bipolar disorder: results from a systematic review and exploratory meta-analysis	EXPERT OPINION ON DRUG SAFETY			English	Review						adverse effects; antipsychotic; augmentation; bipolar disorder; combination; co-treatment; meta-analysis; mood stabilizer; safety; tolerability	PLACEBO-CONTROLLED TRIAL; ADJUNCTIVE ORAL ZIPRASIDONE; DOUBLE-BLIND; ACUTE MANIA; PSYCHIATRIC COMORBIDITY; DRUG-INTERACTIONS; I DISORDER; LITHIUM; DEPRESSION; EFFICACY	Introduction: Mood stabilizer (MS) plus antipsychotic (AP) co-treatment is common in patients with acute bipolar disorder (BD), but adverse effects (AEs) of this strategy have not been systematically reviewed. Areas covered: We conducted a systematic review searching PubMed/MEDLINE and PsycINFO on April 1, 2015 for randomized trials in >= 20 adults with acute manic/mixed or depressed BD comparing MS or AP monotherapy with their combination that reported quantitative AE data. Pooled together, MS+AP versus MS monotherapy (studies = 18, n = 4419) was associated with significantly higher burden regarding 21/53 (39.6%) individual AEs, particularly weight gain-related (5/5 = 100%), extrapyramidal (5/12 = 41.7%) and glucose/lipid-related AEs (3/8 = 37.5%). AP+MS versus AP monotherapy (studies = 3, n = 397) was associated with significantly higher burden regarding 4/21 (19.0%) individual AEs (>= 1 AE, tremor, sedation/somnolence, vomiting). Expert opinion: Efficacy advantages of AP+MS co-treatment versus monotherapy should be balanced with its greater AE burden. AE risk is higher for adding AP to MS (17 additional AEs) than adding MS to an AP, including the particularly concerning cardiometabolic AEs. More data are needed, as only one or two studies provided data for 21/21 (100%) AEs of MS augmentation of AP, and 13/53 (24.5%) AEs of AP augmentation of MS, and as sparse data suggest clinically relevant AE differences across individual AP+MS combinations.	[Galling, Britta; Osuchukwu, Uzoma; Hagi, Katsuhiko; Correll, Christoph U.] Zucker Hillside Hosp, Psychiat Res, North Shore Long Isl Jewish Hlth Syst, Glen Oaks, NY USA; [Garcia, Maryam A.] Hosp Santa Caterina, Inst Assistencia Sanitaria, Salt, Spain; [Hagi, Katsuhiko] Dainippon Sumitomo Pharma Co Ltd, Osaka, Japan; [Correll, Christoph U.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA; [Correll, Christoph U.] Feinstein Inst Med Res, Manhasset, NY USA; [Correll, Christoph U.] Albert Einstein Coll Med, Bronx, NY 10467 USA	Correll, CU (reprint author), Zucker Hillside Hosp, Psychiat Res, Glen Oaks, NY 11004 USA.	ccorrell@nshs.edu			Bristol-Myers Squibb; Otsuka; Takeda	CU Correll has been a consultant and/or advisor to or has received honoraria from: AbbVie, Actavis, Alkermes, Bristol-Myers Squibb, Eli Lilly, Genentech, Gerson Lehrman Group, IntraCellular Therapies, Janssen/J&J, Lundbeck, MedAvante, Medscape, Otsuka, Pfizer, ProPhase, Reviva, Roche, Sunovion, Supernus and Takeda. He has received grant support Bristol-Myers Squibb, Otsuka and Takeda. K Hagi is an employee of Dainippon Sumitomo Pharma. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.	American Psychiatric Association, 2002, AM J PSYCHIAT S, V159, P1; Tohen M, 2008, BRIT J PSYCHIAT, V192, P135, DOI 10.1192/bjp.bp.107.041301; Skogh E, 2002, THER DRUG MONIT, V24, P518, DOI 10.1097/00007691-200208000-00010; Yatham LN, 2013, BIPOLAR DISORD, V15, P1, DOI 10.1111/bdi.12025; Mojtabai R, 2010, ARCH GEN PSYCHIAT, V67, P26, DOI 10.1001/archgenpsychiatry.2009.175; Scherk H, 2007, ARCH GEN PSYCHIAT, V64, P442, DOI 10.1001/archpsyc.64.4.442; [Anonymous], 2014, BIPOLAR DISORDER ASS; Yatham LN, 2003, BRIT J PSYCHIAT, V182, P141, DOI 10.1192/bjp.182.2.141; Berwaerts J, 2011, J AFFECT DISORDERS, V129, P252, DOI 10.1016/j.jad.2010.09.011; Sachs GS, 2002, AM J PSYCHIAT, V159, P1146, DOI 10.1176/appi.ajp.159.7.1146; Chou JCY, 1999, J CLIN PSYCHOPHARM, V19, P500, DOI 10.1097/00004714-199912000-00003; Spina E, 2007, BASIC CLIN PHARMACOL, V100, P4, DOI 10.1111/j.1742-7843.2007.00017.x; Goldberg JF, 2009, J CLIN PSYCHIAT, V70, P155; Sachs GS, 2011, J CLIN PSYCHIAT, V72, P1413, DOI 10.4088/JCP.09m05934; Lucas RA, 1998, EUR J CLIN PHARMACOL, V54, P639, DOI 10.1007/s002280050527; Vieta E, 2013, CNS DRUGS, V27, P515, DOI 10.1007/s40263-013-0073-y; Grunze H, 2003, WORLD J BIOL PSYCHIA, V4, P5; Meltzer HY, 2011, AM J PSYCHIAT, V168, P957, DOI 10.1176/appi.ajp.2011.10060907; Vazquez GH, 2013, INT J NEUROPSYCHOPH, V16, P1673, DOI 10.1017/S1461145713000023; GARFINKEL PE, 1980, J AFFECT DISORDERS, V2, P279, DOI 10.1016/0165-0327(80)90029-4; Vieta E, 2008, J AFFECT DISORDERS, V109, P251, DOI 10.1016/j.jad.2008.06.001; Sachs G, 2004, BIPOLAR DISORD, V6, P213, DOI 10.1111/j.1399-5618.2004.00115.x; van der Loos MLM, 2009, J CLIN PSYCHIAT, V70, P223; Sachs GS, 2012, J CLIN PSYCHIAT, V73, P1412, DOI 10.4088/JCP.11m07388; Tohen M, 2002, ARCH GEN PSYCHIAT, V59, P62, DOI 10.1001/archpsyc.59.1.62; Malhi GS, 2012, BIPOLAR DISORD, V14, P1, DOI 10.1111/j.1399-5618.2012.00989.x; Sidor MM, 2011, J CLIN PSYCHIAT, V72, P156, DOI 10.4088/JCP.09r05385gre; Goodwin GM, 2009, J PSYCHOPHARMACOL, V23, P346, DOI 10.1177/0269881109102919; Spina E, 1996, CLIN PHARMACOKINET, V31, P198; McElroy SL, 2001, AM J PSYCHIAT, V158, P420, DOI 10.1176/appi.ajp.158.3.420; Houston JP, 2009, J CLIN PSYCHIAT, V70, P1540, DOI 10.4088/JCP.08m04895yel; Crump C, 2013, JAMA PSYCHIAT, V70, P931, DOI 10.1001/jamapsychiatry.2013.1394; Singh JB, 2006, BIPOLAR DISORD, V8, P696, DOI 10.1111/j.1399-5618.2006.00371.x; Correll CU, 2010, EUR PSYCHIAT, V25, pS12, DOI 10.1016/S0924-9338(10)71701-6; Baek JH, 2014, J CLIN PSYCHOPHARM, V34, P577, DOI 10.1097/JCP.0000000000000175; Bourin Michel S, 2014, Int J Bipolar Disord, V2, P14, DOI 10.1186/s40345-014-0014-9; Bowden CL, 2004, J CLIN PSYCHIAT, V65, P21; Correll CU, 2007, CNS SPECTRUMS, V12, P12; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; De Hert Marc, 2012, Nat Rev Endocrinol, V8, P114, DOI 10.1038/nrendo.2011.156; Forty L, 2014, BRIT J PSYCHIAT, V205, P465, DOI 10.1192/bjp.bp.114.152249; Gao K, 2014, J CLIN PSYCHIAT; Grunze Heinz, 2002, World J Biol Psychiatry, V3, P115, DOI 10.3109/15622970209150612; Loebel A, 2014, AM J PSYCHIAT, V171, P169, DOI 10.1176/appi.ajp.2013.13070985; McIntyre RS, 2004, HUM PSYCHOPHARM CLIN, V19, P369, DOI 10.1002/hup.612; MOLLER HJ, 1989, BIOL PSYCHIAT, V13, P127; Ogawa Y, 2014, CNS DRUGS, V28, P989, DOI 10.1007/s40263-014-0197-8; Ravindran DA, 2004, CLIN PHARMACOKINET, V43, P733; Smith LA, 2007, ACTA PSYCHIAT SCAND, V115, P12, DOI 10.1111/j.1600-0447.2006.00912.x; Stedman M, 2010, ALCOHOL CLIN EXP RES, V34, P1822, DOI 10.1111/j.1530-0277.2010.01270.x; Szegedi A, 2012, J CLIN PSYCHOPHARM, V32, P46; Weisler RH, 2003, EUROPEAN NEUROPSY S4, V13, P344; Yatham LN, 2007, INT CLIN PSYCHOPHARM, V22, P212, DOI 10.1097/YIC.0b013e328080ca57	53	0	0	INFORMA HEALTHCARE	LONDON	TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND	1474-0338	1744-764X		EXPERT OPIN DRUG SAF	Expert Opin. Drug Saf.	AUG	2015	14	8					1181	1199		10.1517/14740338.2015.1053457		19	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO2HP	WOS:000358977100002		
J	Wang, YQ; Fukuda, T; Isaji, T; Lu, JS; Im, S; Hang, QL; Gu, W; Hou, SC; Ohtsubo, K; Gu, JG				Wang, Yuqin; Fukuda, Tomohiko; Isaji, Tomoya; Lu, Jishun; Im, Sanghun; Hang, Qinglei; Gu, Wei; Hou, Sicong; Ohtsubo, Kazuaki; Gu, Jianguo			Loss of alpha 1,6-fucosyltransferase inhibits chemical-induced hepatocellular carcinoma and tumorigenesis by down-regulating several cell signaling pathways	FASEB JOURNAL			English	Article						N-glycosylation; glycosyltransferase; cell proliferation	FUCOSYL-TRANSFERASE 8; LUNG-CANCER; CORE FUCOSE; INDUCED HEPATOCARCINOGENESIS; COMPENSATORY PROLIFERATION; ACQUIRED-RESISTANCE; LIVER-REGENERATION; COLORECTAL-CANCER; ALPHA-FETOPROTEIN; GROWTH	Up-regulation of core fucosylation catalyzed by alpha 1,6-fucosyltransferase (Fut8) has been observed in hepatocellular carcinoma (HCC). Here, to explore the role of Fut8 expression in hepatocarcinogensis, we established the chemical-induced HCC models in the male wildtype (WT; Fut8(+/+)), hetero (Fut8(+/-)), and knockout (KO; Fut8(-/-)) mice by use of diethylnitrosamine (DEN) and pentobarbital (PB). In the Fut8(+/+) and Fut8(+/-) mice, multiple large and vascularized nodules were induced with an increased expression of Fut8 after DEN and PB treatment. However, the formation of HCC in Fut8(-/-) mice was suppressed almost completely. This potent inhibitory effect of Fut8 deficiency on tumorigenesis was also confirmed by the abolished tumor formation of Fut8 KO human hepatoma cell line cells by use of a xenograft tumor model. Furthermore, loss of the Fut8 gene resulted in attenuated responses to epidermal growth factor (EGF) and hepatocyte growth factor (HGF) in the HepG2 cell line, which provides the possible mechanisms for the contribution of Fut8 to hepatocarcinogensis. Taken together, our study clearly demonstrated that core fucosylation acts as a critical functional modulator in the liver and implicated Fut8 as a prognostic marker, as well as a novel, therapeutic target for HCC.	[Wang, Yuqin; Fukuda, Tomohiko; Isaji, Tomoya; Lu, Jishun; Im, Sanghun; Hang, Qinglei; Gu, Wei; Hou, Sicong; Gu, Jianguo] Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Sendai, Miyagi 9818558, Japan; [Ohtsubo, Kazuaki; Gu, Jianguo] Kumamoto Univ, Fac Life Sci, Dept Analyt Biochem, Kumamoto 860, Japan	Gu, JG (reprint author), Tohoku Pharmaceut Univ, Div Regulatory Glycobiol, Inst Mol Biomembrane & Glycobiol, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi 9818558, Japan.	jgu@tohoku-pharm.ac.jp			Challenging Exploratory Research Grant [15K14408]; Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology of Japan;  [15H04354];  [24590087];  [23790363]	The authors thank Dr. Yuka Kobayashi (J-Oil Mills, Tokyo, Japan) for providing the PhoSL, Dr. Maeda Kento (Kumamoto University, Japan) for technical assistance, and Dr. Lucas Revillon (Tohoku Pharmaceutical University) for the language modification of this manuscript. This work was partially supported by a Grant-in-Aid for Scientific Research 15H04354 to J.G. and 24590087 to T.F.; Challenging Exploratory Research Grant 15K14408 to J.G.; Young Scientists (B) Grant 23790363 to K.O.; Japan Society for the Promotion of Science; and Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Wang XC, 2006, J BIOL CHEM, V281, P2572, DOI 10.1074/jbc.M510893200; Jacinto FV, 2007, DNA REPAIR, V6, P1155, DOI 10.1016/j.dnarep.2007.03.013; Shinkawa T, 2003, J BIOL CHEM, V278, P3466, DOI 10.1074/jbc.M210665200; Goyal L, 2013, CLIN CANCER RES, V19, P2310, DOI 10.1158/1078-0432.CCR-12-2791; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Engelman JA, 2008, CLIN CANCER RES, V14, P2895, DOI 10.1158/1078-0432.CCR-07-2248; Takahashi T, 2000, INT J CANCER, V88, P914, DOI 10.1002/1097-0215(20001215)88:6<914::AID-IJC12>3.0.CO;2-1; Muinelo-Romay L, 2008, INT J CANCER, V123, P641, DOI 10.1002/ijc.23521; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Contessa JN, 2010, CLIN CANCER RES, V16, P3205, DOI 10.1158/1078-0432.CCR-09-3331; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; Ferrara C, 2011, P NATL ACAD SCI USA, V108, P12669, DOI 10.1073/pnas.1108455108; Wang MY, 2014, SCI REP-UK, V4, DOI 10.1038/srep06145; Zhao YY, 2006, J BIOL CHEM, V281, P38343, DOI 10.1074/jbc.M608764200; Wang MJ, 2009, CANCER EPIDEM BIOMAR, V18, P1914, DOI 10.1158/1055-9965.EPI-08-0980; Chen CY, 2013, P NATL ACAD SCI USA, V110, P630, DOI 10.1073/pnas.1220425110; Verna L, 1996, PHARMACOL THERAPEUT, V71, P57, DOI 10.1016/0163-7258(96)00062-9; SATO Y, 1993, NEW ENGL J MED, V328, P1802, DOI 10.1056/NEJM199306243282502; Okazaki A, 2004, J MOL BIOL, V336, P1239, DOI 10.1016/j.jmb.2004.01.007; Zhu AX, 2010, ANN SURG ONCOL, V17, P1247, DOI 10.1245/s10434-010-0975-6; Kang JS, 2007, CANCER RES, V67, P11141, DOI 10.1158/0008-5472.CAN-07-1369; Block TM, 2005, P NATL ACAD SCI USA, V102, P779, DOI 10.1073/pnas.0408928102; Llovet JM, 2008, HEPATOLOGY, V48, P1312, DOI 10.1002/hep.22506; Yamashita F, 1996, GASTROENTEROLOGY, V111, P996, DOI 10.1016/S0016-5085(96)70067-7; Wheeler DL, 2008, ONCOGENE, V27, P3944, DOI 10.1038/onc.2008.19; Haltiwanger RS, 2004, ANNU REV BIOCHEM, V73, P491, DOI 10.1146/annurev.biochems.73.011303.074043; Mizushima T, 2011, GENES CELLS, V16, P1071, DOI 10.1111/j.1365-2443.2011.01552.x; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Noda K, 2003, CANCER RES, V63, P6282; Wang XC, 2005, P NATL ACAD SCI USA, V102, P15791, DOI 10.1073/pnas.0507375102; Taub R, 2004, NAT REV MOL CELL BIO, V5, P836, DOI 10.1038/nrm1489; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Biname F, 2008, MOL BIOL CELL, V19, P945, DOI 10.1091/mbc.E07-09-0967; Fang M, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-215; Fukuda T, 2011, J BIOL CHEM, V286, P18434, DOI 10.1074/jbc.M110.172536; Giordano S, 2014, J HEPATOL, V60, P442, DOI 10.1016/j.jhep.2013.09.009; Gu W, 2013, FASEB J, V27, P3947, DOI 10.1096/fj.12-225805; HUTCHINSON WL, 1991, HEPATOLOGY, V13, P683, DOI 10.1016/0270-9139(91)92564-O; Kobayashi Y, 2012, J BIOL CHEM, V287, P33973, DOI 10.1074/jbc.M111.327692; Lanaya H., 2014, NAT CELL BIOL, V16, P1; Lanaya H, 2014, NAT CELL BIOL, V16, P972, DOI 10.1038/ncb3031; Matsumoto K, 2010, CARCINOGENESIS, V31, P318, DOI 10.1093/carcin/bgp306; Uozumi N, 1996, J BIOL CHEM, V271, P27810	47	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3217	3227		10.1096/fj.15-270710		11	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	WOS:000358796900011		
J	Yamamoto, K; Kakino, A; Takeshita, H; Hayashi, N; Li, L; Nakano, A; Hanasaki-Yamamoto, H; Fujita, Y; Imaizumi, Y; Toyama-Yokoyama, S; Nakama, C; Kawai, T; Takeda, M; Hongyo, K; Oguro, R; Maekawa, Y; Itoh, N; Takami, Y; Onishi, M; Takeya, Y; Sugimoto, K; Kamide, K; Nakagami, H; Ohishi, M; Kurtz, TW; Sawamura, T; Rakugi, H				Yamamoto, Koichi; Kakino, Akemi; Takeshita, Hikari; Hayashi, Norihiro; Li, Lei; Nakano, Atsushi; Hanasaki-Yamamoto, Hiroko; Fujita, Yoshiko; Imaizumi, Yuki; Toyama-Yokoyama, Serina; Nakama, Chikako; Kawai, Tatsuo; Takeda, Masao; Hongyo, Kazuhiro; Oguro, Ryosuke; Maekawa, Yoshihiro; Itoh, Norihisa; Takami, Yoichi; Onishi, Miyuki; Takeya, Yasushi; Sugimoto, Ken; Kamide, Kei; Nakagami, Hironori; Ohishi, Mitsuru; Kurtz, Theodore W.; Sawamura, Tatsuya; Rakugi, Hiromi			Oxidized LDL (oxLDL) activates the angiotensin II type 1 receptor by binding to the lectin-like oxLDL receptor	FASEB JOURNAL			English	Article						G protein-coupled receptor; allosteric activation; vascular dysfunction; receptor multimerization	LOW-DENSITY-LIPOPROTEIN; SMOOTH-MUSCLE-CELLS; ARTERY ENDOTHELIAL-CELLS; 3RD CYTOPLASMIC LOOP; NF-KAPPA-B; OXIDATIVE STRESS; KNOCKOUT MICE; NADPH OXIDASE; EGF RECEPTOR; G-PROTEINS	The angiotensin II type 1 receptor (AT1) is a 7-transmembrane domain GPCR that when activated by its ligand angiotensin II, generates signaling events promoting vascular dysfunction and the development of cardiovascular disease. Here, we show that the single-transmembrane oxidized LDL (oxLDL) receptor (LOX-1) resides in proximity to AT1 on cell-surface membranes and that binding of oxLDL to LOX-1 can allosterically activate AT1-dependent signaling events. oxLDL-induced signaling events in human vascular endothelial cells were abolished by knockdown of AT1 and inhibited by AT1 blockade (ARB). oxLDL increased cytosolic G protein by 350% in Chinese hamster ovary (CHO) cells with genetically induced expression of AT1 and LOX-1, whereas little increase was observed in CHO cells expressing only LOX-1. Immunoprecipitation and in situ proximity ligation assay (PLA) assays in CHO cells revealed the presence of cell-surface complexes involving LOX-1 and AT1. Chimeric analysis showed that oxLDL-induced AT1 signaling events are mediated via interactions between the intracellular domain of LOX-1 and AT1 that activate AT1. oxLDL-induced impairment of endothelium-dependent vascular relaxation of vascular ring from mouse thoracic aorta was abolished by ARB or genetic deletion of AT1. These findings reveal a novel pathway for AT1 activation and suggest a new mechanism whereby oxLDL may be promoting risk for cardiovascular disease.	[Yamamoto, Koichi; Takeshita, Hikari; Hayashi, Norihiro; Hanasaki-Yamamoto, Hiroko; Imaizumi, Yuki; Toyama-Yokoyama, Serina; Nakama, Chikako; Kawai, Tatsuo; Takeda, Masao; Hongyo, Kazuhiro; Oguro, Ryosuke; Maekawa, Yoshihiro; Itoh, Norihisa; Takami, Yoichi; Onishi, Miyuki; Takeya, Yasushi; Sugimoto, Ken; Kamide, Kei; Ohishi, Mitsuru; Rakugi, Hiromi] Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, Suita, Osaka 5650871, Japan; [Kakino, Akemi; Li, Lei; Nakano, Atsushi; Fujita, Yoshiko; Sawamura, Tatsuya] Natl Cerebral & Cardiovasc Ctr, Res Inst, Dept Vasc Physiol, Suita, Osaka, Japan; [Kakino, Akemi; Sawamura, Tatsuya] Osaka Univ, Grad Sch Pharmaceut Sci, Dept Mol Pathophysiol, Suita, Osaka 5650871, Japan; [Kakino, Akemi; Takeshita, Hikari; Sawamura, Tatsuya] Shinshu Univ, Sch Med, Dept Physiol, Asahi, Matsumo, Japan; [Nakagami, Hironori] Osaka Univ, United Grad Sch Child Dev, Div Vasc Med & Epigenet, Suita, Osaka 5650871, Japan; [Kurtz, Theodore W.] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA	Yamamoto, K (reprint author), Osaka Univ, Grad Sch Med, Dept Geriatr Med & Nephrol, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	kyamamoto@geriat.med.osaka-u.ac.jp; ohishi@geriat.med.osaka-u.ac.jp			Kanae Foundation for the Promotion of Medical Science;  [23591102]	The authors are most grateful to Kazuko Iwasa, Takako Baba, Asami Ihara, Aiko Kikuchi, Zhong Chongxia, and Yuka Nakao (Osaka University) for their excellent technical assistance. The authors thank Dr. Takahito Inoue (Asubio Pharma) and Takashi Shimosato (Nissei Bilis) for their technical guidance of the vascular experiments. This work was supported by a Grant-in-Aid for Scientific Research (No. 23591102) and by Kanae Foundation for the Promotion of Medical Science. K.Y. conceived of the idea of the study, designed and performed experiments, and wrote the manuscript. T.S. designed and performed experiments and helped with writing the manuscript with A.K., L.L., A.N., and Y.F. H.T. performed animal experiments. N.H., H.H.-Y., Y.I., S.T.-Y., C.N., T.K., M.T., K.H., R.O., Y.M., N.I., Y. Takami, M. Onishi, Y. Takeya, and K.S. performed experiments. K. K., H.N., M. Ohishi, and H.R. designed experiments. T.W.K. assisted with interpretation of the results and editing of the manuscript.	Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Eguchi S, 2001, J BIOL CHEM, V276, P7957, DOI 10.1074/jbc.M008570200; Ohki I, 2005, STRUCTURE, V13, P905, DOI 10.1016/j.str.2005.03.016; Mehta JL, 2007, CIRC RES, V100, P1634, DOI 10.1161/CIRCRESAHA.107.149724; Inoue K, 2005, CIRC RES, V97, P176, DOI 10.1161/01.RES.0000174286.73200.d4; Erb L, 2001, J CELL BIOL, V153, P491, DOI 10.1083/jcb.153.3.491; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; McLatchie LM, 1998, NATURE, V393, P333; Kumar A, 2006, IMMUNITY, V25, P213, DOI 10.1016/j.immuni.2006.06.015; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Heinloth A, 2000, J AM SOC NEPHROL, V11, P1819; Sawamura T, 1997, NATURE, V386, P73, DOI 10.1038/386073a0; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Fujita Y, 2009, CLIN CHEM, V55, P285, DOI 10.1373/clinchem.2008.119750; Nakano A, 2010, J HYPERTENS, V28, P1273, DOI 10.1097/HJH.0b013e32833835d4; Mehta JL, 2006, CARDIOVASC RES, V69, P36, DOI 10.1016/j.cardiores.2005.09.006; Brown GD, 2006, NAT REV IMMUNOL, V6, P33, DOI 10.1038/nri1745; Dunn S, 2008, BIOCHEM J, V409, P349, DOI 10.1042/BJ20071196; Li DY, 2000, ARTERIOSCL THROM VAS, V20, P1116; Auge N, 2002, ARTERIOSCL THROM VAS, V22, P1990, DOI 10.1161/01.ATV.0000043453.21629.3B; Patel TB, 2004, PHARMACOL REV, V56, P371, DOI 10.1124/pr.56.3.4; Maziere C, 1999, FEBS LETT, V448, P49, DOI 10.1016/S0014-5793(99)00324-5; Nickenig G, 2002, CIRCULATION, V105, P393, DOI 10.1161/hc0302.102618; Wassmann S, 2004, CIRCULATION, V110, P3062, DOI 10.1161/01.CIR.000137970.47771.AF; Li DY, 2000, CIRCULATION, V102, P1970; Oliveira L, 2007, PHYSIOL REV, V87, P565, DOI 10.1152/physrev.00040.2005; Zhang M, 2000, J BIOL CHEM, V275, P15782, DOI 10.1074/jbc.M000198200; Suc I, 1998, FASEB J, V12, P665; Miura S, 2006, J BIOL CHEM, V281, P19288, DOI 10.1074/jbc.M602144200; Li DY, 2003, CIRCULATION, V107, P612, DOI 10.1161/01.CIR.0000047276.52039.FB; Cominacini L, 2000, J BIOL CHEM, V275, P12633, DOI 10.1074/jbc.275.17.12633; GRIENDLING KK, 1994, CIRC RES, V74, P1141; Besler C, 2011, J CLIN INVEST, V121, P2693, DOI 10.1172/JCI42946; Aoyama T, 1999, BIOCHEM J, V339, P177, DOI 10.1042/0264-6021:3390177; Babnigg G, 2003, J BIOL CHEM, V278, P14872, DOI 10.1074/jbc.M210418200; Daugherty A, 2004, CIRCULATION, V110, P3849, DOI 10.1161/01.CIR.0000150540.54220.C4; Haendeler J, 2000, CIRC RES, V86, P729; Hermanz-Falcón P, 2001, Immunogenetics, V53, P288; Iwamoto S, 2011, J ATHEROSCLER THROMB, V18, P818; Jing Q, 1999, CIRC RES, V84, P831; Kusuhara M, 1997, ARTERIOSCL THROM VAS, V17, P141; Lanctot PM, 2005, BIOCHEM J, V390, P367, DOI 10.1042/BJ20059189; Miura SI, 2008, MOL ENDOCRINOL, V22, P139, DOI 10.1210/me.2007-0312; Morawietz H, 1999, CIRCULATION, V100, P899; Nickenig G, 2002, CIRCULATION, V105, P530, DOI 10.1161/hc0402.102619; Rozenfeld R, 2010, TRENDS PHARMACOL SCI, V31, P124, DOI 10.1016/j.tips.2009.11.008; Tanigawa H, 2006, HYPERTENSION, V48, P294, DOI 10.1161/01.HYP.0000229825.98545.5e; Tanigawa H, 2006, ATHEROSCLEROSIS, V188, P245, DOI 10.1016/j.atherosclerosis.2005.10.046; Wang XW, 2014, CARDIOVASC DRUG THER, V28, P441, DOI 10.1007/s10557-014-6541-x; WEISSER B, 1992, ARTERIOSCLER THROMB, V12, P231	51	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3342	3356		10.1096/fj.15-271627		15	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	WOS:000358796900022		
J	Buras, ED; Yang, LN; Saha, P; Kim, J; Mehta, P; Yang, YS; Hilsenbeck, S; Kojima, H; Chen, WH; Smith, CW; Chan, L				Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Mehta, Pooja; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Smith, C. Wayne; Chan, Lawrence			Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice	FASEB JOURNAL			English	Article						inflammation; obesity; diabetes; glucose	NECROSIS-FACTOR-ALPHA; DIET-INDUCED OBESITY; TNF-ALPHA; ADIPOCYTE DEATH; BETA-CELLS; EXPRESSION; INFLAMMATION; NEUROPATHY; SENSITIVITY; FUSION	Adipose tissue macrophages (ATMs) play an important role in the pathogenesis of obese type 2 diabetes. High-fat diet (HFD)-induced obesity has been shown to lead to ATM accumulation in rodents; however, the impact of hyperglycemia on ATMdynamics in HFD-fed type 2 diabetic models has not been studied. We previously showed that hyperglycemia induces the appearance of proinsulin (PI)-producing proinflammatory bone marrow (BM)-derived cells (PI-BMDCs) in rodents. We fed a 60% HFD to C57BL6/J mice to produce an obese type 2 diabetes model. Absent in chow-fed animals, PI-BMDCs account for 60% of the ATMs in the type 2 diabetic mice. The PI-ATM subset expresses TNF-alpha and other inflammatory markers, and is highly enriched within crownlike structures (CLSs). We found that amelioration of hyperglycemia by different hypoglycemic agents forestalled PI-producing ATM accumulation and adipose inflammation in these animals. We developed a diphtheria toxin receptor-based strategy to selectively ablate PI-BMDCs among ATMs. Application of the maneuver in HFD-fed type 2 diabetic mice was found to lead to near total disappearance of complex CLSs and reversal of insulin resistance and hepatosteatosis in these animals. In sum, we have identified a novel ATM subset in type 2 diabetic rodents that underlies systemic insulin resistance.-Buras, E. D., Yang, L., Saha, P., Kim, J., Mehta, P., Yang, Y., Hilsenbeck, S., Kojima, H., Chen, W., Smith, C. W., Chan, L. Proinsulin-producing, hyperglycemia-induced adipose tissue macrophages underlie insulin resistance in high fat-fed diabetic mice.	[Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Chan, Lawrence] Baylor Coll Med, Dept Med, Houston, TX 77030 USA; [Buras, Eric Dale; Yang, Lina; Saha, Pradip; Kim, Jongoh; Yang, Yisheng; Hilsenbeck, Susan; Kojima, Hideto; Chen, Wenhao; Chan, Lawrence] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Mehta, Pooja; Smith, C. Wayne] USDA, Childrens Nutr Res Ctr, Houston, TX USA; [Kojima, Hideto] Shiga Univ Med Sci, Dept Stem Cell Biol & Regenerat Med, Otsu, Shiga 52021, Japan	Chan, L (reprint author), Baylor Coll Med, Diabet Res Ctr, R614,One Baylor Plaza, Houston, TX 77030 USA.	lchan@bcm.edu			U.S. National Institutes of Health (NIH) [National Heart, Lung and Blood Institute (NHLBI)] [R01-HL51586]; Diabetes Research Center [P30-DK079638]; Core Laboratories at Baylor College of Medicine; Betty Rutherford Chair in Diabetes Research at Baylor St. Luke's Medical Center (Houston, TX, USA); Frank and Cindy Liu Family Foundation; Cunningham (Chris, Casey and Jennifer) Family Foundation; T.T. & W.F. Chao Global Foundation; American Diabetes Association [1-14-MN-01]; NIH NHLBI training Grant [T32-HL66991]; Medical Scientist Training Program at Baylor College of Medicine; U.S. National Institutes of Health (NIH) (National Institute of Diabetes and Digestive and Kidney Diseases) [DK105527]	The authors acknowledge Vishal Kaila and Shinasuki Kusui for help with experiments, Vijay Yechoor for advice on experiments and provision of MIP-GFP mice, and Herbert Virgin for provision of iDTR mice. In addition, the authors thank Dr. Benny Hung-Junn Chang and Dr. Christina Camell for advice on experiments, and Sand Yu-Chih Ku and Leslie Wu for administrative help. This work was supported by the U.S. National Institutes of Health (NIH) Grants R01-HL51586 [National Heart, Lung and Blood Institute (NHLBI)] and DK105527 (National Institute of Diabetes and Digestive and Kidney Diseases) to L.C., the Diabetes Research Center (P30-DK079638) and its Core Laboratories at Baylor College of Medicine, the Betty Rutherford Chair in Diabetes Research at Baylor St. Luke's Medical Center (Houston, TX, USA), the Frank and Cindy Liu Family Foundation, the Cunningham (Chris, Casey and Jennifer) Family Foundation, the T.T. & W.F. Chao Global Foundation, and the American Diabetes Association (Grant 1-14-MN-01) to L.C. J.K. was supported by a NIH NHLBI training Grant T32-HL66991, and E.B. was supported by the Medical Scientist Training Program at Baylor College of Medicine. The authors declare no competing financial interests.	Gerner RR, 2013, CAN J PHYSIOL PHARM, V91, P867, DOI 10.1139/cjpp-2013-0050; Brake DK, 2006, AM J PHYSIOL-CELL PH, V291, pC1232, DOI 10.1152/ajpcell.00008.2006; Vandanmagsar B, 2011, NAT MED, V17, P179, DOI 10.1038/nm.2279; De Taeye BM, 2007, AM J PHYSIOL-ENDOC M, V293, pE713, DOI 10.1152/ajpendo.00194.2007; Saberi M, 2009, CELL METAB, V10, P419, DOI 10.1016/j.cmet.2009.09.006; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Saha PK, 2010, J BIOL CHEM, V285, P40581, DOI 10.1074/jbc.M110.176545; Ferrannini E, 2014, J CLIN INVEST, V124, P499, DOI 10.1172/JCI72227; Westcott DJ, 2009, J EXP MED, V206, P3143, DOI 10.1084/jem.20091333; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Parathath S, 2011, DIABETES, V60, P1759, DOI 10.2337/db10-0778; Xu XY, 2013, CELL METAB, V18, P816, DOI 10.1016/j.cmet.2013.11.001; Yong J, 2011, DIABETES, V60, P1383, DOI 10.2337/db10-0907; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI2000319246; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Hara M, 2003, AM J PHYSIOL-ENDOC M, V284, pE177, DOI 10.1152/ajpendo.00321.2002; Apovian CM, 2008, ARTERIOSCL THROM VAS, V28, P1654, DOI 10.1161/ATVBAHA.108.170316; Kojima H, 2014, TRENDS ENDOCRIN MET, V25, P178, DOI 10.1016/j.tem.2014.01.002; Patsouris D, 2008, CELL METAB, V8, P301, DOI 10.1016/j.cmet.2008.08.015; Merovci A, 2014, J CLIN INVEST, V124, P509, DOI 10.1172/JCI70704; Cinti S, 2005, J LIPID RES, V46, P2347, DOI 10.1194/jlr.M500294-JLR200; Ehrenkranz JRL, 2005, DIABETES-METAB RES, V21, P31, DOI 10.1002/dmrr.532; Fujisaka S, 2009, DIABETES, V58, P2574, DOI 10.2337/db08-1475; Gonzalez F, 2006, J ENDOCRINOL, V188, P521, DOI 10.1677/joe.1.06579; Lumeng CN, 2008, DIABETES, V57, P3239, DOI 10.2337/db08-0872; Aljada A, 2006, METABOLISM, V55, P1177, DOI 10.1016/j.metabol.2006.04.016; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Buch T, 2005, NAT METHODS, V2, P419, DOI 10.1038/NMETH762; GARVEY WT, 1985, DIABETES, V34, P222, DOI 10.2337/diabetes.34.3.222; Nagareddy PR, 2013, CELL METAB, V17, P695, DOI 10.1016/j.cmet.2013.04.001; Katagi M, 2014, FEBS LETT, V588, P1080, DOI 10.1016/j.febslet.2014.02.030; ROSSETTI L, 1987, J CLIN INVEST, V79, P1510, DOI 10.1172/JCI112981; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Xu HY, 2002, DIABETES, V51, P1876, DOI 10.2337/diabetes.51.6.1876; Cancello R, 2006, DIABETES, V55, P1554, DOI 10.2337/db06-0133; Chang WT, 2012, FOOD CHEM, V134, P972, DOI 10.1016/j.foodchem.2012.03.002; Dandona P, 2009, J AM COLL CARDIOL, V53, pS14, DOI 10.1016/j.jacc.2008.10.038; Dasu MR, 2011, AM J PHYSIOL-ENDOC M, V300, pE145, DOI 10.1152/ajpendo.00490.2010; Fujimiya M, 2007, P NATL ACAD SCI USA, V104, P4030, DOI 10.1073/pnas.0700220104; Kojima H, 2004, P NATL ACAD SCI USA, V101, P2458, DOI 10.1073/pnas.0308690100; Kratz M, 2014, CELL METAB, V20, P614, DOI 10.1016/j.cmet.2014.08.010; Odegaard JI, 2013, CELL METAB, V18, P767, DOI 10.1016/j.cmet.2013.11.011; Terashima T, 2012, FASEB J, V26, P295, DOI 10.1096/fj.11-186262; Terashima T, 2005, P NATL ACAD SCI USA, V102, P12525, DOI 10.1073/pnas.0505717102; Urabe H, 2015, DIABETOLOGIA, V58, P402, DOI 10.1007/s00125-014-3440-4; Yoon J, 2011, DIABETOLOGIA, V54, P1252, DOI 10.1007/s00125-011-2055-2; Zhang HH, 2001, J CLIN ENDOCR METAB, V86, P2817, DOI 10.1210/jc.86.6.2817	48	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2015	29	8					3537	3548		10.1096/fj.15-271452		12	Biochemistry & Molecular Biology; Biology; Cell Biology	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	CN9VA	WOS:000358796900039		
J	Shirakihara, Y; Shiratori, A; Tanikawa, H; Nakasako, M; Yoshida, M; Suzuki, T				Shirakihara, Yasuo; Shiratori, Aya; Tanikawa, Hiromi; Nakasako, Masayoshi; Yoshida, Masasuke; Suzuki, Toshiharu			Structure of a thermophilic F-1-ATPase inhibited by an epsilon-subunit: deeper insight into the epsilon-inhibition mechanism	FEBS JOURNAL			English	Article						F-1 from thermophilic bacterium; F-1-ATPase; second catch; epsilon-inhibition; epsilon-subunit	BOVINE HEART-MITOCHONDRIA; YEAST F-1 ATPASE; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; TERMINAL DOMAIN; CONFORMATIONAL-CHANGES; CATALYTIC MECHANISM; DIFFRACTION DATA; DELSEED MOTIF; GAMMA-SUBUNIT	F-1-ATPase (F-1) is the catalytic sector in FoF1-ATP synthase that is responsible for ATP production in living cells. In catalysis, its three catalytic -subunits undergo nucleotide occupancy-dependent and concerted open-close conformational changes that are accompanied by rotation of the -subunit. Bacterial and chloroplast F-1 are inhibited by their own epsilon-subunit. In the epsilon-inhibited Escherichiacoli F-1 structure, the epsilon-subunit stabilizes the overall conformation (half-closed, closed, open) of the -subunits by inserting its C-terminal helix into the (33) cavity. The structure of epsilon-inhibited thermophilic F-1 is similar to that of E.coli F-1, showing a similar conformation of the epsilon-subunit, but the thermophilic epsilon-subunit stabilizes another unique overall conformation (open, closed, open) of the -subunits. The epsilon-C-terminal helix2 and hook are conserved between the two structures in interactions with target residues and in their positions. Rest of the epsilon-C-terminal domains are in quite different conformations and positions, and have different modes of interaction with targets. This region is thought to serve epsilon-inhibition differently. For inhibition, the epsilon-subunit contacts the second catches of some of the - and -subunits, the N- and C-terminal helices, and some of the Rossmann fold segments. Those contacts, as a whole, lead to positioning of those - and - second catches in epsilon-inhibition-specific positions, and prevent rotation of the -subunit. Some of the structural features are observed even in IF1 inhibition in mitochondrial F-1. DatabaseStructural data are available in the Worldwide Protein Data Bank database under the accession number	[Shirakihara, Yasuo; Shiratori, Aya; Tanikawa, Hiromi] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Nakasako, Masayoshi] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan; [Yoshida, Masasuke; Suzuki, Toshiharu] Tokyo Inst Technol, Chem Resources Lab, Yokohama, Kanagawa 227, Japan; [Yoshida, Masasuke; Suzuki, Toshiharu] Japan Sci & Technology Corp JST, ERATO, Yokohama, Kanagawa, Japan	Shirakihara, Y (reprint author), Natl Inst Genet, Mishima, Shizuoka 4118540, Japan.	yshiraki@nig.ac.jp			MEXT	We thank Drs Andrew G.W. Leslie, Liang Tong, Eiro Muneyuki and Atsushi Nakagawa for helpful suggestions. We thank the beamline staff at SP-ring 8 (BL44XU, BL41XU) and Photon Factory (BL6A) for help in data collection. A financial support was provided by MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2011-2016.	ABRAHAMS JP, 1994, NATURE, V370, P621, DOI 10.1038/370621a0; AGGELER R, 1995, J BIOL CHEM, V270, P9185; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Bowler MW, 2007, J BIOL CHEM, V282, P14238, DOI 10.1074/jbc.M700203200; Kabaleeswaran V, 2006, EMBO J, V25, P5433, DOI 10.1038/sj.emboj.7601410; Cingolani G, 2011, NAT STRUCT MOL BIOL, V18, P701, DOI 10.1038/nsmb.2058; Hara KY, 2001, J BIOL CHEM, V276, P23969, DOI 10.1074/jbc.M009303200; Tong L, 1997, METHOD ENZYMOL, V276, P594, DOI 10.1016/S0076-6879(97)76080-4; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KRAULIS PJ, 1991, J APPL CRYSTALLOGR, V24, P946, DOI 10.1107/S0021889891004399; Kabaleeswaran V, 2009, J BIOL CHEM, V284, P10546, DOI 10.1074/jbc.M900544200; WILKENS S, 1995, NAT STRUCT BIOL, V2, P961, DOI 10.1038/nsb1195-961; Urzhumtseva L, 2009, ACTA CRYSTALLOGR D, V65, P297, DOI 10.1107/S0907444908044296; Gibbons C, 2000, NAT STRUCT BIOL, V7, P1055; Yagi H, 2007, P NATL ACAD SCI USA, V104, P11233, DOI 10.1073/pnas.0701045104; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Dautant A, 2010, J BIOL CHEM, V285, P29502, DOI 10.1074/jbc.M110.124529; Yoshida M, 2001, NAT REV MOL CELL BIO, V2, P669, DOI 10.1038/35089509; Menz RI, 2001, CELL, V106, P331, DOI 10.1016/S0092-8674(01)00452-4; Rodgers AJW, 2000, NAT STRUCT BIOL, V7, P1051; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1; Stocker A, 2007, STRUCTURE, V15, P904, DOI 10.1016/j.str.2007.06.009; Tsunoda SP, 2001, P NATL ACAD SCI USA, V98, P6560, DOI 10.1073/pnas.111128098; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; Aggeler R, 1996, J BIOL CHEM, V271, P13888; Noji H, 1997, NATURE, V386, P299, DOI 10.1038/386299a0; Sekiya M, 2010, J BIOL CHEM, V285, P42058, DOI 10.1074/jbc.M110.176701; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Brunger AT, 1992, XPLOR VERSION 3 1 MA; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; Doublie S, 1992, CRYSTALLIZATION NUCL, P311; Feniouk BA, 2006, BBA-BIOENERGETICS, V1757, P326, DOI 10.1016/j.bbabio.2006.03.022; Hara KY, 2000, J BIOL CHEM, V275, P14260, DOI 10.1074/jbc.275.19.14260; Hausrath AC, 2001, J BIOL CHEM, V276, P47227, DOI 10.1074/jbc.M107536200; HISABORI T, 1992, J BIOL CHEM, V267, P4551; Kato Y, 1997, J BIOL CHEM, V272, P24906, DOI 10.1074/jbc.272.40.24906; Kato-Yamada Y, 2000, J BIOL CHEM, V275, P35746, DOI 10.1074/jbc.M006575200; LAGET PP, 1979, ARCH BIOCHEM BIOPHYS, V197, P83, DOI 10.1016/0003-9861(79)90222-4; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie AGW, 2007, NATO SCI SER II MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; LESLIE AGW, 1984, J MOL BIOL, V178, P743, DOI 10.1016/0022-2836(84)90250-X; Nakanishi-Matsui M, 2014, J BIOL CHEM, V289, P30822, DOI 10.1074/jbc.M114.578872; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Riboldi Tunnicliffe A, 1999, J APPL CRYSTALLOGR, V32, P1003; Saita E, 2010, J BIOL CHEM, V285, P11441; Shirakihara Y, 1997, STRUCTURE, V5, P825, DOI 10.1016/S0969-2126(97)00236-0; Suzuki T, 2003, J BIOL CHEM, V278, P46840, DOI 10.1074/jbc.M307165200; Suzuki T, 2000, J BIOL CHEM, V275, P37902, DOI 10.1074/jbc.M007075200; Uhlin U, 1997, STRUCTURE, V5, P1219, DOI 10.1016/S0969-2126(97)00272-4; Weber J, 1997, BBA-BIOENERGETICS, V1319, P19, DOI 10.1016/S0005-2728(96)00121-1; YOSHIDA M, 1975, J BIOL CHEM, V250, P7910; YOSHIDA M, 1986, J BIOL CHEM, V261, P5714	55	4	4	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	AUG	2015	282	15					2895	2913		10.1111/febs.13329		19	Biochemistry & Molecular Biology	Biochemistry & Molecular Biology	CO0KS	WOS:000358840500008		
J	Yamasaki, M; Araki, K; Maruyoshi, K; Matsumoto, M; Nakayasu, C; Moritomo, T; Nakanishi, T; Yamamoto, A				Yamasaki, Masatoshi; Araki, Kyosuke; Maruyoshi, Kota; Matsumoto, Megumi; Nakayasu, Chihaya; Moritomo, Tadaaki; Nakanishi, Teruyuki; Yamamoto, Atsushi			Comparative analysis of adaptive immune response after vaccine trials using live attenuated and formalin-killed cells of Edwardsiella tarda in ginbuna crucian carp (Carassius auratus langsdorfii)	FISH & SHELLFISH IMMUNOLOGY			English	Article						Edwardsiella tarda; Vaccine; Cell-mediated immunity; Ginbuna crucian carp; Th1/Th2 balance	JAPANESE FLOUNDER; T-CELLS; PARALICHTHYS-OLIVACEUS; ACTIVATED MACROPHAGES; EXPRESSION ANALYSIS; CYTOKINE PRODUCTION; EEL NEUTROPHILS; IL-10; STRAINS; FISH	Edwardsiella tarda is an intracellular pathogen that causes edwardsiellosis in fish. Although vaccine trials with formalin-killed cells (FKC) have been reported, the vaccinations failed in protect against E. tarda infection. On the other hand, a live attenuated vaccine strategy is effective against edwardsiellosis; however, the mechanism underlying its effectiveness in fish is unclear. In the present study, we compared the adaptive immune responses in fish vaccinated with FKCs and live attenuated vaccines to elucidate the induction of adaptive immune responses following vaccination. After challenge with E. tarda, live cell (LC)-vaccinated fish showed high survival rates, high IFN-g and T-bet gene expression levels, and increased cytotoxic T lymphocytes (CTLs). In contrast, all FKC-vaccinated fish died following E. tarda infection. In addition, FKC vaccination induced high IL-4/13A and IL-10 expression levels and increased antibody titers, whereas Thl-like responses were suppressed. These results indicate that LC vaccination contributes to protection against E. tarda infection by inducing cell-mediated immunity (CMI). Thus our study findings could contribute to the development a vaccine that induces CMI against edwardsiellosis. (C) 2015 Elsevier Ltd. All rights reserved.	[Yamasaki, Masatoshi] Kagoshima Univ, United Grad Sch Agr Sci, Kagoshima 8908580, Japan; [Araki, Kyosuke; Maruyoshi, Kota; Matsumoto, Megumi; Yamamoto, Atsushi] Kagoshima Univ, Fac Fisheries, Kagoshima 8900056, Japan; [Nakayasu, Chihaya] Natl Res Inst Aquaculture, Fisheries Res Agcy, Minamiise, Mie 5160193, Japan; [Moritomo, Tadaaki; Nakanishi, Teruyuki] Nihon Univ, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Araki, K (reprint author), Kagoshima Univ, Fac Fisheries, 4-50-20 Shimoarata, Kagoshima 8900056, Japan.	araki@fish.kagoshima-u.ac.jp			JSPS KAKENHI [25450305]	We thank Dr. Takaji Iida for supplying the E. tarda strain. This work was supported by JSPS KAKENHI Grant number 25450305.	Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Kato G, 2012, FISH SHELLFISH IMMUN, V33, P243, DOI 10.1016/j.fsi.2012.05.002; Toda H, 2011, DEV COMP IMMUNOL, V35, P650, DOI 10.1016/j.dci.2011.01.013; Ishibe K, 2008, FISH SHELLFISH IMMUN, V24, P243, DOI 10.1016/j.fsi.2007.11.001; Ling SHM, 2000, MICROBIOL-UK, V146, P7; Yamasaki M, 2013, VET IMMUNOL IMMUNOP, V153, P83, DOI 10.1016/j.vetimm.2013.02.004; Toda H, 2009, DEV COMP IMMUNOL, V33, P646, DOI 10.1016/j.dci.2008.11.008; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Rao PSS, 2001, INFECT IMMUN, V69, P5689, DOI 10.1128/IAI.69.9.5689-5697.2001; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Redpath S, 2001, TRENDS MICROBIOL, V9, P86, DOI 10.1016/S0966-842X(00)01919-3; Kato G, 2010, DEV COMP IMMUNOL, V34, P133, DOI 10.1016/j.dci.2009.08.013; Araki K, 2013, FISHERIES SCI, V79, P213, DOI 10.1007/s12562-012-0590-5; Chettri J.K., 2013, J FISH DIS, V10, P1111; FIORENTINO DF, 1991, J IMMUNOL, V146, P3444; GAZZINELLI RT, 1992, J IMMUNOL, V148, P1792; Hastings T. S., 1988, Fish vaccination., P93; Igarashi A, 2002, FISH PATHOL, V37, P145; IIDA T, 1993, FISH PATHOL, V28, P191; IIDA T, 1993, FISH PATHOL, V28, P49; Klesius PH, 1999, ADV VETER MED AP, V41, P523; LaFrentz B.R., 2011, VET MICROBIOL, V28, P346; Marsden M.J., 1996, INFECT IMMUNE, V64, P3843; Moral CH, 1998, INFECT IMMUN, V66, P1813; REED L. J., 1938, AMER JOUR HYG, V27, P493; Nakamura T, 1997, J IMMUNOL, V158, P1085; Nakanishi T, 2011, DEV COMP IMMUNOL, V35, P1317, DOI 10.1016/j.dci.2011.03.033; Neild AL, 2004, CELL MICROBIOL, V6, P1011, DOI 10.1111/j.1462-5822.2004.00450.x; Parmer E. G., 2004, NAT REV IMMUNOL, V4, P812; Pasnik DJ, 2006, FISH SHELLFISH IMMUN, V21, P365, DOI 10.1016/j.fsi.2006.01.001; PLUMB JA, 1990, DEV COMP IMMUNOL, V14, P355, DOI 10.1016/0145-305X(90)90026-B; Reece ST, 2008, INT J MED MICROBIOL, V298, P143, DOI 10.1016/j.ijmm.2007.07.004; Salati F., 1983, Fish Pathology, V18, P135; Takano T, 2010, FISH SHELLFISH IMMUN, V29, P687, DOI 10.1016/j.fsi.2010.07.012; Takizawa F, 2008, DEV COMP IMMUNOL, V32, P898, DOI 10.1016/j.dci.2008.01.004; Takizawa F, 2008, MOL IMMUNOL, V45, P127, DOI 10.1016/j.molimm.2007.05.005; Yamasaki M, 2014, FISH SHELLFISH IMMUN, V36, P299, DOI 10.1016/j.fsi.2013.11.016	37	1	1	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	AUG	2015	45	2					437	442		10.1016/j.fsi.2015.04.038		6	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CN7PP	WOS:000358626800027		
J	Thanasaksiri, K; Hirono, I; Kondo, H				Thanasaksiri, Kittipong; Hirono, Ikuo; Kondo, Hidehiro			Temperature-dependent regulation of gene expression in poly (I:C)-treated Japanese flounder, Paralichthys olivaceus	FISH & SHELLFISH IMMUNOLOGY			English	Article						Temperature; Poly (I:C); Japanese flounder; Microarray	VIRAL HEMORRHAGIC SEPTICEMIA; TURBOT SCOPHTHALMUS-MAXIMUS; IMMUNE-RELEVANT GENES; GADUS-MORHUA SPLEEN; ATLANTIC COD; SIGNALING PATHWAY; WATER TEMPERATURE; MOLECULAR-CLONING; YERSINIA-RUCKERI; OLIVE FLOUNDER	Gene expression profiling of poly (I:C)-treated Japanese flounder, Paralichthys olivaceus, under different temperatures was investigated using microarray analysis. The response was analyzed in spleen tissue at 3 and 24 h post injection (hpi) at 15 degrees C and 25 degrees C. A large number of genes in fish treated with poly (I:C) at 25 degrees C were expressed at 3 hpi, whereas the expression profiles at 24 hpi appeared to be similar to those of the controls. Cluster analysis of the different expression profiles showed three distinct groups of up-regulated genes in fish reared at 15 degrees C. These were early (3 hpi), early-to-late (3 and 24 hpi), and late (24 hpi) up-regulated genes. These genes included type I IFN-related genes and inflammatory genes. Among the up-regulated genes, most of the type I IFN-related genes played early-to-late- and late-responding genes at 15 degrees C but early-responding genes at 25 degrees C. Thus, several up-regulated genes in these groups from the microarray result were further verified by qPCR. These results indicate that the type I IFN gene expressions of P. olivaceus treated with poly (I:C) can be regulated in a temperature-dependent manner. (C) 2015 Elsevier Ltd. All rights reserved.	[Thanasaksiri, Kittipong; Hirono, Ikuo; Kondo, Hidehiro] Tokyo Univ Marine Sci & Technol, Grad Sch, Lab Genome Sci, Minato Ku, Tokyo 1088477, Japan	Kondo, H (reprint author), Tokyo Univ Marine Sci & Technol, Grad Sch, Lab Genome Sci, Minato Ku, Konan 4-5-7, Tokyo 1088477, Japan.	h-kondo@kaiyodai.ac.jp	KONDO, Hidehiro/O-1954-2014; HIRONO, Ikuo/O-1940-2014	KONDO, Hidehiro/0000-0001-5102-6831; 	JSPS; JSPS Asian Core University Program; Japanese Government (Monbukagakusho: MEXT) Scholarship	This work was supported in part by grants from JSPS Grant-in-Aid for Young Scientists (B), JSPS Asian Core University Program, and a Japanese Government (Monbukagakusho: MEXT) Scholarship.	Panopoulos AD, 2008, CYTOKINE, V42, P277, DOI 10.1016/j.cyto.2008.03.002; Burnside J, 2005, BMC GENOMICS, V6, DOI 10.1183/1471-2164-6-13; Zheng WB, 2006, FISH SHELLFISH IMMUN, V21, P414, DOI 10.1016/j.fsi.2006.01.006; Takano T, 2007, MOL IMMUNOL, V44, P1845, DOI 10.1016/j.molimm.2006.10.018; Murray PJ, 2007, J IMMUNOL, V178, P2623; Dumrongphol Y, 2009, FISH SHELLFISH IMMUN, V26, P197, DOI 10.1016/j.fsi.2008.03.014; Ndong D, 2007, FISH SHELLFISH IMMUN, V22, P686, DOI 10.1016/j.fsi.2006.08.015; Skjesol A, 2014, DEV COMP IMMUNOL, V45, P177, DOI 10.1016/j.dci.2014.02.009; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Darawiroj D, 2008, FISH SHELLFISH IMMUN, V24, P260, DOI 10.1016/j.fsi.2007.07.011; Magnadottir B, 1999, COMP BIOCHEM PHYS B, V122, P181, DOI 10.1016/S0305-0491(98)10157-8; Dios S, 2010, FISH SHELLFISH IMMUN, V29, P1019, DOI 10.1016/j.fsi.2010.08.006; Rawlings JS, 2004, J CELL SCI, V117, P1281, DOI 10.1242/jcs.00963; Ohtani M, 2012, DEV COMP IMMUNOL, V36, P697, DOI 10.1016/j.dci.2011.10.008; Liu Y, 2008, INVEST OPHTH VIS SCI, V49, P3336, DOI 10.1167/iovs.07-0972; Svingerud T, 2012, J IMMUNOL, V189, P5912, DOI 10.4049/jimmunol.1201188; Caipang CMA, 2003, VIROLOGY, V317, P373, DOI 10.1016/j.virol.2003.08.040; Kurobe T, 2005, DEV COMP IMMUNOL, V29, P515, DOI 10.1016/j.dci.2004.10.005; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093; Fiorini E, 2002, MOL CELL, V9, P637, DOI 10.1016/S1097-2765(02)00469-0; Li DM, 2012, GENE, V504, P31, DOI 10.1016/j.gene.2012.04.091; Zou J, 2011, DEV COMP IMMUNOL, V35, P1376, DOI 10.1016/j.dci.2011.07.001; Lorenzen E, 2009, VACCINE, V27, P3870, DOI 10.1016/j.vaccine.2009.04.012; Yu FF, 2010, MOL IMMUNOL, V47, P2330, DOI 10.1016/j.molimm.2010.05.282; Yasuike M, 2007, FISH SHELLFISH IMMUN, V23, P531, DOI 10.1016/j.fsi.2006.12.006; Perez-Casanova JC, 2008, FISH SHELLFISH IMMUN, V24, P600, DOI 10.1016/j.fsi.2008.01.012; Rise ML, 2008, DEV COMP IMMUNOL, V32, P916, DOI 10.1016/j.dci.2008.01.002; Salinas I, 2004, FISH SHELLFISH IMMUN, V17, P159, DOI 10.1016/j.fsi.2004.01.003; Fagutao FE, 2012, FISH SHELLFISH IMMUN, V32, P711, DOI 10.1016/j.fsi.2012.01.018; Avunje S, 2013, FISH SHELLFISH IMMUN, V34, P1236, DOI 10.1016/j.fsi.2013.02.012; Thanasaksiri K, 2014, FISH SHELLFISH IMMUN, V40, P441, DOI 10.1016/j.fsi.2014.07.035; Raida MK, 2007, DIS AQUAT ORGAN, V77, P41, DOI 10.3354/dao01808; MacKinnon KM, 2009, VET IMMUNOL IMMUNOP, V130, P210, DOI 10.1016/j.vetimm.2009.02.013; Raida MK, 2008, VACCINE, V26, P1050, DOI 10.1016/j.vaccine.2007.12.029; Honda K, 2006, IMMUNITY, V25, P349, DOI 10.1016/j.immuni.2006.08.009; Sun BJ, 2009, DEV COMP IMMUNOL, V33, P547, DOI 10.1016/j.dci.2008.10.001; CASTRIC J, 1984, AQUACULTURE, V41, P203, DOI 10.1016/0044-8486(84)90283-7; Cheng W, 2012, AQUACULTURE, V324, P201, DOI 10.1016/j.aquaculture.2011.10.032; Fernandez-Trujillo A, 2008, FISH SHELLFISH IMMUN, V24, P279, DOI 10.1016/j.fsi.2007.11.008; Grant EC, 2003, J AQUAT ANIM HEALTH, V15, P215, DOI 10.1577/H03-009; Hikima J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051522; Hori TS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-431; Hu GB, 2011, DEV COMP IMMUNOL, V35, P164, DOI 10.1016/j.dci.2010.09.003; Kondo H, 2014, FISH SHELLFISH IMMUN, V41, P437, DOI 10.1016/j.fsi.2014.09.038; Lin CH, 2006, BIOCHEM BIOPH RES CO, V351, P534, DOI 10.1016/j.bbrc.2006.10.063; Lin OE, 2005, DEV COMP IMMUNOL, V29, P443, DOI 10.1016/j.dci.2004.10.003; Nie L, 2014, DEV COMP IMMUNOL, V43, P23, DOI 10.1016/j.dci.2013.10.007; Park EM, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-31; Pereiro P, 2014, DEV COMP IMMUNOL, V45, P233, DOI 10.1016/j.dci.2014.03.006; Pettersen EF, 2005, VET IMMUNOL IMMUNOP, V106, P65, DOI 10.1016/j.vetimm.2005.01.001; Polinski M, 2013, FISH SHELLFISH IMMUN, V34, P1147, DOI 10.1016/j.fsi.2013.01.026; Sano M, 2009, AQUACULTURE, V286, P254, DOI 10.1016/j.aquaculture.2008.09.031; Santos MD, 2006, IMMUNOGENETICS, V58, P422, DOI 10.1007/s00251-006-0106-5; Schuster M, 2013, CELL COMMUN SIGNAL, V11, DOI 10.1186/1478-811X-11-23; Stowell NC, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-43	55	0	0	ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD	LONDON	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND	1050-4648	1095-9947		FISH SHELLFISH IMMUN	Fish Shellfish Immunol.	AUG	2015	45	2					835	840		10.1016/j.fsi.2015.05.036		6	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	Fisheries; Immunology; Marine & Freshwater Biology; Veterinary Sciences	CN7PP	WOS:000358626800072		
J	Ishibashi, M				Ishibashi, Masahiro			Discharge coefficient equation for critical-flow toroidal-throat venturi nozzles covering the boundary-layer transition regime	FLOW MEASUREMENT AND INSTRUMENTATION			English	Article						Critical flow Venturi nozzle; Gas flow standard; Boundary-layer transition; Discharge coefficient; Core flow distribution; Transonic flow		A single, simple correlating equation between the discharge coefficient of critical-flow Venturi nozzles (CFVNs) having an ISO 9300 toroidal throat and their Reynolds number is proposed in the Reynolds number range from 2.1 x 10(4) to 3.2 x 10(7). The equation covers the whole Reynolds number range from laminar to turbulent boundary-layer regimes and can thus be used instead of the two correlating equations defined in ISO 9300 : 2005. The deviation of the discharge coefficients of well-made CFVNs is expected to be less than +/- 0.2% throughout the Reynolds number range. Tolerances for the diffuser length, inlet curvature and inlet diameter are also proposed. It is shown that the widely-accepted theories that estimate the core flow distribution result in significant error when the inlet curvature is small and that removing the third term in Hall's equation results in very good agreement with the experimental data regardless of the magnitude of the inlet curvature. The use of CFVNs with the inlet curvature of 1.0D is discussed in order to reduce the uncertainty owing to undefined boundary-layer transition Reynolds number. A possibility is shown that such a CFVN may not have an apparent boundary-layer transition in the investigated Reynolds number range from 1.5 x 10(4) to 2.0 x 10(6). (C) 2014 Elsevier Ltd. All rights reserved.	Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Gas Flow Stand Sect, Fluid Flow Div, Tsukuba, Ibaraki 3058563, Japan	Ishibashi, M (reprint author), Natl Inst Adv Ind Sci & Technol, Natl Metrol Inst Japan, Gas Flow Stand Sect, Fluid Flow Div, Umezono 1-1-1, Tsukuba, Ibaraki 3058563, Japan.	ishibashi.m@aist.go.jp					Amberg BT, 1974, ASME J FLUIDS ENG, V96, P111; Amberg BT, 1962, T ASME D, V84, P447; [Anonymous], 2004, 195 ASME PTC; [Anonymous], 2005, 9300 ISO; Arnberg B, 2001, P 47 INT INSTR S; Brain TJS, 1978, FLOW MEASUREMENT FLU, P54; Brain TJS, 1977, P FLOW MEAS MID 1970, P103; BROWN EF, 1985, J FLUID ENG-T ASME, V107, P316; Brown OF, 1985, ASME J FLUIDS ENG, V107, P316; Caron RW, 1996, P ASME FED 239, V4, P415; Dietrich H, 2000, P 10 C FLOW MEAS FLO; Geropp D, 1971, DTSCH LUFT RAUMFAHRT, P71; HALL IM, 1962, Q J MECH APPL MATH, V15, P487, DOI 10.1093/qjmam/15.4.487; Inanaga H, 2000, P NIPP C STAND LAB N; Inanaga H, 2000, P SICE ANN C 2000 SI; Ishibashi M, 1997, P 5 TRIENN INT S FLU; Ishibashi M, 1998, P 1998 NCSL WORKSH S, P423; Ishibashi M, 1994, P FLOW MEAS MID 90S; Ishibashi M, 2001, P 2001 ASME FED SUMM; Ishibashi M, 2001, P ASME FED SUMM M FE; Ishibashi M, 1999, P 4 INT S FLUID FLOW; Ishibashi M, 2006, FLOW MEAS INSTRUM, V17, P153, DOI 10.1016/j.flowmeasinst.2006.01.006; Ishibashi M, 2012, FLOW MEAS INSTRUM, V25, P15, DOI 10.1016/j.flowmeasinst.2011.10.005; Japan Society of Thermophysical Properties, 2008, JAP SOC THERM PROP T; Johnson A, 2006, P 6 INT S FLUID FLOW; Johnson AN, 1998, P NCSL WORKSH S SESS, P407; Johnson AN, 2008, P MEAS SCI C; Matz RJ, 1962, ASME, V84, P434; Matz RJ, 1973, ASME FLUIDS ENG, V95, P542; Mickan B, 2006, P 6 INT S FLUID FLOW; Mickan B, 2007, P 14 C FLOW MEAS FLO; Mickan B, 2004, P 12 C FLOW MEAS FLO; Morrow TB, 2004, P 2004 ASME HEAT TRA; Stevens RL, 1986, P INT S FLUID FLOW M, P73; Stratford BS, 1964, J ROYAL AERONAUTICAL, V68, P237; Szaniszlo AJ, 1975, 07848 TN NASA; Szaniszlo AJ, 1975, T ASME J ENG POWER, P521; Takamoto M, 1993, P 6 INT C FLOW MEAS, P75; von Lavante E, 2004, P 12 C FLOW MEAS FLO; Wendt G, 2000, P 10 C FLOW MEAS FLO	40	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0955-5986	1873-6998		FLOW MEAS INSTRUM	Flow Meas. Instrum.	AUG	2015	44				SI		107	121		10.1016/j.flowmeasinst.2014.11.009		15	Engineering, Mechanical; Instruments & Instrumentation	Engineering; Instruments & Instrumentation	CO5BU	WOS:000359175400014		
J	Ahmed, AS; El-Bassiony, T; Elmalt, LM; Ibrahim, HR				Ahmed, Ahmed S.; El-Bassiony, Tawfik; Elmalt, Laila M.; Ibrahim, Hisham R.			Identification of potent antioxidant bioactive peptides from goat milk proteins	FOOD RESEARCH INTERNATIONAL			English	Article						Goat milk proteins; Antioxidant bioactive peptides; Superoxide scavenging; DPPH scavenging	OXIDATIVE STRESS; IN-VITRO; HYDROLYSATE; CHROMATOGRAPHY; PURIFICATION; CASEINS; BREEDS; OVINE	Goat milk proteins have gained increasing attention especially the bioactive peptides released from the parent proteins by digestive enzymes. Specifically, the interest in bioactives of goat milk is intensifying due to its reduced allergenicity compared to bovine milk. In this study, proteins of goat milk were fractionated into caseins (GCP) and whey proteins (GWP), hydrolyzed by pepsin and the generated peptides were examined for radical scavenging activities. The hydrolysates of whey (P-GWP) and casein (P-GCP) proteins exhibited potent superoxide anion (O-2(.-)) scavenging activity in a dose-dependent manner, as investigated using the natural xanthine/xanthine oxidase (X/XOD) system. The P-GWP and P-GCP dramatically quenched the O-2(.-) flux but had negligible effect on the catalytic function of the enzyme, indicating specificity to scavenge O-2(.-) but not oxidase inhibition. Further, both P-GWP and P-GCP were able to remarkably quench the chemical DPPH radical. Fractionation of hydrolysates by size-exclusion chromatography produced four fractions (F1-F4) from both hydrolysates, with variable O-2(.-) scavenging activities. However, the slow eluting fractions (F4) of both hydrolysates and fast eluting fraction (F2) of P-GCP contained peptides with the highest scavenging activities. Peptides in the active fractions of P-GWP and P-GCP, isolated by reversed phase-HPLC, exhibited significantly strong O-2(.-) scavenging activities. MALDI-TOF-MS allowed the identification of several antioxidant peptides derived from both caseins and whey proteins, with beta-casein and beta-lactoglobulin being the major contributors, respectively. The results demonstrate that digestion with pepsin generates multiple soluble peptides from goat milk protein fractions with remarkable ability to scavenge superoxide radicals and thus providing a fascinating opportunity for their potential candidacy as antioxidant bioactive peptides. (C) 2015 Elsevier Ltd. All rights reserved.	[Ahmed, Ahmed S.; Ibrahim, Hisham R.] Kagoshima Univ, Fac Agr, Dept Biochem & Biotechnol, Kagoshima 8900065, Japan; [Ahmed, Ahmed S.; Elmalt, Laila M.] South Valley Univ, Dept Food Hyg & Control, Fac Vet Med, Qena 83523, Egypt; [El-Bassiony, Tawfik] Assiut Univ, Dept Food Hyg & Control, Fac Vet Med, Assiut 71515, Egypt	Ibrahim, HR (reprint author), Kagoshima Univ, Fac Agr, Dept Biochem & Biotechnol, Kagoshima 8900065, Japan.	hishamri@chem.agri.kagoshima-u.ac.jp			Ministry of High Education, Cairo, Egypt	The author Ahmed S. Ahmed was supported by a joint supervision mission from the Ministry of High Education, Cairo, Egypt.	Silva SV, 2005, INT DAIRY J, V15, P1, DOI 10.1016/j.idairyj.2004.04.009; Urso ML, 2003, TOXICOLOGY, V189, P41, DOI 10.1016/S0300-483X(03)00151-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Correa APF, 2011, J SCI FOOD AGR, V91, P2247, DOI 10.1002/jsfa.4446; Chessex P, 2010, FREE RADICAL BIO MED, V49, P1380, DOI 10.1016/j.freeradbiomed.2010.07.018; Saito K, 2003, J AGR FOOD CHEM, V51, P3668, DOI 10.1021/jf021191n; Almaas H, 2006, INT DAIRY J, V16, P961, DOI 10.1016/j.idairyj.2005.10.029; Mendis E, 2005, J AGR FOOD CHEM, V53, P581, DOI 10.1021/jf048877v; Lee J, 2004, COMPR REV FOOD SCI F, V3, P21, DOI 10.1111/j.1541-4337.2004.tb00058.x; Li Z, 2013, J DAIRY SCI, V96, P4242, DOI 10.3168/jds.2012-6511; Davalos A, 2004, J FOOD PROTECT, V67, P1939; Li B, 2007, FOOD CHEM, V102, P1135, DOI 10.1016/j.foodchem.2006.07.002; Yergey AL, 2002, J AM SOC MASS SPECTR, V13, P784, DOI 10.1016/S1044-0305(02)00393-8; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X; Park PJ, 2001, J AM OIL CHEM SOC, V78, P651, DOI 10.1007/s11746-001-0321-0; Ibrahim HR, 2007, INT J BIOL MACROMOL, V41, P631, DOI 10.1016/j.ijbiomac.2007.08.005; Sarmadi BH, 2010, PEPTIDES, V31, P1949, DOI 10.1016/j.peptides.2010.06.020; BRANDWILLIAMS W, 1995, FOOD SCI TECHNOL-LEB, V28, P25; Hiller B, 2009, FOOD RES INT, V42, P899, DOI 10.1016/j.foodres.2009.04.022; De Gobba C, 2014, INT DAIRY J, V39, P28, DOI 10.1016/j.idairyj.2014.03.015; HALLIWELL B, 1994, LANCET, V344, P721, DOI 10.1016/S0140-6736(94)92211-X; Bahareh HS, 2010, PEPTIDES, V31, P1949; Bezerra VS, 2013, FOOD SCI TECH-BRAZIL, V33, P513, DOI 10.1590/S0101-20612013005000074; Carver JD, 2003, AM J CLIN NUTR, V77, p1550S; Collins AR, 2005, EUR J CANCER, V41, P1923, DOI 10.1016/j.ejca.2005.06.004; FAHMI A. H., 1956, INDIAN JOUR DAIRY SCI, V9, P124; Grosclaude F., 1995, IDF SEM IMPL GEN POL; Haenlein G. F. W., 1992, 5 INT C GOATS NEW DE; Hernandez-Ledesma B, 2005, J AGR FOOD CHEM, V53, P588, DOI 10.1021/jf048626m; Korhonen H, 2007, HDB FOOD PRODUCTS MA, P5; MARTIN P, 1993, LAIT, V73, P511; Miloudi K, 2012, PEDIATR RES, V71, P675, DOI 10.1038/pr.2012.29; Moatsou G, 2005, INT DAIRY J, V15, P123, DOI 10.1016/j.idairyj.2004.06.005; MORAGUTIERREZ A, 1991, J DAIRY SCI, V74, P3303; Nandhini B., 2012, INT J PHARM PHARM SC, V4, P367; Nia R., 2004, African Journal of Biomedical Research, V7, P129; Park Y. W., 2009, BIOACTIVE COMPONENTS, P43, DOI 10.1002/9780813821504.ch3; Park Y. W., 2006, THERAPEUTIC HYPOALLE; Roncada P, 2002, PROTEOMICS, V2, P723, DOI 10.1002/1615-9861(200206)2:6<723::AID-PROT723>3.0.CO;2-I; Simos Y, 2011, INT DAIRY J, V21, P901, DOI 10.1016/j.idairyj.2011.05.007	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0963-9969	1873-7145		FOOD RES INT	Food Res. Int.	AUG	2015	74						80	88		10.1016/j.foodres.2015.04.032		9	Food Science & Technology	Food Science & Technology	CO2FJ	WOS:000358971200008		
J	Lee, YS; Choi, SS; Yonezawa, T; Teruya, T; Woo, JT; Kim, HJ; Cha, BY				Lee, Young-Sil; Choi, Sun-Sil; Yonezawa, Takayuki; Teruya, Toshiaki; Woo, Je-Tae; Kim, Hyo Jung; Cha, Byung-Yoon			Honokiol, magnolol, and a combination of both compounds improve glucose metabolism in high-fat diet-induced obese mice	FOOD SCIENCE AND BIOTECHNOLOGY			English	Article						honokiol; magnolol; combination; high-fat diet-induced obese mouse; glucose metabolism	RETINOID-X-RECEPTOR; PPAR-GAMMA; ADIPOCYTE DIFFERENTIATION; INSULIN SENSITIVITY; CHOLESTEROL EFFLUX; ADIPONECTIN; EXPRESSION; GLUT4; TROGLITAZONE; MACROPHAGES	Honokiol and magnolol are neolignans contained in the Chinese medicinal herb Magnolia officinalis that exert anti-tumor and anti-inflammatory effects. Both compounds have been reported to enhance glucose uptake. Little is known about effects when used in combination. The effects of honokiol, magnolol, and a combination of both compounds on lipid and glucose metabolism in highfat diet-induced obese mice were investigated, and underlying mechanisms were examined. All 3 treatments significantly (p < 0.05) reduced plasma total cholesterol and glucose levels, and improved glucose tolerance, compared with controls. In addition, treatments increased mRNA expression of the peroxisome proliferator-activated receptor (PPAR)-gamma, glucose transporter (GLUT)-4, and adiponectin genes in white adipose tissue (WAT). Both compounds individually and in combination significantly (p < 0.05) increased Akt phosphorylation and GLUT4 protein expression in WAT compared to the control group. Honokiol and magnolol improve dyslipidemia and hyperglycemia and act synergistically when used in combination.	[Lee, Young-Sil; Choi, Sun-Sil; Yonezawa, Takayuki; Woo, Je-Tae; Kim, Hyo Jung; Cha, Byung-Yoon] Chubu Univ, Res Inst Biol Funct, Kasugai, Aichi 487, Japan; [Teruya, Toshiaki] Univ Ryukyus, Fac Educ, Nishihara, Okinawa 9030213, Japan; [Lee, Young-Sil] Myongji Univ, Div Biosci & Bioinformat, Coll Nat Sci, Yongin 449728, Gyeonggi, South Korea; [Woo, Je-Tae] Erina Co Inc, Dept Res & Dev, Minato Ku, Tokyo 1050021, Japan	Cha, BY (reprint author), Chubu Univ, Res Inst Biol Funct, 1200 Matsumoto, Kasugai, Aichi 487, Japan.	bycha@isc.chubu.ac.jp					An S, 2008, EXP MOL MED, V40, P407, DOI 10.3858/emm.2008.40.4.407; Lee CH, 2003, ENDOCRINOLOGY, V144, P2201, DOI 10.1210/en.2003-0288; Fu YC, 2005, J LIPID RES, V46, P1369, DOI 10.1194/jlr.M400373-JLR200; Mukherjee R, 1997, NATURE, V386, P407, DOI 10.1038/386407a0; Pajvani UB, 2004, J BIOL CHEM, V279, P12152, DOI 10.1074/jbc.M311113200; Wu ZD, 1998, J CLIN INVEST, V101, P22, DOI 10.1172/JCI1244; Lee J, 2005, PLANTA MED, V71, P338, DOI 10.1055/s-2005-864100; Hu FB, 2001, DIABETOLOGIA, V44, P805, DOI 10.1007/s001250100547; Hu E, 1996, J BIOL CHEM, V271, P10697; Pessin JE, 2000, J CLIN INVEST, V106, P165, DOI 10.1172/JCI10582; Yu JG, 2002, DIABETES, V51, P2968, DOI 10.2337/diabetes.51.10.2968; Leibowitz MD, 2006, ENDOCRINOLOGY, V147, P1044, DOI 10.1210/en.2005-0690; Sharpe PA, 2007, J ALTERN COMPLEM MED, V13, P217, DOI 10.1089/acm.2006.6129; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Choi SS, 2011, J NAT MED-TOKYO, V65, P424, DOI 10.1007/s11418-011-0512-3; Choi SS, 2009, LIFE SCI, V84, P908, DOI 10.1016/j.lfs.2009.04.001; Emilsson V, 2000, METABOLISM, V49, P1610, DOI 10.1053/meta.2000.18692; Furuta M, 2002, DIABETES RES CLIN PR, V56, P159, DOI 10.1016/S0168-8227(01)00373-4; Jung CG, 2010, BIOL PHARM BULL, V33, P1105; Kotani H, 2010, J NAT PROD, V73, P1332, DOI 10.1021/np100120c; Kwon BM, 1997, PLANTA MED, V63, P550, DOI 10.1055/s-2006-957762; NOLAN JJ, 1994, NEW ENGL J MED, V331, P1188, DOI 10.1056/NEJM199411033311803; Ogata M, 1997, J AM OIL CHEM SOC, V74, P557, DOI 10.1007/s11746-997-0180-3; RAMPAL AL, 1995, J BIOL CHEM, V270, P3938; Schulman IG, 1998, MOL CELL BIOL, V18, P3483; Shen Q, 2004, J BIOL CHEM, V279, P19721, DOI 10.1074/jbc.M311729200; Sohn EJ, 2007, LIFE SCI, V80, P468, DOI 10.1016/j.lfs.2006.09.037; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Szeles L, 2010, MOL ENDOCRINOL, V24, P2218, DOI 10.1210/me.2010-0215; Yin HQ, 2009, J PHARMACOL SCI, V109, P486, DOI 10.1254/jphs.08182FP	30	0	0	KOREAN SOCIETY FOOD SCIENCE & TECHNOLOGY-KOSFOST	SEOUL	#605, KOREA SCI TECHNOL CENT, 635-4 YEOKSAM-DONG, KANGNAM-GU, SEOUL, 135-703, SOUTH KOREA	1226-7708	2092-6456		FOOD SCI BIOTECHNOL	Food Sci. Biotechnol.	AUG	2015	24	4					1467	1474		10.1007/s10068-015-0189-6		8	Food Science & Technology	Food Science & Technology	CN9WO	WOS:000358801400038		
J	Ouchi, S				Ouchi, Sunao			On Some Functional Equations with Borel Summable Solutions	FUNKCIALAJ EKVACIOJ-SERIO INTERNACIA			English	Article						Borel summable; Asymptotic expansion; Functional equation	PARTIAL-DIFFERENTIAL-EQUATIONS; FORMAL POWER-SERIES; MULTISUMMABILITY; SUMMABILITY	A functional equation Sigma(m)(i=1) a(i)u(phi(i)(z)) = f(z) is considered, where {phi(i)(z)}(i=1)(m) are holomorphic functions in a neighborhood of z = 0 with phi(i)(0) = 0 and f (z) is holomorphic in a sector with vertex z = 0. It is shown under some conditions of {phi(i)(z)}(i=1)(m), f(z) and {a(i)}(i=1)(m) that the equation has a formal power series solution that is Borel summable.	Sophia Univ, Fac Sci & Technol, Dept Informat & Commun Sci Math, Chiyoda Ku, Tokyo 1028554, Japan	Ouchi, S (reprint author), Sophia Univ, Fac Sci & Technol, Dept Informat & Commun Sci Math, Chiyoda Ku, Tokyo 1028554, Japan.	s_ouchi@sophia.ac.jp					Abel N. H., 1839, DETERMINATION FONCTI, P246; Balser W, 2004, J DIFFER EQUATIONS, V201, P63, DOI 10.1016/j.jde.2004.02.002; Balser W., 1991, ASYMPTOTIC ANAL, V5, P27; BALSER W., 1994, LECT NOTES MATH, V1582; Balser W., 2000, FORMAL POWER SERIES; BRAAKSMA BLJ, 1991, J DIFFER EQUATIONS, V92, P45, DOI 10.1016/0022-0396(91)90063-F; BRAAKSMA BLJ, 1992, ANN I FOURIER, V42, P517; Kawai T., 2005, TRANSLATIONS MATH MO, V227; Lutz DA, 1999, NAGOYA MATH J, V154, P1; OUCHI S, 1983, ANN I FOURIER, V33, P131; Ouchi S, 2006, ASYMPTOTIC ANAL, V47, P187; Ouchi S., 1995, J MATH SCI-U TOKYO, V2, P375; Ouchi S, 2005, J MATH SOC JPN, V57, P415, DOI 10.2969/jmsj/1158242065; Ouchi S, 2002, J DIFFER EQUATIONS, V185, P513, DOI 10.1006/jdeq.2002.4178; Wasow W., 1987, ASYMPTOTIC EXPANSION	15	0	0	KOBE UNIV, DEPT MATHEMATICS	KOBE	FACULTY SCIENCE, KOBE, 657-8501, JAPAN	0532-8721			FUNKC EKVACIOJ-SER I	Funkc. Ekvacioj-Ser. Int.	AUG	2015	58	2					223	251				29	Mathematics, Applied; Mathematics	Mathematics	CO8VC	WOS:000359449300002		
J	Miyake, M				Miyake, Masatake			Reduced Forms of a Singular Vector Field in C-3 with Nilpotent Linear Part	FUNKCIALAJ EKVACIOJ-SERIO INTERNACIA			English	Article						Nilpotent vector field; Normal forms; Formal reduction		We study the reduction problem for a holomorphic singular vector field with nilpotent linear part at the origin, P = (y + a(X))partial derivative(x) + (z + b(X))partial derivative(y) + c(X)partial derivative(z), where X = (x, y, z) is an element of C-3. By introducing a notion of quasi-valuation, which was given in the previous paper [M-S] with A. Shirai, we characterize a class which can be reduced into simpler ones by formal change of coordinates which admit various variations in Theorems A and B.	Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan	Miyake, M (reprint author), Nagoya Univ, Grad Sch Math, Nagoya, Aichi 4648602, Japan.	mmiyake@math.nagoya-u.ac.jp					Bogdanov R. I., 1976, FUNCT ANAL APPL, V10, P61, DOI 10.1007/BF01075774; Iooss G, 2005, J DIFFER EQUATIONS, V212, P1, DOI 10.1016/j.jde.2004.10.015; Kokubu H., 1996, J DIFFERENTIAL EQUAT, V132, P293; Lombardi E, 2010, ANN SCI ECOLE NORM S, V43, P659; Miyake M., 2012, BANACH CTR PUBL, V97, P91; STOLOVITCH L, 1992, CR ACAD SCI I-MATH, V314, P355; Takens F., 1974, I HAUTES ETUDES SCI, P47; Wang D, 2000, J DIFFER EQUATIONS, V163, P223, DOI 10.1006/jdeq.1999.3739	8	0	0	KOBE UNIV, DEPT MATHEMATICS	KOBE	FACULTY SCIENCE, KOBE, 657-8501, JAPAN	0532-8721			FUNKC EKVACIOJ-SER I	Funkc. Ekvacioj-Ser. Int.	AUG	2015	58	2					253	275				23	Mathematics, Applied; Mathematics	Mathematics	CO8VC	WOS:000359449300003		
J	Shimomura, S				Shimomura, Shun			Series Expansions of Painleve Transcendents near the Point at Infinity	FUNKCIALAJ EKVACIOJ-SERIO INTERNACIA			English	Article						Painleve equations; Hamiltonian system; Asymptotic solutions	LINEAR STOKES PHENOMENON; CONNECTION FORMULAS; EQUATION; 2ND; 5TH; ASYMPTOTICS	For the Painleve equations (I) through (V) near the point at infinity we present several families of two-parameter solutions. Our solutions are expressed by asymptotic series with coefficients polynomial in exponential terms, and also by convergent power series in exponential terms with coefficients expanded into asymptotic series. Both expressions are valid without a restriction on integration constants. We propose a direct method to derive asymptotic solutions, which is also applicable to more general nonlinear equations. As applications of our results, for general solutions of the third and the fifth Painleve equations, we give estimates for the number of a-points including poles in given sectors.	Keio Univ, Dept Math, Kohoku Ku, Yokohama, Kanagawa 2238522, Japan	Shimomura, S (reprint author), Keio Univ, Dept Math, Kohoku Ku, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	shimomur@math.keio.ac.jp					Andreev FV, 1997, MATH RES LETT, V4, P741; [Anonymous], 1989, J SOVIET MATH, DOI 10.1007/BF01096090; Sakai H, 2001, COMMUN MATH PHYS, V220, P165, DOI 10.1007/s002200100446; HASTINGS SP, 1980, ARCH RATION MECH AN, V73, P31, DOI 10.1007/BF00283254; Joshi N, 2001, STUD APPL MATH, V107, P253, DOI 10.1111/1467-9590.00187; Andreev FV, 2000, NONLINEARITY, V13, P1801, DOI 10.1088/0951-7715/13/5/319; ITS AR, 1994, NONLINEARITY, V7, P1291, DOI 10.1088/0951-7715/7/5/002; Aoki T., 1996, WKB ANAL PAINLEVE TR, P1; BASSOM AP, 1992, P ROY SOC LOND A MAT, V437, P1, DOI 10.1098/rspa.1992.0043; Bruno A. D., 2004, USP MAT NAUK, V59, p[31, 429]; Costin O, 1999, COMMUN PUR APPL MATH, V52, P461, DOI 10.1002/(SICI)1097-0312(199904)52:4<461::AID-CPA3>3.0.CO;2-T; Fokas A. S., 2006, MATH SURVEYS MONOGRA, V128; Gromak V I, 2002, DEGRUYTER STUDIES MA, V28; Gromak V. I., 1975, DIFF EQUAT, V11, p[373, 398, 285]; Its A. R., 1986, LECT NOTES MATH, V1191; Its AR, 2003, NONLINEARITY, V16, P363, DOI 10.1088/0951-7715/16/1/321; Its AR, 1998, J PHYS A-MATH GEN, V31, P4073, DOI 10.1088/0305-4470/31/17/015; JOSHI N, 1992, STUD APPL MATH, V86, P315; Kapaev AA, 2004, J PHYS A-MATH GEN, V37, P11149, DOI 10.1088/0305-4470/37/46/005; Kapaev A. A., 1988, TEOR MAT FIZ, V77, p[323, 1227]; KAPAEV AA, 1986, DOKL AKAD NAUK SSSR+, V290, P590; Kawai T., 2005, TRANSLATIONS MATH MO, V227; Kitaev A. V., 1988, ZAP NAUCHN SEM LENIN, V169; Kitaev A. V., 1991, VOPROSY KVANT TEOR P, V8, P84; Kitaev A. V., 1991, VOPROSY KVANT TEOR P, V8, P187; Kitaev A. V., 1991, J SOVIET MATH, V54, P916, DOI 10.1007/BF01101121; Kitaev A.V., 1989, MATH USSR SB, V134, p[421, 421], DOI 10.1070/SM1989v062n02ABEH003247; Kitaev AV, 2004, INVERSE PROBL, V20, P1165, DOI 10.1088/0266-5611/20/4/010; NOVOKSHENOV VI, 1985, DOKL AKAD NAUK SSSR+, V283, P1161; Ohyama Y., 2006, J MATH SCI-U TOKYO, V13, P145; OKAMOTO K, 1986, MATH ANN, V275, P221, DOI 10.1007/BF01458459; Okamoto K., 1987, JAPAN J MATH, V13, P47; Okamoto K., 1987, FUNKC EKVACIOJ-SER I, V30, P305; Shimomura S, 2011, FUNKC EKVACIOJ-SER I, V54, P451; Shimomura S, 2013, TOHOKU MATH J, V65, P591; Shimomura S., 1983, FUNKC EKVACIOJ-SER I, V26, P301; Shimomura S., 1987, FUNKC EKVACIOJ-SER I, V30, P203; Takano K., 1983, FUNKC EKVACIOJ-SER I, V26, P79; TAKANO K, 1990, J MATH SOC JPN, V42, P423, DOI 10.2969/jmsj/04230423; Takei Y., 2000, EXACT WKB ANAL DIFFE, p[204, 271]; Wasow W., 1965, PURE APPL MATH, VXIV; Yoshida S., 1984, FUNKC EKVACIOJ-SER I, V27, P367; Yoshida S., 1985, FUNKC EKVACIOJ-SER I, V28, P233	43	0	0	KOBE UNIV, DEPT MATHEMATICS	KOBE	FACULTY SCIENCE, KOBE, 657-8501, JAPAN	0532-8721			FUNKC EKVACIOJ-SER I	Funkc. Ekvacioj-Ser. Int.	AUG	2015	58	2					277	319				43	Mathematics, Applied; Mathematics	Mathematics	CO8VC	WOS:000359449300004		
J	Minoda, R; Miwa, T; Ise, M; Takeda, H				Minoda, R.; Miwa, T.; Ise, M.; Takeda, H.			Potential treatments for genetic hearing loss in humans: current conundrums	GENE THERAPY			English	Review							INNER HAIR-CELLS; ANTISENSE OLIGONUCLEOTIDE; PENDRED SYNDROME; MOUSE MODEL; EAR; IMPAIRMENT; MICE; DEAFNESS; TRANSDUCTION; CONNEXIN26	Genetic defects are a major cause of hearing loss in newborns. Consequently, hearing loss has a profound negative impact on human daily living. Numerous causative genes for genetic hearing loss have been identified. However, presently, there are no truly curative treatments for this condition. There have been several recent reports on successful treatments in mice using embryonic gene therapy, neonatal gene therapy and neonatal antisense oligonucleotide therapy. Herein, we describe state-of-the-art research on genetic hearing loss treatment through gene therapy and discuss the obstacles to overcome in curative treatments of genetic hearing loss in humans.	[Minoda, R.] Kumamoto Univ, Grad Sch Med, Dept Otolaryngol Head, Kumamoto 8600811, Japan; Kumamoto Univ, Grad Sch Med, Dept Neck Surg, Kumamoto 8600811, Japan	Minoda, R (reprint author), Kumamoto Univ, Grad Sch Med, Dept Otolaryngol Head, 1-1-1 Honjo Chuoku, Kumamoto 8600811, Japan.	minoda@gpo.kumamoto-u.ac.jp					Nance WE, 2002, GENET MED, V4, P162; Cohen-Salmon M, 2002, CURR BIOL, V12, P1106, DOI 10.1016/S0960-9822(02)00904-1; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Schrijver I, 2004, J MOL DIAGN, V6, P275, DOI 10.1016/S1525-1578(10)60522-3; Everett LA, 1997, NAT GENET, V17, P411, DOI 10.1038/ng1297-411; del Castillo I, 2003, AM J HUM GENET, V73, P1452, DOI 10.1086/380205; Sun JJ, 2005, AM J PHYSIOL-CELL PH, V288, pC613, DOI 10.1152/ajpcell.00341.2004; Fukui H, 2013, HEARING RES, V297, P99, DOI 10.1016/j.heares.2012.11.017; Boeda B, 2002, EMBO J, V21, P6689, DOI 10.1093/emboj/cdf689; Kelley MW, 2006, NAT REV NEUROSCI, V7, P837, DOI 10.1038/nrn1987; Kenneson A, 2002, GENET MED, V4, P258, DOI 10.1097/01.GIM.0000020750.60733.CA; Guibert J, 2003, HUM REPROD, V18, P1733, DOI 10.1093/humrep/deg320; Miller TM, 2013, LANCET NEUROL, V12, P435, DOI 10.1016/S1474-4422(13)70061-9; Jia SP, 2007, J NEUROSCI, V27, P1006, DOI 10.1523/JNEUROSCI.5452-06.2007; Akil O, 2012, NEURON, V75, P283, DOI 10.1016/j.neuron.2012.05.019; Lentz JJ, 2013, NAT MED, V19, P345, DOI 10.1038/nm.3106; Baker CVH, 2001, DEV BIOL, V232, P1, DOI 10.1006/dbio.2001.0156; Monteleone G, 2012, MOL THER, V20, P870, DOI 10.1038/mt.2011.290; del Castillo I, 2002, NEW ENGL J MED, V346, P243, DOI 10.1056/NEJMoa012052; Seal RP, 2008, NEURON, V57, P263, DOI 10.1016/j.neuron.2007.11.032; Teubner B, 2003, HUM MOL GENET, V12, P13, DOI 10.1093/hmg/ddg001; Sylvester JE, 2004, GENET MED, V6, P73, DOI 10.1097/01.GIM.0000117333.21213.17; Choi BY, 2011, J CLIN INVEST, V121, P4516, DOI 10.1172/JCI59353; Smith RJH, 2005, LANCET, V365, P879, DOI 10.1016/S0140-6736(05)71047-3; Liu YH, 2005, MOL THER, V12, P725, DOI 10.1016/j.ymthe.2005.03.021; Scott DA, 1999, NAT GENET, V21, P440; Bryant J, 2002, BRIT MED BULL, V63, P39, DOI 10.1093/bmb/63.1.39; Carlson BM., 2014, EBOOK LIB HUMAN EMBR; Fekete DM, 1999, TRENDS NEUROSCI, V22, P263, DOI 10.1016/S0166-2236(98)01366-6; Frenz CM, 2000, BRAIN RES REV, V32, P172, DOI 10.1016/S0165-0173(99)00078-8; Fritzsch B, 1998, EARLY EMBRYOLOGY VER; Hall J W 3rd, 2000, J Perinatol, V20, pS12; Hone SW, 2002, OTOLARYNG CLIN N AM, V35, P751, DOI 10.1016/S0030-6665(02)00048-8; Hoppman N, 2013, MOL CYTOGENET, V6, DOI 10.1186/1755-8166-6-19; Ito T, 2011, CELL PHYSIOL BIOCHEM, V28, P545, DOI 10.1159/000335119; Kim HM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017949; Li XM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003641; Lo YM., 2013, REPROD BIOMED ONLINE, V27, P593; Matos TD, 2013, INT J AUDIOL, V52, P466, DOI 10.3109/14992027.2013.783719; Michel V, 2003, NEW ENGL J MED, V349, P716, DOI 10.1056/NEJMc030327; Minoda R, 2006, OTOL JPN, V16, P397; Minoda R, 2004, NEUROREPORT, V15, P1089, DOI 10.1097/01.wnr.0000126216.79493.8d; Minoda R, 2006, TOUKEIBU JURITSUSHIN, V20, P33; Miwa T, 2013, MOL THER, V21, P1142, DOI 10.1038/mt.2013.62; Morsli H, 1998, J NEUROSCI, V18, P3327; Morton CC, 2006, NEW ENGL J MED, V354, P2151, DOI 10.1056/NEJMra050700; Smith RJH, 1993, NONSYNDROMIC HEARING; Soleimani M, 2001, AM J PHYSIOL-RENAL, V280, pF356; Strachan T, 1999, HUM MOL GENET, V2nd; VanCamp G, 1997, AM J HUM GENET, V60, P758; Wang WH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021473; Yu Q, 2014, GENE THER, V21, P71, DOI 10.1038/gt.2013.59	52	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0969-7128	1476-5462		GENE THER	Gene Ther.	AUG	2015	22	8					603	609		10.1038/gt.2015.27		7	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CO6KG	WOS:000359265000001		
J	Uchimura, A; Higuchi, M; Minakuchi, Y; Ohno, M; Toyoda, A; Fujiyama, A; Miura, I; Wakana, S; Nishino, J; Yagi, T				Uchimura, Arikuni; Higuchi, Mayumi; Minakuchi, Yohei; Ohno, Mizuki; Toyoda, Atsushi; Fujiyama, Asao; Miura, Ikuo; Wakana, Shigeharu; Nishino, Jo; Yagi, Takeshi			Germline mutation rates and the long-term phenotypic effects of mutation accumulation in wild-type laboratory mice and mutator mice	GENOME RESEARCH			English	Article							DNA-POLYMERASE-DELTA; SEQUENCING DATA; MOUSE STRAINS; GENOME; REPLICATION; DROSOPHILA; RESOLUTION; EVOLUTION; FRAMEWORK; SELECTION	The germline mutation rate is an important parameter that affects the amount of genetic variation and the rate of evolution. However, neither the rate of germline mutations in laboratory mice nor the biological significance of the mutation rate in mammalian populations is clear. Here we studied genome-wide mutation rates and the long-term effects of mutation accumulation on phenotype in more than 20 generations of wild-type C57BL/6 mice and mutator mice, which have high DNA replication error rates. We estimated the base-substitution mutation rate to be 5.4 x 10(-9) (95% confidence interval = 4.6 x 10(-9)-6.5 x 10(-9)) per nucleotide per generation in C57BL/6 laboratory mice, about half the rate reported in humans. The mutation rate in mutator mice was 17 times that in wild-type mice. Abnormal phenotypes were 4.1-fold more frequent in the mutator lines than in the wild-type lines. After several generations, the mutator mice reproduced at substantially lower rates than the controls, exhibiting low pregnancy rates, lower survival rates, and smaller litter sizes, and many of the breeding lines died out. These results provide fundamental information about mouse genetics and reveal the impact of germline mutation rates on phenotypes in a mammalian population.	[Uchimura, Arikuni; Higuchi, Mayumi; Yagi, Takeshi] Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan; [Minakuchi, Yohei; Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Ohno, Mizuki] Kyushu Univ, Fac Med Sci, Dept Med Biophys & Radiat Biol, Fukuoka 8128582, Japan; [Miura, Ikuo; Wakana, Shigeharu] RIKEN, BioResource Ctr, Japan Mouse Clin, Technol & Dev Team Mouse Phenotype Anal, Tsukuba, Ibaraki 3050074, Japan; [Nishino, Jo] Nagoya Univ, Grad Sch Med, Dept Biostat, Nagoya, Aichi 4668550, Japan	Uchimura, A (reprint author), Osaka Univ, Grad Sch Frontier Biosci, Labs Integrated Biol, KOKORO Biol Grp, Suita, Osaka 5650871, Japan.	uchimura@fbs.osaka-u.ac.jp; yagi@fbs.osaka-u.ac.jp			Neo-Morgan Laboratory; GCOE program of Osaka University FBS; Ministry of Education, Culture, Sports, Science and Technology, Japan [21650099, 23650234, 25640047, 21657062, 24650235, 221S0002]	We thank M. Furusawa for fundamental ideas for our breeding experiment; N. Honda, Y. Hidaka, and M. Kumagai for their help with the experiments; and C. Choji and A. Kinjo for mouse care. This work was financially supported by Neo-Morgan Laboratory, the GCOE program of Osaka University FBS, and a Grant-aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology, Japan (21650099, 23650234, 25640047 to T.Y.; 21657062, 24650235 to A.U.; and 221S0002 for Innovative Areas "Genome Science").	AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Conrad DF, 2011, NAT GENET, V43, P712, DOI 10.1038/ng.862; Ohno M, 2014, SCI REP-UK, V4, DOI 10.1038/srep04689; CROW JF, 1979, P NATL ACAD SCI USA, V76, P396, DOI 10.1073/pnas.76.1.396; Kong A, 2012, NATURE, V488, P471, DOI 10.1038/nature11396; Chen K, 2009, NAT METHODS, V6, P677, DOI [10.1038/nmeth.1363, 10.1038/NMETH.1363]; Eyre-Walker A, 1999, NATURE, V397, P344, DOI 10.1038/16915; Keane TM, 2011, NATURE, V477, P289, DOI 10.1038/nature10413; Burgers PMJ, 2009, J BIOL CHEM, V284, P4041, DOI 10.1074/jbc.R800062200; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lynch M, 2010, TRENDS GENET, V26, P345, DOI 10.1016/j.tig.2010.05.003; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Eory L, 2010, MOL BIOL EVOL, V27, P177, DOI 10.1093/molbev/msp219; Palles C, 2013, NAT GENET, V45, P136, DOI 10.1038/ng.2503; Lesecque Y, 2012, GENETICS, V191, P1321, DOI 10.1534/genetics.112.140343; Keightley PD, 2014, GENETICS, V196, P313, DOI 10.1534/genetics.113.158758; DePristo MA, 2011, NAT GENET, V43, P491, DOI 10.1038/ng.806; Duret L, 2009, ANNU REV GENOM HUM G, V10, P285, DOI 10.1146/annurev-genom-082908-150001; KIMURA M, 1966, GENETICS, V54, P1337; Venn O, 2014, SCIENCE, V344, P1272, DOI [10.1126/science.344.6189.1272, 10.1126/science.1251213]; SIMON M, 1991, EMBO J, V10, P2165; Prindle MJ, 2012, ENVIRON MOL MUTAGEN, V53, P666, DOI 10.1002/em.21745; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Muller U, 1997, CELL, V88, P603, DOI 10.1016/S0092-8674(00)81903-0; Campbell CD, 2013, TRENDS GENET, V29, P575, DOI 10.1016/j.tig.2013.04.005; Crow JF, 2000, NAT REV GENET, V1, P40, DOI 10.1038/35049558; Lynch M, 2010, P NATL ACAD SCI USA, V107, P961, DOI 10.1073/pnas.0912629107; Gondo Y, 2009, BMB REP, V42, P315; Albertson TM, 2009, P NATL ACAD SCI USA, V106, P17101, DOI 10.1073/pnas.0907147106; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Drake JW, 1998, GENETICS, V148, P1667; MULLER HJ, 1950, AM J HUM GENET, V2, P111; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Casellas J, 2011, ANIMAL, V5, P1, DOI 10.1017/S1751731110001667; Choi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046688; DROST JB, 1995, ENVIRON MOL MUTAGEN, V25, P48, DOI 10.1002/em.2850250609; Goldsby RE, 2002, P NATL ACAD SCI USA, V99, P15560, DOI 10.1073/pnas.232340999; Herr AJ, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002282; Herr AJ, 2014, GENETICS, V196, P677, DOI 10.1534/genetics.113.160960; Keays DA, 2006, MAMM GENOME, V17, P230, DOI 10.1007/s00335-005-0101-4; Kimura M., 1983, NEUTRAL THEORY MOL E; KONDRASHOV AS, 1993, HUM MUTAT, V2, P229, DOI 10.1002/humu.1380020312; Lyon FM, 1959, HEREDITY, V13, P341; Mackay T. F. C., 1996, INTRO QUANTITATIVE G; Reed FA, 2006, TRENDS GENET, V22, P479, DOI 10.1016/j.tig.2006.07.005; Russell ES., 1978, ORIGINS INBRED MICE, P33; Simon MM, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r82; Uchimura A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004184; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Yauk CL, 2015, MUTAT RES-GEN TOX EN, V783, P36, DOI 10.1016/j.mrgentox.2015.01.008	50	0	0	COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT	COLD SPRING HARBOR	1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA	1088-9051	1549-5469		GENOME RES	Genome Res.	AUG	2015	25	8					1125	1134		10.1101/gr.186148.114		10	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology; Genetics & Heredity	CO2AL	WOS:000358957500005		
J	Hendry, MJ; Solomon, DK; Person, M; Wassenaar, LI; Gardner, WP; Clark, ID; Mayer, KU; Kunimaru, T; Nakata, K; Hasegawa, T				Hendry, M. J.; Solomon, D. K.; Person, M.; Wassenaar, L. I.; Gardner, W. P.; Clark, I. D.; Mayer, K. U.; Kunimaru, T.; Nakata, K.; Hasegawa, T.			Can argillaceous formations isolate nuclear waste? Insights from isotopic, noble gas, and geochemical profiles	GEOFLUIDS			English	Editorial Material						aquitard; conservative tracers; nuclear waste disposal	NATURAL TRACER PROFILES; MICHIGAN BASIN; PLEISTOCENE GLACIATION; RADIOGENIC HELIUM; CLAY TILL; GROUNDWATER; AQUITARD; UNDERPRESSURES; SALINITY; ONTARIO	There is considerable interest in the use of thick argillaceous geologic formations to contain nuclear waste. Here, we show that diffusion can be the controlling transport process in these formations and diffusional time scales for O-18 and H-2 in water, dissolved He, and Cl transport in shale-dominated aquitards are typically over 10(6) years, well exceeding the regulatory requirements for isolation in most countries. Our scientific understanding of diffusive solute transport processes through argillaceous formations would benefit from the application of additional isotopic tracers (e.g., using new He-4 sampling technology), multidimensional diffusive-dispersive modeling of groundwater flow and diffusive-dispersive solute transport over long geologic time scales, and an improved understanding of spatial heterogeneity as well as time-dependent changes in the subsurface conditions and properties of argillaceous formations in response to events such as glaciation. Based on our current isotopic and geochemical understanding of transport, we argue that argillaceous formations can provide favorable long-term conditions for isolating nuclear wastes.	[Hendry, M. J.] Univ Saskatchewan, Dept Geol Sci, Saskatoon, SK S7N 5E2, Canada; [Solomon, D. K.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Person, M.] New Mexico Inst Min & Technol, Dept Earth & Environm, Sci, Socorro, NM USA; [Wassenaar, L. I.] IAEA, Vienna Int Ctr, Isotope Hydrol Sect, A-1400 Vienna, Austria; [Gardner, W. P.] Sandia Natl Labs, Albuquerque, NM 87185 USA; [Clark, I. D.] Univ Ottawa, Dept Earth Sci, Ottawa, ON, Canada; [Mayer, K. U.] Univ British Columbia, Dept Earth Ocean & Atmospher Sci, Vancouver, BC V5Z 1M9, Canada; [Kunimaru, T.] Nucl Waste Management Org Japan NUMO, Minato Ku, Tokyo, Japan; [Nakata, K.; Hasegawa, T.] Cent Res Inst Elect Power Ind, Civil Engn Res Lab, Abiko, Chiba, Japan	Hendry, MJ (reprint author), Univ Saskatchewan, Dept Geol Sci, 114 Sci Pl, Saskatoon, SK S7N 5E2, Canada.	jim.hendry@usask.ca		Mayer, K. Ulrich/0000-0002-4168-781X			Martini AM, 2008, AAPG BULL, V92, P327, DOI 10.1306/10180706037; McIntosh JC, 2011, GEOFLUIDS, V11, P18, DOI 10.1111/j.1468-8123.2010.00303.x; Hendry MJ, 1999, WATER RESOUR RES, V35, P1751, DOI 10.1029/1999WR900046; Plummer LN, 2012, HYDROGEOL J, V20, P1269, DOI 10.1007/s10040-012-0871-1; Mazurek M, 2011, APPL GEOCHEM, V26, P1035, DOI 10.1016/j.apgeochem.2011.03.124; Lee Y, 2002, AAPG BULL, V86, P145; Harrington GA, 2013, WATER RESOUR RES, V49, P4054, DOI 10.1002/wrcr.20327; Hendry MJ, 2013, WATER RESOUR RES, V49, P4580, DOI 10.1002/wrcr.20321; Lemieux JM, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000928; Edmunds WM, 2001, GEOL SOC SPEC PUBL, V189, P1, DOI 10.1144/GSL.SP.2001.189.01.02; Martini AM, 2003, AAPG BULL, V87, P1355, DOI 10.1306/031903200184; Gardner WP, 2012, J HYDROL, V468, P63, DOI 10.1016/j.jhydro1.2012.08.014; Cartwright J, 2007, AAPG BULL, V91, P1141, DOI 10.1306/04090705181; Sanford WE, 2013, NATURE, V503, P252, DOI 10.1038/nature12714; BELITZ K, 1988, AAPG BULL, V72, P1334; Manga M, 2012, REV GEOPHYS, V50, DOI 10.1029/2011RG000382; Bea SA, 2014, COMPUTATIO UNPUB NOV; Bea SA, 2011, P WAST MAN DEC ENV R; Bense VF, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000969; Christiansen EA, 2002, CAN J EARTH SCI, V39, P1411, DOI 10.1139/E02-038; CHRISTIANSEN EA, 1982, CAN J EARTH SCI, V19, P1122, DOI 10.1139/e82-097; Clark ID, 2013, GEOLOGY, V41, P951, DOI 10.1130/G34372.1; Cohen D, 2010, GROUNDWATER, V48, P1143; Grasby S, 2000, GEOLOGY, V28, P635, DOI 10.1130/0091-7613(2000)28<635:ROTRFS>2.0.CO;2; Hasegawa T, 2013, J GEOGR, V122, P116; Hendry MJ, 2005, GEOCHIM COSMOCHIM AC, V69, P475, DOI 10.1016/j.gca.2004.07.001; Lu A-T, 2014, EARTH-SCI REV, V138, P196; Neuzil C. E., 2013, Eos, Transactions American Geophysical Union, V94, DOI 10.1002/2013EO300001; Neuzil CE, 2012, GEOFLUIDS, V12, DOI 10.1111/j.1468-8123.2011.00347.x; Neuzil CE, 2014, J GEOPHYS RES-SOL EA, V119, P8748, DOI 10.1002/2014JB011643; Normani SD, 2012, GEOFLUIDS, V12, DOI 10.1111/j.1468-8123.2012.00362.x; Osenbruck K, 1998, GEOCHIM COSMOCHIM AC, V62, P3041, DOI 10.1016/S0016-7037(98)00198-7; Shaw GH, 2014, EOS, V95, P71; Sheldon AL, 2003, WATER RESOUR RES, V39, DOI 10.1029/2002WR001797; Smith SD, 2013, APPL GEOCHEM, V35, P187, DOI 10.1016/j.apgeochem.2013.04.010; Vinard P, 2001, J GEOPHYS RES-SOL EA, V106, P30593, DOI 10.1029/2001JB000327	36	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1468-8115	1468-8123		GEOFLUIDS	Geofluids	AUG	2015	15	3								10.1111/gfl.12132		7	Geochemistry & Geophysics; Geology	Geochemistry & Geophysics; Geology	CN8NI	WOS:000358697500001		
J	Niwa, M; Mizuochi, Y; Tanase, A				Niwa, M.; Mizuochi, Y.; Tanase, A.			Changes in chemical composition caused by water-rock interactions across a strike-slip fault zone: case study of the Atera Fault, Central Japan	GEOFLUIDS			English	Article						carbonates; clay minerals; fault zone; rare earth elements; water-rock interactions	RARE-EARTH-ELEMENTS; CLAY-MINERALS; NOJIMA FAULT; PERMEABILITY STRUCTURE; ISOTOPE GEOCHEMISTRY; AQUEOUS GEOCHEMISTRY; SOUTHWEST JAPAN; CHELUNGPU FAULT; OXYGEN; REE	In some cases, water-rock interactions in fault zones can affect radionuclide migration. Here, we analyzed the chemical compositions of well-exposed fault rocks from the strike-slip Atera Fault, Central Japan, in order to understand the variability and behavior of major and selected trace elements. The fault zone has a 1.2-m-wide, smectite-rich fault core and paired damage zones that developed within welded tuff on one side of the core and within granite on the other side. The 30-cm-wide, kaolinite-rich fault gouge is developed in granite cataclasite, and it shows indications of the latest fault activity, while the 1.2-m-wide fault core appears to be older. Hydrogen and oxygen isotope ratios in the clay-rich fault gouges, and carbon and oxygen isotope ratios in carbonates indicate that the two major clay-rich zones formed in bedrock near the surface, consistent with observed deformation structures. Based on chemical analyses, we identified (1) a slight depletion in SiO2, Na2O, K2O, and light rare earth elements at the edges of the 1.2-m-wide fault core, (2) a clear depletion in SiO2, Na2O, K2O, and all rare earth elements except Eu in the 30-cm-wide fault gouge, and (3) an increase in CaO, MnO, and heavy rare earth elements across the entire 1.2-m-wide fault core. Findings (1) and (2) reflect water-rock interactions in the 1.2-m-wide fault core and in the 30-cm-wide fault gouge that resulted in the formation of smectite and kaolinite. Finding (3) reflects carbonate precipitation caused by the addition of basalt fragments from a nearby site to the 1.2-m-wide fault core during faulting, and subsequent sorption reactions of heavy rare earth elements via processes such as complexation with the carbonates.	[Niwa, M.] Japan Atom Energy Agcy, Tono Geosci Ctr, Sect Decommissioning & Radioact Waste Management, Gifu 5096102, Japan; [Mizuochi, Y.] Sumiko Resources Explorat & Dev, Tokyo, Japan; [Tanase, A.] Chi Ken Sogo Consultants Co Ltd, Tokyo, Japan	Niwa, M (reprint author), Japan Atom Energy Agcy, Tono Geosci Ctr, Sect Decommissioning & Radioact Waste Management, Gifu 5096102, Japan.	niwa.masakazu@jaea.go.jp					Akagawa F, 2006, GEOCHEM-EXPLOR ENV A, V6, P49, DOI 10.1144/1467-7873/05-085; Delgado A, 1996, GEOCHIM COSMOCHIM AC, V60, P4285; Kimura JI, 1999, ISL ARC, V8, P304, DOI 10.1046/j.1440-1738.1999.00239.x; Ishikawa T, 2008, NAT GEOSCI, V1, P679, DOI 10.1038/ngeo308; WOOD SA, 1990, CHEM GEOL, V82, P159, DOI 10.1016/0009-2541(90)90080-Q; GODDARD JV, 1995, J STRUCT GEOL, V17, P533, DOI 10.1016/0191-8141(94)00068-B; MCDONOUGH WF, 1995, CHEM GEOL, V120, P223, DOI 10.1016/0009-2541(94)00140-4; WOOD SA, 1993, ENG GEOL, V34, P229, DOI 10.1016/0013-7952(93)90092-Q; CANTRELL KJ, 1987, GEOCHIM COSMOCHIM AC, V51, P597, DOI 10.1016/0016-7037(87)90072-X; Caine JS, 1996, GEOLOGY, V24, P1025, DOI 10.1130/0091-7613(1996)024<1025:FZAAPS>2.3.CO;2; SAVIN SM, 1970, GEOCHIM COSMOCHIM AC, V34, P25, DOI 10.1016/0016-7037(70)90149-3; COPLEN TB, 1983, NATURE, V302, P236, DOI 10.1038/302236a0; CRAIG H, 1961, SCIENCE, V133, P1702, DOI 10.1126/science.133.3465.1702; CRAIG H, 1957, GEOCHIM COSMOCHIM AC, V12, P133, DOI 10.1016/0016-7037(57)90024-8; BYRNE RH, 1990, GEOCHIM COSMOCHIM AC, V54, P2645, DOI 10.1016/0016-7037(90)90002-3; EVANS JP, 1995, J GEOPHYS RES-SOL EA, V100, P13007, DOI 10.1029/94JB02625; SUZUKI K, 1990, GEOCHEM J, V24, P57; WINTSCH RP, 1995, J GEOPHYS RES-SOL EA, V100, P13021, DOI 10.1029/94JB02622; Kameda J, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018252; Evans JP, 1997, J STRUCT GEOL, V19, P1393, DOI 10.1016/S0191-8141(97)00057-6; Nuriel P, 2012, J STRUCT GEOL, V36, P43, DOI 10.1016/j.jsg.2011.12.010; GONFIANTINI R, 1978, NATURE, V271, P534, DOI 10.1038/271534a0; Sheppard SMF, 1996, CLAY MINER, V31, P1, DOI 10.1180/claymin.1996.031.1.01; Coppin F, 2002, CHEM GEOL, V182, P57, DOI 10.1016/S0009-2541(01)00283-2; Arai T, 2003, J GEOGR, V112, P915; AWWILLER DN, 1991, GEOLOGY, V19, P311, DOI 10.1130/0091-7613(1991)019<0311:DMOSNM>2.3.CO;2; Chen WMD, 2007, TECTONOPHYSICS, V443, P243, DOI 10.1016/j.tecto.2007.01.025; CHESTER FM, 1993, J GEOPHYS RES-SOL EA, V98, P771, DOI 10.1029/92JB01866; Dobashi R., 2008, Chikyukagaku (Geochemistry), V42, P79; Escuder-Viruete J, 2004, INT J EARTH SCI, V93, P172, DOI 10.1007/s00531-003-0378-z; Fujimoto K, 2001, ISL ARC, V10, P401, DOI 10.1046/j.1440-1738.2001.00338.x; Hamada Y, 2011, J GEOPHYS RES-SOL EA, V116, DOI 10.1029/2010JB007730; Headquarters for Earthquake Research Promotion, 2004, EV AT FAULT ZON; Hirouchi D, 2003, SUMMARIES RES USING, VXIV, P118; Honda G, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2011GL046722; Inoue A., 1995, ORIGIN MINERALOGY CL, P268; Ishihara S., 2002, B GEOLOGICAL SURVEY, V53, P421; Ishihara S, 2001, B GEOL SURV JAPAN, V52, P471; KANAORI Y, 1992, TECTONICS, V11, P47, DOI 10.1029/91TC01511; Kimura S-I, 1999, J JAPAN SOC ENG GEOL, V40, P281; Kobayashi T, 1989, MIN GEOL, V39, P79; MACFARLANE AW, 1994, GEOCHIM COSMOCHIM AC, V58, P1777, DOI 10.1016/0016-7037(94)90536-3; Marczenko Z, 2000, ANAL SPECTROSCOPY LI, V10, P341; Matsuda T, 2004, TECTONOPHYSICS, V378, P143, DOI 10.1016/j.tecto.2003.09.005; Nagae R, 1996, J GROUNDWATER HYDROL, V38, P51; Nagatomo A., 2009, J GEOL SOC JPN, V115, P512; Nakano S, 1993, J MINERALOGY PETROLO, V88, P272; Niwa M, 2011, PURE APPL GEOPHYS, V168, P887, DOI 10.1007/s00024-010-0167-0; Niwa M, 2009, ISL ARC, V18, P577, DOI 10.1111/j.1440-1738.2009.00674.x; Otani H, 2005, SHIGEN CHISHITSU, V55, P169; Otani JR, 1969, J CHEM PHYS, V51, P5547; Sasao E, 2009, RESOUR GEOL, V59, P209; Schleicher AM, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006092; Shibata H, 1939, J GEOLOGICAL SOC JAP, V46, P465; Shibata H, 1939, J GEOL SOC JAPAN, V46, P547; Shibata H, 1939, J GEOLOGICAL SOC JAP, V46, P503; Shibata H, 1939, J GEOLOGICAL SOC JAP, V46, P583; Shikazono N, 2003, SHIGEN CHISHITSU, V53, P201; Shikazono N, 2007, J GEOLOGICAL SOC JAP, V113, P593; Shimazaki H, 2005, MONOGRAPH ASS GEOLOG, V53, P129; Shimizu S, 1988, B HIRUZEN RES I OKAY, V14, P1; Shirahase T, 2005, MONOGR ASS GEOL COLL, V53, P119; Sonehara T, 2005, MONOGRAPH ASS GEOLOG, V53, P99; SUGIMURA A, 1965, GEOL SOC AM BULL, V76, P509, DOI 10.1130/0016-7606(1965)76[509:AFAIDV]2.0.CO;2; Suzuki K, 1994, B NAGOYA U FURUKAWA, V10, P17; Tanaka H, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2005JB003977; Tanaka H, 2001, J GEOPHYS RES-SOL EA, V106, P8789, DOI 10.1029/2000JB900444; Toda S, 1996, CIVIL ENG LAB REPORT; Ujike O, 1992, J MINERALOGY PETROLO, V87, P102; Uto K, 1985, B GEOL SURV JAPAN, V36, P47; Yamada N, 2005, MONOGR ASS GEOL COLL, V53, P15; Yamada N, 2005, MONOGR ASS GEOL COLL, V53, P29; Yamada R, 2010, TECHNICAL NOTE NATL, V343, P1; YEH HW, 1986, CLAY CLAY MINER, V34, P403, DOI 10.1346/CCMN.1986.0340407	74	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1468-8115	1468-8123		GEOFLUIDS	Geofluids	AUG	2015	15	3								10.1111/gfl.12096		24	Geochemistry & Geophysics; Geology	Geochemistry & Geophysics; Geology	CN8NI	WOS:000358697500002		
J	Nishimura, T; Machida, S; Hashizume, K; Kurosaka, D				Nishimura, Tomoharu; Machida, Shigeki; Hashizume, Kouhei; Kurosaka, Daijiro			Structures affecting recovery of macular function in patients with age-related macular degeneration after intravitreal ranibizumab	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Age-related macular degeneration; Ranibizumab; Focal macular ERG; ERG; SD-OCT	PHOTOPIC NEGATIVE RESPONSE; CHOROIDAL NEOVASCULARIZATION; RETINAL SENSITIVITY; BEVACIZUMAB; THERAPY; EYES; OCT; ELECTRORETINOGRAMS; VERTEPORFIN; ERG	To determine the retinal structures affecting the recovery of macular function in patients with exudative age-related macular degeneration (AMD) treated with intravitreal ranibizumab (IVR). Thirty eyes of 30 patients with exudative AMD who were treated with IVR at monthly intervals for 3 months were studied. Focal macular electroretinograms (fmERGs) and spectral-domain optical coherence tomography (SD-OCT) were performed before and 3 months after beginning the IVR injections. The fmERGs were elicited by a 15A degrees white stimulus spot centered on the fovea. The thickness of different retinal layers, presence of a serous retinal detachment (SRD), and presence of a pigment epithelial detachment (PED) at the fovea was determined in the SD-OCT images. Measurements were made of the inner, middle, and outer layers of the retina and also of the SRD and PED in the horizontal and vertical meridians at 1.2 mm from the fovea (parafoveal regions). The significance of the correlations between these structural parameters and the a-wave amplitude of the fmERG was determined. There was no significant correlation between the structural parameters of the fovea and the a-wave amplitude. In the parafoveal regions, the thickness of the outer retinal layer was significantly correlated with an increase of the a-wave amplitude (R = 0.56, P = 0.001). In addition, the SRD thickness was negatively and significantly correlated with the a-wave amplitude (R = -0.54, P = 0.002). The change in the parafoveal SRD thickness after IVRs was the only independent determinant of recovery of the a-wave amplitude after the treatments (P < 0.05). The macular function measured by the fmERGs was determined by the parafoveal outer layer and SRD thickness in patients with exudative AMD. Of these, changes in the SRD thickness by IVRs most strongly affected the recovery of macular function.	[Nishimura, Tomoharu; Machida, Shigeki; Hashizume, Kouhei; Kurosaka, Daijiro] Iwate Med Univ, Dept Ophthalmol, Sch Med, Morioka, Iwate 0208505, Japan; [Machida, Shigeki] Dokkyo Med Univ, Koshigaya Hosp, Dept Ophthalmol, Koshigaya, Saitama 3438555, Japan	Machida, S (reprint author), Dokkyo Med Univ, Koshigaya Hosp, Dept Ophthalmol, 2-1-50 Minami Koshigaya, Koshigaya, Saitama 3438555, Japan.	machidas@dokkyomed.ac.jp			JSPS KAKENHI [24592677]	This study was supported by JSPS KAKENHI Grant No. 24592677 (SM). We thank Professor Duco Hamasaki for discussions and editing the manuscript.	Munk MR, 2013, AM J OPHTHALMOL, V156, P633, DOI 10.1016/j.ajo.2013.05.037; Ritter M, 2010, EYE, V24, P962, DOI 10.1038/eye.2009.265; Nishihara H, 2008, INVEST OPHTH VIS SCI, V49, P3121, DOI 10.1167/iovs.08-1835; Brown DM, 2009, OPHTHALMOLOGY, V116, P57, DOI 10.1016/j.ophtha.2008.10.018; Mitchell P, 2010, BRIT J OPHTHALMOL, V94, P2, DOI 10.1136/bjo.2009.159160; Ogino K, 2013, INVEST OPHTH VIS SCI, V54, P3771, DOI 10.1167/iovs.12-11494; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Shin HJ, 2013, RETINA-J RET VIT DIS, V33, P964, DOI 10.1097/IAE.0b013e3182835f70; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Kim YM, 2012, AM J OPHTHALMOL, V154, P164, DOI 10.1016/j.ajo.2012.01.030; Sulzbacher F, 2013, INVEST OPHTH VIS SCI, V54, P1310, DOI 10.1167/iovs.12-11046; Lalwani Geeta A, 2009, Am J Ophthalmol, V148, P43, DOI 10.1016/j.ajo.2009.01.024; Machida S, 2008, INVEST OPHTH VIS SCI, V49, P5636, DOI 10.1167/iovs.08-1946; Oishi A, 2013, GRAEF ARCH CLIN EXP, V251, P435, DOI 10.1007/s00417-012-2034-4; BUSH RA, 1994, INVEST OPHTH VIS SCI, V35, P635; Shin HJ, 2011, RETINA-J RET VIT DIS, V31, P1627, DOI 10.1097/IAE.0b013e31820d3d01; Campa C, 2011, INVEST OPHTH VIS SCI, V52, P3446, DOI 10.1167/iovs.10-6588; Cho HJ, 2013, AM J OPHTHALMOL, V155, P118, DOI 10.1016/j.ajo.2012.07.009; Iwata E, 2012, INVEST OPHTH VIS SCI, V53, P4185, DOI 10.1167/iovs.11-9335; Kizawa J, 2006, JPN J OPHTHALMOL, V50, P367, DOI 10.1007/s10384-006-0326-0; Kondo M, 2008, VISION RES, V48, P273, DOI 10.1016/j.visres.2007.11.010; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Miyake Y, 1981, JPN J OPHTHALMOL, V25, P439; Miyake Y., 1988, ACTA SOC OPHTHALMOL, V92, P1419; Moschos MM, 2007, DOC OPHTHALMOL, V114, P37, DOI 10.1007/s10633-006-9036-7; Nishimura Tomoharu, 2012, Clin Ophthalmol, V6, P1073, DOI 10.2147/OPTH.S31674; Ogino K, 2014, JPN J OPHTHALMOL, V58, P155, DOI 10.1007/s10384-013-0295-z; Sulzbacher F, 2012, INVEST OPHTH VIS SCI, V53, P6448, DOI 10.1167/iovs.11-9162; Unver YB, 2009, EYE, V23, P453, DOI 10.1038/eye.2008.349	29	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	AUG	2015	253	8					1201	1209		10.1007/s00417-014-2779-z		9	Ophthalmology	Ophthalmology	CN9AA	WOS:000358736700001		
J	Baba, T; Oshitari, T; Yamamoto, S				Baba, Takayuki; Oshitari, Toshiyuki; Yamamoto, Shuichi			Level of vitreous alpha-B crystallin in eyes with rhegmatogenous retinal detachment	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						alpha B-crystallin; Rhegmatogenous retinal detachment; Vitreous; Apoptosis; Neuroprotection	PIGMENT EPITHELIUM; PHOTORECEPTOR APOPTOSIS; EXPERIMENTAL-MODEL; OWL MONKEY; ACTIVATION; EXPRESSION; CELLS; GENE; TRANSLOCATION; SEQUESTER	Alpha-B crystallin (alpha B-crystallin) is a molecular chaperone, and one of the small heat shock proteins (sHSPs). alpha B-crystallin has been shown to have neuroprotective properties. The purpose of this study was to determine the level of alpha B-crystallin in eyes with a rhegmatogenous retinal detachment (RRD). Vitreous samples were collected before vitrectomy from 32 eyes of 32 consecutive patients with RRD. The concentration of alpha B-crystallin was measured by enzyme-linked immunosorbent assay (ELISA). Vitreous samples were also collected before vitrectomy from 16 patients with an idiopathic macular hole and epiretinal membrane, and used as controls. The mean age was 56 years (range, 31-67 years) in the RRD cases and 66 years (range, 49-77 years) in the controls. The mean level of alpha B-crystallin was significantly higher in the RRD cases (36.7 +/- 37.4 ng/ml) than that in controls (8.5 +/- 12.2 ng/ml; P = 0.0028). The increased level of alpha B-crystallin suggests that alpha B-crystallin may play a neuroprotective role by lessening retinal cell death after a retinal detachment.	[Baba, Takayuki; Oshitari, Toshiyuki; Yamamoto, Shuichi] Chiba Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Chuo Ku, Chiba 2600856, Japan	Baba, T (reprint author), Chiba Univ, Dept Ophthalmol & Visual Sci, Grad Sch Med, Chuo Ku, 1-8-1 Inohana, Chiba 2600856, Japan.	t.baba.oph@faculty.chiba-u.jp			Japan Society for the Promotion of Science KAKENHI [23791966]	This work was supported by Japan Society for the Promotion of Science KAKENHI 23791966, Grant-in-Aid for Young Scientists (B) (TB). The authors indicate no financial support or financial conflict of interest involved in design and conduct of study, collection of data, management, analysis and interpretation of data, and preparation, review, or approval of manuscript. The authors thank Professor Duco Hamasaki of the Bascom Palmer Eye Institute of the University of Miami for his critical discussion and editing the final manuscript.	ANDERSON DH, 1981, INVEST OPHTH VIS SCI, V21, P10; Dong ZY, 2012, RETINA-J RET VIT DIS, V32, P1190, DOI 10.1097/IAE.0b013e318233ab9c; Trichonas G, 2010, P NATL ACAD SCI USA, V107, P21695, DOI 10.1073/pnas.1009179107; Arroyo JG, 2005, AM J OPHTHALMOL, V139, P605, DOI 10.1016/j.ajo.2004.11.046; Liu S, 2007, BIOCHEM BIOPH RES CO, V354, P109, DOI 10.1016/j.bbrc.2006.12.152; Kannan R, 2012, PROG RETIN EYE RES, V31, P576, DOI 10.1016/j.preteyeres.2012.06.001; Hisatomi T, 2001, AM J PATHOL, V158, P1271, DOI 10.1016/S0002-9440(10)64078-3; Vazquez-Chona F, 2004, INVEST OPHTH VIS SCI, V45, P2737, DOI 10.1167/iovs.03-1047; MACHEMER R, 1968, AM J OPHTHALMOL, V66, P396; Mao YW, 2004, CELL DEATH DIFFER, V11, P512, DOI 10.1038/sj.cdd.4401384; Launay N, 2010, J BIOL CHEM, V285, P37324, DOI 10.1074/jbc.M110.124388; COOK B, 1995, INVEST OPHTH VIS SCI, V36, P990; Mao YW, 2001, J BIOL CHEM, V276, P43435, DOI 10.1074/jbc.M102195200; KROLL AJ, 1968, AM J OPHTHALMOL, V66, P410; Kamradt MC, 2001, J BIOL CHEM, V276, P16059, DOI 10.1074/jbc.C100107200; Nakata K, 2005, EXP EYE RES, V80, P821, DOI 10.1016/j.exer.2004.12.011; Yaung J, 2007, MOL VIS, V13, P566; Zacks DN, 2004, INVEST OPHTH VIS SCI, V45, P4563, DOI 10.1167/iovs.04-0598; Hu WF, 2012, CURR MOL MED, V12, P177; Goplen D, 2010, AM J PATHOL, V177, P1618, DOI 10.2353/ajpath.2010.090063; LOWE J, 1992, J PATHOL, V166, P61, DOI 10.1002/path.1711660110; PINEDA R, 1993, CURR EYE RES, V12, P239, DOI 10.3109/02713689308999469; Sreekumar PG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033420; Sreekumar PG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012578; Zacks DN, 2003, INVEST OPHTH VIS SCI, V44, P1262, DOI 10.1167/iovs.02-0492	25	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	AUG	2015	253	8					1251	1254		10.1007/s00417-014-2815-z		4	Ophthalmology	Ophthalmology	CN9AA	WOS:000358736700007		
J	Kitaoka, Y; Kojima, K; Munemasa, Y; Sase, K; Takagi, H				Kitaoka, Yasushi; Kojima, Kaori; Munemasa, Yasunari; Sase, Kana; Takagi, Hitoshi			Axonal protection by brimonidine with modulation of p62 expression in TNF-induced optic nerve degeneration	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						p62; Brimonidine; Autophagy; Tumor necrosis factor; Optic nerve	NECROSIS-FACTOR-ALPHA; RETINAL GANGLION-CELLS; TRANSIENT ISCHEMIA; UBIQUITIN-PROTEASOME; AUTOPHAGY; DEATH; NEUROPROTECTION; DEGRADATION; P62/SQSTM1; NEUROPATHY	The p62, also called sequestosome 1 (SQSTM1), plays a crucial role in tumor necrosis factor (TNF)-induced optic nerve degeneration. Brimonidine has been shown to have protective effects on retinal ganglion cell bodies, although its role in their axons remains to be examined. We determined whether brimonidine modulates axonal loss induced by TNF and affects the expression of p62 in the optic nerve. Experiments were performed on adult male Wistar rats that received an intravitreal injection of 10 ng TNF alone or simultaneous injection of TNF and 2, 20, or 200 pmol of brimonidine tartrate. The expression of p62 in the optic nerve was examined by immunoblot analysis. The effects of brimonidine on axons were evaluated by counting axon numbers 2 weeks after intravitreal injection. Intravitreal injection of brimonidine exerted substantial axonal protection against TNF-induced optic nerve degeneration. Immunoblot analysis showed that p62 was upregulated in the optic nerve after intravitreal injection of TNF, and that this increase was completely inhibited by brimonidine. Treatment with brimonidine alone also significantly decreased p62 protein levels in the optic nerve compared with the basal level. These results suggest that the modulation of p62 levels in the optic nerve by brimonidine may be involved partly in its axonal protection.	[Kitaoka, Yasushi; Kojima, Kaori; Munemasa, Yasunari; Sase, Kana; Takagi, Hitoshi] St Marianna Univ, Sch Med, Dept Ophthalmol, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan; [Kitaoka, Yasushi] St Marianna Univ, Grad Sch Med, Dept Mol Neurosci, Miyamae Ku, Kawasaki, Kanagawa 2168511, Japan	Kitaoka, Y (reprint author), St Marianna Univ, Sch Med, Dept Ophthalmol, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	kitaoka@marianna-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [24592683, 23792016]	This work was supported by Grants-in-Aid No. 24592683 (YK) and No. 23792016 (YM) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. We thank Ms. Yukari Hara for skillful technical support.	Kitaoka Y, 2009, J NEUROPATH EXP NEUR, V68, P915, DOI 10.1097/NEN.0b013e3181afecfa; Fuchs R, 2011, EXP CELL RES, V317, P2239, DOI 10.1016/j.yexcr.2011.07.005; Korolchuk VI, 2009, MOL CELL, V33, P517, DOI 10.1016/j.molcel.2009.01.021; Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; Puissant A, 2012, AM J CANCER RES, V2, P397; Lizaso A, 2013, AUTOPHAGY, V9, P1228, DOI 10.4161/auto.24893; Johansen T, 2011, AUTOPHAGY, V7, P279, DOI 10.4161/auto.7.3.14487; Gal J, 2007, J BIOL CHEM, V282, P11068, DOI 10.1074/jbc.M608787200; Tanabe F, 2011, AUTOPHAGY, V7, P1462, DOI 10.4161/auto.7.12.17892; Yan XM, 2000, ARCH OPHTHALMOL-CHIC, V118, P666; Lopez-Herrera MPL, 2002, EXP NEUROL, V178, P243, DOI 10.1006/exnr.2002.8043; Lafuente MP, 2001, INVEST OPHTH VIS SCI, V42, P2074; Joassard OR, 2013, INT J BIOCHEM CELL B, V45, P2444, DOI 10.1016/j.biocel.2013.07.019; Kitaoka Y, 2006, INVEST OPHTH VIS SCI, V47, P1448, DOI 10.1167/iovs.05-0299; Danylkova NO, 2007, EXP EYE RES, V84, P293, DOI 10.1016/j.exer.2006.10.002; Bjorkoy G, 2009, METHOD ENZYMOL, V452, P181, DOI 10.1016/S0076-6879(08)03612-4; Kuusisto E, 2002, NEUROPATH APPL NEURO, V28, P228, DOI 10.1046/j.1365-2990.2002.00394.x; Kitaoka Y, 2011, ENDOCRINOLOGY, V152, P2775, DOI 10.1210/en.2011-0046; Zatloukal K, 2002, AM J PATHOL, V160, P255, DOI 10.1016/S0002-9440(10)64369-6; Tezel G, 2000, J NEUROSCI, V20, P8693; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Kim HS, 2007, VISUAL NEUROSCI, V24, P127, DOI 10.1017/S0952523807070150; Gao H, 2002, ARCH OPHTHALMOL-CHIC, V120, P797; Sawada H, 2010, INVEST OPHTH VIS SCI, V51, P903, DOI 10.1167/iovs.09-4247; Tezel G, 2001, INVEST OPHTH VIS SCI, V42, P1787; Yuan L, 2000, GLIA, V32, P42, DOI 10.1002/1098-1136(200010)32:1<42::AID-GLIA40>3.0.CO;2-3; Aranguiz-Urroz P, 2011, BBA-MOL BASIS DIS, V1812, P23, DOI 10.1016/j.bbadis.2010.07.003; Fujita Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.298; Kitaoka Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.391; Kojima K, 2014, NEUROSCI LETT, V581, P37, DOI 10.1016/j.neulet.2014.08.021; Lafuente MP, 2002, EXP EYE RES, V74, P181, DOI 10.1006/exer.2001.1122; Lambert WS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-4; Lee D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047098; Levkovitch-Verbin H, 2000, INVEST OPHTH VIS SCI, V41, P4169; Prokosch V, 2010, INVEST OPHTH VIS SCI, V51, P6688, DOI 10.1167/iovs.09-4835; Zhang YB, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.77	36	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	AUG	2015	253	8					1291	1296		10.1007/s00417-015-3005-3		6	Ophthalmology	Ophthalmology	CN9AA	WOS:000358736700012		
J	Hirasawa, K; Shoji, N; Kobashi, C; Yamanashi, A				Hirasawa, Kazunori; Shoji, Nobuyuki; Kobashi, Chieko; Yamanashi, Ayaka			Effects of mydriasis and miosis on kinetic perimetry findings in normal participants	GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY			English	Article						Automated kinetic perimetry; Kinetic perimetry; Pupillary dilation; Pupillary constriction; Octopus 900 perimeter	VISUAL-FIELD; AUTOMATED PERIMETRY; REACTION-TIME; PUPIL; PILOCARPINE; THRESHOLDS; MOVEMENT	To evaluate the effects of pharmacologically induced mydriasis and miosis on kinetic perimetry findings in normal participants. Thirty-eight eyes of 38 healthy young participants underwent kinetic perimetry (Octopus 900 perimeter) with III4e, I4e, I3e, I2e, and I1e stimuli. For each participant, 24 predetermined meridians with 15A degrees intervals were automatically tested with a velocity of 3A degrees/s under normal, mydriatic, and miotic conditions. Mydriasis and miosis were induced by one drop of 0.4 % tropicamide and 2 % pilocarpine hydrochloride, respectively. The isopter area and kinetic sensitivity were compared between the three pupil conditions. The average pupil size in the normal condition was 5.6 +/- 0.9 mm, and it significantly increased to 8.5 +/- 0.7 mm after mydriasis (p < 0.01) and decreased to 3.4 +/- 0.8 mm after miosis (p < 0.01). Compared to the normal pupil, the isopter area of the dilated pupil was not significantly different under the III4e stimulus; however, it significantly decreased under the I4e, I3e, I2e, and I1e stimuli (p < 0.01). Compared to the normal pupil, the isopter area of the constricted pupil significantly decreased (p < 0.01) with the III4e stimulus and significantly increased with the I3e and I2e stimuli (p < 0.05). For both pupil conditions, kinetic sensitivity at each meridian showed a similar trend to the isopter area under each stimulus. The isopter area of the dilated pupil generally decreased, whereas the isopter area of the constricted pupil showed various findings. Therefore, careful attention should be paid to changes in the isopter area associated with changes in the pupil size.	[Hirasawa, Kazunori; Shoji, Nobuyuki; Kobashi, Chieko; Yamanashi, Ayaka] Kitasato Univ, Orthopt & Visual Sci, Sch Allied Hlth Sci, Dept Rehabil,Minami Ku, Sagamihara, Kanagawa 2520374, Japan	Hirasawa, K (reprint author), Kitasato Univ, Orthopt & Visual Sci, Sch Allied Hlth Sci, Dept Rehabil,Minami Ku, 1-15-1 Kitasato, Sagamihara, Kanagawa 2520374, Japan.	hirasawa@kitasato-u.ac.jp					Besada E, 2011, J CLIN PHARMACOL, V51, P1690, DOI 10.1177/0091270010385932; Edgar DF, 1999, GRAEF ARCH CLIN EXP, V237, P117, DOI 10.1007/s004170050206; Freeman MH, 2003, EYE OPTICAL INSTRUME; Gerente VM, 2007, J OCUL PHARMACOL TH, V23, P476, DOI 10.1089/jop.2007.0017.R1; GOLDMANN H, 1945, OPHTHALMOLOGICA, V109, P57; HERSE PR, 1992, INVEST OPHTH VIS SCI, V33, P611; Hirasawa K, 2014, VISION RES, V98, P83, DOI 10.1016/j.visres.2014.03.010; JOHNSON CA, 1987, ARCH OPHTHALMOL-CHIC, V105, P73; Kee C W, 1987, Korean J Ophthalmol, V1, P52; Kim JM, 2011, JPN J OPHTHALMOL, V55, P356, DOI 10.1007/s10384-011-0046-y; Kudrna G R, 1995, J Am Optom Assoc, V66, P675; LINDENMUTH KA, 1990, OPHTHALMOLOGY, V97, P367; LINDENMUTH KA, 1989, OPHTHALMOLOGY, V96, P1298; MCCLUSKEY DJ, 1986, OPHTHALMOLOGY, V93, P843; Mendivil A, 1997, J GLAUCOMA, V6, P217; Nowomiejska K, 2010, ACTA OPHTHALMOL, V88, P65, DOI 10.1111/j.1755-3768.2008.01407.x; Park H J, 1994, Korean J Ophthalmol, V8, P53; Schiefer U, 2001, VISION RES, V41, P2157, DOI 10.1016/S0042-6989(01)00088-8; Thordsen JE, 2004, J CATARACT REFR SURG, V30, P1702, DOI 10.1016/j.jcrs.2004.03.030; TROBE JD, 1980, AM J OPHTHALMOL, V90, P654; Wakayama A, 2011, VISION RES, V51, P174, DOI 10.1016/j.visres.2010.11.002; WEBSTER AR, 1993, BRIT J OPHTHALMOL, V77, P721, DOI 10.1136/bjo.77.11.721; WEINREB RN, 1986, AM J OPHTHALMOL, V101, P706; WOOD JM, 1988, OPHTHAL PHYSL OPT, V8, P26, DOI 10.1111/j.1475-1313.1988.tb01078.x	24	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0721-832X	1435-702X		GRAEF ARCH CLIN EXP	Graefes Arch. Clin. Exp. Ophthalmol.	AUG	2015	253	8					1341	1346		10.1007/s00417-015-3048-5		6	Ophthalmology	Ophthalmology	CN9AA	WOS:000358736700018		
J	Murata, A; Ohtani, M; Muramatsu, K; Matsuda, S				Murata, Atsuhiko; Ohtani, Makoto; Muramatsu, Keiji; Matsuda, Shinya			Influence of comorbidity on outcomes of older patients with acute pancreatitis based on a national administrative database	HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL			English	Article						acute pancreatitis; comorbidity; length of stay; databases	ENDOSCOPIC SUBMUCOSAL DISSECTION; GASTRIC-CANCER; HOSPITAL VOLUME; LAPAROSCOPIC GASTRECTOMY; EPIDEMIOLOGIC SURVEY; FLUID RESUSCITATION; UNITED-STATES; TIME TREND; JAPAN; COMPLICATIONS	BACKGROUND: Little information is available on the influence of comorbidities on outcomes of older patients with acute pancreatitis. This study aimed to investigate the influence of comorbidities on outcomes of older patients with acute pancreatitis using data from a national Japanese administrative database. METHODS: A total of 14 322 older patients (>70 years) with acute pancreatitis were referred to 1090 hospitals between 2010 and 2012 in Japan. We collected patients' data from the administrative database to compare the in-hospital mortality and length of stay of older patients with acute pancreatitis. The patients were categorized into four groups according to comorbidity level using the Charlson Comorbidity Index (CCI): none (CCI score=0; n=6890); mild (1; n=3874); moderate (2; n=2192) and severe (>= 3; n=1366). RESULTS: Multiple logistic and linear regression analyses revealed that severe comorbidity was significantly associated with higher in-hospital mortality and longer length of stay [odds ratio (OR)=2.26; 95% confidence interval (CI): 1.75-2.92, P<0.001 and coefficient 4.37 days; 95% CI: 2.89-5.85, P<0.001, respectively]. In addition, cardiovascular and renal diseases were the most significant comorbidities affecting outcomes of the older patients. ORs of cardiovascular and renal diseases for mortality were 1.44 (95% CI: 1.13-1.85, P=0.003) and 2.69 (95% CI: 1.88-3.85, P<0.001), respectively, and coefficients for length of stay were 3.01 days (95% CI: 1.34-4.67, P<0.001) and 3.72 days (95% CI: 1.01-6.42,P=0.007), respectively. CONCLUSION: This study demonstrated that comorbidities significantly influenced outcomes of older patients with acute pancreatitis and cardiovascular and renal comorbidities were significant factors affecting outcomes.	[Murata, Atsuhiko; Ohtani, Makoto; Muramatsu, Keiji; Matsuda, Shinya] Univ Occupat & Environm Hlth, Sch Med, Dept Prevent Med & Community Hlth, Kitakyushu, Fukuoka 8078555, Japan	Murata, A (reprint author), Univ Occupat & Environm Hlth, Sch Med, Dept Prevent Med & Community Hlth, Yahatanishi Ku, 1-1 Iseigaoka, Kitakyushu, Fukuoka 8078555, Japan.	amurata@med.uoeh-u.ac.jp			Ministry of Health, Labor and Welfare, Japan	This study was supported by grants-in-aid from the Research on Policy Planning and Evaluation from the Ministry of Health, Labor and Welfare, Japan.	Akshintala VS, 2013, PANCREAS, V42, P1245, DOI 10.1097/MPA.0b013e3182a85af3; Murata A, 2014, SURG ENDOSC, V28, P1298, DOI 10.1007/s00464-013-3326-4; Amano H, 2010, J HEPATO-BIL-PAN SCI, V17, P53, DOI 10.1007/s00534-009-0211-6; Murata A, 2014, J THROMB THROMBOLYS, V38, P364, DOI 10.1007/s11239-014-1068-3; Gardner TB, 2009, PANCREATOLOGY, V9, P770, DOI 10.1159/000210022; Murata A, 2012, DIGEST LIVER DIS, V44, P143, DOI 10.1016/j.dld.2011.08.011; Roberts SE, 2013, ALIMENT PHARM THER, V38, P539, DOI 10.1111/apt.12408; Murata A, 2014, J SURG RES, V186, P157, DOI 10.1016/j.jss.2013.09.015; Satoh K, 2011, PANCREAS, V40, P503, DOI 10.1097/MPA.0b013e318214812b; Takeda K, 2010, J HEPATO-BIL-PAN SCI, V17, P37, DOI 10.1007/s00534-009-0213-4; Li H, 2010, J CRIT CARE, V25, P225, DOI 10.1016/j.jcrc.2009.07.009; Murata A, 2011, J HEPATO-BIL-PAN SCI, V18, P678, DOI 10.1007/s00534-011-0375-8; Hirota M, 2010, J HEPATO-BIL-PAN SCI, V17, P45, DOI 10.1007/s00534-009-0210-7; Singh VK, 2011, CLIN GASTROENTEROL H, V9, P1098, DOI 10.1016/j.cgh.2011.08.026; Warndorf MG, 2011, CLIN GASTROENTEROL H, V9, P705, DOI 10.1016/j.cgh.2011.03.032; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Peery AF, 2012, GASTROENTEROLOGY, V143, P1179, DOI 10.1053/j.gastro.2012.08.002; Murata A, 2014, GASTRIC CANCER, V17, P294, DOI 10.1007/s10120-013-0282-6; de-Madaria E, 2011, AM J GASTROENTEROL, V106, P1843, DOI 10.1038/ajg.2011.236; Wolff JL, 2002, ARCH INTERN MED, V162, P2269, DOI 10.1001/archinte.162.20.2269; Murata A, 2011, PANCREAS, V40, P1018, DOI 10.1097/MPA.0b013e31821bd233; de-Madaria Enrique, 2014, Pancreatology, V14, P433, DOI 10.1016/j.pan.2014.09.008; Frey C, 2007, J GASTROINTEST SURG, V11, P733, DOI 10.1007/s11605-007-0164-5; Hamada S, 2014, PANCREAS, V43, P1244, DOI 10.1097/MPA.0000000000000200; Kong L, 2004, WORLD J GASTROENTERO, V10, P3336; Li Xiao-Yan, 2010, World J Emerg Med, V1, P201; McNabb-Baltar J, 2014, PANCREAS, V43, P687, DOI 10.1097/MPA.0000000000000123; Murata A, 2015, ASIAN J SURG, V38, P33, DOI 10.1016/j.asjsur.2014.04.008; Murata A, 2013, GERIATR GERONTOL INT, V13, P731, DOI 10.1111/j.1447-0594.2012.00938.x; Murata A, 2014, J DIGEST DIS, V15, P62, DOI 10.1111/1751-2980.12106; Murray SB, 2006, ACAD EMERG MED, V13, P530, DOI 10.1197/j.aem.2005.11.084; Olsson T, 2005, EUR J EMERG MED, V12, P220, DOI 10.1097/00063110-200510000-00004; Starfield Barbara, 2003, Ann Fam Med, V1, P8, DOI 10.1370/afm.1; Wada K, 2010, J HEPATO-BIL-PAN SCI, V17, P79, DOI 10.1007/s00534-009-0218-z	34	0	0	ZHEJIANG UNIV SCH MEDICINE	HANGZHOU	FIRST AFFILIATED HOSPITAL, 79 QINGCHUN ROAD, HANGZHOU, 310003, PEOPLES R CHINA	1499-3872			HEPATOB PANCREAT DIS	Hepatob. Pancreatic. Dis. Int.	AUG	2015	14	4					422	428		10.1016/S1499-3872(15)60398-8		7	Gastroenterology & Hepatology	Gastroenterology & Hepatology	CO6KX	WOS:000359266700012		
J	Shimanuki, Y; Mitmi, H; Fukumura, Y; Makino, S; Itakura, A; Yao, T; Takeda, S				Shimanuki, Yota; Mitmi, Hiroyuki; Fukumura, Yuki; Makino, Shintaro; Itakura, Atsuo; Yao, Takashi; Takeda, Satoru			Alteration of Delta-like ligand 1 and Notch 1 receptor in various placental disorders with special reference to early onset preeclampsia	HUMAN PATHOLOGY			English	Article						Notch signaling; Methylation; DLL1; Placenta; Preeclampsia	FETAL-GROWTH RESTRICTION; PROMOTER HYPOMETHYLATION; ENDOVASCULAR INVASION; GENE-EXPRESSION; DNA METHYLATION; PROTEIN MEMBERS; PREGNANCY; RISK	Notch signaling pathway has been shown to be dysregulated in placentas with preeclampsia, but there has been a lack of studies on methylation of Notch family genes in this disorder. We therefore executed methylation-specific polymerase chain reaction and immunostaining for Notch 1 receptor and the activating ligand, Delta-like (DLL) 1, with placental tissues from cases of preeclampsia (early onset, n = 18; late-onset, n = 19) and other placental disorders, including maternal complications such as diabetes mellitus and collagen disease (n = 10), fetal growth restriction (n = 17), fetal anomaly (n = 23), preterrn birth (n = 15), miscarriage (n = 25), and hydatidiform moles (n = 9) as well as term births (n = 12). The frequency of DLL1 methylation was higher in early onset preeclamptic placentas (61%) than the other subjects (0%-36%;P <= 016). Appreciable samples (36%) of miscarriage also represented DLL1 methylation. None of the samples studied showed Notch 1 methylation. On gestational period-matched analysis, the rate of DLL1 methylation was higher in early onset preeclampsia (83.3%) than preterm birth (13.3%; P < .001), with no significant differences in clinical backgrounds between the two. In this analysis, increase of syncytial knots and accelerated vinous maturation were most prominent in DLL1-methylated placentas with early onset preeclampsia. Notch 1 and DLL1 expressions in vinous trophoblasts and endothelial cells were significantly lower in early onset preeclamptic placentas as compared with preterm birth controls. In conclusion, altered Notch signaling via methylation of DLL1 is likely involved in possible disease-related mechanisms of early onset preeclampsia. Alternatively, DLL1 methylation in early onset preeclampsia could be a manifestation of a lack of placental maturation; similar to miscarriage. (C) 2015 Elsevier Inc. All rights reserved.	[Shimanuki, Yota; Makino, Shintaro; Itakura, Atsuo; Takeda, Satoru] Juntendo Univ, Sch Med, Dept Obstet & Gynecol, Bunkyo Ku, Tokyo 1138421, Japan; [Shimanuki, Yota; Fukumura, Yuki; Yao, Takashi] Juntendo Univ, Sch Med, Dept Human Pathol, Bunkyo Ku, Tokyo 1138421, Japan; [Mitmi, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Surg & Mol Pathol, Shimotsuga, Tochigi 3210293, Japan	Mitmi, H (reprint author), Dokkyo Med Univ, Sch Med, Dept Surg & Mol Pathol, Shimotsuga, Tochigi 3210293, Japan.	yshima@juntendo.ac.jp; hmitomi@dokkyomed.ac.jp; yfuku@med.juntendo.ac.jp; shintaro@juntendo.ac.jp; a-itakur@juntendo.ac.jp; tyao@juntendo.ac.jp; stakeda@juntendo.ac.jp			Japan Society for the Promotion of Science [24590429]	The authors thank Keiko Mitani, Noriko Sasahara, and Michiko Takahashi for their histologic assistance. The work was supported in part by a Grant-in-Aid from the Japan Society for the Promotion of Science (no. 24590429 to Hiroyuki Mitomi).	Limbourg A, 2007, CIRC RES, V100, P363, DOI 10.1161/01.RES.0000258174.77370.2c; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207; Issa JPJ, 2001, CANCER RES, V61, P3573; Roberts JM, 2005, HYPERTENSION, V46, P1243, DOI 10.1161/01.HYP.0000188408.49896.c5; Sekizawa A, 2003, AM J OBSTET GYNECOL, V188, P480, DOI 10.1067/mob.2003.27; Hunkapiller NM, 2011, DEVELOPMENT, V138, P2987, DOI 10.1242/dev.066589; Cobellis L, 2007, CELL TISSUE RES, V330, P527, DOI 10.1007/s00441-007-0511-6; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Fleming RJ, 1998, SEMIN CELL DEV BIOL, V9, P599, DOI 10.1006/scdb.1998.0260; Zhou Y, 1997, J CLIN INVEST, V99, P2152, DOI 10.1172/JCI119388; Taki A, 2012, CONGENIT ANOM, V52, P97, DOI 10.1111/j.1741-4520.2012.00359.x; Yuen RKC, 2010, EUR J HUM GENET, V18, P1006, DOI 10.1038/ejhg.2010.63; Maekita T, 2006, CLIN CANCER RES, V12, P989, DOI 10.1158/1078-0432.CCR-05-2096; Correa RRM, 2008, ARCH GYNECOL OBSTET, V277, P201, DOI 10.1007/s00404-007-0452-z; Sitras V, 2009, PLACENTA, V30, P424, DOI 10.1016/j.placenta.2009.01.012; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Swift MR, 2009, CIRC RES, V104, P576, DOI 10.1161/CIRCRESAHA.108.188805; Meng T, 2012, OMICS, V16, P301, DOI 10.1089/omi.2011.0066; Muller K, 2001, J BIOL CHEM, V276, P14271; Barker D J, 1997, Rev Reprod, V2, P105, DOI 10.1530/ror.0.0020105; De Falco M, 2007, PLACENTA, V28, P118, DOI 10.1016/j.placenta.2006.03.010; Egbor M, 2006, BJOG-INT J OBSTET GY, V113, P580, DOI 10.1111/j.1471-0528.2006.00882.x; Fajardy I, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-21; Herr F, 2011, PLACENTA, V32, P554, DOI 10.1016/j.placenta.2011.04.018; Hubei CA, 2009, PLACENTA SA, V30, P532; Johansson A, 2011, HUM GENET, V129, P25, DOI 10.1007/s00439-010-0893-5; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Lisonkova S, 2014, OBSTET GYNECOL, V124, P771, DOI 10.1097/AOG.0000000000000472; Liu Q, 2014, PLACENTA, V35, P876, DOI 10.1016/j.placenta.2014.08.088; Loset M, 2011, AM J OBSTET GYNECOL, V204, pe1, DOI [10.1016/j.ajog.2010.08.043, DOI 10.1016/J.AJOG.2010.08.043]; Gifford RW, 2000, AM J OBSTET GYNECOL, V183, pS1, DOI 10.1067/mob.2000.107928; Sankar K Devi, 2012, Anat Cell Biol, V45, P86, DOI 10.5115/acb.2012.45.2.86; Selcizawa A, 2007, J OBSTET GYNECOL RES, V33, P747; Smith GCS, 2001, LANCET, V357, P2002, DOI 10.1016/S0140-6736(00)05112-6; Vinnars MT, 2008, HYPERTENSION, V51, P1295, DOI 10.1161/HYPERTENSIONAHA.107.104844	36	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	AUG	2015	46	8					1129	1137		10.1016/j.humpath.2015.03.013		9	Pathology	Pathology	CN8PG	WOS:000358702500005		
J	Nakamura, Y; Yaguchi, C; Itoh, H; Sakamoto, R; Kimura, T; Furuta, N; Uchida, T; Tamura, N; Suzuki, K; Sumimoto, K; Matsuda, Y; Matsuura, T; Nishimura, M; Kanayama, N				Nakamura, Yuki; Yaguchi, Chizuko; Itoh, Hiroaki; Sakamoto, Ryoko; Kimura, Takako; Furuta, Naomi; Uchida, Toshiyuki; Tamura, Naoaki; Suzuki, Kazunao; Sumimoto, Kazuhiro; Matsuda, Yumiko; Matsuura, Toshiki; Nishimura, Mitsuru; Kanayama, Naohiro			Morphologic characteristics of the placental basal plate in in vitro fertilization pregnancies: a possible association with the amount of bleeding in delivery	HUMAN PATHOLOGY			English	Article						Placenta; Pregnancy; Delivery; Postpartum hemorrhage (PPH); Assisted reproductive technology (ART)	ASSISTED REPRODUCTIVE TECHNOLOGY; SINGLETON PREGNANCIES; PERINATAL OUTCOMES; INVITRO FERTILIZATION; MATERNAL FACTORS; EMBRYO-TRANSFER; BIRTH; METAANALYSIS; CONCEPTION; FRESH	The aim of the present study was to investigate the relationship between assisted reproductive technology procedures, the morphology of the basal plate of placentas, and amount of bleeding in deliveries. Fifty-five whole placentas (fresh-embryo transfer in the in vitro fertilization cycle [n = 6], frozen-thawed embryo transfer in the natural cycle [n = 13] or in the hormonal cycle [n = 10], and age-matched spontaneously conceived pregnancies [n = 26]) were retrospectively enrolled and histologically analyzed. The whole placentas were stored in our pathological division among 512 singleton pregnancies with vaginal deliveries (34-41 weeks of gestation) at Hamamatsu University Hospital. The morphology of the placental basal plate was examined using Azan staining. A total of 20 digital images (each 0.53 mm(2)) of microscopic fields were analyzed per placenta to measure the mean values of the vertical maximum thickness of Rohr and Nitabuch fibrinoid layers and % loss of decidua. The thickness of Rohr fibrinoid layer and % loss of decidua were significantly higher in the frozen-thawed embryo transfer in the hormonal cycle group than in the frozen-thawed embryo transfer in the natural cycle and spontaneously conceived pregnancy groups (each P < .01). The z scores for both the thickness of Rohr fibrinoid layer and % loss of decidua positively correlated with those for the amount of bleeding in deliveries (P < .05 each). Assisted reproductive technology procedures changed the morphology of the placental basal plate, suggesting a possible association with an increase in the amount of bleeding in deliveries. (C) 2015 Elsevier Inc. All rights reserved.	[Nakamura, Yuki; Yaguchi, Chizuko; Itoh, Hiroaki; Sakamoto, Ryoko; Kimura, Takako; Furuta, Naomi; Uchida, Toshiyuki; Tamura, Naoaki; Suzuki, Kazunao; Kanayama, Naohiro] Hamamatsu Univ, Sch Med, Dept Obstet & Gynecol, Hamamatsu, Shizuoka 3413192, Japan; [Sumimoto, Kazuhiro] Tsuruga Nursing Univ, Tsuruga, Fukui 9140814, Japan; [Matsuda, Yumiko; Matsuura, Toshiki] ACT Tower Clin, Hamamatsu, Shizuoka 4307707, Japan; [Nishimura, Mitsuru] Nishimura Womens Clin, Hamamatsu, Shizuoka 4338122, Japan	Itoh, H (reprint author), Hamamatsu Univ, Sch Med, Dept Obstet & Gynecol, Higashi Ku, 1-20-1 Handayama, Hamamatsu, Shizuoka 3413192, Japan.	hitou-endo@umin.ac.jp			Ministry of Education, Science, Culture and Sports, Japan [25670490, 24390273]	This study was supported, in part, by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, Culture and Sports, Japan (No. 25670490 and No. 24390273).	Altshuler G, 1996, CLIN OBSTET GYNECOL, V39, P549, DOI 10.1097/00003081-199609000-00006; Hayashi M, 2012, FERTIL STERIL, V98, P922, DOI 10.1016/j.fertnstert.2012.05.049; Maheshwari A, 2012, FERTIL STERIL, V98, P368, DOI 10.1016/j.fertnstert.2012.05.019; GAVRIIL P, 1993, PEDIATR PATHOL, V13, P453; Oron E, 2012, PHYS BIOL, V9, DOI 10.1088/1478-3975/9/4/045002; Romundstad LB, 2008, LANCET, V372, P737, DOI [10.1016/S0140-6736(08)61041-7, 10.1016/S01406736(08)61041-7]; Shih W, 2008, HUM REPROD, V23, P1644, DOI 10.1093/humrep/den150; Schieve LA, 2007, MATERN CHILD HLTH J, V11, P517, DOI 10.1007/s10995-007-0202-7; Jackson RA, 2004, OBSTET GYNECOL, V103, P551, DOI 10.1097/01.AOG.0000114989.84822.51; Mayhew TM, 2008, PLACENTA, V29, P1, DOI 10.1016/j.placenta.2007.05.010; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; Bower C, 2005, REPROD FERT DEVELOP, V17, P329, DOI 10.1071/RD04095; BURTON G, 1988, AUST NZ J OBSTET GYN, V28, P180, DOI 10.1111/j.1479-828X.1988.tb01659.x; Cunningham FG, 2010, PARTURITION WILLIAMS, V23rd, P136; Daniel Y, 1999, HUM REPROD, V14, P1107, DOI 10.1093/humrep/14.4.1107; De Geyter C, 2006, HUM REPROD, V21, P705, DOI 10.1093/humrep/dei378; ENGLERT Y, 1987, HUM REPROD, V2, P155; Furuta N, 2012, PLACENTA, V33, P24, DOI 10.1016/j.placenta.2011.10.007; Helmerhorst FM, 2004, BRIT MED J, V328, P261, DOI 10.1136/bmj.37957.560278.EE; JAUNIAUX E, 1990, OBSTET GYNECOL, V76, P61; Lambert RD, 2003, HUM REPROD, V18, P1987, DOI 10.1093/humrep/deg361; Nitabuch R, 1887, THESIS STAMPFLI BERN; Rohr K, 1889, VIRCHOWS ARCH PATHOL, V115, P505; SUTCLIFFE RG, 1982, PLACENTA, V3, P297, DOI 10.1016/S0143-4004(82)80006-4; Thomson F, 2005, BJOG, V112, P632; Thu JL, 2007, OBSTET GYNECOL, V110, P1326; Wang JX, 2002, HUM REPROD, V17, P945, DOI 10.1093/humrep/17.4.945; WILLIAMS H, 1994, AUST NZ J OBSTET GYN, V34, P480, DOI 10.1111/j.1479-828X.1994.tb01277.x; Wolska W, 1888, THESIS BERN; WYNN RM, 1967, AM J OBSTET GYNECOL, V97, P832	30	0	0	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0046-8177	1532-8392		HUM PATHOL	Hum. Pathol.	AUG	2015	46	8					1171	1179		10.1016/j.humpath.2015.04.007		9	Pathology	Pathology	CN8PG	WOS:000358702500010		
J	Demura, M; Demura, Y; Takeda, Y; Saijoh, K				Demura, Masashi; Demura, Yosiki; Takeda, Yoshiyu; Saijoh, Kiyofumi			Dynamic regulation of the angiotensinogen gene by DNA methylation, which is influenced by various stimuli experienced in daily life	HYPERTENSION RESEARCH			English	Review						angiotensinogen; corticosteroid; DNA demethylation; DNA remethylation; visceral adipose tissue	HUMAN ADIPOSE-TISSUE; HEPATOMA-CELL LINE; BLOOD-PRESSURE; PROMOTER ACTIVITY; WIDE ASSOCIATION; BINDING-PROTEINS; EXPRESSION; HYPERTENSION; TRANSCRIPTION; DEMETHYLATION	Angiotensinogen (AGT) has a central role in maintaining blood pressure and fluid balance. DNA methylation is an epigenomic modification maintaining a steady pattern in somatic cells. Herein we summarize the link between AGT regulation and DNA methylation. DNA methylation negatively regulates AGT expression and dynamically changes in response to continuous AGT promoter stimulation. High-salt intake and excess circulating aldosterone cause DNA demethylation around the CCAAT enhancer-binding protein-binding sites, thereby converting the phenotype of AGT expression from an inactive to an active state in visceral adipose tissue. Salt-dependent hypertension may be partially affected by increased adipose AGT expression. Because angiotensin II is a well-established aldosterone-releasing hormone, stimulation of adipose AGT by aldosterone creates a positive feedback loop. This effect is pathologically associated with obesity-related hypertension, although it would be physiologically favorable for humans to efficiently retain their body fluid. The clear difference in DNA demethylation patterns between aldosterone and cortisol indicates a difference in the respective target DNA-binding sites between mineralocorticoid and glucocorticoid receptors in the AGT promoter. Stimulation-induced interactions between transcription factors and target DNA-binding sites trigger DNA demethylation. Dynamic changes in DNA methylation occur in relaxed chromatin regions both where transcription factors actively interact and where transcription is initiated. In contrast to rapid histone modifications, DNA demethylation and remethylation will progress relatively slowly over days or years. A wide variety of stimuli in daily life will continue to slowly and dynamically change DNA methylation patterns throughout life. Wise choices of beneficial stimuli will improve health.	[Demura, Masashi; Saijoh, Kiyofumi] Kanazawa Univ, Grad Sch Med Sci, Dept Hyg, Kanazawa, Ishikawa 9208640, Japan; [Demura, Yosiki] Fukui Red Cross Hosp, Dept Resp Med, Fukui, Japan; [Takeda, Yoshiyu] Kanazawa Univ, Grad Sch Med Sci, Div Endocrinol & Hypertens, Kanazawa, Ishikawa 9208640, Japan	Demura, M (reprint author), Kanazawa Univ, Grad Sch Med Sci, Dept Hyg, Kanazawa, Ishikawa 9208640, Japan.	m-demura@med.kanazawa-u.ac.jp	DEMURA, Masashi/E-1278-2011	DEMURA, Masashi/0000-0003-4156-1640	Japan Society for Takeda Science Foundation	This study was supported by the Japan Society for Takeda Science Foundation (to M Demura).	Masuzaki H, 2003, J CLIN INVEST, V112, P83, DOI 10.1172/JCI200317845; van Harmelen V, 2000, OBES RES, V8, P337, DOI 10.1038/oby.2000.40; Wang F, 2014, HYPERTENSION, V63, P281, DOI 10.1161/HYPERTENSIONAHA.113.02303; Bruniquel D, 2003, NAT IMMUNOL, V4, P235, DOI 10.1039/ni887; Petersen AK, 2014, HUM MOL GENET, V23, P534, DOI 10.1093/hmg/ddt430; Yiannikouris F, 2012, HYPERTENSION, V60, P1524, DOI 10.1161/HYPERTENSIONAHA.112.192690; Yiannikouris F, 2012, AM J PHYSIOL-REG I, V302, pR244, DOI 10.1152/ajpregu.00323.2011; Miller CA, 2010, NAT NEUROSCI, V13, P664, DOI 10.1038/nn.2560; Zhao YY, 1999, HYPERTENSION, V33, P108; Arai Y, 2011, J REPROD DEVELOP, V57, P507, DOI 10.1262/jrd.11-034A; Ballestar E, 2001, EUR J BIOCHEM, V268, P1, DOI 10.1046/j.1432-1327.2001.01869.x; Thillainadesan G, 2012, MOL CELL, V46, P636, DOI 10.1016/j.molcel.2012.03.027; Bogdarina I, 2007, CIRC RES, V100, P520, DOI 10.1161/01.RES.0000258855.60637.58; Olearczyk J, 2014, HYPERTENS RES, V37, P405, DOI 10.1038/hr.2013.155; Adams JM, 2007, HYPERTENSION, V50, P354, DOI 10.1161/HYPERTENSIONAHA.107.091843; Thomassin H, 2001, EMBO J, V20, P1974, DOI 10.1093/emboj/20.8.1974; Takeshima H, 2009, GENOME RES, V19, P1974, DOI 10.1101/gr.093310.109; Massiera F, 2001, FASEB J, V15, P2727, DOI 10.1096/fj.01-0457fje; Gorzelniak K, 2002, J HYPERTENS, V20, P965, DOI 10.1097/00004872-200205000-00032; Yasue S, 2010, AM J HYPERTENS, V23, P425, DOI 10.1038/ajh.2009.263; Simmonds SS, 2014, HYPERTENSION, V64, P583, DOI 10.1161/HYPERTENSIONAHA.114.03250; Kangaspeska S, 2008, NATURE, V452, P112, DOI 10.1038/nature06640; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; OLIVER WJ, 1975, CIRCULATION, V52, P146; Aubert J, 1997, BIOCHEM J, V328, P701; Baudrand R, 2013, CLIN ENDOCRINOL OXF, V80, P677; BENARI ET, 1989, J BIOL CHEM, V264, P13074; BENARI ET, 1988, AM J PHYSIOL, V255, pE70; Bind MA, 2014, EPIDEMIOLOGY, V25, P561, DOI 10.1097/EDE.0000000000000120; BRASIER AR, 1990, MOL ENDOCRINOL, V4, P1921; CAMPBELL D J, 1987, Journal of Cardiovascular Pharmacology, V10, pS1; CAMPBELL DJ, 1985, J CLIN INVEST, V75, P1880, DOI 10.1172/JCI111902; CHANG E, 1987, ENDOCRINOLOGY, V121, P513; Dickson ME, 2008, CIRC RES, V103, P940, DOI 10.1161/CIRCRESAHA.108.180653; Goossens GH, 2007, HYPERTENSION, V49, P542, DOI 10.1161/01.HYP.0000256091.55393.92; Guo X, 2014, NATURE, V517, P640, DOI DOI 10.1038/NATURE13899; Gur M, 2013, HYPERTENS RES, V36, P166, DOI 10.1038/hr.2012.156; Hong YC, 2013, HYPERTENS RES, V36, P540, DOI 10.1038/hr.2012.218; Jain S, 2002, J BIOL CHEM, V277, P36889, DOI 10.1074/jbc.M204732200; Jain S, 2007, AM J PHYSIOL-CELL PH, V293, pC401, DOI 10.1152/ajpcell.00433.2006; Jain S, 2005, J MOL MED-JMM, V83, P121, DOI 10.1007/s00109-004-0621-5; KRAKOFF LR, 1973, J CLIN ENDOCR METAB, V37, P110; KUNAPULI SP, 1987, LIFE SCI, V41, P2397, DOI 10.1016/0024-3205(87)90664-3; Li Y, 2012, BMC MOL BIOL, V13, DOI 10.1186/1471-2199-13-16; Nakajima T, 2009, INT J CANCER, V124, P905, DOI 10.1002/ijc.24018; Oka D, 2009, CANCER, V115, P3412, DOI 10.1002/cncr.24394; Qi Y, 2014, HYPERTENS RES, V37, P134, DOI 10.1038/hr.2013.132; Qiang M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008798; Rahmouni K, 2004, AM J PHYSIOL-ENDOC M, V286, pE891, DOI 10.1152/ajpendo.00551.2003; Ronn T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003572; SCHULE R, 1988, SCIENCE, V242, P1418, DOI 10.1126/science.3201230; Sherman CT, 2001, MOL ENDOCRINOL, V15, P441, DOI 10.1210/me.15.3.441; Turban S, 2002, BIOCHEM J, V362, P113, DOI 10.1042/0264-6021:3620113; Umemura S, 1997, AM J HYPERTENS, V10, P629, DOI 10.1016/S0895-7061(97)00053-8; Yanai K, 1999, J BIOL CHEM, V274, P34605, DOI 10.1074/jbc.274.49.34605; Zhang Y, 2014, ENVIRON HEALTH PERSP, V122, P131, DOI 10.1289/ehp.1306937; ZHAO YY, 1993, CELL MOL BIOL RES, V39, P727	57	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	AUG	2015	38	8					519	527		10.1038/hr.2015.42		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CO2VV	WOS:000359015800001		
J	Saeki, M; Sato, N; Kawasaki, M; Tanaka, R; Nagaya, M; Watanabe, T; Ono, K; Noda, T; Zile, MR; Minatoguchi, S				Saeki, Maki; Sato, Noriaki; Kawasaki, Masanori; Tanaka, Ryuhei; Nagaya, Maki; Watanabe, Takatomo; Ono, Koji; Noda, Toshiyuki; Zile, Michael R.; Minatoguchi, Shinya			Left ventricular layer function in hypertension assessed by myocardial strain rate using novel one-beat real-time three-dimensional speckle tracking echocardiography with high volume rates	HYPERTENSION RESEARCH			English	Article						left ventricular function; left ventricular layer function; real-time three-dimensional echocardiography; speckle-tracking echocardiography	DIASTOLIC HEART-FAILURE; LEFT ATRIAL STRUCTURE; SYSTOLIC FUNCTION; TISSUE DOPPLER; LONGITUDINAL STRAIN; FILLING PRESSURES; EJECTION FRACTION; RADIAL STRAIN; HYPERTROPHY; DEFORMATION	We recently developed novel software to measure phasic strain rate (SR) using automated one-beat real-time three-dimensional speckle tracking echocardiography (3D-STE) with high volume rates. We tested the hypothesis that left ventricular (LV) systolic function and relaxation analyzed by SR with the novel 3D-STE in hypertension (HTN) with hypertrophy may be impaired in the endocardium before there is LV systolic dysfunction. We measured LV longitudinal, radial and circumferential SR in patients with HTN (n=80, 69 +/- 7 years) and age-matched normotensive controls (n=60, 69 +/- 10 years) using 3D-STE. HTN patients were divided into four groups according to LV geometry: normal, concentric remodeling, concentric hypertrophy and eccentric hypertrophy. We measured SR during systole as an index of systolic function, SR during isovolumic relaxation (IVR) as an index of relaxation and E/e' as an index of filling pressure. Endocardial SR during systole in HTN with concentric and eccentric hypertrophy decreased compared with that in controls despite no reduction in ejection fraction or epicardial SR. Endocardial radial SR during IVR decreased even in normal geometry, and it was further reduced in concentric remodeling and hypertrophy despite no reduction in epicardial SR. LV phasic SR assessed by 3D-STE with high volume rates is a useful index to detect early decreases in LV systolic function and to predict subclinical LV layer dysfunction in patients with HTN.	[Saeki, Maki; Sato, Noriaki; Tanaka, Ryuhei; Nagaya, Maki; Ono, Koji; Noda, Toshiyuki] Gifu Prefectural Gen Med Ctr, Dept Cardiol, Gifu, Japan; [Kawasaki, Masanori; Watanabe, Takatomo; Minatoguchi, Shinya] Gifu Univ, Dept Cardiol, Grad Sch Med, Gifu 5011194, Japan; [Zile, Michael R.] Med Univ S Carolina, Med Cardiol, Charleston, SC 29425 USA; [Zile, Michael R.] Ralph H Johnson Dept Vet Affairs Med Ctr, Charleston, SC USA	Kawasaki, M (reprint author), Gifu Univ, Dept Cardiol, Grad Sch Med, 1-1 Yanagido, Gifu 5011194, Japan.	masanori@ya2.so-net.ne.jp					Altiok E, 2012, J AM SOC ECHOCARDIOG, V25, P1179, DOI 10.1016/j.echo.2012.07.019; Wang JW, 2007, CIRCULATION, V115, P1376, DOI 10.1161/CIRCULATIONAHA.106.662882; Baicu CF, 2005, CIRCULATION, V111, P2306, DOI 10.1161/01.CIR.0000164273.57823.26; Zabalgoitia M, 2001, AM J CARDIOL, V88, P521, DOI 10.1016/S0002-9149(01)01730-1; LIMA JAC, 1993, J AM COLL CARDIOL, V21, P1741; Thebault C, 2011, EUR J ECHOCARDIOGR, V12, P26, DOI 10.1093/ejechocard/jeq095; AURIGEMMA GP, 1995, J AM COLL CARDIOL, V26, P195, DOI 10.1016/0735-1097(95)00153-Q; Wang J, 2008, EUR HEART J, V29, P1283, DOI 10.1093/eurheartj/ehn141; Lang RM, 2005, J AM SOC ECHOCARDIOG, V18, P1440, DOI 10.1016/j.echo.2005.10.005; Nagaya M, 2013, J CARDIOL, V62, P188, DOI 10.1016/j.jjcc.2013.03.011; Leitman M, 2010, J AM SOC ECHOCARDIOG, V23, P64, DOI 10.1016/j.echo.2009.10.004; Hirose T, 2012, EUR HEART J-CARD IMG, V13, P243, DOI 10.1093/ejechocard/jer251; Leggio M, 2014, HYPERTENS RES, V37, P649, DOI 10.1038/hr.2014.44; Wang SX, 2014, HYPERTENS RES, V37, P870, DOI 10.1038/hr.2014.88; Eshoo S, 2009, CIRC-CARDIOVASC IMAG, V2, P93, DOI 10.1161/CIRCIMAGING.108.793190; Perlini S, 2001, CIRCULATION, V103, P678; Nagueh SF, 1997, J AM COLL CARDIOL, V30, P1527, DOI 10.1016/S0735-1097(97)00344-6; Yodwut C, 2012, J AM SOC ECHOCARDIOG, V25, P978, DOI 10.1016/j.echo.2012.06.001; Hashimoto I, 2003, J AM COLL CARDIOL, V42, P1574, DOI 10.1016/S0735-1097(03)01074-X; Hoit BD, 2011, CIRC-CARDIOVASC IMAG, V4, P179, DOI 10.1161/CIRCIMAGING.110.959817; Hare JL, 2009, AM HEART J, V158, P294, DOI 10.1016/j.ahj.2009.05.031; Abraham TP, 2007, CIRCULATION, V116, P2597, DOI 10.1161/CIRCULATIONAHA.106.647172; Koshizuka R, 2013, J AM SOC ECHOCARDIOG, V26, P316, DOI 10.1016/j.echo.2012.11.015; Cho GY, 2009, J AM COLL CARDIOL, V54, P618, DOI 10.1016/j.jacc.2009.04.061; Greenberg NL, 2002, CIRCULATION, V105, P99, DOI 10.1161/hc0102.101396; Delfino JG, 2008, J MAGN RESON IMAGING, V27, P522, DOI 10.1002/jmri.21211; Ferferieva V, 2012, AM J PHYSIOL-HEART C, V302, P188; Gorcsan J, 1997, CIRCULATION, V95, P2423; Maffessanti F, 2009, AM J CARDIOL, V104, P1775; Matsumoto K, 2013, CIRC J, V77, P1750, DOI 10.1253/circj.CJ-12-1487; Minoshima M, 2009, CIRC J, V73, P2294; Morris DA, 2014, J AM SOC ECHOCARDIOG, V27, P493, DOI 10.1016/j.echo.2014.01.017; Ohara Y, 2014, J CLIN TRAIL CARDIOL, V1, P1; Thavendiranathan P, 2012, JACC-CARDIOVASC IMAG, V5, P239, DOI 10.1016/j.jcmg.2011.12.012; Wang Y, 2010, LECT NOTES COMPUT SC, V6364, P184; Watanabe T, 2013, HYPERTENS RES, V36, P799, DOI 10.1038/hr.2013.25; Weidemann F, 2002, AM J PHYSIOL-HEART C, V283, pH792, DOI 10.1152/ajpheart.00025.2002; Yang L, P IEEE COMP SOC C CO, P1	38	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	AUG	2015	38	8					551	559		10.1038/hr.2015.47		9	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CO2VV	WOS:000359015800006		
J	Sakata, S; Tsuchihashi, T; Oniki, H; Tominaga, M; Arakawa, K; Sakaki, M; Kitazono, T				Sakata, Satoko; Tsuchihashi, Takuya; Oniki, Hideyuki; Tominaga, Mitsuhiro; Arakawa, Kimika; Sakaki, Minako; Kitazono, Takanari			Relationship between salt intake as estimated by a brief self-administered diet-history questionnaire (BDHQ) and 24-h urinary salt excretion in hypertensive patients	HYPERTENSION RESEARCH			English	Article						brief self-administered diet-history questionnaire (BDHQ); hypertensive patients; salt intake; 24-h urine collection	LONG-TERM COMPLIANCE; HIGH BLOOD-PRESSURE; PRIMARY PREVENTION; EDUCATION-PROGRAM; JAPANESE ADULTS; RESTRICTION; OUTPATIENTS; COMMITTEE; VALIDITY	Assessing an individual's salt intake is necessary for providing guidance with respect to salt restriction. However, the methods that exist for assessing salt intake have both merits and limitations. Therefore, the evaluation methods should be selected for their appropriateness to the patients and the environment of the medical facilities. The purpose of the present study was to investigate the validity of a brief self-administered diet-history questionnaire (BDHQ) by comparing the responses with 24-h urinary salt excretion. A total of 136 hypertensive outpatients (54 men and 82 women) were included in this study. All subjects were given the BDHQ and performed 24-h home urine collection. The energy-adjusted salt intake as assessed by the BDHQ was 12.3 (95% confidence interval: 11.8-12.9) g per day, and the urinary salt excretion evaluated by 24-h urinary collection was 9.0 (8.4-9.5) g per day. The energy-adjusted salt intake assessed by the BDHQ correlated significantly with the urinary salt excretion evaluated by 24-h urinary collection (r=0.34, P<0.001). In conclusion, the estimated salt intake evaluated by the BDHQ weakly, but significantly, correlated with 24-h urinary salt excretion. In clinical practice, it seems important to utilize both methods to assess an individual's salt intake in order to provide adequate guidance for salt restriction.	[Sakata, Satoko; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 8128582, Japan; [Sakata, Satoko; Tsuchihashi, Takuya; Tominaga, Mitsuhiro; Arakawa, Kimika; Sakaki, Minako] Kyushu Med Ctr, Div Hypertens, Clin Res Inst, Fukuoka, Japan; [Oniki, Hideyuki] Kyushu Cent Hosp, Div Cardiol, Fukuoka, Japan	Sakata, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka 8128582, Japan.	ssakata@intmed2.med.kyushu-u.ac.jp			MSD KK	TT has received funding for clinical research from MSD KK and honoraria from MSD KK and Dainippon Sumitomo Pharma. The remaining authors declare no conflict of interest.	Ohta Y, 2013, HYPERTENS RES, V36, P172, DOI 10.1038/hr.2012.155; Ohta Y, 2005, HYPERTENS RES, V28, P953, DOI 10.1291/hypres.28.953; Tsuchihashi T, 2013, HYPERTENS RES, V36, P1026, DOI 10.1038/hr.2013.103; Whelton PK, 2002, JAMA-J AM MED ASSOC, V288, P1882, DOI 10.1001/jama.288.15.1882; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Wakai K, 2009, J EPIDEMIOL, V19, P1, DOI 10.2188/jea.JE20081007; Chobanian AV, 2003, JAMA-J AM MED ASSOC, V289, P2560, DOI 10.1001/jama.289.19.2560; Sasaki S, 1998, JPN CIRC J, V62, P431, DOI 10.1253/jcj.62.431; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI [10.2188/jeaJE20110075, 10.2188/jea.JE20110075]; Hirota S, 2013, HYPERTENS RES, V36, P1096, DOI 10.1038/hr.2013.138; Intersalt Cooperative Research Group, 1988, BMJ-BRIT MED J, V297, P319, DOI DOI 10.1136/BMJ.297.66; Ogawa K, 2003, PUBLIC HEALTH NUTR, V6, P147, DOI 10.1079/PHN2002411; Ohta Y, 2004, HYPERTENS RES, V27, P243, DOI 10.1291/hypres.27.243; Ohta Y, 2010, CLIN EXP HYPERTENS, V32, P234, DOI 10.3109/10641963.2010.491888; Ohta Y, 2009, CLIN EXP HYPERTENS, V31, P690, DOI 10.3109/10641960903407058; Sakaki M, 2014, HYPERTENS RES, V37, P939, DOI 10.1038/hr.2014.100; Sasaki S, 1998, J Epidemiol, V8, P203; TOCHIKUBO O, 1983, HYPERTENSION, V5, P270; WHELTON PK, 1993, ARCH INTERN MED, V153, P186	19	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	AUG	2015	38	8					560	563		10.1038/hr.2015.35		4	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CO2VV	WOS:000359015800007		
J	Yamaguchi, Y; Wada, M; Sato, H; Nagasawa, H; Koyama, S; Takahashi, Y; Kawanami, T; Kato, T				Yamaguchi, Yoshitaka; Wada, Manabu; Sato, Hidenori; Nagasawa, Hikaru; Koyama, Shingo; Takahashi, Yoshimi; Kawanami, Toru; Kato, Takeo			Impact of nocturnal heart rate variability on cerebral small-vessel disease progression: a longitudinal study in community-dwelling elderly Japanese	HYPERTENSION RESEARCH			English	Article						ambulatory blood pressure monitoring; blood pressure variability; cerebral small-vessel disease; cognitive decline; heart rate variability	BLOOD-PRESSURE VARIABILITY; OBSTRUCTIVE SLEEP-APNEA; WHITE-MATTER LESIONS; CARDIOVASCULAR EVENTS; HYPERTENSIVE PATIENTS; COGNITIVE DECLINE; ISCHEMIC-STROKE; RISK-FACTOR; DISABILITY; MORTALITY	Recent evidence has shown an effect of ambulatory heart rate (HR) on cardiovascular events and mortality. Our objective was to determine whether ambulatory HR was related to the progression of cerebral small-vessel disease (SVD) or cognitive decline in community-dwelling elderly people. A cohort of 190 community-dwelling elderly people underwent an ambulatory blood pressure monitoring (ABPM), brain magnetic resonance imaging (MRI) and cognitive testing at baseline, with MRI and cognitive tests repeated 4 years later. HR variability in ABPM was quantified by the s.d. (s.d. and the root mean square of successive differences (RMSSD), and the relationship between HR variability and the progression of SVD/cognitive decline was investigated. We also assessed the association of nighttime HR variability and nocturnal HR dipping. The nighttime RMSSD of participants with the progression of SVD was significantly higher than that of those without progression of SVD (P<0.05). Moreover, nighttime RMSSD was independently associated with the progression of SVD (1 b.p.m. increment: odds ratio=1.13, 95% confidence interval=1.04-1.24, P<0.01). We failed to confirm an association between cognitive decline and nighttime HR variability. However, s.d. in the daytime and 24-h HR were independently related to cognitive decline (P<0.05). Nocturnal HR dipping was least in the top quartiles of nighttime HR variability, with a monotonic trend of nocturnal HR dipping that was dependent on the quartiles of nighttime HR variability indices (P<0.01). Increased HR variability during the night is a predictor of the progression of SVD in community-dwelling elderly people.	[Yamaguchi, Yoshitaka; Wada, Manabu; Sato, Hidenori; Nagasawa, Hikaru; Koyama, Shingo; Takahashi, Yoshimi; Kawanami, Toru; Kato, Takeo] Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, Yamagata 9909585, Japan	Yamaguchi, Y (reprint author), Yamagata Univ, Dept Neurol Hematol Metab Endocrinol & Diabetol, Fac Med, 2-2 2 Iida Nishi, Yamagata 9909585, Japan.	y-yamaguchi@med.id.yamagata-u.ac.jp					Tzourio C, 2014, HYPERTENSION, V63, P894, DOI 10.1161/HYPERTENSIONAHA.113.00147; Poggesi A, 2011, CEREBROVASC DIS, V32, P577, DOI 10.1159/000334498; Pantoni L, 2010, LANCET NEUROL, V9, P689, DOI 10.1016/S1474-4422(10)70104-6; van Boxtel MPJ, 2006, J HUM HYPERTENS, V20, P5, DOI 10.1038/sj.jhh.1001934; Goldstein IB, 1998, STROKE, V29, P765; Mena L, 2005, J HYPERTENS, V23, P505, DOI 10.1097/01.hjh.0000160205.81652.5a; Bohm M, 2012, EUR HEART J, V33, P2804, DOI 10.1093/eurheartj/ehs250; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Wardlaw JM, 2013, LANCET NEUROL, V12, P822, DOI 10.1016/S1474-4422(13)70124-8; Bilo G, 2007, J HYPERTENS, V25, P2058; Wardlaw JM, 2013, LANCET NEUROL, V12, P483, DOI 10.1016/S1474-4422(13)70060-7; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Palatini P, 2011, HYPERTENSION, V58, P745, DOI 10.1161/HYPERTENSIONAHA.111.173104; HANDA N, 1990, STROKE, V21, P1567; Ben-Dov IZ, 2007, ARCH INTERN MED, V167, P2116, DOI 10.1001/archinte.167.19.2116; Kario K, 2013, HYPERTENS RES, V36, P478, DOI 10.1038/hr.2013.19; Sierra C, 2002, J HYPERTENS, V20, P519, DOI 10.1097/00004872-200203000-00028; O'Brien JT, 2003, LANCET NEUROL, V2, P89, DOI 10.1016/S1474-4422(03)00305-3; FAZEKAS F, 1993, NEUROLOGY, V43, P1683; Kim H, 2013, SLEEP, V36, P709, DOI 10.5665/sleep.2632; Thorin E, 2009, CARDIOVASC RES, V84, P24, DOI 10.1093/cvr/cvp236; Okada H, 2013, HYPERTENS RES, V36, P996, DOI 10.1038/hr.2013.66; Birns J, 2009, J HYPERTENS, V27, P1042, DOI 10.1097/HJH.0b013e32832810d5; de la Sierra A, 2014, J HUM HYPERTENS, V28, P416, DOI 10.1038/jhh.2013.135; Eguchi K, 2009, J HYPERTENS, V27, P2265, DOI 10.1097/HJH.0b013e328330a938; Eguchi K, 2010, HYPERTENS RES, V33, P737, DOI 10.1038/hr.2010.61; Fukui M, 2013, HYPERTENS RES, V36, P219, DOI 10.1038/hr.2012.177; ISAKSSON H, 1991, CLIN EXP HYPERTENS A, V13, P1195, DOI 10.3109/10641969109042122; Kwon HS, 2014, AM J HYPERTENS, V27, P177, DOI 10.1093/ajh/hpt199; Mancia G, 2013, J HYPERTENS, V131, P1281, DOI DOI 10.1097/01.HJH.0000431740.32696.CC; Palatini P, 2013, INT J CARDIOL, V168, P1490, DOI 10.1016/j.ijcard.2012.12.103; Yamaguchi Y, 2014, AM J HYPERTENS, V27, P1257, DOI 10.1093/ajh/hpu045	32	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0916-9636	1348-4214		HYPERTENS RES	Hypertens. Res.	AUG	2015	38	8					564	569		10.1038/hr.2015.38		6	Peripheral Vascular Disease	Cardiovascular System & Cardiology	CO2VV	WOS:000359015800008		
J	Yoshida, S; Hasegawa, N; Kawasaki, S				Yoshida, Satoshi; Hasegawa, Naoki; Kawasaki, Shigeo			Experimental Demonstration of Microwave Power Transmission and Wireless Communication Within a Prototype Reusable Spacecraft	IEEE MICROWAVE AND WIRELESS COMPONENTS LETTERS			English	Article						Microwave power transmission (MPT); space vehicles; wireless sensor networks		In this letter, a wireless sensor network system powered by microwave power transmission (MPT) technology within a prototype reusable spacecraft is proposed and evaluated. The evaluation was based on a 5.8 GHz, 50 W class MPT integrated with a 2.4 GHz band wireless communication system. Experiments to evaluate energy balance under 25 cm line-of-sight conditions and to test multi-sensor operation under non line-of-sight conditions within the prototype spacecraft, called a reusable vehicle test (RVT).	[Yoshida, Satoshi; Kawasaki, Shigeo] Japan Aerosp Explorat Agcy JAXA, ISAS, Sagamihara, Kanagawa 2525210, Japan; [Hasegawa, Naoki] Kyoto Univ, Res Inst Sustainable Humanosphere, Uji, Kyoto 6110011, Japan	Yoshida, S (reprint author), Japan Aerosp Explorat Agcy JAXA, ISAS, 3-1-1 Yoshinodai, Sagamihara, Kanagawa 2525210, Japan.	yoshida.satoshi@jaxa.jp					Senesky DG, 2009, IEEE SENS J, V9, P1472, DOI 10.1109/JSEN.2009.2026996; Popovic Z, 2013, P IEEE, V101, P1397, DOI 10.1109/JPROC.2013.2244053; Georgiadis A., 2014, P AS PAC MICR C NOV; Ichihara T., 2012, P INT MICROW S SERIE; Kusumi K., 2012, P INT S ANT PROP NOV, P1228; Nonaka S., 2011, P 20 ESA S EUR ROCK; Trevisan A., 2014, P IEEE RFID TECHN AP; Virili M., 2013, P IEEE WIR POW TRANS; Wagner R. S., 2012, P IEEE AER C MAR; Xie L., 2013, IEEE WIREL COMMUN, V20, P140; Yoshida S., 2015, WIRELESS POWER TRANS, DOI [10.1017/wpt.2015.2, DOI 10.1017/WPT.2015.2]; Zheng W. H., 2010, P NASA ESA C AD HARD, P75	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1531-1309	1558-1764		IEEE MICROW WIREL CO	IEEE Microw. Wirel. Compon. Lett.	AUG	2015	25	8					556	558		10.1109/LMWC.2015.2441294		3	Engineering, Electrical & Electronic	Engineering	CO6BT	WOS:000359242900022		
J	Tokiwa, T; Zimin, L; Ishizuka, S; Inoue, T; Fujii, M; Ishiguro, H; Kajigaya, H; Owada, Y; Suzuki, M; Yamakawa, T				Tokiwa, Tatsuji; Zimin, Lev; Ishizuka, Satoru; Inoue, Takao; Fujii, Masami; Ishiguro, Hiroshi; Kajigaya, Hiroshi; Owada, Yuji; Suzuki, Michiyasu; Yamakawa, Takeshi			The Palm-Sized Cryoprobe System Based on Refrigerant Expansion and Boiling and Its Application to an Animal Model of Epilepsy	IEEE TRANSACTIONS ON BIOMEDICAL ENGINEERING			English	Article						Animal model of epilepsy; cryoprobe; cryotherapy; necrosis; palm-sized cryoprobe system; penicillin G; refrigerant expansion and boiling; sealed refrigerant tank; wistar rat	EXPERIMENTAL FOCAL EPILEPSY; EPILEPTOGENIC LESIONS; CAT; CORTEX; CRYOSURGERY; CRYOBIOLOGY; INJURY; NEOCORTEX; SEIZURES; TISSUES	Goal: The purpose of this study is to propose the palm-sized cryoprobe system based on a new concept and to suggest that the freezing technique could be used for treatment of epilepsy. Methods: We propose herein a cryoprobe system based on the boiling effect that uses a specific refrigerants with a boiling point higher than that of liquid nitrogen yet low enough to result in cell necrosis. To evaluate and verify the effectiveness of the proposed system, cooling characteristics are investigated in agar. In addition, the system is applied to a Wistar rat brain-model, in which the epileptic activities are induced in advance by a potent epileptogenic substance. Results: The design concept yielded the following benefits: 1) the selected refrigerant promotes sealing in the tank; 2) the tank can be made as compact as possible, limited only by the volume required for the refrigerant; 3) because the tank and probe units can be separated by a nonconducting, flexible, and high-pressure tube, the tank unit can be manipulated without disturbing the probe tip with mechanical vibrations and electrical noise. Although the agar experiments, we verified that the proposed system can uniquely and reproducibly create an ice ball. Moreover, in the rat experiments in vivo, it was confirmed that penicillin G-induced epileptic activities disappeared on freezing with the proposed system. Conclusions: The palm-sized system has desired characteristics and can apply for an animal model of epilepsy. Significance: Results of in vivo experiments suggest that cryosurgery may be an effective treatment for epilepsy.	[Tokiwa, Tatsuji] Kyushu Inst Technol, Grad Sch Life Sci & Syst Engn, Dept Brain Sci & Engn, Fukuoka, Japan; [Zimin, Lev; Ishizuka, Satoru] Kyushu Inst Technol, Fukuoka, Japan; [Ishiguro, Hiroshi] Kyushu Inst Technol, Dept Biol Funct & Engn, Grad Sch Life Sci & Syst Engn, Fukuoka, Japan; [Inoue, Takao; Suzuki, Michiyasu] Yamaguchi Univ, Dept Neurosurg, Grad Sch Med, Sch Med, Yamaguchi, Japan; [Fujii, Masami] Yamaguchi Univ, Dept Neurosurg, Grad Sch Med, Yamaguchi, Japan; [Owada, Yuji] Yamaguchi Univ, Dept Organ Anat, Grad Sch Med, Yamaguchi, Japan; [Kajigaya, Hiroshi] Nippon Vet & Life Sci Univ, Tokyo, Japan; [Yamakawa, Takeshi] Fuzzy Log Syst Inst, Fukuoka 8080196, Japan	Yamakawa, T (reprint author), Fuzzy Log Syst Inst, Fukuoka 8080196, Japan.	yamakawa@flsi.or.jp			MEXT of Japan [20001008]; Hiroshima City University Grant for Special Academic Research	This work was supported by a Grant-in-Aid for Specially Promoted Research under Project 20001008 granted by MEXT of Japan, and Hiroshima City University Grant for Special Academic Research (General Study). Asterisk indicates corresponding author.	Ishiguro H, 2008, INT J HEAT MASS TRAN, V51, P5642, DOI 10.1016/j.ijheatmasstransfer.2008.04.019; MAZUR P, 1977, CRYOBIOLOGY, V14, P251, DOI 10.1016/0011-2240(77)90175-4; Gage AA, 2009, CRYOBIOLOGY, V59, P229, DOI 10.1016/j.cryobiol.2009.10.001; Gage AA, 1998, CRYOBIOLOGY, V37, P171, DOI 10.1006/cryo.1998.2115; Hoffmann NE, 2002, UROLOGY, V60, P40, DOI 10.1016/S0090-4295(02)01683-7; MAZUR P, 1970, SCIENCE, V168, P939, DOI 10.1126/science.168.3934.939; Arnott J, 1850, LANCET, V2, P257; ARRIGONI E, 1987, NEUROCHEM PATHOL, V7, P207; Baust J, 1997, CRYOBIOLOGY, V34, P373, DOI 10.1006/cryo.1997.2017; BERL S, 1959, J NEUROCHEM, V4, P311, DOI 10.1111/j.1471-4159.1959.tb13210.x; Bickford R. G., 1969, BASIC MECH EPILEPSIE, P543; Chang Zhaohua, 1994, Biomedical Instrumentation and Technology, V28, P383; CLASEN RA, 1953, SURG GYNECOL OBSTET, V96, P605; CLASEN RA, 1962, J NEUROPATH EXP NEUR, V21, P579, DOI 10.1097/00005072-196210000-00006; COOPER IS, 1961, J NERV MENT DIS, V133, P259, DOI 10.1097/00005053-196109000-00013; COOPER IS, 1964, CRYOBIOLOGY, V1, P44, DOI 10.1016/0011-2240(64)90019-7; ESCUETA AV, 1974, BRAIN RES, V78, P223, DOI 10.1016/0006-8993(74)90548-4; FISHER RS, 1989, BRAIN RES REV, V14, P245, DOI 10.1016/0165-0173(89)90003-9; Fujii M, 2012, EPILEPSIA, V53, P485, DOI 10.1111/j.1528-1167.2011.03388.x; GOLDENSOHN ES, 1963, SCIENCE, V139, P840, DOI 10.1126/science.139.3557.840; GRISAR T, 1983, BRAIN RES, V261, P75, DOI 10.1016/0006-8993(83)91285-4; HANNA GR, 1973, NEUROLOGY, V23, P918; HASS GM, 1953, AMA ARCH NEUROL PSY, V69, P145; HOMASSON JP, 1994, CRYOBIOLOGY, V31, P290, DOI 10.1006/cryo.1994.1035; HORI M, 1979, EPILEPSIA, V20, P25, DOI 10.1111/j.1528-1157.1979.tb04773.x; KEITH HM, 1954, AM J PHYSIOL, V179, P650; Kollner P., 1974, U.S. Patent, Patent No. [3 794 039, 3794039]; Korpan N. N., 2002, BASICS CRYOSURGERY; LEWIN E, 1967, ARCH NEUROL-CHICAGO, V16, P321; LOISEAU H, 1987, EPILEPSIA, V28, P251, DOI 10.1111/j.1528-1157.1987.tb04215.x; MOLNAR M, 1983, ACTA NEUROBIOL EXP, V43, P299; MORRELL F, 1959, ARCH NEUROL-CHICAGO, V1, P141; MORRELL F, 1959, NEUROLOGY, V9, P492; MORRELL F, 1958, ELECTROEN CLIN NEURO, V10, P187; Morrell F., 1959, EPILEPSIA, V1, P538, DOI 10.1111/j.1528-1157.1959.tb04288.x; NIMS LESLIE F., 1941, YALE JOUR BIOL AND MED, V13, P477; NOEBELS JL, 1977, BRAIN RES, V125, P293, DOI 10.1016/0006-8993(77)90622-9; Openchowski P., 1883, CR HEBD ACAD SCI, V35, P38; Paxions G., 2007, RAT BRAIN STEREOTAXI; PEDLEY TA, 1976, EXP NEUROL, V50, P346, DOI 10.1016/0014-4886(76)90010-8; Rabin Yoed, 1997, Biomedical Instrumentation and Technology, V31, P251; Rothman SM, 2005, EPILEPSY BEHAV, V7, P214, DOI 10.1016/j.yehbeh.2005.05.021; Rzasa R. P., 1983, U.S. Patent, Patent No. [4 377 168, 4377168]; Schneider A, 1931, ARCH NEURO PSYCHIATR, V25, P1263; SMITH TG, 1960, ELECTROEN CLIN NEURO, V12, P59, DOI 10.1016/0013-4694(60)90061-4; Spencer W. A., 1969, BASIC MECH EPILEPSIE, P575; Speransky A. D., 1943, BASIS THEORY MED; STALMAST.RM, 1972, EPILEPSIA, V13, P313, DOI 10.1111/j.1528-1157.1972.tb05266.x; Yiu Wai-Ki, 2007, Int J Angiol, V16, P1	49	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0018-9294	1558-2531		IEEE T BIO-MED ENG	IEEE Trans. Biomed. Eng.	AUG	2015	62	8					1949	1958		10.1109/TBME.2015.2407692		10	Engineering, Biomedical	Engineering	CN6LK	WOS:000358546100007		
J	Wu, XM; Kashino, K				Wu, Xiaomeng; Kashino, Kunio			Second-Order Configuration of Local Features for Geometrically Stable Image Matching and Retrieval	IEEE TRANSACTIONS ON CIRCUITS AND SYSTEMS FOR VIDEO TECHNOLOGY			English	Article						Feature extraction; geometry; graph theory; image retrieval	SCALE OBJECT RETRIEVAL; SIMILARITY; SEARCH; GRAPHS	Local features offer high repeatability, which supports efficient matching between images, but they do not provide sufficient discriminative power. Imposing a geometric coherence constraint on local features improves the discriminative power but makes the matching sensitive to anisotropic transformations. We propose a novel feature representation approach to solve the latter problem. Each image is abstracted by a set of tuples of local features. We revisit affine shape adaptation and extend its conclusion to characterize the geometrically stable feature of each tuple. The representation thus provides higher repeatability with anisotropic scaling and shearing than found in previous research. We develop a simple matching model by voting in the geometrically stable feature space, where votes arise from tuple correspondences. To make the required index space linear as regards the number of features, we propose a second approach called a centrality-sensitive pyramid to select potentially meaningful tuples of local features on the basis of their spatial neighborhood information. It achieves faster neighborhood association and has a greater robustness to errors in interest point detection and description. We comprehensively evaluated our approach using Flickr Logos 32, Holiday, Oxford Buildings, and Flickr 100 K benchmarks. Extensive experiments and comparisons with advanced approaches demonstrate the superiority of our approach in image retrieval tasks.	[Wu, Xiaomeng; Kashino, Kunio] NTT Commun Sci Labs, Kanagawa 2430198, Japan	Wu, XM (reprint author), NTT Commun Sci Labs, Kanagawa 2430198, Japan.	wu.xiaomeng@lab.ntt.co.jp; kashino.kunio@lab.ntt.co.jp					Jegou H, 2010, INT J COMPUT VISION, V87, P316, DOI 10.1007/s11263-009-0285-2; Zhang YM, 2011, PROC CVPR IEEE, P809; Correa CD, 2011, IEEE T VIS COMPUT GR, V17, P1852, DOI 10.1109/TVCG.2011.245; Arandjelovic R, 2012, PROC CVPR IEEE, P2911, DOI 10.1109/CVPR.2012.6248018; Poullot S, 2010, MULTIMED TOOLS APPL, V47, P279, DOI 10.1007/s11042-009-0323-7; Gao JZ, 2009, IEEE I CONF COMP VIS, P2122; Shen XH, 2012, PROC CVPR IEEE, P3013; Mikolajczyk K, 2004, INT J COMPUT VISION, V60, P63, DOI 10.1023/B:VISI.0000027790.02288.f2; MATULA DW, 1980, GEOGR ANAL, V12, P205; Wu Z, 2009, PROC CVPR IEEE, P25; Yang Y, 2011, 2011 IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION (ICCV), P1465; Chum O, 2011, PROC CVPR IEEE, P889, DOI 10.1109/CVPR.2011.5995601; Carneiro G, 2007, IEEE T PATTERN ANAL, V29, P2089, DOI 10.1109/TPAMI.2007.1126; Jegou H, 2009, PROC CVPR IEEE, P1169; Avrithis Y, 2014, INT J COMPUT VISION, V107, P1, DOI 10.1007/s11263-013-0659-3; Jegou H, 2008, LECT NOTES COMPUT SC, V5302, P304, DOI 10.1007/978-3-540-88682-2_24; Perd'och M, 2009, PROC CVPR IEEE, P9; Qin DF, 2013, PROC CVPR IEEE, P1610, DOI 10.1109/CVPR.2013.211; Lowe DG, 2004, INT J COMPUT VISION, V60, P91, DOI 10.1023/B:VISI.0000029664.99615.94; Avrithis Y., 2013, P IEEE ICCV DEC, P3024; Boiman O., 2008, P IEEE C COMP VIS PA, P1; Bose P., 2009, P CAN C COMP GEOM, P169; Cardinal J, 2009, COMP GEOM-THEOR APPL, V42, P183, DOI 10.1016/j.comgeo.2008.09.003; Chum O., 2007, P IEEE INT C COMP VI, P1; Correa C. D., 2012, P 18 ACM SIGKDD INT, P1330; de Berg M., 2008, COMPUTATIONAL GEOMET; Kalantidis Y., 2011, P ACM ICMR 11; Lebeda K., 2012, P BMVC, P1; Lindeberg T., 1994, SCALE SPACE THEORY C, V256, P383; Lindeberg T., 2007, WILEY ENCY COMPUTER; Liu D., 2008, P IEEE C COMP VIS PA, P1, DOI 10.1145/1506270.1506330; Liu Z., 2012, P ACM INT C MULT, P199; Ma Z., 2013, P IJCAI, P1530; Over P., 2013, P TRECVID, P15; Philbin J., 2007, P IEEE C COMP VIS PA, P1; Philbin J., 2008, P IEEE C COMP VIS PA, P1; Romberg S., 2013, IJMIR, V2, P243; Romberg S., 2011, P ICMR; Sivic J., 2003, P 9 IEEE C COMP VIS, V2, P1470, DOI DOI 10.1109/ICCV.2003.1238663; Tolias G, 2014, COMPUT VIS IMAGE UND, V120, P31, DOI 10.1016/j.cviu.2013.12.002; Turcot P., 2009, P IEEE INT C COMP VI, P2109; van Rijsbergen C.J., 1979, INFORM RETRIEVAL; Zhang W., 2012, P 20 ACM INT C MULT, P609; Zhu C. -Z., 2013, P INT C COMP VIS, P1705	44	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1051-8215	1558-2205		IEEE T CIRC SYST VID	IEEE Trans. Circuits Syst. Video Technol.	AUG	2015	25	8					1395	1408		10.1109/TCSVT.2014.2382985		14	Engineering, Electrical & Electronic	Engineering	CO5QK	WOS:000359213400011		
J	Chen, YJ; Tanaka, M; Tanaka, K; Wang, HO				Chen, Ying-Jen; Tanaka, Motoyasu; Tanaka, Kazuo; Wang, Hua O.			Stability Analysis and Region-of- Attraction Estimation Using Piecewise Polynomial Lyapunov Functions: Polynomial Fuzzy Model Approach	IEEE TRANSACTIONS ON FUZZY SYSTEMS			English	Article						Path-following method; piecewise polynomial Lyapunov function (PPLF); polynomial fuzzy model; region-of-attraction (ROA); stability; sum-of-squares (SOS)	NONLINEAR DYNAMICAL-SYSTEMS; SQUARES APPROACH; STABILIZATION	This paper proposes sum-of-squares (SOS) methodologies for stability analysis and region-of-attraction (ROA) estimation for nonlinear systems represented by polynomial fuzzy models via piecewise polynomial Lyapunov functions (PPLFs). At first, two SOS-based global stability criteria are proposed by applying maximum-type and minimum-type PPLFs, respectively. It is known that less-conservative results can be obtained by reducing global stability to local stability, since it is usually the case for nonlinear systems that the stability cannot be reached globally. Therefore, based on the two types of PPLFs, two local stability criteria are further proposed with the algorithms that enlarge the estimated ROA as much as possible. The constraints for checking (global and local) stability and enlarging the estimated ROA are represented in terms of bilinear SOS problems. Hence, the path-following method is applied to solve the bilinear SOS problems in the proposed methodologies. Finally, some examples are provided to illustrate the utility of the proposed methodologies.	[Chen, Ying-Jen; Tanaka, Motoyasu; Tanaka, Kazuo] Univ Electrocommun, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo 1828585, Japan; [Wang, Hua O.] Boston Univ, Dept Mech Engn, Boston, MA 02215 USA	Chen, YJ (reprint author), Univ Electrocommun, Dept Mech Engn & Intelligent Syst, Chofu, Tokyo 1828585, Japan.	chen@rc.mce.uec.ac.jp; mtanaka@uec.ac.jp; ktanaka@mce.uec.ac.jp; wangh@bu.edu		Tanaka, Motoyasu/0000-0002-3717-8852			Xie L, 1997, SYST CONTROL LETT, V31, P165, DOI 10.1016/S0167-6911(97)00027-3; Lam HK, 2013, IEEE T FUZZY SYST, V21, P800, DOI 10.1109/TFUZZ.2012.2230005; Tanaka K, 2003, IEEE T FUZZY SYST, V11, P582, DOI 10.1109/TFUZZ.2003.814861; Topcu U, 2008, AUTOMATICA, V44, P2669, DOI 10.1016/j.automatica.2008.03.010; Chen YJ, 2012, IEEE T FUZZY SYST, V20, P1166, DOI 10.1109/TFUZZ.2012.2196049; Tanaka K, 2009, IEEE T FUZZY SYST, V17, P911, DOI 10.1109/TFUZZ.2008.924341; Lofberg J, 2009, IEEE T AUTOMAT CONTR, V54, P1007, DOI 10.1109/TAC.2009.2017144; Tibken B, 2006, P AMER CONTR CONF, V1-12, P117, DOI 10.1109/ACC.2006.1655340; Lam HK, 2011, IEEE T FUZZY SYST, V19, P588, DOI 10.1109/TFUZZ.2011.2118215; Tan WH, 2008, IEEE T AUTOMAT CONTR, V53, P565, DOI 10.1109/TAC.2007.914221; Guelton K, 2013, INT J FUZZY SYST, V15, P1; Tanaka K, 2012, IEEE T SYST MAN CY B, V42, P1330, DOI 10.1109/TSMCB.2012.2190277; Balas G., 2009, ROBUSTNESS ANAL NONL; Delmotte F, 2013, CONTROL ENG PRACT, V21, P1386, DOI 10.1016/j.conengprac.2013.06.004; Hachicho O, 2002, IEEE DECIS CONTR P, P3150; Hassibi A., 1999, P AM CONTR C, V2, P1385, DOI 10.1109/ACC.1999.783595; Hu TS, 2008, IEEE T AUTOMAT CONTR, V53, P2571, DOI 10.1109/TAC.2008.2006933; Khalil H. K., 2001, NONLINEAR SYSTEMS; Papachristodoulou A., 2002, C DEC CONTR, V3, P3482; Prajna S., 2004, 5 AS CONTR C, V1, P157; Sala A., 2009, IEEE T FUZZY SYST, V17, P284; Tanaka K., 2001, FUZZY CONTROL SYSTEM	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1063-6706	1941-0034		IEEE T FUZZY SYST	IEEE Trans. Fuzzy Syst.	AUG	2015	23	4					1314	1322		10.1109/TFUZZ.2014.2347993		9	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic	Computer Science; Engineering	CO6JG	WOS:000359262400044		
J	Zanotto, D; Akiyama, Y; Stegall, P; Agrawal, SK				Zanotto, Damiano; Akiyama, Yasuhiro; Stegall, Paul; Agrawal, Sunil K.			Knee Joint Misalignment in Exoskeletons for the Lower Extremities: Effects on User's Gait	IEEE TRANSACTIONS ON ROBOTICS			English	Article						Active leg exoskeleton (ALEX II); force control; human-robot misalignment; rehabilitation robotics	NORMAL WALKING; DESIGN; ROBOT; REHABILITATION; FLEXION; STROKE	Due to the complexity of the human musculoskeletal system and intra/intersubjects variability, powered exoskeletons are prone to human-robot misalignments. These induce undesired interaction forces that may jeopardize safe operation. Uncompensated inertia of the robotic links also generates spurious interaction forces. Current design approaches to compensate for misalignments rely on the use of auxiliary passive degrees of freedom that unavoidably increase robot inertia, which potentially affects their effectiveness in reducing undesired interaction forces. Assessing the relative impact of misalignment and robot inertia on the wearer can, therefore, provide useful insights on how to improve the effectiveness of such approaches, especially in those situations where the dynamics of the movement are quasi-periodic and, therefore, predictable such as in gait. In this paper, we studied the effects of knee joint misalignments on the wearer's gait, by using a treadmill-based exoskeleton developed by our group, the ALEXII. Knee joint misalignments were purposely introduced by adjusting the mismatch between the length of the robot thigh and that of the human thigh. The amount of robot inertia reflected to the user was adjusted through control. Results evidenced that knee misalignment significantly changes human-robot interaction forces, especially at the thigh interface, and this effect can be attenuated by actively compensating for robot inertia. Misalignments caused by an excessively long robot thigh are less critical than misalignments of equal magnitude deriving from an excessively short robot thigh.	[Zanotto, Damiano; Stegall, Paul; Agrawal, Sunil K.] Columbia Univ, Robot & Rehabil Lab, New York, NY 10027 USA; [Akiyama, Yasuhiro] Nagoya Univ, Dept Mech Sci & Engn, Nagoya, Aichi 4678601, Japan	Zanotto, D (reprint author), Columbia Univ, Robot & Rehabil Lab, New York, NY 10027 USA.	damiano.zanotto@columbia.edu; akiyama-yasuhiro@mech.nagoya-u.ac.jp; stegallp@gmail.com; sunil.agrawal@columbia.edu					Aguirre-Ollinger G, 2011, INT J ROBOT RES, V30, P486, DOI 10.1177/0278364910385730; YAMAGUCHI GT, 1989, J BIOMECH, V22, P1, DOI 10.1016/0021-9290(89)90179-6; Kong KC, 2006, IEEE-ASME T MECH, V11, P428, DOI 10.1109/TMECH.2006.878550; Jarrasse N, 2012, IEEE T ROBOT, V28, P697, DOI 10.1109/TRO.2011.2178151; Stienen AHA, 2009, IEEE T ROBOT, V25, P628, DOI 10.1109/TRO.2009.2019147; Gard SA, 1999, ARCH PHYS MED REHAB, V80, P26, DOI 10.1016/S0003-9993(99)90303-9; Schiele A, 2006, IEEE T NEUR SYS REH, V14, P456, DOI 10.1109/TNSRE.2006.881565; MORRISON JB, 1970, J BIOMECH, V3, P51, DOI 10.1016/0021-9290(70)90050-3; Banala SK, 2009, IEEE T NEUR SYS REH, V17, P2, DOI 10.1109/TNSRE.2008.2008280; Patterson KK, 2010, GAIT POSTURE, V31, P241, DOI 10.1016/j.gaitpost.2009.10.014; Veneman JF, 2007, IEEE T NEUR SYS REH, V15, P379, DOI 10.1109/TNSRE.2007.903919; Royer TD, 2005, MED SCI SPORT EXER, V37, P649, DOI 10.1249/01.MSS.0000159007.56083.96; SMIDT GL, 1973, J BIOMECH, V6, P79, DOI 10.1016/0021-9290(73)90040-7; Colombo G, 2000, J REHABIL RES DEV, V37, P693; Noble JW, 2006, EXP BRAIN RES, V169, P482, DOI 10.1007/s00221-005-0162-3; Cempini M, 2013, IEEE T ROBOT, V29, P236, DOI 10.1109/TRO.2012.2226381; Kazerooni H, 2006, J DYN SYST-T ASME, V128, P14, DOI 10.1115/1.2168164; Bridge M. A., 2008, TECHN KNEE SURG, V7, P251, DOI 10.1097/BTK.0b013e31818f8ee7; Buerger S. P., 2006, P INT C INT ROB SYST, P4570; Colgate E., 1989, P IEEE INT C ROB AUT, V1, P404; Fisher S, 2011, TOP STROKE REHABIL, V18, P269, DOI 10.1310/tsr1803-269; Grieve D.W., 1968, Bio-Medical Engineering, V3; International Organization for Standardization, 2010, 121002010 ISO; Kim JS, 2011, CLIN REHABIL, V25, P134, DOI 10.1177/0269215510380822; MAH CD, 1994, J MOTOR BEHAV, V26, P83; Meuleman J. H., 2013, J NEUROENG REHABIL, V10, P1; Spong M. W., 2006, ROBOT MODELING CONTR; Srivastava S., IEEE T NEURAL SYST R; Stegall P, 2013, IEEE T ROBOT, V29, P838, DOI 10.1109/TRO.2013.2256309; van Asseldonk EHF, 2008, IEEE T NEUR SYS REH, V16, P360, DOI 10.1109/TNSRE.2008.925074; Wheeless C., 1996, WHEELESS TXB ORTHOPA; Winfree KN, 2011, P IEEE INT C REH ROB, P1; Winter DA, 1991, BIOMECHANICS MOTOR C; Zanotto D, 2013, IEEE T NEUR SYS REH, V21, P775, DOI 10.1109/TNSRE.2013.2242902; Zanotto D., IEEE INT C REH ROB S; Zanotto D., 2014, P IEEE INT C ROB AUT, P724	36	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1552-3098	1941-0468		IEEE T ROBOT	IEEE Trans. Robot.	AUG	2015	31	4					978	987		10.1109/TRO.2015.2450414		10	Robotics	Robotics	CO5TK	WOS:000359221200013		
J	Pham, QC; Nakamura, Y				Pham, Quang-Cuong; Nakamura, Yoshihiko			A New Trajectory Deformation Algorithm Based on Affine Transformations	IEEE TRANSACTIONS ON ROBOTICS			English	Article						Biomimetics; cognitive human-robot interaction; humanoid robots; kinematics; path planning for manipulators	DRAWING MOVEMENTS; MOTION PERCEPTION; VELOCITY; SPEED; KINEMATICS; GENERATION; CURVATURE; FIGURES; LAW	We propose a new approach to deform robot trajectories based on affine transformations. At the heart of our approach is the concept of affine invariance: Trajectories are deformed in order to avoid unexpected obstacles or to achieve new objectives but, at the same time, certain definite features of the original motions are preserved. Such features include, for instance, trajectory smoothness, periodicity, affine velocity, or more generally, all affine-invariant features, which are of particular importance in human-centered applications. Furthermore, this approach enables one to "convert" the constraints and optimization objectives regarding the deformed trajectory into constraints and optimization objectives regarding the matrix of the deformation in a natural way, making constraints satisfaction and optimization substantially easier and faster in many cases. As illustration, we present an application to the transfer of human movements to humanoid robots while preserving equiaffine velocity, a well-established invariant of human hand movements. Building on the presented affine deformation framework, we finally revisit the concept of trajectory redundancy from the viewpoint of group theory.	[Pham, Quang-Cuong] Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore; [Nakamura, Yoshihiko] Univ Tokyo, Dept Mechano Informat, Tokyo 1138654, Japan	Pham, QC (reprint author), Nanyang Technol Univ, Sch Mech & Aerosp Engn, Singapore 639798, Singapore.	cuong.pham@normalesup.org; nakamura@ynl.t.u-tokyo.ac.jp		Pham, Quang Cuong/0000-0001-9605-4940	Japan Society for the Promotion of Science, Japan [20220001]; Nanyang Technological University, Singapore; Ministry of Education, Singapore	This work was supported by a postdoctoral fellowship and by Grants-in-Aid for Scientific Research-Category S (20220001) from the Japan Society for the Promotion of Science, Japan, by a Start-Up Grant from Nanyang Technological University, Singapore, and by a Tier 1 grant from the Ministry of Education, Singapore.	deSperati C, 1997, J NEUROSCI, V17, P3932; Escande A, 2014, INT J ROBOT RES, V33, P1006, DOI 10.1177/0278364914521306; Yamane K, 2004, ACM T GRAPHIC, V23, P532, DOI 10.1145/1015706.1015756; SCHWARTZ AB, 1994, SCIENCE, V265, P540, DOI 10.1126/science.8036499; Kanoun O, 2011, IEEE T ROBOT, V27, P785, DOI 10.1109/TRO.2011.2142450; Kandel S, 2000, PERCEPT PSYCHOPHYS, V62, P706, DOI 10.3758/BF03206917; Yamane K, 2003, IEEE T ROBOTIC AUTOM, V19, P421, DOI 10.1109/TRA.2003.810579; Duindam V, 2010, INT J ROBOT RES, V29, P789, DOI 10.1177/0278364909352202; Lee J, 1999, COMP GRAPH, P39; Hicheur H, 2005, EXP BRAIN RES, V162, P145, DOI 10.1007/s00221-004-2122-8; Casile A, 2010, CEREB CORTEX, V20, P1647, DOI 10.1093/cercor/bhp229; VIVIANI P, 1991, J EXP PSYCHOL HUMAN, V17, P198; Ude A, 2010, IEEE T ROBOT, V26, P800, DOI 10.1109/TRO.2010.2065430; LACQUANITI F, 1983, ACTA PSYCHOL, V54, P115, DOI 10.1016/0001-6918(83)90027-6; Dayan E, 2007, P NATL ACAD SCI USA, V104, P20582, DOI 10.1073/pnas.0710033104; Bennequin D, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000426; Berthoz A., 2009, LA SIMPLEXITE; Lamiraux F, 2004, IEEE T ROBOTIC AUTOM, V20, P967, DOI 10.1109/TRO.2004.829459; Cheng P, 2008, IEEE T ROBOT, V24, P488, DOI 10.1109/TRO.2007.913993; Gleicher M., 1998, P SIGGRAPH 98, V98, P33; Ijspeert A. J., 2002, Proceedings 2002 IEEE International Conference on Robotics and Automation (Cat. No.02CH37292), DOI 10.1109/ROBOT.2002.1014739; Laumond JP, 1998, ROBOT MOTION PLANNIN; Maoz U, 2009, J NEUROPHYSIOL, V101, P1002, DOI 10.1152/jn.90702.2008; Maoz U, 2014, J NEUROPHYSIOL, V111, P336, DOI 10.1152/jn.01071.2012; Nakamura Y., 1990, ADV ROBOTICS REDUNDA; Pham Q.-C., 2011, P ROB SCI SYST, P265; Pham Q.-C., 2012, P ROB SCI SYST, P329; Pham QC, 2012, 2012 IEEE INTERNATIONAL CONFERENCE ON ROBOTICS AND AUTOMATION (ICRA), P3212; Pollick FE, 1997, VISION RES, V37, P347, DOI 10.1016/S0042-6989(96)00116-2; Pollick FE, 2009, CORTEX, V45, P325, DOI 10.1016/j.cortex.2008.03.010; Rose C., 1996, P SIGGRAPH 96, P147, DOI 10.1145/237170.237229; Seiler K, 2010, SPRINGER TRACTS ADV, V68, P37; Shneiderman B., 1997, P 2 INT C INT US INT, P33, DOI 10.1145/238218.238281; Shoemake K., 1992, P C GRAPH INT, V92, P258; Siciliano B, 1991, P IEEE INT C ADV ROB, V2, P1211; Ude A., 2000, P IEEE INT C ROB AUT, V3, P2223, DOI 10.1109/ROBOT.2000.846358; VIVIANI P, 1985, J EXP PSYCHOL HUMAN, V11, P828, DOI 10.1037//0096-1523.11.6.828; Yamane K, 2003, IEEE T VIS COMPUT GR, V9, P352, DOI 10.1109/TVCG.2003.1207443	38	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1552-3098	1941-0468		IEEE T ROBOT	IEEE Trans. Robot.	AUG	2015	31	4					1054	1063		10.1109/TRO.2015.2450413		10	Robotics	Robotics	CO5TK	WOS:000359221200019		
J	Matsuda, T; Yamada, K; Demachi, H; Iwata, H; Hatakeyama, T; Ishizuka, M; Ohzone, T				Matsuda, Toshihiro; Yamada, Keita; Demachi, Haruka; Iwata, Hideyuki; Hatakeyama, Tomoyuki; Ishizuka, Masaru; Ohzone, Takashi			Analysis of Temperature Distribution in Stacked IC With On-Chip Sensing Device Arrays	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Integrated circuit (IC) thermal factors; IC design; IC measurements; temperature measurement; three dimensional (3-D) ICs	DESIGN	Temperature distributions in 3-D integrated circuits (ICs) are analyzed with a test structure, which has a top-tier chip attached on a bottom dummy chip with adhesive layer. The devices with four kinds of top-tier chip thickness t(Si) of 50-410 mu m were fabricated by a standard 0.18 mu m CMOS process. The test structure consists of 24 sensor blocks, each of which has sensor p-n diodes, an on-chip heater resistor, and selector switches. The temperature distributions of the top-tier test chip under the constant and pulsed heater power were analyzed by both measurements and thermal simulations. Temperature T, which decreases with the distance L, is proportional to the reciprocal of L (1/L). Stacking effects on the temperature distributions become clear for the device with thinner t(Si), and t(Si) = 50 mu m device has a different proportional constant for the region of larger L. Thermal simulations with an entire chip model show similar temperature distributions and the effects of bonding pads. Thermal transient phenomena in stacked ICs were analyzed under the pulsed heating and compared with simulation results. T rises abruptly after the heating pulse input and then gradually increases, and the thermal simulation reproduces the similar results. The test structure and the simulation modeling can provide an effective way for analysis of thermal conduction in stacked ICs.	[Matsuda, Toshihiro; Yamada, Keita; Demachi, Haruka; Iwata, Hideyuki] Toyama Prefectural Univ, Dept Informat Syst Engn, Toyama 9390398, Japan; [Hatakeyama, Tomoyuki; Ishizuka, Masaru] Toyama Prefectural Univ, Dept Mech Syst Engn, Toyama 9390398, Japan; [Ohzone, Takashi] Dawn Enterprise, Nagoya, Aichi 4670808, Japan	Matsuda, T (reprint author), Toyama Prefectural Univ, Dept Informat Syst Engn, Toyama 9390398, Japan.	matsuda@pu-toyama.ac.jp			VLSI Design and Education Center; University of Tokyo; Cadence Design Systems, Inc.; Mentor Graphics, Inc.; Rohm Corporation; Toppan Printing Corporation	This work was supported in part by the VLSI Design and Education Center, and in part by the University of Tokyo in collaboration with Cadence Design Systems, Inc., Mentor Graphics, Inc., Rohm Corporation, and Toppan Printing Corporation.	Pedram M, 2006, P IEEE, V94, P1487, DOI 10.1109/JPROC.2006.879797; Van der Plas G, 2011, IEEE J SOLID-ST CIRC, V46, P293, DOI 10.1109/JSSC.2010.2074070; Ansys, 2015, ANSYS IC; Boianceanu C, 2012, IEEE T SEMICONDUCT M, V25, P542, DOI 10.1109/TSM.2012.2205166; Tsai JL, 2006, P IEEE, V94, P1502, DOI 10.1109/JPROC.2006.879804; Koh R, 2012, IEEE INT C MICROELEC, P191, DOI 10.1109/ICMTS.2012.6190644; Krishnamoorthy S., 2010, P IEEE C EL PERF EL, P277; Matsuda T, 2014, 2014 IEEE INTERNATIONAL CONFERENCE ON MICROELECTRONIC TEST STRUCTURES (ICMTS), P104, DOI 10.1109/ICMTS.2014.6841476; Matsuda T, 2013, IEEE INT C MICROELEC, P131, DOI 10.1109/ICMTS.2013.6528159; Matsuda T, 2014, IEEE T SEMICONDUCT M, V27, P151, DOI 10.1109/TSM.2014.2303820; Minas N, 2012, IEEE T SEMICONDUCT M, V25, P365, DOI 10.1109/TSM.2012.2202809; Minas N., 2010, P IEEE INT C MICR TE, P140; Oprins H., 2010, P INT WORKSH THERMIN, P195; Pan S. H., 2013, P IEEE INT 3D SYST I, P1; Pfost M, 2013, IEEE INT C MICROELEC, P121, DOI 10.1109/ICMTS.2013.6528157; Ramm P, 2010, Proceedings of the 36th European Solid State Circuits Conference (ESSCIRC 2010), DOI 10.1109/ESSCIRC.2010.5619857; Rhayem J., 2010, P THERMINIC, P140; Rhayem J., 2010, P INT C EUROSIME, P1; Shakouri A, 2006, P IEEE, V94, P1473, DOI 10.1109/JPROC.2006.879788; Wang X, 2007, P IEEE SEMICOND THER, P51, DOI 10.1109/STHERM.2007.352405; Yamada K, 2014, 2014 INTERNATIONAL CONFERENCE ON ELECTRONICS PACKAGING (ICEP), P724, DOI 10.1109/ICEP.2014.6826775; Ymashita Y., 2013, THERMOPHYSICAL PROPE	22	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					213	220		10.1109/TSM.2015.2408434		8	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400003		
J	Koike, H				Koike, Hidetoshi			Special Section on the 2014 International Symposium on Semiconductor Manufacturing	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Editorial Material									Toshiba Co Ltd, Semicond & Storage Prod Co, Image Sensor Div, Imaging Device Engn Dept, Kawasaki, Kanagawa 2128520, Japan	Koike, H (reprint author), Toshiba Co Ltd, Semicond & Storage Prod Co, Image Sensor Div, Imaging Device Engn Dept, Kawasaki, Kanagawa 2128520, Japan.	hidetoshi.koike@toshiba.co.jp						0	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					227	228		10.1109/TSM.2015.2453611		2	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400005		
J	Tsuda, T; Inoue, S; Kayahara, A; Imai, S; Tanaka, T; Sato, N; Yasuda, S				Tsuda, Tomio; Inoue, Shinji; Kayahara, Akihiro; Imai, Shin-ichi; Tanaka, Tomoya; Sato, Naoaki; Yasuda, Satoshi			Advanced Semiconductor Manufacturing Using Big Data	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Advanced process control (APC); big data; chemical mechanical polishing (CMP); equipment engineering system (EES); fault detection and classification (FDC); machine-to-machine (M2M); non-production wafer (NPW); run-to-run (R2R); virtual metrology (VM)		This paper describes the development and the actual utilization of fab-wide fault detection and classification (FDC) for the advanced semiconductor manufacturing using big data. In the fab-wide FDC, the collection of equipment's big data for the FDC judgment is required; hence, we developed the equipment monitoring system that handles the data in a superior method in high speed and in real time. We succeeded in stopping equipment and lots automatically when the equipment was detected as fault condition. In addition, we developed the environment that enables immediate data collection for analysis by the data aggregation and merging functions, which extracts keys correlating to yield from the equipment's parameter. Furthermore, we succeeded in development of the high-speed and high-accuracy process control system that implemented virtual metrology and the run-to-run function for the purpose to reduce process variation.	[Tsuda, Tomio; Inoue, Shinji] Panasonic Corp, Uozu, Toyama 9378585, Japan; [Kayahara, Akihiro] Panasonic Corp, Kadoma, Osaka 5718501, Japan; [Imai, Shin-ichi] Panasonic Corp, Moriguchi, Osaka 5708501, Japan; [Tanaka, Tomoya; Sato, Naoaki; Yasuda, Satoshi] TowerJazz Panasonic Semicond Co Ltd, Uozu, Toyama 9378585, Japan	Tsuda, T (reprint author), Panasonic Corp, Uozu, Toyama 9378585, Japan.	tsuda.tomio@jp.panasonic.com; inoue.shinji711@jp.panasonic.com; kayahara.a@jp.panasonic.com; imai.shinichi001@jp.panasonic.com; tanaka.tomoya@tpsemico.com; sato.naoaki@tpsemico.com; yasuda.satoshi@tpsemico.com					Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1; Fukushima S., 2013, P EMPOWER INNOV NEC, P13; Ide T., 2013, STATE SURVEILLANCE T, P28; Imai S, 2009, PANASONIC TECH J, V55, P42; Imai S.-I., 2006, P INT S SEM MAN SEP, P114; Kitabata M., 2011, P AEC APC S AS NOV, P1; Maciejowski J. M., 2000, PREDICTIVE CONTROL C; Tanaka T, 2013, IEEE T SEMICONDUCT M, V26, P339, DOI 10.1109/TSM.2013.2269147	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					229	235		10.1109/TSM.2015.2445320		7	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400006		
J	Ohmori, T; Kashibe, M; Une, S; Yamamoto, K; Shiraishi, D; Inoue, S				Ohmori, Takeshi; Kashibe, Makoto; Une, Satoshi; Yamamoto, Koichi; Shiraishi, Daisuke; Inoue, Satomi			Correlational Study Between SiN Etch Rate and Plasma Impedance in Electron Cyclotron Resonance Plasma Etcher for Advanced Process Control	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Plasma etching; plasma impedance monitor (PIM); optical emission spectroscopy (OES); advanced process control (APC); harmonics analysis of bias waveform	SILICON-NITRIDE; GAS-MIXTURES; METROLOGY; GATE	The correlation between the change in the etching rate of SiN and the change in the monitored plasma impedance was investigated to estimate the capability of critical dimension (CD) prediction with a plasma impedance monitor (PIM). The results obtained with the PIM were compared with those of optical emission spectroscopy (OES), which was performed using the emission intensity ratio of C-2/H, and showed that the SiN etching rate is strongly correlated with several values obtained with the PIM. We conclude that the PIM has the potential to predict CDs with the same accuracy as that of OES.	[Ohmori, Takeshi] Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan; [Kashibe, Makoto; Une, Satoshi; Yamamoto, Koichi; Shiraishi, Daisuke; Inoue, Satomi] Hitachi High Technol Corp, Kasado Design & Prod Div, Yamaguchi 7440002, Japan	Ohmori, T (reprint author), Hitachi Ltd, Cent Res Lab, Tokyo 1858601, Japan.	takeshi.ohmori.kb@hitachi.com					Kastenmeier BEE, 1996, J VAC SCI TECHNOL A, V14, P2802, DOI 10.1116/1.580203; Zeng DK, 2009, IEEE T SEMICONDUCT M, V22, P419, DOI 10.1109/TSM.2009.2031750; Khan AA, 2007, IEEE T SEMICONDUCT M, V20, P364, DOI 10.1109/TSM.2007.907609; Beak K. H., 2014, J VAC SCI TECHNOL B, V32; CAIN SR, 1987, J VAC SCI TECHNOL A, V5, P1578, DOI 10.1116/1.574568; Chemali C. E., 2003, J VAC SCI TECHNOL B, V21, P2304; Fukasawa M, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.08HC01; Imai S., 2005, P ISSM, P139; Ito M., 2012, P INT S DRY PROC TOK, P33; Kanno S, 2004, JPN J APPL PHYS 1, V43, P1199, DOI 10.1143/JJAP.43.1199; Kastenmeier BEE, 1998, J VAC SCI TECHNOL A, V16, P2047, DOI 10.1116/1.581309; Keville B, 2014, J VAC SCI TECHNOL A, V32, DOI 10.1116/1.4879458; Kim Y., 2005, P IEEE INT S SEM MAN, P136; Kota GP, 2003, P SOC PHOTO-OPT INS, V5044, P90, DOI 10.1117/12.487635; Kurihara M, 2007, IEEE T SEMICONDUCT M, V20, P232, DOI 10.1109/TSM.2007.901837; Langan JG, 1998, J VAC SCI TECHNOL A, V16, P2108, DOI 10.1116/1.581317; Lee H. K., 2012, P INT S DRY PROC TOK, P35; Loewenstein L. M., 1988, J APPL PHYS, V65, P386; MELE TC, 1984, J VAC SCI TECHNOL B, V2, P684, DOI 10.1116/1.582863; Schaepkens M., 1998, J VAC SCI TECHNOL A, V16, P26; Sobolewski MA, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.4737615; Standaert T. E. F. M., 2003, J VAC SCI TECHNOL A, V22, P53; Tanaka J., 2003, P AEC APC S 15 COL, P56; Wang Y, 1998, J VAC SCI TECHNOL A, V16, P1582, DOI 10.1116/1.581191; Zhang Y., 1996, J VAC SCI TECHNOL A, V14, P1582	25	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					236	240		10.1109/TSM.2015.2455051		5	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400007		
J	Ishiguro, M; Ikenaga, K; Tamura, T; Shirayone, S; Nawata, M; Sumiya, M				Ishiguro, Masaki; Ikenaga, Kazuyuki; Tamura, Tomoyuki; Shirayone, Shigeru; Nawata, Makoto; Sumiya, Masahiro			Particle Transport in Etching Chamber Influenced by Coulomb Force	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Etching; electric potential; particle charging; plasmas	PLASMA	Particle transport under Coulomb force during plasma on and off periods was studied in a plasma of mixed gases of Ar, O-2, and N-2 generated by a microwave electron cyclotron resonance plasma etching system. The relationship between the number of particles attached to the wafer and the wafer potential was studied, where the wafer potential was supplied by radio frequency (RF) and direct current biases during the plasma on and off periods, respectively. During plasma on periods, the particle counts decreased when a self-bias voltage on the wafer was large in the negative by increasing RF bias power. During plasma off periods, the particle counts decreased when the wafer potential was positive. These results show that particles charge negatively during plasma on periods and particles charge positively during plasma off periods. In this paper, it is found that controlling particle transport with the Coulomb force from the wafer potential is effective for particle attachment prevention.	[Ishiguro, Masaki; Ikenaga, Kazuyuki; Tamura, Tomoyuki; Shirayone, Shigeru; Nawata, Makoto; Sumiya, Masahiro] Hitachi High Technol Corp, Dept Proc Syst Res & Dev, Kudamatsu 7440002, Japan	Ishiguro, M (reprint author), Hitachi High Technol Corp, Dept Proc Syst Res & Dev, Kudamatsu 7440002, Japan.	masaki.ishiguro.yd@hitachi-hightech.com					SELWYN GS, 1990, APPL PHYS LETT, V57, P1876, DOI 10.1063/1.104021; Shiratani M, 2000, JPN J APPL PHYS 1, V39, P287, DOI 10.1143/JJAP.39.287; [Anonymous], 2013, INT TECHNOLOGY ROADM; Samsonov D, 1999, PHYS REV E, V59, P1047, DOI 10.1103/PhysRevE.59.1047; CUI CS, 1994, IEEE T PLASMA SCI, V22, P151; Couedel L, 2008, PHYS PLASMAS, V15, DOI 10.1063/1.2938387; GARRITY MP, 1995, J VAC SCI TECHNOL A, V13, P2939, DOI 10.1116/1.579618; GOREE J, 1992, J VAC SCI TECHNOL A, V10, P3540, DOI 10.1116/1.577781; Kobayashi H, 2008, THIN SOLID FILMS, V516, P3469, DOI 10.1016/j.tsf.2007.08.018; Kobayashi H, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.08JE01; Kobayashi H, 2009, IEEE T SEMICONDUCT M, V22, P462, DOI 10.1109/TSM.2009.2031764; Sheridan TE, 2013, J APPL PHYS, V113, DOI 10.1063/1.4797481	12	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					247	252		10.1109/TSM.2015.2429585		6	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400009		
J	Moriya, T; Sugawara, E; Matsui, H				Moriya, Tsuyoshi; Sugawara, Eiichi; Matsui, Hidefumi			Observation and Elimination of Recoil Particles From Turbo Molecular Pumps	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Semiconductor device manufacture; vacuum technology; plasma applications; particle measurements	LIGHT SCATTERING METHOD; LASER-LIGHT; ETCHING CHAMBER; EQUIPMENT; WAFERS	The existence of recoil particles from the turbo molecular pump has been verified. The recoil particles may be the root cause of yield degradation for the vacuum processes such as the plasma etching processes. To eliminate the recoil particles, they must be trapped inside the turbo molecular pump or inside the manifold chamber. After experimenting with various materials and designs, we have built a novel recoil particle trap and verified its effectiveness in a semiconductor production line.	[Moriya, Tsuyoshi; Matsui, Hidefumi] Tokyo Electron Ltd, Technol Dev Ctr, Tokyo 1076325, Japan; [Sugawara, Eiichi] Tokyo Electron Miyagi Ltd, Dept Syst Technol, Sendai, Miyagi 9813629, Japan	Moriya, T (reprint author), Tokyo Electron Ltd, Technol Dev Ctr, Tokyo 1076325, Japan.	tsuyoshi.moriya@tel.com					Moriya T, 2000, J VAC SCI TECHNOL A, V18, P1282, DOI 10.1116/1.582341; Uesugi F, 1998, J VAC SCI TECHNOL A, V16, P1189, DOI 10.1116/1.581257; Ito N, 1998, J VAC SCI TECHNOL B, V16, P3339, DOI 10.1116/1.590378; Ito N, 2001, J VAC SCI TECHNOL A, V19, P1248, DOI 10.1116/1.1365127; Moriya T., 2005, P INT S SEM MAN, P229; Sato S., 2003, CLEAN TECHNOLOGY, V13, P20	6	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					253	259		10.1109/TSM.2015.2427912		7	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400010		
J	Hirota, J; Harada, K; Nakai, T; Tamaoki, M; Takeno, S; Akahori, H				Hirota, Jun; Harada, Kazunori; Nakai, Tsukasa; Tamaoki, Makiko; Takeno, Shiro; Akahori, Hiroshi			Carrier Profiling Technology in Ten Nanometers Devices	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Atomic force microscopy (AFM); carrier profile; cyclic contact (CC) method; flash memory; scanning spreading resistance microscopy (SSRM); technology-CAD (TCAD)		The advanced carrier concentration evaluation scheme was proposed with combined higher precise scanning spreading resistance microscopy (SSRM) measurement and technology-CAD (TCAD) analysis in this paper. The cyclic contact (CC) method was applied to variation reduction of SSRM resistance to more accurately characterize for the device. The CC method suppresses dust generation. The variation of resistance with the CC method decreased drastically less than 10%. SSRM resistances were corrected to obtain the potential drop in the probe and other resistance component in the measurement system using TCAD analyses. The effective contact probe tip radius was derived from TCAD analysis. The optimization of both sample and measurement conditions were obtained before the actual measurement. The electrical phenomenon in the device measurement can be known by the TCAD analysis. The SSRM measurement of advanced flash memory was successfully demonstrated with adapted these technologies. This result suggests strongly that 10 nm order size device can be measured by using SSRM with the CC method.	[Hirota, Jun; Nakai, Tsukasa; Takeno, Shiro] Toshiba Co Ltd, Semicond & Storage Prod Co, Ctr Semicond Res & Dev, Yokaichi 5128550, Japan; [Harada, Kazunori] Toshiba Co Ltd, Corp Mfg Engn Ctr, Proc Technol Res Dept, Yokohama, Kanagawa 2350017, Japan; [Tamaoki, Makiko; Akahori, Hiroshi] Toshiba Co Ltd, Semicond & Storage Prod Co, Yokkaichi Operat, Yokaichi 5128550, Japan	Hirota, J (reprint author), Toshiba Co Ltd, Semicond & Storage Prod Co, Ctr Semicond Res & Dev, Yokaichi 5128550, Japan.	jun2.hirota@toshiba.co.jp; kazunori2.harada@toshiba.co.jp; tsukasa.nakai@toshiba.co.jp; makiko.tamaoki@toshiba.co.jp; shiro.takeno@toshiba.co.jp; hiroshi2.akahori@toshiba.co.jp					Zhang L, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2736206; Zhang L, 2008, IEEE ELECTR DEVICE L, V29, P799, DOI 10.1109/LED.2008.2000644; Harada K., 2014, P 61 JSAP SPRING M T; Maxwell J.C., 1891, TREATISE ELECT MAGNE	4	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					260	265		10.1109/TSM.2015.2436405		6	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400011		
J	Ohmi, S; Kudoh, S; Atthi, N				Ohmi, Shun-ichiro; Kudoh, Sohya; Atthi, Nithi			Variability Improvement by Si Surface Flattening of Electrical Characteristics in MOSFETs With High-k HfON Gate Insulator	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Electron cyclotron resonance (ECR) plasma sputtering; gate insulator; HfON; high-k; metal-oxide-semiconductor field-effect transistors (MOSFETs); Si surface flattening; variability	1/F NOISE; PERFORMANCE; TECHNOLOGIES; DIELECTRICS; HYDROGEN; LEAKAGE	Variability improvement of metal-oxide-semiconductor field-effect transistors (MOSFETs) characteristics with high-k HfON gate insulator by Si surface flattening was investigated. The Si surface flattening process was carried out by Ar/4.9% H-2 anneal utilizing rapid thermal annealing system. The HfON gate insulator was formed by the in-situ Ar/O-2 plasma oxidation of HfN utilizing electron cyclotron resonance plasma sputtering followed by the post deposition anneal at 600 degrees C for 1 min. The Si surface flattening was found to significantly improve the threshold voltage variability (Delta V-TH) of MOSFET with HfON gate insulator for the first time. Furthermore, the stability of the device characteristics was improved up to the measurement temperature of 100 degrees C by introducing the Si surface flattening process.	[Ohmi, Shun-ichiro; Kudoh, Sohya; Atthi, Nithi] Tokyo Inst Technol, Dept Elect & Appl Phys, Yokohama, Kanagawa 2268502, Japan	Ohmi, S (reprint author), Tokyo Inst Technol, Dept Elect & Appl Phys, Yokohama, Kanagawa 2268502, Japan.	ohmi@ep.titech.ac.jp; kudoh.s.ab@m.titech.ac.jp; atthi.n.aa@m.titech.ac.jp					Kuroda R, 2009, IEEE T ELECTRON DEV, V56, P291, DOI 10.1109/TED.2008.2010591; [Anonymous], 2013, INT TECHNOLOGY ROADM; Balakrishnan K, 2014, IEEE DEVICE RES CONF, P233; Chen DC, 2012, IEEE T SEMICONDUCT M, V25, P155, DOI 10.1109/TSM.2011.2181668; Crupi F, 2009, ECS TRANSACTIONS, V19, P87, DOI 10.1149/1.3122087; Futase T, 2011, IEEE T SEMICONDUCT M, V24, P545, DOI 10.1109/TSM.2011.2163951; Futase T, 2011, IEEE T SEMICONDUCT M, V24, P325, DOI 10.1109/TSM.2010.2099673; Futase T, 2013, IEEE T SEMICONDUCT M, V26, P355, DOI 10.1109/TSM.2013.2268872; Han DH, 2013, IEICE ELECTRON EXPR, V10, DOI 10.1587/elex.10.20130651; Han DH, 2013, IEICE T ELECTRON, VE96C, P669, DOI 10.1587/transele.E96.C.669; Han DH, 2014, IEICE T ELECTRON, VE97C, P413, DOI 10.1587/transele.E97.C.413; Han H, 2012, IEICE ELECTRON EXPR, V9, P1329, DOI 10.1587/elex.9.1329; Han HS, 2013, ELECTRON LETT, V49, P500, DOI 10.1049/el.2013.0319; Kudo S, 2014, IEEE T SEMICONDUCT M, V27, P16, DOI 10.1109/TSM.2013.2284593; Kuroda R., 2010, ECS T, V28, P299, DOI DOI 10.1149/1.3375615; Li YM, 2012, IEEE T SEMICONDUCT M, V25, P266, DOI 10.1109/TSM.2011.2181964; Lim PSY, 2012, J APPL PHYS, V111, DOI 10.1063/1.3700224; Matsushita Y., 2006, ECS T, V3, P159, DOI DOI 10.1149/1.2355754; MORITA Y, 1995, APPL PHYS LETT, V67, P2654, DOI 10.1063/1.114326; Ohmi S, 2014, IEICE ELECTRON EXPR, V11, DOI 10.1587/elex.11.20142006; Ohmi T, 2007, IEEE T ELECTRON DEV, V54, P1471, DOI 10.1109/TED.2007.896391; Paul A., 2013, IEDM, P361; Sano T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DA09; Srinivasan P, 2006, J ELECTROCHEM SOC, V153, pG324, DOI 10.1149/1.2170549; Tao Q, 2011, IEEE T SEMICONDUCT M, V24, P139, DOI 10.1109/TSM.2011.2106167; Zamani D, 2012, IEEE T SEMICONDUCT M, V25, P511, DOI 10.1109/TSM.2012.2196295; Zhong L, 1996, APPL PHYS LETT, V68, P2349, DOI 10.1063/1.115854	27	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					266	271		10.1109/TSM.2015.2431375		6	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400012		
J	Kakegawa, T; Futase, T				Kakegawa, Tomoyasu; Futase, Takuya			Pattern-Independent PMD Layer Planarization by Controlling its Volume Before CMP	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Atomic force microscopy; chemical mechanical polishing (CMP); contact; density distribution; planarization; pre-metal dielectric (PMD); voltage contrast	INSPECTION; SLURRY	We achieved excellent planarization for a pre-metal dielectric (PMD) layer regardless of its pattern density distribution by making the distribution uniform before chemical mechanical polishing (CMP) without any stopper layer. The distribution control was done by lithography using a checkered reticle on the high-density PMD area followed by etching of the PMD layer to uniformize the CMP rates at both areas. After this planarization, the PMD layer was flattened in the local and global regions. The PMD step-height within chip was approximately 8 nm (approximately 1% of PMD height), which is a variation of less than one tenth compared with conventional planarization, and the non-uniformity of PMD thickness within wafer was approximately 2%. The planarized PMD layer suppressed the defocusing in lithography for contact hole formation on the layer, thus dramatically reducing contact-open failures in a chip of approximately 50 x 110 nm in diameter with 620-nm high-contact holes. The number of defects was one-thousandth that of a conventionally planarized PMD layer.	[Kakegawa, Tomoyasu; Futase, Takuya] SanDisk Ltd, Adv Proc & Device Dev Grp, Yokaichi 5128550, Japan; [Futase, Takuya] Interuniv Microelect Ctr, B-3001 Leuven, Belgium	Kakegawa, T (reprint author), SanDisk Ltd, Adv Proc & Device Dev Grp, Yokaichi 5128550, Japan.	tomoyasu.kakegawa@sandisk.com; futase@me.com					ALI I, 1994, SOLID STATE TECHNOL, V37, P63; BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930; Burke P. A., 1991, P VLSI MULT INT C, P379; Chang R., 2001, P SEM MAN S SAN JOS, P133; Katoh T, 2003, JPN J APPL PHYS 1, V42, P1150, DOI 10.1143/JJAP.42.1150; Kwon B., 1999, P 6 INT C VLSI CAD I, P456; Lau W.S., 1993, P IEEE IRPS, P190; LEE B, 2000, P CMP MIC, P255; Lin BT, 2002, ASMC PROC, P362; Murayama K., 2007, P INT C PLAN CMP TEC, P25; NANZ G, 1995, IEEE T SEMICONDUCT M, V8, P382, DOI 10.1109/66.475179; Ouma D, 1998, PROCEEDINGS OF THE IEEE 1998 INTERNATIONAL INTERCONNECT TECHNOLOGY CONFERENCE, P67, DOI 10.1109/IITC.1998.704753; Patterson OD, 2008, IEEE T SEMICONDUCT M, V21, P322, DOI 10.1109/TSM.2008.2001205; Sakurai T, 2003, ISSCC DIG TECH PAP I, V46, P26; Satya AVS, 1997, IEEE T SEMICONDUCT M, V10, P384, DOI 10.1109/66.618211; SIVARAM S, 1992, SOLID STATE TECHNOL, V35, P87; Sonboonton R, 2008, ECTI-CON 2008: PROCEEDINGS OF THE 2008 5TH INTERNATIONAL CONFERENCE ON ELECTRICAL ENGINEERING/ELECTRONICS, COMPUTER, TELECOMMUNICATIONS AND INFORMATION TECHNOLOGY, VOLS 1 AND 2, P777; STINE B, 1997, P CMP MIC C SANT CLA, P266; Tanaka Y., 1998, P SOL STAT INT CIRC, P207; Yamazaki Y., 1999, P INT MICR NAN C, P188; Zika S., 1997, P IEEE INT S SEM MAN, P99	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					272	277		10.1109/TSM.2015.2434388		6	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400013		
J	Tanimura, T; Hsiao, C; Akiyama, K; Hirota, Y; Sato, J; Kaitsuka, T				Tanimura, Tatsuhiko; Hsiao, Chihhsiang; Akiyama, Koji; Hirota, Yoshihiro; Sato, Jun; Kaitsuka, Takanobu			Effect of Plasma Process for SiO2 Film on Sidewall	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Dielectric films; leakage currents; metal oxide semiconductor (MOS) devices; plasma materials processing	CHEMICAL-VAPOR-DEPOSITION; ATOMIC LAYER DEPOSITION; SILICON DIOXIDE; OXIDE; TEMPERATURE; TETRAETHYLORTHOSILICATE	We evaluated the physical and electrical characteristics of SiO2 treated by plasma oxidation on top and sidewall. The plasma process is less effective for SiO2 on sidewall than on top and further less for small pattern. Both the characteristics for SiO2 on sidewall are sensitive to plasma condition in deposition sequence, while not for SiO2 on top. When the plasma process is used as post treatment on SiO2 with high coverage and the poor characteristics, they are also not dependent on the condition. Moreover, the post plasma treatment can improve electrical characteristic beyond the level of SiO2 deposited by the same plasma oxidation condition.	[Tanimura, Tatsuhiko; Hsiao, Chihhsiang; Akiyama, Koji; Hirota, Yoshihiro; Kaitsuka, Takanobu] Tokyo Electron Ltd, Leading Edge Proc Dev Ctr, Nirasaki 4070192, Japan; [Sato, Jun] Tokyo Electron Tohoku Ltd, Dept Dev, Oshu 0231101, Japan	Tanimura, T (reprint author), Tokyo Electron Ltd, Leading Edge Proc Dev Ctr, Nirasaki 4070192, Japan.	tatsuhiko.tanimura@tel.com					Park BR, 2013, IEEE ELECTR DEVICE L, V34, P354, DOI 10.1109/LED.2012.2236678; DESHMUKH SC, 1994, APPL PHYS LETT, V65, P3185, DOI 10.1063/1.112475; BATEY J, 1986, J APPL PHYS, V60, P3136, DOI 10.1063/1.337726; Endo K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.116503; Fridman A., 2004, PLASMA PHYS ENG, P75; Hofmann S, 2011, PLASMA SOURCES SCI T, V20, DOI 10.1088/0963-0252/20/6/065010; Kaspar T, 2003, J VAC SCI TECHNOL B, V21, P895, DOI 10.1116/1.1563254; Kawase K, 2012, J APPL PHYS, V111, DOI 10.1063/1.3679553; Kim JK, 2012, J NANOSCI NANOTECHNO, V12, P3589, DOI 10.1166/jnn.2012.5623; Lee JH, 2004, JPN J APPL PHYS 2, V43, pL328, DOI 10.1143/JJAP.43.L328; Ma J, 2003, PHYS PLASMAS, V10, P4118, DOI 10.1063/1.1605950; Natarajan S., 2014, P INT EL DEV M IEDM, P71; NGUYEN S, 1990, J ELECTROCHEM SOC, V137, P2209, DOI 10.1149/1.2086914; RAUPP GB, 1992, J VAC SCI TECHNOL B, V10, P37, DOI 10.1116/1.586361; SEAWARD KL, 1995, J VAC SCI TECHNOL B, V13, P118, DOI 10.1116/1.588003; Shibata T., 2010, P ISSM TOK JAP, P1; Takeda K., 2007, P INT C SOL STAT DEV, P326; Tanaka H., 2007, VLSI S, P14; Tanaka H, 2003, JPN J APPL PHYS 1, V42, P1911, DOI 10.1143/JJAP.42.1911; Tanimura T, 2013, J APPL PHYS, V113, DOI 10.1063/1.4790884; Won SJ, 2010, IEEE ELECTR DEVICE L, V31, P857, DOI 10.1109/LED.2010.2049978	21	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					278	282		10.1109/TSM.2015.2444404		5	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400014		
J	Watanabe, H				Watanabe, Hiroe			Development of Wafer Transfer Simulator Based on Cellular Automata	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Cellular automata; multicluster tool; pull system; push system; wafer transfer simulator		This paper describes a homemade wafer transfer simulator based on cellular automata theory for many semiconductor manufacturing tools. In such a complicated multicluster tool, all the errors in the simulation result to the actual data became within only 30 s against the around 50 min production time. The cellular automata theory is very simple and the simulator can be created with a spreadsheet application. And it was highly effective that the features of the installed unclear wafer transfer systems became clear by using the simulator, either. Up until now only the tool manufacturer can develop the simulator, but by using cellular automata theory with correct wafer transfer systems, everybody who has some knowledge of the spreadsheet application can develop it without equations even if the transfer logic is not opened at all. This simulator is effective to the tool capacity scrutiny and the productivity improvement. We think this technology is a breakthrough and can be applied to other industrial tools in addition to semiconductor manufacturing tools.	[Watanabe, Hiroe] TowerJazz Panasonic Semicond Co Ltd, Strategy Planning Grp, Uozu, Toyama 9378585, Japan	Watanabe, H (reprint author), TowerJazz Panasonic Semicond Co Ltd, Uozu, Toyama 9378585, Japan.	watanabe.hiroe@tpsemico.com					Hsu P.-M., 2010, P 2010 INT S SEM MAN, P1; Matsuzaki H., 2006, TOYOTA PRODUCTION SY; Nakayama K., 1997, ORSJ, V42, P61; Nishinari K., 2006, SHINCHO SENSHO; Nogi K., 2012, P INT S SEM MAN OCT; Watanabe H., 2012, P INT S SEM MAN OCT; Wolfram S., 1994, CELLULAR AUTOMATA CO; Yanagisawa D., 2012, JPN SOC IND APPL MAT, V22, P2	8	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					283	288		10.1109/TSM.2015.2427273		6	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400015		
J	Komoda, K; Sakuma, M; Yata, M; Yamazaki, Y; Imaizumi, F; Kuroda, R; Sugawa, S				Komoda, Kaori; Sakuma, Masashi; Yata, Masakazu; Yamazaki, Yoshio; Imaizumi, Fuminobu; Kuroda, Rihito; Sugawa, Shigetoshi			Measurement and Analysis of Seismic Response in Semiconductor Manufacturing Equipment	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Earthquakes; signal analysis; transfer functions; semiconductor device manufacture		In this paper, a cost-effective, easy-install and fast measurement and analysis method to obtain seismic response of semiconductor manufacturing equipments was developed and its validity was discussed. In the developed method, micro-vibration measurement experiments are first carried out to obtain transfer functions and coherence functions from the floor to arbitrary part of equipment. Using obtained transfer function, seismic response of the arbitrary part of equipment is analyzed with seismic floor response input. In this paper, the developed method was applied to a vertical furnace and a lithography system and their transfer functions were experimentally obtained. It has been confirmed that with additional excitation on the floor near the equipment is effective to improve the accuracy of obtained transfer functions. The validity of developed analysis method was confirmed by the good agreement between the analytical result and the experimental result obtained with a shaking table. The developed method is to be useful to estimate seismic damage of various types of semiconductor manufacturing equipment as well as to take seismic countermeasures.	[Komoda, Kaori; Yata, Masakazu; Yamazaki, Yoshio] Taisei Corp, Tokyo 1630606, Japan; [Sakuma, Masashi] Orbit Corp, Tokyo 1600023, Japan; [Imaizumi, Fuminobu; Kuroda, Rihito; Sugawa, Shigetoshi] Tohoku Univ, Sendai, Miyagi 9808579, Japan	Komoda, K (reprint author), Taisei Corp, Tokyo 1630606, Japan.	sgwkor00@pub.taisei.co.jp; sakuma@orbit-sys.co.jp; fuminobu.imaizumi.b6@tohoku.ac.jp					[Anonymous], 2014, STRONG MOT SEISM NET; Hanawa T., 2012, P INT S SEM MAN OCT; Hibino H., 2011, REP TAISEI TECHNOL C, V44, P1; Ishida S., 2012, P INT S SEM MAN OCT; Kawaguchi H., 2012, P INT S SEM MAN OCT; Komoda K., 2013, P E MAN DES COLL S E; Matsuoka F., 2012, P INT S SEM MAN OCT; Moriya T., 2012, P INT S SEM MAN OCT; SCHMIDT H, 1985, J SOUND VIB, V101, P347, DOI 10.1016/S0022-460X(85)80135-8; Sherin B, 2000, SSA J-J SEMICOND SAF, V14, P22; Shimizu M., 2012, P INT S SEM MAN OCT; Takahashi Masato, 2010, Journal of the Japan Society of Precision Engineering, V76, DOI 10.2493/jjspe.76.214; Wang Y. P., 2003, P JOINT NCREE JRC WO, P187; Yoshitaka H., 2000, J VIB ACOUST, V123, P269	14	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					289	296		10.1109/TSM.2015.2427807		8	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400016		
J	Wang, HK; Chien, CF; Gen, MS				Wang, Hung-Kai; Chien, Chen-Fu; Gen, Mitsuo			An Algorithm of Multi-Subpopulation Parameters With Hybrid Estimation of Distribution for Semiconductor Scheduling With Constrained Waiting Time	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Hybrid estimation of distribution; limited waiting time constraint; multi-subpopulation; semiconductor manufacturing scheduling	GENETIC ALGORITHM; MACHINE; OPTIMIZATION; FABRICATION	Scheduling for wafer fabrication of advanced technology nodes entails complicated constraints such as limited waiting times. Focusing on real settings, this paper aims to develop a novel genetic algorithm of multi-subpopulation parameters with hybrid estimation of distribution (MSPHEDA) to solve the present problem effectively and efficiently. To estimate the validity of this approach, ten scenarios were simulated on the basis of empirical data as the basis to compare the performance of MSPHEDA and other heuristic methods for minimizing makespan and reducing the total exceeded limited waiting time. The results have shown practical viability of the proposed approach.	[Wang, Hung-Kai; Chien, Chen-Fu] Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Hsinchu 30013, Taiwan; [Gen, Mitsuo] Tokyo Univ Sci, Fuzzy Log Syst Inst, Tokyo 162, Japan; [Gen, Mitsuo] Tokyo Univ Sci, Res Inst Sci & Technol, Tokyo 162, Japan	Wang, HK (reprint author), Natl Tsing Hua Univ, Dept Ind Engn & Engn Management, Hsinchu 30013, Taiwan.	cfchien@mx.nthu.edu.tw			Ministry of Science and Technology [NSC 100-2628-E-007-017-MY3, MOST 103-2218-E-007-023]; Semiconductor Technologies Empowerment Partners Consortium [NSC 102-2622-E-007-013]; Advanced Manufacturing and Service Management Research Center [104N2074E1]; Taiwan Semiconductor Manufacturing Company, Hsinchu Science Park, Taiwan [102A26]; Japan Society of Promotion of Science [24510219.0001]	This work was supported in part by the Ministry of Science and Technology under Grant NSC 100-2628-E-007-017-MY3 and Grant MOST 103-2218-E-007-023, in part by the Semiconductor Technologies Empowerment Partners Consortium under Grant NSC 102-2622-E-007-013, in part by the Advanced Manufacturing and Service Management Research Center under Grant 104N2074E1, in part by the Taiwan Semiconductor Manufacturing Company, Hsinchu Science Park, Taiwan under Grant 102A26, and in part by the Japan Society of Promotion of Science: Grant-in-Aid for Scientific Research under Grant 24510219.0001.	Aguirre AM, 2011, COMPUT CHEM ENG, V35, P2960, DOI 10.1016/j.compchemeng.2011.02.014; Deb K, 2014, IEEE T EVOLUT COMPUT, V18, P577, DOI 10.1109/TEVC.2013.2281535; Wang L, 2012, COMPUT IND ENG, V62, P917, DOI 10.1016/j.cie.2011.12.014; Gao J, 2007, COMPUT IND ENG, V53, P149, DOI 10.1016/j.cie.2007.04.010; Kennedy J, 1995, 1995 IEEE INTERNATIONAL CONFERENCE ON NEURAL NETWORKS PROCEEDINGS, VOLS 1-6, P1942, DOI 10.1109/ICNN.1995.488968; Monch L, 2011, J SCHEDULING, V14, P583, DOI 10.1007/s10951-010-0222-9; Driessel R, 2011, COMPUT IND ENG, V61, P336, DOI 10.1016/j.cie.2010.07.001; Wang L, 2013, IEEE T ENG MANAGE, V60, P617, DOI 10.1109/TEM.2012.2234463; Mason SJ, 2002, J SCHED, V5, P247, DOI 10.1002/jos.102; Chen SH, 2010, EXPERT SYST APPL, V37, P6441, DOI 10.1016/j.eswa.2010.02.073; Unlu Y, 2010, COMPUT IND ENG, V58, P785, DOI 10.1016/j.cie.2010.02.012; Keha AB, 2009, COMPUT IND ENG, V56, P357, DOI 10.1016/j.cie.2008.06.008; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Karaboga D, 2007, J GLOBAL OPTIM, V39, P459, DOI 10.1007/s10898-007-9149-x; Demir Y, 2013, APPL MATH MODEL, V37, P977, DOI 10.1016/j.apm.2012.03.020; Gao J, 2008, COMPUT OPER RES, V35, P2892, DOI 10.1016/j.cor.2007.01.001; Chien CF, 2007, OR SPECTRUM, V29, P391, DOI 10.1007/s00291-006-0062-3; Jarboui B, 2009, COMPUT OPER RES, V36, P2638, DOI 10.1016/j.cor.2008.11.004; Chien CF, 2014, IEEE T AUTOM SCI ENG, V11, P473, DOI 10.1109/TASE.2013.2280618; Attar SF, 2014, INT J COMPUT INTEG M, V27, P450, DOI 10.1080/0951192X.2013.820348; Baluja S., 1994, CMUCS94163 SCH COMP; Bean J. C., 1994, ORSA Journal on Computing, V6; Ceberio J., 2012, PROGR ARTIFICIAL INT, V1, P103, DOI DOI 10.1007/S13748-011-0005-3; Chien CF, 2008, EUR J OPER RES, V189, P1234, DOI 10.1016/j.ejor.2007.01.062; Chien CF, 2011, EUR J IND ENG, V5, P254; Chien CF, 2007, INT J PROD RES, V45, P1763, DOI 10.1080/00207540500380981; Cochran JK, 2003, COMPUT OPER RES, V30, P1087, DOI 10.1016/S0305-0548(02)00059-X; Dauzere-Peres S, 2013, COMPUT OPER RES, V40, P1224, DOI 10.1016/j.cor.2012.12.012; DeBonet JS, 1997, ADV NEUR IN, V9, P424; Gen M, 2008, DECIS ENG, P1; Hao XC, 2014, J INTELL MANUF, V25, P867, DOI 10.1007/s10845-013-0746-x; Jia W., 2015, INT J PROD RES, V53, P1; Jung C, 2014, IEEE T SEMICONDUCT M, V27, P357, DOI 10.1109/TSM.2014.2337310; Klemmt A., 2012, P WINT SIM C BERL GE, P1; Kuo CJ, 2011, IEEE T AUTOM SCI ENG, V8, P103, DOI 10.1109/TASE.2010.2040999; Larranaga P., 2002, ESTIMATION DISTRIBUT; Leachman RC, 2007, IEEE T AUTOM SCI ENG, V4, P501, DOI 10.1109/TASE.2007.906142; Moore G, 1965, ELECTRONICS, V38, P114; Muhlenbein H., 1996, LNCS; Pelikan M., 1999, ADV SOFT COMPUTING E; Pelikan M, 1999, P GEN EV COMP C GECC, VI, P525; Qiao F, 2013, IEEE T AUTOM SCI ENG, V10, P197, DOI 10.1109/TASE.2012.2204049; Robles V, 2002, ESTIMATION DISTRIBUT; Song Y, 2007, IEEE T AUTOM SCI ENG, V4, P569, DOI 10.1109/TASE.2007.906341; Wang HB, 2014, LECT NOTES ELECTR EN, V262, P101, DOI 10.1007/978-3-642-39581-9_11; Wu JZ, 2008, EXPERT SYST APPL, V35, P485, DOI 10.1016/j.eswa.2007.07.026; Yan B, 2013, IEEE T AUTOM SCI ENG, V10, P928, DOI 10.1109/TASE.2013.2277812; Yeniay O., 2005, Mathematical & Computational Applications, V10; Yu X., 2010, INTRO EVOLUTIONARY A, P430; Yun Y., 2003, FUZZY OPTIM DECIS MA, V2, P161, DOI 10.1023/A:1023499201829	50	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					353	366		10.1109/TSM.2015.2439054		14	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400023		
J	Khumpuang, S; Hara, S				Khumpuang, Sommawan; Hara, Shiro			A MOSFET Fabrication Using a Maskless Lithography System in Clean-Localized Environment of Minimal Fab	IEEE TRANSACTIONS ON SEMICONDUCTOR MANUFACTURING			English	Article						Lithography; microelectromechanical systems; micromachining; metal-oxide-semiconductor field-effect-transistors (MOSFETs); semiconductor device manufacture	PROJECTION LITHOGRAPHY; DEVICE	A novel semiconductor manufacturing system minimal fab for customized semiconductor devices and micro electro mechanical systems on a half-inch wafer is developed. A distinct feature of the minimal fab is its clean-localized system eliminating a need of cleanroom environment. The clean level of the system is estimated by measuring separately each clean-localized component of the system including a minimal shipping case, wafer carrier, wafer load-lock system, and machine process chamber using a particle counter. The clean level of the system is analyzed to be in the ISO class 4, which is in the same class of a super clean room. In order to confirm the cleanliness needed for device fabrications, we employ a lithography system of the minimal fab consisting of a minimal coater, a minimal maskless exposure system using digital light processing technique, and a minimal developer hybridizing with conventional fab equipment to fabricate a metaloxide-semiconductor (MOS) field-effect-transistors (FET). The minimum gate-length of the MOSFET is realized at 1 mu m with a good transistor characteristic. The measured interface states density of 2.33 x 10(10) cm(-2) indicates that the whole processes during the fabrication are in the level of a sufficiently low contamination.	[Khumpuang, Sommawan; Hara, Shiro] AIST, Nanoelect Res Inst, Ibaraki 3058568, Japan	Khumpuang, S (reprint author), AIST, Nanoelect Res Inst, Ibaraki 3058568, Japan.	sommawan.khumpuang@aist.go.jp			Ministry of Economy, Trade and Industry	This work was supported by the Ministry of Economy, Trade and Industry under the project "Innovative manufacturing process technology development (minimal fab)" during the fiscal years of 2012-2014.	Dudley D, 2003, P SOC PHOTO-OPT INS, V4985, P14, DOI 10.1117/12.480761; [Anonymous], 1999, 146441 ANSIIESTISO; Kim KR, 2009, APPL SURF SCI, V255, P7835, DOI 10.1016/j.apsusc.2009.05.022; Waldbaur A, 2012, SMALL, V8, P1570, DOI 10.1002/smll.201102163; Braddom E., 2008, DIGITAL PROJECTION U; Cobo Fernando, 2008, Biotechnology Journal, V3, P43, DOI 10.1002/biot.200700122; Hara S., 2011, J JPN SOC PRECIS ENG, V77, P249; Hara S., MINIMAL FAB; Jeyachandran YL, 2015, J PHYS CHEM C, V119, P494, DOI 10.1021/jp510809a; Khumpuang S., 2013, IEEJ T SENSORS MICRO, V133, P272; Negrete OD, 2008, MICROELECTRON ENG, V85, P834, DOI 10.1016/j.mee.2008.01.014; Rajan DK, 2010, PROCEDIA ENGINEER, V5, P331, DOI 10.1016/j.proeng.2010.09.115; Smith D., 2009, P SOC PHOTO-OPT INS, V7210	13	1	1	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	0894-6507	1558-2345		IEEE T SEMICONDUCT M	IEEE Trans. Semicond. Manuf.	AUG	2015	28	3					393	398		10.1109/TSM.2015.2429572		6	Engineering, Manufacturing; Engineering, Electrical & Electronic; Physics, Applied; Physics, Condensed Matter	Engineering; Physics	CO5XI	WOS:000359231400027		
J	Cheng, MM; Feng, K; Isobe, T; Shimada, R				Cheng, Miao-miao; Feng, Kai; Isobe, Takanori; Shimada, Ryuichi			Characteristics of the magnetic energy recovery switch as a static Var compensator technology	IET POWER ELECTRONICS			English	Article							REACTIVE POWER-CONTROL; INDUCTION GENERATOR; STATCOM; QUALITY; SYSTEMS	The magnetic energy recovery switch (MERS) has been proposed as a new reactive power compensator. It has been proven by some series compensation applications. In terms of shunt compensation, however, research on MERS is still at its early stage. In this study, the characteristics of MERS that operates as a static Var compensator (SVC-MERS) technology are clarified. First, the operating principles of SVC-MERS are described. The proposed device achieves continuously controllable capacitive power compensation with a simple control. Its unique characteristics include line frequency switching and wide-range impedance control by a small capacitor, which lead to a wide operating range. Second, the electrical model of SVC-MERS is described using analytical equations, and then followed by a detailed performance analysis. In particular, the optimal parameter design and the optimal combination of control variables are established from the perspectives of low peak capacitor voltage and current harmonics. Simulation and experimental results are presented to verify the characteristics of SVC-MERS. Finally, SVC-MERS is compared with other existing SVC technologies. In conclusion, SVC-MERS is determined to be an attractive alternative shunt compensator.	[Cheng, Miao-miao] Hunan Univ, Coll Elect & Informat Engn, Changsha, Peoples R China; [Feng, Kai] Hunan Univ, Coll Mech & Vehicle Engn, Changsha, Peoples R China; [Isobe, Takanori; Shimada, Ryuichi] Tokyo Inst Technol, Res Lab Nucl Reactors, Tokyo 152, Japan	Cheng, MM (reprint author), Hunan Univ, Coll Elect & Informat Engn, Changsha, Peoples R China.	mmcheng@hnu.edu.cn			National Natural Science Foundation of China [51307048]	The financial support from the National Natural Science Foundation of China (no. 51307048) is gratefully acknowledged.	Acha E, 2013, IEEE T POWER SYST, V28, P2455, DOI 10.1109/TPWRS.2012.2237186; Alves JER, 2008, IEEE T POWER DELIVER, V23, P338, DOI 10.1109/TPWRD.2007.911131; Wiik JA, 2009, IEEE T POWER DELIVER, V24, P828, DOI 10.1109/TPWRD.2008.2005879; Ahmed T, 2005, IEE P-GENER TRANSM D, V152, P145, DOI 10.1049/ip-gtd:20051251; Rahmani S, 2014, IEEE T IND ELECTRON, V61, P2152, DOI 10.1109/TIE.2013.2272271; Luo A, 2012, IEEE T IND ELECTRON, V59, P723, DOI 10.1109/TIE.2011.2161066; Singh B, 2009, IET POWER ELECTRON, V2, P297, DOI 10.1049/iet-pel.2008.0034; Singh B, 2014, IET POWER ELECTRON, V7, P1736, DOI 10.1049/iet-pel.2013.0494; Luo A, 2009, IEEE T IND ELECTRON, V56, P418, DOI 10.1109/TIE.2008.2008357; Camacho A, 2014, IEEE T POWER ELECTR, V29, P6224, DOI 10.1109/TPEL.2014.2301463; Foster S, 2010, IET RENEW POWER GEN, V4, P128, DOI 10.1049/iet-rpg.2008.0057; [Anonymous], 2008, IEEE T POWER DELIVER, DOI DOI 10.1109/TPWRS.2008.923815; Singh B, 2004, IEEE T ENERGY CONVER, V19, P783, DOI 10.1109/TEC.2004.827710; GYUGYI L, 1988, P IEEE, V76, P483, DOI 10.1109/5.4433; Hamadi A, 2010, IEEE T IND ELECTRON, V57, P2419, DOI 10.1109/TIE.2009.2035460; Lee TL, 2013, IEEE T IND ELECTRON, V60, P1417, DOI 10.1109/TIE.2011.2166233; Shuai ZK, 2009, IEEE T POWER ELECTR, V24, P2091, DOI 10.1109/TPEL.2009.2020504; Slepchenkov MN, 2011, IEEE T IND ELECTRON, V58, P1120, DOI 10.1109/TIE.2010.2052536; Wijaya Fransisco Danang, 2009, IEEJ Transactions on Industry Applications, V129, DOI 10.1541/ieejias.129.29	19	0	0	INST ENGINEERING TECHNOLOGY-IET	HERTFORD	MICHAEL FARADAY HOUSE SIX HILLS WAY STEVENAGE, HERTFORD SG1 2AY, ENGLAND	1755-4535	1755-4543		IET POWER ELECTRON	IET Power Electron.	AUG	2015	8	8					1329	1338		10.1049/iet-pel.2014.0609		10	Engineering, Electrical & Electronic	Engineering	CN4PN	WOS:000358412500001		
J	Shi, Y; Ji, SP; Shao, XW; Yang, P; Wu, WB; Shi, ZC; Shibasaki, R				Shi, Yun; Ji, Shunping; Shao, Xiaowei; Yang, Peng; Wu, Wenbin; Shi, Zhongchao; Shibasaki, Ryosuke			Fusion of a panoramic camera and 2D laser scanner data for constrained bundle adjustment in GPS-denied environments	IMAGE AND VISION COMPUTING			English	Article						Panoramic camera; Laser; Sensor fusion; Constrained bundle adjustment	SIMULTANEOUS LOCALIZATION; PROBABILISTIC LOCALIZATION; VISUAL SLAM; TIME; APPEARANCE; FILTER; MODEL; MAP	Pose estimation is a key concern in 3D urban surveying, mapping, and navigation. Although Global Positioning System (GPS) technologies can be used to estimate a robot's or vehicle's pose, there are many urban environments in which GPS functions poorly or not at all. For these situations, we offer a novel approach based on a careful fusion of panoramic camera data and 2D laser scanner input. First, a Constrained Bundle Adjustment (CBA) is introduced to handle scale and loop closure constraints. The fusion of a panoramic image series and laser data then enables an accurate scale to be estimated and loop closures detected. Finally, the two geometric constraints are enforced on the global CBA solution, which in turn produces a robust pose estimate. Experiments show that the proposed method is practicable and more accurate than vision-only methods, with an average error of just 0.2 m in the horizontal plane over a 580 m trajectory. (C). 2015 Elsevier B.V. All rights reserved.	[Shi, Yun; Yang, Peng; Wu, Wenbin] Chinese Acad Agr Sci, Inst Agr Resources & Reg Planning, Beijing 100193, Peoples R China; [Ji, Shunping] Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan 430072, Peoples R China; [Shi, Yun; Ji, Shunping; Shibasaki, Ryosuke] Univ Tokyo, Ctr Spatial Informat Sci, Chiba, Japan; [Shao, Xiaowei] Univ Tokyo, Earth Observat Data Integrat & Fus Res Initiat, Tokyo 1538505, Japan; [Shi, Zhongchao] Tokyo City Univ, Dept Restorat Ecol & Built Environm, Fac Environm Studies, Tuzuki Ku, Yokohama, Kanagawa 2248551, Japan	Ji, SP (reprint author), Wuhan Univ, Sch Remote Sensing & Informat Engn, Wuhan 430072, Peoples R China.	shiyun@caas.cn; jishunping@whu.edu.cn; shaoxw@iis.u-tokyo.ac.jp; Yangpeng@caas.cn; Wuwenbin@caas.cn; shizc@tcu.ac.jp; shiba@csis.u-tokyo.ac.jp			National Key Basic Research Program of China [2012CB719902]; National Natural Science Foundation of China [41301365, 41471288, 61403285]; National High-Tech R&D Program of China [2015AA124001]	This work was jointly supported by the National Key Basic Research Program of China (2012CB719902), the National Natural Science Foundation of China (41301365, 41471288 and 61403285), and the National High-Tech R&D Program of China (2015AA124001).	Agarwal S, 2010, LECT NOTES COMPUT SC, V6312, P29, DOI 10.1007/978-3-642-15552-9_3; Thrun S, 2004, INT J ROBOT RES, V23, P693, DOI 10.1177/0278364904045479; Thrun S, 2006, INT J ROBOT RES, V25, P403, DOI 10.1177/0278364906065387; Brown M, 2005, PROC CVPR IEEE, P510; Paul R, 2010, IEEE INT CONF ROBOT, P2649, DOI 10.1109/ROBOT.2010.5509587; Vasconcelos F, 2012, IEEE T PATTERN ANAL, V34, P2097, DOI 10.1109/TPAMI.2012.18; Dellaert F, 2006, INT J ROBOT RES, V25, P1181, DOI 10.1177/0278364906072768; Strasdat H, 2012, IMAGE VISION COMPUT, V30, P65, DOI 10.1016/j.imavis.2012.02.009; Sim D, 2009, IMAGE VISION COMPUT, V27, P1527, DOI 10.1016/j.imavis.2009.02.009; Cummins M, 2008, INT J ROBOT RES, V27, P647, DOI 10.1177/0278364908090961; Davison AJ, 2007, IEEE T PATTERN ANAL, V29, P1052, DOI 10.1109/TPAMI.2007.1049; Diosi A, 2007, INT J ROBOT RES, V26, P1125, DOI 10.1177/0278364907082042; Sibley G, 2010, INT J ROBOT RES, V29, P958, DOI 10.1177/0278364910369268; Milford MJ, 2004, IEEE INT CONF ROBOT, P403, DOI 10.1109/ROBOT.2004.1307183; Mikolajczyk K, 2005, INT J COMPUT VISION, V65, P43, DOI 10.1007/s11263-005-3848-x; Konolige K, 2008, IEEE T ROBOT, V24, P1066, DOI 10.1109/TRO.2008.2004832; Booij O, 2009, ROBOT AUTON SYST, V57, P1225, DOI 10.1016/j.robot.2009.06.006; Bosse M, 2008, INT J ROBOT RES, V27, P667, DOI 10.1177/0278364908091366; Chli M, 2009, ROBOT AUTON SYST, V57, P1173, DOI 10.1016/j.robot.2009.07.010; Dusha D, 2012, INT J ROBOT RES, V31, P714, DOI 10.1177/0278364911433777; HAMMER E, 2013, PETERMANNS MITT 1, V59, P261; Hinsken L., 2002, INT ARCH PHOTOGRA 3A, V34, P156; Chiuso A, 2002, IEEE T PATTERN ANAL, V24, P523, DOI 10.1109/34.993559; Klein G., 2007, 2007 6 IEEE ACM INT; Li G., 2007, INT ROB SYST 2007 IR, P3854; Maddern W, 2012, INT J ROBOT RES, V31, P429, DOI 10.1177/0278364912438273; Maddern W., 2011, P IEEE INT C ROB AUT, P3595; McGlone C, 2004, MANUAL PHOTOGRAMMETR, VFifthth; Michot J., 2010, 3DPVT 10, P3025; Mouragnon E., 2006, 2006 IEEE COMP SCI C, P1; Newman P, 2009, INT J ROBOT RES, V28, P1406, DOI 10.1177/0278364909341483; Park J., 2009, ICCAS SICE 2009, P5269; Ramisa A, 2009, AUTON ROBOT, V27, P373, DOI 10.1007/s10514-009-9136-9; Shi Y, 2013, SENSORS-BASEL, V13, P119, DOI 10.3390/s130100119; Sola J., 2011, INT J COMPUT VISION, V97, P339, DOI DOI 10.1007/S11263-011-0492-5	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0262-8856	1872-8138		IMAGE VISION COMPUT	Image Vis. Comput.	AUG	2015	40						28	37		10.1016/j.imavis.2015.06.002		10	Computer Science, Artificial Intelligence; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic; Optics	Computer Science; Engineering; Optics	CO4YD	WOS:000359165900003		
J	Hori, T; Ikefuji, M; Mino, K				Hori, Takeo; Ikefuji, Masako; Mino, Kazuo			CONFORMISM AND STRUCTURAL CHANGE	INTERNATIONAL ECONOMIC REVIEW			English	Article							ECONOMIC-GROWTH; POSITIONAL CONCERNS; HABIT FORMATION; CONSUMPTION; EXTERNALITIES; OTHERS; PRODUCTIVITY; INCOME; FACTS; GOODS	Using a simple, multisector model of endogenous growth, we show that commodity-specific consumption externalities can be a source of structural change. When the degrees of consumption externalities are different between goods, each sector grows at a different rate. However, the aggregate economy exhibits balanced growth in that capital stock and expenditure grow at the same constant rate. A three-sector version of our model may reconcile Kaldor's stylized facts with empirically plausible profiles of industrial structure transformation.	[Mino, Kazuo] Aoyamagakuin Univ, Tokyo 1508366, Japan; Univ Southern Denmark, Odense, Denmark; Kyoto Univ, Kyoto 6068501, Japan	Mino, K (reprint author), Aoyamagakuin Univ, Coll Econ, Shibuya Ku, 4-4-25 Shibuya, Tokyo 1508366, Japan.	t-hori@aoyamagakuin.jp			Joint Usage/Research Center Project of ISER from the Ministry of Education, Culture, Sports, Science and Technology in Japan; JSPS Kakenhi Project [23530220]; JSPS [230001]	The authors are grateful to three anonymous referees and the coeditor of this journal, Masaki Aoyagi, for their constructive comments, which helped us to substantially improve the manuscript. We also thank Ryoji Hiraguchi and other attendees of conference at EEA-ESEM Malaga 2012, Association for Public Economic Theory Meeting 2013 in Lisbon, the conference of Macroeconomics for Young Professionals in Kyoto, and seminar participants at Academia Sinica (Taiwan) and Kent University (the United Kingdom) for their helpful comments and suggestions. This study was financially supported by the Joint Usage/Research Center Project of ISER from the Ministry of Education, Culture, Sports, Science and Technology in Japan. Mino's research was also supported by JSPS Kakenhi Project (No. 23530220) as well as by JSPS Grand-in-Aid Specially Promoted Research Project (No. 230001). All remaining errors are ours. Masako Ikefuji is currently at ISER, Osaka University, Japan. Please address correspondence to: Takeo Hori, College of Economics, Aoyamagakuin University, 4-4-25, Shibuya, Shibuya-ku, Tokyo, 150-8366, Japan. E-mail: t-hori@aoyamagakuin.jp.	Alpizar F, 2005, J ECON BEHAV ORGAN, V56, P405, DOI 10.1016/j.jebo.2002.10.007; Ngai LR, 2007, AM ECON REV, V97, P429, DOI 10.1257/aer.97.1.429; Echevarria C, 1997, INT ECON REV, V38, P431, DOI 10.2307/2527382; Frank RH, 2005, AM ECON REV, V95, P137, DOI 10.1257/000282805774670392; Jorgenson DW, 2011, SCAND J ECON, V113, P1, DOI 10.1111/j.1467-9442.2010.01637.x; Laitner J, 2000, REV ECON STUD, V67, P545, DOI 10.1111/1467-937X.00143; Baumol WJ, 1967, AM ECON REV, V57, P415; Solnick SJ, 1998, J ECON BEHAV ORGAN, V37, P373; Ravn M, 2006, REV ECON STUD, V73, P195, DOI 10.1111/j.1467-937X.2006.00374.x; Carlsson F, 2007, ECONOMICA, V74, P586, DOI 10.1111/j.1468-0335.2006.00571.x; Dupor B, 2003, AM ECON REV, V93, P423, DOI 10.1257/000282803321455395; MATSUYAMA K, 1992, J ECON THEORY, V58, P317, DOI 10.1016/0022-0531(92)90057-O; Acemoglu D, 2008, J POLIT ECON, V116, P467, DOI 10.1086/589523; Carroll CD, 2000, AM ECON REV, V90, P341, DOI 10.1257/aer.90.3.341; Buera FJ, 2012, AM ECON REV, V102, P2540, DOI 10.1257/aer.102.6.2540; Frank RH, 2008, J PUBLIC ECON, V92, P1777, DOI 10.1016/j.jpubeco.2008.03.001; Foellmi R, 2008, J MONETARY ECON, V55, P1317, DOI 10.1016/j.jmoneco.2008.09.001; Kongsamut P, 2001, REV ECON STUD, V68, P869, DOI 10.1111/1467-937X.00193; Solnick SJ, 2005, AM ECON REV, V95, P147, DOI 10.1257/000282805774669925; Winkelmann R, 2012, J ECON PSYCHOL, V33, P183, DOI 10.1016/j.joep.2011.08.013; Bah E. -h., 2009, P GERM DEV EC C FRAN, V42; Baumol W. J., 2001, GROWTH SERVICE IND P, P3; Buera FJ, 2009, J EUR ECON ASSOC, V7, P469; Bursztyn L., 2012, 18241 NBER; Carroll Christopher D., 1997, J ECON GROWTH, V2, P339, DOI 10.1023/A:1009740920294; Doi J, 2008, J ECON DYN CONTROL, V32, P3055, DOI 10.1016/j.jedc.2007.10.008; Duarte M, 2010, Q J ECON, V125, P129; Falvey RE, 1996, REV INCOME WEALTH, P257; Felbermayr G. J., 2005, BE J MACROECON, V5, P1; Gollier C, 2004, INT ECON REV, V45, P1169, DOI 10.1111/j.0020-6598.2004.00301.x; Gurbuz AA, 2011, CAMB J ECON, V35, P1061, DOI 10.1093/cje/ber005; Hillesheim I, 2013, J ECON PSYCHOL, V34, P61, DOI 10.1016/j.joep.2012.11.006; Hirsch Fred, 1976, SOCIAL LIMITS GROWTH, VHarvard University Press; Hori T, 2011, J ECON, V102, P29, DOI 10.1007/s00712-010-0160-1; Iscan T, 2010, BE J MACROECON, V10; Kaldor N., 1957, ECON J, V67, P591, DOI DOI 10.2307/2227704; Kaldor Nicholas, 1961, THEORY CAPITAL, P177; Matsuyama K., 2011, LECT NOTES GROWTH DE, V6; Ngai L. R., 2013, 1204 CEP LOND SCH EC; REBELO S, 1991, J POLIT ECON, V99, P500, DOI 10.1086/261764; Salinas-Jimenez MD, 2011, SOC INDIC RES, V103, P409, DOI 10.1007/s11205-010-9709-1; Schettkat R., 2006, Structural Change and Economic Dynamics, V17, DOI 10.1016/j.strueco.2005.04.002; Summers R., 1985, MANAGING SERVICE EC, P27; Weiss J., 2004, OXFORD DEV STUDIES, V32, P283, DOI 10.1080/13600810410001699993	44	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0020-6598	1468-2354		INT ECON REV	Int. Econ. Rev.	AUG	2015	56	3					939	961		10.1111/iere.12127		23	Economics	Business & Economics	CN9SY	WOS:000358790600009		
J	Fukahori, H; Chida, N; Maeda, M; Tasaki, M; Kawashima, T; Noto, T; Tsujimoto, S; Nakamura, K; Oshima, S; Hirose, J; Higashi, Y; Morokata, T				Fukahori, Hidehiko; Chida, Noboru; Maeda, Masashi; Tasaki, Mamoru; Kawashima, Tomoko; Noto, Takahisa; Tsujimoto, Susumu; Nakamura, Koji; Oshima, Shinsuke; Hirose, Jun; Higashi, Yasuyuki; Morokata, Tatsuaki			Effect of novel PKC theta selective inhibitor AS2521780 on acute rejection in rat and non-human primate models of transplantation	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						PKC theta; Transplantation; Tacrolimus; Mycophenolate mofetil; Monotherapy; Combination therapy	KINASE-C-THETA; NF-KAPPA-B; PHASE-II TRIAL; KIDNEY-TRANSPLANTATION; AEB071 SOTRASTAURIN; T-LYMPHOCYTES; IMMUNOSUPPRESSIVE AGENTS; ALLOGRAFT-REJECTION; MOLECULAR-CLONING; CELL-ACTIVATION	Selective inhibition of protein kinase C theta (PKC theta) may be useful in inducing T cell-specific immunosuppression with a reduced rate of side effects. To our knowledge, however, no reports have been published regarding the selective inhibition of PKC theta by small-molecule compounds in animal models of allograft rejection. Here, we investigated the effect of the newly synthesized PKC theta selective inhibitor AS2521780 in mono- and combination therapies on acute rejection in ACI-to-Lewis rat cardiac and non-human primate (NHP) renal transplantation models. In the rat cardiac transplantation model, AS2521780 significantly prolonged graft survival to 14 days at 10 mg/kg twice daily (bid.) and to 20 days at 30 mg/kg b.i.d. In contrast acute rejection occurred in all recipients in the non-treated group by Days 5 or 6 post-transplantation. Significant improvements (P < 0.001) in graft survival were observed following treatment with a combination of A52521 780 at 3 mg/kg b.i.d. and a suboptimal dose of tacrolimus (0.02 mg/kg) or mycophenolate mofetil (15 mg/kg). In the NI-IF renal transplantation model, AS2521780 at 3 mg/kg b.i.d. and tacrolimus at 1 mg/kg (suboptimal dose) significantly improved graft survival compared to tacrolimus alone (P < 0.05). The present study of AS2521780 in rat cardiac and NHP renal transplantation models demonstrates the potential of PKC theta as a novel drug target for organ transplantation. As AS2521780 was well tolerated and the dose of tacrolimus or mycophenolate mofetil can be reduced when used in combination with this drug, immunosuppressive regimens containing selective inhibitors of PKC theta might have good safety profiles. (C) 2015 Elsevier B.V. All rights reserved.	[Fukahori, Hidehiko; Chida, Noboru; Maeda, Masashi; Tasaki, Mamoru; Kawashima, Tomoko; Tsujimoto, Susumu; Nakamura, Koji; Oshima, Shinsuke; Hirose, Jun; Higashi, Yasuyuki; Morokata, Tatsuaki] Astellas Pharma Inc, Drug Discovery Res, Res Portfolio & Sci, Tsukuba, Ibaraki 3058585, Japan; [Noto, Takahisa] Astellas Pharma Inc, Drug Safety Res Labs, Drug Discovery Res, Yodogawa Ku, Osaka 5328514, Japan	Fukahori, H (reprint author), Astellas Pharma Inc, Drug Discovery Res, Res Portfolio & Sci, 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.	hidehiko.fukahori@astellas.com					[Anonymous], 2009, AM J TRANSPLANT S3, V9, pS1; Fang YH, 2011, J SURG RES, V171, pE133, DOI 10.1016/j.jss.2011.06.039; CHANG JD, 1993, J BIOL CHEM, V268, P14208; Schwartzberg L, 2014, BRIT J HAEMATOL, V166, P91, DOI 10.1111/bjh.12853; Evenou JP, 2009, J PHARMACOL EXP THER, V330, P792, DOI 10.1124/jpet.109.153205; Pfeifhofer C, 2003, J EXP MED, V197, P1525, DOI 10.1084/jem.20020234; ONO K, 1969, J THORAC CARDIOV SUR, V57, P225; Skvara H, 2008, J CLIN INVEST, V118, P3151, DOI 10.1172/JCI35636; Sun ZM, 2000, NATURE, V404, P402, DOI 10.1038/35006090; Dienz O, 2000, J BIOL CHEM, V275, P24547, DOI 10.1074/jbc.C000177200; Sis B, 2010, AM J TRANSPLANT, V10, P464, DOI 10.1111/j.1600-6143.2009.02987.x; BaierBitterlich G, 1996, MOL CELL BIOL, V16, P1842; Lin X, 2000, MOL CELL BIOL, V20, P2933, DOI 10.1128/MCB.20.8.2933-2940.2000; HALL BM, 1991, TRANSPLANTATION, V51, P1141, DOI 10.1097/00007890-199106000-00001; Rush D, 2013, TRANSPLANT REV-ORLAN, V27, P93, DOI 10.1016/j.trre.2013.04.003; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; BAIER G, 1993, J BIOL CHEM, V268, P4997; Coudronniere N, 2000, P NATL ACAD SCI USA, V97, P3394, DOI 10.1073/pnas.060028097; Graff JR, 2005, CANCER RES, V65, P7462, DOI 10.1158/0008-5472.CAN-05-0071; Bigaud M, 2012, TRANSPLANTATION, V93, P156, DOI 10.1097/TP.0b013e31823cf92f; Cooper JE, 2010, CLIN NEPHROL, V73, P333; Fukahori H, 2014, EUR J PHARMACOL, V745, P217, DOI 10.1016/j.ejphar.2014.10.045; Haanstra K. G., 2008, DRUG DISCOV TODAY DI, V5, P73, DOI 10.1016/j.ddmod.2008.06.002; Helal I, 2011, TRANSPL P, V43, P472, DOI 10.1016/j.transproceed.2011.01.054; Issa F, 2013, TRENDS IMMUNOL, V34, P107, DOI 10.1016/j.it.2012.11.003; Kinugasa F, 2008, J PHARMACOL SCI, V108, P529, DOI 10.1254/jphs.08142FP; Nakanishi T, 2010, INT IMMUNOPHARMACOL, V10, P91, DOI 10.1016/j.intimp.2009.09.026; Russ GR, 2013, AM J TRANSPLANT, V13, P1746, DOI 10.1111/ajt.12251; Usha L, 2011, GYNECOL ONCOL, V121, P455, DOI 10.1016/j.ygyno.2011.02.013; Weckbecker G, 2010, TRANSPL INT, V23, P543, DOI 10.1111/j.1432-2277.2009.01015.x	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	AUG	2015	27	2			SI		232	237		10.1016/j.intimp.2015.06.016		6	Immunology; Pharmacology & Pharmacy	Immunology; Pharmacology & Pharmacy	CN9YE	WOS:000358806300011		
J	Ranieri, D; Avitabile, D; Shiota, M; Yokomizo, A; Naito, S; Bizzarri, M; Torrisi, MR				Ranieri, Danilo; Avitabile, Daniele; Shiota, Masaki; Yokomizo, Akira; Naito, Seiji; Bizzarri, Mariano; Torrisi, Maria Rosaria			Nuclear redox imbalance affects circadian oscillation in HaCaT keratinocytes	INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY			English	Article						Circadian rhythms; HaCaT keratinocytes; Peroxiredoxin 2; Sirt1; Oxidative stress; N-acetyl cysteine; Melatonin; Resveratrol; Nicotinamide	OXIDATIVE STRESS; DEACETYLASE SIRT1; HYDROGEN-PEROXIDE; DNA-DAMAGE; CLOCK; RHYTHMS; BMAL1; CELLS; PHOSPHORYLATION; PEROXIREDOXINS	Circadian clock is regulated by a transcriptional/translational feedback loop (TTFL) lasting similar to 24h. Circadian oscillation of peroxiredoxins (PRDX1-6) redox status has been shown in mature erythrocytes. We have recently reported that nuclear levels of PRDX2 are circadian regulated in the HaCaT keratinocytes. In this study, we addressed whether PRDX2 translocation could influence the TTFL. A reporter HaCaT cell line stably expressing the luciferase gene under control of Bmal1 promoter was lentivirally transduced either with an empty vector (EV), a vector carrying a myc-tagged wild type PRDX2 (PRDX2-Myc) or the same gene with a nuclear localization sequence (PRDX2-MycNuc). PRDX2 overexpressing cells were protected from H2O2-induced oxidative stress. The amplitude of the Small promoter activity was significantly dampened in PRDX2-MycNuc versus EV cells when synchronized either by dexamethasone treatment or temperature cycles. Clock synchronization was not affected in PRDX2 silenced cells. N-acetyl cysteine or melatonin treatments, significantly dampened the Small promoter activity suggesting that sustained scavenging of ROS impairs clock synchronization. Noteworthy, H2O2 treatment rescued proper oscillation of the clock in synchronized PRDX2-MycNuc HaCaT cells. Since the histone deacetylase Sirtuin 1 (Sirt1) modulates clock gene expression amplitude, the effect of Sirt1 activator resveratrol or Sirt1 inhibitor nicotinamide were also investigated. Interestingly, NAM enhanced the molecular clock synchronization in PRDX2-MycNuc cells. Our findings demonstrate that PRDX2 regulates the TTFL oscillation by finely tuning the cellular redox status of the nucleus likely influencing the deacetilase activity of SIRT1 enzyme. (C) 2015 Elsevier Ltd. All rights reserved.	[Ranieri, Danilo; Avitabile, Daniele; Torrisi, Maria Rosaria] Univ Roma La Sapienza, Dipartimento Med Clin & Mol, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Avitabile, Daniele] Ctr Cardiol Monzino IRCCS, Lab Biol Vasc & Med Rigenerat, Milan, Italy; [Shiota, Masaki; Yokomizo, Akira; Naito, Seiji] Kyushu Univ, Grad Sch Med Sci, Dept Urol, Fukuoka 812, Japan; [Bizzarri, Mariano] Univ Roma La Sapienza, Dipartimento Med Sperimentale, I-00185 Rome, Italy; [Torrisi, Maria Rosaria] Azienda Osped S Andrea, Rome, Italy	Avitabile, D (reprint author), Univ Roma La Sapienza, Dipartimento Med Clin & Mol, Ist Pasteur, Fdn Cenci Bolognetti, Piazzale Aldo Moro 5, I-00185 Rome, Italy.	daniele.avitabile@uniroma1.it		Avitabile, Daniele/0000-0002-1360-2700; Bizzarri, Mariano/0000-0003-0408-4136	ASI - Italian Space Agency [I/003/11/0]; MIUR; AIRC - Associazione Italiana per la Ricerca sul Cancro, Italy [IG 10272]; FP7-PEOPLE-CIG [294176]	This work was partially supported by grants from ASI - Italian Space Agency (I/003/11/0), from MIUR and from AIRC - Associazione Italiana per la Ricerca sul Cancro (IG 10272), Italy, from FP7-PEOPLE-2011-CIG, N.294176.	Khapre RV, 2011, CELL CYCLE, V10, P4162, DOI 10.4161/cc.10.23.18381; De Franceschi L, 2011, HAEMATOL-HEMATOL J, V96, P1595, DOI 10.3324/haematol.2011.043612; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Belden WJ, 2008, CELL, V134, P212, DOI 10.1016/j.cell.2008.07.010; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; O'Neill JS, 2011, NATURE, V469, P498, DOI 10.1038/nature09702; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Lee J, 2008, MOL CELL BIOL, V28, P6056, DOI 10.1128/MCB.00583-08; Fischer TW, 2006, J PINEAL RES, V40, P18, DOI 10.1111/j.1600-079X.2005.00273.x; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Kondratov RV, 2006, GENE DEV, V20, P1868, DOI 10.1101/gad.1432206; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Hirayama J, 2007, NATURE, V450, P1086, DOI 10.1038/nature06394; Hirota T, 2008, P NATL ACAD SCI USA, V105, P20746, DOI 10.1073/pnas.0811410106; Nakahata Y, 2009, SCIENCE, V324, P654, DOI 10.1126/science.1170803; Ishii T, 2012, J CLIN BIOCHEM NUTR, V50, P91, DOI 10.3164/jcbn.11-109; Avitabile D, 2011, P NATL ACAD SCI USA, V108, P6145, DOI 10.1073/pnas.1017935108; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Mishina NM, 2011, ANTIOXID REDOX SIGN, V14, P1, DOI 10.1089/ars.2010.3539; Campeau E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006529; Sporl F, 2011, J INVEST DERMATOL, V131, P338, DOI 10.1038/jid.2010.315; Musiek ES, 2013, J CLIN INVEST, V123, P5389, DOI 10.1172/JCI70317; Vanselow K, 2006, GENE DEV, V20, P2660, DOI 10.1101/gad.397006; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; Geyfman M, 2009, J INVEST DERMATOL, V129, P1063, DOI 10.1038/jid.2008.384; Hardeland R, 2003, CHRONOBIOL INT, V20, P921, DOI 10.1081/CBI-120025245; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Reddy AB, 2006, CURR BIOL, V16, P1107, DOI 10.1016/j.cub.2006.04.026; Geyfman M, 2012, P NATL ACAD SCI USA, V109, P11758, DOI 10.1073/pnas.1209592109; Egler RA, 2005, ONCOGENE, V24, P8038, DOI 10.1038/sj.onc.1208821; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P3333, DOI 10.1073/pnas.1214266110; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Edgar RS, 2012, NATURE, V485, P459, DOI 10.1038/nature11088; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Zhang EE, 2009, CELL, V139, P199, DOI 10.1016/j.cell.2009.08.031; Kang DH, 2011, MOL CELL, V44, P545, DOI 10.1016/j.molcel.2011.08.040; Wilking M, 2013, ANTIOXID REDOX SIGN, V19, P192, DOI 10.1089/ars.2012.4889; Avitabile D., 2013, CELL MOL LIFE SCI, P1; Avitabile D., 2014, INT J BIOCH CELL BIO; Bass J, 2011, NATURE, V469, P476, DOI 10.1038/469476a; Eppler E., 2013, GEN COMP ENDOCR, V188, P67; Gupta N, 2011, J BIOL CHEM, V286, P4392, DOI 10.1074/jbc.M110.193466; Jiang TT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050661; Kleszczynski Konrad, 2012, Dermatoendocrinol, V4, P245, DOI 10.4161/derm.22344; Miyazaki K, 2001, MOL CELL BIOL, V21, P6651, DOI 10.1128/MCB.21.19.6651-6659.2001; Ndiaye M.A., 2013, ANTIOXID REDOX SIGNA; O'Neill J.S., 2013, ANTIOXID REDOX SIGNA; Patel S.A., 2013, ANTIOXID REDOX SIGN, P1; Sandu C., 2012, CELL MOL LIFE SCI; Shiota M, 2011, FREE RADICAL BIO MED, V51, P78, DOI 10.1016/j.freeradbiomed.2011.04.001; Stangherlin A, 2013, J BIOL CHEM, V288, P26505, DOI 10.1074/jbc.R113.457564; Tamaru T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082006; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; Volonte D, 2015, J BIOL CHEM, V290, P4202, DOI 10.1074/jbc.M114.598268	55	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	1357-2725	1878-5875		INT J BIOCHEM CELL B	Int. J. Biochem. Cell Biol.	AUG	2015	65						113	124		10.1016/j.biocel.2015.05.018		12	Biochemistry & Molecular Biology; Cell Biology	Biochemistry & Molecular Biology; Cell Biology	CN9XM	WOS:000358804400012		
J	Watanabe, T				Watanabe, Toshiaki			Current therapeutic strategies for rectal cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Editorial Material									Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, Hongo, Tokyo 1138655, Japan	Watanabe, T (reprint author), Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, 7-3-1, Hongo, Tokyo 1138655, Japan.	toshwatanabe@yahoo.co.jp					Miles WE, 1908, LANCET, V2, P1812; Pahlman L, 1997, NEW ENGL J MED, V336, P980; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Jacobs M, 1991, Surg Laparosc Endosc, V1, P144; STEARNS MW, 1959, SURG GYNECOL OBSTET, V109, P225	5	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					631	632		10.1007/s10147-015-0878-4		2	Oncology	Oncology	CO5GU	WOS:000359188400001		
J	Ishihara, S; Otani, K; Yasuda, K; Nishikawa, T; Tanaka, J; Tanaka, T; Kiyomatsu, T; Hata, K; Kawai, K; Nozawa, H; Kazama, S; Yamaguchi, H; Sunami, E; Kitayama, J; Watanabe, T				Ishihara, Soichiro; Otani, Kensuke; Yasuda, Koji; Nishikawa, Takeshi; Tanaka, Junichiro; Tanaka, Toshiaki; Kiyomatsu, Tomomichi; Hata, Keisuke; Kawai, Kazushige; Nozawa, Hiroaki; Kazama, Shinsuke; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki			Recent advances in robotic surgery for rectal cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Rectal cancer; Robotic surgery; Laparoscopic surgery	TOTAL MESORECTAL EXCISION; SHORT-TERM OUTCOMES; ASSISTED INTERSPHINCTERIC RESECTION; PELVIC SIDEWALL DISSECTION; RANDOMIZED CLINICAL-TRIAL; LOW ANTERIOR RESECTION; MRC CLASICC TRIAL; LEARNING-CURVE; LAPAROSCOPIC-SURGERY; COLORECTAL-CANCER	Robotic technology, which has recently been introduced to the field of surgery, is expected to be useful, particularly in treating rectal cancer where precise manipulation is necessary in the confined pelvic cavity. Robotic surgery overcomes the technical drawbacks inherent to laparoscopic surgery for rectal cancer through the use of multi-articulated flexible tools, three-dimensional stable camera platforms, tremor filtering and motion scaling functions, and greater ergonomic and intuitive device manipulation. Assessments of the feasibility and safety of robotic surgery for rectal cancer have reported similar operation times, blood loss during surgery, rates of postoperative morbidity, and circumferential resection margin involvement when compared with laparoscopic surgery. Furthermore, rates of conversion to open surgery are reportedly lower with increased urinary and male sexual functions in the early postoperative period compared with laparoscopic surgery, demonstrating the technical advantages of robotic surgery for rectal cancer. However, long-term outcomes and the cost-effectiveness of robotic surgery for rectal cancer have not been fully evaluated yet; therefore, large-scale clinical studies are required to evaluate the efficacy of this new technology.	[Ishihara, Soichiro; Otani, Kensuke; Yasuda, Koji; Nishikawa, Takeshi; Tanaka, Junichiro; Tanaka, Toshiaki; Kiyomatsu, Tomomichi; Hata, Keisuke; Kawai, Kazushige; Nozawa, Hiroaki; Kazama, Shinsuke; Yamaguchi, Hironori; Sunami, Eiji; Kitayama, Joji; Watanabe, Toshiaki] Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, Hongo, Tokyo 1138655, Japan	Watanabe, T (reprint author), Tokyo Univ Hosp, Dept Surg Oncol, Bunkyo Ku, Hongo, Tokyo 1138655, Japan.	toshwatanabe@yahoo.co.jp					Kang J, 2013, ANN SURG, V257, P95, DOI 10.1097/SLA.0b013e3182686bbd; Schlachta CM, 2001, DIS COLON RECTUM, V44, P217, DOI 10.1007/BF02234296; Memon S, 2012, ANN SURG ONCOL, V19, P2095, DOI 10.1245/s10434-012-2270-1; Lacy AM, 2008, ANN SURG, V248, P1, DOI 10.1097/SLA.0b013e31816a9d65; Trastulli S, 2012, COLORECTAL DIS, V14, pE134, DOI 10.1111/j.1463-1318.2011.02907.x; Park JS, 2011, SURG ENDOSC, V25, P240, DOI 10.1007/s00464-010-1166-z; Baek JH, 2011, SURG ENDOSC, V25, P521, DOI 10.1007/s00464-010-1204-x; Kim YW, 2012, SURG LAPARO ENDO PER, V22, P400, DOI 10.1097/SLE.0b013e3182622c2d; Baik SH, 2009, ANN SURG ONCOL, V16, P1480, DOI 10.1245/s10434-009-0435-3; Sugihara K, 2006, DIS COLON RECTUM, V49, P1663, DOI 10.1007/s10350-006-0714-z; Green BL, 2013, BRIT J SURG, V100, P75, DOI 10.1002/bjs.8945; Xiong BH, 2014, J SURG RES, V188, P404, DOI 10.1016/j.jss.2014.01.027; Baek SJ, 2012, WORLD J SURG, V36, P2722, DOI 10.1007/s00268-012-1728-4; Kobayashi H, 2009, DIS COLON RECTUM, V52, P567, DOI 10.1007/DCR.0b013e3181a1d994; Collinson FJ, 2012, INT J COLORECTAL DIS, V27, P233, DOI 10.1007/s00384-011-1313-6; D'Annibale A, 2013, SURG ENDOSC, V27, P1887, DOI 10.1007/s00464-012-2731-4; Patriti A, 2009, JSLS-J SOC LAPAROEND, V13, P176; Park SY, 2013, SURG ENDOSC, V27, P48, DOI 10.1007/s00464-012-2405-2; Son GM, 2010, J LAPAROENDOSC ADV S, V20, P609, DOI 10.1089/lap.2010.0007; Kang J, 2012, BRIT J SURG, V99, P133, DOI 10.1002/bjs.7719; Georgiou P, 2009, LANCET ONCOL, V10, P1053, DOI 10.1016/S1470-2045(09)70224-4; Bianchi PP, 2010, SURG ENDOSC, V24, P2888, DOI 10.1007/s00464-010-1134-7; Park SY, 2014, WORLD J SURG, V38, P1834, DOI 10.1007/s00268-013-2419-5; Park JS, 2010, ANN SURG ONCOL, V17, P3195, DOI 10.1245/s10434-010-1162-5; Nagawa H, 2001, DIS COLON RECTUM, V44, P1274, DOI 10.1007/BF02234784; Shibata J, 2015, TECH COLOPROCTOL, V19, P275, DOI 10.1007/s10151-014-1263-4; Ahlering TE, 2003, J UROLOGY, V170, P1738, DOI 10.1097/01.ju.0000092881.24608.5e; Atallah S, 2012, TECH COLOPROCTOL, V16, P389, DOI 10.1007/s10151-012-0833-6; Kim HJ, 2014, DIS COLON RECTUM, V57, P1066, DOI 10.1097/DCR.0000000000000174; Jayne DG, 2007, J CLIN ONCOL, V25, P3061, DOI 10.1200/JCO.2006.09.7758; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; Jayne DG, 2005, BRIT J SURG, V92, P1124, DOI 10.1002/bjs.4989; Sng KK, 2013, SURG ENDOSC, V27, P3297, DOI 10.1007/s00464-013-2909-4; Choi GS, 2009, SURG ENDOSC, V23, P2831, DOI 10.1007/s00464-009-0484-5; Kim JY, 2012, ANN SURG ONCOL, V19, P2485, DOI 10.1245/s10434-012-2262-1; Yang YZ, 2012, ANN SURG ONCOL, V19, P3727, DOI 10.1245/s10434-012-2429-9; Tewari A, 2012, EUR UROL, V62, P1, DOI 10.1016/j.eururo.2012.02.029; Leong QM, 2011, SURG ENDOSC, V25, P2987, DOI 10.1007/s00464-011-1657-6; SCHIESSEL R, 1994, BRIT J SURG, V81, P1376, DOI 10.1002/bjs.1800810944; Bae SU, 2014, ANN SURG TREAT RES, V86, P76, DOI 10.4174/astr.2014.86.2.76; Bonjer HJ, 2009, LANCET ONCOL, V10, P44; Byrn JC, 2014, SURG ENDOSC, V28, P3101, DOI 10.1007/s00464-014-3591-x; Ruiz MG, 2015, DIS COLON RECTUM, V58, P145, DOI 10.1097/DCR.0000000000000265; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Ishihara S, 2015, NEW PERSPEC IN PRESS; Jimenez-Rodriguez RM, 2013, INT J COLORECTAL DIS, V28, P815, DOI 10.1007/s00384-012-1620-6; Kagawa H, 2014, SURG ENDOSC, V29, P995; Kim Nam-Kyu, 2010, J Korean Soc Coloproctol, V26, P377, DOI 10.3393/jksc.2010.26.6.377; Konishi T, 2011, SURG ENDOSC, V25, P2358, DOI 10.1007/s00464-010-1531-y; Kwak JM, 2011, DIS COLON RECTUM, V54, P151, DOI 10.1007/DCR.0b013e3181fec4fd; Nelson H, 2004, NEW ENGL J MED, V350, P2050; Park EJ, 2015, ANN SURG, V261, P129, DOI 10.1097/SLA.0000000000000613; Popescu I, 2010, Acta Chir Iugosl, V57, P29; Watanabe T, 2002, SURGERY, V132, P27, DOI 10.1067/msy.2002.125357; Watanabe T, 2015, INT J CLIN ONCOL, V20, P207, DOI 10.1007/s10147-015-0801-z	55	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					633	640		10.1007/s10147-015-0854-z		8	Oncology	Oncology	CO5GU	WOS:000359188400002		
J	Oki, E; Ando, K; Kasagi, Y; Zaitsu, Y; Sugiyama, M; Nakashima, Y; Sonoda, H; Ohgaki, K; Saeki, H; Maehara, Y				Oki, Eiji; Ando, Koji; Kasagi, Yuta; Zaitsu, Yoko; Sugiyama, Masahiko; Nakashima, Yuichiro; Sonoda, Hideto; Ohgaki, Kippei; Saeki, Hiroshi; Maehara, Yoshihiko			Recent advances in multidisciplinary approach for rectal cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Review						Rectal cancer; Neoadjuvant chemoradiotherapy; Total mesorectal excision; Adjuvant chemotherapy	TOTAL MESORECTAL EXCISION; PHASE-III TRIAL; LYMPH-NODE DISSECTION; AUTONOMIC NERVE PRESERVATION; RANDOMIZED CONTROLLED-TRIAL; MEDIAN FOLLOW-UP; PREOPERATIVE RADIOTHERAPY; ADJUVANT CHEMOTHERAPY; INTERSPHINCTERIC RESECTION; NEOADJUVANT CHEMORADIATION	Surgery is a major treatment option for rectal cancer, and total mesorectal excision has been demonstrated to be advantageous in terms of oncological outcome and thus has been the standard surgical approach. Radiotherapy before or after radical surgery is the optimal treatment to control local recurrence of advanced rectal cancer. To date, in many countries, the combination of neoadjuvant concurrent chemotherapy and radiotherapy is considered the standard therapy. A more recent interest in neoadjuvant therapy has been the use of oxaliplatin or targeted agents for neoadjuvant chemoradiotherapy. However, despite many trials of oxaliplatin and targeted agents, 5-FU-based concurrent chemoradiotherapy has remained the only standard treatment option. Postoperative adjuvant chemotherapy with neoadjuvant chemoradiotherapy or induction chemotherapy with neoadjuvant chemoradiotherapy may further improve patient survival, as some clinical studies recently indicated. In Japan, neoadjuvant therapy is not the standard treatment method, because surgery with lateral lymph node dissection is usually performed and this type of surgery may reduce recurrence rate as does radiation therapy. The phase III study to evaluate the oncological effect of the Japanese standard operation (mesorectal excision, ME) with lateral lymph node dissection in comparison with ME alone for clinical stage II and III lower rectal cancer is currently ongoing.	[Oki, Eiji; Ando, Koji; Kasagi, Yuta; Zaitsu, Yoko; Sugiyama, Masahiko; Nakashima, Yuichiro; Sonoda, Hideto; Ohgaki, Kippei; Saeki, Hiroshi; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan	Oki, E (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.	okieiji@surg2.med.kyushu-u.ac.jp			Yakult Honsha; Merck Serono; Chugai Pharm; Takeda Pharm; Taiho Pharm	Y.M. received research grants from Yakult Honsha, Merck Serono, Chugai Pharm. Takeda Pharm, and Taiho Pharm. E.O. received lecture fees from Yakult Honsha, Merck Serono, Chugai Pharm, Takeda Pharm, and Taiho Pharm. The other authors have no conflict of interest.	Willett CG, 2010, ONCOLOGIST, V15, P845, DOI 10.1634/theoncologist.2010-0030; van Gijn W, 2011, LANCET ONCOL, V12, P575, DOI 10.1016/S1470-2045(11)70097-3; Koyama M, 2014, ANN SURG ONCOL, V21, P422, DOI 10.1245/s10434-014-3573-1; Fujita S, 2012, LANCET ONCOL, V13, P616, DOI 10.1016/S1470-2045(12)70158-4; Bosset JF, 2005, J CLIN ONCOL, V23, P5620, DOI 10.1200/JCO.2005.02.113; Hamaguchi T, 2011, CANCER CHEMOTH PHARM, V67, P587, DOI 10.1007/s00280-010-1358-1; Havenga K, 1996, BRIT J SURG, V83, P384, DOI 10.1002/bjs.1800830329; Yano H, 2008, BRIT J SURG, V95, P33, DOI 10.1002/bjs.6061; Helbling D, 2013, ANN ONCOL, V24, P718, DOI 10.1093/annonc/mds519; Kapiteijn E, 2001, NEW ENGL J MED, V345, P638, DOI 10.1056/NEJMoa010580; Uehara K, 2013, JPN J CLIN ONCOL, V43, P964, DOI 10.1093/jjco/hyt115; Willett CG, 2009, J CLIN ONCOL, V27, P3020, DOI 10.1200/JCO.2008.21.1771; Chua YJ, 2010, LANCET ONCOL, V11, P241, DOI 10.1016/S1470-2045(09)70381-X; Folkesson J, 2005, J CLIN ONCOL, V23, P5644, DOI 10.1200/JCO.2005.08.144; Georgiou P, 2009, LANCET ONCOL, V10, P1053, DOI 10.1016/S1470-2045(09)70224-4; Kusters M, 2010, EJSO-EUR J SURG ONC, V36, P470, DOI 10.1016/j.ejso.2009.11.011; Roh MS, 2009, J CLIN ONCOL, V27, P5124, DOI 10.1200/JCO.2009.22.0467; Bosset JF, 2006, NEW ENGL J MED, V355, P1114, DOI 10.1056/NEJMoa060829; Gerard JP, 2010, J CLIN ONCOL, V28, P1638, DOI 10.1200/JCO.2009.25.8376; Bell S, 2009, COLORECTAL DIS, V11, P443, DOI 10.1111/j.1463-1318.2009.01769.x; Bonnetain F, 2012, EUR J CANCER, V48, P1781, DOI 10.1016/j.ejca.2012.03.016; Landry JC, 2013, CANCER-AM CANCER SOC, V119, P1521, DOI 10.1002/cncr.27890; Sauer R, 2012, J CLIN ONCOL, V30, P1926, DOI 10.1200/JCO.2011.40.1836; Aschele C, 2011, J CLIN ONCOL, V29, P2773, DOI 10.1200/JCO.2010.34.4911; Breugom AJ, 2015, ANN ONCOL, V26, P696, DOI 10.1093/annonc/mdu560; Gerard JP, 2006, J CLIN ONCOL, V24, P4620, DOI 10.1200/JCO.2006.06.7629; Dewdney A, 2012, J CLIN ONCOL, V30, P1620, DOI 10.1200/JCO.2011.39.6036; Camma C, 2000, JAMA-J AM MED ASSOC, V284, P1008, DOI 10.1001/jama.284.8.1008; Pahlman L, 1997, NEW ENGL J MED, V336, P980; Sauer R, 2004, NEW ENGL J MED, V351, P1731, DOI 10.1056/NEJMoa040694; Schrag D, 2014, J CLIN ONCOL, V32, P513, DOI 10.1200/JCO.2013.51.7904; Methy N, 2010, ANN ONCOL, V21, P518, DOI 10.1093/annonc/mdp340; Rodel C, 2012, LANCET ONCOL, V13, P679, DOI 10.1016/S1470-2045(12)70187-0; Peeters KCMJ, 2007, ANN SURG, V246, P693, DOI 10.1097/01.sla.0000257358.56863.ce; Hasegawa J, 2014, CANCER CHEMOTH PHARM, V73, P1079, DOI 10.1007/s00280-014-2417-9; Fernandez-Martos C, 2010, J CLIN ONCOL, V28, P859, DOI 10.1200/JCO.2009.25.8541; Crane CH, 2010, INT J RADIAT ONCOL, V76, P824, DOI 10.1016/j.ijrobp.2009.02.037; Glynne-Jones R, 2014, ANN ONCOL, V25, P1356, DOI 10.1093/annonc/mdu147; Gerard JP, 2012, J CLIN ONCOL, V30, P4558, DOI 10.1200/JCO.2012.42.8771; SCHIESSEL R, 1994, BRIT J SURG, V81, P1376, DOI 10.1002/bjs.1800810944; Berho M, 2015, JAMA SURG, V150, P260, DOI 10.1001/jamasurg.2014.2887; Bosset JF, 2014, LANCET ONCOL, V15, P184, DOI 10.1016/S1470-2045(13)70599-0; De Felice Francesca, 2014, World J Gastrointest Oncol, V6, P438, DOI 10.4251/wjgo.v6.i12.438; Fujita S, 2003, BRIT J SURG, V90, P1580, DOI 10.1002/bjs.4350; HEALD RJ, 1982, BRIT J SURG, V69, P613, DOI 10.1002/bjs.1800691019; Hofheinz RD, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70116-X; Hong YS, 2014, LANCET ONCOL, V15, P1245, DOI 10.1016/S1470-2045(14)70377-8; KASAI Y, 1995, JPN J CLIN ONCOL, V25, P91; Kato T, 2002, LANGENBECK ARCH SURG, V386, P575, DOI 10.1007/s00423-002-9278-x; Kinugasa T, 2014, ANTICANCER RES, V34, P4633; Kye Bong-Hyeon, 2014, Ann Coloproctol, V30, P165, DOI 10.3393/ac.2014.30.4.165; MOREIRA LF, 1994, BRIT J SURG, V81, P293, DOI 10.1002/bjs.1800810250; Mori T, 1998, LANGENBECK ARCH SURG, V383, P409, DOI 10.1007/s004230050153; Mortenson MM, 2007, SURG ONCOL CLIN N AM, V16, P177, DOI 10.1016/j.soc.2006.10.007; Moser L, 2008, INT J COLORECTAL DIS, V23, P227, DOI 10.1007/s00384-007-0419-3; Murata A, 2015, RANDOMIZED PHASE 3 T; Nakagoe T, 2000, ANTICANCER RES, V20, P1069; Nussbaum Nathan, 2015, Curr Oncol Rep, V17, P434, DOI 10.1007/s11912-014-0434-9; Oki Eiji, 2006, Gan To Kagaku Ryoho, V33 Suppl 1, P138; Onyeuku NE, 2015, EXPERT REV GASTROENT, V9, P507, DOI 10.1586/17474124.2015.987753; Petrelli F, 2015, INT J COLORECTAL DIS, V30, P447, DOI 10.1007/s00384-014-2082-9; Phang PT, 2014, SURG ONCOL CLIN N AM, V23, P79, DOI 10.1016/j.soc.2013.09.008; Portier G, 2007, BRIT J SURG, V94, P341, DOI 10.1002/bjs.5621; Poulsen LO, 2015, ACTA ONCOL, V54, P437, DOI 10.3109/0284186X.2014.993768; Rodel C, 2010, STRAHLENTHER ONKOL, V186, P658, DOI 10.1007/s00066-010-2194-2; Roh MS, 2011, J CLIN ONCOL S, V29; Rullier E, 1999, DIS COLON RECTUM, V42, P1168, DOI 10.1007/BF02238569; Sadahiro S, 2015, ONCOLOGY-BASEL, V88, P49, DOI 10.1159/000367972; Saito N, 2006, DIS COLON RECTUM, V49, pS13, DOI 10.1007/s10350-006-0598-y; Salazar R, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1053-z; Sclafani F, 2014, FUTURE ONCOL, V10, P2243, DOI 10.2217/fon.14.127; Sugihara K, 1996, CANCER, V78, P1871, DOI 10.1002/(SICI)1097-0142(19961101)78:9<1871::AID-CNCR5>3.0.CO;2-I; Vaughan-Shaw P, 2015, COLORECTAL DIS, V87, P5302; Weiser Martin R, 2015, Bull Am Coll Surg, V100, P51	74	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					641	649		10.1007/s10147-015-0858-8		9	Oncology	Oncology	CO5GU	WOS:000359188400003		
J	Takiguchi, Y; Iwasawa, S; Minato, K; Miura, Y; Gemma, A; Noro, R; Yoshimori, K; Shingyoji, M; Hino, M; Ando, M; Okamoto, H				Takiguchi, Yuichi; Iwasawa, Shunichiro; Minato, Koichi; Miura, Yosuke; Gemma, Akihiko; Noro, Rintaro; Yoshimori, Kozo; Shingyoji, Masato; Hino, Mitsunori; Ando, Masahiro; Okamoto, Hiroaki			Phase II study of carboplatin, docetaxel and bevacizumab for chemotherapy-naive patients with advanced non-squamous non-small cell lung cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Non-squamous; Non-small cell lung carcinoma; Bevacizumab; Docetaxel; Carboplatin; Phase II study	CISPLATIN PLUS GEMCITABINE; PLATINUM-BASED CHEMOTHERAPY; 1ST-LINE TREATMENT; COMPARING CISPLATIN; RANDOMIZED-TRIAL; MAINTENANCE BEVACIZUMAB; OPEN-LABEL; PACLITAXEL; THERAPY; METAANALYSIS	Purpose To evaluate a 3-drug combination of carboplatin, docetaxel and bevacizumab as a front-line chemotherapy for patients with advanced non-squamous non-small cell carcinoma (NSCLC), a single arm phase II study was conducted. Methods Patients with stage IIIB/IV or postoperative recurrent non-squamous NSCLC were treated with carboplatin (targeted area under the curve of 6 mg h/L), docetaxel (60 mg/m(2)), and bevacizumab (15 mg/kg) on day 1, repeated every 3 weeks for 4 to 6 cycles, followed by maintenance with bevacizumab every 3 weeks until disease progression or occurrence of predefined toxicity. The planned patient number was 40, and the primary endpoint was progression free survival (PFS) as assessed by independent reviewers. Results One patient refused the treatment after enrollment; thus, 39 patients were treated and analyzed. The 3-drug therapy was delivered for a median of 4 cycles, and 54 % of the patients proceeded to the maintenance therapy for a median of 4 cycles. The overall response rate was 74.4 % (29/39), with a 95 % confidence interval (CI) of 60.0 to 88.7 %. The median PFS and overall survival (OS) were 6.2 months (95 % CI, 4.8-8.5 months) and 22.4 months (95 % CI, 11.3-26.2 months), respectively. Toxicities of grade 3 or higher included neutropenia in 71.8 %, febrile neutropenia in 23.1 %, and hypertension in 38.5 % of the patients, but they were transient and manageable. Conclusion The primary endpoint was met. The regimen yielded promising results with an excellent overall response rate, PFS, and OS for chemotherapy-naive patients with advanced non-squamous NSCLC. Further studies are warranted.	[Takiguchi, Yuichi; Iwasawa, Shunichiro] Chiba Univ, Grad Sch Med, Dept Med Oncol, Chuo Ku, Chiba 2608670, Japan; [Minato, Koichi; Miura, Yosuke] Gunma Prefectural Canc Ctr, Dept Resp Med, Ohta, Gumma 3738550, Japan; [Gemma, Akihiko; Noro, Rintaro] Nippon Med Sch, Grad Sch Med, Bunnkyo ku, Tokyo 1138602, Japan; [Yoshimori, Kozo] Anti TB Assoc Fukujuji Hosp, Dept Resp Med, Kiyose, Tokyo 2048522, Japan; [Shingyoji, Masato] Chiba Canc Ctr, Dept Thorac Dis, Chuo Ku, Chiba 2608717, Japan; [Hino, Mitsunori] Chiba Hokusoh Hosp, Nippon Med Sch, INBAHITEC Med Ctr, Resp Dis Ctr, Inzai, Chiba 2701694, Japan; [Ando, Masahiro] Tsuboi Canc Ctr Hosp, Div Canc Chemotherapy, Azumi, Kouriyama 9630197, Japan; [Okamoto, Hiroaki] Yokohama Municipal Citizens Hosp, Dept Resp Med & Med Oncol, Hodogaya Ku, Yokohama, Kanagawa 2408555, Japan	Takiguchi, Y (reprint author), Chiba Univ, Grad Sch Med, Dept Med Oncol, Chuo Ku, 1-8-1 Inohana, Chiba 2608670, Japan.	takiguchi@faculty.chiba-u.jp; iwasawas@chiba-u.jp; kminato@gunma-cc.jp; miura-y@gunma-cc.jp; agemma@nms.ac.jp; r-noro@nms.ac.jp; yoshimorik@fukujuji.org; mshingyoji@chiba-cc.jp; hino@nms.ac.jp; ando@tsuboi-hp.or.jp; hi01-okamoto@city.yokohama.jp			Tokyo Clinical Oncology Group (TCOG)	The authors are grateful for the external review by Dr. Kiyoshi Mori, Department of Respiratory Medicine, Tochigi Cancer Center, and Dr. Masahiko Kusumoto, Department of Diagnostic Radiology, National Cancer Center Hospital. This study was fully funded and conducted by the Tokyo Clinical Oncology Group (TCOG), a non-profit organization.	Reck M, 2009, J CLIN ONCOL, V27, P1227, DOI 10.1200/JCO.2007.14.5466; Sequist LV, 2013, J CLIN ONCOL, V31, P3327, DOI 10.1200/JCO.2012.44.2806; Reck M, 2010, ANN ONCOL, V21, P1804, DOI 10.1093/annonc/mdq020; Boutsikou E, 2013, ONCOTARGETS THER, V6, P125, DOI 10.2147/OTT.S42245; Rosell R, 2012, LANCET ONCOL, V13, P239, DOI 10.1016/S1470-2045(11)70393-X; Patel JD, 2009, J CLIN ONCOL, V27, P3284, DOI 10.1200/JCO.2008.20.8181; Shepherd FA, 2000, J CLIN ONCOL, V18, P2095; Scagliotti GV, 2002, J CLIN ONCOL, V20, P4285, DOI 10.1200/JCO.2002.02.068; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Fossella F, 2003, J CLIN ONCOL, V21, P3016, DOI 10.1200/JCO.2003.12.046; Schiller JH, 2002, NEW ENGL J MED, V346, P92, DOI 10.1056/NEJMoa011954; Patel JD, 2013, J CLIN ONCOL, V31, P4349, DOI 10.1200/JCO.2012.47.9626; Ardizzoni A, 2007, J NATL CANCER I, V99, P847, DOI 10.1093/jnci/djk196; Soria JC, 2013, ANN ONCOL, V24, P20, DOI 10.1093/annonc/mds590; Zhou CC, 2011, LANCET ONCOL, V12, P735, DOI 10.1016/S1470-2045(11)70184-X; Gao GH, 2012, INT J CANCER, V131, pE822, DOI 10.1002/ijc.27396; Hanna N, 2004, J CLIN ONCOL, V22, P1589, DOI 10.1200/JCO.2004.08.163; Ohe Y, 2007, ANN ONCOL, V18, P317, DOI 10.1093/annonc/mdl377; Paz-Ares LG, 2013, J CLIN ONCOL, V31, P2895, DOI 10.1200/JCO.2012.47.1102; Ranpura V, 2011, JAMA-J AM MED ASSOC, V305, P487, DOI 10.1001/jama.2011.51; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; Scagliotti GV, 2008, J CLIN ONCOL, V26, P3543, DOI 10.1200/JCO.2007.15.0375; Sandler A, 2006, NEW ENGL J MED, V355, P2542, DOI 10.1056/NEJMoa061884; Reynolds C, 2009, J THORAC ONCOL, V4, P1537, DOI 10.1097/JTO.0b013e3181c0a2f4; Yamamoto N, 2004, BRIT J CANCER, V90, P87, DOI 10.1038/sj.bjc.6601462; Hotta K, 2004, J CLIN ONCOL, V22, P3852, DOI 10.1200/JCO.2004.02.109; Niho S, 2012, LUNG CANCER, V76, P362, DOI 10.1016/j.lungcan.2011.12.005; Kentepozidis N, 2013, CANCER CHEMOTH PHARM, V71, P605, DOI 10.1007/s00280-012-2037-1; Kubota K, 2004, J CLIN ONCOL, V22, P254, DOI 10.1200/JCO.2004.06.114; Botrel TEA, 2011, LUNG CANCER, V74, P89, DOI 10.1016/j.lungcan.2011.01.028; Kaira K, 2013, LUNG CANCER, V82, P103, DOI 10.1016/j.lungcan.2013.07.008; Leon L, 2012, EXPERT OPIN PHARMACO, V13, P1389, DOI 10.1517/14656566.2012.693165; Lilenbaum R, 2008, J THORAC ONCOL, V3, P511, DOI 10.1097/JTO.0b013e31816de28f; Lima ABC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022681; Mir O, 2012, LUNG CANCER, V77, P104, DOI 10.1016/j.lungcan.2012.01.014; Mok T, 2014, ASCO M S15, V32, P8002; Nuijten Mark, 2010, Lung Cancer, V69 Suppl 1, pS4, DOI 10.1016/S0169-5002(10)70132-X; Park SH, 2007, CANCER, V109, P732, DOI 10.1002/cncr.22446; Raez LE, 2013, CANCER CHEMOTH PHARM, V72, P1103, DOI 10.1007/s00280-013-2301-z; Spigel DR, 2012, LUNG CANCER, V78, P70, DOI 10.1016/j.lungcan.2012.06.008; Syrigos KN, 2010, ANN ONCOL, V21, P556, DOI 10.1093/annonc/mdp392; Urata Y, 2013, CANCER-AM CANCER SOC, V119, P2275, DOI 10.1002/cncr.28048; William WN, 2010, CANCER-AM CANCER SOC, V116, P2401, DOI 10.1002/cncr.24996; Yoshioka H, 2014, P AM SOC CLIN ONCO S, V32	44	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					659	667		10.1007/s10147-014-0755-6		9	Oncology	Oncology	CO5GU	WOS:000359188400005		
J	Ko, R; Kenmotsu, H; Hisamatsu, Y; Akamatsu, H; Omori, S; Nakashima, K; Oyakawa, T; Wakuda, K; Shukuya, T; Ono, A; Imai, H; Taira, T; Naito, T; Murakami, H; Mori, K; Endo, M; Ohde, Y; Takahashi, K; Takahashi, T				Ko, Ryo; Kenmotsu, Hirotsugu; Hisamatsu, Yasushi; Akamatsu, Hiroaki; Omori, Shota; Nakashima, Kazuhisa; Oyakawa, Takuya; Wakuda, Kazushige; Shukuya, Takehito; Ono, Akira; Imai, Hisao; Taira, Tetsuhiko; Naito, Tateaki; Murakami, Haruyasu; Mori, Keita; Endo, Masahiro; Ohde, Yasuhisa; Takahashi, Kazuhisa; Takahashi, Toshiaki			The effect of gefitinib in patients with postoperative recurrent non-small cell lung cancer harboring mutations of the epidermal growth factor receptor	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Non-small cell lung cancer; Epidermal growth factor receptor mutations; Postoperative recurrence; Stage IV; Gefitinib	INTRATUMOR HETEROGENEITY; ADJUVANT CHEMOTHERAPY; SURVIVAL; RESECTION; DETERMINANTS; NEPHRECTOMY; CARCINOMA; DISEASE; IMPACT; TUMORS	Background It is unclear whether there is a difference in the effect of gefitinib treatment between patients with postoperative recurrent non-small cell lung cancer (NSCLC) and those with stage IV NSCLC harboring mutations in the epidermal growth factor receptor (EGFR). Methods We retrospectively reviewed the medical records of consecutive patients with postoperative recurrent NSCLC (postoperative group) or stage IV NSCLC (stage IV group) harboring EGFR mutations who were treated with gefitinib at the Shizuoka Cancer Center between September 2002 and March 2012 to compare the effect of gefitinib on survival from treatment initiation. Results A total of 168 patients were treated with gefitinib (postoperative group, 49 patients; stage IV group, 119 patients). The response rate of gefitinib treatment in the postoperative group was similar to that in the stage IV group (58 vs. 61 %, p = 0.613). In contrast, median progression-free survival (PFS; 15.8 vs. 9.8 months, p < 0.001) and median overall survival (OS; 51.1 vs. 22.2 months, p < 0.001) were significantly longer in the postoperative group. In addition, postoperative recurrent disease, performance status (0-1), and a single metastatic organ were independent favorable prognostic factors in the multivariate analysis of survival. Conclusion PFS and OS were superior in patients with postoperative recurrent NSCLC harboring EGFR mutations treated by gefitinib than in those with stage IV disease. These results suggest that postoperative recurrent disease may be considered a stratification factor in clinical trials for NSCLC with EGFR mutations.	[Ko, Ryo; Kenmotsu, Hirotsugu; Hisamatsu, Yasushi; Akamatsu, Hiroaki; Omori, Shota; Nakashima, Kazuhisa; Oyakawa, Takuya; Wakuda, Kazushige; Shukuya, Takehito; Ono, Akira; Imai, Hisao; Taira, Tetsuhiko; Naito, Tateaki; Murakami, Haruyasu; Takahashi, Toshiaki] Shizuoka Canc Ctr, Div Thorac Oncol, Nagaizumi, Shizuoka 4118777, Japan; [Ko, Ryo; Shukuya, Takehito; Takahashi, Kazuhisa] Juntendo Univ, Grad Sch Med, Dept Resp Med, Bunkyo Ku, Tokyo 1138421, Japan; [Mori, Keita] Shizuoka Canc Ctr, Clin Trial Coordinat Off, Nagaizumi, Shizuoka 4118777, Japan; [Endo, Masahiro] Shizuoka Canc Ctr, Div Diagnost Radiol, Nagaizumi, Shizuoka 4118777, Japan; [Ohde, Yasuhisa] Shizuoka Canc Ctr, Div Thorac Surg, Nagaizumi, Shizuoka 4118777, Japan	Kenmotsu, H (reprint author), Shizuoka Canc Ctr, Div Thorac Oncol, 1007 Shimonagakubo, Nagaizumi, Shizuoka 4118777, Japan.	h.kenmotsu@scchr.jp			Ministry of Health, Labour and Welfare Research Grant in Japan	The authors would like to thank Ms. Mie Yamada for her secretarial assistance. This study was partly supported by Ministry of Health, Labour and Welfare Research Grant in Japan.	Inukai M, 2006, CANCER RES, V66, P7854, DOI 10.1158/0008-5472.CAN-06-1951; Bristow RE, 2002, J CLIN ONCOL, V20, P1248, DOI 10.1200/JCO.20.5.1248; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Maemondo M, 2010, NEW ENGL J MED, V362, P2380, DOI 10.1056/NEJMoa0909530; Turke AB, 2010, CANCER CELL, V17, P77, DOI 10.1016/j.ccr.2009.11.022; Janjigian YY, 2010, CANCER-AM CANCER SOC, V116, P670, DOI 10.1002/cncr.24813; Choueiri TK, 2011, J UROLOGY, V185, P60, DOI 10.1016/j.juro.2010.09.012; Sugimura H, 2007, ANN THORAC SURG, V83, P409, DOI 10.1016/j.athoracsur.2006.08.046; Mitsudomi T, 2010, LANCET ONCOL, V11, P121, DOI 10.1016/S1470-2045(09)70364-X; ALBAIN KS, 1991, J CLIN ONCOL, V9, P1618; Saisho S, 2013, INTERACT CARDIOV TH, V16, P166, DOI 10.1093/icvts/ivs450; Mitsudomi T, 2007, CANCER SCI, V98, P1817, DOI 10.1111/j.1349-7006.2007.00607.x; Eisenhauer EA, 2009, EUR J CANCER, V45, P228, DOI 10.1016/j.ejca.2008.10.026; Hoang T, 2005, J CLIN ONCOL, V23, P175, DOI 10.1200/JCO.2005.04.177; Hanagiri T, 2012, CLIN LUNG CANCER, V13, P220, DOI 10.1016/j.cllc.2011.05.006; Scagliotti GV, 2003, J NATL CANCER I, V95, P1453, DOI 10.1093/jnci/djg059; Liao SR, 2012, EUR J NUCL MED MOL I, V39, P27, DOI 10.1007/s00259-011-1934-6; Flanigan RC, 2001, NEW ENGL J MED, V345, P1655, DOI 10.1056/NEJMoa003013; Sculier JP, 2008, J THORAC ONCOL, V3, P457, DOI 10.1097/JTO.0b013e31816de2b8; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Hishida T, 2010, J THORAC CARDIOV SUR, V140, pE69, DOI 10.1016/j.jtcvs.2010.06.035; Kawano D, 2012, INTERACT CARDIOV TH, V14, P167, DOI 10.1093/icvts/ivr036; Park JH, 2013, CLIN LUNG CANCER, V14, P383, DOI 10.1016/j.cllc.2012.10.007; Sekine I, 2009, J THORAC ONCOL, V4, P518; Turner NC, 2012, LANCET ONCOL, V13, pE178, DOI 10.1016/S1470-2045(11)70335-7; Wakelee HA, 2006, CANCER, V106, P2208, DOI 10.1002/cncr.21869	27	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					668	673		10.1007/s10147-014-0761-8		6	Oncology	Oncology	CO5GU	WOS:000359188400006		
J	Iuchi, T; Shingyoji, M; Itakura, M; Yokoi, S; Moriya, Y; Tamura, H; Yoshida, Y; Ashinuma, H; Kawasaki, K; Hasegawa, Y; Sakaida, T; Iizasa, T				Iuchi, Toshihiko; Shingyoji, Masato; Itakura, Meiji; Yokoi, Sana; Moriya, Yasumitsu; Tamura, Hajime; Yoshida, Yasushi; Ashinuma, Hironori; Kawasaki, Koichiro; Hasegawa, Yuzo; Sakaida, Tsukasa; Iizasa, Toshihiko			Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Non-small cell lung cancer (NSCLC); Epidermal growth factor receptor (EGFR); Brain metastasis; Epidemiology; Survival	TYROSINE KINASE INHIBITORS; PHASE-II TRIAL; EGFR-MUTATIONS; RADIATION-THERAPY; JAPANESE-PATIENTS; ADENOCARCINOMA; SURVIVAL; KRAS; CARCINOMA; TUMORS	Background The brain is a frequent site of metastases from non-small-cell lung cancer (NSCLC). We analyzed the frequency of brain metastases (BMs) from NSCLC in the era of magnetic resonance images, and evaluated the correlation between epidermal growth factor receptor (EGFR) mutations and BMs among East Asian patients. Methods Frequency, number, and size of BMs, and survival of 1,127 NSCLC patients were retrospectively reviewed. Mutation status of EGFR was evaluated in all cases, and its association with BMs was statistically evaluated. Results EGFR mutations were found for 331 cases (29.4 %). BM was the cause of primary symptoms for 52 patients (4.6 %), and found before initiation of treatment for 102 other patients (9.1 %); In addition to these 154 patients, 107 patients (9.5 %) developed BMs, giving a total of 261 patients (23.2 %) who developed BMs from 1,127 with NSCLC. BM frequency was higher among EGFR-mutated cases (31.4 %) than EGFR-wild cases (19.7 %; odds ratio: 1.86; 95 % confidence interval (CI) 1.39-2.49; P < 0.001). BMs from EGFR-mutated NSCLC were small, but often became disseminated. EGFR mutations accounted for 39.9 % of BMs, but patient survival after BMs was significantly longer for EGFR-mutated cases than for EGFR-wild cases (hazard ratio: 2.23; 95 % CI 1.62-3.10; P < 0.001). Conclusion Patients with EGFR-mutated NSCLC were more likely to develop BMs, but apparently also survived longer after BMs.	[Iuchi, Toshihiko; Kawasaki, Koichiro; Hasegawa, Yuzo; Sakaida, Tsukasa] Chiba Canc Ctr, Div Neurol Surg, Chiba 2608717, Japan; [Shingyoji, Masato; Itakura, Meiji; Moriya, Yasumitsu; Tamura, Hajime; Yoshida, Yasushi; Ashinuma, Hironori; Iizasa, Toshihiko] Chiba Canc Ctr, Thorac Dis, Chiba 2608717, Japan; [Yokoi, Sana] Chiba Canc Ctr, Gene Diag, Chiba 2608717, Japan	Iuchi, T (reprint author), Chiba Canc Ctr, Div Neurol Surg, Chiba 2608717, Japan.	tiuchi@chiba-cc.jp					Reinersman JM, 2011, J THORAC ONCOL, V6, P28, DOI 10.1097/JTO.0b013e3181fb4fe2; Welsh JW, 2013, J CLIN ONCOL, V31, P895, DOI 10.1200/JCO.2011.40.1174; Leidner RS, 2009, J CLIN ONCOL, V27, P5620, DOI 10.1200/JCO.2009.23.1431; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Iuchi T, 2013, LUNG CANCER, V82, P282, DOI 10.1016/j.lungcan.2013.08.016; Cote ML, 2011, J THORAC ONCOL, V6, P627, DOI 10.1097/JTO.0b013e31820a0ec0; Arrieta O, 2011, J THORAC ONCOL, V6, P1955, DOI 10.1097/JTO.0b013e31822f655f; Breindel JL, 2013, CANCER RES, V73, P5053, DOI 10.1158/0008-5472.CAN-12-3775; Shigematsu H, 2005, J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Calvo E, 2006, J CLIN ONCOL, V24, P2158, DOI 10.1200/JCO.2006.06.5961; Sun MH, 2009, CLIN CANCER RES, V15, P4829, DOI 10.1158/1078-0432.CCR-08-2921; Matsumoto S, 2006, INT J CANCER, V119, P1491, DOI 10.1002/ijc.21940; Gow CH, 2009, ANN ONCOL, V20, P696, DOI 10.1093/annonc/mdn679; Bauml J, 2013, LUNG CANCER, V81, P347, DOI 10.1016/j.lungcan.2013.05.011; Nishie K, 2012, J THORAC ONCOL, V7, P1722, DOI 10.1097/JTO.0b013e31826913f7; SORENSEN JB, 1988, J CLIN ONCOL, V6, P1474; Nichols L, 2012, ARCH PATHOL LAB MED, V136, P1552, DOI 10.5858/arpa.2011-0521-OA; AUERBACH O, 1975, CHEST, V67, P382, DOI 10.1378/chest.67.4.382; Choi YL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056011; Doval Dinesh Chandra, 2013, J Carcinog, V12, P12, DOI 10.4103/1477-3163.114970; Hsiao SH, 2013, LUNG CANCER, V81, P455, DOI 10.1016/j.lungcan.2013.06.004; KOMAKI R, 1983, INT J RADIAT ONCOL, V9, P1467; Lee HL, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-181; Na II, 2012, J CANCER RES THER, V8, P373, DOI 10.4103/0973-1482.103515; Shingyoji M, 2011, J THORAC ONCOL, V6, P1215, DOI 10.1097/JTO.0b013e318219aaae; STENBYGAARD LE, 1995, J THORAC CARDIOV SUR, V110, P1130, DOI 10.1016/S0022-5223(05)80183-7; Suzuki K, 2004, LUNG CANCER-J IASLC, V46, P357, DOI 10.1016/j.lungcan.2004.05.011; Villalva C, 2013, CANCER MED-US, V2, P296, DOI 10.1002/cam4.82; Xu JP, 2011, CANCER BIOMARK, V10, P63, DOI 10.3233/CBM-2012-0233	29	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					674	679		10.1007/s10147-014-0760-9		6	Oncology	Oncology	CO5GU	WOS:000359188400007		
J	Kanemoto, A; Matsumoto, Y; Sugita, T				Kanemoto, Ayae; Matsumoto, Yasuo; Sugita, Tadashi			Timing and characteristics of radiation pneumonitis after stereotactic body radiotherapy for peripherally located stage I lung cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Stage I lung cancer; Stereotactic body radiotherapy; Radiation pneumonitis; Timing; Predictive factor	THERAPY; PREDICTORS; SBRT	Background This study was conducted to determine the timing and characteristics of radiation pneumonitis (RP) associated with stereotactic body radiotherapy (SBRT) for stage I lung cancer. Methods Two hundred thirty-one patients treated with SBRT using 52 Gy in 4 fractions were identified. Control rate, RP incidence rate, and predictive factors and timing of RP were evaluated retrospectively. Results The 3-year overall survival and local control rates were 80.7 and 92.0 %, respectively. The grade >= 2 RP rate was 13.0 %; no grade 4-5 RP occurred. The most statistically significant predictive factor of grade >= 2 RP was V10. The median intervals to first graphical appearance were 4.2 and 2.5 months for grade 1 and grade 2-3 RP, respectively. Median intervals to maximum radiological density change were 6.0 and 4.6 months for grade 1 and grade 2-3 RP, respectively. A significantly different interval to first graphical appearance between grade 1 and grade 2-3 RP was observed; no significantly different interval to maximum radiological density change was noted. Conclusion The first graphical appearance of grade >= 2 RP was earlier than that of grade 1 RP, although the timing of maximum radiological density change was not significantly different.	[Kanemoto, Ayae; Matsumoto, Yasuo; Sugita, Tadashi] Niigata Canc Ctr Hosp, Dept Radiat Oncol, Niigata 9518566, Japan	Kanemoto, A (reprint author), Niigata Canc Ctr Hosp, Dept Radiat Oncol, 2-15-3 Kawagishi Cho, Niigata 9518566, Japan.	ayae-kanemoto@umin.ac.jp					Liu H, 2012, INT J RADIAT ONCOL, V84, P1017, DOI 10.1016/j.ijrobp.2012.02.020; Simone CB, 2013, CHEST, V143, P1784, DOI 10.1378/chest.12-2580; Matsuo Y, 2012, INT J RADIAT ONCOL, V83, pE545, DOI 10.1016/j.ijrobp.2012.01.018; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Baker R, 2013, INT J RADIAT ONCOL, V85, P190, DOI 10.1016/j.ijrobp.2012.03.041; Linda A, 2011, EUR J RADIOL, V79, P147, DOI 10.1016/j.ejrad.2009.10.029; Guckenberger M, 2010, RADIOTHER ONCOL, V97, P65, DOI 10.1016/j.radonc.2010.04.027; Bongers EM, 2013, RADIOTHER ONCOL, V109, P95, DOI 10.1016/j.radonc.2013.10.011; Barriger RB, 2012, INT J RADIAT ONCOL, V82, P457, DOI 10.1016/j.ijrobp.2010.08.056; Trovo M, 2010, LUNG CANCER, V69, P77, DOI 10.1016/j.lungcan.2009.09.006; Chang JY, 2012, RADIAT ONCOL, V7, DOI 10.1186/1748-717X-7-152; Onishi H, 2013, JPN J CLIN ONCOL, V43, P345, DOI 10.1093/jjco/hyt014; Takeda A, 2010, INT J RADIAT ONCOL, V77, P685, DOI 10.1016/j.ijrobp.2009.06.001; Yamashita H, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-32	14	2	2	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					680	685		10.1007/s10147-014-0766-3		6	Oncology	Oncology	CO5GU	WOS:000359188400008		
J	Matsumoto, A; Jinno, H; Murata, T; Seki, T; Takahashi, M; Hayashida, T; Kameyama, K; Kitagawa, Y				Matsumoto, Akiko; Jinno, Hiromitsu; Murata, Takeshi; Seki, Tomoko; Takahashi, Maiko; Hayashida, Tetsu; Kameyama, Kaori; Kitagawa, Yuko			Prognostic implications of receptor discordance between primary and recurrent breast cancer	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Breast cancer; Receptor; Discordance; Recurrence; Prognosis; Biopsy	LYMPH-NODE METASTASES; TISSUE CONFIRMATION; IMPACT; EXPRESSION; CHEMOTHERAPY; SURVIVAL; THERAPY; DISEASE	Background Discordance rates of hormone receptor (HR) and human epidermal growth factor-2 (HER2) status between primary and recurrent breast cancer were reported to be in the wide range of 10-40 %, although its prognostic relevance remains to be elucidated. Methods Fifty-five breast cancer patients had biopsies or resections of recurrent lesions. Pathological assessments of the HR and HER2 status of primary and recurrent lesions were performed in a single laboratory at Keio University Hospital. Tumors were classified as luminal (HR+ and HER2-), luminal/HER2 (HR+ and HER2+), HER2 (HR- and HER2+), or triple negative (HR- and HER2-). Results Discordance rates in estrogen receptor (ER), progesterone receptor (PgR) and HER2 status between primary tumors and recurrent lesions were 16.4, 30.9 and 10.2 %, respectively. Overall, 14 patients (25.5 %) changed subtypes at recurrent lesions. Patients with a gain in ER and PgR status had a significantly longer disease-free interval compared with the corresponding concordant-negative patients (ER: 99.0 vs. 18.5 months, p = 0.037, PgR: 141.0 vs. 24.4 months, p = 0.011). Patients with a loss of HER2 status experienced a trend toward shorter time to progression, compared with patients who maintained HER2 positivity (4.0 vs. 18.4 months, p = 0.051). Conclusions Discordance in receptor status between primary and recurrent breast cancers were seen in 10-30 %. A gain in HR status was significantly associated with better prognosis.	[Matsumoto, Akiko; Jinno, Hiromitsu; Murata, Takeshi; Seki, Tomoko; Takahashi, Maiko; Hayashida, Tetsu; Kitagawa, Yuko] Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, Tokyo 1608582, Japan; [Kameyama, Kaori] Keio Univ, Sch Med, Div Pathol Diag, Shinjuku Ku, Tokyo 1608582, Japan	Jinno, H (reprint author), Keio Univ, Sch Med, Dept Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo 1608582, Japan.	jinno@z7.keio.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan	This study was supported by a Grant-in-Aid from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bertos NR, 2011, J CLIN INVEST, V121, P3789, DOI 10.1172/JCI57100; Pusztai L, 2010, ONCOLOGIST, V15, P1164, DOI 10.1634/theoncologist.2010-0059; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Liedtke C, 2009, ANN ONCOL, V20, P1953, DOI 10.1093/annonc/mdp263; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Mittendorf EA, 2009, CLIN CANCER RES, V15, P7381, DOI 10.1158/1078-0432.CCR-09-1735; Dieci MV, 2013, ANN ONCOL, V24, P101, DOI 10.1093/annonc/mds248; Wu JM, 2008, CLIN CANCER RES, V14, P1938, DOI 10.1158/1078-0432.CCR-07-4082; Lower EE, 2009, BREAST CANCER RES TR, V113, P301, DOI 10.1007/s10549-008-9931-6; Wilking U, 2011, BREAST CANCER RES TR, V125, P553, DOI 10.1007/s10549-010-1029-2; Pectasides D, 2006, ANTICANCER RES, V26, P647; Amir E, 2012, J CLIN ONCOL, V30, P587, DOI 10.1200/JCO.2010.33.5232; Aitken SJ, 2010, ANN ONCOL, V21, P1254, DOI 10.1093/annonc/mdp427; Feng YM, 2007, BREAST CANCER RES TR, V103, P319, DOI 10.1007/s10549-006-9385-7; Amir E, 2012, CANCER TREAT REV, V38, P708, DOI 10.1016/j.ctrv.2011.11.006; Botteri E, 2012, BREAST, V21, P284, DOI 10.1016/j.breast.2011.12.014; Abe O, 2005, LANCET, V365, P1687; Falck AK, 2010, WORLD J SURG, V34, P1434, DOI 10.1007/s00268-010-0499-z; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; Turner NH, 2013, CANCER TREAT REV, V39, P947, DOI 10.1016/j.ctrv.2013.05.003	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					701	708		10.1007/s10147-014-0759-2		8	Oncology	Oncology	CO5GU	WOS:000359188400011		
J	Yamshiro, H; Iwata, H; Masuda, N; Yamamoto, N; Nishimura, R; Ohtani, S; Sato, N; Takahashi, M; Kamio, T; Yamazaki, K; Saito, T; Kato, M; Lee, T; Ohno, S; Kuroi, K; Takano, T; Takada, M; Yasuno, S; Morita, S; Toi, M				Yamshiro, Hiroyasu; Iwata, Hiroji; Masuda, Norikazu; Yamamoto, Naohito; Nishimura, Reiki; Ohtani, Shoichiro; Sato, Nobuki; Takahashi, Masato; Kamio, Takako; Yamazaki, Kosuke; Saito, Tsuyoshi; Kato, Makoto; Lee, Tecchuu; Ohno, Shinji; Kuroi, Katsumasa; Takano, Toshimi; Takada, Masahiro; Yasuno, Shinji; Morita, Satoshi; Toi, Masakazu			Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Trastuzumab; HER2-positive early-stage breast cancer; Cohort study; Japanese patient population; Treatment outcome	ADJUVANT TRASTUZUMAB; PLUS TRASTUZUMAB; FOLLOW-UP; CHEMOTHERAPY; DOCETAXEL; SURVIVAL; EVENTS; WOMEN	Background Previous large trials with trastuzumab (TZM) showed improved outcome in patients with HER2-positive early-stage breast cancer. However, the efficacy and safety of TZM in Japanese patients have not been fully evaluated. We have therefore conducted an observational study in Japan. Methods This was a retrospective and a prospective observational study in which data on women with histologically confirmed HER2-positive invasive breast cancer who received TZM for stage I-IIIC disease were collected from 56 institutions that participated in the Japan Breast Cancer Research Group and the efficacy of each treatment regimen analyzed. Results A total of 2,024 patients treated between July 2009 and June 2011 were initially enrolled in this study; in August 2013, the patient cohort comprised 2,009 patients. Of these, 142 (7.5 %) were aged A >= 70 years, 1,097 (58.1 %) had clinically node-negative (cN0) breast cancer, and 883 (47.4 %) were estrogen receptor-positive. Treatment options were neoadjuvant therapy (662 patients) and adjuvant therapy with TZM (1,228 patients). Three-year overall survival (OS) rates in the entire cohort and in the neoadjuvant and adjuvant cohorts, respectively, were 98.9 [95 % confidence interval (CI) 98.2-99.3], 98.3 (95 % CI 96.8-99.1 %), and 99.2 % (95 % CI 98.4-99.6), respectively. Three-year disease-free survival (DFS) rates in the entire cohort and in the neoadjuvant and adjuvant cohorts, respectively were 94.2 (95 % CI 93.0-95.2), 94.8 (95 % CI 93.0-95.9), and 93.1 (95 % CI 90.7-94.9 %), respectively. Multivariate analysis showed that age and nodal status negatively correlated with DFS. Age was the only factor which correlated with OS rate. Adverse events (AEs) associated with TZM and grade 3/4 AEs were reported in 356 (18.8 %) and 14 (0.6 %) patients, respectively. Grade 3/4 cardiac toxicities were reported in 11 patients. Conclusion Based on data from our patient cohort of Japanese women with HER2-positive early-stage breast cancer, the efficacy and safety of systemic therapy with TZM are comparable to data from previously conducted large trials. Progress in anti-HER2 therapy for patients aged a >= 70 years who have a poorer prognosis is needed.	[Yamshiro, Hiroyasu] Tenri Hosp, Dept Breast Surg, Tenri, Nara 6328552, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Masuda, Norikazu] NHO Osaka Natl Hosp, Breast Oncol, Surg, Chuo Ku, Osaka 5400006, Japan; [Yamamoto, Naohito] Chiba Canc Ctr, Div Breast Surg, Chuo Ku, Chiba 2608717, Japan; [Nishimura, Reiki] Kumamoto City Hosp, Dept Breast & Endocrine Surg, Higashi Ku, Kumamoto, Kumamoto 8628505, Japan; [Ohtani, Shoichiro] Hiroshima City Hosp, Breast Surg, Naka Ku, Hiroshima, Hiroshima 7308518, Japan; [Sato, Nobuki] Niigata Canc Ctr Hosp, Dept Breast Oncol, Chuo Ku, Niigata 9518566, Japan; [Takahashi, Masato] NHO Hokkaido Canc Ctr, Dept Breast Surg, Shiroishi Ku, Sapporo, Hokkaido 0900011, Japan; [Kamio, Takako] Tokyo Womens Med Univ, Dept Surg 2, Shinjuku Ku, Tokyo 1628666, Japan; [Yamazaki, Kosuke] Japanese Red Cross Hokkaido, Coll Nursing, Kitami, Hokkaido 0900011, Japan; [Saito, Tsuyoshi] Saitama Red Cross Hosp, Dept Breast Surg, Chuo Ku, Saitama, Saitama 3388553, Japan; [Kato, Makoto] Kato Breast Surg Clin, Kusatsu, Shiga 5250037, Japan; [Lee, Tecchuu] Japanese Red Cross Kyoto Daiichi Hosp, Dept Breast Surg, Higashiyama Ku, Kyoto 6050981, Japan; [Ohno, Shinji] NHO Kyusyu Canc Ctr, Clin Res Inst, Minami Ku, Fukuoka 8111395, Japan; [Kuroi, Katsumasa] Komagome Hosp, Tokyo Metropolitan Canc, Dept Breast Surg, Bunkyo Ku, Tokyo 1138677, Japan; [Kuroi, Katsumasa] Komagome Hosp, Ctr Infect Dis, Bunkyo Ku, Tokyo 1138677, Japan; [Takano, Toshimi] Toranomon Gen Hosp, Dept Med Oncol, Minato Ku, Tokyo 1058470, Japan; [Takada, Masahiro] Kyoto Univ Hosp, Dept Surg Breast Surg, Sakyo Ku, Kyoto 6068507, Japan; [Yasuno, Shinji] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept EBM Res, Sakyo Ku, Kyoto 6068507, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Sakyo Ku, Kyoto 6068507, Japan; [Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Surg Breast Surgery, Sakyo Ku, Kyoto 6068507, Japan	Yamshiro, H (reprint author), Tenri Hosp, Dept Breast Surg, 200 Mishima Cho, Tenri, Nara 6328552, Japan.	yamashiro.bcs@gmail.com; hiwata@aichi-cc.jp; nmasuda@alpha.ocn.ne.jp; nyamamot@chiba-cc.jp; nishimura.reiki@cityhosp-kumamoto.jp; sho_ohtani@hotmail.com; nobus@niigata-cc.jp; masatotk@sap-cc.go.jp; ako@surg2.twmu.ac.jp; kosyama@rchokkaido-cn.ac.jp; tsaito@jcom.home.ne.jp; k-chappy@symphony.plala.or.jp; chol-joo-lee@kyoto1-jrc.org; sohno@nk-cc.go.jp; kurochan@dd.iij4u.or.jp; takano@toranomon.gr.jp; masahiro@kuhp.kyoto-u.ac.jp; syasuno@kuhp.kyoto-u.ac.jp; smorita@kuhp.kyoto-u.ac.jp; toi@kuhp.kyoto-u.ac.jp			Chugai Pharmaceutical Co., Ltd.; Pfizer Japan; GSK; JBCRG	This study was conducted using our own funds from JBCRG. The Department of EBM Research, Institute for Advancement of Clinical and Translational Science was partially funded from Chugai Pharmaceutical Co., Ltd. H. Yamshiro and S. Ohno received an honorarium from Chugai, Novartis, and AstraZeneca. H. Iwata and R. Nishimura, N. Sato, T. Takano, S. Morita and M. Toi received an honorarium from from Chugai. N. Masuda received an honorarium from Chugai, Eisai and AstraZeneca. M. Takada received an honorarium from Eisai. H. Iwata, T. Takano, S. Yasuno, S. Morita and M. Toi received research funding from Chugai. N. Yamamoto received research funding from Pfizer Japan and Bayer. S. Yasuno received research funding from Pfizer Japan. H. Iwata recieved research funding from GSK. All other authors declare no conflicts of interest.	Swain SM, 2013, LANCET ONCOL, V14, P461, DOI 10.1016/S1470-2045(13)70130-X; Goldhirsch A, 2013, ANN ONCOL, V24, P2206, DOI 10.1093/annonc/mdt303; de Azambuja E, 2014, J CLIN ONCOL, V32, P2159, DOI 10.1200/JCO.2013.53.9288; Joensuu H, 2009, J CLIN ONCOL, V27, P5685, DOI 10.1200/JCO.2008.21.4577; Gianni L, 2011, LANCET ONCOL, V12, P236, DOI 10.1016/S1470-2045(11)70033-X; Jones SE, 2013, LANCET ONCOL, V14, P1121, DOI 10.1016/S1470-2045(13)70384-X; Freedman RA, 2014, BREAST CANCER RES TR, V145, P491, DOI 10.1007/s10549-014-2968-9; Geyer CE, 2006, NEW ENGL J MED, V355, P2733, DOI 10.1056/NEJMoa064320; Perez EA, 2011, J CLIN ONCOL, V29, P3366, DOI 10.1200/JCO.2011.35.0868; Sawaki M, 2011, JPN J CLIN ONCOL, V41, P709, DOI 10.1093/jjco/hyr011; Slamon D, 2011, NEW ENGL J MED, V365, P1273, DOI 10.1056/NEJMoa0910383; Takada M, 2014, BREAST CANCER RES TR, V145, P143, DOI 10.1007/s10549-014-2907-9; Prat A, 2013, J CLIN ONCOL, V31, P203, DOI 10.1200/JCO.2012.43.4134; Verma S, 2012, NEW ENGL J MED, V367, P1783, DOI 10.1056/NEJMoa1209124; Spielmann M, 2009, J CLIN ONCOL, V27, P6129, DOI 10.1200/JCO.2009.23.0946; Yamashiro H, 2014, INT J CLIN ONCOL, V19, P852, DOI 10.1007/s10147-013-0643-5	16	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					709	722		10.1007/s10147-015-0785-8		14	Oncology	Oncology	CO5GU	WOS:000359188400012		
J	Yamshiro, H; Iwata, H; Masuda, N; Yamamoto, N; Nishimura, R; Ohtani, S; Sato, N; Takahashi, M; Kamio, T; Yamazaki, K; Saito, T; Kato, M; Lee, T; Ohno, S; Kuroi, K; Takano, T; Takada, M; Yasuno, S; Morita, S; Toi, M				Yamshiro, Hiroyasu; Iwata, Hiroji; Masuda, Norikazu; Yamamoto, Naohito; Nishimura, Reiki; Ohtani, Shoichiro; Sato, Nobuaki; Takahashi, Masato; Kamio, Takako; Yamazaki, Kosuke; Saito, Tsuyoshi; Kato, Makoto; Lee, Tecchuu; Ohno, Shinji; Kuroi, Katsumasa; Takano, Toshimi; Takada, Masahiro; Yasuno, Shinji; Morita, Satoshi; Toi, Masakazu			Outcomes of trastuzumab therapy in HER2-positive early breast cancer patients (vol 20, pg 709, 2015)	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Correction									[Yamshiro, Hiroyasu] Tenri Hosp, Dept Breast Surg, Tenri, Nara 6328552, Japan; [Iwata, Hiroji] Aichi Canc Ctr Hosp, Dept Breast Oncol, Chikusa Ku, Nagoya, Aichi 4648681, Japan; [Masuda, Norikazu] NHO Osaka Natl Hosp, Breast Oncol, Surg, Chuo Ku, Osaka 5400006, Japan; [Yamamoto, Naohito] Chiba Canc Ctr, Div Breast Surg, Chuo Ku, Chiba 2608717, Japan; [Nishimura, Reiki] Kumamoto City Hosp, Dept Breast & Endocrine Surg, Higashi Ku, Kumamoto, Kumamoto 8628505, Japan; [Ohtani, Shoichiro] Hiroshima City Hosp, Breast Surg, Naka Ku, Hiroshima, Hiroshima 7308518, Japan; [Sato, Nobuaki] Niigata Canc Ctr Hosp, Dept Breast Oncol, Chuo Ku, Niigata 9518566, Japan; [Takahashi, Masato] NHO Hokkaido Canc Ctr, Dept Breast Surg, Shiroishi Ku, Sapporo, Hokkaido 0900011, Japan; [Kamio, Takako] Tokyo Womens Med Univ, Dept Surg 2, Shinjuku Ku, Tokyo 1628666, Japan; [Yamazaki, Kosuke] Japanese Red Cross Hokkaido Coll Nursing, Kitami, Hokkaido 0900011, Japan; [Saito, Tsuyoshi] Saitama Red Cross Hosp, Dept Breast Surg, Chuo Ku, Saitama, Saitama 3388553, Japan; [Kato, Makoto] Kato Breast Surg Clin, Kusatsu, Shiga 5250037, Japan; [Lee, Tecchuu] Japanese Red Cross Kyoto Daiichi Hosp, Dept Breast Surg, Higashiyama Ku, Kyoto 6050981, Japan; [Ohno, Shinji] NHO Kyusyu Canc Ctr, Clin Res Inst, Minami Ku, Fukuoka 8111395, Japan; [Kuroi, Katsumasa] Komagome Hosp, Tokyo Metropolitan Canc, Dept Breast Surg, Bunkyo Ku, Tokyo 1138677, Japan; [Kuroi, Katsumasa] Komagome Hosp, Ctr Infect Dis, Bunkyo Ku, Tokyo 1138677, Japan; [Takano, Toshimi] Toranomon Gen Hosp, Dept Med Oncol, Minato Ku, Tokyo 1058470, Japan; [Takada, Masahiro] Kyoto Univ Hosp, Dept Surg Breast Surg, Sakyo Ku, Kyoto 6068507, Japan; [Yasuno, Shinji] Kyoto Univ Hosp, Inst Adv Clin & Translat Sci, Dept EBM Res, Sakyo Ku, Kyoto 6068507, Japan; [Morita, Satoshi] Kyoto Univ, Grad Sch Med, Dept Biomed Stat & Bioinformat, Sakyo Ku, Kyoto 6068507, Japan; [Toi, Masakazu] Kyoto Univ, Grad Sch Med, Dept Surg Breast Surg, Sakyo Ku, Kyoto 6068507, Japan	Yamshiro, H (reprint author), Tenri Hosp, Dept Breast Surg, 200 Mishima Cho, Tenri, Nara 6328552, Japan.	yamashiro.bcs@gmail.com; hiwata@aichi-cc.jp; nmasuda@alpha.ocn.ne.jp; nyamamot@chiba-cc.jp; nishimura.reiki@cityhosp-kumamoto.jp; sho_ohtani@hotmail.com; nobus@niigata-cc.jp; masatotk@sap-cc.go.jp; ako@surg2.twmu.ac.jp; kosyama@rchokkaido-cn.ac.jp; tsaito@jcom.home.ne.jp; k-chappy@symphony.plala.or.jp; chol-joo-lee@kyoto1-jrc.org; sohno@nk-cc.go.jp; kurochan@dd.iij4u.or.jp; takano@toranomon.gr.jp; masahiro@kuhp.kyoto-u.ac.jp; syasuno@kuhp.kyoto-u.ac.jp; smorita@kuhp.kyoto-u.ac.jp; toi@kuhp.kyoto-u.ac.jp					Yamshiro H, 2015, INT J CLIN ONCOL, V20, P709, DOI 10.1007/s10147-015-0785-8	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					723	724		10.1007/s10147-015-0814-7		2	Oncology	Oncology	CO5GU	WOS:000359188400013		
J	Takaki, H; Yamakado, K; Tsurusaki, M; Yasumoto, T; Baba, Y; Narimatsu, Y; Shimohira, M; Yamaguchi, M; Matsuo, K; Inaba, Y; Mikami, K; Watanabe, R; Nishida, N; Anai, H; Kakizawa, H; Hirota, S				Takaki, Haruyuki; Yamakado, Koichiro; Tsurusaki, Masakatsu; Yasumoto, Taku; Baba, Yasutaka; Narimatsu, Yoshiaki; Shimohira, Masashi; Yamaguchi, Masato; Matsuo, Kunihiro; Inaba, Yoshitaka; Mikami, Koji; Watanabe, Ryohei; Nishida, Norifumi; Anai, Hiroshi; Kakizawa, Hideaki; Hirota, Shozo			Hepatic arterial infusion chemotherapy with fine-powder cisplatin and iodized-oil suspension in patients with intermediate-stage and advanced-stage (Barcelona Clinic Liver Cancer stage-B or stage-C) hepatocellular carcinoma: multicenter phase-II clinical study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Hepatic arterial infusion chemotherapy; Fine-powder cisplatin; Iodized oil; Hepatocellular carcinomas	VEIN TUMOR THROMBOSIS; LIPIODOL; CHEMOEMBOLIZATION; RADIOEMBOLIZATION; EMBOLIZATION; FORMULATION; SORAFENIB; SURVIVAL; THERAPY; RELEASE	Purpose This single-arm, multicenter, phase-II trial evaluated the efficacy and safety of hepatic arterial infusion chemotherapy (HAIC) using fine-powder cisplatin and iodized-oil suspension in patients with intermediate- and advanced-stage [Barcelona Clinic Liver Cancer (BCLC) stage-B and stage-C] hepatocellular carcinomas (HCCs). Methods The Institutional Review Board approved this study and patients provided written informed consent. Thirty-five patients (24 men and 11 women, mean 74 +/- 6 years [range 60-87 years]) with BCLC stage-B (57 %, 20/35) or stage-C (43 %, 15/35) HCCs who were not candidates for other locoregional treatments were enrolled. HAIC was performed using a suspension of fine-powder cisplatin with a maximum dose of 65 mg/m(2) and iodized oil on demand. The primary endpoint was the response rate evaluated based on Response Evaluation Criteria in Solid Tumor (RECIST) and modified RECIST (mRECIST). Secondary endpoints were overall survival, progression-free survival, and safety. Results The initial and best overall response rates at 4 weeks and 3 months, respectively, were 14 and 17 % based on RECIST, and 57 and 23 % based on mRECIST. The median overall and progression-free survival times were 18 and 4 months, respectively. The most frequent grade-3 or grade-4 adverse events were elevation of serum alanine (23 %) and aspartate aminotransferase (20 %), and thrombocytopenia (17 %). Conclusion This HAIC provides promising therapeutic effects with acceptable safety to patients with intermediate-stage and advanced-stage HCCs.	[Takaki, Haruyuki; Yamakado, Koichiro] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 5148507, Japan; [Takaki, Haruyuki] Mie Univ, Sch Med, Dept Intervent Radiol, Tsu, Mie 5148507, Japan; [Tsurusaki, Masakatsu] Shimane Univ, Fac Med, Dept Radiol, Izumo, Shimane, Japan; [Yasumoto, Taku] Toyonaka City Hosp, Dept Radiol, Toyonaka, Osaka, Japan; [Baba, Yasutaka] Kagoshima Univ, Dept Radiol, Kagoshima 890, Japan; [Narimatsu, Yoshiaki] Kawasaki Municipal Hosp, Dept Radiol, Kawasaki, Kanagawa, Japan; [Shimohira, Masashi] Nagoya City Univ, Grad Sch Med Sci, Dept Radiol, Nagoya, Aichi, Japan; [Yamaguchi, Masato] Kobe Univ, Grad Sch Med, Ctr Endovasc Therapy, Kobe, Hyogo 657, Japan; [Matsuo, Kunihiro] Narumi Hosp, Dept Radiol, Hirosaki, Aomori, Japan; [Inaba, Yoshitaka] Aichi Canc Ctr Hosp, Dept Diagnost & Intervent Radiol, Nagoya, Aichi 464, Japan; [Mikami, Koji] Suita Municipal Hosp, Dept Radiol, Suita, Osaka, Japan; [Watanabe, Ryohei] Matsuyama Shimin Hosp, Dept Surg, Matsuyama, Ehime, Japan; [Nishida, Norifumi] Osaka City Univ, Grad Sch Med, Dept Radiol, Osaka 558, Japan; [Anai, Hiroshi] Nara Med Univ, Dept Radiol, Kashiwara, Japan; [Kakizawa, Hideaki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Diagnost Radiol, Hiroshima, Japan; [Hirota, Shozo] Hyogo Coll Med, Dept Radiol, Nishinomiya, Hyogo 6638501, Japan	Takaki, H (reprint author), Mie Univ, Sch Med, Dept Intervent Radiol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	takaki-h@clin.medic.mie-u.ac.jp			JSPS KAKENHI [23591816]	This work was supported by JSPS KAKENHI Grant Number 23591816. We thank the members of Institute of Human Research Promotion and Drug Development (Dr. Masakatsu Nishikawa, Dr. Satoshi Tamaru, and Dr. Tomomi Yamada) for their support with the data management and advice related to statistical methods. We also thank the members of the study committee for safety and efficacy monitoring (Dr. Shigeaki Narimatsu and Dr. Tsuneo Ishiguchi) and the members of the committee for efficacy evaluation (Dr. Hiroshi Kondo, Dr. Yozo Sato, and Dr. Hideyuki Nishiofuku).	El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Ikeda M, 2014, J GASTROENTEROL, V49, P932, DOI 10.1007/s00535-013-0853-7; Gramenzi A, 2015, LIVER INT, V35, P1036, DOI 10.1111/liv.12574; Tublin ME, 1997, AM J ROENTGENOL, V168, P719; Jemal A, 2011, CA-CANCER J CLIN, V61, P69, DOI 10.3322/caac.20107; Ikeda M, 2013, CANCER CHEMOTH PHARM, V72, P463, DOI 10.1007/s00280-013-2222-x; Hilgard P, 2010, HEPATOLOGY, V52, P1741, DOI 10.1002/hep.23944; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Yamashita T, 2013, HEPATOL RES, V43, P44, DOI 10.1111/j.1872-034X.2012.01029.x; Yoshikawa M, 2008, HEPATOL RES, V38, P474, DOI 10.1111/j.1872-034X.2008.00338.x; Edeline J, 2013, ANN SURG ONCOL, V20, P2518, DOI 10.1245/s10434-013-2906-9; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Lencioni R, 2010, SEMIN LIVER DIS, V30, P52, DOI 10.1055/s-0030-1247132; TAKAYASU K, 1987, RADIOLOGY, V163, P345; Mazzaferro V, 2013, HEPATOLOGY, V57, P1826, DOI 10.1002/hep.26014; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; Peng SY, 2004, INT J CANCER, V112, P44, DOI 10.1002/ijc.20279; NAKAMURA H, 1989, RADIOLOGY, V170, P783; Bruix J, 2004, CANCER CELL, V5, P215, DOI 10.1016/S1535-6108(04)00058-3; Beppu T, 2012, ANTICANCER RES, V32, P4923; Chung YH, 2000, CANCER, V88, P1986, DOI 10.1002/(SICI)1097-0142(20000501)88:9<1986::AID-CNCR2>3.0.CO;2-I; HERESBACH D, 1989, GASTROEN CLIN BIOL, V13, P775; Hu HT, 2011, J VASC INTERV RADIOL, V22, P917, DOI 10.1016/j.jvir.2011.03.005; Ikeda M, 2010, J GASTROENTEROL, V45, P60, DOI 10.1007/s00535-009-0109-8; Ikeda M, 2007, ONCOLOGY-BASEL, V72, P188, DOI 10.1159/000112805; Iwasa S, 2010, JPN J CLIN ONCOL, V41, P770; Kim BK, 2011, J CANCER RES CLIN, V137, P659, DOI 10.1007/s00432-010-0917-5; Kondo M, 2011, JPN J CLIN ONCOL, V41, P69, DOI 10.1093/jjco/hyq145; Kudo M, 2010, DIG DIS, V29, P339; Takaki Y, 2008, HEPATO-GASTROENTEROL, V55, P202; Tsai YJ, 2011, HEPATOL INT, V5, P975, DOI 10.1007/s12072-011-9276-9; U.S. Department of Health and Human Service, 2008, COMM TERM CRIT ADV E; Yamashita Y, 2010, CANCER CHEMOTH PHARM, V65, P301, DOI 10.1007/s00280-009-1034-5; YOSHIKAWA M, 1994, CANCER CHEMOTH PHARM, V33, pS149, DOI 10.1007/BF00686689	35	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					745	754		10.1007/s10147-014-0773-4		10	Oncology	Oncology	CO5GU	WOS:000359188400016		
J	Narita, Y; Taniguchi, H; Komori, K; Kimura, K; Kinoshita, T; Komori, A; Nomura, M; Kadowaki, S; Takahari, D; Ura, T; Andoh, M; Muro, K				Narita, Yukiya; Taniguchi, Hiroya; Komori, Koji; Kimura, Kenya; Kinoshita, Takashi; Komori, Azusa; Nomura, Motoo; Kadowaki, Shigenori; Takahari, Daisuke; Ura, Takashi; Andoh, Masashi; Muro, Kei			Differences in attitude toward adjuvant chemotherapy between colorectal cancer survivors and the medical staff of Japanese hospitals	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Adjuvant chemotherapy; Colorectal cancer; Patients' attitudes	CELL LUNG-CANCER; III COLON-CANCER; STAGE-II; OXALIPLATIN; FLUOROURACIL; LEUCOVORIN; C-07	Background Adding oxaliplatin to fluorouracil-based chemotherapy can improve the survival of patients with stage III colorectal cancer by approximately 20 %. Reportedly, cancer patients are much more likely to prefer chemotherapy than medical professionals, although there is only a very small chance of achieving benefits from treatment. However, chronic neurotoxicity may be long lasting after the administration of oxaliplatin-based chemotherapy. This study aimed to evaluate potential side effects and differences in attitude between colorectal cancer patients and medical staff regarding the risk-benefit trade-offs of chemotherapy. Methods Relapse-free colorectal cancer patients who received adjuvant chemotherapy, doctors, and nurses were surveyed using a questionnaire regarding the side effects of chemotherapy and hypothetical clinical scenarios to quantify gains in the risk of relapse that were deemed necessary to make chemotherapy worthwhile. Results Responses were obtained from 147 patients, 54 doctors, and 84 nurses. Of these, 39 % of patients and 85 % of doctors replied that moderate side effects of adjuvant chemotherapy were worthwhile to achieve an absolute gain in the risk of relapse of 10 % from a baseline of 40 %. More severe side effects, as reported by colorectal cancer patients, were not associated with the larger gains necessary to make treatment worthwhile. Seven percent of patients treated with oxaliplatin, 40 % of doctors, and 43 % of nurses replied that side effects associated with oxaliplatin-based chemotherapy were severe. Conclusions Doctors should consider potential heterogeneity in side effects and attitudes regarding the risk-benefit balance of adjuvant chemotherapy, and that patient perspectives should enhance shared decision-making.	[Narita, Yukiya; Taniguchi, Hiroya; Komori, Azusa; Nomura, Motoo; Kadowaki, Shigenori; Takahari, Daisuke; Ura, Takashi; Andoh, Masashi; Muro, Kei] Aichi Canc Ctr Hosp, Dept Clin Oncol, Chigusa Ku, Nagoya, Aichi 4648681, Japan; [Komori, Koji; Kimura, Kenya; Kinoshita, Takashi] Aichi Canc Ctr Hosp, Dept Surg Gastroenterol, Chigusa Ku, Nagoya, Aichi 4648681, Japan	Narita, Y (reprint author), Aichi Canc Ctr Hosp, Dept Clin Oncol, Chigusa Ku, 1-1 Kanokoden, Nagoya, Aichi 4648681, Japan.	yukiya.narita@aichi-cc.jp					Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; Kidwell KM, 2012, CANCER-AM CANCER SOC, V118, P5614, DOI 10.1002/cncr.27593; Silvestri G, 1998, BRIT MED J, V317, P771; Balmer CE, 2001, PSYCHO-ONCOL, V10, P410, DOI 10.1002/pon.538; Tsuchiya A, 2002, HEALTH ECON, V11, P341, DOI 10.1002/hec.673; Tofthagen C, 2013, SUPPORT CARE CANCER, V21, P3307, DOI 10.1007/s00520-013-1905-5; Haller DG, 2011, J CLIN ONCOL, V29, P1465, DOI 10.1200/JCO.2010.33.6297; Obrand DI, 1997, DIS COLON RECTUM, V40, P15, DOI 10.1007/BF02055676; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; Brundage MD, 2001, PATIENT EDUC COUNS, V45, P149, DOI 10.1016/S0738-3991(01)00155-0; Ferlay J., 2013, IARC CANCERBASE; Kopec JA, 2006, J SUPPORT ONCOL, V4, pW1; Love N, 2007, J CLIN ONCOL 1, V25, P4020; SLEVIN ML, 1990, BRIT MED J, V300, P1458	15	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					755	760		10.1007/s10147-014-0772-5		6	Oncology	Oncology	CO5GU	WOS:000359188400017		
J	Okamoto, Y; Mitomi, H; Ichikawa, K; Tomita, S; Fujimori, T; Igarashi, Y				Okamoto, Yosuke; Mitomi, Hiroyuki; Ichikawa, Kazuhito; Tomita, Shigeki; Fujimori, Takahiro; Igarashi, Yoshinori		Study Grp Depth Tumor Invasion; JSCCR	Effect of skip lymphovascular invasion on hepatic metastasis in colorectal carcinomas	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Skip metastasis; Lymphovascular invasion; Colon carcinoma; Liver metastasis	ADJUVANT CHEMOTHERAPY; VENOUS INVASION; CANCER; DIFFERENTIATION; COLON	Background "Skip" lymphovascular invasion presenting as discontinuous foci of tumor cells within the colon wall is now excluded from consideration when determining T stage in the TNM classification. The purpose of this study was to assess the clinicopathological characteristics of colorectal cancer (CRC) patients with such skip lymphovascular invasion. Methods First, a retrospective questionnaire survey of the incidence of skip lymphovascular invasion was performed for a total of 1,868 patients with CRCs at ten institutions. Next, we comparatively assessed clinicopathological data for 896 CRC patients with or without skip lymphovascular invasion. Results The incidence of skip lymphovascular invasion was 1.1 % (20 out of 1,868). Most of the affected cases were rectal, pT2, and node negative, with moderately differentiated histology. Skip lymphovascular invasion was present in the muscularis propria and subserosa, with the tumors directly invading submucosa (pT1) or muscularis propria (pT2). Hepatic metastasis was greater in CRC with skip lymphovascular invasion (25 %) than in pT1/2 CRC (0 %; P < 0.001) or pT3 CRC without such invasion (13.8 %; P = 0.185). Conclusions Our study suggests that skip lymphovascular invasion is associated with hepatic metastasis in CRC cases. Thus, definition of a T category including such invasion would be useful for clinical practice.	[Okamoto, Yosuke; Igarashi, Yoshinori] Toho Univ, Omori Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol,Ota Ku, Tokyo 1438541, Japan; [Mitomi, Hiroyuki] Dokkyo Med Univ, Sch Med, Dept Surg & Mol Pathol, Mibu, Tochigi 3210293, Japan; [Ichikawa, Kazuhito] Fukushima Med Univ, Reg Med Support Ctr, Fukushima, Fukushima 9601295, Japan; [Ichikawa, Kazuhito; Fujimori, Takahiro] Shinko Hosp, Dept Pathol, Chuo Ku, Kobe, Hyogo 6510072, Japan; [Tomita, Shigeki] Juntendo Univ, Urayasu Hosp, Dept Pathol, Urayasu, Chiba 2790021, Japan	Mitomi, H (reprint author), Dokkyo Med Univ, Sch Med, Dept Surg & Mol Pathol, 880 Kitakobayashi, Mibu, Tochigi 3210293, Japan.	hmitomi@dokkyomed.ac.jp					Ueno H, 2007, AM J CLIN PATHOL, V127, P287, DOI 10.1309/903UT10VQ3LC7B8L; Washington MK, 2009, ARCH PATHOL LAB MED, V133, P1539, DOI 10.1043/1543-2165-133.10.1539; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Tanaka S, 2008, J GASTROENTEROL, V43, P641, DOI 10.1007/s00535-008-2223-4; Kitajima K, 2004, J GASTROENTEROL, V39, P534, DOI 10.1007/s00535-004-1339-4; Lim SB, 2010, DIS COLON RECTUM, V53, P377, DOI 10.1007/DCR.0b013e3181cf8ae5; Harris EI, 2008, AM J SURG PATHOL, V32, P1816, DOI 10.1097/PAS.0b013e3181816083; Center MM, 2009, CA-CANCER J CLIN, V59, P366, DOI 10.3322/caac.20038; Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979; Gertler R, 2009, EUR J CANCER, V45, P2992, DOI 10.1016/j.ejca.2009.07.008; MINSKY BD, 1989, INT J RADIAT ONCOL, V17, P311; Mitomi H, 2005, HEPATO-GASTROENTEROL, V52, P1421; Qiu HB, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-414; Gray R, 2007, LANCET, V370, P2020; Roxburgh CSD, 2014, ANN SURG, V259, P1156, DOI 10.1097/SLA.0000000000000229; SHIROUZU K, 1991, AM J SURG, V162, P216, DOI 10.1016/0002-9610(91)90073-M; Sobin LH, 2009, TNM CLASSIFICATION M; Ueno H, 2013, AM J SURG PATHOL, V37, P1542, DOI 10.1097/PAS.0b013e318297ef6e; Watanabe T, 2010, INT J CLIN ONCOL, V17, P1, DOI DOI 10.1007/S10147-011-0315-2	20	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					761	766		10.1007/s10147-014-0778-z		6	Oncology	Oncology	CO5GU	WOS:000359188400018		
J	Oki, E; Emi, Y; Kojima, H; Higashijima, J; Kato, T; Miyake, Y; Kon, M; Ogata, Y; Takahashi, K; Ishida, H; Saeki, H; Sakaguchi, Y; Yamanaka, T; Kono, T; Tomita, N; Baba, H; Shirabe, K; Kakeji, Y; Maehara, Y				Oki, Eiji; Emi, Yasunori; Kojima, Hiroshi; Higashijima, Jun; Kato, Takeshi; Miyake, Yasuhiro; Kon, Masanori; Ogata, Yutaka; Takahashi, Kenichi; Ishida, Hideyuki; Saeki, Hiroshi; Sakaguchi, Yoshihisa; Yamanaka, Takeharu; Kono, Toru; Tomita, Naohiro; Baba, Hideo; Shirabe, Ken; Kakeji, Yoshihiro; Maehara, Yoshihiko			Preventive effect of Goshajinkigan on peripheral neurotoxicity of FOLFOX therapy (GENIUS trial): a placebo-controlled, double-blind, randomized phase III study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Adjuvant chemotherapy; Colon cancer; Colorectal cancer; Goshajinkigan; Herbal medicine; Kampo; Peripheral neuropathy	OXALIPLATIN-RELATED NEUROTOXICITY; METASTATIC COLORECTAL-CANCER; GOSHA-JINKI-GAN; INDUCED SENSORY NEUROTOXICITY; DIABETIC NEUROPATHY; ADJUVANT TREATMENT; HERBAL MEDICINE; MAGNESIUM; CALCIUM; LEUCOVORIN	Background Peripheral sensory neurotoxicity is a frequent adverse effect of oxaliplatin therapy. Calcium and magnesium (Ca/Mg) infusions are frequently used as preventatives, but a recent phase III trial failed to show that they prevent neurotoxicity. We therefore conducted a multicenter randomized phase III trial to compare fluorouracil, leucovorin, and oxaliplatin (mFOLFOX6) with and without Goshajinkigan (GJG), a traditional Japanese herbal medicine (Kampo), to determine GJG's potential for reducing peripheral neuropathy in patients with colorectal cancer. Methods Patients with colon cancer who were undergoing adjuvant therapy with infusional mFOLFOX6 were randomly assigned to GJG (7.5 mg three times daily) or placebo in a double-blind manner. The primary endpoint was the time to grade 2 or greater neuropathy, which was determined at any point during or after oxaliplatin-based therapy using version 3 of the National Cancer Institute Common Terminology Criteria for Adverse Events (NCI CTCAE). Findings An interim analysis was performed when 142 of the planned 310 patients had been enrolled and the safety assessment committee recommended that the study bediscontinued. One hundred eighty-two patients were evaluable for response. They included 89 patients in the GJG group and 93 patients in the placebo group. The incidence of grade 2 or greater neurotoxicity was 50.6 % in the GJG group and 31.2 % in the placebo group. A Cox proportional hazards analysis indicated that the use of GJG was significantly associated with the incidence of neuropathy (hazard ratio, 1.908; p = 0.007). Conclusion Goshajinkigan did not prevent oxaliplatin-associated peripheral neuropathy in this clinical trial. The clinical study was therefore terminated.	[Oki, Eiji; Saeki, Hiroshi; Shirabe, Ken; Maehara, Yoshihiko] Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan; [Emi, Yasunori] Saiseikai Fukuoka Gen Hosp, Dept Surg, Fukuoka, Japan; [Kojima, Hiroshi] Aichi Hosp, Aichi Canc Ctr, Dept Surg Gastroenterol, Nagoya, Aichi, Japan; [Higashijima, Jun] Univ Tokushima, Fac Med, Dept Digest & Pediat Surg, Tokushima 770, Japan; [Kato, Takeshi] Kansai Rosai Hosp, Dept Surg, Amagasaki, Hyogo, Japan; [Miyake, Yasuhiro] Minoh City Hosp, Dept Surg, Mino, Japan; [Kon, Masanori] Kansai Med Univ, Dept Surg, Osaka, Japan; [Ogata, Yutaka] Kurume Univ, Med Ctr, Dept Surg, Kurume, Fukuoka 830, Japan; [Takahashi, Kenichi] Aomori Prefectural Cent Hosp, Dept Surg, Aomori, Japan; [Ishida, Hideyuki] Saitama Med Sch, Saitama Med Ctr, Dept Digest Tract & Gen Surg, Saitama, Japan; [Sakaguchi, Yoshihisa] Kyushu Natl Med Ctr, Dept Surg Gastroenterol, Fukuoka, Japan; [Yamanaka, Takeharu] Yokohama City Univ, Dept Biostat, Yokohama, Kanagawa 232, Japan; [Kono, Toru] Sapporo Higashi Tokushukai Hosp, Sapporo, Hokkaido, Japan; [Tomita, Naohiro] Hyogo Coll Med, Dept Surg, Nishinomiya, Hyogo 6638501, Japan; [Baba, Hideo] Kumamoto Univ, Grad Sch Med Sci, Dept Surg Gastroenterol, Kumamoto, Japan; [Kakeji, Yoshihiro] Kobe Univ, Dept Gastrointestinal Surg, Kobe, Hyogo 657, Japan	Maehara, Y (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Surg & Sci, Fukuoka 812, Japan.	okieiji@surg2.med.kyushu-u.ac.jp; maehara@surg2.med.kyushu-u.ac.jp			Ministry of Health, Labour and Welfare	We thank all patients who participated in this trial and their families. We are indebted to the physicians and all clinical study teams at the participating institutions. The following departments and hospitals participated in the trial: Department of Surgery and Science, Kyuhsu University (Fukuoka, Japan); Department of Surgery, Saiseikai Fukuoka General Hospital (Fukuoka, Japan); Department of Surgery, Minoh City Hospital, Minoh, Japan; Department of Gastroenterological Surgery, Aichi Cancer Center, Aichi Hospital (Nagoya, Japan); Division of Lower GI Department of Surgery, Hyogo College of Medicine (Nishinomiya, Japan); Department of Surgery, Kitasato University School of Medicine (Kanagawa, Japan); Kochi University Department of Surgery (Nankoku, Japan); Department of Surgery, Kurume University Medical Center (Kurume, Japan); Division of Gastroenterological Surgery, Chiba Cancer Center (Chiba, Japan); Department of Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University (Kumamoto, Japan); Department of Digestive Surgery, Breast and Thyroid Surgery, Graduate School of Medical Sciences, Kagoshima University (Kagoshima, Japan); Department of Surgery, Aomori Prefectural Central Hospital (Aomori City, Japan); Division of Surgical Oncology, Department of Translational Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences (Nagasaki, Japan); Department of Surgery, University of Tokushima (Tokushima, Japan); Asahikawa Medical University Hospital (Asahikawa, Japan); Department of Surgery, Gifu Municipal Hospital (Gifu, Japan); Department of Gastroenterological Surgery, Nagoya University Graduate School of Medicine (Nagoya, Japan); Department of Surgery I, Dokkyo University School of Medicine (Shimotsuga, Japan); Department of Gastroenterological Surgery, Kyushu National Medical Center (Fukuoka, Japan); Japanese Red Cross Kanazawa Hospital (Kanazawa, Japan); First Department of Surgery, University of Fukui (Fukui, Japan); Department of Gastroenterological Surgery, Graduate School of Medicine, Osaka University (Osaka, Japan); First Department of Surgery, Ryukyu University, School of Medicine (Okinawa, Japan); Aichi Cancer Center Aichi Hospital; Department of Surgery, Fujita Health University (Toyoake, Japan); Department of General Surgery, Kawasaki Medical School (Okayama, Japan); Department of Surgical Oncology and Gastroenterological Surgery, Sapporo Medical University (Sapporo, Japan);Department of Gastroenterological Surgery, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Science (Okayama, Japan); Department of Surgical Oncology, Gifu University Graduate School of Medicine (Gifu, Japan); Hamamatsu University School of Medicine (Shizuoka, Japan); Department of Surgery, Kyoto University Graduate School of Medicine (Kyoto, Japan); Department of Gastroenterological Surgery, Hirosaki University Graduate School of Medicine (Hirosaki, Japan); Osaka Medical College (Osaka, Japan); Department of Surgery, Kansai Medical University (Osaka, Japan); Nihon University Itabashi Hospital (Tokyo, Japan); Kanazawa Medical University, Department of Surgical Oncology (Ishikawa, Japan); Department of Digestive Tract and General Surgery, Saitama Medical Center, Saitama Medical School (Saitama, Japan); Kansai Rosai Hospital (Amagasaki, Japan); Department of Gastrointestinal Surgery, Kobe University (Kobe, Japan). This clinical trial was totally supported by a Ministry of Health, Labour and Welfare Grant-in-Aid for Scientific Research in Japan (Tokyo, Japan). We also thank Ms.; Satomi Abe and Ms. Masako Yamashita from the Kyushu University Data Center and the EPS Corporation (Tokyo, Japan) for their excellent secretarial assistance.	Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Hochster HS, 2007, J CLIN ONCOL, V25, P4028, DOI 10.1200/JCO.2007.13.5251; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; USUKI Y, 1991, AM J CHINESE MED, V19, P259, DOI 10.1142/S0192415X9100034X; Wen F, 2013, ANN ONCOL, V24, P171, DOI 10.1093/annonc/mds211; Gamelin L, 2008, J CLIN ONCOL, V26, P1188, DOI 10.1200/JCO.2007.15.3767; Tournigand C, 2004, J CLIN ONCOL, V22, P229, DOI 10.1200/JCO.2004.05.113; Grothey A, 2011, J CLIN ONCOL, V29, P421, DOI 10.1200/JCO.2010.31.5911; Ushio S, 2012, EUR J CANCER, V48, P1407, DOI 10.1016/j.ejca.2011.08.009; TAWATA M, 1994, DIABETES RES CLIN PR, V26, P121, DOI 10.1016/0168-8227(94)90149-X; Loprinzi CL, 2014, J CLIN ONCOL, V32, P997, DOI 10.1200/JCO.2013.52.0536; Mizuno K, 2014, J PHARMACOL SCI, V125, P91, DOI 10.1254/jphs.13244FP; NISHIZAWA M, 1995, J NEUROL SCI, V132, P177, DOI 10.1016/0022-510X(95)00141-N; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Tournigand C, 2006, J CLIN ONCOL, V24, P394, DOI 10.1200/JCO.2005.03.0106; Fuchs CS, 2007, J CLIN ONCOL, V25, P4779, DOI 10.1200/JCO.2007.11.3357; Gamelin L, 2004, CLIN CANCER RES, V10, P4055, DOI 10.1158/1078-0432.CCR-03-0666; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Kono T, 2009, JPN J CLIN ONCOL, V39, P847, DOI 10.1093/jjco/hyp100; Kaku H, 2012, EXP THER MED, V3, P60, DOI 10.3892/etm.2011.375; Uno T, 2005, DIABETES RES CLIN PR, V69, P129, DOI 10.1016/j.diabres.2004.11.017; Sakurai M, 2009, PAIN, V147, P165, DOI 10.1016/j.pain.2009.09.003; Gamelin L, 2008, J CLIN ONCOL, V26, P1189; Imamura T, 2008, NEUROUROL URODYNAM, V27, P832, DOI 10.1002/nau.20559; Inoue N, 2012, INT J CLIN ONCOL, V17, P341, DOI 10.1007/s10147-011-0298-z; Japanese Society for Cancer of the Colon and Rectum, 2009, JAP CLASS COL CARC; Kono T, 2011, EVID-BASED COMPL ALT, V2011; Milla P, 2009, ANTI-CANCER DRUG, V20, P396, DOI 10.1097/CAD.0b013e32832a2dc1; Qin BL, 2004, EVID-BASED COMPL ALT, V1, P269, DOI 10.1093/ecam/neh028; von Delius S, 2007, INVEST NEW DRUG, V25, P173, DOI 10.1007/s10637-006-9010-y; Wu ZJ, 2012, EUR J CANCER, V48, P1791, DOI 10.1016/j.ejca.2012.03.018	31	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					767	775		10.1007/s10147-015-0784-9		9	Oncology	Oncology	CO5GU	WOS:000359188400019		
J	Tokunaga, H; Watanabe, Y; Niikura, H; Nagase, S; Toyoshima, M; Shiro, R; Yokoyama, Y; Mizunuma, H; Ohta, T; Nishiyama, H; Watanabe, T; Sato, N; Sugiyama, T; Takano, T; Takahashi, F; Yaegashi, N				Tokunaga, Hideki; Watanabe, Yoh; Niikura, Hitoshi; Nagase, Satoru; Toyoshima, Masafumi; Shiro, Reiji; Yokoyama, Yoshihito; Mizunuma, Hideki; Ohta, Tsuyoshi; Nishiyama, Hiroshi; Watanabe, Takafumi; Sato, Naoto; Sugiyama, Toru; Takano, Tadao; Takahashi, Fumiaki; Yaegashi, Nobuo			Outcomes of abdominal radical trachelectomy: results of a multicenter prospective cohort study in a Tohoku Gynecologic Cancer Unit	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Abdominal trachelectomy; Fertility-sparing surgery; Cervical cancer; Prospective cohort study; Outcome	STAGE CERVICAL-CANCER; OBSTETRIC OUTCOMES; SERIES	Background This study aimed to evaluate surgical, pregnancy, and prognostic outcomes of radical abdominal trachelectomy (RAT) for Japanese patients with early-stage cervical cancer. Methods This was a multicenter prospective cohort study conducted in member facilities of Tohoku Gynecologic Cancer Unit. Patients with FIGO 1A-1B1 squamous cell carcinoma were included. Results A total of 42 patients were registered in this study, and all patients underwent planned RAT. The median stromal invasion and median horizontal spread of resected specimens were 4.6 (range 1.0-10.0) and 12.4 mm (range 3.0-28.0), respectively. The median surgical time and median blood loss were 304 min (range 233-611) and 848 mL (range 250-3984), respectively. Five patients (11.9 %) received blood transfusion. Five of 18 (27.8 %) patients who attempted to conceive achieved pregnancy, and 3 patients had healthy babies. However, all pregnancies required assisted reproductive technology with in-vitro fertilization and embryo transfer. Four patients (9.5 %) received postoperative adjuvant therapy, and 3 patients (7.1 %) developed disease recurrence. Conclusions RAT may be safely performed for Japanese patients with FIGO 1A-1B1 squamous cell carcinoma of the cervix, even in educational medical facilities. However, less-invasive surgery should be considered more often to improve pregnancy outcomes.	[Tokunaga, Hideki; Watanabe, Yoh; Niikura, Hitoshi; Nagase, Satoru; Toyoshima, Masafumi; Shiro, Reiji; Takano, Tadao; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Watanabe, Yoh; Takano, Tadao; Takahashi, Fumiaki] Tohoku Univ Hosp, Innovat & Educ Ctr, Dept Clin Res Network Clin Res, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Yokoyama, Yoshihito; Mizunuma, Hideki] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori, Japan; [Ohta, Tsuyoshi] Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Yamagata 990, Japan; [Nishiyama, Hiroshi; Watanabe, Takafumi] Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Japan; [Sato, Naoto] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Sugiyama, Toru] Iwate Med Univ, Dept Obstet & Gynecol, Morioka, Iwate 020, Japan	Watanabe, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan.	watanabe@med.tohoku.ac.jp					Abu-Rustum NR, 2008, GYNECOL ONCOL, V111, P261, DOI 10.1016/j.ygyno.2008.07.002; Persson J, 2012, GYNECOL ONCOL, V127, P484, DOI 10.1016/j.ygyno.2012.08.022; Li J, 2011, GYNECOL ONCOL, V121, P565, DOI 10.1016/j.ygyno.2011.01.032; Rob L, 2011, LANCET ONCOL, V12, P192, DOI 10.1016/S1470-2045(10)70084-X; Cao DY, 2013, BRIT J CANCER, V109, P2778, DOI 10.1038/bjc.2013.656; Nishio H, 2013, HUM REPROD, V28, P1793, DOI 10.1093/humrep/det118; Ramirez PT, 2014, GYNECOL ONCOL, V132, P254, DOI 10.1016/j.ygyno.2013.09.004; Pareja R, 2013, GYNECOL ONCOL, V131, P77, DOI 10.1016/j.ygyno.2013.06.010; Wethington SL, 2012, INT J GYNECOL CANCER, V22, P1251, DOI 10.1097/IGC.0b013e318263eee2; Dargent D., 1994, Gynecologic Oncology, V52, P105; Ebisawa K, 2013, GYNECOL ONCOL, V131, P83, DOI 10.1016/j.ygyno.2013.07.108; Niikura H, 2004, GYNECOL ONCOL, V94, P528, DOI 10.1016/j.ygyno.2004.05.016; Niikura H, 2012, INT J GYNECOL CANCER, V22, P1244, DOI 10.1097/IGC.0b013e318263f06a; Nishio H, 2009, GYNECOL ONCOL, V115, P51, DOI 10.1016/j.ygyno.2009.06.036; Okamoto S, 2013, GYNECOL ONCOL, V130, P530, DOI 10.1016/j.ygyno.2013.06.027; Saso S, 2011, BJOG, V119, P187; Sato S, 2011, INT J CLIN ONCOL, V16, P141, DOI 10.1007/s10147-010-0146-6	17	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					776	780		10.1007/s10147-014-0763-6		5	Oncology	Oncology	CO5GU	WOS:000359188400020		
J	Tokunaga, H; Watanabe, Y; Niikura, H; Nagase, S; Toyoshima, M; Shiro, R; Yokoyama, Y; Mizunuma, H; Ohta, T; Nishiyama, H; Watanabe, T; Sato, N; Sugiyama, T; Takano, T; Takahashi, F; Yaegashi, N				Tokunaga, Hideki; Watanabe, Yoh; Niikura, Hitoshi; Nagase, Satoru; Toyoshima, Masafumi; Shiro, Reiji; Yokoyama, Yoshihito; Mizunuma, Hideki; Ohta, Tsuyoshi; Nishiyama, Hiroshi; Watanabe, Takafumi; Sato, Naoki; Sugiyama, Toru; Takano, Tadao; Takahashi, Fumiaki; Yaegashi, Nobuo			Outcomes of abdominal radical trachelectomy: results of a multicenter prospective cohort study in a Tohoku Gynecologic Cancer Unit (vol 20, pg 776, 2015)	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Correction									[Tokunaga, Hideki; Watanabe, Yoh; Niikura, Hitoshi; Nagase, Satoru; Toyoshima, Masafumi; Shiro, Reiji; Takano, Tadao; Yaegashi, Nobuo] Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan; [Watanabe, Yoh; Takano, Tadao; Takahashi, Fumiaki] Tohoku Univ Hosp, Dept Clin Res Network Clin Res, Innovat & Educ Ctr, Aoba Ku, Sendai, Miyagi 9808574, Japan; [Yokoyama, Yoshihito; Mizunuma, Hideki] Hirosaki Univ, Grad Sch Med, Dept Obstet & Gynecol, Hirosaki, Aomori 036, Japan; [Ohta, Tsuyoshi] Yamagata Univ, Fac Med, Dept Obstet & Gynecol, Yamagata 990, Japan; [Nishiyama, Hiroshi; Watanabe, Takafumi] Fukushima Med Univ, Dept Obstet & Gynecol, Fukushima, Japan; [Sato, Naoki] Akita Univ, Grad Sch Med, Dept Obstet & Gynecol, Akita 010, Japan; [Sugiyama, Toru] Iwate Med Univ, Dept Obstet & Gynecol, Morioka, Iwate 020, Japan	Watanabe, Y (reprint author), Tohoku Univ, Grad Sch Med, Dept Obstet & Gynecol, Sendai, Miyagi 980, Japan.	watanabe@med.tohoku.ac.jp					Tokunaga H, 2015, INT J CLIN ONCOL, V20, P776, DOI 10.1007/s10147-014-0763-6	1	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					781	781		10.1007/s10147-014-0777-0		1	Oncology	Oncology	CO5GU	WOS:000359188400021		
J	Nozawa, M; Ohzeki, T; Tamada, S; Hongo, F; Anai, S; Fujimoto, K; Miki, T; Nakatani, T; Fukasawa, S; Uemura, H				Nozawa, Masahiro; Ohzeki, Takayuki; Tamada, Satoshi; Hongo, Fumiya; Anai, Satoshi; Fujimoto, Kiyohide; Miki, Tsuneharu; Nakatani, Tatsuya; Fukasawa, Satoshi; Uemura, Hirotsugu			Differences in adverse event profiles between everolimus and temsirolimus and the risk factors for non-infectious pneumonitis in advanced renal cell carcinoma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Adverse event; Everolimus; Mammalian target of rapamycin; Pneumonitis; Renal cell carcinoma; Temsirolimus	INTRAVENOUS-INFUSION; MTOR INHIBITORS; CANCER-THERAPY; LUNG-CANCER; PHASE-I; PHARMACOKINETICS; KETOCONAZOLE; GEFITINIB; EXPOSURE; CCI-779	Background There have been few reports of the differences in safety between the mammalian target of rapamycin inhibitors, everolimus and temsirolimus. The purpose of this study is to compare the adverse event profiles of both agents and to estimate the risk factors for non-infectious pneumonitis in patients with advanced renal cell carcinoma on the basis of our real-world clinical experience. Methods Data from 218 consecutive patients that received either everolimus or temsirolimus for advanced renal cell carcinoma at five Japanese centers were retrospectively analyzed. Chi-squared test and univariate and multivariate logistic regression analyses were performed to investigate the differences in adverse event profiles and the risk factors associated with non-infectious pneumonitis, respectively. Results A total of 196 patients were evaluable. In the everolimus group compared with temsirolimus, stomatitis (56 vs 30 %, p < 0.001) and non-infectious pneumonitis (38 vs 22 %, p = 0.018) were more frequently observed, and asthenia (11 vs 23 %, p = 0.027), rash (20 vs 36 %, p = 0.018), and fatigue (33 vs 48 %, p = 0.032) occurred less frequently in all grades. On multivariate analysis, male gender (odds ratio 3.65; 95 % confidence interval 1.44-9.26, p = 0.007) and everolimus treatment (odds ratio 2.00; 95 % confidence interval 1.01-3.96, p = 0.046) were significantly associated with development of non-infectious pneumonitis. Conclusion Our findings suggest that adverse event profiles may differ between everolimus and temsirolimus and that non-infectious pneumonitis may occur more frequently in patients treated with everolimus than temsirolimus. Further investigations are needed to confirm these results.	[Nozawa, Masahiro; Uemura, Hirotsugu] Kinki Univ, Fac Med, Dept Urol, Sayama, Osaka 5898511, Japan; [Ohzeki, Takayuki; Fukasawa, Satoshi] Chiba Canc Ctr, Prostate Ctr, Chuo Ku, Chiba 2600801, Japan; [Ohzeki, Takayuki; Fukasawa, Satoshi] Chiba Canc Ctr, Div Urol, Chuo Ku, Chiba 2600801, Japan; [Tamada, Satoshi; Nakatani, Tatsuya] Osaka City Univ, Grad Sch Med, Dept Urol, Abeno Ku, Osaka 5458585, Japan; [Hongo, Fumiya; Miki, Tsuneharu] Kyoto Prefectural Univ Med, Dept Urol, Kamigyo Ku, Kyoto 6020841, Japan; [Anai, Satoshi; Fujimoto, Kiyohide] Nara Med Univ, Dept Urol, Kashihara, Nara 6340813, Japan	Nozawa, M (reprint author), Kinki Univ, Fac Med, Dept Urol, 377-2 Ohno Higashi, Sayama, Osaka 5898511, Japan.	nozawa06@med.kindai.ac.jp			Novartis; Pfizer	Kiyohide Fujimoto has received research grants from Novartis and Pfizer; Tsuneharu Miki has received research grants from Novartis and Pfizer; Hirotsugu Uemura has received research grants from Novartis and Pfizer; the other authors have no conflict of interest.	Raymond E, 2004, J CLIN ONCOL, V22, P2336, DOI 10.1200/JCO.2004.08.116; Benjamin D, 2011, NAT REV DRUG DISCOV, V10, P868, DOI 10.1038/nrd3531; Bellmunt J, 2008, ANN ONCOL, V19, P1387, DOI 10.1093/annonc/mdn066; Ciuffreda L, 2010, CURR CANCER DRUG TAR, V10, P484; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; O'Donnell A, 2008, J CLIN ONCOL, V26, P1588, DOI 10.1200/JCO.2007.14.0988; Hidalgo M, 2006, CLIN CANCER RES, V12, P5755, DOI 10.1158/1078-0432.CCR-06-0118; Pantuck AJ, 2007, CANCER, V109, P2257, DOI 10.1002/cncr.22677; Faivre S, 2006, NAT REV DRUG DISCOV, V5, P671, DOI 10.1038/nrd2062; Kirchner GI, 2004, CLIN PHARMACOKINET, V43, P83, DOI 10.2165/00003088-200443020-00002; Ando M, 2006, J CLIN ONCOL, V24, P2549, DOI 10.1200/JCO.2005.04.9866; Boni J, 2007, J CLIN PHARMACOL, V47, P1430, DOI 10.1177/0091270007306957; Meric-Bernstam F, 2009, J CLIN ONCOL, V27, P2278, DOI 10.1200/JCO.2008.20.0766; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Motzer RJ, 2010, CANCER-AM CANCER SOC, V116, P4256, DOI 10.1002/cncr.25219; Kovarik JM, 2002, PHARMACOTHERAPY, V22, P154, DOI 10.1592/phco.22.3.154.33542; Kovarik JM, 2001, CLIN PHARMACOL THER, V69, P48, DOI 10.1067/mcp.2001.112969; Boni JP, 2008, BRIT J CANCER, V98, P1797, DOI 10.1038/sj.bjc.6604376; Boni JP, 2009, SEMIN ONCOL       S3, V36, P18; Husseinzadeh Holleh D, 2011, Curr Clin Pharmacol, V6, P214; Klumpen HJ, 2010, ONCOLOGIST, V15, P1262, DOI 10.1634/theoncologist.2010-0196; Kovarik JM, 2002, ANN PHARMACOTHER, V36, P981, DOI 10.1345/aph.1A384; Kovarik JM, 2005, J CLIN PHARMACOL, V45, P514, DOI 10.1177/0091270005275368; Lebwohl D, 2011, EXPERT OPIN DRUG DIS, V6, P323, DOI 10.1517/17460441.2011.558079; Morelon E, 2001, TRANSPLANTATION, V72, P787, DOI 10.1097/00007890-200109150-00008	26	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					790	795		10.1007/s10147-014-0764-5		6	Oncology	Oncology	CO5GU	WOS:000359188400023		
J	Miyake, H; Harada, K; Imai, S; Miyazaki, A; Fujisawa, M				Miyake, Hideaki; Harada, Ken-ichi; Imai, Satoshi; Miyazaki, Akira; Fujisawa, Masato			Non-significant impact of proteinuria on renal function in Japanese patients with metastatic renal cell carcinoma treated with axitinib	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Axitinib; Proteinuria; Renal function; Metastatic renal cell carcinoma	PHASE-II; SORAFENIB; TRIAL; EFFICACY; CANCER; AXIS	Background To investigate the impact of proteinuria on the renal function of patients with metastatic renal cell carcinoma (mRCC) who received axitinib, a tyrosine kinase inhibitor specifically targeting vascular endothelial growth factor receptors. Methods This study included 65 consecutive Japanese patients who were diagnosed with mRCC and were subsequently treated with axitinib for at least 12 weeks. The association between the changes in the estimated glomerular filtration rate (eGFR) and proteinuria in these 65 patients was retrospectively assessed. Results Of the 65 patients, 41 (63.1 %) were judged to be positive for proteinuria. There were no significant differences between the eGFR value before the introduction of axitinib and that at the last clinic visit in either group with or without proteinuria. Furthermore, no significant correlation was noted between the changes in eGFR and the urine protein to creatinine ratio in the group positive for proteinuria, and there was no significant effect of the duration of treatment with axitinib on the changes in eGFR in the proteinuria group. Of several factors examined, univariate analysis identified age, eGFR prior to the introduction of axitinib, and timing of axitinib introduction, but not the presence of proteinuria, as predictors of a decrease in eGFR of >10 %; however, only age appeared to be independently associated with a decrease in eGFR of >10 %. Conclusions These findings suggest that treatment with axitinib may not have a significant adverse impact on the renal function in patients with mRCC, irrespective of the presence of proteinuria.	[Miyake, Hideaki; Harada, Ken-ichi; Imai, Satoshi; Miyazaki, Akira; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Miyake, H (reprint author), Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hideakimiyake@hotmail.com			Pfizer	Hideaki Miyake, Ken-ichi Harada, and Masato Fujisawa received lecture fees from Pfizer; Satoshi Imai and Akira Miyazaki have no conflict of interest.	Figlin R, 2012, J UROLOGY, V188, P707, DOI 10.1016/j.juro.2012.04.108; Cohen RB, 2012, INVEST NEW DRUG, V30, P2066, DOI 10.1007/s10637-012-9796-8; Izzedine H, 2010, EUR J CANCER, V46, P439, DOI 10.1016/j.ejca.2009.11.001; Birn H, 2006, KIDNEY INT, V69, P440, DOI 10.1038/sj.ki.5000141; Ueda T, 2013, JPN J CLIN ONCOL, V43, P616, DOI 10.1093/jjco/hyt054; Levey AS, 2009, ANN INTERN MED, V150, P604; Rixe O, 2007, LANCET ONCOL, V8, P975, DOI 10.1016/51470-2045(07)70285-1; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Motzer RJ, 2004, J CLIN ONCOL, V22, P454; PETERSON JC, 1995, ANN INTERN MED, V123, P754; Hu-Lowe DD, 2008, CLIN CANCER RES, V14, P7272, DOI 10.1158/1078-0432.CCR-08-0652; Tomita Y, 2011, EUR J CANCER, V47, P2592, DOI 10.1016/j.ejca.2011.07.014; Kelly RJ, 2009, TARGET ONCOL, V4, P297, DOI 10.1007/s11523-009-0126-9; Patel TV, 2008, J NATL CANCER I, V100, P282, DOI 10.1093/jnci/djm311; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	15	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					796	801		10.1007/s10147-014-0770-7		6	Oncology	Oncology	CO5GU	WOS:000359188400024		
J	Fujii, Y; Ikeda, M; Kurosawa, K; Tabata, M; Kamigaito, T; Hosoda, C; Okaneya, T				Fujii, Yoichi; Ikeda, Masaomi; Kurosawa, Kazuhiro; Tabata, Mariko; Kamigaito, Takayuki; Hosoda, Chihiro; Okaneya, Toshikazu			Different clinicopathological features between patients who developed early and late recurrence following surgery for renal cell carcinoma	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Renal cell carcinoma; Late recurrence; Predictive factor; Surgery; Nephrectomy	PROGNOSTIC-FACTORS; RADICAL NEPHRECTOMY; INTERFERON-ALPHA; BREAST-CANCER; GUIDELINES; SURVIVAL; SURVEILLANCE; METASTASIS; SORAFENIB; TRIAL	Background To evaluate the clinicopathological features and identify predictive factors in patients with early and late recurrence following initial surgery for localized renal cell carcinoma. Methods From April 1988 to January 2013, 486 patients without metastases at the initial diagnosis underwent either radical nephrectomy or partial nephrectomy and were followed up thereafter. Patients were divided into 3 groups; no recurrence, early recurrence (recurrence within 5 years), and late recurrence (recurrence after 5 years). Cancer-specific survival after recurrence was analyzed by using the Kaplan-Meier method. Multivariate logistic regression analysis was applied to define clinical and pathological factors correlated to early and late recurrence following surgery. Results Seventy-seven (15.8 %) and 18 (3.7 %) patients developed early and late recurrence, respectively. In multivariate logistic regression analysis, positive symptoms at diagnosis, >= pT2, positive lymphovascular invasion, and grade 3 were independent predictive factors for early recurrence. Age at surgery and >= pT2 were significantly correlated to late recurrence. The 5-year cancer-specific survival rate after recurrence was 72.4 and 52.9 % in the late and the early recurrence groups, respectively (P = 0.044). Conclusions The risk factors for clinical recurrence differed according to the time that had elapsed between initial surgery and the first metastasis in patients with localized renal cell carcinoma. Our study showed age at initial surgery and the pT stage were independent predictive factors for late recurrence. Further investigation of a larger number of patients is required to predict which patients may develop recurrence in the future and to choose appropriate treatment.	[Fujii, Yoichi; Ikeda, Masaomi; Kurosawa, Kazuhiro; Tabata, Mariko; Kamigaito, Takayuki; Hosoda, Chihiro; Okaneya, Toshikazu] Toranomon Gen Hosp, Dept Urol, Minato Ku, Tokyo 1058470, Japan	Ikeda, M (reprint author), Toranomon Gen Hosp, Dept Urol, Minato Ku, 2-2-2 Toranomon, Tokyo 1058470, Japan.	ikeda.masaomi@grape.plala.or.jp					Kavolius JP, 1998, J CLIN ONCOL, V16, P2261; Braun S, 2000, NEW ENGL J MED, V342, P525, DOI 10.1056/NEJM200002243420801; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Uchida K, 2002, INT J UROL, V9, P19, DOI 10.1046/j.1442-2042.2002.00418.x; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Hollingsworth JM, 2007, CANCER, V109, P1763, DOI 10.1002/cncr.22600; Adamy A, 2011, J UROLOGY, V185, P433, DOI 10.1016/j.juro.2010.09.100; Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Kim SP, 2011, UROLOGY, V78, P1101, DOI 10.1016/j.urology.2011.05.012; Rini BI, 2011, LANCET, V378, P1931, DOI 10.1016/S0140-6736(11)61613-9; Naumov GN, 2009, CLIN EXP METASTAS, V26, P51, DOI 10.1007/s10585-008-9176-0; Kroeger N, 2014, EUR UROL, V65, P1086, DOI 10.1016/j.eururo.2013.07.031; Ljungberg B, 1999, BJU INT, V84, P405; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Ljungberg B, 2010, EUR UROL, V58, P398, DOI 10.1016/j.eururo.2010.06.032; Kyoda Y, 2014, INT J CLIN ONCOL, V19, P146, DOI 10.1007/s10147-013-0533-x; Brookman-May S, 2013, EUR UROL, V64, P472, DOI 10.1016/j.eururo.2012.06.030; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; Gelb AB, 1997, CANCER, V80, P981; Levy DA, 1998, J UROLOGY, V159, P1163, DOI 10.1016/S0022-5347(01)63541-9; MALDAZYS JD, 1986, J UROLOGY, V136, P376; NAKANO E, 1984, EUR UROL, V10, P347; Nguyen MM, 2006, J UROLOGY, V176, P2397, DOI 10.1016/j.juro.2006.07.144; Park YH, 2012, BJU INT, V110, P553; THRASHER JB, 1993, UROL CLIN N AM, V20, P247	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					802	807		10.1007/s10147-014-0775-2		6	Oncology	Oncology	CO5GU	WOS:000359188400025		
J	Miyake, H; Hinata, N; Imai, S; Furukawa, J; Tanaka, K; Fujisawa, M				Miyake, Hideaki; Hinata, Nobuyuki; Imai, Satoshi; Furukawa, Junya; Tanaka, Kazushi; Fujisawa, Masato			Partial nephrectomy for hilar tumors: comparison of conventional open and robot-assisted approaches	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Robot-assisted partial nephrectomy; Open partial nephrectomy; Hilar tumor	LAPAROSCOPIC PARTIAL NEPHRECTOMY; OUTCOMES	Background To characterize clinical advantages in robot-assisted partial nephrectomy (RAPN) for targeting renal hilar tumors, and compare them with those of open PN (OPN). Methods This study included 31 consecutive patients with renal hilar tumors, consisting of 15 and 16 who received OPN and RAPN, respectively, between January 2012 and May 2014. The perioperative and oncological outcomes of the two approaches were compared. In this series, a hilar tumor was defined as a renal cortical tumor located in the renal hilum that was shown, by preoperative imaging, to be in direct physical contact with the renal artery and/or vein. Results There were no significant differences between demographic variables of the OPN and RAPN groups. Intended surgical procedures were successfully completed for all 31 cases. Despite lack of a significant difference between ischemia times in the two groups, operative time for RAPN was significantly longer than for OPN, and estimated blood loss during RAPN was significantly less than that during OPN. There were no significant differences between incidence of postoperative complications or percentage decrease in estimated glomerular filtration rate 4 weeks after surgery in the two groups. Indicators of postoperative recovery seemed to favor RAPN compared with OPN, with significant differences. No patient in either group was pathologically diagnosed with a positive surgical margin. Conclusions These findings suggest that, compared with OPN, RAPN is an effective, safe, and less invasive surgical option for renal hilar tumors.	[Miyake, Hideaki; Hinata, Nobuyuki; Imai, Satoshi; Furukawa, Junya; Tanaka, Kazushi; Fujisawa, Masato] Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, Kobe, Hyogo 6500017, Japan	Miyake, H (reprint author), Kobe Univ, Grad Sch Med, Div Urol, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	hideakimiyake@hotmail.com	Hinata, Nobuyuki/M-9421-2015	Hinata, Nobuyuki/0000-0001-7014-6812			George AK, 2014, UROLOGY, V83, P111, DOI 10.1016/j.urology.2013.08.059; Dindo D, 2004, ANN SURG, V240, P205, DOI 10.1097/01.sla.0000133083.54934.ae; Eyraud R, 2013, UROLOGY, V81, P1246, DOI 10.1016/j.urology.2012.10.072; Gill IS, 2007, J UROLOGY, V178, P41, DOI 10.1016/j.juro.2007.03.038; Benway BM, 2009, J UROLOGY, V182, P866, DOI 10.1016/j.juro.2009.05.037; Gill IS, 2005, J UROLOGY, V174, P850, DOI 10.1097/01.ju.0000169493.05498.c3; Aboumarzouk OM, 2012, EUR UROL, V62, P1023, DOI 10.1016/j.eururo.2012.06.038; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Levey AS, 2009, ANN INTERN MED, V150, P604; Di Pierro GB, 2014, EJSO-EUR J SURG ONC, V40, P769, DOI 10.1016/j.ejso.2013.11.023; Dulabon LM, 2011, EUR UROL, V59, P325, DOI 10.1016/j.eururo.2010.11.017; Abreu ALC, 2011, BJU INT, V108, P948, DOI 10.1111/j.1464-410X.2011.10552.x; Gill IS, 2010, NEW ENGL J MED, V362, P624, DOI 10.1056/NEJMcp0910041; Tanaka K, 2013, J ENDOUROL, V27, P1384, DOI 10.1089/end.2012.0641; Khalifeh A, 2012, UROLOGY, V80, P466, DOI 10.1016/j.urology.2012.03.058; Campbell S C, 1995, Semin Urol Oncol, V13, P281; Furukawa J, 2014, INT J MED R IN PRESS; Jean-Baptiste L, 2008, EUR UROL, V54, P409, DOI 10.1016/j.eururo.2008.04.007; Porpiglia F, 2008, EUR UROL, V53, P732, DOI 10.1016/j.eururo.2008.01.025; Reisiger K, 2005, UROLOGY, V65, P888, DOI 10.1016/j.urology.2004.11.026; Richstone L, 2008, UROLOGY, V71, P36, DOI 10.1016/j.urology.2007.09.062	21	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					808	813		10.1007/s10147-015-0783-x		6	Oncology	Oncology	CO5GU	WOS:000359188400026		
J	Tamura, K; Saito, H; Asakura, H; Okamoto, K; Tagawa, J; Hayakawa, T; Aoki, N				Tamura, Kazuo; Saito, Hidehiko; Asakura, Hidesaku; Okamoto, Kohji; Tagawa, Jun; Hayakawa, Toru; Aoki, Nobuo			Recombinant human soluble thrombomodulin (thrombomodulin alfa) to treat disseminated intravascular coagulation in solid tumors: results of a one-arm prospective trial	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Disseminated intravascular coagulation; Solid tumors; Anticoagulants; Thrombomodulin; Clinical trial	CANCER-PATIENTS; GASTRIC-CANCER	Bvackground Disseminated intravascular coagulation (DIC) associated with solid tumors (DIC-ST) is often encountered in clinical practice. Patients with DIC-ST are usually in poor condition and have bleeding diathesis due to advanced or metastatic diseases. Although some affected patients are treated with heparin, this strategy has not been prospectively studied. Recombinant human soluble thrombomodulin (thrombomodulin alfa, TM-alpha) is a new anticoagulant developed in Japan. We conducted a prospective study that evaluated the efficacy and safety of TM-alpha in patients with DIC-ST. Methods A prospective one-arm study with TM-alpha was conducted for DIC-ST. TM-alpha (380 U/kg) was given for 30 min intravenously once daily for 6-14 days. The primary efficacy endpoint was the DIC resolution rate. Change in DIC scores and improvement in bleeding symptoms and outcomes were also evaluated. Safety endpoints included the incidence of bleeding-related adverse events. Results A total of 101 patients were treated with TM-alpha. The three main underlying malignant diseases were lung, stomach, and breast cancer, which accounted for 60 % of all patients. The DIC resolution rate was 34.0 % at the end of TM-alpha treatment. Improvement in DIC scores was seen in 55.2 % of patients, while only 22.9 % of patients had worsening of DIC scores. The overall survival rate was 55.4 % on day 28. The incidence of hemorrhage related to TM-alpha was 12.9 % until day 28. Cases of severe hemorrhage related to TM-alpha did not occur. Conclusions TM-alpha is effective and safe for DIC-ST. This agent is the treatment of choice for the management of DIC-ST.	[Tamura, Kazuo] Fukuoka Univ Hosp, Dept Med, Div Med Oncol Hematol & Infect Dis, Jonan Ku, Fukuoka, Fukuoka 8140180, Japan; [Saito, Hidehiko] Nagoya Med Ctr, Natl Hosp Org, Naka Ku, Nagoya, Aichi 4600001, Japan; [Asakura, Hidesaku] Kanazawa Univ, Grad Sch Med Sci, Dept Internal Med 3, Kanazawa, Ishikawa 9208641, Japan; [Okamoto, Kohji] Kitakyushu Municipal Yahata Hosp, Ctr Gastroenterol & Liver Dis, Kitakyushu, Fukuoka 8050061, Japan; [Tagawa, Jun; Hayakawa, Toru] Asahi Kasei Pharma Corp, Clin Dev Ctr, Chiyoda Ku, Tokyo 1018101, Japan; [Aoki, Nobuo] Tokyo Med & Dent Univ, Bunkyo Ku, Tokyo 1138510, Japan	Tamura, K (reprint author), Fukuoka Univ Hosp, Dept Med, Div Med Oncol Hematol & Infect Dis, Jonan Ku, 7-45-1 Nanakuma, Fukuoka, Fukuoka 8140180, Japan.	ktamura@fukuoka-u.ac.jp			Asahi Kasei Pharma Corporation (AKP)	This work was supported by Asahi Kasei Pharma Corporation (AKP). In addition to the authors, 34 institutions participated in this study. The institutions and investigators are shown in Table 7. The authors have access to all primary data, which can be made available to the journal editors upon request.	Levi M, 2009, BEST PRACT RES CL HA, V22, P129, DOI 10.1016/j.beha.2008.12.005; Tsuruta K, 2011, J CLIN PHARMACOL, V51, P1276, DOI 10.1177/0091270010381900; PASQUINI E, 1995, ONCOLOGY, V52, P505; Saba Hussain I., 2009, V148, P137, DOI 10.1007/978-0-387-79962-9_9; Saito H, 2007, J THROMB HAEMOST, V5, P31, DOI 10.1111/j.1538-7836.2006.02267.x; Sallah S, 2001, THROMB HAEMOSTASIS, V86, P828; Kobayashi N., 1983, BIBL HAEMATOL, P265; Lebelle CA, 2005, CLEV CLIN J MED, V72, P377; Lin PH, 2010, ANTICANCER RES, V30, P3087; Rhee J, 2010, J GASTROEN HEPATOL, V25, P1537, DOI 10.1111/j.1440-1746.2010.06289.x; Tokar M, 2006, ISRAEL MED ASSOC J, V8, P853; Voulgaris E, 2009, LUNG CANCER, V64, P247, DOI 10.1016/j.lungcan.2008.10.027	12	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					821	828		10.1007/s10147-014-0768-1		8	Oncology	Oncology	CO5GU	WOS:000359188400028		
J	Watanabe, A; Tanabe, A; Maruoka, R; Nakamura, K; Hatta, K; Ono, Y; Terai, Y; Ohmichi, M				Watanabe, Ayako; Tanabe, Akiko; Maruoka, Risa; Nakamura, Kiyoko; Hatta, Koji; Ono, Yoshihiro J.; Terai, Yoshito; Ohmichi, Masahide			Fibrates protect against vascular endothelial dysfunction induced by paclitaxel and carboplatin chemotherapy for cancer patients: a pilot study	INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY			English	Article						Bezafibrate; Platinum-based chemotherapy; Carboplatin; Paclitaxel; Gynecological cancer; Triglyceride; FMD	LONG-TERM SURVIVORS; ACUTE-RENAL-FAILURE; C-REACTIVE PROTEIN; TESTICULAR CANCER; PPAR-ALPHA; PENTRAXIN PTX3; CARDIOVASCULAR RISK; CISPLATIN; EXPRESSION; INFLAMMATION	Background Although we previously demonstrated that paclitaxel and carboplatin chemotherapy (TCchem) is associated with vascular toxicities, the underlying mechanisms remain unclear. Cisplatin is known to inhibit PPAR alpha following microvascular damage to the kidneys. The primary aim of this study was to evaluate whether TCchem induces vascular endothelial dysfunction via systemic PPAR alpha deficiency. In addition, human umbilical vein endothelial cells (HUVECs) were used to elucidate the mechanisms responsible for TCchem-induced vascular toxicities. Methods This study enrolled 45 gynecological cancer patients with normal lipid profiles who underwent surgical treatment followed by TCchem. The elevated triglyceride (TG) group included patients (n = 19) who exhibited hypertriglyceridemia during TCchem, and the stable TG group (n = 15) included patients with a normal TG level. Eleven patients exhibiting hypertriglyceridemia during TCchem were administered bezafibrate (fibrate group). Endothelial dysfunction was evaluated based on flow-mediated dilation (FMD) values and serum pentraxin-3 levels measured before TCchem and immediately after the final TCchem. HUVECs were used to elucidate the biological mechanisms underlying the endothelial dysfunction induced by TCchem. Results The administration of TCchem induced hypertriglyceridemia in 66 percent of the participants, and bezafibrate reduced the serum TG levels. Meanwhile, the decrease in flow-mediated dilatation (%FMD) induced by TCchem improved following treatment with bezafibrate. The serum pentraxin-3 level increased rapidly after TCchem and decreased following bezafibrate treatment. An in vitro examination demonstrated TCchem attenuated nitric oxide production and PPAR alpha activity in HUVECs, which was partially improved by treatment with bezafibrate. Conclusions Bezafibrate prevents endothelial dysfunction induced by TCchem via TG-dependent and TG-independent mechanisms.	[Watanabe, Ayako; Tanabe, Akiko; Maruoka, Risa; Nakamura, Kiyoko; Hatta, Koji; Ono, Yoshihiro J.; Terai, Yoshito; Ohmichi, Masahide] Osaka Med Coll, Dept Obstet & Gynecol, Takatsuki, Osaka 5698686, Japan	Tanabe, A (reprint author), Osaka Med Coll, Dept Obstet & Gynecol, 2-7 Daigaku Machi, Takatsuki, Osaka 5698686, Japan.	gyn074@poh.osaka-med.ac.jp			JSPS KAKENHI [24592535]	We are grateful to Junko Hayashi, Akiko Hashimoto, and Kumiko Satoh for secretarial assistance. This study was supported by JSPS KAKENHI Grant Number 24592535.	Garlanda C, 2002, NATURE, V420, P182, DOI 10.1038/nature01195; Li SY, 2005, AM J PHYSIOL-RENAL, V289, pF469, DOI 10.1152/ajprenal.00038.2005; Haugnes HS, 2007, ANN ONCOL, V18, P241, DOI 10.1093/annonc/mdl372; Kureishi Y, 2000, NAT MED, V6, P1004; Sekijima T, 2011, CLIMACTERIC, V14, P31, DOI 10.3109/13697137.2010.522278; STEEL DM, 1994, IMMUNOL TODAY, V15, P81, DOI 10.1016/0167-5699(94)90138-4; Rowinsky EK, 1997, ANNU REV MED, V48, P353; Kirchmair R, 2005, CIRCULATION, V111, P2662, DOI 10.1161/CIRCULATIONAHA.104.470849; Meinardi MT, 2000, J CLIN ONCOL, V18, P1725; Wang LM, 2009, J LIPID RES, V50, P204, DOI 10.1194/jlr.M700505-JLR200; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667; Vogel RA, 1997, AM J CARDIOL, V79, P350; Schoonjans K, 1996, J LIPID RES, V37, P907; Haugnes HS, 2010, J CLIN ONCOL, V28, P4649, DOI 10.1200/JCO.2010.29.9362; Kohn S, 1997, ULTRASTRUCT PATHOL, V21, P289; Vaughn DJ, 2008, CANCER, V112, P1949, DOI [10.1002/cncr.23389, 10.1002/cncr23389]; Li SY, 2004, AM J PHYSIOL-RENAL, V287, pF990, DOI 10.1152/ajprenal.00206.2004; Hefler LA, 2008, CLIN CANCER RES, V14, P710, DOI 10.1158/1078-0432.CCR-07-1044; Wolfrum S, 2003, ARTERIOSCL THROM VAS, V23, P729, DOI 10.1161/01.ATV.0000063385.12476.A7; Fazzini F, 2001, ARTHRITIS RHEUM, V44, P2841, DOI 10.1002/1529-0131(200112)44:12<2841::AID-ART472>3.0.CO;2-6; Mantovani A, 2006, VASC PHARMACOL, V45, P326, DOI 10.1016/j.vph.2006.08.011; Mantovani A, 2008, J CLIN IMMUNOL, V28, P1, DOI 10.1007/s10875-007-9126-7; Brouet A, 2001, CIRC RES, V89, P866, DOI 10.1161/hh2201.100319; Laufs U, 1998, J BIOL CHEM, V273, P24266, DOI 10.1074/jbc.273.37.24266; Lundman P, 2003, AM J CARDIOL, V91, P1128, DOI 10.1016/S0002-9149(03)00165-6; Eiselein L, 2007, AM J PHYSIOL-HEART C, V292, pH2745, DOI 10.1152/ajpheart.00686.2006; Sagstuen H, 2005, J CLIN ONCOL, V23, P4980, DOI 10.1200/JCO.2005.06.882; Nuver J, 2004, EUR J CANCER, V40, P701, DOI 10.1016/j.ejca.2003.12.012; Martin G, 2001, J CLIN INVEST, V107, P1423, DOI 10.1172/JCI10852; Vamecq J, 1999, LANCET, V354, P141, DOI 10.1016/S0140-6736(98)10364-1; Belotti D, 1996, CLIN CANCER RES, V2, P1843; Kohn S, 2002, ULTRASTRUCT PATHOL, V26, P371, DOI 10.1080/01913120290104683; Yano M, 2007, CIRC RES, V100, P1442, DOI 10.1161/01.RES.0000268411.49545.9c; DOLL DC, 1986, ANN INTERN MED, V105, P48; Haubenwallner S, 1995, J LIPID RES, V36, P2541; LEDERMAN GS, 1987, J UROLOGY, V137, P1236; Li SY, 2004, AM J PHYSIOL-RENAL, V286, pF572, DOI 10.1152/ajprenal.00190.2003; Nagothu KK, 2005, KIDNEY INT, V68, P2680, DOI 10.1111/j.1523-1755.2005.00739.x; Portilla D, 2007, SEMIN NEPHROL, V27, P609, DOI 10.1016/j.semnephrol.2007.09.006; Portilla D, 2002, KIDNEY INT, V62, P1208, DOI 10.1046/j.1523-1755.2002.00553.x; Schonefeld M, 1996, KIDNEY INT, V49, P1289, DOI 10.1038/ki.1996.184; VOGELZANG NJ, 1980, CANCER TREAT REP, V64, P1159; Yoshikawa Atsushi, 1997, Kobe Journal of Medical Sciences, V43, P109	43	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1341-9625	1437-7772		INT J CLIN ONCOL	Int. J. Clin. Oncol.	AUG	2015	20	4					829	838		10.1007/s10147-014-0779-y		10	Oncology	Oncology	CO5GU	WOS:000359188400029		
J	Minami, Y; Kajimoto, K; Sato, N; Aokage, T; Mizuno, M; Asai, K; Munakata, R; Yumino, D; Murai, K; Hagiwara, N; Mizuno, K; Kasanuki, H; Takano, T				Minami, Y.; Kajimoto, K.; Sato, N.; Aokage, T.; Mizuno, M.; Asai, K.; Munakata, R.; Yumino, D.; Murai, K.; Hagiwara, N.; Mizuno, K.; Kasanuki, H.; Takano, T.			Third heart sound in hospitalised patients with acute heart failure: insights from the ATTEND study	INTERNATIONAL JOURNAL OF CLINICAL PRACTICE			English	Article							JUGULAR VENOUS-PRESSURE; RENAL-FUNCTION; TASK-FORCE; AUSCULTATION; STETHOSCOPE; GUIDELINES; PROGNOSIS; DIAGNOSIS; MEDICINE; REGISTRY	Background: Several previous studies have suggested that detection of a third heart sound (S3) in patients with chronic congestive heart failure is associated with adverse long-term outcomes. However, the short-term prognostic value of identifying an S3 on admission in patients with acute heart failure (AHF) is not well established. We therefore analysed the in-hospital prognostic value of detecting an S3 on admission in hospitalised patients with AHF. Methods: The Acute Decompensated Heart Failure Syndromes (ATTEND) study investigators enrolled 4107 patients hospitalised with AHF. Investigators evaluated the presence or absence of an S3 during routine physical examination. Results: On admission to hospital, 1673 patients (41%) had an S3. Patients with an S3 had a higher heart rate, higher serum level of B-type natriuretic peptide and higher creatinine levels than patients without an S3. However, there were no significant differences of systolic blood pressure, serum sodium, haemoglobin, C-reactive protein and total bilirubin between the two groups. Multivariate analysis adjusted for various markers of disease severity revealed that only the presence of an S3 was independently associated with an increase of in-hospital all cause death [adjusted odds ratio (OR), 1.69; 95% confidence interval (CI), 1.19-2.41; p = 0.003] and cardiac death (adjusted OR, 1.66; 95% CI, 1.08-2.54; p = 0.020) among the congestive physical findings related to heart failure (S3, rales, jugular venous distension and peripheral oedema). Conclusions: Detecting an S3 on admission was independently associated with adverse in-hospital outcomes in patients with AHF. Our findings suggest that careful bedside assessment is clinically meaningful.	[Minami, Y.; Mizuno, M.; Yumino, D.; Hagiwara, N.; Kasanuki, H.] Tokyo Womens Med Univ, Dept Cardiol, Tokyo 1628666, Japan; [Kajimoto, K.] Sensoji Hosp, Dept Cardiol, Tokyo, Japan; [Sato, N.] Musashi Kosugi Hosp, Nippon Med Sch, Internal Med Cardiol & Intens Care Unit, Kawasaki, Kanagawa, Japan; [Aokage, T.; Munakata, R.; Murai, K.] Nippon Med Sch, Intens & Cardiac Care Unit, Tokyo 113, Japan; [Asai, K.; Mizuno, K.; Takano, T.] Nippon Med Sch, Dept Internal Med, Tokyo 113, Japan	Minami, Y (reprint author), Tokyo Womens Med Univ, Dept Cardiol, Shinjuku Ku, 8-1 Kawada Cho, Tokyo 1628666, Japan.	yuichiro24@celery.ocn.ne.jp			Japan Heart Foundation	This study was supported by the Japan Heart Foundation. We express our appreciation to all of the ATTEND study investigators for their contributions to this study.	Adolph RJ, 1998, CHEST, V114, P1235, DOI 10.1378/chest.114.5.1235; Kajimoto K, 2013, INT J CARDIOL, V168, P554, DOI 10.1016/j.ijcard.2013.01.187; Sato N, 2013, CIRC J, V77, P944, DOI 10.1253/circj.CJ-13-0187; Azevedo ER, 2000, CIRCULATION, V101, P2053; Mullens W, 2009, J AM COLL CARDIOL, V53, P589, DOI 10.1016/j.jacc.2008.05.068; PINAMONTI B, 1993, J AM COLL CARDIOL, V22, P808; Zile MR, 2008, CIRCULATION, V118, P1433, DOI 10.1161/CIRCULATIONAHA.108.783910; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; Collins SP, 2009, ANN EMERG MED, V53, P748, DOI 10.1016/j.annemergmed.2008.12.029; Marcus G, 2006, ARCH INTERN MED, V166, P617, DOI 10.1001/archinte.166.6.617; Sato N, 2010, AM HEART J, V159, P949, DOI 10.1016/j.ahj.2010.03.019; CAMPANA C, 1993, J HEART LUNG TRANSPL, V12, P756; Minami Y, 2011, INT J CARDIOL, V153, P102, DOI 10.1016/j.ijcard.2011.09.020; Drazner MH, 2001, NEW ENGL J MED, V345, P574, DOI 10.1056/NEJMoa010641; FLETCHER RH, 1992, ANN INTERN MED, V117, P786; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; ISHMAIL AA, 1987, CHEST, V91, P870, DOI 10.1378/chest.91.6.870; Gheorghiade M, 2009, J AM COLL CARDIOL, V53, P557, DOI 10.1016/j.jacc.2008.10.041; McMurray JJV, 2012, EUR HEART J, V33, P1787, DOI 10.1093/eurheartj/ehs104; Damman K, 2009, J AM COLL CARDIOL, V53, P582, DOI 10.1016/j.jacc.2008.08.080; Lee CH, 2011, INT J CLIN PRACT, V65, P852, DOI 10.1111/j.1742-1241.2011.02699.x; Leri A, 1998, J CLIN INVEST, V101, P1326, DOI 10.1172/JCI316; Stevenson LW, 2005, JAMA-J AM MED ASSOC, V294, P1625; Breidthardt T, 2012, AM J MED, V125; CRAIGE E, 1988, NEW ENGL J MED, V318, P1611, DOI 10.1056/NEJM198806163182409; Drazner MH, 2003, AM J MED, V114, P431, DOI 10.1016/S0002-9343(03)00058-5; FOLLAND ED, 1992, NEW ENGL J MED, V327, P458, DOI 10.1056/NEJM199208133270703; GLOWER DD, 1992, J AM COLL CARDIOL, V19, P450; KONO T, 1993, J AM COLL CARDIOL, V21, P419; Mangione S, 1997, JAMA-J AM MED ASSOC, V278, P717, DOI 10.1001/jama.278.9.717; POZZOLI M, 1990, EUR HEART J, V11, P500; SHAH PM, 1969, AM HEART J, V78, P823, DOI 10.1016/0002-8703(69)90450-5; STEVENSON LW, 1989, JAMA-J AM MED ASSOC, V261, P884, DOI 10.1001/jama.261.6.884; VANDEWERF F, 1984, CIRCULATION, V69, P1070; VANDEWERF F, 1984, J CLIN INVEST, V73, P1400, DOI 10.1172/JCI111344; Weitz HH, 2000, AM J MED, V108, P669, DOI 10.1016/S0002-9343(00)00385-5; Wynne J, 2001, AM J MED, V111, P157, DOI 10.1016/S0002-9343(01)00809-9; XIE GY, 1994, J AM COLL CARDIOL, V24, P132	38	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-5031	1742-1241		INT J CLIN PRACT	Int. J. Clin. Pract.	AUG	2015	69	8					820	828		10.1111/ijcp.12603		9	Medicine, General & Internal; Pharmacology & Pharmacy	General & Internal Medicine; Pharmacology & Pharmacy	CO6FB	WOS:000359251500003		
J	Yagi, T; Takeuchi, N				Yagi, T.; Takeuchi, N.			An Explicit Dynamic Method of Rigid Bodies-Spring Model	INTERNATIONAL JOURNAL OF COMPUTATIONAL METHODS			English	Article						Explicit dynamic method; RBSM; DEM		The rigid bodies-spring model (RBSM) has been developed as a numerical model to generalize limit analysis in plasticity, in which the structure to be analyzed is idealized as an assemblage of rigid bodies connected by normal and tangential springs. Originally, this approach was a discrete model for handling static problem. In this paper, we illustrate the formulation of an explicit dynamic method for each element using the principle of hybrid-type virtual work. Additionally, we propose a new RBSM approach for contact mechanism and friction characteristics. Finally, we verify the accuracy of dynamic analysis by RBSM with some numerical examples.	[Yagi, T.] Hosei Univ, Grad Sch Engn & Design, Shinjuku Ku, Tokyo 1620843, Japan; [Takeuchi, N.] Hosei Univ, Fac Engn & Design, Shinjuku Ku, Tokyo 1620843, Japan	Yagi, T (reprint author), Hosei Univ, Grad Sch Engn & Design, Shinjuku Ku, 2-33 Ichigayatamachi, Tokyo 1620843, Japan.	tadao.yagi.9u@stu.hosei.ac.jp; takeuchi@hosei.ac.jp					BELYTSCHKO T, 1984, COMPUT METHOD APPL M, V42, P225, DOI 10.1016/0045-7825(84)90026-4; Matsushima T, 2009, J AEROSPACE ENG, V22, P15, DOI 10.1061/(ASCE)0893-1321(2009)22:1(15); Cundall P.A., 1971, P S INT SOC ROCK MEC, V2, P129; Kawai T., 1977, J SOC NAVAL ARCHITEC, V141, P187; Lemos J. V., 2011, ADV DISCONTINUOUS NU, P17; Moriguchi S., 2010, P INT S GEOM GEOT, P531; Munjiza A, 1995, INT J ENG COMP, V12, P145; Munjiza A., 2004, COMBINED FINITE DISC; Takeuchi N, 2010, ANALYSIS OF DISCONTINUOUS DEFORMATION: NEW DEVELOPMENTS AND APPLICATIONS, P395, DOI 10.3850/9789810844554-0037; Takeuchi N., 2000, J STRUCT ENG A, V46A, P261; Takeuchi N., 2001, T JSCES, V2001, P1; Yagi T., 2013, FRONTIERS DISCONTINU, P419; Yagi T., 2011, ADV DISCONTINUOUS NU, P419	13	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0219-8762	1793-6969		INT J COMP METH-SING	Int. J. Comput. Methods	AUG	2015	12	4			SI				1540014	10.1142/S0219876215400149		15	Engineering, Multidisciplinary; Mathematics, Interdisciplinary Applications	Engineering; Mathematics	CO7DL	WOS:000359318500015		
J	Shibasaki, H; Yusof, R; Lshida, Y				Shibasaki, Hiroki; Yusof, Rubiyah; Lshida, Yoshihisa			A Design Method of a Model-following Control System	INTERNATIONAL JOURNAL OF CONTROL AUTOMATION AND SYSTEMS			English	Article						DC motor; model-following control; switching function		This paper describes and demonstrates a model-following control system that is based on a switching function where an optimal gain matrix is determined by the LQR method. In our proposed method, the optimal gain matrix is derived such that it does not depend on the plant parameters. Simulation results show various cases including the nominal plant and the plant with a modeling error. The experimental study is also performed using a DC motor. The simulation and experimental results show that the proposed method has superior effectiveness.	[Shibasaki, Hiroki] Meiji Univ, Grad Sch Sci & Technol, Tama Ku, Kanagawa 2148571, Japan; [Yusof, Rubiyah] UTM, MJIIT, Ctr Artificial Intelligence & Robot CAIRO, Kuala Lumpur 54100, Malaysia; [Lshida, Yoshihisa] Meiji Univ, Sch Sci & Technol, Tama Ku, Kanagawa 2148571, Japan	Shibasaki, H (reprint author), Meiji Univ, Grad Sch Sci & Technol, Tama Ku, 1-1-1 Higashi Mita, Kanagawa 2148571, Japan.	shiba@meiji.ac.jp; rubiyah.kl@utm.my; ishida@isc.meiji.ac.jp			SMC Corporation Ltd., Tokyo, JAPAN; Yoshioka Scholar Ship	The authors would like to thank SMC Corporation Ltd., Tokyo, JAPAN, and Yoshioka Scholar Ship for studying in Malaysia-Japan International Institute of Technology (MJIIT) for supporting this work. The authors would like to thank the editor and reviewers of this article for their helpful suggestions.	Aguilar-Ibanez C, 2012, ISA T, V51, P801, DOI 10.1016/j.isatra.2012.06.015; Anderson B.D., 1990, OPTIMAL CONTROL LINE; Chern TL, 1997, IEEE T POWER ELECTR, V12, P53, DOI 10.1109/63.554169; CHERN TL, 1991, IEE PROC-D, V138, P439; Pai MC, 2013, INT J CONTROL AUTOM, V11, P225, DOI 10.1007/s12555-012-0017-1; CHERN TL, 1992, IEE PROC-D, V139, P161; Furuta K., 1982, SICE T, V18, P8; FURUTA K, 1982, IEEE T AUTOMAT CONTR, V27, P725, DOI 10.1109/TAC.1982.1102962; Grimble M. J., 1988, OPTIMAL CONTROL STOC, VI; Hashimoto S, 2007, C IND ELECT APPL, P2148, DOI 10.1109/ICIEA.2007.4318790; Ishikawa Y., 2007, IEICE T FUND ELECTR, VJ90-A, P663; Nadius D. S., 2003, OPTIMAL CONTROL SYST; Nonami K., 1994, SLIDING MODE CONTROL; Kondo Hiroyuki, 2010, Transactions of the Society of Instrument and Control Engineers, V46; Ogawa H, 2010, SOC INSTRUM CONTROL, V9, P120; Phanphairoje S., 2004, P SICE ANN C, P388; Shimada A., 1993, Transactions of the Institute of Electrical Engineers of Japan, Part D, V113-D; Siouris G. M., 1996, ENG APPROACH OPTIMAL; Takeichi K., 2001, T JAPAN HYDRAULICS P, V32, P91; Tanaka R, 2013, ISA T, V52, P744, DOI 10.1016/j.isatra.2013.07.003; Valkenburg M. E. V., 1982, ANALOG FILTER DESIGN; Varga A., 1991, DEC CONTR 1991 P 30, V2, P1062; Wang D., 2010, P 2 INT AS C INF CON, P445; Xinmin D., 2003, P 2003 INT C NEUR NE, P301; Yamaguchi T., 2007, NANOSCALE SERVO CONT; Yang Z.-J., 2009, P 4 IEEE C IND EL AP, P287	26	0	0	INST CONTROL ROBOTICS & SYSTEMS, KOREAN INST ELECTRICAL ENGINEERS	BUCHEON	BUCHEON TECHNO PARK 401-1506, 193 YAKDAE-DONG WONMI-GU, BUCHEON, GYEONGGI-DO 420-734, SOUTH KOREA	1598-6446	2005-4092		INT J CONTROL AUTOM	Int. J. Control Autom. Syst.	AUG	2015	13	4					843	852		10.1007/s12555-014-0131-3		10	Automation & Control Systems	Automation & Control Systems	CO0FM	WOS:000358825500008		
J	Muramatsu, K; Youn, Y; Han, Y; Hasegawa, Y; Shikazono, N				Muramatsu, Kenshiro; Youn, Youngjik; Han, Youngbae; Hasegawa, Yosuke; Shikazono, Naoki			Numerical study on the effect of initial flow velocity on liquid film thickness of accelerated slug flow in a micro tube	INTERNATIONAL JOURNAL OF HEAT AND FLUID FLOW			English	Article						Two-phase flow; Liquid film thickness; Micro tube; Acceleration; Phase-Field method	HEAT-TRANSFER; 2-PHASE FLOW; TAYLOR FLOW; FLUID; DEPOSITION; SIMULATION; INTERFACE; WALL	Numerical simulation of air-water slug flows accelerated from steady states with different initial velocities in a micro tube is conducted. It is shown that the liquid film formed between the gas bubble and the wall in an accelerated flow is significantly thinner than that in a steady flow at the same instantaneous capillary number. Specifically, the liquid film thickness is kept almost unchanged just after the onset of acceleration, and then gradually increases and eventually converges to that of an accelerated flow from zero initial velocity. Due to the flow acceleration, the Stokes layer is generated from the wall, and the instant velocity profile can be given by superposition of the Stokes layer and the initial parabolic velocity profile of a steady flow. It is found that the velocity profile inside a liquid slug away from the bubble can be well predicted by the analytical solution of a single-phase flow with acceleration. The change of the velocity profile in an accelerated flow changes the balance between the inertia, surface tension and viscous forces around the meniscus region, and thus the resultant liquid film thickness. By introducing the displacement thickness, the existing correlation for liquid film thickness in a steady flow (Han and Shikazono, 2009) is extended so that it can be applied to a flow with acceleration from an arbitrary initial velocity. It is demonstrated that the proposed correlation can predict liquid film thickness at Re <4600 within the range of +/- 10% accuracy. (C) 2015 Elsevier Inc. All rights reserved.	[Muramatsu, Kenshiro; Youn, Youngjik; Hasegawa, Yosuke; Shikazono, Naoki] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1530041, Japan; [Muramatsu, Kenshiro] DENSO Corp, Kariya, Aichi 4488661, Japan; [Han, Youngbae] Hongik Univ, Dept Mech & Design Engn, Sejong 339701, South Korea	Muramatsu, K (reprint author), Univ Tokyo, Inst Ind Sci, Meguro Ku, 4-6-1 Komaba, Tokyo 1530041, Japan.	murama2@iis.u-tokyo.ac.jp					Amsden AA, 1970, LA4370 LOS AL SCI LA; Thome JR, 2004, INT J HEAT MASS TRAN, V47, P3375, DOI 10.1016/j.ijheatmasstransfer.2004.01.006; BRETHERTON FP, 1961, J FLUID MECH, V10, P166, DOI 10.1017/S0022112061000160; Yabe T, 2001, J COMPUT PHYS, V169, P556, DOI 10.1006/jcph.2000.6625; Han Y, 2009, INT J HEAT FLUID FL, V30, P842, DOI 10.1016/j.ijheatfluidflow.2009.02.019; Kreutzer MT, 2005, AICHE J, V51, P2428, DOI 10.1002/aic.10495; Jacqmin D, 2000, J FLUID MECH, V402, P57, DOI 10.1017/S0022112099006874; Jacqmin D, 1999, J COMPUT PHYS, V155, P96, DOI 10.1006/jcph.1999.6332; Zhou CF, 2010, J COMPUT PHYS, V229, P498, DOI 10.1016/j.jcp.2009.09.039; Han YB, 2010, INT J HEAT FLUID FL, V31, P630, DOI 10.1016/j.ijheatfluidflow.2010.02.002; Anderson DM, 1998, ANNU REV FLUID MECH, V30, P139, DOI 10.1146/annurev.fluid.30.1.139; Fukagata K, 2007, INT J HEAT FLUID FL, V28, P72, DOI 10.1016/j.ijheatfluidflow.2006.04.010; Aussillous P, 2000, PHYS FLUIDS, V12, P2367, DOI 10.1063/1.1289396; Das D, 2000, J APPL MECH-T ASME, V67, P274, DOI 10.1115/1.1304843; Edvinsson RK, 1996, AICHE J, V42, P1815, DOI 10.1002/aic.690420703; He Q., 2008, THESIS U TOKYO TOKYO; He QW, 2008, FLUID DYN RES, V40, P497, DOI 10.1016/j.fluiddyn.2008.01.002; Jamet D, 2002, J COMPUT PHYS, V182, P262, DOI 10.1006/jcph.2002.7165; Kenning DBR, 2006, INT J HEAT MASS TRAN, V49, P4653, DOI 10.1016/j.ijheatmasstransfer.2006.04.010; Klaseboer E, 2014, PHYS FLUIDS, V26, DOI 10.1063/1.4868257; Muramatsu K., 2014, P IHTC 15; Nishihara K., 2008, J JSEM, V8, P32; Qu W., 2004, INT J HEAT MASS TRAN, V46, P3387; TAYLOR GI, 1961, J FLUID MECH, V10, P161, DOI 10.1017/S0022112061000159; Yokota S., 1980, J JAPAN HYDRAULICS P, V11, P41; Youn Y., 2014, INT J MULTI IN PRESS	26	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0142-727X	1879-2278		INT J HEAT FLUID FL	Int. J. Heat Fluid Flow	AUG	2015	54						77	86		10.1016/j.ijheatfluidflow.2015.04.005		10	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CO0CM	WOS:000358817700007		
J	Shen, XZ; Hibiki, T				Shen, Xiuzhong; Hibiki, Takashi			Interfacial area concentration in gas-liquid bubbly to churn flow regimes in large diameter pipes	INTERNATIONAL JOURNAL OF HEAT AND FLUID FLOW			English	Article						Void fraction; Interfacial area concentration; Interfacial area density; Bubble diameter; Bubbly to churn flow regimes; Large diameter pipes	MULTIDIMENSIONAL 2-PHASE FLOW; DRIFT-FLUX MODEL; 4-SENSOR PROBE; TRANSPORT-EQUATION; VOID FRACTION; 2-FLUID MODEL; VELOCITY; COEFFICIENT; TRANSITION; CLOSURE	This study performed a survey on existing correlations for interfacial area concentration (IAC) prediction and collected an IAC experimental database of two-phase flows taken under various flow conditions in large diameter pipes. Although some of these existing correlations were developed by partly using the IAC databases taken in the low-void-fraction two-phase flows in large diameter pipes, no correlation can satisfactorily predict the IAC in the two-phase flows changing from bubbly, cap bubbly to churn flow in the collected database of large diameter pipes. So this study presented a systematic way to predict the IAC for the bubbly-to-churn flows in large diameter pipes by categorizing bubbles into two groups (group 1: spherical or distorted bubble, group 2: cap bubble). A correlation was developed to predict the group 1 void fraction by using the void fraction for all bubble. The group 1 bubble IAC and bubble diameter were modeled by using the key parameters such as group 1 void fraction and bubble Reynolds number based on the analysis of Hibiki and Ishii (2001, 2002) using one-dimensional bubble number density and interfacial area transport equations. The correlations of IAC and bubble diameter for group 2 cap bubbles were developed by taking into account the characteristics of the representative bubbles among the group 2 bubbles and the comparison between a newly-derived drift velocity correlation for large diameter pipes and the existing drift velocity correlation of Kataoka and Ishii (1987) for large diameter pipes. The predictions from the newly-developed two-group IAC correlation were compared with the collected experimental data in gas-liquid bubbly to churn flow regimes in large diameter pipes and their mean absolute relative deviations were obtained to be 28.1%, 54.4% and 29.6% for group 1, group 2 and all bubbles respectively. (C) 2015 Elsevier Inc. All rights reserved.	[Shen, Xiuzhong] Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan; [Hibiki, Takashi] Purdue Univ, Sch Nucl Engn, W Lafayette, IN 47907 USA	Shen, XZ (reprint author), Kyoto Univ, Inst Res Reactor, Kumatori, Osaka 5900494, Japan.	xzshen@rri.kyoto-u.ac.jp			Ministry of Education, Science, Sport and Culture of Japan [26420870]; Kansai Atomic Society (Kangenkon) of Japan	The research project was supported by Grant-in-Aid for Scientific Research from the Ministry of Education, Science, Sport and Culture of Japan (Grant No.: 26420870) and Grant from Kansai Atomic Society (Kangenkon) of Japan.	Shen XZ, 2005, INT J HEAT MASS TRAN, V48, P211, DOI 10.1016/j.ijheatmasstransfer.2004.06.034; Hibiki T, 2000, NUCL ENG DES, V202, P39, DOI 10.1016/S0029-5493(00)00286-7; Shen XZ, 2012, INT J HEAT FLUID FL, V34, P70, DOI 10.1016/j.ijheatfluidflow.2012.02.004; Hibiki T, 2001, INT J HEAT MASS TRAN, V44, P1869, DOI 10.1016/S0017-9310(00)00232-5; Prasser HM, 2007, NUCL ENG DES, V237, P1608, DOI 10.1016/j.nucengdes.2007.02.024; ISHII M, 1984, NUCL ENG DES, V82, P107, DOI 10.1016/0029-5493(84)90207-3; AKITA K, 1974, IND ENG CHEM PROC DD, V13, P84, DOI 10.1021/i260049a016; Schlegel JP, 2014, INT J HEAT FLUID FL, V47, P42, DOI 10.1016/j.ijheatfluidflow.2014.03.001; Ishii M, 2004, NUCL SCI ENG, V146, P257; Hibiki T, 2001, INT J HEAT MASS TRAN, V44, P3443, DOI 10.1016/S0017-9310(00)00365-3; Shen XZ, 2015, INT J HEAT FLUID FL, V52, P140, DOI 10.1016/j.ijheatfluidflow.2015.01.001; KOCAMUSTAFAOGULLARI G, 1994, NUCL ENG DES, V148, P437, DOI 10.1016/0029-5493(94)90124-4; LOCKHART RW, 1949, CHEM ENG PROG, V45, P39; Brooks CS, 2012, INT J HEAT FLUID FL, V37, P196, DOI 10.1016/j.ijheatfluidflow.2012.04.002; ISHII M, 1979, AICHE J, V25, P843, DOI 10.1002/aic.690250513; Ozar B, 2012, INT J HEAT FLUID FL, V38, P168, DOI 10.1016/j.ijheatfluidflow.2012.08.006; Shen X, 2008, INT J HEAT MASS TRAN, V51, P882, DOI 10.1016/j.ijheatmasstransfer.2006.01.054; Clift R, 1978, BUBBLES DROPS PARTIC; Fu X.Y., 2002, NUCL ENG DES, V219, P143; Hibiki T, 2002, CHEM ENG SCI, V57, P3967, DOI 10.1016/S0009-2509(02)00263-4; Ishii M., 1980, NUREGCR1873; Ishii M., 2010, THERMOFLUID DYNAMICS; Ishii M., 1975, THERMOFLUID DYNAMIC; KATAOKA I, 1987, INT J HEAT MASS TRAN, V30, P1927; KATAOKA I, 1986, INT J MULTIPHAS FLOW, V12, P505, DOI 10.1016/0301-9322(86)90057-1; KOCAMUSTAFAOGULLARI G, 1995, INT J HEAT MASS TRAN, V38, P481, DOI 10.1016/0017-9310(94)00183-V; Kocamustafaogullari G., 1984, NUREGCR4028 ARG NAT; Schlegel JP, 2009, NUCL ENG DES, V239, P2864, DOI 10.1016/j.nucengdes.2009.08.004; Shen X., 2010, JPN J MULTIPHASE FLO, V23, P605; Shen XZ, 2014, INT J MULTIPHAS FLOW, V60, P11, DOI 10.1016/j.ijmultiphaseflow.2013.11.010; Shen X., 2010, P 8 INT C NUCL ENG I; Shen XZ, 2013, INT J HEAT FLUID FL, V44, P312, DOI 10.1016/j.ijheatfluidflow.2013.06.010; Shen X., 2011, JPN J MULTIPHASE FLO, V24, P595; Shen X., 2014, FRONTIERS PROGR MULT, VI, P55; Shen XZ, 2005, INT J MULTIPHAS FLOW, V31, P593, DOI 10.1016/j.ijmultiphaseflow.2005.02.003; Shen XZ, 2013, INT J HEAT MASS TRAN, V67, P843, DOI 10.1016/j.ijheatmasstransfer.2013.08.064; Shen XZ, 2002, NUCL ENG DES, V217, P103, DOI 10.1016/S0029-5493(02)00154-1; Shen XZ, 2006, EXP THERM FLUID SCI, V31, P21, DOI 10.1016/j.expthermflusci.2006.01.007; Shen XZ, 2010, NUCL ENG DES, V240, P3991, DOI 10.1016/j.nucengdes.2010.01.004; Shen XZ, 2008, INT J MULTIPHAS FLOW, V34, P502, DOI 10.1016/j.ijmultiphaseflow.2007.11.006; Smith T.R., 2002, THESIS PURDUE U US; Sun HM, 2014, J NUCL SCI TECHNOL, V51, P267, DOI 10.1080/00223131.2014.863718; Sun XD, 2002, EXP THERM FLUID SCI, V27, P97, DOI 10.1016/S0894-1777(02)00220-0; YU Pingan, 2002, NUCL REACTOR THERMAL	44	1	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0142-727X	1879-2278		INT J HEAT FLUID FL	Int. J. Heat Fluid Flow	AUG	2015	54						107	118		10.1016/j.ijheatfluidflow.2015.05.002		12	Thermodynamics; Engineering, Mechanical; Mechanics	Thermodynamics; Engineering; Mechanics	CO0CM	WOS:000358817700010		
J	Chairaksa-Fujimoto, R; Inoue, Y; Umeda, N; Itoh, S; Nagasaka, T				Chairaksa-Fujimoto, Romchat; Inoue, Yosuke; Umeda, Naoyoshi; Itoh, Satoshi; Nagasaka, Tetsuya			New pyrometallurgical process of EAF dust treatment with CaO addition	INTERNATIONAL JOURNAL OF MINERALS METALLURGY AND MATERIALS			English	Article						electric arc furnace dust; pyrometallurgy; zinc oxide; zinc ferrite; calcium oxide	ELECTRIC-ARC FURNACE; THERMODYNAMIC ANALYSIS; ZINC; REMOVAL; REDUCTION; BEHAVIOR; STEEL; LEAD	The non-carbothermic zinc pyrometallurgical processing of electric arc furnace (EAF) dust was investigated on a laboratory scale. The main objective of this process was to convert highly stable zinc ferrite (ZnFe2O4), which accounts for more than half of total zinc in the EAF dust, into ZnO and Ca2Fe2O5 by CaO addition. The EAF dust was mixed with CaO powder in various ratios, pressed into pellets, and heated in a muffle furnace in air at temperatures ranging from 700 to 1100A degrees C for a predetermined holding time. All ZnFe2O4 was transformed into ZnO and Ca2Fe2O5 at a minimum temperature of 900A degrees C within 1 h when sufficient CaO to achieve a Ca/Fe molar ratio of 1.1 was added. However, at higher temperatures, excess CaO beyond the stoichiometric ratio was required because it was consumed by reactions leading to the formation of compounds other than ZnFe2O4. The evaporation of halides and heavy metals in the EAF dust was also studied. These components could be preferentially volatilized into the gas phase at 1100A degrees C when CaO was added.	[Chairaksa-Fujimoto, Romchat; Itoh, Satoshi; Nagasaka, Tetsuya] Tohoku Univ, Grad Sch Engn, Dept Met, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Inoue, Yosuke] Toho Titanium Co Ltd, Chigasaki, Kanagawa 2538510, Japan; [Umeda, Naoyoshi] Honda Motor Co Ltd, Naka Ku, Hamamatsu, Shizuoka 4338501, Japan	Chairaksa-Fujimoto, R (reprint author), Tohoku Univ, Grad Sch Engn, Dept Met, Aoba Ku, 6-6-02 Aramaki Aza Aoba, Sendai, Miyagi 9808579, Japan.	chairaksaromchat@material.tohoku.ac.jp			ISIJ Innovative Program for Advanced Technology; Iron and Steel Institute of Japan (ISIJ); Ministry of Education, Culture, Sports, Science and Technology (MEXT) [22656171, 25249105]; Global COE Program "Materials Integration International Center of Education and Research, Tohoku University"; Steel Foundation for Environmental Protection Technology	This project was financially supported by the ISIJ Innovative Program for Advanced Technology, the Iron and Steel Institute of Japan (ISIJ) in 2008-2010. It was supported by a Grant-in-Aid for Challenging Exploratory Research (contract No. 22656171) in 2010-2011 and is supported by a Grant-in-Aid for Scientific Research (Basic Research A, contract No. 25249105) for 2013 through 2015 from the Ministry of Education, Culture, Sports, Science and Technology (MEXT). The cooperation of Aichi Steel Corp. is gratefully acknowledged. We also thank the support provided by the Global COE Program "Materials Integration International Center of Education and Research, Tohoku University", Steel Foundation for Environmental Protection Technology and the valuable comments from members of the division of EAF, ISIJ.	Guezennec AG, 2005, POWDER TECHNOL, V157, P2, DOI 10.1016/j.powtec.2005.05.006; Shawabkeh RA, 2010, HYDROMETALLURGY, V104, P61, DOI 10.1016/j.hydromet.2010.04.014; Havlik T, 2006, J HAZARD MATER, V135, P311, DOI 10.1016/j.jhazmat.2005.11.067; Ruiz O, 2007, J HAZARD MATER, V141, P33, DOI 10.1016/j.jhazmat.2006.06.079; Laforest G, 2006, J HAZARD MATER, V135, P156, DOI 10.1016/j.jhazmat.2005.11.037; Kelebek S, 2004, MINER ENG, V17, P285, DOI 10.1016/j.mineng.2003.10.030; Wu CC, 2014, J ENVIRON MANAGE, V143, P208, DOI 10.1016/j.jenvman.2014.04.005; Antrekowitsch J, 2001, JOM-J MIN MET MAT S, V53, P26, DOI 10.1007/s11837-001-0008-9; Bruckard WJ, 2005, INT J MINER PROCESS, V75, P1, DOI 10.1016/j.minpro.2004.04.007; Chairaksa R., 2010, AISTECH IRON STEEL T, P273; Chairaksa R., 2013, 13 CHIN JAP S SCI TE, P215; Gordon R. B., 2003, RESOUR CONSERV RECY, V39, P108; Grabda M, 2011, J HAZARD MATER, V187, P473, DOI 10.1016/j.jhazmat.2011.01.060; Inoue Y., 2010, THESIS TOHOKU U SEND, P42; Itoh S., 2008, ISIJ INT, V48, P1340; Leclerc N., 2003, HYDROMETALLURGY, V70, P176; Lee GS, 2007, MINER ENG, V20, P739, DOI 10.1016/j.mineng.2007.03.001; Ma HW, 2011, RESOUR CONSERV RECY, V56, P134, DOI 10.1016/j.resconrec.2011.08.005; Nagasaka T., 2013, Japanese Patent, Appl., Patent No. [JP5137110, 5137110]; Nakajima K., 2008, ISIJ INT, V48, P1480; Peng C, 2009, ISIJ INT, V49, P1874; Pickles CA, 2009, J HAZARD MATER, V166, P1030, DOI 10.1016/j.jhazmat.2008.11.110; Pickles CA, 2008, J HAZARD MATER, V150, P265, DOI 10.1016/j.jhazmat.2007.04.097; Tsubone A., 2012, IRON STEEL TECHNOL, V9, P184; Umeda N., 2008, THESIS TOHOKU U SEND, P34; Yoo JM, 2005, MATER TRANS, V46, P323, DOI 10.2320/matertrans.46.323; Zabett A, 2008, CALPHAD, V32, P535, DOI 10.1016/j.calphad.2008.05.001	27	1	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1674-4799	1869-103X		INT J MIN MET MATER	Int. J. Miner. Metall. Mater.	AUG	2015	22	8					788	797		10.1007/s12613-015-1135-6		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	CO4WK	WOS:000359161400002		
J	Liu, CS; Yang, SF; Kim, K; Li, JS; Shibata, H; Kitamura, S				Liu, Cheng-song; Yang, Shu-feng; Kim, Kyung-ho; Li, Jing-she; Shibata, Hiroyuki; Kitamura, Shin-ya			Influence of FeO and sulfur on solid state reaction between MnO-SiO2-FeO oxides and an Fe-Mn-Si solid alloy during heat treatment at 1473 K	INTERNATIONAL JOURNAL OF MINERALS METALLURGY AND MATERIALS			English	Article						refining; solid state reactions; heat treatment; inclusions; iron oxides; sulfur	STAINLESS-STEEL; INCLUSIONS; IRON	To clarify the influence of FeO and sulfur on solid state reaction between an Fe-Mn-Si alloy and MnO-SiO2-FeO oxides under the restricted oxygen diffusion flux, two diffusion couples with different sulfur contents in the oxides were produced and investigated after heat treatment at 1473 K. The experimental results were also compared with previous work in which the oxides contained higher FeO. It was found that although the FeO content in the oxides decreased from 3wt% to 1wt% which was lower than the content corresponding to the equilibrium with molten steel at 1873 K, excess oxygen still diffused from the oxides to solid steel during heat treatment at 1473 K and formed oxide particles. In addition, increasing the sulfur content in the oxides was observed to suppress the diffusion of oxygen between the alloy and the oxides.	[Liu, Cheng-song; Yang, Shu-feng; Li, Jing-she] Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China; [Kim, Kyung-ho; Shibata, Hiroyuki; Kitamura, Shin-ya] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Yang, SF (reprint author), Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China.	yangshufeng@ustb.edu.cn			National Natural Science Foundation of China [51374021, 51304016]; Fundamental Research Funds for the Central Universities of China [FRF-TP-14-114A2]; State Key Laboratory of Advanced Metallurgy [41603014]	The authors would like to acknowledge the National Natural Science Foundation of China (Nos. 51374021 and 51304016) and the Fundamental Research Funds for the Central Universities of China (No. FRF-TP-14-114A2) and Research Funds of State Key Laboratory of Advanced Metallurgy (No. 41603014).	Choi W, 2011, ISIJ INT, V51, P1951; Shibata H, 2011, ISIJ INT, V51, P1944, DOI 10.2355/isijinternational.51.1944; Kim KH, 2014, ISIJ INT, V54, P2144, DOI 10.2355/isijinternational.54.2144; Park JH, 2005, METALL MATER TRANS B, V36, P495, DOI 10.1007/s11663-005-0041-0; Shibata H, 2010, IRONMAK STEELMAK, V37, P522, DOI 10.1179/030192310X12700328925903; BANYA S, 1993, ISIJ INT, V33, P2, DOI 10.2355/isijinternational.33.2; Ban-ya S., 1996, PHYS CHEM METALS, P198; Hino M., 2011, THERMODYNAMIC DATA S, P167; Kim K. H., 2012, P 5 INT C SCI TECHN, P772; Kim KS, 2014, J INEQUAL APPL, DOI 10.1186/1029-242X-2014-2; Lee C, 2011, ISIJ INT, V51, P2036; Liu C. S., 2015, METALL MAT T B; Ono H, 2010, ISIJ INT, V50, P1955, DOI 10.2355/isijinternational.50.1955; Yang SF, 2011, INT J MIN MET MATER, V18, P18, DOI 10.1007/s12613-011-0394-0; Yin WJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3647756; Yuan FM, 2006, J UNIV SCI TECHNOL B, V13, P486, DOI 10.1016/S1005-8850(06)60099-6	16	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1674-4799	1869-103X		INT J MIN MET MATER	Int. J. Miner. Metall. Mater.	AUG	2015	22	8					811	819		10.1007/s12613-015-1138-3		9	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	Materials Science; Metallurgy & Metallurgical Engineering; Mining & Mineral Processing	CO4WK	WOS:000359161400005		
J	Macedo, CFB; Crispino, LCB; Cardoso, V; Okawa, H; Pani, P				Macedo, Caio F. B.; Crispino, Luis C. B.; Cardoso, Vitor; Okawa, Hirotada; Pani, Paolo			Evidence for event horizons: Long-lived modes in ultracompact objects	INTERNATIONAL JOURNAL OF MODERN PHYSICS D			English	Article						Event horizons; long-lived modes; ultracompact stars; gravastars	GRAVITATIONAL-WAVE DETECTORS; STARS	Gravitational compact astrophysical objects are excellent laboratories to test the strong field regime of theories of gravity. Among these compact objects, lies the ultracompact class: stellar structures that possess a light ring (circular null geodesic). Such ultracompact stars were presented in literature in the earlier solutions of general relativity, and some are claimed to be good candidates to the supermassive objects present at the center of galaxies. In this paper, we present evidences for the claim that compact objects with a light ring should be black holes, based on the existence of long-lived modes obtained through a first-order perturbation theory. These first-order long-lived modes can source nonlinear terms which could turn the star unstable. We show, in particular, a comparison between modes computed through an exact direct integration and through the WKB approximation. Moreover, we present the time evolution of wavepackets for different field configurations. We conjecture some possible outcomes of the nonlinear instability. The discussion presented in this work complements our previous paper [Phys. Rev. D 90 (2014) 044069].	[Macedo, Caio F. B.; Crispino, Luis C. B.] Fed Univ Para, Fac Fis, BR-66075110 Belem, Para, Brazil; [Cardoso, Vitor; Okawa, Hirotada; Pani, Paolo] Univ Nova Lisboa, Inst Super Tecn, Dept Fis, CENTRA, P-1049 Lisbon, Portugal; [Cardoso, Vitor] Perimeter Inst Theoret Phys, Waterloo, ON N2J 2W9, Canada; [Cardoso, Vitor] Univ Mississippi, Dept Phys & Astron, University, MS 38677 USA; [Okawa, Hirotada] Kyoto Univ, Yukawa Inst Theoret Phys, Kyoto 6068502, Japan; [Okawa, Hirotada] Waseda Univ, Adv Res Inst Sci & Engn, Shinjuku Ku, Tokyo 1698555, Japan; [Pani, Paolo] Univ Roma La Sapienza, Dept Fis, I-00185 Rome, Italy	Macedo, CFB (reprint author), Fed Univ Para, Fac Fis, BR-66075110 Belem, Para, Brazil.	caiomacedo@ufpa.com; crispino@ufpa.br; vitor.cardoso@ist.utl.pt; h.okawa@aoni.waseda.jp; paolo.pani@roma1.infn.it	Pani, Paolo/G-7412-2012; Cardoso, Vitor/K-1877-2015	Pani, Paolo/0000-0003-4443-1761; Cardoso, Vitor/0000-0003-0553-0433	European Union's FP7 ERC Starting Grant "The dynamics of black holes: testing the limits of Einstein's theory" Grant [DyBHo-256667]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para (FAPESPA), from Brazil; NRHEP [295189]; FCT-Portugal [IF/00293/2013, CERN/FP/123593/2011]; European Community through the Intra-European Marie Curie Contract [AstroGRAphy-2013-623439]	The authors acknowledge financial support provided under the European Union's FP7 ERC Starting Grant "The dynamics of black holes: testing the limits of Einstein's theory" Grant Agreement No. DyBHo-256667. The authors would also like to thank Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao Amazonia de Amparo a Estudos e Pesquisas do Para (FAPESPA), from Brazil, for partial financial support. This work was also supported by the NRHEP 295189 FP7-PEOPLE-2011-IRSES Grant and by FCT-Portugal through projects IF/00293/2013 and CERN/FP/123593/2011, and by the European Community through the Intra-European Marie Curie Contract No. AstroGRAphy-2013-623439. Computations were performed on the "Baltasar Sete-Sois" cluster at IST.	Cardoso V, 2014, PHYS REV D, V90, DOI 10.1103/PhysRevD.90.044069; Guzman FS, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.021501; Bizon P, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.031102; Berti E, 2006, PHYS REV D, V73, DOI 10.1103/PhysRevD.73.064030; Berti E, 2006, INT J MOD PHYS D, V15, P2209, DOI 10.1142/S0218271806009637; Dias OJC, 2012, CLASSICAL QUANT GRAV, V29, DOI 10.1088/0264-9381/29/23/235019; Berti E, 2009, CLASSICAL QUANT GRAV, V26, DOI 10.1088/0264-9381/26/16/163001; Barausse E, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.104059; Herdeiro CAR, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.221101; CHANDRASEKHAR S, 1953, ASTROPHYS J, V118, P116, DOI 10.1086/145732; Cardoso V, 2009, PHYS REV D, V79, DOI 10.1103/PhysRevD.79.064016; Balasubramanian V., ARXIV14036471HEPTH; Barausse E., ARXIV14047140ASTROPH; Berti E., ARXIV150107274GRQC; Buchel A, 2013, PHYS REV D, V87, DOI 10.1103/PhysRevD.87.123006; Cardoso V., ARXIV150505509GRQC; COMINS N, 1978, P ROY SOC LOND A MAT, V364, P211, DOI 10.1098/rspa.1978.0196; Dolan SR, 2010, PHYS REV D, V82, DOI 10.1103/PhysRevD.82.084037; Dolan SR, 2012, PHYS REV D, V85, DOI 10.1103/PhysRevD.85.044031; Dyson F. W., 1892, PHILOS T ROY SOC LON, V184, P43; Dyson F. W., 1893, PHIL T R SOC LOND A, V184A, P1041, DOI 10.1098/rsta.1893.0020; Gair JR, 2013, LIVING REV RELATIV, V16; GURVITZ SA, 1988, PHYS REV A, V38, P1747, DOI 10.1103/PhysRevA.38.1747; Keir J., ARXIV14047036GRQC; KOJIMA Y, 1995, P R SOC-MATH PHYS SC, V451, P341, DOI 10.1098/rspa.1995.0129; KOKKOTAS KD, 1994, MON NOT R ASTRON SOC, V268, P1015; Kokkotas Kostas D., 1999, LIVING REV RELATIV, V2, P1999, DOI 10.12942/lrr-1999-2; Lehner L, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.101102; Lu RS, 2014, ASTROPHYS J, V788, DOI 10.1088/0004-637X/788/2/120; Macedo CFB, 2013, ASTROPHYS J, V774, DOI 10.1088/0004-637X/774/1/48; Mazur P. O., ARXIVGRQC0109035; Okawa H., ARXIV150405203GRQC; Okawa H, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.104032; Oliveira LA, 2014, PHYS REV D, V89, DOI 10.1103/PhysRevD.89.124008; Pani P, 2013, INT J MOD PHYS A, V28, DOI 10.1142/S0217751X13400186; Richartz M, 2013, PHYS REV D, V88, DOI 10.1103/PhysRevD.88.044008; Yunes N, 2013, LIVING REV RELATIV, V16, P1	37	0	0	WORLD SCIENTIFIC PUBL CO PTE LTD	SINGAPORE	5 TOH TUCK LINK, SINGAPORE 596224, SINGAPORE	0218-2718	1793-6594		INT J MOD PHYS D	Int. J. Mod. Phys. D	AUG	2015	24	9			SI				1542023	10.1142/S0218271815420237		9	Astronomy & Astrophysics	Astronomy & Astrophysics	CN9TX	WOS:000358793200024		
J	Noda, S; Onoda, N; Morisaki, T; Kashiwagi, S; Takashima, T; Hirakawa, K				Noda, Satoru; Onoda, Naoyoshi; Morisaki, Tamami; Kashiwagi, Shinichiro; Takashima, Tsutomu; Hirakawa, Kosei			The significance and the predictive factors of microscopic lymph node metastasis in patients with clinically node negative papillary thyroid cancer: A retrospective cohort study	INTERNATIONAL JOURNAL OF SURGERY			English	Article						Thyroid cancer; Microscopic node metastasis; Predictive factor	RADICAL-NECK-DISSECTION; BRAF MUTATIONS; FOLLOW-UP; PROGNOSTIC-FACTORS; CARCINOMA; LEVEL; ULTRASONOGRAPHY; CLASSIFICATION; PREVALENCE; MANAGEMENT	Background: The management of pathological lateral node involvement (pN1b) from papillary thyroid cancer (PTC) are controvertial. Methods: A consecutive series of 246 patients, diagnosed with clinically node negative (cN0) PTC who had undergone surgery with prophyractic lateral node dissection, and without postoperative radioactive iodine administration from 2001 to 11, were reviewed to clarify the significance of pN1b. Results: Eighty-five (35%) patients had pN1b disease. One-half and 30% had pN1b in younger (age less than 45) and older patients (age 45 or over), respectively. Tumor size (>= 21 mm) could predict pN1b disease in older patients. Patients with pN1b disease recurred more frequently (9 cases, 10.6%) than those without (4 cases, 2.4%), and 2 cases with pN1b died of the disease. Conclusions: pN1b disease was commonly found in patients with PTC even when they were diagnosed clinically as node negative. pN1b disease with prognostic meaning was often found in the older patients with larger PTC indicating the necessity for adjuvant treatments. (C) 2015 IJS Publishing Group Limited. Published by Elsevier Ltd. All rights reserved.	[Noda, Satoru; Onoda, Naoyoshi; Morisaki, Tamami; Kashiwagi, Shinichiro; Takashima, Tsutomu; Hirakawa, Kosei] Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, Osaka 5458585, Japan	Noda, S (reprint author), Osaka City Univ, Grad Sch Med, Dept Surg Oncol, Abeno Ku, 1-4-3 Asahi Machi, Osaka 5458585, Japan.	s-noda@med.osaka-cu.ac.jp			JSPS Kakenhi [25461992]	This study was supported in part by Grant-in-aid for Scientific Research (C) (JSPS Kakenhi #25461992).	Abboud Bassam, 2011, J Med Liban, V59, P206; Bonnet S, 2009, J CLIN ENDOCR METAB, V94, P1162, DOI 10.1210/jc.2008-1931; Cranshaw IM, 2008, SURG ONCOL, V17, P253, DOI 10.1016/j.suronc.2008.04.005; Lima J, 2004, J CLIN ENDOCR METAB, V89, P4267, DOI 10.1210/jc.2003-032224; Sato N, 1998, J SURG ONCOL, V69, P151, DOI 10.1002/(SICI)1096-9098(199811)69:3<151::AID-JSO6>3.0.CO;2-V; Noguchi S, 1998, ARCH SURG-CHICAGO, V133, P276, DOI 10.1001/archsurg.133.3.276; Tallini G, 1998, CLIN CANCER RES, V4, P287; Roh JL, 2008, ANN SURG ONCOL, V15, P1177, DOI 10.1245/s10434-008-9813-5; ANTONELLI A, 1995, THYROID, V5, P25, DOI 10.1089/thy.1995.5.25; Lundgren CI, 2006, CANCER, V106, P524, DOI 10.1002/cncr.21653; Mirallie E, 1999, EUR J CANCER, V35, P420; Soares P, 1998, J PATHOL, V185, P71; Wada N, 2008, EJSO-EUR J SURG ONC, V34, P202, DOI 10.1016/j.ejso.2007.10.001; Sugitani I, 2004, SURGERY, V135, P139, DOI 10.1016/S0039-6060(03)00384-2; Nikiforova MN, 2004, CANCER LETT, V209, P1, DOI 10.1016/j.canlet.2003.12.004; SCHEUMANN GFW, 1994, WORLD J SURG, V18, P559; Pacini F, 2006, EUR J ENDOCRINOL, V154, P787, DOI 10.1530/eje.1.02158; Kutler DI, 2012, HEAD NECK-J SCI SPEC, V34, P260, DOI 10.1002/hed.21728; Antonelli A, 2003, THYROID, V13, P479, DOI 10.1089/105072503322021142; Trovisco V, 2005, VIRCHOWS ARCH, V446, P589, DOI 10.1007/s00428-005-1236-0; Blanchard C, 2013, BRIT J SURG, V100, P1312, DOI 10.1002/bjs.9210; Caron NR, 2006, WORLD J SURG, V30, P833, DOI 10.1007/s00268-005-0358-5; Dean D S, 2000, Cancer Control, V7, P229; Gradoni Paolo, 2011, Acta Biomed, V82, P14; Ito Y, 2009, ENDOCR J, V56, P177; Jiang LH, 2014, INT J ENDOCRINOL, V2014, DOI [DOI 10.1155/2014/385787, 10.1155/2014/385787]; Khafif A, 2013, HEAD NECK-J SCI SPEC, V35, P605, DOI 10.1002/hed.21952; Kupferman ME, 2008, HEAD NECK-J SCI SPEC, V30, P1469, DOI 10.1002/hed.20904; Moo TAS, 2011, SEMIN NUCL MED, V41, P84, DOI 10.1053/j.semnuclmed.2010.10.003; Nakamura M, 2014, MOL CLIN ONCOL, V2, P226; Onoda N, 2013, SURG TODAY, V43, P178, DOI 10.1007/s00595-012-0228-3; Sobin L, UICC TNM CLASSIFICAT	32	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1743-9191	1743-9159		INT J SURG	Int. J. Surg.	AUG	2015	20						52	57		10.1016/j.ijsu.2015.06.023		6	Surgery	Surgery	CO6YX	WOS:000359305200010		
J	Yamada, S; Fukutani, K; Yamaguchi, K; Funahashi, H; Ebata, K; Uematsu, H; Tanoue, S				Yamada, S.; Fukutani, K.; Yamaguchi, K.; Funahashi, H.; Ebata, K.; Uematsu, H.; Tanoue, S.			Dispersive Mixing Performance Evaluation of Special Rotor Segments in an Intermeshing Co-Rotating Twin-Screw Extruder by Using Weighted Probability Distributions	INTERNATIONAL POLYMER PROCESSING			English	Article							NUMERICAL-SIMULATION; KNEADING DISCS; FEM ANALYSIS; WALL SLIP; FLOW; ELEMENTS; DESIGN	An intermeshing co-rotating twin-screw extruder is widely used for producing polymer composites. In order to satisfy properties of the composites, it is important to understand mixing performance of segments. In this study, we discussed mixing performance of special rotor segments commercially named VCMT (various clearance mixing technology) by using a numerical analysis method. The several tip clearances of VCMT work for achievement of both self-cleaning and effective mixing. We adopted a particle tracking method to obtain the following two evaluation indices; 1) residence time for the evaluation of its uniformity and 2) maximum 1st principal stress for the evaluation of dispersive mixing. And we evaluated mixing performance of VCMT by using probability distributions of each index. Moreover, we proposed weighted probability distributions as theoretically better evaluation. The probability distributions of VCMT were compared with those of two kinds of kneading disk segments (KDs). From the comparison, it was found that the probability of VCMT in large 1st principal stress region is higher than those of KDs. As a conclusion, VCMT has better mixing performance than KDs for the geometries and operating conditions that were investigated.	[Yamada, S.; Fukutani, K.; Yamaguchi, K.; Funahashi, H.] Kobe Steel Ltd, Tech Dev Grp, Mech Engn Res Lab, Kobe, Hyogo 6512271, Japan; [Ebata, K.; Uematsu, H.; Tanoue, S.] Univ Fukui, Grad Sch Engn, Fukui 910, Japan	Yamada, S (reprint author), Kobe Steel Ltd, Tech Dev Grp, Mech Engn Res Lab, Nishi Ku, 1-5-5 Takatsukadai, Kobe, Hyogo 6512271, Japan.	yamada.sayaka@kobelco.com					Bravo VL, 2004, POLYM ENG SCI, V44, P779, DOI 10.1002/pen.20070; Kalyon DM, 2007, INT POLYM PROC, V22, P293; Jonoobi M, 2010, COMPOS SCI TECHNOL, V70, P1742, DOI 10.1016/j.compscitech.2010.07.005; LAWAL A, 1995, POLYM ENG SCI, V35, P1325, DOI 10.1002/pen.760351702; Ishikawa T, 2000, POLYM ENG SCI, V40, P357, DOI 10.1002/pen.11169; Yao CH, 1998, POLYM ENG SCI, V38, P936, DOI 10.1002/pen.10261; Zhang XM, 2009, POLYM ENG SCI, V49, P1772, DOI 10.1002/pen.21404; Cheng HF, 1998, POLYM ENG SCI, V38, P926, DOI 10.1002/pen.10260; Funatsu K, 2002, POLYM ENG SCI, V42, P707, DOI 10.1002/pen.10983; Avalosse T, 2000, INT POLYM PROC, V15, P117; Avalosse T, 2002, J REINF PLAST COMP, V21, P419, DOI 10.1106/073168402026442; Inoue K., 2004, SEIKEI KAKOU, V16, P510; Kohlgruber K., 2008, CO ROTATING TWIN SCR; Lawal A, 1997, INT J HEAT MASS TRAN, V40, P3883, DOI 10.1016/S0017-9310(97)00016-1; LAWAL A, 1995, J APPL POLYM SCI, V58, P1501, DOI 10.1002/app.1995.070580912; LAWAL A, 1993, POLYM ENG SCI, V33, P140, DOI 10.1002/pen.760330304; Malik M, 2014, INT POLYM PROC, V29, P51, DOI 10.3139/217.2802; Nakayama Y., 2010, CHEM ENG SCI, V66, P103, DOI [10.1016/j.ces2010.10.022, DOI 10.1016/J.CES2010.10.022]; Wei J, 2013, INT J PRECIS ENG MAN, V14, P451, DOI 10.1007/s12541-013-0061-7	19	0	0	CARL HANSER VERLAG	MUNICH	KOLBERGERSTRASSE 22, POSTFACH 86 04 20, D-81679 MUNICH, GERMANY	0930-777X			INT POLYM PROC	Int. Polym. Process.	AUG	2015	30	4					451	459		10.3139/217.2972		9	Engineering, Chemical; Polymer Science	Engineering; Polymer Science	CO8UX	WOS:000359448700003		
J	Abe, T				Abe, Toshihiro			On Families of Distributions with Shape Parameters Discussion	INTERNATIONAL STATISTICAL REVIEW			English	Editorial Material									Tokyo Univ Sci, Tokyo 162, Japan	Abe, T (reprint author), Tokyo Univ Sci, Tokyo 162, Japan.	abe@ms.kagu.tus.ac.jp					Abramowitz M., 1972, HDB MATH FUNCTIONS F; Jones MC, 2014, STAT SINICA, V24, P749, DOI 10.5705/ss.2011.304	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0306-7734	1751-5823		INT STAT REV	Int. Stat. Rev.	AUG	2015	83	2					193	197		10.1111/insr.12076		5	Statistics & Probability	Mathematics	CN9SM	WOS:000358789300002		
J	Uemura, T				Uemura, Takeshi			Understanding Chinese Foreign Relations: A Cultural Constructivist Approach	INTERNATIONAL STUDIES PERSPECTIVES			English	Review						culture; Constructivism; strategic culture; China; guanxi	STRATEGIC CULTURE; INTERNATIONAL-RELATIONS; SECURITY DILEMMA; UNITED-STATES; GUANXI; POLITICS; THINKING; JAPAN	The ideational definition of culture has hindered a meaningful debate of the role that culture plays in the discipline of International Relations. Focusing on the behavior side of culture instead, this paper proposes the Cultural Constructivist approach that takes account of both the cultural and the social in interstate relations. Academic puzzles in contemporary China's relations with Japan, the former Soviet Union, and the United States are better explained by taking into account China's cultural behavior pattern and its role in the country's identity construction of these other states. Cultural Constructivism is a falsifiable theory that enables us to see under which circumstances culture intervenes in a country's foreign policy making. A cultural behavior pattern has complicated the PRC's relations with Japan and the former Soviet Union, but material constraints and cultural differences prevented its ascendance to the main stage of Sino-US relations.	Waseda Univ, Tokyo, Japan	Uemura, T (reprint author), Waseda Univ, Tokyo, Japan.						Aleksandrov I, 1974, CURRENT DIGEST SOVIE, V28, p[4, 124]; Ando Masashi, 1994, GENTEN CHUGOKU GENDA, V8; KIRKBRIDE PS, 1991, ORGAN STUD, V12, P365, DOI 10.1177/017084069101200302; Lo MCM, 2003, POLIT SOC, V31, P131, DOI 10.1177/0032329202250165; Mitzen J, 2006, EUR J INT RELAT, V12, P341, DOI 10.1177/1354066106067346; Christensen TJ, 1999, INT SECURITY, V23, P49; SEWELL WH, 1992, AM J SOCIOL, V98, P1; WENDT A, 1992, INT ORGAN, V46, P391; Emirbayer M, 1997, AM J SOCIOL, V103, P281, DOI 10.1086/231209; Gray CS, 1999, REV INT STUD, V25, P49, DOI 10.1017/S0260210599000492; FEARON JD, 1994, AM POLIT SCI REV, V88, P577, DOI 10.2307/2944796; Yang MMH, 2002, CHINA QUART, P459; Anthony Lake, 1993, DEP STATE DISPATCH; Barnett Doak A, 1982, US ARMS SALES CHINA; Bates RH, 1998, POLIT SOC, V26, P603, DOI 10.1177/0032329298026004007; Bousquet A, 2011, CAMB REV INT AFF, V24, P43, DOI 10.1080/09557571.2011.558054; Brzezinski Zbigniew, 1983, POWER PRINCIPLE MEMO; Burr William, 1999, KISSINGER TRANSCRIPT; Buzan B, 2010, EUR J INT RELAT, V16, P315, DOI 10.1177/1354066109350064; Chang Gordon H, 1990, FRIENDS ENEMIES US C; Clinton William Jefferson, 1997, 2 INAUGURAL ADDRESS, P14; Curtin Sean, 2005, JAPAN FOCUS; Dittmer L., 1992, SINO SOVIET NORMALIZ; Dudden A., 2008, TROUBLED APOLOGIES J; Dunning JH, 2007, WORLD ECON, V30, P329, DOI 10.1111/j.1467-9701.2007.00885.x; Fewsmith Joseph, 1997, POLITICS CHINA, V2nd; Foot Rosemary, 2001, REEXAMINING COLD WAR; FRIEDBERG AL, 1983, COMP STRATEGY, V4, P113, DOI 10.1080/01495938308402660; Garver John W, 1997, SINO AMERICAN ALLIAN; Goh Evelyn, 2005, CONSTRUCTING US RAPP; Gray Colin S, 1999, MODERN STRATEGY; GRAY CS, 1981, INT SECURITY, V6, P21, DOI 10.2307/2538645; Gries Peter, 2005, CHINA QUART      DEC, V184, P831; Haig Alexander M, 1984, CAVEAT REALISM REAGA; He Yinan, 2009, SEARCH RECONCILIATIO; Hilali A. Z, 2001, CENTRAL ASIAN SURVEY, V20, P323, DOI 10.1080/02634930120095349; Hofstede Geert, 2004, INT COMMUNICATION DI; Huang Dahui, 2006, RIBEN DUIHUA ZHENGCE; HWANG KK, 1987, AM J SOCIOL, V92, P944, DOI 10.1086/228588; Hyland William, 1979, ASIAN SECURITY 1980S; Jacobsen Carl Gustav, 1989, SECUR DIOLOGUE, V20, P37, DOI 10.1177/096701068902000103; Jiang Lifeng, 2004, RIBEN XUEKAN, V6, P6; Johnston Alastair I, 1995, CULTURAL REALISM; Johnston AI, 1999, REV INT STUD, V25, P519, DOI 10.1017/S0260210599005197; Kazankai, 1998, NITCHU KANKEI KIHON; Kissinger Henry A, 1979, WHITE HOUSE YEARS; Klein Bradley, 1994, STRATEGIC STUDIES WO; Lampton David, 2001, SAME BED DIFFERENT D; Lampton DM, 1997, ASIAN SURV, V37, P1099, DOI 10.1525/as.1997.37.12.01p0300n; LEVINE SI, 1992, ANN AM ACAD POLIT SS, V519, P26, DOI 10.1177/0002716292519001003; Li Danhui, 2006, SHEHUI KEXUE, V6, P132; Liu Ta Jen, 1978, HIST SINO AM DIPLOMA; Lock E, 2010, REV INT STUD, V36, P685, DOI 10.1017/S0260210510000276; LORD C, 1985, COMP STRATEGY, V5, P269, DOI 10.1080/01495938508402693; Luo Y., 2000, GUANXI BUSINESS; Luthi LM, 2008, PRINC STUD INT HIST, P1; Mancall Mark, 1984, CHINA CTR; Mao Zedong, 1999, SELECTED WORKS M ZED, V6; Medvedev Roy, 1986, CHINA SUPERPOWERS; Nie Rongzhen, 1984, NIE RONGZHEN HUIYILU; Nisbett Richard E., 2003, GEOGRAPHY THOUGHT AS; Niu Jun, 2008, SOCIAL SCI CHINA, V29, P54; Nixon R., 1978, RN MEMOIRS R NIXON; Ogata Sadako, 1992, SENGO NITCHU BEICHU; Okabe Tatsumi, 2002, CHUGOKU NO TAIGAI SE; Okada Minoru, 2008, NICHU KANKEI TO ODA; OKSENBERG M, 1982, FOREIGN AFF, V61, P175, DOI 10.2307/20041357; Qin Yaqing, 2009, SOCIAL SCI CHINA, V30, P5; Qing Simei, 2007, ALLIES ENEMIES VISIO; Rice Edward E, 1972, MAOS WAY; Roger Benjamin, 1985, DEMOCRATIC STATE; Rose Caroline, 1998, INTERPRETING HIST SI; Ross Robert S, 2002, GOLDEN AGES US CHINA; Sapir Edward, 1994, PSYCHOL CULTURE; Schultz Kenneth, 2001, DEMOCRACY COERCIVE D; Shen ZH, 2010, COLD WAR HIST, V10, P513, DOI 10.1080/14682740903167978; Shen Zhihua, 2004, SHIXUE YUEKAN, V8, P57; Shengfa Zhang, 1999, DONGOU ZHONGYA YANJI, V5, P32; Shills E. A., 1904, METHODOLOGY SOCIAL S; Shinohara Hiroshi, 1971, CHUO KORAN, P138; Soeya Yoshihide, 2005, NIHON NO MIDORU PAWA; Soeya Yoshihide, 1995, NIHON GAIKOU TO CHUG; Suganami Hidemi, 1989, DOMESTIC ANALOGY WOR; Sun L-K., 1991, AUSTR J CHINESE AFFA, V26, P1; Sun Zexue, 2004, XINHUA WENZHAI, P18; Takeuchi Yoshimi, 1981, TAKEUCHI YOSHIMI ZEN, V11; Terhalle Maximilian, 2011, EUROPEAN J INT RELAT, V48, P165; Tyler Patrick, 1999, GRET WALL 6 PRESIDEN; Usami Shigeru, 1982, CHUGOKU SORAN 1982 N; Waldron Arthur, 1994, DIPLOMACY CRUCIAL DE; Wan Ming, 2006, SINO JAPANESE RELATI; Wang Taiping, 1999, ZHONGHUA RENMIN GONG, V3; Weldes Jutta, 1996, EUROPEAN J INT RELAT, V2, P275, DOI DOI 10.1177/1354066196002003001; Wendt Alexander, 1999, SOCIAL THEORY INT PO; Westad Odd Arne, 1998, BROTHERS ARMS RISE F; Wishnick Elizabeth, 2001, MENDING FENCES; Wong YH, 2007, TOTAL QUAL MANAG BUS, V18, P875, DOI 10.1080/14783360701350607; Wu Lengxi, 1999, SHINIAN LUNZHAN 1956; Yang KS, 2010, DIPLOMATIC HIST, V34, P395; Yang Kuisong, 2001, LISHI YANJIU, V6, P103; Yang Y. Y., 2009, SOCIAL SCI CHINA, V30, P49; Young Kenneth T, 1967, DIPLOMACY POWER WASH; Young Kenneth T, 1968, NEGOTIATING CHINESE; Zhang Peisen, 2000, ZHANG WENTIAN NIANPU; Zhou Ji'nian, 1991, RIBENREN XINMU ZHONG	105	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1528-3577	1528-3585		INT STUD PERSPECT	Int. Stud. Perspect.	AUG	2015	16	3					345	365		10.1111/insp.12038		21	International Relations	International Relations	CO0SX	WOS:000358864100008		
J	Akaki, Y; Sugimoto, K; Nakamura, S; Yamaguchi, T; Yoshino, K				Akaki, Yoji; Sugimoto, Kanta; Nakamura, Shigeyuki; Yamaguchi, Toshiyuki; Yoshino, Kenji			Characterization of CuInS2 thin films prepared from materials grown by using the mechanochemical method and their photovoltaic applications	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							VACUUM EVAPORATION METHOD; SOLAR-CELLS; OPTICAL-PROPERTIES; CRYSTALS	Cu-In-S thin films were deposited on glass substrates using single-source thermal evaporation with ternary compounds as source materials. Polycrystalline CuInS2 powder grown using the mechanochemical method was employed as the source material. After deposition, the films were annealed in H2S gas at different temperatures from 250 to 500 degrees C for 60 min. X-ray diffraction patterns indicated that single-phase CuInS2 was formed when annealed above 400 degrees C. The grain size of the crystals in thin films was approximately 0.2 to 2.0 mu m. The best Al/ZnO:Al/ZnO/CdS/CuInS2/Mo solar cell had an open-circuit voltage of 360 mV, a short-circuit current density of 18.6mA/cm(2), and a fill factor of 35.5%, resulting in 2.38% efficiency. (C) 2015 The Japan Society of Applied Physics	[Akaki, Yoji; Sugimoto, Kanta] Miyakonojo Coll, Natl Inst Technol, Miyakonojo, Miyazaki 8858567, Japan; [Nakamura, Shigeyuki] Tsuyama Coll, Natl Inst Technol, Tsuyama, Okayama 7088509, Japan; [Yamaguchi, Toshiyuki] Wakayama Coll, Natl Inst Technol, Gobo, Wakayama 6440023, Japan; [Yoshino, Kenji] Miyazaki Univ, Miyazaki 8892192, Japan	Akaki, Y (reprint author), Miyakonojo Coll, Natl Inst Technol, Miyakonojo, Miyazaki 8858567, Japan.	akaki@cc.miyakonojo-nct.ac.jp					Abaab M, 1999, SOL ENERG MAT SOL C, V59, P299, DOI 10.1016/S0927-0248(99)00043-4; Akaki Y, 2008, J PHYS CONF SER, V100, DOI 10.1088/1742-6596/100/8/082022; Akaki Y, 2002, J VAC SCI TECHNOL A, V20, P1486, DOI 10.1116/1.1488944; Akaki Y., 2011, 21 INT PHOT SCI ENG; Akaki Y, 2006, PHYS STATUS SOLIDI C, V3, P2597, DOI 10.1002/pssc.200669626; Klenk R, 2005, THIN SOLID FILMS, V480, P509, DOI 10.1016/j.tsf.2004.11.042; Braunger D, 1996, SOL ENERG MAT SOL C, V40, P97, DOI 10.1016/0927-0248(95)00069-0; Siemer K, 2001, SOL ENERG MAT SOL C, V67, P159, DOI 10.1016/S0927-0248(00)00276-2; Akaki Y, 2003, J PHYS CHEM SOLIDS, V64, P1863, DOI 10.1016/S0022-3697(03)00249-X; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Seeger S, 2009, THIN SOLID FILMS, V517, P3143, DOI 10.1016/j.tsf.2008.11.120; Wada T, 2003, THIN SOLID FILMS, V431, P11, DOI 10.1016/S0040-6090(03)00231-1; KAZMERSKI LL, 1975, J APPL PHYS, V46, P4865, DOI 10.1063/1.321521; Ard MB, 2000, THIN SOLID FILMS, V361, P9; HWANG HL, 1980, THIN SOLID FILMS, V67, P83, DOI 10.1016/0040-6090(80)90291-6; HWANG HL, 1981, J CRYST GROWTH, V55, P116, DOI 10.1016/0022-0248(81)90278-5; Klaer J, 1998, SEMICOND SCI TECH, V13, P1456, DOI 10.1088/0268-1242/13/12/022; Komaki H, 2002, J CRYST GROWTH, V236, P253, DOI 10.1016/S0022-0248(01)02133-9; Metzner H, 1996, APPL PHYS LETT, V69, P1900, DOI 10.1063/1.117615; MIYAKE H, 1993, JPN J APPL PHYS 1, V32, P156; Rabeh M. B., 2007, THIN SOLID FILMS, V515, P5943, DOI 10.1016/j.tsf.2006.12.081; Scheer R, 1996, SOL ENERG MAT SOL C, V41-2, P261, DOI 10.1016/0927-0248(95)00106-9; SHAY JL, 1972, PHYS REV B, V5, P5003, DOI 10.1103/PhysRevB.5.5003; Sugimoto K, 2013, PHYS STATUS SOLIDI C, V10, P1019, DOI 10.1002/pssc.201200878; SUN C, 1980, JPN J APPL PHYS, V19, P81; Yamaguchi T, 2013, PHYS STATUS SOLIDI C, V10, P1071, DOI 10.1002/pssc.201200810; Zhao Y, 2013, MAT SCI SEMICON PROC, V16, P1472, DOI 10.1016/j.mssp.2013.03.015	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC19	10.7567/JJAP.54.08KC19		4	Physics, Applied	Physics	CN8BU	WOS:000358662900044		
J	Al Husna, H; Ota, Y; Minemoto, T; Nishioka, K				Al Husna, Husyira; Ota, Yasuyuki; Minemoto, Takashi; Nishioka, Kensuke			Field test analysis of concentrator photovoltaic system focusing on average photon energy and temperature	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							JUNCTION SOLAR-CELLS; SHAPED FRESNEL LENSES; OUTDOOR PERFORMANCE; MODULES; EFFICIENCY; MODEL; IRRADIANCE; PARAMETERS; SPECTRUM; IMPACT	The concentrator photovoltaic (CPV) system is unique and different from the common flat-plate PV system. It uses a multi-junction solar cell and a Fresnel lens to concentrate direct solar radiation onto the cell while tracking the sun throughout the day. The cell efficiency could reach over 40% under high concentration ratio. In this study, we analyzed a one year set of environmental condition data of the University of Miyazaki, Japan, where the CPV system was installed. Performance ratio (PR) was discussed to describe the system's performance. Meanwhile, the average photon energy (APE) was used to describe the spectrum distribution at the site where the CPV system was installed. A circuit simulator network was used to simulate the CPV system electrical characteristics under various environmental conditions. As for the result, we found that the PR of the CPV systems depends on the APE level rather than the cell temperature. (C) 2015 The Japan Society of Applied Physics	[Al Husna, Husyira; Ota, Yasuyuki; Nishioka, Kensuke] Miyazaki Univ, Miyazaki 8892192, Japan; [Minemoto, Takashi] Ritsumeikan Univ, Kusatsu, Shiga 5258577, Japan	Al Husna, H (reprint author), Miyazaki Univ, Miyazaki 8892192, Japan.	y-ota@cc.miyazaki-u.ac.jp	Minemoto, Takashi/F-9342-2011		European Commission; NEDO through the project NGCPV E-J (EU) [283798]	Part of this work was supported by the European Commission and NEDO through the funding of the project NGCPV E-J (EU Ref. No. 283798). The authors would like to thank Dr. Kenji Araki for many suggestions and discussions on the concentrator photovoltaic module.	Araki K, 2005, PROG PHOTOVOLTAICS, V13, P513, DOI 10.1002/pip.643; Geisz JF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753729; Segev G, 2012, SOL ENERG MAT SOL C, V98, P57, DOI 10.1016/j.solmat.2011.10.013; Nishioka K, 2005, SOL ENERG MAT SOL C, V85, P429, DOI 10.1016/j.solmat.2004.05.008; Fernandez EF, 2014, SOL ENERG MAT SOL C, V127, P179, DOI 10.1016/j.solmat.2014.04.026; Green MA, 2010, PROG PHOTOVOLTAICS, V18, P346, DOI 10.1002/pip.1021; Sasaki K, 2013, AIP CONF PROC, V1556, P22, DOI 10.1063/1.4822190; Minemoto T, 2009, SOL ENERGY, V83, P1294, DOI 10.1016/j.solener.2009.03.004; Fernandez EF, 2013, SOL ENERGY, V92, P221, DOI 10.1016/j.solener.2013.03.012; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P57, DOI 10.1016/j.solmat.2005.01.011; Araki K, 2010, OPT EXPRESS, V18, pA53, DOI [10.1364/OE.18.000A53, 10.1364/OE.18.0000A53]; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; Nishioka K, 2010, J ELECTRON MATER, V39, P704, DOI 10.1007/s11664-010-1171-y; Minemoto T, 2007, SOL ENERG MAT SOL C, V91, P919, DOI 10.1016/j.solmat.2007.02.012; Yamaguchi M, 2003, SOL ENERG MAT SOL C, V75, P261, DOI 10.1016/S0927-0248(02)00168-X; Helmers H, 2013, SOL ENERG MAT SOL C, V116, P144, DOI 10.1016/j.solmat.2013.03.039; Guter W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148341; Marion B, 2005, IEEE PHOT SPEC CONF, P1601, DOI 10.1109/PVSC.2005.1488451; Ota Y, 2010, IEEE PHOT SPEC CONF, P2093; Nagae S, 2006, SOL ENERG MAT SOL C, V90, P3568, DOI 10.1016/j.solmat.2006.06.045; Peharz G, 2011, PROG PHOTOVOLTAICS, V19, P54, DOI 10.1002/pip.987; Ouennoughi Z, 1999, SOLID STATE ELECTRON, V43, P1985, DOI 10.1016/S0038-1101(99)00174-4; Araki K, 2006, SOL ENERG MAT SOL C, V90, P3312, DOI 10.1016/j.solmat.2005.09.017; Bett A. W., 2014, 10 INT C CONC PHOT; Chantana J, 2015, RENEW ENERG, V75, P762, DOI 10.1016/j.renene.2014.10.059; Fukushige S, 2009, SOL ENERG MAT SOL C, V93, P926, DOI 10.1016/j.solmat.2008.11.009; Jaus J., 2009, IEEE PHOT SPEC C; Leutz R., 2001, NONIMAGING FRESNEL L; Nishioka K, 2003, JPN J APPL PHYS 1, V42, P7175, DOI 10.1143/JJAP.42.7175; Ota Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BP03; Ota Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CR03; Sabnis V, 2012, AIP CONF PROC, V1477, P14, DOI 10.1063/1.4753823; Sakurada Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DP13; Yandt MD, 2012, AIP CONF PROC, V1477, P172, DOI 10.1063/1.4753861; Zamora P, 2012, PROC SPIE, V8468, DOI 10.1117/12.929698	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KE05	10.7567/JJAP.54.08KE05		4	Physics, Applied	Physics	CN8BU	WOS:000358662900075		
J	Aonuma, O; Hoshi, Y; Tayagaki, T; Novikov, A; Yurasov, D; Usami, N				Aonuma, Osamu; Hoshi, Yusuke; Tayagaki, Takeshi; Novikov, Alexey; Yurasov, Dmitry; Usami, Noritaka			Control of surface dip diameter in Si-based photonic nanostructures by changing growth temperature of Ge quantum dot multilayer structures and its impact on their optical properties	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SOLAR-CELLS; ISLANDS; SILICON; STRAIN	We fabricate photonic nanostructures by combination of growth of Ge quantum dot (QD) multilayer structures and maskless wet etching, and demonstrate that surface dip diameters in photonic nanostructures can be tuned by changing the growth temperature of QDs. Increase of growth temperature from 700 to 800 degrees C leads to the enlargement of surface dip diameters by a factor of more than two through the increase of QDs lateral sizes. In addition, the wet etching rate of the stacked Ge QDs depends on the Ge composition in the QDs and the dislocation generation in the Ge QD multilayer structures. The surface dips with larger diameters leads to an enhanced optical absorption in the near-infrared region. These results show that varying the growth temperature of QDs is effective to control the photonic nanostructures geometry and optical properties. (C) 2015 The Japan Society of Applied Physics	[Aonuma, Osamu; Hoshi, Yusuke; Usami, Noritaka] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Tayagaki, Takeshi] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Novikov, Alexey; Yurasov, Dmitry] Russian Acad Sci, Inst Phys Microstruct, Nizhnii Novgorod 603950, Russia; [Novikov, Alexey; Yurasov, Dmitry] Nizhnii Novgorod State Univ, Nizhnii Novgorod 603950, Russia	Aonuma, O (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	aonuma.osamu@d.mbox.nagoya-u.ac.jp	Tayagaki, Takeshi/E-7830-2010; Usami, Noritaka/C-1720-2009; Hoshi, Yusuke/A-2135-2012		Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST); Russian Foundation for Basic Research; Ministry of Education and Science [02.B.49.21.0003]	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) of the Japan Science and Technology Agency (JST), the Russian Foundation for Basic Research, and by the grant of the Ministry of Education and Science (Agreement No. 02.B.49.21.0003).	Chaparro SA, 1999, PHYS REV LETT, V83, P1199, DOI 10.1103/PhysRevLett.83.1199; Wood RW, 1935, PHYS REV, V48, P928, DOI 10.1103/PhysRev.48.928; Fahr S, 2011, OPT EXPRESS, V19, pA865, DOI 10.1364/OE.19.00A865; Chattopadhyay S, 2010, MAT SCI ENG R, V69, P1, DOI 10.1016/j.mser.2010.04.001; Green MA, 2002, PROG PHOTOVOLTAICS, V10, P235, DOI 10.1002/pip.404; Xie GY, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/9/095605; Zhao JH, 1996, SOL ENERG MAT SOL C, V41-2, P87, DOI 10.1016/0927-0248(95)00117-4; Chen HL, 2007, OPT EXPRESS, V15, P14793, DOI 10.1364/OE.15.014793; Xi JQ, 2007, NAT PHOTONICS, V1, P176, DOI 10.1038/nphoton.2007.26; Blanco A, 2000, NATURE, V405, P437; YABLONOVITCH E, 1987, PHYS REV LETT, V58, P2059, DOI 10.1103/PhysRevLett.58.2059; CAMPBELL P, 1987, J APPL PHYS, V62, P243, DOI 10.1063/1.339189; Usami N, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/18/185401; GREEN MA, 1995, PROG PHOTOVOLTAICS, V3, P189, DOI 10.1002/pip.4670030303; Aonuma O., 2014, WCPEC 6; Capellini G, 1999, SEMICOND SCI TECH, V14, pL21, DOI 10.1088/0268-1242/14/6/101; Hoshi Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.080202; Hoshi Y, 2014, THIN SOLID FILMS, V557, P338, DOI 10.1016/j.tsf.2013.10.066; JOHN S, 1987, PHYS REV LETT, V58, P2486, DOI 10.1103/PhysRevLett.58.2486; Kiguchi T., 2013, MRS P, V1510; Krasil'nik ZF, 2000, THIN SOLID FILMS, V367, P171, DOI 10.1016/S0040-6090(00)00683-0; Nelso Z. J., 2003, PHYS SOLAR CELLS; Sai H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2205173; Spinelli P, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1691; Tanaka K, 1996, J APPL PHYS, V80, P6991, DOI 10.1063/1.363773; Tayagaki T, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.122301	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA01	10.7567/JJAP.54.08KA01		5	Physics, Applied	Physics	CN8BU	WOS:000358662900002		
J	Asaka, T; Itayama, T; Nagasaki, H; Iwami, K; Yamamoto, C; Hara, Y; Masuda, A; Umeda, N				Asaka, Takashi; Itayama, Tomohiro; Nagasaki, Hideaki; Iwami, Kentaro; Yamamoto, Chizuko; Hara, Yukiko; Masuda, Atsushi; Umeda, Norihiro			Development of a pH sensor based on a nanostructured filter adding pH-sensitive fluorescent dye for detecting acetic acid in photovoltaic modules	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOISTURE INGRESS; PV MODULE; DEGRADATION; ENCAPSULANT; PERFORMANCE	Acetic acid formed via the hydrolysis of ethylene vinyl acetate (EVA) as an encapsulant in photovoltaic (PV) modules causes a decrease in the conversion efficiency of such modules by grid corrosion. Here, a nondestructive and simple optical method for evaluating the condition of PV modules is proposed. This method uses a dual-wavelength pH-sensitive fluorescent dye to detect acetic acid in PV modules using a change in pH. The change in pH induced by the formation of acetic acid is detected by the change in the ratio of the fluorescent intensities of two peaks of the dye. A pH-sensitive fluorescent dye showed sensitivity for small amounts of acetic acid such as that produced from EVA. Furthermore, a membrane filter dyed with a pH-sensitive fluorescent dye was confirmed to detect acetic acid in aged EVA after a damp-heat test (85 degrees C, 85%) for 5000 h in PV modules. (C) 2015 The Japan Society of Applied Physics	[Asaka, Takashi; Itayama, Tomohiro; Nagasaki, Hideaki; Iwami, Kentaro; Umeda, Norihiro] Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan; [Yamamoto, Chizuko; Hara, Yukiko; Masuda, Atsushi] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan	Asaka, T (reprint author), Tokyo Univ Agr & Technol, Dept Mech Syst Engn, Koganei, Tokyo 1848588, Japan.	50014833001@st.tuat.ac.jp			Japan Society for the Promotion of Science (JSPS) [25630438]; International Cooperation Project for Research and Standardization of Clean Energy Technologies from the Ministy of Economy, Trade and Industry	This work was supported in part by a Grant-in-Aid for Challenging Exploratory Research No. 25630438 from the Japan Society for the Promotion of Science (JSPS) and the International Cooperation Project for Research and Standardization of Clean Energy Technologies from the Ministy of Economy, Trade and Industry.	Allen N. S., 2000, POLYM DEGRAD STABIL, V71, P1; Meyer EL, 2004, IEEE T RELIAB, V53, P83, DOI 10.1109/TR.2004.824831; Chou KS, 1999, SENSOR ACTUAT B-CHEM, V56, P106, DOI 10.1016/S0925-4005(99)00187-2; Neimark AV, 2001, MICROPOR MESOPOR MAT, V44, P697, DOI 10.1016/S1387-1811(01)00251-7; Czanderna AW, 1996, SOL ENERG MAT SOL C, V43, P101, DOI 10.1016/0927-0248(95)00150-6; Miller DC, 2013, PROG PHOTOVOLTAICS, V21, P631, DOI 10.1002/pip.1241; Peike C, 2013, SOL ENERG MAT SOL C, V116, P49, DOI 10.1016/j.solmat.2013.03.022; Kempe MD, 2006, SOL ENERG MAT SOL C, V90, P2720, DOI 10.1016/j.solmat.2006.04.002; Sanchez-Friera P, 2011, PROG PHOTOVOLTAICS, V19, P658, DOI 10.1002/pip.1083; Liu JX, 2001, BIOORG MED CHEM LETT, V11, P2903, DOI 10.1016/S0960-894X(01)00595-9; Buck RP, 2002, PURE APPL CHEM, V74, P2169, DOI 10.1351/pac200274112169; Skoczek A, 2009, PROG PHOTOVOLTAICS, V17, P227, DOI 10.1002/pip.874; Kasik I, 2010, ANAL BIOANAL CHEM, V398, P1883, DOI 10.1007/s00216-010-4130-9; Jorgensen GJ, 2006, SOL ENERG MAT SOL C, V90, P2739, DOI 10.1016/j.solmat.2006.04.003; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Schlothauer J, 2012, SOL ENERG MAT SOL C, V102, P75, DOI 10.1016/j.solmat.2012.03.022; Agroui K, 2003, SOL ENERG MAT SOL C, V80, P33, DOI 10.1016/S0927-0248(03)00112-0; Klemchuk P, 1997, POLYM DEGRAD STABIL, V55, P347, DOI 10.1016/S0141-3910(96)00162-0; Kempe MD, 2007, SOL ENERG MAT SOL C, V91, P315, DOI 10.1016/j.solmat.2006.10.009; King DL, 2000, PROG PHOTOVOLTAICS, V8, P241, DOI 10.1002/(SICI)1099-159X(200003/04)8:2<241::AID-PIP290>3.0.CO;2-D; Asaka T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER18; Kanazashi Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.117001; Kempe MD, 2014, PROG PHOTOVOLTAICS, V22, P1159, DOI 10.1002/pip.2374; Masuda A., 2014, P 6 WORLD C PHOT EN, P979; Masuda A., 2014, P 29 EUR PHOT SOL EN, P2566; Masuda A., 2013, P 28 EUR PHOT SOL EN, P2978; Matsuda K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NF07; Miyashita M, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NF12; Miyashita M., 2013, P 28 EUR PHOT SOL EN, P2828; Peike C, 2011, SOL ENERG MAT SOL C, V95, P1686, DOI 10.1016/j.solmat.2011.01.030; Rashtchi S, 2012, PROC SPIE, V8472, DOI 10.1117/12.928959; Sakamoto S., 2014, P 29 EUR PHOT SOL EN, P3364; Wang E, 2013, ENRGY PROCED, V33, P256, DOI 10.1016/j.egypro.2013.05.066	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KG07	10.7567/JJAP.54.08KG07		6	Physics, Applied	Physics	CN8BU	WOS:000358662900095		
J	Breyer, C; Bogdanov, D; Komoto, K; Ehara, T; Song, J; Enebish, N				Breyer, Christian; Bogdanov, Dmitrii; Komoto, Keiichi; Ehara, Tomoki; Song, Jinsoo; Enebish, Namjil			North-East Asian Super Grid: Renewable energy mix and economics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ELECTRICITY; SYSTEM	Further development of the North-East Asian energy system is at a crossroads due to severe limitations of the current conventional energy based system. For North-East Asia it is proposed that the excellent solar and wind resources of the Gobi desert could enable the transformation towards a 100% renewable energy system. An hourly resolved model describes an energy system for North-East Asia, subdivided into 14 regions interconnected by high voltage direct current (HVDC) transmission grids. Simulations are made for highly centralized, decentralized and country-wide grids scenarios. The results for total system levelized cost of electricity (LCOE) are 0.065 and 0.081 (sic)/(kW.h) for the centralized and decentralized approaches for 2030 assumptions. The presented results for 100% renewable resources-based energy systems are lower in LCOE by about 30-40% than recent findings in Europe for conventional alternatives. This research clearly indicates that a 100% renewable resources-based energy system is THE real policy option. (C) 2015 The Japan Society of Applied Physics	[Breyer, Christian; Bogdanov, Dmitrii] Lappeenranta Univ Technol, Lappeenranta 53850, Finland; [Komoto, Keiichi] Mizuho Informat & Res Inst, Chiyoda Ku, Tokyo 1018443, Japan; [Ehara, Tomoki] E Konzal, Kyoto 6048074, Japan; [Song, Jinsoo] Silla Univ, Busan 617736, South Korea; [Enebish, Namjil] Natl Univ Mongolia, Ulaanbaatar 210646, Mongol Peo Rep	Breyer, C (reprint author), Lappeenranta Univ Technol, Lappeenranta 53850, Finland.	christian.breyer@lut.fi; dmitrii.bogdanov@lut.fi			Tekes, the Finnish Funding Agency for Innovation [40101/14]	The LUT authors gratefully acknowledge the public financing of Tekes, the Finnish Funding Agency for Innovation, for the "Neo-Carbon Energy" project under the number 40101/14. The authors would like to thank Michael Child for proofreading.	Agora Energiewende, 2013, KOST AUSB ERN EN DEU; Agora Energiewende, 2014, STROMSP EN UNT BED N; Murray J, 2012, NATURE, V481, P433, DOI 10.1038/481433a; [Anonymous], 2014, REN 2014 GLOB STAT R; Van de Graaf T, 2014, ENERG POLICY, V74, P16, DOI 10.1016/j.enpol.2014.06.027; Taggart S, 2012, P IEEE, V100, P348, DOI 10.1109/JPROC.2011.2159089; Huld T, 2008, PROG PHOTOVOLTAICS, V16, P595, DOI 10.1002/pip.846; Lin BQ, 2010, ENERG POLICY, V38, P512, DOI 10.1016/j.enpol.2009.09.042; Epstein PR, 2011, ANN NY ACAD SCI, V1219, P73, DOI 10.1111/j.1749-6632.2010.05890.x; Breuer W., 2010, 21 WORLD EN C; Callavik M., 2011, EWEA OFFSH WIND C; Connolly D, 2014, INT J SUSTAIN ENERGY, V1, P7; Dii, 2012, 2050 DES POW PERSP S; Droege P., 2009, 100 PER CENT RENEWAB; Energiewende Agora, 2014, COMP COST LOW CARB T, P10; Energy Watch Group, 2013, FOSS NUCL FUELS SUPP; European Commission, 2014, INT REN EN EUR STUD, p[7, 54]; Faiman D., 2009, ENERGY DESERT VERY L; Fell H.-J., 2012, GLOBAL COOLING STRAT; Fraunhofer Institute for Solar Energy Systems, 2014, PV COST VIS 2050 SCE; Gasch R., 2010, WINDKRAFTANLAGEN GRU, V6th, P505; Gerlach A.-K., 2011, 26 EUR HPOT SOL EN C; Grossmann WD, 2014, RENEW SUST ENERG REV, V32, P983, DOI 10.1016/j.rser.2014.01.003; Hau E., 2008, WINDKRAFTANLAGEN GRU, V4th, P732; Heier S., 2010, WINDKRAFTANLAGEN SYS, V5th, P393; Henning HM, 2014, RENEW SUST ENERG REV, V30, P1003, DOI 10.1016/j.rser.2013.09.012; Hoffmann W., 2014, 29 EUR PHOT SOL EN C; Hoffmann W., 2014, EC COMPETITIVENESS R; Intergovernal Panel on Climate Change, 2014, IPCC 5 ASS SYNTH REP; Knies G., 2009, CLEAN POWER DESERTS, V4th; Komoto K., 2013, 39 IEEE PHOT SPEC C; Mano S., 2014, GOBITEC ASIAN SUPER; Muller B., 2014, VERGLEICH OPTIMIERUN; Plessmann G, 2014, ENRGY PROCED, V46, P22, DOI 10.1016/j.egypro.2014.01.154; Song J., 2014, ASIA PAC TECH MONIT, V31, P24; Song J., 2012, INT C REN EN COOP GR; Stackhouse P. W., 2008, SURFACE METEOROLOGY; Stackhouse P. W., 2009, SURFACE METEOROLOGY; Stern NH, 2006, STERN REV EC CLIMATE; Stetter D., 2012, THESIS U STUTTGART S; UBS, 2014, Q SER GLOB UT AUT CH; UDI, 2012, UDI WORLD EL POW PLA; World Wild Fund for Nature International, 2014, LIV PLAN REP 2014 SP; Zentrum fur Sonnenenergie-und Wasserstoff-Forschung, 2014, STROM SOL STRAHL VOR	44	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KJ01	10.7567/JJAP.54.08KJ01		18	Physics, Applied	Physics	CN8BU	WOS:000358662900098		
J	Fujimura, S; Someya, T; Yoshiba, S; Tsukamoto, T; Kamisako, K; Suda, Y				Fujimura, Sohei; Someya, Takahiro; Yoshiba, Shuhei; Tsukamoto, Takahiro; Kamisako, Koichi; Suda, Yoshiyuki			Low-temperature fabrication technologies of Si solar cell by sputter epitaxy method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; MOLECULAR-BEAM EPITAXY; CRYSTALLINE SILICON; RECOMBINATION ACTIVITY; DIFFUSION LENGTH; ATOMIC-HYDROGEN; IN-SITU; SURFACE; LIFETIME; GROWTH	We applied an epitaxial n(+)-type Si emitter layer grown on a p-type Si substrate by our environmentally-light-load sputter epitaxy method using RF magnetron sputtering without dopant activation annealing for a Si solar cell. We also applied low-temperature cleaning of the substrate with a hydrogen-fluoride treatment at room temperature prior to the emitter layer growth instead of the conventionally used high-temperature thermal cleaning under vacuum condition. In addition, by our sputter epitaxy method, we determined the optimum temperature for the emitter growth. An emitter layer with good crystallinity is obtained, and the solar cell, formed with an emitter layer grown at the optimum growth temperature of 410 degrees C, exhibits an energy conversion efficiency of 12.3% in 100% aperture ratio equivalent without a texture or an antireflection coat. By the above low-temperature processes, a solar cell can be fabricated with process temperatures below 410 degrees C, which exhibits low temperature processes. (C) 2015 The Japan Society of Applied Physics	[Fujimura, Sohei; Someya, Takahiro; Yoshiba, Shuhei; Tsukamoto, Takahiro; Kamisako, Koichi; Suda, Yoshiyuki] Tokyo Univ Agr & Technol, Grad Sch Engn, Koganei, Tokyo 1848588, Japan	Fujimura, S (reprint author), Tokyo Univ Agr & Technol, Grad Sch Engn, Koganei, Tokyo 1848588, Japan.	sudayos@cc.tuat.ac.jp	TSUKAMOTO, Takahiro/F-9253-2013		Tokyo University of Agriculture and Technology TLO Co., Ltd	The work reported here was partially supported by the collaborative project with Tokyo University of Agriculture and Technology TLO Co., Ltd.	GUPTA P, 1988, PHYS REV B, V37, P8234, DOI 10.1103/PhysRevB.37.8234; SAKAI A, 1994, APPL PHYS LETT, V64, P52, DOI 10.1063/1.110919; Macdonald D, 2004, APPL PHYS LETT, V85, P4061, DOI 10.1063/1.1812833; NIWANO M, 1994, J APPL PHYS, V76, P2157, DOI 10.1063/1.357627; YABLONOVITCH E, 1986, PHYS REV LETT, V57, P249, DOI 10.1103/PhysRevLett.57.249; Zhao JH, 1999, PROG PHOTOVOLTAICS, V7, P471, DOI 10.1002/(SICI)1099-159X(199911/12)7:6<471::AID-PIP298>3.0.CO;2-7; Hanafusa H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.024102; Aberle AG, 2000, PROG PHOTOVOLTAICS, V8, P473, DOI 10.1002/1099-159X(200009/10)8:5<473::AID-PIP337>3.0.CO;2-D; Hanafusa H, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.055502; Hanafusa H, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.025701; HORANYI TS, 1993, APPL SURF SCI, V63, P306, DOI 10.1016/0169-4332(93)90112-O; Hanafusa H, 2008, JPN J APPL PHYS, V47, P3020, DOI 10.1143/JJAP.47.3020; Zhao JH, 1998, APPL PHYS LETT, V73, P1991, DOI 10.1063/1.122345; Fellmeth T, 2011, IEEE ELECTR DEVICE L, V32, P1101, DOI 10.1109/LED.2011.2157656; Bothe K., 2003, P 3 WORLD C PHOT EN, P927; BUCZKOWSKI A, 1993, J ELECTROCHEM SOC, V140, P3240, DOI 10.1149/1.2221017; Dhamrin M., 2002, P 29 IEEE PHOT SPEC, P395; Geerligs LJ, 2004, PROG PHOTOVOLTAICS, V12, P309, DOI 10.1002/pip.546; Joyce BA, 1997, ADV MATER OPT ELECTR, V7, P215; Kubota J, 2006, THIN SOLID FILMS, V508, P20, DOI 10.1016/j.tsf.2005.08.402; Maekawa H, 2006, JPN J APPL PHYS 2, V45, pL1247, DOI 10.1143/JJAP.45.L1247; Maekawa H, 2007, J CRYST GROWTH, V301, P1017, DOI 10.1016/j.jcrysgro.2006.11.269; MALIK R, 1995, J CRYST GROWTH, V150, P984, DOI 10.1016/0022-0248(95)80087-S; MEYERSON BS, 1986, APPL PHYS LETT, V48, P797, DOI 10.1063/1.96673; MIENO F, 1990, J ELECTRON MATER, V19, P1095, DOI 10.1007/BF02651987; MSAAD H, 1995, J ELECTROCHEM SOC, V142, P2833, DOI 10.1149/1.2050100; OHTA G, 1994, APPL PHYS LETT, V65, P2975, DOI 10.1063/1.112481; Palais O, 2000, EUR PHYS J-APPL PHYS, V10, P157, DOI 10.1051/epjap:2000128; Someya T., 2012, 73 SPRING M JAP SOC; Suda Y, 2012, PROCEDIA ENGINEER, V36, P396, DOI 10.1016/j.proeng.2012.03.058; Suda Y., 2012, Japan Patent, Patent No. 4910124; Thiesen J, 1999, APPL PHYS LETT, V75, P992, DOI 10.1063/1.124576; Tsukamoto T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826501; Uzum A., 2013, THESIS TOKYO U AGR T; YAMADA A, 1990, J ELECTRON MATER, V19, P1083, DOI 10.1007/BF02651985; Yeh W, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.025502; Yoshikawa M., 2013, ECS T, V50, P145	37	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD01	10.7567/JJAP.54.08KD01		5	Physics, Applied	Physics	CN8BU	WOS:000358662900046		
J	Fukabori, A; Takenouchi, T; Matsuda, Y; Tsuno, Y; Hishikawa, Y				Fukabori, Akihiro; Takenouchi, Takakazu; Matsuda, Youji; Tsuno, Yuki; Hishikawa, Yoshihiro			Study of highly precise outdoor characterization technique for photovoltaic modules in terms of reproducibility	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CALIBRATION; SUNLIGHT	In this study, novel outdoor measurements were conducted for highly precise characterization of photovoltaic (PV) modules by measuring current-voltage (I-V) curves with fast sweep speeds and module's temperature, and with a PV sensor for reference. Fast sweep speeds suppressed the irradiance variation. As a result, smooth I-V curves were obtained and the PV parameter deviation was suppressed. The module's temperature was measured by attaching resistive temperature detector sensors on the module's backsheet. The PV sensor was measured synchronously with the PV module. The PV parameters including I-sc, P-max, V-oc, and FF were estimated after correcting the I-V curves using the IEC standards. The reproducibility of I-sc, P-max, V-oc, and FF relative to the outdoor fits was evaluated as 0.43, 0.58, 0.24, and 0.23%, respectively. The results demonstrate that highly precise measurements are possible using a PV measurement system with the three above-mentioned features. (C) 2015 The Japan Society of Applied Physics	[Fukabori, Akihiro; Takenouchi, Takakazu; Matsuda, Youji; Tsuno, Yuki; Hishikawa, Yoshihiro] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan	Fukabori, A (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan.	y-hishikawa@aist.go.jp			NEDO under METI	This work was supported in part by NEDO under METI. The authors appreciate fruitful discussions with Dr. Yanqun Xue of AIST.	Mullejans H, 2005, PROG PHOTOVOLTAICS, V13, P661, DOI 10.1002/pip.625; [Anonymous], 2005, C8919 JIS; [Anonymous], 2009, IEC 60891 PROC 1; [Anonymous], 2006, 609041 IEC; Mullejans H, 2005, MEAS SCI TECHNOL, V16, P1250, DOI 10.1088/0957-0233/16/6/002; Betts T. R., 2006, P 4 IEEE WCPEC WAIK, P2238; Faiman D., 2008, P 23 EUPVSEC, P2801; Herrmann W., 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Herrmann W., 2008, P 23 EUR PHOT SOL EN, P2719; Herrmann W., 2007, P 22 EUPVSEC; Hishikawa Y., 2014, P JSES JWEA JOINT C, P305; Hishikawa Y, 2013, PROG PHOTOVOLTAICS, V21, P1181, DOI 10.1002/pip.2255; Kenny RP, 2013, PROG PHOTOVOLTAICS, V21, P1384, DOI 10.1002/pip.2365; Matsukawa H., 2014, INT PVSEC 14; Mihaylov B., 2014, P 29 EUPVSEC, P2443; Mullejans H, 2004, THIN SOLID FILMS, V451, P145, DOI 10.1016/j.tsf.2003.11.006; Mullejans H, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/7/075101; Rummel S., 2006, PHOT EN CONV C 2006, P2034; SHIMOKAWA R, 1987, JPN J APPL PHYS 1, V26, P86, DOI 10.1143/JJAP.26.86; Tsuno Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NF02; Virtuani A, 2012, MEAS SCI TECHNOL, V23, DOI 10.1088/0957-0233/23/11/115604	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KG06	10.7567/JJAP.54.08KG06		6	Physics, Applied	Physics	CN8BU	WOS:000358662900094		
J	Halim, MA; Islam, MM; Luo, XJ; Sakurai, T; Sakai, N; Kato, T; Sugimoto, H; Tampo, H; Shibata, H; Niki, S; Akimoto, K				Halim, Mohammad Abdul; Islam, Muhammad Monirul; Luo, Xianjia; Sakurai, Takeaki; Sakai, Noriyuki; Kato, Takuya; Sugimoto, Hiroki; Tampo, Hitoshi; Shibata, Hajime; Niki, Shigeru; Akimoto, Katsuhiro			Study of time-resolved photoluminescence in Cu2ZnSn(S,Se)(4) thin films with different Cu/Sn ratio	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SOLAR-CELLS; OPTICAL-PROPERTIES; CU(IN,GA)SE-2; EFFICIENCY; RECOMBINATION	To determine the minority carrier lifetime, room temperature time-resolved photoluminescence (TR-PL) measurements have been performed on a set of Cu2ZnSn(S,Se)(4) (CZTSSe) samples with different Cu/Sn ratios of 1.65, 1.75, and 1.85. TR-PL measurements were carried out on the bare CZTSSe thin films, CdS covered CZTSSe films and on solar cell structure using a femtosecond laser. The sample containing high Cu/Sn ratio of 1.85 shows the lowest lifetime, while films with Cu/Sn ratios of 1.65 and 1.75 show almost equal lifetime. The difference in lifetime between the CdS covered and solar structure samples is not remarkable. This demonstrates domination of recombination than charge separation by electric field. The bare films show extremely small lifetime. To examine surface quality, TR-PL emission spectra of uncovered CZTSSe and Cu(In,Ga)Se-2 (CIGS) films were measured with two different excitation wavelengths of 420 and 750 nm, which generate excess carriers at different depths in absorbers. This comparison confirms the dominant surface recombination by CZTSSe than CIGS. (C) 2015 The Japan Society of Applied Physics	[Halim, Mohammad Abdul; Islam, Muhammad Monirul; Luo, Xianjia; Sakurai, Takeaki; Akimoto, Katsuhiro] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan; [Sakai, Noriyuki; Kato, Takuya; Sugimoto, Hiroki] Showa Shell Sekiyu KK, Energy Solut Business Ctr, Minato Ku, Tokyo 1358074, Japan; [Tampo, Hitoshi; Shibata, Hajime; Niki, Shigeru] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Halim, MA (reprint author), Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan.	halimtsukuba2012@gmail.com			New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry of Japan (METI)	The author would like to gratefully acknowledge Xiabo Hu for valuable discussions. This work is supported by the New Energy and Industrial Technology Development Organization (NEDO) and the Ministry of Economy, Trade and Industry of Japan (METI).	Ahrenkiel R. K., 1993, MINORITY CARRIERS 3; THOMAS DG, 1965, PHYS REV, V140, pA202, DOI 10.1103/PhysRev.140.A202; Ohnesorge B, 1998, APPL PHYS LETT, V73, P1224, DOI 10.1063/1.122134; Persson C, 2010, J APPL PHYS, V107, DOI 10.1063/1.3318468; Maiberg M, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896483; Shirakata S, 2007, THIN SOLID FILMS, V515, P6151, DOI 10.1016/j.tsf.2006.12.040; Bag S, 2012, ENERG ENVIRON SCI, V5, P7060, DOI 10.1039/c2ee00056c; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Mitzi DB, 2011, SOL ENERG MAT SOL C, V95, P1421, DOI 10.1016/j.solmat.2010.11.028; Scragg JJ, 2010, J ELECTROANAL CHEM, V646, P52, DOI 10.1016/j.jelechem.2010.01.008; Tanaka T, 2005, J PHYS CHEM SOLIDS, V66, P1978, DOI 10.1016/j.jpcs.2005.09.037; Shin B, 2013, PROG PHOTOVOLTAICS, V21, P72, DOI 10.1002/pip.1174; Metzger WK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2957983; Katagiri H, 2001, JPN J APPL PHYS 1, V40, P500, DOI 10.1143/JJAP.40.500; Barkhouse DAR, 2012, PROG PHOTOVOLTAICS, V20, P6, DOI 10.1002/pip.1160; Metzger WK, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.035301; SCHMIDT T, 1992, PHYS REV B, V45, P8989, DOI 10.1103/PhysRevB.45.8989; Katagiri H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.041201; Puttnins S, 2013, SOL ENERG MAT SOL C, V119, P281, DOI 10.1016/j.solmat.2013.08.029; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Seol JS, 2003, SOL ENERG MAT SOL C, V75, P155, DOI 10.1016/S0927-0248(02)00127-7; DINGLE R, 1969, PHYS REV, V184, P788, DOI 10.1103/PhysRev.184.788; Babu GS, 2008, SEMICOND SCI TECH, V23, DOI 10.1088/0268-1242/23/8/085023; Bhattacharya P., 1997, SEMICONDUCTOR OPTOEL, V2nd; Buffiere M., 2013, P IEEE 39 PHOT SPEC, P1941; Chen SY, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3074499; Gokmen T, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4820250; Gunawan O, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3522884; Keyes BM, 2003, J APPL PHYS, V94, P5584, DOI 10.1063/1.1613804; ITO K, 1988, JPN J APPL PHYS 1, V27, P2094, DOI 10.1143/JJAP.27.2094; O'Connor D., 1984, TIME CORRELATED SING; Pankove J. I., 1971, OPTICAL PROCESSES SE; Repins IL, 2006, PROG PHOTOVOLTAICS, V14, P25, DOI 10.1002/pip.654; Sakurai T, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.05FC01; Shirakata S, 2013, PHYS STATUS SOLIDI A, V210, P1322, DOI 10.1002/pssa.201200859	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC15	10.7567/JJAP.54.08KC15		6	Physics, Applied	Physics	CN8BU	WOS:000358662900040		
J	Hirohata, T; Ota, Y; Nishioka, K				Hirohata, Takuya; Ota, Yasuyuki; Nishioka, Kensuke			Anti-soiling coating based on silica for Fresnel lens of concentrator photovoltaics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MULTIJUNCTION SOLAR-CELLS; HIGH-EFFICIENCY MULTIJUNCTION; SYSTEMS; CPV; FILMS; DUST	A simple anti-soiling layer was coated on the surface of poly( methyl methacrylate), which is the primary material of Fresnel lenses for concentrator photovoltaics. The main material of the anti-soiling layer was silica and the layer contained abundant hydroxyl groups that adsorbed water on the surface. After 9 months of exposure, the transmittance of the sample without the coating was 83.9%. On the other hand, the transmittance of the sample with the coating was 90.7%. The relationship between the electrostatic potential and the adhesion of sand on a Fresnel lens was evaluated. The electrostatic potential and mass of the adherent sand were decreased by the anti-soiling coating. (C) 2015 The Japan Society of Applied Physics	[Hirohata, Takuya; Ota, Yasuyuki; Nishioka, Kensuke] Miyazaki Univ, Miyazaki 8892192, Japan	Hirohata, T (reprint author), Miyazaki Univ, Miyazaki 8892192, Japan.	nishioka@cc.miyazaki-u.ac.jp			incorporated administrative agency New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry, Japan (METI)	A part of this work was supported by the incorporated administrative agency New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry, Japan (METI). We would like to thank Mr. Akihito Hirai and Ms. Ryoko Kubota of Central Automotive Products Ltd. for valuable discussion. The authors are grateful to the Institute of Advanced Energy (IAE) of Kyoto University, the Ministry of Education, Culture, Sports, Science and Technology (MEXT) "Project for Creation of Research Platforms and Sharing of Advanced Research Infrastructure" for TEM measurement.	Geisz JF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753729; Nishioka K, 2005, SOL ENERG MAT SOL C, V85, P429, DOI 10.1016/j.solmat.2004.05.008; Garcia M, 2011, PROG PHOTOVOLTAICS, V19, P211, DOI 10.1002/pip.1004; Ota Y, 2012, SOL ENERGY, V86, P476, DOI 10.1016/j.solener.2011.10.021; Sasaki K, 2013, AIP CONF PROC, V1556, P22, DOI 10.1063/1.4822190; Yamaguchi M, 2006, SOL ENERG MAT SOL C, V90, P3068, DOI 10.1016/j.solmat.2006.06.028; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P57, DOI 10.1016/j.solmat.2005.01.011; Tanaka K, 2008, LANGMUIR, V24, P296, DOI 10.1021/la702132t; Araki K, 2010, OPT EXPRESS, V18, pA53, DOI [10.1364/OE.18.000A53, 10.1364/OE.18.0000A53]; Takamoto T, 2005, PROG PHOTOVOLTAICS, V13, P495, DOI 10.1002/pip.642; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; Nishioka K, 2010, J ELECTRON MATER, V39, P704, DOI 10.1007/s11664-010-1171-y; Yamaguchi M, 2003, SOL ENERG MAT SOL C, V75, P261, DOI 10.1016/S0927-0248(02)00168-X; Guter W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148341; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P1308, DOI 10.1016/j.solmat.2005.08.003; Nishioka K, 2004, JPN J APPL PHYS 1, V43, P882, DOI 10.1143/JJAP.43.882; Sueto T, 2013, SOL ENERGY, V97, P414, DOI 10.1016/j.solener.2013.09.006; Vivar M, 2010, SOL ENERGY, V84, P1327, DOI 10.1016/j.solener.2010.03.031; Araki K, 2006, SOL ENERG MAT SOL C, V90, P3320, DOI 10.1016/j.solmat.2005.09.014; Elminir HK, 2006, ENERG CONVERS MANAGE, V47, P3192, DOI 10.1016/j.enconman.2006.02.014; Haeberlin H., 1998, P 2 WORLD C EXH PHOT, P2764; Hammond R., 1997, P 26 IEEE PHOT SPEC, P1121; Horiuchi Y, 2011, APPL CATAL A-GEN, V400, P1, DOI 10.1016/j.apcata.2011.04.027; Jaus J, 2011, PROG PHOTOVOLTAICS, V19, P580, DOI 10.1002/pip.1065; Nabemoto K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10ND11; Ota Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BP03; Ota Y, 2012, AIP CONF PROC, V1477, P340, DOI 10.1063/1.4753900; Ota Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CR03; Piliougine M, 2013, APPL ENERG, V112, P626, DOI 10.1016/j.apenergy.2013.01.048; Sabnis V, 2012, AIP CONF PROC, V1477, P14, DOI 10.1063/1.4753823; Sakurada Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DP13; Shibata N, 2011, AIP CONF PROC, V1407, DOI 10.1063/1.3658357	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KE09	10.7567/JJAP.54.08KE09		4	Physics, Applied	Physics	CN8BU	WOS:000358662900079		
J	Hishikawa, Y; Yamagoe, K; Onuma, T				Hishikawa, Yoshihiro; Yamagoe, Kengo; Onuma, Tsuyoshi			Non-contact measurement of electric potential of photovoltaic cells in a module and novel characterization technologies	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PV MODULE	A novel noncontact method of measuring the electric potential of component cells in photovoltaic (PV) modules is investigated using electrostatic field measurement technology. Experimental results for various kinds of PV cells and modules are presented, and their measurement principle as well as practical factors that affect the measurement results are discussed. It is demonstrated that the DC electric potential of the cells in various crystalline silicon and thin-film PV modules can be measured indoors through their cover glass or backsheet within a resolution of the output voltage of about 1 cell. The method is also applicable to the outdoor measurement of PV modules under grid-connected operation, and enables various kinds of characterization such as identifying low-performance cells in a PV module and degraded modules in a PV array, and determining the balance of their output current under outdoor operating conditions. Different distributions of electric potential measured from the front and back surfaces are observed for some types of modules. These differences are suggested, by the results of the analysis of experiments and numerical simulations, to originate from the modification of the module's surface electric potential by slight current flow through its component materials such as the cover glass, ethylene vinyl acetate (EVA), and backsheet. (C) 2015 The Japan Society of Applied Physics	[Hishikawa, Yoshihiro; Yamagoe, Kengo; Onuma, Tsuyoshi] RCPVT, Natl Inst Adv Ind Sci & Technol AIST, Tsukuba, Ibaraki 3058568, Japan	Hishikawa, Y (reprint author), RCPVT, Natl Inst Adv Ind Sci & Technol AIST, Tsukuba, Ibaraki 3058568, Japan.	y-hishikawa@aist.go.jp			NEDO under METI	This work was supported in part by NEDO under METI. The authors are grateful to M. Higa for discussion on the numerical simulation, to T. Suzuki, T. Inagawa, and Y. Miyabayashi of Kasuga Denki, and K. Shinji of Kansai Electronics for discussing the basics of electrostatic field measurement.	Takashima T, 2009, SOL ENERG MAT SOL C, V93, P1079, DOI 10.1016/j.solmat.2008.11.060; EMERY KA, 1986, SOL CELLS, V17, P253, DOI 10.1016/0379-6787(86)90016-5; [Anonymous], 1997, P 26 IEEE PHOT SPEC; del Cueto JA, 2002, PROG PHOTOVOLTAICS, V10, P15, DOI 10.1002/pip.401; HORENSTEIN MN, 1995, J ELECTROSTAT, V35, P203, DOI 10.1016/0304-3886(95)96917-T; Bellmore D. G., 2002, EL OV EL DISCH S, P226; Dirnberger D, 2014, MEAS SCI TECHNOL, V25, DOI 10.1088/0957-0233/25/10/105005; Hacke P., 2011, P 37 IEEE PHOT SPEC, P814; Herous L., 2009, J ENG SCI TECHNOL RE, V2, P87; Hishikawa Y., 2012, P 27 EUPVSEC FRANKF, P2954; Hishikawa Y., 2014, WCPEC 6, P1121; Hishikawa Y., 2014, P JSES JWEA JOINT C, P282; Hishikawa Y, 2013, PROG PHOTOVOLTAICS, V21, P1181, DOI 10.1002/pip.2255; Kawamura H, 2003, SOL ENERG MAT SOL C, V75, P613, DOI 10.1016/S0927-0248(02)00134-4; Kurokawa K, 1998, RENEW ENERG, V15, P157, DOI 10.1016/S0960-1481(98)00144-X; Nishimoto H., 1989, 27 AER SCI M; Shindo K., 2011, P IEEJ ANN M, P58; Simon M, 2010, SOL ENERG MAT SOL C, V94, P106, DOI 10.1016/j.solmat.2009.09.016; Tobita H., 2011, P 37 IEEE PHOT SPEC, P2336; Vosteen R. E., 1974, 9 ANN M IEEE IND APP; Wohlgemuth J., 2005, P 31 IEEE PV SPEC C, P1062	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KG05	10.7567/JJAP.54.08KG05		7	Physics, Applied	Physics	CN8BU	WOS:000358662900093		
J	Ikeno, N; Yamashita, Y; Oji, H; Miki, S; Arafune, K; Yoshida, H; Satoh, S; Hirosawa, I; Chikyow, T; Ogura, A				Ikeno, Norihiro; Yamashita, Yoshihiro; Oji, Hiroshi; Miki, Shohei; Arafune, Koji; Yoshida, Haruhiko; Satoh, Shin-ichi; Hirosawa, Ichiro; Chikyow, Toyohiro; Ogura, Atsushi			Relationship between passivation properties and band alignment in O-3-based atomic-layer-deposited AlOx on crystalline Si for photovoltaic applications	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SURFACE PASSIVATION; TRAPPING PHENOMENA; ALUMINUM-OXIDE; SOLAR-CELLS; SILICON; INTERFACE; CHARGE; AL2O3; FILMS	The passivation properties and band structures in aluminum oxide (AlOx) deposited by ozone-based atomic layer deposition (ALD) at room temperature on p-type crystalline silicon were investigated by X-ray photoelectron spectroscopy (XPS). The effective carrier lifetime depends on the thickness of AlOx films, since the field effects induced in the films by fixed charges depend on film thickness. The fixed charges are different by two orders of magnitude between films with thicknesses of 10 and 30 nm. At the 30-nm-thick AlOx/Si interface, the completely accumulated band bending of the Si surface was observed. On the other hand, a thin depletion layer was formed at the 10-nm-thick AlOx/Si interface. From the time-dependent XPS measurements, a hole trap was observed toward AlOx, in which trapping centers existed. (C) 2015 The Japan Society of Applied Physics	[Ikeno, Norihiro; Yamashita, Yoshihiro; Ogura, Atsushi] Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan; [Oji, Hiroshi; Hirosawa, Ichiro] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Miki, Shohei; Arafune, Koji; Yoshida, Haruhiko; Satoh, Shin-ichi] Univ Hyogo, Himeji, Hyogo 6712280, Japan; [Chikyow, Toyohiro] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Ikeno, Norihiro] Japan Soc Promot Sci, Tokyo, Tokyo 1028472, Japan; [Arafune, Koji; Yoshida, Haruhiko; Satoh, Shin-ichi; Ogura, Atsushi] JST, CREST, Kawaguchi, Saitama 3320012, Japan	Ikeno, N (reprint author), Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan.	n_ikeno@meiji.ac.jp; a_ogura@meiji.ac.jp			Core Research for Evolution Science and Technology (CREST), Japan Science and Technology Agency (JST)	This work was supported in part by Core Research for Evolution Science and Technology (CREST), Japan Science and Technology Agency (JST). The HAXPES measurements were performed with the approval of the Industrial Application Division Beamline Station (Proposal Nos. 2012A1771 and 2014A1544).	Aberle A. G., 1994, Progress in Photovoltaics: Research and Applications, V2, DOI 10.1002/pip.4670020402; Hoex B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2784168; Hoex B, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240736; Schmidt J, 2008, PROG PHOTOVOLTAICS, V16, P461, DOI 10.1002/pip.823; Saint-Cast P, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3250157; Glunz SW, 1999, J APPL PHYS, V86, P683, DOI 10.1063/1.370784; Miyazaki S, 2001, J VAC SCI TECHNOL B, V19, P2212, DOI 10.1116/1.1418405; Agostinelli G, 2006, SOL ENERG MAT SOL C, V90, P3438, DOI 10.1016/j.solmat.2006.04.014; Hebling C, 1997, SOL ENERG MAT SOL C, V48, P335, DOI 10.1016/S0927-0248(97)00145-1; Dingemans G, 2010, PHYS STATUS SOLIDI-R, V4, P10, DOI 10.1002/pssr.200903334; Poodt P, 2010, ADV MATER, V22, P3564, DOI 10.1002/adma.201000766; Benick J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945287; Petermann JH, 2012, PROG PHOTOVOLTAICS, V20, P1, DOI 10.1002/pip.1129; BROWER KL, 1988, APPL PHYS LETT, V53, P508, DOI 10.1063/1.100620; De Wolf S., 2012, GREEN, V2, P7, DOI DOI 10.1515/GREEN-2011-0018; Dingemans G, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.4728205; Dupuis J., 2009, P 24 EUR PHOT SOL EN, P287; Glunz S.W., 2007, ADV OPTOELECTRON, V2007, P97370; Hagimoto Y, 2000, APPL PHYS LETT, V77, P4175, DOI 10.1063/1.1334657; Hayashi Y., 1991, P 10 EUR PHOT SOL EN, P254; Hirose K, 2004, APPL SURF SCI, V237, P411, DOI 10.1016/j.apsusc.2004.06.094; Hirose K, 2010, J ELECTRON SPECTROSC, V176, P46, DOI 10.1016/j.elspec.2009.06.003; Ikeno N., 2014, WORLD C PHOT EN CONV; Lee H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER06; Lee H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3701280; Li TT, 2009, PHYS STATUS SOLIDI-R, V3, P160, DOI 10.1002/pssr.200903140; Sameshima T, 1999, APPL PHYS A-MATER, V69, P221, DOI 10.1007/s003390050993	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD19	10.7567/JJAP.54.08KD19		3	Physics, Applied	Physics	CN8BU	WOS:000358662900064		
J	Itoh, T; Katayama, R; Yamakawa, K; Matsui, K; Saito, M; Sugiyama, S; Sichanugrist, P; Nonomura, S; Konagai, M				Itoh, Takashi; Katayama, Ryuichi; Yamakawa, Koki; Matsui, Kento; Saito, Masaru; Sugiyama, Shuhichiroh; Sichanugrist, Porponth; Nonomura, Shuichi; Konagai, Makoto			Electrical characterization of hydrogenated amorphous silicon oxide films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PHOTOTHERMAL DEFLECTION SPECTROSCOPY; RF GLOW-DISCHARGE; SOLAR-CELLS; GROWTH-PROCESS; A-SIOH; ABSORPTION; GENERATION	The electrical characterization of hydrogenated amorphous silicon oxide (a-SiOx:H) films was performed by electron spin resonance (ESR) and electrical conductivity measurements. In the ESR spectra of the a-SiOx:H films, two ESR peaks with g-values of 2.005 and 2.013 were observed. The ESR peak with the g-value of 2.013 was not observed in the ESR spectra of a-Si:H films. The photoconductivity of the a-SiOx:H films decreased with increasing spin density estimated from the ESR peak with the g-value of 2.005. On the other hand, photoconductivity was independent of spin density estimated from the ESR peak with the g-value of 2.013. The optical absorption coefficient spectra of the a-SiOx:H films were also measured. The spin density estimated from the ESR peak with the g-value of 2.005 increased proportionally with increasing optical absorption owing to the gap-state defect. (C) 2015 The Japan Society of Applied Physics	[Itoh, Takashi; Katayama, Ryuichi; Yamakawa, Koki; Matsui, Kento; Nonomura, Shuichi] Gifu Univ, Ctr Innovat Photovolta Syst, Cavendish Lab, Gifu 5011193, Japan; [Saito, Masaru; Sugiyama, Shuhichiroh] Sharp Co Ltd, Katsuragi, Nara 6392198, Japan; [Sichanugrist, Porponth; Konagai, Makoto] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Konagai, Makoto] MEXT JST FUTURE PV Innovat Res, Meguro Ku, Tokyo 1528552, Japan	Itoh, T (reprint author), Gifu Univ, Ctr Innovat Photovolta Syst, Cavendish Lab, Gifu 5011193, Japan.	itoh@gifu-u.ac.jp			International Research Center for Innovative Solar Cell Program from NEDO	This work was funded by the International Research Center for Innovative Solar Cell Program from NEDO.	STREET RA, 1981, PHYS REV B, V24, P969, DOI 10.1103/PhysRevB.24.969; Das D, 1997, J NON-CRYST SOLIDS, V210, P148, DOI 10.1016/S0022-3093(96)00597-2; Holovsky J, 2008, J NON-CRYST SOLIDS, V354, P2167, DOI 10.1016/j.jnoncrysol.2007.09.106; Matsuda A, 2004, JPN J APPL PHYS 1, V43, P7909, DOI 10.1143/JJAP.43.7909; Vanecek M, 2002, APPL PHYS LETT, V80, P719, DOI 10.1063/1.1446207; Yan BJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3638068; Das D, 2000, SOL ENERG MAT SOL C, V60, P167, DOI 10.1016/S0927-0248(99)00081-1; Zeman M, 2008, J MATER RES, V23, P889, DOI [10.1557/jmr.2008.0125, 10.1557/JMR.2008.0125]; TAUC J, 1968, MATER RES BULL, V3, P37, DOI 10.1016/0025-5408(68)90023-8; JACKSON WB, 1982, PHYS REV B, V25, P5559, DOI 10.1103/PhysRevB.25.5559; CODY GD, 1981, PHYS REV LETT, V47, P1480, DOI 10.1103/PhysRevLett.47.1480; STUTZMANN M, 1987, PHYS REV B, V35, P5666, DOI 10.1103/PhysRevB.35.5666; ASANO A, 1986, JPN J APPL PHYS 2, V25, pL388, DOI 10.1143/JJAP.25.L388; Bartoll J, 2001, RADIAT MEAS, V33, P893, DOI 10.1016/S1350-4487(01)00091-9; DERSCH H, 1981, PHYS STATUS SOLIDI B, V105, P265, DOI 10.1002/pssb.2221050129; Hishida M, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.092301; Inthisang Sorapong, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Inthisang S, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201001145; Itoh T., 6 WORLD C P IN PRESS; Janotta A, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.115206; Kaneta C, 1996, JPN J APPL PHYS 1, V35, P1540, DOI 10.1143/JJAP.35.1540; OTSUBO S, 1988, JPN J APPL PHYS 2, V27, pL1999; Sobajima Y, 2014, CAN J PHYS, V92, P582, DOI 10.1139/cjp-2013-0558; Wang S, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.011401; Wang YF, 2014, CAN J PHYS, V92, P589, DOI 10.1139/cjp-2013-0569; YOKOGAWA K, 1991, JPN J APPL PHYS 1, V30, P3199, DOI 10.1143/JJAP.30.3199; Yunaz IA, 2007, JPN J APPL PHYS 2, V46, pL1152, DOI 10.1143/JJAP.46.L1152; Zeman M., 2006, THIN FILM SOLAR CELL, P189	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KB11	10.7567/JJAP.54.08KB11		5	Physics, Applied	Physics	CN8BU	WOS:000358662900025		
J	Jonai, S; Hara, K; Tsutsui, Y; Nakahama, H; Masuda, A				Jonai, Sachiko; Hara, Kohjiro; Tsutsui, Yuji; Nakahama, Hidenari; Masuda, Atsushi			Relationship between cross-linking conditions of ethylene vinyl acetate and potential induced degradation for crystalline silicon photovoltaic modules	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SI SOLAR-CELLS; STACKING-FAULTS; MECHANISM	In this study, we investigated the relationship in crystalline silicon (c-Si) photovoltaic (PV) modules between the cross-linking level of copolymer of ethylene and vinyl acetate (EVA) as the encapsulant and the degree of degradation due to potential induced degradation (PID) phenomenon. We used three methods for the determination of cross-linking level of EVA: xylene method, which is one of the solvent extraction methods (SEM), curing degree by differential scanning calorimetry (DSC), and viscoelastic properties by dynamic mechanical analysis (DMA). The results indicate that degradation of PV modules by PID test depends on the cross-linking level of EVA. The PV modules encapsulated by EVA with higher cross-linking level show lower degradation degree due to PID phenomenon. Also we showed that EVA with higher cross-linking level tended to be higher volume resistivity. This tendency is similar to that for electrical resistance value during the PID test. The PID test was also done by changing thickness of EVA between front cover glass and c-Si with the same cross-linking level. The PV modules encapsulated by thicker EVA between front cover glass and c-Si cell show lower degradation by PID. From these results, the PV modules encapsulated by EVA with higher cross-linking level, higher volume resistivity and increased thickness would be tolerant of PID phenomenon. (C) 2015 The Japan Society of Applied Physics	[Jonai, Sachiko; Hara, Kohjiro; Masuda, Atsushi] Natl Inst Adv Ind Sci & Technol, Tosu, Saga 8410052, Japan; [Tsutsui, Yuji; Nakahama, Hidenari] Nisshinbo Holdings Inc, Okazaki, Aichi 4448560, Japan	Jonai, S (reprint author), Natl Inst Adv Ind Sci & Technol, Tosu, Saga 8410052, Japan.	atsushi-masuda@aist.go.jp					Hirschl C, 2013, SOL ENERG MAT SOL C, V116, P203, DOI 10.1016/j.solmat.2013.04.022; Naumann V, 2014, SOL ENERG MAT SOL C, V120, P383, DOI 10.1016/j.solmat.2013.06.015; Stark W, 2011, POLYM TEST, V30, P236, DOI 10.1016/j.polymertesting.2010.12.003; Naumann V, 2012, ENRGY PROCED, V27, P1, DOI 10.1016/j.egypro.2012.07.020; Li FK, 1999, J APPL POLYM SCI, V71, P1063, DOI 10.1002/(SICI)1097-4628(19990214)71:7<1063::AID-APP4>3.0.CO;2-A; Bianchi O, 2011, POLYM TEST, V30, P616, DOI 10.1016/j.polymertesting.2011.05.001; [Anonymous], 2010, P 35 IEEE PHOT SPEC; Bauer J, 2012, PHYS STATUS SOLIDI-R, V6, P331, DOI 10.1002/pssr.201206276; Berghold J., 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Hacke Peter, 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Hacke P., 2011, P 37 IEEE PHOT SPEC, P814; Hara K, 2014, RSC ADV, V4, P44291, DOI 10.1039/c4ra06791f; Kambe M., 2013, P 28 EU PVSEC PAR, P2861; Kapur J., 2013, P 28 EUR PHOT SOL EN, P476; Koch Simon, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Hoffmann S, 2014, PROG PHOTOVOLTAICS, V22, P173, DOI 10.1002/pip.2238; Lausch D, 2014, ENRGY PROCED, V55, P486, DOI 10.1016/j.egypro.2014.08.013; Lechner P., 2012, P 27 EU PVSEC FRANKF, P3152; Li H.-Y., 2010, P 25 EU PVSEC, P4044; Liu H. C., 2013, ENERGY POWER ENG, V5, P455; Miller D. C., 2013, 23 INT PHOT SCI ENG; Mishina K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.03CE01; Nagel H., 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Reyes-Labarta JA, 2011, IND ENG CHEM RES, V50, P7964, DOI 10.1021/ie200276v; Schulze S. H., 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Schulze S.-H., 2013, P 28 EU PVSEC PAR, P503; Schutze Matthias, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Naumann V, 2013, ENRGY PROCED, V33, P76, DOI 10.1016/j.egypro.2013.05.042	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KG01	10.7567/JJAP.54.08KG01		5	Physics, Applied	Physics	CN8BU	WOS:000358662900089		
J	Joonwichien, S; Takahashi, I; Matsushima, S; Usami, N				Joonwichien, Supawan; Takahashi, Isao; Matsushima, Satoru; Usami, Noritaka			Comparison of phosphorus gettering effect in faceted dendrite and small grain of multicrystalline silicon wafers grown by floating cast method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							IMPURITIES; BOUNDARY; DEFECTS	We attempt to clarify the effect of phosphorus diffusion gettering (PDG) on the differences in microstructures of multicrystalline silicon (mc-Si) wafers. From the results of the floating cast method, the obtained microstructure of mc-Si was determined to contain unique microstructures, consisting of large faceted dendrites and small grains with low and high dislocation densities. The PDG efficiency was evaluated through the change in minority carrier lifetime. As a result, a stronger positive PDG effect was found for large faceted dendrites with low dislocation density, attributed to a small number of defects that can act as recombination centers of carriers. Lifetime improvement was also found in dislocation regions possibly owing to the redistribution of interstitial metals. These results suggest the importance of controlling the microstructure of mc-Si, which could strongly affect the PDG efficiency and existence of incorporated impurities. (C) 2015 The Japan Society of Applied Physics	[Joonwichien, Supawan; Takahashi, Isao; Matsushima, Satoru; Usami, Noritaka] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Joonwichien, S (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	supawan@numse.nagoya-u.ac.jp	Usami, Noritaka/C-1720-2009; Takahashi, Isao/E-8501-2013	Takahashi, Isao/0000-0003-0416-5462	New Energy and Industrial Technology Development Organization (NEDO) of Japan	The authors would like to thank Silicon Plus Corporation for mc-Si ingot growth. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) of Japan.	Chen J, 2005, J APPL PHYS, V97, DOI 10.1063/1.1836009; THAI ND, 1970, SOLID STATE ELECTRON, V13, P165, DOI 10.1016/0038-1101(70)90047-X; Nose Y, 2009, J CRYST GROWTH, V311, P228, DOI 10.1016/j.jcrysgro.2008.10.098; Joonwichien S, 2013, J APPL PHYS, V113, DOI 10.1063/1.4798600; NEWMAN RC, 1982, REP PROG PHYS, V45, P1163, DOI 10.1088/0034-4885/45/10/003; Manshanden P, 2006, SOL ENERG MAT SOL C, V90, P998, DOI 10.1016/j.solmat.2005.05.015; Usami N, 2011, J APPL PHYS, V109, DOI 10.1063/1.3576108; Fenning DP, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3575583; Chen J, 2004, J APPL PHYS, V96, P5490, DOI 10.1063/1.1797548; Joonwichien S., 2014, 6 WORLD C PHOT EN CO, P557; Joonwichien S., 2013, P 28 EUR PHOT SOL EN, P911; Joonwichien S, 2014, PROG PHOTOVOLTAICS, V22, P726, DOI 10.1002/pip.2428; Joonwichien S, 2014, ENRGY PROCED, V55, P203, DOI 10.1016/j.egypro.2014.08.119; Knorlein M, 2014, ENRGY PROCED, V55, P539, DOI 10.1016/j.egypro.2014.08.021; Kutsukake K, 2007, MATER TRANS, V48, P143, DOI 10.2320/matertrans.48.143; Lu JG, 2003, J APPL PHYS, V94, P140, DOI 10.1063/1.1578699; McHugo SA, 1997, APPL PHYS A-MATER, V64, P127, DOI 10.1007/s003390050453; Perichaud I, 2002, SOL ENERG MAT SOL C, V72, P315, DOI 10.1016/S0927-0248(01)00179-9; Seibt M, 2006, PHYS STATUS SOLIDI A, V203, P696, DOI 10.1002/pssa.200664516; Sopori B. L., 1996, P 25 IEEE PHOT SPEC, P625; Usami Noritaka, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD11	10.7567/JJAP.54.08KD11		4	Physics, Applied	Physics	CN8BU	WOS:000358662900056		
J	Kaigawa, R; Hashimoto, S; Irago, T; Klenk, R				Kaigawa, Ryuji; Hashimoto, Shintaro; Irago, Tomoki; Klenk, Reiner			Direct preparation of Cu2ZnSnSe4 films by microwave irradiation and its dependence on the Sn/(Sn plus Zn) ratio	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PULSED-LASER DEPOSITION; THIN-FILMS; INSTANTANEOUS PREPARATION; NONVACUUM PROCESS; PRECURSOR FILMS; SULFURIZATION; SE; CU	Cu2ZnSnSe4 (CZTSe) films with various Sn/(Sn + Zn) ratios were directly prepared on metallic Ti foils by microwave irradiation and their properties were investigated. The Sn/(Sn + Zn) ratio and Cu/(Sn + Zn) ratio of the precursor could be preserved by using a sealed container filled with 0.15 atm of Ar. Single-phase CZTSe crystals with a kesterite (stannite) structure and without by-products were observed with Sn/(Sn + Zn) ratios between 0.4 and 0.6. The hole densities of the Cu-Zn-Sn-Se films are minimal (<10(17)/cm(3)) with Sn/(Sn + Zn) ratios ranging from 0.5 to 0.6. (C) 2015 The Japan Society of Applied Physics	[Kaigawa, Ryuji; Hashimoto, Shintaro; Irago, Tomoki] Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan; [Klenk, Reiner] Inst Heterogeneous Mat Syst, Helmholtz Zentrum Mat & Energie, D-14109 Berlin, Germany	Kaigawa, R (reprint author), Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan.	kaigawa@rins.ryukoku.ac.jp					Wibowo RA, 2007, PHYS STATUS SOLIDI A, V204, P3373, DOI 10.1002/pssa.200723144; Scragg JJ, 2011, CHEM MATER, V23, P4625, DOI 10.1021/cm202379s; Prabhakar T, 2011, SOL ENERG MAT SOL C, V95, P1001, DOI 10.1016/j.solmat.2010.12.012; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Weber A, 2009, THIN SOLID FILMS, V517, P2524, DOI 10.1016/j.tsf.2008.11.033; LANDRY CC, 1993, SCIENCE, V260, P1653, DOI 10.1126/science.260.5114.1653; Long B, 2014, THIN SOLID FILMS, V573, P117, DOI 10.1016/j.tsf.2014.11.008; Moriya K, 2007, JPN J APPL PHYS 1, V46, P5780, DOI 10.1143/JJAP.46.5780; Araki H, 2008, THIN SOLID FILMS, V517, P1457, DOI 10.1016/j.tsf.2008.09.058; Nagaoka A, 2013, PHYS STATUS SOLIDI A, V210, P1328, DOI 10.1002/pssa.201200815; Redinger A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3483760; Shin SW, 2011, SOL ENERG MAT SOL C, V95, P3202, DOI 10.1016/j.solmat.2011.07.005; Tiwari D, 2014, THIN SOLID FILMS, V551, P42, DOI 10.1016/j.tsf.2013.11.095; Kaigawa R, 2009, THIN SOLID FILMS, V517, P2184, DOI 10.1016/j.tsf.2008.10.084; Katagiri H, 2009, THIN SOLID FILMS, V517, P2455, DOI 10.1016/j.tsf.2008.11.002; Brammertz G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826448; Kaigawa R, 2010, THIN SOLID FILMS, V518, P5802, DOI 10.1016/j.tsf.2010.05.071; Kaigawa R, 2011, ENRGY PROCED, V10, DOI 10.1016/j.egypro.2011.10.194; Kaigawa R, 2013, PHYS STATUS SOLIDI C, V10, P1012, DOI 10.1002/pssc.201200842; Kaigawa R, 2012, THIN SOLID FILMS, V520, P4996, DOI 10.1016/j.tsf.2012.02.023; Susaki M, 2005, JPN J APPL PHYS 2, V44, pL866, DOI 10.1143/JJAP.44.L866; Tanaka T, 2012, J APPL PHYS, V111, DOI 10.1063/1.3691964; Tsega M, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.091201; Weber A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3273495; Zhang YW, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.012301	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC02	10.7567/JJAP.54.08KC02		4	Physics, Applied	Physics	CN8BU	WOS:000358662900027		
J	Kaigawa, R; Shibata, S; Klenk, R				Kaigawa, Ryuji; Shibata, Shotaro; Klenk, Reiner			Cu2ZnSnSe4 films directly synthesized by the reaction for 1 s from elemental metal precursor using a spot welding machine	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SOLAR-CELLS; NONVACUUM PROCESS; CIS; CU	Cu2ZnSn(S1-y,Se-y)(4) (CZTSSe) solid solution films were successfully prepared by non vacuum, instantaneous, direct synthesis from Sn/Zn/Cu/(S and Se suspension) precursor films on Mo foil by passing an electrical current through the Mo foil substrate. The structure and composition of the resulting films were dependent on the energy of the spot welding machine used as a power source. In a power range between 0.66 and 0.81 kVA, at Sn/(Sn + Zn) = 0.7, single-phase CZTSSe crystals exhibiting a kesterite (stannite) structure were observed. (C) 2015 The Japan Society of Applied Physics	[Kaigawa, Ryuji; Shibata, Shotaro] Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan; [Klenk, Reiner] Inst Heterogeneous Mat Syst, Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany	Kaigawa, R (reprint author), Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan.						Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Weber A, 2009, THIN SOLID FILMS, V517, P2524, DOI 10.1016/j.tsf.2008.11.033; Kapur VK, 2003, THIN SOLID FILMS, V431, P53, DOI 10.1016/S0040-6090(03)00253-0; Kaelin M, 2005, THIN SOLID FILMS, V480, P486, DOI 10.1016/j.tsf.2004.11.007; Aono M, 2013, PHYS STATUS SOLIDI C, V10, P1058, DOI 10.1002/pssc.201200796; Jackson P, 2015, PHYS STATUS SOLIDI-R, V9, P28, DOI 10.1002/pssr.201409520; Redinger A, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3483760; Eberspacher C, 2001, THIN SOLID FILMS, V387, P18, DOI 10.1016/S0040-6090(00)01729-6; Kaelin M, 2003, THIN SOLID FILMS, V431, P58, DOI 10.1016/S0040-6090(03)00194-9; Kaigawa R, 2009, THIN SOLID FILMS, V517, P2184, DOI 10.1016/j.tsf.2008.10.084; Katagiri H, 2009, THIN SOLID FILMS, V517, P2455, DOI 10.1016/j.tsf.2008.11.002; Brammertz G, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826448; Danilson M, 2011, THIN SOLID FILMS, V519, P7407, DOI 10.1016/j.tsf.2010.12.165; Kaigawa R, 2010, THIN SOLID FILMS, V518, P5802, DOI 10.1016/j.tsf.2010.05.071; Kaigawa R, 2011, ENRGY PROCED, V10, DOI 10.1016/j.egypro.2011.10.194; Weber A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3273495; Zhang YW, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.012301	17	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC04	10.7567/JJAP.54.08KC04		4	Physics, Applied	Physics	CN8BU	WOS:000358662900029		
J	Kaigawa, R; Nakano, S; Gerhardt, P; Klenk, R				Kaigawa, Ryuji; Nakano, Shohei; Gerhardt, Paul; Klenk, Reiner			Wide-band-gap Cu(In,Ga)S-2 solar cells with the junction prepared on the rear surface of the three-stage Cu-deficient absorber films	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CUIN5S8 SINGLE-CRYSTALS; THIN-FILMS; SPECTROSCOPY; SULFIDATION; EVAPORATION; OXIDE; MOO3	Cu(In,Ga)S-2 (CIGS) solar cells were prepared from Cu-deficient absorber films using a lift-off process and then compared with CIGS solar cells prepared without using the lift-off process. The lift-off was achieved through sacrificial molybdenum layers and optimized by different modifications of the latter. We report on the properties of the detached surfaces in terms of their dependence on the composition of the films and compare them to those of the original upper surfaces. This comparison suggests the advantageous properties of the detached surfaces in terms of composition, absence of Cu-deficient phases, and effective doping. (C) 2015 The Japan Society of Applied Physics	[Kaigawa, Ryuji; Nakano, Shohei] Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan; [Gerhardt, Paul; Klenk, Reiner] Inst Heterogeneous Mat Syst, Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany	Kaigawa, R (reprint author), Ryukoku Univ, Dept Elect & Informat, Otsu, Shiga 5202194, Japan.	kaigawa@rins.ryukoku.ac.jp					Abe Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.040201; Abe Y, 2012, THIN SOLID FILMS, V520, P5640, DOI 10.1016/j.tsf.2012.04.073; Anegawa T, 2009, J CRYST GROWTH, V311, P742, DOI 10.1016/j.jcrysgro.2008.09.136; Zhao XY, 2013, MATER RES BULL, V48, P2289, DOI 10.1016/j.materresbull.2013.02.050; Muijsers JC, 1995, J CATAL, V157, P698, DOI 10.1006/jcat.1995.1335; Gannouni M, 2015, MATER RES BULL, V61, P519, DOI 10.1016/j.materresbull.2014.10.070; Weber T, 1996, J PHYS CHEM-US, V100, P14144, DOI 10.1021/jp961204y; Makhova L, 2005, THIN SOLID FILMS, V472, P157, DOI 10.1016/j.tsf.2004.06.128; Merdes S, 2013, PROG PHOTOVOLTAICS, V21, P88, DOI 10.1002/pip.2165; Nishiwaki S, 2003, PROG PHOTOVOLTAICS, V11, P243, DOI 10.1002/pip.486; Galtayries A, 1997, J ELECTRON SPECTROSC, V87, P31, DOI 10.1016/S0368-2048(97)00071-6; Aoyagi K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW05; ENDO S, 1983, NUOVO CIMENTO D, V2, P1875, DOI 10.1007/BF02457879; Marron DF, 2005, J APPL PHYS, V97, DOI 10.1063/1.1891274; Kaigawa R, 2006, THIN SOLID FILMS, V511, P430, DOI 10.1016/j.tsf.2005.11.073; Kaigawa R, 2008, THIN SOLID FILMS, V516, P7046, DOI 10.1016/j.tsf.2007.12.073; Kaigawa R, 2002, THIN SOLID FILMS, V415, P266, DOI 10.1016/S0040-6090(02)00554-0; Kaigawa R, 2005, THIN SOLID FILMS, V480, P71, DOI 10.1016/j.tsf.2004.11.002; Klenk R., 1991, P 22 IEEE PHOT SPEC, P1071; Marsen B, 2011, THIN SOLID FILMS, V519, P7224, DOI 10.1016/j.tsf.2011.01.146; Minemoto T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.012301; Minemoto T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.04DP06; Osada S, 2011, SOL ENERG MAT SOL C, V95, P223, DOI 10.1016/j.solmat.2010.03.033; Qasrawi AF, 2003, CRYST RES TECHNOL, V38, P1063, DOI 10.1002/crat.200310137; SCHEER R, 1995, J VAC SCI TECHNOL A, V13, P1924, DOI 10.1116/1.579631; Shafarman W. N., 2005, P 31 IEEE PVSC, P231; Tamura A, 2013, THIN SOLID FILMS, V546, P379, DOI 10.1016/j.tsf.2013.05.050; Walter T, 1996, SOL ENERG MAT SOL C, V41-2, P355, DOI 10.1016/0927-0248(95)00103-4	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC11	10.7567/JJAP.54.08KC11		5	Physics, Applied	Physics	CN8BU	WOS:000358662900036		
J	Kamioka, T; Hayashi, Y; Nakamura, K; Ohshita, Y				Kamioka, Takefumi; Hayashi, Yutaka; Nakamura, Kyotaro; Ohshita, Yoshio			Simulation of interdigitated back-contact silicon heterojunction solar cells with quantum transport model	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CRYSTALLINE SILICON; EFFICIENCY; DENSITY	A simulation of interdigitated back-contact silicon heterojunction (IBC-SHJ) solar cells was performed using a quantum transport model to consider the quantum effect at the crystalline/amorphous (c/a) heterojunction interface. It was found that the impact of the quantum effect on the open-circuit voltage is comparable to that of the interface defect density at the c/a interface, indicating the importance of implementation of the quantum model. The optimal back-contact design was also discussed from the viewpoint of mass production, in which the design rule is relaxed. The degradation of the conversion efficiency by widening the gap between the p- and n-aSi:H layers can be compensated by improving passivation quality at the c/a interface. (C) 2015 The Japan Society of Applied Physics	[Kamioka, Takefumi; Hayashi, Yutaka; Ohshita, Yoshio] Toyota Technol Inst, Nagoya, Aichi 4688511, Japan; [Nakamura, Kyotaro] Meiji Univ, Kawasaki, Kanagawa 2148571, Japan	Kamioka, T (reprint author), Toyota Technol Inst, Nagoya, Aichi 4688511, Japan.	t-kamioka@toyota-ti.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) under Ministry of Economy, Trade and Industry of Japan	This work was partly supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry of Japan. We also thank our co-workers at SHARP Corporation.	Fujiwara H, 2007, J APPL PHYS, V101, DOI 10.1063/1.2559975; Lu MJ, 2011, PROG PHOTOVOLTAICS, V19, P326, DOI 10.1002/pip.1032; Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Wettstein A, 2001, IEEE T ELECTRON DEV, V48, P279, DOI 10.1109/16.902727; [Anonymous], 2012, ATL VER 5 18 3 R; SLOTBOOM JW, 1976, SOLID STATE ELECTRON, V19, P857, DOI 10.1016/0038-1101(76)90043-5; Nakamura J, 2014, IEEE J PHOTOVOLT, V4, P1491, DOI 10.1109/JPHOTOV.2014.2358377; DZIEWIOR J, 1977, APPL PHYS LETT, V31, P346, DOI 10.1063/1.89694; YANG KH, 1993, SOLID STATE ELECTRON, V36, P321, DOI 10.1016/0038-1101(93)90083-3; Granek F, 2009, PROG PHOTOVOLTAICS, V17, P47, DOI 10.1002/pip.862; STUTZMANN M, 1987, PHYS REV B, V35, P5666, DOI 10.1103/PhysRevB.35.5666; Diouf D, 2010, PHYS STATUS SOLIDI C, V7, P1033, DOI 10.1002/pssc.200982778; FOSSUM JG, 1982, SOLID STATE ELECTRON, V25, P741, DOI 10.1016/0038-1101(82)90203-9; Ghosh K., 2010, P IEEE PHOT SPEC C; Gudovskikh AS, 2006, THIN SOLID FILMS, V511, P385, DOI 10.1016/j.tsf.2005.12.111; Herasimenka S., 2010, P IEEE PHOT SPEC C; Hurkx G. A. M., 1989, International Electron Devices Meeting 1989. Technical Digest (Cat. No.89CH2637-7), DOI 10.1109/IEDM.1989.74285; Kamioka T., 2013, PHOT SCI ENG C, P1; Kamioka T., 2014, EUR PHOT SOL EN C; Lu M., 2009, P IEEE PHOT SPEC C; Nakamura J., 2014, SHARP TECH J, V39, P8; Noge H., COMMUNICATION; Noge H., 2014, 6 WORLD C PHOT EN CO; Saito K., 2014, EUR PHOT SOL EN C EX; Shu Z, 2015, PROG PHOTOVOLTAICS, V23, P78, DOI 10.1002/pip.2400; van Sark W. G. H. M., 2012, PHYS TECHNOLOGY AMOR; van Sark W. G. J. H. M., 2012, PHYS TECHNOLOGY AMOR, DOI DOI 10.1007/978-3-642-22275-7	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD07	10.7567/JJAP.54.08KD07		6	Physics, Applied	Physics	CN8BU	WOS:000358662900052		
J	Kanai, A; Toyonaga, K; Chino, K; Katagiri, H; Araki, H				Kanai, Ayaka; Toyonaga, Kotoba; Chino, Kotaro; Katagiri, Hironori; Araki, Hideaki			Fabrication of Cu2SnS3 thin-film solar cells with power conversion efficiency of over 4%	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							OPTICAL-PROPERTIES; PHOTOVOLTAIC PROPERTIES	Cu2SnS3 (CTS) thin films were produced by the co-evaporation of Cu, Sn, and cracked sulfur, followed by annealing. The as-deposited films were then annealed at 570 degrees C for 5 min in the presence of 100 mg of sulfur lumps in a rapid thermal processing furnace filled with N-2 gas at atmospheric pressure. Solar cells were then fabricated using the CTS films as absorber layers, and their efficiency was evaluated for different Cu/Sn compositional ratios. The largest grain size was found for films with a slightly Sn-rich composition. The highest performance was obtained for solar cells containing a CTS thin film with a Cu/Sn ratio of about 1.9. A cell with a Cu/Sn ratio of 1.87 exhibited an open-circuit voltage of 258 mV, a short-circuit current density of 35.6mA/cm(2), a fill factor of 0.467, and a power conversion efficiency of 4.29%. (C) 2015 The Japan Society of Applied Physics	[Kanai, Ayaka; Toyonaga, Kotoba; Chino, Kotaro; Katagiri, Hironori; Araki, Hideaki] Nagaoka Natl Coll Technol, Nagaoka, Niigata 9408532, Japan; [Araki, Hideaki] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kanai, A (reprint author), Nagaoka Natl Coll Technol, Nagaoka, Niigata 9408532, Japan.	h-araki@nagaoka-ct.ac.jp			PRESTO, Japan Science and Technology Agency, Japan; NS Promotion Foundation for Science of Perception; Foundation for Applied Research and Technological Uniqueness at Nagaoka University of Technology	This work was supported in part by PRESTO, Japan Science and Technology Agency, Japan. The authors sincerely thank Mr. K. Jimbo and the members of Professor H. Katagiri's laboratory at Nagaoka National College of Technology for the J-V measurements. One of the authors (A. Kanai) would like to thank the NS Promotion Foundation for Science of Perception, and the Foundation for Applied Research and Technological Uniqueness at Nagaoka University of Technology for supporting this research.	Aihara N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW13; Onoda M, 2000, MATER RES BULL, V35, P1563, DOI 10.1016/S0025-5408(00)00347-0; Kanai A, 2015, PHYS STATUS SOLIDI B, V252, P1239, DOI 10.1002/pssb.201400297; Fernandes PA, 2010, PHYS STATUS SOLIDI C, V7, P901, DOI 10.1002/pssc.200982746; Tiwari D, 2013, SOL ENERG MAT SOL C, V113, P165, DOI 10.1016/j.solmat.2013.02.017; Vanalakar SA, 2015, ACTA MATER, V85, P314, DOI 10.1016/j.actamat.2014.11.043; Chen QM, 2012, J COLLOID INTERF SCI, V376, P327, DOI 10.1016/j.jcis.2012.03.015; Fiechter S, 2003, J PHYS CHEM SOLIDS, V64, P1859, DOI 10.1016/S0022-3697(03)00172-0; Berg DM, 2012, THIN SOLID FILMS, V520, P6291, DOI 10.1016/j.tsf.2012.05.085; Dahman H, 2014, VACUUM, V101, P208, DOI 10.1016/j.vacuum.2013.08.019; Berg DM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4712623; Bouaziz M, 2011, VACUUM, V85, P783, DOI 10.1016/j.vacuum.2010.10.001; Fernandes PA, 2010, J PHYS D APPL PHYS, V43, DOI 10.1088/0022-3727/43/21/215403; Aihara N, 2013, PHYS STATUS SOLIDI C, V10, P1086, DOI 10.1002/pssc.201200866; KUKU TA, 1987, SOL ENERG MATER, V16, P199, DOI 10.1016/0165-1633(87)90019-0; Amlouk A, 2010, VACUUM, V85, P60, DOI 10.1016/j.vacuum.2010.04.002; Toyama T, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.075503; Bouaziz M, 2009, THIN SOLID FILMS, V517, P2527, DOI 10.1016/j.tsf.2008.11.039; Araki H., 2014, P INT C GRAND REN EN; Chierchia R., 2014, P 29 EUR PHOT SOL EN; Chino K., 2011, 21 INT PHOT SCI ENG; Chino K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC35; Cho DH, 2014, J MATER CHEM A, V2, P14593, DOI 10.1039/c4ta02507e; Kanai A., 2014, P 29 EUR PHOT SOL EN, P1805; Koike J., 2011, 21 INT PHOT SCI ENG; Koike J, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC34; Nomura T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW01; Powalla M., 2014, P 29 EUR PHOT SOL EN; Tiwari D, 2014, APPL PHYS A-MATER, V117, P1139, DOI 10.1007/s00339-014-8484-2; Tiwari D, 2014, J MATER SCI-MATER EL, V25, P3687, DOI 10.1007/s10854-014-2076-y; Umehara M, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.045501	31	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC06	10.7567/JJAP.54.08KC06		4	Physics, Applied	Physics	CN8BU	WOS:000358662900031		
J	Kanematsu, D; Yata, S; Terakawa, A; Tanaka, M; Konagai, M				Kanematsu, Daiji; Yata, Shigeo; Terakawa, Akira; Tanaka, Makoto; Konagai, Makoto			Photovoltaic properties of axial-junction silicon nanowire solar cells with integrated arrays	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ATOMIC-FORCE MICROSCOPY; P-N-JUNCTIONS; CONTROLLED GROWTH; NANOPARTICLES; LITHOGRAPHY; CONFINEMENT; ABSORPTION; NANOHOLES; CATALYST	Wide-gap Si nanowire (SiNW) solar cells that use the quantum size effect require a p-n junction to be formed inside wires with a diameter smaller than 4 nm. To realize this, we developed a device integration process and confirmed power generation, for the first time, by an axial-junction SiNW solar cell with a diameter of 30 nm and a device area of 1 mm(2). We confirmed that such a SiNW solar cell had almost the same open-circuit voltage and low short-circuit current density as a bulk Si solar cell. We also investigated the problems related to SiNW solar cells by measuring the functioning SiNW density. (C) 2015 The Japan Society of Applied Physics	[Kanematsu, Daiji; Yata, Shigeo; Terakawa, Akira; Tanaka, Makoto] Panasonic Corp, Kadoma, Osaka 5718686, Japan; [Kanematsu, Daiji; Konagai, Makoto] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan	Kanematsu, D (reprint author), Panasonic Corp, Kadoma, Osaka 5718686, Japan.	kanematsu.daiji@jp.panasonic.com			MEXT FUTURE-PV Innovation	Part of this work was performed under the management of JST supported by MEXT FUTURE-PV Innovation.	Kempa TJ, 2008, NANO LETT, V8, P3456, DOI 10.1021/nl8023438; Ma DDD, 2003, SCIENCE, V299, P1874, DOI 10.1126/science.1080313; Weisse JM, 2011, NANO LETT, V11, P1300, DOI 10.1021/nl104362e; Garnett E, 2010, NANO LETT, V10, P1082, DOI 10.1021/nl100161z; Hoffmann S, 2009, NANO LETT, V9, P1341, DOI 10.1021/nl802977m; Sturmberg BCP, 2011, OPT EXPRESS, V19, pA1067, DOI 10.1364/OE.19.0A1067; Hochbaum AI, 2005, NANO LETT, V5, P457, DOI 10.1021/nl047990x; Cho EC, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/24/245201; Wu Y, 2004, NANO LETT, V4, P433, DOI 10.1021/nl035162i; Tsujino K, 2005, ADV MATER, V17, P1045, DOI 10.1002/adma.200401681; Chang SW, 2009, ADV FUNCT MATER, V19, P2495, DOI 10.1002/adfm.200900181; Weisse JM, 2012, NANO LETT, V12, P3339, DOI 10.1021/nl301659m; Sivakov V, 2009, NANO LETT, V9, P1549, DOI 10.1021/nl803641f; Conibeer G, 2008, THIN SOLID FILMS, V516, P6748, DOI 10.1016/j.tsf.2007.12.096; Zhang X, 2013, J PHYS CHEM LETT, V4, P2002, DOI 10.1021/jz400533v; Feng SQ, 2000, J CRYST GROWTH, V209, P513, DOI 10.1016/S0022-0248(99)00608-9; Moutinho HR, 2006, THIN SOLID FILMS, V514, P150, DOI 10.1016/j.tsf.2006.03.003; Dossou KB, 2012, J OPT SOC AM A, V29, P817, DOI 10.1364/JOSAA.29.000817; Kurokawa Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.11PE12; Tsakalakos L, 2007, J NANOPHOTONICS, V1, DOI 10.1117/1.2768999; Wang J, 2011, OPT EXPRESS, V19, P23078, DOI 10.1364/OE.19.023078; Choi WK, 2008, NANO LETT, V8, P3799, DOI 10.1021/nl802129f; Chang SW, 2010, ADV FUNCT MATER, V20, P4364, DOI 10.1002/adfm.201000437; Musin RN, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.165308; Hu L, 2007, NANO LETT, V7, P3249, DOI 10.1021/nl071018b; Kato S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BP09; Kato S, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-361; Tsujino K, 2005, ELECTROCHEM SOLID ST, V8, pC193, DOI 10.1149/1.2109347; Stelzner T, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295203; Trenkler T, 2000, J VAC SCI TECHNOL B, V18, P418, DOI 10.1116/1.591205; Xu DG, 2005, NANO LETT, V5, P571, DOI 10.1021/nl048218x; Yoo J, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4794541; Zhang ML, 2008, J PHYS CHEM C, V112, P4444, DOI 10.1021/jp077053o	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA09	10.7567/JJAP.54.08KA09		4	Physics, Applied	Physics	CN8BU	WOS:000358662900010		
J	Kang, DW; Sichanugrist, P; Miyajima, S; Konagai, M				Kang, Dong-Won; Sichanugrist, Porponth; Miyajima, Shinsuke; Konagai, Makoto			Low-temperature-processed a-SiOx:H/a-Si:H tandem cells for full spectrum solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							AMORPHOUS-SILICON; HIGH-EFFICIENCY; HYDROGEN DILUTION; VAPOR-DEPOSITION; JUNCTION; TRIPLE; FILMS; TECHNOLOGY; GERMANIUM	We developed wide-bandgap amorphous silicon (a-Si:H) and amorphous silicon oxide (a-SiOx:H) absorbers by extremely decreasing deposition temperature to as low as 100 degrees C. By adjusting hydrogen and carbon dioxide gas flow rates, device-quality absorbers and thus suitable single junction cells were obtained. An a-SiOx:H single-junction cell (i = 100 nm) fabricated employing the absorber we developed showed an open circuit voltage (V-oc) of 1.007V and a fill factor of 0.741, which are better than those of a-Si:H cells. This a-SiOx:H cell was introduced in a-SiOx:H/a-Si:H tandem cells as the top cell, which contributed to the achievement of a markedly high V-oc of 1.910 V. This tandem cell with an efficiency of 9.25% showed better V-oc and current matching property than the a-Si:H/a-Si:H (8.74%) tandem structure. The low-temperature-gradient a-SiOx:H/a-Si:H tandem cells can be a promising configuration for spectrum splitting applications. (C) 2015 The Japan Society of Applied Physics	[Kang, Dong-Won; Sichanugrist, Porponth; Miyajima, Shinsuke; Konagai, Makoto] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Konagai, Makoto] Tokyo Inst Technol, Photovolta Res Ctr, Meguro Ku, Tokyo 1528552, Japan	Kang, DW (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.	kang.d.aa@m.titech.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) under Ministry of Economy, Trade, and Industry, Japan (METI)	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade, and Industry, Japan (METI).	McCambridge JD, 2011, PROG PHOTOVOLTAICS, V19, P352, DOI 10.1002/pip.1030; Descoeudres A, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3641899; Kim S, 2013, SOL ENERG MAT SOL C, V119, P214, DOI 10.1016/j.solmat.2013.07.011; Han DX, 2003, J APPL PHYS, V93, P3776, DOI 10.1063/1.1555680; Yang J, 1997, APPL PHYS LETT, V70, P2975, DOI 10.1063/1.118761; Kroll U, 1998, J NON-CRYST SOLIDS, V227, P68, DOI 10.1016/S0022-3093(98)00329-9; Imenes AG, 2004, SOL ENERG MAT SOL C, V84, P19, DOI 10.1016/j.solmat.2004.01.038; Deng XM, 2000, SOL ENERG MAT SOL C, V62, P89, DOI 10.1016/S0927-0248(99)00139-7; Sritharathikhun J, 2013, THIN SOLID FILMS, V546, P383, DOI 10.1016/j.tsf.2013.05.138; Kroll U, 1996, J APPL PHYS, V80, P4971, DOI 10.1063/1.363541; Yan BJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3638068; Barnett A, 2009, PROG PHOTOVOLTAICS, V17, P75, DOI 10.1002/pip.852; Sritharathikhun J, 2011, CURR APPL PHYS, V11, pS17, DOI 10.1016/j.cap.2010.11.100; Zheng XX, 2012, SOL ENERG MAT SOL C, V101, P15, DOI 10.1016/j.solmat.2012.02.021; Lee JE, 2013, SOLID STATE SCI, V20, P70, DOI 10.1016/j.solidstatesciences.2013.03.015; Kim S, 2013, SOL ENERG MAT SOL C, V119, P26, DOI 10.1016/j.solmat.2013.04.016; Schuttauf JW, 2015, SOL ENERG MAT SOL C, V133, P163, DOI 10.1016/j.solmat.2014.11.006; Schuttauf JW, 2014, IEEE J PHOTOVOLT, V4, P757, DOI 10.1109/JPHOTOV.2014.2307162; Banerjee A., 2011, P 37 IEEE PHOT SPEC, P3583; Barnett A., 2008, 33 IEEE PHOT SPEC C; Chang PK, 2012, THIN SOLID FILMS, V520, P3684, DOI 10.1016/j.tsf.2011.12.083; Inthisang S, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.122402; Ito M, 2001, THIN SOLID FILMS, V383, P129, DOI 10.1016/S0040-6090(00)01590-X; Kang D.-W., 2014, P 6 WORLD C PHOT EN, P219; Koch C, 2001, SOL ENERG MAT SOL C, V68, P227, DOI 10.1016/S0927-0248(00)00249-X; Myong SY, 2013, SOL ENERG MAT SOL C, V116, P182, DOI 10.1016/j.solmat.2013.04.031; Shu GW, 2013, OPT EXPRESS, V21, pA123, DOI 10.1364/OE.21.00A123; Soderstrom K, 2012, J APPL PHYS, V112, DOI 10.1063/1.4768272; Uzu H, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905177; Yunaz IA, 2007, JPN J APPL PHYS 2, V46, pL1152, DOI 10.1143/JJAP.46.L1152	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KB02	10.7567/JJAP.54.08KB02		5	Physics, Applied	Physics	CN8BU	WOS:000358662900016		
J	Khatri, I; Matsuyama, I; Yamaguchi, H; Fukai, H; Nakada, T				Khatri, Ishwor; Matsuyama, Isamu; Yamaguchi, Hiroshi; Fukai, Hirofumi; Nakada, Tokio			Surface sulfurization on MBE-grown Cu(In1-x,Ga-x)Se-2 thin films and devices	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TIME-RESOLVED PHOTOLUMINESCENCE; CU(IN,GA)SE-2 SOLAR-CELLS; SULFUR; DITERTIARYBUTYLSULFIDE; DIFFUSION	Molecular beam epitaxy (MBE) grown Cu(In1-x,Ga-x)Se-2 (CIGS) thin films were sulfurized at temperatures of 450-550 degrees C for 30 min in a 10% H2S-N-2 mixture gas. The micro-roughness together with the S diffusion in the CIGS surfaces increased with increasing sulfurization temperature. Both near-band-edge PL intensity and decay time of the CIGS absorber layer enhanced after sulfurization. PL sub-peak around 80 meV below the main peak almost disappeared after sulfurization above 500 degrees C, which is expected due to the occupation of Se vacancies (V-se) with S. The open-circuit voltage (V-oc), hence conversion efficiency, improved after sulfurization. The photovoltaic performance of the solar cells was consistent with PL intensity. Moreover, it is found for the first time from the SIMS analysis that the Cu atoms were depleted at the surface of CIGS layer after sulfurization, which could result in the improved V-oc. (C) 2015 The Japan Society of Applied Physics	[Khatri, Ishwor; Matsuyama, Isamu; Yamaguchi, Hiroshi; Fukai, Hirofumi; Nakada, Tokio] Tokyo Univ Sci, Res Inst Sci & Technol, Photovolta Sci & Technol Res Div, Noda, Chiba 2788510, Japan	Khatri, I (reprint author), Tokyo Univ Sci, Res Inst Sci & Technol, Photovolta Sci & Technol Res Div, Noda, Chiba 2788510, Japan.	i_khatri@rs.tus.ac.jp			Solar Frontier KK under a NEDO project "Development of Next-generation High-Performance Technology for PV Power Generation System"	This work was supported in part by Solar Frontier KK under a NEDO project "Development of Next-generation High-Performance Technology for PV Power Generation System".	Kushiya K, 2014, SOL ENERG MAT SOL C, V122, P309, DOI 10.1016/j.solmat.2013.09.014; Shimakawa S, 2008, SOL ENERG MAT SOL C, V92, P1086, DOI 10.1016/j.solmat.2008.03.014; Pistor P, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4892882; Nagoya Y, 2001, SOL ENERG MAT SOL C, V67, P247, DOI 10.1016/S0927-0248(00)00288-9; Shirakata S, 2007, THIN SOLID FILMS, V515, P6151, DOI 10.1016/j.tsf.2006.12.040; Kobayashi T, 2015, PROG PHOTOVOLTAICS, V23, P1367, DOI 10.1002/pip.2554; Ohashi D, 2001, SOL ENERG MAT SOL C, V67, P261, DOI 10.1016/S0927-0248(00)00290-7; Nakada T, 1999, APPL PHYS LETT, V74, P2444, DOI 10.1063/1.123875; Shafarman WN, 1996, J APPL PHYS, V79, P7324, DOI 10.1063/1.361431; Bar M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2955532; Metzger WK, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2957983; Wada T, 2001, SOL ENERG MAT SOL C, V67, P305, DOI 10.1016/S0927-0248(00)00296-8; Nakada T, 1997, SOL ENERG MAT SOL C, V49, P285, DOI 10.1016/S0927-0248(97)00054-8; Turcu M, 2002, J APPL PHYS, V91, P1391, DOI 10.1063/1.1432126; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Pianezzi F, 2014, PHYS CHEM CHEM PHYS, V16, P8843, DOI 10.1039/c4cp00614c; Bar M, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3046780; Basol BM, 2000, PROG PHOTOVOLTAICS, V8, P227, DOI 10.1002/(SICI)1099-159X(200003/04)8:2<227::AID-PIP308>3.0.CO;2-G; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Liu XH, 2014, SOL ENERG MAT SOL C, V124, P227, DOI 10.1016/j.solmat2014.02.008; Liu XH, 2014, THIN SOLID FILMS, V558, P400, DOI 10.1016/j.tsf.2014.02.066; Nakada T., 2012, P 29 IEEE PHOT SPEC, P527; Pianezzi F, 2013, J APPL PHYS, V114, DOI 10.1063/1.4832781; Shirakata S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW11; Shirakata S, 2009, PHYS STATUS SOLIDI C, V6, P1059, DOI 10.1002/pssc.200881164; Shirakata S, 2011, SOL ENERG MAT SOL C, V95, P219, DOI 10.1016/j.solmat.2010.04.067; Singh UP, 2006, SOL ENERG MAT SOL C, V90, P623, DOI 10.1016/j.solmat.2005.04.037	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC10	10.7567/JJAP.54.08KC10		4	Physics, Applied	Physics	CN8BU	WOS:000358662900035		
J	Kojima, T; Tachibana, T; Ohshita, Y; Prakash, RR; Sekiguchi, T; Yamaguchi, M				Kojima, Takuto; Tachibana, Tomihisa; Ohshita, Yoshio; Prakash, Ronit R.; Sekiguchi, Takashi; Yamaguchi, Masafumi			Origin of recombination activity at small angle grain boundaries in multicrystalline silicon using multi-seed casting growth method	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							BEAM-INDUCED-CURRENT; DIRECTIONAL SOLIDIFICATION; TEMPERATURE; SI; CONTAMINATION; LUMINESCENCE; EVOLUTION; CONTRAST; DEFECTS; INGOTS	The effect of misorientation on the recombination activity of tilt small angle grain boundaries was studied by temperature-dependent electron beam induced current (EBIC) analyses of artificially induced grain boundaries in multicrystal grown by casting from multiple seeds. For small misorientation, there is no significant difference in the recombination of grain boundaries at the middle of a grown ingot, whereas moderate contamination on grain boundaries caused changes in the EBIC contrast, especially at room temperature. The EBIC contrast of moderately contaminated grain boundaries at room temperature has a peak at a misorientation of similar to 3 degrees, and for misorientation theta > 6 degrees, the recombinative nature diminishes with increasing misorientation. The results indicate differences in the gettering ability of small angle grain boundaries. (C) 2015 The Japan Society of Applied Physics	[Kojima, Takuto; Tachibana, Tomihisa; Ohshita, Yoshio; Yamaguchi, Masafumi] Toyota Technol Inst, Nagoya, Aichi 4688511, Japan; [Prakash, Ronit R.; Sekiguchi, Takashi] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Prakash, Ronit R.; Sekiguchi, Takashi] Univ Tsukuba, Grad Sch Pure & Appl Sci, Tsukuba, Ibaraki 3058571, Japan	Kojima, T (reprint author), Toyota Technol Inst, Nagoya, Aichi 4688511, Japan.	tkojima@toyota-ti.ac.jp	takashi, Sekiguchi/D-2603-2010		New Energy and Industrial Technology Development Organization (NEDO)	Part of this study was supported by the New Energy and Industrial Technology Development Organization (NEDO).	Chen J, 2005, J APPL PHYS, V97, DOI 10.1063/1.1836009; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Kittler M, 2002, SOL ENERG MAT SOL C, V72, P465, DOI 10.1016/S0927-0248(01)00194-5; Autruffe A, 2015, J CRYST GROWTH, V411, P12, DOI 10.1016/j.jcrysgro.2014.10.054; Arafune K, 2007, J CRYST GROWTH, V308, P5, DOI [10.1016/j.jcrysgro.2007.06.035, 10.1016/j.jerysgro.2007.06.035]; Corkish R, 1998, J APPL PHYS, V84, P5473, DOI 10.1063/1.368310; Kvande R, 2008, J APPL PHYS, V104, DOI 10.1063/1.2956697; Oriwol D, 2013, ACTA MATER, V61, P6903, DOI 10.1016/j.actamat.2013.08.002; Stokkan G, 2014, SOL ENERG MAT SOL C, V130, P679, DOI 10.1016/j.solmat.2014.02.034; Chen J, 2004, J APPL PHYS, V96, P5490, DOI 10.1063/1.1797548; [Anonymous], 1983, IEEE COMPUT, DOI DOI 10.1109/MC.1983.1654163; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Breitenstein O, 2008, SCANNING, V30, P331, DOI 10.1002/sca.20112; Chen J., 2008, SOLID STATE PHENOM, V131-133, P9; Chen J, 2007, PHYS STATUS SOLIDI C, V4, P2908, DOI 10.1002/pssc.200675435; Chen J, 2007, JPN J APPL PHYS 1, V46, P6489, DOI 10.1143/JJAP.46.6489; Chen J., 2010, SOLID STATE PHENOM, V156-158, P19; Chen J, 2005, PHYSICA B, V364, P162, DOI 10.1016/j.physb.2005.04.008; Ikeda K, 2000, J CRYST GROWTH, V210, P90, DOI 10.1016/S0022-0248(99)00653-3; Jiptner K, 2013, PHYS STATUS SOLIDI C, V10, P141, DOI 10.1002/pssc.201200884; KITTLER M, 1993, PHYS STATUS SOLIDI A, V138, P687, DOI 10.1002/pssa.2211380240; RIZK R, 1995, J APPL PHYS, V77, P1875, DOI 10.1063/1.358888; Sameshima T, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.042301; Sugimoto H, 2007, J APPL PHYS, V102, DOI 10.1063/1.2776003; Yang YM, 2015, PROG PHOTOVOLTAICS, V23, P340, DOI 10.1002/pip.2437	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD16	10.7567/JJAP.54.08KD16		4	Physics, Applied	Physics	CN8BU	WOS:000358662900061		
J	Kojima, Y; Isomura, M				Kojima, Yuji; Isomura, Masao			Crystalline silicon germanium films grown on crystalline silicon substrates by solid phase crystallization	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SIGE THIN-FILMS; MOLECULAR-BEAM EPITAXY; JUNCTION SOLAR-CELLS; CONVERSION EFFICIENCY; ALLOYS; GAP	We researched on crystalline silicon-germanium films (c-SiGe) for bottom cells of silicon-based multijunction solar cells. We conducted the epitaxial crystal growth of SiGe with approximately 75% Ge fraction due to solid phase crystallization (SPC) from amorphous silicon-germanium (a-SiGe) precursors on n-type (100) Si substrates. We evaluated the preparation conditions of a-SiGe precursors for the SPC epitaxial growth. The epitaxial growth was successfully conducted and (100)-oriented c-SiGe films were formed. The epitaxial growth was effectively promoted in the a-SiGe precursors prepared at the substrate temperature from 250 to 300 degrees C, but is not sufficiently promoted in the a-SiGe precursors prepared below 250 degrees C. The density of a-SiGe precursors is relatively low at the substrate temperature below 250 degrees C, and the low-density structures cause the impurity incorporation from the air-exposed surface. The impurities are probably the main cause of disturbance of the epitaxial growth. On the other hand, the random crystallization occurred in the SPC of the a-SiGe precursors prepared at 350 degrees C. The precursors have the slightly crystallized structure and are not suitable for the SPC. (C) 2015 The Japan Society of Applied Physics	[Kojima, Yuji; Isomura, Masao] Tokai Univ, Grad Sch Engn, Hiratsuka, Kanagawa 2571292, Japan; [Isomura, Masao] Tokai Univ, Dept Elect & Elect Engn, Hiratsuka, Kanagawa 2571292, Japan	Kojima, Y (reprint author), Tokai Univ, Grad Sch Engn, Hiratsuka, Kanagawa 2571292, Japan.	isomura@tokai-u.jp			Incorporated Administrative Agency New Energy and Industrial Technology Development Organization under Ministry of Economy, Trade and Industry	This work was supported by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization under the Ministry of Economy, Trade and Industry.	Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Matsui T, 2006, J NON-CRYST SOLIDS, V352, P1255, DOI 10.1016/j.jnoncrysol.2005.11.144; Isomura M, 2002, SOL ENERG MAT SOL C, V74, P519, DOI 10.1016/S0927-0248(02)00069-7; Dimoulas A, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2410241; HISHIKAWA Y, 1991, JPN J APPL PHYS 1, V30, P1008, DOI 10.1143/JJAP.30.1008; ALONSO MI, 1989, PHYS REV B, V39, P10056, DOI 10.1103/PhysRevB.39.10056; Nakamura I, 2006, VACUUM, V80, P712, DOI 10.1016/j.vacuum.2005.11.032; Zhao JH, 1998, APPL PHYS LETT, V73, P1991, DOI 10.1063/1.122345; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Green MA, 2001, PROG PHOTOVOLTAICS, V9, P123, DOI 10.1002/pip.360; HIRAYAMA H, 1990, APPL PHYS LETT, V56, P1107, DOI 10.1063/1.102582; Isomura M, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.04DR08; Kanai M, 2014, CAN J PHYS, V92, P576, DOI 10.1139/cjp-2013-0588; Kawauchi H, 2008, J NON-CRYST SOLIDS, V354, P2109, DOI 10.1016/j.jnoncrysol.2007.09.019; KUHNE H, 1992, THIN SOLID FILMS, V222, P34, DOI 10.1016/0040-6090(92)90033-8; Matsui T, 2008, J NON-CRYST SOLIDS, V354, P2468, DOI [10.1016/j.jnoncrysol.2007.09.026, 10.1016/j.jnoncryso1.2007.09.026]; Matsui T, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779928; Matsui T, 2009, SOL ENERG MAT SOL C, V93, P1100, DOI 10.1016/j.solmat.2008.12.023; Matsui T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2358318; Matsui T, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.031501; Mulligan W.P., 2004, P 19 EUR PHOT SOL EN, P387; Nakahata K, 2003, SOL ST PHEN, V93, P231; Pallik E. D., 1991, HDB OPTICAL CONSTANT; PEOPLE R, 1986, APPL PHYS LETT, V48, P538, DOI 10.1063/1.96499; Suzuki A, 2012, J NON-CRYST SOLIDS, V358, P2166, DOI 10.1016/j.jnoncrysol.2011.12.015; VAN DE WALLE CG, 1985, J VAC SCI TECHNOL B, V3, P1256, DOI 10.1116/1.583051; YAMADA A, 1991, J APPL PHYS, V69, P1008, DOI 10.1063/1.347415; Yamaguchi T., 2012, P 22 INT PHOT SCI EN, P4	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KB01	10.7567/JJAP.54.08KB01		5	Physics, Applied	Physics	CN8BU	WOS:000358662900015		
J	Kutsukake, K; Deura, M; Ohno, Y; Yonenaga, I				Kutsukake, Kentaro; Deura, Momoko; Ohno, Yutaka; Yonenaga, Ichiro			Characterization of silicon ingots: Mono-like versus high-performance multicrystalline	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SINGLE CRYSTALLINE SILICON; EFFICIENCY SOLAR-CELLS; DIRECTIONAL SOLIDIFICATION; GRAIN-BOUNDARIES; GROWTH; QUALITY; WAFERS	Mono-like Si and high-performance multicrystalline Si ingots were grown using the same furnace and the same procedure for growth, but different seeds. In addition, a conventional multicrystalline Si ingot was grown using the same furnace, by a different growth procedure. By comparing the grain structures, the distribution of carrier lifetime, and dislocations in the ingots, we qualitatively illustrated their material features. The average carrier lifetime of the mono-like Si is almost the same as that of the high-performance multicrystalline Si, and slightly shorter than that of the conventional multicrystalline Si. This would be caused by the higher density of metal contaminants owing to the longer process time for raw material melting. The density of dislocations and their clusters was significantly lower in the mono-like Si and high-performance multicrystalline Si than that in the conventional multicrystalline Si. The origin of these differences was discussed on the basis of the difference in the growth procedure and grain structure of the ingots. (C) 2015 The Japan Society of Applied Physics	[Kutsukake, Kentaro; Deura, Momoko; Ohno, Yutaka; Yonenaga, Ichiro] Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan; [Kutsukake, Kentaro] Japan Sci & Technol Agcy, PRESTO, Kawaguchi, Saitama 3320012, Japan	Kutsukake, K (reprint author), Tohoku Univ, Inst Mat Res, Sendai, Miyagi 9808577, Japan.	kutukake@imr.tohoku.ac.jp	Ohno, Yutaka/C-1908-2009; Deura, Momoko/M-8461-2014; Kutsukake, Kentaro/M-7636-2014		Ministry of Education, Culture, Sports, Science and Technology of Japan [25706018]; Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST)	We would like to acknowledge N. Usami and I. Takahashi of Nagoya University, K. Nakajima and R. Murai of Fukushima Top-Level United Center for Renewable Energy Research-PhotoVoltaics (FUTURE-PV) Innovation, K. Morishita of Kyoto University, and K. Fujiwara of Tohoku University for their support in the experiments and fruitful discussions. We would also like to acknowledge Silicon Plus Co., Ltd. for carrying out the crystal growth experiments. This work was partially supported by a Grant-in-Aid for Scientific Research (No. 25706018) from the Ministry of Education, Culture, Sports, Science and Technology of Japan and a grant for Precursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency (JST).	Jouini A, 2012, PROG PHOTOVOLTAICS, V20, P735, DOI 10.1002/pip.1221; Lan CW, 2012, J CRYST GROWTH, V360, P68, DOI 10.1016/j.jcrysgro.2012.01.007; Kaden T, 2012, ENRGY PROCED, V27, P103, DOI 10.1016/j.egypro.2012.07.036; Wong YT, 2014, J CRYST GROWTH, V387, P10, DOI 10.1016/j.jcrysgro.2013.10.021; Zhu DD, 2014, J CRYST GROWTH, V386, P52, DOI 10.1016/j.jcrysgro.2013.09.051; Gu X, 2012, SOL ENERG MAT SOL C, V101, P95, DOI 10.1016/j.solmat.2012.02.024; Kutsukake K, 2007, J APPL PHYS, V101, DOI 10.1063/1.2710348; Trempa M, 2012, J CRYST GROWTH, V351, P131, DOI 10.1016/j.jcrysgro.2012.04.035; Kutsukake K, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.025505; Stoddard N, 2008, SOL ST PHEN, V131-133, P1; Stokkan G, 2014, SOL ENERG MAT SOL C, V130, P679, DOI 10.1016/j.solmat.2014.02.034; Prakash RR, 2014, J CRYST GROWTH, V401, P717, DOI [10.1016/j.jcrysgro.2014.01.067, 10.1016/j.jcrysgro.2013.01.067]; Jay F, 2014, SOL ENERG MAT SOL C, V130, P690, DOI 10.1016/j.solmat.2014.02.025; Kutsukake K, 2014, IEEE J PHOTOVOLT, V4, P84, DOI 10.1109/JPHOTOV.2013.2281730; Haunschild J, 2010, SOL ENERG MAT SOL C, V94, P2007, DOI 10.1016/j.solmat.2010.06.003; Ma WC, 2012, SOL ENERG MAT SOL C, V100, P231, DOI 10.1016/j.solmat.2012.01.024; Chen J, 2007, JPN J APPL PHYS 1, V46, P6489, DOI 10.1143/JJAP.46.6489; Garandet J. P., 1994, HDB CRYSTAL GROWTH, V2; Jiptner K, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.065501; Kutsukake K., 2014, 6 WORLD C PHOT EN CO; Kutsukake K, 2009, J APPL PHYS, V105, DOI 10.1063/1.3079504; Kutsukake K, 2007, MATER TRANS, V48, P143, DOI 10.2320/matertrans.48.143; Li ZY, 2014, J APPL PHYS, V115, DOI 10.1063/1.4874941; Mrcarica M., 2013, PHOTOVOLTAICS INT, V19, P28; Neuberger M., 1969, SILICON DATA SHEETS, P48; Petter K., 2012, P 27 EUR PHOT SOL EN, P984; Sze S. M., 1981, PHYSICS SEMICONDUCTO, V2nd, P32; Takahashi I, 2008, JPN J APPL PHYS, V47, P8790, DOI 10.1143/JJAP.47.8790; Verlinden P. J., 2014, 6 WORLD C PHOT EN CO; Yang YM, 2015, PROG PHOTOVOLTAICS, V23, P340, DOI 10.1002/pip.2437	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD10	10.7567/JJAP.54.08KD10		5	Physics, Applied	Physics	CN8BU	WOS:000358662900055		
J	Lee, H; Ueda, K; Enomoto, Y; Arafune, K; Yoshida, H; Satoh, S; Chikyow, T; Ogura, A				Lee, Hyunju; Ueda, Keigo; Enomoto, Yuya; Arafune, Koji; Yoshida, Haruhiko; Satoh, Shin-ichi; Chikyow, Toyohiro; Ogura, Atsushi			Surface passivation of crystalline silicon by sputtered AlOx/AlNx stacks toward low-cost high-efficiency silicon solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							OPTIMIZED ANTIREFLECTION COATINGS; CHEMICAL-VAPOR-DEPOSITION; ALN THIN-FILMS; THERMAL-STABILITY; ALUMINUM NITRIDE; ELECTRICAL-PROPERTIES; AL2O3/SINX STACKS; ABSORPTION-EDGE; RECOMBINATION; OXIDE	Recently, excellent surface passivation has been achieved for both p- and n-type silicon solar cells using AlOx/SiNx:H stacks deposited by atomic layer deposition and plasma-enhanced chemical vapor deposition. However, alternative materials and deposition methods could provide practical options for large-scale manufacturing of commercial solar cells. In this study we demonstrate that AlOx/AlNx stacks fabricated by reactive radio-frequency magnetron sputtering can provide fairly good surface passivation (S-max of similar to 30 cm/s) regardless of AlOx thickness, which is found to be due to the high negative fixed charge density (Q(eff) of -2.8 x 10(12) cm(-2)) and moderately low interface trap density (D-it of 2.0 x 10(11) eV(-1).cm(-2)). The stacks also show fairly good antireflection performance in the visible and near-infrared spectral region. The demonstrated surface passivation and antireflection performance of in situ reactively sputtered AlOx/AlNx stacks make them a promising candidate for a surface-passivating antireflection coating on silicon solar cells. (C) 2015 The Japan Society of Applied Physics	[Lee, Hyunju; Ogura, Atsushi] Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan; [Ueda, Keigo; Enomoto, Yuya; Arafune, Koji; Yoshida, Haruhiko; Satoh, Shin-ichi] Univ Hyogo, Grad Sch Engn, Himeji, Hyogo 6712280, Japan; [Chikyow, Toyohiro] Natl Inst Mat Sci, Tsukuba, Ibaraki 3050044, Japan; [Lee, Hyunju; Arafune, Koji; Yoshida, Haruhiko; Satoh, Shin-ichi; Ogura, Atsushi] Japan Sci & Technol Agcy JST, CREST, Kawaguchi, Saitama 3320012, Japan	Lee, H (reprint author), Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan.	leehyunju@toyota-ti.ac.jp			Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)	The authors thank the MANA foundry at NIMS for the experimental support on sample fabrication and analysis. This work was supported by the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST).	AITA CR, 1989, J APPL PHYS, V66, P4360, DOI 10.1063/1.343986; Stampfl C, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.155212; Profijt HB, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3609974; Hoex B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2784168; Hoex B, 2008, J APPL PHYS, V104, DOI 10.1063/1.3021091; Lopez G, 2013, BEILSTEIN J NANOTECH, V4, P726, DOI 10.3762/bjnano.4.82; ABID A, 1986, J MATER SCI, V21, P1301, DOI 10.1007/BF00553267; Mattila T, 1997, PHYS REV B, V55, P9571, DOI 10.1103/PhysRevB.55.9571; Johnson RS, 2001, J VAC SCI TECHNOL A, V19, P1353, DOI 10.1116/1.1379316; SPROUL AB, 1994, J APPL PHYS, V76, P2851, DOI 10.1063/1.357521; Schmidt J, 2012, ENRGY PROCED, V15, P30, DOI 10.1016/j.egypro.2012.02.004; Cheng H, 2003, J CRYST GROWTH, V254, P46, DOI 10.1016/S0022-0248(03)01176-X; Slack GA, 2002, J CRYST GROWTH, V246, P287, DOI 10.1016/S0022-0248(02)01753-0; Dingemans G, 2011, ELECTROCHEM SOLID ST, V14, pH1, DOI 10.1149/1.3501970; Agostinelli G, 2006, SOL ENERG MAT SOL C, V90, P3438, DOI 10.1016/j.solmat.2006.04.014; Schmidt J, 2009, PHYS STATUS SOLIDI-R, V3, P287, DOI 10.1002/pssr.200903272; CASTAGNE R, 1971, SURF SCI, V28, P157, DOI 10.1016/0039-6028(71)90092-6; Benick J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945287; Schmidt J, 1999, J APPL PHYS, V85, P3626, DOI 10.1063/1.369725; Nagel H, 1999, PROG PHOTOVOLTAICS, V7, P245, DOI 10.1002/(SICI)1099-159X(199907/08)7:4<245::AID-PIP255>3.3.CO;2-V; Duttagupta S, 2012, ENRGY PROCED, V15, P78, DOI 10.1016/j.egypro.2012.02.009; Asim N, 2014, INT J PHOTOENERGY, V2014; Cho M, 2002, APPL PHYS LETT, V81, P3630, DOI 10.1063/1.1520333; Dingemans G, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.4728205; Dullweber T, 2013, ENRGY PROCED, V38, P430, DOI 10.1016/j.egypro.2013.07.300; Elmazria O, 2003, PHYS STATUS SOLIDI A, V196, P416, DOI 10.1002/pssa.200306446; Gadenne M, 1998, THIN SOLID FILMS, V333, P251, DOI 10.1016/S0040-6090(98)00816-5; Kang YS, 2002, J ELECTROCHEM SOC, V149, pG51, DOI 10.1149/1.1423644; Krugel G, 2013, PHYS STATUS SOLIDI-R, V7, P457, DOI 10.1002/pssr.201307153; Krugel G, 2014, ENRGY PROCED, V55, P797, DOI 10.1016/j.egypro.2014.08.062; Li TT, 2009, PHYS STATUS SOLIDI-R, V3, P160, DOI 10.1002/pssr.200903140; Li TTA, 2011, SOL ENERG MAT SOL C, V95, P69, DOI 10.1016/j.solmat.2010.03.034; Meng W. J., 1994, PROPERTIES GROUP 3 N, P22; Otto M, 2012, ENRGY PROCED, V27, P361, DOI 10.1016/j.egypro.2012.07.077; Park HB, 2003, J APPL PHYS, V94, P1898, DOI 10.1063/1.1590418; Rahman M. Z., 2012, MAT RENEWABLE SUSTAI, V1, P1; Richter A, 2013, IEEE J PHOTOVOLT, V3, P236, DOI 10.1109/JPHOTOV.2012.2226145; Schmidt Jan, 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Schroder D. K., 1998, SEMICONDUCTOR MAT DE, V2nd, P356; Schuldis D., 2012, P 26 EUR PHOT SOL EN, P1933; ZARWASCH R, 1992, J APPL PHYS, V71, P5275, DOI 10.1063/1.350592; Zhang XY, 2013, PHYS STATUS SOLIDI-R, V7, P619, DOI 10.1002/pssr.201308027	42	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD18	10.7567/JJAP.54.08KD18		5	Physics, Applied	Physics	CN8BU	WOS:000358662900063		
J	Maeda, T; Kawabata, A; Wada, T				Maeda, Tsuyoshi; Kawabata, Atsuhito; Wada, Takahiro			First-principles study on alkali-metal effect of Li, Na, and K in CuInSe2 and CuGaSe2	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FILM SOLAR-CELLS; GENERALIZED GRADIENT APPROXIMATION; SYNCHRONOUS-TRANSIT METHOD; TOTAL-ENERGY CALCULATIONS; CU(IN,GA)SE-2 THIN-FILMS; STRUCTURAL-PROPERTIES; SELENIUM SYSTEM; SODIUM; DIFFUSION; CHALCOGENIDES	The substitution energies and migration energies of the alkali metal atoms of Li, Na, and K in CuInSe2 (CIS) and CuGaSe2 (CGS) were investigated by first-principles calculations. The substitution energies of Li, Na, and K atoms in CIS and CGS were calculated for two different cationic atom positions of Cu and In/Ga in the chalcopyrite unit cell. In CIS and CGS, the substitution energies of NaCu are much lower than those of NaIn and NaGa. The substitution energies of the LiCu atoms in CIS and CGS are lower than those of NaCu, while the substitution energies of KCu atoms in CIS and CGS are much higher than those of NaCu. Therefore, it is difficult to form KCu in CIS and CGS. The migration energies of Li, Na, and K atoms in CIS and CGS are obtained by a combination of the linear and quadratic synchronous transit (LST/QST) methods and the nudged elastic band (NEB) method. The theoretical migration energies of a Na atom at the Cu site to the nearest Cu vacancy (Na-Cu -> V-Cu) in CIS and CGS are much lower than those of (Cu-Cu -> V-Cu) in CIS and CGS. The mechanism underlying the alkali metal effect of Li, Na, and K in the CIGS film during the post-deposition treatment of LiF, NaF, and KF is discussed on the basis of the calculated substitution and migration energies. (C) 2015 The Japan Society of Applied Physics	[Maeda, Tsuyoshi; Kawabata, Atsuhito; Wada, Takahiro] Ryukoku Univ, Dept Chem Mat, Otsu, Shiga 5202194, Japan	Maeda, T (reprint author), Ryukoku Univ, Dept Chem Mat, Otsu, Shiga 5202194, Japan.	tmaeda@ad.ryukoku.ac.jp			Incorporated Administrative Agency of the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI); Ministry of Education, Culture, Sports, Science and Technology (MEXT)	This work was supported by the Incorporated Administrative Agency of the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI). This work was partially supported by a grant for private universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT).	Kresse G, 1996, PHYS REV B, V54, P11169, DOI 10.1103/PhysRevB.54.11169; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Sangster J, 1997, J PHASE EQUILIB, V18, P177, DOI 10.1007/BF02665702; Henkelman G, 2000, J CHEM PHYS, V113, P9978, DOI 10.1063/1.1323224; Sutter-Fella CM, 2014, CHEM MATER, V26, P1420, DOI 10.1021/cm403504u; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; HALGREN TA, 1977, CHEM PHYS LETT, V49, P225, DOI 10.1016/0009-2614(77)80574-5; Zellner MB, 2003, PROG PHOTOVOLTAICS, V11, P543, DOI 10.1002/pip.515; PAYNE MC, 1992, REV MOD PHYS, V64, P1045, DOI 10.1103/RevModPhys.64.1045; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Granath K, 2000, SOL ENERG MAT SOL C, V60, P279, DOI 10.1016/S0927-0248(99)00089-6; Kemell M, 2005, CRIT REV SOLID STATE, V30, P1, DOI 10.1080/10408430590918341; Rudmann D, 2003, THIN SOLID FILMS, V431, P37, DOI 10.1016/S0040-6090(03)00246-3; DELLEY B, 1990, J CHEM PHYS, V92, P508, DOI 10.1063/1.458452; Jackson P, 2015, PHYS STATUS SOLIDI-R, V9, P28, DOI 10.1002/pssr.201409520; Pyykko P, 2009, CHEM-EUR J, V15, P186, DOI 10.1002/chem.200800987; Wei SH, 1999, J APPL PHYS, V85, P7214, DOI 10.1063/1.370534; Jackson P, 2014, PHYS STATUS SOLIDI-R, V8, P219, DOI 10.1002/pssr.201409040; Ishizuka S, 2014, ACS APPL MATER INTER, V6, P14123, DOI 10.1021/am503480m; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Govind N, 2003, COMP MATER SCI, V28, P250, DOI 10.1016/S0927-0256(03)00111-3; Schroeder DJ, 1997, J APPL PHYS, V82, P4982, DOI 10.1063/1.366365; Bastek J., 2013, THESIS WESTFALISCHE; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Kubaschewski O., 1993, MAT THERMOCHEMISTRY, V6th, P167; Laemmle A, 2014, J APPL PHYS, V115, DOI 10.1063/1.4871457; Maeda T., 2013, MRS P, V1538, P179; Nakamura M., 2014, 40 IEEE PHOT SPEC C, P107; Nakamura S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CR01; Nakamura S, 2013, PHYS STATUS SOLIDI A, V210, P1317, DOI 10.1002/pssa.201200860; Oikkonen LE, 2013, J APPL PHYS, V114, DOI 10.1063/1.4819105; PRESS WH, 1992, NUMERICAL RECIPES, P418; Ruckh M., 1994, 24 IEEE PHOT SPEC C, P156; Sangster J, 1997, J PHASE EQUILIB, V18, P185, DOI 10.1007/BF02665704; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC20	10.7567/JJAP.54.08KC20		8	Physics, Applied	Physics	CN8BU	WOS:000358662900045		
J	Matsui, T; Maejima, K; Bidiville, A; Sai, H; Koida, T; Suezaki, T; Matsumoto, M; Saito, K; Yoshida, I; Kondo, M				Matsui, Takuya; Maejima, Keigou; Bidiville, Adrien; Sai, Hitoshi; Koida, Takashi; Suezaki, Takashi; Matsumoto, Mitsuhiro; Saito, Kimihiko; Yoshida, Isao; Kondo, Michio			High-efficiency thin-film silicon solar cells realized by integrating stable a-Si:H absorbers into improved device design	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; TRANSFORM PHOTOCURRENT SPECTROSCOPY; MICROCRYSTALLINE SILICON; LAYERS; INTERFACE; TEMPERATURE; OXIDE	We report that thin-film silicon solar cells exhibiting high stabilized efficiencies can be obtained by depositing hydrogenated amorphous silicon (a-Si:H) absorbers using triode-type plasma-enhanced chemical vapor deposition. The improved light-soaking stability and performance of solar cells are also realized by optimizing the device design, such as p and p-i buffer layers. As a result, we attain independently confirmed stabilized efficiencies of 10.1-10.2% for a-Si:H single-junction solar cells (absorber thickness: t(i) = 220-310 nm) and 12.69% for an a-Si:H (t(i) = 350 nm)/hydrogenated microcrystalline silicon (mu c-Si:H) tandem solar cell fabricated using textured SnO2 and ZnO substrates, respectively. The relative efficiency degradations of these solar cells are similar to 10 and 3%, respectively, under 1 sun illumination at 50 degrees C for 1000 h. (C) 2015 The Japan Society of Applied Physics	[Matsui, Takuya; Bidiville, Adrien; Sai, Hitoshi; Koida, Takashi; Kondo, Michio] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Maejima, Keigou; Suezaki, Takashi; Matsumoto, Mitsuhiro; Saito, Kimihiko; Yoshida, Isao] Photovolta Power Generat Technol Res Assoc PVTEC, Tsukuba, Ibaraki 3058568, Japan; [Suezaki, Takashi] Kaneka Corp, Toyooka, Hyogo 6680831, Japan; [Matsumoto, Mitsuhiro] Panason Corp, Kyoto 6190237, Japan; [Saito, Kimihiko] Fukushima Univ, Fukushima 9601296, Japan	Matsui, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	t-matsui@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO)	The authors are grateful to Mr. Miyagi, Mr. Murata, Mr. Sato, and Ms. Hozuki for their help in sample preparation, and to Dr. Hishikawa, Ms. Sasaki, and Mr. Shimura in CSMT-RCPVT of AIST for the high-accuracy I-V measurements. They are also grateful to the technical board members of PVTEC for discussion and continuous support. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO).	Das C, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2841824; Boccard M, 2012, NANO LETT, V12, P1344, DOI 10.1021/nl203909u; Koh JH, 1998, APPL PHYS LETT, V73, P1526, DOI 10.1063/1.122194; Fay S, 2005, SOL ENERG MAT SOL C, V86, P385, DOI 10.1016/j.solmat.2004.08.002; MATSUDA A, 1983, J NON-CRYST SOLIDS, V59-6, P687, DOI 10.1016/0022-3093(83)90264-8; Stuckelberger M, 2014, J APPL PHYS, V116, DOI 10.1063/1.4894457; Holovsky J, 2008, J NON-CRYST SOLIDS, V354, P2167, DOI 10.1016/j.jnoncrysol.2007.09.106; Sonobe H, 2006, THIN SOLID FILMS, V502, P306, DOI 10.1016/j.tsf.2005.07.300; Tan HR, 2015, SOL ENERG MAT SOL C, V132, P597, DOI 10.1016/j.solmat.2014.10.020; Fujibayashi T, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2200741; Stannowski B, 2013, SOL ENERG MAT SOL C, V119, P196, DOI 10.1016/j.solmat.2013.06.043; Vanecek M, 2002, APPL PHYS LETT, V80, P719, DOI 10.1063/1.1446207; Shimizu S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1846132; Rech B, 1996, SOL ENERG MAT SOL C, V41-2, P475, DOI 10.1016/0927-0248(95)00127-1; Matsui T, 2013, PROG PHOTOVOLTAICS, V21, P1363, DOI 10.1002/pip.2300; Meier J, 2004, SOL ENERGY, V77, P983, DOI 10.1016/j.solener.2004.08.026; Buehlmann P, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2794423; Boccard M, 2014, IEEE J PHOTOVOLT, V4, P1368, DOI 10.1109/JPHOTOV.2014.2357495; Sai H, 2014, IEEE J PHOTOVOLT, V4, P1349, DOI 10.1109/JPHOTOV.2014.2355037; STAEBLER DL, 1977, APPL PHYS LETT, V31, P292, DOI 10.1063/1.89674; Maejima K, 2014, THIN SOLID FILMS, V559, P83, DOI 10.1016/j.tsf.2013.11.137; Melskens J, 2008, THIN SOLID FILMS, V516, P6877, DOI 10.1016/j.tsf.2007.12.049; Yamamoto K, 2004, SOL ENERGY, V77, P939, DOI 10.1016/j.solener.2004.08.028; Benagli S., 2009, P 24 EUR PHOT SOL EN, P21; Bidiville A, 2014, J APPL PHYS, V116, DOI 10.1063/1.4891684; Kadota N., 2011, 21 INT PHOT SCI ENG, p2A; Koga K, 2002, JPN J APPL PHYS 2, V41, pL168, DOI 10.1143/JJAP.41.L168; Kroll U., 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; LIM KS, 1984, J APPL PHYS, V56, P538, DOI 10.1063/1.333943; Luft W., 1993, P 23 IEEE PHOT SPEC, P860; Matsui T., 2014, MATER RES SOC S P, V1666, pa01; Matsui T., 2013, P 28 EUR PHOT SOL EN, P2213; SAKAI H, 1990, J APPL PHYS, V67, P3494, DOI 10.1063/1.345340; Siamchai P., 1996, P 25 IEEE PHOT SPEC, P1093; Terakawa Akira, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy	35	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KB10	10.7567/JJAP.54.08KB10		4	Physics, Applied	Physics	CN8BU	WOS:000358662900024		
J	Meng, L; Miyajima, S; Konagai, M				Meng, Lei; Miyajima, Shinsuke; Konagai, Makoto			Effect of Al doping concentration on the electrical and optical properties of sol-gel derived Zn0.87Mg0.13O thin film	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TRANSPARENT CONDUCTING OXIDES; THERMOELECTRIC PROPERTIES; DOPED ZNO; CELLS; DEPOSITION; MGXZN1-XO; SUBSTRATE; ALLOY; TCO	Zn0.87Mg0.13O thin film was developed by the sol-gel process. The effect of the Al doping concentration on the electrical and optical properties of Zn0.87Mg0.13O thin film was investigated. The lowest resistivity of 7.96 x 10(-3) Omega-cm with an optical bandgap energy of 3.64 eV was achieved at a doping concentration of 0.8 mol% in solution (0.6 at.% in film). Al doping contributes to the decrease of resistivity and the increase of optical bandgap energy, whereas heavy doping of greater than 0.8 mol% shows detrimental effects on the resistivity and film crystallinity. The mobility is dominated by grain boundary scattering. (C) 2015 The Japan Society of Applied Physics	[Meng, Lei; Miyajima, Shinsuke; Konagai, Makoto] Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Konagai, Makoto] Tokyo Inst Technol, Japan Photovolta Res Ctr PVREC, Meguro Ku, Tokyo 1528552, Japan	Meng, L (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.	meng.l.aa@m.titech.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade, and Industry, Japan (METI)	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade, and Industry, Japan (METI).	Sharma AK, 1999, APPL PHYS LETT, V75, P3327, DOI 10.1063/1.125340; Matsubara K, 2004, APPL PHYS LETT, V85, P1374, DOI 10.1063/1.1784544; Calnan S, 2010, THIN SOLID FILMS, V518, P1839, DOI 10.1016/j.tsf.2009.09.044; Krc J, 2010, THIN SOLID FILMS, V518, P3054, DOI 10.1016/j.tsf.2009.09.164; Luka G, 2014, J MATER SCI, V49, P1512, DOI 10.1007/s10853-013-7832-5; Beyer W, 2007, THIN SOLID FILMS, V516, P147, DOI [10.1016/j.tsf.2007.08.110, 10.1016/j.tsf.007.08.110]; Nasuno Y, 2001, JPN J APPL PHYS 2, V40, pL303, DOI 10.1143/JJAP.40.L303; Ohtomo A, 1998, APPL PHYS LETT, V72, P2466, DOI 10.1063/1.121384; Katsuyama S, 2002, J APPL PHYS, V92, P1391, DOI 10.1063/1.1489091; Minami T, 2000, MRS BULL, V25, P38, DOI 10.1557/mrs2000.149; Muller J, 2004, SOL ENERGY, V77, P917, DOI 10.1016/j.solener.2004.03.015; Makino T, 2001, APPL PHYS LETT, V78, P1237, DOI 10.1063/1.1350632; Tsubota T, 1997, J MATER CHEM, V7, P85, DOI 10.1039/a602506d; Minemoto T, 2000, THIN SOLID FILMS, V372, P173, DOI 10.1016/S0040-6090(00)01009-9; TANG W, 1994, THIN SOLID FILMS, V238, P83, DOI 10.1016/0040-6090(94)90653-X; Yu QJ, 2007, THIN SOLID FILMS, V515, P3840, DOI 10.1016/j.tsf.2006.10.077; Isabella O, 2013, PROG PHOTOVOLTAICS, V21, P94, DOI 10.1002/pip.1257; Shirouzu K, 2007, J CERAM SOC JPN, V115, P254, DOI 10.2109/jcersj.115.254; Gordon RG, 2000, MRS BULL, V25, P52, DOI 10.1557/mrs2000.151; Hongsingthong A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.051102; BURSTEIN E, 1954, PHYS REV, V93, P632, DOI 10.1103/PhysRev.93.632; Cohen DJ, 2004, J APPL PHYS, V96, P459, DOI 10.1063/1.1760239; Li C, 2010, J CRYST GROWTH, V312, P1929, DOI 10.1016/j.jcrysgro.2010.03.018; Lu JG, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2424308; Luque A., 2011, HDB PHOTOVOLTAIC SCI, V2nd, P737; Maejima K, 2010, THIN SOLID FILMS, V518, P2949, DOI 10.1016/j.tsf.2009.09.196; Meng L., 2013, 6 WORLD C PHOT EN CO, P253; Singh A, 2013, SEMICOND SCI TECH, V28, DOI 10.1088/0268-1242/28/2/025004; Sobajima Y, 2007, J MATER SCI-MATER EL, V18, P159, DOI DOI 10.1007/S10854-007-9186-8; Sobajima Y., 2008, P 33 IEEE PHOT SPEC, P1; Wada H, 2014, CAN J PHYS, V92, P920, DOI 10.1139/cjp-2013-0621; Wang JH, 2009, J CRYST GROWTH, V311, P2305, DOI 10.1016/j.jcrysgro.2009.02.039; Wei M, 2011, APPL PHYS LETT, V98, DOI 10.1063/1.3604782	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KB09	10.7567/JJAP.54.08KB09		4	Physics, Applied	Physics	CN8BU	WOS:000358662900023		
J	Miki, S; Iguchi, K; Kitano, S; Hayakashi, K; Hotta, Y; Yoshida, H; Ogura, A; Satoh, S; Arafune, K				Miki, Shohei; Iguchi, Koji; Kitano, Sho; Hayakashi, Koki; Hotta, Yasushi; Yoshida, Haruhiko; Ogura, Atsushi; Satoh, Shin-ichi; Arafune, Koji			Passivation properties of aluminum oxide films deposited by mist chemical vapor deposition for solar cell applications	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ATOMIC LAYER DEPOSITION; THIN-FILMS; AL2O3; SILICON; GROWTH; RECOMBINATION; TEMPERATURE	Aluminum oxide (AlOx) films were deposited by mist chemical vapor deposition (MCVD) in air for p-type crystalline silicon, and the effects of the deposition temperature (T-dep) and AlOx film thickness on the maximum surface recombination velocities (S-max) were evaluated. It was found that S-max was improved with increasing T-dep. The AlOx film deposited at 400 degrees C exhibited the best S-max value of 2.8cm/s, and the passivation quality was comparable to that of AlOx deposited by other vacuum-based techniques. S-max was also improved with increasing film thickness. When the film thickness was above 10 nm, S-max was approximately 10 cm/s. From the Fourier transform infrared spectra, it was found that the AlOx films deposited by MCVD consisted of an AlOx layer and a Si-diffused AlOx layer. In addition, it is important for the layers to be thick enough to obtain high-quality passivation. (C) 2015 The Japan Society of Applied Physics	[Miki, Shohei; Iguchi, Koji; Kitano, Sho; Hayakashi, Koki; Hotta, Yasushi; Yoshida, Haruhiko; Satoh, Shin-ichi; Arafune, Koji] Univ Hyogo, Himeji, Hyogo 6712280, Japan; [Ogura, Atsushi] Meiji Univ, Kawasaki, Kanagawa 2148571, Japan; [Miki, Shohei; Iguchi, Koji; Hotta, Yasushi; Yoshida, Haruhiko; Ogura, Atsushi; Satoh, Shin-ichi; Arafune, Koji] JST, Kawaguchi, Saitama 3320012, Japan; [Miki, Shohei; Iguchi, Koji; Hotta, Yasushi; Yoshida, Haruhiko; Ogura, Atsushi; Satoh, Shin-ichi; Arafune, Koji] CREST, Kawaguchi, Saitama 3320012, Japan	Miki, S (reprint author), Univ Hyogo, Himeji, Hyogo 6712280, Japan.	arafune@eng.u-hyogo.ac.jp			Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST)	This work was supported in part by the Core Research for Evolutional Science and Technology (CREST), Japan Science and Technology Agency (JST).	Hoex B, 2008, J APPL PHYS, V104, DOI 10.1063/1.3021091; Hoex B, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240736; ABERLE AG, 1992, J APPL PHYS, V71, P4422, DOI 10.1063/1.350782; Hoex B, 2008, J APPL PHYS, V104, DOI 10.1063/1.2963707; Singh P, 2008, B MATER SCI, V31, P573, DOI 10.1007/s12034-008-0089-y; Miyajima S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.012301; Goldstein DN, 2008, J PHYS CHEM C, V112, P19530, DOI 10.1021/jp804296a; Kamada Y, 2006, JPN J APPL PHYS 2, V45, pL857, DOI 10.1143/JJAP.45.L857; Kawaharamura T, 2008, JPN J APPL PHYS, V47, P4669, DOI 10.1143/JJAP.47.4669; Kawaharamura T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.040207; Jeon HJ, 2014, J ALLOY COMPD, V614, P244, DOI 10.1016/j.jallcom.2014.06.116; Arafune K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.04DP06; Kaneko K, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.075501; Kim KH, 2010, J NANOELECTRON OPTOE, V5, P247, DOI 10.1166/jno.2010.1103; Kuse R, 2003, J APPL PHYS, V94, P6411, DOI 10.1063/1.1618918; Lee H, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER06; Lee H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3701280; Lee WJ, 2008, J CERAM PROCESS RES, V9, P38; Li TT, 2009, PHYS STATUS SOLIDI-R, V3, P160, DOI 10.1002/pssr.200903140; Ohwaki T, 1997, JPN J APPL PHYS 1, V36, P5507, DOI 10.1143/JJAP.36.5507; Park DG, 2001, J APPL PHYS, V89, P6275, DOI 10.1063/1.1368869; Sakai C, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.122303; Takenaka K, 2012, J PHYS CONF SER, V379, DOI 10.1088/1742-6596/379/1/012031; Werner F, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3505311; Zhao Y, 2013, NANOSCALE RES LETT, V8, DOI 10.1186/1556-276X-8-114	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD25	10.7567/JJAP.54.08KD25		5	Physics, Applied	Physics	CN8BU	WOS:000358662900070		
J	Mishina, K; Ogishi, A; Ueno, K; Jonai, S; Ikeno, N; Saruwatari, T; Hara, K; Ogura, A; Yamazaki, T; Doi, T; Shinohara, M; Masuda, A				Mishina, Ken; Ogishi, Atsufumi; Ueno, Kiyoshi; Jonai, Sachiko; Ikeno, Norihiro; Saruwatari, Tetsuya; Hara, Kohjiro; Ogura, Atsushi; Yamazaki, Toshiharu; Doi, Takuya; Shinohara, Makoto; Masuda, Atsushi			Plasma-enhanced chemical-vapor deposition of silicon nitride film for high resistance to potential-induced degradation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SI SOLAR-CELLS; STACKING-FAULTS; CVD	The antireflection coating (ARC) on crystalline silicon solar cells plays an important role in preventing potential-induced degradation (PID). In a previous work, we reported that the module, which has an ARC prepared by plasma-enhanced chemical-vapor deposition (PE-CVD) using a hollow cathode, indicated high resistance to PID with a constant conventional refractive index (RI). In this work, we report further investigation of the high-PID-resistant ARC. The results indicate that the high-PID resistant ARC had high conductivity, high Si-H bond density, and low N-H bond density. Furthermore, both higher PID resistance and higher conversion efficiency are achieved using an ARC of double or triple layers comprising stacked silicon nitride layers of different RI than those of a conventional single-layer ARC. (C) 2015 The Japan Society of Applied Physics	[Mishina, Ken; Ogishi, Atsufumi; Saruwatari, Tetsuya; Shinohara, Makoto] Shimadzu Co Ltd, Ind Machinery Div, Hadano, Kanagawa 2591304, Japan; [Ueno, Kiyoshi; Yamazaki, Toshiharu] Choshu Ind Co Ltd, Sanyo Onoda, Yamaguchi 7578511, Japan; [Jonai, Sachiko; Hara, Kohjiro; Doi, Takuya; Masuda, Atsushi] Natl Inst Adv Ind Sci & Technol, Tosu, Saga 8410052, Japan; [Ikeno, Norihiro; Ogura, Atsushi] Meiji Univ, Kawasaki, Kanagawa 2148571, Japan	Mishina, K (reprint author), Shimadzu Co Ltd, Ind Machinery Div, Hadano, Kanagawa 2591304, Japan.	ken_m@shimadzu.co.jp			"Consortium Study on Fabrication and Characterization of Solar Cell Modules with Long Life and High Reliability" at AIST	This work was supported by the "Consortium Study on Fabrication and Characterization of Solar Cell Modules with Long Life and High Reliability" at AIST. We thank Professor Yoshio Ohshita, and Mr. Isao Sumita, Toyota Technological Institute, and Professor Kyotaro Nakamura, Meiji University, for providing valuable information in relation to the study.	Naumann V, 2013, PHYS STATUS SOLIDI-R, V7, P315, DOI 10.1002/pssr.201307090; Naumann V, 2014, SOL ENERG MAT SOL C, V120, P383, DOI 10.1016/j.solmat.2013.06.015; [Anonymous], 2012, IEC NEW WORK IT PROP; Naumann V, 2012, ENRGY PROCED, V27, P1, DOI 10.1016/j.egypro.2012.07.020; [Anonymous], 2010, P 35 IEEE PHOT SPEC; Bauer J, 2012, PHYS STATUS SOLIDI-R, V6, P331, DOI 10.1002/pssr.201206276; Berghold J., 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Findlay A., 2013, P SNEC 7 INT PHOT PO; FUJITA S, 1983, JPN J APPL PHYS 2, V22, pL100, DOI 10.1143/JJAP.22.L100; Fukuda T, 1996, JPN J APPL PHYS 2, V35, pL729, DOI 10.1143/JJAP.35.L729; Hacke Peter, 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Hacke P., 2011, P 37 IEEE PHOT SPEC, P814; Hara K, 2014, RSC ADV, V4, P44291, DOI 10.1039/c4ra06791f; Kajisa T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.092302; Koch S., 2012, P 27 EUR PHOT SOL EN, P1991; Koch S., 2012, P 27 EUR PHOT SOL EN; Hoffmann S, 2014, PROG PHOTOVOLTAICS, V22, P173, DOI 10.1002/pip.2238; Koga K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.01AD02; KOGA K, 2005, JPN J APPL PHYS, V48, pL1430; LING CH, 1985, JPN J APPL PHYS 1, V24, P1238, DOI 10.1143/JJAP.24.1238; Masuda K., 2013, TAIYO ENERGY, V39, P71; Mathiak G., 2012, P 27 EUR PHOT SOL EN, P3157; Mehlich H., 2012, P 27 EUR PHOT SOL EN, P3411; Mishina K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.03CE01; Murata T, 2010, JPN J APPL PHYS, V49, DOI 10.1143/JJAP.49.08JF08; Nagel H., 2014, P 29 EUR PHOT SOL EN, P2351; Raykov A., 2012, P 27 EUR PHOT SOL EN, P3399; Schutze Matthias, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Swanson R., 2005, 15 INT PHOT SCI ENG, P410; Wilson M., 2013, P 39 IEEE PHOT SPEC, P218; Yambe K, 2007, JPN J APPL PHYS 1, V46, P6032, DOI 10.1143/JJAP.46.6032	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD12	10.7567/JJAP.54.08KD12		6	Physics, Applied	Physics	CN8BU	WOS:000358662900057		
J	Miyashita, N; Ahsan, N; Okada, Y				Miyashita, Naoya; Ahsan, Nazmul; Okada, Yoshitaka			Evaluation of concentrator photovoltaic properties of GaInNAsSb solar cells for multijunction solar cell applications	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TIME-RESOLVED PHOTOLUMINESCENCE; MOLECULAR-BEAM EPITAXY; SERIES RESISTANCE; GAAS; TEMPERATURE; EFFICIENCY; ANTIMONY; SYSTEMS	In this work, we focus on the growth and characterization of undoped GaInNAsSb layers in solar cells and also study their concentrator photovoltaic properties. Concentrated light current-voltage characteristics of three GaInNAsSb-based solar cells with various thicknesses of GaInNAsSb layers (t(i)) from 1.0 to 3.0 mu m were evaluated. The photogenerated carriers from the GaInNAsSb layers are well collected even for the t(i) = 2.0 and 3.0 mu m devices. The comparison of the solar cell parameters under high concentration conditions showed no significant difference among the devices. This behavior is consistent with the results of series resistance analyses. This suggests that the bulk resistance due to the GaInNAsSb thickness is a minor factor for the series resistance in the present devices. (C) 2015 The Japan Society of Applied Physics	[Miyashita, Naoya; Ahsan, Nazmul; Okada, Yoshitaka] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan	Miyashita, N (reprint author), Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan.	miyashita@mbe.rcast.u-tokyo.ac.jp			Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO); Ministry of Economy, Trade and Industry (METI), Japan	This work was supported by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO), and Ministry of Economy, Trade and Industry (METI), Japan. Part of this work was performed under the EU-NEDO new generation of concentrator photovoltaic cells, modules and systems (NGCPV) joint project.	Loke WK, 2002, J APPL PHYS, V91, P4900, DOI 10.1063/1.1454193; Friedman DJ, 1998, J CRYST GROWTH, V195, P409, DOI 10.1016/S0022-0248(98)00561-2; King RR, 2012, PROG PHOTOVOLTAICS, V20, P801, DOI 10.1002/pip.1255; Kurtz SR, 1999, APPL PHYS LETT, V74, P729, DOI 10.1063/1.123105; Guter W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148341; Wiemer M, 2011, PROC SPIE, V8108, DOI 10.1117/12.897769; SITES JR, 1989, SOL CELLS, V27, P411, DOI 10.1016/0379-6787(89)90050-1; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P1308, DOI 10.1016/j.solmat.2005.08.003; Jackrel DB, 2007, J APPL PHYS, V101, DOI 10.1063/1.2744490; Ptak AJ, 2007, J VAC SCI TECHNOL B, V25, P955, DOI 10.1116/1.2715993; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P1, DOI 10.1002/pip.2452; Bett A. W., 2013, P 28 EUR PHOT SOL EN, P1; Cheknane A, 2006, SOLID STATE SCI, V8, P556, DOI 10.1016/j.solidstatesciences.2006.01.001; Dimroth F, 2004, J CRYST GROWTH, V272, P726, DOI 10.1016/j.jcrysgro.2004.08.038; Geisz JF, 1998, J CRYST GROWTH, V195, P401, DOI 10.1016/S0022-0248(98)00563-6; Geisz JF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988497; Gubanov A, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-80; Hashimoto A, 2005, J CRYST GROWTH, V278, P532, DOI 10.1016/j.jcrysgro.2004.12.115; Hierro A, 2003, J APPL PHYS, V94, P2319, DOI 10.1063/1.1591416; Khelifi S, 2008, EUR PHYS J-APPL PHYS, V41, P115, DOI 10.1051/epjap:2008010; King RR, 2011, PROG PHOTOVOLTAICS, V19, P797, DOI 10.1002/pip.1044; Mair RA, 2000, APPL PHYS LETT, V76, P188, DOI 10.1063/1.125698; Miyashita N., PROG PHOTOV IN PRESS, DOI [10.1002/pip.2641, DOI 10.1002/PIP.2641]; Miyashita N., 2013, P 39 IEEE PHOT SPEC, P2109; Miyashita N, 2009, J CRYST GROWTH, V311, P3249, DOI 10.1016/j.jcrysgro.2009.03.024; Miyashita N., 2009, P 34 IEEE PHOT SPEC; Miyashita N., 2006, P 4 WORLD C PHOT EN, P869; Miyashita N, 2007, J APPL PHYS, V102, DOI 10.1063/1.2770833; Miyashita N, 2013, SOL ENERG MAT SOL C, V111, P127, DOI 10.1016/j.solmat.2012.12.036; Nelson J., 2003, PHYS SOLAR CELLS; Tibbits T. N. D., 2014, P 29 EUR PHOT SOL EN, P1975; Watanabe K, 2012, AIP CONF PROC, V1477, P40, DOI 10.1063/1.4753829	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KE06	10.7567/JJAP.54.08KE06		5	Physics, Applied	Physics	CN8BU	WOS:000358662900076		
J	Morita, H; Miyashita, M; Masuda, A				Morita, Hideyuki; Miyashita, Masanori; Masuda, Atsushi			Module composition for reliability test of organic photovoltaics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POTENTIAL-INDUCED DEGRADATION; SOLAR-CELLS; PV MODULES; STACKING-FAULTS; STABILITY; LIFETIME; DEVICES; TEMPERATURE; COMMUNITY; HUMIDITY	This work focuses on investigating the degradation factor for organic photovoltaic (OPV) modules. We established the composition of a test module that has suitable barrier properties against moisture ingress using the Ca method. Then, we mounted an OPV cell in the test module and conducted durability tests. We determined in reliability tests that the main degradation factors for OPV modules are products from encapsulants. Then, we added a vacuum process to the sample preparation procedure. We conducted durability tests on the OPV module prepared by the improved process, and we observed a change in the pattern of degradation. We concluded that the vacuum process affected the degradation mechanism. (C) 2015 The Japan Society of Applied Physics	[Morita, Hideyuki] Photovolta Power Generat Technol Res Assoc, Minato Ku, Tokyo 1050011, Japan; [Morita, Hideyuki; Miyashita, Masanori] Toray Industries Ltd, Otsu, Shiga 5202141, Japan; [Masuda, Atsushi] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Morita, H (reprint author), Photovolta Power Generat Technol Res Assoc, Minato Ku, Tokyo 1050011, Japan.	Hideyuki_Morita@nts.toray.co.jp; Masanori_Miyashita@nts.toray.co.jp; atsushi-masuda@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO) under Ministry of Economy, Trade and Industry	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry.	Anda M, 2014, RENEW ENERG, V67, P119, DOI 10.1016/j.renene.2013.11.020; Bertho S, 2008, SOL ENERG MAT SOL C, V92, P753, DOI 10.1016/j.solmat.2008.01.006; Grossiord N, 2012, ORG ELECTRON, V13, P432, DOI 10.1016/j.orgel.2011.11.027; Bedeloglu A, 2009, SYNTHETIC MET, V159, P2043, DOI 10.1016/j.synthmet.2009.07.019; Naumann V, 2014, SOL ENERG MAT SOL C, V120, P383, DOI 10.1016/j.solmat.2013.06.015; Peike C, 2013, SOL ENERG MAT SOL C, V116, P49, DOI 10.1016/j.solmat.2013.03.022; Reese MO, 2011, REV SCI INSTRUM, V82, DOI 10.1063/1.3606644; Kempe MD, 2006, SOL ENERG MAT SOL C, V90, P2720, DOI 10.1016/j.solmat.2006.04.002; Haillant O, 2011, SOL ENERG MAT SOL C, V95, P1284, DOI 10.1016/j.solmat.2010.08.033; Drakonakis VM, 2014, SOL ENERG MAT SOL C, V130, P544, DOI 10.1016/j.solmat.2014.07.051; Cros S, 2011, SOL ENERG MAT SOL C, V95, pS65, DOI 10.1016/j.solmat.2011.01.035; Seemann A, 2011, SOL ENERGY, V85, P1238, DOI 10.1016/j.solener.2010.09.007; Nikiforov MP, 2013, SOL ENERG MAT SOL C, V110, P36, DOI 10.1016/j.solmat.2012.06.028; Weerasinghe HC, 2015, SOL ENERG MAT SOL C, V132, P485, DOI 10.1016/j.solmat.2014.09.030; Marszal AJ, 2011, ENERG BUILDINGS, V43, P971, DOI 10.1016/j.enbuild.2010.12.022; Bertho S, 2007, SOL ENERG MAT SOL C, V91, P385, DOI 10.1016/j.solmat.2006.10.008; Kempe MD, 2007, SOL ENERG MAT SOL C, V91, P315, DOI 10.1016/j.solmat.2006.10.009; Bertho S, 2013, SOL ENERG MAT SOL C, V110, P69, DOI 10.1016/j.solmat.2012.12.007; Carta C., 2013, MULTIDISIPLINARY KNO, P253; Kajari-Schroder S, 2012, ENRGY PROCED, V27, P658, DOI 10.1016/j.egypro.2012.07.125; Kim N, 2012, SOL ENERG MAT SOL C, V101, P140, DOI 10.1016/j.solmat.2012.02.002; Kojima T, 2005, SOL ENERG MAT SOL C, V85, P63, DOI 10.1016/j.solmat.2004.04.007; Lausch D, 2014, ENRGY PROCED, V55, P486, DOI 10.1016/j.egypro.2014.08.013; Miyashita M., 2013, P 28 EUR PHOT SOL EN, P2828; Paggi M, 2013, ENRGY PROCED, V38, P506, DOI 10.1016/j.egypro.2013.07.310; Rodprasert R, 2014, ENRGY PROCED, V56, P678, DOI 10.1016/j.egypro.2014.07.208	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KF07	10.7567/JJAP.54.08KF07		5	Physics, Applied	Physics	CN8BU	WOS:000358662900087		
J	Motohiro, T; Ichiki, A; Ichikawa, T; Ito, H; Hasegawa, K; Mizuno, S; Ito, T; Kajino, T; Takeda, Y; Higuchi, K				Motohiro, Tomoyoshi; Ichiki, Akihisa; Ichikawa, Tadashi; Ito, Hiroshi; Hasegawa, Kazuo; Mizuno, Shintaro; Ito, Tadashi; Kajino, Tsutomu; Takeda, Yasuhiko; Higuchi, Kazuo			Consideration of coordinated solar tracking of an array of compact solar-pumped lasers combined with photovoltaic cells for electricity generation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SHAPED FRESNEL LENSES; SUN-TRACKING; SYSTEM; CONCENTRATORS; FORMULA; MODULES; DESIGN	A monochromatic laser light with a photon energy just above the band edge of photovoltaic cells can be converted into electricity with minimal thermal loss. To attain efficient conversion of sunlight to laser light, a coordinated solar tracking system for an array of originally designed compact solar-pumped lasers of 50mm aperture diameter is being constructed. As for the feasibility of this system, a prototype with a holding capacity of 25 compact solar-pumped lasers has been fabricated. The primary requisite of this system is that the angular accuracy of tracking should be below 1 mrad for all 25 compact solar-pumped lasers to sustain their continuous lasing. To realize this, imperative challenges have been elucidated including thermal expansion under sunlight. A prototype fabricated with its main frame made of Super Invar alloy was found to fulfill the requisite by measurement using a three-dimensional coordinate measuring machine. (C) 2015 The Japan Society of Applied Physics	[Motohiro, Tomoyoshi; Ichiki, Akihisa; Ito, Hiroshi; Higuchi, Kazuo] Nagoya Univ, Green Mobil Collaborat Res Ctr, Nagoya, Aichi 4648603, Japan; [Motohiro, Tomoyoshi; Ichiki, Akihisa] Nagoya Univ, Dept Mat Sci & Engn, Nagoya, Aichi 4648603, Japan; [Motohiro, Tomoyoshi; Ichikawa, Tadashi; Ito, Hiroshi; Hasegawa, Kazuo; Mizuno, Shintaro; Ito, Tadashi; Kajino, Tsutomu; Takeda, Yasuhiko; Higuchi, Kazuo] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Motohiro, T (reprint author), Nagoya Univ, Green Mobil Collaborat Res Ctr, Nagoya, Aichi 4648603, Japan.	motohiro@gvm.nagoya-u.ac.jp			Advanced Low Carbon Technology R&D Program (ALCA) of the Japan Science and Technology Agency	This work was partially supported by the Advanced Low Carbon Technology R&D Program (ALCA) of the Japan Science and Technology Agency. The authors thanks Sakae-Seiki Co., Ltd., Kisin Co., Ltd., Satoru Matsushima, and Masanori Suzuki for fabrication of the prototype CST system.	Chong KK, 2009, SENSORS-BASEL, V9, P7849, DOI 10.3390/s91007849; Araki K, 2005, PROG PHOTOVOLTAICS, V13, P513, DOI 10.1002/pip.643; Abdallah S, 2004, ENERG CONVERS MANAGE, V45, P1671, DOI 10.1016/j.enconman.2003.10.006; Nishimura A, 2010, APPL ENERG, V87, P2797, DOI 10.1016/j.apenergy.2009.08.011; Xu P, 2014, APPL OPTICS, V53, P3941, DOI 10.1364/AO.53.003941; Abdallah S, 2004, ENERG CONVERS MANAGE, V45, P1931, DOI 10.1016/j.enconman.2003.10.007; Mousazadeh H, 2009, RENEW SUST ENERG REV, V13, P1800, DOI 10.1016/j.rser.2009.01.022; Al-Mohamad A, 2004, APPL ENERG, V79, P345, DOI 10.1016/j.apenergy.2003.12.004; Chan NLA, 2013, PROG PHOTOVOLTAICS, V21, P1598, DOI 10.1002/pip.2241; Araki K, 2010, OPT EXPRESS, V18, pA53, DOI [10.1364/OE.18.000A53, 10.1364/OE.18.0000A53]; RABL A, 1976, SOL ENERGY, V18, P93, DOI 10.1016/0038-092X(76)90043-8; Lee CY, 2009, SENSORS-BASEL, V9, P3875, DOI 10.3390/s90503875; Mizuno S, 2012, OPT EXPRESS, V20, P5891, DOI 10.1364/OE.20.005891; Roth P, 2004, RENEW ENERG, V29, P393, DOI 10.1016/S0960-1481(03)00196-4; WINSTON R, 1974, SOL ENERGY, V16, P89, DOI 10.1016/0038-092X(74)90004-8; Chong KK, 2009, SOL ENERGY, V83, P298, DOI 10.1016/j.solener.2008.08.003; Mills D, 2004, SOL ENERGY, V76, P19, DOI 10.1016/S0038-092X(03)00102-6; Rubio FR, 2007, ENERG CONVERS MANAGE, V48, P2174, DOI 10.1016/j.enconman.2006.12.020; Araki K., 2010, P 35 IEEE PHOT SPEC, P2994; Araki K, 2006, SOL ENERG MAT SOL C, V90, P3312, DOI 10.1016/j.solmat.2005.09.017; Dinh TH, 2014, APPL OPTICS, V53, P2711, DOI 10.1364/AO.53.002711; Ito H., 2012, P 1 ADV LAS PHOT SOU, P220; Kim YS, 2014, PROG PHOTOVOLTAICS, V22, P1001, DOI 10.1002/pip.2340; Renzi M, 2015, INT J ENERG RES, V39, P265, DOI 10.1002/er.3238; Takeda Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4885758; Takeda Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896263; Takeda Y., 2014, P WCPEC 6; Zhao K., 1996, SOL ENERG MAT SOL C, V41-42, P87	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KE04	10.7567/JJAP.54.08KE04		5	Physics, Applied	Physics	CN8BU	WOS:000358662900074		
J	Muller, M; Hyvl, M; Kratzer, M; Teichert, C; Misra, S; Foldyna, M; Yu, LW; Cabarrocas, PRI; Itoh, T; Hajkova, Z; Vetushka, A; Ledinsky, M; Kocka, J; Fejfar, A				Mueller, Martin; Hyvl, Matej; Kratzer, Markus; Teichert, Christian; Misra, Soumyadeep; Foldyna, Martin; Yu, Linwei; Cabarrocas, Pere Roca I.; Itoh, Takashi; Hajkova, Zdenka; Vetushka, Aliaksei; Ledinsky, Martin; Kocka, Jan; Fejfar, Antonin			Investigating inhomogeneous electronic properties of radial junction solar cells using correlative microscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ATOMIC-FORCE MICROSCOPY; SILICON THIN-FILMS; GROWTH; NANOWIRES; MECHANISM; OXIDATION	Solar cells with radial junctions based on silicon nanowires were investigated using correlative microscopy in order to determine the nature and origin of previously reported inhomogeneity of their electronic properties. For correlating various microscopy techniques, we have prepared sets of three Vickers type nanoindents arranged in a right triangle with 20 mu m sides as marks of local frame of reference. Due to the shape of the indents (squares with 4 mu m sides and clear diagonals) the position of the marks can be located with high precision by various microscopes. This makes it possible to correlate the results from scanning electron microscopy, Kelvin probe force microscopy and conductive atomic force microscopy techniques on the same place of the sample, with a precision down to individual nanowires, obtaining new information about the electronic inhomogeneity. Using the conductive AFM we analyzed the growth process of silicon nanowires step by step in order to find possible origins of the local (photo) current variations. (C) 2015 The Japan Society of Applied Physics	[Mueller, Martin; Hyvl, Matej; Hajkova, Zdenka; Vetushka, Aliaksei; Ledinsky, Martin; Kocka, Jan; Fejfar, Antonin] Acad Sci Czech Republic, Inst Phys, Prague 16200 6, Czech Republic; [Kratzer, Markus; Teichert, Christian] Univ Leoben, Inst Phys, A-8700 Leoben, Austria; [Misra, Soumyadeep; Foldyna, Martin; Yu, Linwei] Ecole Polytech, CNRS, LPICM, F-91128 Palaiseau, France; [Itoh, Takashi] Gifu Univ, Gifu 5011193, Japan	Muller, M (reprint author), Acad Sci Czech Republic, Inst Phys, Cukrovarnicka 10, Prague 16200 6, Czech Republic.	fejfar@fzu.cz	Ledinsky, Martin/H-3092-2014; Foldyna, Martin/C-5981-2014; Teichert, Christian/F-1003-2013	Foldyna, Martin/0000-0001-8413-0504; Teichert, Christian/0000-0002-0796-2355	Czech Science Foundation [14-15357S, 14-37427G, 13-12386S, 13-25747S]; Austrian Academic Exchange Service project [CZ SP 04-2014]; Ministry of Education, Youth and Sports of the Czech Republic [7AMB14ATE004, LM2011026]; Solarium project [ANR-14-CE05-0005]; PLATOFIL [ANR-14-CE26-0020]	This work was supported by the Czech Science Foundation projects 14-15357S, 14-37427G, 13-12386S, and 13-25747S, Austrian Academic Exchange Service project CZ SP 04-2014 and the Ministry of Education, Youth and Sports of the Czech Republic through Mobility project 7AMB14ATE004 and infrastructure project LM2011026. The work at LPICM was partly supported by Solarium project ANR-14-CE05-0005 and PLATOFIL ANR-14-CE26-0020. We would also like to thank A. Marek and J. Vyskocil of HVM Plasma Ltd. for help with nanoindentation, Tescan Brno Ltd. for providing the ultra-high resolution SEM Maia 3 and Pavla Bauerova for assistance with the SEM measurements.	Westwater J, 1997, J VAC SCI TECHNOL B, V15, P554, DOI 10.1116/1.589291; Spadafora EJ, 2010, NANO LETT, V10, P3337, DOI 10.1021/nl101001d; Fejfar A, 2013, SOL ENERG MAT SOL C, V119, P228, DOI 10.1016/j.solmat.2013.07.042; Egerton RF, 2004, MICRON, V35, P399, DOI 10.1016/j.micron.2004.02.003; Kayes B. M., 2005, Journal of Applied Physics, V97, DOI 10.1063/1.1901835; Misra S, 2013, J PHYS CHEM C, V117, P17786, DOI 10.1021/jp403063d; Yu LW, 2013, NANOTECHNOLOGY, V24, DOI [10.1088/0957-4484/24/27/275401, 10.1088/0957-4484/24/23/235401]; Misra S, 2014, J PHYS D APPL PHYS, V47, DOI 10.1088/0022-3727/47/39/393001; Kuang YH, 2013, REP PROG PHYS, V76, DOI 10.1088/0034-4885/76/10/106502; Avouris P, 1997, APPL PHYS LETT, V71, P285, DOI 10.1063/1.119521; Fejfar A, 2015, SOL ENERG MAT SOL C, V135, P106, DOI 10.1016/j.solmat.2014.10.027; Yu LW, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/19/194011; Beinik I, 2013, BEILSTEIN J NANOTECH, V4, P208, DOI 10.3762/bjnano.4.21; Misra S, 2015, IEEE J PHOTOVOLT, V5, P40, DOI 10.1109/JPHOTOV.2014.2366688; NONNENMACHER M, 1991, APPL PHYS LETT, V58, P2921, DOI 10.1063/1.105227; Karpov VG, 2002, APPL PHYS LETT, V80, P4256, DOI 10.1063/1.1483118; Tsakalakos L, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2821113; Garnett EC, 2008, J AM CHEM SOC, V130, P9224, DOI 10.1021/ja8032907; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975; Cervenka J, 2010, PHYS STATUS SOLIDI-R, V4, P37, DOI 10.1002/pssr.200903348; Chen WH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5134; Fejfar A., 2014, 6 WORLD C PHOT EN CO, P15; Kratzer M, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.245320; Ledinsky M, 2011, PHYS STATUS SOLIDI-R, V5, P373, DOI 10.1002/pssr.201105413; Li C., 2011, 132 BRUK, V132; O'Donnell B, 2012, J NON-CRYST SOLIDS, V358, P2299, DOI 10.1016/j.jnoncrysol.2011.11.026; Vetushka A, 2010, PHYS STATUS SOLIDI C, V7, P728, DOI 10.1002/pssc.200982777	27	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA08	10.7567/JJAP.54.08KA08		5	Physics, Applied	Physics	CN8BU	WOS:000358662900009		
J	Murugadoss, G; Tanaka, S; Mizuta, G; Kanaya, S; Nishino, H; Umeyama, T; Imahori, H; Ito, S				Murugadoss, Govindhasamy; Tanaka, Soichiro; Mizuta, Gai; Kanaya, Shusaku; Nishino, Hitoshi; Umeyama, Tomokazu; Imahori, Hiroshi; Ito, Seigo			Light stability tests of methylammonium and formamidinium Pb-halide perovskites for solar cell applications	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							LOW-COST; EFFICIENT; DEPOSITION; LAYER; TIO2	We have prepared perovskite [CH3NH3PbI3 (MALI), CH3NH3PbBr3 (MALB), NH2CH=NH2PbI3 (FALI), and NH2CH=NH2PbBr3 (FALB)] thin films by a one-step process on glass/TiO2 and glass/Al2O3 substrates and studied the stability of the perovskite under UV/visible light radiation up to 24 h at 1.5AM in air. After irradiation, the films were characterized by UV-vis absorption and X-ray diffraction measurements. In addition, photovoltaic performance characteristics in air were studied using different perovskites before (0 h) and after 24 h irradiation. The results revealed that Al2O3 protected the perovskite crystal from degradation. However, the perovskites were unstable except for NH2CH=NH2PbI3 un der the same conditions using a TiO2 scaffold layer. (C) 2015 The Japan Society of Applied Physics	[Murugadoss, Govindhasamy; Tanaka, Soichiro; Mizuta, Gai; Kanaya, Shusaku; Ito, Seigo] Univ Hyogo, Sch Engn, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712280, Japan; [Nishino, Hitoshi] Osaka Gas Co Ltd, Energy Technol Labs, Osaka 5540051, Japan; [Umeyama, Tomokazu; Imahori, Hiroshi] Kyoto Univ, Grad Sch Engn, Dept Mol Engn, Kyoto 6158510, Japan; [Imahori, Hiroshi] Kyoto Univ, Inst Integrated Cell Mat Sci WPI iCeMS, Kyoto 6158510, Japan	Murugadoss, G (reprint author), Univ Hyogo, Sch Engn, Dept Elect Engn & Comp Sci, Himeji, Hyogo 6712280, Japan.	itou@eng.u-hyogo.ac.jp	Imahori, Hiroshi/B-5574-2013	Imahori, Hiroshi/0000-0003-3506-5608	Advanced Low Carbon Technology Research and Development Program (ALCA, JST, Japan)	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA, JST, Japan).	Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; Habisreutinger SN, 2014, NANO LETT, V14, P5561, DOI 10.1021/nl501982b; Niu GD, 2014, J MATER CHEM A, V2, P705, DOI 10.1039/c3ta13606j; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Eperon GE, 2014, ENERG ENVIRON SCI, V7, P982, DOI 10.1039/c3ee43822h; Ito S, 2014, J PHYS CHEM C, V118, P16995, DOI 10.1021/jp500449z; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Ito S, 2014, CHEMPHYSCHEM, V15, P1194, DOI 10.1002/cphc.201301047; Liu J, 2014, ENERG ENVIRON SCI, V7, P2963, DOI 10.1039/c4ee01589d; Gao P, 2014, ENERG ENVIRON SCI, V7, P2448, DOI 10.1039/c4ee00942h; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Stoumpos CC, 2013, INORG CHEM, V52, P9019, DOI 10.1021/ic401215x; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Shi JJ, 2014, ACS APPL MATER INTER, V6, P9711, DOI 10.1021/am502131t; Park NG, 2013, J PHYS CHEM LETT, V4, P2423, DOI 10.1021/jz400892a; Zhao YX, 2014, J AM CHEM SOC, V136, P12241, DOI 10.1021/ja5071398; Snaith HJ, 2013, J PHYS CHEM LETT, V4, P3623, DOI 10.1021/jz4020162; Bi DQ, 2014, NANO, V9, DOI 10.1142/S1793292014400013; Cheng ZY, 2010, CRYSTENGCOMM, V12, P2646, DOI 10.1039/c001929a; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Leijtens T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3885; Murugadoss G, 2014, APL MATER, V2, DOI 10.1063/1.4891597; Ouellette R. J., 1997, ORGANIC CHEM BRIEF I, V2nd	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KF08	10.7567/JJAP.54.08KF08		5	Physics, Applied	Physics	CN8BU	WOS:000358662900088		
J	Nakagawa, Y; Hara, KO; Suemasu, T; Usami, N				Nakagawa, Yoshihiko; Hara, Kosuke O.; Suemasu, Takashi; Usami, Noritaka			Fabrication of single-phase polycrystalline BaSi2 thin films on silicon substrates by vacuum evaporation for solar cell applications	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOLECULAR-BEAM EPITAXY; ION-IMPLANTATION; SI; SILICIDES; MECHANISM; SI(111)	We report on the successful fabrication of single-phase polycrystalline BaSi2 films on Si(111) substrates by a simple vacuum evaporation method using BaSi2 granules. Substrate heating was found to be the key, and high substrate temperatures are required to realize single-phase BaSi2. The underlying mechanism is discussed considering the composition of vapor flux, and we confirmed that the vapor flux is Ba-rich at the initial stage of evaporation. The reevaporation of excess Ba atoms or their reaction with Si substrates would be responsible for the realization of stoichiometric single-phase BaSi2, which explains why high substrate temperatures are necessary. (C) 2015 The Japan Society of Applied Physics	[Nakagawa, Yoshihiko; Usami, Noritaka] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Hara, Kosuke O.] Univ Yamanashi, Ctr Crystal Sci & Technol, Kofu, Yamanashi 4008511, Japan; [Hara, Kosuke O.; Suemasu, Takashi; Usami, Noritaka] Japan Sci & Technol Agcy, Core Res Evolut Sci & Technol, Chiyoda Ku, Tokyo 1020076, Japan; [Suemasu, Takashi] Univ Tsukuba, Inst Appl Phys, Tsukuba, Ibaraki 3058573, Japan	Nakagawa, Y (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	nakagawa.yoshihiko@f.mbox.nagoya-u.ac.jp	Usami, Noritaka/C-1720-2009		Japan Science and Technology Agency (JST-CREST)	This work was financially supported by the Japan Science and Technology Agency (JST-CREST).	Latiff NAA, 2013, PHYS STATUS SOLIDI C, V10, P1759, DOI 10.1002/pssc.201300333; Yoneyama T, 2013, THIN SOLID FILMS, V534, P116, DOI 10.1016/j.tsf.2013.02.003; Baba M, 2012, J CRYST GROWTH, V348, P75, DOI 10.1016/j.jcrysgro.2012.03.044; Toh K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.068001; Hara KO, 2013, THIN SOLID FILMS, V534, P470, DOI 10.1016/j.tsf.2013.02.014; Morita K, 2006, THIN SOLID FILMS, V508, P363, DOI 10.1016/j.tsf.2005.07.344; Inomata Y, 2004, JPN J APPL PHYS 2, V43, pL771, DOI 10.1143/JJAP.43.L771; Hara KO, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.112302; Toh K, 2012, J CRYST GROWTH, V345, P16, DOI 10.1016/j.jcrysgro.2012.01.049; Du WJ, 2014, J APPL PHYS, V115, DOI 10.1063/1.4882117; Baba M, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4824335; Balducci G, 2008, INTERMETALLICS, V16, P1006, DOI 10.1016/j.intermet.2008.05.001; Hara KO, 2014, THIN SOLID FILMS, V567, P105, DOI 10.1016/j.tsf.2014.07.049; Khan MA, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4796142; Khan MA, 2012, THIN SOLID FILMS, V522, P95, DOI 10.1016/j.tsf.2012.09.005; Kobayashi M, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.051403; MCKEE RA, 1993, APPL PHYS LETT, V63, P2818, DOI 10.1063/1.110297; Somer M, 2000, Z ANORG ALLG CHEM, V626, P2478, DOI 10.1002/1521-3749(200012)626:12<2478::AID-ZAAC2478>3.0.CO;2-A; Takabe R, 2013, PHYS STATUS SOLIDI C, V10, P1753, DOI 10.1002/pssc.201300326; Takabe R, 2014, J APPL PHYS, V115, DOI 10.1063/1.4878159	20	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC03	10.7567/JJAP.54.08KC03		4	Physics, Applied	Physics	CN8BU	WOS:000358662900028		
J	Nakamura, T; Fukumochi, S; Maruyama, Y; Tsujii, S; Yamada, K; Nishida, T; Yukawa, H; Yoshihara, T; Nakajima, T; Yoshida, T; Shima, M; Haga, T; Okamoto, S				Nakamura, Takahiro; Fukumochi, Syuji; Maruyama, Yu; Tsujii, Shinichiro; Yamada, Kazuki; Nishida, Takahiko; Yukawa, Hiroyuki; Yoshihara, Tomohiro; Nakajima, Takeharu; Yoshida, Tomohide; Shima, Masaki; Haga, Takahiro; Okamoto, Shingo			Development of high-efficiency bifacial photovoltaic module and simulation method for its power generation	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article								We have been producing the bifacial module, the HIT (R) Double, since 2000. This module was the first to be released in the world.(1)) We have since been developing high efficiency bifacial modules. We released a new bifacial photovoltaic (PV) module in 2013. It has a conversion efficiency of 16.0% in spite of having a light-through area of 8% within the total module area, and the temperature coefficient of the output power is quite good at -0.29%/degrees C. It passed various environmental tests that are much stricter than the industrial standard. Our field test showed the effectiveness of vertically installing the bifacial module, especially when installed on ground that highly reflects light such as snow or white limestone. We developed an original simulation method to accurately estimate the energy production of the bifacial module. A simulation accuracy of about 3.7% was confirmed through practical test results at our field test site in Niigata Prefecture, Japan. (C) 2015 The Japan Society of Applied Physics	[Nakamura, Takahiro; Fukumochi, Syuji; Maruyama, Yu; Tsujii, Shinichiro; Yamada, Kazuki; Nishida, Takahiko; Yukawa, Hiroyuki; Yoshihara, Tomohiro; Nakajima, Takeharu; Yoshida, Tomohide; Shima, Masaki; Haga, Takahiro; Okamoto, Shingo] Panasonic Corp, Eco Solut Co, Solar Business Unit, Kaizuka, Osaka 5970094, Japan	Nakamura, T (reprint author), Panasonic Corp, Eco Solut Co, Solar Business Unit, Kaizuka, Osaka 5970094, Japan.	nakamura.takahiro-1@jp.panasonic.com					Taguchi M, 2000, PROG PHOTOVOLTAICS, V8, P503, DOI 10.1002/1099-159X(200009/10)8:5<503::AID-PIP347>3.0.CO;2-G; [Anonymous], 2012, HYOJ KISH DAT NO KAI; [Anonymous], 2012, BOT SEIN SHIK HYOK G, P78; Araki I., 2004, 17 INT PHOT SCI ENG, P913; Chang T., 2013, 23 INT PHOT SCI ENG, P7; Gambogi W., 2014, 6 WORLD C PHOT EN CO, P893; Maruyama E., 2013, P 39 IEEE PHOT SPEC, P96; Masuda A., 2014, P 29 EUR PHOT SOL EN, P2566; Masuda A., 2013, P 28 EUR PHOT SOL EN, P2978; Masuko K., 2014, P 40 IEEE PHOT SPEC, P1433; Murata K., 2001, 12 INT PHOT SCI ENG, P175; Nakahara H., 2004, 17 INT PHOT SCI ENG, P915; Okamoto S., 2014, 6 WORLD C PHOT EN CO, P477; Oshizawa N., 1999, 11 INT PHOT SCI ENG, P277; Sakata H., 2000, P 28 IEEE PHOT SPEC, P7, DOI 10.1109/PVSC.2000.915742; Stamenic L., 2004, 14 INT PHOT SCI ENG, P125; Sugibuchi K., 2014, 6 WORLD C PHOT EN CO, P1165; Taguchi M., 2009, P 24 EUR PHOT SOL EN, P1690; Taguchi M., 1990, 5 INT PHOT SCI ENG C, P689; Tanaka M., 2014, 6 WORLD C PHOT EN CO, P1033; Wada N., 2007, 14 INT PHOT SCI ENG, P641	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KG04	10.7567/JJAP.54.08KG04		5	Physics, Applied	Physics	CN8BU	WOS:000358662900092		
J	Nakano, S; Takeuchi, Y				Nakano, Shinya; Takeuchi, Yoshiaki			Simulation study of effect of heteroepitaxial growth on crystalline germanium heterojunction solar cell	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SURFACE PASSIVATION	The impact of crystalline silicon (c-Si) heteroepitaxial growth on a crystalline germanium (c-Ge) heterojunction solar cell has been investigated by numerical simulation. It is revealed that the defect state density of the c-Si heteroepitaxial growth layer does not significantly affect the conversion efficiency, in contrast to the case of a c-Si heterojunction solar cell. A valence band offset between the c-Ge and the c-Si heteroepitaxial growth layer prevents recombination at the defect states. On the other hand, interface defect states have a greater impact on the performance due to the weak built-in potential. From these results, reducing the effect of the interface defects is essential to improve the solar cell performance. Possible ways to reduce the effect of the interface defect states are also discussed. (C) 2015 The Japan Society of Applied Physics	[Nakano, Shinya; Takeuchi, Yoshiaki] Mitsubishi Heavy Ind Co Ltd, Solar Power Dept, Nagasaki 8540065, Japan	Nakano, S (reprint author), Mitsubishi Heavy Ind Co Ltd, Solar Power Dept, Nagasaki 8540065, Japan.	shinya_nakano@mhps.com; yoshiaki_takeuchi@mhi.co.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan	The authors thank Assistant Professor Tetsuya Kaneko of Tokai University, Professor Michio Kondo at AIST, and Professors Akihisa Matsuda and Hiroaki Okamoto of Osaka University for insightful discussions. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan.	Burrows MZ, 2008, J VAC SCI TECHNOL A, V26, P683, DOI 10.1116/1.2897929; Delabie A, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2773759; Korte L, 2009, SOL ENERG MAT SOL C, V93, P905, DOI 10.1016/j.solmat.2008.10.020; Fujiwara H, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2790815; Dao VA, 2010, SOL ENERGY, V84, P777, DOI 10.1016/j.solener.2010.01.029; Das UK, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857465; Lee CH, 2009, APPL PHYS EXPRESS, V2, DOI 10.1143/APEX.2.071404; Kuzum D, 2008, IEEE ELECTR DEVICE L, V29, P328, DOI 10.1109/LED.2008.918272; Fujiwara H, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2426900; Matsubara H, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2959731; van der Heide J, 2009, SOL ENERG MAT SOL C, V93, P1810, DOI 10.1016/j.solmat.2009.06.017; Wang TH, 2006, THIN SOLID FILMS, V501, P284, DOI 10.1016/j.tsf.2005.07.196; Broqvist P, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.075203; Hekmatshoar B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4737166; Kaneko T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CR04; Lee CH, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.114001; Makita K., 2013, MRS P, V1538, P167; Nakano S., 2014, 6 IEEE INT NAN C; Nakano S, 2012, J NON-CRYST SOLIDS, V358, P2249, DOI 10.1016/j.jnoncrysol.2011.12.045; Nakano S, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER12; Olibet S., 2008, 23 EUR PHOT SOL EN C, P1140; Sritharathikhun J, 2008, JPN J APPL PHYS, V47, P8452, DOI 10.1143/JJAP.47.8452; Stangl R., 2002, P PV EUR ROM IT OCT, P123; Stangl R, 2010, SOLAR ENERGY, P319; Sze S. M., 1981, PHYSICS SEMICONDUCTO, V2nd, P7; Wolf S. D., 2012, PHYS TECHNOLOGY AMOR, P223	26	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KB06	10.7567/JJAP.54.08KB06		5	Physics, Applied	Physics	CN8BU	WOS:000358662900020		
J	Niki, S; Usami, N; Toyama, T; Itoh, T; Arafune, K; Doi, T; Eguchi, Y; Hayase, S; Hishikawa, Y; Imaizumi, M; Ishikawa, Y; Kaizuka, I; Katagiri, H; Kato, K; Kobayashi, T; Kojima, N; Komoto, K; Kushiya, K				Niki, Shigeru; Usami, Noritaka; Toyama, Toshihiko; Itoh, Takashi; Arafune, Koji; Doi, Takuya; Eguchi, Yoshihito; Hayase, Shuzi; Hishikawa, Yoshihiro; Imaizumi, Mitsuru; Ishikawa, Yasuaki; Kaizuka, Izumi; Katagiri, Hironori; Kato, Kazuhiko; Kobayashi, Tomonao; Kojima, Nobuaki; Komoto, Keiichi; Kushiya, Katsumi			Photovoltaic Science and Engineering FOREWORD	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Editorial Material									[Niki, Shigeru; Doi, Takuya; Hishikawa, Yoshihiro; Kato, Kazuhiko] AIST, Tsukuba, Ibaraki, Japan; [Usami, Noritaka] Nagoya Univ, Nagoya, Aichi 4648601, Japan; [Toyama, Toshihiko] Osaka Univ, Suita, Osaka 565, Japan; [Itoh, Takashi; Kobayashi, Tomonao] Gifu Univ, Gifu, Japan; [Arafune, Koji] Univ Hyogo, Kobe, Hyogo 6500044, Japan; [Eguchi, Yoshihito] Mitsui Chem, Tokyo, Japan; [Hayase, Shuzi] Kyushu Inst Technol, Kitakyushu, Fukuoka, Japan; [Imaizumi, Mitsuru] Japan Aerosp Explorat Agcy, Chofu, Tokyo, Japan; [Ishikawa, Yasuaki] Nara Inst Sci & Technol, Nara, Japan; [Kaizuka, Izumi] RTS Corp, Lakewood, CO USA; [Katagiri, Hironori] Nagaoka Coll, Natl Inst Technol, Nagaoka, Niigata, Japan; [Kojima, Nobuaki] Toyota Technol Inst, Toyota, Japan; [Komoto, Keiichi] Mizuho Informat & Res Inst, Tokyo, Japan; [Kushiya, Katsumi] SOLAR FRONTIER, Tokyo, Japan	Niki, S (reprint author), AIST, Tsukuba, Ibaraki, Japan.		Usami, Noritaka/C-1720-2009					0	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08K001	10.7567/JJAP.54.08K001		1	Physics, Applied	Physics	CN8BU	WOS:000358662900001		
J	Nishimura, T; Hirai, Y; Kurokawa, Y; Yamada, A				Nishimura, Takahito; Hirai, Yoshiaki; Kurokawa, Yasuyoshi; Yamada, Akira			Control of valence band offset at CdS/Cu(In,Ga)Se-2 interface by inserting wide-bandgap materials for suppression of interfacial recombination in Cu(In,Ga)Se-2 solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS; RAMAN-SPECTRA; EFFICIENCY; CUIN3SE5; DEVICES; CUINSE2; SURFACE; SYSTEM; LAYER	We inserted Cu(In,Ga)(3)Se-5 into the CdS/Cu(In,Ga)Se-2 interface of Cu(In,Ga)Se-2 solar cells with a flat band profile and energy bandgaps (E-g) of 1.2 and 1.4 eV in order to investigate the repelling of holes by the effect of valence band offset (Delta E-v). We found that open circuit voltage (V-OC) was clearly improved from 0.66 to 0.75V with E-g of 1.4 eV, although V-OC was only increased from 0.63 to 0.64 V with E-g of 1.2 eV. For high efficiency, we fabricated Cu(In,Ga)Se-2 solar cells with a single-graded band profile and an average E-g of 1.4 eV. Eventually, a conversion efficiency of 14.4% was obtained when Cu(In,Ga)(3)Se-5 with a thickness of 30 nm was inserted, although the conversion efficiency was 10.5% without Cu(In,Ga)(3)Se-5. These results suggest the importance of Delta E-v in the suppression of interfacial recombination by repelling holes and possibility that the highest efficiency of Cu(In,Ga)Se-2 solar cells with an average E-g of 1.4 eV could be achieved. (C) 2015 The Japan Society of Applied Physics	[Nishimura, Takahito; Hirai, Yoshiaki; Kurokawa, Yasuyoshi; Yamada, Akira] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Yamada, Akira] Tokyo Inst Technol, Photovolta Res Ctr PVREC, Meguro Ku, Tokyo 1528552, Japan	Nishimura, T (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.	nishimura.t.ak@m.titech.ac.jp	Kurokawa, Yasuyoshi/P-1057-2014		New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry.	Schmid D, 1996, SOL ENERG MAT SOL C, V41-2, P281, DOI 10.1016/0927-0248(95)00107-7; Heath JT, 2002, APPL PHYS LETT, V80, P4540, DOI 10.1063/1.1485301; Marin G, 1998, MATER RES BULL, V33, P1057; Siebentritt S, 2011, SOL ENERG MAT SOL C, V95, P1471, DOI 10.1016/j.solmat.2010.12.014; RINCON C, 1992, J APPL PHYS, V72, P4321; Nagoya Y, 2001, SOL ENERG MAT SOL C, V67, P247, DOI 10.1016/S0927-0248(00)00288-9; MATSUSHITA H, 1992, JPN J APPL PHYS 1, V31, P18, DOI 10.1143/JJAP.31.18; Rincon C, 1998, APPL PHYS LETT, V73, P441, DOI 10.1063/1.121893; Minemoto T, 2001, SOL ENERG MAT SOL C, V67, P83, DOI 10.1016/S0927-0248(00)00266-X; Contreras MA, 2012, PROG PHOTOVOLTAICS, V20, P843, DOI 10.1002/pip.2244; Kwon SH, 1998, SOL ENERGY, V64, P55, DOI 10.1016/S0038-092X(98)00024-3; Turcu M, 2002, J APPL PHYS, V91, P1391, DOI 10.1063/1.1432126; Contreras MA, 2005, PROG PHOTOVOLTAICS, V13, P209, DOI 10.1002/pip.626; HONLE W, 1988, CRYST RES TECHNOL, V23, P1347, DOI 10.1002/crat.2170231027; GABOR AM, 1994, APPL PHYS LETT, V65, P198, DOI 10.1063/1.112670; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Hirai Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.014101; Ward JS, 2002, PROG PHOTOVOLTAICS, V10, P41, DOI 10.1002/pip.424; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Chirila A, 2013, NAT MATER, V12, P1107, DOI [10.1038/nmat3789, 10.1038/NMAT3789]; Hashimoto Y, 1998, SOL ENERG MAT SOL C, V50, P71, DOI 10.1016/S0927-0248(97)00124-4; Hirai Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.012301; Hirai Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC03; Nakamura M., 2014, P 40 IEEE PHOT SPEC, P107; NEGAMI T, 1995, APPL PHYS LETT, V67, P825, DOI 10.1063/1.115456; Nishimura T., 2014, 6 WORLD C PHOT EN CO; Powalla M., 2014, 29 EUR PHOT SOL EN C; TANINO H, 1993, JPN J APPL PHYS 1, V32, P436	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC08	10.7567/JJAP.54.08KC08		5	Physics, Applied	Physics	CN8BU	WOS:000358662900033		
J	Noge, H; Saito, K; Sato, A; Kaneko, T; Kondo, M				Noge, Hiroshi; Saito, Kimihiko; Sato, Aiko; Kaneko, Tetsuya; Kondo, Michio			Two-dimensional simulation of interdigitated back contact silicon heterojunction solar cells having overlapped p/i and n/i a-Si:H layers	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CRYSTALLINE SILICON; EFFICIENCY; DENSITY; LIMITS; GE	The performance of interdigitated back contact silicon heterojunction solar cells having overlapped p/i and n/i a-Si:H layers on the back has been investigated by two-dimensional simulation in comparison with the conventional cell structure having a gap between p/i and n/i layers. The results show that narrower overlap width leads to higher short circuit current and conversion efficiency, especially for poor heterojunction interface and thinner silicon substrate of the cells in addition to narrower uncovered width of p/i layer by a metal electrode. This is similar to the gap width dependence in the conventional cells, since both overlap and gap act as dead area for diffused excess carriers in the back contacts. (C) 2015 The Japan Society of Applied Physics	[Noge, Hiroshi; Saito, Kimihiko; Sato, Aiko; Kaneko, Tetsuya; Kondo, Michio] Fukushima Univ, Fac Symbol Syst Sci, Fukushima 9601296, Japan; [Kaneko, Tetsuya] Tokai Univ, Sch Engn, Hiratsuka, Kanagawa 2591292, Japan; [Kondo, Michio] Natl Inst Adv Ind Sci & Technol, Fukushima Renewable Energy Inst FREA, Koriyama, Fukushima 9630298, Japan	Noge, H (reprint author), Fukushima Univ, Fac Symbol Syst Sci, Fukushima 9601296, Japan.	noge.hiroshi@aist.go.jp; michio.kondo@aist.go.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) in Fukushima Regional Innovation Strategy Promotion Program	The authors acknowledge FREA and Research Center for Photovoltaic Technologies (RCPVT) of AIST for the experimental facilities. This work was supported by Ministry of Education, Culture, Sports, Science and Technology of Japan (MEXT) in Fukushima Regional Innovation Strategy Promotion Program.	Lu MJ, 2011, PROG PHOTOVOLTAICS, V19, P326, DOI 10.1002/pip.1032; Diouf D, 2009, MATER SCI ENG B-ADV, V159-60, P291, DOI 10.1016/j.mseb.2008.09.002; Gudovskikh AS, 2007, THIN SOLID FILMS, V515, P7481, DOI 10.1016/j.tsf.2006.11.198; Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Kerr MJ, 2002, J APPL PHYS, V91, P2473, DOI 10.1063/1.1432476; HALL RN, 1952, PHYS REV, V87, P387, DOI 10.1103/PhysRev.87.387; Mishima T, 2011, SOL ENERG MAT SOL C, V95, P18, DOI 10.1016/j.solmat.2010.04.030; [Anonymous], US MAN ATLAS VERS 5; ANDERSON RL, 1962, SOLID STATE ELECTRON, V5, P341, DOI 10.1016/0038-1101(62)90115-6; Nakamura J, 2014, IEEE J PHOTOVOLT, V4, P1491, DOI 10.1109/JPHOTOV.2014.2358377; SHOCKLEY W, 1952, PHYS REV, V87, P835, DOI 10.1103/PhysRev.87.835; Cousins P. J., 2010, P 35 IEEE PHOT SPEC; Desrues T., 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Desrues T., 2009, P 24 EUR PHOT SOL EN, P2202; Diouf D., 2012, PHYS TECHNOLOGY AMOR; Diouf D, 2010, ENRGY PROCED, V2, P59, DOI 10.1016/j.egypro.2010.07.011; FOSSUM JG, 1982, SOLID STATE ELECTRON, V25, P741, DOI 10.1016/0038-1101(82)90203-9; Haschke J, 2013, ENRGY PROCED, V38, P732, DOI 10.1016/j.egypro.2013.07.340; Hayashi Y, 2013, IEEE J PHOTOVOLT, V3, P1149, DOI 10.1109/JPHOTOV.2013.2274616; Hertanto Anthony, 2009, Proceedings of the 2009 34th IEEE Photovoltaic Specialists Conference (PVSC 2009), DOI 10.1109/PVSC.2009.5411466; Lu M., 2007, APPL PHYS LETT, V91, DOI DOI 10.1063/1.2768635; MASETTI G, 1983, IEEE T ELECTRON DEV, V30, P764, DOI 10.1109/T-ED.1983.21207; O'Sullivan B. J., 2010, P 35 IEEE PHOT SPEC, P3549; Saito K., 2014, P 29 EUR PHOT SOL EN, P1249; Stangl R., 2008, P 33 IEEE PHOT SPEC, P1; Stangl R, 2009, SOL ENERG MAT SOL C, V93, P1900, DOI 10.1016/j.solmat.2009.06.010; TANAKA M, 1992, JPN J APPL PHYS 1, V31, P3518, DOI 10.1143/JJAP.31.3518; THORPE MF, 1971, PHYS REV LETT, V27, P1581, DOI 10.1103/PhysRevLett.27.1581; Tucci M., 2008, P 23 EUR PHOT SOL EN, P1749; Van Kerschaver E, 2006, PROG PHOTOVOLTAICS, V14, P107, DOI 10.1002/pip.657; Zhu K, 2003, MATER RES SOC SYMP P, V762, P297	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD17	10.7567/JJAP.54.08KD17		6	Physics, Applied	Physics	CN8BU	WOS:000358662900062		
J	Nomura, K; Imai, K; Ota, Y; Minemoto, T; Nishioka, K				Nomura, Kei; Imai, Kenta; Ota, Yasuyuki; Minemoto, Takashi; Nishioka, Kensuke			Effect of aerosols on performance of concentrator photovoltaics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MULTIJUNCTION SOLAR-CELLS; HIGH-EFFICIENCY MULTIJUNCTION; V COMPOUND MULTIJUNCTION; SHAPED FRESNEL LENSES; OUTDOOR PERFORMANCE; OUTPUT ESTIMATION; MODULES; TEMPERATURE; SYSTEM	The performance of a concentrator photovoltaic (CPV) system under atmospheric condition was observed. On the basis of measurement data, the effect of aerosols on the system performance was investigated. In this study, visual range and air mass (AM) were used as indices for estimating the performance ratio (PR) of the CPV system. We found a strong correlation between visual range and average photon energy (APE). APE decreased with decreasing visual range owing to the Rayleigh scattering, and eventually the PR of CPV decreased. APE decreased with increasing AM. The travel distance of the light path through the aerosol increased with increasing AM; thus, a low APE was observed. These results indicate the possibility of estimating the APE and PR of the CPV system from environmental factors such as visual range and AM, which can be easily obtained. (C) 2015 The Japan Society of Applied Physics	[Nomura, Kei; Imai, Kenta; Ota, Yasuyuki; Nishioka, Kensuke] Miyazaki Univ, Fac Engn, Miyazaki 8892192, Japan; [Minemoto, Takashi] Ritsumeikan Univ, Coll Sci & Engn, Kusatsu, Shiga 5258577, Japan	Nomura, K (reprint author), Miyazaki Univ, Fac Engn, Miyazaki 8892192, Japan.	nishioka@cc.miyazaki-u.ac.jp	Minemoto, Takashi/F-9342-2011		Incorporated Administrative Agency, New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry, Japan (METI)	Part of this work was supported by the Incorporated Administrative Agency, New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry, Japan (METI).	Araki K, 2005, PROG PHOTOVOLTAICS, V13, P513, DOI 10.1002/pip.643; Geisz JF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753729; Nishioka K, 2005, SOL ENERG MAT SOL C, V85, P429, DOI 10.1016/j.solmat.2004.05.008; Hess M, 1998, B AM METEOROL SOC, V79, P831, DOI 10.1175/1520-0477(1998)079<0831:OPOAAC>2.0.CO;2; Sasaki K, 2013, AIP CONF PROC, V1556, P22, DOI 10.1063/1.4822190; Yamaguchi M, 2006, SOL ENERG MAT SOL C, V90, P3068, DOI 10.1016/j.solmat.2006.06.028; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P57, DOI 10.1016/j.solmat.2005.01.011; Peharz G, 2011, SOL ENERG MAT SOL C, V95, P2734, DOI 10.1016/j.solmat.2011.03.030; Araki K, 2010, OPT EXPRESS, V18, pA53, DOI [10.1364/OE.18.000A53, 10.1364/OE.18.0000A53]; Takamoto T, 2005, PROG PHOTOVOLTAICS, V13, P495, DOI 10.1002/pip.642; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; Minemoto T, 2007, SOL ENERG MAT SOL C, V91, P919, DOI 10.1016/j.solmat.2007.02.012; Yamaguchi M, 2003, SOL ENERG MAT SOL C, V75, P261, DOI 10.1016/S0927-0248(02)00168-X; Guter W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148341; Peharz G, 2011, PROG PHOTOVOLTAICS, V19, P54, DOI 10.1002/pip.987; Araki K, 2006, SOL ENERG MAT SOL C, V90, P3312, DOI 10.1016/j.solmat.2005.09.017; Brown TM, 2001, ASTROPHYS J, V553, P1006, DOI 10.1086/320950; Cotal H. L., 2000, P 28 IEEE PHOT SPEC, P955; Fahrenbruch A. L., 1983, FUNDAMENTALS SOLAR C, P238; Nakada Y, 2010, CURR APPL PHYS, V10, pS261, DOI 10.1016/j.cap.2009.11.026; Nomura K, 2014, PHYS STATUS SOLIDI C, V11, P1427, DOI 10.1002/pssc.201300629; Nomura K, 2014, ACTA PHYS POL A, V125, P1021; Ota Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.122301; Ota Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.04CR03; Sabnis V, 2012, AIP CONF PROC, V1477, P14, DOI 10.1063/1.4753823; Sakurada Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.04DP13; Sze S. M., 1981, PHYS SEMICONDUCTOR D, V2nd, P833; Yamaguchi M, 2012, ENRGY PROCED, V15, P265, DOI 10.1016/j.egypro.2012.02.031; Yandt MD, 2012, AIP CONF PROC, V1477, P172, DOI 10.1063/1.4753861	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KE07	10.7567/JJAP.54.08KE07		4	Physics, Applied	Physics	CN8BU	WOS:000358662900077		
J	Osada, K; Suzuki, T; Yagi, S; Naitoh, S; Shoji, Y; Hijikata, Y; Okada, Y; Yaguchi, H				Osada, Kazuki; Suzuki, Tomoya; Yagi, Shuhei; Naitoh, Shunya; Shoji, Yasushi; Hijikata, Yasuto; Okada, Yoshitaka; Yaguchi, Hiroyuki			Control of intermediate-band configuration in GaAs: N delta-doped superlattice	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SOLAR-CELLS; OPTICAL-PROPERTIES; GAINNAS ALLOYS; EFFICIENCY; NITROGEN; TRANSITIONS; LASERS	GaAs: N delta-doped superlattices (SLs) consisting of alternating layers of undoped and N delta-doped GaAs were fabricated by molecular beam epitaxy (MBE) as possible candidates for the light-absorbing material of intermediate-band solar cells (IBSCs). Since the energy gaps in IBSCs need to be adjusted to optimum values to achieve sufficiently high conversion efficiency, it is important to control precisely the band configuration of intermediate-band (IB) materials. In this study, we demonstrated the control of the IB energy configuration in GaAs: N delta-doped SLs by changing their structural parameters. Optical transitions due to the SL minibands related to the N-induced conduction subbands E+ and E- were clearly observed and the transition energies depended systematically on the N area density and period length of the SLs. Conversion efficiency calculations based on the detailed balance model indicated that IBSCs with an efficiency of nearly 60% are achievable by using the fabricated GaAs: N delta-doped SLs. (C) 2015 The Japan Society of Applied Physics	[Osada, Kazuki; Suzuki, Tomoya; Yagi, Shuhei; Hijikata, Yasuto; Yaguchi, Hiroyuki] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Naitoh, Shunya; Shoji, Yasushi; Okada, Yoshitaka] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan	Osada, K (reprint author), Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan.	osadak@opt.ees.saitama-u.ac.jp; yagi@opt.ees.saitama-u.ac.jp	Yaguchi, Hiroyuki/B-3902-2012; Hijikata, Yasuto/B-3843-2012	Yaguchi, Hiroyuki/0000-0003-0621-3501; 			Ahsan N, 2013, IEEE J PHOTOVOLT, V3, P730, DOI 10.1109/JPHOTOV.2012.2228296; Lopez N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028701; Shan W, 1999, PHYS REV LETT, V82, P1221, DOI 10.1103/PhysRevLett.82.1221; Harris JS, 2002, SEMICOND SCI TECH, V17, P880, DOI 10.1088/0268-1242/17/8/317; Shan W, 2000, PHYS REV B, V62, P4211, DOI 10.1103/PhysRevB.62.4211; Shan W, 1999, J APPL PHYS, V86, P2349, DOI 10.1063/1.371148; Ahsan N, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4709405; Linares PG, 2011, J APPL PHYS, V109, DOI 10.1063/1.3527912; Perkins JD, 1999, PHYS REV LETT, V82, P3312, DOI 10.1103/PhysRevLett.82.3312; Luque A, 2012, NAT PHOTONICS, V6, P146, DOI [10.1038/nphoton.2012.1, 10.1038/NPHOTON.2012.1]; Grau A, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2387973; ASPNES DE, 1973, SURF SCI, V37, P418, DOI 10.1016/0039-6028(73)90337-3; Luque A, 2001, PROG PHOTOVOLTAICS, V9, P73, DOI 10.1002/pip.354; Green MA, 2001, PROG PHOTOVOLTAICS, V9, P123, DOI 10.1002/pip.360; Canovas E, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3013570; Francoeur S, 1998, APPL PHYS LETT, V72, P1857, DOI 10.1063/1.121206; Geddo M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709629; Li LH, 2000, J APPL PHYS, V87, P245, DOI 10.1063/1.371852; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Marti A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247701; Noguchi S, 2013, IEEE J PHOTOVOLT, V3, P1287, DOI 10.1109/JPHOTOV.2013.2271978; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Oshima R, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000461; Palacios P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085206; Rao EVK, 1998, APPL PHYS LETT, V72, P1409, DOI 10.1063/1.120579; Strandberg R, 2009, J APPL PHYS, V105, DOI 10.1063/1.3153141; Tablero C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195203; Walukiewicz W., 2005, DILUTE NITRIDE SEMIC, P325, DOI 10.1016/B978-008044502-1/50010-X; Wu FC, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4750981; Yagi S, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.102301; Yagi S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.102302; Yeh JY, 2004, J CRYST GROWTH, V272, P719, DOI [10.1016/j.jcrysgro.2004.09.005, 10.1016/j.crysgro.2004.09.005]	32	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA04	10.7567/JJAP.54.08KA04		3	Physics, Applied	Physics	CN8BU	WOS:000358662900005		
J	Oshima, R; Makita, K; Mizuno, H; Takato, H; Matsubara, K; Sugaya, T				Oshima, Ryuji; Makita, Kikuo; Mizuno, Hidenori; Takato, Hidetaka; Matsubara, Koji; Sugaya, Takeyoshi			MBE-grown InGaAsP solar cells with 1.0 eV bandgap on InP(001) substrates for application to multijunction solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOLECULAR-BEAM EPITAXY; COMPOSITION MODULATION; LAYERS; EFFICIENCY; DESIGN; INP	In this study, we have developed the first ever solid-source molecular beam epitaxy (SS-MBE)-grown In0.81Ga0.19As0.43P0.57/In0.47Ga0.53As dual-junction solar cells grown on InP substrates with a 1.0/0.7 eV bandgap for use in mechanically stacked multijunction solar cells. We studied the adsorption efficiencies of As-2 and P-2 to determine the optimal parameters for the growth of lattice-matched In0.81Ga0.19As0.43P0.57 by SS-MBE. The adsorption efficiency of As-2 was found to be seven times greater than that of P-2, and lattice-matched In(0.81)Ga(0.19)AsyP(1-y) (y = 0.43) can be achieved at a P-As/(P-P + P-As) ratio of similar to 0.10. Then, we studied the effect of growth temperature on the characteristics of lattice-matched In0.81Ga0.19As0.43P0.57 single-junction solar cells. The open-circuit voltage (V-OC) was found to be greatly affected by the growth temperature, and the highest V-OC = 0.47V (efficiency eta = 10.5%) was obtained for cells grown at 440 degrees C. On the other hand, photoluminescence intensity measured for these cells at room temperature monotonically increased with an increase in the growth temperature, which implies that the reduction in V-OC for the cells grown at 400 and 420 degrees C was due to the increase in the intrinsic defects and unexpected contaminations. By contrast, the reduction in VOC for the cell grown at 450 degrees C is presumably attributed to an increase in local compositional fluctuations. We integrated the abovementioned In0.81Ga0.19As0.43P0.57 top cell with the In0.47Ga0.53As bottom cell and an eta of 3.7% was obtained using an 880-nm-long pass filter. (C) 2015 The Japan Society of Applied Physics	[Oshima, Ryuji; Makita, Kikuo; Matsubara, Koji; Sugaya, Takeyoshi] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan; [Mizuno, Hidenori; Takato, Hidetaka] Natl Inst Adv Ind Sci & Technol, Renewable Energy Res Ctr, Koriyama, Fukushima 9630298, Japan	Oshima, R (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan.	r.oshima@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO)	This study was supported by the New Energy and Industrial Technology Development Organization (NEDO).	Geisz JF, 2014, AIP CONF PROC, V1616, P114, DOI 10.1063/1.4897041; Derendorf K, 2013, IEEE J PHOTOVOLT, V3, P1423, DOI 10.1109/JPHOTOV.2013.2273097; Sugaya T, 2013, J CRYST GROWTH, V378, P576, DOI 10.1016/j.jcrysgro.2012.11.008; Green MA, 2013, PROG PHOTOVOLTAICS, V21, P1, DOI 10.1002/pip.2352; Friedman DJ, 1998, J CRYST GROWTH, V195, P409, DOI 10.1016/S0022-0248(98)00561-2; Sasaki K, 2013, AIP CONF PROC, V1556, P22, DOI 10.1063/1.4822190; Yamaguchi M, 2006, SOL ENERG MAT SOL C, V90, P3068, DOI 10.1016/j.solmat.2006.06.028; Mizuno H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766339; Cotal H, 2009, ENERG ENVIRON SCI, V2, P174, DOI 10.1039/b809257e; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; NORMAN AG, 1985, J APPL PHYS, V57, P4715, DOI 10.1063/1.335333; Aiken DJ, 2000, PROG PHOTOVOLTAICS, V8, P563, DOI 10.1002/1099-159X(200011/12)8:6<563::AID-PIP327>3.0.CO;2-8; LaPierre RR, 1996, J CRYST GROWTH, V158, P6, DOI 10.1016/0022-0248(95)00364-9; Philipps SP, 2010, SOL ENERG MAT SOL C, V94, P869, DOI 10.1016/j.solmat.2010.01.010; Law DC, 2010, SOL ENERG MAT SOL C, V94, P1314, DOI 10.1016/j.solmat.2008.07.014; Chiu P. T., 2012, P 38 IEEE PHOT SPEC; Dharmarasu N, 2001, APPL PHYS LETT, V79, P2399, DOI 10.1063/1.1409270; Dimroth F., 2003, P 3 WORLD C PHOT EN, V1, P616; Emziane M, 2007, J APPL PHYS, V101, DOI 10.1063/1.2709525; Geisz JF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2988497; HENOC P, 1982, APPL PHYS LETT, V40, P963, DOI 10.1063/1.92968; Ji L, 2014, SOL ENERG MAT SOL C, V127, P1, DOI 10.1016/j.solmat.2014.03.051; Konaka Y, 2010, J CRYST GROWTH, V312, P2056, DOI 10.1016/j.jcrysgro.2010.03.038; Law D. C., 2009, PHOT SPEC C PVSC 34; Leite MS, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4758300; Otsuka N, 1997, J CRYST GROWTH, V170, P626, DOI 10.1016/S0022-0248(96)00585-4; Pessa M, 1995, THIN SOLID FILMS, V267, P99, DOI 10.1016/0040-6090(95)06626-8; Shi W, 1999, J CRYST GROWTH, V197, P89, DOI 10.1016/S0022-0248(98)00909-9; Toberer E. S., 2012, P IEEE 38 PHOT SPEC; Zhang DH, 2000, J CRYST GROWTH, V211, P384, DOI 10.1016/S0022-0248(99)00806-4	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KE10	10.7567/JJAP.54.08KE10		4	Physics, Applied	Physics	CN8BU	WOS:000358662900080		
J	Otsuka, R; Endo, T; Takano, T; Takemura, S; Murakami, R; Muramoto, R; Madarasz, J; Okuya, M				Otsuka, Rena; Endo, Takeshi; Takano, Takafumi; Takemura, Shuichiro; Murakami, Ryo; Muramoto, Ryosuke; Madarasz, Janos; Okuya, Masayuki			Fluorine doped tin oxide film with high haze and transmittance prepared for dye-sensitized solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SPRAY-PYROLYSIS DEPOSITION; SNO2 THIN-FILMS; SPD TECHNIQUE; CONVERSION EFFICIENCY; FABRICATION; LIGHT; ELECTRODES; SCATTERING; GROWTH	Fluorine doped tin oxide (FTO) transparent conductive oxide (TCO) film for dye-sensitized solar cell (DSSC) was investigated. Haze of the incident light through TCO film was easily tuned by controlling the surface morphology of FTO deposited on tin doped indium oxide (ITO) nano-particle seed layer pre-coated on a glass substrate, and the light harvest within the cell was effectively enhanced with high haze TCO film. The conversion efficiency of DSSC fabricated with TCO film with the haze of 30.1% reached as high as 7.7%, attributing to the consequence of the effective light harvest with the scattering within the cell. (C) 2015 The Japan Society of Applied Physics	[Otsuka, Rena; Endo, Takeshi; Takano, Takafumi; Takemura, Shuichiro; Murakami, Ryo; Muramoto, Ryosuke; Okuya, Masayuki] Shizuoka Univ, Dept Elect & Mat Sci, Hamamatsu, Shizuoka 4328561, Japan; [Madarasz, Janos] Budapest Univ Technol & Econ, Inst Gen & Analyt Chem, H-1521 Budapest, Hungary; [Okuya, Masayuki] Shizuoka Univ, Res Inst Green Sci & Technol, Hamamatsu, Shizuoka 4328561, Japan	Otsuka, R (reprint author), Shizuoka Univ, Dept Elect & Mat Sci, Hamamatsu, Shizuoka 4328561, Japan.	okuya.masayuki@shizuoka.ac.jp					Gratzel M, 2014, NAT MATER, V13, P838, DOI 10.1038/nmat4065; Wu ZB, 2001, THIN SOLID FILMS, V385, P109, DOI 10.1016/S0040-6090(00)01906-4; Yella A, 2011, SCIENCE, V334, P629, DOI 10.1126/science.1209688; SMESTAD G, 1994, SOL ENERG MAT SOL C, V32, P259, DOI 10.1016/0927-0248(94)90263-1; Muto T, 2010, J ELECTROCHEM SOC, V157, pB1195, DOI 10.1149/1.3447740; Okuya M, 2002, SOL ENERG MAT SOL C, V70, P425, DOI 10.1016/S0927-0248(01)00033-2; Kumara GRA, 2014, J PHYS CHEM C, V118, P16479, DOI 10.1021/jp411354b; Hoshikawa T, 2005, J ELECTROCHEM SOC, V152, pE68, DOI 10.1149/1.1849776; Okuya M, 2004, SOLID STATE IONICS, V172, P527, DOI 10.1016/j.ssi.2004.02.060; Kosugi T, 1998, J AM CERAM SOC, V81, P3117, DOI 10.1111/j.1151-2916.1998.tb02746.x; Hodes G, 2013, SCIENCE, V342, P317, DOI 10.1126/science.1245473; OREGAN B, 1991, NATURE, V353, P737, DOI 10.1038/353737a0; Zhang ZP, 2007, Z PHYS CHEM, V221, P319, DOI 10.1524/zpch.2007.221.3.319; Ito S, 2008, THIN SOLID FILMS, V516, P4613, DOI 10.1016/j.tsf.2007.05.090; Chiba Y, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2208920; Usami A, 1997, CHEM PHYS LETT, V277, P105, DOI 10.1016/S0009-2614(97)00878-6; Fujiwara T, 2002, J CERAM SOC JPN, V110, P81, DOI 10.2109/jcersj.110.81; Kim D, 2011, J ELECTROCHEM SOC, V158, pD191, DOI 10.1149/1.3546850; Murakami K, 1996, J AM CERAM SOC, V79, P2557; Okuya M, 2008, ELECTROCHEMISTRY, V76, P132; Okuya M, 2001, J EUR CERAM SOC, V21, P2099, DOI 10.1016/S0955-2219(01)00180-7; Okuya M., 2000, CERAM T, V109, P473; Okuya M, 1999, J EUR CERAM SOC, V19, P903, DOI 10.1016/S0955-2219(98)00341-0; Okuya M, 2004, J PHOTOCH PHOTOBIO A, V164, P167, DOI 10.1016/j.jphotonchem.2003.11.019; Okuya M, 2002, KEY ENG MAT, V228-2, P247; Premalal EVA, 2012, ELECTROCHEMISTRY, V80, P624, DOI 10.5796/electrochemistry.80.624; Takayama A, 2004, SOLID STATE IONICS, V172, P257, DOI [10.1016/j.ssi.2004.02.040, 10.1016/j.ssi.02.040]; VIGUIE JC, 1975, J ELECTROCHEM SOC, V122, P585; YAGI I, 1992, CHEM LETT, P2345, DOI 10.1246/cl.1992.2345; Yamamoto T., 2010, T MAT RES SOC JPN, V35, P409	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KF03	10.7567/JJAP.54.08KF03		3	Physics, Applied	Physics	CN8BU	WOS:000358662900083		
J	Sadono, A; Hino, M; Ichikawa, M; Yamamoto, K; Kurokawa, Y; Konagai, M; Yamada, A				Sadono, Adiyudha; Hino, Masashi; Ichikawa, Mitsuru; Yamamoto, Kenji; Kurokawa, Yasuyoshi; Konagai, Makoto; Yamada, Akira			Flexible Cu(In,Ga)Se-2 solar cells fabricated using a polyimide-coated soda-lime glass substrate	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MO BACK CONTACT; STAINLESS-STEEL FOILS; EFFICIENCY; DIFFUSION; MODULES; GROWTH; CU(IN	Flexible solar cells with a Cu(In,Ga)Se-2 (CIGS) absorber layer were fabricated on a polyimide thin film using a lift-off process. Polyimide-coated soda-lime glass (SLG) was used as a substrate for fabricating CIGS solar cells before the lift-off process conducted to make the cells flexible. A conversion efficiency of 13.4% was achieved by low temperature deposition; this value is comparable to that obtained by direct deposition on a rigid glass substrate even without an external Na source. The final conversion efficiency after the lift-off process was 12.7% with some area correction due to the partial peeling-off between CIGS and Mo. Open-circuit voltage and fill factor did not change before and after the lift-off process, suggesting that the lift-off process did not give any physical damage. (C) 2015 The Japan Society of Applied Physics	[Sadono, Adiyudha; Kurokawa, Yasuyoshi; Konagai, Makoto; Yamada, Akira] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan; [Konagai, Makoto; Yamada, Akira] Tokyo Inst Technol, Meguro Ku, Photovolta Res Ctr PVREC, Tokyo 1528552, Japan; [Hino, Masashi; Ichikawa, Mitsuru; Yamamoto, Kenji] Kaneka Corp, Settsu, Osaka 5660072, Japan	Sadono, A (reprint author), Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan.	sadono.a.aa@m.titech.ac.jp	Kurokawa, Yasuyoshi/P-1057-2014				Amouzou D., 2011, P 37 IEEE PHOT SPEC; Caballero R, 2009, PHYS STATUS SOLIDI A, V206, P1049, DOI 10.1002/pssa.200881144; Wuerz R, 2012, SOL ENERG MAT SOL C, V100, P132, DOI 10.1016/j.solmat.2012.01.004; Caballero R, 2011, PROG PHOTOVOLTAICS, V19, P547, DOI 10.1002/pip.1064; Yoon JH, 2013, PROG PHOTOVOLTAICS, V21, P58, DOI 10.1002/pip.2193; Yoon JH, 2014, PROG PHOTOVOLTAICS, V22, P90, DOI 10.1002/pip.2377; SCOFIELD JH, 1995, THIN SOLID FILMS, V260, P26, DOI 10.1016/0040-6090(94)06462-8; Wuerz R, 2011, THIN SOLID FILMS, V519, P7268, DOI 10.1016/j.tsf.2011.01.399; Chirila A, 2011, NAT MATER, V10, P857, DOI [10.1038/nmat3122, 10.1038/NMAT3122]; Thongkham W, 2013, SOL ENERGY, V92, P189, DOI 10.1016/j.solener.2013.03.010; Pianezzi F, 2012, PROG PHOTOVOLTAICS, V20, P253, DOI 10.1002/pip.1247; Kessler F, 2004, SOL ENERGY, V77, P685, DOI 10.1016/j.solener.2004.04.010; Rudmann D, 2005, J APPL PHYS, V97, DOI 10.1063/1.1857059; Tiwari AN, 1999, PROG PHOTOVOLTAICS, V7, P393, DOI 10.1002/(SICI)1099-159X(199909/10)7:5<393::AID-PIP289>3.0.CO;2-4; Rudmann D, 2005, THIN SOLID FILMS, V480, P55, DOI 10.1016/j.tsf.2004.11.071; Kessler F, 2005, THIN SOLID FILMS, V480, P491, DOI 10.1016/j.tsf.2004.11.063; Jackson P, 2011, PROG PHOTOVOLTAICS, V19, P894, DOI 10.1002/pip.1078; Blosch P, 2011, IEEE J PHOTOVOLT, V1, P194, DOI 10.1109/JPHOTOV.2011.2166589; Bodegard M., 2000, Thin Solid Films, V361-362, DOI 10.1016/S0040-6090(99)00828-7; Guttler D., 2010, P PHOT SPEC C HON HI, P3420; Herz K, 2003, THIN SOLID FILMS, V431, P392, DOI 10.1016/S0040-6090(03)00259-1; Hirai Y, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.012301; Mansfield L. M., 2011, P 37 IEEE PHOT SPEC, P3636; Monig H, 2011, J APPL PHYS, V110, DOI 10.1063/1.3656986; Nakada T., 2010, P IEEE PHOT SPEC C, P330; Nishimura T., 2014, 6 WORLD C PHOT EN CO, P313; Powalla M., 2014, 29 EUR PHOT SOL EN C; Reinhard Patrick, 2013, 2013 Twentieth International Workshop on Active-Matrix Flatpanel Displays and Devices (AM-FPD); Repins I, 2008, IEEE PHOT SPEC CONF, P1127; Sadono A., 2014, 6 WORLD C PHOT EN CO, P351; Kamikawa-Shimizu Y, 2009, PHYS STATUS SOLIDI A, V206, P1063, DOI 10.1002/pssa.200881200; Yamada A., 2009, P 34 IEEE PHOT SPEC, P2349; Yoon JH, 2011, SOL ENERG MAT SOL C, V95, P2959, DOI 10.1016/j.solmat.2011.02.030	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC16	10.7567/JJAP.54.08KC16		4	Physics, Applied	Physics	CN8BU	WOS:000358662900041		
J	Sai, H; Maejima, K; Matsui, T; Koida, T; Kondo, M; Nakao, S; Takeuchi, Y; Katayama, H; Yoshida, I				Sai, Hitoshi; Maejima, Keigo; Matsui, Takuya; Koida, Takashi; Kondo, Michio; Nakao, Sachiko; Takeuchi, Yoshiaki; Katayama, Hirotaka; Yoshida, Isao			High-efficiency microcrystalline silicon solar cells on honeycomb textured substrates grown with high-rate VHF plasma-enhanced chemical vapor deposition	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PRESSURE	The potential of high-rate growth of high-quality microcrystalline silicon (mu c-Si:H) films for solar cell applications is investigated by very high frequency plasma-enhanced chemical vapor deposition (VHF-PECVD) under a high-pressure SiH4 depletion condition. It is found that the morphology of textured substrates plays an important role in not only light trapping but also mu c-Si:H film growth. A high conversion efficiency of 11.1% is attained in a substrate-type mu c-Si:H cell on a substrate with honeycomb textures, which has rounded concaves in a honeycomb arrangement with an appropriate period. It is also clarified that ZnO:B films grown by metal organic chemical vapor deposition (MOCVD) are beneficial in terms of carrier collection compared with the standard In2O3:Sn (ITO) film grown by sputtering. On the basis of these findings, a new world-record mu c-Si:H cell with a certified conversion efficiency of 11.8% is developed with a relatively high deposition rate of 1 nm/s. (C) 2015 The Japan Society of Applied Physics	[Sai, Hitoshi; Matsui, Takuya; Koida, Takashi; Kondo, Michio] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Maejima, Keigo; Yoshida, Isao] Photovolta Power Generat Technol Res Assoc PVTEC, Tsukuba Lab, Tsukuba, Ibaraki 3058568, Japan; [Nakao, Sachiko; Takeuchi, Yoshiaki] Mitsubishi Heavy Ind Co Ltd, Nagasaki 8540065, Japan; [Katayama, Hirotaka] Panasonic Corp, Kadoma, Osaka 5718686, Japan	Sai, H (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	hitoshi-sai@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO), Japan; "Nanotechnology Network Japan" of Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)	The authors thank Dr. Hishikawa, Ms. Sasaki, and Mr. Shimura of the CSM-RCPVT-AIST for their cooperation in cell characterization, Mr. Miyagi, Mr. Murata, Ms. Hozuki, and Mr. Hinano of PVTEC, and Mr. H. Kumagai and his colleagues of Choryo Engineering for their technical support. This work was supported by the New Energy and Industrial Technology Development Organization (NEDO), Japan. Part of the photolithography process was conducted at the AIST Nano-Processing Facility, supported by the "Nanotechnology Network Japan" of the Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT).	Sai H, 2015, PROG PHOTOVOLTAICS, V23, P1572, DOI 10.1002/pip.2594; Boccard M, 2012, NANO LETT, V12, P1344, DOI 10.1021/nl203909u; Sai H, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.104101; Yamamoto K, 1997, JPN J APPL PHYS 2, V36, pL569, DOI 10.1143/JJAP.36.L569; Takatsuka H, 2004, SOL ENERGY, V77, P951, DOI 10.1016/j.solener.2004.06.007; Yan BJ, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3638068; Sobajima Y, 2009, SOL ENERG MAT SOL C, V93, P980, DOI 10.1016/j.solmat.2008.11.042; Smets AHM, 2008, J APPL PHYS, V104, DOI 10.1063/1.2961334; Smit C, 2003, J APPL PHYS, V94, P3582, DOI 10.1063/1.1596364; Sai H, 2014, IEEE J PHOTOVOLT, V4, P1349, DOI 10.1109/JPHOTOV.2014.2355037; Meier J, 1997, SOL ENERG MAT SOL C, V49, P35, DOI 10.1016/S0927-0248(97)00173-6; Hongsingthong A, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.051102; Maejima K, 2014, THIN SOLID FILMS, V559, P83, DOI 10.1016/j.tsf.2013.11.137; Bugnon G, 2009, J APPL PHYS, V105, DOI 10.1063/1.3095488; Cuony P, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3517492; Gordijn A, 2006, JPN J APPL PHYS 1, V45, P6166, DOI 10.1143/JJAP.45.6166; Hanni S, 2013, PROG PHOTOVOLTAICS, V21, P821, DOI 10.1002/pip.2398; Koida T, 2007, JPN J APPL PHYS 2, V46, pL685, DOI 10.1143/JJAP.46.L685; Matsui T, 2003, JPN J APPL PHYS 2, V42, pL901, DOI 10.1143/JJAP.42.L901; Sai H, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790642; Saito K, 2005, SOL ENERG MAT SOL C, V86, P565, DOI 10.1016/j.solmat.2004.09.006; Tan HR, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826639	22	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KB05	10.7567/JJAP.54.08KB05		6	Physics, Applied	Physics	CN8BU	WOS:000358662900019		
J	Sakakima, H; Nishitani, M; Yamamoto, K; Wada, T				Sakakima, Hiroshi; Nishitani, Mikihiko; Yamamoto, Koichi; Wada, Takahiro			Theoretical and experimental studies on wide-band-gap p-type conductive BaCuSeF and related compounds	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							1ST PRINCIPLES; CUALO2	BaCuSeF and related compounds, MCuQF (M = Ba, Sr; Q = Se, S), are known to show p-type conduction. The formation energies of the Cu vacancy Delta H[V-Cu] in a MCuQF system were computed by first-principles calculation with a generalized gradient approximation (GGA) of the Perdew-Burke-Ernzerhof (PBE) functional as an electron exchange and correlation functional. The density of states (DOS) of BaCuSeF was calculated with the hybrid functional of Heyd-Scuseria-Ernzerhof (HSE) 06. Delta H[V-Cu] was found to be very small under both the Cu- and Q-rich conditions, which probably contributes to p-type conduction. The electronic structure of BaCuSeF was studied by X-ray photoelectron spectroscopy (XPS) with UV photoelectron yield spectroscopy (UVPYS) and photoemission yield spectroscopy (PYS). The determined depth of the top of the valence band relative to the vacuum level was about 4.9 eV. This value is desirable for applications in compound semiconductor thin-film tandem solar cells since the absorbers of polycrystalline thin-film solar cells, such as CdTe and Cu(In,Ga)Se-2, are p-type semiconductors. The DOS of BaCuSeF calculated with the HSE06 functional was almost consistent with the XPS spectrum. (C) 2015 The Japan Society of Applied Physics	[Sakakima, Hiroshi; Yamamoto, Koichi; Wada, Takahiro] Ryukoku Univ, Dept Mat Chem, Otsu, Shiga 5202194, Japan; [Nishitani, Mikihiko] Osaka Univ, Panason Device Sci Res Alliance Lab, Suita, Osaka 5650871, Japan	Sakakima, H (reprint author), Ryukoku Univ, Dept Mat Chem, Otsu, Shiga 5202194, Japan.	twada@rins.ryukoku.ac.jp			Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI)	This work was supported in part by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI). We thank Drs. T. Maeda and H. Nishihara of Ryukoku University for their advice on the first-principles calculations and Mr. M. Terauchi of Panasonic Corporation for his assistance with the UVPYS measurements.	Heyd J, 2003, J CHEM PHYS, V118, P8207, DOI 10.1063/1.1564060; BENKO FA, 1984, J PHYS CHEM SOLIDS, V45, P57, DOI 10.1016/0022-3697(84)90101-X; PERDEW JP, 1992, PHYS REV B, V46, P6671, DOI 10.1103/PhysRevB.46.6671; Nolan M, 2006, PHYS CHEM CHEM PHYS, V8, P5350, DOI 10.1039/b611969g; MONKHORST HJ, 1976, PHYS REV B, V13, P5188, DOI 10.1103/PhysRevB.13.5188; Yanagi H, 2003, APPL PHYS LETT, V82, P2814, DOI 10.1063/1.1571224; Seidl A, 1996, PHYS REV B, V53, P3764, DOI 10.1103/PhysRevB.53.3764; Schaeffer JK, 2004, APPL PHYS LETT, V85, P1826, DOI 10.1063/1.1786656; Park CH, 2003, THIN SOLID FILMS, V445, P288, DOI 10.1016/j.tsf.2003.08.034; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Clark SJ, 2005, Z KRISTALLOGR, V220, P567, DOI 10.1524/zkri.220.5.567.65075; Kawazoe H, 1997, NATURE, V389, P939, DOI 10.1038/40087; Tate J, 2008, THIN SOLID FILMS, V516, P5795, DOI 10.1016/j.tsf.2007.10.073; Moriwake H, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.153103; Okamoto T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.102301; Park CH, 2007, J SOLID STATE CHEM, V180, P1672, DOI 10.1016/j.jssc.2007.03.021; Yamamoto K, 2015, JPN J APPL PHYS, V54, DOI 10.7567/JJAP.54.08KC01; Yamamoto K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FX02; Yamazoe S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC40; Yanagi H, 2006, J APPL PHYS, V100, DOI 10.1063/1.2358828; Zakutayev A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3405757; Zakutayev A, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.155103; Zakutayev A, 2010, PHYS REV B, V82, DOI 10.1103/PhysRevB.82.195204	23	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC07	10.7567/JJAP.54.08KC07		6	Physics, Applied	Physics	CN8BU	WOS:000358662900032		
J	Sato, Y; Aoshima, T; Muraki, Y				Sato, Yuichi; Aoshima, Tadahiko; Muraki, Yuhei			Effects of two-step heat treatment on properties of In2O3:Zr thin film epitaxially grown on c-face sapphire substrate	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SOLAR-CELLS; BAND-GAP; INN; INGAN; ALLOYS; OXIDE; MOVPE	A two-step heat treatment was carried out on a zirconium-doped indium oxide thin film epitaxially grown on a c-face sapphire substrate by a radio-frequency magnetron sputtering method. First, the as-grown film was heat-treated to improve its crystallinity. Air was selected as the heat-treatment atmosphere to avoid the precipitation of indium that occurs at high temperatures, and the crystallinity of the as-grown film was successfully improved by adopting this first-step heat treatment. The film with crystallinity improved by the first-step treatment was then heat-treated in N-2 to lower its resistivity. The resistivity of the film could be lowered about three orders of magnitude compared with that of the as-grown film after the second-step heat treatment under conditions at which the optical transmittance of the film remained sufficiently high in the wavelength region from 350 to 2000 nm. (C) 2015 The Japan Society of Applied Physics	[Sato, Yuichi; Aoshima, Tadahiko; Muraki, Yuhei] Akita Univ, Dept Elect & Elect Engn, Akita 0108502, Japan	Sato, Y (reprint author), Akita Univ, Dept Elect & Elect Engn, Akita 0108502, Japan.	yusato@gipc.akita-u.ac.jp					NAKAMURA S, 1991, JPN J APPL PHYS 2, V30, pL1705; Meng FY, 2014, SOL ENERG MAT SOL C, V122, P70, DOI 10.1016/j.solmat.2013.11.030; Davydov VY, 2002, PHYS STATUS SOLIDI B, V234, P787, DOI 10.1002/1521-3951(200212)234:3<787::AID-PSSB787>3.0.CO;2-H; Ohta H, 2002, J APPL PHYS, V91, P3547, DOI 10.1063/1.1448873; Kuwahara Y, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.021001; Young NG, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4826483; Matsuoka T, 2002, APPL PHYS LETT, V81, P1246, DOI 10.1063/1.1499753; OSAMURA K, 1972, SOLID STATE COMMUN, V11, P617, DOI 10.1016/0038-1098(72)90474-7; WEIHER RL, 1966, J APPL PHYS, V37, P299, DOI 10.1063/1.1707830; YOSHIDA S, 1983, APPL PHYS LETT, V42, P427, DOI 10.1063/1.93952; Liang YC, 2009, THIN SOLID FILMS, V517, P3874, DOI 10.1016/j.tsf.2009.01.124; MARUSKA HP, 1969, APPL PHYS LETT, V15, P327, DOI 10.1063/1.1652845; Wu J, 2002, APPL PHYS LETT, V80, P3967, DOI 10.1063/1.1482786; Gherasoiu I, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201001169; GUO QX, 1992, J ELECTROCHEM SOC, V139, P2008, DOI 10.1149/1.2221165; Koida T, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2337281; Koida T, 2007, J APPL PHYS, V101, DOI 10.1063/1.2712161; MATSUOKA T, 1992, J ELECTRON MATER, V21, P157, DOI 10.1007/BF02655831; Matsuoka T., 1990, Optoelectronics - Devices and Technologies, V5; NAGATOMO T, 1989, JPN J APPL PHYS 2, V28, pL1334; Nakazawa H, 2006, J APPL PHYS, V100, DOI 10.1063/1.2358829; Ohki Y., 1981, I PHYS C SER, V63, P479; Sato Y, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.108004; Yamamoto A, 2002, PHYS STATUS SOLIDI A, V194, P510, DOI 10.1002/1521-396X(200212)194:2<510::AID-PSSA510>3.0.CO;2-6; Yamamoto A, 2010, PHYS STATUS SOLIDI C, V7, P1309, DOI 10.1002/pssc.200983106	25	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC09	10.7567/JJAP.54.08KC09		5	Physics, Applied	Physics	CN8BU	WOS:000358662900034		
J	Satoh, N; Yamaki, M; Noda, K; Katori, S; Kobayashi, K; Matsushige, K; Yamada, H				Satoh, Nobuo; Yamaki, Michio; Noda, Kei; Katori, Shigetaka; Kobayashi, Kei; Matsushige, Kazumi; Yamada, Hirofumi			Surface potential measurement of fullerene derivative/copper phthalocyanine on indium tin oxide electrode by Kelvin probe force microscopy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FIELD-EFFECT TRANSISTORS; HETEROJUNCTION SOLAR-CELLS; WORK FUNCTION; LEVEL ALIGNMENT; DISSIPATION; DEPENDENCE; INTERFACES; INVERTERS; DEVICES; METAL	We have investigated the organic semiconductor thin films deposited by vacuum evaporation deposition using intersecting metal shadow masks on indium tin oxide (ITO) electrode/glass substrates to simulate organic solar cells by simultaneous observation with dynamic force microscopy (DFM)/Kelvin-probe force microscopy (KFM). The energy band diagram was depicted by simultaneously obtaining topographic and surface potential images of the same area using DFM/KFM. We considered the charge behavior at the interface having band bending in the phenyl-C-61-butyric acid methyl ester (PCBM) film. (C) 2015 The Japan Society of Applied Physics	[Satoh, Nobuo; Yamaki, Michio; Noda, Kei; Katori, Shigetaka; Matsushige, Kazumi; Yamada, Hirofumi] Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan; [Satoh, Nobuo] Chiba Inst Technol, Narashino, Chiba 2750016, Japan; [Kobayashi, Kei] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto 6158520, Japan	Satoh, N (reprint author), Kyoto Univ, Dept Elect Sci & Engn, Kyoto 6158510, Japan.	n-satoh@kuee.kyoto-u.ac.jp			Global Center of Excellence Program of Kyoto University [C09]; Ministry of Education, Culture, Sports, Science and Technology of Japan [20760469]	This research was partially supported by the Global Center of Excellence Program of Kyoto University (C09) and a Grant-in-Aid for Young Scientists (B) (Grant No. 20760469) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. We would also like to acknowledge the Kyoto University Venture Business Laboratory Project.	Akaike K., 2009, MRS P, V1115, pH08; Ishii H, 2004, PHYS STATUS SOLIDI A, V201, P1075, DOI 10.1002/pssa.200404346; Sharma A, 2009, J MATER CHEM, V19, P5298, DOI 10.1039/b823148f; STRAYER RW, 1973, SURF SCI, V34, P225, DOI 10.1016/0039-6028(73)90117-9; Sugimura H, 2002, APPL PHYS LETT, V80, P1459, DOI 10.1063/1.1455145; Southwick RG, 2006, IEEE T DEVICE MAT RE, V6, P136, DOI 10.1109/TDMR.2006.876971; Meijer EJ, 2003, NAT MATER, V2, P678, DOI 10.1038/nmat978; ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347; Scott JC, 2003, J VAC SCI TECHNOL A, V21, P521, DOI 10.1116/1.1559919; Fukuma T, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1896938; GIESSIBL FJ, 1995, SCIENCE, V267, P68, DOI 10.1126/science.267.5194.68; Ishii H, 1999, ADV MATER, V11, P605, DOI 10.1002/(SICI)1521-4095(199906)11:8<605::AID-ADMA605>3.0.CO;2-Q; Hoppe H, 2006, J MATER CHEM, V16, P45, DOI 10.1039/b510618b; Yasuda T, 2005, CHEM PHYS LETT, V402, P395, DOI 10.1016/j.cplett.2004.12.072; Sueyoshi T, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3258351; Tang JX, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2966155; NONNENMACHER M, 1991, APPL PHYS LETT, V58, P2921, DOI 10.1063/1.105227; Larson BW, 2014, CHEM MATER, V26, P2361, DOI 10.1021/cm500594u; Tada H, 2000, APPL PHYS LETT, V76, P873, DOI 10.1063/1.125614; Sugiyama K, 2000, J APPL PHYS, V87, P295, DOI 10.1063/1.371859; Sullivan P, 2004, APPL PHYS LETT, V84, P1210, DOI 10.1063/1.1643549; Anthopoulos TD, 2004, APPL PHYS LETT, V85, P4205, DOI 10.1063/1.1812577; BOUWMAN R, 1970, J CATAL, V19, P127, DOI 10.1016/0021-9517(70)90275-7; Fukuma T, 2004, J APPL PHYS, V95, P4742, DOI 10.1063/1.1690485; Hein C, 2009, PHYS STATUS SOLIDI A, V206, P2757, DOI 10.1002/pssa.200925290; Honda M, 2007, J APPL PHYS, V102, DOI 10.1063/1.2809360; Ishii H, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.205208; Itoh E, 2008, THIN SOLID FILMS, V516, P2562, DOI 10.1016/j.tsf.2007.04.101; Katori S, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.071601; Kobayashi K, 2001, REV SCI INSTRUM, V72, P4383, DOI 10.1063/1.1416104; Kobayashi K, 2000, APPL SURF SCI, V157, P228, DOI 10.1016/S0169-4332(99)00531-0; Loppacher C, 2000, PHYS REV B, V62, P13674, DOI 10.1103/PhysRevB.62.13674; Mihailetchi VD, 2003, J APPL PHYS, V94, P6849, DOI 10.1063/1.1620683; Nakayama Y, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2908888; Quate CF, 2003, JPN J APPL PHYS 1, V42, P4777, DOI 10.1143/JJAP.42.4777; Sakanoue T, 2008, J APPL PHYS, V103, DOI 10.1063/1.2919738; Satoh N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FY03; TANG CW, 1987, APPL PHYS LETT, V51, P913, DOI 10.1063/1.98799; Taur Y., 2009, FUNDAMENTALS MODERN; Zhang L, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3626851	40	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KF06	10.7567/JJAP.54.08KF06		6	Physics, Applied	Physics	CN8BU	WOS:000358662900086		
J	Seki, K; Furube, A; Yoshida, Y				Seki, Kazuhiko; Furube, Akihiro; Yoshida, Yuji			Theoretical limit of power conversion efficiency for organic and hybrid halide perovskite photovoltaics	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							HETEROJUNCTION SOLAR-CELLS; HIGH-PERFORMANCE; CHARGE-TRANSFER; RECOMBINATION; DEPOSITION; ORIGINS; ENERGY	We calculated the maximum power conversion efficiency as a function of the optical band gap for organic photovoltaic (PV) cells by assuming that charge separation is accompanied by the energy loss required to dissociate strongly bound charge pairs. The dissociation energy can be estimated from the relationship between the open circuit voltage (V-OC) and the optical band gap (E-g). By analyzing the published data on V-OC and E-g, the dissociation energy can be estimated. The result could be used as a guide for selecting donor and acceptor materials. We also studied the theoretical limit of power conversion efficiency of hybrid halide perovskite by taking into account the energy loss involved in the carrier transfer from the perovskite phase to the metal oxide charge transport layer. (C) 2015 The Japan Society of Applied Physics	[Seki, Kazuhiko] Natl Inst Adv Ind Sci & Technol, NMRI, Tsukuba, Ibaraki 3058565, Japan; [Furube, Akihiro] Natl Inst Adv Ind Sci & Technol, RIIF, Tsukuba, Ibaraki 3058568, Japan; [Yoshida, Yuji] Natl Inst Adv Ind Sci & Technol, RCPV, Tsukuba, Ibaraki 3058565, Japan	Seki, K (reprint author), Natl Inst Adv Ind Sci & Technol, NMRI, Tsukuba, Ibaraki 3058565, Japan.	k-seki@aist.go.jp					Frost JM, 2014, NANO LETT, V14, P2584, DOI 10.1021/nl500390f; Credgington D, 2012, J PHYS CHEM LETT, V3, P1465, DOI 10.1021/jz300293q; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Janssen RAJ, 2013, ADV MATER, V25, P1847, DOI 10.1002/adma.201202873; Gruber M, 2012, ADV ENERGY MATER, V2, P1100, DOI 10.1002/aenm.201200077; Koster LJA, 2012, ADV ENERGY MATER, V2, P1246, DOI 10.1002/aenm.201200103; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Jung HS, 2015, SMALL, V11, P10, DOI 10.1002/smll.201402767; Scharber MC, 2013, PROG POLYM SCI, V38, P1929, DOI 10.1016/j.progpolymsci.2013.05.001; Shen Q, 2014, PHYS CHEM CHEM PHYS, V16, P19984, DOI 10.1039/c4cp03073g; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Yin WJ, 2014, ADV MATER, V26, P4653, DOI 10.1002/adma.201306281; Einax M, 2014, J PHYS CHEM C, V118, P27226, DOI 10.1021/jp5084373; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Lunt RR, 2011, ADV MATER, V23, P5712, DOI 10.1002/adma.201103404; Ponseca CS, 2014, J AM CHEM SOC, V136, P5189, DOI 10.1021/ja412583t; Nayak PK, 2014, ADV MATER, V26, P1622, DOI 10.1002/adma.201304620; Rutten B, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.235122; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Veldman D, 2009, ADV FUNCT MATER, V19, P1939, DOI 10.1002/adfm.200900090; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Seki K, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4852676; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Park NG, 2013, J PHYS CHEM LETT, V4, P2423, DOI 10.1021/jz400892a; Yamada Y, 2014, J AM CHEM SOC, V136, P11610, DOI 10.1021/ja506624n; Nelson J, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.035337; Kirchartz T, 2009, J PHYS CHEM C, V113, P17958, DOI 10.1021/jp906292h; Einax M, 2013, EPL-EUROPHYS LETT, V104, DOI 10.1209/0295-5075/104/40002; Einax M, 2011, J PHYS CHEM C, V115, P21396, DOI 10.1021/jp205856x; Giebink NC, 2011, PHYS REV B, V83, DOI 10.1103/PhysRevB.83.195326; Han GS, 2015, J MATER CHEM A, V3, P9160, DOI 10.1039/c4ta03684k; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI 10.1038/NPHOTON.2013.80; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Miyadera T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.01AB12; Seki K., 2014, HYOMEN KAGAKU, V35, P595; Stranks SD, 2013, SCIENCE, V342, P341, DOI 10.1126/science.1243982	36	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KF04	10.7567/JJAP.54.08KF04		5	Physics, Applied	Physics	CN8BU	WOS:000358662900084		
J	Shigekawa, N; Liang, J; Onitsuka, R; Agui, T; Juso, H; Takamoto, T				Shigekawa, Naoteru; Liang, Jianbo; Onitsuka, Ryusuke; Agui, Takaaki; Juso, Hiroyuki; Takamoto, Tatsuya			Current-voltage and spectral-response characteristics of surface-activated-bonding-based InGaP/GaAs/Si hybrid triple-junction cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TANDEM SOLAR-CELLS; HIGH CONVERSION EFFICIENCY; ROOM-TEMPERATURE; INTERFACE CURRENT; WAFERS; PHOTOVOLTAICS; 30-PERCENT; RESISTANCE; STRENGTH	We measured the current-voltage (I-V) and spectral-response characteristics of InGaP/GaAs/Si hybrid triple-junction cells that were fabricated by using surface-activated bonding methods. We found by spectral response measurements that the current generated in the Si-based bottom cell was lower than those in the top and middle cells under the conditions of an air mass of 1.5G and one sun. Furthermore we observed a discrepancy between the short-circuit current, which was obtained by subtracting the estimated contribution of Si ledges surrounding InGaP/GaAs mesas to the I-V characteristics, and the results of spectral response measurements. One possible model for explaining the discrepancy was discussed on the basis of the electrical coupling scheme between subcells. The intrinsic conversion efficiency of a 5 x 5 mm(2) triple-junction cell was crudely estimated to be similar to 26% by compensating for the shadow loss as well as subtracting the contribution of Si ledges. (C) 2015 The Japan Society of Applied Physics	[Shigekawa, Naoteru; Liang, Jianbo] Osaka City Univ, Grad Sch Engn, Osaka 5588585, Japan; [Onitsuka, Ryusuke; Agui, Takaaki; Juso, Hiroyuki; Takamoto, Tatsuya] Sharp Co Ltd, Yamato Koriyama, Nara 6391186, Japan	Shigekawa, N (reprint author), Osaka City Univ, Grad Sch Engn, Osaka 5588585, Japan.	shigekawa@elec.eng.osaka-cu.ac.jp			"Creative Research for Clean Energy Generation Using Solar Energy" project of the Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST)	The authors are grateful to L. Chai, M. Morimoto, and S. Nishida for their assistance in device fabrication and characterization. This work was partly supported by the "Creative Research for Clean Energy Generation Using Solar Energy" project of the Core Research for Evolutional Science and Technology (CREST) program of Japan Science and Technology Agency (JST).	BERTNESS KA, 1994, APPL PHYS LETT, V65, P989, DOI 10.1063/1.112171; Geisz JF, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753729; Howlader MMR, 2001, J VAC SCI TECHNOL B, V19, P2114, DOI 10.1116/1.1414115; Derendorf K, 2013, IEEE J PHOTOVOLT, V3, P1423, DOI 10.1109/JPHOTOV.2013.2273097; SUGIURA H, 1988, JPN J APPL PHYS 1, V27, P269, DOI 10.1143/JJAP.27.269; Derkacs D, 2013, IEEE J PHOTOVOLT, V3, P520, DOI 10.1109/JPHOTOV.2012.2213579; Yamaguchi M, 1999, IEEE T ELECTRON DEV, V46, P2139, DOI 10.1109/16.792009; Wang CX, 2008, JPN J APPL PHYS, V47, P2526, DOI 10.1143/JJAP.47.2526; Lueck MR, 2006, IEEE ELECTR DEVICE L, V27, P142, DOI 10.1109/LED.2006.870250; Mizuno H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766339; Tanabe K, 2006, APPL PHYS LETT, V89, DOI [10.1063/1.2347280, 10.1063/1.2348280]; Takamoto T, 2005, PROG PHOTOVOLTAICS, V13, P495, DOI 10.1002/pip.642; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; Steiner MA, 2013, IEEE J PHOTOVOLT, V3, P1437, DOI 10.1109/JPHOTOV.2013.2278666; Takamoto T, 1997, JPN J APPL PHYS 1, V36, P6215, DOI 10.1143/JJAP.36.6215; Moutanabbir O, 2010, ANNU REV MATER RES, V40, P469, DOI 10.1146/annurev-matsci-070909-104448; Nishioka K, 2006, SOL ENERG MAT SOL C, V90, P1308, DOI 10.1016/j.solmat.2005.08.003; CHAND N, 1985, IEEE T ELECTRON DEV, V32, P622, DOI 10.1109/T-ED.1985.21988; Soga T, 1997, J CRYST GROWTH, V174, P579, DOI 10.1016/S0022-0248(97)00064-X; Takagi H, 1998, JPN J APPL PHYS 1, V37, P4197, DOI 10.1143/JJAP.37.4197; Howlader MMR, 2002, J APPL PHYS, V91, P3062, DOI 10.1063/1.1430883; Green MA, 2001, PROG PHOTOVOLTAICS, V9, P123, DOI 10.1002/pip.360; Takagi H, 1996, APPL PHYS LETT, V68, P2222, DOI 10.1063/1.115865; KOMNINOU P, 1994, J APPL PHYS, V75, P143, DOI 10.1063/1.355903; OLSON JM, 1990, APPL PHYS LETT, V56, P623, DOI 10.1063/1.102717; Takagi H, 1999, JPN J APPL PHYS 1, V38, P1589, DOI 10.1143/JJAP.38.1589; Takamoto T, 1997, APPL PHYS LETT, V70, P381, DOI 10.1063/1.118419; Archer MJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2887904; Jackson MJ, 2011, J APPL PHYS, V110, DOI 10.1063/1.3662144; Liang J, 2013, ELECTRON LETT, V49, P830, DOI 10.1049/el.2013.1553; Liang JB, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.021801; MILANO RA, 1979, APPL PHYS LETT, V34, P562, DOI 10.1063/1.90867; Shigekawa N., 2014, P 40 IEEE PHOT SPEC, P534; Shigekawa N., 2014, 6 WORLD C PHOT EN CO; Shigekawa N, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.04ER05; Shigekawa N, 2014, ECS TRANSACTIONS, V64, P235, DOI 10.1149/06405.0235ecst; Shigekawa N., 2012, P 3 INT IEEE WORKSH, P109; Tanabe K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00349	38	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KE03	10.7567/JJAP.54.08KE03		5	Physics, Applied	Physics	CN8BU	WOS:000358662900073		
J	Soosaimanickam, A; Jeyagopal, R; Hayakawa, Y; Sridharan, MB				Soosaimanickam, Ananthakumar; Jeyagopal, Ramkumar; Hayakawa, Yasuhiro; Sridharan, Moorthy Babu			Synthesis of oleylamine-capped Cu2ZnSn(S,Se)(4) nanoparticles using 1-dodecanethiol as sulfur source	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SENSITIZED SOLAR-CELLS; THIN-FILMS; CU2ZNSNS4 NANOCRYSTALS; COUNTER ELECTRODES; SIZE CONTROL; FABRICATION; TEMPERATURE; DISSOLUTION; PHASE	Oleyalmine capped Cu2ZnSn(S,Se)(4) (CZTSSe) nanoparticles were synthesized by the colloidal method at 240 degrees C. 1-dodecanethiol (1-DDT), which releases sulfur atoms at high refluxing temperatures, is used as a sulfur source. It was observed that at high temperatures (over 150 degrees C) 1-DDT decomposes and releases sulfur atoms that combine with selenide ions. The resultant CZTSSe powder was homogenously dispersed in chloroform. Formation of the kesterite structure was identified through X-ray diffraction (XRD) analysis which could be tuned to stannite on the basis of the ratio of S/Se. Attenuated total reflectance-Fourier transform infrared (ATR-FTIR) analysis clearly shows the presence of oleylamine on the surface of the nanoparticles. Scanning electron microscope (SEM) and transmission electron microscope (TEM) analyses indicate the formation of 10-20 nm nearly spherical particles with agglomeration. Energy dispersive X-ray analysis (EDX) analysis further confirms the presence of sulfur in addition to Cu, Zn, Sn, and Se. (C) 2015 The Japan Society of Applied Physics	[Soosaimanickam, Ananthakumar; Jeyagopal, Ramkumar; Sridharan, Moorthy Babu] Anna Univ, Crystal Growth Ctr, Madras 600025, Tamil Nadu, India; [Hayakawa, Yasuhiro] Shizuoka Univ, Res Inst Elect, Hamamatsu, Shizuoka 4328011, Japan	Soosaimanickam, A (reprint author), Anna Univ, Crystal Growth Ctr, Madras 600025, Tamil Nadu, India.	smoorthybabu@gmail.com			UGC [42-855/2013(SR)]; DST, Government of India [DST/TMC/SERI/FR/90]; Ministry of New and Renewable Energy (MNRE), Government of India	The authors sincerely thank UGC [F. No. 42-855/2013(SR)] and DST (DST/TMC/SERI/FR/90), Government of India, for funding the research. S. Ananthakumar and J. RamKumar sincerely thank, the Ministry of New and Renewable Energy (MNRE), Government of India for providing fellowships under the National Renewable Energy Fellowship (NREF) scheme for doctoral studies. The authors sincerely thank Hamamatsu Campus Center for Instrumental Analysis for extending the characterization facilities and part of the work reported in the article was carried out as the cooperative research projects of the Research Institute of Electronics, Shizuoka University, Japan.	Zhou HP, 2013, ENERG ENVIRON SCI, V6, P2822, DOI 10.1039/c3ee41627e; Wang G, 2013, ACS APPL MATER INTER, V5, P10042, DOI 10.1021/am402558a; Cao Y, 2013, ACS APPL MATER INTER, V5, P479, DOI 10.1021/am302522c; Hochbaum AI, 2010, CHEM REV, V110, P527, DOI 10.1021/cr900075v; Jeon JO, 2014, CHEMSUSCHEM, V7, P1073, DOI 10.1002/cssc.201301347; Guo Q, 2010, J AM CHEM SOC, V132, P17384, DOI 10.1021/ja108427b; Riha SC, 2011, J AM CHEM SOC, V133, P15272, DOI 10.1021/ja2058692; Niu JZ, 2012, B KOREAN CHEM SOC, V33, P393, DOI 10.5012/bkcs.2012.33.2.393; Hou B, 2013, CHEM-EUR J, V19, P15847, DOI 10.1002/chem.201302722; Willner I, 2007, BIOSENS BIOELECTRON, V22, P1841, DOI 10.1016/j.bios.2006.09.018; Khare A, 2011, CHEM COMMUN, V47, P11721, DOI 10.1039/c1cc14687d; Li M, 2012, J PHYS CHEM C, V116, P26507, DOI 10.1021/jp307346k; Park Y, 2014, CRYSTENGCOMM, V16, P8642, DOI 10.1039/c4ce01079e; Cao YY, 2012, J AM CHEM SOC, V134, P15644, DOI 10.1021/ja3057985; Todorov TK, 2013, ADV ENERGY MATER, V3, P34, DOI 10.1002/aenm.201200348; Xin XK, 2011, ANGEW CHEM INT EDIT, V50, P11739, DOI 10.1002/anie.201104786; Katagiri H, 2001, SOL ENERG MAT SOL C, V65, P141, DOI 10.1016/S0927-0248(00)00088-X; Alvarado SR, 2014, COORDIN CHEM REV, V263, P182, DOI 10.1016/j.ccr.2013.09.001; Ramasamy K, 2012, CHEM COMMUN, V48, P5703, DOI 10.1039/c2cc30792h; Liu Y, 2012, J AM CHEM SOC, V134, P7207, DOI 10.1021/ja300064t; Singh A, 2012, J AM CHEM SOC, V134, P2910, DOI 10.1021/ja2112146; Katagiri H, 2008, APPL PHYS EXPRESS, V1, DOI 10.1143/APEX.1.041201; Wang L, 2012, J MATER CHEM, V22, P6553, DOI 10.1039/c2jm16515e; Yang YC, 2015, ACS APPL MATER INTER, V7, P460, DOI 10.1021/am5064926; Katagiri H, 2009, THIN SOLID FILMS, V517, P2455, DOI 10.1016/j.tsf.2008.11.002; Cattley CA, 2013, CHEM COMMUN, V49, P3745, DOI 10.1039/c3cc39042j; Fan F. J., 2012, SCI REP, V2, P1; Gupta SM, 2012, HIGH ENERG CHEM+, V46, P1, DOI 10.1134/S0018143912010134; Kim GY, 2014, NANOSCALE RES LETT, V9, DOI 10.1186/1556-276X-9-10; Lee D, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/6/065401; Yuan SJ, 2013, CHEM-EUR J, V19, P10107, DOI 10.1002/chem.201300283	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA10	10.7567/JJAP.54.08KA10		4	Physics, Applied	Physics	CN8BU	WOS:000358662900011		
J	Sugaya, T; Mochizuki, T; Makita, K; Oshima, R; Matsubara, K; Okano, Y; Niki, S				Sugaya, Takeyoshi; Mochizuki, Toru; Makita, Kikuo; Oshima, Ryuji; Matsubara, Koji; Okano, Yoshinobu; Niki, Shigeru			Investigation of InGaP/(In)AlGaAs/GaAs triple-junction top cells for smart stacked multijunction solar cells grown using molecular beam epitaxy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EFFICIENCY	We report high-quality InGaP/(In)AlGaAs/GaAs triple-junction solar cells fabricated using solid-source molecular beam epitaxy (MBE) for the first time. The triple-junction cells can be used as top cells for smart stacked multijunction solar cells. A growth temperature of 480 degrees C was found to be suitable for an (In)AlGaAs second cell to obtain high-quality tunnel junctions. The properties of AlGaAs solar cells were better than those of InAlGaAs solar cells when a second cell was grown at 480 degrees C. The high-quality InGaP/AlGaAs/GaAs solar cell had an impressive open-circuit voltage of 3.1 V. This result indicates that high-performance InGaP/AlGaAs/GaAs triple-junction solar cells can be fabricated using solid-source MBE. (C) 2015 The Japan Society of Applied Physics	[Sugaya, Takeyoshi; Mochizuki, Toru; Makita, Kikuo; Oshima, Ryuji; Matsubara, Koji; Niki, Shigeru] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan; [Mochizuki, Toru; Okano, Yoshinobu] Tokyo City Univ, Setagaya Ku, Tokyo 1588557, Japan	Sugaya, T (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan.	t.sugaya@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI)	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI).	Sugaya T, 2013, J CRYST GROWTH, V378, P576, DOI 10.1016/j.jcrysgro.2012.11.008; Sugaya T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4755757; Haapamaa J, 2001, SOL ENERG MAT SOL C, V66, P573, DOI 10.1016/S0927-0248(00)00241-5; Mizuno H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4766339; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; Sugaya T, 2013, J APPL PHYS, V114, DOI 10.1063/1.4812567; Sugaya T, 2013, J CRYST GROWTH, V378, P430, DOI 10.1016/j.jcrysgro.2012.12.065; Archer MJ, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2887904; Boisvert J., 2010, P 35 IEEE PHOT SPEC, P123; Chiu P. T., 2014, P 40 IEEE PHOT SPEC, P11; Lammasniemi J., 1997, P 26 IEEE PHOT SPEC, P823; Makita K., 2013, MRS P, V1538, P167; Makita K., 2013, P 28 EUR PHOT SOL EN, P2279; Makita K., 2014, P 40 IEEE PHOT SPEC, P495; Makita K., 2014, P 29 EUR PHOT SOL EN, P1427; Onitsuka R., 2014, 6 WORLD C PHOT EN CO, P763; Sabnis V, 2012, AIP CONF PROC, V1477, P14, DOI 10.1063/1.4753823; Sugaya T, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FV06; Takahara T., 2014, P 40 IEEE PHOT SPEC, P1; Yoshida A., 2011, 21 PHOT SCI ENG C, p4B; Zahler JM, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2753751	21	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KE02	10.7567/JJAP.54.08KE02		5	Physics, Applied	Physics	CN8BU	WOS:000358662900072		
J	Suzuki, S; Nishiyama, N; Yoshino, S; Ujiro, T; Watanabe, S; Doi, T; Masuda, A; Tanahashi, T				Suzuki, Soh; Nishiyama, Naoki; Yoshino, Seiji; Ujiro, Takumi; Watanabe, Shin; Doi, Takuya; Masuda, Atsushi; Tanahashi, Tadanori			Acceleration of potential-induced degradation by salt-mist preconditioning in crystalline silicon photovoltaic modules	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SI SOLAR-CELLS; STACKING-FAULTS	We examined the sequential effects of salt-mist stress followed by high-system-voltage stress on the power loss of crystalline silicon photovoltaic (PV) modules to determine whether a crucial failure as potential-induced degradation (PID) is accelerated by material-property changes caused by the long-term effects of a less harmful stress such as salt-mist spraying. Degradation profiles confirmed in this study show that PID is accelerated by certain types of salt-mist preconditioning. For the acceleration of PID, the contribution of sodium ions liberated from the front glass of the PV module seems to be excluded. Therefore, we consider that the sodium ions penetrating into the PV modules from the ambient environment may also cause degradation according to the proposed mechanisms of PID, as the sodium ions existing in the front glass cause PID. Furthermore, this type of degradation may indicate the wear-out phenomenon after a long-term exposure in the field (especially near the coast). (C) 2015 The Japan Society of Applied Physics	[Suzuki, Soh] ESPEC Corp, Reliabil Testing Headquarters, Tsukuba, Ibaraki 3050035, Japan; [Nishiyama, Naoki] JFE Technores Corp, Solut Div, Chiba 2600835, Japan; [Yoshino, Seiji; Watanabe, Shin] NPC Inc, Photovolta Business Div, Matsuyama, Ehime 7918044, Japan; [Doi, Takuya; Masuda, Atsushi] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tosu, Saga 8410052, Japan; [Tanahashi, Tadanori] ESPEC Corp, Dev Headquarters, Tsukuba, Ibaraki 3050035, Japan	Tanahashi, T (reprint author), Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta, Module Reliabil Res Team, Tsukuba, Ibaraki 3058568, Japan.	tadanori.tanahashi@aist.go.jp			Consortium Study on Fabrication and Characterization of Solar Cell Modules with Long Life and High Reliability (National Institute of Advanced Industrial Science and Technology, Japan)	We wish to thank Katsuhiko Shirasawa (National Institute of Advanced Industrial Science and Technology, Japan) for his helpful discussions and support. This work was supported by the Consortium Study on Fabrication and Characterization of Solar Cell Modules with Long Life and High Reliability (National Institute of Advanced Industrial Science and Technology, Japan).	Hacke P, 2010, IEEE PHOT SPEC CONF, P244; Pingel S, 2010, IEEE PHOT SPEC CONF, P2817; [Anonymous], 1996, 600682521996 CEIIEC; Naumann V, 2013, PHYS STATUS SOLIDI-R, V7, P315, DOI 10.1002/pssr.201307090; Naumann V, 2014, SOL ENERG MAT SOL C, V120, P383, DOI 10.1016/j.solmat.2013.06.015; [Anonymous], 2011, 617012011 CEIIEC; del Cueto JA, 2002, PROG PHOTOVOLTAICS, V10, P15, DOI 10.1002/pip.401; Naumann V, 2012, ENRGY PROCED, V27, P1, DOI 10.1016/j.egypro.2012.07.020; Jain A, 2004, SOL ENERG MAT SOL C, V81, P269, DOI 10.1016/j.solmat.2003.11.018; [Anonymous], 2001, 149932001 ISO; [Anonymous], 1999, H85021999 JIS; [Anonymous], 2005, 612152005 CEIIEC; Zhang CF, 2011, J APPL PHYS, V110, DOI 10.1063/1.3632971; [Anonymous], 1995, 617011995 CEIIEC; Bauer J, 2012, PHYS STATUS SOLIDI-R, V6, P331, DOI 10.1002/pssr.201206276; Aoki Y., 2012, JPN J APPL PHYS, V51; BARKER RE, 1976, PURE APPL CHEM, V46, P157, DOI 10.1351/pac197646020157; Berghold J., 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Breitenstein Otwin, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Breitenstein Otwin, 2013, International Journal of Nanoparticles, V6; Charlaix E., 2010, HDB NANOPHYSICS PRIN, P12; Dhere N. G., 2009, P SOC PHOTO-OPT INS, V7412; Hacke Peter, 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Hacke P., 2012, 22 WORKSH CRYST SIL; Hacke P., 2012, 38 IEEE PHOT SPEC C; Hacke P, 2014, PROG PHOTOVOLTAICS, V22, P775, DOI 10.1002/pip.2434; Hacke P., 2011, 37 IEEE PHOT SPEC C, P814, DOI DOI 10.1109/PVSC.2011.6186079; Kambe M., 2013, 39 IEEE PHOT SPEC C, P3500; Katawaki K., 1985, J PRESTRESSED CONC J, V27, P68; Koch Simon, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Koch S., 2012, 2012 PV MOD REL WORK; Koch S., 2012, P 27 EUR PHOT SOL EN; Hoffmann S, 2014, PROG PHOTOVOLTAICS, V22, P173, DOI 10.1002/pip.2238; Kurtz S., 2014, 6 WORLD C PHOT EN CO; Lausch D, 2014, ENRGY PROCED, V55, P486, DOI 10.1016/j.egypro.2014.08.013; Lechner P., 2012, P 27 EU PVSEC FRANKF, P3152; Mathiak G., 2012, P 27 EUR PHOT SOL EN, P3536; Nagel H., 2012, SOPHIA WORKSH PV MOD; Ross R. G., 1986, FLAT PLATE SOLAR ARR, VVI, P19; Sato K., 2003, P 25 ANN CONV JAP CO, P851; Schinkothe P., 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Schutze M., 2011, 37 IEEE PHOT SPEC C, P821, DOI DOI 10.1109/PVSC.2011.6186080; Schutze Matthias, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Sugianto A, 2012, PROG PHOTOVOLTAICS, V20, P452, DOI 10.1002/pip.1163; Suzuki S., 2014, 6 WORLD C PHOT EN CO, P1397; Taubitz C., 2012, P 27 EUR PHOT SOL EN, P3172; Naumann V, 2013, ENRGY PROCED, V33, P76, DOI 10.1016/j.egypro.2013.05.042; Wohlgemuth J., 2014, P SOC PHOTO-OPT INS, V9179; Yamada Y., 1996, P 18 ANN CONV JAP JA, P945	49	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KG08	10.7567/JJAP.54.08KG08		12	Physics, Applied	Physics	CN8BU	WOS:000358662900096		
J	Suzuki, T; Osada, K; Yagi, S; Naitoh, S; Shoji, Y; Hijikata, Y; Okada, Y; Yaguchi, H				Suzuki, Tomoya; Osada, Kazuki; Yagi, Shuhei; Naitoh, Shunya; Shoji, Yasushi; Hijikata, Yasuto; Okada, Yoshitaka; Yaguchi, Hiroyuki			Molecular beam epitaxial growth of intermediate-band materials based on GaAs: N delta-doped superlattices	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SOLAR-CELLS; CONVERSION EFFICIENCY; NITROGEN; TRANSITIONS	We fabricated GaAs: N delta-doped superlattices (SLs) by molecular beam epitaxy and investigated their potential as an intermediate-band photoabsorber in high-efficiency solar cells. The N area concentration in a N delta-doped layer was well controlled by adjusting the fabrication conditions, and the SLs with the average N composition of up to 1.5% were obtained. The SL minibands related to the N-induced E+ and E- conduction subbands were formed with well-separated bottom energies of up to 0.4 eV, indicating the suitability of this material system for use in intermediate-band solar cells. A two-step photoabsorption process in a solar cell with the SL absorber was successfully demonstrated through external quantum efficiency measurements under additional infrared illumination at room temperature. (C) 2015 The Japan Society of Applied Physics	[Suzuki, Tomoya; Osada, Kazuki; Yagi, Shuhei; Hijikata, Yasuto; Yaguchi, Hiroyuki] Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan; [Naitoh, Shunya; Shoji, Yasushi; Okada, Yoshitaka] Univ Tokyo, RCAST, Meguro Ku, Tokyo 1538904, Japan	Suzuki, T (reprint author), Saitama Univ, Grad Sch Sci & Engn, Saitama 3388570, Japan.	tsuzuki@opt.ees.saitama-u.ac.jp; yagi@opt.ees.saitama-u.ac.jp	Yaguchi, Hiroyuki/B-3902-2012; Hijikata, Yasuto/B-3843-2012	Yaguchi, Hiroyuki/0000-0003-0621-3501; 			Ahsan N, 2013, IEEE J PHOTOVOLT, V3, P730, DOI 10.1109/JPHOTOV.2012.2228296; Lopez N, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028701; Shan W, 2000, PHYS REV B, V62, P4211, DOI 10.1103/PhysRevB.62.4211; Ahsan N, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.4709405; Tanaka T, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4790643; Linares PG, 2011, J APPL PHYS, V109, DOI 10.1063/1.3527912; Perkins JD, 1999, PHYS REV LETT, V82, P3312, DOI 10.1103/PhysRevLett.82.3312; Grau A, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2387973; ASPNES DE, 1973, SURF SCI, V37, P418, DOI 10.1016/0039-6028(73)90337-3; Luque A, 2001, PROG PHOTOVOLTAICS, V9, P73, DOI 10.1002/pip.354; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Green MA, 2001, PROG PHOTOVOLTAICS, V9, P123, DOI 10.1002/pip.360; Geddo M, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2709629; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Marti A, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.247701; Noguchi S, 2013, IEEE J PHOTOVOLT, V3, P1287, DOI 10.1109/JPHOTOV.2013.2271978; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Osada K., JPN J APPL IN PRESS; Osada K., 2014, 6 WORLD C PHOT EN CO; Oshima R, 2011, PHYS STATUS SOLIDI C, V8, DOI 10.1002/pssc.201000461; Palacios P, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085206; Strandberg R, 2009, J APPL PHYS, V105, DOI 10.1063/1.3153141; Sugiyama M, 2012, IEEE J PHOTOVOLT, V2, P298, DOI 10.1109/JPHOTOV.2012.2196258; Tablero C, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.195203; Walukiewicz W., 2005, DILUTE NITRIDE SEMIC, P325, DOI 10.1016/B978-008044502-1/50010-X; Wu FC, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4750981; Yagi S, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.102301; Yagi S, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.102302	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA07	10.7567/JJAP.54.08KA07		5	Physics, Applied	Physics	CN8BU	WOS:000358662900008		
J	Taima, T; Tanaka, J; Kuwabara, T; Takahashi, K				Taima, Tetsuya; Tanaka, Jun; Kuwabara, Takayuki; Takahashi, Kohshin			Insertion effects of interlayers for efficient polymer-based organic solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							POWER CONVERSION EFFICIENCY; PHOTOVOLTAIC CELLS; PERFORMANCE; ELECTRODES; HETEROJUNCTIONS; MORPHOLOGY; INTERFACE; NETWORK	We report the improvement of power conversion efficiency (PCE) by introducing an organic-inorganic hybrid interlayer, which was composed of C-60 as an n-type semiconductor and lithium fluoride (LiF) as metal fluoride between a thienothiophene-benzodithiophene based polymer (PTB7): phenyl-C-61-butyric acid methyl ester (PC61BM) photoactive layer and an Al electrode. An additional C-60 layer in the C-60/LiF interlayer improves charge carrier collection from a photoactive layer to an Al electrode. In addition, the contact between PTB7 as a p-type semiconducting polymer in the photoactive layer and the C-60 layer in the C-60/LiF interlayer increases the number of photo produced charge carrier sites. These effects increases the short-circuit current density compared with that in the case of a solar cell with a conventional LiF interlayer. On the other hand, the open-circuit voltage and fill factor of the solar cell with the C-60/LiF interlayer are the same as those of the solar cell with a conventional LiF interlayer. By optimizing the thickness of the C-60 layer, a maximum PCE of 6.76% was obtained with a C-60 layer thickness of 3 nm in the C-60/LiF interlayer. (C) 2015 The Japan Society of Applied Physics.	[Taima, Tetsuya; Tanaka, Jun; Kuwabara, Takayuki; Takahashi, Kohshin] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Taima, Tetsuya; Kuwabara, Takayuki; Takahashi, Kohshin] Kanazawa Univ, Res Ctr Sustainable Energy & Technol, Kanazawa, Ishikawa 9201192, Japan; [Taima, Tetsuya] Japan Sci & Technol Agcy, JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Taima, T (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	taima@se.kanazawa-u.ac.jp	TAKAHASHI, Kohshin/L-3519-2015; Kuwabara, Takayuki/C-3424-2015	TAKAHASHI, Kohshin/0000-0001-8659-4054; 			Cheng K, 2005, MACROMOL RAPID COMM, V26, P247, DOI 10.1002/marc.200400462; YU G, 1995, SCIENCE, V270, P1789, DOI 10.1126/science.270.5243.1789; Lewis NS, 2007, SCIENCE, V315, P798, DOI 10.1126/science.1137014; Jonsson SKM, 2003, SYNTHETIC MET, V139, P1, DOI 10.1016/S0379-6779(02)01259-6; Scharber MC, 2006, ADV MATER, V18, P789, DOI 10.1002/adma.200501717; Kim YH, 2011, ADV FUNCT MATER, V21, P1076, DOI 10.1002/adfm.201002290; Hung LS, 2001, APPL PHYS LETT, V78, P544, DOI 10.1063/1.1327273; Li G, 2012, NAT PHOTONICS, V6, P153, DOI 10.1038/NPHOTON.2012.11; Ratcliff EL, 2011, J PHYS CHEM LETT, V2, P1337, DOI 10.1021/jz2002259; Garcia-Belmonte G, 2008, ORG ELECTRON, V9, P847, DOI 10.1016/j.orgel.2008.06.007; Crispin X, 2006, CHEM MATER, V18, P4354, DOI 10.1021/cm061032+; Brabec CJ, 2002, APPL PHYS LETT, V80, P1288, DOI 10.1063/1.1446988; He ZC, 2012, NAT PHOTONICS, V6, P591, DOI 10.1038/NPHOTON.2012.190; Ma H, 2010, ADV FUNCT MATER, V20, P1371, DOI 10.1002/adfm.200902236; Brabec CJ, 2010, ADV MATER, V22, P3839, DOI 10.1002/adma.200903697; Tang JX, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2966155; Choi KH, 2009, SOL ENERG MAT SOL C, V93, P1248, DOI 10.1016/j.solmat.2009.01.015; Ma WL, 2005, ADV FUNCT MATER, V15, P1617, DOI 10.1002/adfm.200500211; Mihailetchi VD, 2004, APPL PHYS LETT, V85, P970, DOI 10.1063/1.1782252; Gommans H, 2008, ADV FUNCT MATER, V18, P3686, DOI 10.1002/adfm.200800815; Chen W, 2011, NANO LETT, V11, P3707, DOI 10.1021/nl201715q; Yang LQ, 2011, ACS APPL MATER INTER, V3, P4075, DOI 10.1021/am2009585; Gunes S, 2007, CHEM REV, V107, P1324, DOI 10.1021/cr050149z; Hung LS, 1997, APPL PHYS LETT, V70, P152, DOI 10.1063/1.118344; Chan MY, 2006, J APPL PHYS, V100, DOI 10.1063/1.2363649; Liang YY, 2010, ADV MATER, V22, pE135, DOI 10.1002/adma.200903528; Baral JK, 2011, EUR PHYS J-APPL PHYS, V55, DOI 10.1051/epjap/2011110047; Hoven CV, 2010, ADV MATER, V22, pE63, DOI 10.1002/adma.200903677; Singh J., 2014, NANOSCI TECHNOL, V1, P8; You JB, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2411	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KF05	10.7567/JJAP.54.08KF05		4	Physics, Applied	Physics	CN8BU	WOS:000358662900085		
J	Takahashi, I; Hoshi, Y; Tayagaki, T; Oikawa, T; Ohdaira, K; Usami, N				Takahashi, Isao; Hoshi, Yusuke; Tayagaki, Takeshi; Oikawa, Takafumi; Ohdaira, Keisuke; Usami, Noritaka			Application of heterojunction to Si-based solar cells using photonic nanostructures coupled with vertically aligned Ge quantum dots	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EFFICIENCY; VOLTAGE	We have recently developed a new structure for solar cells that consists of photonic nanostructures coupled with vertically aligned Ge quantum dots on a crystalline Si substrate. For the fabrication of a solar cell device, a heterojunction with a-Si:H was chosen because its processing temperature is less than 200 degrees C, at which point Ge atoms cannot diffuse into Si layers. In this study, we developed a guideline for the most appropriate cell structures to take advantage of the Ge layer by fabricating heterojunction solar cells with various structures. As a result, we confirmed that the carriers absorbed in Ge quantum dots contributed output current when Ge quantum dots are fabricated on the pn-junction side. Hence, the presence of built-in potential in a Ge dot layer was found to be necessary to extract the carriers generated in the Ge layer. In addition, carrier transport in Ge quantum dots is improved under conditions of reverse bias. Therefore, the electrical field in the Ge layer is a key parameter to improve solar cell performance in our proposed structure. (C) 2015 The Japan Society of Applied Physics	[Takahashi, Isao; Hoshi, Yusuke; Usami, Noritaka] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan; [Tayagaki, Takeshi] Kyoto Univ, Inst Chem Res, Uji, Kyoto 6110011, Japan; [Oikawa, Takafumi; Ohdaira, Keisuke] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9321292, Japan	Takahashi, I (reprint author), Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan.	itaka@numse.nagoya-u.ac.jp	Tayagaki, Takeshi/E-7830-2010; Usami, Noritaka/C-1720-2009; Hoshi, Yusuke/A-2135-2012; Takahashi, Isao/E-8501-2013	Takahashi, Isao/0000-0003-0416-5462	Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency	This work was supported by the Advanced Low Carbon Technology Research and Development Program (ALCA) of Japan Science and Technology Agency.	Ekins-Daukes NJ, 1999, APPL PHYS LETT, V75, P4195, DOI 10.1063/1.125580; Dimmock JAR, 2014, PROG PHOTOVOLTAICS, V22, P151, DOI 10.1002/pip.2444; Lam P, 2014, NANO ENERGY, V6, P159, DOI 10.1016/j.nanoen.2014.03.016; Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Tayagaki T, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4756895; Taguchi M, 2005, PROG PHOTOVOLTAICS, V13, P481, DOI 10.1002/pip.646; VAN DE WALLE CG, 1989, PHYS REV B, V39, P1871, DOI 10.1103/PhysRevB.39.1871; Bivour M, 2012, SOL ENERG MAT SOL C, V106, P11, DOI 10.1016/j.solmat.2012.06.036; Alguno A, 2003, APPL PHYS LETT, V83, P1258, DOI 10.1063/1.1600838; Koyama K, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3483853; Usami N, 2012, NANOTECHNOLOGY, V23, DOI 10.1088/0957-4484/23/18/185401; Hubbard SM, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2903699; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Hoshi Y, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.080202; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Maruyama E., 2013, P 39 IEEE PHOT SPEC, P96; Takahashi I., 2014, WORLD C PHOT EN CONV; Tayagaki T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02703; Tayagaki T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NE24; Yano Ayumu, 2013, 28th European Photovoltaic Solar Energy Conference and Exhibition (EU PVSEC 2013). Proceedings	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA06	10.7567/JJAP.54.08KA06		4	Physics, Applied	Physics	CN8BU	WOS:000358662900007		
J	Takeda, Y; Ito, T				Takeda, Yasuhiko; Ito, Tadashi			Light trapping for silicon photovoltaic cells illuminated by solar-pumped lasers emitting at 1064 nm	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							REFLECTION; EFFICIENCY	We have demonstrated a significant light-trapping effect for a silicon photovoltaic cell using a bandpass filter on the front surface and a diffuse reflector on the back surface, which is coupled with a solar-pumped laser emitting at 1064 nm, as a new approach to highly efficient solar photovoltaics. We carried out Monte-Carlo simulation of the light-trapping process to consider the effects of realistic optical properties of the surface treatments, and clarified the requisites to remarkably improve the absorbance of the cell. A multilayer bandpass filter consisting of TiO2 and SiO2 was employed, in which the thickness of each layer was optimized. A Si surface roughened by acid etching and covered with a Ag layer realized sufficient diffuse reflection properties. The prototype for optical evaluations using a 45-mu m-thick Si wafer, which is extremely thin compared with conventional silicon solar cells, almost perfectly absorbed the monochromatic incident light even though the wavelength was very close to the absorption edge. (C) 2015 The Japan Society of Applied Physics	[Takeda, Yasuhiko; Ito, Tadashi] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Takeda, Y (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	takeda@mosk.tytlabs.co.jp			Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency	We thank Dr. T. Mitsuoka for AFM observations. The bandpass filters and AR coatings were fabricated by Nidek Co., Ltd., Japan. This work was partially supported by Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency.	JOHNSON PB, 1972, PHYS REV B, V6, P4370, DOI 10.1103/PhysRevB.6.4370; Xu P, 2014, APPL OPTICS, V53, P3941, DOI 10.1364/AO.53.003941; GREEN MA, 1986, IEEE ELECTR DEVICE L, V7, P583, DOI 10.1109/EDL.1986.26481; YABLONOVITCH E, 1982, J OPT SOC AM, V72, P899, DOI 10.1364/JOSA.72.000899; Castro M, 2008, SOL ENERG MAT SOL C, V92, P1697, DOI 10.1016/j.solmat.2008.08.001; Altermatt PP, 2003, J APPL PHYS, V93, P1598, DOI 10.1063/1.1529297; Rakic AD, 1998, APPL OPTICS, V37, P5271, DOI 10.1364/AO.37.005271; Liang D, 2013, APPL PHYS B-LASERS O, V111, P305, DOI 10.1007/s00340-013-5334-4; Nishimoto Y, 1999, J ELECTROCHEM SOC, V146, P457, DOI 10.1149/1.1391628; Vazsonyi E, 1999, SOL ENERG MAT SOL C, V57, P179, DOI 10.1016/S0927-0248(98)00180-9; Mizuno S, 2012, OPT EXPRESS, V20, P5891, DOI 10.1364/OE.20.005891; Green MA, 2008, SOL ENERG MAT SOL C, V92, P1305, DOI 10.1016/j.solmat.2008.06.009; Papet P, 2006, SOL ENERG MAT SOL C, V90, P2319, DOI 10.1016/j.solmat.2006.03.005; TORRANCE KE, 1967, J OPT SOC AM, V57, P1105, DOI 10.1364/JOSA.57.001105; Daub E, 1996, J APPL PHYS, V80, P5325, DOI 10.1063/1.363471; Dinh TH, 2014, APPL OPTICS, V53, P2711, DOI 10.1364/AO.53.002711; Hasegawa K, 2015, OPT EXPRESS, V23, pA519, DOI 10.1364/OE.23.00A519; Haus H. M., 1984, WAVES FIELDS OPTOELE; Hermle M., 2005, P 20 EU PVSEC UNPUB, P810; Iwata H, 2000, SOL ENERG MAT SOL C, V61, P353, DOI 10.1016/S0927-0248(99)00119-1; Kanou D., 2014, 6 WORLD C PHOT EN CO; Kim K., 2008, SOLAR ENERGY MAT SOL, V92, P960, DOI 10.1016/j.solmat.2008.02.036; Kray D, 2008, PROG PHOTOVOLTAICS, V16, P1, DOI 10.1002/pip.769; Macleod H. A., 2010, THIN FILM OPTICAL FI, V4th; Mizuno S., 2014, 6 WORLD C PHOT EN CO; Motohiro T., 2014, 6 WORLD C PHOT EN CO; PHONG BT, 1975, COMMUN ACM, V18, P311, DOI 10.1145/360825.360839; Takeda Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4885758	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD13	10.7567/JJAP.54.08KD13		6	Physics, Applied	Physics	CN8BU	WOS:000358662900058		
J	Takeda, Y; Iizuka, H; Ito, T; Mizuno, S; Hasegawa, K; Ichikawa, T; Ito, H; Kajino, T; Higuchi, K; Ichiki, A; Motohiro, T				Takeda, Yasuhiko; Iizuka, Hideo; Ito, Tadashi; Mizuno, Shintaro; Hasegawa, Kazuo; Ichikawa, Tadashi; Ito, Hiroshi; Kajino, Tsutomu; Higuchi, Kazuo; Ichiki, Akihisa; Motohiro, Tomoyoshi			Optimal design of bandpass filters to reduce emission from photovoltaic cells under monochromatic illumination	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SOLAR-CELLS; LASER; NANOSTRUCTURES; EFFICIENCY; FIBER; GAAS	We have theoretically investigated photovoltaic cells used under the illumination condition of monochromatic light incident from a particular direction, which is very different from that for solar cells under natural sunlight, using detailed balance modeling. A multilayer bandpass filter formed on the surface of the cell has been found to trap the light generated by radiative recombination inside the cell, reduce emission from the cell, and consequently improve conversion efficiency. The light trapping mechanism is interpreted in terms of a one-dimensional photonic crystal, and the design guide to optimize the multilayer structure has been clarified. For obliquely incident illumination, as well as normal incidence, a significant light trapping effect has been achieved, although the emission patterns are extremely different from each other depending on the incident directions. (C) 2015 The Japan Society of Applied Physics	[Takeda, Yasuhiko; Iizuka, Hideo; Ito, Tadashi; Mizuno, Shintaro; Hasegawa, Kazuo; Ichikawa, Tadashi; Ito, Hiroshi; Kajino, Tsutomu; Higuchi, Kazuo] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan; [Higuchi, Kazuo; Ichiki, Akihisa; Motohiro, Tomoyoshi] Nagoya Univ, Green Mobil Collaborat Res Ctr, Nagoya, Aichi 4648601, Japan	Takeda, Y (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	takeda@mosk.tytlabs.co.jp			Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency	This work was partially supported by the Advanced Low Carbon Technology Research and Development Program (ALCA), Japan Science and Technology Agency.	Fink Y, 1998, SCIENCE, V282, P1679, DOI 10.1126/science.282.5394.1679; Hua B, 2013, NANOSCALE, V5, P6627, DOI 10.1039/c3nr01152f; Xu P, 2014, APPL OPTICS, V53, P3941, DOI 10.1364/AO.53.003941; YEH P, 1977, J OPT SOC AM, V67, P423, DOI 10.1364/JOSA.67.000423; Liang D, 2013, APPL PHYS B-LASERS O, V111, P305, DOI 10.1007/s00340-013-5334-4; Melninkaitis A, 2011, APPL OPTICS, V50, pC188, DOI 10.1364/AO.50.00C188; Mizuno S, 2012, OPT EXPRESS, V20, P5891, DOI 10.1364/OE.20.005891; SHOCKLEY W, 1961, J APPL PHYS, V32, P510, DOI 10.1063/1.1736034; Spinelli P, 2012, J OPTICS-UK, V14, DOI 10.1088/2040-8978/14/2/024002; BURKHARD H, 1982, J APPL PHYS, V53, P655, DOI 10.1063/1.329973; Luque A, 2011, J APPL PHYS, V110, DOI 10.1063/1.3600702; Benitez P, 2010, OPT EXPRESS, V18, pA25, DOI [10.1364/OE.18.000A25, 10.1364/OE.18.0000A25]; Chen JS, 1996, APPL OPTICS, V35, P90, DOI 10.1364/AO.35.000090; Dinh TH, 2014, APPL OPTICS, V53, P2711, DOI 10.1364/AO.53.002711; Guo CF, 2014, LIGHT-SCI APPL, V3, DOI 10.1038/lsa.2014.42; Hasegawa K., 2011, P IEEE PHOT C, P907; Haus H. M., 1984, WAVES FIELDS OPTOELE; Hirst H., 2011, PROG PHOTOVOLTAICS, V19, P286; Kanou D., 2014, 6 WORLD C PHOT EN CO; Kosten ED, 2013, LIGHT-SCI APPL, V2, DOI 10.1038/lsa.2013.1; LANDRY MJ, 1991, APPL OPTICS, V30, P1052, DOI 10.1364/AO.30.001052; Madelung O., 2003, SEMICONDUCTORS DATA; Markvart T, 2008, PHYS STATUS SOLIDI A, V205, P2752, DOI 10.1002/pssa.200880460; Mizuno S., 2014, 6 WORLD C PHOT EN CO; Mokkapati S, 2012, J APPL PHYS, V112, DOI 10.1063/1.4747795; Motohiro T., 2014, JPN J APPL PHYS; Motohiro T., 2014, 6 WORLD C PHOT EN CO; Paire M, 2013, J RENEW SUSTAIN ENER, V5, DOI 10.1063/1.4791778; Paire M, 2010, J APPL PHYS, V108, DOI 10.1063/1.3460629; Peters M, 2010, SOL ENERG MAT SOL C, V94, P1393, DOI 10.1016/j.solmat.2010.04.009; SIQUEIROS JM, 1988, APPL OPTICS, V27, P2549, DOI 10.1364/AO.27.002549; Takeda Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4885758; Takeda Y, 2014, J APPL PHYS, V116, DOI 10.1063/1.4896263; Tanaka Y, 2009, OPT REV, V16, P257, DOI 10.1007/s10043-009-0048-x; WURFEL P, 1982, J PHYS C SOLID STATE, V15, P3967, DOI 10.1088/0022-3719/15/18/012	35	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA05	10.7567/JJAP.54.08KA05		6	Physics, Applied	Physics	CN8BU	WOS:000358662900006		
J	Tamakoshi, M; Matsuki, N				Tamakoshi, Masato; Matsuki, Nobuyuki			Impact of sputter-induced ion bombardment at the heterointerfaces of a-Si:H/c-Si solar cells with double-layered In2O3:Sn structures	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TRANSPARENT CONDUCTIVE OXIDE; THIN-FILMS; SUBSTRATE; SILICON; OPTIMIZATION; DEPOSITION; VOLTAGE	The effect of ion bombardment on photovoltaic characteristics, induced during the sputtering deposition of In2O3:Sn (ITO) layers, has been investigated using hydrogenated amorphous silicon/crystalline silicon (a-Si:H/c-Si) heterojunction solar cells with double-layered ITO structures. The experimental results indicate that the significant decrease in the fill factor (FF) induced at a sputtering rf power higher than 30 W is attributed to the increase in series resistance (R-s), which is caused by property degradation in the ITO/a-Si:H interface region. Furthermore, it has been found that the impact of the sputter-induced ion bombardment on the property degradation reaches the ITO/a-Si: H interface region through the deposited ITO layer even up to a thickness of 20 nm. (C) 2015 The Japan Society of Applied Physics	[Tamakoshi, Masato; Matsuki, Nobuyuki] Gifu Univ, CIPS, Gifu 5011193, Japan	Tamakoshi, M (reprint author), Gifu Univ, CIPS, Gifu 5011193, Japan.	matsuki@kanagawa-u.ac.jp	马, 忠权/I-4498-2014	马, 忠权/0000-0002-6471-2985			Fujiwara H, 2007, J APPL PHYS, V101, DOI 10.1063/1.2559975; ISHIBASHI S, 1990, J VAC SCI TECHNOL A, V8, P1403, DOI 10.1116/1.576890; Wendt R, 1997, SURF COAT TECH, V93, P27, DOI 10.1016/S0257-8972(97)00036-4; Pla J, 2003, THIN SOLID FILMS, V425, P185, DOI 10.1016/S0040-6090(02)01143-4; Koida T, 2009, SOL ENERG MAT SOL C, V93, P851, DOI 10.1016/j.solmat.2008.09.047; Jellison GE, 1996, APPL PHYS LETT, V69, P371, DOI 10.1063/1.118064; Wendt R, 1997, J APPL PHYS, V82, P2115, DOI 10.1063/1.366092; Holman ZC, 2013, J APPL PHYS, V113, DOI 10.1063/1.4772975; Ellmer K, 2012, J MATER RES, V27, P765, DOI 10.1557/jmr.2011.428; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Mishima T, 2011, SOL ENERG MAT SOL C, V95, P18, DOI 10.1016/j.solmat.2010.04.030; Rovira PI, 1999, J APPL PHYS, V85, P2015, DOI 10.1063/1.369496; Jellison GE, 1996, APPL PHYS LETT, V69, P2137, DOI 10.1063/1.118155; Descoeudres A, 2013, IEEE J PHOTOVOLT, V3, P83, DOI 10.1109/JPHOTOV.2012.2209407; Fujiwara H, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.075109; Fay S, 2010, THIN SOLID FILMS, V518, P2961, DOI 10.1016/j.tsf.2009.09.189; Zhang D, 2011, ENRGY PROCED, V8, P207, DOI 10.1016/j.egypro.2011.06.125; Demaurex B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4764529; Balestrieri M, 2011, SOL ENERG MAT SOL C, V95, P2390, DOI 10.1016/j.solmat.2011.04.012; Favre W, 2013, APPL PHYS LETT, V102, DOI 10.1063/1.4804985; Filipic M, 2013, J APPL PHYS, V114, DOI 10.1063/1.4818709; Forcht K, 1997, THIN SOLID FILMS, V302, P43, DOI 10.1016/S0040-6090(96)09555-7; Fujiwara H., 2007, SPECTROSCOPIC ELLIPS; Honda S, 1997, APPL SURF SCI, V113, P408, DOI 10.1016/S0169-4332(96)00939-7; Plagernann A, 2007, J VAC SCI TECHNOL A, V25, P1341, DOI 10.1116/1.2753843; Rossler R, 2013, J APPL PHYS, V113, DOI 10.1063/1.4799042; Sago K, 2014, J APPL PHYS, V115, DOI 10.1063/1.4870443; STREET R, 1979, PHILOS MAG B, V40, P451, DOI 10.1080/01418637908226769; Taguchi M., 2013, IEEE J PHOTOVOLT, V4, P96; Tawada Y, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.085802; Voget-Grote U., 1976, AIP C P, V31, P91; Yang ZW, 2000, THIN SOLID FILMS, V366, P4, DOI 10.1016/S0040-6090(00)00919-6; Zhao L, 2005, APPL SURF SCI, V252, P385, DOI 10.1016/j.apsusc.2005.01.033	33	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD09	10.7567/JJAP.54.08KD09		6	Physics, Applied	Physics	CN8BU	WOS:000358662900054		
J	Tokuhisa, H; Ise, S; Morita, S; Tsukamoto, S; Tomita, M; Yoshida, M				Tokuhisa, Hideo; Ise, Shogo; Morita, Satoko; Tsukamoto, Shiho; Tomita, Mitsuru; Yoshida, Manabu			Reliability of a printed Cu busbar electrode on a conventional silicon solar cell	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS; COPPER; OXIDATION; DIFFUSION; METALLIZATION; FRONT; KINETICS; CONTACT; SILVER; PASTE	In this paper, we describe the reliability of the Cu busbar electrode fabricated by screen printing of resin-based Cu pastes on a crystal silicon solar cell with conventional front and rear electrodes excluding the busbar. The damp heat test (DHT) and thermal cycling test (TCT) of the cells were carried out with ethylene-vinyl acetate (EVA) and glass encapsulation, and without any encapsulation. No significant degradation was observed for either case. Oxidation was confined to the surface region even without encapsulation after 2,500 h of DHT. Cu diffusion into Si was evaluated using pseudo fill factor (pFF). No significant changes in pFF were found after heat treatment (400 degrees C, 1 h) in the case of resin-based Cu, where 10% pFF loss was observed when Cu was introduced by vapor deposition. From these findings, the role of resin used as a binder in Cu pastes is considered a key material parameter of Cu diffusion in Si. (C) 2015 The Japan Society of Applied Physics	[Tokuhisa, Hideo; Ise, Shogo; Morita, Satoko; Tsukamoto, Shiho; Tomita, Mitsuru; Yoshida, Manabu] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan	Tokuhisa, H (reprint author), Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058565, Japan.	h-tokuhisa@aist.go.jp			New Energy and Industrial Technology Development Organization (NEDO); Tsukuba West; Nano Processing Facility (NPF) of AIST	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO). This work was partly supported by Tsukuba West and the Nano Processing Facility (NPF) of AIST.	Zhu YF, 2002, MATER TRANS, V43, P2173, DOI 10.2320/matertrans.43.2173; Herzig C, 2003, MATER TRANS, V44, P14, DOI 10.2320/matertrans.44.14; Ramanandan GKP, 2012, J APPL PHYS, V111, DOI 10.1063/1.4729808; Wood D, 2014, ENRGY PROCED, V55, P724, DOI 10.1016/j.egypro.2014.08.052; Keil P, 2007, AIP CONF PROC, V882, P490; Platzman I, 2008, J PHYS CHEM C, V112, P1101, DOI 10.1021/jp076981k; KOLAWA E, 1991, J APPL PHYS, V70, P1369, DOI 10.1063/1.349594; Han WS, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/39/395705; Kim DH, 2013, ELECTRON MATER LETT, V9, P677, DOI 10.1007/s13391-013-2169-4; Geissbuhler J, 2014, IEEE J PHOTOVOLT, V4, P1055, DOI 10.1109/JPHOTOV.2014.2321663; Oku T, 1996, APPL SURF SCI, V99, P265, DOI 10.1016/0169-4332(96)00464-3; Rehman AU, 2014, MATERIALS, V7, P1318, DOI 10.3390/ma7021318; Jang S, 2010, SCRIPTA MATER, V62, P258, DOI 10.1016/j.scriptamat.2009.11.011; Istratov AA, 2002, J ELECTROCHEM SOC, V149, pG21, DOI 10.1149/1.1421348; Bartsch J, 2010, J ELECTROCHEM SOC, V157, pH942, DOI 10.1149/1.3466984; Eom YS, 2011, ETRI J, V33, P864, DOI 10.4218/etrij.11.0110.0520; Fischer M., 2012, P EUR PHOT SOL EN C, P527; ITRPV, 2013, INT TECHN ROADM PHOT; Kato T, 2012, IEEE J PHOTOVOLT, V2, P499, DOI 10.1109/JPHOTOV.2012.2188018; Kraft A, 2014, ENRGY PROCED, V55, P478, DOI 10.1016/j.egypro.2014.08.012; Kuroda K., 2012, T JPN I ELECT PACKAG, V5, P20; Lee JH, 2011, SOL ENERG MAT SOL C, V95, P22, DOI 10.1016/j.solmat.2010.04.065; Lee YS, 2013, T NONFERR METAL SOC, V23, P562, DOI 10.1016/S1003-6326(13)62500-5; Meier D. L., 2006, IEEE 4 WORLD C PHOT, P1315; Meier DL, 2013, IEEE J PHOTOVOLT, V3, P199, DOI 10.1109/JPHOTOV.2012.2217939; Rauer M, 2013, ENRGY PROCED, V38, P449, DOI 10.1016/j.egypro.2013.07.303; ROY R, 1993, THIN SOLID FILMS, V223, P189, DOI 10.1016/0040-6090(93)90747-D; ROY SK, 1970, ACTA METALL MATER, V18, P519, DOI 10.1016/0001-6160(70)90139-2; Sinton R.A., 2000, P 16 EUR PHOT SOL EN, P1152; Yoshiba S., 2012, 27 EUR PHOT SOL EN C; Zhu YF, 2006, METALL MATER TRANS A, V37A, P1231	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD22	10.7567/JJAP.54.08KD22		5	Physics, Applied	Physics	CN8BU	WOS:000358662900067		
J	Tomizawa, Y; Imamura, T; Soeda, M; Ikeda, Y; Shiro, T				Tomizawa, Yuka; Imamura, Tetsuya; Soeda, Masaya; Ikeda, Yoshinori; Shiro, Takashi			Laser doping of boron-doped Si paste for high-efficiency silicon solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SELECTIVE EMITTER; LAYER	Boron laser doping (LD) is a promising technology for high-efficiency solar cells such as p-type passivated locally diffused solar cells and n-type Si-wafer-based solar cells. We produced a printable phosphorus- or boron-doped Si paste (NanoGram(R) Si paste/ink) for use as a diffuser in the LD process. We used the boron LD process to fabricate high-efficiency passivated emitter and rear locally diffused (PERL) solar cells. PERL solar cells on Czochralski Si (Cz-Si) wafers yielded a maximum efficiency of 19.7%, whereas the efficiency of a reference cell was 18.5%. Fill factors above 79% and open circuit voltages above 655 mV were measured. We found that the boron-doped area effectively performs as a local boron back surface field (BSF). The characteristics of the solar cell formed using NanoGram(R) Si paste/ink were better than those of the reference cell. (C) 2015 The Japan Society of Applied Physics	[Tomizawa, Yuka; Imamura, Tetsuya; Soeda, Masaya; Ikeda, Yoshinori; Shiro, Takashi] Teijin Ltd, New Business Dev Business Unit, Elect Mat Dev Project, Hino, Tokyo 1918512, Japan; [Soeda, Masaya; Shiro, Takashi] NanoGram Corp, Milpitas, CA 95035 USA	Tomizawa, Y (reprint author), Teijin Ltd, New Business Dev Business Unit, Elect Mat Dev Project, Hino, Tokyo 1918512, Japan.	y.tomizawa@teijin.co.jp					Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Kim M, 2015, SOL ENERG MAT SOL C, V132, P215, DOI 10.1016/j.solmat.2014.08.021; Green MA, 2015, PROG PHOTOVOLTAICS, V23, P1, DOI 10.1002/pip.2573; Hameiri Z, 2011, SOL ENERG MAT SOL C, V95, P1085, DOI 10.1016/j.solmat.2010.12.006; ZHAO J, 1995, APPL PHYS LETT, V66, P3636, DOI 10.1063/1.114124; Hameiri Z, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3515866; Hallam B, 2015, SOL ENERG MAT SOL C, V134, P89, DOI 10.1016/j.solmat.2014.11.028; Xiao SQ, 2014, CRIT REV SOLID STATE, V39, P277, DOI 10.1080/10408436.2013.834245; Jager U, 2011, THIN SOLID FILMS, V519, P3827, DOI 10.1016/j.tsf.2011.01.237; Ogane A, 2009, JPN J APPL PHYS, V48, DOI 10.1143/JJAP.48.071201; Benick J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945287; Chang HC, 2014, ENRGY PROCED, V55, P643, DOI 10.1016/j.egypro.2014.08.038; Chiruvolu S, 2006, NANOTECHNOLOGY, V1, P325; FOULON F, 1989, APPL SURF SCI, V43, P333, DOI 10.1016/0169-4332(89)90235-3; Franklin E., 2014, PROGR PHOTOVOLTAICS, DOI [10.1002/pip.2556., DOI 10.1002/PIP.2556]; Gall S, 2012, ENRGY PROCED, V27, P449, DOI 10.1016/j.egypro.2012.07.092; Gall S, 2013, ENRGY PROCED, V38, P270, DOI 10.1016/j.egypro.2013.07.277; Jager U., 2014, P 29 EUR PHOT SOL EN, P1111; KATO S, 1987, J APPL PHYS, V62, P3656, DOI 10.1063/1.339245; Kluska S, 2011, IEEE ELECTR DEVICE L, V32, P1257, DOI 10.1109/LED.2011.2159699; Lin D., 2013, P 28 EU PVSEC PAR, P1029; Lin D, 2014, SOL ENERG MAT SOL C, V130, P83, DOI 10.1016/j.solmat2014.06.037; Lohmuller E, 2013, ENRGY PROCED, V38, P436, DOI 10.1016/j.egypro.2013.07.301; Muller R, 2014, APPL PHYS LETT, V105, DOI 10.1063/1.4895538; Nishimura H., 2014, P 6 WORLD C PHOT EN, P1424; Schneiderlochner E, 2002, PROG PHOTOVOLTAICS, V10, P29, DOI 10.1002/pip.422; Steinhauser B., 2013, P 28 EUR PHOT SOL EN, P722; Tomizawa Y., 2013, P 28 EUR PHOT SOL EN, P1255; Tous L, 2015, PROG PHOTOVOLTAICS, V23, P660, DOI 10.1002/pip.2478; Xiao B., 2013, P 28 EUR PHOT SOL EN, P1989	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD06	10.7567/JJAP.54.08KD06		5	Physics, Applied	Physics	CN8BU	WOS:000358662900051		
J	Urabe, S; Irikawa, J; Konagai, M; Miyajima, S				Urabe, Shunsuke; Irikawa, Junpei; Konagai, Makoto; Miyajima, Shinsuke			Characterization of laser transferred contact through aluminum oxide passivation layer	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SILICON SOLAR-CELLS; SURFACE PASSIVATION; CRYSTALLINE SILICON; N-TYPE; BACK; FILMS	The point contact structure of the rear side of crystalline silicon solar cells is used to realize high passivation quality and good electrical contact. A conversion efficiency of 19.8% was achieved on the passivated emitter and rear cell (PERC) structure with a widegap heterojunction emitter. In this solar cell, laser-fired contact (LFC) process is used to make the point contacts. In the LFC process, laser irradiation damage to the surface of crystalline silicon was found to be the big issues for higher passivation quality. We investigated laser-transferred contact (LTC) process as a new contacts formation process. The LTC samples showed higher effective minority carrier lifetime and good contact resistivity compared with the LFC samples. (C) 2015 The Japan Society of Applied Physics	[Urabe, Shunsuke; Irikawa, Junpei; Konagai, Makoto; Miyajima, Shinsuke] Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro, Tokyo 1528552, Japan; [Konagai, Makoto] Tokyo Inst Technol, Photovolta Res Ctr PVREC, Meguro, Tokyo 1528552, Japan	Urabe, S (reprint author), Tokyo Inst Technol, Grad Sch Sci & Engn, Meguro, Tokyo 1528552, Japan.	urabe.s.ac@m.titech.ac.jp			New Energy and Industrial Technology Development Organization (NEDO)	This work was partially supported by New Energy and Industrial Technology Development Organization (NEDO).	Aberle A. G., 1994, Progress in Photovoltaics: Research and Applications, V2, DOI 10.1002/pip.4670020402; Aberle AG, 2001, SOL ENERG MAT SOL C, V65, P239, DOI 10.1016/S0927-0248(00)00099-4; Hoex B, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240736; Miyajima S, 2007, JPN J APPL PHYS 1, V46, P1415, DOI 10.1143/JJAP.46.1415; Schmidt J, 2001, SEMICOND SCI TECH, V16, P164, DOI 10.1088/0268-1242/16/3/308; Hofmann M, 2009, SOL ENERG MAT SOL C, V93, P1074, DOI 10.1016/j.solmat.2008.11.056; Schmidt J, 2008, PROG PHOTOVOLTAICS, V16, P461, DOI 10.1002/pip.823; Gatz S, 2011, ENRGY PROCED, V8, P318, DOI 10.1016/j.egypro.2011.06.143; Miyajima S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.012301; Agostinelli G, 2006, SOL ENERG MAT SOL C, V90, P3438, DOI 10.1016/j.solmat.2006.04.014; Aberle AG, 1997, PROG PHOTOVOLTAICS, V5, P29, DOI 10.1002/(SICI)1099-159X(199701/02)5:1<29::AID-PIP149>3.0.CO;2-M; Irikawa J, 2011, APPL PHYS EXPRESS, V4, DOI 10.1143/APEX.4.092301; Miyajima S, 2010, APPL PHYS LETT, V97, DOI 10.1063/1.3460917; Brendle W, 2006, PROG PHOTOVOLTAICS, V14, P653, DOI 10.1002/pip.696; Carstens K, 2012, SOL ENERG MAT SOL C, V106, P27, DOI 10.1016/j.solmat.2012.06.020; Colina M, 2015, APPL SURF SCI, V336, P89, DOI 10.1016/j.apsusc.2014.09.172; Dahlinger M, 2013, ENRGY PROCED, V38, P250, DOI 10.1016/j.egypro.2013.07.274; Ferre R, 2011, PHYS STATUS SOLIDI A, V208, P1964, DOI 10.1002/pssa.201127046; He JB, 2015, PROG PHOTOVOLTAICS, V23, P1091, DOI 10.1002/pip.2520; Basu PK, 2013, SOL ENERG MAT SOL C, V117, P412, DOI 10.1016/j.solmat.2013.06.046; Kray D, 2006, PROG PHOTOVOLTAICS, V14, P195, DOI 10.1002/pip.660; Kray D, 2008, PROG PHOTOVOLTAICS, V16, P1, DOI 10.1002/pip.769; Li TTA, 2011, PROG PHOTOVOLTAICS, V19, P320, DOI 10.1002/pip.1031; Ortega P, 2012, PROG PHOTOVOLTAICS, V20, P173, DOI 10.1002/pip.1115; Roder T. C., 2011, ENERGY PROCEDIA, V8, P552; Roder TC, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685469; Schneiderlochner E, 2002, PROG PHOTOVOLTAICS, V10, P29, DOI 10.1002/pip.422; Shimizu K., 2014, P 40 IEEE PHOT SPEC, P1253; Urabe S., 2014, 6 INT WORLD C PHOT E; Wang LT, 2015, PROG PHOTOVOLTAICS, V23, P61, DOI 10.1002/pip.2395; Weber T, 2013, ENRGY PROCED, V38, P474, DOI 10.1016/j.egypro.2013.07.306	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD02	10.7567/JJAP.54.08KD02		5	Physics, Applied	Physics	CN8BU	WOS:000358662900047		
J	Nguyen, VH; Tutashkonko, S; Hoshi, Y; Usami, N				Van Hoang Nguyen; Tutashkonko, Sergii; Hoshi, Yusuke; Usami, Noritaka			Effects of anodization process of aluminum oxide template fabrication on selective growth of Si nanowire arrays	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; SILICON DIOXIDE; EPITAXIAL-GROWTH; NUCLEATION; DISILANE; TIME; SURFACES; KINETICS; SILANE; SYSTEM	We report on effects of anodization process of anodic aluminum oxide (AAO) template on selective growth of Si nanowires using gas source molecular beam epitaxy. By switching off the anodization currents at several points, the structure of Si surface was altered, which was critical factor for the Si nanowire array growth. With reasonable switched-off point of anodization current at R of 10%, the selective growth of Si nanowire growth was favorable and 1-mu m-long Si nanowire arrays were successfully grown. It was interesting that their structures were epitaxial structures; whereas, long anodization of AAO was found to be unfavorable for growth of Si nanowires due to anodization of Si surface. It caused the density of Si nanowire arrays to be modest and their structures were polycrystal structure. (C) 2015 The Japan Society of Applied Physics	[Van Hoang Nguyen; Tutashkonko, Sergii; Usami, Noritaka] Japan Sci & Technol Agcy JST, FUTURE PV Innovat, MEXT, Koriyama, Fukushima 9630215, Japan; [Van Hoang Nguyen; Tutashkonko, Sergii; Hoshi, Yusuke; Usami, Noritaka] Nagoya Univ, Grad Sch Engn, Nagoya, Aichi 4648603, Japan	Nguyen, VH (reprint author), Japan Sci & Technol Agcy JST, FUTURE PV Innovat, MEXT, Koriyama, Fukushima 9630215, Japan.	van.hoang.nguyen@pb.jst.jp	Usami, Noritaka/C-1720-2009; Hoshi, Yusuke/A-2135-2012; Tutashkonko, Sergii/H-2352-2014	Tutashkonko, Sergii/0000-0002-1256-5223	MEXT; FUTURE-PV Innovation (FUkushima Top-level United center for Renewable Energy research-PhotoVoltaics Innovation) Project	This work is supported by MEXT, FUTURE-PV Innovation (FUkushima Top-level United center for Renewable Energy research-PhotoVoltaics Innovation) Project. We acknowledge Professor Makoto Konagai and Dr. M Ajmal Khan for their discussions.	MUROTA J, 1989, APPL PHYS LETT, V54, P1007, DOI 10.1063/1.100781; DANA SS, 1992, APPL PHYS LETT, V61, P3035, DOI 10.1063/1.108001; AKETAGAWA K, 1991, J CRYST GROWTH, V111, P860, DOI 10.1016/0022-0248(91)91097-T; Tsakalakos L, 2007, J NANOPHOTONICS, V1, DOI 10.1117/1.2768999; CLAASSEN WAP, 1980, J ELECTROCHEM SOC, V127, P194, DOI 10.1149/1.2129616; Hannon JB, 2006, NATURE, V440, P69, DOI 10.1038/nature04574; Nguyen VH, 2014, APPL SURF SCI, V305, P9, DOI 10.1016/j.apsusc.2014.02.103; VIOLETTE KE, 1994, J ELECTROCHEM SOC, V141, P3269, DOI 10.1149/1.2059317; HIRAYAMA H, 1988, APPL PHYS LETT, V52, P2242, DOI 10.1063/1.99654; GATES SM, 1991, CHEM PHYS LETT, V184, P448, DOI 10.1016/0009-2614(91)80017-R; HU YZ, 1995, APPL PHYS LETT, V66, P700, DOI 10.1063/1.114104; Hu YZ, 1996, J VAC SCI TECHNOL B, V14, P744, DOI 10.1116/1.588708; KOHLER U, 1994, MICROSC MICROANAL M, V5, P247, DOI 10.1051/mmm:0199400504-6024700; MASUDA H, 1995, SCIENCE, V268, P1466, DOI 10.1126/science.268.5216.1466; Nguyen V. H., UNPUB; Nguyen V. H., 2013, P IEEE 39 PHOT SPEC, P2443; URISU T, 1993, APPL PHYS LETT, V62, P2821, DOI 10.1063/1.109221; Zhang Z., 2010, THESIS M LUTHER U HA	18	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA02	10.7567/JJAP.54.08KA02		6	Physics, Applied	Physics	CN8BU	WOS:000358662900003		
J	Watanabe, K; Inoue, T; Sodabanlu, H; Sugiyama, M; Nakano, Y				Watanabe, Kentaroh; Inoue, Tomoyuki; Sodabanlu, Hassanet; Sugiyama, Masakazu; Nakano, Yoshiaki			Thin-film solar cells with InGaAs/GaAsP multiple quantum wells and a rear surface etched with light trapping micro-hole array	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							EPITAXIAL LIFT-OFF; GALLIUM-ARSENIDE; EFFICIENCY; ENHANCEMENT; ABSORPTION	A light trapping effect in GaAs p-i-n solar cells with InGaAs/GaAsP multiple quantum wells (MQWs) in the i-layer was demonstrated by applying a light scattering texture to the rear surface of the cell. A thin-film MQW solar cell was successfully fabricated by metal organic vapor phase epitaxy (MOVPE) to grow an inverted n-i-p photovoltaic (PV) structure; this structure was then transferred to a Si support substrate to prevent optical loss due to free carrier absorption. For the light scattering texture, the use of both the wet-etched micro-hole arrayed SiO2 dielectric layer on the rear surface of the cell and the secondarily etched micro hole array on the GaAs layer was attempted. On the SiO2 layer, the micro hole array pattern was obtained by the radio frequency sputtering of the layer followed by wet etching with photolithographic patterning. On the GaAs layer, the micro-hole array pattern was obtained by direct etching through a SiO2 template. Compared with the light scattering effects of the micro-hole-arrayed SiO2 layer, the secondarily etched GaAs rear contact layer showed a significant improvement in external quantum efficiency (EQE) in the wavelength range from 855 to 1000 nm that corresponds to the photon absorption wavelength in MQWs. (C) 2015 The Japan Society of Applied Physics	[Watanabe, Kentaroh; Sodabanlu, Hassanet; Nakano, Yoshiaki] Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan; [Inoue, Tomoyuki; Sugiyama, Masakazu; Nakano, Yoshiaki] Univ Tokyo, Sch Engn, Dept Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan	Watanabe, K (reprint author), Univ Tokyo, Res Ctr Adv Sci & Technol, Meguro Ku, Tokyo 1538904, Japan.	kentaroh@hotaka.t.u-tokyo.ac.jp	Sugiyama, Masakazu/P-9616-2015	Sugiyama, Masakazu/0000-0002-4303-4038			ADACHI S, 1983, J ELECTROCHEM SOC, V130, P2427, DOI 10.1149/1.2119608; Ekins-Daukes NJ, 1999, APPL PHYS LETT, V75, P4195, DOI 10.1063/1.125580; Ma SJ, 2011, J APPL PHYS, V110, DOI 10.1063/1.3663309; Nozik AJ, 2002, PHYSICA E, V14, P115, DOI 10.1016/S1386-9477(02)00374-0; YABLONOVITCH E, 1982, IEEE T ELECTRON DEV, V29, P300, DOI 10.1109/T-ED.1982.20700; King RR, 2012, PROG PHOTOVOLTAICS, V20, P801, DOI 10.1002/pip.1255; Green MA, 2002, PROG PHOTOVOLTAICS, V10, P235, DOI 10.1002/pip.404; Dimroth F, 2014, PROG PHOTOVOLTAICS, V22, P277, DOI 10.1002/pip.2475; BARNHAM KWJ, 1990, J APPL PHYS, V67, P3490, DOI 10.1063/1.345339; Guter W, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3148341; Wiemer M, 2011, PROC SPIE, V8108, DOI 10.1117/12.897769; King RR, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2734507; CAMPBELL P, 1987, J APPL PHYS, V62, P243, DOI 10.1063/1.339189; Zhao JH, 1998, APPL PHYS LETT, V73, P1991, DOI 10.1063/1.122345; Bauhuis GJ, 2009, SOL ENERG MAT SOL C, V93, P1488, DOI 10.1016/j.solmat.2009.03.027; Hirst LC, 2014, IEEE J PHOTOVOLT, V4, P244, DOI 10.1109/JPHOTOV.2013.2289321; Browne B, 2013, AIP CONF PROC, V1556, P3, DOI 10.1063/1.4822185; Cheng CW, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2583; Inoue T, 2015, IEEE J PHOTOVOLT, V5, P697, DOI 10.1109/JPHOTOV.2015.2392941; Kim B., 2012, P 22 PHOT SCI ENG C; Luque A, 1997, PHYS REV LETT, V78, P5014, DOI 10.1103/PhysRevLett.78.5014; Okada Y, 2011, J APPL PHYS, V109, DOI 10.1063/1.3533423; Scheiman D., 2014, P 40 IEEE PHOT SPEC, P1376; Sodabanlu H, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.062301; SPITZER WG, 1959, PHYS REV, V114, P59, DOI 10.1103/PhysRev.114.59; Sugiyama M, 2012, IEEE J PHOTOVOLT, V2, P298, DOI 10.1109/JPHOTOV.2012.2196258; Takahara T., 2014, P 40 IEEE PHOT SPEC, P1; Toprasertpong K., PROG PHOTOV IN PRESS, DOI [10.1002/pip.2585, DOI 10.1002/PIP.2585]; Watanabe K, 2014, IEEE J PHOTOVOLT, V4, P1086, DOI 10.1109/JPHOTOV.2014.2312486; Watanabe K., 2012, P 38 IEEE PHOT SPEC; Zorn M, 2006, SEMICOND SCI TECH, V21, pL45, DOI 10.1088/0268-1242/21/9/L01	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA13	10.7567/JJAP.54.08KA13		5	Physics, Applied	Physics	CN8BU	WOS:000358662900014		
J	Watanabe, T; Yamashita, K				Watanabe, Tomoki; Yamashita, Kenichi			Doping effects of fluorinated organic dyes on the open-circuit voltage of bulk-heterojunction photovoltaic devices	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							RESONANCE ENERGY-TRANSFER; SOLAR-CELLS; POLYMER; EFFICIENCY	We have investigated photovoltaic properties of bulk-heterojunction (BHJ) organic absorption layer doped with fluorinated Coumarin dyes. By dilute doping of a fluorinated Coumarin dye, Coumarin 307, into poly(3-hexylthiophene-2,5-diyl) (P3HT) and [6,6]-phenyl-C61-butyric acid methyl ester (PCBM) BHJ absorption layer, the open-circuit voltage of photovoltaic device increased by similar to 90mV without the significant degradation in the short-circuit current density. On the other hand, the doping of non-fluorinated Coumarin dye such as Coumarin 2 did not induce such the enhancement effect in the open-circuit voltage. In ultraviolet photoelectron spectroscopies, the doping of Coumarin 307 was found to have no impact on P3HT, but the density of state of PCBM was significantly modified by the doping. The change in the density of state was confirmed also in ultraviolet absorption measurement. Possible explanations for the enhancement in the open-circuit voltage are discussed from the experimental results, and a shift of the vacuum level by the doping can be considered as a direct origin. (C) 2015 The Japan Society of Applied Physics	[Watanabe, Tomoki; Yamashita, Kenichi] Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Elect, Kyoto 6068585, Japan	Yamashita, K (reprint author), Kyoto Inst Technol, Grad Sch Sci & Technol, Dept Elect, Kyoto 6068585, Japan.	yamasita@kit.ac.jp					Peet J, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3001802; Vandewal K, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.125204; Dastoor PC, 2007, J PHYS CHEM C, V111, P15415, DOI 10.1021/jp0748664; Tada A, 2011, NAT MATER, V10, P450, DOI [10.1038/nmat3026, 10.1038/NMAT3026]; Kim JY, 2007, SCIENCE, V317, P222, DOI 10.1126/science.1141711; Luo J, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3157278; Yamashita K, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.080207; SARICIFTCI NS, 1992, SCIENCE, V258, P1474, DOI 10.1126/science.258.5087.1474; Wei QS, 2008, ADV MATER, V20, P2211, DOI 10.1002/adma.200792876; Kooistra FB, 2007, ORG LETT, V9, P551, DOI 10.1021/ol062666p; Luhman WA, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3120566; Wei QS, 2009, J AM CHEM SOC, V131, P17597, DOI 10.1021/ja9057053; Honda S, 2009, ACS APPL MATER INTER, V1, P804, DOI 10.1021/am800229p; Mor GK, 2010, NANO LETT, V10, P2387, DOI 10.1021/nl100415q; Arif M, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3082081; Yang DF, 2011, APPL PHYS LETT, V99, DOI 10.1063/1.3658875; Xu Z, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3163056; Rand BP, 2009, APPL PHYS LETT, V95, DOI 10.1063/1.3257383; HIRAMOTO M, 1991, APPL PHYS LETT, V58, P1062, DOI 10.1063/1.104423; Watanabe T, 2012, PHYS STATUS SOLIDI C, V9, P2399, DOI 10.1002/pssc.201200171; Bao Q., 2013, ADV ENERGY MATER, V4; Brabec C., 2008, ORGANIC PHOTOVOLTAIC; Chan MY, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2430783; Guchhait A, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3292183; Huang JS, 2013, NAT PHOTONICS, V7, P480, DOI 10.1038/NPHOTON.2013.82; Li H, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4761246; Rand BP, 2007, PHYS REV B, V75, DOI 10.1103/PhysRevB.75.115327; Xu ZH, 2008, J APPL PHYS, V103, DOI 10.1063/1.2885349	28	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KF01	10.7567/JJAP.54.08KF01		4	Physics, Applied	Physics	CN8BU	WOS:000358662900081		
J	Yamaguchi, S; Jonai, S; Hara, K; Komaki, H; Shimizu-Kamikawa, Y; Shibata, H; Niki, S; Kawakami, Y; Masuda, A				Yamaguchi, Seira; Jonai, Sachiko; Hara, Kohjiro; Komaki, Hironori; Shimizu-Kamikawa, Yukiko; Shibata, Hajime; Niki, Shigeru; Kawakami, Yuji; Masuda, Atsushi			Potential-induced degradation of Cu(In,Ga)Se-2 photovoltaic modules	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SILICON SOLAR-CELLS; STACKING-FAULTS; FILM; NA; SHUNTS; PHOTOLUMINESCENCE; EXPLANATION; RECOVERY; LAYERS	Potential-induced degradation (PID) of Cu(In,Ga)Se-2 (CIGS) photovoltaic (PV) modules fabricated from integrated submodules is investigated. PID tests were performed by applying a voltage of -1000V to connected submodule interconnector ribbons at 85 degrees C. The normalized energy conversion efficiency of a standard module decreases to 0.2 after the PID test for 14 days. This reveals that CIGS modules suffer PID under this experimental condition. In contrast, a module with non-alkali glass shows no degradation, which implies that the degradation occurs owing to alkali metal ions, e.g., Na+, migrating from the cover glass. The results of dynamic secondary ion mass spectrometry show Na accumulation in the n-ZnO transparent conductive oxide layer of the degraded module. A CIGS PV module with an ionomer (IO) encapsulant instead of a copolymer of ethylene and vinyl acetate shows no degradation. This reveals that the IO encapsulant can prevent PID of CIGS modules. A degraded module can recover from its performance losses by applying +1000V to connected submodule interconnector ribbons from an Al plate placed on the test module. (C) 2015 The Japan Society of Applied Physics	[Yamaguchi, Seira] JAIST, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan; [Jonai, Sachiko; Hara, Kohjiro; Komaki, Hironori; Shimizu-Kamikawa, Yukiko; Shibata, Hajime; Niki, Shigeru; Masuda, Atsushi] Natl Inst Adv Ind Sci & Technol, Res Ctr Photovolta Technol, Tsukuba, Ibaraki 3058568, Japan; [Kawakami, Yuji] Kurume Natl Coll Technol, Dept Mat Sci & Engn, Kurume, Fukuoka 8308555, Japan	Yamaguchi, S (reprint author), JAIST, Sch Mat Sci, Nomi, Ishikawa 9231292, Japan.	atsushi-masuda@aist.go.jp					Kohara N, 2001, SOL ENERG MAT SOL C, V67, P209, DOI 10.1016/S0927-0248(00)00283-X; Park CH, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.073202; Rockett A, 2000, THIN SOLID FILMS, V372, P212, DOI 10.1016/S0040-6090(00)01028-2; Steingrube S, 2011, J APPL PHYS, V110, DOI 10.1063/1.3607310; Naumann V, 2013, PHYS STATUS SOLIDI-R, V7, P315, DOI 10.1002/pssr.201307090; Naumann V, 2014, SOL ENERG MAT SOL C, V120, P383, DOI 10.1016/j.solmat.2013.06.015; Osinniy V, 2011, SOL ENERG MAT SOL C, V95, P564, DOI 10.1016/j.solmat.2010.09.017; Zhang SB, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.075205; Cojocaru-Miredin O, 2011, IEEE J PHOTOVOLT, V1, P207, DOI 10.1109/JPHOTOV.2011.2170447; Komaki H, 2012, PROG PHOTOVOLTAICS, V20, P595, DOI 10.1002/pip.2172; HALL RN, 1952, PHYS REV, V87, P387, DOI 10.1103/PhysRev.87.387; Caballero R, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3340459; Granath K, 2000, SOL ENERG MAT SOL C, V60, P279, DOI 10.1016/S0927-0248(99)00089-6; Naumann V, 2012, ENRGY PROCED, V27, P1, DOI 10.1016/j.egypro.2012.07.020; Zheng Z, 2013, MAT SCI SEMICON PROC, V16, P647, DOI 10.1016/j.mssp.2012.12.003; Kamikawa-Shimizu Y, 2013, APPL PHYS EXPRESS, V6, DOI 10.7567/APEX.6.112303; Breitenstein O, 2008, PROG PHOTOVOLTAICS, V16, P325, DOI 10.1002/pip.803; Fjallstrom V, 2015, IEEE J PHOTOVOLT, V5, P664, DOI 10.1109/JPHOTOV.2014.2384839; Fjallstrom V, 2013, IEEE J PHOTOVOLT, V3, P1090, DOI 10.1109/JPHOTOV.2013.2253833; Wurfel P, 2007, J APPL PHYS, V101, DOI 10.1063/1.2749201; SHOCKLEY W, 1952, PHYS REV, V87, P835, DOI 10.1103/PhysRev.87.835; [Anonymous], 2010, P 35 IEEE PHOT SPEC; Kasemann M, 2008, PROG PHOTOVOLTAICS, V16, P297, DOI 10.1002/pip.812; Lausch D, 2014, IEEE J PHOTOVOLT, V4, P834, DOI 10.1109/JPHOTOV.2014.2300238; Bauer J, 2012, PHYS STATUS SOLIDI-R, V6, P331, DOI 10.1002/pssr.201206276; Berghold J., 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Bodeg Ard M., 2000, THIN SOLID FILMS, V361-362, P9; Granata J.E., 1997, P 26 IEEE PHOT SPEC, P387; Grove A. S., 1967, PHYS TECHNOL       S, P187; Hacke P., 2013, P 2013 IEEE INT REL, p4B1; Hacke Peter, 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Hacke P., 2011, P 37 IEEE PHOT SPEC, P814; Hara K, 2014, RSC ADV, V4, P44291, DOI 10.1039/c4ra06791f; Hedstrom J., 1993, P 23 IEEE PHOT SPEC, P364; Hara K, 2015, RSC ADV, V5, P15017, DOI 10.1039/c4ra13360a; Koch S., 2012, P 27 EUR PHOT SOL EN, P1991; Koch S., 2012, P 27 EUR PHOT SOL EN; Lausch D, 2014, ENRGY PROCED, V55, P486, DOI 10.1016/j.egypro.2014.08.013; Matson RJ, 1999, AIP CONF PROC, V462, P542; Mishina K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.03CE01; Nagel H., 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Osterwald CR, 2003, SOL ENERG MAT SOL C, V79, P21, DOI 10.1016/S0927-0248(02)00363-X; Powalla M., 2014, P 29 EUR PHOT SOL EN; Schutze Matthias, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Sze S. M., 2006, PHYS SEMICONDUCTOR D, V3rd, P26; Taubitz C., 2012, P 27 EUR PHOT SOL EN, P3172; Naumann V, 2013, ENRGY PROCED, V33, P76, DOI 10.1016/j.egypro.2013.05.042; ZWINGEL D, 1974, SOLID STATE COMMUN, V14, P45, DOI 10.1016/0038-1098(74)90229-4	48	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC13	10.7567/JJAP.54.08KC13		7	Physics, Applied	Physics	CN8BU	WOS:000358662900038		
J	Yamaha, T; Kurosawa, M; Takeuchi, W; Nakatsuka, O; Zaima, S				Yamaha, Takashi; Kurosawa, Masashi; Takeuchi, Wakana; Nakatsuka, Osamu; Zaima, Shigeaki			Growth of Si1-x-ySnxCy ternary alloy layer on Si(001) substrate and characterization of its crystalline properties	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							MOLECULAR-BEAM EPITAXY; MULTIJUNCTION SOLAR-CELLS; SOLID-PHASE EPITAXY; HIGH-EFFICIENCY; SI1-XSNX; CARBON; HETEROSTRUCTURES; SI	We have demonstrated the crystal growth of Si1-x-ySnxCy ternary alloy layers on Si(001) substrates by radio-frequency magnetron sputtering. We have investigated the crystalline properties of the ternary alloy layers and clarified the influence of Sn and C on the crystalline structure of Si1-x-ySnxCy layers. We found that the epitaxial growth temperature of Si1-x-ySnxCy decreased and the island growth was suppressed by the introduction of Sn. The Sn precipitation was also effectively suppressed by C introduction. The substitutional C content of Si1-x-ySnxCy was estimated to be 2.7% and exceeded the thermal equilibrium solid solubility of C into the Si matrix. (C) 2015 The Japan Society of Applied Physics	[Yamaha, Takashi; Kurosawa, Masashi; Takeuchi, Wakana; Nakatsuka, Osamu; Zaima, Shigeaki] Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan; [Yamaha, Takashi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1020083, Japan; [Kurosawa, Masashi; Zaima, Shigeaki] Nagoya Univ, EcoTopia Sci Inst, Nagoya, Aichi 4648603, Japan	Yamaha, T (reprint author), Nagoya Univ, Grad Sch Engn, Dept Crystalline Mat Sci, Nagoya, Aichi 4648603, Japan.	tyamaha@alice.xtal.nagoya-u.ac.jp	KUROSAWA, Masashi/F-4737-2010		Advanced Low Carbon Technology Research and Development (ALCA) program of Japan Science and Technology Agency (JST)	This work was partly supported by the Advanced Low Carbon Technology Research and Development (ALCA) program of the Japan Science and Technology Agency (JST).	Fang YY, 2008, J AM CHEM SOC, V130, P16095, DOI 10.1021/ja806636c; Tonkikh AA, 2014, J CRYST GROWTH, V392, P49, DOI [10.1016/j.jcrysgro.2014.01.047, 10.1016/j.jcrysgro.2013.01.047]; Bauer M, 2007, SEMICOND SCI TECH, V22, pS183, DOI 10.1088/0268-1242/22/1/S43; Green MA, 2012, PROG PHOTOVOLTAICS, V20, P12, DOI 10.1002/pip.2163; Yamaguchi M, 2008, SOL ENERGY, V82, P173, DOI 10.1016/j.solener.2007.06.011; Matsutani R, 2014, PHYS STATUS SOLIDI C, V11, P1718, DOI 10.1002/pssc.201400029; Min KS, 1998, APPL PHYS LETT, V72, P1884, DOI 10.1063/1.121215; Dimroth F, 2007, MRS BULL, V32, P230, DOI 10.1557/mrs2007.27; Fyhn MF, 1999, APPL PHYS A-MATER, V68, P259, DOI 10.1007/s003390050885; Fyhn MF, 1998, J VAC SCI TECHNOL B, V16, P1777, DOI 10.1116/1.590089; Gaiduk PI, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4882175; Guarin FJ, 1996, APPL PHYS LETT, V68, P3608, DOI 10.1063/1.115745; HE G, 1994, APPL PHYS LETT, V65, P1159, DOI 10.1063/1.112127; Kim YJ, 2001, JPN J APPL PHYS 1, V40, P773, DOI 10.1143/JJAP.40.773; LEE HS, 1995, JPN J APPL PHYS 2, V34, pL1340; LIN XW, 1995, J VAC SCI TECHNOL B, V13, P1805, DOI 10.1116/1.587816; Madelung O., 1996, SEMICONDUCTORS BASIC, V2nd, P22; Park SY, 2002, J APPL PHYS, V91, P5716, DOI 10.1063/1.1465122; SHIRYAEV SY, 1995, APPL PHYS LETT, V67, P2287, DOI 10.1063/1.115128; Terasawa K., 2014, 7 INT SIGE TECHN DEV, P179; Yamaha T., 2013, ECS T, V50, P907; Yamaha T., 2014, INT C SOL STAT DEV M, P552	22	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA11	10.7567/JJAP.54.08KA11		5	Physics, Applied	Physics	CN8BU	WOS:000358662900012		
J	Yamamoto, A; Kodama, K; Hasan, MT; Shigekawa, N; Kuzuhara, M				Yamamoto, Akio; Kodama, Kazuki; Hasan, Md. Tanvir; Shigekawa, Naoteru; Kuzuhara, Masaaki			MOVPE growth of thick (similar to 1 mu m) InGaN on AIN/Si substrates for InGaN/Si tandem solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; LAYER THICKNESS; GAN EPILAYER; SI(111); SI; CHALLENGES; FILMS; INN	In order to develop key technologies for InGaN/Si two-junction tandem solar cells, MOVPE growth of thick InGaN on Si p-on-n cell structures has been studied. By clarifying the phase separation behavior of MOVPE InGaN, a thick (similar to 1 mu m) InxGa1-xN (x similar to 0.5) without phase separation is successfully grown on AlN/Si(111) wafers. A sufficient current flow for the operation of the tandem cell is obtained through n-InGaN/AlN/p-Si structures by employing the annealing of AlN/Si wafer at around 1000 degrees C in NH3 flow just before InGaN growth. The annealing of AlN/Si wafers also brings about the degradation of the underlying Si pn junction. The optimization of the annealing conditions is required to balance such favorable and unfavorable effects. (C) 2015 The Japan Society of Applied Physics	[Yamamoto, Akio; Kodama, Kazuki; Hasan, Md. Tanvir; Kuzuhara, Masaaki] Univ Fukui, Fukui 9108507, Japan; [Yamamoto, Akio; Hasan, Md. Tanvir] JST CREST, Chiyoda Ku, Tokyo 1020076, Japan; [Shigekawa, Naoteru] Osaka City Univ, Osaka 5588585, Japan	Yamamoto, A (reprint author), Univ Fukui, Fukui 9108507, Japan.				"Creative research for clean energy generation using solar energy" project in CREST programs of JST, Japan	This work was supported in part by "Creative research for clean energy generation using solar energy" project in CREST programs of JST, Japan.	Ager JW, 2008, IEEE PHOT SPEC CONF, P110; Pereira S, 2002, APPL PHYS LETT, V81, P1207, DOI 10.1063/1.1499220; Bhuiyan AG, 2012, IEEE J PHOTOVOLT, V2, P276, DOI 10.1109/JPHOTOV.2012.2193384; Wu J, 2003, J APPL PHYS, V94, P6477, DOI 10.1063/1.1618353; Wierer JJ, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3301262; Lin KL, 2010, J VAC SCI TECHNOL B, V28, P473, DOI 10.1116/1.3385672; Ubukata A, 2007, J CRYST GROWTH, V298, P198, DOI 10.1016/j.jcrysgro.2006.10.147; Luo WJ, 2008, MICROELECTRON J, V39, P1710, DOI 10.1016/j.mejo.2008.01.042; Zhang BS, 2003, J CRYST GROWTH, V258, P34, DOI 10.1016/S0022-0248(03)01416-7; Bhuiyan AG, 2012, PHYS STATUS SOLIDI C, V9, P670, DOI 10.1002/pssc.201100355; Hsu L, 2008, J APPL PHYS, V104, DOI 10.1063/1.2952031; Okamoto M, 2001, DIAM RELAT MATER, V10, P1322, DOI 10.1016/S0925-9635(00)00597-5; Wongchotigul K, 1996, MATER LETT, V26, P223, DOI 10.1016/0167-577X(95)00225-1; Wu G. M., 2007, J ACHIEV MAT MANUF E, V24, P193; Yamamoto A., 2013, Materials For Renewable and Sustainable Energy, V2, DOI 10.1007/s40243-013-0010-5; Yamamoto A, 2010, PHYS STATUS SOLIDI C, V7, P1309, DOI 10.1002/pssc.200983106; YAMAMOTO A, 1994, J CRYST GROWTH, V137, P415, DOI 10.1016/0022-0248(94)90979-2; Yamamoto A, 2014, APPL PHYS EXPRESS, V7, DOI 10.7567/APEX.7.035502; Yamamoto A, 2015, J CRYST GROWTH, V419, P64, DOI 10.1016/j.jcrysgro.2015.02.100	19	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KA12	10.7567/JJAP.54.08KA12		4	Physics, Applied	Physics	CN8BU	WOS:000358662900013		
J	Yamamoto, K; Adachi, D; Uzu, H; Ichikawa, M; Terashita, T; Meguro, T; Nakanishi, N; Yoshimi, M; Hernandez, JL				Yamamoto, Kenji; Adachi, Daisuke; Uzu, Hisashi; Ichikawa, Mitsuru; Terashita, Toru; Meguro, Tomomi; Nakanishi, Naoaki; Yoshimi, Masashi; Hernandez, Jose Luis			High-efficiency heterojunction crystalline Si solar cell and optical splitting structure fabricated by applying thin-film Si technology	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CONVERSION EFFICIENCY	Thin-film Si technology for solar cells has been developed for over 40 years. Improvements in the conversion efficiency and industrialization of thin-film Si solar cells have been realized through continuous research and development of the thin-film Si technology. The thin-film Si technology covers a wide range of fields such as fundamental understanding of the nature of thin-film Si, cell/module production, simulation, and reliability technologies. These technologies are also significant for solar cells other than the thin-film Si solar cells. Utilizing the highly developed thin-film Si solar cell technology, we have achieved similar to 24% efficiency heterojunction crystalline Si solar cells using 6-in. wafers and >26% efficiency solar cells with an optical splitting structure. These results indicate that further improvement of thin-film Si technology and its synergy with crystalline Si solar cell technology will enable further improvement of solar cells with efficiencies above 26%. (C) 2015 The Japan Society of Applied Physics	[Yamamoto, Kenji; Adachi, Daisuke; Uzu, Hisashi; Ichikawa, Mitsuru; Terashita, Toru; Meguro, Tomomi; Nakanishi, Naoaki; Yoshimi, Masashi] KANEKA Corp, Settsu, Osaka 5660072, Japan; [Yamamoto, Kenji; Hernandez, Jose Luis] KANEKA Belgium NV, B-2260 Westerlo Oevel, Belgium	Yamamoto, K (reprint author), KANEKA Corp, Settsu, Osaka 5660072, Japan.				New Energy and Industrial Technology Development Organization (NEDO) under Ministry of Economy, Trade and Industry of Japan	The authors acknowledge the contribution of the members of the Park laboratory of Sungkyunkwan University in Korea for fabricating the high-performance perovskite solar cells. This work was supported in part by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry of Japan.	McCambridge JD, 2011, PROG PHOTOVOLTAICS, V19, P352, DOI 10.1002/pip.1030; Kim S, 2013, SOL ENERG MAT SOL C, V119, P214, DOI 10.1016/j.solmat.2013.07.011; Holman ZC, 2012, IEEE J PHOTOVOLT, V2, P7, DOI 10.1109/JPHOTOV.2011.2174967; Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; Imenes AG, 2004, SOL ENERG MAT SOL C, V84, P19, DOI 10.1016/j.solmat.2004.01.038; Green MA, 2014, PROG PHOTOVOLTAICS, V22, P701, DOI 10.1002/pip.2525; Im JH, 2011, NANOSCALE, V3, P4088, DOI 10.1039/c1nr10867k; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Jeon NJ, 2014, NAT MATER, V13, P897, DOI [10.1038/nmat4014, 10.1038/NMAT4014]; Barnett A, 2009, PROG PHOTOVOLTAICS, V17, P75, DOI 10.1002/pip.852; Feltrin A, 2013, SOL ENERG MAT SOL C, V119, P219, DOI 10.1016/j.solmat.2013.07.012; Barnett A., 2008, 33 IEEE PHOT SPEC C; Barnett A., 2007, 22 EUR PHOT SOL EN C; De Wolf Stefaan, 2012, Green, V2, DOI 10.1515/green-2011-0018; Herasimenka SY, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4817723; Hernandez J. L., 2012, 27 EUR PHOT SOL EN C; Hernandez JL, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NA04; Hernandez J.L., 2013, 28 EUR PHOT SOL EN C; Im JH, 2014, APL MATER, V2, DOI 10.1063/1.4891275; Meguro T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NB02; Uzu H, 2015, APPL PHYS LETT, V106, DOI 10.1063/1.4905177; Yamamoto K., 2013, 9 WORKSH FUT DIR PHO	22	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD15	10.7567/JJAP.54.08KD15		5	Physics, Applied	Physics	CN8BU	WOS:000358662900060		
J	Yamamoto, K; Sakakima, H; Ogawa, Y; Hosono, A; Okamoto, T; Wada, T				Yamamoto, Koichi; Sakakima, Hiroshi; Ogawa, Yohei; Hosono, Aikyo; Okamoto, Tamotsu; Wada, Takahiro			Fabrication of CdS/CdTe solar cells with transparent p-type conductive BaCuSeF back contact	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							WIDE-BAND-GAP; THIN-FILMS; ELECTRICAL-CONDUCTION; DELAFOSSITE STRUCTURE; GROWTH; DEPOSITION; SRCU2O2; CUALO2; OXIDE	BaCuSeF films were applied to CdS/CdTe solar cells as back electrodes. The interfaces between the CdTe and BaCuSeF layers in the CdS/CdTe solar cells with BaCuSeF back contact deposited at substrate temperatures (TS) of 200 and 300 degrees C were analyzed by transmission electron microscopy (TEM) and energy dispersive X-ray spectroscopy (EDS). We clearly observed many dislocations in the CdTe layer in the CdS/CdTe solar cell with the BaCuSeF layer deposited at T-S = 300 degrees C. We also observed a reaction layer of Cu2.72Te2 between the BaCuSeF and CdTe layers in both solar cells. We concluded that (1) the substrate temperature for the pulsed laser deposition of the BaCuSeF layer and (2) the interface between the CdTe and BaCuSeF layers are important factors for the performance of the CdTe solar cells. We obtained high conversion efficiency of 8.31% for a solar cell with a BaCuSeF layer deposited at T-S = 200 degrees C on a CdTe surface etched in a NH3 aqueous solution. The highest conversion efficiency of 9.91% was obtained for a solar cell with a CdTe surface etched in a bromide-bromate solution. (C) 2015 The Japan Society of Applied Physics	[Yamamoto, Koichi; Sakakima, Hiroshi; Wada, Takahiro] Ryukoku Univ, Dept Mat Chem, Otsu, Shiga 5202194, Japan; [Ogawa, Yohei; Hosono, Aikyo; Okamoto, Tamotsu] Kisarazu Natl Coll Technol, Kisarazu, Chiba 2920041, Japan	Yamamoto, K (reprint author), Ryukoku Univ, Dept Mat Chem, Otsu, Shiga 5202194, Japan.	twada@rins.ryukoku.ac.jp			Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI)	This work was in part supported by the Incorporated Administrative Agency New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI). We thank Professor Nozomu Tsuboi of Niigata University for his advice about measurement of J-V curves of CdS/CdTe solar cells.	Wu X, 2007, THIN SOLID FILMS, V515, P5798, DOI 10.1016/j.tsf.2006.12.151; Okamoto T, 2001, SOL ENERG MAT SOL C, V67, P187, DOI 10.1016/S0927-0248(00)00280-4; Jayaraj MK, 2001, THIN SOLID FILMS, V397, P244, DOI 10.1016/S0040-6090(01)01362-1; Yanagi H, 2003, APPL PHYS LETT, V82, P2814, DOI 10.1063/1.1571224; Kaigawa R, 2010, SOL ENERG MAT SOL C, V94, P1880, DOI 10.1016/j.solmat.2010.06.029; Nagarajan R, 2001, J APPL PHYS, V89, P8022, DOI 10.1063/1.1372636; Nishiwaki S, 2003, PROG PHOTOVOLTAICS, V11, P243, DOI 10.1002/pip.486; Kudo A, 1998, APPL PHYS LETT, V73, P220, DOI 10.1063/1.121761; Duan N, 2000, APPL PHYS LETT, V77, P1325, DOI 10.1063/1.1289906; Nagarajan R, 2001, INT J INORG MATER, V3, P265, DOI 10.1016/S1466-6049(01)00006-X; Kawazoe H, 1997, NATURE, V389, P939, DOI 10.1038/40087; Ueda K, 2001, J APPL PHYS, V89, P1790, DOI 10.1063/1.1337587; Tate J, 2008, THIN SOLID FILMS, V516, P5795, DOI 10.1016/j.tsf.2007.10.073; Ginley D, 2003, THIN SOLID FILMS, V445, P193, DOI 10.1016/j.tsf.2003.08.008; Yanagi H, 2000, J APPL PHYS, V88, P4159, DOI 10.1063/1.1308103; Deschanvres JL, 2008, PHYS STATUS SOLIDI A, V205, P2013, DOI 10.1002/pssa.200778920; Hiramatsu H, 2003, J APPL PHYS, V94, P5805, DOI 10.1063/1.1618932; Hiramatsu H, 2002, THIN SOLID FILMS, V411, P125, DOI 10.1016/S0040-6090(02)00200-6; Luo GC, 2014, INT J PHOTOENERGY, DOI 10.1155/2014/762576; Nakada T., 2006, P 4 WORLD C PHOT EN, P400; Okamoto T, 2013, JPN J APPL PHYS, V52, DOI 10.7567/JJAP.52.102301; Park CH, 2007, J SOLID STATE CHEM, V180, P1672, DOI 10.1016/j.jssc.2007.03.021; Tsuji M, 2000, JPN J APPL PHYS 1, V39, P3902, DOI 10.1143/JJAP.39.3902; Yamamoto K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FX02; Yamazoe S, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC40; Yanagi H, 2001, APPL PHYS LETT, V78, P1583, DOI 10.1063/1.1355673	26	1	1	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC01	10.7567/JJAP.54.08KC01		4	Physics, Applied	Physics	CN8BU	WOS:000358662900026		
J	Yamamoto, K; Kuwabara, T; Takahashi, K; Taima, T				Yamamoto, Kouhei; Kuwabara, Takayuki; Takahashi, Kohshin; Taima, Tetsuya			Study of planar heterojunction perovskite photovoltaic cells using compact titanium oxide by chemical bath deposition	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							ORGANOMETAL HALIDE PEROVSKITES; SOLAR-CELLS; EFFICIENT; HYSTERESIS; LIGHT; LAYER	Spin-coated perovskite solar cells from sol-gels result in high processing costs because of the need for high temperatures. Here, we report a low-temperature spin-coating route to fabricate planar heterojunction perovskite solar cells using chemical bath deposition of compact-TiOx layers. Comparison of the solar cell properties of compact-TiOx and compact-TiO2 layers show that the power conversion efficiency of the planar heterojunction perovskite solar cell fabricated by the low-temperature, compact-TiOx route is comparable to that of conventional TiO2. The chemical bath deposition method requires heating to 150 degrees C only to form amorphous compact-TiOx films compared with the 450 degrees C required for crystalline anatase compact-TiO2 films. (C) 2015 The Japan Society of Applied Physics	[Yamamoto, Kouhei; Kuwabara, Takayuki; Takahashi, Kohshin; Taima, Tetsuya] Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan; [Kuwabara, Takayuki; Takahashi, Kohshin; Taima, Tetsuya] Kanazawa Univ, Res Ctr Sustainable Energy & Technol, Kanazawa, Ishikawa 9201192, Japan; [Taima, Tetsuya] Japan Sci & Technol Agcy, JST PRESTO, Kawaguchi, Saitama 3320012, Japan	Yamamoto, K (reprint author), Kanazawa Univ, Grad Sch Nat Sci & Technol, Kanazawa, Ishikawa 9201192, Japan.	taima@se.kanazawa-u.ac.jp	TAKAHASHI, Kohshin/L-3519-2015; Kuwabara, Takayuki/C-3424-2015	TAKAHASHI, Kohshin/0000-0001-8659-4054; 	Precursory Research for Embryonic Science and Technology (PRESTO) program from the Japan Science and Technology Agency (JST)	This work was supported by the Precursory Research for Embryonic Science and Technology (PRESTO) program from the Japan Science and Technology Agency (JST).	Noh JH, 2013, NANO LETT, V13, P1764, DOI 10.1021/nl400349b; You JB, 2014, ACS NANO, V8, P1674, DOI 10.1021/nn406020d; Kojima A, 2009, J AM CHEM SOC, V131, P6050, DOI 10.1021/ja809598r; Chen Q, 2014, J AM CHEM SOC, V136, P622, DOI 10.1021/ja411509g; Green MA, 2014, NAT PHOTONICS, V8, P506, DOI [10.1038/nphoton.2014.134, 10.1038/NPHOTON.2014.134]; Burschka J, 2013, NATURE, V499, P316, DOI 10.1038/nature12340; Wojciechowski K, 2014, ENERG ENVIRON SCI, V7, P1142, DOI 10.1039/c3ee43707h; Gao P, 2014, ENERG ENVIRON SCI, V7, P2448, DOI 10.1039/c4ee00942h; Qin P, 2014, NANOSCALE, V6, P1508, DOI 10.1039/c3nr05884k; Kuwabara T, 2010, ORG ELECTRON, V11, P1136, DOI 10.1016/j.orgel.2010.04.008; Kim HS, 2014, J PHYS CHEM LETT, V5, P2927, DOI 10.1021/jz501392m; Zhou HP, 2014, SCIENCE, V345, P542, DOI 10.1126/science.1254050; Kuwabara T, 2009, THIN SOLID FILMS, V517, P3766, DOI 10.1016/j.tsf.2008.12.039; Yella A, 2014, NANO LETT, V14, P2591, DOI 10.1021/nl500399m; Snaith HJ, 2014, J PHYS CHEM LETT, V5, P1511, DOI 10.1021/jz500113x; Lee MM, 2012, SCIENCE, V338, P643, DOI 10.1126/science.1228604; Noh JH, 2013, J MATER CHEM A, V1, P11842, DOI 10.1039/c3ta12681a; Liu MZ, 2013, NATURE, V501, P395, DOI 10.1038/nature12509; Wakamiya A, 2014, CHEM LETT, V43, P711, DOI 10.1246/cl.140074; Kim JY, 2006, ADV MATER, V18, P572, DOI 10.1002/adma.200501825; Dualeh A, 2014, ACS NANO, V8, P362, DOI 10.1021/nn404323g; Heo JH, 2013, NAT PHOTONICS, V7, P487, DOI 10.1038/NPHOTON.2013.80; Kim HS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00591; Lotsch BV, 2014, ANGEW CHEM INT EDIT, V53, P635, DOI 10.1002/anie.201309368	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KF02	10.7567/JJAP.54.08KF02		3	Physics, Applied	Physics	CN8BU	WOS:000358662900082		
J	Yamamoto, T; Negami, T; Matsubara, K; Niki, S				Yamamoto, Teruaki; Negami, Takayuki; Matsubara, Koji; Niki, Shigeru			Wide-gap solar cells using a novel ZnCuGaSe2 absorber	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							PULSED-LASER DEPOSITION; THIN-FILMS; BAND-GAP; GROWTH; EFFICIENCY; INTERFACE; VOLTAGE	We successfully prepared ZnCuGaSe2 (Zn2xCu1-xGa1-xSe2, ZCGSe) thin films as a novel wide-gap absorber for a top cell. The bandgap of ZCGSe films was controlled from 1.66 to 1.80 eV by incorporating Zn into CuGaSe2 (CGSe, x from 0 to 0.4). The X-ray diffraction (XRD) peaks of ZCGSe films with the Zn/(Zn + Cu + Ga) (Zn/Metal) ratio of the film of less than 0.3 were similar to those of CGSe, and impurity phases such as Ga2Se3 and ZnSe were not observed. However, the peaks related to ZnSe were observed in the film with the Zn/Metal ratio of 0.4. Current-voltage (I-V) characteristics showed that efficiencies were almost the same at the Zn/Metal ratio of the films from 0.1 to 0.3. The open-circuit voltage (V-OC) increased to 0.91 V with increasing Zn/Metal ratio of the film. However, the efficiency and short-circuit current density (J(SC)) steeply decreased when the Zn/Metal ratio of the film was more than 0.35. The elemental depth profiles and the electron-beam-induced current (EBIC) images showed that carriers excited in a Zn-rich layer near the surface were recombined in the film with the bulk Zn/Metal ratio of 0.4. These results suggest that the upper Zn-rich layer consists of n-type ZnSe and the JSC is decreased owing to carrier recombination. The best cell performance obtained was an efficiency of 9.0% (V-OC = 0.90V, J(SC) = 15.3mA/cm(2), FF = 0.65) achieved by the ZCGSe solar cell with the bandgap of 1.7 eV without an anti-reflection (AR) coating at the Zn/Metal ratio of 0.3. (C) 2015 The Japan Society of Applied Physics	[Yamamoto, Teruaki; Negami, Takayuki] Panason Corp, Kadoma, Osaka 5718501, Japan; [Matsubara, Koji; Niki, Shigeru] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058568, Japan	Yamamoto, T (reprint author), Panason Corp, Kadoma, Osaka 5718501, Japan.	yamamoto.teruaki@jp.panasonic.com			New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI)	This work was supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry (METI).	Schorr S, 2006, J ALLOY COMPD, V414, P26, DOI 10.1016/j.jallcom.2005.07.014; Young DL, 2003, PROG PHOTOVOLTAICS, V11, P535, DOI 10.1002/pip.516; Ishizuka S, 2014, PROG PHOTOVOLTAICS, V22, P821, DOI 10.1002/pip.2464; Rao KG, 2013, MAT SCI SEMICON PROC, V16, P269, DOI 10.1016/j.mssp.2012.10.015; Bente K., 1991, CHEM ERDE-GEOCHEM, V51, P291; Braunger D., 1996, P 25 IEEE PHOT SPEC, P1001; Caballero R, 2007, MATER RES SOC SYMP P, V1012, P469; DENEUVILLE A, 1991, APPL SURF SCI, V50, P285, DOI 10.1016/0169-4332(91)90183-K; Ishizuka S, 2013, APPL PHYS LETT, V103, DOI 10.1063/1.4823585; Ishizuka S, 2014, APPL PHYS LETT, V104, DOI 10.1063/1.4861858; LAMBRECH.VG, 1973, MATER RES BULL, V8, P1383, DOI 10.1016/0025-5408(73)90022-6; Luck I., 1996, CRYST RES TECHNOL, V31, P841; Negami T., 2010, P 3 INT S INN SOL CE, P180; Neumann H., 1981, OPTOELECTRONIC MAT D, P174; Noma T., 2001, ADV XRAY ANAL, V45, P359; Orsal G, 2001, THIN SOLID FILMS, V387, P198, DOI 10.1016/S0040-6090(00)01835-6; Saad M, 1996, APPL PHYS A-MATER, V62, P181; Saad M, 2011, SOL ENERG MAT SOL C, V95, P1927, DOI 10.1016/j.solmat.2011.02.022; Schmidt SS, 2011, J APPL PHYS, V110, DOI 10.1063/1.3639284; Strok OM, 2013, J PHASE EQUILIB DIFF, V34, P94, DOI 10.1007/s11669-013-0188-3; Takei K, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.05FW07; Wagner G, 2005, J SOLID STATE CHEM, V178, P3631, DOI 10.1016/j.jssc.2005.09.009; Wagner G, 2000, THIN SOLID FILMS, V376, P82, DOI 10.1016/S0040-6090(00)01412-7; Wagner G, 2000, THIN SOLID FILMS, V358, P80, DOI 10.1016/S0040-6090(99)00663-X; Walter T, 1996, SOL ENERG MAT SOL C, V41-2, P355, DOI 10.1016/0927-0248(95)00103-4; Wibowo RA, 2009, SOL ENERG MAT SOL C, V93, P941, DOI 10.1016/j.solmat.2008.11.020; Wolfframm D, 2000, J CRYST GROWTH, V216, P119, DOI 10.1016/S0022-0248(00)00401-2; Yamamoto T., 2015, PHYS STATUS SOLIDI C, V12, P769; Yamamoto Teruaki, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Yamamoto T, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.10NC06	30	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC17	10.7567/JJAP.54.08KC17		5	Physics, Applied	Physics	CN8BU	WOS:000358662900042		
J	Yamashita, Y; Ikeno, N; Tachibana, T; Ohshita, Y; Ogura, A				Yamashita, Yoshihiro; Ikeno, Norihiro; Tachibana, Tomihisa; Ohshita, Yoshio; Ogura, Atsushi			X-ray evaluation of electronic and chemical properties and film structures in SiN passivation layer on crystalline Si solar cells	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							FIELD-EFFECT PASSIVATION; SURFACE PASSIVATION; DEPOSITED AL2O3; SILICON-NITRIDE; RECOMBINATION; INTERFACE	We investigated the electronic chemical properties and film structures in SiN passivation layers on crystalline Si by X-ray photoelectron spectroscopy (XPS) and X-ray reflectometry (XRR). From XPS analyses, a N-rich component (N-Si-N) and oxygen mixing were observed at the interface. The longest lifetime was obtained after post deposition annealing at 600 degrees C, where the N-rich layer was the thinnest with small peak height. Therefore, longer lifetime could be obtained as the N concentration at the interface decreased. The film consisted of three SiN layers and one SiO2 layer, as confirmed by XRR profile fitting. From the density profiles, a longer lifetime was obtained when the density gradient in the oxygen mixing layer was small. Results of XPS and XRR suggested that N at the interface significantly affected the lifetime. We believe it is important to understand the electronic chemical properties at the passivation interface to realize high-efficiency Si solar cells. (C) 2015 The Japan Society of Applied Physics	[Yamashita, Yoshihiro; Ikeno, Norihiro; Ogura, Atsushi] Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan; [Tachibana, Tomihisa; Ohshita, Yoshio] Toyota Technol Inst, Nagoya, Aichi 4688511, Japan	Yamashita, Y (reprint author), Meiji Univ, Sch Sci & Technol, Kawasaki, Kanagawa 2148571, Japan.	ce41099@meiji.ac.jp; a_ogura@meiji.ac.jp			New Energy and Industrial Technology Development Organization (NEDO) under Ministry of Economy, Trade and Industry	We appreciate Professor H. Yoshida for his help in C-V measurements. This work is partly supported by the New Energy and Industrial Technology Development Organization (NEDO) under the Ministry of Economy, Trade and Industry. The HAXPES measurements were performed at SPring-8 (No. SP82014B1938).	ABERLE AG, 1993, SOL ENERG MAT SOL C, V29, P175, DOI 10.1016/0927-0248(93)90075-E; Zielke D, 2011, PHYS STATUS SOLIDI-R, V5, P298, DOI 10.1002/pssr.201105285; Aberle AG, 2001, SOL ENERG MAT SOL C, V65, P239, DOI 10.1016/S0927-0248(00)00099-4; Hoex B, 2006, APPL PHYS LETT, V89, DOI 10.1063/1.2240736; Terlinden NM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3334729; Wolden CA, 2011, J VAC SCI TECHNOL A, V29, DOI 10.1116/1.3569757; Schmidt J, 2008, PROG PHOTOVOLTAICS, V16, P461, DOI 10.1002/pip.823; Leguijt C, 1996, SOL ENERG MAT SOL C, V40, P297, DOI 10.1016/0927-0248(95)00155-7; Hoex B, 2008, J APPL PHYS, V104, DOI 10.1063/1.2963707; Kerr MJ, 2002, SEMICOND SCI TECH, V17, P166, DOI 10.1088/0268-1242/17/2/314; Glunz SW, 1999, J APPL PHYS, V86, P683, DOI 10.1063/1.370784; Miyajima S, 2010, APPL PHYS EXPRESS, V3, DOI 10.1143/APEX.3.012301; Gatz S, 2011, PHYS STATUS SOLIDI-R, V5, P147, DOI 10.1002/pssr.201105045; Benick J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945287; Schmidt J, 1999, J APPL PHYS, V85, P3626, DOI 10.1063/1.369725; Petermann JH, 2012, PROG PHOTOVOLTAICS, V20, P1, DOI 10.1002/pip.1129; De Wolf S, 2005, J APPL PHYS, V97, DOI 10.1063/1.1861138; Butler KT, 2012, J APPL PHYS, V112, DOI 10.1063/1.4764012; Dingemans G, 2012, J VAC SCI TECHNOL A, V30, DOI 10.1116/1.4728205; Gall S., 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Green MA, 2009, APPL PHYS A-MATER, V96, P153, DOI 10.1007/s00339-009-5090-9; Grover S, 2013, IEEE J PHOTOVOLT, V3, P230, DOI 10.1109/JPHOTOV.2012.2223455; Henley F. J., 2010, P IEEE 35 PHOT SPEC; KARCHER R, 1984, PHYS REV B, V30, P1896, DOI 10.1103/PhysRevB.30.1896; Keipert-Colberg Sinje, 2011, Proceedings of the 26th European International Conference on Photovoltaic Solar Energy; Lee H, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3701280; Mishina K., 2013, P 28 EUR PHOT SOL EN, P2044; Olibet S, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.035326; PAVLYAK F, 1993, SURF INTERFACE ANAL, V20, P221, DOI 10.1002/sia.740200306; Suzuki Hidenori, 2010, Proceedings of the 25th European Photovoltaic Solar Energy Conference and Exhibition and the 5th World Conference on Photovoltaic Energy Conversion; Yamashita Y., 2014, 6 WORLD C PHOT EN CO	31	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD14	10.7567/JJAP.54.08KD14		4	Physics, Applied	Physics	CN8BU	WOS:000358662900059		
J	Yeh, WC; Matsumoto, A; Sugihara, K				Yeh, Wenchang; Matsumoto, Akihiro; Sugihara, Keisuke			Sputter epitaxy of heavily doped p(+)/n(+) Ge film on Si(100) by cosputtering with Al/Sb for solar cell application	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							CHEMICAL-VAPOR-DEPOSITION; SI PHOTODETECTORS; SILICON 001; GERMANIUM; GROWTH	Heavily doped p(+) or n(+) Ge films were grown on Si substrates by sputter epitaxy. Ge was cosputtered with Al or Sb to add dopant impurities. The maximum carrier densities were 1.0 x 10(21) for p-type films and 8.4 x 10(19) cm(-3) for n-type films. The activation ratio of Sb was 56%. A pn junction diode was fabricated on a Si(100) substrate; it exhibited a good rectifying property with an on/off ratio of 529. (C) 2015 The Japan Society of Applied Physics	[Yeh, Wenchang; Matsumoto, Akihiro; Sugihara, Keisuke] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan	Yeh, WC (reprint author), Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan.	yeh@riko.shimane-u.ac.jp			JST through ALCA project	We thank JST for their financial support through the ALCA project.	Michel J, 2010, NAT PHOTONICS, V4, P527, DOI [10.1038/NPHOTON.2010.157, 10.1038/nphoton.2010.157]; CUNNINGHAM B, 1991, APPL PHYS LETT, V59, P3574, DOI 10.1063/1.105636; BROWN DM, 1962, PHYS REV, V127, P1593, DOI 10.1103/PhysRev.127.1593; Oehme M, 2008, J CRYST GROWTH, V310, P4531, DOI 10.1016/j.jcrysgro.2008.08.018; Tan YH, 2012, THIN SOLID FILMS, V520, P2711, DOI 10.1016/j.tsf.2011.11.046; BAJOR G, 1982, APPL PHYS LETT, V40, P696, DOI 10.1063/1.93239; Luan HC, 1999, APPL PHYS LETT, V75, P2909, DOI 10.1063/1.125187; Sorianello V, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4747213; Schmidt OG, 2001, IEEE T ELECTRON DEV, V48, P1175, DOI 10.1109/16.925244; Bandaru PR, 2004, MAT SCI ENG B-SOLID, V113, P79, DOI 10.1016/j.mseb.2004.07.007; CERDEIRA F, 1972, PHYS REV B, V5, P580, DOI 10.1103/PhysRevB.5.580; CLAEYS C, 2007, GERMANIUM BASED TECH; Fistul V., 2004, IMPURITIES SEMICONDU, P157; Hartmann JM, 2008, J CRYST GROWTH, V310, P5287, DOI 10.1016/j.jcrysgro.2008.08.062; Huang H, 2009, ELECTROCHEM SOLID ST, V12, pH67, DOI 10.1149/1.3054285; HUNG CS, 1954, PHYS REV, V96, P1226, DOI 10.1103/PhysRev.96.1226; OHMI T, 1988, APPL PHYS LETT, V53, P45, DOI 10.1063/1.100121; Yeh W., 2011, 58 SPRING M JAP SOC; Yeh W, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.025502; Yeh W, 2014, ECS J SOLID STATE SC, V3, pQ195, DOI 10.1149/2.0091410jss	20	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD08	10.7567/JJAP.54.08KD08		4	Physics, Applied	Physics	CN8BU	WOS:000358662900053		
J	Yeh, W; Wasa, T				Yeh, Wenchang; Wasa, Takuya			Single-crystal Si solar cells with pulsed-DC sputtered SiNx:H anti-reflection film and phosphoric-acid-diffused n(+) emitter	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							SURFACE PASSIVATION; SILICON-NITRIDE; EFFICIENCY; QUALITY; OXIDE	A low-environmental-load single-crystal Si solar-cell fabrication method was demonstrated, in which SiNx:H anti-reflection film was formed using a pulsed-DC reactive sputtering method with Ar and a forming gas (FG: 3.8% H-2 in N-2), and an n(+) emitter was created using thermal diffusion of diluted phosphoric acid. In the SiNx: H film, it was shown that both exposure of the Si surface to FG plasma and FG annealing of the SiNx:H film dramatically decreased the surface recombination velocity, S, of the Si substrate, because of an improved Si/SiNx:H interface. The interface state density was found to be 2.1 x 10(11) cm(-2).eV(-1) and the minimum S was 72 cm.s(-1); these values are comparable to those obtained using the plasma-enhanced chemical vapor deposition method. The characteristics of the fabricated solar cells were: a short-circuit current of 38.1 A.cm(-2), open-circuit voltage of 594.6V, fill factor of 73.8, and an energy conversion efficiency of 16.7%. (C) 2015 The Japan Society of Applied Physics	[Yeh, Wenchang; Wasa, Takuya] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan	Yeh, WC (reprint author), Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan.	yeh@riko.shimane-u.ac.jp					Hoex B, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2784168; Tang YH, 2013, SOL ENERGY, V95, P265, DOI 10.1016/j.solener.2013.04.024; Masuko K, 2014, IEEE J PHOTOVOLT, V4, P1433, DOI 10.1109/JPHOTOV.2014.2352151; KOUSIK GS, 1992, J APPL PHYS, V72, P141, DOI 10.1063/1.352174; Karunagaran B, 2007, MATER CHEM PHYS, V106, P130, DOI 10.1016/j.matchemphys.2007.05.028; Vetter M, 1999, THIN SOLID FILMS, V337, P118, DOI 10.1016/S0040-6090(98)01195-X; Kerr MJ, 2001, J APPL PHYS, V89, P3821, DOI 10.1063/1.1350633; Bouhafs D, 2006, THIN SOLID FILMS, V510, P325, DOI 10.1016/j.tsf.2006.01.005; Duerinckx F, 2002, SOL ENERG MAT SOL C, V72, P231, DOI 10.1016/S0927-0248(01)00170-2; Sinton RA, 1996, APPL PHYS LETT, V69, P2510, DOI 10.1063/1.117723; Zhao JH, 1999, PROG PHOTOVOLTAICS, V7, P471, DOI 10.1002/(SICI)1099-159X(199911/12)7:6<471::AID-PIP298>3.0.CO;2-7; Benick J, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2945287; Papet P, 2006, SOL ENERG MAT SOL C, V90, P2319, DOI 10.1016/j.solmat.2006.03.005; LAMMERT MD, 1977, IEEE T ELECTRON DEV, V24, P337, DOI 10.1109/T-ED.1977.18738; Fellmeth T, 2011, IEEE ELECTR DEVICE L, V32, P1101, DOI 10.1109/LED.2011.2157656; Bateman N, 2011, ENRGY PROCED, V8, P509, DOI 10.1016/j.egypro.2011.06.174; Cuevas A, 2003, PROCEEDINGS OF 3RD WORLD CONFERENCE ON PHOTOVOLTAIC ENERGY CONVERSION, VOLS A-C, P913; Huang H, 2009, ELECTROCHEM SOLID ST, V12, pH67, DOI 10.1149/1.3054285; Jana T, 2002, SOL ENERG MAT SOL C, V71, P197, DOI 10.1016/S0927-0248(01)00058-7; Do Kim Y, 2011, SOL ENERG MAT SOL C, V95, P73, DOI 10.1016/j.solmat.2010.04.049; Kumar D., 2011, P 37 IEEE PHOT SPEC; MANDELKORN J, 1962, J ELECTROCHEM SOC, V109, P313, DOI 10.1149/1.2425407; Nagel H., 1997, P 14 EUR PHOT SOL EN, P762; Ralph E.L., 1975, P 11 IEEE PHOT SPEC, P315; Rattanapan S, 2010, CURR APPL PHYS, V10, pS215, DOI 10.1016/j.cap.2009.11.021; Sze S. M., 1981, PHYSICS SEMICONDUCTO, P381; Sze S. M., 1981, PHYSICS SEMICONDUCTO, P794; Wolke W., 2004, P 19 EUR PHOT SOL EN, P419; Yeh W, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.025502	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KD05	10.7567/JJAP.54.08KD05		6	Physics, Applied	Physics	CN8BU	WOS:000358662900050		
J	Yeh, WC; Tatebe, K				Yeh, Wenchang; Tatebe, Kyohei			Single-crystal p-i-n-Si thin-film solar cells grown on Si substrate by sputter epitaxy	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							TEMPERATURE SILICON EPITAXY; MOLECULAR-BEAM EPITAXY; INDUCED CRYSTALLIZATION; VAPOR-DEPOSITION	An intrinsic sputter-epitaxial (SE) Si film with a thickness of 1000 nm and a 50-nm-thick n(+) SE-Si film were successfully grown as the light-absorbing layer and emitter layer, respectively, on a heavily doped p-Si(100) wafer to form the p-i-n junction of a solar cell (SC). Heavily doped n(+) SE-Si with an electron concentration n of 3 x 10(20) cm(-3) was grown by cosputtering of Sb with Si. The characteristics of SE-Si grown at 310 degrees C was investigated in relation to annealing temperature. The oxygen concentration in SE-Si was similar to 10(18) cm(-3), which was found to originate from the gas released in the chamber. Oxygen-induced thermal donors then became the source of n in the film, and n was reduced to 1 x 10(16) cm(-3) after forming-gas annealing at 700 degrees C because the thermal donors were neutralized by hydrogen. The SC exhibited a maximum internal quantum efficiency of 73.7%. (C) 2015 The Japan Society of Applied Physics	[Yeh, Wenchang; Tatebe, Kyohei] Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan	Yeh, WC (reprint author), Shimane Univ, Interdisciplinary Grad Sch Sci & Engn, Matsue, Shimane 6908504, Japan.	yeh@riko.shimane-u.ac.jp			ALCA project of Japan Science and Technology Agency (JST)	We thank the ALCA project of Japan Science and Technology Agency (JST) for its financial support.	Alsema EA, 2000, PROG PHOTOVOLTAICS, V8, P17, DOI 10.1002/(SICI)1099-159X(200001/02)8:1<17::AID-PIP295>3.0.CO;2-C; HOBART KD, 1995, SURF SCI, V334, P29, DOI 10.1016/0039-6028(95)00435-1; Smith M, 2005, J CRYST GROWTH, V285, P249, DOI 10.1016/j.jcrysgro.2005.08.033; Pecz B, 2005, APPL SURF SCI, V242, P185, DOI 10.1016/j.apsusc.2004.08.015; Amkreutz D, 2011, PROG PHOTOVOLTAICS, V19, P937, DOI 10.1002/pip.1098; Becker C, 2013, SOL ENERG MAT SOL C, V119, P112, DOI 10.1016/j.solmat.2013.05.043; GREEN MA, 1995, PROG PHOTOVOLTAICS, V3, P189, DOI 10.1002/pip.4670030303; Gordon I, 2007, PROG PHOTOVOLTAICS, V15, P575, DOI 10.1002/pip.765; Dore J., 2013, IEEE J PHOTOVOLT, V4, P33; Endo Y, 2010, THIN SOLID FILMS, V518, P5003, DOI 10.1016/j.tsf.2010.03.008; Fujita Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.02BH05; Huang H., 2007, THESIS NATL TAIWAN U; Huang H, 2009, ELECTROCHEM SOLID ST, V12, pH67, DOI 10.1149/1.3054285; IRVIN JC, 1962, AT&T TECH J, V41, P387; JOHNSON NM, 1986, APPL PHYS LETT, V48, P709, DOI 10.1063/1.96697; MALIK R, 1995, J CRYST GROWTH, V150, P984, DOI 10.1016/0022-0248(95)80087-S; Morikawa H, 1998, SOL ENERG MAT SOL C, V53, P23, DOI 10.1016/S0927-0248(98)00003-8; OHMI T, 1988, APPL PHYS LETT, V53, P45, DOI 10.1063/1.100121; RADAMSON HH, 1994, J APPL PHYS, V76, P763, DOI 10.1063/1.357778; STEIN HJ, 1986, J APPL PHYS, V59, P3495, DOI 10.1063/1.336820; Sze S. M., 1981, PHYSICS SEMICONDUCTO, V2nd, P69; Sze S. M., 1981, PHYSICS SEMICONDUCTO, P794; Thiesen J, 1999, APPL PHYS LETT, V75, P992, DOI 10.1063/1.124576; THOMSEN EV, 1994, J VAC SCI TECHNOL B, V12, P3016, DOI 10.1116/1.587552; WEIR BE, 1991, APPL PHYS LETT, V59, P204, DOI 10.1063/1.105966; YAMADA A, 1995, J ELECTRON MATER, V24, P1511, DOI 10.1007/BF02655470; Yeh W., 2011, 58 SPRING M JAP SOC; Yeh W, 2014, JPN J APPL PHYS, V53, DOI 10.7567/JJAP.53.025502; Yeh W, 2014, ECS J SOLID STATE SC, V3, pQ195, DOI 10.1149/2.0091410jss	29	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KB07	10.7567/JJAP.54.08KB07		5	Physics, Applied	Physics	CN8BU	WOS:000358662900021		
J	Zhang, YW; Suyama, N; Goto, M; Kuwana, J; Sugimoto, K; Satake, T; Kurokawa, Y; Yin, M; Yamada, A				Zhang, Yiwen; Suyama, Naoki; Goto, Masanori; Kuwana, Jun; Sugimoto, Kanta; Satake, Tetsuo; Kurokawa, Yasuyoshi; Yin, Ming; Yamada, Akira			Microstructural characterization of Cu2ZnSn(S,Se)(4) solar cells fabricated from nanoparticles	JAPANESE JOURNAL OF APPLIED PHYSICS			English	Article							THIN-FILMS	We characterized the microstructure of Cu2ZnSn(S,Se)(4) (CZTSSe) solar cells fabricated from Cu-poor, Zn-rich Cu2ZnSnSe4 (CZTSe) nanoparticles. Various sintering atmospheres of sulfur and selenium led to different microstructural properties. For the samples sintered under sulfur atmosphere, a large number of ZnS secondary phases were observed and the Zn/Sn ratio of the grains was significantly lower than 1. Regions of the ZnS secondary phases showed a dark contrast in electron-beam-induced current (EBIC) images, indicating that the existence of the ZnS phases reduced the minority carrier collection efficiency. In contrast, for the samples sintered under selenium atmosphere, Cu was found to accumulate near the grain boundaries to form the Cu-rich CZTSe phases and only a small number of ZnSe secondary phases were detected. (C) 2015 The Japan Society of Applied Physics	[Zhang, Yiwen; Satake, Tetsuo; Yin, Ming] Toppan Printing Co Ltd, Tech Res Inst, Sugito, Saitama 3458508, Japan; [Suyama, Naoki; Goto, Masanori; Kuwana, Jun; Sugimoto, Kanta; Kurokawa, Yasuyoshi; Yamada, Akira] Tokyo Inst Technol, Dept Phys Elect, Meguro Ku, Tokyo 1528552, Japan	Zhang, YW (reprint author), Toppan Printing Co Ltd, Tech Res Inst, Sugito, Saitama 3458508, Japan.	iuen.cho@toppan.co.jp	Kurokawa, Yasuyoshi/P-1057-2014		Japan Science and Technology Agency, Advanced Low Carbon Technology Research and Development Program	This research was partially supported by the Japan Science and Technology Agency, Advanced Low Carbon Technology Research and Development Program.	Hsieh TP, 2011, SOLID STATE ELECTRON, V56, P175, DOI 10.1016/j.sse.2010.11.019; Hegedus SS, 2004, PROG PHOTOVOLTAICS, V12, P155, DOI 10.1002/pip.518; Wang W, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301465; Guo Q, 2010, J AM CHEM SOC, V132, P17384, DOI 10.1021/ja108427b; Mitzi DB, 2011, SOL ENERG MAT SOL C, V95, P1421, DOI 10.1016/j.solmat.2010.11.028; Shin B, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4740276; Hsu CJ, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301287; Chen SY, 2010, PHYS REV B, V81, DOI 10.1103/PhysRevB.81.245204; Wada T, 1997, J MATER RES, V12, P1456, DOI 10.1557/JMR.1997.0200; Cao YY, 2012, J AM CHEM SOC, V134, P15644, DOI 10.1021/ja3057985; Redinger A, 2011, J AM CHEM SOC, V133, P3320, DOI 10.1021/ja111713g; Olekseyuk ID, 2004, J ALLOY COMPD, V368, P135, DOI 10.1016/j.jallcom.2003.08.084; Guo QJ, 2009, J AM CHEM SOC, V131, P11672, DOI 10.1021/ja904981r; Chen SY, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3275796; Jiang F, 2014, ADV ENERGY MATER, V4, DOI 10.1002/aenm.201301381; Katagiri H., THIN SOLID FILMS, V517, P2455; Kato T., 2013, P 27 EUR PHOT SOL EN, P2236; Maeda K, 2011, JPN J APPL PHYS, V50, DOI 10.1143/JJAP.50.05FB08; ITO K, 1988, JPN J APPL PHYS 1, V27, P2094, DOI 10.1143/JJAP.27.2094; Weber A, 2010, J APPL PHYS, V107, DOI 10.1063/1.3273495; Zeng X, 2014, SOL ENERG MAT SOL C, V124, P55, DOI 10.1016/j.soimat.2014.01.029; Zhang YW, 2012, APPL PHYS EXPRESS, V5, DOI 10.1143/APEX.5.012301	22	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0021-4922	1347-4065		JPN J APPL PHYS	Jpn. J. Appl. Phys.	AUG	2015	54	8			1				08KC05	10.7567/JJAP.54.08KC05		5	Physics, Applied	Physics	CN8BU	WOS:000358662900030		
J	Ichikawa, T				Ichikawa, Takashi			Algebraic and rigid geometry on the Schottky problem	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article							ANALYTIC CONSTRUCTION; VARIETIES; CURVES; EQUATIONS; JACOBIANS; RINGS	We study the Schottky problem by giving the KP characterization of Jacobian varieties among abelian varieties in terms of their algebraic or nonarchimedean theta functions.	Saga Univ, Dept Math, Grad Sch Sci & Engn, Saga 8408502, Japan	Ichikawa, T (reprint author), Saga Univ, Dept Math, Grad Sch Sci & Engn, Saga 8408502, Japan.	ichikawa@ms.saga-u.ac.jp					ANDERSON GW, 1994, INVENT MATH, V118, P475, DOI 10.1007/BF01231542; MUMFORD D, 1972, COMPOS MATH, V24, P129; ARBARELLO E, 1984, ANN MATH, V120, P119, DOI 10.2307/2007073; Darmon H, 2001, ANN MATH, V154, P589, DOI 10.2307/3062142; Deligne P., 1969, PUBL MATH-PARIS, V36, P75, DOI 10.1007/BF02684599; Fay J.D., 1973, LECT NOTES MATH, V352; Gerritzen L., 1980, LECT NOTES MATH, V817; HONDA T, 1970, J MATH SOC JPN, V22, P213; Ichikawa T, 1996, COMMUN MATH PHYS, V176, P383, DOI 10.1007/BF02099554; Kempf G. R., 1989, LECT NOTES MATH, V1414, P99; Krichever I, 2010, ANN MATH, V172, P485; Krichever I. M., 1977, RUSS MATH SURV, V32, P185, DOI 10.1070/RM1977v032n06ABEH003862; MANIN Y, 1973, J REINE ANGEW MATH, V262, P239; Marini G, 1998, COMPOS MATH, V111, P305, DOI 10.1023/A:1000310019510; MUMFORD D, 1972, COMPOS MATH, V24, P239; Mumford D., 1983, PROGR MATH, V28; Mumford D., 1984, PROGR MATH; Polishchuk A, 2003, MOSC MATH J, V3, P105; POOR C, 1992, P AM MATH SOC, V114, P667, DOI 10.2307/2159386; SHIOTA T, 1986, INVENT MATH, V83, P333, DOI 10.1007/BF01388967; WELTERS GE, 1984, ANN MATH, V120, P497, DOI 10.2307/1971084; Yamazaki T., 2010, SATO THEORY P ADIC F	22	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	AUG	2015	705						23	33		10.1515/crelle-2013-0059		11	Mathematics	Mathematics	CO5JT	WOS:000359196100002		
J	Matui, H				Matui, Hiroki			Topological full groups of one-sided shifts of finite type	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article							C-ASTERISK-ALGEBRAS; MEASURE PRESERVING TRANSFORMATIONS; CUNTZ-KRIEGER ALGEBRAS; CANTOR MINIMAL SYSTEMS; MARKOV SHIFTS; ORBIT EQUIVALENCE; PIMSNER ALGEBRAS; CHAINS	We explore the topological full group [G] of an essentially principal etale groupoid G on a Cantor set. When G is minimal, we show that [G] (and its certain normal subgroup) is a complete invariant for the isomorphism class of the etale groupoid G. Furthermore, when G is either almost finite or purely infinite, the commutator subgroup D([G]) is shown to be simple. The etale groupoid G arising from a one-sided irreducible shift of finite type is a typical example of a purely infinite minimal groupoid. For such G, [G] is thought of as a generalization of the Higman-Thompson group. We prove that [G] is of type F-infinity, and so in particular it is finitely presented. This gives us a new infinite family of finitely presented infinite simple groups. Also, the abelianization of [G] is calculated and described in terms of the homology groups of G.	Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan	Matui, H (reprint author), Chiba Univ, Grad Sch Sci, Inage Ku, Chiba 2638522, Japan.	matui@math.s.chiba-u.ac.jp					STEIN M, 1992, T AM MATH SOC, V332, P477, DOI 10.2307/2154179; DYE HA, 1959, AM J MATH, V81, P119, DOI 10.2307/2372852; Rordam M, 2012, ERGOD THEOR DYN SYST, V32, P273, DOI 10.1017/S0143385710000829; BROWN KS, 1987, J PURE APPL ALGEBRA, V44, P45, DOI 10.1016/0022-4049(87)90015-6; BROWN KS, 1984, J PURE APPL ALGEBRA, V32, P1, DOI 10.1016/0022-4049(84)90009-4; DYE HA, 1963, AM J MATH, V85, P551, DOI 10.2307/2373108; CUNTZ J, 1980, INVENT MATH, V56, P251, DOI 10.1007/BF01390048; Giordano T, 1999, ISRAEL J MATH, V111, P285, DOI 10.1007/BF02810689; Matui H, 2006, INT J MATH, V17, P231, DOI 10.1142/S0129167X06003448; Bezuglyi S., 2008, C MATH, V110, P409, DOI 10.4064/cm110-2-6; Brown K. S., 1982, GRAD TEXTS MATH, V87; BROWN KS, 1992, MATH SCI R, V23, P121; BROWN KS, 1984, INVENT MATH, V77, P367, DOI 10.1007/BF01388451; Cannon J.W., 1996, ENSEIGN MATH, V42, P215, DOI DOI 10.5169/SEALS-87877; Cleary S, 2000, ILLINOIS J MATH, V44, P453; CUNTZ J, 1981, INVENT MATH, V63, P25, DOI 10.1007/BF01389192; de la Harpe P., 2000, CHICAGO LECT MATH; Franks J., 1984, ERGOD THEOR DYN SYST, V4, P53, DOI 10.1017/S0143385700002261.; FREMLIN D. H., 2004, MEASURE THEORY, V3; Geoghegan R., 2008, GRAD TEXTS MATH, V243; Giordano T, 2010, INVENT MATH, V179, P119, DOI 10.1007/s00222-009-0213-7; Grigorchuk R., 2011, PREPRINT; Higman G., 1974, NOTES PURE MATH, V8; Hughes B, 2009, GROUP GEOM DYNAM, V3, P299; Jolissaint P, 2000, J FUNCT ANAL, V175, P197, DOI 10.1006/jfan.2000.3608; Juschenko K., 2012, PREPRINT; Katayama Y, 1998, ERGOD THEOR DYN SYST, V18, P937, DOI 10.1017/S0143385798108350; Lind D., 1995, INTRO SYMBOLIC DYNAM; Matsumoto K, 2010, PAC J MATH, V246, P199; Matsumoto K., 2012, PREPRINT; Matsumoto K, 2013, P AM MATH SOC, V141, P2329; Matsumoto K, 2013, DISCRETE CONT DYN-A, V33, P3753, DOI 10.3934/dcds.2013.33.3753; Matui H., ERGODIC THE IN PRESS; Matui H, 2012, P LOND MATH SOC, V104, P27, DOI 10.1112/plms/pdr029; Medynets K, 2011, B LOND MATH SOC, V43, P1104, DOI 10.1112/blms/bdr045; Nekrashevych VV, 2004, J OPERAT THEOR, V52, P223; Okayasu R, 2002, PUBL RES I MATH SCI, V38, P147, DOI 10.2977/prims/1145476420; Pardo E, 2011, J ALGEBRA, V344, P172, DOI 10.1016/j.jalgebra.2011.07.026; Renault J., 1980, LECT NOTES MATH, P793; Renault J., 2008, IRISH MATH SOC B, V61, P29; Spielberg J., 1991, INT J MATH, V2, P457, DOI 10.1142/S0129167X91000260	41	1	1	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	AUG	2015	705						35	84		10.1515/crelle-2013-0041		50	Mathematics	Mathematics	CO5JT	WOS:000359196100003		
J	Honda, S				Honda, Shouhei			Ricci curvature and L-p-convergence	JOURNAL FUR DIE REINE UND ANGEWANDTE MATHEMATIK			English	Article							RIEMANNIAN-MANIFOLDS; ALEXANDROV SPACES; LAPLACE OPERATOR; 1ST EIGENVALUE; SPECTRAL CONVERGENCE; LIPSCHITZ FUNCTIONS; LARGE-DIAMETER; METRIC-SPACES; LIMIT SPACES; LOWER BOUNDS	We give the definition of L-p-convergence of tensor fields with respect to the Gromov-Hausdorff topology and several fundamental properties of the convergence. We apply this to establish a Bochner-type inequality which keeps the term of Hessian on the Gromov-Hausdorff limit space of a sequence of Riemannian manifolds with a lower Ricci curvature bound and to give a geometric explicit formula for the Dirichlet Laplacian on a limit space defined by Cheeger-Colding. We also prove the continuity of the first eigenvalues of the p-Laplacian with respect to the Gromov-Hausdorff topology.	Kyushu Univ, Fac Math, Nishi Ku, Fukuoka 8190395, Japan	Honda, S (reprint author), Kyushu Univ, Fac Math, Nishi Ku, 744 Motooka, Fukuoka 8190395, Japan.	honda@math.kyushu-u.ac.jp			 [24740046]	The author was supported by Grant-in-Aid for Young Scientists (B) 24740046.	ANDERSON MT, 1990, MANUSCRIPTA MATH, V68, P405, DOI 10.1007/BF02568774; Cheeger J, 1996, ANN MATH, V144, P189, DOI 10.2307/2118589; Colding TH, 2012, ANN MATH, V176, P1173, DOI 10.4007/annals.2012.176.2.10; Cheeger J, 2000, J DIFFER GEOM, V54, P13; Cheeger J, 1999, GEOM FUNCT ANAL, V9, P428, DOI 10.1007/s000390050094; Cheeger J, 2000, J DIFFER GEOM, V54, P37; Gigli N, 2013, COMMUN PUR APPL MATH, V66, P307, DOI 10.1002/cpa.21431; FUKAYA K, 1987, INVENT MATH, V87, P517, DOI 10.1007/BF01389241; Bakry D, 2000, ADV MATH, V155, P98, DOI 10.1006/aima.2000.1932; Kuwae K, 2001, MATH Z, V238, P269, DOI 10.1007/s002090100252; Rademacher H, 1919, MATH ANN, V79, P340, DOI 10.1007/BF01498415; Cheeger J, 1997, J DIFFER GEOM, V46, P406; CHENG SY, 1975, COMMUN PUR APPL MATH, V28, P333, DOI 10.1002/cpa.3160280303; Clarkson JA, 1936, T AM MATH SOC, V40, P396; Zhang HC, 2012, J DIFFER GEOM, V91, P445; Bakry D., 1997, NEW TRENDS STOCHASTI, P43; Burago Y., 1992, USP MAT NAUK, V47, P3, DOI DOI 10.1070/RM1992V047N02ABEH000877; Cheeger J., 2001, DEGENERATION RIEMANN; Cheeger Jeff, 1971, J DIFFER GEOM, V6, P119; Colding T., 2011, PREPRINT; Colding TH, 1996, INVENT MATH, V124, P175, DOI 10.1007/s002220050049; Colding TH, 1998, COMMUN PUR APPL MATH, V51, P113, DOI 10.1002/(SICI)1097-0312(199802)51:2<113::AID-CPA1>3.0.CO;2-E; Ding Y, 2002, COMMUN ANAL GEOM, V10, P475; Federer H., 1969, GEOMETRIC MEASURE TH; Fukaya K., 1990, ADV STUDIES PURE MAT, V18, P143; Fukushima M., 1980, DIRICHLET FORMS MARK; Gigli N., 2013, PREPRINT; Gilbarg D., 2001, CLASSICS MATH; Gromov M., 1999, METRIC STRUCTURES RI; HAJLASZ P, 1995, CR ACAD SCI I-MATH, V320, P1211; Heikkinen T, 2007, STUD MATH, V181, P1, DOI 10.4064/sm181-1-1; Honda S, 2011, COMMUN ANAL GEOM, V19, P79; Honda S, 2011, J MATH SOC JPN, V63, P419, DOI 10.2969/jmsj/06320419; Kasue A, 1996, TOHOKU MATH J, V48, P71, DOI 10.2748/tmj/1178225413; Kasue A, 2006, POTENTIAL ANAL, V24, P137, DOI 10.1007/s11118-005-8568-x; Kasue A, 2002, ANN I FOURIER, V52, P1219; KASUE A, 1994, TOHOKU MATH J, V46, P147, DOI 10.2748/tmj/1178225756; Kawai S, 2003, NONLINEAR ANAL-THEOR, V55, P33, DOI 10.1016/S0362-546X(03)00209-8; Kuwae K, 2003, COMMUN ANAL GEOM, V11, P599; Kuwae K, 2008, T AM MATH SOC, V360, P35, DOI 10.1090/S0002-9947-07-04167-0; Kuwae K, 2003, J REINE ANGEW MATH, V555, P39; Le A, 2006, NONLINEAR ANAL-THEOR, V64, P1057, DOI 10.1016/j.na.2005.05.056; Ledoux M., 2000, Annales de la Faculte des Sciences de Toulouse, Mathematiques, V9; Lin-Feng W., 2009, LOBACHEVSKII J MATH, V30, P235, DOI [10.1134/S199508020903007X, DOI 10.1134/S199508020903007X]; Matei AM, 2000, NONLINEAR ANAL-THEOR, V39, P1051, DOI 10.1016/S0362-546X(98)00266-1; Morrey C, 1966, MULTIPLE INTEGRALS C; Naber A., 2013, PREPRINT; OTSU Y, 1994, J DIFFER GEOM, V39, P629; OTSU Y, 1991, MATH Z, V206, P255, DOI 10.1007/BF02571341; Perelman G., 1991, AD ALEXANDROV SPACES; Perelman G., 1995, DC STRUCTURE ALEXAND; Schoen R., 1995, LECT DIFFERENTIAL GE; Simon L. M., 1983, P CTR MATH ANAL AUST, V3; Takeuchi H., 1998, TOKYO J MATH, V21, P135; Valtorta D, 2012, NONLINEAR ANAL-THEOR, V75, P4974, DOI 10.1016/j.na.2012.04.012; Veron L, 1991, C MATH SOC J BOLYAI, V62, P317; Wu JY, 2010, ANN GLOB ANAL GEOM, V38, P27, DOI 10.1007/s10455-010-9199-z; Zhang HC, 2007, ADV GEOM, V7, P145, DOI 10.1515/ADVGEOM.2007.009	58	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0075-4102	1435-5345		J REINE ANGEW MATH	J. Reine Angew. Math.	AUG	2015	705						85	154		10.1515/crelle-2013		70	Mathematics	Mathematics	CO5JT	WOS:000359196100004		
J	Inoue, G; Ono, M; Uehara, K; Isono, F				Inoue, Gaku; Ono, Masahiro; Uehara, Keita; Isono, Fumiaki			Stated-preference analysis to estimate the domestic transport demand following the future entry of LCCs and the inauguration of the Linear Chuo Shinkansen in Japan	JOURNAL OF AIR TRANSPORT MANAGEMENT			English	Article						Aviation demand forecast; Stated-preference; Low Cost Carriers (LCC)	HIGH-SPEED RAIL; SERVICES; LEVEL	Using a stated-preference survey, we examine changes in air transport demand by the entry of low cost carriers into domestic service, and with the beginning of operation of the Linear Chuo Shinkansen. In order to construct a choice model, we estimate the Nested-Logit model parameters by the two kinds of travel purposes in order to consider the differences in the price-sensitivity between business and nonbusiness travelers. Simulation results for the each targeted OD vary in the shares of each transportation mode, depending upon the travel times, the aviation network, travel purpose. Non-business travelers who are more price-sensitive are less likely to choose the Linear Chuo Shinkansen with higher fares. On the route between the metropolitan area and Kinki area, total aviation demand will increase by the entry of LCCs to/from Tokyo-Haneda airport even when the Linear Chuo Shinkansen begins operating, showing that the development of the Linear Chuo Shinkansen service will not prevent strong growth in aviation demand for the trunk domestic routes. (C) 2015 Elsevier Ltd. All rights reserved.	[Inoue, Gaku; Ono, Masahiro] Natl Inst Land & Infrastruct Management, Minist Land Infrastruct Transport & Tourism, Yokosuka, Kanagawa 2390826, Japan; [Uehara, Keita; Isono, Fumiaki] Mitsubishi Res Inst Inc, Chiyoda Ku, Tokyo 1008141, Japan	Inoue, G (reprint author), Natl Inst Land & Infrastruct Management, Minist Land Infrastruct Transport & Tourism, 3-1-1 Nagase, Yokosuka, Kanagawa 2390826, Japan.	inoue-g23i@mlit.go.jp					Dobruszkes F, 2011, TRANSPORT POLICY, V18, P870, DOI 10.1016/j.tranpol.2011.06.002; Mumbower S, 2014, TRANSPORT RES A-POL, V66, P196, DOI 10.1016/j.tra.2014.05.003; Ben-Akiva M., 1985, TRANSPORTATION STUDI; Chang LY, 2012, J AIR TRANSP MANAG, V20, P15, DOI 10.1016/j.jairtraman.2011.09.003; DEVANY A, 1974, REV ECON STAT, V56, P77; Dobruszkes F, 2014, TRANSPORT RES A-POL, V69, P461, DOI 10.1016/j.tra.2014.09.004; Friederiszick H., 2009, WP10901 ESMT; Fukuda D., 2004, J INFRASTRUCT PLAN M, P227; Givoni M, 2013, TRANSPORT REV, V33, P720, DOI 10.1080/01441647.2013.853707; Inoue G., 2014, STATED CHOICE ANAL E, V784; International Air Transport Association, 2008, AIR TRAV DEM; Japan Civil Aviation Bureau, 2013, INF DISCL AIR TRANSP; Japan Civil Aviation Bureau, 2013, TECHN STUD FURTH ENH; Japan Railway Bureau, 2012, MAN COST BEN AN JAP; Jung J., 1976, J TRANSP ECON POLICY, P257; Kato H., 2009, TRANSP EC, P69; Kato H., 2009, TRANSP EC, P24; Ministry of Land Infrastructure Transport and Tourism, 2013, INT TRAV SURV; National Institute for Land and Infrastructure Management, 2007, METH AIR TRANSP DEM; National Tax Agency, 2013, PRIV SAL ACT STAT SU; Nihon Keizai Shinbun, 2013, NIHON KEIZAI SH 0913; Tansei K., 2010, ANAL DOMESTIC AIRFAR, V612; Tansei K., 2011, P INFRASTRUCT PLAN, V44; Yai T., 2013, REGIONAL JETS WILL C	24	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0969-6997	1873-2089		J AIR TRANSP MANAG	J. Air Transp. Manag.	AUG	2015	47						199	217		10.1016/j.jairtraman.2015.06.004		19	Transportation	Transportation	CO3AD	WOS:000359027700022		
J	Okano, M; Fujiwara, T; Kariya, S; Haruna, T; Higaki, T; Noyama, Y; Makihara, S; Kanai, K; Nishizaki, K				Okano, Mitsuhiro; Fujiwara, Tazuko; Kariya, Shin; Haruna, Takenori; Higaki, Takaya; Noyama, Yasuyuki; Makihara, Sei-ichiro; Kanai, Kengo; Nishizaki, Kazunori			Staphylococcal protein A-formulated immune complexes suppress enterotoxin-induced cellular responses in nasal polyps	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Chronic rhinosinusitis with nasal polyps; cytokines; enterotoxins; immune complexes; immunoglobulins; immune evasion; Staphylococcus aureus; staphylococcal protein A	CHRONIC RHINOSINUSITIS; HUMAN MONOCYTES; T-CELLS; AUREUS; IL-10; INFLAMMATION; ACTIVATION; INFECTIONS; DISEASES; LIGANDS	Background: Recent studies have revealed that Staphylococcus aureus and its components participate in the pathogenesis of eosinophilic airway diseases, such as chronic rhinosinusitis with nasal polyps. Objective: We sought to determine whether staphylococcal protein A (SpA) from S aureus regulated cellular responses in nasal polyps, especially when coupled to immunoglobulins in immune complexes (ICs). Methods: Dispersed nasal polyp cells (DNPCs) or peripheral blood monocytes were cultured in vitro with SpA in the presence or absence of IgG, and IL-5, IL-13, IFN-gamma, IL-17A, and IL-10 levels were measured in the supernatants. The effect of SpA exposure on staphylococcal enterotoxin B-induced cytokine production by DNPCs in the presence and absence of IgG, IgA, and autologous serum was also examined. Results: Exposure to SpA induced DNPCs to produce significantly higher IL-10, IL-13, and IL-17A levels than DNPCs without SpA, although the magnitude of the IL-17A increase was less than that of IL-10 and IL-13. SpA induced IL-10 production mainly from adherent DNPCs, and this was significantly enhanced in the presence of IgG; similar results were observed in peripheral blood monocytes. IC formation between SpA and IgG (SpA-IgG ICs) was confirmed by using native polyacrylamide gel electrophoresis. SpA-IgG ICs, but not SpA alone, almost completely suppressed staphylococcal enterotoxin B-induced IL-5, IL-13, IFN-gamma, and IL-17A production by DNPCs; similar inhibition was observed in DNPCs treated with SpA in the presence of either IgA or autologous serum. Conclusions: Our results suggest that SpA can regulate the pathogenesis of enterotoxin-induced inflammation in patients with chronic rhinosinusitis with nasal polyps through coupling to immunoglobulins.	[Okano, Mitsuhiro; Fujiwara, Tazuko; Kariya, Shin; Haruna, Takenori; Higaki, Takaya; Noyama, Yasuyuki; Nishizaki, Kazunori] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, Okayama 7008558, Japan; [Makihara, Sei-ichiro] Kagawa Rosai Hosp, Dept Otorhinolaryngol, Marugame, Kagawa, Japan; [Kanai, Kengo] Kagawa Prefectural Cent Hosp, Dept Otorhinolaryngol, Takamatsu, Kagawa, Japan	Okano, M (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Otolaryngol Head & Neck Surg, 2-5-1 Shikatacho, Okayama 7008558, Japan.	mokano@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan [23592511, 26670742]	Supported in part by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan (23592511 and 26670742).	Ambarus CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035994; Lloyd CM, 2009, IMMUNITY, V31, P438, DOI 10.1016/j.immuni.2009.08.007; Hamilos DL, 2014, J ALLERGY CLIN IMMUN, V133, P640, DOI 10.1016/j.jaci.2013.06.049; MacLellan LM, 2011, ARTHRITIS RHEUM-US, V63, P3897, DOI 10.1002/art.30629; Okano M, 2011, CLIN EXP ALLERGY, V41, P171, DOI 10.1111/j.1365-2222.2010.03584.x; Foreman A, 2010, LARYNGOSCOPE, V120, P1701, DOI 10.1002/lary.21024; Faith A, 2012, ALLERGY, V67, P1007, DOI 10.1111/j.1398-9995.2012.02852.x; Kim HK, 2012, CURR OPIN MICROBIOL, V15, P92, DOI 10.1016/j.mib.2011.10.012; Okano M, 2011, J ALLERGY CLIN IMMUN, V127, P277, DOI 10.1016/j.jaci.2010.09.029; Hofmann SR, 2012, CLIN IMMUNOL, V143, P116, DOI 10.1016/j.clim.2012.02.005; Tan BK, 2011, J ALLERGY CLIN IMMUN, V128, P1198, DOI 10.1016/j.jaci.2011.08.037; Lee GA, 2008, CLIN EXP OPHTHALMOL, V36, P119, DOI 10.1111/j.1442-9071.2008.01680.x; Okano M, 2009, J ALLERGY CLIN IMMUN, V123, P868, DOI 10.1016/j.jaci.2009.01.047; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Gomez MI, 2004, NAT MED, V10, P842, DOI 10.1038/nm1079; Peres AG, 2013, BURNS, V39, P380, DOI 10.1016/j.burns.2012.12.008; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Chau TA, 2009, NAT MED, V15, P641, DOI 10.1038/nm.1965; Gallo P, 2010, IMMUNOL LETT, V133, P70, DOI 10.1016/j.imlet.2010.07.004; Higaki T, 2012, CLIN EXP ALLERGY, V42, P1217, DOI 10.1111/j.1365-2222.2012.04015.x; Escotte S, 2006, AM J RESP CELL MOL, V34, P348, DOI 10.1165/rcmb.2005-0191OC; Zecconi A, 2013, IMMUNOL LETT, V150, P12, DOI 10.1016/j.imlet.2013.01.004; Berger S, 1997, EUR J IMMUNOL, V27, P2994, DOI 10.1002/eji.1830271136; Bernstein JM, 2011, LARYNGOSCOPE, V121, P647, DOI 10.1002/lary.21400; DiMartino SJ, 2008, CLIN IMMUNOL, V127, P56, DOI 10.1016/j.clim.2007.11.014; Fokkens WJ, 2012, RHINOLOGY, V50, P1; Giai C, 2013, INFECT IMMUN, V81, P4200, DOI 10.1128/IAI.00593-13; Gisch K, 2007, INT ARCH ALLERGY IMM, V144, P183, DOI 10.1159/000103991; Issa R, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-30; Jendeberg L, 1996, BIOCHEMISTRY-US, V35, P22, DOI 10.1021/bi9512814; Kekehata S, 2008, OTOL NEUROTOL, V29, P791; Kim YM, 2014, CLIN BIOCHEM, V47, P96, DOI 10.1016/j.clinbiochem.2013.10.030; Kobayashi SD, 2013, MBIO, V4, DOI 10.1128/mBio.00764-13; Kuroda-Morimoto M, 2010, INT IMMUNOL, V22, P561, DOI 10.1093/intimm/dxq040; Parcina M, 2013, J IMMUNOL, V190, P1591, DOI 10.4049/jimmunol.1201222; Poullin P, 2005, JOINT BONE SPINE, V72, P101, DOI 10.1016/j.jbspin.2004.02.009; Tejde T, 2004, CLIN EXP IMMUNOL, V137, P521; Wang JH, 2012, SCI REP-UK, V2, DOI 10.1038/srep00606; Wehling P, 2007, BIODRUGS, V21, P323, DOI 10.2165/00063030-200721050-00004	40	1	1	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					343	+		10.1016/j.jaci.2014.10.058		16	Allergy; Immunology	Allergy; Immunology	CO2RS	WOS:000359004900015		
J	Mashiko, S; Bouguermouh, S; Rubio, M; Baba, N; Bissonnette, R; Sarfati, M				Mashiko, Shunya; Bouguermouh, Salim; Rubio, Manuel; Baba, Nobuyasu; Bissonnette, Robert; Sarfati, Marika			Human mast cells are major IL-22 producers in patients with psoriasis and atopic dermatitis	JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY			English	Article						Mast cells; T cells; IL-22; IL-17; psoriasis; atopic dermatitis	INNATE LYMPHOID-CELLS; SKIN INFLAMMATION; T-CELLS; POTENTIAL ROLE; GAMMA; CYTOKINE; DISEASE; MEMORY; GENES; IL-17	Background: Psoriasis is a systemic inflammatory disease in which IL-17 and IL-22 levels are markedly increased in the skin and blood. The prevalent concept, using skin cells that are isolated from psoriatic plaques and examined after cell expansion and in vitro stimulation, is that IL-17 and IL-22 production essentially results from T cells and the rare type 3 innate lymphoid cells. Objective: We sought to examine the cellular source of IL-17A and IL-22 at the protein and transcriptional single-cell level immediately after ex vivo skin cell isolation from psoriatic plaques. Methods: Skin biopsy specimens were collected from patients with psoriasis, as well as from patients with atopic dermatitis. Cell suspensions were prepared by combining mild enzymatic digestion and mechanical dissociation and analyzed for cytokine expression without prior in vitro culture and stimulation. Expression of IL-17 and IL-22 was quantified at the protein and mRNA single-cell level by using flow cytometry. Results: IL-22 is predominantly expressed by CD3(-)c-Kit(+) cells relative to CD3(+) T cells in lesional skin of patients with psoriasis and patients with atopic dermatitis. Strikingly, we identified c-Kit(+) FceRI(+) mast cells as major IL-22 producers. The proportion of mast cells that produce IL-22 ranges from 20% to 80% in patients with psoriasis or those with atopic dermatitis. Skin mast cells express IL-22 and IL-17 mRNA. Conversely, IL-17-producing T cells outnumber IL-17-producing mast cells, which also express IL-17 receptor. Conclusion: Human skin mast cells are previously unrecognized IL-22 producers. We further established that skin mast cells express IL-17. Thus mast cells might play an important role in the physiopathology of chronic inflammatory skin disorders.	[Mashiko, Shunya; Bouguermouh, Salim; Rubio, Manuel; Sarfati, Marika] Ctr Hosp Univ Montreal CRCHUM, Ctr Rech, Immunoregulat Lab, Montreal, PQ, Canada; [Baba, Nobuyasu] Kochi Univ, Sch Med, Ctr Innovat & Translat Med, Nankoku, Kochi, Japan; [Bissonnette, Robert] Innovaderm Res, Montreal, PQ, Canada	Sarfati, M (reprint author), Ctr Hosp Univ Montreal, Ctr Rech, Immunoregulat Lab, Tour Viger R-12-424-204,900 St Denis St East, Montreal, PQ H2X 0A9, Canada.	m.sarfati@umontreal.ca			Innovaderm Research	Supported by Innovaderm Research.	Ackermann L, 1999, BRIT J DERMATOL, V140, P624; Cargill M, 2007, AM J HUM GENET, V80, P273, DOI 10.1086/511051; Laggner U, 2011, J IMMUNOL, V187, P2783, DOI 10.4049/jimmunol.1100804; Gaudenzio N, 2013, J ALLERGY CLIN IMMUN, V131, P1400, DOI 10.1016/j.jaci.2013.01.029; Elder JT, 2010, J INVEST DERMATOL, V130, P1213, DOI 10.1038/jid.2009.319; Sofen H, 2014, J ALLERGY CLIN IMMUN, V133, P1032, DOI 10.1016/j.jaci.2014.01.025; Gottlieb AB, 2005, J IMMUNOL, V175, P2721; Lin AM, 2011, J IMMUNOL, V187, P490, DOI 10.4049/jimmunol.1100123; Lowes MA, 2008, J INVEST DERMATOL, V128, P1207, DOI 10.1038/sj.jid.5701213; Capon F, 2007, HUM GENET, V122, P201, DOI 10.1007/s00439-007-0397-0; Hueber AJ, 2010, J IMMUNOL, V184, P3336, DOI 10.4049/jimmunol.0903566; Dumoutier L, 2000, J IMMUNOL, V164, P1814; Meephansan J, 2011, EUR J DERMATOL, V21, P501, DOI 10.1684/ejd.2011.1335; Noordenbos T, 2012, ARTHRITIS RHEUM-US, V64, P99, DOI 10.1002/art.33396; Grimbaldeston MA, 2007, NAT IMMUNOL, V8, P1095, DOI 10.1038/ni1503; Bernink JH, 2013, NAT IMMUNOL, V14, P221, DOI 10.1038/ni.2534; Langley RG, 2014, NEW ENGL J MED, V371, P326, DOI 10.1056/NEJMoa1314258; Kumari S, 2013, IMMUNITY, V39, P899, DOI 10.1016/j.immuni.2013.10.009; Wang B, 2013, CANCER IMMUNOL IMMUN, V62, P1575, DOI 10.1007/s00262-013-1460-4; Wolk K, 2006, EUR J IMMUNOL, V36, P1309, DOI 10.1002/eji.200535503; Rutz S, 2013, IMMUNOL REV, V252, P116, DOI 10.1111/imr.12027; Papp KA, 2012, NEW ENGL J MED, V366, P1181, DOI 10.1056/NEJMoa1109017; Zheng Y, 2007, NATURE, V445, P648, DOI 10.1038/nature05505; Keijsers RRMC, 2014, J INVEST DERMATOL, V134, P1276, DOI 10.1038/jid.2013.526; Gurish MF, 2012, IMMUNITY, V37, P25, DOI 10.1016/j.immuni.2012.07.003; Perera GK, 2012, ANNU REV PATHOL-MECH, V7, P385, DOI 10.1146/annurev-pathol-011811-132448; Van Belle AB, 2012, J IMMUNOL, V188, P462, DOI 10.4049/jimmunol.1102224; Teunissen MBM, 2014, J INVEST DERMATOL, V134, P2351, DOI 10.1038/jid.2014.146; Cai YH, 2011, IMMUNITY, V35, P596, DOI 10.1016/j.immuni.2011.08.001; Dumoutier L, 2001, J IMMUNOL, V167, P3545; Sa SM, 2007, J IMMUNOL, V178, P2229; Lai YP, 2012, IMMUNITY, V37, P74, DOI 10.1016/j.immuni.2012.04.010; Lowes MA, 2014, ANNU REV IMMUNOL, V32, P227, DOI 10.1146/annurev-immunol-032713-120225; Volpe E, 2008, NAT IMMUNOL, V9, P650, DOI 10.1038/ni.1613; Villanova F, 2014, J INVEST DERMATOL, V134, P984, DOI 10.1038/jid.2013.477; Wolk K, 2004, IMMUNITY, V21, P241, DOI 10.1016/j.immuni.2004.07.007; Kalesnikoff J, 2008, NAT IMMUNOL, V9, P1215, DOI 10.1038/ni.f.216; Rodewald HR, 2012, IMMUNITY, V37, P13, DOI 10.1016/j.immuni.2012.07.007; Wolk K, 2009, J MOL MED-JMM, V87, P523, DOI 10.1007/s00109-009-0457-0; LEE FI, 1990, AM J GASTROENTEROL, V85, P962; Boniface K, 2007, CLIN EXP IMMUNOL, V150, P407, DOI 10.1111/j.1365-2249.2007.03511.x; Chapuy L, 2014, J ALLERGY CLIN IMMUN, V134, P978, DOI 10.1016/j.jaci.2014.05.025; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085226; Cheuk S, 2014, J IMMUNOL, V192, P3111, DOI 10.4049/jimmunol.1302313; Jiang WY, 2001, INT J DERMATOL, V40, P699, DOI 10.1046/j.1365-4362.2001.01262.x; Pfizer, SINGL DOS STUD SAF T; Shefler I, 2014, J ALLERGY CLIN IMMUN, V133, P217, DOI 10.1016/j.jaci.2013.04.035; Suurmond J, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3466; Takaishi M, 2014, J DERMATOL SCI, V73, P261, DOI 10.1016/j.jdermsci.2013.11.008; TORUNIOWA B, 1988, ARCH DERMATOL RES, V280, P189, DOI 10.1007/BF00513956; TOYRY S, 1988, ARCH DERMATOL RES, V280, P282, DOI 10.1007/BF00440601	51	0	0	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0091-6749	1097-6825		J ALLERGY CLIN IMMUN	J. Allergy Clin. Immunol.	AUG	2015	136	2					351	+		10.1016/j.jaci.2015.01.033		10	Allergy; Immunology	Allergy; Immunology	CO2RS	WOS:000359004900016		
J	Ogaya, S; Naito, H; Iwata, A; Higuchi, Y; Fuchioka, S; Tanaka, M				Ogaya, Shinya; Naito, Hisashi; Iwata, Akira; Higuchi, Yumi; Fuchioka, Satoshi; Tanaka, Masao			Toe-Out Gait Decreases the Second Peak of the Medial Knee Contact Force	JOURNAL OF APPLIED BIOMECHANICS			English	Article						adduction moment; simulation; quadriceps; gastrocnemius	FOOT PROGRESSION ANGLE; ADDUCTION MOMENT; LOWER-EXTREMITY; MUSCLE; OSTEOARTHRITIS; PREDICTION; LOCOMOTION; CRITERION; HIP	Toe-out angle alternation is a potential tactic for decreasing the knee adduction moment during walking. Published reports have not examined the medial knee contact force during the toe-out gait, although it is a factor affecting knee articular cartilage damage. This study investigated the effects of increased toe-out angle on the medial knee contact force, using musculoskeletal simulation analysis. For normal and toe-out gaits in 18 healthy subjects, the muscle tension forces were simulated based on the joint moments and ground reaction forces with optimization process. The medial knee contact force during stance phase was determined using the sum of the muscle force and joint reaction force components. The first and second peaks of the medial knee contact force were compared between the gaits. The toe-out gait showed a significant decrease in the medial knee contact force at the second peak, compared with the normal gait. In contrast, the medial knee contact forces at the first peak were not significantly different between the gaits. These results suggest that the toe-out gait is beneficial for decreasing the second peak of the medial knee contact force.	[Ogaya, Shinya; Iwata, Akira; Higuchi, Yumi; Fuchioka, Satoshi] Osaka Prefecture Univ, Dept Comprehens Rehabil, Div Phys Therapy, Osaka, Japan; [Naito, Hisashi] Kanazawa Univ, Coll Sci & Engn, Sch Mech Engn, Kanazawa, Ishikawa, Japan; [Tanaka, Masao] Osaka Univ, Grad Sch Engn Sci, Dept Mech Sci & Bioengn, Div Bioengn, Osaka, Japan	Ogaya, S (reprint author), Osaka Prefecture Univ, Dept Comprehens Rehabil, Div Phys Therapy, Osaka, Japan.	ogaya@rehab.osakafu-u.ac.jp					Ae M, 1992, BIOMECHANISMS, V11, P23; Guo M, 2007, GAIT POSTURE, V26, P436, DOI 10.1016/j.gaitpost.2006.10.008; Horsman MDK, 2007, CLIN BIOMECH, V22, P239, DOI 10.1016/j.clinbiomech.2006.10.003; Rasmussen J, 2001, J BIOMECH, V34, P409, DOI 10.1016/S0021-9290(00)00191-3; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; Miyazaki T, 2002, ANN RHEUM DIS, V61, P617, DOI 10.1136/ard.61.7.617; Pandy MG, 2010, ANNU REV BIOMED ENG, V12, P401, DOI 10.1146/annurev-bioeng-070909-105259; Zhao D, 2007, J ORTHOP RES, V25, P789, DOI 10.1002/jor.20379; Walter JP, 2010, J ORTHOP RES, V28, P1348, DOI 10.1002/jor.21142; Wu G, 2002, J BIOMECH, V35, P543, DOI 10.1016/S0021-9290(01)00222-6; Simic M, 2011, ARTHRIT CARE RES, V63, P405, DOI 10.1002/acr.20380; BELL AL, 1990, J BIOMECH, V23, P617, DOI 10.1016/0021-9290(90)90054-7; Buchanan TS, 2004, J APPL BIOMECH, V20, P367; Cleather DJ, 2011, ANN BIOMED ENG, V39, P147, DOI 10.1007/s10439-010-0161-9; CROWNINSHIELD RD, 1981, J BIOMECH, V14, P793, DOI 10.1016/0021-9290(81)90035-X; DELP SL, 1990, IEEE T BIO-MED ENG, V37, P757, DOI 10.1109/10.102791; Jenkyn TR, 2008, J BIOMECH, V41, P276, DOI 10.1016/j.jbiomech.2007.09.015; Ko SU, 2011, GAIT POSTURE, V33, P205, DOI 10.1016/j.gaitpost.2010.11.006; Lin CJ, 2001, GAIT POSTURE, V14, P85, DOI 10.1016/S0966-6362(01)00126-6; Lynn SK, 2008, CLIN BIOMECH, V23, P779, DOI 10.1016/j.clinbiomech.2008.01.012; Ogaya S, 2015, J MECH MED BIOL, V15, DOI 10.1142/S0219519415500025; Ogaya S, 2014, GAIT POSTURE, V40, P341, DOI 10.1016/j.gaitpost.2014.04.205	22	0	0	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	1065-8483	1543-2688		J APPL BIOMECH	J. Appl. Biomech.	AUG	2015	31	4					275	280		10.1123/jab.2014-0310		6	Engineering, Biomedical; Sport Sciences	Engineering; Sport Sciences	CO3YI	WOS:000359096800011		
J	Miyazaki, T; Shimokita, K; Ogawa, H; Yamamoto, K				Miyazaki, Tsukasa; Shimokita, Keisuke; Ogawa, Hiroki; Yamamoto, Katsuhiro			System for in situ observation of three-dimensional structural changes in polymer films during uniaxial deformation	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						small-angle X-ray scattering; wide-angle X-ray diffraction; stress-strain relationships; three-dimensional structural evaluation	X-RAY-SCATTERING; POLY(VINYL ALCOHOL) FILM; SIMULTANEOUS SMALL-ANGLE; AMORPHOUS POLY(ETHYLENE-TEREPHTHALATE); GLASS TEMPERATURE; STRESS-STRAIN; POLYETHYLENE; DIFFRACTION; SPRING-8; WATER	A simple three-dimensional structural evaluation system for a film during uniaxial deformation has been developed. The system is realized with an automatic film stretching machine, which allows the horizontally symmetric stretching of a film, and a synchrotron radiation X-ray scattering apparatus. Using this system, two-dimensional patterns of small-angle X-ray scattering and wide-angle X-ray diffraction can be obtained simultaneously during film stretching in the so-called edge and end views, together with stress-strain data. As cylindrical symmetry of the structure can be expected for a uniaxially stretched film, the two-dimensional patterns in the through view are identical to those in the edge view, indicating that three-dimensional structural characterization can be performed with a combination of edge and end views during film stretching. For amorphous poly-ethylene terephthalate) and crystalline poly-(vinyl alcohol) films, the preliminary results of three-dimensional structural characterization during film stretching are shown.	[Miyazaki, Tsukasa; Shimokita, Keisuke] Nitto Denko Corp, Funct Design Technol Ctr, Ibaraki, Osaka 5678680, Japan; [Ogawa, Hiroki] Japan Synchrotron Radiat Res Inst, Sayo, Hyogo 6795198, Japan; [Yamamoto, Katsuhiro] Nagoya Inst Technol, Dept Mat Sci, Showa Ku, Nagoya, Aichi 4668555, Japan	Miyazaki, T (reprint author), Nitto Denko Corp, Funct Design Technol Ctr, 1-1-2 Shimohozumi, Ibaraki, Osaka 5678680, Japan.	tsukasa_miyazaki@gg.nitto.co.jp					Masunaga H, 2011, POLYM J, V43, P471, DOI 10.1038/pj.2011.18; Chu B, 2001, CHEM REV, V101, P1727, DOI 10.1021/cr9900376; Kawakami D, 2003, MACROMOLECULES, V36, P9275, DOI 10.1021/ma034791b; Breiby DW, 2008, J APPL CRYSTALLOGR, V41, P262, DOI 10.1107/S0021889808001064; BUTLER MF, 1995, MACROMOLECULES, V28, P6383, DOI 10.1021/ma00123a001; Miyazaki T, 2010, POLYMER, V51, P5539, DOI 10.1016/j.polymer.2010.09.048; Baker JL, 2010, LANGMUIR, V26, P9146, DOI 10.1021/la904840q; Miyazaki T, 2005, POLYMER, V46, P7436, DOI 10.1016/j.polymer.2005.05.129; Wu J, 2000, MACROMOLECULES, V33, P1765, DOI 10.1021/ma990896w; Ogawa H, 2013, POLYM J, V45, P109, DOI 10.1038/pj.2012.194; Hughes DJ, 1997, POLYMER, V38, P6427, DOI 10.1016/S0032-3861(97)00351-0; Kawakami D, 2004, POLYMER, V45, P905, DOI 10.1016/j.polymer.2003.11.027; MAHENDRASINGAM A, 1995, NUCL INSTRUM METH B, V97, P238, DOI 10.1016/0168-583X(94)00377-7; MAHENDRASINGAM A, 1992, REV SCI INSTRUM, V63, P1087, DOI 10.1063/1.1143104; Miyazaki T, 2007, MACROMOLECULES, V40, P8277, DOI 10.1021/ma070731k; Miyazaki T, 2006, MACROMOLECULES, V39, P2921, DOI 10.1021/ma052595u; Nogales A, 2003, MACROMOLECULES, V36, P4827, DOI 10.1021/ma0210877; Shimokita K, 2014, J APPL CRYSTALLOGR, V47, P476, DOI 10.1107/S1600576713031774; Valladares B., 2005, MACROMOLECULES, V38, P9229; van Aerle N. A. J. M., 1988, J APPL CRYSTALLOGR, V21, P106; Ward I. M., 2000, SOLID PHASE PROCESSI	21	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	AUG	2015	48		4				1016	1022		10.1107/S1600576715008031		7	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CN9TL	WOS:000358791900005		
J	Hayashi, Y; Hirose, Y; Seno, Y				Hayashi, Yujiro; Hirose, Yoshiharu; Seno, Yoshiki			Polycrystal orientation mapping using scanning three-dimensional X-ray diffraction microscopy	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						polycrystal orientation; mapping; scanning microscopy; three-dimensional X-ray diffraction	INDIVIDUAL BULK GRAINS; CONTRAST TOMOGRAPHY; SUBMICROMETER-RESOLUTION; FAST METHODOLOGY; MAPS; RECONSTRUCTION; DEFORMATION; ALGORITHM; RECRYSTALLIZATION; MICRODIFFRACTION	A modified three-dimensional X-ray diffraction (3DXRD) technique is proposed as a solution to the main problem with 3DXRD-type experiments, namely, polycrystalline diffraction spot overlap. The modified method, termed scanning 3DXRD, enables three-dimensional crystallographic orientation mapping in polycrystals using a narrow incident X-ray beam with a beam size sufficiently smaller than the average grain size. This method can potentially allow one to apply a 3DXRD-type technique to specimens with a larger number of grains. Moreover, because of the use of a far-field area detector, scanning 3DXRD provides spacious specimen surroundings for equipment such as stress rigs, which are not feasible in 3DXRD methods using a near-field detector. As a first demonstration, a three-dimensional orientation map was obtained by an experiment using a 20 x 20 mu m beam and a well annealed iron specimen with an average grain size of 60 mu m. Scanning 3DXRD compared reasonably well with orientation image microscopy by electron backscatter diffraction (EBSD), considering the influence of the beam size in the case of scanning 3DXRD. The spatial resolution was estimated to be about twice the incident beam size from a scanning 3DXRD reconstruction simulation using an orientation map modeled on the EBSD orientation image of the specimen.	[Hayashi, Yujiro; Hirose, Yoshiharu; Seno, Yoshiki] Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan	Hayashi, Y (reprint author), Toyota Cent Res & Dev Labs Inc, Nagakute, Aichi 4801192, Japan.	y-hayashi@mosk.tytlabs.co.jp			JSPS KAKENHI [22760571, 26870932]	The authors are deeply grateful to Drs J. P. Wright and G. B. M. Vaughan of the European Synchrotron Radiation Facility for preparatory experiments and for providing the software ImageD11, and to Dr H. O. Sorensen for openly releasing the software PolyXSim. The authors would like to thank Dr T. Suzuki and Mr H. Kadoura for specimen preparation and evaluation and to acknowledge the moral support and encouragement they received from Drs D. Setoyama and K. Dohmae of Toyota Central R&D Laboratories Inc. The experiments were performed at the BL33XU beamline of SPring-8 with the approval of the Japan Synchrotron Radiation Institute (proposal Nos. 2010A7002, 2010B1008, 2010B7002, 2011B7002, 2012A7002, 2012B7002 and 2014B7002). This work was supported by JSPS KAKENHI grant Nos. 22760571 and 26870932.	Alpers A, 2006, J APPL CRYSTALLOGR, V39, P582, DOI 10.1107/S002188980601939X; Lienert U, 2011, JOM-US, V63, P70, DOI 10.1007/s11837-011-0116-0; Poulsen HF, 2001, J APPL CRYSTALLOGR, V34, P751, DOI 10.1107/S0021889801014273; Reischig P, 2013, J APPL CRYSTALLOGR, V46, P297, DOI 10.1107/S0021889813002604; Ice GE, 2005, J SYNCHROTRON RADIAT, V12, P155, DOI 10.1107/S0909049504026949; Adams BL, 1997, ULTRAMICROSCOPY, V67, P11, DOI 10.1016/S0304-3991(96)00103-9; Ludwig W, 2009, REV SCI INSTRUM, V80, DOI 10.1063/1.3100200; Ludwig W, 2008, J APPL CRYSTALLOGR, V41, P302, DOI 10.1107/S0021889808001684; Levine LE, 2006, NAT MATER, V5, P619, DOI 10.1038/nmat1698; Edmiston JK, 2011, J APPL CRYSTALLOGR, V44, P299, DOI 10.1107/S0021889811002123; Johnson G, 2008, J APPL CRYSTALLOGR, V41, P310, DOI 10.1107/S0021889808001726; Sharma H, 2012, J APPL CRYSTALLOGR, V45, P705, DOI 10.1107/S0021889812025599; Suter RM, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2400017; Oddershede J, 2015, ACTA MATER, V85, P301, DOI 10.1016/j.actamat.2014.11.038; Rowenhorst DJ, 2010, ACTA MATER, V58, P5511, DOI 10.1016/j.actamat.2010.06.030; Batenburg KJ, 2010, J APPL CRYSTALLOGR, V43, P1464, DOI 10.1107/S0021889810034114; Poulsen HF, 2003, ACTA MATER, V51, P3821, DOI 10.1016/S1359-6454(03)00206-4; Sorensen HO, 2012, Z KRISTALLOGR, V227, P63, DOI 10.1524/zkri.2012.1438; Larson BC, 2002, NATURE, V415, P887, DOI 10.1038/415887a; Pokharel R, 2014, ANNU REV CONDEN MA P, V5, P317, DOI 10.1146/annurev-conmatphys-031113-133846; Lauridsen EM, 2001, J APPL CRYSTALLOGR, V34, P744, DOI 10.1107/S0021889801014170; Poulsen HF, 2012, J APPL CRYSTALLOGR, V45, P1084, DOI 10.1107/S0021889812039143; Nonaka T, 2012, REV SCI INSTRUM, V83, DOI 10.1063/1.4746770; Lyckegaard A, 2011, ADV ENG MATER, V13, P165, DOI 10.1002/adem.201000258; Bleuet P, 2008, NAT MATER, V7, P468, DOI 10.1038/nmat2168; Larson BC, 2013, J APPL CRYSTALLOGR, V46, P153, DOI 10.1107/S0021889812043737; Oddershede J, 2010, J APPL CRYSTALLOGR, V43, P539, DOI 10.1107/S0021889810012963; Bernier JV, 2011, J STRAIN ANAL ENG, V46, P527, DOI 10.1177/0309324711405761; MacSleyne J, 2009, ACTA MATER, V57, P6251, DOI 10.1016/j.actamat.2009.08.053; Margulies L, 2001, SCIENCE, V291, P2392, DOI 10.1126/science.1057956; Ice GE, 2011, SCIENCE, V334, P1234, DOI 10.1126/science.1202366; Li SF, 2012, J APPL CRYSTALLOGR, V45, P1098, DOI 10.1107/S0021889812039519; Banhart J., 2008, ADV TOMOGRAPHIC METH, P249; Barabash RI, 2009, MICRON, V40, P28, DOI 10.1016/j.micron.2008.03.010; Borthwick VE, 2012, GEOCHEM GEOPHY GEOSY, V13, DOI 10.1029/2012GC004057; Hayashi Y, 2014, MATER SCI FORUM, V777, P118, DOI 10.4028/www.scientific.net/MSF.777.118; Hefferan M., 2009, COMPUT MAT CONTINUA, V14, P209; King A., 2010, P 31 RIS INT S MAT S, P43; Lauridsen EM, 2006, SCRIPTA MATER, V55, P51, DOI 10.1016/j.scriptamat.2006.02.028; Lyckegaard A, 2012, MATER SCI FORUM, V715-716, P518, DOI 10.4028/www.scientific.net/MSF.715-716.518; Lyckegaard A., 2010, P 31 RIS INT S MAT S, P329; Moscicki M, 2009, MAT SCI ENG A-STRUCT, V524, P64, DOI 10.1016/j.msea.2009.05.002; Oddershede J., 2010, P 31 RIS INT S MAT S, P329; Poulsen H. F., 2004, 3 DIMENSIONAL XRAY D; Poulsen H. F., 2008, ADV TOMOGRAPHIC METH, P249; Poulsen HF, 2003, J APPL CRYSTALLOGR, V36, P1062, DOI 10.1107/S0021889803011063; Rodek L, 2007, J APPL CRYSTALLOGR, V40, P313, DOI 10.1107/S0021889807001288; Setoyama D, 2014, MATER SCI FORUM, V777, P142, DOI 10.4028/www.scientific.net/MSF.777.142; Sharma H, 2012, J APPL CRYSTALLOGR, V45, P693, DOI 10.1107/S0021889812025563; West SS, 2009, SCRIPTA MATER, V61, P875, DOI 10.1016/j.scriptamat.2009.07.027	50	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	AUG	2015	48		4				1094	1101		10.1107/S1600576715009899		8	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CN9TL	WOS:000358791900013		
J	Adachi, H; Kawata, H; Ito, M				Adachi, H.; Kawata, H.; Ito, M.			Resonance effect in white X-ray magnetic diffraction of GdAl2	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						X-ray magnetic diffraction; resonant X-ray magnetic scattering; GdAl2; white synchrotron radiation; dispersion effects	EXCHANGE SCATTERING; POLARIZATION DEPENDENCE; ANOMALOUS SCATTERING; FERROMAGNETIC IRON; GADOLINIUM; YIELDS; AUGER	Using elliptically polarized white synchrotron radiation and an energy-sensitive detector, the 444 reflection from a single-crystal sample of the ferromagnetic compound GdAl2 magnetized along the scattering vector has been measured, and the asymmetry of the diffraction intensity upon the magnetization reversal has been studied in the X-ray energy range across the Gd L-II edge. The dependence of the magnetic asymmetry on the scattering angle or on the X-ray energy is understood as the superposition of the sharp near-edge structure and the much broader component arising from the interference between the electric scattering and the resonant and nonresonant magnetic scattering, respectively. To interpret the experimental results, an analytical treatment of the magnetic asymmetry is developed, and in the course of the analysis it is pointed out that in general the pseudo-extinction of the Bragg reflection due to the dispersion effects can be utilized as a technique to raise the magnetic sensitivity in the X-ray scattering from ferromagnetic materials. The potential of an unconventional approach to the resonant X-ray scattering using a white beam, as is clearly demonstrated by the present experiment, is also discussed.	[Adachi, H.; Kawata, H.] KEK, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan; [Adachi, H.] Shinshu Univ, Inst Humanities, Matsumoto, Nagano 3908621, Japan; [Ito, M.] Gunma Univ, Fac Engn, Kiryu, Gumma 3768515, Japan	Adachi, H (reprint author), KEK, Inst Mat Struct Sci, Tsukuba, Ibaraki 3050801, Japan.	adachih@shinshu-u.ac.jp					ADACHI H, 2002, PHYS REV B, V66, DOI 10.1103/PhysRevB.66.224428; Adachi H., 2001, PHYS REV B, V63; Adachi H, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.212409; Adachi H, 2007, J MAGN MAGN MATER, V310, P2705, DOI 10.1016/j.jmmm.2006.10.1000; Hill JP, 1996, ACTA CRYSTALLOGR A, V52, P236, DOI 10.1107/S0108767395012670; Maiti K, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.167205; HANNON JP, 1988, PHYS REV LETT, V61, P1245, DOI 10.1103/PhysRevLett.61.1245; BAMBYNEK W, 1972, REV MOD PHYS, V44, P716, DOI 10.1103/RevModPhys.44.716; COLLINS SP, 1992, PHILOS MAG B, V65, P37, DOI 10.1080/13642819208223045; BLUME M, 1985, J APPL PHYS, V57, P3615, DOI 10.1063/1.335023; Murakami Y, 1998, PHYS REV LETT, V81, P582, DOI 10.1103/PhysRevLett.81.582; LAUNDY D, 1991, J PHYS-CONDENS MAT, V3, P369, DOI 10.1088/0953-8984/3/3/011; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P329; Donath M, 1996, PHYS REV LETT, V77, P5138, DOI 10.1103/PhysRevLett.77.5138; KRAUSE MO, 1979, J PHYS CHEM REF DATA, V8, P307; Murakami Y, 1998, PHYS REV LETT, V80, P1932, DOI 10.1103/PhysRevLett.80.1932; BLUME M, 1988, PHYS REV B, V37, P1779, DOI 10.1103/PhysRevB.37.1779; NAMIKAWA K, 1985, J PHYS SOC JPN, V54, P4099, DOI 10.1143/JPSJ.54.4099; BARBARA B, 1977, PHYSICA B & C, V86, P183, DOI 10.1016/0378-4363(77)90279-0; DEBERGEVIN F, 1981, ACTA CRYSTALLOGR A, V37, P314, DOI 10.1107/S0567739481000739; Blume M., 1994, RESONANT ANOMALOUS X, P495; CARRA P, 1989, PHYS REV B, V40, P7324, DOI 10.1103/PhysRevB.40.7324; Cromer D. T., 1974, INT TABLES CRYSTALLO, VIV, P71; GIBBS D, 1991, PHYS REV B, V43, P5663, DOI 10.1103/PhysRevB.43.5663; Hannon J. P., 1994, RESONANT ANOMALOUS X, P565; HANNON JP, 1989, PHYS REV LETT, V62, P2644, DOI 10.1103/PhysRevLett.62.2644; KIM B, 1992, PHYS REV LETT, V68, P1931, DOI 10.1103/PhysRevLett.68.1931; LOVESEY SW, 1987, J PHYS C SOLID STATE, V20, P5625, DOI 10.1088/0022-3719/20/34/003; PENGRA DB, 1994, J PHYS-CONDENS MAT, V6, P2409, DOI 10.1088/0953-8984/6/12/016; Platzman PM, 1970, PHYS REV B-SOLID ST, V2, P3556, DOI 10.1103/PhysRevB.2.3556; Sasaki S., 1989, 8814 KEK; Schussler-Langeheine C, 2000, PHYS REV LETT, V84, P5624, DOI 10.1103/PhysRevLett.84.5624; TEMPLETON DH, 1982, ACTA CRYSTALLOGR A, V38, P62, DOI 10.1107/S0567739482000114; TEMPLETON LK, 1982, ACTA CRYSTALLOGR A, V38, P74, DOI 10.1107/S056773948200014X; VETTIER C, 1986, PHYS REV LETT, V56, P757, DOI 10.1103/PhysRevLett.56.757; ZHIZHIMOV OL, 1984, ZH EKSP TEOR FIZ+, V87, P547	36	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	AUG	2015	48		4				1114	1121		10.1107/S1600576715010699		8	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CN9TL	WOS:000358791900015		
J	Zhang, QH; Zhai, Z; Nie, ZH; Harjo, S; Cong, DY; Wang, MG; Li, J; Wang, YD				Zhang, Q. H.; Zhai, Z.; Nie, Z. H.; Harjo, S.; Cong, D. Y.; Wang, M. G.; Li, J.; Wang, Y. D.			An in situ neutron diffraction study of anomalous superelasticity in a strain glass Ni43Fe18Ga27Co12 alloy	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						strain glass; neutron diffraction; peak broadening; modulus softening; phase transformation; superelasticity	PHASE-TRANSITIONS; TRANSFORMATION; CRYSTALS; SYSTEMS	Superelastic behavior is traditionally related to the martensitic transition with a collective transformation scenario in some shape memory alloys. A kind of quasi-linear superelasticity accompanied by a finite avalanche or confined martensitic transformation was recently found in some alloy systems with strain glass state. Here, an in situ neutron diffraction technique was used to study the deformation behavior in an Ni43Fe18Ga27Co12 alloy with strain glass state in order to reveal the new intrinsic physical nature of the quasi-linear superelasticity. A significant modulus softening prior to the stress-induced martensitic transformation was observed during compression in the studied alloy, which is similar to the characteristics exhibited in the tweed precursor phenomena prior to temperature-induced martensitic transformation. Moreover, the diffraction peak broadening was further shown during the elastic stage of deformation for both single-crystal and polycrystalline samples, which mainly stems from the short-range fluctuation in the strain field inside each grain based on Williamson-Hall analysis. The authors believe that there exists a spatial heterogeneity in the modulus of the confined martensitic transformation alloy.	[Zhang, Q. H.; Zhai, Z.; Nie, Z. H.] Beijing Inst Technol, Sch Mat Sci & Engn, Beijing 100081, Peoples R China; [Zhang, Q. H.; Cong, D. Y.; Wang, Y. D.] Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Beijing 100083, Peoples R China; [Harjo, S.] Mat & Life Sci Expt Facil Japan Proton Accelerato, Tokai, Ibaraki 3191195, Japan; [Wang, M. G.] Northeastern Univ, Dept Phys, Shenyang 110004, Peoples R China; [Li, J.] Inst Nucl Phys & Chem, Mianyang 621900, Peoples R China	Wang, YD (reprint author), Univ Sci & Technol Beijing, State Key Lab Adv Met & Mat, Beijing 100083, Peoples R China.	ydwang@mail.neu.edu.cn	wang, yandong/G-9404-2013; Nie, Zhihua/G-9459-2013	Nie, Zhihua/0000-0002-2533-933X	National Basic Research Program of China (973 Program) [2012CB619405]; Fundamental Research Funds for the Central Universities [06111020]; State Key Laboratory for Advanced Metals and Materials [2014Z-01]; NPL [2012BA02]; US Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06-CH11357]; Materials and Life Science Experimental Facility of the Japan Proton Accelerator Research Complex [2012 A0106]	We would like to acknowledge Dr Tatsushi Nakamoto of KEK for his help with the neutron experiment. The authors are grateful to the National Basic Research Program of China (973 Program) under contract No. 2012CB619405. This project is also supported by the Fundamental Research Funds for the Central Universities (grant No. 06111020), the State Key Laboratory for Advanced Metals and Materials (grant No. 2014Z-01), and NPL under contract No. 2012BA02. Use of the Advanced Photon Source was supported by the US Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract No. DE-AC02-06-CH11357. This research project has also been supported by the Materials and Life Science Experimental Facility of the Japan Proton Accelerator Research Complex under contract No. 2012 A0106.	Sarkar S, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.205702; Sutou Y, 2004, APPL PHYS LETT, V84, P1275, DOI 10.1063/1.1642277; Cerny R, 2000, J APPL CRYSTALLOGR, V33, P997, DOI 10.1107/S0021889800004556; Ungar T, 1996, APPL PHYS LETT, V69, P3173; VUGMEISTER BE, 1990, REV MOD PHYS, V62, P993, DOI 10.1103/RevModPhys.62.993; KUHN W, 1950, NATURE, V165, P514, DOI 10.1038/165514a0; Aktas O, 2013, PHYS REV B, V88, DOI 10.1103/PhysRevB.88.174112; WILLIAMSON GK, 1953, ACTA METALL MATER, V1, P22, DOI 10.1016/0001-6160(53)90006-6; Liu JP, 2014, ACTA MATER, V81, P476, DOI 10.1016/j.actamat.2014.08.019; CHANG LC, 1951, T AM I MIN MET ENG, V191, P47; BINDER K, 1986, REV MOD PHYS, V58, P801, DOI 10.1103/RevModPhys.58.801; Ni Y, 2007, ACTA MATER, V55, P4903, DOI 10.1016/j.actamat.2007.05.016; Balzar D, 2004, J APPL CRYSTALLOGR, V37, P911, DOI 10.1107/S0021889804022551; Wang Y, 2012, APPL PHYS LETT, V101, DOI 10.1063/1.4751250; Ungar T, 2010, SCRIPTA MATER, V63, P69, DOI 10.1016/j.scriptamat.2010.03.016; Salje EKH, 2014, PHYS STATUS SOLIDI B, V251, P2061, DOI 10.1002/pssb.201350242; ERICKSEN JL, 1980, ARCH RATION MECH AN, V73, P99, DOI 10.1007/BF00258233; Larson A.C., 2004, 86748 LAUR LOS AL NA; Mu J, 2013, ACTA MATER, V61, P5008, DOI 10.1016/j.actamat.2013.04.045; Olander A, 1932, J AM CHEM SOC, V54, P3819, DOI 10.1021/ja01349a004; Pirc R, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.020101; PITTERI M, 1984, J ELASTICITY, V14, P175, DOI 10.1007/BF00041664; REYESMOREL PE, 1988, J AM CERAM SOC, V71, P648, DOI 10.1111/j.1151-2916.1988.tb06383.x; Salje EKH, 2005, ACTA CRYSTALLOGR A, V61, P3, DOI 10.1107/S0108767304020318; Uchino K., 1989, P MRS INT M ADV MAT, V9, P489; Ungar T, 2010, METALL MATER TRANS A, V41A, P1202, DOI 10.1007/s11661-009-9961-7; Viehland DD, 2014, ADV PHYS, V63, P267, DOI 10.1080/00018732.2014.974304; Wang DP, 2012, EPL-EUROPHYS LETT, V98, DOI 10.1209/0295-5075/98/46004; Wang Y, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.225703; Wang Y, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.132201	30	0	0	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	AUG	2015	48		4				1183	1191		10.1107/S1600576715011334		9	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CN9TL	WOS:000358791900022		
J	Nespolo, M				Nespolo, Massimo			The ash heap of crystallography: restoring forgotten basic knowledge	JOURNAL OF APPLIED CRYSTALLOGRAPHY			English	Article						crystal forms; systematic absences; Miller indices; symmetry restrictions; crystallographic education	INTEGRAL LATTICES; BRAVAIS; MORPHOLOGY; CRYSTALS	A critical analysis of some basic notions often overlooked in crystallographic education is presented to correct some common oversights occurring both in the literature and in textbooks. The crystal forms (face forms), defined in terms of their geometric eigensymmetry, are 47 in number, not 48 as often found in the literature. The split of the dihedron into dome and sphenoid calls for the consideration of the physical properties of the faces building a form; in that case, however, the same criterion should be used for all forms. By taking the handedness of the faces as representative of the physical properties of the faces, the occurrence of 128 crystallographic face forms (97 affine face forms and 31 enantiomorphic pairs) is demonstrated. Next, the correct use of non-coprime Miller indices when a centred unit cell is adopted is shown, and the inconsistent multiplication of Miller indices in the Bravais-Friedel-Donnay-Harker law is pointed out. A geometric derivation of the reflection conditions is reviewed. Finally, the inconsistent presentation of metric restrictions imposed by the structural symmetry is pointed out and corrected.	Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan	Nespolo, M (reprint author), Tokyo Inst Technol, Mat & Struct Lab, Midori Ku, Yokohama, Kanagawa 2268503, Japan.	massimo.nespolo@crm2.uhp-nancy.fr					Nespolo M, 2007, ACTA CRYSTALLOGR A, V63, P278, DOI 10.1107/S0108767307012135; Donnay JDH, 1937, AM MINERAL, V22, P446; Buerger M. J., 1942, XRAY CRYSTALLOGRAPHY; Donnay J. D. H., 1936, AM MIN 2, V21, P4; Friedel G., 1907, B SOC FR MINERAL CR, V30, P326; Friedel Georges, 1926, LECONS CRISTALLOGRAP; Grimmer H, 2015, ACTA CRYSTALLOGR A, V71, P143, DOI 10.1107/S2053273314027351; Hahn Th, 2005, INT TABLES CRYSTALLO, VA; HARTMAN P, 1955, ACTA CRYSTALLOGR, V8, P49, DOI 10.1107/S0365110X55000121; Janner A, 2004, ACTA CRYSTALLOGR A, V60, P198, DOI 10.1107/S0108767304003101; Janner A, 2004, ACTA CRYSTALLOGR A, V60, P611, DOI 10.1107/S0108767304022627; Leopardi G., 1836, POEMS; Li L, 2010, J APPL CRYSTALLOGR, V43, P1108, DOI 10.1107/S0021889810029493; Nespolo M, 2010, J APPL CRYSTALLOGR, V43, P1144, DOI 10.1107/S0021889810023915; Nespolo M, 2009, Z KRISTALLOGR, V224, P127, DOI 10.1524/zkri.2009.1107; Schmueli U., 2008, INT TABLES CRYSTALLO, V3rd; Sunagawa I., 2005, CRYSTALS GROWTH MORP; Ungemach H, 1935, Z KRISTALLOGR, V91, P97	18	1	1	INT UNION CRYSTALLOGRAPHY	CHESTER	2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND	1600-5767			J APPL CRYSTALLOGR	J. Appl. Crystallogr.	AUG	2015	48		4				1290	1298		10.1107/S1600576715011206		9	Chemistry, Multidisciplinary; Crystallography	Chemistry; Crystallography	CN9TL	WOS:000358791900032		
J	Andrade, JCS; de Oliveira, JAP				Silveira Andrade, Jose Celio; de Oliveira, Jose Antonio Puppim			The Role of the Private Sector in Global Climate and Energy Governance	JOURNAL OF BUSINESS ETHICS			English	Article						Architecture; Climate change; Energy; Governance; Private sector	BRAZIL	The private sector plays an active role in implementation of mechanisms concerning the mitigation of climate change. In spite of that, the corporate actors play a limited direct role in international arenas when it comes to negotiating the design of climate and energy regime. The climate and energy governance in the United Nations system remains mostly state-centric, but the active participation of corporate actors in negotiation of climate and energy regimes is essential to increase the effectiveness of their governance. Business is not just a subject of a regulatory climate and energy imposed by the state; rather, business is an intrinsic part of the fabric of climate and energy governance, as "rule-maker," particularly in the many voluntary regimes. However, the architecture in place should guarantee that the private sector does not highjack the decisions and its positions are balanced by other non-governmental actors in the process. This article analyzes the role that the private sector can play in the global climate and energy governance. The private sector does not only play a "rule taker" role in the climate change and energy regime. Indeed, they are not passive observers as they influence through indirect means. The results suggest that the private sector is able to play a key role in global climate and energy governance based on the principle of multi-stakeholder participation in global decision-making, but the architecture should be able to balance the goods and bads of private direct influence in international regimes.	[Silveira Andrade, Jose Celio] Univ Fed Bahia, Sch Management, Salvador, BA, Brazil; [de Oliveira, Jose Antonio Puppim] UNU IAS, Tokyo, Japan	Andrade, JCS (reprint author), Univ Fed Bahia, Sch Management, Salvador, BA, Brazil.	jcelio.andrade@gmail.com; puppim@ias.unu.edu					Andrade J. C. S., 2009, CRITIQUE INT, V45, P119; Knox-Hayes J, 2011, STRATEG ORGAN, V9, P91, DOI 10.1177/1476127010395066; Prado-Lorenzo JM, 2010, J BUS ETHICS, V97, P391, DOI 10.1007/s10551-010-0515-0; Eberlein B, 2009, J BUS ETHICS, V86, P241, DOI 10.1007/s10551-009-0194-x; Rasche A, 2012, BUS ETHICS, V21, P100, DOI 10.1111/j.1467-8608.2011.01642.x; Backstrand K., 2006, European Environment, V16, DOI 10.1002/eet.425; Benedick Richard E., 1998, OZONE DIPLOMACY NEW; Bled A., 2007, POLITICAL PERSPECTIV, V1, P20; Brown J. W, 1996, GLOBAL ENV POLITICS; Bruhl T., 2002, P 2001 BERL C HUM DI, P371; Bruno K., 2002, GREENWASH 10 UNS GLO; Bulkeley H, 2007, 112 TYND CTR; Campbell L., 1998, GLOBAL CLIMATE GOVER, P15; CDP, 2013, MEMB SIGN; Clapp J., 2005, GLOBAL ENVIRON POLIT, V5, P23, DOI 10.1162/1526380054794916; Clapp Jennifer, 2005, PATHS GREEN WORLD PO; Dawkins, 2011, J BUS ETHICS, V100, P303; de Oliveira JAP, 2005, J PLAN EDUC RES, V24, P420, DOI 10.1177/0739456X04270196; Dunn S., 2005, BUSINESS CLIMATE CHA, P31; Falkner R., 2007, BUSINESS POWER CONFL; Falkner R., 2003, GLOBAL ENVIRON POLIT, V3, P78, DOI DOI 10.1162/152638003322068227; Gangale F, 2011, INT J SUST DEV WORLD, V18, P283, DOI 10.1080/13504509.2011.553354; Garcia-Johnson R, 2000, EXPORTING ENV US MUL; ICE, 2013, CHIC CLIM EXCH; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; IPCC, 2013, CLIMATE CHANGE 2013; Ivanova M., 2007, RECIEL, V16, P123, DOI 10.1111/j.1467-9388.2007.00558.x; Kalfagianni A, 2014, J BUS ETHICS, V122, P307, DOI 10.1007/s10551-013-1747-6; Kanie N, 2013, ENVIRONMENT, V55, P14, DOI 10.1080/00139157.2013.824339; Karakosta C, 2012, INT J SUST DEV WORLD, V19, P311, DOI 10.1080/13504509.2011.644638; Karakosta C, 2013, INT J SUST DEV WORLD, V20, P1, DOI 10.1080/13504509.2012.752768; Kolk A., 2007, EUROPEAN MANAGEMENT, V25, P411, DOI 10.1016/j.emj.2007.08.003; Kolk A, 2007, BUSINESS SOC, V46, P201, DOI 10.1177/0007650307301383; Kollmuss A, 2008, MAKING SENSE VOLUNTA; Kulovesi K., 2007, RECIEL, V16, P145, DOI 10.1111/j.1467-9388.2007.00551.x; Le Prestre P., 2005, PROTECTION ENV RELAT; Levy D. L., 2002, BUSINESS POLITICS, V4, P275, DOI DOI 10.2202/1469-3569.1042; Levy D. L., 2008, BUSINESS STRATEGIES; Levy DL, 2000, ENVIRONMENT, V42, P8; Morgera E, 2006, REV EUROPEAN COMMUNI, V15, P93, DOI 10.1111/j.1467-9388.2006.00505.x; Newell P., 2005, BUSINESS GLOBAL ENV; Newell Peter, 2000, CLIMATE CHANGE NONST; ONeill K, 2009, THEME INT RELAT, P1, DOI 10.1017/CBO9780511805974; Peters G. F., 2013, J BUSINESS ETHICS; Pinkse J., 2009, INT BUSINESS GLOBAL; Pinto RF, 2008, PUBLIC ADMIN DEVELOP, V28, P340, DOI 10.1002/pad.516; Pulver S, 2005, BUSINESS CLIMATE CHA, P47; Rasche A, 2008, J BUS ETHICS, V80, P151, DOI 10.1007/s10551-007-9418-0; Ruggie John, 2002, J CORPORATE CITIZENS, V2002, P27; Sampson G, 1998, GLOBAL CLIMATE GOVER, P12; Schmidheiny S., 1992, CHANGING COURSE GLOB; Sethi SP, 2014, J BUS ETHICS, V122, P193, DOI 10.1007/s10551-013-1629-y; STRECK C, 2004, J ENVIRON DEV, V13, P295, DOI 10.1177/1070496504268696; Taiyab N., 2006, GLOBAL ENV GOVERNANC; Thistlethwaite J., 2012, BUSINESS CLIMATE POL, P53; United Nations Global Compact, 2014, GLOB COMP GOV	56	0	0	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0167-4544	1573-0697		J BUS ETHICS	J. Bus. Ethics	AUG	2015	130	2					375	387		10.1007/s10551-014-2235-3		13	Business; Ethics	Business & Economics; Social Sciences - Other Topics	CN9WV	WOS:000358802100009		
J	Hensley, MT; de Andrade, J; Keene, B; Meurs, K; Tang, JN; Wang, ZG; Caranasos, TG; Piedrahita, J; Li, TS; Cheng, K				Hensley, Michael Taylor; de Andrade, James; Keene, Bruce; Meurs, Kathryn; Tang, Junnan; Wang, Zegen; Caranasos, Thomas G.; Piedrahita, Jorge; Li, Tao-Sheng; Cheng, Ke			Cardiac regenerative potential of cardiosphere-derived cells from adult dog hearts	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						cardiosphere-derived cells; dogs; dilated cardiomyopathy; stem cell therapy	STEM-CELLS; DILATED CARDIOMYOPATHY; DOBERMAN-PINSCHER; INFARCTION; EXPRESSION; EFFICACY; MODEL	The regenerative potential of cardiosphere-derived cells (CDCs) for ischaemic heart disease has been demonstrated in mice, rats, pigs and a recently completed clinical trial. The regenerative potential of CDCs from dog hearts has yet to be tested. Here, we show that canine CDCs can be produced from adult dog hearts. These cells display similar phenotypes in comparison to previously studied CDCs derived from rodents and human beings. Canine CDCs can differentiate into cardiomyocytes, smooth muscle cells and endothelial cells in vitro. In addition, conditioned media from canine CDCs promote angiogenesis but inhibit cardiomyocyte death. In a doxorubicin-induced mouse model of dilated cardiomyopathy (DCM), intravenous infusion of canine CDCs improves cardiac function and decreases cardiac fibrosis. Histology revealed that injected canine CDCs engraft in the mouse heart and increase capillary density. Out study demonstrates the regenerative potential of canine CDCs in a mouse model of DCM.	[Hensley, Michael Taylor; de Andrade, James; Tang, Junnan; Piedrahita, Jorge; Cheng, Ke] N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27695 USA; [Keene, Bruce; Meurs, Kathryn] N Carolina State Univ, Coll Vet Med, Dept Clin Sci, Raleigh, NC USA; [Meurs, Kathryn; Piedrahita, Jorge; Cheng, Ke] N Carolina State Univ, Ctr Comparat Med & Translat Res, Raleigh, NC 27695 USA; [Tang, Junnan] Zhengzhou Univ, Affiliated Hosp 1, Coll Med, Dept Cardiol, Zhengzhou 450052, Peoples R China; [Wang, Zegen; Cheng, Ke] Soochow Univ, Cyrus Tang Hematol Ctr, Suzhou, Peoples R China; [Caranasos, Thomas G.] Univ N Carolina, Div Cardiothorac Surg, Chapel Hill, NC USA; [Li, Tao-Sheng] Nagasaki Univ, Atom Bomb Dis Inst, Dept Stem Cell Biol, Nagasaki 852, Japan; [Cheng, Ke] Univ N Carolina, Joint Dept Biomed Engn, Chapel Hill, NC USA; [Cheng, Ke] N Carolina State Univ, Chapel Hill, NC USA	Cheng, K (reprint author), N Carolina State Univ, Coll Vet Med, Dept Mol Biomed Sci, Raleigh, NC 27695 USA.	ke_cheng@unc.edu			American Heart Association [12BGIA12040477]; NC State University Chancellor's Faculty Excellence Program; NC State University Center for Comparative Medicine and Translational Researches; National Natural Science Foundation of China [H020381370216]; CNPq, Brazil; Atomic Bomb Disease Institute at Nagasaki University, Nagasaki, Japan	This study was supported by funding from American Heart Association 12BGIA12040477, NC State University Chancellor's Faculty Excellence Program, NC State University Center for Comparative Medicine and Translational Researches and National Natural Science Foundation of China H020381370216. J.D.A. is supported by CNPq, Brazil. The study is also partially supported by the 2014 Cooperative Research Grant(s) of Atomic Bomb Disease Institute at Nagasaki University, Nagasaki, Japan.	Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Kapoor N, 2013, NAT BIOTECHNOL, V31, P54, DOI 10.1038/nbt.2465; Cheng K, 2012, STEM CELLS, V30, P2835, DOI 10.1002/stem.1184; Kapoor N, 2011, J BIOL CHEM, V286, P14073, DOI 10.1074/jbc.M110.185298; Gago-Lopez N, 2014, STEM CELL REP, V2, P576, DOI 10.1016/j.stemcr.2014.03.003; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cheng K, 2012, CELL TRANSPLANT, V21, P1121, DOI 10.3727/096368911X627381; Shen DL, 2012, J CELL MOL MED, V16, P2112, DOI 10.1111/j.1582-4934.2011.01512.x; Li TS, 2010, STEM CELLS, V28, P2088, DOI 10.1002/stem.532; Li TS, 2012, J AM COLL CARDIOL, V59, P942, DOI 10.1016/j.jacc.2011.11.029; Lee ST, 2011, J AM COLL CARDIOL, V57, P455, DOI 10.1016/j.jacc.2010.07.049; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Cheng K, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001260; ClinicalTrials.gov, 2011, ALL HEART STEM CELLS; Davis DR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007195; Giacomello A, 2005, World patent, Patent No. [WO2005012510, 2005012510]; Ma Y, 2012, PLOS ONE, V7, P1; Malliaras K, 2012, EMBO MOL MED, V5, P191; Malliaras K, 2014, J AM COLL CARDIOL, V63, P110, DOI 10.1016/j.jacc.2013.08.724; Meurs KM, 2007, J VET INTERN MED, V21, P1016, DOI 10.1892/0891-6640(2007)21[1016:APGEOF]2.0.CO;2; Schiller N B, 1989, J Am Soc Echocardiogr, V2, P358; SMUCKER ML, 1990, J AM COLL CARDIOL, V16, P200; Tseliou E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088590; Wess G, 2010, J VET INTERN MED, V24, P533, DOI 10.1111/j.1939-1676.2010.0479.x; Zhang YQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012559	28	1	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1582-4934			J CELL MOL MED	J. Cell. Mol. Med.	AUG	2015	19	8					1805	1813		10.1111/jcmm.12585		9	Cell Biology; Medicine, Research & Experimental	Cell Biology; Research & Experimental Medicine	CO1OO	WOS:000358925100005		
J	Ibaraki, M; Ohmura, T; Matsubara, K; Kinoshita, T				Ibaraki, Masanobu; Ohmura, Tomomi; Matsubara, Keisuke; Kinoshita, Toshibumi			Reliability of CT perfusion-derived CBF in relation to hemodynamic compromise in patients with cerebrovascular steno-occlusive disease: a comparative study with O-15 PET	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						brain imaging; cerebral blood flow measurement; cerebrovascular disease; hemodynamics; positron emission tomography	CEREBRAL-BLOOD-FLOW; POSITRON-EMISSION-TOMOGRAPHY; SUSCEPTIBILITY CONTRAST MRI; SINGULAR-VALUE DECOMPOSITION; ACUTE ISCHEMIC-STROKE; DECONVOLUTION ALGORITHMS; INTRAVASCULAR TRACER; CLINICAL-EXPERIENCE; OXYGEN-METABOLISM; QUANTIFICATION	In the bolus tracking technique with computed tomography (CT) or magnetic resonance imaging, cerebral blood flow (CBF) is computed from deconvolution analysis, but its accuracy is unclear. To evaluate the reliability of CT perfusion (CTP)-derived CBF, we examined 27 patients with symptomatic or asymptomatic unilateral cerebrovascular steno-occlusive disease. Results from three deconvolution algorithms, standard singular value decomposition (sSVD), delay-corrected SVD (dSVD), and block-circulant SVD (cSVD), were compared with O-15 positron emission tomography (PET) as a reference standard. To investigate CBF errors associated with the deconvolution analysis, differences in lesion-to-normal CBF ratios between PET and CTP were correlated with prolongation of arterial-tissue delay (ATD) and mean transit time (MTT) in the lesion hemisphere. Computed tomography perfusion results strongly depended on the deconvolution algorithms used. Standard singular value decomposition showed ATD-dependent underestimation of CBF ratio, whereas cSVD showed overestimation of the CBF ratio when MTT was severely prolonged in the lesions. The computer simulations reproduced the trend observed in patients. Deconvolution by dSVD can provide lesion-to-normal CBF ratios less dependent on ATD and MTT, but requires accurate ATD maps in advance. A practical and accurate method for CTP is required to assess CBF in patients with MTT-prolonged regions.	[Ibaraki, Masanobu; Ohmura, Tomomi; Matsubara, Keisuke; Kinoshita, Toshibumi] Akita Res Inst Brain & Blood Vessels, Dept Radiol & Nucl Med, Akita 0100874, Japan	Ibaraki, M (reprint author), Akita Res Inst Brain & Blood Vessels, Dept Radiol & Nucl Med, 6-10 Senshu Kubota Machi, Akita 0100874, Japan.	iba@akita-noken.jp			JSPS KAKENHI Grant [23791461, 21791226]	This work was supported by JSPS KAKENHI Grant Number 23791461 and 21791226.	Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Smith MR, 2004, MAGNET RESON MED, V51, P631, DOI 10.1002/mrm.20006; Takeuchi R, 2004, EUR J NUCL MED MOL I, V31, P578, DOI 10.1007/s00259-003-1406-8; Ibaraki M, 2008, J NUCL MED, V49, P50, DOI 10.2967/jnumed.107.044008; GIBBS JM, 1984, LANCET, V1, P310; REMPP KA, 1994, RADIOLOGY, V193, P637; Konstas AA, 2009, AM J NEURORADIOL, V30, P662, DOI 10.3174/ajnr.A1487; Koenig M, 2001, STROKE, V32, P431; Kudo K, 2003, AM J NEURORADIOL, V24, P419; Willats L, 2013, NMR BIOMED, V26, P913, DOI 10.1002/nbm.2833; Kudo K, 2010, RADIOLOGY, V254, P200, DOI 10.1148/radiol.254082000; Klingebiel R, 2009, ACAD RADIOL, V16, P123, DOI 10.1016/j.acra.2008.11.004; Siebert E, 2009, BRIT J RADIOL, V82, P561, DOI 10.1259/bjr/27721218; Wintermark M, 2013, STROKE, V44, P2628, DOI 10.1161/STROKEAHA.113.002015; Ibaraki M, 2005, J CEREBR BLOOD F MET, V25, P378, DOI 10.1038/sj.jcbfm.9600037; Kudo K, 2013, RADIOLOGY, V267, P201, DOI 10.1148/radiol.12112618; Boutelier T, 2012, IEEE T MED IMAGING, V31, P1381, DOI 10.1109/TMI.2012.2189890; Bredno J, 2010, MAGN RESON MED, V64, P280, DOI 10.1002/mrm.22431; Calamante F, 2000, MAGNET RESON MED, V44, P466, DOI 10.1002/1522-2594(200009)44:3<466::AID-MRM18>3.0.CO;2-M; Ibaraki M, 2010, J CEREBR BLOOD F MET, V30, P1296, DOI 10.1038/jcbfm.2010.13; Kudo K, 2009, RADIOLOGY, V251, P241, DOI 10.1148/radiol.2511080983; LASSEN NA, 1984, J CEREBR BLOOD F MET, V4, P633; Leiva-Salinas C, 2012, NEURORADIOLOGY, V54, P907, DOI 10.1007/s00234-012-1028-6; MacDonald ME, 2011, MAGN RESON IMAGING, V29, P620, DOI 10.1016/j.mri.2011.02.024; Mehndiratta A, 2013, NEUROIMAGE, V64, P560, DOI 10.1016/j.neuroimage.2012.08.083; Murayama K, 2014, J COMPUT ASSIST TOMO, V38, P639, DOI 10.1097/RCT.0000000000000110; Murayama K, 2009, RADIOLOGY, V250, P202, DOI 10.1148/radiol.2501071809; POWERS WJ, 1984, ANN NEUROL, V16, P546, DOI 10.1002/ana.410160504; Riordan AJ, 2013, AM J NEURORADIOL, V34, P1353, DOI 10.3174/ajnr.A3397; Salluzzi M, 2005, MAGN RESON IMAGING, V23, P481, DOI 10.1016/j.mri.2004.12.001; Sasaki M, 2009, AM J NEURORADIOL, V30, P188, DOI 10.3174/ajnr.A1274; SETTE G, 1989, BRAIN, V112, P931, DOI 10.1093/brain/112.4.931; Shinohara Y, 2010, J COMPUT ASSIST TOMO, V34, P830, DOI 10.1097/RCT.0b013e3181ebd16a; Ibaraki M, 2011, PHYS MED BIOL, V56, P3061, DOI 10.1088/0031-9155/56/10/011; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522	35	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2015	35	8					1280	1288		10.1038/jcbfm.2015.39		9	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CN9WN	WOS:000358801300009		
J	Ishibashi, K; Kawasaki, K; Ishiwata, K; Ishii, K				Ishibashi, Kenji; Kawasaki, Keiichi; Ishiwata, Kiichi; Ishii, Kenji			Reduced uptake of F-18-FDG and O-15-H2O in Alzheimer's disease-related regions after glucose loading	JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM			English	Article						F-18-FDG; O-15-H2O; Alzheimer's disease; glucose; insulin	CEREBRAL-BLOOD-FLOW; MILD COGNITIVE IMPAIRMENT; POSITRON-EMISSION-TOMOGRAPHY; DEFAULT-MODE NETWORK; ACUTE HYPERGLYCEMIA; INSULIN-RESISTANCE; SERUM GLUCOSE; FDG-PET; BRAIN; METABOLISM	Increased plasma glucose levels are known to reduce fluorine-18-labeled fluorodeoxyglucose (F-18-FDG) uptake in Alzheimer's disease (AD)-related regions, resulting in the appearance of an AD-like pattern. However, the relationships of its appearance with cerebral blood flow and insulin levels are uncertain. We performed F-18-FDG and oxygen-15-labeled water (O-15-H2O) positron emission tomography in the fasting and glucose-loading conditions on nine young healthy volunteers with no cognitive impairments. Measurement of plasma glucose and insulin levels confirmed that all subjects were free of insulin resistance, and that glucose loading significantly increased plasma glucose and insulin levels. Fluorine-18-labeled fluorodeoxyglucose and O-15-H2O images were compared between the two conditions, focusing on AD-related regions: precuneus/posterior cingulate (PP), lateral parietal cortex (LPC), and frontal cortex (FC). Volume-of-interest analyses showed significantly lower uptake of both F-18-FDG and O-15-H2O in PP, LPC, and FC after glucose loading (P < 0.05). Whole-brain voxel-wise analyses also revealed the PP, LPC, and FC areas where uptake of both F-18-FDG and O-15-H2O decreased (P<0.05, family wise error rate-corrected). We concluded that increased plasma glucose and insulin levels can cause the appearance of the AD-like pattern in both F-18-FDG and O-15-H2O images, and this phenomenon can occur even in subjects without insulin resistance.	[Ishibashi, Kenji; Kawasaki, Keiichi; Ishiwata, Kiichi; Ishii, Kenji] Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Tokyo 1730015, Japan	Ishibashi, K (reprint author), Tokyo Metropolitan Inst Gerontol, Res Team Neuroimaging, Itabashi Ku, 35-2 Sakae Cho, Tokyo 1730015, Japan.	ishibashi@pet.tmig.or.jp			Nakayama Foundation for Human Science	This work was supported in part by Nakayama Foundation for Human Science (to KIshibashi).	Matsuzaki T, 2010, NEUROLOGY, V75, P764, DOI 10.1212/WNL.0b013e3181eee25f; Yakushev I, 2009, NEUROIMAGE, V44, P43, DOI 10.1016/j.neuroimage.2008.07.015; FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003; Baker LD, 2011, ARCH NEUROL-CHICAGO, V68, P51, DOI 10.1001/archneurol.2010.225; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; DUCKROW RB, 1987, STROKE, V18, P52; Grillo CA, 2009, BRAIN RES, V1296, P35, DOI 10.1016/j.brainres.2009.08.005; Musen G, 2012, DIABETES, V61, P2375, DOI 10.2337/db11-1669; Burns CM, 2013, NEUROLOGY, V80, P1557, DOI 10.1212/WNL.0b013e31828f17de; Langbaum JBS, 2009, NEUROIMAGE, V45, P1107, DOI 10.1016/j.neuroimage.2008.12.072; Hara T, 2009, ANN NUCL MED, V23, P657, DOI 10.1007/s12149-009-0288-7; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sperling RA, 2009, NEURON, V63, P178, DOI 10.1016/j.neuron.2009.07.003; Hasselbalch SG, 2001, J CLIN ENDOCR METAB, V86, P1986, DOI 10.1210/jc.86.5.1986; PHELPS ME, 1979, ANN NEUROL, V6, P371, DOI 10.1002/ana.410060502; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; RAICHLE ME, 1983, J NUCL MED, V24, P790; Binnewijzend MAA, 2013, RADIOLOGY, V267, P221, DOI 10.1148/radiol.12120928; BRONDSTED HE, 1990, ACTA NEUROL SCAND, V81, P233; CAMBIEN F, 1987, ARTERIOSCLEROSIS, V7, P197; Chen CH, 1999, INT J CARDIOL, V68, P179, DOI 10.1016/S0167-5273(98)00366-0; DUCKROW RB, 1987, J NEUROCHEM, V48, P989, DOI 10.1111/j.1471-4159.1987.tb05614.x; Gray SM, 2014, DIABETES, V63, P3992, DOI 10.2337/db14-0340; HARIK SI, 1988, J NEUROCHEM, V51, P1924, DOI 10.1111/j.1471-4159.1988.tb01179.x; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Ishibashi K, 2014, J ALZHEIMERS DIS, V42, P385, DOI 10.3233/JAD-140639; Ishibashi K, 2015, J NUCL MED, V56, P229, DOI 10.2967/jnumed.114.150045; Kawasaki K, 2008, ANN NUCL MED, V22, P191, DOI 10.1007/s12149-007-0099-7; KNUDSEN GM, 1992, NEUROREPORT, V3, P987, DOI 10.1097/00001756-199211000-00010; LUCIGNANI G, 1987, J CEREBR BLOOD F MET, V7, P309; Marian T, 2001, ACTA BIOL HUNG, V52, P35, DOI 10.1556/ABiol.52.2001.1.5; Matsuda H, 2001, ANN NUCL MED, V15, P85, DOI 10.1007/BF02988596; ORZI F, 1988, J CEREBR BLOOD F MET, V8, P346; Poline JB, 1996, NEUROIMAGE, V4, P34, DOI 10.1006/nimg.1996.0027; SUHONENPOLVI H, 1995, J NUCL MED, V36, P1249; WAHL RL, 1992, RADIOLOGY, V183, P643; WANG GJ, 1994, J NUCL MED, V35, P1457; Wang L, 2013, JAMA NEUROL, V70, P1242, DOI 10.1001/jamaneurol.2013.3253; Wienhard K, 2002, METHODS, V27, P218, DOI 10.1016/S1046-2023(02)00077-4; YAMADA K, 1985, EUR J NUCL MED, V10, P341	42	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	0271-678X	1559-7016		J CEREBR BLOOD F MET	J. Cereb. Blood Flow Metab.	AUG	2015	35	8					1380	1385		10.1038/jcbfm.2015.127		6	Endocrinology & Metabolism; Hematology; Neurosciences	Endocrinology & Metabolism; Hematology; Neurosciences & Neurology	CN9WN	WOS:000358801300020		
J	Ohtsu, Y; Otsuka, S; Nakamura, T; Noguchi, K				Ohtsu, Yoshiaki; Otsuka, Shohei; Nakamura, Takeshi; Noguchi, Kiyoshi			Regulated bioanalysis of conformers - A case study with ASP2151 in dog plasma and urine	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						ASP2151; Plasma; Regulated bioanalysis; Column-switching; LC-MS/MS; Conformer	HELICASE-PRIMASE INHIBITOR; ASSISTED-LASER-DESORPTION/IONIZATION; PERFORMANCE LIQUID-CHROMATOGRAPHY; REACTION MONITORING MODE; VARICELLA-ZOSTER-VIRUS; GENITAL HERPES; SOLVENT SELECTIVITY; MASS-SPECTROMETRY; TYPE-2 INFECTION; INTERCONVERSION	We developed and validated bioanalytical methods for a potent helicase-primase inhibitor ASP2151 that has two conformers. These conformers elute as unseparated broad peaks under ordinary high-performance liquid chromatographic conditions, indicating discernable differences in hydrophobicity. We observed that column temperature and mobile phase pH have no effect on these peaks and that conformers form a single symmetrical peak when tetrahydrofuran is added to the mobile phase. In addition, we needed to develop semi-automated methods where inter-conversion of the conformers is unlikely to cause sample-to-sample extraction variability. Briefly, following the addition of deuteriumlabeled ASP2151 as an internal standard (IS), dog plasma samples or acetonitrile-added urine samples were filtrated. The filtrates were then injected into a column-switching liquid chromatography tandem mass spectrometry (LC-MS/MS) system and trapped onto an extraction column. Extracts were back-flushed onto an analytical C18 column (4.6 x 50 mm, 3 mu m) with a mobile phase consisting of methanol, tetrahydrofuran, and 20 mmol/L ammonium acetate (45:5:50, v/v/v). The eluent was monitored in the negative atmospheric pressure chemical ionization mode. The calibration curve was linear over a range of 5-1000 ng/mL for plasma and 0.5-100 mu g/mL for urine. Validation data met the acceptance criteria in accordance with regulatory guidance and demonstrated that these methods were selective, accurate, and reproducible. In addition, the present methods were successfully applied to a pharmacokinetic study in dogs. (C) 2015 Elsevier B.V. All rights reserved.	[Ohtsu, Yoshiaki; Noguchi, Kiyoshi] Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Osaka 5328514, Japan; [Otsuka, Shohei; Nakamura, Takeshi] Shin Nippon Biomed Labs Ltd, Pharmacokinet & Bioanal Ctr, Kainan, Japan	Ohtsu, Y (reprint author), Astellas Pharma Inc, Anal & Pharmacokinet Res Labs, Yodogawa Ku, 1-6 Kashima,2 Chome, Osaka 5328514, Japan.	yoshiaki.ohtsu@zoho.com		Otsu, Yoshiaki/0000-0003-0494-5717	Astellas Pharma	Yoshiaki Ohtsu and Kiyoshi Noguchi are employees of Astellas Pharma. Shohei Otsuka was an employee of Shin Nippon Biomedical Laboratories when the planning and experimental phase of this research was conducted. Shohei Otsuka is now an employee of Medipolis Medical Research Institute. Takeshi Nakamura is an employee of Shin Nippon Biomedical Laboratories. This research was funded by Astellas Pharma.	Tyring S, 2012, J INFECT DIS, V205, P1100, DOI 10.1093/infdis/jis019; BOWERS LD, 1985, J CHROMATOGR, V333, P231, DOI 10.1016/S0021-9673(01)87348-9; Weller SK, 2013, EXPERT OPIN THER TAR, V17, P1119, DOI 10.1517/14728222.2013.827663; Yu SX, 2009, ANAL CHEM, V81, P193, DOI 10.1021/ac801734t; Rizzo V, 1999, J PHARM SCI, V88, P73, DOI 10.1021/js980225w; Katsumata K, 2013, ANTIMICROB AGENTS CH, V57, P1339, DOI 10.1128/AAC.01803-12; SNYDER LR, 1974, J CHROMATOGR, V92, P223, DOI 10.1016/S0021-9673(00)85732-5; Katsumata K, 2011, MOLECULES, V16, P7210, DOI 10.3390/molecules16097210; Looker KJ, 2008, B WORLD HEALTH ORGAN, V86, P805, DOI 10.2471/BLT.07.046128; Gupta R, 2007, LANCET, V370, P2127, DOI 10.1016/S0140-6736(07)61908-4; Jackson AU, 2010, ANALYST, V135, P927, DOI 10.1039/b920155f; Chono K, 2010, J ANTIMICROB CHEMOTH, V65, P1733, DOI 10.1093/jac/dkq198; Whitley RJ, 1998, CLIN INFECT DIS, V26, P541, DOI 10.1086/514600; Wagner M, 2008, J CHROMATOGR B, V872, P68, DOI 10.1016/j.jchromb.2008.07.009; BAKALYAR SR, 1977, J CHROMATOGR, V142, P353, DOI 10.1016/S0021-9673(01)92050-3; Bouabdallah S, 2003, J PHARMACEUT BIOMED, V31, P731, DOI 10.1016/S0731-7085(02)00661-1; Chernetsova ES, 2011, BIOANAL REV, V3, P1, DOI 10.1007/s12566-010-0019-5; Chono K, 2012, BIOCHEM PHARMACOL, V84, P459, DOI 10.1016/j.bcp.2012.05.020; Chono K, 2013, ANTIVIR RES, V97, P154, DOI 10.1016/j.antiviral.2012.12.006; DONDI F, 1989, J CHROMATOGR, V461, P281, DOI 10.1016/S0021-9673(00)94295-X; FDA, 2001, GUID IND BIOAN METH; Hashi Y., 2004, ASIAN J DRUG METAB P, V4, P177; Himaki T, 2012, ANTIVIR RES, V93, P301, DOI 10.1016/j.antiviral.2011.11.015; ICH, 2009, GUID NONCL SAF STUD; ICH, 1994, NOT GUID TOX ASS SYS; Katsumata K, 2012, ANTIMICROB AGENTS CH, V56, P3587, DOI 10.1128/AAC.00133-12; Kovarik P, 2007, RAPID COMMUN MASS SP, V21, P911, DOI 10.1002/rcm.2912; Nicolas O, 2005, CLIN CHEM, V51, P593, DOI 10.1373/clinchem.2004.042580; NISHIKAWA T, 1993, PHARMACEUT RES, V10, P1785, DOI 10.1023/A:1018938618032; Sasaki S, 2013, BRIT J OPHTHALMOL, V97, P498, DOI 10.1136/bjophthalmol-2012-302062; TANAKA N, 1978, J CHROMATOGR, V158, P233, DOI 10.1016/S0021-9673(00)89970-7; Yang SH, 2013, J SEP SCI, V36, P2922, DOI 10.1002/jssc.201300595; Yoshida T., 2012, COLLOID POLYM SCI, V291, P1191	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	AUG 1	2015	997						56	63		10.1016/j.jchromb.2015.05.028		8	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CO0BZ	WOS:000358816400008		
J	Onozato, M; Nishikiori, M; Iizuka, H; Ichiba, H; Sadamoto, K; Fukushima, T				Onozato, Mayu; Nishikiori, Minami; Iizuka, Hideaki; Ichiba, Hideaki; Sadamoto, Kiyomi; Fukushima, Takeshi			Determination of sex-based differences in serum gamma-linoleic acid and dihomo-gamma-linoleic acid using gas chromatography-mass spectrometry	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Polyunsaturated fatty acid; gamma-Linoleic acid; Dihomo-gamma-linoleic acid; Human serum; Sex-based difference	FREE FATTY-ACIDS; PERFORMANCE LIQUID-CHROMATOGRAPHY; FLUORESCENT LABELING REAGENT; CARBOXYLIC-ACIDS; DOCOSAHEXAENOIC ACID; BILE-ACID; SCHIZOPHRENIA; DEPRESSION; METABOLISM; PLASMA	Because serum unsaturated fatty acids can provide useful information on disease diagnosis, the simultaneous determination of several fatty acids in small volumes of human serum would be beneficial for clinical applications. In the present study, serum fatty acids were extracted with n-heptane/chloroform from 10 mu L of serum collected from 26 healthy Japanese subjects (11 men, ages 23-37 years; 15 women, ages 18-37 years) after deproteinization with perchloric acid, derivatization to their methyl ester using p-toluenesulfonic acid as an acid catalyst, and subsequent separation and measurement by gas chromatography-mass spectrometry (GC-MS) in the selected ion monitoring mode. Nine types of fatty acids (palmitoleic acid [PLA], oleic acid [OA], lenoleic acid [LA], gamma-linolenic acid [GLA], alpha-linolenic acid [ALA], dihomo-GLA [DGLA], arachidonic acid [AA], eicosapentaenoic acid [EPA], and docosahexaenoic acid [DHA]) were analyzed in the serum within 35 min by GC-MS. The concentrations of these fatty acids in serum ranged from 3.64 +/- 0.38 mu M (GLA) to 413 +/- 26.3 mu M (LA). Among these nine fatty acids, GLA and DGLA levels were significantly lower in women than in men (p = 0.0034 and 0.0012, respectively), suggesting that there may be sex-based differences in the biosynthetic production or metabolic processes of GLA and DGLA in humans. (C) 2015 Elsevier B.V. All rights reserved.	[Onozato, Mayu; Nishikiori, Minami; Iizuka, Hideaki; Ichiba, Hideaki; Fukushima, Takeshi] Toho Univ, Fac Pharmaceut Sci, Chiba 2748510, Japan; [Sadamoto, Kiyomi] Yokohama Coll Pharm, Fac Pharmaceut Sci, Totsuka Ku, Yokohama, Kanagawa 2450066, Japan	Fukushima, T (reprint author), Toho Univ, Fac Pharmaceut Sci, 2-2-1 Miyama, Chiba 2748510, Japan.	t-fukushima@phar.toho-u.ac.jp					NIMURA N, 1988, ANAL CHEM, V60, P2067, DOI 10.1021/ac00170a017; Horrocks LA, 2004, PROSTAG LEUKOTR ESS, V70, P361, DOI 10.1016/j.plefa.2003.12.011; Peet M, 2002, ARCH GEN PSYCHIAT, V59, P913, DOI 10.1001/archpsyc.59.10.913; Li GL, 2012, J CHROMATOGR B, V895, P191, DOI 10.1016/j.jchromb.2012.03.029; Frangou S, 2006, BRIT J PSYCHIAT, V188, P46, DOI 10.1192/bjp.188.1.46; BRENNER RR, 1974, MOL CELL BIOCHEM, V3, P41, DOI 10.1007/BF01660076; Sethom MM, 2010, PROSTAG LEUKOTR ESS, V83, P131, DOI 10.1016/j.plefa.2010.07.001; Bakewell L, 2006, BRIT J NUTR, V96, P93, DOI 10.1079/BJN20061801; Sumiyoshi T, 2011, PSYCHIAT RES, V186, P23, DOI 10.1016/j.psychres.2010.07.049; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Taha AY, 2013, J PSYCHIATR RES, V47, P636, DOI 10.1016/j.jpsychires.2013.01.016; Horrobin DF, 1999, PROSTAG LEUKOTR ESS, V60, P217, DOI 10.1054/plef.1999.0037; REAVEN GM, 1988, DIABETES, V37, P1020, DOI 10.2337/diabetes.37.8.1020; Sanchez-Avila N, 2009, J CHROMATOGR A, V1216, P6864, DOI 10.1016/j.chroma.2009.08.045; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Yuen AWC, 2005, EPILEPSY BEHAV, V7, P253, DOI 10.1016/j.yehbeh.2005.04.014; Wang DC, 2012, NEUROBIOL AGING, V33, P1057, DOI 10.1016/j.neurobiolaging.2010.09.013; Bzard J., 1994, REPROD NUTR DEV, V34, P539; Carmona MA, 2010, J FOOD ENG, V101, P210, DOI 10.1016/j.jfoodeng.2010.07.004; Das UN, 2013, PROG NEURO-PSYCHOPH, V42, P122, DOI 10.1016/j.pnpbp.2012.06.010; DAYAL B, 1981, STEROIDS, V37, P239, DOI 10.1016/S0039-128X(81)80021-9; HOLMAN RT, 1979, AM J CLIN NUTR, V32, P2390; HORROBIN DF, 1993, AM J CLIN NUTR, V57, P732; HORROBIN DF, 1981, MED HYPOTHESES, V7, P1211, DOI 10.1016/0306-9877(81)90064-5; Kotani A, 2002, ANAL CHIM ACTA, V465, P199, DOI 10.1016/S0003-2670(01)01520-3; Maekawa M, 2011, CURR PHARM DESIGN, V17, P168, DOI 10.2174/138161211795049615; MANKU MS, 1983, LIPIDS, V18, P906, DOI 10.1007/BF02534572; MILLER CC, 1988, PROSTAGLANDINS, V35, P917, DOI 10.1016/0090-6980(88)90116-5; NAKASHIMA K, 1993, J CHROMATOGR-BIOMED, V619, P1, DOI 10.1016/0378-4347(93)80440-F; Nishikiori M, 2015, J CHROMATOGR SCI, V53, P537, DOI 10.1093/chromsci/bmu081; Otsuka R., 2013, Journal of Japanese Society of Nutrition and Food Science, V66, P147, DOI 10.4327/jsnfs.66.147; Parker GB, 2006, PSYCHIAT RES, V141, P279, DOI 10.1016/j.psychres.2005.08.005; Scorza FA, 2009, PROSTAG LEUKOTR ESS, V81, P241, DOI 10.1016/j.plefa.2009.06.008; Sfar S., 2010, EXP GERONTOL, V45, P719; TAKAHASHI R, 1991, J NUTR SCI VITAMINOL, V37, P401; TOYOOKA T, 1991, J CHROMATOGR, V588, P61, DOI 10.1016/0021-9673(91)85008-4; TOYOOKA T, 1995, BIOMED CHROMATOGR, V9, P162, DOI 10.1002/bmc.1130090403; YAMAGUCHI M, 1989, ANAL SCI, V5, P35, DOI 10.2116/analsci.5.35; YASAKA Y, 1990, J CHROMATOGR, V508, P133, DOI 10.1016/S0021-9673(00)91246-9; YOSHIDA T, 1988, ANAL BIOCHEM, V173, P70, DOI 10.1016/0003-2697(88)90161-3	40	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	AUG 1	2015	997						116	121		10.1016/j.jchromb.2015.05.011		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CO0BZ	WOS:000358816400017		
J	Ogasawara, Y; Ishida, YI; Takikawa, M; Funaki, Y; Suzuki, T; Koike, S				Ogasawara, Y.; Ishida, Y. I.; Takikawa, M.; Funaki, Y.; Suzuki, T.; Koike, S.			A simple high performance liquid chromatography method for quantitatively determining the reduced form of peroxiredoxin 2 and the mass spectrometric analysis of its oxidative status	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Oxidative stress; Biomarker; High performance liquid chromatography; Peroxiredoxin 2; Red blood cell	CYSTEINE-SULFINIC ACID; CELL; BLOOD; STRESS; IDENTIFICATION; INACTIVATION; THIOREDOXIN; ERYTHROCYTE; MECHANISMS; EXPRESSION	Peroxiredoxins (Prxs) are a family of thiol peroxidases, which have been suggested to serve as biomarkers for diseases caused by oxidative stress. In this study, we established a high performance liquid chromatography (HPLC) method for quantifying the amount of Prx2 in red blood cells (RBCs). RBC proteins were separated using HPLC, and a single peak was detected that matched that produced by recombinant Prx2. Under improved conditions, the calibration curve for Prx2 (reduced form) was linear over the range of 0.5-20.0 mu g with a correlation coefficient of 0.999. The minimum detectable level of the recombinant Prx2 was 0.2 mu g, with a signal-to-noise ratio of 3 per 20 mu l of injection volume. SOS-PAGE and mass spectrometric analysis showed that the proteins comprising the peak were almost exclusively Prx2. Further high-resolution analysis using nanoLC-MS/MS demonstrated that the oxidation sensitive, Cys-51 was carbamidomethylated by iodoacetamide-alkylation during in-gel digestion but was not modified with sulfinic acid (-SO2H) or sulfonic acid (-SO3H). These results indicated that the separated Prx2 was the reduced form and not the hyperoxidized form. These basic experiments allowed us to determine the relative amounts of native Prx2 in RBCs taken from healthy subjects. The average levels of Prx2 in male and female subjects were 7.28 ng/mg and 8.29 ng/mg, respectively, and no significant difference was observed between the sexes. Therefore, the HPLC method with UV detection described herein offers a convenient method to quantitatively determine the levels of reduced form of Prx2 and its oxidative decrease in human RBCs. (C) 2015 Elsevier B.V. All rights reserved.	[Ogasawara, Y.; Takikawa, M.; Funaki, Y.; Suzuki, T.; Koike, S.] Meiji Pharmaceut Univ, Dept Analyt Biochem, Kiyose, Tokyo 2048588, Japan; [Ishida, Y. I.] Meiji Pharmaceut Univ, Dept Mol & Cellular Biochem, Kiyose, Tokyo 2048588, Japan	Ogasawara, Y (reprint author), Meiji Pharmaceut Univ, Dept Analyt Biochem, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan.	yo@my-pharm.ac.jp					CHAE HZ, 1994, J BIOL CHEM, V269, P27670; Low FM, 2007, BLOOD, V109, P2611, DOI 10.1182/blood-2006-09-048728; Yoshida Y, 2009, NEUROBIOL AGING, V30, P174, DOI 10.1016/j.neurobiolaging.2007.06.012; Yang KS, 2002, J BIOL CHEM, V277, P38029, DOI 10.1074/jbc.M206626200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Noh DY, 2001, ANTICANCER RES, V21, P2085; Hall A, 2009, FEBS J, V276, P2469, DOI 10.1111/j.1742-4658.2009.06985.x; Cumming RC, 2007, J BIOL CHEM, V282, P30523, DOI 10.1074/jbc.M700869200; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeadbiomed.2005.02.026; Moon JC, 2005, J BIOL CHEM, V280, P28775, DOI 10.1074/jbc.M505362200; Takeshita M, 2009, J BIOL CHEM, V284, P21165, DOI 10.1074/jbc.M109.004945; Ishida Y, 2014, HUM CELL, V27, P68, DOI 10.1007/s13577-013-0083-6; Bayer SB, 2013, FASEB J, V27, P3315, DOI 10.1096/fj.13-227298; Carta F, 2005, MELANOMA RES, V15, P235, DOI 10.1097/00008390-200508000-00002; Cha MK, 1995, BIOCHEM BIOPH RES CO, V217, P900, DOI 10.1006/bbrc.1995.2856; Ishida YI, 2014, FEBS OPEN BIO, V4, P848, DOI 10.1016/j.fob.2014.10.003; Kwon HS, 2012, LIFE SCI, V90, P502, DOI 10.1016/j.lfs.2012.01.003; Li Y, 2008, PROTEOMICS, V8, P1490, DOI 10.1002/pmic.200700229; Low F.M., 2007, ANTIOXID REDOX SIGN, V10, P1621; Memon AA, 2005, CANCER DETECT PREV, V29, P249, DOI 10.1016/j.cdp.2005.01.002; Park J., 2014, INT J CELL BIOL, V2014, P7158; Poynton RA, 2014, BBA-GEN SUBJECTS, V1840, P906, DOI 10.1016/j.bbagen.2013.08.001	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	AUG 1	2015	997						136	141		10.1016/j.jchromb.2015.06.007		6	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CO0BZ	WOS:000358816400020		
J	Nagamine, T; Hayakawa, K; Nakazato, K; Iha, M				Nagamine, Takeaki; Hayakawa, Kou; Nakazato, Kyoumi; Iha, Masahiko			Determination of the active transport of fucoidan derived from Okinawa Mozuku across the human intestinal Caco-2 cells as assessed by size-exclusion chromatography	JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES			English	Article						Fucoidan; Caco-2; Active transport; SEC; Azide; Uncoupler	GEL-PERMEATION CHROMATOGRAPHY; PROTEIN DETERMINATION; PERFORMANCE; BIOTINIDASE	Introduction: In order to clarify the mechanism of fucoidan transport, we developed the chromatographic determination method. Method: A size-exclusion chromatography (SEC) method for the determination of Okinawa-fucoidan using Develosil 300 Diol-5 (60 x 8.0 mm I.D., 30 nm pore-diameter) with the eluent containing 1% nonionic detergent is developed. Determination range (UV at 210 nm) is from 0 to 100 ng of fucoidan with the linear calibration line inserting to zero. Results: A transport activity of fucoidan is demonstrated by using Caco-2 cells (model of gut transport system); i.e., the initial transport velocity 12 nmol/h/mg of protein (25-fold slower rate as compared to a bacterial L-alanine active-transport activity 300 nmol/h/mg of protein) is found to occur. Since this fucoidan transport is inhibited by 10 mM sodium azide (respiration inhibitor) and 0.05 mM FCCP (uncoupler), this transport by Caco-2 cells is found to be an active one requiring energy-source. On the other hand, colchicine (inhibitor of phagocytosis/pinocytosis) and mannitol (putative competitive-inhibitor of tight-junction transport) cannot inhibit the fucoidan transport at all. Conclusion: We firstly report that the active transport occurs for such a high molecular-weight sulphated-polyfucose of fucoidan in vitro using Caco-2 cells. (C) 2015 Elsevier B.V. All rights reserved.	[Nagamine, Takeaki; Hayakawa, Kou; Nakazato, Kyoumi] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gumma 3718514, Japan; [Iha, Masahiko] South Prod Co Ltd, Uruma, Okinawa 9042234, Japan	Hayakawa, K (reprint author), 2-5-B-308 Fukiage Fujimi, Kohnosu City, Saitama, Japan.						Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; ANDREU JM, 1982, P NATL ACAD SCI-BIOL, V79, P6753, DOI 10.1073/pnas.79.22.6753; Hayakawa K, 2009, ANTICANCER RES, V29, P1211; Nagaoka M, 1999, GLYCOCONJUGATE J, V16, P19, DOI 10.1023/A:1006945618657; AOYAGI Y, 1993, CANCER, V72, P615, DOI 10.1002/1097-0142(19930715)72:2<615::AID-CNCR2820720246>3.0.CO;2-T; DEFELICE C, 1993, J CHROMATOGR, V645, P101, DOI 10.1016/0021-9673(93)80623-G; HAYAKAWA K, 1976, BIOCHEM BIOPH RES CO, V72, P1548, DOI 10.1016/S0006-291X(76)80190-8; Hayakawa K, 2001, J CHROMATOGR B, V754, P65, DOI 10.1016/S0378-4347(00)00587-9; Hayakawa K., 2015, HEPATOMA RES UNPUB; Hayakawa K, 1997, J CHROMATOGR B, V696, P19, DOI 10.1016/S0378-4347(97)00219-3; Hayakawa K, 2014, CANCER GENOM PROTEOM, V11, P93; Hayakawa K, 1998, ANAL CHIM ACTA, V372, P281, DOI 10.1016/S0003-2670(98)00340-7; HAYAKAWA K, 1986, BUNSEKI KAGAKU, V35, P207; Hayakawa K, 2003, J BIOCHEM BIOPH METH, V56, P153, DOI 10.1016/S0165-022X(03)00056-3; Hayakawa K, 2001, CURR TOP ANALYT CHEM, V2, P195; Hayakawa K, 1995, J LIQ CHROMATOGR, V18, P3955, DOI 10.1080/10826079508013738; Nagamine T, 2015, MAR DRUGS, V13, P48, DOI 10.3390/md13010048; Nishimura Nobuhiro, 2004, Drug Metab Pharmacokinet, V19, P48, DOI 10.2133/dmpk.19.48; Terentyeva EA, 1997, EUR J CLIN CHEM CLIN, V35, P21	19	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1570-0232	1873-376X		J CHROMATOGR B	J. Chromatogr. B	AUG 1	2015	997						187	193		10.1016/j.jchromb.2015.05.026		7	Biochemical Research Methods; Chemistry, Analytical	Biochemistry & Molecular Biology; Chemistry	CO0BZ	WOS:000358816400026		
J	Kazenwadel, J; Betterman, KL; Chong, CE; Stokes, PH; Lee, YK; Seeker, GA; Agalarov, Y; Demir, CS; Lawrence, DM; Sutton, DL; Tabruyn, SP; Miura, N; Salminen, M; Petrova, TV; Matthews, JM; Hahn, CN; Seott, HS; Harvey, NL				Kazenwadel, Jan; Betterman, Kelly L.; Chong, Chan-Eng; Stokes, Philippa H.; Lee, Young K.; Seeker, Genevieve A.; Agalarov, Yan; Demir, Cansaran Saygili; Lawrence, David M.; Sutton, Drew L.; Tabruyn, Sebastien P.; Miura, Naoyuld; Salminen, Marjo; Petrova, Tatiana V.; Matthews, Jacqueline M.; Hahn, Christopher N.; Seott, Hamish S.; Harvey, Natasha L.			GATA2 is required for lymphatic vessel valve development and maintenance	JOURNAL OF CLINICAL INVESTIGATION			English	Article							GENOME-WIDE ANALYSIS; TRANSCRIPTION FACTOR GATA-2; CORONARY-ARTERY-DISEASE; ACUTE MYELOID-LEUKEMIA; PRIMARY LYMPHEDEMA; DNA-BINDING; HEMATOPOIETIC DEFECT; EMBERGER SYNDROME; CELL; VASCULATURE	Heterozygous germline mutations in the zinc finger transcription factor GATA2 have recently been shown to underlie a range of clinical phenotypes, including Emberger syndrome, a disorder characterized by lymphedema and predisposition to myelodysplastic syndrome/acute myeloid leukemia (MDS/AML). Despite well-defined roles in hematopoiesis, the functions of GATA2 in the lymphatic vasculature and the mechanisms by which GATA2 mutations result in lymphedema have not been characterized. Here, we have provided a molecular explanation for lymphedema predisposition in a subset of patients with germline GATA2 mutations. Specifically, we demonstrated that Emberger-associated GATA2 missense mutations result in complete loss of GATA2 function, with respect to the capacity to regulate the transcription of genes that are important for lymphatic vessel valve development. We identified a putative enhancer element upstream of the key lymphatic transcriptional regulator PROX1 that is bound by GATA2, and the transcription factors FOXC2 and NFATC1. Emberger GATA2 missense mutants had a profoundly reduced capacity to bind this element. Conditional Gata2 deletion in mice revealed that GATA2 is required for both development and maintenance of lymphovenous and lymphatic vessel valves. Together, our data unveil essential roles for GATA2 in the lymphatic vasculature and explain why a select catalogue of human GATA2 mutations results in lymphedema.	[Kazenwadel, Jan; Betterman, Kelly L.; Chong, Chan-Eng; Lee, Young K.; Seeker, Genevieve A.; Sutton, Drew L.; Tabruyn, Sebastien P.; Hahn, Christopher N.; Seott, Hamish S.; Harvey, Natasha L.] Univ S Australia, Ctr Canc Biol, Adelaide, SA 5001, Australia; [Kazenwadel, Jan; Betterman, Kelly L.; Seeker, Genevieve A.; Lawrence, David M.; Sutton, Drew L.; Tabruyn, Sebastien P.; Seott, Hamish S.; Harvey, Natasha L.] SA Pathol, Adelaide, SA 5000, Australia; [Chong, Chan-Eng; Lee, Young K.; Hahn, Christopher N.; Seott, Hamish S.] SA Pathol, Dept Mol Pathol, Adelaide, SA, Australia; [Stokes, Philippa H.; Matthews, Jacqueline M.] Univ Sydney, Sch Mol Biosci, Sydney, NSW 2006, Australia; [Agalarov, Yan; Demir, Cansaran Saygili; Petrova, Tatiana V.] Univ Lausanne Hosp, Dept Oncol, Lausanne, Switzerland; [Agalarov, Yan; Demir, Cansaran Saygili; Petrova, Tatiana V.] Univ Lausanne Hosp, Dept Biochem, Lausanne, Switzerland; [Lawrence, David M.; Seott, Hamish S.] Univ S Australia, Ctr Canc Biol, Canc Genom Facil, ACRF, Adelaide, SA, Australia; [Seott, Hamish S.] Univ Adelaide, Sch Mol & Biomed Biosci, Adelaide, SA, Australia; [Miura, Naoyuld] Hamamatsu Univ Sch Med, Dept Biochem, Hamamatsu, Shizuoka 4313192, Japan; [Salminen, Marjo] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland; [Petrova, Tatiana V.] Ecole Polytech Fed Lausanne, Swiss Inst Expt Canc Res iSREC, Lausanne, Switzerland; [Hahn, Christopher N.; Seott, Hamish S.; Harvey, Natasha L.] Univ Adelaide, Sch Med, Adelaide, SA, Australia	Harvey, NL (reprint author), UniSA, Ctr Canc Biol, POB 14, Adelaide, SA 5000, Australia.	Natasha.harvey@unisa.edu.au	Kazenwadel, Janette/E-6620-2012	Kazenwadel, Janette/0000-0001-6216-3444	NHMRC [APP1061365, APP1004651]; South Australian Health & Medical Research Institute Beat Cancer Project; Swiss National Science Foundation [CRII3 141811]; ARC; European Union [317250]	We thank Sylvia Tichborne, Chris Brown, Kelly Wicks, and staff at the SA Pathology Animal Facility for animal husbandry; Guillermo Oliver for Prox1-Cre<SUP>ERT2</SUP> mice; Leigh Coultas for Tie2-Cre mice; Mat Francois for the pGL2BasicProx1-4kbintron1 construct; Junia Melo for K562 cells; Stuart Pitson for HEK293 cells; and John Pimanda, Guillermo Oliver, and Brian Black for helpful discussions. This work was supported by project grants from the NHMRC (APP1061365, to N.L. Harvey and H.S. Scott; APP1004651, to J.M. Matthews), South Australian Health & Medical Research Institute Beat Cancer Project (to N.L. Harvey and H.S. Scott), and Swiss National Science Foundation (CRII3 141811, to T.V. Petrova). N.L. Harvey is supported by an ARC Future Fellowship. J.M. Matthews is a Senior Research Fellow and HSS, a Principal Research Fellow of the NHMRC. C.S. Demir was supported by the People Programme (Marie Curie Actions) of the European Union's Seventh Framework Programme FP7 (2007-2013) under REA grant agreement 317250.	Hahn CN, 2011, NAT GENET, V43, P1012, DOI 10.1038/ng.913; Turner CJ, 2014, DEV BIOL, V392, P381, DOI 10.1016/j.ydbio.2014.05.006; Bazigou E, 2011, J CLIN INVEST, V121, P2984, DOI 10.1172/JCI58050; Ostergaard P, 2011, NAT GENET, V43, P929, DOI 10.1038/ng.923; Fujiwara T, 2009, MOL CELL, V36, P667, DOI 10.1016/j.molcel.2009.11.001; Grass JA, 2006, MOL CELL BIOL, V26, P7056, DOI 10.1128/MCB.01033-06; Kala K, 2009, DEVELOPMENT, V136, P253, DOI 10.1242/dev.029900; Guiu J, 2013, J EXP MED, V210, P71, DOI 10.1084/jem.20120993; TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0; Shen B, 2014, ARTERIOSCL THROM VAS, V34, P1221, DOI 10.1161/ATVBAHA.113.302923; Petrova TV, 2004, NAT MED, V10, P974, DOI 10.1038/nm1094; Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024; Chen YH, 2012, CELL REP, V2, P1197, DOI 10.1016/j.celrep.2012.10.012; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Srinivasan RS, 2011, GENE DEV, V25, P2187, DOI 10.1101/gad.16974811; Mansour S, 2010, AM J MED GENET A, V152A, P2287, DOI 10.1002/ajmg.a.33445; Charles MA, 2006, MOL ENDOCRINOL, V20, P1366; Bazigou E, 2009, DEV CELL, V17, P175, DOI 10.1016/j.devcel.2009.06.017; Francois M, 2008, NATURE, V456, P643, DOI 10.1038/nature07391; Mammoto A, 2009, NATURE, V457, P1103, DOI 10.1038/nature07765; Srinivasan RS, 2007, GENE DEV, V21, P2422, DOI 10.1101/gad.1588407; Tijssen MR, 2011, DEV CELL, V20, P597, DOI 10.1016/j.devcel.2011.04.008; Makinen T, 2005, GENE DEV, V19, P397, DOI 10.1101/gad.330105; Wigle JT, 1999, CELL, V98, P769, DOI 10.1016/S0092-8674(00)81511-1; Norrmen C, 2009, J CELL BIOL, V185, P439, DOI 10.1083/jcb.200901104; Kazenwadel J, 2012, BLOOD, V119, P1283, DOI 10.1182/blood-2011-08-374363; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Jurisic G, 2012, CIRC RES, V111, P426, DOI 10.1161/CIRCRESAHA.112.269399; Muiya NP, 2014, GENE, V544, P152, DOI 10.1016/j.gene.2014.04.064; Garg V, 2003, NATURE, V424, P443, DOI 10.1038/nature01827; Rodrigues NP, 2005, BLOOD, V106, P477, DOI 10.1182/blood-2004-08-2989; Liu YH, 2014, GENET MOL RES, V13, P2619, DOI 10.4238/2014.April.8.4; Bouvree K, 2012, CIRC RES, V111, P437, DOI 10.1161/CIRCRESAHA.112.269316; Johnson KD, 2012, J CLIN INVEST, V122, P3692, DOI 10.1172/JCI61623; Sabine A, 2012, DEV CELL, V22, P430, DOI 10.1016/j.devcel.2011.12.020; Ishida H, 2012, EUR J PEDIATR, V171, P1273, DOI 10.1007/s00431-012-1715-7; Levet S, 2013, BLOOD, V122, P598, DOI 10.1182/blood-2012-12-472142; Robert-Moreno A, 2005, DEVELOPMENT, V132, P1117, DOI 10.1242/dev.01660; Gale NW, 2002, DEV CELL, V3, P411, DOI 10.1016/S1534-5807(02)00217-4; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Bazigou E., 2012, CELL MOL LIFE SCI, V70, P1055; Bowles J, 2013, DEV BIOL, V386, P25; Bresnick EH, 2012, NUCLEIC ACIDS RES, V40, P5819, DOI 10.1093/nar/gks281; Connelly JJ, 2006, PLOS GENET, V2, P1265, DOI 10.1371/journal.pgen.0020139; Danussi C, 2013, MOL CELL BIOL, V33, P4381, DOI 10.1128/MCB.00872-13; de Pater E, 2013, J EXP MED, V210, P2843, DOI 10.1084/jem.20130751; Haugas M, 2010, DEV DYNAM, V239, P2452, DOI 10.1002/dvdy.22373; Hess PR, 2014, J CLIN INVEST, V124, P273, DOI 10.1172/JCI70422; Huang Z, 2009, MOL CELL BIOL, V29, P5168, DOI 10.1128/MCB.00482-09; Kanki Y, 2011, EMBO J, V30, P2582, DOI 10.1038/emboj.2011.173; Khandekar M, 2007, DEVELOPMENT, V134, P1703, DOI 10.1242/dev.001297; Lim KC, 2012, J CLIN INVEST, V122, P3705, DOI 10.1172/JCI61619; Linnemann AK, 2011, P NATL ACAD SCI USA, V108, P13641, DOI 10.1073/pnas.1108440108; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; Murtomaki A, 2014, DEVELOPMENT, V141, P2446, DOI 10.1242/dev.101188; Oren T, 2005, NUCLEIC ACIDS RES, V33, P4357, DOI 10.1093/nar/gki746; Pimanda JE, 2008, BLOOD, V112, P4512, DOI 10.1182/blood-2008-05-157560; Rivera-Feliciano J, 2006, DEVELOPMENT, V133, P3607, DOI 10.1242/dev.02519; Sabine A, 2014, ADV ANAT EMBRYOL CEL, V214, P67, DOI 10.1007/978-3-7091-1646-3_6; Spinner M. A., 2013, BLOOD, V123, P809; OMICHINSKI JG, 1993, SCIENCE, V261, P438, DOI 10.1126/science.8332909; Tsuzuki S, 2004, MOL CELL BIOL, V24, P6824, DOI 10.1128/mcb.24.15.6824-6836.2004; VANDERPUTTE SCJ, 1975, ACTA MORPHOL NEER SC, V13, P245; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689; Zhu C, 2011, DEVELOPMENT, V138, P4555, DOI 10.1242/dev.066779	67	1	1	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	AUG	2015	125	8					2979	2994		10.1172/JCI78888		16	Medicine, Research & Experimental	Research & Experimental Medicine	CO3CS	WOS:000359034800012		
J	Yuasa, M; Mignemi, NA; Nyman, JS; Duvall, CL; Schwartz, HS; Okawa, A; Yoshii, T; Bhattacharjee, G; Zhao, CG; Bible, JE; Obremskey, WT; Flick, MJ; Degen, JL; Barnett, JV; Cates, JMM; Schoenecker, JG				Yuasa, Masato; Mignemi, Nicholas A.; Nyman, Jeffry S.; Duvall, Craig L.; Schwartz, Herbert S.; Okawa, Atsushi; Yoshii, Toshitaka; Bhattacharjee, Gourab; Zhao, Chenguang; Bible, Jesse E.; Obremskey, William T.; Flick, Matthew J.; Degen, Jay L.; Barnett, Joey V.; Cates, Justin M. M.; Schoenecker, Jonathan G.			Fibrinolysis is essential for fracture repair and prevention of heterotopic ossification	JOURNAL OF CLINICAL INVESTIGATION			English	Article							TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; PLASMINOGEN DEFICIENCY; CARDIOVASCULAR-DISEASE; IN-VIVO; CIGARETTE-SMOKING; BONE-FORMATION; MICE; FIBRINOGEN; ANGIOGENESIS	Bone formation during fracture repair inevitably initiates within or around extravascular deposits of a fibrin-rich matrix. In addition to a central role in hemostasis, fibrin is thought to enhance bone repair by supporting inflammatory and mesenchymal progenitor egress into the zone of injury. However, given that a failure of efficient fibrin clearance can impede normal wound repair, the precise contribution of fibrin to bone fracture repair, whether supportive or detrimental, is unknown. Here, we employed mice with genetically and pharmacologically imposed deficits in the fibrin precursor fibrinogen and fibrin-degrading plasminogen to explore the hypothesis that fibrin is vital to the initiation of fracture repair, but impaired fibrin clearance results in derangements in bone fracture repair. In contrast to our hypothesis, fibrin was entirely dispensable for long-bone fracture repair, as healing fractures in fibrinogen-deficient mice were indistinguishable from those in control animals. However, failure to clear fibrin from the fracture site in plasminogen-deficient mice severely impaired fracture vascularization, precluded bone union, and resulted in robust heterotopic ossification. Pharmacological fibrinogen depletion in plasminogen-deficient animals restored a normal pattern of fracture repair and substantially limited heterotopic ossification. Fibrin is therefore not essential for fracture repair, but inefficient fibrinolysis decreases endochondral angiogenesis and ossification, thereby inhibiting fracture repair.	[Yuasa, Masato; Mignemi, Nicholas A.; Nyman, Jeffry S.; Schwartz, Herbert S.; Bible, Jesse E.; Obremskey, William T.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Orthopaed, Nashville, TN USA; [Yuasa, Masato; Okawa, Atsushi; Yoshii, Toshitaka] Tokyo Med & Dent Univ, Dept Orthopaed Surg, Tokyo, Japan; [Mignemi, Nicholas A.; Schwartz, Herbert S.; Cates, Justin M. M.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pathol, Nashville, TN 37232 USA; [Nyman, Jeffry S.; Duvall, Craig L.] Vanderbilt Univ, Med Ctr, Dept Biomed Engn, Nashville, TN USA; [Nyman, Jeffry S.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Ctr Bone Biol, Nashville, TN USA; [Nyman, Jeffry S.] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA; [Bhattacharjee, Gourab; Zhao, Chenguang] ISIS Pharmaceut Inc, Carlsbad, CA USA; [Flick, Matthew J.; Degen, Jay L.] Cincinnati Childrens Hosp Med Ctr, Div Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Barnett, Joey V.; Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pharmacol, Nashville, TN 37232 USA; [Schoenecker, Jonathan G.] Vanderbilt Univ, Med Ctr, Dept Pediat, Nashville, TN 37232 USA	Schoenecker, JG (reprint author), 4202 Doctors Off Tower,2200 Childrens Way, Nashville, TN 37232 USA.	Jon.Schoenecker@vanderbilt.edu			Musculoskeletal Transplantation Foundation; Orthopaedic Trauma Association; Vanderbilt Orthopaedic Institute research grant; Caitlin Lovejoy Fund	Funding was provided by the Musculoskeletal Transplantation Foundation, the Orthopaedic Trauma Association, a Vanderbilt Orthopaedic Institute research grant, and the Caitlin Lovejoy Fund.	Anitua E, 2004, THROMB HAEMOSTASIS, V91, P4, DOI 10.1160/TH03-07-0440; Burns DM, 2003, PROG CARDIOVASC DIS, V46, P11, DOI 10.1016/S0033-0620(03)00079-3; Purnell JQ, 2013, CIRCULATION, V127, P180, DOI 10.1161/CIRCULATIONAHA.111.077487; Willigendael EM, 2004, J VASC SURG, V40, P1158, DOI 10.1016/j.jvs.2004.08.049; Rodriguez EK, 2014, INJURY, V45, P554, DOI 10.1016/j.injury.2013.10.042; Duvall CL, 2007, J BONE MINER RES, V22, P286, DOI 10.1359/JBMR.061103; Grundy SM, 1999, CIRCULATION, V100, P1134; Maes C, 2010, DEV CELL, V19, P329, DOI 10.1016/j.devcel.2010.07.010; Bugge TH, 1996, CELL, V87, P709, DOI 10.1016/S0092-8674(00)81390-2; Gerber HP, 1999, NAT MED, V5, P623; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; MACEY LR, 1989, J BONE JOINT SURG AM, V71A, P722; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; BUGGE TH, 1995, GENE DEV, V9, P794, DOI 10.1101/gad.9.7.794; Harper J, 1999, NAT MED, V5, P617, DOI 10.1038/9460; Hausman MR, 2001, BONE, V29, P560, DOI 10.1016/S8756-3282(01)00608-1; Duvall CL, 2004, AM J PHYSIOL-HEART C, V287, pH302, DOI 10.1152/ajpheart.00928.2003; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940; Cole HA, 2014, ARTHRITIS RHEUMATOL, V66, P2222, DOI 10.1002/art.38639; Dhillon RS, 2013, J BONE MINER RES, V28, P586, DOI 10.1002/jbmr.1765; MEADE TW, 1979, BRIT MED J, V1, P153; Potter BK, 2010, J BONE JOINT SURG AM, V92A, P74, DOI 10.2106/JBJS.J.00776; Daci E, 1999, J BONE MINER RES, V14, P946, DOI 10.1359/jbmr.1999.14.6.946; Martino MM, 2013, P NATL ACAD SCI USA, V110, P4563, DOI 10.1073/pnas.1221602110; Kawao N, 2013, J BONE MINER RES, V28, P1561, DOI 10.1002/jbmr.1921; COBB TK, 1994, FOOT ANKLE, V15, P64; Roth D, 2006, AM J PATHOL, V168, P670, DOI 10.2353/ajpath.2006.050372; Pandolfi A, 2001, ARTERIOSCL THROM VAS, V21, P1378, DOI 10.1161/hq0801.093667; Cipriano CA, 2009, J AM ACAD ORTHOP SUR, V17, P689; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Castillo RC, 2005, J ORTHOP TRAUMA, V19, P151, DOI 10.1097/00005131-200503000-00001; Ploplis VA, 1998, BLOOD, V91, P2005; O'Neill KR, 2012, BONE, V50, P1357, DOI 10.1016/j.bone.2012.03.008; Sahni A, 2000, BLOOD, V96, P3772; Gruber R, 2006, EXP GERONTOL, V41, P1080, DOI 10.1016/j.exger.2006.09.008; Kline AJ, 2009, FOOT ANKLE INT, V30, P1042, DOI 10.3113/FAI.2009.1042; Gailit J, 1997, EXP CELL RES, V232, P118, DOI 10.1006/excr.1997.3512; Ebraheim NA, 2013, ORTHOP SURG, V5, P46, DOI 10.1111/os.12017; Sakellariou VI, 2012, J MUSCULOSKEL NEURON, V12, P230; Shefelbine SJ, 2005, BONE, V36, P480, DOI 10.1016/j.bone.2004.11.007; Baker BF, 1997, J BIOL CHEM, V272, P11994, DOI 10.1074/jbc.272.18.11994; Aoki K, 2001, BURNS, V27, P569, DOI 10.1016/S0305-4179(01)00011-0; Beamer Brandon, 2010, HSS J, V6, P85, DOI 10.1007/s11420-009-9129-4; BROOKES M, 1964, J BONE JOINT SURG BR, V46, P336; Bugge TH, 1996, P NATL ACAD SCI USA, V93, P5899, DOI 10.1073/pnas.93.12.5899; Cole HA, 2013, BONE, V52, P337, DOI 10.1016/j.bone.2012.10.011; Douglas TEL, 2012, J BIOMED MATER RES A, V100A, P1335, DOI 10.1002/jbm.a.34073; Everts V, 2008, BONE, V43, P915, DOI 10.1016/j.bone.2008.07.004; Flick MJ, 2004, EXP BIOL MED, V229, P1105; Forsberg JA, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3010168; FOULK DA, 1995, ORTHOPEDICS, V18, P333; Gunnar BJ, 2011, US BONE JOINT INITIA; HAMMOND JDS, 1959, BRIT J HAEMATOL, V5, P431, DOI 10.1111/j.1365-2141.1959.tb04053.x; Hofstra JJ, 2011, J TRAUMA, V70, P1389, DOI 10.1097/TA.0b013e31820f85a7; Key JA, 1946, MANAGEMENT FRACTURES; Khalil N, 1996, AM J RESP CELL MOL, V15, P252; Kolar P, 2010, TISSUE ENG PART B-RE, V16, P427, DOI 10.1089/ten.TEB.2009.0687; Lehmann W, 2004, BONE, V35, P1247, DOI 10.1016/j.bone.2004.08.017; Meigs James B, 2010, Diabetes Care, V33, P1865, DOI 10.2337/dc10-0641; Nyman Jeffry S, 2015, Bonekey Rep, V4, P664, DOI 10.1038/bonekey.2015.31; Robinson M, 2004, J BONE JOINT SURG AM, V86A, P1359; Rockwood CABR, 2010, ROCKWOOD GREENS FRAC; Romer J, 1996, NAT MED, V2, P287, DOI 10.1038/nm0396-287; Schoenecker J, 2010, SPINE, V35, P1008, DOI 10.1097/BRS.0b013e3181d3cffe; Stepien E, 2011, J THROMB THROMBOLYS, V32, P177, DOI 10.1007/s11239-011-0593-6; Suelves M, 2007, J CELL BIOL, V178, P1039, DOI 10.1083/jcb.200705127; Whither K, 1992, THROMB RES, V65, P469; Wu Andy C, 2013, Bonekey Rep, V2, P373, DOI 10.1038/bonekey.2013.107; YEE JA, 1993, J CELL PHYSIOL, V157, P528, DOI 10.1002/jcp.1041570312; Yuasa M, 2014, BONE, V67, P208, DOI 10.1016/j.bone.2014.07.002	70	3	3	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	AUG	2015	125	8					3117	3131		10.1172/JCI80313		15	Medicine, Research & Experimental	Research & Experimental Medicine	CO3CS	WOS:000359034800022		
J	de Couto, G; Liu, WX; Tseliou, E; Sun, BM; Makkar, N; Kanazawa, H; Arditi, M; Marban, E				de Couto, Geoffrey; Liu, Weixin; Tseliou, Eleni; Sun, Baiming; Makkar, Nupur; Kanazawa, Hideaki; Arditi, Moshe; Marban, Eduardo			Macrophages mediate cardioprotective cellular postconditioning in acute myocardial infarction	JOURNAL OF CLINICAL INVESTIGATION			English	Article							CARDIOSPHERE-DERIVED CELLS; ISCHEMIA-REPERFUSION INJURY; HEART REGENERATION; CARDIAC REPAIR; MICROVASCULAR OBSTRUCTION; INFLAMMATORY RESPONSE; TISSUE MACROPHAGES; HEMATOPOIETIC STEM; PORCINE MODEL; MONOCYTES	Ischemic injury in the heart induces an inflammatory cascade that both repairs damage and exacerbates scar tissue formation. Cardiosphere-derived cells (CDCs) are a stem-like population that is derived ex vivo from cardiac biopsies; they confer both cardioprotection and regeneration in acute myocardial infarction (MI). While the regenerative effects of CDCs in chronic settings have been studied extensively, little is known about how CDCs confer the cardioprotective process known as cellular postconditioning. Here, we used an in vivo rat model of ischemia/reperfusion (IR) injury-induced MI and in vitro coculture assays to investigate how CDCs protect stressed cardiomyocytes. Compared with control animals, animals that received CDCs 20 minutes after IR had reduced infarct size when measured at 48 hours. CDCs modified the myocardial leukocyte population after ischemic injury. Specifically, introduction of CDCs reduced the number of CD68(+) macrophages, and these CDCs secreted factors that polarized macrophages toward a distinctive cardioprotective phenotype that was not M1 or M2. Systemic depletion of macrophages with clodronate abolished CDC-mediated cardioprotection. Using both in vitro coculture assays and a rat model of adoptive transfer after IR, we determined that CDC-conditioned macrophages attenuated cardiomyocyte apoptosis and reduced infarct size, thereby recapitulating the beneficial effects of CDC therapy. Together, our data indicate that CDCs limit acute injury by polarizing an effector macrophage population within the heart.	[de Couto, Geoffrey; Liu, Weixin; Tseliou, Eleni; Sun, Baiming; Makkar, Nupur; Kanazawa, Hideaki; Arditi, Moshe; Marban, Eduardo] Cedars Sinai Heart Inst, Los Angeles, CA USA; [Kanazawa, Hideaki] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan	Marban, E (reprint author), 8700 Beverly Blvd, Los Angeles, CA 90048 USA.	eduardo.marban@cshs.org			Board of Governors of the Cedars-Sinai Medical Center; NIH; Department of Defense	We would like to thank Patricia Lin and Carolina Castillo for assistance with flow cytometry and tissue sectioning, Hee Cheol Cho and Eugenio Cingolani for helpful discussions, P.K. Shah for comments on the manuscript, and Elizabeth Kim, Eli Simsolo, and Ryan Middleton for technical assistance. This work was supported by the Board of Governors of the Cedars-Sinai Medical Center. General laboratory support was provided by grants to E. Marban from the NIH and the Department of Defense.	Aminzadeh MA, 2014, EUR HEART J, V36, P751; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Saxena A, 2013, J IMMUNOL, V191, P4838, DOI 10.4049/jimmunol.1300725; Smith RR, 2007, CIRCULATION, V115, P896, DOI 10.1161/CIRCULATIONAHA.106.655209; Malliaras K, 2013, EMBO MOL MED, V5, P191, DOI 10.1002/emmm.201201737; Zhang CC, 2013, J BIOL CHEM, V288, P1489, DOI 10.1074/jbc.M112.419788; Kloner RA, 2013, CIRC RES, V113, P451, DOI 10.1161/CIRCRESAHA.112.300627; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Chow A, 2011, J EXP MED, V208, P261, DOI 10.1084/jem.20101688; Frangogiannis NG, 2014, NAT REV CARDIOL, V11, P255, DOI 10.1038/nrcardio.2014.28; Yang XM, 2004, J AM COLL CARDIOL, V44, P1103, DOI 10.1016/j.jacc.2004.05.060; MURRY CE, 1986, CIRCULATION, V74, P1124; Godwin JW, 2013, P NATL ACAD SCI USA, V110, P9415, DOI 10.1073/pnas.1300290110; Johnston PV, 2009, CIRCULATION, V120, P1075, DOI 10.1161/CIRCULATIONAHA.108.816058; Frantz S, 2013, FASEB J, V27, P871, DOI 10.1096/fj.12-214049; Malliaras K, 2012, CIRCULATION, V125, P100, DOI 10.1161/CIRCULATIONAHA.111.042598; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Nahrendorf M, 2007, CIRC RES, V100, P1218, DOI 10.1161/01.RES.0000265064.46075.31; Ehninger A, 2011, J EXP MED, V208, P421, DOI 10.1084/jem.20110132; ENTMAN ML, 1991, FASEB J, V5, P2529; Martinez FO, 2006, J IMMUNOL, V177, P7303; Aurora AB, 2014, J CLIN INVEST, V124, P1382, DOI [10.1172/JCI72181, 10.1172/JC172181]; Tseliou E, 2013, J AM COLL CARDIOL, V61, P1108, DOI 10.1016/j.jacc.2012.10.052; Davies LC, 2011, EUR J IMMUNOL, V41, P2155, DOI 10.1002/eji.201141817; Epelman S, 2014, IMMUNITY, V40, P91, DOI 10.1016/j.immuni.2013.11.019; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01069.2002; Staat P, 2005, CIRCULATION, V112, P2143, DOI 10.1161/CIRCULATIONAHA.105.558122; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Cheng K, 2010, CIRC RES, V106, P1570, DOI 10.1161/CIRCRESAHA.109.212589; Ye L, 2013, CIRC RES, V113, P922, DOI 10.1161/CIRCRESAHA.113.300216; Rochitte CE, 1998, CIRCULATION, V98, P1006; Winkler IG, 2010, BLOOD, V116, P4815, DOI 10.1182/blood-2009-11-253534; Kin H, 2004, CARDIOVASC RES, V62, P74, DOI 10.1016/j.cardiores.2004.01.006; Chimenti I, 2010, CIRC RES, V106, P971, DOI 10.1161/CIRCRESAHA.109.210682; Cheng K, 2012, CELL TRANSPLANT, V21, P1121, DOI 10.3727/096368911X627381; Shi C, 2011, NAT REV IMMUNOL, V11, P762, DOI 10.1038/nri3070; Smith JNP, 2013, STEM CELLS, V31, P1044, DOI 10.1002/stem.1370; MICHL J, 1979, J EXP MED, V150, P607, DOI 10.1084/jem.150.3.607; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; REIMER KA, 1977, CIRCULATION, V56, P786; Troidl C, 2009, J CELL MOL MED, V13, P3485, DOI 10.1111/j.1582-4934.2009.00707.x; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Ibrahim AGE, 2014, STEM CELL REP, V2, P606, DOI 10.1016/j.stemcr.2014.04.006; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Lee WW, 2012, J AM COLL CARDIOL, V59, P153, DOI 10.1016/j.jacc.2011.08.066; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Swirski FK, 2009, SCIENCE, V325, P612, DOI 10.1126/science.1175202; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Mills CD, 2000, J IMMUNOL, V164, P6166; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; GOTTLIEB RA, 1994, J CLIN INVEST, V94, P1621, DOI 10.1172/JCI117504; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Jenkins SJ, 2011, SCIENCE, V332, P1284, DOI 10.1126/science.1204351; BRAUNWALD E, 1985, J CLIN INVEST, V76, P1713, DOI 10.1172/JCI112160; Frangogiannis NG, 2012, CIRC RES, V110, P159, DOI 10.1161/CIRCRESAHA.111.243162; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; de Couto G, 2014, CIRCULATION, V130; DUNN PA, 1983, J IMMUNOL METHODS, V64, P71, DOI 10.1016/0022-1759(83)90385-X; Gutierrez-Fernandez A, 2007, FASEB J, V21, P2580, DOI 10.1096/fj.06-7860com; Jordan JE, 1999, CARDIOVASC RES, V43, P860, DOI 10.1016/S0008-6363(99)00187-X; Kanazawa H, 2015, CIRC-HEART FAIL, V8, P322, DOI 10.1161/CIRCHEARTFAILURE.114.001484; Lagasse E, 1996, J IMMUNOL METHODS, V197, P139, DOI 10.1016/0022-1759(96)00138-X; Lauden L, 2013, CIRC RES, V112, P451, DOI 10.1161/CIRCRESAHA.112.276501; Garbern JC, 2013, CELL STEM CELL, V12, P689, DOI 10.1016/j.stem.2013.05.008; Malliaras K, 2014, EMBO MOL MED, V6, P760, DOI 10.1002/emmm.201303626; NORTON JM, 1980, J IMMUNOL, V125, P252; Pillai MM, 2006, BLOOD, V107, P3520, DOI 10.1182/blood-2005-10-4285; Sekar RB, 2009, CIRC RES, V104, P355, DOI 10.1161/CIRCRESAHA.108.178335; SIMPSON PJ, 1987, J LAB CLIN MED, V110, P13; Tseliou E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088590; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667	77	1	1	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	AUG	2015	125	8					3147	3162		10.1172/JCI81321		16	Medicine, Research & Experimental	Research & Experimental Medicine	CO3CS	WOS:000359034800024		
J	Tohmonda, T; Yoda, M; Iwawaki, T; Matsumoto, M; Nakamura, M; Mikoshiba, K; Toyama, Y; Horiuchi, K				Tohmonda, Takahide; Yoda, Masaki; Iwawaki, Takao; Matsumoto, Mono; Nakamura, Masaya; Mikoshiba, Katsuhiko; Toyama, Yoshiaki; Horiuchi, Keisuke			IRE1 alpha/XBP1-mediated branch of the unfolded protein response regulates osteoclastogenesis	JOURNAL OF CLINICAL INVESTIGATION			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER STRESS; MULTIPLE-MYELOMA; IRE1-ALPHA-XBP1 PATHWAY; TRANSCRIPTION FACTOR; MESSENGER-RNA; BONE-MARROW; DIFFERENTIATION; EXPRESSION; PATHOGENESIS	The unfolded protein response (UPR) is a cellular adaptive mechanism that is activated in response to the accumulation of unfolded proteins in the endoplasmic reticulum. The inositol-requiring protein-1 alpha/X-box-binding protein-mediated (IRE1 alpha/XBP1-mediated) branch of the UPR is highly conserved and has also been shown to regulate various cell-fate decisions. Herein, we have demonstrated a crucial role for the IRE alpha/XBP1-mediated arm of the UPR in osteoclast differentiation. Using murine models, we found that the conditional abrogation of IRE1 alpha in bone marrow cells increases bone mass as the result of defective osteoclastic bone resorption. In osteoclast precursors, IRE1 alpha was transiently activated during osteoclastogenesis, and suppression of the IRE1 alpha/XBP1 pathway in these cells substantially inhibited the formation of multinucleated osteoclasts in vitro. We determined that XBP1 directly binds the promoter and induces transcription of the gene encoding the master regulator of osteoclastogenesis nuclear factor of activated T cells cytoplasmic 1 (NFATc1). Moreover, activation of IRE1 alpha was partially dependent on Ca2+ oscillation mediated by inositol 1,4,5-trisphosphate receptors 2 and 3 (ITPR2 and ITPR3) in the endoplasmic reticulum, as pharmacological inhibition or deletion of these receptors markedly decreased Xbp1 mRNA processing. The present study thus reveals an intracellular pathway that integrates the UPR and osteoclast differentiation through activation of the IRE1 alpha/XBP1 pathway.	[Tohmonda, Takahide; Yoda, Masaki; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Antiaging Orthoped Res, Tokyo 1608582, Japan; [Tohmonda, Takahide; Mikoshiba, Katsuhiko] RIKEN, Dev Neurobiol Lab, Brain Sci Inst, Wako, Saitama, Japan; [Iwawaki, Takao] Gunma Univ, Iwawaki Lab, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan; [Matsumoto, Mono; Nakamura, Masaya; Toyama, Yoshiaki; Horiuchi, Keisuke] Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo 1608582, Japan	Horiuchi, K (reprint author), Keio Univ, Sch Med, Dept Orthoped Surg, Tokyo 1608582, Japan.	tohmonda@z7.keio.jp; horiuchi@z3.keio.jp			MEXT KAKENHI [24390358, 24791566]	The authors thank Shizue Yamanashi, Kaori Sue, and Mayumi Ito for their technical assistance, Akemi Ito (Ito Bone Science Institute) for advice on bone morphometric analysis, and Taku Saito (The University of Tokyo) for technical help with viral gene transfer. This work was supported, in part, by MEXT KAKENHI (24390358 to K. Horiuchi; 24791566 to T. Tohmonda).	Willey JS, 2010, BONE, V46, P101, DOI 10.1016/j.bone.2009.09.002; Murakami T, 2009, NAT CELL BIOL, V11, P1205, DOI 10.1038/ncb1963; McInnes IB, 2007, NAT REV IMMUNOL, V7, P429, DOI 10.1038/nri2094; Iwawaki T, 2009, P NATL ACAD SCI USA, V106, P16657, DOI 10.1073/pnas.0903775106; Kitamura T, 2003, EXP HEMATOL, V31, P1007, DOI 10.1016/j.exphem.2003.07.005; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Saito A, 2011, J BIOL CHEM, V286, P4809, DOI 10.1074/jbc.M110.152900; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; TAKAHASHI N, 1988, ENDOCRINOLOGY, V122, P1373; Chen X, 2014, NATURE, V508, P103, DOI 10.1038/nature13119; Raisz LG, 2005, J CLIN INVEST, V115, P3318, DOI 10.1172/JCI27071; Tohmonda T, 2011, EMBO REP, V12, P451, DOI 10.1038/embor.2011.34; Teitelbaum SL, 2000, SCIENCE, V289, P1504, DOI 10.1126/science.289.5484.1504; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Sha HB, 2011, TRENDS ENDOCRIN MET, V22, P374, DOI 10.1016/j.tem.2011.05.002; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Lee AH, 2003, MOL CELL BIOL, V23, P7448, DOI 10.1128/MCB.23.21.7448-7459.2003; Patterson RL, 2004, ANNU REV BIOCHEM, V73, P437, DOI 10.1146/annurev.biochem.73.071403.161303; Boyle WJ, 2003, NATURE, V423, P337, DOI 10.1038/nature01658; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Futatsugi A, 2005, SCIENCE, V309, P2232, DOI 10.1126/science.1114110; Vincenz L, 2013, MOL CANCER THER, V12, P831, DOI 10.1158/1535-7163.MCT-12-0782; Kiviluoto S, 2013, BBA-MOL CELL RES, V1833, P1612, DOI 10.1016/j.bbamcr.2013.01.026; Mimura N, 2012, BLOOD, V119, P5772, DOI 10.1182/blood-2011-07-366633; Hetz C, 2011, PHYSIOL REV, V91, P1219, DOI 10.1152/physrev.00001.2011; Guise TA, 1998, ENDOCR REV, V19, P18, DOI 10.1210/er.19.1.18; Wagner LE, 2012, J PHYSIOL-LONDON, V590, P3245, DOI 10.1113/jphysiol.2012.228320; Papandreou I, 2011, BLOOD, V117, P1311, DOI 10.1182/blood-2010-08-303099; Ruiz A, 2009, CELL CALCIUM, V46, P273, DOI 10.1016/j.ceca.2009.08.005; Carrasco DR, 2007, CANCER CELL, V11, P349, DOI 10.1016/j.ccr.2007.02.015; Kuroda Y, 2008, P NATL ACAD SCI USA, V105, P8643, DOI 10.1073/pnas.0800642105; Saito A, 2009, NAT CELL BIOL, V11, P1197, DOI 10.1038/ncb1962; Tabas I, 2011, NAT CELL BIOL, V13, P184, DOI 10.1038/ncb0311-184; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Hetz C, 2009, MOL CELL, V35, P551, DOI 10.1016/j.molcel.2009.08.021; Negishi-Koga T, 2009, IMMUNOL REV, V231, P241, DOI 10.1111/j.1600-065X.2009.00821.x; Niederreiter L, 2013, J EXP MED, V210, P2041, DOI 10.1084/jem.20122341; Arai F, 1999, J EXP MED, V190, P1741, DOI 10.1084/jem.190.12.1741; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Semerad CL, 2005, BLOOD, V106, P3020, DOI 10.1182/blood-2004-01-0272; Auf G, 2010, P NATL ACAD SCI USA, V107, P15553, DOI 10.1073/pnas.0914072107; Edwards JR, 2011, NAT REV RHEUMATOL, V7, P235, DOI 10.1038/nrrheum.2011.23; Weinstein RS, 2002, J CLIN INVEST, V109, P1041, DOI 10.1172/JCI200214538; Lazarowski ER, 2003, MOL PHARMACOL, V64, P785, DOI 10.1124/mol.64.4.785; Nakashima T, 2012, TRENDS ENDOCRIN MET, V23, P582, DOI 10.1016/j.tem.2012.05.005; Martinon F, 2011, CURR OPIN IMMUNOL, V23, P35, DOI 10.1016/j.coi.2010.10.016; Mahoney DJ, 2011, CANCER CELL, V20, P443, DOI 10.1016/j.ccr.2011.09.005; Fujimoto T, 2007, ANTICANCER RES, V27, P127; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Tohmonda T, 2013, J BIOL CHEM, V288, P1691, DOI 10.1074/jbc.C112.424606	50	0	0	AMER SOC CLINICAL INVESTIGATION INC	ANN ARBOR	35 RESEARCH DR, STE 300, ANN ARBOR, MI 48103 USA	0021-9738	1558-8238		J CLIN INVEST	J. Clin. Invest.	AUG	2015	125	8					3269	3279		10.1172/JCI76765		11	Medicine, Research & Experimental	Research & Experimental Medicine	CO3CS	WOS:000359034800033		
J	Tada, H; Kawashiri, MA; Nakahashi, T; Yagi, K; Chujo, D; Ohbatake, A; Mori, Y; Mori, S; Kometani, M; Fujii, H; Nohara, A; Inazu, A; Mabuchi, H; Yamagishi, M; Hayashi, K				Tada, Hayato; Kawashiri, Masa-aki; Nakahashi, Takuya; Yagi, Kunimasa; Chujo, Daisuke; Ohbatake, Azusa; Mori, Yukiko; Mori, Shunsuke; Kometani, Mitsuhiro; Fujii, Hiroshi; Nohara, Atsushi; Inazu, Akihiro; Mabuchi, Hiroshi; Yamagishi, Masakazu; Hayashi, Kenshi			Clinical characteristics of Japanese patients with severe hypertriglyceridemia	JOURNAL OF CLINICAL LIPIDOLOGY			English	Article						Triglyceride; Lipoprotein; Coronary artery disease; Pancreatitis; Hypertriglyceridemia	ISCHEMIC-HEART-DISEASE; REMNANT CHOLESTEROL; NONFASTING TRIGLYCERIDES; RISK-FACTORS; HISAYAMA; EVENTS	BACKGROUND: Although of interest, few data exist on the clinical characteristics of Japanese patients with an extremely high triglyceride level (>= 1000 mg/dL). OBJECTIVE: We assessed the clinical characteristics of Japanese patients with an extremely high triglyceride level. METHODS: We investigated the presence of coronary artery disease, history of pancreatitis, the presence of fatty liver, and the potential causes of elevated triglyceride in Japanese subjects with an extremely high level of fasting triglyceride (>= 1000 mg/dL) among 70,368 subjects whose serum triglyceride was measured for any reason at Kanazawa University Hospital from April 2004 to March 2014. RESULTS: We identified 215 (0.31%) subjects (mean age, 46 years; male, 170, mean body mass index, 25 kg/m(2)) with severe hypertriglyceridemia. Among them, 4 (1.9%) subjects were classified as type I, 97 (45.1%) subjects were type IV, and 114 (53.0%) subjects were type V hyperlipidemia, according to Fredrickson's classification. Among 215 subjects, 116 subjects (54.0%) drank alcohol, 58 (27.0%) showed heavy intake (>= 60 g/d), and 64 (29.8%) subjects had diabetes. In total, 59 (27.4%) subjects had transient severe hypertriglyceriderhia caused by corticosteroids (N = 19), antidepressant (N = 18), L-asparaginase and steroids for acute lymphoid leukemia (N = 15), hormone replacement therapy for breast cancer (N = 9), O-blocker (N = 5), hypothyroidism (N = 4), pregnancy (N = 4), and panhypopituitarism (N = 2). As many as 119 (55.3%) subjects exhibited fatty liver. Moreover, 12 (5.6%) and 17 (7.9%) subjects had a history of pancreatitis and coronary artery disease, respectively.	[Tada, Hayato; Kawashiri, Masa-aki; Nakahashi, Takuya; Yagi, Kunimasa; Chujo, Daisuke; Ohbatake, Azusa; Mori, Yukiko; Mori, Shunsuke; Kometani, Mitsuhiro; Fujii, Hiroshi; Yamagishi, Masakazu; Hayashi, Kenshi] Kanazawa Univ, Div Cardiovasc Med, Grad Sch Med, Kanazawa, Ishikawa 9208641, Japan; [Nohara, Atsushi; Mabuchi, Hiroshi] Kanazawa Univ, Grad Sch Med Sci, Dept Lipidol, Kanazawa, Ishikawa 9208641, Japan; [Inazu, Akihiro] Kanazawa Univ, Dept Lab Sci Mol Biochem & Mol Biol, Grad Sch Med Sci, Kanazawa, Ishikawa 9208641, Japan	Tada, H (reprint author), Kanazawa Univ, Div Cardiovasc Med, Grad Sch Med, 13-1 Takara Machi, Kanazawa, Ishikawa 9208641, Japan.	ht240z@sa3.so-net.ne.jp			Ministry of Education, Science, and Culture of Japan [26893094]	This work was supported by a scientific research grant from the Ministry of Education, Science, and Culture of Japan (No. 26893094).	Seino Y, 2010, J DIABETES INVEST, V1, P212, DOI 10.1111/j.2040-1124.2010.00074.x; Kugiyama K, 1999, CIRCULATION, V99, P2858; Varbo A, 2013, CIRCULATION, V128, P1298, DOI 10.1161/CIRCULATIONAHA.113.003008; Saari K, 2004, J CLIN PSYCHIAT, V65, P547; Berglund L, 2012, J CLIN ENDOCR METAB, V97, P2969, DOI 10.1210/jc.2011-3213; Thomsen M, 2014, CLIN CHEM, V60, P737, DOI 10.1373/clinchem.2013.219881; Fujishima M, 1996, DIABETES, V45, pS14; Kannel WB, 2009, CURR OPIN CARDIOL, V24, P345, DOI 10.1097/HCO.0b013e32832c1284; Tabas I, 2007, CIRCULATION, V116, P1832, DOI 10.1161/CIRCULATIONAHA.106.676890; Jorgensen AB, 2013, EUR HEART J, V34, P1826, DOI 10.1093/eurheartj/ehs431; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Bhojwani D, 2014, EUR J CANCER, V50, P2685, DOI 10.1016/j.ejca.2014.06.023; Brunzell J D, 1973, Trans Assoc Am Physicians, V86, P245; CHAIT A, 1983, METABOLISM, V32, P209, DOI 10.1016/0026-0495(83)90184-1; FREDRICK.DS, 1965, CIRCULATION, V31, P321; Haitas B, 1988, Am J Med, V85, P586, DOI 10.1016/0002-9343(88)90664-X; Hata J, 2011, CEREBROVASC DIS, V31, P477, DOI 10.1159/000324392; KISSEBAH AH, 1973, HORM METAB RES, V5, P184; Murad MH, 2012, BMC ENDOCR DISORD, V12, DOI 10.1186/1472-6823-12-2; Murase T, 2000, THERAPEUTIC RES, V21, P2347; Murase T., 2005, GUIDELINES DIAGNOSIS; R Core Team, 2012, R LANG ENV STAT COMP; Roerecke M., 2014, OPEN HEART, V1, DOI DOI 10.1136/OPENHRT-2014-000135; Tada Hayato, 2015, JIMD Rep, V21, P115, DOI 10.1007/8904_2014_404	24	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-2874	1876-4789		J CLIN LIPIDOL	J. Clin. Lipidol.	AUG	2015	9	4					519	524		10.1016/j.jacl.2015.05.004		6	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO3CT	WOS:000359034900006		
J	Azuma, M; Adachi, M; Motohashi, M; Muramatsu, Y				Azuma, Munehiro; Adachi, Makoto; Motohashi, Masayuki; Muramatsu, Yasunori			Symmetrical lipomatosis of the tongue: Case report and literature review	JOURNAL OF CLINICAL LIPIDOLOGY			English	Review						Lipoma; Lipomatosis; Multiple symmetric; lipOthatosis; Made lung disease; Symmetric lipomatosis of the tongue	MADELUNGS-DISEASE; SURGICAL-TREATMENT; MACROGLOSSIA	Multiple symmetric lipomatosis is rare and characterized by diffuse growth and nonencapsulated lipomas. It is usually found in the posterior neck and upper trunk, and the entity is known as "benign symmetric lipomatosis," "Made lung disease," and "Launois-Bensaude syndrome." Symmetric lipomatosis of the tongue was first described by Desmond and is an extremely rare condition. A 74-year-old man complained of painless tongue swelling and difficulty speaking. Clinical findings revealed no tumor masses on the trunk, limbs, or head and neck region. Intraoral findings included of soft yellowish masses with a smooth surface without erosions on the side of the tongue bilaterally. They were 30 mm in diameter. An incisional biopsy was taken from the mass, and the lipoma was diagnosed. The bilateral tongue lesions were resected under general anesthesia. Intraoperative findings revealed adipose tissues interspersed with lingual muscles and no capsulation. The lesion was finally diagnosed as symmetric lipomatosis of the tongue based on clinical findings and radiological and histologic examination. (C) 2015 National Lipid Association. All rights reserved.	[Azuma, Munehiro; Adachi, Makoto; Motohashi, Masayuki; Muramatsu, Yasunori] Asahi Univ Murakami Mem Hosp, Dept Oral & Maxillofacial Surg, Gifu, Gifu 5008523, Japan	Adachi, M (reprint author), Asahi Univ Murakami Mem Hosp, Dept Oral & Maxillofacial Surg, 3-23 Hashimotocho, Gifu, Gifu 5008523, Japan.	madachi_dds_phd@yahoo.co.jp	Adachi, Makoto/B-1979-2012	Adachi, Makoto/0000-0002-9382-7052			KATOU F, 1993, J CRANIO MAXILL SURG, V21, P298, DOI 10.1016/S1010-5182(05)80351-8; Fregnani ER, 2003, INT J ORAL MAX SURG, V32, P49, DOI 10.1054/ijom.2002.0317; Busetto L, 2003, INT J OBESITY, V27, P1419, DOI 10.1038/sj.ijo.0802427; Calvo-Garcia N, 1999, ORAL SURG ORAL MED O, V87, P610, DOI 10.1016/S1079-2104(99)70143-5; DESMOND AM, 1947, BRIT J SURG, V35, P210, DOI 10.1002/bjs.18003513816; DONHAUSER G, 1991, HAUTARZT, V42, P311; Enzi G, 2002, INT J OBESITY, V26, P253, DOI 10.1038/sj.ijo.0801867; ENZI G, 1983, J LIPID RES, V24, P566; Ishikawa Y, 2006, ORAL SCI INT, V3, P90; Jinbu Y, 2008, ORAL MED PATHOLOGY, V9, P123; Kang JW, 2013, NEW ENGL J MED, V369, pE5, DOI 10.1056/NEJMicm1303413; Lopez-Ceres A, 2006, J CRANIO MAXILL SURG, V34, P489, DOI 10.1016/j.jcms.2006.06.003; Murakami H, 2009, NEW ENGL J MED, V360, pE33, DOI 10.1056/NEJMicm0801797; OGAWA A, 1988, J ORAL MAXIL SURG, V46, P502, DOI 10.1016/0278-2391(88)90424-7; TIZIAN C, 1983, BRIT J PLAST SURG, V36, P187, DOI 10.1016/0007-1226(83)90089-9; Ujpal M, 2001, INT J ORAL MAX SURG, V30, P479, DOI 10.1054/ijom.2001.0162; Vargas-Diez E, 2000, J AM ACAD DERMATOL, V42, P511, DOI 10.1016/S0190-9622(00)90230-5; Vasileiadis I, 2013, LARYNGOSCOPE, V123, P422, DOI 10.1002/lary.23724	18	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1933-2874	1876-4789		J CLIN LIPIDOL	J. Clin. Lipidol.	AUG	2015	9	4					602	606		10.1016/j.jacl.2015.03.002		5	Pharmacology & Pharmacy	Pharmacology & Pharmacy	CO3CT	WOS:000359034900017		
J	Orsini, C; Binnie, V; Evans, P; Ledezma, P; Fuentes, F; Villegas, MJ				Orsini, Cesar; Binnie, Vivian; Evans, Phillip; Ledezma, Priscilla; Fuentes, Fernando; Villegas, Maria J.			Psychometric Validation of the Academic Motivation Scale in a Dental Student Sample	JOURNAL OF DENTAL EDUCATION			English	Article						dental education; academic motivation; Academic Motivation Scale; psychometrics; Chile	SELF-DETERMINATION THEORY; INTRINSIC MOTIVATION; PROCESS QUESTIONNAIRE; PROFESSIONAL CAREER; REVISED 2-FACTOR; NEGATIVE AFFECT; EDUCATION; VALIDITY; AUTONOMY; WELL	The Academic Motivation Scale is one of the most frequently used instruments to assess academic motivation. It relies on the self-determination theory of human motivation. However, motivation has been understudied in dental education. Therefore, to address the lack of valid instruments to assess academic motivation in dental education and contribute to future research in the field, the aim of this study was to analyze the psychometric properties of this instrument in a sample of dental students. Participants were 989 Chilean undergraduate dental students (86% response rate) who completed a survey containing a Chilean face-valid version of the Spanish Academic Motivation Scale and three other motivation-related instruments to assess the survey's construct and criterion validity. Later, 76 of the students (out of 100 invited) took the survey again to assess its test-retest stability. The instrument's construct validity was supported by the superior goodness of fit of the seven-subscale Academic Motivation Scale over competing models through confirmatory factor analysis and by the expected correlations among its subscales. The concurrent criterion validity was supported by the confirmation of correlations between its subscales and external criteria. Adequate internal consistency and test-retest correlations were also found. The evidence from this study suggests that the Academic Motivation Scale is a preliminarily valid and reliable instrument to assess motivation in the predoctoral dental context. Future research in this area is needed to confirm or refute these results. Dr. Orsini is a doctoral candidate in Health Professions Education, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, UK, and Researcher, Teaching and Learning Centre FEN, University of Chile, Santiago, Chile; Dr. Binnie is Clinical Senior University Teacher, Dental School, College of Medical, Veterinary, and Life Sciences, University of Glasgow, Glasgow, UK; Prof Evans is Professor of Medical Education, Medical Education Development Centre, Medical School, Gifu University, Gifu, Japan; Dr. Ledezma is Secretary of Studies, Dental School, University San Sebastian, Santiago, Chile; Dr. Fuentes is Director, Dental School, University San Sebastian, Santiago, Chile; and Dr. Villegas is a Private Dental Practitioner, Santiago, Chile. Direct correspondence to Dr. Cesar Orsini, 27 Hillhead Street (Ground Floor), Glasgow, UK, G12 8PX; +447799485024; corsini@fen.uchile.cl.	[Orsini, Cesar] Univ Glasgow, Coll Med Vet & Life Sci, Hlth Profess Educ, Glasgow, Lanark, Scotland; [Orsini, Cesar] Univ Chile, Teaching & Learning Ctr FEN, Santiago, Chile; [Binnie, Vivian] Univ Glasgow, Coll Med Vet & Life Sci, Sch Dent, Glasgow, Lanark, Scotland; [Evans, Phillip] Gifu Univ, Sch Med, Med Educ, Med Educ Dev Ctr, Gifu 500, Japan; [Ledezma, Priscilla] Univ San Sebastian, Sch Dent, Studies, Santiago, Chile; [Fuentes, Fernando] Univ San Sebastian, Sch Dent, Santiago, Chile	Orsini, C (reprint author), 27 Hillhead St,Ground Floor, Glasgow G12 8PX, Lanark, Scotland.	corsini@fen.uchile.cl					Ames C, 1988, J ED PSYCHOL, V80; Kusurkar RA, 2013, ADV HEALTH SCI EDUC, V18, P57, DOI 10.1007/s10459-012-9354-3; Nunez JL, 2005, PSICOTHEMA, V17, P344; Ryan RM, 2000, AM PSYCHOL, V55, P68, DOI 10.1037//0003-066X.55.1.68; GOTTFRIED AE, 1985, J EDUC PSYCHOL, V77, P631, DOI 10.1037//0022-0663.77.6.631; WATSON D, 1988, J PERS SOC PSYCHOL, V54, P1063, DOI 10.1037/0022-3514.54.6.1063; Baker SR, 2004, CURR PSYCHOL, V23, P189, DOI 10.1007/s12144-004-1019-9; Fairchild AJ, 2005, CONTEMP EDUC PSYCHOL, V30, P331, DOI 10.1016/j.cedpsych.2004.11.001; Williams GC, 1998, ANN INTERN MED, V129, P303; VALLERAND RJ, 1992, EDUC PSYCHOL MEAS, V52, P1003, DOI 10.1177/0013164492052004025; VALLERAND RJ, 1989, CAN J BEHAV SCI, V21, P323, DOI 10.1037/h0079855; Cokley KO, 2000, PSYCHOL REP, V86, P560, DOI 10.2466/PR0.86.2.560-564; VALLERAND RJ, 1993, EDUC PSYCHOL MEAS, V53, P159, DOI 10.1177/0013164493053001018; DECI EL, 1991, EDUC PSYCHOL, V26, P325, DOI 10.1207/s15326985ep2603&4_6; ten Cate TJ, 2011, MED TEACH, V33, P961, DOI 10.3109/0142159X.2011.595435; Biggs J, 2001, BRIT J EDUC PSYCHOL, V71, P133, DOI 10.1348/000709901158433; Freire MDM, 2011, J DENT EDUC, V75, P115; Smith KJ, 2010, PSYCHOL REP, V106, P323, DOI 10.2466/PR0.106.2.323-341; GROLNICK WS, 1987, J PERS SOC PSYCHOL, V52, P890, DOI 10.1037/0022-3514.52.5.890; Cokley KO, 2001, MEAS EVAL COUNS DEV, V34, P109; Robles R, 2003, SALUD MENT, V26, P69; Justicia F, 2008, EUR J PSYCHOL EDUC, V23, P355; Sheldon KM, 1998, PERS SOC PSYCHOL B, V24, P1319, DOI 10.1177/01461672982412006; Aggarwal A, 2012, J DENT EDUC, V76, P1532; VALLERAND RJ, 1992, J PERS, V60, P599, DOI 10.1111/j.1467-6494.1992.tb00922.x; KOESTNER R, 1984, J PERS, V52, P233, DOI 10.1111/j.1467-6494.1984.tb00879.x; Bandura A., 1977, PSYCHOL REV, P192; Benson J., 1998, ED MEASUREMENT ISSUE, V1, P10, DOI DOI 10.1111/J.1745-3992.1998.TB00616.X; Byrne B., 2001, INT J TESTING, V1, P55, DOI DOI 10.1207/S15327574IJT0101_; Creswell J., 2003, RES DESIGN QUALITATI; Deci E. L., 1985, INTRINSIC MOTIVATION; Deci E. L., 1995, EFFICACY AGENCY SELF, P31; dos Santos BF, 2013, J DENT EDUC, V77, P337; Graham S, 1997, EDUC PSYCHOL, V32, P21, DOI 10.1207/s15326985ep3201_2; HOELTER JW, 1983, SOCIOL METHOD RES, V11, P325, DOI 10.1177/0049124183011003003; Karaguven MHU, 2012, KURAM UYGUL EGIT BIL, V12, P2611; Kline R. B., 2011, PRINCIPLES PRACTICE; McClelland D. C., 1987, HUMAN MOTIVATION; MCGRAW KO, 1979, J EXP SOC PSYCHOL, V15, P285, DOI 10.1016/0022-1031(79)90039-8; Miserandino M, 1996, J EDUC PSYCHOL, V88, P203, DOI 10.1037/0022-0663.88.2.203; Nunez JL, 2006, REV INTERAMERICANA P, V40, P391; Nunez JL, 2007, ESTUDIOS PSICOLOGIA, V28, P333, DOI 10.1174/021093907782506461; RYAN RM, 1995, J PERS, V63, P397, DOI 10.1111/j.1467-6494.1995.tb00501.x; Smith K. J., 2012, ASSESSMENT ED PRINCI, V19, P231; Stover JB, 2012, PSYCHOL RES BEHAV MA, V25, P71; University of Chile, 2008, DROP REAS HIGH ED; Vallerand RJ, 1997, ADV EXP SOC PSYCHOL, V29, P271, DOI 10.1016/S0065-2601(08)60019-2; Wrzesniewski A, 2014, NY TIMES	48	0	0	AMER DENTAL EDUCATION ASSOC-ADEA	WASHINGTON	655 K STREET NW, SUITE 800, WASHINGTON, DC 20001 USA	0022-0337	1930-7837		J DENT EDUC	J. Dent. Educ.	AUG	2015	79	8					971	981				11	Dentistry, Oral Surgery & Medicine	Dentistry, Oral Surgery & Medicine	CO3CN	WOS:000359034300013		
J	Kato, N; Yanagawa, T; Fujiwara, T; Morawska, A				Kato, Noriko; Yanagawa, Toshihiko; Fujiwara, Takeo; Morawska, Alina			Prevalence of Children's Mental Health Problems and the Effectiveness of Population-Level Family Interventions	JOURNAL OF EPIDEMIOLOGY			English	Review						child; mental health; prevalence; family intervention; evaluation	RANDOMIZED CONTROLLED-TRIAL; EARLY START PROGRAM; BEHAVIORAL-PROBLEMS; PARENTING PROGRAMS; EMOTIONAL-PROBLEMS; ANXIETY-DISORDERS; CONDUCT PROBLEMS; HOME VISITATION; YOUNG-PEOPLE; ADOLESCENTS	The prevalence of mental health problems among children and adolescents is of growing importance. Intervening in children's mental health early in life has been shown to be more effective than trying to resolve these problems when children are older. With respect to prevention activities in community settings, the prevalence of problems should be estimated, and the required level of services should be delivered. The prevalence of children's mental health disorders has been reported for many countries. Preventive intervention has emphasized optimizing the environment. Because parents are the primary influence on their children's development, considerable attention has been placed on the development of parent training to strengthen parenting skills. However, a public-health approach is necessary to confirm that the benefits of parent-training interventions lead to an impact at the societal level. This literature review clarifies that the prevalence of mental health problems is measured at the national level in many countries and that population-level parenting interventions can lower the prevalence of mental health problems among children in the community.	[Kato, Noriko] Natl Inst Publ Hlth, Area Hlth Promot Res, Wako, Saitama 3510197, Japan; [Yanagawa, Toshihiko] Wakayama Med Univ, Sch Hlth & Nursing Sci, Wakayama, Japan; [Fujiwara, Takeo] Natl Res Inst Child Hlth & Dev, Dept Social Med, Tokyo, Japan; [Morawska, Alina] Univ Queensland, Parenting & Family Support Ctr, Brisbane, Qld 4072, Australia	Kato, N (reprint author), Jumonji Univ, Dept Presch Educ, 2-1-28 Sugasawa, Niiza, Saitama 3528510, Japan.	kato@niph.go.jp					Achenbach TM., 1991, MANUAL CHILD BEHAV C; Sawyer MG, 2001, AUST NZ J PSYCHIAT, V35, P806, DOI 10.1046/j.1440-1614.2001.00964.x; Bayer J, 2009, AUST NZ J PSYCHIAT, V43, P695, DOI 10.1080/00048670903001893; Sanders MR, 2007, J ABNORM CHILD PSYCH, V35, P983, DOI 10.1007/s10802-007-9148-x; Turner KMT, 2006, BEHAV THER, V37, P131, DOI 10.1016/j.beth.2005.05.004; Fergusson DM, 2005, PEDIATRICS, V116, pE803, DOI 10.1542/peds.2005-0948; Kjobli J, 2008, SCAND J PSYCHOL, V49, P365, DOI 10.1111/j.1467-9450.2008.00648.x; Lindsay G, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-972; Davis E, 2010, ACAD PEDIATR, V10, P41, DOI 10.1016/j.acap.2009.08.007; Sanders MR, 2008, J PRIM PREV, V29, P197, DOI 10.1007/s10935-008-0139-7; Belfer ML, 2008, J CHILD PSYCHOL PSYC, V49, P226, DOI 10.1111/j.1469-7610.2007.01855.x; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Kessler RC, 2007, CURR OPIN PSYCHIATR, V20, P359, DOI 10.1097/YCO.0b013e32816ebc8c; Birmaher B, 1999, J AM ACAD CHILD PSY, V38, P1230, DOI 10.1097/00004583-199910000-00011; Rapee RM, 2005, J CONSULT CLIN PSYCH, V73, P488, DOI 10.1037/0022-006X.73.3.488; Erol N, 2005, J AM ACAD CHILD PSY, V44, P80, DOI 10.1097/01.chi.0000145234.18056.82; Webster-Stratton C, 2004, J CLIN CHILD ADOLESC, V33, P105, DOI 10.1207/S15374424JCCP3301_11; Horwitz SM, 2012, J AM ACAD CHILD PSY, V51, P572, DOI 10.1016/j.jaac.2012.03.006; CUNNINGHAM CE, 1995, J CHILD PSYCHOL PSYC, V36, P1141, DOI 10.1111/j.1469-7610.1995.tb01362.x; Durlak JA, 1997, AM J COMMUN PSYCHOL, V25, P115, DOI 10.1023/A:1024654026646; FAULSTICH ME, 1986, AM J PSYCHIAT, V143, P1024; Costello EJ, 2005, J AM ACAD CHILD PSY, V44, P972, DOI 10.1097/01.chi.0000172552.041596.6f; Kennedy SJ, 2009, J AM ACAD CHILD PSY, V48, P602, DOI 10.1097/CHI.0b013e31819f6fa9; Sanders MR, 2008, J FAM PSYCHOL, V22, P506, DOI 10.1037/0893-3200.22.3.506; Baker-Henningham H, 2012, BRIT J PSYCHIAT, V201, P101, DOI 10.1192/bjp.bp.111.096834; Kessler RC, 2004, INT J METH PSYCH RES, V13, P93, DOI 10.1002/mpr.168; Bayer JK, 2008, J CHILD PSYCHOL PSYC, V49, P1166, DOI 10.1111/j.1469-7610.2008.01943.x; Roberts C, 2006, J CLIN CHILD ADOLESC, V35, P180, DOI 10.1207/s15374424jccp3502_2; Ravens-Sieberer U, 2008, EUR CHILD ADOLES PSY, V17, P22, DOI 10.1007/s00787-008-1003-2; Wang JN, 2014, CHILD CARE HLTH DEV, V40, P319, DOI 10.1111/cch.12101; Roberts RE, 1998, AM J PSYCHIAT, V155, P715; Prinz RJ, 2009, PREV SCI, V10, P1, DOI 10.1007/s11121-009-0123-3; Bayer JK, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-11; BIEDERMAN J, 1993, J AM ACAD CHILD PSY, V32, P814, DOI 10.1097/00004583-199307000-00016; Coatsworth J Douglas, 2014, New Dir Youth Dev, V2014, P45, DOI 10.1002/yd.20096; CONNERS CK, 1985, PSYCHOPHARMACOL BULL, V21, P243; Day C, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1107; Eapen Valsamma, 2004, J Pediatr Health Care, V18, P186, DOI 10.1016/S0891-5245(04)00061-6; Fergusson DM, 2006, PEDIATRICS, V117, P781, DOI 10.1542/peds.2005-1517; Fuchs S, 2013, CHILD PSYCHIAT HUM D, V44, P493, DOI 10.1007/s10578-012-0343-9; Fujiwara T, 2011, J CHILD FAM STUD, V20, P804, DOI 10.1007/s10826-011-9448-1; Gritti A, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-19; Holling H, 2008, EUR CHILD ADOLES PSY, V17, P34, DOI 10.1007/s00787-008-1004-1; Izumi M, 2008, J JAPAN PEDIAT SOC, V112, P476; Kilroy Sarah, 2011, Clin Child Psychol Psychiatry, V16, P459, DOI 10.1177/1359104510384338; Lindsay G, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-962; Ma XQ, 2013, ASIA-PAC PSYCHIAT, V5, pE1, DOI 10.1111/j.1758-5872.2012.00211.x; Matthew R. F., 2005, AM J HLTH STUDIES, V20, P164; Palfrey JS, 2005, PEDIATRICS, V115, P1121, DOI 10.1542/peds.2004-2825B; Patel V, 2007, LANCET, V369, P1302, DOI 10.1016/S0140-6736(07)60368-7; Sanders M R, 1999, Clin Child Fam Psychol Rev, V2, P71, DOI 10.1023/A:1021843613840; SAWYER MG, 1990, AUST NZ J PSYCHIAT, V24, P323, DOI 10.3109/00048679009077699; Zubrick SR, 2005, PREV SCI, V6, P287, DOI 10.1007/s11121-005-0013-2	53	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	AUG	2015	25	8					507	516		10.2188/jea.JE20140198		10	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN9TW	WOS:000358793100001		
J	Iwamoto, T; Hashimoto, H; Horiguchi, H; Yasunaga, H				Iwamoto, Tetsuya; Hashimoto, Hideki; Horiguchi, Hiromasa; Yasunaga, Hideo			Effectiveness of Hospital Functions for Acute Ischemic Stroke Treatment on In-Hospital Mortality: Results From a Nationwide Survey in Japan	JOURNAL OF EPIDEMIOLOGY			English	Article						ischemic stroke; acute care; stroke care unit; in-hospital mortality; instrumental variable estimation	INSTRUMENTAL VARIABLES; ATTACK; CENTERS; PATIENT; BENEFIT; INJURY; VOLUME; LEVEL; INDEX	Background: Though evidence is limited in Japan, clinical controlled studies overseas have revealed that specialized care units are associated with better outcomes for acute stoke patients. This study aimed to examine the effectiveness of hospital functions for acute care of ischemic stroke on in-hospital mortality, with statistical accounting for referral bias. Methods: We derived data from a large Japanese claim-based inpatient database linked to the Survey of Medical Care Institutions and Hospital Report data. We compared the mortality of acute ischemic stroke patients (n = 41 476) in hospitals certified for acute stroke treatment with that in non-certified institutions. To adjust for potential referral bias, we used differential distance to hospitals from the patient's residence as an instrumental variable and constructed bivariate probit models. Results: With the ordinary probit regression model, in-hospital mortality in certified hospitals was not significantly different from that in non-certified institutions. Conversely, the model with the instrumental variable method showed that admission to certified hospitals reduced in-hospital mortality by 30.7% (P < 0.001). This difference remained after adjusting for hospital size, volume, staffing, and intravenous use of tissue plasminogen activator. Conclusions: Comparison accounting for referral selection found that certified hospital function for acute ischemic stroke care was associated with significantly lower in-hospital mortality. Our results indicate that organized stroke care-with certified subspecialty physicians and around-the-clock availability of personnel, imaging equipment, and emergency neurosurgical procedures in an intensive stroke care unit-is effective in improving outcomes in acute ischemic stroke care.	[Iwamoto, Tetsuya; Yasunaga, Hideo] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo 1130033, Japan; [Iwamoto, Tetsuya; Hashimoto, Hideki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Tokyo 1130033, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Dept Clin Data Management & Res, Clin Res Ctr, Tokyo, Japan	Hashimoto, H (reprint author), Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1130033, Japan.	hidehashimoto-circ@umin.ac.jp			Ministry of Health, Labour and Welfare [H21-seisaku-shitei-033, H22-seisaku-shitei-01]; Japan Society for the Promotion of Science; Funding Program for Innovative R&D on Science and Technology (FIRST) program	This study was supported in part by a Grant-in-Aid for Scientific Research from the Ministry of Health, Labour and Welfare (H21-seisaku-shitei-033 and H22-seisaku-shitei-01) and by a research grant from the Japan Society for the Promotion of Science, the Funding Program for Innovative R&D on Science and Technology (FIRST) program, initiated by the Council for Science and Technology Policy. We thank Dr. Takashi Fukuda at the National Institute of Public Health for his helpful suggestions on an earlier draft and Prof. Rei Goto at Kyoto University for his comments on statistical analysis.	Ono K, 2007, NEUROL MED-CHIR, V47, P291, DOI 10.2176/nmc.47.291; Yasunaga H, 2013, BRIT J SURG, V100, P1335, DOI 10.1002/bjs.9221; Alberts MJ, 2005, STROKE, V36, P1597, DOI 10.1161/01.STR.0000170622.07210.b4; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Rassen JA, 2009, J CLIN EPIDEMIOL, V62, P1233, DOI 10.1016/j.jclinepi.2008.12.006; BOUND J, 1995, J AM STAT ASSOC, V90, P443, DOI 10.2307/2291055; Newhouse JP, 1998, ANNU REV PUBL HEALTH, V19, P17, DOI 10.1146/annurev.publhealth.19.1.17; MCCLELLAN M, 1994, JAMA-J AM MED ASSOC, V272, P859, DOI 10.1001/jama.272.11.859; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS31, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.004; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Saposnik G, 2007, NEUROLOGY, V69, P1142, DOI 10.1212/01.wnl.0000268485.93349.58; WHITE H, 1982, ECONOMETRICA, V50, P1, DOI 10.2307/1912526; Harris KM, 1998, HEALTH SERV RES, V33, P1337; Xian Y, 2011, JAMA-J AM MED ASSOC, V305, P373, DOI 10.1001/jama.2011.22; Sugihara T, 2014, INT J UROL, V21, P566, DOI 10.1111/iju.12368; Kimura K, 2005, CEREBROVASC DIS, V19, P171, DOI 10.1159/000083252; Au Yeung S L, 2012, Am J Epidemiol, V175, P1021, DOI 10.1093/aje/kwr462; Iihara K, 2014, PLOS ONE, V9; Matsuda S, 2009, EUROHEALTH, V14, P27; McConnell KJ, 2005, HEALTH SERV RES, V40, P435, DOI 10.1111/j.1475-6773.2005.0u367.x; Ogbu UC, 2010, MED CARE, V48, P149, DOI 10.1097/MLR.0b013e3181bd4df1; Reeves MJ, 2010, STROKE, V41, P2924, DOI 10.1161/STROKEAHA.110.598664; Stroke Unit Trialists' Collaboration, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD000197.pub2, DOI 10.1002/14651858.CD000197.PUB2]; TODO T, 1991, J NEUROSURG, V74, P81, DOI 10.3171/jns.1991.74.1.0081; Uyttenboogaart M, 2007, J NEUROL, V254, P1113, DOI 10.1007/s00415-007-0646-0; Yagura H, 2005, CEREBROVASC DIS, V20, P258, DOI 10.1159/000087708	26	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	AUG	2015	25	8					522	528		10.2188/jea.JE20140181		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN9TW	WOS:000358793100003		
J	Obayashi, K; Saeki, K; Miyata, K; Nishi, T; Tone, N; Ogata, N; Kurumatani, N				Obayashi, Kenji; Saeki, Keigo; Miyata, Kimie; Nishi, Tomo; Tone, Nobuhiro; Ogata, Nahoko; Kurumatani, Norio			Comparisons of Objective Sleep Quality Between Elderly Individuals With and Without Cataract Surgery: A Cross-Sectional Study of the HEIJO-KYO Cohort	JOURNAL OF EPIDEMIOLOGY			English	Article						sleep quality; cataract surgery; circadian rhythms; actigraphy; melatonin	HEALTHY OLDER; FOLLOW-UP; LIGHT; MELATONIN; INSOMNIA; EXPOSURE; EXCRETION; ADULTS; POPULATION; BLOCKING	Background: Cataract surgery (CS) drastically increases the capacity for light reception to the retina. Several previous studies have suggested the beneficial effect of CS on subjectively measured sleep quality; however, the association between CS and objectively measured sleep quality remains uncertain. Methods: To evaluate the association between CS and objectively measured sleep quality in home settings, we conducted a cross-sectional study in 1037 elderly individuals (mean age, 71.9 years). We evaluated actigraphically measured sleep quality, urinary 6-sulfatoxymelatonin excretion, and ambulatory light levels, in addition to CS status. Results: The CS group (n = 174) showed significantly higher sleep efficiency and shorter wake after sleep onset than the no CS group (n = 863), even after adjustment for age, gender, body mass index, current smoking status, alcohol consumption, hypertension, diabetes, sleep medication, bedtime, rising time, daytime physical activity, daytime and nighttime light exposure, and urinary 6-sulfatoxymelatonin excretion (sleep efficiency: 85.8% in the CS group vs 84.4% in the no CS group, P = 0.042; wake after sleep onset: 45.7 min vs 50.6 min, respectively, P = 0.033). In contrast, urinary 6-sulfatoxymelatonin excretion, sleep onset latency, total sleep time, and sleep-mid time did not differ significantly between the CS and no CS groups. Conclusions: Among a community-dwelling elderly population, CS is significantly associated with objectively measured sleep quality, but urinary levels of melatonin metabolite do not differ between individuals with and without CS. These associations are independent of daily light exposure profiles.	[Obayashi, Kenji; Saeki, Keigo; Kurumatani, Norio] Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, Kashihara, Nara 6348521, Japan; [Miyata, Kimie; Nishi, Tomo; Ogata, Nahoko] Nara Med Univ, Sch Med, Dept Ophthalmol, Kashihara, Nara 6348521, Japan; [Tone, Nobuhiro] Nara Med Univ, Sch Med, Ctr Acad Ind & Govt Relat, Kashihara, Nara 6348521, Japan	Obayashi, K (reprint author), Nara Med Univ, Sch Med, Dept Community Hlth & Epidemiol, 840 Shijocho, Kashihara, Nara 6348521, Japan.	obayashi@naramed-u.ac.jp			Department of Indoor Environmental Medicine, Nara Medical University; JSPS KAKENHI Grant [24790774, 22790567, 25860567, 25461393]; Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; Japan Science and Technology Agency; YKK AP Inc.; Nara Prefecture Health Promotion Foundation; Nara Medical University	We would like to thank Sachiko Uemura, Naomi Takenaka, and Keiko Nakajima for their valuable support during the data collection. This work was supported by Grants from the Department of Indoor Environmental Medicine, Nara Medical University; JSPS KAKENHI Grant Number (24790774, 22790567, 25860567, 25461393); Mitsui Sumitomo Insurance Welfare Foundation; Meiji Yasuda Life Foundation of Health and Welfare; Osaka Gas Group Welfare Foundation; Japan Diabetes Foundation; Daiwa Securities Health Foundation; the Japan Science and Technology Agency; YKK AP Inc.; Nara Prefecture Health Promotion Foundation; and Nara Medical University Grant-in-Aid for Collaborative Research Projects.	Alexander I, 2014, INVEST OPHTH VIS SCI, V55, P4999, DOI 10.1167/iovs.14-14054; Wei X, 2013, J CLIN SLEEP MED, V9, P741, DOI 10.5664/jcsm.2908; Ayaki M, 2013, REJUV RES, V16, P35, DOI 10.1089/rej.2012.1369; Lieverse R, 2011, ARCH GEN PSYCHIAT, V68, P61, DOI 10.1001/archgenpsychiatry.2010.183; Cricco M, 2001, J AM GERIATR SOC, V49, P1185, DOI 10.1046/j.1532-5415.2001.49235.x; EAKER ED, 1992, AM J EPIDEMIOL, V135, P854; van den Berg JF, 2009, SLEEP, V32, P1367; Asplund R, 2002, ARCH GERONTOL GERIAT, V35, P179, DOI 10.1016/S0167-4943(02)00022-5; Cajochen C, 2000, BEHAV BRAIN RES, V115, P75, DOI 10.1016/S0166-4328(00)00236-9; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Mishima K, 2001, J CLIN ENDOCR METAB, V86, P129, DOI 10.1210/jc.86.1.129; Calem M, 2012, SLEEP, V35, P377, DOI 10.5665/sleep.1700; Turner PL, 2010, SLEEP MED REV, V14, P269, DOI 10.1016/j.smrv.2009.11.002; Zeitzer JM, 2000, J PHYSIOL-LONDON, V526, P695; Tanaka M, 2010, J PHYSIOL ANTHROPOL, V29, P219, DOI 10.2114/jpa2.29.219; Dew MA, 2003, PSYCHOSOM MED, V65, P63, DOI 10.1097/01.PSY.0000039756.23250.7C; Obayashi K, 2012, J CLIN ENDOCR METAB, V97, P4166, DOI 10.1210/jc.2012-1873; Leger D, 2004, AM J MED, V116, P91, DOI 10.1016/j.amjmed.2003.07.017; Yokoyama E, 2010, SLEEP, V33, P1693; Duncan DD, 2002, DEV OPHTHALMOL, V35, P76; Walsh JK, 2011, SLEEP, V34, P997, DOI 10.5665/SLEEP.1150; Asplund R, 2004, ARCH GERONTOL GERIAT, V38, P69, DOI 10.1016/j.archger.2003.08.001; Baskett JJ, 1998, J PINEAL RES, V24, P58, DOI 10.1111/j.1600-079X.1998.tb00366.x; Brzezinski Amnon, 1997, New England Journal of Medicine, V336, P186; CAMPBELL SS, 1988, PHYSIOL BEHAV, V42, P141, DOI 10.1016/0031-9384(88)90289-2; PRINZ PN, 1990, NEW ENGL J MED, V323, P520; Scheuermaier K, 2010, J BIOL RHYTHM, V25, P113, DOI 10.1177/0748730410361916; Spira AP, 2012, J AM GERIATR SOC, V60, P1237, DOI 10.1111/j.1532-5415.2012.04044.x; Turner PL, 2008, BRIT J OPHTHALMOL, V92, P1439, DOI 10.1136/bjo.2008.141747	29	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	AUG	2015	25	8					529	535		10.2188/jea.JE20140201		7	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN9TW	WOS:000358793100004		
J	Kubota, Y; Iso, H; Tamakoshi, A				Kubota, Yasuhiko; Iso, Hiroyasu; Tamakoshi, Akiko		JACC Study Grp	Association of Body Mass Index and Mortality in Japanese Diabetic Men and Women Based on Self-Reports: The Japan Collaborative Cohort (JACC) Study	JOURNAL OF EPIDEMIOLOGY			English	Article						diabetes; body mass index; mortality; infection; obesity paradox	RISK; ADULTS; MELLITUS; DEATH; BMI	Background: The association between body mass index (BMI) and mortality among Asian diabetic people, especially with respect to the obesity paradox (ie, higher BMI is associated with lower mortality risk), remains unresolved. Methods: We followed a cohort of 3851 self-reported Japanese diabetics (2115 men and 1736 women) in the Japan Collaborative Cohort Study from 1988-1990 through 2009. Individuals were aged 40 to 79 years and free from a history of cardiovascular disease, cancer, renal disease, or tuberculosis. BMI was grouped into the following four categories: <20.0, 20.0-22.9, 23.0-24.9, and >= 25.0 kg/m(2). Results: During 54 707 person-years of follow-up, 1457 deaths from all causes, 445 from cardiovascular disease, 421 from cancer, 43 from renal disease, and 148 from infectious disease were documented. Mortality from all causes, cardiovascular disease, cancer, and renal disease showed L-shaped associations with BMI. Compared to diabetics with BMI of 20.0-22.9 kg/m(2), those with BMIs of 23.0-24.9 kg/m(2) and >= 25.0 kg/m(2) had lower risks of mortality from infectious disease (ie, obesity paradox). The multivariable HRs for mortality from infectious disease were 0.50 (95% confidence interval, 0.31-0.81) and 0.51 (95% confidence interval, 0.32-0.82) among participants with BMIs of 23.0-24.9 kg/m(2) and >= 25.0 kg/m(2), respectively. Similar results were observed after stratification by smoking status and age and exclusion of early deaths. Conclusions: We observed L-shaped associations between BMI and mortality from all causes, cardiovascular disease, cancer, and renal disease, while the association between BMI and mortality from infectious disease manifested the obesity paradox.	[Kubota, Yasuhiko; Iso, Hiroyasu] Osaka Univ, Grad Sch Med, Publ Hlth, Dept Social Med, Suita, Osaka 5650871, Japan; [Tamakoshi, Akiko] Hokkaido Univ, Grad Sch Med, Dept Publ Hlth, Sapporo, Hokkaido, Japan	Iso, H (reprint author), Osaka Univ, Grad Sch Med, Publ Hlth, Dept Social & Environm Med, 2-2 Yamadaoka, Suita, Osaka 5650871, Japan.	iso@pbhel.med.osaka-u.ac.jp		Iso, Hiroyasu/0000-0002-9241-7289	Ministry of Education, Science, Sports, and Culture of Japan (Monbusho); Japanese Ministry of Education, Culture, Sports, Science and Technology (Monbukagaku-sho) [61010076, 62010074, 63010074, 1010068, 2151065, 3151064, 4151063, 5151069, 6279102, 11181101, 17015022, 18014011, 20014026, 20390156]	This study was supported by the Ministry of Education, Science, Sports, and Culture of Japan (Monbusho) and the Japanese Ministry of Education, Culture, Sports, Science and Technology (Monbukagaku-sho): grant numbers 61010076, 62010074, 63010074, 1010068, 2151065, 3151064, 4151063, 5151069, 6279102, 11181101, 17015022, 18014011, 20014026, and 20390156.	Tamakoshi A, 2013, J EPIDEMIOL, V23, P227, DOI 10.2188/jea.JE20120161; BUSH TL, 1989, AM J PUBLIC HEALTH, V79, P1554, DOI 10.2105/AJPH.79.11.1554; Tseng CH, 2013, ATHEROSCLEROSIS, V226, P186, DOI 10.1016/j.atherosclerosis.2012.09.004; Bertoni AG, 2001, DIABETES CARE, V24, P1044, DOI 10.2337/diacare.24.6.1044; Tamakoshi A, 2010, OBESITY, V18, P362, DOI 10.1038/oby.2009.190; Iso H, 2006, ANN INTERN MED, V144, P554; Logue J, 2013, DIABETES CARE, V36, P887, DOI 10.2337/dc12-0944; Doehner W, 2012, INT J CARDIOL, V162, P20, DOI 10.1016/j.ijcard.2011.09.039; Hu FB, 2011, DIABETES CARE, V34, P1249, DOI 10.2337/dc11-0442; Chan JCN, 2009, JAMA-J AM MED ASSOC, V301, P2129, DOI 10.1001/jama.2009.726; Carnethon MR, 2012, JAMA-J AM MED ASSOC, V308, P581, DOI 10.1001/jama.2012.9282; Barba C, 2004, LANCET, V363, P157; KEHOE R, 1994, AM J EPIDEMIOL, V139, P813; McEwen LN, 2012, DIABETES CARE, V35, P1301, DOI 10.2337/dc11-2281; Seshasai SRK, 2011, NEW ENGL J MED, V364, P829; Morimoto A., 2010, JMAJ - Japan Medical Association Journal, V53, P36; Tanaka S, 2014, J CLIN ENDOCRINOL ME; Tobias DK, 2014, NEW ENGL J MED, V370, P233, DOI 10.1056/NEJMoa1304501; Yano Y, 2013, DIABETES CARE, V36, P1186, DOI 10.2337/dc12-1736	19	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	AUG	2015	25	8					553	558		10.2188/jea.JE20150011		6	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN9TW	WOS:000358793100007		
J	Tokudome, S				Tokudome, Shinkan			Re: Effect of Individual Omega-3 Fatty Acids on the Risk of Prostate Cancer: A Systematic Review and Dose-Response Meta-Analysis of Prospective Cohort Studies	JOURNAL OF EPIDEMIOLOGY			English	Letter							FATTY-ACIDS; PREVENTION; MORTALITY; JAPANESE; DISEASE; TRIAL; RATIO		[Tokudome, Shinkan] Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo 1628636, Japan	Tokudome, S (reprint author), Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Shinjuku Ku, 1-23-1 Toyama, Tokyo 1628636, Japan.	tokudome2013@gmail.com					TAKESHITA T, 1994, HUM GENET, V94, P217; Thun MJ, 2002, J NATL CANCER I, V94, P252; Pauwels EKJ, 2008, DRUG NEWS PERSPECT, V21, P504, DOI 10.1358/dnp.2008.21.9.1290819; Okuyama H, 2001, EUR J LIPID SCI TECH, V103, P418, DOI 10.1002/1438-9312(200106)103:6<418::AID-EJLT418>3.0.CO;2-#; Simopoulos AP, 2008, EXP BIOL MED, V233, P674, DOI 10.3181/0711-MR-311; Andriole GL, 2009, NEW ENGL J MED, V360, P1310, DOI 10.1056/NEJMoa0810696; Akaza H, 2004, JPN J CLIN ONCOL, V34, P86, DOI 10.1093/jjco/hyh015; Carter BD, 2015, NEW ENGL J MED, V372, P631, DOI 10.1056/NEJMsa1407211; Cuzick J, 2014, LANCET ONCOL, V15, pE484, DOI 10.1016/S1470-2045(14)70211-6; Fu YQ, 2015, J EPIDEMIOL, V25, P261, DOI 10.2188/jea.JE20140120; Tokudome Y, 1999, J Epidemiol, V9, P78; LANDS WEM, 1995, AM J CLIN NUTR, V61, p721S; Schroeder FH, 2009, NEW ENGL J MED, V360, P1320, DOI 10.1056/NEJMoa0810084; Tokudome S, 2015, PROSTAG LEUKOTR ESS, V94, P1, DOI 10.1016/j.plefa.2014.09.001; Tokudome S., 2014, JNCI-J NATL CANCER I, V106; Wakabayashi K., 2000, ASIAN PAC J CANCER P, V1, P97; World Cancer Research Fund/ American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	17	0	0	JAPAN EPIDEMIOLOGICAL ASSOC	TOKYO	C/O UNIBO PRESS, HONGO MT BLDG 4F, 7-2-2 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0917-5040	1349-9092		J EPIDEMIOL	J. Epidemiol.	AUG	2015	25	8					559	560		10.2188/jea.JE20150135		2	Public, Environmental & Occupational Health	Public, Environmental & Occupational Health	CN9TW	WOS:000358793100008		
J	Takasuka, K; Yasui, T; Ishigami, T; Nakata, K; Matsumoto, R; Ikeda, K; Maeto, K				Takasuka, Keizo; Yasui, Tomoki; Ishigami, Toru; Nakata, Kensuke; Matsumoto, Rikio; Ikeda, Kenichi; Maeto, Kaoru			Host manipulation by an ichneumonid spider ectoparasitoid that takes advantage of preprogrammed web-building behaviour for its cocoon protection	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Cocoon web; Cyclosa argenteoalba; Fibrous thread decoration (FTD); Reclinervellus nielseni; Resting web; Tensile test	GASTERACANTHA-CANCRIFORMIS ARANEAE; HYMENOPTERA-ICHNEUMONIDAE; SILK DECORATIONS; ARANEIDAE; PREY; STABILIMENTA; PIMPLINAE; ADVERTISEMENT; PARASITOIDS; ATTRACTION	Host manipulation by parasites and parasitoids is a fascinating phenomenon within evolutionary ecology, representing an example of extended phenotypes. To elucidate the mechanism of host manipulation, revealing the origin and function of the invoked actions is essential. Our study focused on the ichneumonid spider ectoparasitoid Reclinervellus nielseni, which turns its host spider (Cyclosa argenteoalba) into a drugged navvy, to modify the web structure into a more persistent cocoon web so that the wasp can pupate safely on this web after the spider's death. We focused on whether the cocoon web originated from the resting web that an unparasitized spider builds before moulting, by comparing web structures, building behaviour and silk spectral/tensile properties. We found that both resting and cocoon webs have reduced numbers of radii decorated by numerous fibrous threads and specific decorating behaviour was identical, suggesting that the cocoon web in this system has roots in the innate resting web and ecdysteroid-related components may be responsible for the manipulation. We also show that these decorations reflect UV light, possibly to prevent damage by flying web-destroyers such as birds or large insects. Furthermore, the tensile test revealed that the spider is induced to repeat certain behavioural steps in addition to resting web construction so that many more threads are laid down for web reinforcement.	[Takasuka, Keizo; Maeto, Kaoru] Kobe Univ, Grad Sch Agr Sci, Lab Insect Biodivers & Ecosyst Sci, Kobe, Hyogo 6578501, Japan; [Yasui, Tomoki; Ishigami, Toru] Kobe Univ, Grad Sch Engn, Dept Chem Sci & Engn, Kobe, Hyogo 6578501, Japan; [Nakata, Kensuke] Kyoto Womens Univ, Fac Study Contemporary Soc, Kyoto 6058501, Japan; [Matsumoto, Rikio] Osaka Museum Nat Hist, Osaka 5460034, Japan; [Ikeda, Kenichi] Kobe Univ, Grad Sch Agr Sci, Lab Stress Cytol, Kobe, Hyogo 6578501, Japan	Takasuka, K (reprint author), Kobe Univ, Grad Sch Agr Sci, Lab Insect Biodivers & Ecosyst Sci, Kobe, Hyogo 6578501, Japan.	keizaf@gmail.com	Nakata, Kensuke/D-9447-2011	Nakata, Kensuke/0000-0002-1207-3448	Japan Society for the Promotion of Science for Young Scientists	K.T. was financially supported for this study by Research Fellowship of Japan Society for the Promotion of Science for Young Scientists.	Lefevre T, 2009, TRENDS ECOL EVOL, V24, P41, DOI 10.1016/j.tree.2008.08.007; Matsumoto R, 2007, ENTOMOL SCI, V10, P267, DOI 10.1111/j.1479-8298.2007.00223.x; Thomas F, 2005, BEHAV PROCESS, V68, P185, DOI 10.1016/j.beproc.2004.06.010; Nakata K, 2009, ANIM BEHAV, V78, P1255, DOI 10.1016/j.anbehav.2009.08.012; Eberhard WG, 2010, ANIM BEHAV, V79, P375, DOI 10.1016/j.anbehav.2009.10.033; Eberhard WG, 2000, NATURE, V406, P255, DOI 10.1038/35018636; Matsumoto R, 2009, J INSECT BEHAV, V22, P39, DOI 10.1007/s10905-008-9152-1; Blackledge TA, 2011, ADV INSECT PHYSIOL, V41, P175, DOI 10.1016/B978-0-12-415919-8.00004-5; Gonzaga MO, 2010, ETHOL ECOL EVOL, V22, P151, DOI 10.1080/03949371003707836; Blackledge TA, 1999, BEHAV ECOL, V10, P372, DOI 10.1093/beheco/10.4.372; Eberhard WG, 2001, J ARACHNOL, V29, P354, DOI 10.1636/0161-8202(2001)029[0354:UTIWAB]2.0.CO;2; Sato T, 2011, ECOLOGY, V92, P201, DOI 10.1890/09-1565.1; Herberstein ME, 2000, BIOL REV, V75, P649; Gonzaga MO, 2011, ENTOMOL SCI, V14, P220, DOI 10.1111/j.1479-8298.2010.00436.x; Eberhard WG, 2013, ANN ENTOMOL SOC AM, V106, P652, DOI 10.1603/AN12147; Lafferty KD, 2013, J EXP BIOL, V216, P56, DOI 10.1242/jeb.073668; Korenko S, 2014, ECOL ENTOMOL, V39, P30, DOI 10.1111/een.12067; Sobczak JF, 2009, J NAT HIST, V43, P2691, DOI 10.1080/00222930903244010; Blackledge TA, 1998, P ROY SOC B-BIOL SCI, V265, P1991, DOI 10.1098/rspb.1998.0530; Bruce MJ, 2001, J EVOLUTION BIOL, V14, P786, DOI 10.1046/j.1420-9101.2001.00326.x; Bruce MJ, 2006, J ZOOL, V269, P89, DOI 10.1111/j.1469-7998.2006.00047.x; CODDINGTON JA, 1989, J ARACHNOL, V17, P71; Eberhard WG, 2010, PSYCHE, V2010; Eberhard WG, 2007, BIOTROPICA, V39, P216, DOI 10.1111/j.1744-7429.2006.00254.x; EISNER T, 1983, SCIENCE, V219, P185, DOI 10.1126/science.219.4581.185; Fritzen Niclas R., 2005, Memoranda Societatis pro Fauna et Flora Fennica, V81, P49; Gawryszewski FM, 2008, BEHAVIOUR, V145, P277, DOI 10.1163/156853908783402911; Jaffe R, 2006, J ARACHNOL, V34, P448, DOI 10.1636/S04-28.1; Kadoya E. Z., 2014, ECOLOGY, V96, P1361; Korenko S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024628; Nielsen E., 1923, Entomologiske Meddelelser, V14, P137; R Development Core Team, 2013, R LANG ENV STAT COMP; ROBINSON M H, 1973, Psyche (Cambridge), V80, P277, DOI 10.1155/1973/86980; TRUMAN JW, 1984, J COMP PHYSIOL, V155, P521, DOI 10.1007/BF00611916; TRUMAN J W, 1992, P423; Walter A, 2008, J ARACHNOL, V36, P538, DOI 10.1636/ST07-58.1; Yoshida Makoto, 1999, Acta Arachnologica, V48, P1, DOI 10.2476/asjaa.48.1; Zschokke Samuel, 2007, Arachnologische Mitteilungen, P11	38	1	1	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	AUG	2015	218	15					2326	2332		10.1242/jeb.122739		7	Biology	Life Sciences & Biomedicine - Other Topics	CO2TI	WOS:000359009100010		
J	Mori, F; Hanida, S; Kumahata, K; Miyabe-Nishiwaki, T; Suzuki, J; Matsuzawa, T; Nishimura, TD				Mori, Futoshi; Hanida, Sho; Kumahata, Kiyoshi; Miyabe-Nishiwaki, Takako; Suzuki, Juri; Matsuzawa, Teruo; Nishimura, Takeshi D.			Minor contributions of the maxillary sinus to the air-conditioning performance in macaque monkeys	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Computational fluid dynamics; Humidity; Nasal airflow; Nasal cavity; Primates; Temperature	HUMAN NASAL CAVITY; PARANASAL SINUSES; SECONDARY PNEUMATIZATION; NUMERICAL-SIMULATION; MACACA-FASCICULARIS; JAPANESE MACAQUES; WORLD MONKEYS; HUMAN NOSE; FLOW; MODEL	The nasal passages mainly adjust the temperature and humidity of inhaled air to reach the alveolar condition required in the lungs. By contrast to most other non-human primates, macaque monkeys are distributed widely among tropical, temperate and subarctic regions, and thus some species need to condition the inhaled air in cool and dry ambient atmospheric areas. The internal nasal anatomy is believed to have undergone adaptive modifications to improve the air-conditioning performance. Furthermore, the maxillary sinus (MS), an accessory hollow communicating with the nasal cavity, is found in macaques, whereas it is absent in most other extant Old World monkeys, including savanna monkeys. In this study, we used computational fluid dynamics simulations to simulate the airflow and heat and water exchange over the mucosal surface in the nasal passage. Using the topology models of the nasal cavity with and without the MS, we demonstrated that the MS makes little contribution to the airflow pattern and the air-conditioning performance within the nasal cavity in macaques. Instead, the inhaled air is conditioned well in the anterior portion of the nasal cavity before reaching the MS in both macaques and savanna monkeys. These findings suggest that the evolutionary modifications and coetaneous variations in the nasal anatomy are rather independent of transitions and variations in the climate and atmospheric environment found in the habitats of macaques.	[Mori, Futoshi] Univ Tokyo, Interfac Initiat Informat Studies, Bunkyo Ku, Tokyo 1130032, Japan; [Mori, Futoshi] Univ Tokyo, Earthquake Res Inst, Bunkyo Ku, Tokyo 1130032, Japan; [Hanida, Sho] Kanazawa Inst Technol, Nonoichi, Ishikawa 9218501, Japan; [Kumahata, Kiyoshi] RIKEN Adv Inst Computat Sci, Kobe, Hyogo 6500047, Japan; [Miyabe-Nishiwaki, Takako; Suzuki, Juri; Nishimura, Takeshi D.] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Matsuzawa, Teruo] Japan Adv Inst Sci & Technol, Nomi, Ishikawa 9231292, Japan	Nishimura, TD (reprint author), Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan.	nishimura.takeshi.2r@kyoto-u.ac.jp			Asahi Grass Foundation, Tokyo, Japan; Japan Society for the Promotion of Science [26650171, 26304019]; Japan Society for the Promotion of Science [Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation]	This work was supported financially by the Asahi Grass Foundation, Tokyo, Japan (to T.D.N.) and by the Japan Society for the Promotion of Science [Grants-in-Aid for Scientific Research, 26650171 to T.D.N. and 26304019 to M. Takai; Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation, to T.D.N.].	Elad D, 2008, RESP PHYSIOL NEUROBI, V163, P121, DOI 10.1016/j.resp.2008.05.002; STAHL WR, 1967, J APPL PHYSIOL, V22, P453; HAHN I, 1993, J APPL PHYSIOL, V75, P2273; Keyhani K, 1995, J BIOMECH ENG-T ASME, V117, P429, DOI 10.1115/1.2794204; Smith TD, 2005, ANAT REC PART A, V285A, P677, DOI 10.1002/ar.a.20209; FRANCISCUS RG, 1991, AM J PHYS ANTHROPOL, V85, P419, DOI 10.1002/ajpa.1330850406; Doorly DJ, 2008, RESP PHYSIOL NEUROBI, V163, P100, DOI 10.1016/j.resp.2008.07.027; SCHRECK S, 1993, J APPL PHYSIOL, V75, P1767; Rae TC, 2003, AM J PRIMATOL, V59, P153, DOI 10.1002/ajp.10072; LEE CY, 1954, IND ENG CHEM, V46, P2381, DOI 10.1021/ie50539a046; Na Y, 2012, RESP PHYSIOL NEUROBI, V181, P62, DOI 10.1016/j.resp.2012.01.013; Spence CJT, 2012, EXP FLUIDS, V52, P569, DOI 10.1007/s00348-011-1044-z; Lervik A, 2010, PHYS CHEM CHEM PHYS, V12, P1610, DOI 10.1039/b918607g; Marquez S, 2008, ANAT REC, V291, P1420, DOI 10.1002/ar.20785; HARKEMA JR, 1987, AM J ANAT, V180, P266, DOI 10.1002/aja.1001800308; Rossie JB, 2008, ANAT REC, V291, P1485, DOI 10.1002/ar.20781; Bastir M, 2013, AM J PHYS ANTHROPOL, V152, P287, DOI 10.1002/ajpa.22359; SHEA BT, 1977, AM J PHYS ANTHROPOL, V47, P289, DOI 10.1002/ajpa.1330470209; Alba DM, 2014, J HUM EVOL, V67, P1, DOI 10.1016/j.jhevol.2013.11.001; ANTON SC, 1989, AM J PHYS ANTHROPOL, V79, P253, DOI 10.1002/ajpa.1330790213; Cave A. J. E., 1973, P LINN SOC LONDON, V5, P377; Cole P., 1982, NOSE, P350; Curtis AA, 2014, ANAT REC, V297, P2047, DOI 10.1002/ar.23025; Delson E., 1980, P10; Dumonceaux GA, 1997, J ZOO WILDLIFE MED, V28, P215; Fleagle JG, 2013, PRIMATE ADAPTATION AND EVOLUTION, 3RD EDITION, P1; FOODEN J, 1993, AM J PHYS ANTHROPOL, V92, P521, DOI 10.1002/ajpa.1330920409; Fooden J., 1980, P1; Hanida S., 2013, J BIOMECH SCI ENG, V8, P209; HORNUNG DE, 1987, ARCH OTOLARYNGOL, V113, P169; Ito T, 2015, PRIMATES, V56, P11, DOI 10.1007/s10329-014-0440-4; Ito T, 2014, AM J PHYS ANTHROPOL, V154, P27, DOI 10.1002/ajpa.22469; Koppe Thomas, 1999, P77; Koppe T, 2006, PRIMATES, V47, P140, DOI 10.1007/s10329-005-0153-9; Kumahata Kiyoshi, 2010, Journal of Biomechanical Science and Engineering, V5, DOI 10.1299/jbse.5.565; Lang J., 1989, CLIN ANATOMY NOSE NA; Lindemann J, 2004, LARYNGOSCOPE, V114, P1037, DOI 10.1097/00005537-200406000-00015; Naftali S, 2005, ANN BIOMED ENG, V33, P545, DOI 10.1007/s10439-005-2513-4; Nishimura TD, 2014, PRIMATES, V55, P501, DOI 10.1007/s10329-014-0428-0; Nishimura TD, 2014, ANTHROPOL SCI, V122, P101, DOI 10.1537/ase.140624; Pan Ru-Liang, 2000, Zoological Research, V21, P308; Rae TC, 2002, AM J PHYS ANTHROPOL, V117, P293, DOI 10.1002/ajpa.10008; Rae TC, 2008, ANAT REC, V291, P1414, DOI 10.1002/ar.20786; Rae TC, 2004, EVOL ANTHROPOL, V13, P211, DOI 10.1002/evan.20036; Rogers R. R., 1989, SHORT COURSE CLOUD P; Smith TD, 2010, ANAT REC, V293, P91, DOI 10.1002/ar.21017; Swift D. L., 1977, RESP DEFENSE MECH, V5, P63; Van Valkenburgh B, 2014, ANAT REC, V297, P1975, DOI 10.1002/ar.23021; WORTHINGTON J, 1991, J EXP BIOL, V161, P533; Xiong GX, 2008, AM J RHINOL, V22, P477, DOI 10.2500/ajr.2008.22.3211; Zhu JH, 2012, RESP PHYSIOL NEUROBI, V183, P91, DOI 10.1016/j.resp.2012.06.026; Zimmermann N, 2011, J MED PRIMATOL, V40, P365, DOI 10.1111/j.1600-0684.2011.00490.x; Zollikofer CPE, 2008, ANAT REC, V291, P1446, DOI 10.1002/ar.20784	53	0	0	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	AUG	2015	218	15					2394	2401		10.1242/jeb.118059		8	Biology	Life Sciences & Biomedicine - Other Topics	CO2TI	WOS:000359009100017		
J	Reber, SA; Nishimura, T; Janisch, J; Robertson, M; Fitch, WT				Reber, Stephan A.; Nishimura, Takeshi; Janisch, Judith; Robertson, Mark; Fitch, W. Tecumseh			A Chinese alligator in heliox: formant frequencies in a crocodilian	JOURNAL OF EXPERIMENTAL BIOLOGY			English	Article						Bioacoustics; Source-filter theory; Alligator sinensis; Vocal tract resonance; Bellow; Archosauria	VOCAL-TRACT RESONANCES; RED DEER STAGS; BODY-SIZE; PHASCOLARCTOS-CINEREUS; CROCODYLUS-JOHNSTONI; DESCENDED LARYNX; DAMA-DAMA; COMMUNICATION; VOCALIZATION; PERCEPTION	Crocodilians are among the most vocal non-avian reptiles. Adults of both sexes produce loud vocalizations known as 'bellows' year round, with the highest rate during the mating season. Although the specific function of these vocalizations remains unclear, they may advertise the caller's body size, because relative size differences strongly affect courtship and territorial behaviour in crocodilians. In mammals and birds, a common mechanism for producing honest acoustic signals of body size is via formant frequencies (vocal tract resonances). To our knowledge, formants have to date never been documented in any non-avian reptile, and formants do not seem to play a role in the vocalizations of anurans. We tested for formants in crocodilian vocalizations by using playbacks to induce a female Chinese alligator (Alligator sinensis) to bellow in an airtight chamber. During vocalizations, the animal inhaled either normal air or a helium/oxygen mixture (heliox) in which the velocity of sound is increased. Although heliox allows normal respiration, it alters the formant distribution of the sound spectrum. An acoustic analysis of the calls showed that the source signal components remained constant under both conditions, but an upward shift of high-energy frequency bands was observed in heliox. We conclude that these frequency bands represent formants. We suggest that crocodilian vocalizations could thus provide an acoustic indication of body size via formants. Because birds and crocodilians share a common ancestor with all dinosaurs, a better understanding of their vocal production systems may also provide insight into the communication of extinct Archosaurians.	[Reber, Stephan A.; Janisch, Judith; Fitch, W. Tecumseh] Univ Vienna, Dept Cognit Biol, A-1150 Vienna, Austria; [Nishimura, Takeshi] Kyoto Univ, Primate Res Inst, Inuyama, Aichi 4848506, Japan; [Robertson, Mark] St Augustine Alligator Farm Zool Pk, St Augustine, FL 32080 USA	Reber, SA (reprint author), Univ Vienna, Dept Cognit Biol, A-1150 Vienna, Austria.	stephan.reber@univie.ac.at; tecumseh.fitch@univie.ac.at			European Research Council (ERC) [230604]; Austrian Science Fund (FWF) [W1234-G17]; Japan Society for the Promotion of Science (JSPS)	This research was funded by the European Research Council (ERC) Advanced Grant SOMACCA [no. 230604] and the Austrian Science Fund (FWF) [W1234-G17] to W.T.F., and a travelling grant from the Japan Society for the Promotion of Science (JSPS) [Strategic Young Researcher Overseas Visits Program for Accelerating Brain Circulation] to T.N. Deposited in PMC for immediate release.	HERZOG HA, 1977, Z TIERPSYCHOL, V44, P294; Budka M, 2013, ETHOLOGY, V119, P960, DOI 10.1111/eth.12141; ROBERTS LH, 1975, ULTRASONICS, V13, P83, DOI 10.1016/0041-624X(75)90052-9; Reby D, 2005, P ROY SOC B-BIOL SCI, V272, P941, DOI 10.1098/rspb.2004.2954; GARRICK LD, 1977, AM ZOOL, V17, P225; Charlton BD, 2012, ANIM COGN, V15, P999, DOI 10.1007/s10071-012-0527-5; Wang XY, 2007, J ACOUST SOC AM, V121, P2984, DOI 10.1121/1.2714910; Hardouin LA, 2014, J AVIAN BIOL, V45, P157, DOI 10.1111/j.1600-048X.2013.00144.x; Charlton BD, 2011, J EXP BIOL, V214, P3414, DOI 10.1242/jeb.061358; Hardouin LA, 2007, AM NAT, V169, P552, DOI 10.1086/512136; Riede T, 1999, J EXP BIOL, V202, P2859; BrittanPowell EF, 1997, J ACOUST SOC AM, V101, P578, DOI 10.1121/1.418121; VLIET KA, 1989, AM ZOOL, V29, P1019; Wang XY, 2009, ETHOLOGY, V115, P832, DOI 10.1111/j.1439-0310.2009.01671.x; Taylor AM, 2010, J ZOOL, V280, P221, DOI 10.1111/j.1469-7998.2009.00661.x; Tucker AD, 1998, BEHAV ECOL SOCIOBIOL, V44, P85, DOI 10.1007/s002650050519; Fitch WT, 2000, ETHOLOGY, V106, P559, DOI 10.1046/j.1439-0310.2000.00572.x; Reby D, 2003, ANIM BEHAV, V65, P519, DOI 10.1006/anbe.2003.2078; Charlton BD, 2007, ANIM BEHAV, V74, P707, DOI 10.1016/j.anbehav.2006.09.021; RAND AS, 1993, PHYSIOL ZOOL, V66, P793; Wang XY, 2009, J ACOUST SOC AM, V126, P2082, DOI 10.1121/1.3203667; Vergne AL, 2009, BIOL REV, V84, P391, DOI 10.1111/j.1469-185X.2009.00079.x; McElligott AG, 2006, J ZOOL, V270, P340, DOI 10.1111/j.1469-7998.2006.00144.x; Brazaitis P, 2011, HIST BIOL, V23, P73, DOI 10.1080/08912963.2011.560723; HINDS DS, 1971, EVOLUTION, V25, P429, DOI 10.2307/2406936; Fitch WT, 1997, J ACOUST SOC AM, V102, P1213, DOI 10.1121/1.421048; HARTLEY DJ, 1988, J ACOUST SOC AM, V84, P1201, DOI 10.1121/1.396621; Harris TR, 2006, ETHOLOGY, V112, P911, DOI 10.1111/j.1439-0310.2006.01247.x; BEIL RG, 1962, J ACOUST SOC AM, V34, P347, DOI 10.1121/1.1928124; Britton ARC, 2001, CROCODILIAN BIOLOGY AND EVOLUTION, P364; CAMPBELL HW, 1973, ZOOLOGICA-NEW YORK, V58, P1; Fant G., 1960, ACOUSTIC THEORY SPEE; Fitch W. T., 2002, ACOUSTIC COMMUNICATI, V16, P65; Fitch WT, 2001, P ROY SOC B-BIOL SCI, V268, P1669; GARRICK L D, 1978, Bulletin of the American Museum of Natural History, V160, P157; GARRICK L D, 1975, Herpetologica, V31, P26; GAUNT AS, 1987, J COMP PHYSIOL A, V161, P43, DOI 10.1007/BF00609454; Herrsch G. L., 1966, THESIS U CALIFORNIA; HOLYWELL K, 1964, J ACOUST SOC AM, V36, P210, DOI 10.1121/1.1918935; Jones MR, 2014, J EVOLUTION BIOL, V27, P1256, DOI 10.1111/jeb.12397; Koda H, 2012, AM J PHYS ANTHROPOL, V149, P347, DOI 10.1002/ajpa.22124; Madsen PT, 2012, BIOL LETTERS, V8, P211, DOI 10.1098/rsbl.2011.0701; Miller EH, 2007, J AVIAN BIOL, V38, P224, DOI 10.1111/j.2007.0908-8857.03695.x; NOWICKI S, 1987, NATURE, V325, P53, DOI 10.1038/325053a0; REESE AM, 1945, ANAT REC, V92, P273, DOI 10.1002/ar.1090920308; ROBERTS LH, 1973, PERIOD BIOL, V75, P27; Titze I., 1994, PRINCIPLES VOICE PRO; Vannoni E, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003113; WEBB GJW, 1983, AUST WILDLIFE RES, V10, P407; WEISHAMPEL DB, 1981, PALEOBIOLOGY, V7, P252	50	2	2	COMPANY OF BIOLOGISTS LTD	CAMBRIDGE	BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL, CAMBS, ENGLAND	0022-0949	1477-9145		J EXP BIOL	J. Exp. Biol.	AUG	2015	218	15					2442	2447		10.1242/jeb.119552		6	Biology	Life Sciences & Biomedicine - Other Topics	CO2TI	WOS:000359009100023		
J	Changkaew, K; Intarapuk, A; Utrarachkij, F; Nakajima, C; Suthienkul, O; Suzuki, Y				Changkaew, Kanjana; Intarapuk, Apiradee; Utrarachkij, Fuangfa; Nakajima, Chie; Suthienkul, Orasa; Suzuki, Yasuhlko			Antimicrobial Resistance, Extended-Spectrum beta-Lactamase Productivity, and Class 1 Integrons in Escherichia coil from Healthy Swine	JOURNAL OF FOOD PROTECTION			English	Article							FOOD-PRODUCING ANIMALS; ANTIBIOTIC-RESISTANCE; CTX-M; COLI STRAINS; SALMONELLA; PIGS; ENTEROBACTERIACEAE; CHICKENS; GENES; PREVALENCE	Administration of antimicrobials to food-producing animals increases the risk of higher antimicrobial resistance in the normal intestinal flora of these animals. The present cross-sectional study was conducted to investigate antimicrobial susceptibility and extended-spectrum beta-lactamase (ESBL) producing strains and to characterize class 1 integrons in Escherichia coil in healthy swine in Thailand. All 122 of the tested isolates had drug-resistant phenotypes. High resistance was found to ampicillin (98.4% of isolates), chloramphenicol (95.9%), gentamicin (78.7%), streptomycin (77.9%), tetracycline (74.6%), and cefotaxime (72.1%). Fifty-four (44.3%) of the E. coil isolates were confirmed as ESBL-producing strains. Among them, bla(CTX-M) (45 isolates) and bla(TEM) (41 isolates) were detected. Of the bla(CTX-M)-positive E. coli isolates, 37 carried the bla(CTX-M-1) cluster, 12 carried the bla(CTX-M-9) cluster, and 5 carried both clusters. Sequence analysis revealed bla(TEM-1), bla(TEM-135), and bla(TEM-175) in 38, 2, and 1 isolate, respectively. Eighty-seven (71%) of the 122isolates carried class 1 integrons, and eight distinct drug-resistance gene cassettes with seven different integron profiles were identified in 43 of these isolates. Gene cassettes were associated with resistance to aminoglycosides (aadAl, aadA2, aadA22, or aadA23), trimethoprim (dfrA5, dfrAl2, or dftA17), and lincosamide (linF). Genes encoding beta-lactamases were not found in class 1 integrons. This study is the first to report ESBL-producing E. coli with a class 1 integron carrying the linF gene cassette in swine in Thailand. Our findings confirm that swine can be a reservoir of ESBL-producing E. coli harboring class 1 integrons, which may become a potential health risk if these integrons are transmitted to humans. Intensive analyses of animal, human, and environmental isolates are needed to control the spread of ESBL-producing E. coil strains.	[Changkaew, Kanjana; Nakajima, Chie; Suzuki, Yasuhlko] Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioresources, Sapporo, Hokkaido, Japan; [Nakajima, Chie; Suzuki, Yasuhlko] Hokkaido Univ, Global Stn Zoonosis Control, Sapporo, Hokkaido, Japan; [Intarapuk, Apiradee] Mahanakorn Univ Technol, Fac Vet Med, Dept Clin, Bangkok, Thailand; [Utrarachkij, Fuangfa; Suthienkul, Orasa] Mahidol Univ, Fac Publ Hlth, Dept Microbiol, Bangkok 10700, Thailand	Suzuki, Y (reprint author), Hokkaido Univ, Res Ctr Zoonosis Control, Div Bioresources, Sapporo, Hokkaido, Japan.	suzuki@cze.holoidai.ac.jp	Nakajima, Chie/A-5020-2012		Department of Microbiology grant from China Medical Board (Faculty of Public Health, Mahidol University, Bangkok); National Development of Science and Technology (Ministry of Science and Technology, Bangkok); Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan; Japan Initiative for Global Research Network on Infectious Diseases from MEXT	This work was supported in part by a Department of Microbiology grant from the China Medical Board (Faculty of Public Health, Mahidol University, Bangkok) and the National Development of Science and Technology (Ministry of Science and Technology, Bangkok) to O. Suthienkul; in part by a grant from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT) of Japan for the Joint Research Program of the Research Center for Zoonosis Control (Hokkaido University, Sapporo) to Y. Suzuki; and in part by the Japan Initiative for Global Research Network on Infectious Diseases from MEXT to Y. Suzuki.	Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614; Batchelor M, 2005, ANTIMICROB AGENTS CH, V49, P1319, DOI 10.1128/AAC.49.4.1319-1322.2005; Li RC, 2013, INT J FOOD MICROBIOL, V163, P14, DOI 10.1016/j.ijfoodmicro.2013.01.020; Ben Sallem R, 2012, FOODBORNE PATHOG DIS, V9, P1137, DOI 10.1089/fpd.2012.1267; Clemente L, 2013, INT J FOOD MICROBIOL, V167, P221, DOI 10.1016/j.ijfoodmicro.2013.08.009; Rayamajhi N, 2008, INT J FOOD MICROBIOL, V124, P183, DOI 10.1016/j.ijfoodmicro.2008.03.009; Geser N, 2011, J FOOD PROTECT, V74, P446, DOI 10.4315/0362-028X.JFP-10-372; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Reich F, 2013, EMERG INFECT DIS, V19, P1253, DOI 10.3201/eid1908.120879; Li XZ, 2007, VET MICROBIOL, V121, P197, DOI 10.1016/j.vetmic.2007.01.015; Smet A, 2010, FEMS MICROBIOL REV, V34, P295, DOI 10.1111/j.1574-6976.2009.00198.x; Hasman H, 2005, J ANTIMICROB CHEMOTH, V56, P115, DOI 10.1093/jac/dki190; Wang XM, 2010, FEMS MICROBIOL LETT, V306, P15, DOI 10.1111/j.1574-6968.2010.01917.x; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Hansen KH, 2013, APPL ENVIRON MICROB, V79, P794, DOI 10.1128/AEM.02399-12; Pitout JDD, 2004, J CLIN MICROBIOL, V42, P5715, DOI 10.1128/JCM.42.12.5715-5721.2004; Lewis JS, 2007, ANTIMICROB AGENTS CH, V51, P4015, DOI 10.1128/AAC.00576-07; Jouini A, 2007, J ANTIMICROB CHEMOTH, V60, P1137, DOI 10.1093/jac/dkm316; Wannaprasat W, 2011, INT J ANTIMICROB AG, V37, P457, DOI 10.1016/j.ijantimicag.2010.12.001; Machado E, 2008, J ANTIMICROB CHEMOTH, V62, P296, DOI 10.1093/jac/dkn179; Kiratisin P, 2008, ANTIMICROB AGENTS CH, V52, P2818, DOI 10.1128/AAC.00171-08; Fluit AC, 2004, CLIN MICROBIOL INFEC, V10, P272, DOI 10.1111/j.1198-743X.2004.00858.x; Ahmed AM, 2007, APPL ENVIRON MICROB, V73, P6686, DOI 10.1128/AEM.01054-07; Phongpaichit S, 2007, J FOOD PROTECT, V70, P292; Hunter PA, 2010, J ANTIMICROB CHEMOTH, V65, pI3, DOI 10.1093/jac/dkp433; Wang MG, 2004, ANTIMICROB AGENTS CH, V48, P1295, DOI 10.1128/AAC.48.4.1295-1299.2004; Chuanchuen Rungtip, 2008, Southeast Asian Journal of Tropical Medicine and Public Health, V39, P419; Bischoff KM, 2005, FEMS MICROBIOL LETT, V243, P285, DOI 10.1016/j.femsle.2004.12.017; Burow E, 2014, PREV VET MED, V113, P364, DOI 10.1016/j.prevetmed.2013.12.007; Chang LL, 2007, KAOHSIUNG J MED SCI, V23, P273; Changkaew K, 2014, J FOOD PROTECT, V77, P1394, DOI 10.4315/0362-028X.JFP-13-510; Chen T, 2013, INDIAN J MED MICROBI, V31, P385, DOI 10.4103/0255-0857.118903; Clinical Laboratory Standards Institute, 2009, M100S19 CLIN LAB STA; Collignon P, 2007, CLIN INFECT DIS, V44, P1391, DOI 10.1086/516612; Heir Even, 2004, Ann Clin Microbiol Antimicrob, V3, P12, DOI 10.1186/1476-0711-3-12; Kasbohrer A, 2012, ZOONOSES PUBLIC H S2, V59, P158; Khemtong S, 2008, MICROB DRUG RESIST, V14, P65, DOI 10.1089/mdr.2008.0807; Koo HJ, 2012, J FOOD PROTECT, V75, P966, DOI 10.4315/0362-028X.JFP-11-003; Kumai Y, 2005, EPIDEMIOL INFECT, V133, P59, DOI [10.1017/S0950268804003280, 10.1017/S050268804003280]; Lay KK, 2012, FOODBORNE PATHOG DIS, V9, P992, DOI 10.1089/fpd.2012.1175; Marchant M, 2013, VET MICROBIOL, V163, P124, DOI 10.1016/j.vetmic.2012.12.011; Preston KE, 2003, ANTIMICROB AGENTS CH, V47, P2179, DOI 10.1128/AAC.47.7.2179-2185.2003; Sanpong P., 2010, Kasetsart Journal, Natural Sciences, V44, P643; Villa L, 2000, ANTIMICROB AGENTS CH, V44, P2911, DOI 10.1128/AAC.44.10.2911-2914.2000; von Baum H, 2005, INT J MED MICROBIOL, V295, P503, DOI 10.1016/j.ijmm.2005.07.002	45	0	0	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	AUG	2015	78	8					1442	1450		10.4315/0362-028X.JFP-14-445		9	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CO3CQ	WOS:000359034600003		
J	Terao, Y; Takeshita, K; Nishiyama, Y; Morishita, N; Matsumoto, T; Morimatsu, F				Terao, Yoshitaka; Takeshita, Kana; Nishiyama, Yasutaka; Morishita, Naoki; Matsumoto, Takashi; Morimatsu, Fumiki			Promising Nucleic Acid Lateral Flow Assay Plus pCR for Shiga Toxin-Producing Escherichia coli	JOURNAL OF FOOD PROTECTION			English	Article							HEMOLYTIC-UREMIC SYNDROME; MOLECULAR DIAGNOSIS; UNITED-STATES; DIPSTICK-TYPE; IMMUNOASSAY; INFECTIONS; DNA; BIOSENSORS; PATHOGENS; REAGENT	Shiga toxin (Stx)-producing Escherichia coli (STEC) is a frequent cause of foodborne infections, and methods for rapid and reliable detection of STEC are needed. A nucleic acid lateral flow assay (NALFA) plus PCR was evaluated for detecting STEC after enrichment. When cell suspensions of 45 STEC strains, 14 non-STEC strains, and 13 non-E. coli strains were tested with the NALFA plus PCR, all of the STEC strains yielded positive results, and all of the non-STEC and non-E. coli strains yielded negative results. The lower detection limit for the STEC strains ranged from 0.1 to 1 pg of genomic DNA (about 20 to 200 CFU) per test, and the NALFA plus PCR was able to detect Stx1- and Stx2-producing E. coli strains with similar sensitivities. The ability of the NALFA plus PCR to detect STEC in enrichment cultures of radish sprouts, tomato, raw ground beef, and beef liver inoculated with 10-fold serially diluted STEC cultures was comparable to that of a real-time PCR assay (at a level of 100 to 100,000 CFU/ml in enrichment culture). The bacterial inoculation test in raw ground beef revealed that the lower detection limit of the NALFA plus PCR was also comparable to that obtained with a real-time PCR assay that followed the U.S. Department of Agriculture guidelines. Although further evaluation is required, these results suggest that the NALFA plus PCR is a specific and sensitive method for detecting STEC in a food manufacturing plant.	[Terao, Yoshitaka; Takeshita, Kana; Nishiyama, Yasutaka; Morishita, Naoki; Matsumoto, Takashi; Morimatsu, Fumiki] NH Foods Ltd, R&D Ctr, Tsukuba, Ibaraki 3002646, Japan	Terao, Y (reprint author), NH Foods Ltd, R&D Ctr, 3-3 Midorigahara, Tsukuba, Ibaraki 3002646, Japan.	y.terao@nipponham.co.jp					Alocilja EC, 2003, BIOSENS BIOELECTRON, V18, P841, DOI 10.1016/S0956-5663(03)00009-5; Scallan E, 2011, EMERG INFECT DIS, V17, P7, DOI 10.3201/eid1701.091101p1; Litos IK, 2009, BIOSENS BIOELECTRON, V24, P3135, DOI 10.1016/j.bios.2009.03.010; Aldus CF, 2003, J APPL MICROBIOL, V95, P380, DOI 10.1046/j.1365-2672.2003.01989.x; Oku Y, 2001, J IMMUNOL METHODS, V258, P73, DOI 10.1016/S0022-1759(01)00470-7; Kainz P, 2000, BBA-GENE STRUCT EXPR, V1494, P23, DOI 10.1016/S0167-4781(00)00200-1; Gordon J, 2008, CLIN CHEM, V54, P1250, DOI 10.1373/clinchem.2007.102491; Brooks JT, 2005, J INFECT DIS, V192, P1422, DOI 10.1086/466536; Posthuma-Trumpie GA, 2009, ANAL BIOANAL CHEM, V393, P569, DOI 10.1007/s00216-008-2287-2; DUNCAN RJS, 1983, ANAL BIOCHEM, V132, P68, DOI 10.1016/0003-2697(83)90426-8; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450; Ngom B, 2010, ANAL BIOANAL CHEM, V397, P1113, DOI 10.1007/s00216-010-3661-4; Kalogianni DP, 2009, BIOSENS BIOELECTRON, V24, P1811, DOI 10.1016/j.bios.2008.08.056; Ivnitski D, 1999, BIOSENS BIOELECTRON, V14, P599, DOI 10.1016/S0956-5663(99)00039-1; Bettelheim KA, 2007, CRIT REV MICROBIOL, V33, P67, DOI 10.1080/10408410601172172; Nataro JP, 1998, CLIN MICROBIOL REV, V11, P142; Fuller CA, 2011, INFECT IMMUN, V79, P1329, DOI 10.1128/IAI.01182-10; Blazkova M, 2009, EUR FOOD RES TECHNOL, V229, P867, DOI 10.1007/s00217-009-1115-z; Johnson KE, 2006, CLIN INFECT DIS, V43, P1587, DOI 10.1086/509573; Mellmann A, 2009, EMERG INFECT DIS, V15, P1474, DOI 10.3201/eid1509.090161; Mathusa EC, 2010, J FOOD PROTECT, V73, P1721; Paton AW, 1999, J CLIN MICROBIOL, V37, P3357; Capps KL, 2004, J AOAC INT, V87, P68; Carter DJ, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm269; European Food Safety Authority, 2009, EFSA J, V7, P1366, DOI DOI 10.2903/J.EFSA.2009.1366; GRIFFIN PM, 1991, EPIDEMIOL REV, V13, P60; Gyles CL, 2007, J ANIM SCI, V85, pE45, DOI 10.2527/jas.2006-508; Kalogianni DP, 2007, ANAL BIOCHEM, V361, P169, DOI 10.1016/j.ab.2006.11.013; Karmali M.A., 1989, J CLIN MICROBIOL, V2, P15; Mens PF, 2008, DIAGN MICR INFEC DIS, V61, P421, DOI 10.1016/j.diagmicrobio.2008.03.009; Parma YR, 2012, FRONT CELL INFECT MI, V2, DOI 10.3389/fcimb.2012.00084; Rule GS, 1996, CLIN CHEM, V42, P1206; Schaffzin JK, 2012, EPIDEMIOL INFECT, V140, P283, DOI 10.1017/S0950268811000719; Tokarskyy O, 2008, FOOD MICROBIOL, V25, P1, DOI 10.1016/j.fm.2007.07.005; U.S. Department of Agriculture Food Safety and Inspection Service, 2012, MICR LAB GUID	35	0	0	INT ASSOC FOOD PROTECTION	DES MOINES	6200 AURORA AVE SUITE 200W, DES MOINES, IA 50322-2863 USA	0362-028X	1944-9097		J FOOD PROTECT	J. Food Prot.	AUG	2015	78	8					1560	1568		10.4315/0362-028X.JFP-14-495		9	Biotechnology & Applied Microbiology; Food Science & Technology	Biotechnology & Applied Microbiology; Food Science & Technology	CO3CQ	WOS:000359034600018		
J	Golgeleyen, F; Yamamoto, M				Goelgeleyen, Fikret; Yamamoto, Masahiro			An inverse problem for the Vlasov-Poisson system	JOURNAL OF INVERSE AND ILL-POSED PROBLEMS			English	Article						Vlasov-Poisson system; inverse problem; uniqueness; stability	BOUNDARY-VALUE PROBLEM; GLOBAL EXISTENCE; 3 DIMENSIONS; INITIAL DATA; EQUATION	In this paper, we discuss an inverse problem for the Vlasov-Poisson system. We prove local uniqueness and stability theorems by using the method in Anikonov and Amirov [5] under the specular reflection boundary condition and with a prescribed outward electrical field at the boundary.	[Goelgeleyen, Fikret] Bulent Ecevit Univ, Dept Math, TR-67100 Zonguldak, Turkey; [Yamamoto, Masahiro] Univ Tokyo, Dept Math Sci, Meguro Ku, Tokyo 1538914, Japan	Golgeleyen, F (reprint author), Bulent Ecevit Univ, Dept Math, TR-67100 Zonguldak, Turkey.	f.golgeleyen@beun.edu.tr; myama@ms.u-tokyo.ac.jp			Council of Higher Education of Turkey	The first-named author was supported by a research grant from the Council of Higher Education of Turkey.	Abdallah N., 1994, MATH METHOD APPL SCI, V17, P451, DOI 10.1002/mma.1670170604; Amirov A.K., 2001, INTEGRAL GEOMETRY IN; Andreasson H, 2011, LIVING REV RELATIV, V14; Anikonov Y. E., 2001, INVERSE PROBLEMS KIN; Anikonov Y. E., 1983, DOKL AKAD NAUK SSSR, V272, P1292; BARDOS C, 1985, ANN I H POINCARE-AN, V2, P101; LIONS PL, 1991, INVENT MATH, V105, P415, DOI 10.1007/BF01232273; Arsen'ev A., 1975, USSR COMP MATH MATH, V15, P131, DOI 10.1016/0041-5553(75)90141-X; BATT J, 1977, J DIFFER EQUATIONS, V25, P342, DOI 10.1016/0022-0396(77)90049-3; Batt J., 1993, ANN MATH PURE APPL, V4, P133; Binney J., 1987, GALACTIC DYNAMICS; Bostan M, 2006, MATH METHOD APPL SCI, V29, P1801, DOI 10.1002/mma.752; Degond P., 1991, Asymptotic Analysis, V4; Glassey R., 1996, CAUCHY PROBLEM KINET; Goldston R J, 1995, INTRO PLASMA PHYS; Golgeleyen F, 2011, MATH COMMUN, V16, P283; GREENGARD C, 1990, COMMUN PUR APPL MATH, V43, P473, DOI 10.1002/cpa.3160430404; Horst E., 1982, MATH METHOD APPL SCI, V4, P19, DOI 10.1002/mma.1670040104; Horst E., 1981, MATH METHOD APPL SCI, V3, P229, DOI 10.1002/mma.1670030117; HORST E, 1993, MATH METHOD APPL SCI, V16, P75, DOI 10.1002/mma.1670160202; Hwang HJ, 2010, ARCH RATION MECH AN, V195, P763, DOI 10.1007/s00205-009-0239-4; PFAFFELMOSER K, 1992, J DIFFER EQUATIONS, V95, P281, DOI 10.1016/0022-0396(92)90033-J; Samarskii A. A., 1980, DIFF URAVN, V16, P1925; SCHAEFFER J, 1991, COMMUN PART DIFF EQ, V16, P1313, DOI 10.1080/03605309108820801	24	0	0	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	0928-0219	1569-3945		J INVERSE ILL-POSE P	J. Inverse Ill-Posed Probl.	AUG	2015	23	4					363	372		10.1515/jiip-2014-0004		10	Mathematics, Applied; Mathematics	Mathematics	CO2KX	WOS:000358986200006		
J	Nomura, K; Hidaka, H; Takata, Y; Katori, Y				Nomura, K.; Hidaka, H.; Takata, Y.; Katori, Y.			Minimally invasive transnasal approach to infratemporal fossa abscess	JOURNAL OF LARYNGOLOGY AND OTOLOGY			English	Article						Abscess; Dental Caries; Endoscopy; Infection; Skull Base	MASTICATOR SPACE; COMPLICATION; CELLULITIS; INFECTION	Background: Infratemporal fossa abscess following odontogenic infection is not rare, and usually occurs as a sequela of dental disease. Infratemporal fossa abscess was previously treated with the combination of buccal incision and temporal incision, or via a transoral approach. Method: This paper reports a case of infratemporal fossa abscess in a 51-year-old female. Results: The abscess was drained transnasally via an endoscopic modified medial maxillectomy approach, preserving the inferior turbinate and nasolacrimal duct. The pain remitted the next day and trismus had diminished in one week. Conclusion: The transnasal approach with endoscopic modified medial maxillectomy is a direct, minimally invasive method that provides a direct field of view for drainage of infratemporal fossa abscess. This approach is recommended for infratemporal fossa abscess.	[Nomura, K.; Hidaka, H.; Takata, Y.; Katori, Y.] Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Sendai, Miyagi 9808574, Japan	Nomura, K (reprint author), Tohoku Univ, Grad Sch Med, Dept Otolaryngol Head & Neck Surg, Aoba Ku, 1-1 Seiryo Machi, Sendai, Miyagi 9808574, Japan.	kazuhiroe@gmail.com					Nakayama T, 2012, AM J RHINOL ALLERGY, V26, P405, DOI 10.2500/ajra.2012.26.3791; Akst LM, 2005, AM J OTOLARYNG, V26, P35, DOI 10.1016/j.amjoto.2004.06.015; Hidaka H, 2014, ANN OTO RHINOL LARYN, V123, P333, DOI 10.1177/0003489414526360; Leventhal D, 2008, ARCH OTOLARYNGOL, V134, P551, DOI 10.1001/archotol.134.5.551; Nishizaki K, 1998, ANN OTO RHINOL LARYN, V107, P807; BRADLEY J L, 1955, Oral Surg Oral Med Oral Pathol, V8, P151, DOI 10.1016/0030-4220(55)90186-9; Chong VFH, 1996, CLIN RADIOL, V51, P457, DOI 10.1016/S0009-9260(96)80183-8; CHOSSEGROS C, 1995, J ORAL MAXIL SURG, V53, P949, DOI 10.1016/0278-2391(95)90291-0; Freling N, 2009, LARYNGOSCOPE, V119, P1745, DOI 10.1002/lary.20606; Kim IK, 2007, ORAL SURG ORAL MED O, V103, pE1, DOI 10.1016/j.tripleo.2006.07.002; Maroldi R, 2005, IMAGING TREATMENT PL; Muñoz-Guerra Mario F, 2006, Oral Surg Oral Med Oral Pathol Oral Radiol Endod, V102, pe9, DOI 10.1016/j.tripleo.2006.03.009; Okushi T, 2012, AURIS NASUS LARYNX, V39, P31, DOI 10.1016/j.anl.2011.02.008; Raghava N, 2004, J LARYNGOL OTOL, V118, P377; Varshney R, 2013, CASE REP OTOLARYNGOL, V2013	15	0	0	CAMBRIDGE UNIV PRESS	CAMBRIDGE	EDINBURGH BLDG, SHAFTESBURY RD, CB2 8RU CAMBRIDGE, ENGLAND	0022-2151	1748-5460		J LARYNGOL OTOL	J. Laryngol. Otol.	AUG	2015	129	8					812	816		10.1017/S0022215115001541		5	Otorhinolaryngology	Otorhinolaryngology	CO6KA	WOS:000359264400015		
J	Hayasaka, T; Yoshida, S; Inoue, KY; Nakano, M; Matsue, T; Esashi, M; Tanaka, S				Hayasaka, Takeshi; Yoshida, Shinya; Inoue, Kumi Y.; Nakano, Masanori; Matsue, Tomokazu; Esashi, Masayoshi; Tanaka, Shuji			Integration of Boron-Doped Diamond Microelectrode on CMOS-Based Amperometric Sensor Array by Film Transfer Technology	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						Amperometric sensor array; boron-doped diamond; heterogeneous integration; film transfer technology; chemical sensor; electrochemical biosensor; large-scale integration (LSI) integrated microelectromechanical systems (MEMS)	ELECTROCHEMICAL OXIDATION; ELECTRODES; POTENTIOSTAT; BEHAVIOR	This paper reports on the fabrication of a complementary metal oxide semiconductor (CMOS)-based 20 x 20 amperometric sensor array integrated with boron-doped diamond (BDD) microelectrodes. The BDD electrodes were formed on a Si wafer at 800 degrees C, and then transferred to a 0.18 mu m CMOS large-scale integration (LSI) wafer with a benzocyclobutene bonding interlayer. As a result, the BDD microelectrodes were arrayed without significant damage to CMOS circuit or BDD electrodes. The integrated BDD electrodes on the CMOS LSI exhibited excellent performance for electrochemical analysis. The wider potential window and smaller background current compared with Au microelectrodes were experimentally verified. The electron transfer rate to ferrocenemethanol as a standard reagent was large. The fully implemented device successfully detected 100-nm histamine, and was used for the 2-D real-time imaging of histamine diffused in a solution.	[Hayasaka, Takeshi; Tanaka, Shuji] Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan; [Yoshida, Shinya; Esashi, Masayoshi] Tohoku Univ, World Premier Int Res Ctr, Adv Inst Mat Res, Sendai, Miyagi 9808579, Japan; [Inoue, Kumi Y.; Nakano, Masanori; Matsue, Tomokazu] Tohoku Univ, Environm Studies, Sendai, Miyagi 9808576, Japan	Hayasaka, T (reprint author), Tohoku Univ, Dept Bioengn & Robot, Sendai, Miyagi 9808579, Japan.	hayasaka@mems.mech.tohoku.ac.jp; s-yoshida@mems.mech.tohoku.ac.jp; inoue@bioinfo.che.tohoku.ac.jp; masa.n.nak@gmail.com; matsue@bioinfo.che.tohoku.ac.jp; esashi@mems.mech.tohoku.ac.jp; tanaka@mems.mech.tohoku.ac.jp	Yoshida, Shinya/B-7781-2010; Matsue, Tomokazu/F-9688-2010		Formation of Innovation Center for Fusion of Advanced Technologies; Ministry of Education, Culture, Sports, Science, and Technology, World Premier International Research Center Initiative, Advanced Institute for Materials Research, Tohoku University, Sendai, Japan	This work was supported in part by the Formation of Innovation Center for Fusion of Advanced Technologies; and in part by the Ministry of Education, Culture, Sports, Science, and Technology, World Premier International Research Center Initiative, Advanced Institute for Materials Research, Tohoku University, Sendai, Japan. Subject Editor S. Shoji.	Joo S, 2008, CHEM REV, V108, P638, DOI 10.1021/cr068113+; Inoue KY, 2012, LAB CHIP, V12, P3481, DOI 10.1039/c2lc40323d; Sarada BV, 2000, ANAL CHEM, V72, P1632, DOI 10.1021/ac9908748; Niklaus F, 2006, J ELECTROCHEM SOC, V153, pG291, DOI 10.1149/1.2168409; Sen M, 2013, BIOSENS BIOELECTRON, V48, P12, DOI 10.1016/j.bios.2013.03.069; Kim BN, 2013, BIOSENS BIOELECTRON, V41, P736, DOI 10.1016/j.bios.2012.09.058; Bernstein JJ, 2013, J MICROMECH MICROENG, V23, DOI 10.1088/0960-1317/23/12/125007; Nazari MH, 2013, IEEE T BIOMED CIRC S, V7, P338, DOI 10.1109/TBCAS.2012.2203597; Yano T, 1998, J ELECTROCHEM SOC, V145, P1870, DOI 10.1149/1.1838569; Murata M, 2008, J ELECTROANAL CHEM, V612, P29, DOI 10.1016/j.jelechem.2007.09.006; Heller A, 2008, CHEM REV, V108, P2482, DOI 10.1021/cr068069y; Xu JS, 1997, ANAL CHEM, V69, pA591; Kruppa P, 2010, BIOSENS BIOELECTRON, V26, P1414, DOI 10.1016/j.bios.2010.07.070; Watanabe T, 2006, ANAL CHEM, V78, P7857, DOI 10.1021/ac060860j; Luong JHT, 2009, ANALYST, V134, P1965, DOI 10.1039/b910206j; Granger MC, 2000, ANAL CHEM, V72, P3793, DOI 10.1021/ac0000675; Sepulveda N, 2006, DIAM RELAT MATER, V15, P398, DOI 10.1016/j.diamond.2005.08.032; Zhou YL, 2009, TALANTA, V79, P1189, DOI 10.1016/j.talanta.2009.05.026; Kochhar A, 2012, IEEE INT ULTRA SYM, P1047, DOI 10.1109/ULTSYM.2012.0262; Einaga Y, 2001, DIAM RELAT MATER, V10, P306, DOI 10.1016/S0925-9635(01)00375-2; Fujishima A., 2005, DIAMOND ELECTROCHEMI; Fujishima A, 1999, J ELECTROANAL CHEM, V473, P179, DOI 10.1016/S0022-0728(99)00106-0; Hayasaka T, 2014, 2014 IEEE 27TH INTERNATIONAL CONFERENCE ON MICRO ELECTRO MECHANICAL SYSTEMS (MEMS), P322, DOI 10.1109/MEMSYS.2014.6765641; Inoue KY, 2013, ANALYST, V138, P6523, DOI 10.1039/c3an01202f; Ivandini TA, 2006, ANAL CHEM, V78, P6291, DOI 10.1021/ac0519514; Ivandini TA, 2006, ANAL CHEM, V78, P3467, DOI 10.1021/ac0502029x; Kuno T., 2014, JPN J APPL PHYS, V53; Lapisa M, 2009, PROC IEEE MICR ELECT, P1007; Martin HB, 1996, J ELECTROCHEM SOC, V143, P133; Matsuo K., 2012, P IEEE 25 INT C MEMS, P1153; MIRKIN MV, 1992, ANAL CHEM, V64, P2293, DOI 10.1021/ac00043a020; Moriwaki N., 2013, IEICE T A, VJ96-A, P342; Niklaus F, 2001, J MICROELECTROMECH S, V10, P525, DOI 10.1109/84.967375; Ogihara M, 2006, ELECTRON LETT, V42, P881, DOI 10.1049/el:20061226; POLO MC, 1994, THIN SOLID FILMS, V253, P136, DOI 10.1016/0040-6090(94)90308-5; Rothe J., 2011, J MICROMECH MICROENG, V21, P1; Shahid M, 2009, OPEN IMMUNOL J, V2, P9; The Dow Chemical Company, 2012, PROC PROC CYCLOTENE	38	2	2	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	AUG	2015	24	4					958	967		10.1109/JMEMS.2014.2360837		10	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CO1YQ	WOS:000358952600023		
J	Shibata, Y; Sugiyama, T; Mimura, H; Hashiguchi, G				Shibata, Yasushi; Sugiyama, Tatsuhiko; Mimura, Hidenori; Hashiguchi, Gen			In Situ Measurement of Charging Process in Electret-Based Comb-Drive Actuator and High-Voltage Charging	JOURNAL OF MICROELECTROMECHANICAL SYSTEMS			English	Article						MEMS; energy harvesting; electret; BT procedure	EQUIVALENT-CIRCUIT; TRANSDUCERS; GENERATION; SIO2	We report in situ measurements of the charging process for an electret-based comb-drive actuator and an experiment on high-voltage charging. The ac current flowing between the comb-drive electrodes, which is proportional to the displacement, is monitored during the application of a dc bias voltage at an elevated temperature. As the charge voltage increases, it opposes the applied voltage, causing the current to decrease and become a minimum, which indicates the completion of the charging process. The proposed electret-based method allows voltage-controlled charging in silicon microelectromechanical systems (MEMSs) devices, which offers advantages for commercial MEMS device fabrication. This paper also discusses the importance of high-voltage charging for improving the efficiency of the actuator as an electrostatic vibration-energy harvesting device. A charging mechanism is proposed to explain the experimental results, and the stability of the movable comb-drive electrode against the pull-in effect is discussed. Using the proposed method, a large force factor is obtained, and charging to a voltage of up to 380 V is demonstrated.	[Shibata, Yasushi; Sugiyama, Tatsuhiko; Mimura, Hidenori; Hashiguchi, Gen] Shizuoka Univ, Elect Res Inst, Shizuoka 4228529, Japan	Shibata, Y (reprint author), Shizuoka Univ, Elect Res Inst, Shizuoka 4228529, Japan.	y-shibata@rie.shizuoka.ac.jp; t.sugiyama@rie.shizuoka.ac.jp; mimura@rie.shizuoka.ac.jp; hasiguti@rie.shizuoka.ac.jp					Altafim R. A. C., 1991, P 7 INT EL S ISE 7, P267; Roundy S, 2003, COMPUT COMMUN, V26, P1131; Robion A, 2007, INT TELECOM ENERGY, P460, DOI 10.1109/INTLEC.2007.4448821; Tsutsumino T, 2006, PROC IEEE MICR ELECT, P98; WALLIS G, 1969, J APPL PHYS, V40, P3946, DOI 10.1063/1.1657121; Ali SF, 2011, J INTEL MAT SYST STR, V22, P1929, DOI 10.1177/1045389X11417650; Jung SM, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3360219; Elata D, 2011, J MICROELECTROMECH S, V20, P150, DOI 10.1109/JMEMS.2010.2090499; Ericka M, 2005, ULTRASON, P946; Fujiwara N, 2009, IEEJ T ELECTR ELECTR, V4, P352, DOI 10.1002/tee.20417; GUNTHER P, 1992, SENSOR ACTUAT A-PHYS, V32, P357, DOI 10.1016/0924-4247(92)80012-R; Hashiguchi G, 2014, IEICE ELECTRON EXPR, V11, DOI 10.1587/elex.11.20142007; HILLEN MW, 1979, J APPL PHYS, V50, P4834, DOI 10.1063/1.326547; Honzumi M, 2010, PROC IEEE MICR ELECT, P635; Joseph A. D., 2005, IEEE Pervasive Computing, V4; KERR DR, 1964, IBM J RES DEV, V8, P385; Mescheder U., 2008, P POWERMEMS 2008 SEN, P501; Nishimori Y., 2009, JPN J APPL PHYS, V48; Saadon S., 2011, Proceedings of the 2011 4th International Conference on Developments in e-systems Engineering (DeSE 2011), DOI 10.1109/DeSE.2011.85; Sangani K., 2007, ENG TECHNOL, V2, P36; Sankar R., 2012, P IEEE GLOB HUM TECH, P299; Senturia S. D., 2001, MICROSYSTEMS DESIGN, P231; Senturia S. D., 2001, MICROSYSTEM DESIGN, P134; Sugiyama T., 2011, APPL PHYS EXP, V4; Suzuki M., 2012, POWERMEMS2012 ATL, P247; Tang W. C., 1989, Proceedings: IEEE Micro Electro Mechanical Systems. An Investigation of Micro Structures, Sensors, Actuators, Machines and Robots (IEEE Cat. No.89THO249-3), DOI 10.1109/MEMSYS.1989.77961; Tilmans HAC, 1996, J MICROMECH MICROENG, V6, P157, DOI 10.1088/0960-1317/6/1/036; Tsutsumino T., 2005, P POWERMEMS C, P9; Yakovlev A., 2011, P DES AUT TEST EUR C, P1; Yeatman E. M., 2007, P 2 INT WORKSH ADV S, P1	30	0	0	IEEE-INST ELECTRICAL ELECTRONICS ENGINEERS INC	PISCATAWAY	445 HOES LANE, PISCATAWAY, NJ 08855-4141 USA	1057-7157	1941-0158		J MICROELECTROMECH S	J. Microelectromech. Syst.	AUG	2015	24	4					1052	1060		10.1109/JMEMS.2014.2379959		9	Engineering, Electrical & Electronic; Engineering, Mechanical	Engineering	CO1YQ	WOS:000358952600034		
J	Miyazaki, J; Sudo, N; Yamada, Y				Miyazaki, Jun; Sudo, Nao; Yamada, Yasuhiro			Infrared spectroscopic and density functional theoretical study of tris(cyclopentadienyl)ytterbium (YbCp3) and acetone adduct molecules of YbCp3 in low-temperature matrices	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						Tris(cyclopentadienyl)ytterbium; Acetone adduct molecule of tris(cyclopentadienyl)ytterbium; Matrix-isolation; Infrared spectroscopy; Density functional theory calculations	ATOMIC LAYER DEPOSITION; OXIDE THIN-FILMS; TRANSMETALATION REACTIONS; ARGON MATRICES; SOLID ARGON; COMPLEXES; CYCLOPENTADIENIDES; ORGANOLANTHANOIDS; SCANDIUM; CRYSTAL	Tris(cyclopentadienyl)ytterbium (YbCp3) was isolated in solid argon matrices, and the monomeric structure of YbCp3 was studied by means of infrared spectroscopy and density functional theory calculations. Compared with our previous study on the structure of tris(cyclopentadienyl)scandium (ScCp3) isolated in solid argon matrices, it was apparent that the monomeric structure of YbCp3 has three eta(5)-Cp bonds to the Yb atom, Yb(eta(5)-Cp)(3), analogous to the structure of matrix-isolated ScCp3. In addition, the stable dimer structures of YbC(p)3 were also predicted using density functional theory calculations. Furthermore, we produced the acetone adduct molecules of YbCp3 for the first time by co-condensing YbCp3 and an acetone/argon mixture gas on a cold substrate at 20 K. Molecules with Yb-O bonding between YbCp3 and acetone were detected in low-temperature acetone/argon matrices. By using natural bond orbital (NBO) and curve fitting analysis, the structures of the acetone adduct molecules of YbCp3 were deduced. (C) 2015 Elsevier Inc. All rights reserved.	[Miyazaki, Jun] Tokyo Univ Agr & Technol, Dept Chem Engn, Koganei, Tokyo 1848588, Japan; [Sudo, Nao; Yamada, Yasuhiro] Tokyo Univ Sci, Dept Chem, Fac Sci, Shinjuku Ku, Tokyo 1628601, Japan	Miyazaki, J (reprint author), Tokyo Univ Agr & Technol, Dept Chem Engn, 2-24-16 Naka Cho, Koganei, Tokyo 1848588, Japan.	jmiya@cc.tuat.ac.jp; yyasu@rs.kagu.tus.ac.jp			Japan Science Society [18-103]	J. M. is grateful to Prof. Sachi Kotani and Prof. Harue Yamagata at CIT for partial support in this project and thanks Dr. Hiroshi Imamura at AIST for meaningful discussions about the curve fitting analysis. This study was (partly) supported by the Sasakawa Scientific Research Grant from The Japan Science Society (18-103).	Adam M., 1990, B MAGN RESON, V12, P101; REED AE, 1988, CHEM REV, V88, P899, DOI 10.1021/cr00088a005; Denning RG, 2011, J AM CHEM SOC, V133, P20644, DOI 10.1021/ja209311g; BIRMINGHAM JM, 1956, J AM CHEM SOC, V78, P42, DOI 10.1021/ja01582a009; Coreno M, 2010, ORGANOMETALLICS, V29, P4752, DOI 10.1021/om100240m; Edelmann FT, 2012, CHEM SOC REV, V41, P7657, DOI 10.1039/c2cs35180c; FISCHER RD, 1965, J ORGANOMET CHEM, V4, P412, DOI 10.1016/S0022-328X(00)80334-4; Han JH, 2014, CHEM MATER, V26, P1404, DOI 10.1021/cm403390j; Edelmann FT, 2009, CHEM SOC REV, V38, P2253, DOI 10.1039/b800100f; ATWOOD JL, 1973, J AM CHEM SOC, V95, P1488, DOI 10.1021/ja00786a023; Blanquart T, 2014, CHEM VAPOR DEPOS, V20, P217, DOI 10.1002/cvde.201407116; CALDERAZ.F, 1966, J INORG NUCL CHEM, V28, P987, DOI 10.1016/0022-1902(66)80195-1; DEACON GB, 1987, AUST J CHEM, V40, P895; Deacon GB, 1998, J ORGANOMET CHEM, V565, P201, DOI 10.1016/S0022-328X(98)00456-2; DOMINGOS A, 1993, POLYHEDRON, V12, P2545, DOI 10.1016/S0277-5387(00)80079-0; EGGERS SH, 1987, ACTA CRYSTALLOGR C, V43, P2288, DOI 10.1107/S0108270187088036; FISCHER EO, 1966, J ORGANOMET CHEM, V6, P141, DOI 10.1016/S0022-328X(00)93649-0; Frisch M. J., 2004, GAUSSIAN 03 REVISION; HAMMEL A, 1989, J ORGANOMET CHEM, V363, pC29, DOI 10.1016/0022-328X(89)87130-X; Han SW, 1996, J PHYS CHEM-US, V100, P17124, DOI 10.1021/jp961538n; Janiak C, 2010, Z ANORG ALLG CHEM, V636, P2387, DOI 10.1002/zaac.201000239; Miyazaki J, 2004, J MOL STRUCT, V692, P145, DOI 10.1016/j.molstruc.2004.01.023; Miyazaki J, 2005, J MOL STRUCT, V734, P115, DOI 10.1016/j.molstruc.2004.09.015; Niinisto J, 2005, J CRYST GROWTH, V285, P191, DOI 10.1016/j.jcrysgro.2005.08.002; Pappalardo R., 1967, CHEM PHYS, V46, P632; QIAN CT, 1983, J ORGANOMET CHEM, V247, P161, DOI 10.1016/S0022-328X(00)98751-5; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; WEBER J, 1988, APPL PHYS LETT, V53, P2525, DOI 10.1063/1.100197; Yao Y., 2010, RARE EARTH COORDINAT, P309, DOI 10.1002/9780470824870.ch8	29	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	AUG	2015	314						26	34		10.1016/j.jms.2015.05.006		9	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CO3YC	WOS:000359096200005		
J	Hirano, T; Nagashima, U				Hirano, Tsuneo; Nagashima, Umpei			Ro-vibrational properties of FeCO in the (X)over-tilde(3)Sigma(-) and (a)over-tilde(5)Sigma(-) electronic states: A computational molecular spectroscopy study	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						FeCO; 3D potential energy surface; Ro-vibrational properties; Perturbation analyses; DVR3D; Ro-vibrationally averaged structures; Linear or bent	AMPLITUDE BENDING MOTION; CARBONYL RADICAL FECO; GROUND-STATE; AB-INITIO; MICROWAVE SPECTROSCOPY; ALKALI HYDROXIDES; TRIATOMIC-MOLECULES; QUASI-LINEARITY; BASIS-SETS; ATOMS	The present work complements our previous study of the geometry and electronic structure in the ground and low-lying electronic states of FeCO. Here, we report three-dimensional potential energy surfaces (PESs) for the (3)Sigma(-) electronic ground state and its high-spin counterpart, the excited state a(5)Sigma(-), calculated ab initio at the MR-SDCI+Q_DK3/[5ZP ANO-RCC (Fe, C, O)] level of theory. These PESs are employed in 2nd-order-perturbation-theory and DVR3D calculations of the rotation-vibration energies and ro-vibrationally averaged structures. The equilibrium structures determined from the 3D PESs have r(e)(Fe-C) = 1.7247 angstrom, r(e)(C-O) = 1.1587 angstrom, and angle(e)(Fe-C-O) = 180 degrees for the (X) over tilde (3)Sigma(-) state, and r(e)(Fe-C) = 1.8429 angstrom, r(e)(C-O) = 1.1522 angstrom, and angle(e)(Fe-C-O) = 180 degrees for the a(5)Sigma(-) state. The ro-vibrationally averaged structures, determined as expectation values over DVR3D wavefunctions, have < r(Fe-C)>(0) = 1.7303 angstrom, (r(C-O))0 = 1.1631 angstrom, and (angle(Fe-C-O))(0) = 172.6 degrees for the (X) over tilde (3)Sigma(-) state, and < r(Fe-C)>(0) = 1.8471 angstrom, (r(C-O))(0) = 1.1568 angstrom, and (angle(Fe-C-O))(0) = 171.4 degrees for the (a) over tilde (5)Sigma(-) state. The coordinate-covalent Fe-C bond in the (X) over tilde (3)Sigma(-) state, which elongates significantly as the molecule bends, is shown to exhibit normal large amplitude bending motion with strong coupling (manifested by the large value of the relevant third order force constant) between bending and Fe-C stretching modes. The ionic Fe-C bond in the (a) over tilde (5)Sigma(-) state shows anormal bending behavior due to a severe Fermi resonance which also gives rise to a large coupling between the bending and the Fe-C stretching motions, even though the corresponding third order force constant is small. The Yamada-Winnewisser quasi-linearity parameter gamma(0) is calculated to be -1.00 and -0.90, values characteristic for a linear molecule, for the (X) over tilde (3)Sigma(-) and (a) over tilde (5)Sigma(-) states, respectively. The ro-vibrationally averaged structures of the (X) over tilde (3)Sigma(-) state are discussed in detail and it is concluded that any triatomic, linear molecule will be observed as being bent on to-vibrational average. (C) 2015 Elsevier Inc. All rights reserved.	[Hirano, Tsuneo] Ochanomizu Univ, Dept Chem, Fac Sci, Bunkyo Ku, Tokyo 1128610, Japan; [Nagashima, Umpei] Natl Inst Adv Ind Sci & Technol, Nanosyst Res Inst, Tsukuba, Ibaraki 3058568, Japan	Hirano, T (reprint author), Ochanomizu Univ, Dept Chem, Fac Sci, Bunkyo Ku, 2-1-1 Otsuka, Tokyo 1128610, Japan.	hirano@nccsk.com					Adamo C, 1995, J CHEM PHYS, V103, P10605, DOI 10.1063/1.469845; Amano M., 2002, 57 OH STAT U INT S M, pRF11; HOY AR, 1972, MOL PHYS, V24, P1265, DOI 10.1080/00268977200102361; Tennyson J, 2004, COMPUT PHYS COMMUN, V163, P85, DOI 10.1016/j.cpc.2003.10.003; SZALAY PG, 1993, CHEM PHYS LETT, V214, P481, DOI 10.1016/0009-2614(93)85670-J; Roos BO, 2004, J PHYS CHEM A, V108, P2851, DOI 10.1021/jp031064+; Winnewisser M, 2006, J MOL STRUCT, V798, P1, DOI 10.1016/j.molstruc.2006.06.036; Roos BO, 2005, J PHYS CHEM A, V109, P6575, DOI 10.1021/jp0581126; Reiher M, 2004, J CHEM PHYS, V121, P2037, DOI 10.1063/1.1768160; NAKATA M, 1980, J MOL SPECTROSC, V83, P118, DOI 10.1016/0022-2852(80)90315-X; LANGHOFF SR, 1974, INT J QUANTUM CHEM, V8, P61, DOI 10.1002/qua.560080106; Reiher M, 2004, J CHEM PHYS, V121, P10945, DOI 10.1063/1.1818681; BARNES LA, 1991, J CHEM PHYS, V94, P2031, DOI 10.1063/1.459924; BAUSCHLICHER CW, 1987, J CHEM PHYS, V87, P2129, DOI 10.1063/1.453137; BAUSCHLICHER CW, 1986, J CHEM PHYS, V85, P354, DOI 10.1063/1.451610; BOHACEK I, 1976, CHEM PHYS LETT, V42, P395, DOI 10.1016/0009-2614(76)80393-4; Bunker P. R., 2006, MOL SYMMETRY SPECTRO; CASTRO M, 1994, J CHEM PHYS, V100, P8233, DOI 10.1063/1.466766; Daoudi A., 1990, J MOL STRUCT, V210, P139, DOI 10.1016/0166-1280(90)80035-M; DOUGLAS M, 1974, ANN PHYS-NEW YORK, V82, P89, DOI 10.1016/0003-4916(74)90333-9; Hirano T., 2008, 63 OH STAT U INT S M; Hirano T, 2010, J CHEM PHYS, V132, DOI 10.1063/1.3317405; Hirano T, 2008, CHEM PHYS, V346, P13, DOI 10.1016/j.chemphys.2008.01.022; Hirano T, 2007, J MOL SPECTROSC, V243, P267, DOI 10.1016/j.jms.2007.02.005; Hirano T, 2010, J MOL SPECTROSC, V263, P150, DOI 10.1016/j.jms.2010.07.009; Hirano T, 2009, J MOL SPECTROSC, V256, P45, DOI 10.1016/j.jms.2009.01.013; Hirano T, 2012, J CHEM PHYS, V137, DOI 10.1063/1.4769283; Hirano T, 2006, J MOL SPECTROSC, V236, P234, DOI 10.1016/j.jms.2006.02.002; Hirano T, 2008, J MOL SPECTROSC, V250, P33, DOI 10.1016/j.jms.2008.04.001; Hirano T, 2007, J MOL SPECTROSC, V243, P202, DOI 10.1016/j.jms.2007.02.006; Hirano T, 2007, MOL PHYS, V105, P599, DOI 10.1080/00268970601126734; Hirano T., 2014, J CHEM PHYS, V141; Hirano T, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2723110; Honda H, 2000, THEOR CHEM ACC, V104, P140, DOI 10.1007/s002140000128; HOUGEN JT, 1970, J MOL SPECTROSC, V34, P136, DOI 10.1016/0022-2852(70)90080-9; Ikeda S., 2006, 61 OSU INT S MOL SPE; Kagi E, 1997, ASTROPHYS J, V488, P776, DOI 10.1086/304735; KASAI Y, 1995, J CHEM PHYS, V103, P90, DOI 10.1063/1.469626; LIDE DR, 1969, J CHEM PHYS, V50, P3080, DOI 10.1063/1.1671509; LIDE DR, 1967, J CHEM PHYS, V46, P4768, DOI 10.1063/1.1840634; MATSUMUR.C, 1969, J CHEM PHYS, V50, P71, DOI 10.1063/1.1670871; Mills I.M., 1972, MOL SPECTROSCOPY MOD, V1; Nagashima U., 2005, S MOL STRUCT TOK; NAKATA M, 1994, J MOL STRUCT, V320, P179, DOI 10.1016/0022-2860(93)08012-S; NAKATA M, 1981, J MOL SPECTROSC, V86, P241, DOI 10.1016/0022-2852(81)90122-3; Noro T, 2000, THEOR CHEM ACC, V104, P146, DOI 10.1007/s002140000126; Ricca A, 2001, THEOR CHEM ACC, V106, P314, DOI 10.1007/s002140100279; Sarka K., 2000, COMPUTATIONAL MOL SP; Takano K., 1994, S MOL STRUCT TOKV; Taketsugu T, 1996, J CHEM PHYS, V104, P6081, DOI 10.1063/1.471275; Tanaka K, 1997, J CHEM PHYS, V106, P2118, DOI 10.1063/1.473143; Tanaka K, 1997, J CHEM PHYS, V106, P6820, DOI 10.1063/1.473709; Tanaka K., J CHEM PHYS IN PRESS; Tennyson J., DVR3D PROGRAM SUITE; VILLALTA PW, 1993, J CHEM PHYS, V98, P7730, DOI 10.1063/1.464580; Walker KA, 2001, J MOL SPECTROSC, V209, P178, DOI 10.1006/jmsp.2001.8421; Watson JKG, 1999, J MOL SPECTROSC, V196, P102, DOI 10.1006/jmsp.1999.7843; Werner H.-J., MOLPRO VERSIONS 2006; YAMADA K, 1976, Z NATURFORSCH A, V31, P139	59	1	1	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	AUG	2015	314						35	47		10.1016/j.jms.2015.05.007		13	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CO3YC	WOS:000359096200006		
J	Kawaguchi, K; Fujimori, R; Tang, J; Ishiwata, T				Kawaguchi, Kentarou; Fujimori, Ryuji; Tang, Jian; Ishiwata, Takashi			On the vibrational assignment in the ground electronic state of NO3	JOURNAL OF MOLECULAR SPECTROSCOPY			English	Article						Nitrate radical; IR spectroscopy; Vibrational assignments; Vibronic interaction	SPECTROSCOPY; BAND	The vibration-rotational structure of the ground A(2)', state of the NO3 radical is re-considered, because Hirota (2015) presented an objection to the vibrational assignment of our previous papers (Kawaguchi et al., 2011, 2013; Fujimori et al., 2013). The present study examines the vibrational assignment in the following points, (1) laser induced fluorescence (LIF) spectra observed by Fukushima and Ishiwata in the 1050 cm(-1) region, (2) Fourier transform (FT) spectra of vibrational bands from the v(4) = 1 state, and a diode laser spectrum of the 2v(4) band. These considerations support our previous assignments, that is, v(3) + v(4)= 1492 cm(-1) and v(3) = 1055 cm(-1) for (NO3)-N-14. (C) 2015 Elsevier Inc. All rights reserved.	[Kawaguchi, Kentarou; Tang, Jian] Okayama Univ, Fac Sci, Okayama 7008530, Japan; [Fujimori, Ryuji] Nagoya Univ, Solar Terr Environm Lab, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Ishiwata, Takashi] Hiroshima City Univ, Grad Sch Informat Sci, Hiroshima 7313194, Japan	Kawaguchi, K (reprint author), Okayama Univ, Fac Sci, 3-1-1 Tsushima Naka, Okayama 7008530, Japan.	okakent@cc.okayama-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21550009, 21104003]	The present study was supported by the Grant-in-Aid (Grant Nos. 21550009, and 21104003) from the Ministry of Education, Culture, Sports, Science and Technology of Japan.	OKA T, 1967, J CHEM PHYS, V47, P5410, DOI 10.1063/1.1701809; Kawaguchi K, 2011, J MOL SPECTROSC, V268, P85, DOI 10.1016/j.jms.2011.04.003; Fujimori R, 2013, J MOL SPECTROSC, V283, P10, DOI 10.1016/j.jms.2012.11.005; Fukushima M., 2013, 68 INT S MOL SPECTR; Hirota E, 2015, J MOL SPECTROSC, V310, P99, DOI 10.1016/j.jms.2014.12.010; HIROTA E, 1991, J CHEM PHYS, V95, P771, DOI 10.1063/1.461083; Homayoon Z., 2014, J CHEM PHYS, V141; ISHIWATA T, 1985, J CHEM PHYS, V82, P2196, DOI 10.1063/1.448362; Jacox M.E., 2008, J CHEM PHYS, V129; Kawaguchi K, 2013, J PHYS CHEM A, V117, P13732, DOI 10.1021/jp407822g; KAWAGUCHI K, 1990, J CHEM PHYS, V93, P951, DOI 10.1063/1.459121; KIM BS, 1992, J CHEM PHYS, V96, P4057, DOI 10.1063/1.461861; Kroto HW, 1975, MOL ROTATION SPECTRA; Maki A., COMMUNICATION; Masiello T, 2007, J MOL SPECTROSC, V243, P16, DOI 10.1016/j.jms.2007.02.019; Stanton JF, 2009, MOL PHYS, V107, P1059, DOI 10.1080/00268970902740530; Stanton J.F., 2007, J CHEM PHYS, V126; Tada K., 2014, J CHEM PHYS, V141; WEAVER A, 1991, J CHEM PHYS, V94, P1740, DOI 10.1063/1.459947	19	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0022-2852	1096-083X		J MOL SPECTROSC	J. Mol. Spectrosc.	AUG	2015	314						73	78		10.1016/j.jms.2015.06.008		6	Physics, Atomic, Molecular & Chemical; Spectroscopy	Physics; Spectroscopy	CO3YC	WOS:000359096200010		
J	Nagata, C; Wada, K; Tamura, T; Konishi, K; Kawachi, T; Tsuji, M; Nakamura, K				Nagata, Chisato; Wada, Keiko; Tamura, Takashi; Konishi, Kie; Kawachi, Toshiaki; Tsuji, Michiko; Nakamura, Kozue			Choline and Betaine Intakes Are Not Associated with Cardiovascular Disease Mortality Risk in Japanese Men and Women	JOURNAL OF NUTRITION			English	Article						betaine; choline; cohort studies; coronary heart disease; seafood; stroke	TOTAL HOMOCYSTEINE CONCENTRATION; FOOD-FREQUENCY QUESTIONNAIRE; GLYCINE BETAINE; DIETARY CHOLINE; COMMON FOODS; STROKE; PHOSPHATIDYLCHOLINE; METAANALYSIS; METABOLISM; HEALTH	Background: Dietary intakes of betaine and choline may reduce the risk of cardiovascular disease; however, epidemiologic evidence is limited. Seafood is a rich source of betaine and is a popular traditional food in Japan. Objective: We examined the associations of betaine and choline intakes with cardiovascular disease mortality in a population-based cohort study in Japan. Methods: Study subjects were 13,355 male and 15,724 female residents of Takayama City, Japan, who were aged >= 35 y and enrolled in 1992. Their diets were assessed by a validated food frequency questionnaire. Deaths from coronary heart disease and stroke were identified from death certificates over 16 y. Multivariable-adjusted HRs were computed by using Cox regression models. Results: During follow-up, we documented 308 deaths from coronary heart disease and 676 deaths from stroke 1393 from ischemic and 153 from hemorrhagic strokes). Compared with the lowest quartile, the second, third, and highest quartiles of betaine intake were significantly associated with a decreased risk of mortality from coronary heart disease in men after controlling for covariates. The HRs were 0.58 (95% Cl: 0.36, 0.93), 0.62 (95% Cl: 0.39, 0.998), and 0.60 (95% Cl: 0.37, 0.971, respectively. The trend was not statistically significant (P = 0.08). There was no significant association between betaine intake and the risk of mortality from ischemic stroke. In women, betaine intake was unrelated risk of mortality from coronary heart disease and stroke (P = 0.32 and 0.73, respectively, for interaction by sex). There was no significant association between choline intake and cardiovascular disease mortality risk in men or women. Conclusion: Overall, we found no clear evidence of significant associations between choline and betaine intakes and cardiovascular disease mortality risk in Japanese men and women.	[Nagata, Chisato; Wada, Keiko; Tamura, Takashi; Konishi, Kie; Kawachi, Toshiaki; Tsuji, Michiko; Nakamura, Kozue] Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu, Japan; [Tsuji, Michiko] Nagoya Womens Univ, Dept Food Sci & Nutr, Nagoya, Aichi, Japan; [Nakamura, Kozue] Gifu City Womens Coll, Dept Food & Nutr, Gifu, Japan	Nagata, C (reprint author), Gifu Univ, Grad Sch Med, Dept Epidemiol & Prevent Med, Gifu, Japan.	chisato@gifu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology, Japan.	Supported by grants from the Ministry of Education, Culture, Sports, Science, and Technology, Japan.	ABE S, 1975, B JPN SOC SCI FISH, V41, P467; Craig SAS, 2004, AM J CLIN NUTR, V80, P539; Dionisio N, 2010, CURR MED CHEM, V17, P3109; de Zwart FJ, 2003, FOOD CHEM, V83, P197, DOI 10.1016/S0308-8146(03)00063-3; Xun P, 2012, EUR J CLIN NUTR, V66, P1199, DOI 10.1038/ejcn.2012.133; Lewis ED, 2014, PLANT FOOD HUM NUTR, V69, P115, DOI 10.1007/s11130-014-0412-2; Dalmeijer GW, 2008, EUR J CLIN NUTR, V62, P386, DOI 10.1038/sj.ejcn.1602725; Lee JE, 2010, AM J CLIN NUTR, V91, P1303, DOI 10.3945/ajcn.2009.28456; Ruxton CHS, 2005, NUTR RES REV, V18, P113, DOI 10.1079/NRR200497; Humphrey LL, 2008, MAYO CLIN PROC, V83, P1203, DOI 10.4065/83.11.1203; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Bidulescu A, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-14; KONOSU S, 1975, B JPN SOC SCI FISH, V41, P743; Zeng FF, 2014, BRIT J CANCER, V110, P808, DOI 10.1038/bjc.2013.686; FUKE S, 1991, PHYSIOL BEHAV, V49, P863, DOI 10.1016/0031-9384(91)90195-T; Tang WHW, 2013, NEW ENGL J MED, V368, P1575, DOI 10.1056/NEJMoa1109400; Atkinson W, 2009, NUTR METAB CARDIOVAS, V19, P767, DOI 10.1016/j.numecd.2009.01.004; Zhang CX, 2013, CANCER SCI, V104, P250, DOI 10.1111/cas.12064; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Cho E, 2006, AM J CLIN NUTR, V83, P905; YAO ZM, 1988, J BIOL CHEM, V263, P2998; Bidulescu Aurelian, 2007, BMC Cardiovasc Disord, V7, P20, DOI 10.1186/1471-2261-7-20; Council for Science and Technology; Ministry of Education Culture Sports Science and Technology Japan, 2008, STAND TABL FOOD COMP, V5th; Golia E, 2014, CURR ATHEROSCLER REP, V16, DOI 10.1007/s11883-014-0435-z; Hayashi T, 1978, B JPN SOC SCI FISH, V12, P1357; He YS, 2014, NUTR METAB CARDIOVAS, V24, P1158, DOI 10.1016/j.numecd.2014.05.011; Howe JC, 2004, USDA DATABASE CHOLIN; Konosu S, 1973, JPN J FOOD ENG, V20, P38; KONOSU S., 1961, BULL JAPANESE SOC SCI FISH, V27, P194; Konosu S., 1986, Bulletin of the Japanese Society of Scientific Fisheries [Nihon Suisan Gakkai-shi], V52, P869; McRae Marc P, 2013, J Chiropr Med, V12, P20, DOI 10.1016/j.jcm.2012.11.001; Nagata C, 2015, J NUTR, V145, P720, DOI 10.3945/jn.114.201293; Olthof MR, 2005, PLOS MED, V2, P446, DOI 10.1371/journal.pmed.0020135; Patterson KY., 2008, USDA DATABASE CHOLIN; Rajaie Somayeh, 2011, ARYA Atheroscler, V7, P78; Ross AB, 2014, FOOD CHEM, V145, P859, DOI 10.1016/j.foodchem.2013.08.122; Sakamoto A, 2002, PEDIATR INT, V44, P409, DOI 10.1046/j.1442-200X.2002.01591.x; Sasaki S, 1999, J Epidemiol, V9, P190; Shimizu H, 1999, JPN J CLIN ONCOL, V29, P38, DOI 10.1093/jjco/29.1.38; Shimizu H, 1996, BASIC REPORT TAKAYAM; Shinagawa A, 1992, B GAKUSHUIN WOMENS J, V30, P99; Spence JD, 2006, INT J STROKE, V1, P242, DOI 10.1111/j.1747-4949.2006.00057.x; Suzuki H, 1998, J EPIDEMIOL, V8, P152; Suzuki H, 2002, J EPIDEMIOL, V12, P54; USDA Agriculture Research Service, 2011, USDA NUTR DAT STAND; Willett W, 1990, NUTR EPIDEMIOLOGY, P245; Zeisel SH, 2003, J NUTR, V133, P1302	47	0	0	AMER SOC NUTRITION-ASN	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3166	1541-6100		J NUTR	J. Nutr.	AUG	2015	145	8					1787	1792		10.3945/jn.114.209296		6	Nutrition & Dietetics	Nutrition & Dietetics	CO3DT	WOS:000359037500015		
J	Ryan, DJ; Yoshihara, H; Yoneoka, D; Egol, KA; Zuckerman, JD				Ryan, Devon J.; Yoshihara, Hiroyuki; Yoneoka, Daisuke; Egol, Kenneth A.; Zuckerman, Joseph D.			Delay in Hip Fracture Surgery: An Analysis of Patient-Specific and Hospital-Specific Risk Factors	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article							PROXIMAL FEMORAL FRACTURES; TIME-TO-SURGERY; OPERATIVE DELAY; ELDERLY-PATIENTS; SURGICAL DELAY; UNITED-STATES; MORTALITY; ASSOCIATION; MORBIDITY; SURVIVAL	Objectives: To empirically define a "delay" for hip fracture surgery based on clinical outcomes, and to identify patient demographics and hospital factors contributing to surgical delay. Design: Retrospective database analysis. Setting: Hospital discharge data. Patients/Participants: A total of 2,121,215 patients undergoing surgical repair of hip fracture in the National Inpatient Sample between 2000 and 2009. Intervention: Internal fixation or partial/total hip replacement. Main Outcome Measurements: Logistic regressions were performed to assess the effect of surgical timing on in-hospital complication and mortality rates, controlling for patient characteristics and hospital attributes. Subsequent regressions were performed to analyze which patient characteristics (age, gender, race, comorbidity burden, insurance status, and day of admission) and hospital factors (size, teaching status, and region) independently contributed to the likelihood of surgical delay. Results: Compared to same-day surgery, each additional day of delay was associated with a significantly higher overall complication rate. However, next-day surgery was not associated with an increased risk of in-hospital mortality. Surgery 2 calendar days (odds ratio: 1.13) and 3+ days (odds ratio: 1.33) after admission was associated with higher mortality rates. Based on these findings, "delay" was defined as surgery performed 2 or more days after admission. Significant factors related to surgical delay included comorbidity score, race, insurance status, hospital region, and day of admission. Conclusions: Surgical delay in hip fracture care contributes to patient morbidity and mortality. A variety of patient and hospital characteristics seem to contribute to surgical delay and point to important health care disparities. Level of Evidence: Prognostic Level II. See Instructions for Authors for a complete description of levels of evidence.	[Ryan, Devon J.; Egol, Kenneth A.; Zuckerman, Joseph D.] NYU, Hosp Joint Dis, Dept Orthopaed Surg, New York, NY USA; [Yoshihara, Hiroyuki] Nassau Univ, Med Ctr, Dept Orthopaed Surg, E Meadow, NY 11554 USA; [Yoshihara, Hiroyuki] Suny Downstate Med Ctr, Dept Orthopaed Surg, Brooklyn, NY 11203 USA; [Yoneoka, Daisuke] Grad Univ Adv Studies, Sch Adv Sci, Dept Stat Sci, Tachikawa, Tokyo, Japan	Yoshihara, H (reprint author), Nassau Univ, Med Ctr, Dept Orthopaed Surg, 2201 Hempstead Turnpike, E Meadow, NY 11554 USA.	hiroyoshihara55@yahoo.co.jp		Yoneoka, Daisuke/0000-0002-3525-5092	OTA; Omega; Synthes	K. A. Egol received consultancy fees and royalties from Exactech for other work, and NYU has received grants from OTA, Omega, and Synthes for other work. The remaining authors report no conflict of interest.	Brauer CA, 2009, JAMA-J AM MED ASSOC, V302, P1573, DOI 10.1001/jama.2009.1462; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300; Richmond J, 2003, J ORTHOP TRAUMA, V17, P53, DOI 10.1097/00005131-200301000-00008; Parker M, 2006, BRIT MED J, V333, P27, DOI 10.1136/bmj.333.7557.27; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Siegmeth AW, 2005, J BONE JOINT SURG BR, V87B, P1123, DOI 10.1302/0301-620X.87B8; Bottle A, 2006, BRIT MED J, V332, P947, DOI 10.1136/bmj.38790.468519.55; HARTZ AJ, 1989, NEW ENGL J MED, V321, P1720, DOI 10.1056/NEJM198912213212506; Bergeron E, 2006, J TRAUMA, V60, P753, DOI 10.1097/01.ta.0000214649.53190.2a; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; Shiga T, 2008, CAN J ANAESTH, V55, P146, DOI 10.1007/BF03016088; Elliott J, 2003, J CLIN EPIDEMIOL, V56, P788, DOI 10.1016/S0895-4356(03)00129-X; Grimes JP, 2002, AM J MED, V112, P702, DOI 10.1016/S0002-9343(02)01119-1; Uzoigwe CE, 2013, INJURY, V44, P726, DOI 10.1016/j.injury.2012.08.025; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; Johnell O, 2004, OSTEOPOROSIS INT, V15, P897, DOI 10.1007/s00198-004-1627-0; Rae HC, 2007, ANZ J SURG, V77, P889, DOI 10.1111/j.1445-2197.2007.04267.x; Lefaivre KA, 2009, J BONE JOINT SURG BR, V91B, P922, DOI 10.1302/0301-620X.91B7.22446; PARKER MJ, 1992, J BONE JOINT SURG BR, V74, P203; Beringer TRO, 1996, ULSTER MED J, V65, P32; DAVIS TRC, 1988, INJURY, V19, P244, DOI 10.1016/0020-1383(88)90036-8; Dorotka R, 2003, J BONE JOINT SURG BR, V85B, P1107, DOI 10.1302/0301-620X.85B8.14282; Doruk H, 2004, ARCH GERONTOL GERIAT, V39, P179, DOI 10.1016/j.archger.2004.03.004; Hamlet W P, 1997, Am J Orthop (Belle Mead NJ), V26, P621; Hardin G T, 1990, Orthop Rev, V19, P861; HARRIES DJ, 1991, AGE AGEING, V20, P41, DOI 10.1093/ageing/20.1.41; Ho V, 2000, HEALTH SERV RES, V34, P1499; Majumdar SR, 2006, MED CARE, V44, P552, DOI 10.1097/01.mlr.0000215812.13720.2e; MULLEN JO, 1992, CLIN ORTHOP RELAT R, P214; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Smektala R, 2008, BMC MUSCULOSKEL DIS, V9, DOI 10.1186/1471-2474-9-171; ZUCKERMAN JD, 1995, J BONE JOINT SURG AM, V77, P1551; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307	33	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	AUG	2015	29	8					343	348		10.1097/BOT.0000000000000313		6	Orthopedics; Sport Sciences	Orthopedics; Sport Sciences	CN2VN	WOS:000358280400001		
J	Amano, K; Maeda, I; Shimoyama, S; Shinjo, T; Shirayama, H; Yamada, T; Ono, S; Yamamoto, R; Yamamoto, N; Shishido, H; Shimizu, M; Kawahara, M; Aoki, S; Demizu, A; Goshima, M; Goto, K; Gyoda, Y; Hashimoto, K; Otomo, S; Sekimoto, M; Shibata, T; Sugimoto, Y; Morita, T				Amano, Koji; Maeda, Isseki; Shimoyama, Satofumi; Shinjo, Takuya; Shirayama, Hiroto; Yamada, Takeshi; Ono, Shigeki; Yamamoto, Ryo; Yamamoto, Naoki; Shishido, Hideki; Shimizu, Mie; Kawahara, Masanori; Aoki, Shigeru; Demizu, Akira; Goshima, Masahiro; Goto, Keiji; Gyoda, Yasuaki; Hashimoto, Kotaro; Otomo, Sen; Sekimoto, Masako; Shibata, Takemi; Sugimoto, Yuka; Morita, Tatsuya			The Accuracy of Physicians' Clinical Predictions of Survival in Patients With Advanced Cancer	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Physicians' clinical predictions of survival; actual survival; advanced cancer patients; palliative care; chemotherapy	QUALITY-OF-LIFE; PALLIATIVE-CARE; INCURABLE CANCER; PROSPECTIVE COHORT; PROGNOSTIC-FACTORS; TERMINAL CANCER; END; AGGRESSIVENESS; TRENDS; ASSOCIATION	Context. Accurate prognoses are needed for patients with advanced cancer. Objectives. To evaluate the accuracy of physicians' clinical predictions of survival (CPS) and assess the relationship between CPS and actual survival (AS) in patients with advanced cancer in palliative care units, hospital palliative care teams, and home palliative care services, as well as those receiving chemotherapy. Methods. This was a multicenter prospective cohort study conducted in 58 palliative care service centers in Japan. The palliative care physicians evaluated patients on the first day of admission and followed up all patients to their death or six months after enrollment. We evaluated the accuracy of CPS and assessed the relationship between CPS and AS in the four groups. Results. We obtained a total of 2036 patients: 470, 764, 404, and 398 in hospital palliative care teams, palliative care units, home palliative care services, and chemotherapy, respectively. The proportion of accurate CPS (0.67-1.33 times AS) was 35% (95% CI 33-37%) in the total sample and ranged from 32% to 39% in each setting. While the proportion of patients living longer than CPS (pessimistic CPS) was 20% (95% CI 18-22%) in the total sample, ranging from 15% to 23% in each setting, the proportion of patients living shorter than CPS (optimistic CPS) was 45% (95% CI 43-47%) in the total sample, ranging from 43% to 49% in each setting. Conclusion. Physicians tend to overestimate when predicting survival in all palliative care patients, including those receiving chemotherapy. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Amano, Koji] Osaka City Gen Hosp, Dept Palliat Med, Osaka 5340021, Japan; [Maeda, Isseki] Osaka Univ, Grad Sch Med, Dept Palliat Med, Suita, Osaka, Japan; [Shimoyama, Satofumi] Aichi Canc Ctr Hosp, Dept Palliat Care, Nagoya, Aichi 464, Japan; [Shinjo, Takuya] Shinjo Clin, Kobe, Hyogo, Japan; [Shirayama, Hiroto] Iryouhoujinn Takumikai Osaka Kita Homecare Clin, Osaka, Japan; [Yamada, Takeshi] Nippon Med Sch, Dept Gastrointestinal & Hepatobiliary Pancreat Su, Tokyo 113, Japan; [Ono, Shigeki] Shizuoka Canc Ctr Hosp, Div Palliat Med, Shizuoka, Japan; [Yamamoto, Ryo] Saku Cent Hosp Adv Care Ctr, Dept Palliat Med, Saku, Japan; [Yamamoto, Naoki] Shinsei Hosp, Dept Primary Care Serv, Nagano, Japan; [Shishido, Hideki] Shishido Internal Med Clin, Sakura, Chiba, Japan; [Shimizu, Mie] Saiseikai Matsusaka Gen Hosp, Matsusaka, Japan; [Kawahara, Masanori] Soshukai Okabe Clin, Natori, Miyagi, Japan; [Aoki, Shigeru] Sakanoue Family Clin, Hamamatsu, Shizuoka, Japan; [Demizu, Akira] Demizu Clin, Kishiwada, Japan; [Goshima, Masahiro] Homecare Clin Kobe, Kobe, Hyogo, Japan; [Goto, Keiji] Himawari Zaitaku Clin, Kumamoto, Japan; [Gyoda, Yasuaki] Kanamecyo Home Care Clin, Tokyo, Japan; [Hashimoto, Kotaro] Fukushima Home Palliat Care Clin, Fukushima, Japan; [Otomo, Sen] Shonan Int Village Clin, Kanagawa, Japan; [Sekimoto, Masako] Sekimoto Clin, Kobe, Hyogo, Japan; [Shibata, Takemi] Kanwakeakurinikku Eniwa, Eniwa, Japan; [Sugimoto, Yuka] Sugimoto Homecare Clin, Nagoya, Aichi, Japan; [Morita, Tatsuya] Palliat & Support Care Div, Hamamatsu, Shizuoka, Japan	Amano, K (reprint author), Osaka City Gen Hosp, Dept Palliat Med, Palliat Care Team, Miyakojima Ku, 2-13-22 Miyakojima Hondori, Osaka 5340021, Japan.	kojiamano4813@gmail.com			National Cancer Center Research and Development Fund [25-A-22]	This work was supported in part by The National Cancer Center Research and Development Fund (25-A-22). The authors declare no potential conflicts of interest with respect to the research, authorship, and publication of this article.	ADDINGTONHALL JM, 1990, BRIT J CANCER, V62, P695, DOI 10.1038/bjc.1990.360; Amano K, 2015, J PALLIAT MED, V18, P270, DOI 10.1089/jpm.2014.0132; Maltoni M, 2005, J CLIN ONCOL, V23, P6240, DOI 10.1200/JCO.2005.06.866; Llobera J, 2000, EUR J CANCER, V36, P2036, DOI 10.1016/S0959-8049(00)00291-4; Hagerty RG, 2005, J CLIN ONCOL, V23, P1278, DOI 10.1200/JCO.2005.11.138; Vigano A, 2004, CANCER, V101, P1090, DOI 10.1002/cncr.20472; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Morita T, 1999, SUPPORT CARE CANCER, V7, P128, DOI 10.1007/s005200050242; Glare P, 2008, EUR J CANCER, V44, P1146, DOI 10.1016/j.ejca.2008.02.030; Innes S, 2009, PALLIATIVE MED, V23, P29, DOI 10.1177/0269216308098799; Barnato AE, 2004, HEALTH SERV RES, V39, P363, DOI 10.1111/j.1475-6773.2004.00232.x; Baba M, 2015, J PAIN SYMPTOM MANAG, V49, P853, DOI 10.1016/j.jpainsymman.2014.10.010; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.036; Stiel S, 2010, SUPPORT CARE CANCER, V18, P43, DOI 10.1007/s00520-009-0628-0; Glare P, 2003, BRIT MED J, V327, P195, DOI 10.1136/bmj.327.7408.195; Mackillop WJ, 1997, J CLIN EPIDEMIOL, V50, P21, DOI 10.1016/S0895-4356(96)00316-2; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; Gripp S, 2007, J CLIN ONCOL, V25, P3313, DOI 10.1200/JCO.2006.10.5411; Temel JS, 2008, CANCER-AM CANCER SOC, V113, P826, DOI 10.1002/cncr.23620; Kiely BE, 2013, J CLIN ONCOL, V31, P3565, DOI 10.1200/JCO.2012.44.7821; Hauser CA, 2006, SUPPORT CARE CANCER, V14, P999, DOI 10.1007/s00520-006-0079-9; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Bland M., 2000, INTRO MED STAT; BRUERA E, 1992, J PAIN SYMPTOM MANAG, V7, P82, DOI 10.1016/0885-3924(92)90118-2; Casarett D, 2006, ANN INTERN MED, V145, P700; Fairchild A, 2014, SUPPORT CARE CANCER, V22, P611, DOI 10.1007/s00520-013-2013-2; Glare Paul, 2005, J Support Oncol, V3, P331; Glare P, 2010, PREDICTING SURVIVAL, P81; Gwilliam B, 2012, ANN ONCOL, V24, P482, DOI DOI 10.1093/ANOC/MDS341; Gwilliam B, 2011, BMJ-BRIT MED J, V343, P4920; Heyse-Moore L, 1987, PALLIATIVE MED, V1, P165, DOI 10.1177/026921638700100213; Hui D, 2014, CANCER-AM CANCER SOC, V120, P1743, DOI 10.1002/cncr.28628; Morita T, 2001, PALLIATIVE MED, V15, P419, DOI 10.1191/026921601680419474; Stockler MR, 2006, BRIT J CANCER, V94, P208, DOI 10.1038/sj.bjc.6602908; Vigano A, 1999, CANCER, V86, P170, DOI 10.1002/(SICI)1097-0142(19990701)86:1<170::AID-CNCR23>3.0.CO;2-S	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	AUG	2015	50	2					139	+		10.1016/j.jpainsymman.2015.03.004		9	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CO1YL	WOS:000358952100004		
J	Morita, T; Oyama, Y; Cheng, SY; Suh, SY; Koh, SJ; Kim, HS; Chiu, TY; Hwang, SJ; Shirado, A; Tsuneto, S				Morita, Tatsuya; Oyama, Yasuhiro; Cheng, Shao-Yi; Suh, Sang-Yeon; Koh, Su Jin; Kim, Hyun Sook; Chiu, Tai-Yuan; Hwang, Shinn-Jang; Shirado, Akemi; Tsuneto, Satoru			Palliative Care Physicians' Attitudes Toward Patient Autonomy and a Good Death in East Asian Countries	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Culture; end of life; Asia; good death; autonomy	ILL CANCER-PATIENTS; OF-LIFE ATTITUDES; INTENSIVE-CARE; TERMINAL ILLNESS; DECISION-MAKING; END; JAPAN; UNIT; DISCLOSURE; INVENTORY	Context. Clarification of the potential differences in end-of-life care among East Asian countries is necessary to provide palliative care that is individualized for each patient. Objectives. The aim was to explore the differences in attitude toward patient autonomy and a good death among East Asian palliative care physicians. Methods. A cross-sectional survey was performed involving palliative care physicians in Japan, Taiwan, and Korea. Physicians' attitudes toward patient autonomy and physician-perceived good death were assessed. Results. A total of 505, 207, and 211 responses were obtained from Japanese, Taiwanese, and Korean physicians, respectively. Japanese (82%) and Taiwanese (93%) physicians were significantly more likely to agree that the patient should be informed first of a serious medical condition than Korean physicians (74%). Moreover, 41% and 49% of Korean and Taiwanese physicians agreed that the family should be told first, respectively; whereas 7.4% of Japanese physicians agreed. Physicians' attitudes with respect to patient autonomy were significantly correlated with the country (Japan), male sex, physician specialties of surgery and oncology, longer clinical experience, and physicians having no religion but a specific philosophy. In all 12 components of a good death, there were significant differences by country. Japanese physicians regarded physical comfort and autonomy as significantly more important and regarded preparation, religion, not being a burden to others, receiving maximum treatment, and dying at home as less important. Taiwanese physicians regarded life completion and being free from tubes and machines as significantly more important. Korean physicians regarded being cognitively intact as significantly more important. Conclusion. There are considerable intercountry differences in physicians' attitudes toward autonomy and physician-perceived good death. East Asia is not culturally the same; thus, palliative care should be provided in a culturally acceptable manner for each country. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Palliat Care Team, Hamamatsu, Shizuoka 4338558, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Seirei Hosp, Hamamatsu, Shizuoka 4338558, Japan; [Oyama, Yasuhiro] Kyoto Univ, Div Clin Psychol, Kyoto, Japan; [Cheng, Shao-Yi; Chiu, Tai-Yuan] Natl Taiwan Univ, Coll Med & Hosp, Dept Family Med, Taipei 10764, Taiwan; [Suh, Sang-Yeon] Dongguk Univ Sch Med, Dongguk Univ Ilsan Hosp, Dept Family Med, Seoul, South Korea; [Koh, Su Jin] Univ Ulsan Coll Med, Ulsan Univ Hosp, Dept Hematol & Oncol, Ulsan, South Korea; [Kim, Hyun Sook] Korea Natl Univ Transportat, Dept Social Welf, Chungju City, South Korea; [Hwang, Shinn-Jang] Taipei Vet Gen Hosp, Dept Family Med, Taipei, Taiwan; [Hwang, Shinn-Jang] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Shirado, Akemi] Seirei Mikatahara Gen Hosp, Palliat Care Team, Hamamatsu, Shizuoka 4338558, Japan; [Tsuneto, Satoru] Kyoto Univ, Grad Sch Med, Dept Multidisciplinary Canc Treatment, Kyoto, Japan	Morita, T (reprint author), Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Palliat Care Team, 3453 Mikatahara Cho, Hamamatsu, Shizuoka 4338558, Japan.	tmorita@sis.seirei.or.jp			Japan Hospice Foundation	This study was supported by the Japan Hospice Foundation. The authors have no conflicts of interest.	Akechi T, 2012, PALLIATIVE MED, V26, P768, DOI 10.1177/0269216312437214; Searight HR, 2005, AM FAM PHYSICIAN, V71, P515; Hu WY, 2010, SOC SCI MED, V70, P1701, DOI 10.1016/j.socscimed.2010.02.011; Ruhnke GW, 2000, CHEST, V118, P1172, DOI 10.1378/chest.118.4.1172; Cuttini M, 2000, LANCET, V355, P2112, DOI 10.1016/S0140-6736(00)02378-3; Kwak J, 2005, GERONTOLOGIST, V45, P634; Yaguchi A, 2005, ARCH INTERN MED, V165, P1970, DOI 10.1001/archinte.165.17.1970; Johnstone MJ, 2009, J TRANSCULT NURS, V20, P405, DOI 10.1177/1043659609340803; Phelps AC, 2012, J CLIN ONCOL, V30, P2538, DOI 10.1200/JCO.2011.40.3766; Miccinesi G, 2005, SOC SCI MED, V60, P1961, DOI 10.1016/j.socscimed.2004.08.061; Yun YH, 2011, J CLIN ONCOL, V29, P2474, DOI 10.1200/JCO.2010.30.1184; Kagawa-Singer M, 2001, JAMA-J AM MED ASSOC, V286, P2993, DOI 10.1001/jama.286.23.2993; Raijmakers NJH, 2011, ANN ONCOL, V22, P1478, DOI 10.1093/annonc/mdq620; Chiu TY, 2009, J CLIN ONCOL, V27, P3964, DOI 10.1200/JCO.2008.21.4643; Matsumura S, 2002, J GEN INTERN MED, V17, P531, DOI 10.1046/j.1525-1497.2002.10734.x; Cheng SY, 2012, J PALLIAT MED, V15, P854, DOI 10.1089/jpm.2012.0033; Shin DW, 2011, J PAIN SYMPTOM MANAG, V42, P632, DOI 10.1016/j.jpainsymman.2010.12.012; Morita T, 2004, SUPPORT CARE CANCER, V12, P137, DOI 10.1007/s00520-003-0561-6; ASAI A, 1995, LANCET, V346, P356, DOI 10.1016/S0140-6736(95)92230-X; BLACKHALL LJ, 1995, JAMA-J AM MED ASSOC, V274, P820, DOI 10.1001/jama.274.10.820; Bruera E, 2000, PALLIATIVE MED, V14, P287, DOI 10.1191/026921600674582192; Chen CH, 2011, PALLIATIVE MED, V26, P206; Cheng SY, 2013, JPN J CLIN ONCOL, V43, P795, DOI 10.1093/jjco/hyt085; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Devictor DJ, 2008, PEDIATR CRIT CARE ME, V9, P560, DOI 10.1097/PCC.0b013e31818d3581; Glass Anne P, 2010, J Cross Cult Gerontol, V25, P1, DOI 10.1007/s10823-009-9108-8; Gysels M, 2012, J PAIN SYMPTOM MANAG, V44, P285, DOI 10.1016/j.jpainsymman.2011.09.013; Kumakura N, 1992, Asia Pac J Public Health, V6, P120; Kurumatani T, 2004, SOC PSYCH PSYCH EPID, V39, P402, DOI 10.1007/s00127-004-0758-0; Leung KK, 2009, SUPPORT CARE CANCER, V17, P691, DOI 10.1007/s00520-008-0530-1; Miyashita M, 2008, J PAIN SYMPTOM MANAG, V35, P486, DOI [10.1016/j.jpainsymman.2007.07.009, 10.1016/j.jpainsmman.2007.07.009]; Mo HN, 2011, PALLIATIVE MED, V26, P222; Morita T, 2013, CURR OPIN SUPPORT PA, V7, P207, DOI 10.1097/SPC.0b013e3283612241; Murata Hisayuki, 2006, Palliat Support Care, V4, P279; Mystakidou K, 2004, SUPPORT CARE CANCER, V12, P147, DOI 10.1007/s00520-003-0552-7; Olkin I., 1985, STAT METHODS METAANA; Ramondetta L, 2011, INT J GYNECOL CANCER, V21, P573, DOI 10.1097/IGC.0b013e31820ba507; Steinhauser Karen E., 2000, JAMA (Journal of the American Medical Association), V284, P2476, DOI 10.1001/jama.284.19.2476; Yun YH, 2004, J CLIN ONCOL, V22, P307, DOI 10.1200/JCO.2004.07.053	39	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	AUG	2015	50	2					190	+		10.1016/j.jpainsymman.2015.02.020		11	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CO1YL	WOS:000358952100009		
J	Kizawa, Y; Morita, T; Miyashita, M; Shinjo, T; Yamagishi, A; Suzuki, S; Kinoshita, H; Shirahige, Y; Yamaguchi, T; Eguchi, K				Kizawa, Yoshiyuki; Morita, Tatsuya; Miyashita, Mitsunori; Shinjo, Takuya; Yamagishi, Akemi; Suzuki, Satoshi; Kinoshita, Hiroya; Shirahige, Yutaka; Yamaguchi, Takuhiro; Eguchi, Kenji			Improvements in Physicians' Knowledge, Difficulties, and Self-Reported Practice After a Regional Palliative Care Program	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Article						Physician; knowledge; difficulty; palliative care; regional palliative care	GOLD STANDARDS FRAMEWORK; CANCER PAIN MANAGEMENT; GENERAL-PRACTITIONERS; HEALTH-PROFESSIONALS; MEDICAL ONCOLOGISTS; OF-LIFE; WELL; INTERVENTIONS; COMMUNITIES; RELIABILITY	Context. Although several studies have explored the effects of regional palliative care programs, no studies have investigated the changes in physician-related outcomes. Objectives. The primary aims of this study were to: 1) clarify the changes in knowledge, difficulties, and self-reported practice of physicians before and after the intervention, 2) explore the potential associations between the level of physicians' participation in the program and outcomes, and 3) identify the reasons and characteristics of physicians who did not participate in the program. Methods. As a part of the regional palliative care intervention trial, questionnaires were sent to physicians recruited consecutively to obtain a representative sample of each region. Physician-reported knowledge, difficulty of palliative care, and self-perceived practice were measured using the Palliative Care Knowledge Test, Palliative Care Difficulty Scale, and Palliative Care Self-Reported Practice Scale (PCPS), respectively. The level of their involvement in the program and reason for non-participation were ascertained from self-reported questionnaires. Results. The number of eligible physicians identified was 1870 in pre-intervention and 1763 in post-intervention surveys, and we obtained 911 and 706 responses. Total scores of the Palliative Care Knowledge Test, PCPS, and PCPS were significantly improved after the intervention, with effect sizes of 0.30, 0.52, and 0.17, respectively. Physicians who participated in workshops more frequently were significantly more likely to have better knowledge, less difficulties, and better self-reported practice. Conclusion. After the regional palliative care program, there were marked improvements in physicians' knowledge and difficulties. These improvements were associated with the level of physicians' participation in the program. (C) 2015 American Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.	[Kizawa, Yoshiyuki] Kobe Univ Grad Sch Med, Dept Palliat Med, Kobe, Hyogo 6500017, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Dept Palliat & Support Care, Palliat Care Team, Hamamatsu, Shizuoka, Japan; [Morita, Tatsuya] Seirei Mikatahara Gen Hosp, Seirei Hosp, Hamamatsu, Shizuoka, Japan; [Miyashita, Mitsunori] Tohoku Univ Grad Sch Med, Div Palliat Nursing, Hlth Sci, Sendai, Miyagi, Japan; [Shinjo, Takuya] Shinjo Clin, Kobe, Hyogo, Japan; [Yamagishi, Akemi] Hamamatsu Univ Sch Med, Dept Community Hlth Care, Hamamatsu, Shizuoka 4313192, Japan; [Suzuki, Satoshi] Tsuruoka Municipal Shonai Hosp, Dept Surg, Tsuruoka, Yamagata, Japan; [Kinoshita, Hiroya] Natl Canc Ctr Hosp, Dept Palliat Med, Kashiwa, Chiba, Japan; [Shirahige, Yutaka] Shirahige Clin, Nagasaki, Japan; [Yamaguchi, Takuhiro] Tohoku Univ Grad Sch Med, Div Biostat, Sendai, Miyagi, Japan; [Eguchi, Kenji] Teikyo Univ Sch Med, Div Med Oncol, Itabashi Ku, Tokyo, Japan	Kizawa, Y (reprint author), Kobe Univ Grad Sch Med, Dept Palliat Med, Chuo Ku, 7-5-1 Kusunokicho, Kobe, Hyogo 6500017, Japan.	kizawa-ysyk@umin.org			Third Term Comprehensive Control Research for Cancer Health and Labor Sciences Research Grants in Japan [H23-Sanjigan-Shitei-001]	This study was funded by the Third Term Comprehensive Control Research for Cancer Health and Labor Sciences Research Grants in Japan (H23-Sanjigan-Shitei-001). The authors have declared no conflicts of interest.	Alvarez MP, 2006, PALLIATIVE MED, V20, P673, DOI 10.1177/0269216306071797; Breuer B, 2011, J CLIN ONCOL, V29, P4769, DOI 10.1200/JCO.2011.35.0561; Shanafelt TD, 2005, ONCOLOGY-BASEL, V68, P23, DOI 10.1159/000084519; Oldenmenger WH, 2009, EUR J CANCER, V45, P1370, DOI 10.1016/j.ejca.2009.01.007; Jordhoy MS, 2000, LANCET, V356, P888, DOI 10.1016/S0140-6736(00)02678-7; Meier DE, 2001, JAMA-J AM MED ASSOC, V286, P3007, DOI 10.1001/jama.286.23.3007; Walshe C, 2008, PALLIATIVE MED, V22, P736, DOI 10.1177/0269216308094103; Buss MK, 2011, CANCER-AM CANCER SOC, V117, P4304, DOI 10.1002/cncr.25952; Morita T, 2005, J CLIN ONCOL, V23, P2637; Nakazawa Y, 2010, J PALLIAT MED, V13, P427, DOI 10.1089/jpm.2009.0289; Mitchell GK, 2002, PALLIATIVE MED, V16, P457, DOI 10.1191/0269216302pm573oa; Groot MM, 2007, PALLIATIVE MED, V21, P697, DOI 10.1177/0269216307083384; Jordhoy MS, 2001, J CLIN ONCOL, V19, P3884; Morita T, 2013, LANCET ONCOL, V14, P638, DOI 10.1016/S1470-2045(13)70127-X; Dale J, 2009, QUAL SAF HEALTH CARE, V18, P174, DOI 10.1136/qshc.2007.024836; Shaw KL, 2010, PALLIATIVE MED, V24, P317, DOI 10.1177/0269216310362005; Kelley ML, 2007, J PALLIAT CARE, V23, P143; Nakazawa Y, 2009, PALLIATIVE MED, V23, P754, DOI 10.1177/0269216309106871; Barclay S, 2003, PALLIATIVE MED, V17, P27, DOI 10.1191/0269216303pm665oa; Fassbender K, 2005, PALLIATIVE MED, V19, P513, DOI 10.1191/0269216305pm1071oa; Masso M, 2009, AUST J RURAL HEALTH, V17, P263, DOI 10.1111/j.1440-1584.2009.01089.x; Bajwah Sabrina, 2008, BMC Palliat Care, V7, P18, DOI 10.1186/1472-684X-7-18; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dudgeon DJ, 2009, J PAIN SYMPTOM MANAG, V38, P483, DOI 10.1016/j.jpainsymman.2008.12.006; Elliott TE, 1997, J PAIN SYMPTOM MANAG, V13, P191, DOI 10.1016/S0885-3924(96)00275-8; Gknnez-Batiste X, 2007, J PAIN SYMPTOM MANAG, V33, P584; Goldschmidt D, 2005, PALLIATIVE MED, V19, P241, DOI 10.1191/0269216305pm1007oa; Hoffmann W, 2004, J PAIN SYMPTOM MANAG, V28, P342, DOI 10.1016/j.jpainsymman.2004.01.006; Imura C, 2014, J PAIN SYMPTOM MANAG, V47, P849, DOI 10.1016/j.jpainsymman.2013.06.002; Nikbakht-Van de Sande C V M Vahedi, 2005, J Palliat Med, V8, P808; Olkin I., 1985, STAT METHODS METAANA; Shaw Elizabeth Ann, 2010, J Palliat Med, V13, P1091, DOI 10.1089/jpm.2010.0034; World Health Organization (WHO), 2002, NAT CANC CONTR PROGR	33	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	AUG	2015	50	2					232	240		10.1016/j.jpainsymman.2015.02.025		9	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CO1YL	WOS:000358952100014		
J	Hatano, Y; Fujimoto, S; Hosokawa, T; Fukui, K				Hatano, Yutaka; Fujimoto, Sawako; Hosokawa, Toyoshi; Fukui, Kenji			Association Between "Good Death" of Cancer Patients and Post-Traumatic Growth in Bereaved Caregivers	JOURNAL OF PAIN AND SYMPTOM MANAGEMENT			English	Letter							PERSPECTIVE; INVENTORY; CARE		[Hatano, Yutaka; Fukui, Kenji] Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Psychiat, Kyoto, Japan; [Fujimoto, Sawako; Hosokawa, Toyoshi] Kyoto Prefectural Univ Med, Dept Pain Management & Palliat Care Med, Kyoto, Japan	Hatano, Y (reprint author), Kyoto Prefectural Univ Med, Grad Sch Med Sci, Dept Psychiat, Kyoto, Japan.	yhatano@koto.kpu-m.ac.jp					Morita T, 2004, J PAIN SYMPTOM MANAG, V27, P492, DOI 10.1016/j.jpainsymman.2003.10.014; Zoellner T, 2006, CLIN PSYCHOL REV, V26, P626, DOI 10.1016/j.cpr.2006.01.008; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665; Rosenberg AR, 2013, J PALLIAT MED, V16, P645, DOI 10.1089/jpm.2012.0494; Kim Y, 2013, J PALLIAT MED, V16, P1040, DOI 10.1089/jpm.2013.0049; Asukai N, 2002, J NERV MENT DIS, V190, P175, DOI 10.1097/00005053-200203000-00006; Ferlay J., 2013, IARC CANCERBASE; Fukuhara S, 2004, MANUAL SF 8 JAPANESE; Kitamura T., 1993, ARCH PSYCHIAT DIAGNO, V4, P371; Miyashita M, 2008, J PAIN SYMPTOM MANAG, V35, P486, DOI [10.1016/j.jpainsymman.2007.07.009, 10.1016/j.jpainsmman.2007.07.009]; Taku K, 2007, ANXIETY STRESS COPIN, V20, P353, DOI 10.1080/10615800701295007; Tedeschi RG, 1996, J TRAUMA STRESS, V9, P455, DOI 10.1007/BF02103658; Wong W K Tim, 2009, Palliat Support Care, V7, P187, DOI 10.1017/S1478951509000248	13	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0885-3924	1873-6513		J PAIN SYMPTOM MANAG	J. Pain Symptom Manage.	AUG	2015	50	2					E4	E6		10.1016/j.jpainsymman.2015.05.002		4	Health Care Sciences & Services; Medicine, General & Internal; Clinical Neurology	Health Care Sciences & Services; General & Internal Medicine; Neurosciences & Neurology	CO1YL	WOS:000358952100002		
J	Matsuda, K; Kakibuchi, M; Sotsuka, Y; Kubo, T; Shibata, M; Hosokawa, K				Matsuda, Ken; Kakibuchi, Masao; Sotsuka, Yohei; Kubo, Tateki; Shibata, Minoru; Hosokawa, Ko			End-to-side "loop" graft for total facial nerve reconstruction: Over 10 years experience	JOURNAL OF PLASTIC RECONSTRUCTIVE AND AESTHETIC SURGERY			English	Article						Facial nerve reconstruction; End-to-side neurorrhaphy; Nerve graft; Hypoglossal nerve; Facial reanimation	JUMP GRAFT; GRADING SYSTEM; NEURORRHAPHY; REANIMATION; PARALYSIS; INNERVATION; ANASTOMOSIS; OUTCOMES; REPAIR; PALSY	Background: Multiple-branch reconstruction is required in order to attain facial reanimation for extensive facial nerve defects. We previously reported that end-to-side nerve grafting, with the use of a single nerve graft for defect reconstruction, was easy to perform. We have also demonstrated the efficacy of end-to-side nerve suture of the recipient nerve to the donor graft nerve, in experimental rat models and clinical cases. The regenerating axons, which extended into the nerve graft, were "distributed" to multiple recipient nerves via end-to-side nerve-suture sites. Methods: Thirty-two patients who underwent facial nerve reconstruction (five to 10 branches) had a single sural nerve graft coapted to the proximal stump of the facial nerve in an end-to-end manner, followed by end-to-side nerve suture of the recipient nerve stumps to the side of the nerve graft. In 19 patients who were expected to undergo postoperative radiotherapy and/or chemotherapy, the distal end of the graft was connected to the side of the hypoglossal nerve for "axonal supercharging," to enhance the recovery of the facial muscles. Results: Initial facial movements were noted at 5-12 months postoperatively, and good recovery (House-Brackmann grade III/IV) was observed during long-term follow-up in most patients. Conclusion: End-to-side nerve suture of the recipient nerve stumps to the nerve graft requires less graft nerve material and less technical mastery to reconstruct multiple branches of the facial nerve. We also described the concept of "axonal supercharging," namely the connection of double-donor neural sources to the graft, and "axonal distribution," namely the reinnervation of multiple recipient nerve stumps connected to the graft in an end-to-side manner. This combination of axonal supercharging and distribution can be a useful option in facial nerve reconstruction. (C) 2015 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by Elsevier Ltd. All rights reserved.	[Matsuda, Ken; Shibata, Minoru] Niigata Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Niigata 9518510, Japan; [Kakibuchi, Masao; Sotsuka, Yohei] Hyogo Coll Med, Dept Plast Surg, Nishinomiya, Hyogo, Japan; [Kubo, Tateki; Hosokawa, Ko] Osaka Univ, Dept Plast & Reconstruct Surg, Grad Sch Med, Osaka, Japan	Matsuda, K (reprint author), Niigata Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Chuo Ku, 1-757 Asahimachi Dori, Niigata 9518510, Japan.	matsuken@med.niigata-u.ac.jp			Japanese Ministry of Education, Science, Sports, and Culture [26462740]	This work was supported by a research grant-in-aid from the Japanese Ministry of Education, Science, Sports, and Culture (26462740).	HOUSE JW, 1985, OTOLARYNG HEAD NECK, V93, P146; Yamamoto Y, 2007, J PLAST RECONSTR AES, V60, P223, DOI 10.1016/j.bjps.2006.05.012; MAY M, 1991, OTOLARYNG HEAD NECK, V104, P818; Klebuc MJA, 2011, PLAST RECONSTR SURG, V127, P1909, DOI 10.1097/PRS.0b013e31820e9138; Iseli TA, 2010, LARYNGOSCOPE, V120, P478, DOI 10.1002/lary.20789; Bitter T, 2011, LARYNGOSCOPE, V121, P699, DOI 10.1002/lary.21399; Ross BG, 1996, OTOLARYNG HEAD NECK, V114, P380, DOI 10.1016/S0194-5998(96)70206-1; Falcioni M, 2003, OTOL NEUROTOL, V24, P486, DOI 10.1097/00129492-200305000-00022; Sawamura Y, 1997, J NEUROSURG, V86, P203, DOI 10.3171/jns.1997.86.2.0203; Fujiwara T, 2007, J NEUROSURG, V107, P821, DOI 10.3171/JNS-07/10/0821; Matsuda K, 2005, J RECONSTR MICROSURG, V21, P581, DOI 10.1055/s-2005-922439; Faria JCM, 2010, ANN PLAS SURG, V64, P31, DOI 10.1097/SAP.0b013e3181999ea9; Biglioli F, 2012, J PLAST RECONSTR AES, V65, P1343, DOI 10.1016/j.bjps.2012.04.030; Watanabe Y, 2009, J PLAST RECONSTR AES, V62, P1589, DOI 10.1016/j.bjps.2008.07.025; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ozmen OA, 2011, OTOL NEUROTOL, V32, P1341, DOI 10.1097/MAO.0b013e31822e952d; Flores LP, 2007, ACTA NEUROCHIR, V149, P1205, DOI 10.1007/s00701-007-1412-x; Groves ML, 2005, EXP NEUROL, V195, P278, DOI 10.1016/j.expneurol.2005.04.007; Hayashi A, 2004, PLAST RECONSTR SURG, V114, P129, DOI 10.1097/01.PRS.0000129075.96217.92; Kakibuchi M, 2004, ANN PLAS SURG, V53, P496, DOI 10.1097/01.sap.0000116283.76872.de; Kerrebijn JDF, 1998, J OTOLARYNGOL, V27, P183; Koh KS, 2002, BRIT J PLAST SURG, V55, P25, DOI 10.1054/bjps.2001.3727; Matsuda K, 2008, J PLAST RECONSTR AES, V61, P1357, DOI 10.1016/j.bjps.2008.04.013; Matsumine Hajime, 2014, Plast Reconstr Surg Glob Open, V2, pe240, DOI 10.1097/GOX.0000000000000206; Ueda K, 2007, J RECONSTR MICROSURG, V23, P181, DOI 10.1055/s-2007-974654	25	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1748-6815	1878-0539		J PLAST RECONSTR AES	J. Plast. Reconstr. Aesthet. Surg.	AUG	2015	68	8					1054	1063		10.1016/j.bjps.2015.04.005		10	Surgery	Surgery	CO5ZL	WOS:000359236900005		
J	Kiuchi, T; Shimizu, Y; Nagasao, T; Ohnishi, F; Minabe, T; Kishi, K				Kiuchi, Tomoki; Shimizu, Yusuke; Nagasao, Tomohisa; Ohnishi, Fumio; Minabe, Toshiharu; Kishi, Kazuo			Composite grafting for distal digital amputation with respect to injury type and amputation level	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Composite graft; fingertip amputation; digital amputation; rnicroanastomosis	FINGERTIP AMPUTATIONS; EAR GRAFTS; REPLANTATION; REATTACHMENT; REPLACEMENT; TIPS; BED	Purpose. This study evaluated the composite graft survival rate in distal digital amputations with respect to injury type and amputation level. Methods. Twenty-seven patients with complete fingertip amputations (32 digits) distal to the distal interphalangeal joint who were treated by composite grafting from January 2010 to February 2012 were enrolled. Injury type was classified as clean-cut, blunt-cut, or crush-avulsion. Amputation level was classified according to Ishikawa's classification: subzones I-IV. Graft survival was categorised as complete, partial, or no survival. Results. The graft was more likely to exhibit complete survival in clean-cut injuries (50%) than in blunt-cut (10%) or crush-avulsion injuries (12.5%). However, when complete and partial survival were combined, there was no significant difference among injury types (clean-cut = 83.3%, blunt-cut = 70.0%; crush-avulsion = 68.8%). Composite grafting in sub-zone I provided good results (complete survival = 50%; partial survival = 50.0%; no survival = 0%). When complete and partial survival were combined, there was no significant difference with respect to amputation level except sub-zone 1(1= 70.6%; III = 66.7%; IV = 60%). In sub-zone II, clean-cut injuries exhibited better graft survival than blunt-cut or crush-avulsion injuries. In sub-zones LEE and IV, no complete graft survival was observed. Conclusion. In conclusion, all types of injuries in sub-zone I and clean-cut injuries in sub-zone II are candidates for composite grafting. Blunt-cut and crush-avulsion injuries in sub-zone II are marginal candidates for composite grafting. Any type of injury in sub-zone III or IV is contraindicated for composite grafting and should be treated by microanastomosis.	[Kiuchi, Tomoki; Shimizu, Yusuke; Nagasao, Tomohisa; Kishi, Kazuo] Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ku, Tokyo, Japan; [Ohnishi, Fumio; Minabe, Toshiharu] Saitma Med Univ, Saitama Med Ctr, Dept Plast Surg, Kawagoe, Saitama, Japan	Shimizu, Y (reprint author), Keio Univ, Sch Med, Dept Plast & Reconstruct Surg, Shinjuku Ku, 35 Shinanomachi, Tokyo, Japan.	yyssprs@gmail.com					Alper Netanel, 2013, Eplasty, V13, pic32; ROSE EH, 1989, J HAND SURG-AM, V14A, P513; Waikakul S, 2000, INJURY, V31, P33, DOI 10.1016/S0020-1383(99)00196-5; Sebastin SJ, 2011, PLAST RECONSTR SURG, V128, P723, DOI 10.1097/PRS.0b013e318221dc83; BIEMER E, 1980, BRIT J PLAST SURG, V33, P164, DOI 10.1016/0007-1226(80)90006-5; CONWAY H, 1951, PLAST RECONSTR SURG, V8, P312, DOI 10.1097/00006534-195110000-00014; Dagregorio G, 2006, ORTHOPEDICS, V29, P22; ELSAHY NI, 1977, PLAST RECONSTR SURG, V60, P14; Eo S, 2009, J PLAST RECONSTR AES, V62, P764, DOI 10.1016/j.bjps.2007.09.064; Heistein JB, 2003, ANN PLAS SURG, V50, P299, DOI 10.1097/01.SAP.0000037260.89312.BF; Hirase Y, 1997, ANN PLAS SURG, V38, P151, DOI 10.1097/00000637-199702000-00009; Hwang E, 2013, J HAND SURG-AM, V38A, P1307, DOI 10.1016/j.jhsa.2013.03.032; Ishikawa K, 1990, J JAPAN SOC RECONSTR, V3, P54; Johnson D, 2011, J PLAST RECONSTR AES, V64, P776, DOI 10.1016/j.bjps.2010.08.032; Kim KS, 2001, PLAST RECONSTR SURG, V107, P73, DOI 10.1097/00006534-200101000-00012; Lee KS, 2013, J PLAST RECONSTR AES, V66, pE43, DOI 10.1016/j.bjps.2012.10.017; Lee Sang-Mok, 2012, Hand Surg, V17, P145; MACCOLLUM MS, 1977, PLAST RECONSTR SURG, V60, P759, DOI 10.1097/00006534-197711000-00015; MCLAUGHLIN CR, 1954, BRIT J PLAST SURG, V7, P274, DOI 10.1016/S0007-1226(54)80031-2; Moiemen NS, 1997, J HAND SURG-BRIT EUR, V22B, P346, DOI 10.1016/S0266-7681(97)80400-7; NICHTER LS, 1991, PLAST RECONSTR SURG, V87, P337, DOI 10.1097/00006534-199102000-00017; Son Daegu, 2005, Int Wound J, V2, P315, DOI 10.1111/j.1742-4801.2005.00153.x; Young D. M., 1996, Journal of Burn Care and Rehabilitation, V17, P305, DOI 10.1097/00004630-199607000-00005	23	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	AUG	2015	49	4					224	228		10.3109/2000656X.2015.1020314		5	Orthopedics; Surgery	Orthopedics; Surgery	CO2FX	WOS:000358972700008		
J	Asami, T; Soejima, K; Kashimura, T; Kazama, T; Matsumoto, T; Morioka, K; Nakazawa, H				Asami, Takashi; Soejima, Kazutaka; Kashimura, Tsutomu; Kazama, Tomohiko; Matsumoto, Taro; Morioka, Kosuke; Nakazawa, Hiroaki			Effects of combination therapy using basic fibroblast growth factor and mature adipocyte-derived dedifferentiated fat (DFAT) cells on skin graft revascularisation	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						Skin graft; basic fibroblast growth factor; adiocyte progenitor cell; angigenesis	IN-VIVO; ENDOTHELIAL-CELLS; ARTIFICIAL DERMIS; SERUM IMBIBITION; STEM-CELLS; TISSUE; ANGIOGENESIS; REGENERATION; CYTOKINES; WOUNDS	Background. Although the benefits of basic fibroblast growth factor (bFGF) for wound healing and angiogenesis are well known, its effects on the process of skin graft revascularisation have not been clarified. It was hypothesised that bFGF would be beneficial to promote taking of skin grafts, but that the effect might be limited in the case of bFGF monotherapy. Therefore, this study investigated the efficacy of combination therapy using bFGF and dedifferentiated fat (DFAT) cells. DFAT cells have multilineage differentiation potential, including into endothelial cells, similar to the case of mesenchymal stem cells (MSC). Methods. Commercially available human recombinant bFGF was used. DFAT cells were prepared from SD strain rats as an adipocyte progenitor cell line from mature adipocytes. Full-thickness skin was lifted from the back of SD strain rats and then grafted back to the original wound site. Four groups were established prior to skin grafting: control group (skin graft alone), bFGF group (treated with bFGF), DFAT group (treated with DFAT cells), and combination group (treated with both bFGF and DFAT cells). Tissue specimens for histological examination were harvested 48 hours after grafting. Results. The histological findings for the bFGF group showed vascular augmentation in the grafted dermis compared with the control group. However, the difference in the number of revascularised vessels per unit area did not reach statistical significance against the control group. In contrast, in the combination group, skin graft revascularisation was significantly promoted, especially in the upper dermis. Conclusion. The results suggest that replacement of the existing graft vessels was markedly promoted by the combination therapy using bFGF and DFAT cells, which may facilitate skin graft taking.	[Asami, Takashi; Soejima, Kazutaka; Kashimura, Tsutomu; Nakazawa, Hiroaki] Nihon Univ, Sch Med, Dept Plast & Reconstruct Surg, Tokyo 1738610, Japan; [Kazama, Tomohiko; Matsumoto, Taro] Adv Med Res Ctr, Tokyo, Japan; [Morioka, Kosuke] Kagoshima City Hosp, Dept Plast & Reconstruct Surg, Kagoshima, Japan	Soejima, K (reprint author), Nihon Univ, Sch Med, Dept Plast & Reconstruct Surg, Itabashi Ku, 30-1 Kamicho, Tokyo 1738610, Japan.	soejima.kazutaka@nihon-u.ac.jp			JSPR KAKENHI [24592721]	This work was supported by JSPR KAKENHI Grant Number 24592721.	Ackermann M, 2011, EUR SURG RES, V47, P81, DOI 10.1159/000328143; Sakrak T, 2012, BURNS, V38, P225, DOI 10.1016/j.burns.2011.08.015; Jumabay M, 2012, J MOL CELL CARDIOL, V53, P790, DOI 10.1016/j.yjmcc.2012.09.005; Kawai K, 2000, BIOMATERIALS, V21, P489, DOI 10.1016/S0142-9612(99)00207-0; Barrientos S, 2008, WOUND REPAIR REGEN, V16, P585, DOI 10.1111/j.1524-475X.2008.00410.x; Zuk PA, 2001, TISSUE ENG, V7, P211, DOI 10.1089/107632701300062859; Akita S, 2005, BURNS, V31, P855, DOI 10.1016/j.burns.2005.04.008; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Akita S, 2008, J TRAUMA, V64, P809, DOI 10.1097/TA.0b013e31802c8247; Mizuno H, 2011, METHODS MOL BIOL, V702, P453, DOI 10.1007/978-1-61737-960-4_33; Calcagni M, 2011, MICROVASC RES, V82, P237, DOI 10.1016/j.mvr.2011.07.003; DAVIDSON JM, 1985, J CELL BIOL, V100, P1219, DOI 10.1083/jcb.100.4.1219; Jumabay M, 2009, J MOL CELL CARDIOL, V47, P565, DOI 10.1016/j.yjmcc.2009.08.004; Hanson SE, 2010, PLAST RECONSTR SURG, V125, P510, DOI 10.1097/PRS.0b013e3181c722bb; Matsumoto T, 2008, J CELL PHYSIOL, V215, P210, DOI 10.1002/jcp.21304; Lee OK, 2004, BLOOD, V103, P1669, DOI 10.1182/blood-2003-05-1670; Capla JM, 2006, PLAST RECONSTR SURG, V117, P836, DOI 10.1097/01.prs.0000201459.91559.7f; CONVERSE JM, 1969, PLAST RECONSTR SURG, V43, P495, DOI 10.1097/00006534-196905000-00007; Cooper DM, 1994, ANN SURG, V219, P691; COOPER DM, 1994, ANN SURG, V219, P688, DOI 10.1097/00000658-199406000-00012; Loots MAM, 2002, EUR J CELL BIOL, V81, P153, DOI 10.1078/0171-9335-00228; Maeda M, 1999, PLAST RECONSTR SURG, V104, P2100, DOI 10.1097/00006534-199912000-00023; Oki Y, 2008, CELL STRUCT FUNCT, V33, P211; Przybylski M, 2009, J Wound Care, V18, P516; SCHWEIGERER L, 1988, TRENDS PHARMACOL SCI, V9, P427, DOI 10.1016/0165-6147(88)90125-3; Soejima K, 1998, PLAST RECONSTR SURG, V101, P1552, DOI 10.1097/00006534-199805000-00019; Soejima K, 2014, J PLAST SURG HAND SU, V49, P1; Soejima K, 2006, BURNS, V32, P312, DOI 10.1016/j.burns.2005.10.013; Wang HJ, 1996, BURNS, V22, P10, DOI 10.1016/0305-4179(95)00079-8; Yagi K, 2004, BIOCHEM BIOPH RES CO, V321, P967, DOI 10.1016/j.bbrc.2004.07.055	30	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	AUG	2015	49	4					229	233		10.3109/2000656X.2015.1020315		5	Orthopedics; Surgery	Orthopedics; Surgery	CO2FX	WOS:000358972700009		
J	Kaneshiro, Y; Hidaka, N; Fukuda, M; Ota, M; Akashi, K				Kaneshiro, Yasunori; Hidaka, Noriaki; Fukuda, Makoto; Ota, Mitsutoshi; Akashi, Kenichi			Late volar plate repair for chronic, post-traumatic hyperextension deformity of the proximal interphalangeal joint of the little finger	JOURNAL OF PLASTIC SURGERY AND HAND SURGERY			English	Article						proximal interphalangeal joint; hyperextension deformity; volar plate; little finger		A chronic traumatic hyperextension of the proximal interphalangeal (PIP) joint can result from traumatic volar plate (VP) disruption. For the treatment of this disorder, reconstruction procedures have been traditionally recommended, because the condition of the VP was not considered susceptible to repair due to retraction or attenuation. The purpose of this paper is to present the operative technique and report the clinical results of late VP repair. Late VP repair was performed for chronic, post-traumatic hyperextension deformity of the PIP joint of the little finger resulting from VP disruption in seven consecutive patients. The range of motion and the lateral stability of the PIP joint were evaluated. The radiographic images were also used to evaluate the alignment and degenerative changes of the PIP joint. Clinical results were classified according to Catalano's criteria. Intraoperative findings showed that the VP could be mobilised and repaired in all cases. The hyperextension was well corrected, and none showed recurrence of the initial deformity. Average flexion of the PIP joint was 92 degrees (range = 75-98 degrees), and flexion contracture was 9 degrees (range = 0-20 degrees). On clinical evaluation, there were two excellent, three good, and two fair results. The postoperative radiographs revealed no degenerative change in the PT joint in six patients. Late VP repair is a successful and reliable alternative and more physiologic than other reconstruction methods. One should first consider late VP repair, despite a long interval between injury and repair.	[Kaneshiro, Yasunori; Hidaka, Noriaki; Fukuda, Makoto; Ota, Mitsutoshi; Akashi, Kenichi] Yodogawa Christians Hosp, Dept Orthopaed Surg, Osaka, Osaka 5330024, Japan	Kaneshiro, Y (reprint author), Yodogawa Christians Hosp, Dept Orthopaed Surg, Higashiyodogawa Ku, 1-7-50 Kunijima, Osaka, Osaka 5330024, Japan.	yasunorikaneshiro@gmail.com					Akashi K, 2008, J JPN SOC SURG HAND, V25, P48; Catalano LW, 2003, J HAND SURG-AM, V28A, P448, DOI 10.1053/jhsu.2003.50084; KLEINERT HE, 1965, J BONE JOINT SURG AM, VA 47, P958; ADAMS JP, 1959, J BONE JOINT SURG AM, V41, P111; Littler JW, 1959, TXB ORTHOPEDICS, P284; Melone Charles P Jr, 2010, Am J Orthop (Belle Mead NJ), V39, P190; Merrell G, 2011, OPERATIVE HAND SURG, V6th, P291; Ochiai N, 1979, J Hand Surg Am, V4, P321; Onishi Yasuo, 2007, Hand Surg, V12, P47, DOI 10.1142/S0218810407003390	9	0	0	INFORMA HEALTHCARE	NEW YORK	52 VANDERBILT AVE, NEW YORK, NY 10017 USA	2000-656X	2000-6764		J PLAST SURG HAND SU	J. Plast. Surg. Hand Surg.	AUG	2015	49	4					238	241		10.3109/2000656X.2014.964721		4	Orthopedics; Surgery	Orthopedics; Surgery	CO2FX	WOS:000358972700011		
J	Yamamoto, K; Goto, H; Hirao, K; Nakajima, A; Origasa, H; Tanaka, K; Tomobe, M; Totsuka, K				Yamamoto, Kazuhiko; Goto, Hajime; Hirao, Kenzo; Nakajima, Atsuo; Origasa, Hideki; Tanaka, Kunihiko; Tomobe, Minako; Totsuka, Kyoichi			Longterm Safety of Tocilizumab: Results from 3 Years of Followup Postmarketing Surveillance of 5573 Patients with Rheumatoid Arthritis in Japan	JOURNAL OF RHEUMATOLOGY			English	Article						RHEUMATOID ARTHRITIS; POSTMARKETING PRODUCT SURVEILLANCE; TOCILIZUMAB; INTERLEUKIN 6	INTERLEUKIN-6 RECEPTOR INHIBITION; INADEQUATE RESPONSE; CONTROLLED-TRIAL; DISEASE-ACTIVITY; THERAPY; METHOTREXATE; METAANALYSIS; MONOTHERAPY; MALIGNANCY; COHORT	Objective. To evaluate the longterm safety of tocilizumab (TCZ) for the treatment of rheumatoid arthritis (RA) in a real-world clinical setting in Japan. Methods. In this longterm extension of a single-arm, observational postmarketing surveillance study, a total of 5573 patients who initiated intravenous TCZ between April 2008 and July 2009 were observed for 3 years, regardless of its continuation, for incidence of fatal events, serious infections, malignancy, gastrointestinal perforations, and serious cardiac dysfunction. Results. Of the 5573 patients who were enrolled, 4527 patients (81.23%) completed 3 years of followup. There were no increases in the proportions of patients with fatal events, serious infection, malignancy, GI perforation, or serious cardiac dysfunction over 3 years. The all-cause mortality rate during followup was 2.58% (0.95/100 patient-yrs), and the standardized mortality ratio was 1.27 (95% CI, 1.08 to 1.50). Patients who were older with longer disease duration and respiratory comorbidities were more likely to discontinue TCZ treatment following serious infection during the first year. Among patients who completed 3 years of TCZ treatment, serious infection developed at a constant rate during the 3-year treatment period. The proportion of malignancy during followup was 2.24% (0.83/100 patient-yrs), and the standardized incidence ratio was 0.79 (95% CI, 0.66 to 0.95). Conclusion. The safety profile of TCZ was consistent over time regarding mortality, serious infections, malignancy, gastrointestinal perforation, and serious cardiac dysfunction. These data confirm the longterm safety of TCZ use in patients with RA in a real-world clinical setting.	[Yamamoto, Kazuhiko] Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Tokyo 1138655, Japan; [Goto, Hajime] Fukujuji Hosp, Dept Resp Med, Tokyo, Japan; [Hirao, Kenzo] Tokyo Med & Dent Univ, Heart Rhythm Ctr, Tokyo, Japan; [Nakajima, Atsuo] Tokyo Metropolitan Police Hosp, Dept Rheumatol, Tokyo, Japan; [Origasa, Hideki] Toyama Univ, Sch Med, Div Biostat & Clin Epidemiol, Toyama 930, Japan; [Tanaka, Kunihiko; Tomobe, Minako] Chugai Pharmaceut Co Ltd, Tokyo, Japan; [Totsuka, Kyoichi] Kitatama Hosp, Dept Internal Med, Tokyo, Japan	Yamamoto, K (reprint author), Univ Tokyo, Grad Sch Med, Dept Allergy & Rheumatol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	yamamoto-tky@umin.ac.jp					Westlake SL, 2010, RHEUMATOLOGY, V49, P295, DOI 10.1093/rheumatology/kep366; Nishimoto N, 2009, MOD RHEUMATOL, V19, P12, DOI 10.1007/s10165-008-0125-1; Takeuchi T, 2008, ANN RHEUM DIS, V67, P189, DOI 10.1136/ard.2007.072967; Kremer JM, 2011, ARTHRITIS RHEUM-US, V63, P609, DOI 10.1002/art.30158; Nishimoto N, 2009, ANN RHEUM DIS, V68, P1580, DOI 10.1136/ard.2008.092866; Smolen JS, 2008, LANCET, V371, P987, DOI 10.1016/S0140-6736(08)60453-5; Nakajima A, 2010, SCAND J RHEUMATOL, V39, P360, DOI 10.3109/03009741003604542; Koike T, 2014, MOD RHEUMATOL, V24, P390, DOI 10.3109/14397595.2013.843760; Gout T, 2011, CLIN RHEUMATOL, V30, P1471, DOI 10.1007/s10067-011-1827-x; Jones G, 2010, ANN RHEUM DIS, V69, P88, DOI 10.1136/ard.2008.105197; Barnabe C, 2011, ARTHRIT CARE RES, V63, P522, DOI 10.1002/acr.20371; Nishimoto N, 2007, ANN RHEUM DIS, V66, P1162, DOI 10.1136/ard.2006.068064; Emery P, 2008, ANN RHEUM DIS, V67, P1516, DOI 10.1136/ard.2008.092932; Genovese MC, 2008, ARTHRITIS RHEUM, V58, P2968, DOI 10.1002/art.23940; Koike T, 2011, MOD RHEUMATOL, V21, P343, DOI 10.1007/s10165-010-0406-3; Genovese MC, 2013, J RHEUMATOL, V40, P768, DOI 10.3899/jrheum.120687; Harigai M, 2011, ARTHRITIS RHEUM-US, V63, pS41; Koike T, 2014, J RHEUMATOL, V41, P15, DOI 10.3899/jrheum.130466; Schiff MH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3455; Smitten AL, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2404; Yamada T, 2011, RHEUMATOL INT, V31, P1487, DOI 10.1007/s00296-010-1524-0	21	2	2	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	AUG	2015	42	8					1368	1375		10.3899/jrheum.141210		8	Rheumatology	Rheumatology	CO0UD	WOS:000358868000005		
J	Ohara, Y; Kishimoto, M; Takizawa, N; Yoshida, K; Okada, M; Eto, H; Deshpande, GA; Ritchlin, CT; Tanaka, A; Higashiyama, M; Matsui, K; Tsuji, S				Ohara, Yuri; Kishimoto, Mitsumasa; Takizawa, Naoho; Yoshida, Kazuki; Okada, Masato; Eto, Hikaru; Deshpande, Gautam A.; Ritchlin, Christopher T.; Tanaka, Atsushi; Higashiyama, Mari; Matsui, Kazuo; Tsuji, Shigeyoshi			Prevalence and Clinical Characteristics of Psoriatic Arthritis in Japan	JOURNAL OF RHEUMATOLOGY			English	Article						PSORIATIC ARTHRITIS; PSORIASIS; PREVALENCE; ASIA; JAPAN	CLASSIFICATION CRITERIA; EPIDEMIOLOGY; FEATURES; SMOKING; SOCIETY; PATTERN; RISK	Objective. To investigate the prevalence of psoriatic arthritis (PsA) in Japanese patients with psoriasis. Methods. A multicenter, noninterventional, retrospective cross-sectional study was conducted at 3 tertiary care centers in Japan. PsA was diagnosed by rheumatologists based on clinical findings. Prevalence of PsA, clinical characteristics, comorbidities, and treatment patterns were examined. Results. PsA was identified in 431 of 3021 patients with psoriasis, with a mean prevalence of 14.3% (range, 8.8-20.4%). No large differences between these results and previous reports from Western countries were observed in arthritis distribution, skin disease type, or treatment selection. Conclusion. The prevalence of PsA in patients with psoriasis in Japan approaches 20% in some areas, similar to that observed in Western countries, and is higher than previously reported in Asia. Clinical features including age, sex, age at onset, and manifestation patterns were also similar to those reported in the West.	[Ohara, Yuri; Kishimoto, Mitsumasa; Okada, Masato; Deshpande, Gautam A.] St Lukes Int Hosp, Immunorheumatol Ctr, Tokyo, Japan; [Eto, Hikaru] St Lukes Int Hosp, Dept Dermatol, Tokyo, Japan; [Takizawa, Naoho; Tanaka, Atsushi; Matsui, Kazuo] Kameda Med Ctr, Dept Rheumatol, Chiba, Japan; [Yoshida, Kazuki] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Ritchlin, Christopher T.] Univ Rochester, Med Ctr, Allergy Immunol & Rheumatol Div, Rochester, NY 14642 USA; [Tsuji, Shigeyoshi] Nissay Hosp, Dept Dermatol, Osaka, Japan; [Tsuji, Shigeyoshi] Natl Hosp Org, Osaka Minami Med Ctr, Dept Orthoped, Osaka, Japan	Kishimoto, M (reprint author), St Lukes Int Hosp, Immunorheumatol Ctr, Chuo Ku, 9-1 Akashicho, Tokyo, Japan.	kishimotomi@gmail.com		Yoshida, Kazuki/0000-0002-2030-3549			Haroon M, 2013, ANN RHEUM DIS, V72, P736, DOI 10.1136/annrheumdis-2012-201706; Husni ME, 2007, J AM ACAD DERMATOL, V57, P581, DOI 10.1016/j.jaad.2007.04.001; Fan X, 2007, ACTA DERM-VENEREOL, V87, P335, DOI 10.2340/00015555-0253; Reich K, 2009, BRIT J DERMATOL, V160, P1040, DOI 10.1111/j.1365-2133.2008.09023.x; Wu SW, 2014, ARTHRITIS RHEUMATOL, V66, P304, DOI 10.1002/art.38227; Eder L, 2012, ANN RHEUM DIS, V71, P219, DOI 10.1136/ard.2010.147793; Kawada A, 2003, J DERMATOL SCI, V31, P59, DOI 10.1016/S0923-1811(02)00142-1; Yang Q, 2011, J EUR ACAD DERMATOL, V25, P1409, DOI 10.1111/j.1468-3083.2011.03985.x; [Anonymous], 2012, 2012 NAT HLTH NUTR S; Taylor W, 2006, ARTHRITIS RHEUM, V54, P2665, DOI 10.1002/art.21972; Mease PJ, 2013, J AM ACAD DERMATOL, V69, P729, DOI 10.1016/j.jaad.2013.07.023; Armstrong AW, 2014, BRIT J DERMATOL, V170, P304, DOI 10.1111/bjd.12670; Rudwaleit M, 2011, ANN RHEUM DIS, V70, P25, DOI 10.1136/ard.2010.133645; Parisi R, 2013, J INVEST DERMATOL, V133, P377, DOI 10.1038/jid.2012.339; Ritchlin CT, 2009, ANN RHEUM DIS, V68, P1387, DOI 10.1136/ard.2008.094946; Ibrahim G, 2009, ARTHRIT CARE RES, V61, P1373, DOI 10.1002/art.24608; Zachariae H, 2003, AM J CLIN DERMATOL, V4, P441, DOI 10.2165/00128071-200304070-00001; Baek HJ, 2000, RHEUMATOL INT, V19, P89, DOI 10.1007/s002960050109; Chang YT, 2009, ACTA DERM-VENEREOL, V89, P262, DOI 10.2340/00015555-0642; Gladman DD, 2005, ANN RHEUM DIS, V64, P14, DOI 10.1136/ard.2004.032482; Kubota K, 2013, 28 ANN M JAP SOC P S, pii76; Langley RG, 2005, ANN RHEUM DIS, V64, pii18; MOLL J M H, 1973, Seminars in Arthritis and Rheumatism, V3, P55, DOI 10.1016/0049-0172(73)90035-8; Soltani-Arabshahi R, 2010, ARCH DERMATOL, V146, P721, DOI 10.1001/archdermatol.2010.141; Takahashi H, 2011, J DERMATOL, V38, P1125, DOI 10.1111/j.1346-8138.2010.01145.x	25	0	0	J RHEUMATOL PUBL CO	TORONTO	365 BLOOR ST E, STE 901, TORONTO, ONTARIO M4W 3L4, CANADA	0315-162X	1499-2752		J RHEUMATOL	J. Rheumatol.	AUG	2015	42	8					1439	1442		10.3899/jrheum.141598		4	Rheumatology	Rheumatology	CO0UD	WOS:000358868000015		
J	Hara, T; Otsuka, F; Tsukamoto-Yamauchi, N; Inagaki, K; Hosoya, T; Nakamura, E; Terasaka, T; Komatsubara, M; Makino, H				Hara, Takayuki; Otsuka, Fumio; Tsukamoto-Yamauchi, Naoko; Inagaki, Kenichi; Hosoya, Takeshi; Nakamura, Eri; Terasaka, Tomohiro; Komatsubara, Motoshi; Makino, Hirofumi			Mutual effects of melatonin and activin on induction of aldosterone production by human adrenocortical cells	JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY			English	Article						Activin; Adrenocorticotropin; Aldosterone; Melatonin; Steroidogenesis	BONE MORPHOGENETIC PROTEIN-6; RAT ADRENAL-GLAND; ANGIOTENSIN-II; 3-BETA-HYDROXYSTEROID DEHYDROGENASE; CATECHOLAMINE PRODUCTION; SIGNALING PATHWAYS; NCI-H295R CELLS; GRANULOSA-CELLS; MT1 MELATONIN; EXPRESSION	Melatonin has been reported to suppress adrenocorticotropin (ACTH) secretion in the anterior pituitary and cortisol production in the adrenal by different mechanisms. However, the effect of melatonin on aldosterone production has remained unknown. In this study, we investigated the role of melatonin in the regulation of aldosterone production using human adrenocortical H295R cells by focusing on the activin system expressed in the adrenal. Melatonin receptor MT1 mRNA and protein were expressed in H295R cells and the expression levels of MT1 were increased by activin treatment. Activin increased ACTH-induced, but not angiotensin II (Ang II)-induced, aldosterone production. Melatonin alone did not affect basal synthesis of either aldosterone or cortisol. However, melatonin effectively enhanced aldosterone production induced by co-treatment with ACTH and activin, although melatonin had no effect on aldosterone production induced by Ang II in combination with activin. These changes in steroidogenesis became apparent when the steroid production was evaluated by the ratio of aldosterone/cortisol. Melatonin also enhanced dibutyryl-AMP-induced aldosterone/cortisol levels in the presence of activin, suggesting a functional link to the cAMP-PICA pathway for induction of aldosterone production by melatonin and activin. In accordance with the data for steroids, ACTH-induced, but not Ang II-induced, CAMP synthesis was also amplified by co-treatment with melatonin and activin. Furthermore, the ratio of ACTH-induced mRNA level of CYP11B2 compared with that of CYP17 was amplified in the condition of treatment with both rnelatonin and activin. In addition, melatonin increased expression of the activin type-I receptor ALK-4 but suppressed expression of inhibitory Smads6/7, leading to the enhancement of Smad2 phosphorylation. Collectively, the results showed that melatonin facilitated aldosterone production induced by ACTH and activin via the cAMP-PICA pathway. The results also suggested that mutual enhancement of melatonin and activin receptor signaling is involved in the induction of aldosterone output by adrenocortical cells. (C) 2015 Elsevier Ltd. All rights reserved.	[Hara, Takayuki; Tsukamoto-Yamauchi, Naoko; Inagaki, Kenichi; Hosoya, Takeshi; Terasaka, Tomohiro; Komatsubara, Motoshi] Dept Med & Clin Sci, Kita Ku, Okayama 7008558, Japan; [Otsuka, Fumio; Nakamura, Eri] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, Okayama 7008558, Japan; [Makino, Hirofumi] Okayama Univ Hosp, Kita Ku, Okayama 7008558, Japan	Otsuka, F (reprint author), Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gen Med, Kita Ku, 2-5-1 Shikata Cho, Okayama 7008558, Japan.	fumiotsu@md.okayama-u.ac.jp			Foundation for Growth Science; Astellas Foundation for Research on Metabolic Disorders; Japan Foundation for Applied Enzymology (Japan);  [24591364]	This work was supported in part by Grants-in-Aid for Scientific Research (No. 24591364), Foundation for Growth Science and Astellas Foundation for Research on Metabolic Disorders, and Japan Foundation for Applied Enzymology (Japan).	Vanttinen T, 2003, J ENDOCRINOL, V178, P479, DOI 10.1677/joe.0.1780479; Proietti S, 2011, J PINEAL RES, V50, P150, DOI 10.1111/j.1600-079X.2010.00824.x; Lichtenauer UD, 2013, HORM METAB RES, V45, P124, DOI 10.1055/s-0032-1323810; Xing YW, 2011, J ENDOCRINOL, V209, P327, DOI 10.1530/JOE-10-0493; Dubocovich ML, 2005, ENDOCRINE, V27, P101, DOI 10.1385/ENDO:27:2:101; Miyoshi T, 2006, BIOL REPROD, V74, P1073, DOI 10.1095/biolreprod.105.047969; Torres-Farfan C, 2011, ENDOCRINOLOGY, V152, P1891, DOI 10.1210/en.2010-1260; Shimasaki S, 2004, ENDOCR REV, V25, P72, DOI 10.1210/er.2003-0007; BIRD IM, 1993, ENDOCRINOLOGY, V133, P1555, DOI 10.1210/en.133.4.1555; Otsuka F, 2011, MOL REPROD DEV, V78, P9, DOI 10.1002/mrd.21265; Goto J, 2009, AM J PHYSIOL-ENDOC M, V296, pE904, DOI 10.1152/ajpendo.90840.2008; Samandari E, 2007, J ENDOCRINOL, V195, P459, DOI 10.1677/JOE-07-0166; Reiter RJ, 2010, PROG BRAIN RES, V181, P127, DOI 10.1016/S0079-6123(08)81008-4; Vanttinen T, 2002, J CLIN ENDOCR METAB, V87, P4257, DOI 10.1210/jc.2002-020460; Borjigin J, 2012, MOL CELL ENDOCRINOL, V349, P13, DOI 10.1016/j.mce.2011.07.009; Parmar J, 2008, J CLIN ENDOCR METAB, V93, P4542, DOI 10.1210/jc.2008-0903; Park KH, 2011, J PINEAL RES, V51, P187, DOI 10.1111/j.1600-079X.2011.00875.x; Torres-Farfan C, 2003, J CLIN ENDOCR METAB, V88, P450, DOI 10.1210/jc.2002-021048; Campino C, 2011, HORM METAB RES, V43, P337, DOI 10.1055/s-0031-1271693; DIBLASIO AM, 1987, J CLIN ENDOCR METAB, V65, P170; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; HOLLAND OB, 1993, MOL CELL ENDOCRINOL, V94, pR9, DOI 10.1016/0303-7207(93)90175-J; HOTTA M, 1986, P NATL ACAD SCI USA, V83, P7795, DOI 10.1073/pnas.83.20.7795; Inagaki K, 2006, ENDOCRINOLOGY, V147, P2681, DOI 10.1210/en.2005-1250; Janes ME, 2008, ENDOCRINOLOGY, V149, P1898, DOI 10.1210/en.2007-0949; Kano Y, 2005, ENDOCRINOLOGY, V146, P5332, DOI 10.1210/en.2005-0474; Kirschner LS, 2002, ANN NY ACAD SCI, V968, P222; Le Roy C, 2000, ENDOCRINOLOGY, V141, P1599, DOI 10.1210/en.141.5.1599; Lucki NC, 2012, MOL CELL ENDOCRINOL, V348, P165, DOI 10.1016/j.mce.2011.08.003; Matsumoto Y, 2012, J STEROID BIOCHEM, V132, P8, DOI 10.1016/j.jsbmb.2012.04.004; Nakamura E, 2014, J STEROID BIOCHEM, V143, P233, DOI 10.1016/j.jsbmb.2014.04.003; Otani H, 2008, ENDOCRINOLOGY, V149, P2816, DOI 10.1210/en.2007-1476; Otsuka F, 1999, GROWTH HORM IGF RES, V9, P41, DOI 10.1054/ghir.1998.0086; Rahman SA, 2008, ENDOCRINOLOGY, V149, P6125, DOI 10.1210/en.2007-1742; Richter HG, 2008, ENDOCRINOLOGY, V149, P995, DOI 10.1210/en.2007-1009; Rimler A, 1999, PROSTATE, V40, P211; Suzuki J, 2004, ENDOCRINOLOGY, V145, P639; Tomova A, 2008, MED SCI MONITOR, V14, pCR327; Torres-Farfan C, 2008, J PHYSIOL-LONDON, V586, P4017, DOI 10.1113/jphysiol.2008.154351; Tsukamoto N, 2013, MOL CELL ENDOCRINOL, V375, P1, DOI 10.1016/j.mce.2013.05.010	40	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0960-0760			J STEROID BIOCHEM	J. Steroid Biochem. Mol. Biol.	AUG	2015	152						8	15		10.1016/j.jsbmb.2015.04.012		8	Biochemistry & Molecular Biology; Endocrinology & Metabolism	Biochemistry & Molecular Biology; Endocrinology & Metabolism	CN9ZQ	WOS:000358810100002		
J	Chiba, R; Takeuchi, H; Nakamura, R				Chiba, Ryoichi; Takeuchi, Hiroshi; Nakamura, Ryo			Forming-limit prediction of perforated aluminium sheets with square holes	JOURNAL OF STRAIN ANALYSIS FOR ENGINEERING DESIGN			English	Article						Aluminium alloy; anisotropy; crystal plasticity; forming-limit diagram; perforated sheet; stretch forming	FINITE-ELEMENT-ANALYSIS; BIAXIAL STRESS STATE; DUCTILE FRACTURE; PLASTIC BEHAVIOR; YIELD SURFACES; ALLOY SHEETS; DEFORMATION; FORMABILITY; DIAGRAM; CRITERIA	The forming-limit strains of perforated aluminium alloy (AA5052-O) sheets with square holes were theoretically and experimentally estimated for two types of hole arrangements: square and triangular patterns. The theoretical forming-limit curves were obtained by finite-element analyses on a unit module of the perforated sheets using two different approaches: the phenomenological theory and crystal plasticity theory. Hill's quadratic anisotropic and von Mises yield functions were used for the phenomenological analysis, and the one-element-per-grain model was adopted for the crystal plasticity analysis. To determine the forming limits, two different types of plastic instability criteria were applied. The experimental forming-limit strains were also obtained through a Nakazima stretching test. The theoretical predictability of the forming-limit curves was assessed by comparing the theoretical and experimental results. The comparison demonstrated that (1) the plastic instability criterion based on the external force power predicted qualitatively the same forming-limit curves as the criterion based on the equivalent plastic strain of the ligament for both hole arrangement patterns and (2) although the shapes of the predicted forming-limit curves were in reasonable agreement with the experimental results, the level of the predicted limit strains was considerably higher than that of the experimental limit strains. Thus, it was found that neither of the plastic instability criteria previously proposed for perforated sheets is appropriate to characterise the formability of perforated aluminium sheets with square holes.	[Chiba, Ryoichi] Asahikawa Natl Coll Technol, Dept Mech Syst Engn, Asahikawa, Hokkaido 0718142, Japan; [Takeuchi, Hiroshi; Nakamura, Ryo] Asahikawa Natl Coll Technol, Adv Course Prod Syst Engn, Asahikawa, Hokkaido, Japan; [Takeuchi, Hiroshi] Univ Tsukuba, Grad Sch Syst & Informat Engn, Tsukuba, Ibaraki, Japan	Chiba, R (reprint author), Asahikawa Natl Coll Technol, Dept Mech Syst Engn, 2-2-1-6 Shunkodai, Asahikawa, Hokkaido 0718142, Japan.	chiba@asahikawa-nct.ac.jp					Zhang K, 2015, INT J PLASTICITY, V66, P3, DOI 10.1016/j.ijplas.2014.02.003; PEIRCE D, 1983, ACTA METALL MATER, V31, P1951, DOI 10.1016/0001-6160(83)90014-7; Narayanasamy R, 2009, MATER DESIGN, V30, P1804, DOI 10.1016/j.matdes.2008.09.011; OYANE M, 1980, J MECH WORK TECHNOL, V4, P65, DOI 10.1016/0378-3804(80)90006-6; Chiba R, 2013, COMP MATER SCI, V77, P61, DOI 10.1016/j.commatsci.2013.04.025; Engler O, 2002, MAT SCI ENG A-STRUCT, V336, P249, DOI 10.1016/S0921-5093(01)01968-2; Tadano Y, 2012, COMP MATER SCI, V51, P290, DOI 10.1016/j.commatsci.2011.07.024; Silva MB, 2008, J STRAIN ANAL ENG, V43, P15, DOI 10.1243/03093247JSA340; Jain M, 1999, INT J MECH SCI, V41, P1273, DOI 10.1016/S0020-7403(98)00070-8; Isik K, 2014, J MATER PROCESS TECH, V214, P1557, DOI 10.1016/j.jmatprotec.2014.02.026; Wu PD, 1998, METALL MATER TRANS A, V29, P527, DOI 10.1007/s11661-998-0134-x; BAIK SC, 1995, SCRIPTA METALL MATER, V33, P1201, DOI 10.1016/0956-716X(95)00349-Z; Baik SC, 1996, J MATER PROCESS TECH, V58, P139; Baik SC, 2000, INT J MECH SCI, V42, P523, DOI 10.1016/S0020-7403(99)00007-7; Baik SC, 1997, INT J MECH SCI, V39, P781, DOI 10.1016/S0020-7403(96)00091-4; Banabic D, 1998, SHEET METAL FORMING, P343; Bate PS, 2004, SCRIPTA MATER, V51, P973, DOI 10.1016/j.scriptamat.2004.07.018; Bhattacharya A, 2004, NUCL ENG DES, V231, P219, DOI 10.1016/j.nucengdes.2004.04.001; Brocca M, 2000, ASME, V53, P265; CHEN FK, 1993, J MATER PROCESS TECH, V37, P175, DOI 10.1016/0924-0136(93)90089-O; Duan XJ, 2008, J PRESS VESS-T ASME, V130, DOI 10.1115/1.2967881; Elangovan K, 2011, INT J MATER FORM, V4, P389, DOI 10.1007/s12289-010-1003-x; Elangovan K, 2010, COMP MATER SCI, V47, P1072, DOI 10.1016/j.commatsci.2009.12.016; Elangovan1 K., 2010, INT J ENG SCI TECHNO, V2, P300; Ghazanfari A, 2012, MATER DESIGN, V34, P185, DOI 10.1016/j.matdes.2011.07.057; HILL R, 1948, PROC R SOC LON SER-A, V193, P281, DOI 10.1098/rspa.1948.0045; Hino R, 2013, KEY ENG MATER, V535-536, P254, DOI 10.4028/www.scientific.net/KEM.535-536.254; Inal K, 2010, INT J SOLIDS STRUCT, V47, P2223, DOI 10.1016/j.ijsolstr.2010.04.017; Iseki H, 1989, T JAPAN SOC MECH E A, V55, P994; Iseki H, 1989, J JPN SOC TECHNOL PL, V30, P304; Jia S, 2002, INT J SOLIDS STRUCT, V39, P2517, DOI 10.1016/S0020-7683(02)00115-4; Khatam H, 2011, INT J PLASTICITY, V27, P1537, DOI 10.1016/j.ijplas.2010.10.004; Kiley EM, 2011, THESIS WORCESTER POL; Kitazawa K, 1997, T JPN SOC MECH ENG-C, V63, P3681; Kuroda M, 2004, MAT SCI ENG A-STRUCT, V385, P235, DOI 10.1016/j.msea.2004.06.029; Lee YC, 2000, J MATER PROCESS TECH, V103, P353, DOI 10.1016/S0924-0136(00)00506-9; NEALE KW, 1980, INT J MECH SCI, V22, P563, DOI 10.1016/0020-7403(80)90018-1; ODONNELL WJ, 1973, J APPL MECH-T ASME, V40, P263; Takuda H, 1998, ARCH APPL MECH, V68, P566, DOI 10.1007/s004190050187; Takuda H, 1995, J JAPAN SOC TECH PLA, V36, P985; van Rens BJE, 1998, COMPUT STRUCT, V69, P537, DOI 10.1016/S0045-7949(98)00120-5; Venkatachalam G, 2012, INT J MECH MAT ENG, V7, P209; Venkatachalam G., 2012, Advanced Materials Research, V548, DOI 10.4028/www.scientific.net/AMR.548.382; Venkatachalam G., 2012, Applied Mechanics and Materials, V232, DOI 10.4028/www.scientific.net/AMM.232.961; Venkatachalam G, 2013, J ENG APPL SCI, V8, P652; Zaba K, 2008, ARCH CIV MECH ENG, V8, P145	46	0	0	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0309-3247	2041-3130		J STRAIN ANAL ENG	J. Strain Anal. Eng. Des.	AUG	2015	50	6					391	404		10.1177/0309324715594735		14	Engineering, Mechanical; Mechanics; Materials Science, Characterization & Testing	Engineering; Mechanics; Materials Science	CO4RD	WOS:000359147400006		
J	Hokari, M; Nakayama, N; Kazumata, K; Osanai, T; Nakamura, T; Yasuda, H; Ushikoshi, S; Shichinohe, H; Abumiya, T; Kuroda, S; Houkin, K				Hokari, Masaaki; Nakayama, Naoki; Kazumata, Ken; Osanai, Toshiya; Nakamura, Toshitaka; Yasuda, Hiroshi; Ushikoshi, Satoshi; Shichinohe, Hideo; Abumiya, Takeo; Kuroda, Satoshi; Houkin, Kiyohiro			Surgical Outcomes for Cervical Carotid Artery Stenosis: Treatment Strategy for Bilateral Cervical Carotid Artery Stenosis	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Carotid endareterectomy; bilateral carotid stenosis; carotid stenting; risk factors	SYMPTOMATIC PATIENTS; PLAQUE PROTRUSION; ENDARTERECTOMY; OCCLUSION; DISEASE; REVASCULARIZATION; ANGIOPLASTY; STROKE; IMPACT; METAANALYSIS	Background: Carotid endarterectomy (CEA) and carotid stenting (CAS) are beneficial procedures for patients with high-grade cervical carotid stenosis. However, it is sometimes difficult to manage patients with bilateral carotid stenosis. To decide the treatment strategy, one of the most important questions is whether contralateral stenosis increases the risk of patients undergoing CEA. Methods: This retrospective study included 201 patients with carotid stenosis who underwent a total of 219 consecutive procedures (CEA 189/CAS 30). We retrospectively analyzed outcomes in patients with carotid stenosis who were treated with either CEA or CAS and evaluated whether or not contralateral lesions increases the risk of patients undergoing CEA or CAS. Furthermore, we retrospectively verified our treatment strategy for bilateral carotid stenosis. Results: The incidences of perioperative complications were 5.3% in the CEA patients and 6.7% in the CAS patients, respectively. There was no significant difference between these 2 groups. The existences of contralateral occlusion and/or contralateral stenosis were not associated with perioperative complications in both the groups. There were 32 patients with bilateral severe carotid stenosis (>50%). Of those, 13 patients underwent bilateral revascularizations; CEA followed by CEA in 8, CEA followed by CAS in 3, CAS followed by CEA 1 coronary artery bpass grafting in 1, and CAS followed by CAS in 1. Conclusions: Our date showed that the existence of contralateral carotid lesion was not associated with perioperative complications, and most of our cases with bilateral carotid stenosis initially underwent CEA.	[Hokari, Masaaki; Nakayama, Naoki; Kazumata, Ken; Osanai, Toshiya; Shichinohe, Hideo; Abumiya, Takeo; Houkin, Kiyohiro] Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Sapporo, Hokkaido 0608638, Japan; [Osanai, Toshiya] Azabu Neurosurg Hosp, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Yasuda, Hiroshi; Ushikoshi, Satoshi] Hokkaido Med Ctr, Dept Neurosurg, Sapporo, Hokkaido, Japan; [Kuroda, Satoshi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Neurosurg, Toyama 930, Japan	Hokari, M (reprint author), Hokkaido Univ, Grad Sch Med, Dept Neurosurg, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan.	karimasa@med.hokudai.ac.jp					Alric P, 2002, J ENDOVASC THER, V9, P14, DOI 10.1583/1545-1550(2002)009<0014:CASFSF>2.0.CO;2; Alurkar A, 2013, J CLIN IMAGING SCI, V2, P72; WARLOW C, 1991, LANCET, V337, P1235; GASECKI AP, 1995, J NEUROSURG, V83, P778, DOI 10.3171/jns.1995.83.5.0778; Antoniou GA, 2013, JAMA SURG, V148, P1140, DOI 10.1001/jamasurg.2013.4135; Goodney PP, 2012, J VASC SURG, V55, P61, DOI 10.1016/j.jvs.2011.07.046; Touze E, 2013, STROKE, V44, P3394, DOI 10.1161/STROKEAHA.113.002756; Yang SS, 2014, J VASC SURG, V59, P749, DOI 10.1016/j.jvs.2013.10.055; Takigawa T, 2009, NEUROL MED-CHIR, V49, P413; Henry M, 2005, CATHETER CARDIO INTE, V64, P275, DOI 10.1002/ccd.20287; Balucani C, 2012, NEUROLOGY, V79, P1788, DOI 10.1212/WNL.0b013e318270402e; Qureshi AI, 1999, STROKE, V30, P2086; Rantner B, 2005, EUR J VASC ENDOVASC, V30, P36, DOI 10.1016/j.ejvs.2005.02.045; Goodney PP, 2008, J VASC SURG, V48, P1139, DOI 10.1016/j.jvs.2008.05.013; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Sheffet AJ, 2010, INT J STROKE, V5, P40, DOI 10.1111/j.1747-4949.2009.00405.x; Aikawa H, 2008, RADIAT MED, V26, P318, DOI 10.1007/s11604-008-0231-1; BURKE PE, 1993, EUR J VASCULAR SURG, V7, P317, DOI 10.1016/S0950-821X(05)80015-5; Dong H, 2012, CHINESE MED J-PEKING, V125, P1010, DOI 10.3760/cma.j.issn.0366-6999.2012.06.010; Estruch-Perez MJ, 2012, ARCH MED SCI, V8, P236, DOI 10.5114/aoms.2012.28550; Faggioli G, 2013, EUR J VASC ENDOVASC, V46, P10, DOI 10.1016/j.ejvs.2013.03.021; Hokari M, 2014, J STROKE CEREBROVASC, V23, P2851, DOI 10.1016/j.jstrokecerebrovasdis.2014.07.014; ILLE O, 1995, STROKE, V26, P488; Iwasaki M, 2011, J STROKE CEREBROVASC, V20, P55, DOI 10.1016/j.jstrokecerebrovasdis.2009.11.001; Kawabata Y, 2001, SURG CEREBRAL STROKE, V29, P339, DOI 10.2335/scs.29.339; Keldahl ML, 2012, ANN VASC SURG, V26, P40, DOI 10.1016/j.avsg.2011.07.005; Kiris I, 2007, J CARDIAC SURG, V22, P149, DOI 10.1111/j.1540-8191.2007.00358.x; Maleux G, 2006, AM J NEURORADIOL, V27, P1830; Melliere D, 1997, J CARDIOVASC SURG, V38, P261; MEYER FB, 1994, J NEUROSURG, V80, P781, DOI 10.3171/jns.1994.80.5.0781; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Ogata Nobuhiko, 2014, Cardiovasc Interv Ther, V29, P65, DOI 10.1007/s12928-013-0192-x; Rothwell PM, 1996, STROKE, V27, P266; Shichinohe H, 2005, NEUROL SURG TOKYO, V33, P149; Tsukahara T, 2005, ACT NEUR S, V94, P133	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					1768	1774		10.1016/j.jstrokecerebrovasdis.2015.03.052		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000022		
J	Mitsumura, H; Miyagawa, S; Komatsu, T; Hirai, T; Kono, Y; Iguchi, Y				Mitsumura, Hidetaka; Miyagawa, Shinji; Komatsu, Teppei; Hirai, Toshiaki; Kono, Yu; Iguchi, Yasuyuki			Clinical Characteristics of Intracranial Reversed Vertebral Artery Flow Evaluated by Transcranial Color Flow Imaging	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Reversed vertebral artery flow; vertebral artery dissection; transcranial color flow imaging; carotid duplex ultrasound; acute ischemic stroke; ischemia of the vertebrobasilar territory	INTERNAL CAROTID-ARTERY; MIDDLE CEREBRAL-ARTERY; DISSECTING ANEURYSM; BASILAR ARTERY; OCCLUSION; DOPPLER; ULTRASONOGRAPHY	Background: Carotid duplex ultrasonography (CUS) has been used to identify reversed vertebral artery flow (RVAF) at the extracranial cervical artery in some patients with subclavian steal syndrome. However, the characteristics of intracranial RVAF as evaluated by transcranial color flow imaging (TC-CFI), which can examine intracranial hemodynamics in a real-time and noninvasive fashion, remain unclear. The goal of this study was to analyze the prevalence of intracranial RVAF and its associated clinical characteristics. Methods: Subjects were consecutive patients who underwent TC-CFI and CUS. We evaluated blood flow in both intracranial vertebral arteries (VAs) from the suboccipital echo window using TC-CFI. RVAF was defined as a flow signal directed toward the probe. We calculated the prevalence of intracranial RVAF in our subjects. Then, we investigated vascular condition (ie, site of lesion, stenosis, occlusion, and dissection) using magnetic resonance angiography, computed tomography angiography, and CUS in patients with intracranial RVAF. Results: Seven hundred twenty patients (508 men; median age, 73 years) were included in this study from September 2007 to March 2013. Intracranial RVAF was seen in 12 patients (1.7%; 11 men; median age, 61 years). Among the 12 patients with intracranial RVAF, 8 patients (67%) had ischemia of the vertebrobasilar territory with distal VA occlusion, according to CUS. Of those patients, 6 (75%) had dissection of the VA. Conclusions: TC-CFI detected intracranial RVAF in 1.7% of consecutive examinations in our facility. In vertebrobasilar territory stroke patients with intracranial RVAF, VA dissection may contribute to the development of stroke.	[Mitsumura, Hidetaka; Miyagawa, Shinji; Komatsu, Teppei; Hirai, Toshiaki; Kono, Yu; Iguchi, Yasuyuki] Jikei Univ, Sch Med, Dept Neurol, Tokyo 1058461, Japan	Mitsumura, H (reprint author), Jikei Univ, Sch Med, Dept Neurol, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	hmitsumura@jikei.ac.jp					Adams Jr HP, 1993, ARTERIOSCLER THROMB, V24, P35, DOI DOI 10.1161/01.STR.24.1.35; FRIEDMAN AH, 1984, J NEUROSURG, V60, P325, DOI 10.3171/jns.1984.60.2.0325; KAPS M, 1990, STROKE, V21, P532; Kim BM, 2011, NEUROLOGY, V76, P1735, DOI 10.1212/WNL.0b013e31821a7d94; Demchuk AM, 2000, STROKE, V31, P140; Saito K, 2004, STROKE, V35, P1068, DOI 10.1161/01.STR.0000125857.63427.59; FISHER CM, 1970, ARCH NEUROL-CHICAGO, V22, P13; Harper C, 2008, J VASC SURG, V48, P859, DOI 10.1016/j.jvs.2008.05.057; HART RG, 1988, NEUROLOGY, V38, P987; Heary RF, 1996, SPINE, V21, P2074, DOI 10.1097/00007632-199609150-00004; HOUSER OW, 1984, AM J NEURORADIOL, V5, P27; Kimura K, 1998, ULTRASOUND MED BIOL, V24, P1121, DOI 10.1016/S0301-5629(98)00108-2; KUNZE S, 1971, NEURORADIOLOGY, V2, P201; Lee SI, 2008, J NEUROIMAGING, V18, P451, DOI 10.1111/j.1552-6569.2007.00201.x; LINDEGAARD KF, 1986, J NEUROL NEUROSUR PS, V49, P510, DOI 10.1136/jnnp.49.5.510; MAS JL, 1987, STROKE, V18, P1037; NEW PFJ, 1969, RADIOLOGY, V93, P41; OJEMANN R G, 1972, Stroke, V3, P434; Provenzale JM, 1996, J COMPUT ASSIST TOMO, V20, P185, DOI 10.1097/00004728-199603000-00004; Ribo M, 2004, STROKE, V35, P79, DOI 10.1161/01.STR.0000106760.25228.2C; Sharma VK, 2009, J CLIN NEUROSCI, V16, P1493, DOI 10.1016/j.jocn.2009.01.024; THOMASSEN L, 1994, ACTA NEUROL SCAND, V90, P241	22	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					1775	1780		10.1016/j.jstrokecerebrovasdis.2015.03.044		6	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000023		
J	Dozono, K; Hachisuka, A; Wada, F; Hachisuka, K				Dozono, Koichiro; Hachisuka, Akiko; Wada, Futoshi; Hachisuka, Kenji			Peripheral Neuropathies in Nonparetic Upper Extremities of Stroke Patients Induced by Excessive Use of a Walking Device	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Entrapment neuropathies; nonparetic side; overuse; walking device; rehabilitation	CARPAL-TUNNEL-SYNDROME; SPINAL-CORD-INJURY; ENTRAPMENT NEUROPATHIES; SENSORY CONDUCTION; NERVE; WRIST; AMBULATION; MOBILITY; BALANCE; PAIN	Background: Poststroke patients reportedly experience entrapment neuropathies in the nonparetic upper extremities, and the use of an assistive device for long periods may increase this risk. We examined nerve conduction velocities in hemiparetic patients and investigated the relationship between abnormal measurements and duration of walking. Methods: Twenty-eight male hemiparetic outpatients who used a cane or a crutch participated in this study. Clinical characteristics such as age, period of time from stroke onset, side and severity of paresis, activities of daily living, and basic ability to walk, as well as each patient's approximate number of hours walking per day, were collected. Electrophysiological evaluation was performed via nerve conduction studies of the median, ulnar, and radial nerves. The clinical features were compared between patients with and without peripheral neuropathies. Results: Twelve patients (43%) had peripheral neuropathies involving a total of 15 nerves. There was no difference in age, duration of hemiparesis, side and severity of paresis, Barthel index, and Functional Ambulation Classification between the 2 groups. Abnormalities were absent in the patients who walked at or less than an hour but were present in 50% and 63.4% of patients with walking times of 1-2 hours and more than 2 hours, respectively. Conclusions: Excessive use of a T-cane or a Lofstrand crutch was hypothesized to induce entrapment neuropathies in the nonparetic upper extremity. To prevent these injuries, a well-balanced gait should be established to reduce the load on the walking device.	[Dozono, Koichiro] Imamura Bun In Hosp, Dept Rehabil Med, Kagoshima, Japan; [Hachisuka, Akiko; Wada, Futoshi] Univ Occupat & Environm Hlth, Dept Rehabil Med, Kitakyushu, Fukuoka 807, Japan; [Hachisuka, Kenji] Japan Labour Hlth & Welf Org, Kyushu Rosai Hosp, Moji Med Ctr, Kitakyushu, Fukuoka, Japan	Dozono, K (reprint author), 11-23 Kamoikeshin Machi, Kagoshima 8900064, Japan.	kdozono@jiaikai.jp					Kuan TS, 1999, ARCH PHYS MED REHAB, V80, P777, DOI 10.1016/S0003-9993(99)90227-7; JORGENSEN HS, 1995, ARCH PHYS MED REHAB, V76, P27, DOI 10.1016/S0003-9993(95)80038-7; HOLDEN MK, 1986, PHYS THER, V66, P1530; KUMAR R, 1995, ARCH PHYS MED REHAB, V76, P1173, DOI 10.1016/S0003-9993(95)80129-4; Ginanneschi F, 2009, ARCH PHYS MED REHAB, V90, P522, DOI 10.1016/j.apmr.2008.09.568; Bateni H, 2005, ARCH PHYS MED REHAB, V86, P134, DOI 10.1016/j.apmr.2004.04.023; Laufer Y, 2003, PHYS THER, V83, P112; GELBERMAN RH, 1981, J BONE JOINT SURG AM, V63, P380; Koh ESC, 2002, QJM-INT J MED, V95, P389, DOI 10.1093/qjmed/95.6.389; Keir PJ, 1998, J HAND SURG-AM, V23A, P1004, DOI 10.1016/S0363-5023(98)80007-5; Brunnstrom S., 1970, MOVEMENT THERAPY HEM; DOZONO K, 1995, PARAPLEGIA, V33, P208; FELSENTHAL G, 1989, ARCH PHYS MED REHAB, V70, P668; Hug U, 2004, Chir Main, V23, P49, DOI 10.1016/j.main.2003.12.009; Hunkar R, 2012, J CLIN NEUROPHYSIOL, V29, P96, DOI 10.1097/WNP.0b013e318246b73d; Jain NB, 2010, PM&R, V2, P896, DOI 10.1016/j.pmrj.2010.05.004; Kabayel L, 2009, ACTA NEUROL SCAND, V120, P53, DOI 10.1111/j.1600-0404.2008.01122.x; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kellner W S, 1986, Orthop Rev, V15, P608; Kimura J, 1989, ELECTRODIAGNOSIS DIS; MAHONEY F I, 1965, Md State Med J, V14, P61; McQuade KJ, 2011, REV BRAS FISIOTER, V15, P332; Millius R, 2000, ARCH PHYS MED REHAB, V81, P569; OLNEY RK, 1988, MUSCLE NERVE, V11, P828, DOI 10.1002/mus.880110805; Paoloni M, 2010, J CLIN NEUROPHYSIOL, V27, P48, DOI 10.1097/WNP.0b013e3181cb42ae; Ropper AH, 2009, ADAMS VICTORS PRINCI, P746; Sala DA, 1998, ARCH PHYS MED REHAB, V79, P1473, DOI 10.1016/S0003-9993(98)90247-7; Sato Y, 1999, STROKE, V30, P414; TROJABOR.W, 1969, J NEUROL NEUROSUR PS, V32, P354, DOI 10.1136/jnnp.32.4.354; Tsai HC, 2009, J REHABIL MED, V41, P26, DOI 10.2340/16501977-0290; Verdon ME, 1996, PRIMARY CARE, V23, P305, DOI 10.1016/S0095-4543(05)70278-5; Werner C, 1981, ACTA ORTHOP SCAND, V54, P312; Yang J, 2009, AM J PHYS MED REHAB, V88, P1007, DOI 10.1097/PHM.0b013e3181bbddc9	33	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					1841	1847		10.1016/j.jstrokecerebrovasdis.2015.04.022		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000032		
J	Nishioka, R; Kinoshita, S; Shiibashi, M; Shimazu, T; Nakazato, Y; Yamamoto, T; Tamura, N; Araki, N				Nishioka, Ryoji; Kinoshita, Shunsuke; Shiibashi, Michio; Shimazu, Tomokazu; Nakazato, Yoshihiko; Yamamoto, Toshimasa; Tamura, Naotoshi; Araki, Nobuo			Evaluation of the Differences in the Effects of Antihypertensive Drugs on Blood Pressure Variability by 24-Hour Ambulatory Blood Pressure Monitoring in Chronic Cerebrovascular Disease	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Hypertension; beta-blocker; blood pressure variability; cerebrovascular disease(CVD); cilnidipine; antihypertensive drugs	PROGNOSTIC-SIGNIFICANCE; HYPERTENSION; CILNIDIPINE; STROKE; PREVENTION; CANDESARTAN; BLOCKER; RISK	Background: It has been suggested that antihypertensive drug therapy is attributable to the lower blood pressure variability, we investigated the effects of 4 classes of antihypertensives on the blood pressure variability; in addition, we also compared the effects among 4 calcium channel blockers. Methods: We measured the 24-hour blood pressure variability in 309 patients with a history of cerebrovascular disease treated with angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, beta blocker, or calcium channel blocker. Results: The daytime blood pressure variability treated with beta blockers (14.3 +/- 3.1) was higher than that treated with an angiotensin receptor blockers (11.5 +/- 3.1) or calcium channel blockers (12.6 +/- 3.4) in patients with cerebrovascular disease (P < .05). In the analysis of the patient distribution of blood pressure variability, patients receiving beta blockers occurred more frequently in the higher blood pressure variability (P = .0023). Treatment with angiotensin receptor blockers and cilnidipine, which blocks N-type calcium channels, was shown to be more frequently associated with the lower blood pressure variability (P = .0202 and .0467). The mean blood pressure of patients grouped by distribution of blood pressure variability was found to be independent to blood pressure variability, for any of the antihypertensive drugs or calcium channel blockers examined. Conclusions: From the results, it is suggested that angiotensin receptor blocker and calcium channel blockers rather than beta blockers may be more favorable for blood pressure management in patients with cerebrovascular disease. Among the calcium channel blockers, cilnidipine may be more favorable than other calcium channel blockers. (C) 2015 by National Stroke Association	[Nishioka, Ryoji; Kinoshita, Shunsuke; Shimazu, Tomokazu; Nakazato, Yoshihiko; Yamamoto, Toshimasa; Tamura, Naotoshi; Araki, Nobuo] Saitama Med Univ, Dept Neurol, Sch Med, Fac Med, Moroyama, Saitama 3500495, Japan; [Nishioka, Ryoji] Saitama Med Univ, Fac Hlth & Med Care, Sch Phys Therapy, Moroyama, Saitama 3500495, Japan; [Shiibashi, Michio] Saitama Med Univ, Fac Med, Ctr Informat Technol, Moroyama, Saitama 3500495, Japan	Araki, N (reprint author), Saitama Med Univ, Neurol, Sch Med, Fac Med, 38 Morohongo, Moroyama, Saitama 3500495, Japan.	arakin@saitama-med.ac.jp					Schrader J, 2003, STROKE, V34, P1699, DOI 10.1161/01.STR.000007577.18006.89; Schrader J, 2005, STROKE, V36, P1218, DOI 10.1161/01.STR.0000166048.35740.a9; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Kikuya M, 2000, HYPERTENSION, V36, P901; Sakata K, 1999, HYPERTENSION, V33, P1447; Rothwell PM, 2010, LANCET, V375, P895, DOI 10.1016/S0140-6736(10)60308-X; Papademetriou V, 2004, J AM COLL CARDIOL, V44, P1175, DOI 10.1016/j.jacc.2004.06.034; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; [Anonymous], 1990, STROKE, V21, P637; FRATTOLA A, 1993, J HYPERTENS, V11, P1133, DOI 10.1097/00004872-199310000-00019; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Takahara A, 2009, CARDIOVASC THER, V27, P124, DOI 10.1111/j.1755-5922.2009.00079.x; Ogihara T, 2009, HYPERTENS RES, V32, P3, DOI 10.1038/hr.2008.15; Ekbom T, 1992, Blood Press, V1, P168, DOI 10.3109/08037059209077513; Kato Y, 2009, J CEREB BLOOD FLOW S, V29, P237; Kobayashi N, 2001, EUR J PHARMACOL, V422, P149, DOI 10.1016/S0014-2999(01)01067-6; Sorond FA, 2005, J GERONTOL A-BIOL, V60, P1484; Takahara A, 1997, JPN J PHARMACOL, V75, P27, DOI 10.1254/jjp.75.27; Tartaro A, 1999, J Stroke Cerebrovasc Dis, V8, P66, DOI 10.1016/S1052-3057(99)80056-1; Yusuf S, 2008, NEW ENGL J MED, V358, P1547	20	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					1848	1854		10.1016/j.jstrokecerebrovasdis.2015.04.023		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000033		
J	Imaizumi, T; Inamura, S; Nomura, T				Imaizumi, Toshio; Inamura, Shigeru; Nomura, Tatsufumi			Contribution of Deep Microbleeds to Stroke Recurrence: Differences between Patients with Past Deep Intracerebral Hemorrhages and Lacunar Infarctions	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Cerebral microbleeds; intracerebral hemorrhage; lacunar infarction; recurrence; risk factor	TRANSIENT ISCHEMIC ATTACK; CEREBRAL MICROBLEEDS; BRAIN MICROBLEEDS; RISK; PREVALENCE; DEMENTIA; DISEASE; UPDATE	Background: This study investigated the contribution of deep cerebral microbleeds (MBs) to stroke recurrences in patients with histories of deep intracerebral hemorrhages (ICHs) or lacunar infarctions (LIs). Methods: We prospectively analyzed stroke recurrences in patients admitted to our hospital who were treated for deep ICHs or LIs between April 2004 and December 2011. The number of deep MBs was counted on admission. Stroke recurrence-free rate curves were generated with the Kaplan-Meier method using the log-rank test. The odds ratios (ORs) for recurrent strokes were derived using multivariate logistic regression models, based on deep MBs and risk factors. Results: We evaluated magnetic resonance images or the recurrences of 231 deep-ICH patients (92 women, 68.0 +/- 12.0 years old) and 309 LI patients (140 women, 70.7 +/- 11.7 years old). The incidences of deep ICHs (1.5%/year) and LIs (2.1%/ year) presenting as stroke recurrences were significantly larger in LI patients with deep MBs than in those without (.01 [P = .0001] and.08%/year [P = .005], respectively). However, there was no significant difference between deep-ICH patients with and without MBs in terms of incidence of recurrences. Multivariate analyses revealed that deep MBs independently and significantly elevated the rate of deep ICHs (OR, 19.0; P = .007) or LIs (OR, 3.62; P = .008) presenting as recurrences in LI patients, but not in deep-ICH patients, when adjusted for stroke risk factors. Conclusions: There may be differences between patients with deep ICHs and those with LIs in terms of the contribution of deep MBs to stroke recurrence. (C) 2015 by National Stroke Association	[Imaizumi, Toshio; Inamura, Shigeru; Nomura, Tatsufumi] Kushiro City Gen Hosp, Dept Neurosurg, Kushiro, Hokkaido 0850822, Japan	Imaizumi, T (reprint author), Kushiro City Gen Hosp, Dept Neurosurg, 1-12 Shunkodai, Kushiro, Hokkaido 0850822, Japan.	timaizum@d9.dion.ne.jp					Altmann-Schneider I, 2011, STROKE, V42, P638, DOI 10.1161/STROKEAHA.110.595611; Tang WK, 2011, STROKE, V42, P2443, DOI 10.1161/STROKEAHA.111.614586; Yakushiji Y, 2012, STROKE, V43, P1800, DOI 10.1161/STROKEAHA.111.647065; O'Sullivan M, 2002, NEUROLOGY, V59, P321; Bokura H, 2011, STROKE, V42, P1867, DOI 10.1161/STROKEAHA.110.601922; Greenberg SM, 2009, STROKE, V40, P2382, DOI 10.1161/STROKEAHA.109.548974; Shoamanesh A, 2011, CEREBROVASC DIS, V32, P528, DOI 10.1159/000331466; Charidimou A, 2013, STROKE, V44, P995, DOI 10.1161/STROKEAHA.111.000038; FAZEKAS F, 1987, AM J ROENTGENOL, V149, P351; Fazekas F, 1999, AM J NEURORADIOL, V20, P637; Jellinger KA, 2002, J NEURAL TRANSM, V109, P813, DOI 10.1007/s007020200068; Poels MMF, 2010, STROKE, V41, pS103, DOI 10.1161/STROKEAHA.110.595181; Gregoire SM, 2009, NEUROLOGY, V73, P1759, DOI 10.1212/WNL.0b013e3181c34a7d; Koennecke HC, 2006, NEUROLOGY, V66, P165, DOI 10.1212/01.wnl.0000194266.55694.1e; Black S, 2009, STROKE, V40, pS48, DOI 10.1161/STROKEAHA.108.537704; Thijs V, 2010, STROKE, V41, P2005, DOI 10.1161/STROKEAHA.110.588020; Ayaz M, 2010, J MAGN RESON IMAGING, V31, P142, DOI 10.1002/jmri.22001; Watanabe A, 2005, NEURORADIOLOGY, V47, P908, DOI 10.1007/s00234-005-1441-1; Greenberg SM, 2004, STROKE, V35, P1415, DOI 10.1161/01.STR.0000126807.69758.0e; Boulanger JM, 2006, STROKE, V37, P911, DOI 10.1161/01.STR.0000204237.66466.5f; Poels MMF, 2011, STROKE, V42, P656, DOI 10.1161/STROKEAHA.110.607184; Goos JDC, 2009, STROKE, V40, P3455, DOI 10.1161/STROKEAHA.109.558197; Dierksen DA, 2010, ANN NEUROL, V68, P545; Imaizumi T, 2014, J STROKE CEREBROVASC, V23, P520, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.035; Imaizumi T, 2004, J NEUROSURG, V101, P915, DOI 10.3171/jns.2004.101.6.0915; Imaizumi T, 2014, J STROKE CEREBROVASC, V23, P610, DOI 10.1016/j.jstrokecerebrovasdis.2013.05.011; Sueda Y, 2010, AM J NEURORADIOL, V31, P1498, DOI 10.3174/ajnr.A2100	27	1	1	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					1855	1864		10.1016/j.jstrokecerebrovasdis.2015.04.027		10	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000034		
J	Nishino, K; Hasegawa, H; Ito, Y; Fujii, Y				Nishino, Kazuhiko; Hasegawa, Hitoshi; Ito, Yasushi; Fujii, Yukihiko			Bilateral Cavernous Carotid Aneurysms: The Growth Potential of a Contralateral Aneurysm after Therapeutic Unilateral Internal Carotid Artery Occlusion	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Therapeutic carotid occlusion; cavernous carotid aneurysm; stent-assisted coil embolization; enlargement	CEREBRAL ANEURYSMS; INTRACRANIAL ANEURYSMS; ASSISTED COILING; GIANT ANEURYSM; FLOW DIVERSION; PARENT VESSEL; FOLLOW-UP; EMBOLIZATION; SINUS; LIGATION	Background: Although the introduction of flow-diverter stents has been recognized as a major revolution in the treatment of cavernous carotid aneurysms (CCAs), therapeutic internal carotid artery occlusion (TICAO) remains a reliable procedure for alleviating symptoms caused by CCAs. However, TICAO has the potential risk of the enlargement of coexisting aneurysms that are frequently detected in CCA patients. The purpose of this study is to assess the occurrence of the enlargement of aneurysms coexisting with CCAs after TICAO. Methods: We reviewed medical charts of CCA patients who were managed using unilateral TICAO. Coexisting aneurysms were identified using angiograms obtained before TICAO, and imaging data in long follow-up periods were retrospectively examined to determine the extent of the enlargement after TICAO. Results: Of 12 patients with CCAs, 10 had 12 coexisting aneurysms; 5 of the coexisting aneurysms (41.7%) showed enlargement during a mean follow-up period of 8.1 years, and all enlarged aneurysms were smaller of the bilateral CCAs; the larger CCA had been managed by TICAO. Five of 6 (83.3%) patients with bilateral CCAs showed enlargement of the contralateral aneurysm after TICAO. Two contralateral CCAs showed marked enlargement after TICAO and were subsequently treated with stent-assisted coil embolization. Conclusions: Contralateral, smaller aneurysms frequently enlarge after unilateral TICAO in patients with bilateral CCAs. The findings emphasize the importance of long-term observation after TICAO and appropriate interventions against enlarging contralateral aneurysms. (C) 2015 by National Stroke Association	[Nishino, Kazuhiko; Hasegawa, Hitoshi; Ito, Yasushi; Fujii, Yukihiko] Niigata Univ, Dept Neurosurg, Brain Res Inst, Niigata 9518585, Japan	Nishino, K (reprint author), Niigata Univ, Dept Neurosurg, Brain Res Inst, Chuo Ku, 1-757 Asahimachidori, Niigata 9518585, Japan.	nishino@bri.niigata-u.ac.jp					Ambekar S, 2014, WORLD NEUROSURG, V82, DOI 10.1016/j.wneu.2014.03.042; Lopes DK, 2014, NEUROSURGERY, V74, P286, DOI 10.1227/NEU.0000000000000263; Arambepola PK, 2010, SKULL BASE-INTERD AP, V20, P405, DOI 10.1055/s-0030-1253578; van Rooij WJ, 2008, AM J NEURORADIOL, V29, P997, DOI 10.3174/ajnr.A1023; Clarencon F, 2011, NEURORADIOLOGY, V53, P973, DOI 10.1007/s00234-010-0800-8; Fargen KM, 2012, NEUROSURGERY, V71, P239, DOI 10.1227/NEU.0b013e3182571953; LINSKEY ME, 1990, NEUROSURGERY, V26, P71; Mattei TA, 2013, NEUROSURG REV, V36, P505, DOI 10.1007/s10143-013-0459-9; FUJIWARA S, 1993, ACTA NEUROCHIR, V120, P20, DOI 10.1007/BF02001464; Choulakian A, 2010, J NEUROINTERV SURG, V2, P359, DOI 10.1136/jnis.2010.003137; Shimizu H, 2010, CLIN NEUROL NEUROSUR, V112, P32, DOI 10.1016/j.clineuro.2009.10.002; Puffer RC, 2014, AM J NEURORADIOL, V35, P948, DOI 10.3174/ajnr.A3826; Yamada K, 2000, SURG NEUROL, V54, P361, DOI 10.1016/S0090-3019(00)00304-9; Kim LJ, 2014, NEUROSURGERY, V74, P51, DOI 10.1227/NEU.0000000000000192; RINNE J, 1994, NEUROSURGERY, V35, P803; Burns JD, 2009, STROKE, V40, P406, DOI 10.1161/STROKEAHA.108.519165; van der Schaaf IC, 2002, STROKE, V33, P313, DOI 10.1161/hs0102.101479; Araki T, 2002, NEUROL SURG TOKYO, V30, P853; Arnaout OM, 2012, NEUROSURGERY, V71, P764; DEMORAIS JV, 1978, SURG NEUROL, V9, P379; EGUCHI T, 1982, J NEUROSURG, V56, P443, DOI 10.3171/jns.1982.56.3.0443; FARIA MA, 1980, SURG NEUROL, V14, P207; HIGASHIDA RT, 1988, NEUROSURGERY, V22, P297; Larson J J, 1995, Neurosurgery, V36, P26; Matouk CC, 2012, AM J NEURORADIOL, V33, P1991, DOI 10.3174/ajnr.A3079; Niiro M, 2000, NEUROL MED-CHIR, V40, P88, DOI 10.2176/nmc.40.88; Ponte KF, 2006, ARQ NEURO-PSIQUIAT, V64, P881, DOI 10.1590/S0004-282X2006000500034; REBOLLO M, 1983, J NEUROL NEUROSUR PS, V46, P284, DOI 10.1136/jnnp.46.3.284; Turfe ZA, 2015, J NEUROINTERV SURG, V7, P250, DOI 10.1136/neurintsurg-2014-011102; Yamanaka C, 1989, Neurol Med Chir (Tokyo), V29, P151, DOI 10.2176/nmc.29.151	30	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					1865	1872		10.1016/j.jstrokecerebrovasdis.2015.04.025		8	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000035		
J	Nagano, A; Yamada, Y; Miyake, H; Domen, K; Koyama, T				Nagano, Ayano; Yamada, Yoshitaka; Miyake, Hiroji; Domen, Kazuhisa; Koyama, Tetsuo			Comparisons of Predictive Equations for Resting Energy Expenditure in Patients with Cerebral Infarct during Acute Care	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Diet; formula; metabolism; prediction; stroke	BIOELECTRICAL-IMPEDANCE ANALYSIS; BODY-COMPOSITION; INDIRECT CALORIMETRY; STROKE PATIENTS; METABOLIC SYSTEMS; REQUIREMENTS; RELIABILITY; NUTRITION; MALNUTRITION; WATER	Background: Estimation of resting energy expenditure (REE) is essential in planning nutrition support. Several equations are used for this estimation in the clinical setting. The purpose of this study was to compare the predictive accuracy of existing equations for REE in patients with cerebral infarct during acute care. Methods: We assessed the Harris-Benedict, Mifflin, Owen, Japanese simplified, Wang, and Cunningham equations. The Owen and Japanese simplified equations use sex and weight as explanatory variables, the Harris-Benedict and Mifflin equations include sex, weight, age, and height, and the Wang and Cunningham equations use fat-free mass (FFM) measured using bioelectrical impedance technology. Actual REE values were measured by indirect calorimetry on days 2 and 7 and were then averaged. Applying analysis of variance, predictive accuracy was assessed by comparing the predicted and actual values. Results: A total of 30 patients were analyzed. Actual REE values ranged from 796 to 1637 kcal (mean, 1109). The standard deviation of these values was the smallest with the Harris-Benedict equation (99), followed by the Cunningham (165), and Wang (181) equations. The Mifflin equation underestimated REE in females, whereas the Owen and Japanese simplified equations tended to overestimate it. Conclusions: Based on our results, the Harris-Benedict equation provides the most accurate prediction of REE. In addition, the Cunningham and Wang equations may be useful in long-term care settings involving patients at risk of malnutrition resulting in uneven loss of FFM relative to weight. (C) 2015 by National Stroke Association	[Nagano, Ayano] Nishinomiya Kyoritsu Neurosurg Hosp, Dept Nursing Care, Nishinomiya, Hyogo 6638211, Japan; [Yamada, Yoshitaka; Miyake, Hiroji] Nishinomiya Kyoritsu Neurosurg Hosp, Dept Neurosurg, Nishinomiya, Hyogo 6638211, Japan; [Domen, Kazuhisa; Koyama, Tetsuo] Hyogo Coll Med, Dept Rehabil Med, Nishinomiya, Hyogo 6638501, Japan; [Koyama, Tetsuo] Nishinomiya Kyoritsu Neurosurg Hosp, Dept Rehabil Med, Nishinomiya, Hyogo 6638211, Japan	Koyama, T (reprint author), Nishinomiya Kyoritsu Neurosurg Hosp, Dept Rehabil Med, 11-1 Imazu Yamanaka Cho, Nishinomiya, Hyogo 6638211, Japan.	koyama.t@nk-hospital.or.jp			Japan Society for the Promotion of Science (KAKENHI) [25282168]; Medical Research Fund of Hyogo Medical Association [MRF-H-10-14]	This study was supported in part by a Grand-in-Aid for Scientific Research (B), the Japan Society for the Promotion of Science (KAKENHI [25282168]), and the Medical Research Fund of Hyogo Medical Association (MRF-H-10-14).	Dennis M, 2005, LANCET, V365, P2005, DOI 10.1016/S0140-6736(05)66691-3; CUNNINGHAM JJ, 1991, AM J CLIN NUTR, V54, P963; Sartorio A, 2005, EUR J CLIN NUTR, V59, P155, DOI 10.1038/sj.ejcn.1602049; Dennis M, 2000, BRIT MED BULL, V56, P466, DOI 10.1258/0007142001903102; Shinohara Y, 2011, J STROKE CEREBROVASC, V20, pS31, DOI 10.1016/j.jstrokecerebrovasdis.2011.05.004; Vandarakis D, 2013, RES SPORTS MED, V21, P187, DOI 10.1080/15438627.2012.757226; OWEN OE, 1987, AM J CLIN NUTR, V46, P875; VANSWIETEN JC, 1988, STROKE, V19, P604; JEQUIER E, 1987, ANNU REV NUTR, V7, P187, DOI 10.1146/annurev.nu.07.070187.001155; Wang ZM, 2000, AM J PHYSIOL-ENDOC M, V279, pE539; ROZA AM, 1984, AM J CLIN NUTR, V40, P168; Schadewaldt P, 2013, AM J CLIN NUTR, V97, P763, DOI 10.3945/ajcn.112.035014; LYDEN P, 1994, STROKE, V25, P2220; Gariballa SE, 1998, AM J CLIN NUTR, V68, P275; Frankenfield DC, 2011, JPEN-PARENTER ENTER, V35, P563, DOI 10.1177/0148607111415859; Davalos A, 1996, STROKE, V27, P1028; Jensky-Squires NE, 2008, BRIT J NUTR, V100, P859, DOI 10.1017/S0007114508925460; Haugen HA, 2007, NUTR CLIN PRACT, V22, P377, DOI 10.1177/0115426507022004377; Corrigan ML, 2011, NUTR CLIN PRACT, V26, P242, DOI 10.1177/0884533611405795; Foley NC, 2009, J REHABIL MED, V41, P707, DOI 10.2340/16501977-0415; Malavolti M, 2003, ANN HUM BIOL, V30, P380, DOI 10.1080/0301446031000095211; Takizawa S, 2013, J STROKE CEREBROVASC, V22, P36, DOI [10.1016/j.jstrokecerebrovasdis.2011.06.005, 10.1016/j.strokecerebrovasdis.2011.06.005]; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241; Brisswalter J, 2014, SCAND J CLIN LAB INV, V74, P722, DOI 10.3109/00365513.2014.930711; CHA KC, 1995, J APPL PHYSIOL, V79, P1316; FERRANNINI E, 1988, METABOLISM, V37, P287, DOI 10.1016/0026-0495(88)90110-2; Finestone HM, 2003, STROKE, V34, P502, DOI 10.1161/01.STR.0000053031.12332.FB; Frankenfield DC, 2012, NUTRITION, V28, P906, DOI 10.1016/j.nut.2011.12.008; Guttormsen AB, 2014, CURR OPIN CLIN NUTR, V17, P171, DOI 10.1097/MCO.0000000000000028; Kawakami M, 2015, CEREBROVASC DIS, V39, P170, DOI 10.1159/000375155; Koyama T, 2014, J STROKE CEREBROVASC, V23, P2397, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.017; Lupinsky L, 2015, NUTRITION, V31, P176, DOI 10.1016/j.nut.2014.07.013; Nieman David C, 2006, Res Sports Med, V14, P89, DOI 10.1080/15438620600651512; Ohtani Y., 1982, Japanese Journal of Nutrition, V40, P275; Stewart CL, 2005, JPEN-PARENTER ENTER, V29, P212, DOI 10.1177/0148607105029003212	35	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					1879	1885		10.1016/j.jstrokecerebrovasdis.2015.04.029		7	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000037		
J	Endo, H; Niizuma, K; Fujimura, M; Sato, K; Inoue, T; Osawa, S; Tominaga, T				Endo, Hidenori; Niizuma, Kuniyasu; Fujimura, Miki; Sato, Kenichi; Inoue, Takashi; Osawa, Shin-ichiro; Tominaga, Teiji			Ruptured Cerebral Microaneurysm Diagnosed by 3-Dimensional Fast Spin-Echo T1 Imaging with Variable Flip Angles	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Cerebral microaneurysm; black blood imaging; gadolinium enhancement; bypass surgery	3D ROTATIONAL ANGIOGRAPHY; SUBARACHNOID HEMORRHAGE; INTRACRANIAL ANEURYSMS; WALL	Cerebral microaneurysms, which are 2 mm or small in size, are a rare cause of subarachnoid hemorrhage (SAH). The authors present 2 cases with ruptured microaneurysms, in which 3-dimensional (3D) fast spin-echo T1 imaging with variable flip angles (CUBE T1) using gadolinium-diethylenetriaminepentaacetic acid (Gd) enhancement was useful in diagnosing the microaneurysms as the source of bleeding. Case 1 was a 61-year-old woman who had an SAH localized to the left Sylvian fissure. A small bulge (1.4 mm) at the bifurcation of left middle cerebral artery (MCA), which was detected by 3D angiography, was well enhanced by CUBE T1 with Gd enhancement. The patient was successfully treated by trapping of the lower division of the left M2 segment with superficial temporal artery-M3 bypass. The intraoperative findings indicated that the microaneurysm at the bifurcation of the left MCA was the ruptured site. Case 2 was a 41-year-old man who had a diffuse SAH. A small bulge (1.5 mm) at the inferolateral wall of the left internal carotid artery (ICA), which was detected by 3D angiography, was well enhanced by CUBE T1 with Gd enhancement. The patient was treated by trapping of the left ICA with external carotid artery-saphenous vein graft-M2 bypass without complications. The intraoperative findings indicated that the microaneurysm at the inferolateral wall of the left ICA was the ruptured site. CUBE T1 with Gd enhancement was useful as an adjunctive tool for the diagnosis of ruptured cerebral microaneurysms. This sequence might enable neurosurgeons to perform curative surgery with certainty for ruptured microaneurysms.	[Endo, Hidenori; Osawa, Shin-ichiro] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi 9828523, Japan; [Niizuma, Kuniyasu; Fujimura, Miki; Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi 980, Japan; [Sato, Kenichi] Kohnan Hosp, Dept Neuroendovasc Therapy, Sendai, Miyagi 9828523, Japan; [Inoue, Takashi] Sendai Med Ctr, Dept Neurosurg, Sendai, Miyagi, Japan	Endo, H (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 4-20-1 Nagamachi Minami, Sendai, Miyagi 9828523, Japan.	hideendo@gmail.com					Ishikawa T, 1997, NEUROSURGERY, V40, P403, DOI 10.1097/00006123-199702000-00038; Meling TR, 2008, J NEUROSURG, V108, P662, DOI 10.3171/JNS/2008/108/4/0662; van Rooij WJ, 2008, AM J NEURORADIOL, V29, P976, DOI 10.3174/ajnr.A0964; van Rooij WJ, 2008, AM J NEURORADIOL, V29, P962, DOI 10.3174/ajnr.A0972; Ishikawa T, 1997, NEUROSURGERY, V40, P405; Karasawa H, 1997, ACTA NEUROCHIR, V139, P416, DOI 10.1007/BF01808877; Karasawa H, 1997, ACTA NEUROCHIR WIEN, P9; Matouk CC, 2013, NEUROSURGERY, V72, P492, DOI 10.1227/NEU.0b013e31827d1012; Nagahata S, 2014, CLIN NEURORADIOL; Nussbaum ES, 1999, NEUROSURGERY, V45, P1172, DOI 10.1097/00006123-199911000-00031; Nussbaum ES, 1999, NEUROSURGERY, V45, P1174	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					E231	E235		10.1016/j.jstrokecerebrovasdis.2015.04.031		5	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000010		
J	Itabashi, R; Yazawa, Y; Kawata, K; Shigehatake, Y; Yang, S; Otomo, K; Furui, E				Itabashi, Ryo; Yazawa, Yukako; Kawata, Kenta; Shigehatake, Yuya; Yang, Sunghoon; Otomo, Kiyoshi; Furui, Eisuke			Paradoxical Brain Emboli Related to Heparin-Induced Thrombocytopenia after Catheter Ablation	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Stroke; paradoxical brain emboli; heparin; induced thrombocytopenia; venous thrombosis; catheter ablation.		Background: Thromboembolism associated with catheter ablation of atrial fibrillation has been considered to be derived from catheters, ablation sites, or a left atrial appendage. Paradoxical brain embolism due to iatrogenic shunt after catheter ablation has yet to be described. Methods: We described a patient with atrial fibrillation who developed acute ischemic stroke while coughing 36 hours after successful catheter ablation. He had venous thrombosis due to heparin-induced thrombocytopenia and a right-to-left shunt, likely due to a trans-septal puncture during catheter ablation. Results: The final diagnosis was paradoxical brain embolism associated with heparin-induced thrombocytopenia. Conclusions: In addition to anticoagulation, we should pay attention to deep venous thrombosis including preventive intermittent compression for high-risk patients to reduce the risk of stroke after catheter ablation.	[Itabashi, Ryo; Yazawa, Yukako; Kawata, Kenta; Shigehatake, Yuya; Yang, Sunghoon; Furui, Eisuke] Kohnan Hosp, Dept Stroke Neurol, Sendai, Miyagi 9828523, Japan; [Otomo, Kiyoshi] Sendai Kousei Hosp, Div Cardiol, Cardiovasc Ctr, Sendai, Miyagi, Japan	Itabashi, R (reprint author), Kohnan Hosp, Dept Stroke Neurol, Taihaku Ku, 4-20-1 Nagamachi Minami, Sendai, Miyagi 9828523, Japan.	ritabash@kohnan-sendai.or.jp			Tanabe Mitsubishi Pharma	R. I. received honoraria of oral speaker from Tanabe Mitsubishi Pharma and received funding for a trip from Stryker Japan. Y. Y. received funding for a trip from Stryker Japan. E. F. received honoraria of oral speaker from Tanabe Mitsubishi Pharma and Daiichi Sankyo.	Lo GK, 2006, J THROMB HAEMOST, V4, P759, DOI 10.1111/j.1538-7836.2006.01787.x; Yasaka M, 2005, INTERNAL MED, V44, P434, DOI 10.2169/internalmedicine.44.434; Calkins H, 2012, HEART RHYTHM, V9, P632, DOI 10.1016/j.hrthm.2011.12.016; Hammerstingl C, 2006, AM HEART J, V152, DOI 10.1016/j.ahj.2006.04.034	4	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					E219	E221		10.1016/j.jstrokecerebrovasdis.2015.04.021		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000007		
J	Kochi, R; Endo, H; Fujimura, M; Sato, K; Sugiyama, S; Osawa, S; Tominaga, T				Kochi, Ryuzaburo; Endo, Hidenori; Fujimura, Miki; Sato, Kenichi; Sugiyama, Shin-ichiro; Osawa, Shin-ichiro; Tominaga, Teiji			Outflow Occlusion with Occipital Artery-Posterior Inferior Cerebellar Artery Bypass for Growing Vertebral Artery Fusiform Aneurysm with Ischemic Onset: A Case Report	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Vertebral artery; fusiform aneurysm; outflow occlusion; bypass surgery; ischemic onset	DISSECTING ANEURYSMS; GROWTH	Surgical treatments should be considered for vertebral artery fusiform aneurysms, which become symptomatic due to cerebral ischemia or mass effect. Ischemic complication is one of the major problems after surgical or endovascular trapping, which is associated with unfavorable outcomes. The authors present a case with growing vertebral artery (VA) fusiform aneurysm with ischemic onset successfully treated with outflow occlusion with occipital artery-posterior inferior cerebellar artery (OA-PICA) bypass. A 50-year-old woman presented with left PICA territory infarction. Left vertebral angiography (VAG) showed occlusion of the left VA at the proximal V4 segment. Right VAG revealed that the distal part of the left V4 segment with fusiform aneurysmal dilatation was reconstituted through vertebrobasilar junction, and the left PICA was the outlet of the blood flow from the fusiform aneurysm. Although the patient was treated conservatively, enlargement of the left VA fusiform aneurysm was observed 8 months after the initial presentation. Considering the potential risks for future stroke or bleeding, we performed clip occlusion of the origin of the left PICA, which could achieve outflow occlusion of the fusiform aneurysm with preservation of the perforators arising around the aneurysm. We created OA-PICA anastomosis for revascularization of the distal PICA. The postoperative course was uneventful, and the postoperative right VAG revealed occlusion of the fusiform aneurysm. Outflow occlusion instead of trapping is an effective surgical option for VA fusiform aneurysm to achieve obliterate the aneurysm with preservation of the perforator at the blind end.	[Kochi, Ryuzaburo; Endo, Hidenori; Osawa, Shin-ichiro] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi 9828523, Japan; [Kochi, Ryuzaburo; Fujimura, Miki; Tominaga, Teiji] Tohoku Univ, Grad Sch Med, Dept Neurosurg, Sendai, Miyagi 980, Japan; [Sato, Kenichi] Kohnan Hosp, Dept Neuroendovasc Therapy, Sendai, Miyagi 9828523, Japan; [Sugiyama, Shin-ichiro] Kohnan Hosp, Dept Neuroanesthesia, Sendai, Miyagi 9828523, Japan	Endo, H (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 20-1 Nagamachi Minami, Sendai, Miyagi 9828523, Japan.	hideendo@gmail.com					Nakatomi H, 2000, STROKE, V31, P896; AKAR ZC, 1995, J NEUROSURG, V82, P97, DOI 10.3171/jns.1995.82.1.0097; Nussbaum ES, 2009, J NEUROSURG, V111, P78, DOI 10.3171/2009.1.JNS081250; Portanova A, 2013, RADIOLOGY, V267, P667, DOI 10.1148/radiol.13112310; Sanai N, 2009, NEUROSURGERY, V65, P670, DOI 10.1227/01.NEU.0000348557.11968.F1; Mizutani T, 1999, NEUROSURGERY, V45, P253, DOI 10.1097/00006123-199908000-00010; Endo H, 2013, J NEUROSURG, V118, P131, DOI 10.3171/2012.9.JNS12566; Miyamoto S, 2011, J NEUROSURG, V114, P1028, DOI 10.3171/2010.9.JNS10448; Mizutani T, 1999, NEUROSURGERY, V45, P259; Sacho RH, 2014, STROKE, V45, P3251, DOI 10.1161/STROKEAHA.114.006292; SUZUKI J, 1978, J NEUROSURG, V48, P505, DOI 10.3171/jns.1978.48.4.0505	11	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					E223	E226		10.1016/j.jstrokecerebrovasdis.2015.04.020		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000008		
J	Rashad, S; Endo, H; Sultan, AE; Shimizu, H; Fujimura, M; Sato, K; Matsumoto, Y; Tominaga, T				Rashad, Sherif; Endo, Hidenori; Sultan, Ahmed Elsayed; Shimizu, Hiroaki; Fujimura, Miki; Sato, Kenichi; Matsumoto, Yasushi; Tominaga, Teiji			Therapeutic Clip Occlusion of the Anterior Choroidal Artery Involved with Partially Thrombosed Fusiform Aneurysm: A Case Report	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Fusiform aneurysm; thrombosed aneurysm; anterior choroidal artery; ischemic stroke; proximal occlusion	ISCHEMIC COMPLICATIONS; PERFORATING ARTERIES; BLOOD-FLOW; SURGERY	Background: We describe a rare case with partially thrombosed fusiform anterior choroidal artery (AchA) aneurysm successfully treated with therapeutic occlusion of the AchA. Clinical presentation: A 58-year-old man presented with transient mild hemiparesis of the right side. Magnetic resonance imaging (MRI) showed an ischemic lesion in the posterior limb of the left internal capsule. Digital subtraction angiography (DSA) revealed a left internal carotid artery saccular aneurysm (14.5-mm diameter) arising from the supraclinoid segment. The left AchA was not detected in the initial DSA, and MRI showed the aneurysm to be partially thrombosed. The second DSA performed 2 weeks after the onset showed recanalization of the thrombosed portion of the aneurysm with the left AchA apparently arising from its tip. The aneurysm was diagnosed as a partially thrombosed fusiform AchA aneurysm. Results: Open surgery was performed and a titanium clip was applied to the base of the fusiform aneurysm under motor evoked potential monitoring, which remained unchanged after clipping. Occlusion of the aneurysm was confirmed by Doppler ultrasound and intraoperative fluorescence angiography. Furthermore, Doppler ultrasound and fluorescence angiography showed that the blood flow supplying the pyramidal tract was reconstituted by the retrograde collateral flow from the choroidal segment. The aneurysm was completely obliterated in postoperative DSA, which demonstrated retrograde filling of the AchA through the posterior circulation. The patient manifested transient weakness of the right side postoperatively, which was completely recovered after short-term rehabilitation. Conclusions: This case illustrates the unique clinical course of a rare partially thrombosed fusiform AchA aneurysm, successfully treated with therapeutic clip occlusion of the AchA under the multimodal monitoring.	[Rashad, Sherif; Sultan, Ahmed Elsayed; Fujimura, Miki; Tominaga, Teiji] Tohoku Univ, Dept Neurosurg, Grad Sch Med, Sendai, Miyagi 980, Japan; [Endo, Hidenori] Kohnan Hosp, Dept Neurosurg, Sendai, Miyagi 9828523, Japan; [Sultan, Ahmed Elsayed; Sato, Kenichi; Matsumoto, Yasushi] Kohnan Hosp, Dept Neuroendovasc Therapy, Sendai, Miyagi 9828523, Japan; [Sultan, Ahmed Elsayed] Univ Alexandria, Dept Neurosurg, Fac Med, Alexandria, Egypt; [Shimizu, Hiroaki] Akita Univ, Grad Sch Med, Dept Neurosurg, Akita 010, Japan	Endo, H (reprint author), Kohnan Hosp, Dept Neurosurg, Taihaku Ku, 4-20-1 Nagamachi Minami, Sendai, Miyagi 9828523, Japan.	hideendo@gmail.com					Kang HS, 2009, J NEUROSURG, V111, P963, DOI 10.3171/2009.4.JNS08934; Friedman JA, 2001, J NEUROSURG, V94, P565, DOI 10.3171/jns.2001.94.4.0565; Bailes JE, 1997, NEUROSURGERY, V40, P965, DOI 10.1097/00006123-199705000-00018; Bailes JE, 1997, NEUROSURGERY, V40, P970; Bohnstedt BN, 2013, NEUROSURGERY, V73, P939; Bohnstedt BN, 2013, NEUROSURGERY, V73, P933, DOI 10.1227/NEU.0000000000000131; de Oliveira JG, 2007, NEUROSURGERY, V61, P63, DOI [10.1227/01.neu.0000333795.21468.d4, 10.1227/01.NEU.0000279982.48426.A1]; Irie T, 2010, J NEUROSURG ANESTH, V22, P247, DOI 10.1097/ANA.0b013e3181de4eae; Lehecka M, 2010, WORLD NEUROSURG, V73, P486, DOI 10.1016/j.wneu.2010.02.001; Nishida A, 2011, NEUROL MED-CHIR, V51, P716; Piotin M, 2004, AM J NEURORADIOL, V25, P314; Shih P, 2010, NEUROSURGERY, V67, pE518, DOI 10.1227/01.NEU.0000371986.84423.DE; Suzuki K, 2007, J NEUROSURG, V107, P68, DOI 10.3171/JNS-07/07/0068; Suzuki K, 2003, J NEUROSURG, V98, P507, DOI 10.3171/jns.2003.98.3.0507; TAKAHASHI S, 1992, NEURORADIOLOGY, V34, P504; Yasargil MG., 1984, MICRONEUROSURGERY CL, P99	16	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					E227	E230		10.1016/j.jstrokecerebrovasdis.2015.04.024		4	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000009		
J	Sasame, J; Nomura, M				Sasame, Jo; Nomura, Motohiro			Dissecting Aneurysm of Anterior Inferior Cerebellar Artery Initially Presenting with Nonhemorrhagic Symptom	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Anterior inferior cerebellar artery; dissecting aneurysm; subarachnoid hemorrhage; rupture	OCCLUSION	We report a patient with a probable dissecting aneurysm of the anterior inferior cerebellar artery (AICA) initially presenting with a nonhemorrhagic symptom, which resulted in subarachnoid hemorrhage. A 61-year-old woman suddenly experienced nausea. Computed tomography (CT) on admission showed a high-density mass with a double lumen in the right cerebellopontine angle without subarachnoid hemorrhage. Five days after the onset, she suddenly lost consciousness. CT demonstrated subarachnoid hemorrhage. Emergency angiography revealed a probable dissecting aneurysm at the lateral pontomedullary segment of the right AICA. Although the initial symptom is not hemorrhage, an unruptured dissecting aneurysm of the AICA may have a high risk of rupture. Immediate radical treatment to prevent subsequent rupture is necessary for even an unruptured dissecting aneurysm of the AICA.	[Sasame, Jo; Nomura, Motohiro] Yokohama Sakae Kyosai Hosp, Dept Neurosurg, Sakae Ku, Yokohama, Kanagawa 2478581, Japan	Nomura, M (reprint author), Yokohama Sakae Kyosai Hosp, Dept Neurosurg, Sakae Ku, 132 Katsura Cho, Yokohama, Kanagawa 2478581, Japan.	nomura413jp@yahoo.co.jp					Andrade G, 2010, ARQ NEURO-PSIQUIAT, V68, P645, DOI 10.1590/S0004-282X2010000400031; Choi CH, 2006, ACTA NEUROCHIR, V148, P363, DOI 10.1007/s00701-005-0702-4; Fukushima S, 2009, NEUROL MED-CHIR, V49, P81; Hancock JH, 2000, NEURORADIOLOGY, V42, P535; Kang HS, 2007, INTERV NEURORADIOL, V13, P271; Matsuyama T, 2002, NEUROL MED-CHIR, V42, P214, DOI 10.2176/nmc.42.214; Saito A, 2000, NEUROL SURG TOKYO, V28, P269; Takeuchi Satoru, 2009, Brain and Nerve (Tokyo), V61, P203	8	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					E197	E199		10.1016/j.jstrokecerebrovasdis.2015.03.055		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000002		
J	Yoshimura, S; Ago, T; Koga, M; Kamouchi, M; Kitazono, T				Yoshimura, Sohei; Ago, Tetsuro; Koga, Masatoshi; Kamouchi, Masahiro; Kitazono, Takanari			Cerebral Small-Vessel Disease in Neuro-Behcet Disease	JOURNAL OF STROKE & CEREBROVASCULAR DISEASES			English	Article						Neuro-Behcet disease; lacunar infarction; apparent diffusion coefficient; diffusion-weighted image		Background: Involvement of central nervous system is very common in Behcet disease, known as neuro-Behcet disease (NBD). However, there have been few reports which evaluated stroke-like cerebral small-vessel disease associated with Behcet disease. Objective: We evaluated cerebral small-vessel lesions by using magnetic resonance imaging in 2 patients with NBD. Clinical Cases: In a 41-year-old woman case, who developed dysarthria and left hemiparesis, diffusion-weighted images (DWI) showed small high-intensity areas in the bilateral internal capsule. The right lesion had a low apparent diffusion coefficient (ADC) value, whereas the left one had a high value. In a 59-year-old woman case, who developed dysarthria and left hemi-hypesthesia, DWI showed high-intensity areas in the right side of the pons and in the right peduncle of the midbrain. The lesion in the pons had a low ADC value, whereas the lesion in the midbrain had a high value. ADC map may be useful to identify symptomatic lesions in the brain, because only the lesions with low ADC values were symptomatic. Conclusions: NBD should be considered in those who had not had any risk factors for ischemic stroke but experienced cerebral small-vessel disease. (C) 2015 by National Stroke Association	[Yoshimura, Sohei] Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, Suita, Osaka 5658565, Japan; [Ago, Tetsuro; Kamouchi, Masahiro; Kitazono, Takanari] Kyushu Univ Hosp, Dept Nephrol Hypertens & Strokol, Fukuoka 812, Japan; [Ago, Tetsuro; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Koga, Masatoshi] Natl Cerebral & Cardiovasc Ctr, Div Cerebrovasc Med & Neurol, Suita, Osaka 5658565, Japan; [Kamouchi, Masahiro] Kyushu Univ, Dept Hlth Care Adm & Management, Grad Sch Med Sci, Fukuoka, Japan	Yoshimura, S (reprint author), Natl Cerebral & Cardiovasc Ctr, Dept Cerebrovasc Med, 5-7-1 Fujishirodai, Suita, Osaka 5658565, Japan.	sohei-y@ncvc.go.jp					WECHSLER B, 1992, NEUROLOGY, V42, P614; Arai Y, 2006, NEUROPATHOLOGY, V26, P579, DOI 10.1111/j.1440-1789.2006.00734.x; BAHAR S, 1993, NEURORADIOLOGY, V35, P352; Ehrlich G E, 1997, Int Rev Immunol, V14, P81, DOI 10.3109/08830189709116846; Hadfield MG, 1997, CLIN NEUROPATHOL, V16, P55; Krespi Y, 2001, EUR J NEUROL, V8, P719, DOI 10.1046/j.1468-1331.2001.00300.x; Kunimatsu A, 2003, NEURORADIOLOGY, V45, P524, DOI 10.1007/s00234-002-0890-z; RUBINSTEIN LJ, 1963, BRAIN, V86, P151, DOI 10.1093/brain/86.1.151; WOLF SM, 1965, ARCH NEUROL-CHICAGO, V12, P315	9	0	0	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	1052-3057	1532-8511		J STROKE CEREBROVASC	J. Stroke Cerebrovasc. Dis.	AUG	2015	24	8					E237	E239		10.1016/j.jstrokecerebrovasdis.2015.05.012		3	Neurosciences; Peripheral Vascular Disease	Neurosciences & Neurology; Cardiovascular System & Cardiology	CO6XB	WOS:000359300000011		
J	Fukunaga, H; Owada, S				Fukunaga, Hisanori; Owada, Shigeyoshi			Radiology After the Fukushima Disaster: A Case Report Of Soma General Hospital	JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY			English	Letter							EARTHQUAKE		[Fukunaga, Hisanori; Owada, Shigeyoshi] Soma Gen Hosp, Soma, Fukushima 9760011, Japan	Fukunaga, H (reprint author), Soma Gen Hosp, 142 Tsubogasaku, Soma, Fukushima 9760011, Japan.	fukunaga@bb.soma.or.jp					Fukunaga H, 2015, J ROY SOC MED, V108, P151, DOI 10.1177/0141076815572936; Kodama Y, 2014, DISASTER MED PUBLIC, V8, P471, DOI 10.1017/dmp.2014.112	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1546-1440			J AM COLL RADIOL	J. Am. Coll. Radiol.	AUG	2015	12	8					773	774		10.1016/j.jacr.2015.05.020		2	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CO5CK	WOS:000359177000004		
J	Mishima, E; Fukuda, S; Shinna, H; Hirayama, A; Akiyama, Y; Takeuchi, Y; Fukuda, NN; Suzuki, T; Suzuki, C; Yuri, A; Kikuchi, K; Tomioka, Y; Ito, S; Soga, T; Abe, T				Mishima, Eikan; Fukuda, Shinji; Shinna, Hisato; Hirayama, Akiyoshi; Akiyama, Yasutoshi; Takeuchi, Yoichi; Fukuda, Noriko N.; Suzuki, Takehiro; Suzuki, Chitose; Yuri, Akinori; Kikuchi, Koichi; Tomioka, Yoshihisa; Ito, Sadayoshi; Soga, Tomoyoshi; Abe, Takaaki			Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							COLONIC MICROBIAL-METABOLISM; GUT BACTERIAL TRANSLOCATION; CHLORIDE CHANNEL ACTIVATOR; KIDNEY-DISEASE; CAPILLARY-ELECTROPHORESIS; MASS-SPECTROMETRY; INDOXYL SULFATE; UREMIC TOXINS; FLORA; MICROINFLAMMATION	The accumulation of uremic toxins is involved in the progression of CKD. Various uremic toxins are derived from gut microbiota, and an imbalance of gut microbiota or dysbiosis is related to renal failure. However, the pathophysiologic mechanisms underlying the relationship between the gut microbiota and renal failure are still obscure. Using an adenine-induced renal failure mouse model, we evaluated the effects of the CIC-2 chloride channel activator lubiprostone (commonly used for the treatment of constipation) on CKD. Oral administration of lubiprostone (500 mu g/kg per day) changed the fecal and intestinal properties in mice with renal failure. Additionally, lubiprostone treatment reduced the elevated BUN and protected against tubulointerstitial damage, renal fibrosis, and inflammation. Gut microbiome analysis of 16S rRNA genes in the renal failure mice showed that lubiprostone treatment altered their microbial composition, especially the recovery of the levels of the Lactobacillaceae family and Prevotella genus, which were significantly reduced in the renal failure mice. Furthermore, capillary electrophoresis mass spectrometry-based metabolome analysis showed that lubiprostone treatment decreased the plasma level of uremic toxins, such as indoxyl sulfate and hippurate, which are derived from gut microbiota, and a more recently discovered uremic toxin, trans-aconitate. These results suggest that lubiprostone ameliorates the progression of CKD and the accumulation of uremic toxins by improving the gut microbiota and intestinal environment.	[Mishima, Eikan; Shinna, Hisato; Akiyama, Yasutoshi; Takeuchi, Yoichi; Suzuki, Takehiro; Suzuki, Chitose; Ito, Sadayoshi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Div Nephrol Endocrinol & Vasc Med, Sendai, Miyagi 9808574, Japan; [Kikuchi, Koichi; Abe, Takaaki] Tohoku Univ, Grad Sch Med, Dept Clin Biol & Hormonal Regulat, Sendai, Miyagi 9808574, Japan; [Mishima, Eikan; Akiyama, Yasutoshi] Tohoku Univ, Tohoku Med Megabank Org, Sendai, Miyagi 9808574, Japan; [Fukuda, Shinji; Hirayama, Akiyoshi; Fukuda, Noriko N.; Soga, Tomoyoshi] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Fukuda, Shinji] RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan; [Yuri, Akinori; Tomioka, Yoshihisa] Tohoku Univ, Grad Sch Pharmaceut Sci, Lab Oncol Pharm Practice & Sci, Sendai, Miyagi 9808574, Japan; [Abe, Takaaki] Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Sendai, Miyagi 9808574, Japan	Abe, T (reprint author), Tohoku Univ, Grad Sch Biomed Engn, Div Med Sci, Sendai, Miyagi 9808574, Japan.	takaabe@med.tohoku.ac.jp			JSPS [26860624, 24380072, 23390033]; Japan Kidney Foundation; Miyagi Kidney Foundation	This work was supported, in part, by JSPS Grants-in-Aid for Scientific Research (KAKENHI) Grants 26860624 (to E.M.), 24380072 (to S.F.), and 23390033 (to T.A.), the Japan Kidney Foundation, and the Miyagi Kidney Foundation.	Akiyama Y, 2012, TOXINS, V4, P1309, DOI 10.3390/toxins4111309; Musch MW, 2013, DIGEST DIS SCI, V58, P668, DOI 10.1007/s10620-012-2509-5; Fukuda S, 2014, SEMIN IMMUNOPATHOL, V36, P103, DOI 10.1007/s00281-013-0399-z; Niwa T, 1997, KIDNEY INT, V52, pS23; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Wong J, 2014, AM J NEPHROL, V39, P230, DOI 10.1159/000360010; Soga T, 2003, J PROTEOME RES, V2, P488, DOI 10.1021/pr034020m; Wikoff WR, 2009, P NATL ACAD SCI USA, V106, P3698, DOI 10.1073/pnas.0812874106; Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Evenepoel P, 2009, KIDNEY INT, V76, pS12, DOI 10.1038/ki.2009.402; Wang IK, 2012, APPL ENVIRON MICROB, V78, P1107, DOI 10.1128/AEM.05605-11; Khalif IL, 2005, DIGEST LIVER DIS, V37, P838, DOI 10.1016/j.dld.2005.06.008; Decleves AE, 2014, NAT REV NEPHROL, V10, P257, DOI 10.1038/nrneph.2014.31; Lacy BE, 2007, J CLIN GASTROENTEROL, V41, P345, DOI 10.1097/01.mcg.0000225665.68920.df; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Furusawa Y, 2013, NATURE, V504, P446, DOI 10.1038/nature12721; Kim SW, 2013, DNA RES, V20, P241, DOI 10.1093/dnares/dst006; Ramezani A, 2014, J AM SOC NEPHROL, V25, P657, DOI 10.1681/ASN.2013080905; Vanholder R, 2008, J AM SOC NEPHROL, V19, P863, DOI 10.1681/ASN.2007121377; STEPHEN AM, 1987, GUT, V28, P601, DOI 10.1136/gut.28.5.601; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Kakino M, 2010, BIOSCI BIOTECH BIOCH, V74, P1550, DOI 10.1271/bbb.100122; Vaziri ND, 2013, AM J NEPHROL, V37, P1, DOI 10.1159/000345969; Toyohara T, 2009, J AM SOC NEPHROL, V20, P2546, DOI 10.1681/ASN.2009070696; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Niwa T, 2010, J RENAL NUTR, V20, pS2, DOI 10.1053/j.jrn.2010.05.002; De Lisle RC, 2012, BMC GASTROENTEROL, V12, DOI 10.1186/1471-230X-12-156; Fei GJ, 2009, AM J PHYSIOL-GASTR L, V296, pG823, DOI 10.1152/ajpgi.90447.2008; Meyer TW, 2012, KIDNEY INT, V81, P949, DOI 10.1038/ki.2011.504; Moeser AJ, 2008, WORLD J GASTROENTERO, V14, P6012, DOI 10.3748/wjg.14.6012; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Vaziri ND, 2013, AM J NEPHROL, V38, P99, DOI 10.1159/000353764; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Wang FQ, 2012, DIGEST DIS SCI, V57, P2856, DOI 10.1007/s10620-012-2242-0	34	2	2	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	AUG	2015	26	8					1787	1794		10.1681/ASN.2014060530		8	Urology & Nephrology	Urology & Nephrology	CO1DY	WOS:000358895100008		
J	Sato, Y; Sato, W; Maruyama, S; Wilcox, CS; Falck, JR; Masuda, T; Kosugi, T; Kojima, H; Maeda, K; Furuhashi, K; Ando, M; Imai, E; Matsuo, S; Kadomatsu, K				Sato, Yuka; Sato, Waichi; Maruyama, Shoichi; Wilcox, Christopher S.; Falck, John R.; Masuda, Tomohiro; Kosugi, Tomoki; Kojima, Hiroshi; Maeda, Kayaho; Furuhashi, Kazuhiro; Ando, Masahiko; Imai, Enyu; Matsuo, Seiichi; Kadomatsu, Kenji			Midkine Regulates BP through Cytochrome P450-Derived Eicosanoids	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							SOLUBLE EPOXIDE HYDROLASE; ARACHIDONIC-ACID METABOLISM; RENIN-ANGIOTENSIN SYSTEM; EPOXYEICOSATRIENOIC ACIDS; EPOXYGENASE METABOLITES; ENDOTHELIAL-CELLS; HYPERPOLARIZING FACTORS; MOLECULAR-CLONING; DEFICIENT MICE; BLOOD-PRESSURE	The effects of endothelium-derived hyperpolarizing factors have been attributed to cytochrome P450-derived epoxyeicosatrienoic acids (EETs), but the regulation and role of EETs in endothelial dysfunction remain largely unexplored. Hypertension is a primary risk factor for renal dysfunction, which is frequently accompanied by various systemic diseases induced by endothelial dysfunction in the microcirculation. We previously reported that the endothelial growth factor midkine (MK) enhances hypertension in a model of CKD. Here, we investigated the hypothesis that MK regulates EET activity and thereby BP. MK gene-deleted mice were resistant to hypertension and developed less glomerulosclerosis and proteinuria after administration of a nitric oxide synthase (NOS) inhibitor in the setting of uninephrectomy. The hypertension observed in uninephrectomized wild-type mice after NOS inhibition was ameliorated by anti-MK antibody. MK-deficient mice produced higher amounts of EETs, and EETs dominantly regulated BP in these mice. Furthermore, MK administration to MK-deficient mice recapitulated the BP control observed in wild-type mice. EETs also dominantly regulated renal blood flow, which may influence renal function, in MK-deficient mice. Taken together, these results suggest that the MK/EET pathway is physiologically engaged in BP control and could be a target for the treatment of hypertension complicated by endothelial dysfunction.	[Sato, Yuka; Kadomatsu, Kenji] Nagoya Univ, Grad Sch Med, Dept Biochem, Nagoya, Aichi 4668550, Japan; [Sato, Yuka; Sato, Waichi; Maruyama, Shoichi; Masuda, Tomohiro; Kosugi, Tomoki; Kojima, Hiroshi; Maeda, Kayaho; Furuhashi, Kazuhiro; Imai, Enyu; Matsuo, Seiichi] Nagoya Univ, Grad Sch Med, Dept Nephrol, Nagoya, Aichi 4668550, Japan; [Ando, Masahiko] Nagoya Univ, Grad Sch Med, Ctr Adv Med & Clin Res, Nagoya, Aichi 4668550, Japan; [Wilcox, Christopher S.] Georgetown Univ, Hypertens Kidney & Vasc Res Ctr, Washington, DC USA; [Falck, John R.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA	Kadomatsu, K (reprint author), Nagoya Univ, Grad Sch Med, Dept Biochem, Showa Ku, 65 Tsurumai Cho, Nagoya, Aichi 4668550, Japan.	kkadoma@med.nagoya-u.ac.jp	Kadomatsu, Kenji/G-8083-2012		Ministry of Education, Culture, Sports, Science and Technology of Japan [23110002, 18390099, 20390092, 22590886, 19590947]; Global COE Program to Nagoya University; Ministry of Health, Labour and Welfare of Japan; Robert A. Welch Foundation [GL 625910]; US National Institutes of Health [GM31278, DK49870, DK36079, HL68686]; George E. Schreiner Chair of Nephrology	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan (Grant-in-Aid for Scientific Research on Innovative Areas 23110002 to K.K.; Grants-in-Aid 18390099 and 20390092 to K.K., 22590886 to and 19590947 to Y.Y.; and funds from the Global COE Program to Nagoya University), the Ministry of Health, Labour and Welfare of Japan (Grant-in-Aid for Progressive Renal Diseases Research, Research on Intractable Disease), the Robert A. Welch Foundation (grant GL 625910 to J.R.F.), the US National Institutes of Health (grants GM31278 to J.R.F., and DK49870, DK36079, and HL68686 to C.S.W.), and the George E. Schreiner Chair of Nephrology (funds to C.S.W.).	Lim YC, 2003, AM J PATHOL, V162, P1591, DOI 10.1016/S0002-9440(10)64293-9; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Nakamura E, 1998, GENES CELLS, V3, P811, DOI 10.1046/j.1365-2443.1998.00231.x; Imig JD, 2001, J VASC RES, V38, P247, DOI 10.1159/000051053; Zou HZ, 2007, CANCER EPIDEM BIOMAR, V16, P2686, DOI 10.1158/1055-9965.EPI-07-0518; Sun P, 2012, HYPERTENSION, V59, P339, DOI 10.1161/HYPERTENSIONAHA.111.178475; Pidkovka N, 2013, J BIOL CHEM, V288, P5223, DOI 10.1074/jbc.M112.407981; Kadomatsu KJ, 2004, CANCER LETT, V204, P127, DOI 10.1016/S0304-3835(03)00450-6; Zatz R, 1998, HYPERTENSION, V32, P958; Imig JD, 2009, NAT REV DRUG DISCOV, V8, P794, DOI 10.1038/nrd2875; Krotz F, 2004, ARTERIOSCL THROM VAS, V24, P595, DOI 10.1161/01.ATV.0000116219.09040.8c; Ledent C, 1997, NATURE, V388, P674; Nishikawa Y, 1999, AM J PHYSIOL-HEART C, V277, pH1252; Imig JD, 2005, AM J PHYSIOL-RENAL, V289, pF496, DOI 10.1152/ajprenal.00350.2004; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; Endemann DH, 2004, J AM SOC NEPHROL, V15, P1983, DOI 10.1097/01.ASN.0000132474.50966.DA; Bomback AS, 2007, NAT CLIN PRACT NEPHR, V3, P486, DOI 10.1038/ncpneph0575; Fisslthaler B, 1999, NATURE, V401, P493; Roman RJ, 2002, PHYSIOL REV, V82, P131; ZELDIN DC, 1995, ARCH BIOCHEM BIOPHYS, V322, P76, DOI 10.1006/abbi.1995.1438; Ishii M, 2009, NATURE, V458, P524, DOI 10.1038/nature07713; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; MAKITA K, 1994, J CLIN INVEST, V94, P2414, DOI 10.1172/JCI117608; KADOMATSU K, 1988, BIOCHEM BIOPH RES CO, V151, P1312, DOI 10.1016/S0006-291X(88)80505-9; Bauersachs J, 1996, CIRCULATION, V94, P3341; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Horiba M, 2000, J CLIN INVEST, V105, P489, DOI 10.1172/JCI7208; Campbell WB, 2007, HYPERTENSION, V49, P590, DOI 10.1161/01.HYP.0000255173.50317.fc; Ikematsu S, 2000, BRIT J CANCER, V83, P701, DOI 10.1054/bjoc.2000.1339; Wu S, 1996, J BIOL CHEM, V271, P3460; Davis BB, 2002, P NATL ACAD SCI USA, V99, P2222, DOI 10.1073/pnas.261710799; Chen JK, 1998, J BIOL CHEM, V273, P29254, DOI 10.1074/jbc.273.44.29254; Imig JD, 1996, J AM SOC NEPHROL, V7, P2364; Sato W, 2001, J IMMUNOL, V167, P3463; Wang JY, 2008, P NATL ACAD SCI USA, V105, P3915, DOI 10.1073/pnas.0709592105; Schiffrin EL, 2000, CIRCULATION, V101, P1653; Campbell WB, 1996, CIRC RES, V78, P415; NAGAO T, 1992, AM J PHYSIOL, V263, pH1090; Imig JD, 2006, CARDIOVASC DRUG REV, V24, P169, DOI 10.1111/j.1527-3466.2006.00169.x; Lee CR, 2010, FASEB J, V24, P3770, DOI 10.1096/fj.10-160119; Arima S, 1997, J CLIN INVEST, V100, P2816, DOI 10.1172/JCI119829; Baragatti B, 2009, AM J PHYSIOL-HEART C, V297, pH2161, DOI 10.1152/ajpheart.00576.2009; Bro S, 2007, ARTERIOSCL THROM VAS, V27, P1080, DOI 10.1161/ATVBAHA.107.139634; Campbell W B, 2001, Med Sci Monit, V7, P578; Dzielak DJ, 1992, HYPERTENSION S1, V19, P136; Feick JR, 2009, J MED CHEM, V52, P5069; Fleming I, 2006, HYPERTENSION, V47, P629, DOI 10.1061/01.HYP.0000208597.87957.89; HIRSCH AT, 1992, CIRCULATION, V86, P1566; Hobo A, 2009, J CLIN INVEST, V119, P1616, DOI 10.1172/JCI37249; Liclican EL, 2009, HYPERTENSION, V54, P1284, DOI 10.1161/HYPERTENSIONAHA.108.123570; Maehara H, 2007, BIOCHEM BIOPH RES CO, V358, P757, DOI 10.1016/j.bbrc.2007.04.183; MURAMATSU H, 1991, BIOCHEM BIOPH RES CO, V177, P652, DOI 10.1016/0006-291X(91)91838-4; SCHWARTZMAN ML, 1990, KIDNEY INT, V37, P94, DOI 10.1038/ki.1990.13; Shen HC, 2009, J MED CHEM, V52, P5009, DOI 10.1021/jm900725r; Struthers A D, 1996, J Card Fail, V2, P47, DOI 10.1016/S1071-9164(96)80009-1	55	0	0	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	AUG	2015	26	8					1806	1815		10.1681/ASN.2013121259		10	Urology & Nephrology	Urology & Nephrology	CO1DY	WOS:000358895100010		
J	Motonishi, S; Nangaku, M; Wada, T; Ishimoto, Y; Ohse, T; Matsusaka, T; Kubota, N; Shimizu, A; Kadowaki, T; Tobe, K; Inagi, R				Motonishi, Shuta; Nangaku, Masaomi; Wada, Takehiko; Ishimoto, Yu; Ohse, Takannoto; Matsusaka, Taiji; Kubota, Naoto; Shimizu, Akira; Kadowaki, Takashi; Tobe, Kazuyuki; Inagi, Reiko			Sirtuin1 Maintains Actin Cytoskeleton by Deacetylation of Cortactin in Injured Podocytes	JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY			English	Article							CRESCENTIC GLOMERULONEPHRITIS; CALORIE RESTRICTION; DIABETIC-NEPHROPATHY; GLOMERULAR-DISEASES; SIRT1 DEACETYLASE; KIDNEY-DISEASE; CELL-MIGRATION; PROTECTS; OVEREXPRESSION; ACTIVATION	Recent studies have highlighted the renoprotective effect of sirtuin1 (SIRT1), a deacetylase that contributes to cellular regulation. However, the pathophysiologic role of SIRT1 in podocytes remains unclear. Here, we investigated the function of SIRT1 in podocytes. We first established podocyte-specific Sirt1 knockout (SIRT1(pod-/-)) mice. We then induced glomerular disease by nephrotoxic serum injection. The increase in urinary albumin excretion and BUN and the severity of glomerular injury were all significantly greater in SIRT1(pod-/-) mice than in wild-type mice. Western blot analysis and immunofluorescence showed a significant decrease in podocyte-specific proteins in SIRT1(pod-/-) mice, and electron microscopy showed marked exacerbation of podocyte injury, including actin cytoskeleton derangement in SIRT1(pod-/-) mice compared with wild-type mice. Protamine sulfate-induced podocyte injury was also exacerbated by podocyte-specific SIRT1 deficiency. In vitro, actin cytoskeleton derangement in H2O2-treated podocytes became prominent when the cells were pretreated with SIRT1 inhibitors. Conversely, this H2O2-induced derangement was ameliorated by SIRT1 activation. Furthermore, SIRT1 activation deacetylated the actin-binding and -polymerizing protein cortactin in the nucleus and facilitated deacetylated cortactin localization in the cytoplasm. Cortactin knockdown or inhibition of the nuclear export of cortactin induced actin cytoskeleton derangement and dissociation of cortactin from F-actin, suggesting the necessity of cytoplasmic cortactin for maintenance of the actin cytoskeleton. Taken together, these findings indicate that SIRT1 protects podocytes and prevents glomerular injury by deacetylating cortactin and thereby, maintaining actin cytoskeleton integrity.	[Motonishi, Shuta; Nangaku, Masaomi; Wada, Takehiko; Ishimoto, Yu; Ohse, Takannoto; Inagi, Reiko] Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Tokyo 1138655, Japan; [Inagi, Reiko] Univ Tokyo, Grad Sch Med, Div CKD Pathophysiol, Tokyo 1138655, Japan; [Kubota, Naoto; Kadowaki, Takashi] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138655, Japan; [Matsusaka, Taiji] Tokai Univ, Dept Internal Med, Sch Med, Hiratsuka, Kanagawa 25912, Japan; [Shimizu, Akira] Nippon Med Sch, Dept Analyt Human Pathol, Tokyo 113, Japan; [Tobe, Kazuyuki] Toyama Univ, Fac Med, Dept Internal Med 1, Toyama 930, Japan	Nangaku, M (reprint author), Univ Tokyo, Grad Sch Med, Div Nephrol & Endocrinol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138655, Japan.	mnangaku-tky@umin.ac.jp; inagi-npr@umin.ac.jp			Japan Society for the Promotion of Science [24390213, 24591189, 25461207]; Japanese Association of Dialysis Physicians Grant [2012-05]; Kyowa Hakko Kirin Co., Ltd.; Charitable Trust Araki Memorial Foundation for Medical and Biochemical Research	This work was supported by Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research 24390213 (to M.N.), 24591189 (to T.W.), and 25461207 (to R.I.). The study was also supported by Japanese Association of Dialysis Physicians Grant 2012-05 (to R.I.), Kyowa Hakko Kirin Co., Ltd. (R.I.), and Charitable Trust Araki Memorial Foundation for Medical and Biochemical Research.	Guarente L, 2011, NEW ENGL J MED, V364, P2235, DOI 10.1056/NEJMra1100831; Jung YJ, 2012, BIOCHEM BIOPH RES CO, V419, P206, DOI 10.1016/j.bbrc.2012.01.148; Hasegawa K, 2010, J BIOL CHEM, V285, P13045, DOI 10.1074/jbc.M109.067728; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Zhao JP, 2013, MOL CELL BIOL, V33, P38, DOI 10.1128/MCB.00734-12; Hering H, 2003, J NEUROSCI, V23, P11759; Qin WP, 2006, J BIOL CHEM, V281, P21745, DOI 10.1074/jbc.M602909200; He WJ, 2010, J CLIN INVEST, V120, P1056, DOI 10.1172/JCI41563; Nangaku M, 2005, NEPHROL DIAL TRANSPL, V20, P2661, DOI 10.1093/ndt/gfi096; Mundel P, 2010, KIDNEY INT, V77, P571, DOI 10.1038/ki.2009.424; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Kume S, 2010, J CLIN INVEST, V120, P1043, DOI 10.1172/JCI41376; Nakagawa T, 2011, J CELL SCI, V124, P833, DOI 10.1242/jcs.081067; Nakahata Y, 2008, CELL, V134, P329, DOI 10.1016/j.cell.2008.07.002; Reiser J, 2010, KIDNEY INT, V77, P662, DOI 10.1038/ki.2009.559; Zhang Y, 2009, ONCOGENE, V28, P445, DOI 10.1038/onc.2008.388; Lan F, 2008, J BIOL CHEM, V283, P27628, DOI 10.1074/jbc.M805711200; Guo JK, 2002, HUM MOL GENET, V11, P651, DOI 10.1093/hmg/11.6.651; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Dioum EM, 2009, SCIENCE, V324, P1289, DOI 10.1126/science.1169956; Yuan YG, 2012, KIDNEY INT, V82, P771, DOI 10.1038/ki.2012.188; Lu C, 2012, CELL METAB, V16, P9, DOI 10.1016/j.cmet.2012.06.001; Moeller MJ, 2003, GENESIS, V35, P39, DOI 10.1002/gene.10164; Kaluza D, 2011, EMBO J, V30, P4142, DOI 10.1038/emboj.2011.298; Kume S, 2006, FREE RADICAL BIO MED, V40, P2175, DOI 10.1016/j.freeradbiomed.2006.02.014; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2008.08.011; Weaver AM, 2008, CANCER LETT, V265, P157, DOI 10.1016/j.canlet.2008.02.066; Reiser J, 2013, ANNU REV MED, V64, P357, DOI 10.1146/annurev-med-050311-163340; Chiang CK, 2011, LAB INVEST, V91, P1564, DOI 10.1038/labinvest.2011.114; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; WU H, 1991, MOL CELL BIOL, V11, P5113; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Zhang XH, 2007, MOL CELL, V27, P197, DOI 10.1016/j.molcel.2007.05.033; Oh J, 2004, PEDIATR NEPHROL, V19, P130, DOI 10.1007/s00467-003-1367-y; Buday L, 2007, BBA-REV CANCER, V1775, P263, DOI 10.1016/j.bbcan.2006.12.002; Ichimura K, 2003, J HISTOCHEM CYTOCHEM, V51, P1589; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Hasegawa K, 2013, NAT MED, V19, P1496, DOI 10.1038/nm.3363; Planavila A, 2011, CARDIOVASC RES, V90, P276, DOI 10.1093/cvr/cvq376; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Singh SK, 2013, J EXP MED, V210, P987, DOI 10.1084/jem.20121608; Wang RH, 2008, MOL CELL, V32, P11, DOI 10.1016/j.molcel.2008.09.011; Baur JA, 2010, BBA-PROTEINS PROTEOM, V1804, P1626, DOI 10.1016/j.bbapap.2009.10.025; Pfluger PT, 2008, P NATL ACAD SCI USA, V105, P9793, DOI 10.1073/pnas.0802917105; Schaldecker T, 2013, J CLIN INVEST, V123, P5298, DOI 10.1172/JCI71165; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Bariety J, 2005, KIDNEY INT, V68, P1109, DOI 10.1111/j.1523-1755.2005.00503.x; Besse-Eschmann V, 2004, HISTOCHEM CELL BIOL, V122, P139, DOI 10.1007/s00418-004-0683-z; Chiang CK, 2010, NAT REV NEPHROL, V6, P539, DOI 10.1038/nrneph.2010.103; Chuang PY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023566; Chugh S, 2001, KIDNEY INT, V59, P601, DOI 10.1046/j.1523-1755.2001.059002601.x; Firestein R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002020; Hao CM, 2010, J AM SOC NEPHROL, V21, P1620, DOI 10.1681/ASN.2010010046; Kitada M, 2013, CLIN SCI, V124, P153, DOI 10.1042/CS20120190; Kobayashi T, 2009, NEPHRON EXP NEPHROL, V113, pE89, DOI 10.1159/000235245; Martínez-Redondo Paloma, 2013, Genes Cancer, V4, P148, DOI 10.1177/1947601913483767; Matsusaka T, 2010, HYPERTENSION, V55, P967, DOI 10.1161/HYPERTENSIONAHA.109.141994; Min SW, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00053; Rigothier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037695; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Sadoul K, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/970382; Stern JS, 2001, J NUTR, V131, p913S; Tryggvason K, 2006, NEW ENGL J MED, V354, P1387, DOI 10.1056/NEJMra052131; Wada T, 2005, KIDNEY INT, V68, P1618, DOI 10.1111/j.1523-1755.2005.00574.x; WU H, 1993, J CELL BIOL, V120, P1417, DOI 10.1083/jcb.120.6.1417	69	0	0	AMER SOC NEPHROLOGY	WASHINGTON	1725 I ST, NW STE 510, WASHINGTON, DC 20006 USA	1046-6673	1533-3450		J AM SOC NEPHROL	J. Am. Soc. Nephrol.	AUG	2015	26	8					1939	1959		10.1681/ASN.2014030289		21	Urology & Nephrology	Urology & Nephrology	CO1DY	WOS:000358895100019		
J	Hirose, E; Sakai, D; Shibata, T; Nishii, J; Mayama, H; Miyauchi, A; Nishikawa, J				Hirose, Euichi; Sakai, Daisuke; Shibata, Tomohiro; Nishii, Junji; Mayama, Hiroyuki; Miyauchi, Akihiro; Nishikawa, Jun			Does the tunic nipple array serve to camouflage diurnal salps?	JOURNAL OF THE MARINE BIOLOGICAL ASSOCIATION OF THE UNITED KINGDOM			English	Article						antireflection; nipple array; rigorous coupled wave analysis (RCWA); tunic cuticle; ultrastructure; UV	VERTICAL MIGRATION; MORPHOLOGY; THALIACEA; LIGHT	The salp Thalia rhomboides is distributed in the shallow depths during the day, and is thus at increased risk of predation by visual predators and from the damaging effects of ultraviolet (UV) radiation compared with species distributed in deeper layers in the daytime. The integument (tunic) of T. rhomboides may have adaptive optical properties, but the absorption spectra of the unfixed tunic demonstrate that the tunic transmits UV as well as visible light, indicating that the tunic is not an effective barrier against UV radiation. Ultrastructural observation revealed that the surface of the tunic cuticle is covered in a nipple array consisting of hemispherical protuberances approximately 40 and 30 nm in diameter in solitary and aggregate zooids, respectively. Simulation of light reflection of a nipple array using rigorous coupled wave analysis (RCWA) indicated that the reflection is slightly lower for the nipple array than for a flat surface at high angles of incidence (theta > 80 degrees). This result supports the idea that the nipple array serves to make the salp less visible. The simulation also indicated that the height and distribution of the salp nipple array do not have an optimal structure for causing an antireflection effect. A mechanical restriction might exist on the structures, and the nipple array could also serve another function. The size and distribution of nipples may be controlled by the need to meet the complex requirements of multiple essential functions.	[Hirose, Euichi] Univ Ryukyus, Fac Sci, Nishihara, Okinawa 9030213, Japan; [Sakai, Daisuke] Kitami Inst Technol, Dept Elect & Elect Engn, Kitami, Hokkaido 0908507, Japan; [Shibata, Tomohiro; Nishii, Junji] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0010020, Japan; [Mayama, Hiroyuki] Asahikawa Med Univ, Dept Chem, Asahikawa, Hokkaido 0788510, Japan; [Miyauchi, Akihiro] Hitachi Ltd, Hitachi Res Lab, Hitachi, Ibaraki 3191292, Japan; [Nishikawa, Jun] Tokai Univ, Sch Marine Sci & Technol, Dept Marine Biol, Shimizu, Shizuoka 4248610, Japan	Hirose, E (reprint author), Univ Ryukyus, Fac Sci, Nishihara, Okinawa 9030213, Japan.	euichi@sci.u-ryukyu.ac.jp			Interdisciplinary Collaborative Research Programme of Atmosphere and Ocean Research Institute, University of Tokyo	This study is supported by the Interdisciplinary Collaborative Research Programme of the Atmosphere and Ocean Research Institute, the University of Tokyo. We thank Shohei Kadena and Yoshikatsu Nakano (Tropical Biosphere Research Center, University of the Ryukyus) for supporting material collection.	Gibbons MJ, 1997, J MAR BIOL ASSOC UK, V77, P493; BERNHARD CG, 1967, ENDEAVOUR, V26, P79; Kuwabara K, 2008, J VAC SCI TECHNOL B, V26, P582, DOI 10.1116/1.2889396; Hirose E, 1999, BIOL BULL, V196, P113, DOI 10.2307/1543173; Hirose E, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2013.0552; Johnsen S, 2003, INTEGR COMP BIOL, V43, P580, DOI 10.1093/icb/43.4.580; Stavenga DG, 2006, P ROY SOC B-BIOL SCI, V273, P661, DOI 10.1098/rspb.2005.3369; Gagnon YL, 2007, J EXP BIOL, V210, P3728, DOI 10.1242/jeb.003251; Hausen H, 2005, HYDROBIOLOGIA, V535, P25, DOI 10.1007/s10750-004-4442-x; Hirose E, 1997, ZOOL SCI, V14, P683, DOI 10.2108/zsj.14.683; Hirose E, 2004, J MAR BIOL ASSOC UK, V84, P789, DOI 10.1017/S0025315404009956h; Holland ND, 1984, BIOL INTEGUMENT, V1, P756; Iseto T, 2010, J MORPHOL, V271, P1185, DOI 10.1002/jmor.10863; Kashkina AA, 1986, J ICHTHYOL, V26, P57; Madin LP, 1996, J PLANKTON RES, V18, P747, DOI 10.1093/plankt/18.5.747; Nielsen C., 1997, MICROSCOPIC ANATOMY, V13, P13; Nishikawa J, 2001, POLAR BIOL, V24, P299, DOI 10.1007/s003000100227	17	1	1	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	0025-3154	1469-7769		J MAR BIOL ASSOC UK	J. Mar. Biol. Assoc. U.K.	AUG	2015	95	5					1025	1031		10.1017/S0025315415000119		7	Marine & Freshwater Biology	Marine & Freshwater Biology	CO0NJ	WOS:000358848400018		
J	Hayashi, N; Sugizono, R; Harimaya, K; Shijo, K; Tsubota, K; Mitsunaga, M				Hayashi, Nobuhito; Sugizono, Ryuta; Harimaya, Kazuki; Shijo, Kotaro; Tsubota, Kosuke; Mitsunaga, Masaharu			Interference between electromagnetically induced transparency and N-type resonances in Na vapor	JOURNAL OF THE OPTICAL SOCIETY OF AMERICA B-OPTICAL PHYSICS			English	Article							DARK RESONANCES; ATOMIC VAPOR; CLOCK; LIGHT; REDUCTION; STORAGE; SHIFTS; STATES; GAS	We show theoretically and experimentally that the line shapes observed in ordinary electromagnetically induced transparency (EIT) experiments in sodium atomic vapor can be explained by the superposition of two processes, EIT and N-type resonances (NTR). When the higher frequency side of the Doppler absorption profile is excited, EIT is dominant, whereas, for the lower frequency side, NTR is dominant, and, in between, interference between EIT and NTR takes place. Theoretical simulations, based on a perturbative approach, agreed reasonably well with the experimental observations. The signal behavior concerning ac Stark shifts has also been studied for EIT and NTR; it was found that, although the signal peak always shifts toward the higher frequency in the case of EIT, for NTR, the shift can be nullified by adjusting the power balance of the two incident beams. (C) 2015 Optical Society of America	[Hayashi, Nobuhito; Sugizono, Ryuta; Harimaya, Kazuki; Shijo, Kotaro; Tsubota, Kosuke; Mitsunaga, Masaharu] Kumamoto Univ, Grad Sch Sci & Technol, Kumamoto, Kumamoto 8608555, Japan	Mitsunaga, M (reprint author), Kumamoto Univ, Grad Sch Sci & Technol, 2-39-1 Kurokami, Kumamoto, Kumamoto 8608555, Japan.	mitunaga@sci.kumamoto-u.ac.jp					Phillips DF, 2001, PHYS REV LETT, V86, P783, DOI 10.1103/PhysRevLett.86.783; Hayashi N, 2010, J OPT SOC AM B, V27, P1645, DOI 10.1364/JOSAB.27.001645; Wynands R, 1999, APPL PHYS B-LASERS O, V68, P1, DOI 10.1007/s003400050581; Lukin MD, 1999, PHYS REV LETT, V82, P1847, DOI 10.1103/PhysRevLett.82.1847; Merimaa M, 2003, J OPT SOC AM B, V20, P273, DOI 10.1364/JOSAB.20.000273; FIELD JE, 1991, PHYS REV LETT, V67, P3062, DOI 10.1103/PhysRevLett.67.3062; Fleischhauer M, 2000, PHYS REV LETT, V84, P5094, DOI 10.1103/PhysRevLett.84.5094; Liu C, 2001, NATURE, V409, P490, DOI 10.1038/35054017; Brandt S, 1997, PHYS REV A, V56, pR1063; BOLLER KJ, 1991, PHYS REV LETT, V66, P2593, DOI 10.1103/PhysRevLett.66.2593; Castagna N, 2009, IEEE T ULTRASON FERR, V56, P246, DOI 10.1109/TUFFC.2009.1033; van der Wal CH, 2003, SCIENCE, V301, P196, DOI 10.1126/science.1085946; Guerandel S, 2007, IEEE T INSTRUM MEAS, V56, P383, DOI 10.1109/TIM.2007.891124; Hancox C, 2008, OPT LETT, V33, P1536, DOI 10.1364/OL.33.001536; Hau LV, 1999, NATURE, V397, P594, DOI 10.1038/17561; Hayashi N, 2013, OPT LETT, V38, P2687, DOI 10.1364/OL.38.002687; Hoshina Y, 2014, J OPT SOC AM B, V31, P1808, DOI 10.1364/JOSAB.31.001808; Novikova I, 2006, OPT LETT, V31, P622, DOI 10.1364/OL.31.000622; Novikova I, 2006, OPT LETT, V31, P2353, DOI 10.1364/OL.31.002353; Sargsyan A, 2012, OPT LETT, V37, P4871, DOI 10.1364/OL.37.004871; Takahashi K, 2011, PHYS REV A, V83, DOI 10.1103/PhysRevA.83.063824; Wynands R, 1998, PHYS REV A, V58, P196, DOI 10.1103/PhysRevA.58.196; Yano Y, 2012, JPN J APPL PHYS, V51, DOI 10.1143/JJAP.51.122401; Yoshida I, 2013, PHYS REV A, V87, DOI 10.1103/PhysRevA.87.023836; Zibrov AS, 2002, PHYS REV A, V65, DOI [10.1103/PhysRevA.65.043817, 10.1103/PhysRevB.65.043817]; Zibrov S, 2005, PHYS REV A, V72, DOI 10.1103/PhysRevA.72.011801	26	0	0	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	0740-3224	1520-8540		J OPT SOC AM B	J. Opt. Soc. Am. B-Opt. Phys.	AUG 1	2015	32	8					1754	1760		10.1364/JOSAB.32.001754		7	Optics	Optics	CN9SB	WOS:000358788200030		
J	Ravi, K; Ichikawa, Y; Deplancke, T; Ogawa, K; Lame, O; Cavaille, JY				Ravi, Kesavan; Ichikawa, Yuji; Deplancke, Tiana; Ogawa, Kazuhiro; Lame, Olivier; Cavaille, Jean-Yves			Development of Ultra-High Molecular Weight Polyethylene (UHMWPE) Coating by Cold Spray Technique	JOURNAL OF THERMAL SPRAY TECHNOLOGY			English	Review						coating; cold spray; nano-ceramic particle; ultra-high molecular weight polyethylene (UHMWPE)	NANOCOMPOSITES; POLYMERS; BEHAVIOR; POWDERS; IMPACT; WEAR	Ultra-high molecular weight polyethylene or UHMWPE is an extremely difficult material to coat with, as it is rubbery and chemically very inert. The Cold Spray process appears to be a promising alternative processing technique but polymers are in general difficult to deposit using this method. So, attempts to develop UHMWPE coatings were made using a downstream injection cold spray technique incorporating a few modifications. A conventional cold spray machine yielded only a few deposited particles of UHMWPE on the substrate surface, but with some modifications in the nozzle geometry (especially the length and inner geometry) a thin coating of 45 mu m on Al substrate was obtained. Moreover, experiments with the addition of fumed nano-alumina to the feedstock yielded a coating of 1-4 mm thickness on Al and polypropylene substrates. UHMWPE was seen to be melt crystallized during the coating formation, as can be seen from the differential calorimetry curves. Influence of nano-ceramic particles was explained by observing the creation of a bridge bond between UHMWPE particles.	[Ravi, Kesavan; Ichikawa, Yuji; Ogawa, Kazuhiro] Tohoku Univ, Fracture & Reliabil Res Inst, Aoba Ku, Sendai, Miyagi 9808579, Japan; [Deplancke, Tiana; Lame, Olivier; Cavaille, Jean-Yves] Univ Lyon, CNRS, UMR5510, Mat Engn & Sci MATEIS,INSA Lyon, F-69621 Villeurbanne, France	Ravi, K (reprint author), Tohoku Univ, Fracture & Reliabil Res Inst, Aoba Ku, 6-6-11-720 Aoba, Sendai, Miyagi 9808579, Japan.	kesavan_ravi@rift.mech.tohoku.ac.jp		Ichikawa, Yuji/0000-0002-9474-3467	ONR (USA); JTSS internship program; JSPS	The authors are indebted to Ticona (Oberhausen, Germany) for the generous supply of the UHMWPE sample together with its molecular characteristics. One of us, Tiana Deplancke acknowledges ONR (USA) for its financial support through the NICOP project. Authors would also like to thank JTSS internship program for financing and supporting the internship, carried out at Iwate Industrial Research Institute. This work was partly supported by the JSPS Core-to-Core Program, A. Advanced Research Networks, "International research core on smart layered materials and structures for energy saving." Authors would also like to thank Prof. Hidemasa Takana from Institute of Fluid Science (Tohoku University) for his valuable insights to understanding the flow dynamics within the nozzles.	Alhulaifi AS, 2012, J THERM SPRAY TECHN, V21, P852, DOI 10.1007/s11666-012-9743-4; Xu Y, 2006, SURF COAT TECH, V201, P3044, DOI 10.1016/j.surfcoat.2006.06.016; Dykhuizen RC, 1998, J THERM SPRAY TECHN, V7, P205, DOI 10.1361/105996398770350945; Rastogi S, 2005, NAT MATER, V4, P635, DOI 10.1038/nmat1437; Liu CZ, 1999, WEAR, V225, P199, DOI 10.1016/S0043-1648(99)00011-3; Lin LL, 1997, POLYMER, V38, P1997, DOI 10.1016/S0032-3861(96)00713-6; Kontou E, 2006, POLYMER, V47, P1267, DOI 10.1016/j.polymer.2005.12.039; Jauffres D, 2008, MACROMOLECULES, V41, P9793, DOI 10.1021/ma801133v; Sitaram SP, 1997, J COATING TECHNOL, V69, P65, DOI 10.1007/BF02696146; Kosarev VF, 2003, J THERM SPRAY TECHN, V12, P265, DOI 10.1361/105996303770348384; Papyrin A, 2001, ADV MATER PROCESS, V159, P49; WROBEL AM, 1978, POLYMER, V19, P908, DOI 10.1016/0032-3861(78)90197-0; [Anonymous], TECHN INF, P1283; Assadi H, 2003, ACTA MATER, V51, P4379, DOI [10.1016/S1359-6454(03)00274-X, 10.1016/S1359-6465(03)00274-X]; Grujicic M, 2004, MAT SCI ENG A-STRUCT, V368, P222, DOI 10.1016/j.msea.2003.10.312; Yang J, 2005, POWDER TECHNOL, V158, P21, DOI 10.1016/j.powtec.2005.04.032; Bartczak Z, 2012, J APPL POLYM SCI, V125, P4155, DOI 10.1002/app.36595; Bhimaraj P, 2008, WEAR, V264, P632, DOI 10.1016/j.wear.2007.05.009; Brandrup J., 1999, POLYM HDB, V89; CHANZY HD, 1974, COLLOID POLYM SCI, V252, P8, DOI 10.1007/BF01381688; Coguill S.L., 2012, U.S. Patent Application, Patent No. [13/506, 215, 135062152012]; Deplancke T., 2013, MACROMOLECULES, V47, P197; Kurtz S. M., 2004, UHMWPE HDB ULTRAHIGH; Leivo E, 2004, PROG ORG COAT, V49, P69, DOI 10.1016/j.porgcoat.2003.08.011; Lima CRC, 2013, SURF COAT TECH, V220, P140, DOI 10.1016/j.surfcoat.2012.05.051; Lortz W., 2010, U.S. Patent, Patent No. [7,834,076, 7834076]; Mikos A. G., 1996, U.S. patent, Patent No. [5,514,378, 5514378]; PREVORSEK DC, 1994, POLYM ENG SCI, V34, P141, DOI 10.1002/pen.760340211; Ravi K., 2015, INT THERM SPRAY C EX; Scott G., 1999, POLYM ENV; Wang YQ, 1998, WEAR, V218, P128, DOI 10.1016/S0043-1648(97)00289-5; Zhang G, 2007, PROG ORG COAT, V60, P39, DOI 10.1016/j.porgcoat.2007.06.004	32	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1059-9630	1544-1016		J THERM SPRAY TECHN	J. Therm. Spray Technol.	AUG	2015	24	6					1015	1025		10.1007/s11666-015-0276-5		11	Materials Science, Coatings & Films	Materials Science	CO2DL	WOS:000358965400013		
J	Hashimoto, T; Fang, YI; Ohata, H; Honda, K				Hashimoto, Terumasa; Fang, Yang-Il; Ohata, Hisayuki; Honda, Kazuo			Change in soluble epoxide hydrolase (sEH) during cisplatin-induced acute renal failure in mice	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Cisplatin; Nephrotoxicity; Soluble epoxide hydrolase; Epoxyeicosatrienoic acid	ACID-BINDING PROTEIN; FACTOR-KAPPA-B; KIDNEY INJURY; NEPHROTOXICITY; ATTENUATION; MECHANISMS; BIOMARKER; RATS	Cisplatin is one of the most effective chemotherapeutic agents against various types of cancers; however, it is also associated with nephrotoxicity. Recently, it was reported that inflammatory mechanisms play a key role in the development of nephrotoxicity. Epoxyeicosatrienoic acids (EETs) have an anti-inflammatory effect and are metabolized by soluble epoxide hydrolase (sEH: encoded by EPHX2 gene). Here, we determined the change in sEH activity and EPHX2 expression in renal tissue associated with the development of cisplatin-induced nephrotoxicity. Cisplatin administration decreased hydrolase activity accompanied by down-regulation of sEH and EPHX2 expression. The down-regulation occurred prior to the elevation of blood urea nitrogen (BUN) and tumor necrosis factor-alpha (TNF-alpha) gene expression or at treatment with low dose cisplatin. In addition, a negative correlation was found between EPHX2 expression and renal thiobarbituric acid reactive substance (TBARS), and edaravone, a radical scavenger, administration did not down-regulate expression of this gene. The results of this study suggest that cisplatin decreased sEH activity through the down-regulation of sEH and EPHX2 expression, and this down-regulation was involved in a negative feedback loop to protect renal tissue from further damage. Thus, sEH is a potential therapeutic target of cisplatin-induced nephrotoxicity.	[Hashimoto, Terumasa; Fang, Yang-Il; Ohata, Hisayuki; Honda, Kazuo] Showa Univ, Sch Pharm, Div Pharmacol, Dept Pharmacol Toxicol & Therapeut,Shinagawa Ku, Tokyo 1428555, Japan	Hashimoto, T (reprint author), Showa Univ, Sch Pharm, Div Pharmacol, Dept Pharmacol Toxicol & Therapeut,Shinagawa Ku, 1-5-8 Hatanodai, Tokyo 1428555, Japan.	t-hashi@pharm.showa-u.ac.jp			Showa University; Japanese Ministry of Education, Culture, Sports, Science and Technology	This work was supported in part by a Showa University Special Grant-in-Aid for Innovative Collaborative Research Project and a Special Research Grant-in-Aid for Development of Characteristic Education from the Japanese Ministry of Education, Culture, Sports, Science and Technology. The funding bodies had no role in the study design, data collection or analysis, writing of the report, or the decision to submit the article for publication.	MADIAS NE, 1978, AM J MED, V65, P307, DOI 10.1016/0002-9343(78)90825-2; Simon AR, 1998, AM J PHYSIOL-CELL PH, V275, pC1640; SCHRECK R, 1992, FREE RADICAL RES COM, V17, P221, DOI 10.3109/10715769209079515; Miller RP, 2010, TOXINS, V2, P2490, DOI 10.3390/toxins2112490; Spector AA, 2007, AM J PHYSIOL-CELL PH, V292, pC996, DOI 10.1152/ajpcell.00402.2006; Xu JF, 2003, FREE RADICAL BIO MED, V34, P1531, DOI 10.1016/S0891-5849(03)00152-7; Luo JH, 2008, NEPHROL DIAL TRANSPL, V23, P2198, DOI 10.1093/ndt/gfn090; Liu YM, 2012, J PHARMACOL EXP THER, V341, P725, DOI 10.1124/jpet.111.191247; HANNEMANN J, 1988, TOXICOLOGY, V51, P119; Hosohata K, 2012, J PHARMACOL EXP THER, V341, P656, DOI 10.1124/jpet.112.192807; Ichimura T, 2004, AM J PHYSIOL-RENAL, V286, pF552, DOI 10.1152/ajprenal.00285.2002; Khan MAH, 2013, FASEB J, V27, P2946, DOI 10.1096/fj.12-218040; Kuwata H, 2014, BBA-MOL CELL BIOL L, V1841, P44, DOI 10.1016/j.bbalip.2013.09.015; Lee JP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037075; Lee S, 2006, NEPHROL DIAL TRANSPL, V21, P2085, DOI 10.1093/ndt/gfl209; Nakamura K, 2008, DRUG METAB PHARMACOK, V23, P271, DOI 10.2133/dmpk.23.271; Tanaka T, 2009, AM J PATHOL, V174, P1203, DOI 10.2353/ajpath.2009.080511; Oguro A, 2009, DRUG METAB PHARMACOK, V24, P438; Sueishi K, 2002, EUR J PHARMACOL, V451, P203, DOI 10.1016/S0014-2999(02)02251-3	19	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	AUG	2015	40	4					451	457				7	Toxicology	Toxicology	CO5DU	WOS:000359180600003		
J	Oyanagi, K; Tashiro, T; Negishi, T				Oyanagi, Koshi; Tashiro, Tomoko; Negishi, Takayuki			Cell-type-specific and differentiation-status-dependent variations in cytotoxicity of tributyltin in cultured rat cerebral neurons and astrocytes	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Rat; Neuron; Astrocyte; Tributyltin; Cytotoxicity	ORGANOTIN COMPOUNDS; AROMATASE INHIBITOR; CHLORIDE EXPOSURE; TRIMETHYLTIN TMT; BRAIN-REGIONS; IN-VITRO; METABOLISM; ACTIVATION; EXPRESSION; TOXICITY	Tributyltin (TBT) is an organotin used as an anti-fouling agent for fishing nets and ships and it is a widespread environmental contaminant at present. There is an increasing concern about imperceptible but serious adverse effect(s) of exposure to chemicals existing in the environment on various organs and their physiological functions, e.g. brain and mental function. Here, so as to contribute to improvement of and/or advances in in vitro cell-based assay systems for evaluating brain-targeted adverse effect of chemicals, we tried to evaluate cell-type-specific and differentiation-status-dependent variations in the cytotoxicity of TBT towards neurons and astrocytes using the four culture systems differing in the relative abundance of these two types of cells; primary neuron culture (> 95% neurons), primary neuron-astrocyte (2 : 1) mix culture, primary astrocyte culture (> 95% astrocytes), and passaged astrocyte culture (100% proliferative astrocytes). Cell viability was measured at 48 hr after exposure to TBT in serum-free medium. IC50's of TBT were 198 nM in primary neuron culture, 288 nM in primary neuron-astrocyte mix culture, 2001 nM in primary astrocyte culture, and 1989 nM in passaged astrocyte culture. Furthermore, in primary neuron-astrocyte mix culture, vulnerability of neurons cultured along with astrocytes to TBT toxicity was lower than that of neurons cultured purely in primary neuron culture. On the other hand, astrocytes in primary neuron-astrocyte mix culture were considered to be more vulnerable to TBT than those in primary or passaged astrocyte culture. The present study demonstrated variable cytotoxicity of TBT in neural cells depending on the culture condition.	[Oyanagi, Koshi; Tashiro, Tomoko] Aoyama Gakuin Univ, Dept Chem & Biol Sci, Chuo Ku, Sagamihara, Kanagawa 2525258, Japan; [Negishi, Takayuki] Meijo Univ, Fac Pharm, Dept Physiol, Tempaku Ku, Nagoya, Aichi 4688503, Japan	Negishi, T (reprint author), Meijo Univ, Fac Pharm, Dept Physiol, Tempaku Ku, 150 Yagotoyama, Nagoya, Aichi 4688503, Japan.	taka-u@yayoi.club.ne.jp			JSPS KAKENHI [20310037, 23681010]; Long-range Research Initiative (LRI), Japan Chemical Industry Association, Japan; MEXT	This study was supported by JSPS KAKENHI (Grant-in-Aid for Scientific Research (B) (20310037) to T.T. and Grant-in-Aid for Young Scientists (A) (23681010) to T.N.), the Long-range Research Initiative (LRI), Japan Chemical Industry Association, Japan, and MEXT-supported Program for the Strategic Research Foundation at Private Universities, 2013-2017, Japan. They had no control over the interpretation, writing, or publication of this work.	Adeeko A, 2003, TOXICOL SCI, V74, P407, DOI 10.1093/toxsci/kfg131; Chamorro-Garcia R, 2013, ENVIRON HEALTH PERSP, V121, P359, DOI 10.1289/ehp.1205701; Gatson JW, 2011, ENDOCRINOLOGY, V152, P207, DOI 10.1210/en.2010-0724; Janesick A, 2012, INT J ANDROL, V35, P437, DOI 10.1111/j.1365-2605.2012.01247.x; Lattanzi W, 2013, INT J MOL SCI, V14, P16817, DOI 10.3390/ijms140816817; von Ballmoos C, 2004, P NATL ACAD SCI USA, V101, P11239, DOI 10.1073/pnas.0402869101; Aleshin S, 2009, MOL PHARMACOL, V76, P414, DOI 10.1124/mol.109.056010; Tsuda T, 1995, J AOAC INT, V78, P941; Taib B, 2013, J BIOL CHEM, V288, P37216, DOI 10.1074/jbc.M113.506238; Ricci G, 2009, J BIOL PHYS, V35, P317, DOI 10.1007/s10867-009-9157-9; Van Wagoner NJ, 1999, J NEUROSCI, V19, P5236; McAllister BG, 2003, AQUAT TOXICOL, V65, P309, DOI 10.1016/S0166-445X(03)00154-1; Graceli JB, 2013, REPROD TOXICOL, V36, P40, DOI 10.1016/j.reprotox.2012.11.008; Yamada J, 2010, TOXICOL LETT, V198, P282, DOI 10.1016/j.toxlet.2010.07.011; Ronnett GV, 2009, J NEUROCHEM, V109, P17, DOI 10.1111/j.1471-4159.2009.05916.x; Mitra S, 2013, TOXICOLOGY, V314, P39, DOI [10.1016/j.tox.2013.09.003, 10.1016/j.cox.2013.09.003]; Asakawa H, 2010, ARCH ENVIRON CON TOX, V58, P1065, DOI 10.1007/s00244-009-9421-9; Dineley KE, 2000, NEUROBIOL DIS, V7, P310, DOI 10.1006/nbdi.2000.0303; Giordano G, 2008, TOXICOL APPL PHARM, V232, P161, DOI 10.1016/j.taap.2008.06.018; Hasegawa Y, 2013, NEUROENDOCRINOL LETT, V34, P129; Hiromori Y., 2014, J STEROID BIOCH MOL; Konno Nobuhiro, 2005, Environmental Health and Preventive Medicine, V10, P335, DOI [10.1007/BF02898194, 10.1265/ehpm.10.335]; Madrigal JLM, 2010, J NEUROCHEM, V113, P543, DOI 10.1111/j.1471-4159.2010.06623.x; Markovic T, 2015, TOXICOL LETT, V233, P8, DOI 10.1016/j.toxlet.2014.12.013; Mitra S, 2014, ENVIRON TOXICOL PHAR, V37, P1048, DOI 10.1016/j.etap.2014.03.020; Mizuhashi S, 2000, NEUROSCI RES, V38, P35, DOI 10.1016/S0168-0102(00)00137-1; Nakanishi T, 2008, J TOXICOL SCI, V33, P269, DOI 10.2131/jts.33.269; Negishi T, 2012, J NEUROPATH EXP NEUR, V71, P468, DOI 10.1097/NEN.0b013e3182561327; Nesci S, 2014, BIOCHIMIE, V97, P128, DOI 10.1016/j.biochi.2013.10.002; Orellana JA, 2013, NEUROPHARMACOLOGY, V75, P567, DOI 10.1016/j.neuropharm.2013.02.020; Oyanagi K, 2015, J NEUROSCI RES, V93, P592, DOI 10.1002/jnr.23519; Perez-Alvarez A, 2013, CURR DRUG TARGETS, V14, P1220; REY C, 1984, VET HUM TOXICOL, V26, P121; Rohl C, 2009, TOXICOL IN VITRO, V23, P1541, DOI 10.1016/j.tiv.2009.04.013; Shawky S, 1998, CHEMOSPHERE, V36, P523, DOI 10.1016/S0045-6535(97)10011-X; Shintani N, 2007, YAKUGAKU ZASSHI, V127, P451, DOI 10.1248/yakushi.127.451; Thoren AE, 2005, J CEREBR BLOOD F MET, V25, P440, DOI 10.1038/sj.jcbfm.9600035; Tsunoda M, 2006, TOXICOL IND HEALTH, V22, P15, DOI 10.1191/0748233706th240oa; Whalen MM, 2002, ENVIRON RES, V88, P19, DOI 10.1006/enrs.2001.4318; Yamada S, 2013, METALLOMICS, V5, P484, DOI 10.1039/c3mt20268b	40	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	AUG	2015	40	4					459	468				10	Toxicology	Toxicology	CO5DU	WOS:000359180600004		
J	Hojo, R				Hojo, Rieko			Evaluation of the ability of mice to detect VOCs, using a positive operant reinforcement procedure	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Mouse; Three-odor detection (TOD); Operant behavior	ODOR; AIR	To examine the validity of a newly established "three-odor detection (TOD)" procedure using one of volatile organic compounds (VOCs), limonene, food-restricted male mice were used. Five animals each were assigned to either TOD or single-odor detection (SOD). TOD was composed of two trainings and one test (TEST) session. Mice were trained to discriminate an odor of coffee from no odor and odors of coffee and cheese from no odor in trainings 1 and 2, respectively. In TEST, mice were required to discriminate odors of coffee, cheese, and limonene from no odor. In SOD, mice were required to discriminate an odor of limonene from no odor. Each training or test was conducted once a day until animals achieved a learning criterion (75% correct response rate for 2 consecutive days), or until a maximum number of sessions (20 sessions) was completed. The number of sessions for reaching the learning criterion of animals in TEST (8.2 +/- 0.8) was smaller than that of animals in SOD (19.2 +/- 0.8). Results indicated that mice in TOD detected low levels of VOCs more rapidly than animals in SOD. I concluded that TOD is a useful procedure for detecting low levels of VOCs.	NIOSH, Tama Ku, Kawasaki, Kanagawa 2148585, Japan	Hojo, R (reprint author), NIOSH, Tama Ku, Nagao 6-21-1, Kawasaki, Kanagawa 2148585, Japan.	hojo@h.jniosh.go.jp					IVERSEN IH, 1986, J EXP ANAL BEHAV, V45, P297, DOI 10.1901/jeab.1986.45-297; Singer BC, 2006, INDOOR AIR, V16, P179, DOI 10.1111/j.1600-0668.2005.00414.x; Wolkoff P, 2006, INDOOR AIR, V16, P7, DOI 10.1111/j.1600-0668.2005.00393.x; Wainman T, 2000, ENVIRON HEALTH PERSP, V108, P1139, DOI 10.2307/3434825; Berger-Sweeney J, 1998, BEHAV NEUROSCI, V112, P1318, DOI 10.1037/0735-7044.112.6.1318; Hutter HP, 2006, INT J HYG ENVIR HEAL, V209, P65, DOI 10.1016/j.ijheh.2005.08.010; Nakayama K, 2009, JPN J HYG, V64, P689, DOI [10.1265/jjh.64.689, DOI 10.1265/JJH.64.689]; Seifert B., 1999, INDOOR AIR 99, V1, P499; WALKER JC, 1986, CHEM SENSES, V11, P439, DOI 10.1093/chemse/11.4.439; Zagreda L, 1999, J NEUROSCI, V19, P6175	10	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	AUG	2015	40	4					479	483				5	Toxicology	Toxicology	CO5DU	WOS:000359180600006		
J	Takechi, S; Ito, S; Kashige, N; Ishida, T; Yamaguchi, T				Takechi, Shinji; Ito, Shigeru; Kashige, Nobuhiro; Ishida, Takumi; Yamaguchi, Tadatoshi			Identification of dihydropyrazine-glutathione adducts	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Dihydropyrazine; Glutathione; Adduct; Oxidative stress; FAB-MS; NMR	HEPATOMA HEPG2 CELLS	Dihydropyrazines (DHPs) are glycation intermediates generated both in vivo and in food. DHPs can lead to the formation of a variety of different radical species, which can lead to DNA damage and enzyme inhibition. In addition, the presence of DHPs can lead to a decrease in cellular glutathione (GSH) levels, and induce the expression of antioxidant genes. In this study, the products resulting from the reaction of DHP with GSH have been analyzed in detail, with some of the products being separated by reversed-phase HPLC. The structures of the isolated DHP-GSH adducts were determined by FAB-MS and NMR analyses. These data suggested that the reaction of DHP with a thiol moiety could be involved in oxidative stress, because an increase in the amount of DHP-GSH adducts would result in a decrease in the cellular GSH levels.	[Takechi, Shinji; Ishida, Takumi; Yamaguchi, Tadatoshi] Sojo Univ, Fac Pharmaceut Sci, Kumamoto 8600082, Japan; [Ito, Shigeru] Tokyo Med & Dent Univ, Inst Biomat & Bioengn, Tokyo 1010062, Japan; [Kashige, Nobuhiro] Fukuoka Univ, Fac Pharmaceut Sci, Fukuoka 8140180, Japan	Takechi, S (reprint author), Sojo Univ, Fac Pharmaceut Sci, Ikeda 4-22-1, Kumamoto 8600082, Japan.	stakechi@ph.sojo-u.ac.jp			Japan Society for the Promotion of Science [24590169]	This study was supported by a Grant-in-Aid for Scientific Research C (No. 24590169) from the Japan Society for the Promotion of Science. We would like to thank Takahiro Fujimoto, Mami Mamitsuka, Sayaka Taki, Naoki Yahisa, Rise Yamamoto, Ayumi Yamasaki and Ryousuke Yamashita for their valuable assistance.	Takeda O, 2005, BIOL PHARM BULL, V28, P1161, DOI 10.1248/bpb.28.1161; BHATTACHARYA SK, 1955, BIOCHEM J, V60, P696; Ishida T, 2014, J TOXICOL SCI, V39, P601; Ishida T, 2012, J TOXICOL SCI, V37, P1065; Ito S, 2010, CHEM PHARM BULL, V58, P922; Mitchell J B, 1987, Br J Cancer Suppl, V8, P96; Takechi S, 2011, J TOXICOL SCI, V36, P231; Takechi S, 2009, BIOL PHARM BULL, V32, P186; Teixeira PC, 2001, BIOL CHEM, V382, P913, DOI 10.1515/BC.2001.113; Yamaguchi T, 1998, TETRAHEDRON LETT, V39, P8311, DOI 10.1016/S0040-4039(98)01859-0; Yamaguchi T, 1996, BIOL PHARM BULL, V19, P1261; ZLATKIS A, 1973, ANAL CHEM, V45, P763, DOI 10.1021/ac60326a036	12	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	AUG	2015	40	4					495	500				6	Toxicology	Toxicology	CO5DU	WOS:000359180600008		
J	Fujino, T; Maruko-Ohtake, A; Ohtake, Y; Kobayashi, T; Ando, K; Takeuchi, A; Ohkubo, Y; Hayakawa, M				Fujino, Tomofumi; Maruko-Ohtake, Akiko; Ohtake, Yosuke; Kobayashi, Tomonori; Ando, Ken; Takeuchi, Airi; Ohkubo, Yasuhito; Hayakawa, Makio			Farnesoid X receptor knockdown provides significant growth inhibition in hepatocellular carcinoma cells while it does not interfere with the proliferation of primary human hepatocyte-derived cells	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Farnesoid X receptor; Cyclin-dependent kinase inhibitors; Carcinoma-specific cytotoxicity	REG-GAMMA-PROTEASOME; NUCLEAR RECEPTOR; BILE-ACIDS; GENE-EXPRESSION; DEGRADATION; LIGANDS; FXR	Identification of substances with specific toxicity for carcinoma cells promises to facilitate the development of cancer chemotherapeutics that cause minimal side effects. Here, we show that knockdown of the farnesoid X receptor (FXR) effectively suppresses the proliferation of human hepatocellular carcinoma cell lines HepG2 and HLE accompanied by elevated expression of cyclin-dependent kinase (CDK) inhibitor p16/INK4a and p21/Cip1 proteins. On the other hand, the growth of the primary human hepatocyte-derived cell line Fa2N-4 is not affected by the treatment with FXR siRNA irrespective of marked increases in the mRNAs of p16/INK4a and p21/Cip1. Surprisingly, the expression levels of p16/INK and p21/Cip1 proteins are left unchanged in Fa2N-4 cells that are subjected to the FXR siRNA treatment. Since the expression levels of these CDK inhibitor proteins in FXR-knockdown Fa2N-4 cells were elevated in the presence of proteasomal inhibitor MG132, these CDK inhibitors may be subjected to the proteasomal degradation, thereby counteracting the increased expression of their cognate mRNAs, therefore similar levels of p16 and p21 proteins were observed in control and FXR-knockdown Fa2N-4 cells. These results suggest that FXR-knockdown is effective for inhibiting the proliferation of hepatocellular carcinoma cells, not interfering with the regulatory mechanism of normal hepatocyte growth.	[Fujino, Tomofumi; Ando, Ken; Takeuchi, Airi; Hayakawa, Makio] Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Hyg & Hlth Sci, Hachioji, Tokyo 1920392, Japan; [Maruko-Ohtake, Akiko; Ohtake, Yosuke; Kobayashi, Tomonori; Ohkubo, Yasuhito] Tohoku Pharmaceut Univ, Dept Radiopharm, Aoba Ku, Sendai, Miyagi 9818558, Japan	Fujino, T (reprint author), Tokyo Univ Pharm & Life Sci, Sch Pharm, Dept Hyg & Hlth Sci, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	tfujino@ps.toyaku.ac.jp			Japan Private School Promotion Foundation	We thank Toshiaki Tanaka for helpful advice and discussions. This work was supported in part by a grant from the Japan Private School Promotion Foundation.	Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Lew JL, 2004, J BIOL CHEM, V279, P8856, DOI 10.1074/jbc.M306422200; Li XT, 2007, MOL CELL, V26, P831, DOI 10.1016/j.molcel.2007.05.028; Chen XY, 2007, MOL CELL, V26, P843, DOI 10.1016/j.molcel.2007.05.022; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Sirvent A, 2004, J LIPID RES, V45, P2110, DOI 10.1194/jlr.M400221-JLR200; Zhang YQ, 2004, GENE DEV, V18, P157, DOI 10.1101/gad.1138104; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Teixeira LK, 2013, ANNU REV BIOCHEM, V82, P387, DOI 10.1146/annurev-biochem-060410-105307; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Fujino T, 2012, J BIOCHEM, V152, P577, DOI 10.1093/jb/mvs101; Han J, 2013, CELL DEATH DIFFER, V20, P1055, DOI 10.1038/cdd.2013.33; Roberti A, 2011, CELL CYCLE, V10, P127, DOI 10.4161/cc.10.1.14446	14	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	AUG	2015	40	4					501	508				8	Toxicology	Toxicology	CO5DU	WOS:000359180600009		
J	Shirai, M; Matsuoka, M; Makino, T; Kai, K; Teranishi, M; Takasaki, W				Shirai, Makoto; Matsuoka, Miho; Makino, Toshihiko; Kai, Kiyonori; Teranishi, Munehiro; Takasaki, Wataru			Hepatic glutathione contributes to attenuation of thioacetamide-induced hepatic necrosis due to suppression of oxidative stress in diet-induced obese mice	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Mouse; Oxidative stress; High-fat diet; Thioacetamide; Glutathione; Liver	FATTY LIVER-DISEASE; AMINO-ACIDS; METABOLISM; HEPATOTOXICITY	We previously reported that hepatic necrosis induced by thioacetamide (TA), a hepatotoxicant, was attenuated in mice fed a high-fat diet (HFD mice) in comparison with mice fed a normal rodent diet (ND mice). In this study, we focused on investigation of the mechanism of the attenuation. Hepatic content of thiobarbituric acid reactive substances (TBARS), an oxidative stress marker, significantly increased in ND mice at 24 and 48 hr after TA administration in comparison to that in vehicle-treated ND mice. At these time points, severe hepatic necrosis was observed in ND mice. Treatment with an established antioxidant, butylated hydroxyanisole, attenuated the TA-induced hepatic necrosis in ND mice. In contrast, in HFD mice, hepatic TBARS content did not increase, and hepatic necrosis was attenuated in comparison with ND mice at 24 and 48 hr after TA dosing. Metabolomics analysis regarding hepatic glutathione, a biological antioxidant, revealed decreased glutathione and changes in the amount of glutathione metabolism-related metabolites, such as increased ophtalmate and decreased cysteine, and this indicated activation of glutathione synthesis and usage in HFD mice. Finally, after treatment with L-buthionine-S,R-sulfoxinine, an inhibitor of glutathione synthesis, TA-induced hepatic necrosis was enhanced and hepatic TBARS contents increased after TA dosing in HFD mice. These results suggested that activated synthesis and usage of hepatic GSH, which suppresses hepatic oxidative stress, is one of the factors that attenuate TA-induced hepatic necrosis in HFD mice.	[Shirai, Makoto; Matsuoka, Miho; Makino, Toshihiko; Kai, Kiyonori; Teranishi, Munehiro; Takasaki, Wataru] Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, Tokyo 1340081, Japan	Shirai, M (reprint author), Daiichi Sankyo Co Ltd, Med Safety Res Labs, Edogawa Ku, 1-16-13 Kitakasai, Tokyo 1340081, Japan.	shirai.makoto.v7@daiichisankyo.co.jp					Agudo-Barriuso M, 2013, INVEST OPHTH VIS SCI, V54, P4249, DOI 10.1167/iovs.12-11451; Alberici LC, 2011, J BIOENERG BIOMEMBR, V43, P19, DOI 10.1007/s10863-011-9326-y; Wu GY, 2004, J NUTR, V134, P489; Yuan LY, 2009, MOL ASPECTS MED, V30, P29, DOI 10.1016/j.mam.2008.08.003; Yuan XL, 2006, MOL CARCINOGEN, V45, P841, DOI 10.1002/mc.20234; Videla LA, 2004, CLIN SCI, V106, P261, DOI 10.1042/CS20030285; Kretzschmar M, 1996, EXP TOXICOL PATHOL, V48, P439; Lu SC, 2000, CURR TOP CELL REGUL, V36, P95; Mantena SK, 2009, BIOCHEM J, V417, P183, DOI 10.1042/BJ20080868; Shimizu S, 2009, ARCH TOXICOL, V83, P701, DOI 10.1007/s00204-009-0436-9; Merrell MD, 2011, DRUG METAB REV, V43, P317, DOI 10.3109/03602532.2011.577781; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Lu SC, 1999, FASEB J, V13, P1169; Nair S, 2006, PHARM RES, V23, P2621, DOI 10.1007/s11095-006-9099-x; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; BANERJEE S, 1995, CANCER LETT, V88, P163, DOI 10.1016/0304-3835(94)03633-T; Chilakapati J, 2005, DRUG METAB DISPOS, V33, P1877, DOI 10.1124/dmd.105.005520; Cohen J. C., 2011, SCIENCE, V332, P1519; Filomeni Giuseppe, 2003, FASEB Journal, V17, P64; Kim SK, 2003, AMINO ACIDS, V24, P103, DOI 10.1007/s00726-002-0324-6; SEKURA R, 1974, P NATL ACAD SCI USA, V71, P2969, DOI 10.1073/pnas.71.8.2969; Shirai Makoto, 2013, Journal of Toxicologic Pathology, V25, P175, DOI 10.1293/tox.26.175; Stankova P, 2010, TOXICOL IN VITRO, V24, P2097, DOI 10.1016/j.tiv.2010.06.011; STIPANUK MH, 1992, J NUTR, V122, P420; Walther UI, 2003, ARCH TOXICOL, V77, P131, DOI 10.1007/s00204-002-0421-z; Watanabe Toshiyuki, 2003, J Toxicol Sci, V28, P455, DOI 10.2131/jts.28.455	26	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	AUG	2015	40	4					509	521				13	Toxicology	Toxicology	CO5DU	WOS:000359180600010		
J	Morita, J; Izumi, T; Sunouchi, M; Arima, K; Tsutsumi, S				Morita, Junya; Izumi, Tomoko; Sunouchi, Mana; Arima, Kazunori; Tsutsumi, Shunsuke			Effects of reduced food intake on the parameters of toxicity evaluation in dogs	JOURNAL OF TOXICOLOGICAL SCIENCES			English	Article						Food consumption; Body weight; Electrocardiography; Clinical pathology; Dog; Toxicity study	NERVOUS-SYSTEM; BLOOD-PRESSURE	It is crucial to evaluate the variations in the toxicity parameters in experimental animals during the development of new drugs. Reduced food intake has been reported to have an impact on the toxicity parameters in rats; however, there are few reports of such studies in dogs. The aim of this study was to clarify the effects of reduced food intake on the general toxicity parameters and their reversibility in dogs. Male beagle dogs were fed 300 g/day of diet for 12 weeks in the control group, and 150 g/day for the first 8 weeks and 200 g/day for the subsequent 4 weeks in the low feeding group. During the following 4-week recovery period, the amount of feeding was set at 300 g/day. There were no clinical changes in any of the dogs. The low feeding group showed a body weight loss of 9.0%, 16.7% and 14.3% relative to the pre-test values at Week 4, 8 and 12, respectively. The following changes from the pre-test values and/or the control group in the examined parameters were observed in this group: decreased heart rate, prolonged PR interval on the ECG, decreased leukocyte count, and increased serum free fatty acid and gamma-glutamyl transpeptidase levels. Significant changes of these parameters were not observed any more during the recovery period. This fact supports biological or physiological reaction to reduced food intake. These results are considered to represent useful information for toxicologists to distinguish between the direct effects of drugs and the changes attributable to reduced food intake.	[Morita, Junya; Izumi, Tomoko; Sunouchi, Mana; Arima, Kazunori; Tsutsumi, Shunsuke] Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Drug Safety, Kita Ku, Saitama, Saitama 3319530, Japan	Morita, J (reprint author), Taisho Pharmaceut Co Ltd, Drug Safety & Pharmacokinet Labs, Drug Safety, Kita Ku, 1-403 Yoshino Cho, Saitama, Saitama 3319530, Japan.	ju-morita@so.taisho.co.jp					Suzuki S, 1997, CLIN EXP IMMUNOL, V110, P500, DOI 10.1046/j.1365-2249.1997.4411460.x; Seki Makoto, 1997, Journal of Toxicological Sciences, V22, P427; SOWERS JR, 1982, J CLIN ENDOCR METAB, V54, P1181; Takamatsu K., 2015, EXP ANIM; Truett AA, 1996, AM J PHYSIOL-REG I, V270, pR541; UCHIYAMA T, 1985, EXP ANIM TOKYO, V34, P367; Yoshii A, 2003, BIOL REFERENCE DATA, P73	7	0	0	JAPANESE SOC TOXICOLOGICAL SCIENCES	TOKYO	INTERNATIONAL MEDICAL INFORMATION CENTER, SHINANOMACHI RENGAKAN, 35 SHINANO-MACHI, SHINJUKU-KU, TOKYO, 160-0016, JAPAN	0388-1350	1880-3989		J TOXICOL SCI	J. Toxicol. Sci.	AUG	2015	40	4					523	533				11	Toxicology	Toxicology	CO5DU	WOS:000359180600011		
J	Tada, S; Watanabe, T; Suzuki, C; Nohisa, Y; Shinoda, K; Furuta, N; Ito, H; Okumura, Y; Shu, E; Seishima, M				Tada, Saori; Watanabe, Tsuneo; Suzuki, Chigusa; Nohisa, Yuzuru; Shinoda, Koichi; Furuta, Nobuyuki; Ito, Hiroyasu; Okumura, Yoko; Shu, En; Seishima, Mariko			Sonographic Findings of Subcutaneous Sarcoidosis in 3 Cases	JOURNAL OF ULTRASOUND IN MEDICINE			English	Article						Doppler sonography; granuloma; sarcoidosis; sonography; superficial structures		Subcutaneous sarcoidosis occurs infrequently among cases of cutaneous sarcoidosis. To our knowledge, few studies have described the sonographic characteristics of subcutaneous sarcoidosis. Here we report the sonographic characteristics of 3 cases of this condition. Our results revealed 4 features: (1) an irregular hypoechoic appearance, (2) heterogeneous echogenicity, (3) perilesional hyperechoic changes, and (4) abnormal Doppler signals. Sonography is a rapid, simple, and noninvasive procedure that is useful for initial evaluation of granulomatous lesions such as subcutaneous sarcoidosis.	[Tada, Saori; Watanabe, Tsuneo; Suzuki, Chigusa; Nohisa, Yuzuru; Shinoda, Koichi; Furuta, Nobuyuki; Ito, Hiroyasu] Gifu Univ Hosp, Div Clin Lab, Gifu 5011194, Japan; [Okumura, Yoko; Shu, En; Seishima, Mariko] Gifu Univ, Grad Sch Med, Dept Dermatol, Gifu, Japan	Watanabe, T (reprint author), Gifu Univ Hosp, Div Clin Lab, 1-1 Yanagido, Gifu 5011194, Japan.	tsuneo_w@gifu-u.ac.jp					Marcoval J, 2008, DERMATOL CLIN, V26, P553, DOI 10.1016/j.det.2008.05.003; Marcoval J, 2005, BRIT J DERMATOL, V153, P790, DOI 10.1111/j.1365-2133.2005.06815.x; MAYOCK RL, 1963, AM J MED, V35, P67, DOI 10.1016/0002-9343(63)90165-7; Mana J, 1997, ARCH DERMATOL, V133, P882, DOI 10.1001/archderm.133.7.882; VAINSENCHER D, 1984, ARCH DERMATOL, V120, P1028, DOI 10.1001/archderm.120.8.1028; Barbosa Luciana, 2014, J Radiol Case Rep, V8, P39, DOI 10.3941/jrcr.v8i3.1934; Cammarota T, 1998, EUR J RADIOL, V27, pS215, DOI 10.1016/S0720-048X(98)00065-5; Ceovic R, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-147; Chen HH, 2009, J ULTRAS MED, V28, P813	9	0	0	AMER INST ULTRASOUND MEDICINE	LAUREL	SUBSCRIPTION DEPT, 14750 SWEITZER LANE, STE 100, LAUREL, MD 20707-5906 USA	0278-4297	1550-9613		J ULTRAS MED	J. Ultrasound Med.	AUG	2015	34	8					1485	1488		10.7863/ultra.34.8.1485		4	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	Acoustics; Radiology, Nuclear Medicine & Medical Imaging	CO0DB	WOS:000358819200017		
J	Yamanaka, T; Yamakado, K; Yamada, T; Fujimori, M; Takaki, H; Nakatsuka, A; Sakuma, H; Sugimura, Y				Yamanaka, Takashi; Yamakado, Koichiro; Yamada, Tomomi; Fujimori, Masashi; Takaki, Haruyuki; Nakatsuka, Atsuhiro; Sakuma, Hajime; Sugimura, Yoshiki			CT-Guided Percutaneous Cryoablation in Renal Cell Carcinoma: Factors Affecting Local Tumor Control	JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY			English	Review							RADIOFREQUENCY ABLATION; ICE-BALL; MASSES; COMPLICATIONS; EXPERIENCE; KIDNEYS; TISSUE	Purpose: To retrospectively evaluate factors affecting local tumor control in cryoablation of renal cell carcinomas (RCCs). Materials and Methods: This study examined 61 patients (43 men, 18 women) with a mean age of 69.1 years +/- 10.8 (range 38-87 y) who underwent computed tomography (CT) guided percutaneous cryoablation for a single RCC and were followed for 6 months or longer. Maximum tumor diameter was 0.8-4.8 cm (mean +/- standard deviation, 2.4 +/- 0.9 cm). Factors affecting local tumor control were evaluated. Deep tumor location was defined as the center side of the body perpendicular to the kidney midline. Results: Median follow-up was 12.7 months. Residual unablated tumors and local tumor progression were observed after initial cryoablation in 4 patients each (13%, 8 of 61). All uncontrolled tumors were located in the deep side of the kidney (100%, 8 of 8), and were covered by an ice-ball margin of 5 mm or less. Deep tumor location (P = .005) and ice-ball margin (P = .002) were detected as significant factors affecting local tumor control on univariate analysis, and ice-ball margin remained significant in a stepwise logistic regression model (P = .006; odds ratio, 0.57; 95% confidence interval, 0.38-0.83). Complete tumor control rates were 42.9% (3 of 7), 92.6% (50 of 54), and 100% (20 of 20) with ice-ball margins of less than 3 mm, 3 mm or larger, and 6 mm or larger, respectively. Conclusions: Deep tumor location and ice-ball margins less than 6 mm were associated with incomplete local control following CT-guided percutaneous cryoablation for RCC.	[Yamanaka, Takashi; Yamakado, Koichiro; Fujimori, Masashi; Takaki, Haruyuki; Nakatsuka, Atsuhiro; Sakuma, Hajime] Mie Univ, Sch Med, Dept Radiol, Tsu, Mie 5148507, Japan; [Sugimura, Yoshiki] Mie Univ, Sch Med, Dept Nephrourol Surg, Tsu, Mie 5148507, Japan; [Yamada, Tomomi] Osaka Univ, Grad Sch Med, Dept Clin Epidemiol & Biostat, Suita, Osaka, Japan	Yamanaka, T (reprint author), Mie Univ, Sch Med, Dept Radiol, 2-174 Edobashi, Tsu, Mie 5148507, Japan.	yama@clin.medic.mie-u.ac.jp					Ahmed M, 2014, J VASC INTERV RADIOL, V25, P1691, DOI 10.1016/j.jvir.2014.08.027; Remer EM, 2000, AM J ROENTGENOL, V174, P635; Takaki H, 2010, JPN J RADIOL, V28, P460, DOI 10.1007/s11604-010-0451-z; Balageas P, 2013, EUR RADIOL, V23, P1925, DOI 10.1007/s00330-013-2784-3; Buy X, 2013, AM J ROENTGENOL, V201, P1353, DOI 10.2214/AJR.13.11084; Rosenberg MD, 2011, AM J ROENTGENOL, V196, P935, DOI 10.2214/AJR.10.5182; Venkatesan AM, 2011, RADIOLOGY, V261, P375, DOI 10.1148/radiol.11091207; Kutikov A, 2009, J UROLOGY, V182, P844, DOI 10.1016/j.juro.2009.05.035; Kim EH, 2013, BJU INT, V111, P872, DOI 10.1111/j.1464-410X.2012.11432.x; Takaki H, 2013, RADIOLOGY, V267, P285, DOI 10.1148/radiol.12121070; Porter CA, 2010, AM J ROENTGENOL, V194, P790, DOI 10.2214/AJR.09.2518; Campbell SC, 2009, J UROLOGY, V182, P1271, DOI 10.1016/j.juro.2009.07.004; Breen DJ, 2013, BJU INT, V112, P758, DOI 10.1111/bju.12122; Georgiades C, 2013, CARDIOVASC INTER RAD, V36, P783, DOI 10.1007/s00270-012-0470-5; Kunkle DA, 2008, CANCER, V113, P2671, DOI 10.1002/cncr.23896; Atwell TD, 2013, AM J ROENTGENOL, V200, P461, DOI 10.2214/AJR.12.8618; Bandi G, 2007, BJU INT, V100, P798, DOI 10.1111/j.1464-410X.2007.07158.x; Beda A, 2009, EUR UROL, V55, P836; Blute ML, 2013, BJU INT, V111, pE181, DOI 10.1111/j.1464-410X.2012.11538.x; Campbell C, 2012, AM J ROENTGENOL, V199, P677, DOI 10.2214/AJR.11.7999; Georgiades Christos, 2013, Tech Vasc Interv Radiol, V16, P230, DOI 10.1053/j.tvir.2013.08.006; Mogami T, 2007, INT J CLIN ONCOL, V12, P79, DOI 10.1007/s10147-006-0654-6; Schwartz BF, 2006, UROLOGY, V68, P14, DOI 10.1016/j.urology.2006.03.067; Sommer CM, 2013, J VASC INTERV RADIOL, V24, P1241, DOI 10.1016/j.jvir.2013.04.008; U.S Department of Health and Human Services, 2010, COMM TERM CRIT ADV E	25	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1051-0443	1535-7732		J VASC INTERV RADIOL	J. Vasc. Interv. Radiol.	AUG	2015	26	8					1147	1153		10.1016/j.jvir.2015.04.031		7	Radiology, Nuclear Medicine & Medical Imaging; Peripheral Vascular Disease	Radiology, Nuclear Medicine & Medical Imaging; Cardiovascular System & Cardiology	CO3YP	WOS:000359097500007		
J	Hayashi, T; Miyatake, A				Hayashi, Tomoyuki; Miyatake, Atsushi			Recent research and development on sugi (Japanese cedar) structural glued laminated timber	JOURNAL OF WOOD SCIENCE			English	Review						Sugi; Glued laminated timber; Composite glulam; Japanese Agricultural Standard; Fireproof glulam	COMPOSITE-GLULAM BEAMS; PERFORMANCE PREDICTION; PROBABILISTIC MODEL; STRENGTH PROPERTIES; BENDING STRENGTH; VENEER LUMBER; TENSILE; WOOD; MOMENT	Sugi (Japanese cedar: Cryptomeria japonica) is the most important afforestation species in Japan. Its growing stock has been increasing year by year. Thus, development of new wood products made of sugi has been a national priority for more than two decades. Development of sugi structural glued laminated timber (glulam) was one of the responses to this push. However, in the 1990s, the Japanese glued laminated timber (GLT) industry did not accept sugi as a raw material for glulam, because several problems existed in the wood quality of sugi such as lower strength properties than those of the major imported species. This drawback spurred intensive research on sugi glulam in Japan. The results contributed to the significant revision of the Japanese Agricultural Standard (JAS) for GLT in 2008. The standard permitted the use of various new laminae and products such as a sugi composite GLT beams using different species of laminae with high modulus of elasticity. Although fireproof GLT is not part of the existing JAS for GLT, several fireproof laminated products with 1-h fireproofing performance have been developed since the Japanese Building Standards Law was revised in 2000.	[Hayashi, Tomoyuki] Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita 0160876, Japan; [Miyatake, Atsushi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan	Hayashi, T (reprint author), Akita Prefectural Univ, Inst Wood Technol, Noshiro, Akita 0160876, Japan.	tomoyuki_hayashi@iwt.akita-pu.ac.jp					FOSCHI RO, 1980, J STRUCT DIV-ASCE, V106, P1735; Bender DA, 1985, 460 USDA FOR SERV RE; Biblis E. J., 1966, Forest Products Journal, V16, P39; BRAUN MO, 1977, FOREST PROD J, V27, P46; Forestry Agency, 2015, STAT DIR FOR FOR 201, P8; Forestry Agency, 2014, 2014159 FOR AG; Forestry and Forest Products Research Institute, 2009, FFPRI GRANT RES REP; Fujimoto K, 2010, J WOOD SCI, V56, P444, DOI 10.1007/s10086-010-1134-1; Harada T, 2010, STRUCTURE ARCHITECTU, P365; Harada T, 2007, P 11 INT FIR SCI ENG, P765; HATTORI N, 1991, MOKUZAI GAKKAISHI, V37, P766; Hayashi T, 2002, J SOC MATER SCI JPN, V51, P373; Hayashi T, 2004, P C FOR FOR PROD RES, P226; HAYASHI T, 1991, MOKUZAI GAKKAISHI, V37, P904; HAYASHI T, 1990, MOKUZAI GAKKAISHI, V36, P812; HAYASHI T, 1992, MOKUZAI GAKKAISHI, V38, P247; HAYASHI T, 1991, MOKUZAI GAKKAISHI, V37, P200; Hiramatsu Y, 2011, J WOOD SCI, V57, P66, DOI 10.1007/s10086-010-1127-0; HIRASHIMA Y, 1994, MOKUZAI GAKKAISHI, V40, P1172; Iijima Y, 2011, CONCISE ENCY WOOD, P94; Ishikawa T, 2014, ANN M ARCH I JAP, P277; Japanese Agricultural Standard, 2008, JAP GROW HLTH FOOD M, P1; Komatsu K, 1997, MOKUZAI GAKKAISHI, V43, P934; Koseki M, 2012, MOKUZAI GAKKAISHI, V58, P125; Mihashi H, 1996, MOKUZAI GAKKAISHI, V42, P122; Miyatake A, 2009, RES J FOOD AGR, V34, P20; Moody RC, 1974, 236 USDA FOR SER RES; Mori T, 2001, J STRUCT CONSTR ENG, V541, P51; Oka H, 2008, B JAPANESE ASS FIRE, V58, P13; Okabe M, 2014, J WOOD SCI, V60, P49, DOI 10.1007/s10086-013-1377-8; Onishi Y, 2008, 58 ANN M JAP WOOD RE, P24; Tabuchi A, 2007, 57 ANN M JAP WOOD RE, P20; TAYLOR SE, 1989, FOREST PROD J, V39, P71; Yusa S, 2003, P JAP ASS FIR SCI EN, P106	34	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	AUG	2015	61	4					337	342		10.1007/s10086-015-1475-x		6	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CO4NO	WOS:000359137800001		
J	Miyafuji, H				Miyafuji, Hisashi			Application of ionic liquids for effective use of woody biomass	JOURNAL OF WOOD SCIENCE			English	Review						Ionic liquid; Woody biomass; Cellulose; Preservation; Biorefinery	ACID-CATALYZED HYDROLYSIS; IN-SITU SACCHARIFICATION; 1-ETHYL-3-METHYLIMIDAZOLIUM CHLORIDE; 1-ALLYL-3-METHYLIMIDAZOLIUM CHLORIDE; CELLULOSE DISSOLUTION; ENZYMATIC-HYDROLYSIS; REACTION BEHAVIOR; MILD CONDITIONS; 1-N-BUTYL-3-METHYLIMIDAZOLIUM CHLORIDE; 1-H-3-METHYLIMIDAZOLIUM CHLORIDE	Ionic liquids are salts that have melting points around ambient temperature and unique characteristics, such as high solubility, extremely low volatility, incombustibility and low viscosity. Application of ionic liquids in wood processing technology has attracted attention and is expected to promote further use of wood. They are effective as wood-preserving agents to enhance decay-resistance and also improve fire resistance of wood. Ionic liquids have been used as reaction solvents for preparing various cellulose derivatives or composites with other materials. Attempts have been made to use ionic liquids in pretreatments for enzymatic hydrolysis when producing bio-ethanol from cellulose or wood. Ionic liquids also have been shown to be effective for dissolution of cellulose or wood, forming the basis for studies into the separation of cellulose, hemicellulose and lignin from wood. The effective separation of these components is essential for chemical use of wood, and ionic liquid treatment thus has potential as an enabling technique in biorefineries. Moreover, ionic liquids induce depolymerization of solubilized wood polymers, which may be applicable to the production of useful chemicals from wood polymers such as cellulose, hemicellulose and lignin.	Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Miyafuji, H (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Hangi Cho, Kyoto 6068522, Japan.	miyafuji@kpu.ac.jp			Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry;  [25450246]	This research was partly supported by a Grant-in-Aid for Scientific Research (C) (25450246) and the Science and Technology Research Promotion Program for Agriculture, Forestry, Fisheries and Food Industry, for which the authors are grateful.	Li WY, 2011, GREEN CHEM, V13, P2038, DOI 10.1039/c1gc15522a; Miyafuji H, 2012, J WOOD SCI, V58, P222, DOI 10.1007/s10086-011-1245-3; Heinze T, 2005, MACROMOL BIOSCI, V5, P520, DOI 10.1002/mabi.200500039; Murakami MA, 2007, CARBOHYD POLYM, V69, P378, DOI 10.1016/j.carbpol.2006.12.002; Maki-Arvela P, 2010, IND CROP PROD, V32, P175, DOI 10.1016/j.indcrop.2010.04.005; Kanbayashi T, 2013, J WOOD SCI, V59, P410, DOI 10.1007/s10086-013-1343-5; Zhang YT, 2010, ENERG FUEL, V24, P2410, DOI 10.1021/ef1000198; Dee SJ, 2011, CHEMSUSCHEM, V4, P1166, DOI 10.1002/cssc.201000426; Pinkert A, 2009, CHEM REV, V109, P6712, DOI 10.1021/cr9001947; Kadokawa JI, 2008, COMPOS SCI TECHNOL, V68, P493, DOI 10.1016/j.compscitech.2007.06.004; Ohno E, 2013, J WOOD SCI, V59, P221, DOI 10.1007/s10086-013-1322-x; Zhang H, 2007, ADV MATER, V19, P698, DOI 10.1002/adma.200600442; Zavrel M, 2009, BIORESOURCE TECHNOL, V100, P2580, DOI 10.1016/j.biortech.2008.11.052; Mikkola JP, 2007, GREEN CHEM, V9, P1229, DOI 10.1039/b708533h; Miyafuji H, 2011, J WOOD SCI, V57, P459, DOI 10.1007/s10086-011-1190-1; Vanoye L, 2009, GREEN CHEM, V11, P390, DOI 10.1039/b817882h; Bose S, 2010, J PHYS CHEM B, V114, P8221, DOI 10.1021/jp9120518; Xu AR, 2010, GREEN CHEM, V12, P268, DOI 10.1039/b916882f; Kubo S, 2008, J WOOD CHEM TECHNOL, V28, P84, DOI [10.1080/02773810802124845, 10.1080/02773810802124928]; Liu CF, 2007, J AGR FOOD CHEM, V55, P2399, DOI 10.1021/jf062876g; Nakamura A, 2010, J WOOD SCI, V56, P256, DOI 10.1007/s10086-009-1081-x; Watanabe H, 2010, CARBOHYD POLYM, V80, P1168, DOI 10.1016/j.carbpol.2010.01.039; Sievers C, 2009, IND ENG CHEM RES, V48, P1277, DOI 10.1021/ie801174x; Kamiya N, 2008, BIOTECHNOL LETT, V30, P1037, DOI 10.1007/s10529-008-9638-0; Barthel S, 2006, GREEN CHEM, V8, P301, DOI 10.1039/b513157j; Vitz J, 2009, GREEN CHEM, V11, P417, DOI 10.1039/b818061j; Remsing RC, 2008, J PHYS CHEM B, V112, P11071, DOI 10.1021/jp8042895; Nakamura A, 2010, HOLZFORSCHUNG, V64, P289, DOI 10.1515/HF.2010.042; Casas A, 2012, SEP PURIF TECHNOL, V97, P115, DOI 10.1016/j.seppur.2011.12.032; Jia SY, 2010, CHEMSUSCHEM, V3, P1078, DOI 10.1002/cssc.201000112; Dadi AP, 2006, BIOTECHNOL BIOENG, V95, P904, DOI 10.1002/bit.21047; Miyafuji H, 2009, J WOOD SCI, V55, P215, DOI 10.1007/s10086-009-1020-x; Viell J, 2011, HOLZFORSCHUNG, V65, P519, DOI 10.1515/HF.2011.072; Wang XJ, 2011, BIORESOURCE TECHNOL, V102, P7959, DOI 10.1016/j.biortech.2011.05.064; Li CZ, 2007, ADV SYNTH CATAL, V349, P1847, DOI 10.1002/adsc.200700259; Li CZ, 2008, GREEN CHEM, V10, P177, DOI 10.1039/b711512a; Cox BJ, 2012, BIORESOURCE TECHNOL, V118, P584, DOI 10.1016/j.biortech.2012.05.012; Fukaya Y, 2008, GREEN CHEM, V10, P44, DOI 10.1039/b713289a; Youngs TGA, 2007, J PHYS CHEM B, V111, P13765, DOI 10.1021/Jp076728k; Torr KM, 2012, GREEN CHEM, V14, P778, DOI 10.1039/c2gc16362d; Sun N, 2009, GREEN CHEM, V11, P646, DOI 10.1039/b822702k; Swatloski RP, 2002, J AM CHEM SOC, V124, P4974, DOI 10.1021/ja025790m; Dadi AP, 2007, APPL BIOCHEM BIOTECH, V137, P407, DOI 10.1007/s12010-007-9068-9; Xie HL, 2010, WOOD SCI TECHNOL, V44, P119, DOI 10.1007/s00226-009-0273-2; Zhang H, 2005, MACROMOLECULES, V38, P8272, DOI 10.1021/ma0505676; Chidambaram M, 2010, GREEN CHEM, V12, P1253, DOI 10.1039/c004343e; Abels C, 2013, BIORESOURCE TECHNOL, V149, P58, DOI 10.1016/j.biortech.2013.09.012; Youngs TGA, 2006, CHEMPHYSCHEM, V7, P2279, DOI 10.1002/cphc.200600569; Moulthrop JS, 2005, CHEM COMMUN, P1557, DOI 10.1039/b417745b; Stasiewicz M, 2008, HOLZFORSCHUNG, V62, P309, DOI 10.1515/HF2008.028; Kuo CH, 2009, CARBOHYD POLYM, V77, P41, DOI 10.1016/j.carbpol.2008.12.003; Amarasekara AS, 2009, IND ENG CHEM RES, V48, P10152, DOI 10.1021/ie901047u; Rinaldi R, 2008, ANGEW CHEM INT EDIT, V47, P8047, DOI 10.1002/anie.200802879; Zhang JM, 2009, CELLULOSE, V16, P299, DOI 10.1007/s10570-008-9260-2; Liu CF, 2007, CARBOHYD RES, V342, P919, DOI 10.1016/j.carres.2007.02.006; Yang F, 2010, CARBOHYD POLYM, V81, P311, DOI 10.1016/j.carbpol.2010.02.031; Binder JB, 2009, BIOMASS BIOENERG, V33, P1122, DOI 10.1016/j.biombioe.2009.03.006; Labbe N, 2012, BIORESOURCE TECHNOL, V104, P701, DOI 10.1016/j.biortech.2011.10.062; Xie HB, 2009, J APPL POLYM SCI, V111, P2468, DOI 10.1002/app.29251; Fort DA, 2007, GREEN CHEM, V9, P63, DOI 10.1039/b607614a; Cheng G, 2011, BIOMACROMOLECULES, V12, P933, DOI 10.1021/bm101240z; Wu J, 2004, BIOMACROMOLECULES, V5, P266, DOI 10.1021/bm034398d; Zhang ZH, 2010, BIORESOURCE TECHNOL, V101, P1111, DOI 10.1016/j.biortech.2009.09.010; Liu CF, 2010, IND CROP PROD, V31, P363, DOI 10.1016/j.indcrop.2009.12.002; Zhang X, 2014, MICROSC RES TECHNIQ, V77, P609, DOI 10.1002/jemt.22379; Cox BJ, 2013, BIORESOURCE TECHNOL, V134, P59, DOI 10.1016/j.biortech.2013.01.081; Kilpelainen I, 2007, J AGR FOOD CHEM, V55, P9142, DOI 10.1021/jf071692e; Pernak J, 2004, HOLZFORSCHUNG, V58, P286, DOI 10.1515/HF.2004.044; Lan W, 2011, CARBOHYD POLYM, V86, P672, DOI 10.1016/j.carbpol.2011.05.013; Datta S, 2010, GREEN CHEM, V12, P338, DOI 10.1039/b916564a; Ebner G, 2008, TETRAHEDRON LETT, V49, P7322, DOI 10.1016/j.tetlet.2008.10.052; Liu HB, 2010, J PHYS CHEM B, V114, P4293, DOI 10.1021/jp9117437; Xie H, 2007, BIOMACROMOLECULES, V8, P3740, DOI 10.1021/bm700679s; Kanbayashi T, 2014, J WOOD SCI, V60, P152, DOI 10.1007/s10086-014-1389-z; Feng DX, 2011, APPL MICROBIOL BIOT, V91, P399, DOI 10.1007/s00253-011-3263-x; Cetinkol Ö. P., 2010, Biofuels, V1, P33, DOI 10.4155/bfs.09.5; Chen C, 2010, ADV MATER RES-SWITZ, V113-116, P407, DOI 10.4028/www.scientific.net/AMR.113-116.407; Cuissinat C, 2008, CARBOHYD POLYM, V72, P590, DOI 10.1016/j.carbpol.2007.09.029; Cybulski J, 2008, CHEM A EUR J, V14, P9035; Guo LY, 2010, ADV MATER RES-SWITZ, V113-116, P1744, DOI 10.4028/www.scientific.net/AMR.113-116.1744; Hameed N, 2010, CELLULOSE, V17, P803, DOI 10.1007/s10570-010-9411-0; Kanbayashi T, 2015, HOLZFORSCHUNG, V69, P273; Lee SH, 2008, BIOTECHNOL BIOENG, V102, P1368; Lin B, 2010, IND ENG CHEM RES, V49, P2477; Lin B, 2010, IND ENG CHEM RES, V49, P3129; Liu CF, 2009, J AGR FOOD CHEM, V57, P1814, DOI 10.1021/jf803097k; Miao SD, 2006, MICROPOR MESOPOR MAT, V95, P26, DOI 10.1016/j.micromeso.2006.04.013; Miyafuji H, 2013, IONIC LIQUIDS - NEW ASPECTS FOR THE FUTURE, P299, DOI 10.5772/51798; Miyafuji H, 2013, HOLZFORSCHUNG, V67, P787, DOI 10.1515/hf-2012-0166; Miyata A, 2014, J WOOD SCI, V60, P438, DOI 10.1007/s10086-014-1420-4; Ohno E, 2014, J WOOD SCI, V60, P428, DOI 10.1007/s10086-014-1421-3; Ohno E, 2014, J WOOD SCI, V61, P65; Remsing RC, 2006, CHEM COMMUN, P1271, DOI 10.1039/b600586c; Samayam IP, 2010, BIORESOURCE TECHNOL, V101, P3561, DOI 10.1016/j.biortech.2009.12.066; Uju Shoda Y, 2012, BIORESOURCE TECHNOL, V103, P446; Wang Y, 2010, BIOTECHNOL BIOENG, V108, P1042; Wasserscheid P, 2003, NATO SCI SER II MATH, V92, P29; Yokoo T, 2014, J WOOD SCI, V60, P339, DOI 10.1007/s10086-014-1409-z; Yuan TQ, 2010, J AGR FOOD CHEM, V58, P11302, DOI 10.1021/jf103050t	99	1	1	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	AUG	2015	61	4					343	350		10.1007/s10086-015-1489-4		8	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CO4NO	WOS:000359137800002		
J	Mitsunaga, T; Yamauchi, K				Mitsunaga, Tohru; Yamauchi, Kosei			Effect of quercetin derivatives on melanogenesis stimulation of melanoma cells	JOURNAL OF WOOD SCIENCE			English	Review						Helminthostachys zeylanica; Quercetin glycoside; Melanin biosynthesis; Tyrosinase; p-p38 MAPK	ACTIVATED PROTEIN-KINASE; HAIR FOLLICLE MELANOCYTES; HELMINTHOSTACHYS-ZEYLANICA; P38 MAPK; PROTEASOMAL DEGRADATION; ENHANCES MELANOGENESIS; INHIBITORY COMPONENTS; DEPENDENT ACTIVATION; TRANSCRIPTION FACTOR; SIGNALING PATHWAY	Controlling melanogenesis is important for maintaining the good health and cosmetic appearance of a human body. This study aims to search the active compounds from natural products exhibiting the melanogenesis modulating activity and elucidate the mechanism underlying the observed activity. Two novel quercetin glycosides namely 4'-O-beta-D-glucopyranosyl-quercetin-3-O-beta-D-glucopyranosyl-(1 -> 4)-beta-D-glucopyranoside 1 and 4'-O-beta-D-glucopyranosyl-(1 -> 2)-beta-D-glucopyranosyl-quercetin-3-O-beta-D-glucopyranosyl-(1 -> 4)-beta-D-glucopyranoside 2 were isolated and identified from Helminthostachys zeylanica roots 50 % ethanol extract. Compound 1 exhibited intracellular melanogenesis stimulatory activity, while 2 showed no effect even the structural similarity. To understand the structure-activity relationships, twelve quercetin glycosides and seven methylquercetins were synthesized from rutin as starting material. As the result of bioassay using synthesized nineteen quercetin derivatives in B16 melanoma cells, some quercetin-3-O-beta-D-glucopyranosides stimulated the intracellular melanogenesis. On the other hand, synthesized 3-O-methylquercetin 12 and 3,4',7-O-trimethylquercetin 15 increased both intra and extracellular melanin contents with no cytotoxicity. Compoud 15 increased the phosphorylated p38 mitogen-activated protein kinase (MAPK) and microphthalmia-associated transcription factor (MITF) which regulates the expression of tyrosinase, TRP-1 and TRP-2. While 12 enhanced the expression of the melanogenic enzymes without involving the MITF, as evidenced by its lack of any stimulation of the expression of MITF and p-p38 MAPK. This result indicates that 12 may stimulate the expression of tyrosinase, TRP-1, and TRP-2 by stimulating currently unidentified transcriptional factors and/or by regulating the degradation of melanogenic enzymes.	[Mitsunaga, Tohru] Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan; [Mitsunaga, Tohru; Yamauchi, Kosei] Gifu Univ, United Grad Sch Agr Sci, Gifu 5011193, Japan	Mitsunaga, T (reprint author), Gifu Univ, Fac Appl Biol Sci, Gifu 5011193, Japan.	mitunaga@gifu-u.ac.jp					Adewole S O, 2007, Cardiovasc J Afr, V18, P221; Alvaro FS, 1995, BIOCHIM BIOPHYS ACTA, V1247, P1; Ando H, 2004, J BIOL CHEM, V279, P15427, DOI 10.1074/jbc.M313701200; Wang YJ, 2014, FOOD CHEM, V163, P226, DOI 10.1016/j.foodchem.2014.04.106; Aksan I, 1998, MOL CELL BIOL, V18, P6930; Nerya O, 2003, J AGR FOOD CHEM, V51, P1201, DOI 10.1021/jf020935u; Kim Sang Suk, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P617, DOI 10.1016/S2221-1691(13)60125-2; Lopez-Bergami P, 2011, PIGM CELL MELANOMA R, V24, P902, DOI 10.1111/j.1755-148X.2011.00908.x; Bertolotto C, 1998, MOL CELL BIOL, V18, P694; Lee CH, 2012, EUR J PHARMACOL, V676, P26, DOI 10.1016/j.ejphar.2011.12.001; Shimizu K, 2000, PLANTA MED, V66, P11, DOI 10.1055/s-2000-11113; Yang YM, 2011, PHYTOTHER RES, V25, P1166, DOI 10.1002/ptr.3417; SLOMINSKI A, 1994, J INVEST DERMATOL, V102, P862, DOI 10.1111/1523-1747.ep12382606; Arung ET, 2011, FITOTERAPIA, V82, P198, DOI 10.1016/j.fitote.2010.09.008; Ikawati Z, 2001, J ETHNOPHARMACOL, V75, P249, DOI 10.1016/S0378-8741(01)00201-X; Rees JL, 2003, ANNU REV GENET, V37, P67, DOI 10.1146/annurev.genet.37.110801.143233; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Bellei B, 2010, J BIOL CHEM, V285, P7288, DOI 10.1074/jbc.M109.070573; Cooksey CJ, 1998, BIOCHEM J, V333, P685; Bertolotto C, 1998, ONCOGENE, V16, P1665, DOI 10.1038/sj.onc.1201685; Bu J, 2008, AM J CHINESE MED, V36, P245, DOI 10.1142/S0192415X08005758; Bouktaib M, 2002, TETRAHEDRON, V58, P10001, DOI 10.1016/S0040-4020(02)01306-6; Jian D, 2011, STEROIDS, V76, P1297, DOI 10.1016/j.steroids.2011.06.008; Mingo-Sion AM, 2004, ONCOGENE, V23, P596, DOI 10.1038/sj.onc.1207147; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Ye Y, 2010, J ETHNOPHARMACOL, V132, P533, DOI 10.1016/j.jep.2010.09.007; Lan WC, 2013, PHYTOCHEMISTRY, V89, P78, DOI 10.1016/j.phytochem.2013.01.011; Manach C, 2004, AM J CLIN NUTR, V79, P727; Chiang HM, 2014, FOOD CHEM TOXICOL, V65, P129, DOI 10.1016/j.fct.2013.12.032; Englaro W, 1998, J BIOL CHEM, V273, P9966, DOI 10.1074/jbc.273.16.9966; Park SY, 2010, BMB REP, V43, P824, DOI 10.5483/BMBRep.2010.43.12.824; Guo HY, 2012, BIOCHEM BIOPH RES CO, V420, P799, DOI 10.1016/j.bbrc.2012.03.077; Kajjout M, 2011, TETRAHEDRON LETT, V52, P4738, DOI 10.1016/j.tetlet.2011.06.108; Bertolotto C, 1998, J CELL BIOL, V142, P827, DOI 10.1083/jcb.142.3.827; Lee CH, 2011, EUR J PHARMACOL, V668, P383, DOI 10.1016/j.ejphar.2011.06.059; Kajjout M, 2011, TETRAHEDRON, V67, P4731, DOI 10.1016/j.tet.2011.03.110; Tobin DJ, 1999, J INVEST DERM SYMP P, V4, P323, DOI 10.1038/sj.jidsp.5640239; Wang HS, 2006, LWT-FOOD SCI TECHNOL, V39, P496, DOI 10.1016/j.lwt.2005.04.001; Yoshida M, 2000, J INVEST DERMATOL, V114, P334, DOI 10.1046/j.1523-1747.2000.00874.x; Jiang ZQ, 2009, LIFE SCI, V85, P345, DOI 10.1016/j.lfs.2009.05.022; Arung ET, 2011, FOOD CHEM, V124, P1024, DOI 10.1016/j.foodchem.2010.07.067; Busca R, 2000, EMBO J, V19, P2900, DOI 10.1093/emboj/19.12.2900; Chen CH, 2009, MOLECULES, V14, P2947, DOI 10.3390/molecules14082947; CHEN QX, 2002, AGR FOOD CHEM, V50, P4108; Chiu NY, 1992, ILLUSTRATED MED PLAN, V3rd, P18; Fuji T, 2009, BIOSCI BIOTECH BIOCH, V9, P1989; Gibellini L, 2009, CANCERS, V2, P1288; Hertog GLM, 1992, J AGR FOOD CHEM, V40, P2379; Hollman C. H., 1999, FOOD CHEM TOXICOL, V37, P937; Huang YC, 2009, J NAT PROD, V72, P1273, DOI 10.1021/np900148a; Huang YL, 2003, PHYTOCHEMISTRY, V64, P1277, DOI 10.1016/j.phytochem.2003.09.009; Jang YJ, 2011, J ETHNOPHARMACOL, V137, P1207; Kamiya K, 2001, PHYTOCHEMISTRY, V57, P297, DOI 10.1016/S0031-9422(01)00005-X; KARIN M, 1995, J BIOL CHEM, V270, P16483; KUBO I, 1992, PHYTOCHEMISTRY, V31, P1063; Kurkin V, 1985, J MED PLANTS, P1231; LUKIEWICZ S, 1972, Folia Histochemica et Cytochemica, V10, P93; Mendoza-Wilson AM, 2011, J MOL STRUCT, V995, P134, DOI 10.1016/j.molstruc.2011.04.004; MURAKAMI T, 1973, CHEM PHARM BULL, V21, P1849; MURAKAMI T, 1973, Chemical and Pharmaceutical Bulletin (Tokyo), V21, P1851; Nagata H, 2004, PIGM CELL RES, V17, P66, DOI 10.1046/j.1600-0749.2003.00113.x; Oh EY, 2010, J ETHNOPHARMACOL, V132, P219, DOI 10.1016/j.jep.2010.08.010; Prota G, 1995, Fortschr Chem Org Naturst, V64, P93; Saratikov A, 1967, P SIBERIAN ACAD SCI, V1, P54; Shimizu K, 1998, PLANTA MED, V64, P408, DOI 10.1055/s-2006-957470; SLOMINSKI A, 1993, J INVEST DERMATOL, V101, pS90, DOI 10.1111/1523-1747.ep12362991; Suja SR, 2004, J ETHNOPHARMACOL, V92, P61, DOI 10.1016/j.jep.2004.01.019; Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50; Tobin DJ, 1998, J INVEST DERMATOL, V111, P941, DOI 10.1046/j.1523-1747.1998.00417.x; Uzgare RA, 2004, CANCER RES, V64, P6190; Wei B, 2014, BIOCHEM BIOPH RES CO, V443, P617, DOI 10.1016/j.bbrc.2013.12.017; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Woerdenbag JH Elfahmi, 2014, J HERB MED, V4, P51; Yamauchi K, 2013, J NAT MED-TOKYO, V67, P369, DOI 10.1007/s11418-012-0672-9; Yamauchi K, 2014, BIOORGAN MED CHEM, V22, P937, DOI 10.1016/j.bmc.2013.12.062; Yamauchi K, 2014, BIOORGAN MED CHEM, V22, P3331, DOI 10.1016/j.bmc.2014.04.053; Yamauchi K, 2011, NAT RESOUR, V2, P167; Ye Y, 2010, PHYTOMEDICINE, V18, P32, DOI 10.1016/j.phymed.2010.06.004	78	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	AUG	2015	61	4					351	363		10.1007/s10086-015-1476-9		13	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CO4NO	WOS:000359137800003		
J	Kawahara, K; Ando, K; Taniguchi, Y				Kawahara, Ken; Ando, Kosei; Taniguchi, Yusuke			Time dependence of Poisson's effect in wood IV: influence of grain angle	JOURNAL OF WOOD SCIENCE			English	Article						Poisson ratio; Grain angle; Shear effect; Viscoelasticity; Creep	3-DIMENSIONAL VISCOELASTIC COMPLIANCE; ELASTIC-CONSTANTS; TENSILE CREEP; COMPRESSION; BEHAVIOR	Off-axis tensile creep tests were conducted on woods taken from Japanese cypress and Kalopanax by changing the angle of load to the grain direction in the longitudinal-tangential (LT) plane. The dependence of the Poisson's ratio and trend of the viscoelastic Poisson's ratio on grain angle were investigated. The Poisson's ratios were found to reach their extrema when the grain angle was around 30 degrees. Moreover, the Poisson's ratio in the LT plane was observed to be negative when the grain angle was in the range of 15 degrees-45 degrees. Comparing the experimental results with theoretical values obtained from the theory of orthotropic elasticity, it was revealed that, although the Poisson's ratio reached an extremum in both cases, the specific values did not match, especially when the angle was between 15 degrees and 45 degrees. Furthermore, the temporal variation of the viscoelastic Poisson's ratio was found to depend on the grain angle and the measurement plane. It also appeared to be affected by the Poisson's ratio, showing an increasing tendency above a specific Poisson's ratio (Japanese cypress: 0.196, Kalopanax: 0.102) and a decreasing tendency below it, regardless of the grain angle and measurement plane. Additionally, the increment in the viscoelastic Poisson's ratio after 24 h of creep was observed to reach its extremum when the grain angle was around 30 degrees. Finally, by improving the six-element Frandsen-Muszynski viscoelastic model, which simultaneously considers the longitudinal and transverse strains, an eight-element model was presented, and the trend of the viscoelastic Poisson's ratio was well reproduced by this model.	[Kawahara, Ken; Ando, Kosei] Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan; [Taniguchi, Yusuke] Daiken Corp, Nanto, Toyama 9320298, Japan	Ando, K (reprint author), Nagoya Univ, Grad Sch Bioagr Sci, Chikusa Ku, Nagoya, Aichi 4648601, Japan.	musica@agr.nagoya-u.ac.jp					Anderson B., 1970, Research Briefs, School of Forest Resources, Pennsylvania State University, V4, P39; Ando K, 2013, J WOOD SCI, V59, P290, DOI 10.1007/s10086-013-1333-7; Ozyhar T, 2013, J RHEOL, V57, P699, DOI 10.1122/1.4790170; Keunecke D, 2008, WOOD SCI TECHNOL, V42, P633, DOI 10.1007/s00226-008-0192-7; Qing H, 2009, MECH MATER, V41, P1034, DOI 10.1016/j.mechmat.2009.04.011; Liu JY, 2002, WOOD FIBER SCI, V34, P205; LAKES R, 1987, SCIENCE, V235, P1038, DOI 10.1126/science.235.4792.1038; Garab J, 2010, WOOD SCI TECHNOL, V44, P451, DOI 10.1007/s00226-010-0362-2; HAYASHI K, 1993, MATER STRUCT, V26, P370, DOI 10.1007/BF02472963; Reiterer A, 2001, MECH MATER, V33, P705, DOI 10.1016/S0167-6636(01)00086-2; SCHNIEWI.AP, 1972, WOOD SCI TECHNOL, V6, P43; Bodig J, 1982, MECH WOOD WOOD COMPO, P87; Bodig J., 1973, Wood Science, V5, P249; Bucur V, 2003, NONDESTRUCTIVE CHARACTERIZATION OF MATERIALS XI, P47; Frandsen HL, 2006, P INT C INT APPR WOO, P139; Hankinson RL, 1921, AIR SERV INF CIRC, V259, P3; Hearmon RFS, 1948, ELASTICITY WOOD PLYW, P30; Jeong GY, 2010, WOOD FIBER SCI, V42, P51; Kollmann FFP, 1968, MECH RHEOLOGY WOOD P, P292; Marklund E, 2009, APPL COMPOS MATER, V16, P245, DOI 10.1007/s10443-009-9091-9; Mascia NT, 2013, CONSTR BUILD MATER, V41, P691, DOI 10.1016/j.conbuildmat.2012.12.014; Morooka T., 1979, Journal of the Society of Materials Science, Japan, V28; Murata K, 2010, J SOC MAT SCI JPN, V59, P285; Ohgama T, 1982, B FAC ED CHIBA U 2, V31, P99; Qing H, 2010, INT J SOLIDS STRUCT, V47, P1253, DOI 10.1016/j.ijsolstr.2010.01.014; SLIKER A, 1993, WOOD FIBER SCI, V25, P8; Sobue N, 1979, MOKUZAI GAKKAISHI, V25, P258; Taniguchi Y, 2010, J WOOD SCI, V56, P350, DOI 10.1007/s10086-009-1100-y; Taniguchi Y, 2010, J WOOD SCI, V56, P100, DOI 10.1007/s10086-009-1070-0; Taniguchi Y, 2010, J WOOD SCI, V56, P82, DOI 10.1007/s10086-009-1069-6; Yamai R, 1957, J JPN FOREST SOC, V39, P328; YOSHIHARA H, 1995, MOKUZAI GAKKAISHI, V41, P218	32	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	AUG	2015	61	4					372	383		10.1007/s10086-015-1477-8		12	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CO4NO	WOS:000359137800005		
J	Korai, H; Fujimoto, Y				Korai, Hideaki; Fujimoto, Yoshiyasu			Nail-head pull-through strength and lateral nail resistance strength of wood-based boards subjected to various climatic conditions in Japan	JOURNAL OF WOOD SCIENCE			English	Article						Wood-based board; Outdoor exposure; Nail-head pull-through strength; Biodeterioration; Density	OUTDOOR EXPOSURE; PANELS; PARTICLEBOARD; DETERIORATION; PERFORMANCE; DURABILITY	Particleboard (PB), oriented strand board (OSB), and medium-density fiberboard (MDF) were subjected to various climatic conditions at four sites (Morioka, Tsukuba, Okayama, and Miyakonojo; sites 1, 2, 3, and 4, respectively) in Japan. The reduction in the nail-head pull-through strength and lateral nail resistance strength (both strengths combined are hereafter referred to as nailed board strength) of PB and OSB at sites 3 and 4, which are high-temperature sites, was larger than that at the other sites. Temperature played a significant role in decreasing the nailed board strength. However, the nailed board strength of MDF did not significantly decrease for any site. Biodeterioration, rather than the extraction of wood components and the removal of materials on the board surface, was the main cause of mass loss. In particular, OSB exhibited noticeable biodeterioration. In contrast, there was hardly any biodeterioration in MDF. The correlation between density and nailed board strength was observed to be strong after the outdoor exposure test of PB and OSB.	[Korai, Hideaki] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Fujimoto, Yoshiyasu] Miyazaki Univ, Fac Educ & Culture, Miyazaki 8892192, Japan	Korai, H (reprint author), Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan.	korai@ffpri.affrc.go.jp; fujigen@cc.miyazaki-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [21380108]	This study was supported by a Grant-in-Aid for Scientific Research (21380108) from the Ministry of Education, Culture, Sports, Science and Technology of Japan. The authors are grateful for the grant received. The outdoor exposure test was conducted as part of a project organized by the Research Working Group on Wood-based Panels from the Japan Wood Research Society. The authors express their thanks to all participants in this project.	RIVER BH, 1994, FOREST PROD J, V44, P55; Kojima Y, 2012, J WOOD SCI, V58, P525, DOI 10.1007/s10086-012-1287-1; SEKINO N, 1986, MOKUZAI GAKKAISHI, V32, P163; Sekino N, 2014, J WOOD SCI, V60, P141, DOI 10.1007/s10086-013-1384-9; Korai H, 2012, MOKUZAI GAKKAISHI, V58, P347; [Anonymous], 1996, D103796A ASTM; Okkonen EA, 1996, FOREST PROD J, V46, P68; [Anonymous], 2003, A5905 JIS; [Anonymous], 2003, A5908 JIS; Kojima Y, 2011, J WOOD SCI, V57, P7, DOI 10.1007/s10086-010-1131-4; Kojima Y, 2009, FOREST PROD J, V59, P35; Korai H, 2013, J WOOD SCI, V59, P24, DOI 10.1007/s10086-012-1291-5; Korai H, 2012, FOREST PROD J, V62, P184; Kojima Y, 2011, J WOOD SCI, V57, P126, DOI 10.1007/s10086-010-1146-x; CARLL CG, 1989, FOREST PROD J, V39, P25; Gatchell C. J., 1966, Forest Products Journal, V16, P46; Hann R. A., 1962, Forest Products Journal, V12, P577; IMAMURA Y, 1984, MOKUZAI GAKKAISHI, V30, P1027; Korai H, 2014, J ADHES SOC JPN, V50, P260; Korai H, 2015, J WOOD SCI, V61, P35, DOI 10.1007/s10086-014-1433-z; SCHMIDT EL, 1978, FOREST PROD J, V28, P26; Sekino N, 2003, B IWATE U FOR, P23; Suzuki S, 2001, WOOD IND, V56, P7; Toole E. R., 1974, Forest Products Journal, V24, P55	24	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	AUG	2015	61	4					401	411		10.1007/s10086-015-1485-8		11	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CO4NO	WOS:000359137800008		
J	Hiraide, M; Sunagawa, M; Neda, H; Abdullah, NHLB; Yoshida, S				Hiraide, Masakazu; Sunagawa, Masahide; Neda, Hitoshi; Abdullah, Nur Humaira' Lau Bt.; Yoshida, Satoshi			Reducing radioactive cesium transfer from sawdust media to Pleurotus ostreatus fruiting bodies	JOURNAL OF WOOD SCIENCE			English	Article						Radiocesium; Pleurotus ostreatus; Reducing transfer; Prussian blue	PRUSSIAN BLUE; RADIOCESIUM; MUSHROOMS; ACCUMULATION; ADSORPTION; POTASSIUM; FOREST; SOILS	The Fukushima Daiichi nuclear power plant was damaged, and radionuclides such as Cs-137 were spread into the environment. Three years have passed since the accident, and ingestion of foods contaminated with radioactive material through the food chain is a health hazard of concern. Mushrooms are known for absorbing radionuclides, and methods for reducing fruiting body radioactivity are needed. We investigated radiocesium transfer activities and methods of reducing radiocesium transfer from sawdust media into fruiting bodies using Pleurotus ostreatus. Fruiting body radiocesium activity increased linearly with increasing media radioactivity. The radiocesium activities of fruiting bodies cultivated in different sawdust media were 0.2-0.9-fold (on wet-weight basis) and 1.3-3.7-fold (on dry-weight basis) higher than those of sawdust media, showing that transfer rates vary with cultivation conditions. From the reducing fruiting body radiocesium activity tests by medium additives, Prussian blue was effective and nanoparticle insoluble Prussian blue was more efficient than soluble Prussian blue. However, nanoparticle insoluble Prussian blue is more expensive than soluble Prussian blue. If mushroom growers use Prussian blue, it will be necessary to determine the type and the additional amounts that correspond to used strains, consumer needs, commercial value and cost.	[Hiraide, Masakazu; Sunagawa, Masahide; Neda, Hitoshi] Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan; [Abdullah, Nur Humaira' Lau Bt.] Agensi Nuklear Malaysia, Kajang, Malaysia; [Yoshida, Satoshi] Natl Inst Radiol Sci, Chiba 260, Japan	Hiraide, M (reprint author), Forestry & Forest Prod Res Inst, Tsukuba, Ibaraki 3058687, Japan.	hiraide@ffpri.affrc.go.jp			research and development projects for application in promoting new policies for agriculture, forestry, and fisheries - Ministry of Agriculture, Forestry and Fisheries of Japan [23063]	A part of this study was supported by research and development projects for application in promoting new policies for agriculture, forestry, and fisheries, supported by the Ministry of Agriculture, Forestry and Fisheries of Japan (Grant No. 23063). We would like to specially thank Mr. Toshio Hattori, a group deputy general manager of Dainichiseika Color & Chemicals Mfg. Co., Ltd, for providing Prussian blue (in 2011); Dr. Atsushi Kumata, forest resources director of Forest Research Center of Fukushima Pref., for introducing sawdust providers (in 2011); Mr. Yoji Ohashi, a senior researcher of Tochigi Prefectural Forestry Center, for providing Fagus crenata logs; and Ms. Keiko Hata for her helpful assistance.	Altagracia-Martinez M, 2012, ORPHAN DRUGS RES REV, V2, P13; Kalac P, 2000, FOOD CHEM, V69, P273, DOI 10.1016/S0308-8146(99)00264-2; Kalac P, 2001, FOOD CHEM, V75, P29, DOI 10.1016/S0308-8146(01)00171-6; Vinichuk M, 2010, SCI TOTAL ENVIRON, V408, P2543, DOI 10.1016/j.scitotenv.2010.02.024; Ishizaki M, 2013, DALTON T, V42, P16049, DOI 10.1039/c3dt51637g; Zhu YG, 2000, J EXP BOT, V51, P1635, DOI 10.1093/jexbot/51.351.1635; Nisbet AF, 2000, HEALTH PHYS, V78, P279, DOI 10.1097/00004032-200003000-00005; Torad NL, 2012, J MATER CHEM, V22, P18261, DOI 10.1039/c2jm32805d; Luque-Almagro VM, 2005, APPL ENVIRON MICROB, V71, P940, DOI 10.1128/AEM.71.2.940-947.2005; CREMERS A, 1988, NATURE, V335, P247, DOI 10.1038/335247a0; Birgitta A, 1990, RANGIFER, V10, P73; Consumer Affairs Agency of Japan, 2014, 3 SURV CONS AW HARMF; Fujimura S, 2013, PLANT PROD SCI, V16, P166; Harada A, 1997, J HOKKAIDO FOR PROD, V11, P7; International Atomic Energy Agency, 1997, 926 IAEA TECDOC; Japan Chemical Analysis Center, 1992, GAMM RAY SPECTR GERM; Kakimoto Y, 1991, BASIC SCI LATEST TEC, P230; Ministry of Agriculture Forestry and Fisheries of Japan, 2011, PROV REF IND MUSHR B; Patil SS, 2010, INNOV ROM FOOD BIOTE, V7, P61; Sato Itaru, 1994, Radioisotopes, V43, P468; Sugiyama Hideo, 1993, Radioisotopes, V42, P683; Takahashi T, 2011, SR COUNCIL NEWS CATA, V33, P1; Terada H, 1998, J RADIOANAL NUCL CH, V235, P195, DOI 10.1007/BF02385961; Tsukada H, 1998, J ENVIRON RADIOACTIV, V39, P149, DOI 10.1016/S0265-931X(97)00051-9; Tsumura A, 1984, B NATL I AGR SCI B, V36, P57; UNSWORTH EF, 1989, SCI TOTAL ENVIRON, V85, P339, DOI 10.1016/0048-9697(89)90333-1; Yokota S, 2013, B UTSUNOMIYA U, V49, P15	27	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	AUG	2015	61	4					420	430		10.1007/s10086-015-1483-x		11	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CO4NO	WOS:000359137800010		
J	Ito, R; Miyafuji, H; Kasuya, N				Ito, Ryoya; Miyafuji, Hisashi; Kasuya, Nobuhiko			Rhizome and root anatomy of moso bamboo (Phyllostachys pubescens) observed with scanning electron microscopy	JOURNAL OF WOOD SCIENCE			English	Article						Moso bamboo; Rhizome; Root; Scanning electron microscopy; Anatomy	FREE GLUCOSE; STARCH; FIBER	In this study, we observed the rhizome and root anatomy of moso bamboo (Phyllostachys pubescens) with scanning electron microscopy compared with the anatomy of the culm. The epidermis of culm, rhizome, and root were hard multi-layered and composed silica cells. The culm and rhizome consist of the epidermal, parenchyma, and vascular tissues. Although features of the anatomical structure of the rhizome were similar to those of the culm, the shape and distribution of vascular bundles and parenchyma differed between the organs.	[Ito, Ryoya; Miyafuji, Hisashi; Kasuya, Nobuhiko] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Kyoto 6068522, Japan	Miyafuji, H (reprint author), Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Environm Sci, Sakyo Ku, Hangi Cho, Kyoto 6068522, Japan.	miyafuji@kpu.ac.jp					Akakabe Y, 2006, BIOSCI BIOTECH BIOCH, V70, P2797, DOI 10.1271/bbb.60317; GROSSER D, 1971, WOOD SCI TECHNOL, V5, P290; LIESE W, 1987, WOOD SCI TECHNOL, V21, P189; Liese W, 1996, WOOD SCI TECHNOL, V30, P77; Asada T, 2002, J HEALTH SCI, V48, P473, DOI 10.1248/jhs.48.473; Evert RF, 2006, ESAUS PLANT ANATOMY, P539; FENGEL D, 1984, WOOD SCI TECHNOL, V18, P103; Hattori T, 2005, ROOT RES, V14, P41; Ide J., 2010, HYDROLOGICAL RES LET, V4, P80, DOI DOI 10.3178/HRL.4.80; Ito R, 2014, J SOC MATER SCI JPN, V63, P865; Larpkern P, 2011, OECOLOGIA, V165, P161, DOI 10.1007/s00442-010-1707-0; Li BX, 2007, J TROP FOR SCI, V19, P6; Li HS, 1997, J MATER SCI-MATER M, V8, P427; Lybeer B, 2006, WOOD SCI TECHNOL, V40, P477, DOI 10.1007/s00226-006-0078-5; Ogawa K, 2008, J ADV MECH DES SYST, V2, P550, DOI 10.1299/jamdsm.2.550; Okahisa Y., 2007, Journal of Bamboo and Rattan, V6, P21; Okahisa Y, 2006, J WOOD SCI, V52, P445, DOI 10.1007/s10086-005-0776-x; Saiki H, 1982, STRUCTURE DOMESTIC I, P120; Saroinsong BF, 2006, J JAP SOC REVEG TECH, V32, P15	19	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	AUG	2015	61	4					431	437		10.1007/s10086-015-1482-y		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CO4NO	WOS:000359137800011		
J	Tsuyama, T; Takabe, K				Tsuyama, Taku; Takabe, Keiji			Coniferin beta-glucosidase is ionically bound to cell wall in differentiating xylem of poplar	JOURNAL OF WOOD SCIENCE			English	Article						Coniferin beta-glucosidase; Poplar; Differentiating xylem; Cell wall	LIGNIN BIOSYNTHESIS; LODGEPOLE PINE; LIGNIFICATION; TRANSPORT; MONOLIGNOLS; PRECURSORS; SEEDLINGS; SPRUCE	Lignin is crucial for the growth and persistence of vascular plants in diverse environments. Although biosynthesis and polymerization of lignin precursors have been subjected to in-depth studies, only limited information exists on the ways in which these precursors are transported. Recent research has demonstrated that V-ATPase-dependent transport of coniferyl alcohol glucoside (coniferin) is a major metabolic function in differentiating xylem of both angiosperms and gymnosperms. Localization of beta-glucosidase involved in the cleavage of coniferin to coniferyl alcohol and glucose is important to clarify the role of coniferin in lignification; nevertheless, only little has been reported in angiosperms. Here, we demonstrated the presence of coniferin beta-glucosidase activity in a cell wall ionically bound protein fraction extracted from differentiating xylem of poplar. Coniferin beta-glucosidase localization is very likely in cell wall similar to previous reports in conifers. We identified a putative poplar coniferin beta-glucosidase through phylogenetic analysis and named this protein "PtrBGL6''. Immunoprecipitation assays showed that the anti-PtrBGL6 antibody recognizes a coniferin beta-glucosidase in a cell wall ionically bound protein fraction. Conserved coniferin beta-glucosidases localized in cell wall in both angiosperm and gymnosperm implies their important roles in the formation of lignified cell wall.	[Tsuyama, Taku; Takabe, Keiji] Kyoto Univ, Lab Tree Cell Biol, Div Forest & Biomat Sci, Grad Sch Agr,Sakyo Ku, Kyoto 6068502, Japan	Takabe, K (reprint author), Kyoto Univ, Lab Tree Cell Biol, Div Forest & Biomat Sci, Grad Sch Agr,Sakyo Ku, Kitashirakawa Oiwake Cho, Kyoto 6068502, Japan.	kjtakabe@kais.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology, Japan [11J02570]	We thank Dr. Shunzo Inoue, Akita Jujo Chemicals Co., Ltd. for providing hybrid poplar trees; Dr. Noritsugu Terashima, Nagoya University, for providing coniferin and syringin; Dr. Tatsuya Awano and Shota Nishine, Kyoto University, for technical assistance. This work was supported in part by a Grant-in-Aid for Scientific Research on Priority Areas from The Ministry of Education, Culture, Sports, Science and Technology, Japan (Grant no. 11J02570 to T.T.).	Vanholme R, 2010, PLANT PHYSIOL, V153, P895, DOI 10.1104/pp.110.155119; BOUDET AM, 1995, NEW PHYTOL, V129, P203, DOI 10.1111/j.1469-8137.1995.tb04292.x; Schumacher K, 2010, CURR OPIN PLANT BIOL, V13, P724, DOI 10.1016/j.pbi.2010.07.003; Boerjan W, 2003, ANNU REV PLANT BIOL, V54, P519, DOI 10.1146/annurev.arplant.54.031902.134938; Kaneda M, 2008, PLANT PHYSIOL, V147, P1750, DOI 10.1104/pp.108.121533; Alejandro S, 2012, CURR BIOL, V22, P1207, DOI 10.1016/j.cub.2012.04.064; DHARMAWARDHANA DP, 1995, PLANT PHYSIOL, V107, P331, DOI 10.1104/pp.107.2.331; WHETTEN R, 1995, PLANT CELL, V7, P1001; Miao YC, 2010, P NATL ACAD SCI USA, V107, P22728, DOI 10.1073/pnas.1007747108; Chang S. J., 1993, Plant Molecular Biology Reporter, V11, P113, DOI 10.1007/BF02670468; Chapelle A, 2012, PLANT PHYSIOL, V160, P1204, DOI 10.1104/pp.112.203364; DESA MM, 1992, PLANT PHYSIOL, V98, P728, DOI 10.1104/pp.98.2.728; Dharmawardhana DP, 1999, PLANT MOL BIOL, V40, P365, DOI 10.1023/A:1006226931512; Escamilla-Trevino LL, 2006, PHYTOCHEMISTRY, V67, P1651, DOI 10.1016/j.phytochem.2006.05.022; FREUDENB.K, 1967, LIEBIGS ANN CHEM, V703, P225; HERMAN EM, 1994, PLANT PHYSIOL, V106, P1313; Higuchi T., 1985, BIOSYNTHESIS BIODEGR, P141; HOSEL W, 1980, PHYTOCHEMISTRY, V19, P1349; Liu CJ, 2012, MOL PLANT, V5, P304, DOI 10.1093/mp/ssr121; MARCINOWSKI S, 1978, EUR J BIOCHEM, V87, P37, DOI 10.1111/j.1432-1033.1978.tb12349.x; MARCINOWSKI S, 1977, PHYTOCHEMISTRY, V16, P1665, DOI 10.1016/0031-9422(71)85067-7; Marjamaa K, 2003, TREE PHYSIOL, V23, P977; Neish AC, 1968, CONSTITUTION BIOSYNT, P3; Samuels AL, 2002, PLANTA, V216, P72, DOI 10.1007/s00425-002-0884-4; Terashima N, 2014, LIGN S FUK JAP 11 12, P2; Tsuyama T, 2013, PLANT PHYSIOL, V162, P918, DOI 10.1104/pp.113.214957; Tsuyama T, 2014, J WOOD SCI, V60, P353, DOI 10.1007/s10086-014-1417-z; Whetten RW, 1998, ANNU REV PLANT PHYS, V49, P585, DOI 10.1146/annurev.arplant.49.1.585	28	0	0	SPRINGER JAPAN KK	TOKYO	CHIYODA FIRST BLDG EAST, 3-8-1 NISHI-KANDA, CHIYODA-KU, TOKYO, 101-0065, JAPAN	1435-0211	1611-4663		J WOOD SCI	J. Wood Sci.	AUG	2015	61	4					438	444		10.1007/s10086-015-1486-7		7	Forestry; Materials Science, Paper & Wood	Forestry; Materials Science	CO4NO	WOS:000359137800012		
J	Danaei, G; Fahimi, S; Lu, Y; Zhou, B; Hajifathalian, K; Di Cesare, M; Lo, WC; Reis-Santos, B; Cowan, MJ; Shaw, JE; Bentham, J; Lin, JK; Bixby, H; Magliano, D; Bovet, P; Miranda, JJ; Khang, YH; Stevens, GA; Riley, LM; Ali, MK; Ezzati, M; Abdeen, ZA; Kadir, KA; Abu-Rmeileh, NM; Acosta-Cazares, B; Aekplakorn, W; Aguilar-Salinas, CA; Ahmadvand, A; Al Nsour, M; Alkerwi, A; Amouyel, P; Andersen, LB; Anderssen, SA; Andrade, DS; Anjana, RM; Aounallah-Skhiri, H; Aris, T; Arlappa, N; Arveiler, D; Assah, FK; Avdicova, M; Balakrishna, N; Bandosz, P; Barbagallo, CM; Barcelo, A; Batieha, AM; Baur, LA; Ben Romdhane, H; Bernabe-Ortiz, A; Bhargava, SK; Bi, YF; Bjerregaard, P; Bjorkelund, C; Blake, M; Blokstra, A; Bo, S; Boehm, BO; Boissonnet, CP; Bovet, P; Brajkovich, I; Breckenkamp, J; Brewster, LM; Brian, GR; Bruno, G; Bugge, A; de Leon, AC; Can, G; Candido, APC; Capuano, V; Carvalho, MJ; Casanueva, FF; Caserta, CA; Castetbon, K; Chamukuttan, S; Chaturvedi, N; Chen, CJ; Chen, F; Chen, S; Cheng, CY; Chetrit, A; Chiou, ST; Cho, Y; Chudek, J; Cifkova, R; Claessens, F; Concin, H; Cooper, C; Cooper, R; Costanzo, S; Cottel, D; Cowell, C; Crujeiras, AB; D'Arrigo, G; Dallongeville, J; Dankner, R; Dauchet, L; de Gaetano, G; De Henauw, S; Deepa, M; Dehghan, A; Dhana, K; Di Castelnuovo, AF; Djalalinia, S; Doua, K; Drygas, W; Du, Y; Egbagbe, EE; Eggertsen, R; El Ati, J; Elosua, R; Erasmus, RT; Erem, C; Ergor, G; Eriksen, L; la Penaa, JED; Fall, CH; Farzadfar, F; Felix-Redondo, FJ; Ferguson, TS; Fernandez-Berges, D; Ferrari, M; Ferreccio, C; Finn, JD; Foger, B; Foo, LH; Fouad, HM; Francis, DK; Franco, MDC; Franco, OH; Frontera, G; Furusawa, T; Gaciong, Z; Galbarczyk, A; Garnett, SP; Gaspoz, JM; Gasull, M; Gates, L; Geleijnse, JM; Ghasemain, A; Giampaoli, S; Gianfagna, F; Giovannelli, J; Gross, MG; Rivas, JPG; Gorbea, MB; Gottrand, F; Grant, JF; Grodzicki, T; Grontved, A; Gruden, G; Gu, DF; Guan, OP; Guerrero, R; Guessous, I; Guimaraes, AL; Gutierrez, L; Hardy, R; Kumar, RH; He, J; Heidemann, C; Hihtaniemi, IT; Ho, SY; Ho, SC; Hofman, A; Russo, ARV; Hormiga, CM; Horta, BL; Houti, L; Hussieni, AS; Huybrechts, I; Hwalla, N; Iacoviello, L; Iannone, AG; Ibrahim, MM; Ikeda, N; Ikram, MA; Irazola, VE; Islam, M; Iwasaki, M; Jacobs, JM; Jafar, T; Jasienska, G; Jiang, CQ; Jonas, JB; Joshi, P; Kafatos, A; Kalter-Leibovici, O; Kasaeian, A; Katz, J; Kaur, P; Kavousi, M; Kelishadi, R; Kengne, AP; Kersting, M; Khader, YS; Khang, YH; Kiechl, S; Kim, J; Kiyohara, Y; Kolsteren, P; Korrovits, P; Koskinen, S; Kratzer, W; Kromhout, D; Kula, K; Kurjata, P; Kyobutungi, C; Lachat, C; Laid, Y; Lam, TH; Landrove, O; Lanska, V; Lappas, G; Laxmaiah, A; Leclercq, C; Lee, J; Lee, J; Lehtimaaki, T; Lekhraj, R; Leon-Munoz, LM; Li, Y; Lim, WY; Lima-Costa, MF; Lin, HH; Lin, X; Lissner, L; Lorbeer, R; Lozano, JE; Lundqvist, A; Lytsy, P; Ma, G; Machado-Coelho, GLL; Machi, S; Maggi, S; Magliano, D; Makdisse, M; Rao, KM; Manios, Y; Manzato, E; Margozzini, P; Marques-Vidal, P; Martorell, R; Masoodi, SR; Matsha, TE; Mbanya, JCN; McFarlane, SR; McGarvey, ST; McLachlan, S; McNulty, BA; Mediene-Benchekor, S; Meirhaeghe, A; Menezes, AMB; Merat, S; Meshram, II; Mi, J; Miquel, JF; Miranda, JJ; Mohamed, MK; Mohammad, K; Mohan, V; Yusoff, MFM; Moller, NC; Molnar, D; Mondo, CK; Moreno, LA; Morgan, K; Moschonis, G; Mossakowska, M; Mostafa, A; Mota, J; Muiesan, ML; Muller-Nurasyid, M; Mursu, J; Nagel, G; Namesna, J; Nang, EEK; Nangia, VB; Navarrete-Munoz, EM; Ndiaye, NC; Nervi, F; Nguyen, ND; Nieto-Martinez, RSE; Ning, G; Ninomiya, T; Noale, M; Noto, D; Ochoa-Aviles, AM; Oh, K; Onat, A; Osmond, C; Otero, JA; Palmieri, L; Panda-Jonas, S; Panza, F; Parsaeian, M; Peixoto, SV; Pereira, AC; Peters, A; Peykari, N; Pilav, A; Pitakaka, F; Piwonska, A; Piwonski, J; Plans-Rubio, P; Porta, M; Portegies, MLP; Poustchi, H; Pradeepa, R; Price, JF; Punab, M; Qasrawi, RF; Qorbani, M; Raitakari, O; Rao, SR; Ramachandran, A; Ramos, R; Rampal, S; Rathmann, W; Redon, J; Reganit, PFM; Rigo, F; Robinson, SM; Robitaille, C; Rodriguez, LA; Rodriguez-Artalejo, F; Rodriguez-Perez, MDC; Rojas-Martinez, R; Romaguera, D; Rosengren, A; Rubinstein, A; Rui, O; Ruiz-Betancourt, BS; Rutkowski, M; Sabanayagam, C; Sachdev, HS; Saidi, O; Sakarya, S; Salanave, B; Salonen, JT; Salvetti, M; Sanchez-Abanto, J; Nunes, R; Santos, R; Sardinha, LB; Scazufca, M; Schargrodsky, H; Scheidt-Nave, C; Shaw, JE; Shibuya, K; Shin, Y; Shiri, R; Siantar, R; Sibai, AM; Simon, M; Simons, J; Simons, LA; Sjostrom, M; Slowikowska-Hilczer, J; Slusarczyk, P; Smeeth, L; Snijder, MB; Solfrizzi, V; Sonestedt, E; Soumare, A; Staessen, JA; Steene-Johannessen, J; Stehle, P; Stein, AD; Stessman, J; Stockl, D; Stokwiszewski, J; Strufaldi, MW; Sun, CA; Sundstrom, J; Suriyawongpaisal, P; Sy, RG; Tai, ES; Tarawneh, M; Tarqui-Mamani, CB; Thijs, L; Tolstrup, JS; Topbas, M; Torrent, M; Traissac, P; Trinh, OTH; Tulloch-Reid, MK; Tuomainen, TP; Turley, ML; Tzourio, C; Ueda, P; Ukoli, FM; Ulmer, H; Valdivia, G; Van Valkengoed, IGM; Vanderschueren, D; Vanuzzo, D; Vega, T; Velasquez-Melendez, G; Veronesi, G; Verschuren, M; Vioque, J; Virtanen, J; Visvikis-Siest, S; Viswanathan, B; Vollenweider, P; Voutilainen, S; Wade, AN; Wagner, A; Walton, J; Mohamud, WNW; Wang, MD; Wang, YX; Wannamethee, SG; Weerasekera, D; Whincup, PH; Widhalm, K; Wiecek, A; Wilks, RJ; Willeit, J; Wojtyniak, B; Wong, TY; Woo, J; Woodward, M; Wu, AG; Wu, FC; Wu, SL; Xu, HQ; Yang, XG; Ye, XW; Yoshihara, A; Younger-Coleman, NO; Zambon, S; Zargar, AH; Zdrojewski, T; Zhao, WH; Zheng, YF				Danaei, Goodarz; Fahimi, Saman; Lu, Yuan; Zhou, Bin; Hajifathalian, Kaveh; Di Cesare, Mariachiara; Lo, Wei-Cheng; Reis-Santos, Barbara; Cowan, Melanie J.; Shaw, Jonathan E.; Bentham, James; Lin, John K.; Bixby, Honor; Magliano, Dianna; Bovet, Pascal; Miranda, J. Jaime; Khang, Young-Ho; Stevens, Gretchen A.; Riley, Leanne M.; Ali, Mohammed K.; Ezzati, Majid; Abdeen, Ziad A.; Kadir, Khalid Abdul; Abu-Rmeileh, Niveen M.; Acosta-Cazares, Benjamin; Aekplakorn, Wichai; Aguilar-Salinas, Carlos A.; Ahmadvand, Alireza; Al Nsour, Mohannad; Alkerwi, Ala'a; Amouyel, Philippe; Andersen, Lars Bo; Anderssen, Sigmund A.; Andrade, Dolores S.; Anjana, Ranjit Mohan; Aounallah-Skhiri, Hajer; Aris, Tahir; Arlappa, Nimmathota; Arveiler, Dominique; Assah, Felix K.; Avdicova, Maria; Balakrishna, Nagalla; Bandosz, Piotr; Barbagallo, Carlo M.; Barcelo, Alberto; Batieha, Anwar M.; Baur, Louise A.; Ben Romdhane, Habiba; Bernabe-Ortiz, Antonio; Bhargava, Santosh K.; Bi, Yufang; Bjerregaard, Peter; Bjorkelund, Cecilia; Blake, Margaret; Blokstra, Anneke; Bo, Simona; Boehm, Bernhard O.; Boissonnet, Carlos P.; Bovet, Pascal; Brajkovich, Imperia; Breckenkamp, Juergen; Brewster, Lizzy M.; Brian, Garry R.; Bruno, Graziella; Bugge, Anna; de Leon, Antonio Cabrera; Can, Gunay; Candido, Ana Paula C.; Capuano, Vincenzo; Carvalho, Maria J.; Casanueva, Felipe F.; Caserta, Carmelo A.; Castetbon, Katia; Chamukuttan, Snehalatha; Chaturvedi, Nishi; Chen, Chien-Jen; Chen, Fangfang; Chen, Shuohua; Cheng, Ching-Yu; Chetrit, Angela; Chiou, Shu-Ti; Cho, Yumi; Chudek, Jerzy; Cifkova, Renata; Claessens, Frank; Concin, Hans; Cooper, Cyrus; Cooper, Rachel; Costanzo, Simona; Cottel, Dominique; Cowell, Chris; Crujeiras, Ana B.; D'Arrigo, Graziella; Dallongeville, Jean; Dankner, Rachel; Dauchet, Luc; de Gaetano, Giovanni; De Henauw, Stefaan; Deepa, Mohan; Dehghan, Abbas; Dhana, Klodian; Di Castelnuovo, Augusto F.; Djalalinia, Shirin; Doua, Kouamelan; Drygas, Wojciech; Du, Yong; Egbagbe, Eruke E.; Eggertsen, Robert; El Ati, Jalila; Elosua, Roberto; Erasmus, Rajiv T.; Erem, Cihangir; Ergor, Gul; Eriksen, Louise; la Penaa, Jorge Escobedo-De; Fall, Caroline H.; Farzadfar, Farshad; Felix-Redondo, Francisco J.; Ferguson, Trevor S.; Fernandez-Berges, Daniel; Ferrari, Marika; Ferreccio, Catterina; Finn, Joseph D.; Foger, Bernhard; Foo, Leng Huat; Fouad, Heba M.; Francis, Damian K.; Franco, Maria do Carmo; Franco, Oscar H.; Frontera, Guillermo; Furusawa, Takuro; Gaciong, Zbigniew; Galbarczyk, Andrzej; Garnett, Sarah P.; Gaspoz, Jean-Michel; Gasull, Magda; Gates, Louise; Geleijnse, Johanna M.; Ghasemain, Anoosheh; Giampaoli, Simona; Gianfagna, Francesco; Giovannelli, Jonathan; Gross, Marcela Gonzalez; Rivas, Juan P. Gonzalez; Gorbea, Mariano Bonet; Gottrand, Frederic; Grant, Janet F.; Grodzicki, Tomasz; Grontved, Anders; Gruden, Grabriella; Gu, Dongfeng; Guan, Ong Peng; Guerrero, Ramiro; Guessous, Idris; Guimaraes, Andre L.; Gutierrez, Laura; Hardy, Rebecca; Kumar, Rachakulla Hari; He, Jiang; Heidemann, Christin; Hihtaniemi, Ilpo Tapani; Ho, Sai Yin; Ho, Suzanne C.; Hofman, Albert; Russo, Andrea R. V.; Hormiga, Claudia M.; Horta, Bernardo L.; Houti, Leila; Hussieni, Abdullatif S.; Huybrechts, Inge; Hwalla, Nahla; Iacoviello, Licia; Iannone, Anna G.; Ibrahim, Mohsen M.; Ikeda, Nayu; Ikram, M. Arfan; Irazola, Vilma E.; Islam, Muhammad; Iwasaki, Masanori; Jacobs, Jeremy M.; Jafar, Tazeen; Jasienska, Grazyna; Jiang, Chao Qiang; Jonas, Jost B.; Joshi, Pradeep; Kafatos, Anthony; Kalter-Leibovici, Ofra; Kasaeian, Amir; Katz, Joanne; Kaur, Prabhdeep; Kavousi, Maryam; Kelishadi, Roya; Kengne, Andre P.; Kersting, Mathilde; Khader, Yousef Saleh; Khang, Young-Ho; Kiechl, Stefan; Kim, Jeongseon; Kiyohara, Yutaka; Kolsteren, Patrick; Korrovits, Paul; Koskinen, Seppo; Kratzer, Wolfgang; Kromhout, Daan; Kula, Krzysztof; Kurjata, Pawel; Kyobutungi, Catherine; Lachat, Carl; Laid, Youcef; Lam, Tai Hing; Landrove, Orlando; Lanska, Vera; Lappas, Georg; Laxmaiah, Avula; Leclercq, Catherine; Lee, Jeannette; Lee, Jeonghee; Lehtimaki, Terho; Lekhraj, Rampal; Leon-Munoz, Luz M.; Li, Yanping; Lim, Wei-Yen; Lima-Costa, M. Fernanda; Lin, Hsien-Ho; Lin, Xu; Lissner, Lauren; Lorbeer, Roberto; Lozano, Jose Eugenio; Lundqvist, Annamari; Lytsy, Per; Ma, Guansheng; Machado-Coelho, George L. L.; Machi, Suka; Maggi, Stefania; Magliano, Dianna; Makdisse, Marcia; Rao, Kodavanti Mallikharjuna; Manios, Yannis; Manzato, Enzo; Margozzini, Paula; Marques-Vidal, Pedro; Martorell, Reynaldo; Masoodi, Shariq R.; Matsha, Tandi E.; Mbanya, Jean Claude N.; McFarlane, Shelly R.; McGarvey, Stephen T.; McLachlan, Stela; McNulty, Breige A.; Mediene-Benchekor, Sounnia; Meirhaeghe, Aline; Menezes, Ana Maria B.; Merat, Shahin; Meshram, Indrapal I.; Mi, Jie; Miquel, Juan Francisco; Miranda, J. Jaime; Mohamed, Mostafa K.; Mohammad, Kazem; Mohan, Viswanathan; Yusoff, Muhammad Fadhli Mohd; Moller, Niels C.; Molnar, Denes; Mondo, Charles K.; Moreno, Luis A.; Morgan, Karen; Moschonis, George; Mossakowska, Malgorzata; Mostafa, Aya; Mota, Jorge; Muiesan, Maria L.; Muller-Nurasyid, Martina; Mursu, Jaakko; Nagel, Gabriele; Namesna, Jana; Nang, Ei Ei K.; Nangia, Vinay B.; Navarrete-Munoz, Eva Maria; Ndiaye, Ndeye Coumba; Nervi, Flavio; Nguyen, Nguyen D.; Nieto-Martinez, Ramfi S. E.; Ning, Guang; Ninomiya, Toshiharu; Noale, Marianna; Noto, Davide; Ochoa-Aviles, Angelica M.; Oh, Kyungwon; Onat, Altan; Osmond, Clive; Otero, Johanna A.; Palmieri, Luigi; Panda-Jonas, Songhomitra; Panza, Francesco; Parsaeian, Mahboubeh; Peixoto, Sergio Viana; Pereira, Alexandre C.; Peters, Annette; Peykari, Niloofar; Pilav, Aida; Pitakaka, Freda; Piwonska, Aleksandra; Piwonski, Jerzy; Plans-Rubio, Pedro; Porta, Miquel; Portegies, Marileen L. P.; Poustchi, Hossein; Pradeepa, Rajendra; Price, Jacqueline F.; Punab, Margus; Qasrawi, Radwan F.; Qorbani, Mostafa; Raitakari, Olli; Rao, Sudha Ramachandra; Ramachandran, Ambady; Ramos, Rafel; Rampal, Sanjay; Rathmann, Wolfgang; Redon, Josep; Reganit, Paul Ferdinand M.; Rigo, Fernando; Robinson, Sian M.; Robitaille, Cynthia; Rodriguez, Laura A.; Rodriguez-Artalejo, Fernando; Rodriguez-Perez, Maria del Cristo; Rojas-Martinez, Rosalba; Romaguera, Dora; Rosengren, Annika; Rubinstein, Adolfo; Rui, Ornelas; Ruiz-Betancourt, Blanca Sandra; Rutkowski, Marcin; Sabanayagam, Charumathi; Sachdev, Harshpal S.; Saidi, Olfa; Sakarya, Sibel; Salanave, Benoit; Salonen, Jukka T.; Salvetti, Massimo; Sanchez-Abanto, Jose; Nunes, Renata; Santos, Rute; Sardinha, Luis B.; Scazufca, Marcia; Schargrodsky, Herman; Scheidt-Nave, Christa; Shaw, Jonathan E.; Shibuya, Kenji; Shin, Youchan; Shiri, Rahman; Siantar, Rosalynn; Sibai, Abla M.; Simon, Mary; Simons, Judith; Simons, Leon A.; Sjostrom, Michael; Slowikowska-Hilczer, Jolanta; Slusarczyk, Przemyslaw; Smeeth, Liam; Snijder, Marieke B.; Solfrizzi, Vincenzo; Sonestedt, Emily; Soumare, Aicha; Staessen, Jan A.; Steene-Johannessen, Jostein; Stehle, Peter; Stein, Aryeh D.; Stessman, Jochanan; Stockl, Doris; Stokwiszewski, Jakub; Strufaldi, Maria Wany; Sun, Chien-An; Sundstrom, Johan; Suriyawongpaisal, Paibul; Sy, Rody G.; Tai, E. Shyong; Tarawneh, Mohammed; Tarqui-Mamani, Carolina B.; Thijs, Lutgarde; Tolstrup, Janne S.; Topbas, Murat; Torrent, Maties; Traissac, Pierre; Trinh, Oanh T. H.; Tulloch-Reid, Marshall K.; Tuomainen, Tomi-Pekka; Turley, Maria L.; Tzourio, Christophe; Ueda, Peter; Ukoli, Flora M.; Ulmer, Hanno; Valdivia, Gonzalo; Van Valkengoed, Irene G. M.; Vanderschueren, Dirk; Vanuzzo, Diego; Vega, Tomas; Velasquez-Melendez, Gustavo; Veronesi, Giovanni; Verschuren, Monique; Vioque, Jesus; Virtanen, Jyrki; Visvikis-Siest, Sophie; Viswanathan, Bharathi; Vollenweider, Peter; Voutilainen, Sari; Wade, Alisha N.; Wagner, Aline; Walton, Janette; Mohamud, Wan Nazaimoon Wan; Wang, Ming-Dong; Wang, Ya Xing; Wannamethee, S. Goya; Weerasekera, Deepa; Whincup, Peter H.; Widhalm, Kurt; Wiecek, Andrzej; Wilks, Rainford J.; Willeit, Johann; Wojtyniak, Bogdan; Wong, Tien Yin; Woo, Jean; Woodward, Mark; Wu, Aleksander Giwercman; Wu, Frederick C.; Wu, Shou Ling; Xu, Haiquan; Yang, Xiaoguang; Ye, Xingwang; Yoshihara, Akihiro; Younger-Coleman, Novie O.; Zambon, Sabina; Zargar, Abdul Hamid; Zdrojewski, Tomasz; Zhao, Wenhua; Zheng, Yingfeng			Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331288 participants	LANCET DIABETES & ENDOCRINOLOGY			English	Article							FASTING PLASMA-GLUCOSE; HEMOGLOBIN A(1C) MEASUREMENT; GLYCATED HEMOGLOBIN; CARDIOVASCULAR-DISEASE; WORLDWIDE STANDARDIZATION; CONSENSUS STATEMENT; SYSTEMATIC ANALYSIS; INSULIN-RESISTANCE; SCREENING-TEST; TOLERANCE TEST	Background Diabetes has been defined on the basis of different biomarkers, including fasting plasma glucose (FPG), 2-h plasma glucose in an oral glucose tolerance test (2hOGTT), and HbA(1c). We assessed the effect of different diagnostic definitions on both the population prevalence of diabetes and the classification of previously undiagnosed individuals as having diabetes versus not having diabetes in a pooled analysis of data from population-based health examination surveys in different regions. Methods We used data from 96 population-based health examination surveys that had measured at least two of the biomarkers used for defining diabetes. Diabetes was defined using HbA(1c) (HbA(1c) >= 6 . 5% or history of diabetes diagnosis or using insulin or oral hypoglycaemic drugs) compared with either FPG only or FPG-or-2hOGTT definitions (FPG >= 7 . 0 mmol/L or 2hOGTT >= 11 . 1 mmol/L or history of diabetes or using insulin or oral hypoglycaemic drugs). We calculated diabetes prevalence, taking into account complex survey design and survey sample weights. We compared the prevalences of diabetes using different definitions graphically and by regression analyses. We calculated sensitivity and specificity of diabetes diagnosis based on HbA1c compared with diagnosis based on glucose among previously undiagnosed individuals (ie, excluding those with history of diabetes or using insulin or oral hypoglycaemic drugs). We calculated sensitivity and specificity in each survey, and then pooled results using a random-effects model. We assessed the sources of heterogeneity of sensitivity by meta-regressions for study characteristics selected a priori. Findings Population prevalence of diabetes based on FPG- or-2hOGTT was correlated with prevalence based on FPG alone (r= 0 . 98), but was higher by 2-6 percentage points at different prevalence levels. Prevalence based on HbA(1c) was lower than prevalence based on FPG in 42 . 8% of age-sex-survey groups and higher in another 41 . 6%; in the other 15 . 6%, the two definitions provided similar prevalence estimates. The variation across studies in the relation between glucose-based and HbA(1c)-based prevalences was partly related to participants' age, followed by natural logarithm of per person gross domestic product, the year of survey, mean BMI, and whether the survey population was national, subnational, or from specific communities. Diabetes defined as HbA(1c) 6 . 5% or more had a pooled sensitivity of 52 . 8% (95% CI 51 . 3-54 . 3%) and a pooled specificity of 99 . 74% (99 . 71-99 . 78%) compared with FPG 7 . 0 mmol/L or more for diagnosing previously undiagnosed participants; sensitivity compared with diabetes defined based on FPG-or-2hOGTT was 30 . 5% (28 . 7-32 . 3%). None of the preselected study-level characteristics explained the heterogeneity in the sensitivity of HbA(1c) versus FPG. Interpretation Different biomarkers and definitions for diabetes can provide different estimates of population prevalence of diabetes, and differentially identify people without previous diagnosis as having diabetes. Using an HbA(1c)-based definition alone in health surveys will not identify a substantial proportion of previously undiagnosed people who would be considered as having diabetes using a glucose-based test.	[Danaei, Goodarz; Fahimi, Saman; Lu, Yuan; Hajifathalian, Kaveh] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Zhou, Bin; Di Cesare, Mariachiara; Bentham, James; Bixby, Honor; Ezzati, Majid; Hihtaniemi, Ilpo Tapani] Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England; [Lo, Wei-Cheng] Natl Taiwan Univ, Taipei, Taiwan; [Reis-Santos, Barbara] Univ Fed Pelotas, Capao Do Leao, RS, Brazil; [Cowan, Melanie J.; Stevens, Gretchen A.; Riley, Leanne M.] World Hlth Org, Geneva, Switzerland; [Shaw, Jonathan E.; Magliano, Dianna] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Lin, John K.] Univ San Francisco, San Francisco, CA 94117 USA; [Bovet, Pascal] Univ Lausanne, CH-1015 Lausanne, Switzerland; [Bovet, Pascal] Minist Hlth, Victoria, Seychelles; [Miranda, J. Jaime] Univ Peruana Cayetano Heredia, San Martin De Porres, Peru; [Khang, Young-Ho] Seoul Natl Univ, Seoul 151, South Korea; [Ali, Mohammed K.; Martorell, Reynaldo] Emory Univ, Atlanta, GA 30322 USA; [Abdeen, Ziad A.] Al Quds Univ, Jerusalem, Israel; [Kadir, Khalid Abdul] Monash Univ Malaysia, Subang Jaya, Selangor, Malaysia; [Abu-Rmeileh, Niveen M.] Birzeit Univ, Jerusalem, Israel; [Acosta-Cazares, Benjamin] Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Aekplakorn, Wichai] Mahidol Univ, Bangkok 10700, Thailand; [Aguilar-Salinas, Carlos A.] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico; [Ahmadvand, Alireza; Ghasemain, Anoosheh; Kasaeian, Amir; Merat, Shahin; Mohammad, Kazem; Parsaeian, Mahboubeh; Peykari, Niloofar; Poustchi, Hossein] Univ Tehran Med Sci, Tehran, Iran; [Al Nsour, Mohannad] Eastern Mediterranean Publ Hlth Network, Amman, Jordan; [Alkerwi, Ala'a] Luxembourg Hlth Inst, Luxembourg, Luxembourg; [Amouyel, Philippe] Lille Univ & Hosp, Lille, France; [Andersen, Lars Bo; Bjerregaard, Peter; Bugge, Anna; Eriksen, Louise; Grontved, Anders] Univ Southern Denmark, Odense, Denmark; [Anderssen, Sigmund A.] Norwegian Sch Sport Sci, Oslo, Norway; [Andrade, Dolores S.] Univ Cuenca, Cuenca, Ecuador; [Anjana, Ranjit Mohan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Aounallah-Skhiri, Hajer] Natl Inst Publ Hlth, Tunis, Tunisia; [Aris, Tahir] Minist Hlth Malaysia, Kuala Lumpur, Malaysia; [Arlappa, Nimmathota; Balakrishna, Nagalla] Indian Council Med Res, Madras, Tamil Nadu, India; [Arlappa, Nimmathota; Arveiler, Dominique] Strasbourg Univ & Hosp, Strasbourg, France; [Assah, Felix K.] Hlth Populat Transit Res Grp, Yaounde, Cameroon; [Avdicova, Maria] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Bandosz, Piotr] Med Univ Gdansk, Gdansk, Poland; [Barbagallo, Carlo M.] Univ Palermo, I-90133 Palermo, Italy; [Barcelo, Alberto] Pan Amer Hlth Org, New York, NY USA; [Batieha, Anwar M.] Jordan Univ Sci & Technol, Amman, Jordan; [Baur, Louise A.; Garnett, Sarah P.; Woodward, Mark] Univ Sydney, Sydney, NSW 2006, Australia; [Ben Romdhane, Habiba] Univ Tunis El Manar, Tunis, Tunisia; [Bernabe-Ortiz, Antonio] Univ Peruana Cayetano Heredia, San Martin De Porres, Peru; [Bhargava, Santosh K.] Sunder Lal Jain Hosp, Delhi, India; [Bi, Yufang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Bjerregaard, Peter] Univ Greenland, Nuuk, Greenland; [Bjorkelund, Cecilia] Univ Gothenburg, Gothenburg, Sweden; [Blake, Margaret] NatCen Social Res, London, England; [Blokstra, Anneke] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Bo, Simona; Bruno, Graziella; Gruden, Grabriella] Univ Turin, I-10124 Turin, Italy; [Boehm, Bernhard O.] Nanyang Technol Univ, Singapore 639798, Singapore; [Boissonnet, Carlos P.] Ctr Educac Med Invest Clin, Buenos Aires, DF, Argentina; [Bovet, Pascal] Univ Lausanne, CH-1015 Lausanne, Switzerland; [Bovet, Pascal] Minist Hlth, Victoria, Seychelles; [Brajkovich, Imperia] Cent Univ Venezuela, Caracas, Venezuela; [Breckenkamp, Juergen] Univ Bielefeld, Bielefeld, Germany; [Brewster, Lizzy M.; Snijder, Marieke B.] Univ Amsterdam, NL-1012 WX Amsterdam, Netherlands; [Brian, Garry R.] Fred Hollows Fdn New Zealand, Auckland, New Zealand; [Bugge, Anna] Canarian Hlth Serv, Santa Cruz De Tenerife, Spain; [Can, Gunay] Istanbul Univ, Istanbul, Turkey; [Candido, Ana Paula C.] Univ Fed Juiz Fora, Juiz De Fora, Brazil; [Capuano, Vincenzo] Reparto Cardiol UTIC Mercato S, Mercato San Severino, Italy; [Carvalho, Maria J.; Mota, Jorge] Univ Porto, P-4100 Oporto, Portugal; [Casanueva, Felipe F.] Univ Santiago de Compostela, Santiago De Compostela, Spain; [Caserta, Carmelo A.] Associaz Calabrese Epatol, Reggio Di Calabria, Italy; [Castetbon, Katia] French Inst Hlth Surveillance, St Maurice, France; [Chamukuttan, Snehalatha; Ramachandran, Ambady; Simon, Mary] India Diabet Res Fdn, Madras, Tamil Nadu, India; [Chen, Chien-Jen] Acad Sinica, Taipei, Taiwan; [Chen, Fangfang] Capital Inst Pediat, Beijing, Peoples R China; [Chen, Shuohua] Kailuan Gen Hosp, Kailua, HI USA; [Cheng, Ching-Yu] Duke NUS Grad Med Sch, Singapore, Singapore; [Chetrit, Angela] Gertner Inst Epidemiol & Hlth Policy Res, Tel Hashomer, Israel; [Chiou, Shu-Ti] Minist Hlth & Welf, Taipei, Taiwan; [Cho, Yumi] Korea Ctr Dis Control & Prevent, Chungcheongbuk Do, South Korea; [Chudek, Jerzy] Med Univ Silesia, Katowice, Poland; [Cifkova, Renata] Charles Univ Prague, Prague, Czech Republic; [Claessens, Frank] Katholieke Univ Leuven, Leuven, Belgium; [Concin, Hans] Agcy Prevent & Social Med, Bregenz, Austria; [Cooper, Cyrus] Univ Southampton, Southampton SO9 5NH, Hants, England; [Cooper, Rachel; Hardy, Rebecca; Wannamethee, S. Goya] UCL, London WC1E 6BT, England; [Costanzo, Simona] IRCCS, Ist Neurol Mediterraneo Neuromed, Milan, Italy; [Cottel, Dominique] Inst Pasteur, Lille, France; [Cowell, Chris] Westmead Univ Sydney, Sydney, NSW, Australia; [Crujeiras, Ana B.; de Gaetano, Giovanni] CIBERobn, Madrid, Spain; [D'Arrigo, Graziella] CNR, Rome, Italy; [Dallongeville, Jean] Inst Pasteur, Lille, France; [Dankner, Rachel] Gertner Inst Epidemiol & Hlth Policy Res, Ramat Gan, Israel; [Dauchet, Luc] Lille Univ Hosp, Lille, France; [de Gaetano, Giovanni] IRCCS, Ist Neurol Mediterraneo Neuromed, Milan, Italy; [De Henauw, Stefaan; Lachat, Carl] Univ Ghent, B-9000 Ghent, Belgium; [Deepa, Mohan] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Dehghan, Abbas; Dhana, Klodian; Franco, Oscar H.; Hofman, Albert; Ikram, M. Arfan; Kavousi, Maryam; Portegies, Marileen L. P.] Univ Med Ctr Rotterdam, Rotterdam, Netherlands; [Djalalinia, Shirin] Univ Tehran Med Sci, Tehran, Iran; [Doua, Kouamelan] Minist St & Lutte Sida, Abidjan, Cote Ivoire; [Drygas, Wojciech] Cardinal Wyszynski Inst Cardiol, Warsaw, Poland; [Du, Yong] Robert Koch Inst, Berlin, Germany; [Egbagbe, Eruke E.] Univ Benin, Coll Med Sci, Benin, Nigeria; [Eggertsen, Robert] Univ Gothenburg, Gothenburg, Sweden; [El Ati, Jalila] Natl Inst Nutr & Food Technol, Tunis, Tunisia; [Elosua, Roberto] Inst Hosp Mar Invest Mar, Barcelona, Spain; [Erasmus, Rajiv T.] Univ Stellenbosch, Stellenbosch, South Africa; [Erasmus, Rajiv T.] Karadeniz Tech Univ, Trabzon, Turkey; [Ergor, Gul] Dokuz Eylul Univ, Izmir, Turkey; [la Penaa, Jorge Escobedo-De] Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Fall, Caroline H.] MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Farzadfar, Farshad] Univ Tehran Med Sci, Tehran, Iran; [Felix-Redondo, Francisco J.] Ctr Salud Villanueva Norte, Badajoz, Spain; [Ferguson, Trevor S.; Francis, Damian K.; McFarlane, Shelly R.; Tulloch-Reid, Marshall K.; Wilks, Rainford J.; Younger-Coleman, Novie O.] Univ W Indies, Jamaica, NY USA; [Fernandez-Berges, Daniel] Hosp Don Benitovillanueva Serena, Badajoz, Spain; [Ferrari, Marika] Natl Res Inst Food & Nutr, Rome, Italy; [Ferreccio, Catterina; Margozzini, Paula] Pontificia Univ Catolica Chile, Santiago, Chile; [Finn, Joseph D.] Univ Manchester, Manchester M13 9PL, Lancs, England; [Foger, Bernhard] Agcy Prevent & Social Med, Bregenz, Austria; [Foo, Leng Huat] Univ Sains Malaysia, Gelugor, Penang, Malaysia; [Fouad, Heba M.] World Hlth Org Reg Off Eastern Mediterranean, Cairo, Egypt; [Franco, Maria do Carmo; Strufaldi, Maria Wany] Univ Fed Sao Paulo, Sao Paulo, Brazil; [Frontera, Guillermo] Hosp Univ Son Espases, Palma De Mallorca, Spain; [Furusawa, Takuro] Kyoto Univ, Kyoto 6068501, Japan; [Gaciong, Zbigniew] Med Univ Warsaw, Warsaw, Poland; [Galbarczyk, Andrzej; Grodzicki, Tomasz] Jagiellonian Univ, Coll Med, PL-31007 Krakow, Poland; [Gaspoz, Jean-Michel; Guessous, Idris] Univ Hosp Geneva, Geneva, Switzerland; [Gasull, Magda] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Gates, Louise] Australian Bur Stat, Canberra, ACT, Australia; [Geleijnse, Johanna M.] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Giampaoli, Simona] Ist Super Sanita, Rome, Italy; [Gianfagna, Francesco] Univ Insubria, Como, CO, Italy; [Giovannelli, Jonathan] Lille Univ Hosp, Lille, France; [Gross, Marcela Gonzalez] Univ Politecn Madrid, E-28040 Madrid, Spain; [Rivas, Juan P. Gonzalez] Andes Clin Cardio Metab Studies, Merida, Venezuela; [Gorbea, Mariano Bonet] Natl Inst Hyg Epidemiol & Microbiol, Havana, Cuba; [Gottrand, Frederic] Univ Lille 1, F-59655 Villeneuve Dascq, France; [Grant, Janet F.] Univ Adelaide, Adelaide, SA 5005, Australia; [Gu, Dongfeng] Natl Ctr Cardiovasc Dis, Beijing, Peoples R China; [Guan, Ong Peng; Sabanayagam, Charumathi; Shin, Youchan; Siantar, Rosalynn; Zheng, Yingfeng] Singapore Eye Res Inst, Singapore, Singapore; [Guerrero, Ramiro] Univ Icesi, Cali, Colombia; [Guimaraes, Andre L.] Univ Estadual Montes Claros, Montes Claros, MG, Brazil; [Gutierrez, Laura] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Kumar, Rachakulla Hari] Indian Council Med Res, New Delhi, India; [He, Jiang] Tulane Univ, New Orleans, LA 70118 USA; [Heidemann, Christin] Robert Koch Inst, Berlin, Germany; [Ho, Sai Yin] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Ho, Suzanne C.] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Russo, Andrea R. V.; Pereira, Alexandre C.] Inst Heart, Sao Paulo, Brazil; [Hormiga, Claudia M.] Fdn Oftalmol Santander, Bucaramanga, Colombia; [Horta, Bernardo L.] Univ Fed Pelotas, Capao Do Leao, RS, Brazil; [Houti, Leila] Univ Oran 1, Es Senia, Algeria; [Hussieni, Abdullatif S.] Birzeit Univ, Ramallah, Israel; [Huybrechts, Inge] Int Agcy Res Canc, Lyon, France; [Hwalla, Nahla] Amer Univ Beirut, Beirut, Lebanon; [Iacoviello, Licia] IRCCS Ist Neurol Mediterraneo Neuromed, Milan, Italy; [Iannone, Anna G.] Reparto Cardiol UTIC Mercato S, Mercato San Severin, Italy; [Ibrahim, Mohsen M.] Cairo Univ, Cairo, Egypt; [Ikeda, Nayu] Natl Inst Hlth & Nutr, Tokyo, Japan; [Irazola, Vilma E.] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Islam, Muhammad] Aga Khan Univ, Karachi, Pakistan; [Iwasaki, Masanori; Yoshihara, Akihiro] Niigata Univ, Niigata 95021, Japan; [Jacobs, Jeremy M.] Hadassah Univ, Med Ctr, Jerusalem, Israel; [Jafar, Tazeen; Wong, Tien Yin] Duke NUS Grad Med Sch, Singapore, Singapore; [Jasienska, Grazyna] Jagiellonian Univ, Coll Med, PL-31007 Krakow, Poland; [Jiang, Chao Qiang] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Jonas, Jost B.; Panda-Jonas, Songhomitra] Heidelberg Univ, D-69115 Heidelberg, Germany; [Joshi, Pradeep] World Hlth Org Country Off, Jodhpur, Rajasthan, India; [Kafatos, Anthony] Univ Crete, Rethimnon, Greece; [Kalter-Leibovici, Ofra] Gertner Inst Epidemiol & Hlth Policy Res, Tel Hashomer, Israel; [Katz, Joanne] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Kaur, Prabhdeep] Natl Inst Epidemiol, Madras, Tamil Nadu, India; [Kelishadi, Roya] Isfahan Univ Med Sci, Esfahan, Iran; [Kengne, Andre P.] South African Med Res Council, Cape Town, South Africa; [Kersting, Mathilde] Res Inst Child Nutr, Dortmund, Germany; [Khader, Yousef Saleh] Jordan Univ Sci & Technol, Yousef Saleh Khader, Irbid, Jordan; [Khang, Young-Ho] Seoul Natl Univ, Seoul 151, South Korea; [Kiechl, Stefan; Ulmer, Hanno; Willeit, Johann] Med Univ Innsbruck, A-6020 Innsbruck, Austria; [Kim, Jeongseon] Natl Canc Ctr, Goyang Si, South Korea; [Kiyohara, Yutaka] Kyushu Univ, Fukuoka 812, Japan; [Kolsteren, Patrick] Inst Trop Med, Antwerp, Belgium; [Korrovits, Paul; Punab, Margus] Tartu Univ Clin, Tartu, Estonia; [Koskinen, Seppo] Natl Inst Hlth & Welf, Helsinki, Finland; [Kratzer, Wolfgang] Univ Hosp Ulm, Ulm, Germany; [Kromhout, Daan] Wageningen Univ, NL-6700 AP Wageningen, Netherlands; [Kula, Krzysztof; Slowikowska-Hilczer, Jolanta] Med Univ Lodz, Lodz, Poland; [Kurjata, Pawel] Cardinal Wyszynski Inst Cardiol, Warsaw, Poland; [Kyobutungi, Catherine] African Populat & Hlth Res Ctr, Nairobi, Kenya; [Laid, Youcef] Natl Inst Publ Hlth, Algiers, Algeria; [Lam, Tai Hing] Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Landrove, Orlando] Minist Salud Publ, Havana, Cuba; [Lanska, Vera] Inst Clin & Expt Med Prague, Prague, Czech Republic; [Lappas, Georg; Rosengren, Annika] Sahlgrens Acad, Gothenburg, Sweden; [Laxmaiah, Avula; Rao, Kodavanti Mallikharjuna] Indian Council Med Res, New Delhi, India; [Leclercq, Catherine] Food & Agr Org, Rome, Italy; [Lee, Jeannette] Natl Univ Singapore, Singapore 117548, Singapore; [Lee, Jeonghee] Natl Canc Ctr, Koyang, South Korea; [Lehtimaki, Terho] Tampere Univ Hosp, Tampere, Finland; [Lekhraj, Rampal] Univ Putra Malaysia, Serdang 43400, Malaysia; [Leon-Munoz, Luz M.; Rodriguez-Artalejo, Fernando] Univ Autonoma Madrid, E-28049 Madrid, Spain; [Li, Yanping; Ueda, Peter] Harvard TH Chan Sch Publ Hlth, Boston, MA USA; [Lim, Wei-Yen] Natl Univ Singapore, Singapore 117548, Singapore; [Lima-Costa, M. Fernanda; Peixoto, Sergio Viana] Fundacao Oswaldo Cruz, Rene Rachou Res Inst, Rio De Janeiro, Brazil; [Lin, Hsien-Ho] Natl Taiwan Univ, Taipei, Taiwan; [Lin, Xu; Ye, Xingwang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Lissner, Lauren] Gothenburg Univ, S-41124 Gothenburg, Sweden; [Lorbeer, Roberto] Univ Med Greifswald, Greifswald, Germany; [Lozano, Jose Eugenio; Vega, Tomas] Consejeria Sanidad Junta Castilla & Leon, Valladolid, Spain; [Lundqvist, Annamari] Natl Inst Hlth & Welf, Tampere, Finland; [Lytsy, Per; Sundstrom, Johan] Uppsala Univ, S-75105 Uppsala, Sweden; [Ma, Guansheng] Peking Univ, Beijing, Peoples R China; [Machado-Coelho, George L. L.] Univ Fed Ouro Preto, Ouro Preto, MG, Brazil; [Machi, Suka] Jikei Univ, Sch Med, Tokyo, Japan; [Maggi, Stefania] CNR, Rome, Italy; [Shaw, Jonathan E.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia; [Makdisse, Marcia] Hosp Israelita Albert Einstein, Sao Paulo, Brazil; [Manios, Yannis] Harokopio Univ Athens, Athens, Greece; [Manzato, Enzo] Univ Padua, I-35100 Padua, Italy; [Marques-Vidal, Pedro] Univ Lausanne Hosp, Lausanne, Switzerland; [Masoodi, Shariq R.] Sher & Kashmir Inst Med Sci, Srinagar, Jammu & Kashmir, India; [Matsha, Tandi E.] Cape Peninsula Univ Technol, Cape Town, South Africa; [Mbanya, Jean Claude N.] Univ Yaounde I, Yaounde, Cameroon; [McGarvey, Stephen T.] Brown Univ, Providence, RI 02912 USA; [McLachlan, Stela] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [McNulty, Breige A.] Univ Coll Dublin, Dublin, Ireland; [Mediene-Benchekor, Sounnia] Univ Oran 1, Es Senia, Algeria; [Meirhaeghe, Aline; Visvikis-Siest, Sophie] INSERM, F-75654 Paris 13, France; [Menezes, Ana Maria B.] Univ Fed Pelotas, Capao Do Leao, RS, Brazil; [Meshram, Indrapal I.] Indian Council Med Res, New Delhi, India; [Mi, Jie] Capital Inst Pediat, Beijing, Peoples R China; [Miquel, Juan Francisco; Nervi, Flavio; Valdivia, Gonzalo] Pontificia Univ Catolica Chile, Santiago, Chile; Univ Peruana Cayetano Heredia, San Martin De Porres, Peru; [Mohamed, Mostafa K.] Ain Shams Univ, Cairo, Egypt; [Mohan, Viswanathan; Pradeepa, Rajendra] Madras Diabet Res Fdn, Madras, Tamil Nadu, India; [Yusoff, Muhammad Fadhli Mohd] Minist Hlth Malaysia, Kuala Lumpur, Malaysia; [Moller, Niels C.] Univ Southern Denmark, Odense, Denmark; [Molnar, Denes] Univ Pecs, Pecs, Hungary; [Mondo, Charles K.] Mulago Hosp, Kampala, Uganda; [Moreno, Luis A.] Univ Zaragoza, E-50009 Zaragoza, Spain; [Morgan, Karen] PU RCSI Sch Med, Kuala Lumpur, Malaysia; [Moschonis, George] Harokopio Univ Athens, Athens, Greece; [Mossakowska, Malgorzata] Int Inst Mol & Cell Biol, Warsaw, Poland; [Mostafa, Aya] Ain Shams Univ, Cairo, Egypt; [Muiesan, Maria L.] Univ Brescia, I-25121 Brescia, Italy; [Muller-Nurasyid, Martina; Peters, Annette; Stockl, Doris] Helmholtz Zentrum Munchen, Munich, Germany; [Mursu, Jaakko; Tuomainen, Tomi-Pekka; Virtanen, Jyrki; Voutilainen, Sari] Univ Eastern Finland, Joensuu, Finland; [Nagel, Gabriele] Univ Ulm, D-89069 Ulm, Germany; [Namesna, Jana] Reg Author Publ Hlth, Banska Bystrica, Slovakia; [Nang, Ei Ei K.; Tai, E. Shyong] Natl Univ Singapore, Singapore 117548, Singapore; [Nangia, Vinay B.] Suraj Eye Inst, Nagpur, Maharashtra, India; [Navarrete-Munoz, Eva Maria] CIBER Epidemiol & Salud Publ, Barcelona, Spain; [Ndiaye, Ndeye Coumba] INSERM, F-75654 Paris 13, France; [Nguyen, Nguyen D.; Trinh, Oanh T. H.] Univ Pharm & Med Ho Chi Minh City, Ho Chi Minh, Vietnam; [Nieto-Martinez, Ramfi S. E.] Univ Ctr Occidental Lisandro Alvarado, Barquisimeto, Venezuela; [Ning, Guang] Shanghai Jiao Tong Univ, Sch Med, Shanghai 200030, Peoples R China; [Ninomiya, Toshiharu] Kyushu Univ, Fukuoka 812, Japan; [Noale, Marianna] CNR, Rome, Italy; [Noto, Davide] Univ Palermo, I-90133 Palermo, Italy; [Ochoa-Aviles, Angelica M.] Univ Cuenca, Cuenca, Ecuador; [Oh, Kyungwon] Korea Ctr Dis Control & Prevent, Taejon, South Korea; [Onat, Altan] Istanbul Univ, Istanbul, Turkey; [Osmond, Clive] MRC, Lifecourse Epidemiol Unit, London W1N 4AL, England; [Otero, Johanna A.] Fdn Oftalmol Santander, Bucaramanga, Colombia; [Palmieri, Luigi] Ist Super Sanita, Rome, Italy; [Panza, Francesco; Solfrizzi, Vincenzo] Univ Bari, I-70121 Bari, Italy; [Pilav, Aida] Fed Minist Hlth, Sarajevo, Bosnia & Herceg; [Pitakaka, Freda] Univ New S Wales, Sydney, NSW 2052, Australia; [Piwonska, Aleksandra] Cardinal Wyszynski Inst Cardiol, Warsaw, Poland; [Piwonski, Jerzy] Cardinal Wyszynski Inst Cardiol, Warsaw, Poland; [Plans-Rubio, Pedro] Publ Hlth Agcy Catalonia, Catalonia, Spain; [Porta, Miquel] Hosp Mar Med Res Inst IMIM, Barcelona, Spain; [Price, Jacqueline F.] Univ Edinburgh, Edinburgh EH8 9YL, Midlothian, Scotland; [Qasrawi, Radwan F.] Al Quds Univ, Jerusalem, Israel; [Qorbani, Mostafa] Alborz Univ Med Sci, Karaj, Alborz, Iran; [Raitakari, Olli] Univ Turku, SF-20500 Turku, Finland; [Rao, Sudha Ramachandra] Natl Inst Epidemiol, Madras, Tamil Nadu, India; [Ramos, Rafel] Inst Univ Invest Atencio Primaria Jordi Gol, Barcelona, Spain; [Rampal, Sanjay] Univ Malaya, Kuala Lumpur, Malaysia; [Rathmann, Wolfgang] German Diabet Ctr, Dusseldorf, Germany; [Redon, Josep] Univ Valencia, E-46003 Valencia, Spain; [Reganit, Paul Ferdinand M.; Sy, Rody G.] Univ Philippines, Quezon City 1101, Philippines; [Rigo, Fernando] Hlth Ctr San Agustin, Mallorca, Spain; [Robinson, Sian M.] Univ Southampton, Southampton SO9 5NH, Hants, England; [Robitaille, Cynthia; Wang, Ming-Dong] Publ Hlth Agcy Canada, Calgary, AB, Canada; [Rodriguez, Laura A.] Univ Ind Santander, Santander, Colombia; [Rojas-Martinez, Rosalba] Inst Nacl Salud Publ, Mexico City, DF, Mexico; [Romaguera, Dora] Ctr Res Environm Epidemiol, Madrid, Spain; Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Rubinstein, Adolfo] Inst Clin Effectiveness & Hlth Policy, Buenos Aires, DF, Argentina; [Rui, Ornelas] Univ Madeira, Funchal, Portugal; [Ruiz-Betancourt, Blanca Sandra] Inst Mexicano Seguro Social, Mexico City, DF, Mexico; [Rutkowski, Marcin] Med Univ Gdansk, Gdansk, Poland; [Sachdev, Harshpal S.] Sitaram Bhartia Inst Sci & Res, New Delhi, India; [Saidi, Olfa] Univ Tunis El Manar, El Manar, Tunisia; [Sakarya, Sibel] Marmara Univ, Kadikoy, Turkey; [Salanave, Benoit] French Inst Hlth Surveillance, St Maurice, France; [Salonen, Jukka T.] Univ Helsinki, FIN-00014 Helsinki, Finland; [Salvetti, Massimo] Univ Brescia, I-25121 Brescia, Italy; [Nunes, Renata; Scazufca, Marcia] Univ Sao Paulo, BR-05508 Sao Paulo, Brazil; [Santos, Rute] Univ Porto, P-4100 Oporto, Portugal; [Sardinha, Luis B.] Univ Lisbon, P-1699 Lisbon, Portugal; [Schargrodsky, Herman] Hosp Italiano Buenos Aires, Buenos Aires, DF, Argentina; [Scheidt-Nave, Christa] Robert Koch Inst, Berlin, Germany; [Shibuya, Kenji] Univ Tokyo, Tokyo 1138654, Japan; [Shiri, Rahman] Finnish Inst Occupat Hlth, Helsinki, Finland; [Sibai, Abla M.] Amer Univ Beirut, Beirut, Lebanon; [Simons, Judith] St Vincents Hosp, Melbourne, Vic, Australia; [Simons, Leon A.] Univ New S Wales, Sydney, NSW, Australia; [Sjostrom, Michael] Karolinska Inst, S-10401 Stockholm, Sweden; [Slusarczyk, Przemyslaw] Int Inst Mol & Cell Biol, Warsaw, Poland; [Smeeth, Liam] London Sch Hyg & Trop Med, London, England; [Sonestedt, Emily; Wu, Aleksander Giwercman] Lund Univ, S-22100 Lund, Sweden; [Soumare, Aicha; Tzourio, Christophe] Univ Bordeaux, Bordeaux, France; [Staessen, Jan A.] Univ Leuven, Leuven, Belgium; [Steene-Johannessen, Jostein] Norwegian Sch Sport Sci, Oslo, Norway; [Stehle, Peter] Univ Bonn, Bonn, Germany; [Stein, Aryeh D.] Emory Univ, Atlanta, GA 30322 USA; [Stessman, Jochanan] Hadassah Univ, Med Ctr, Jerusalem, Israel; [Stokwiszewski, Jakub; Wojtyniak, Bogdan] Natl Inst Hyg, Warsaw, Poland; [Sun, Chien-An] Fu Jen Catholic Univ, New Taipei City, Taiwan; [Suriyawongpaisal, Paibul] Mahidol Univ, Bangkok 10700, Thailand; [Tarawneh, Mohammed] Minist Hlth, Amman, Jordan; [Thijs, Lutgarde] Univ Leuven, Leuven, Belgium; [Tolstrup, Janne S.] Univ Southern Denmark, Odense, Denmark; [Topbas, Murat] Karadeniz Tech Univ, Trabzon, Turkey; [Torrent, Maties] Area Salut Menorca, Menorca, Spain; [Traissac, Pierre] Inst Rech Dev, Paris, France; [Turley, Maria L.; Weerasekera, Deepa] Minist Hlth, Wellington, New Zealand; [Ukoli, Flora M.] Meharry Med Coll, Nashville, TN USA; [Van Valkengoed, Irene G. M.] Univ Amsterdam, Acad Med Ctr, NL-1012 WX Amsterdam, Netherlands; [Vanderschueren, Dirk] Katholieke Univ Leuven, Leuven, Belgium; [Velasquez-Melendez, Gustavo] Univ Fed Minas Gerais, Belo Horizonte, MG, Brazil; [Verschuren, Monique] Univ Insubria, Como, CO, Italy; [Verschuren, Monique] Natl Inst Publ Hlth & Environm, Bilthoven, Netherlands; [Vioque, Jesus] Univ Miguel Hernandez, Alicante, Spain; [Viswanathan, Bharathi] Minist Hlth, Victoria, Seychelles; [Vollenweider, Peter] Univ Lausanne Hosp, Lausanne, Switzerland; [Wade, Alisha N.] Univ Witwatersrand, ZA-2050 Johannesburg, South Africa; [Wagner, Aline] Univ Strasbourg, Strasbourg, France; [Walton, Janette] Natl Univ Ireland Univ Coll Cork, Cork, Ireland; [Mohamud, Wan Nazaimoon Wan] Inst Med Res, Kuala Lumpur, Malaysia; [Wang, Ya Xing] Beijing Tongren Hosp, Beijing, Peoples R China; [Whincup, Peter H.] St Georges Univ London, London, England; [Widhalm, Kurt] Med Univ Vienna, Vienna, Austria; [Wiecek, Andrzej] Med Univ Silesia, Silesia, Poland; [Woo, Jean] Chinese Univ Hong Kong, Hong Kong, Hong Kong, Peoples R China; [Woodward, Mark] Univ Oxford, Oxford OX1 2JD, England; [Wu, Frederick C.] Univ Manchester, Manchester M13 9PL, Lancs, England; [Wu, Shou Ling] Kailuan Gen Hosp, Tangshan, Hebei, Peoples R China; [Xu, Haiquan] Minist Agr, Inst Food & Nutr Dev, Beijing, Peoples R China; [Yang, Xiaoguang] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zambon, Sabina] Univ Padua, I-35100 Padua, Italy; [Zargar, Abdul Hamid] Ctr Diabet & Endocrine Care, Bangalore, Karnataka, India; [Zdrojewski, Tomasz] Med Univ Gdansk, Gdansk, Poland; [Zhao, Wenhua] Chinese Ctr Dis Control & Prevent, Beijing, Peoples R China	Ezzati, M (reprint author), Univ London Imperial Coll Sci Technol & Med, London W2 1PG, England.		Veronesi, Giovanni/E-3859-2010; Morgan, Karen/C-3846-2012; Woo, Jean/K-2625-2014; Menezes, Ana/G-7266-2012; Marques-Vidal, Pedro/C-9449-2009; Meirhaeghe, Aline/E-4663-2015; Ahmadvand, Alireza/J-8932-2015; Virtanen, Jyrki/G-5149-2013; Porta, Miquel/B-5787-2008; Staessen, Jan/A-1065-2011; Nagel, Gabriele/C-3635-2012; Chen, Chien-Jen/C-6976-2008; Woodward, Mark/D-8492-2015; mota, jorge/B-2980-2013; Guimaraes, Andre/D-8122-2011; Bovet, Pascal/F-4477-2011; Rampal, Sanjay/B-9691-2010; Horta, Bernardo/A-7604-2008; vhmpp, aks/F-9756-2012; Ulmer, Hanno/C-3488-2011	Veronesi, Giovanni/0000-0002-4119-6615; Noto, Davide/0000-0002-5346-2829; Whincup, Peter/0000-0002-5589-4107; Gianfagna, Francesco/0000-0003-4615-0816; Morgan, Karen/0000-0001-6193-1747; Woo, Jean/0000-0001-7593-3081; Marques-Vidal, Pedro/0000-0002-4548-8500; Ahmadvand, Alireza/0000-0001-5568-8787; Virtanen, Jyrki/0000-0002-0648-999X; Barbagallo, Carlo M./0000-0002-4114-038X; giovannelli, jonathan/0000-0002-7516-4670; Porta, Miquel/0000-0003-1684-7428; Staessen, Jan/0000-0002-3026-1637; mota, jorge/0000-0001-7571-9181; Guimaraes, Andre/0000-0002-3162-3206; Bovet, Pascal/0000-0002-0242-4259; Rampal, Sanjay/0000-0002-0105-6407; Ulmer, Hanno/0000-0001-5911-1002	Wellcome Trust; US National Institutes of Health [DK090435]	This study was funded by the Wellcome Trust and US National Institutes of Health (DK090435). The authors alone are responsible for the views expressed in this Article and they do not necessarily represent the views, decisions, or policies of the institutions with which they are affiliated.	Almoosawi S, 2014, J EPIDEMIOL COMMUN H, V68, P51, DOI 10.1136/jech-2013-202885; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS81, DOI DOI 10.2337/DC14-S081; American Diabetes Association, 2014, DIABETES CARE S1, V37, pS14, DOI [DOI 10.2337/DC14-S014, 10.2337/dc14-S014]; American Diabetes Association, 2000, DIABETES CARE S1, V23, pS24; Committee C, 2007, DIABETOLOGIA, V50, P2042, DOI 10.1007/s00125-007-0789-7; Adamu AN, 2011, AFR HEALTH SCI, V11, P421; Nakagawa S, 2013, METHODS ECOL EVOL, V4, P133, DOI 10.1111/j.2041-210x.2012.00261.x; Selvin E, 2011, DIABETES CARE, V34, P84, DOI 10.2337/dc10-1235; Selvin E, 2011, ANN INTERN MED, V154, P303, DOI [10.7326/0003-4819-154-5-201103010-00004, 10.1059/0003-4819-154-5-201103010-00004]; Nakagami T, 2007, DIABETES RES CLIN PR, V76, P251, DOI 10.1016/j.diabres.2006.09.015; Olson DE, 2010, DIABETES CARE, V33, P2184, DOI 10.2337/dc10-0433; Ziemer DC, 2010, ANN INTERN MED, V152, P770, DOI 10.7326/0003-4819-152-12-201006150-00004; Hoelzel W, 2004, CLIN CHEM, V50, P166, DOI 10.1373/clinchem.2003.024802; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Christensen DL, 2010, DIABETES CARE, V33, P580, DOI 10.2337/dc09-1843; Colagiuri S, 2011, DIABETES CARE, V34, P145, DOI 10.2337/dc10-1206; Hare MJL, 2012, J INTERN MED, V271, P227, DOI 10.1111/j.1365-2796.2012.02513.x; Zimmet PZ, 2014, LANCET DIABETES ENDO, V2, P56, DOI 10.1016/S2213-8587(13)70112-8; Shibata K, 2005, J CLIN EPIDEMIOL, V58, P1052, DOI 10.1016/j.jclinepi.2005.01.019; Soulimane S, 2011, DIABETIC MED, V28, P1311, DOI 10.1111/j.1464-5491.2011.03403.x; Di Angelantonio E, 2014, JAMA-J AM MED ASSOC, V311, P1225, DOI 10.1001/jama.2014.1873; Choi SH, 2011, DIABETES CARE, V34, P944, DOI 10.2337/dc10-0644; Zamboni M, 1997, AM J CLIN NUTR, V66, P111; Yach D, 2006, NAT MED, V12, P62, DOI 10.1038/nm0106-62; Carson AP, 2010, DIABETES CARE, V33, P95, DOI 10.2337/dc09-1227; Kontis V, 2014, LANCET, V384, P427, DOI 10.1016/S0140-6736(14)60616-4; Cowie CC, 2010, DIABETES CARE, V33, P562, DOI 10.2337/dc09-1524; Kumar PR, 2010, J CLIN ENDOCR METAB, V95, P2832, DOI 10.1210/jc.2009-2433; Rathmann W, 2012, ANN MED, V44, P170, DOI 10.3109/07853890.2010.531759; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Ito C, 2000, DIABETES RES CLIN PR, V50, P225, DOI 10.1016/S0168-8227(00)00187-X; Droumaguet C, 2006, DIABETES CARE, V29, P1619, DOI 10.2337/dc05-2525; Stevens GA, 2012, POPUL HEALTH METR, V10, DOI 10.1186/1478-7954-10-22; Nakagami T, 2004, DIABETOLOGIA, V47, P385, DOI 10.1007/s00125-004-1334-6; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Di Cesare M, 2013, LANCET, V381, P585, DOI 10.1016/S0140-6736(12)61851-0; Nazir A, 2012, DIABETES TECHNOL THE, V14, P665, DOI 10.1089/dia.2012.0059; Araneta MRG, 2010, DIABETES CARE, V33, P2626, DOI [10.2337/dc10-0958, 10.2337/dc10.0958]; Hare MJL, 2013, DIABETES CARE, V36, P1534, DOI 10.2337/dc12-1210; Little RR, 2011, CLIN CHEM, V57, P205, DOI 10.1373/clinchem.2010.148841; Stevens GA, 2013, LANCET GLOB HEALTH, V1, pE16, DOI 10.1016/S2214-109X(13)70001-9; Cederberg H, 2010, DIABETES CARE, V33, P2077, DOI 10.2337/dc10-0262; Balkau B, 2011, DIABETES CARE, V34, P957, DOI 10.2337/dc10-1581; Bao YQ, 2010, BRIT MED J, V340, DOI 10.1136/bmj.c2249; Barrett-Connor E, 2002, EUR HEART J, V23, P1229, DOI 10.1053/euhj.2002.3243; BLUNT BA, 1991, DIABETES CARE, V14, P989, DOI 10.2337/diacare.14.11.989; Cohen J., 2013, APPL MULTIPLE REGRES; Davidson MB, 2011, DIABETES CARE, V34, P524, DOI 10.2337/dc10-1689; DECODE Study Group, 1999, DIABETOLOGIA, V42, P647; DECODE study group, 1998, BMJ-BRIT MED J, V317, P371; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; de Vegt F, 2000, DIABETES CARE, V23, P40, DOI 10.2337/diacare.23.1.40; Tuomilehto J, 2003, DIABETES CARE, V26, P61; Engelgau MM, 1997, DIABETES CARE, V20, P785, DOI 10.2337/diacare.20.5.785; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus, 2003, DIABETES CARE S1, V26, pS5, DOI DOI 10.2337/DIACARE.26.2007.S5; Danaei G, 2014, LANCET DIABETES ENDO, V2, P634, DOI 10.1016/S2213-8587(14)70102-0; Borch-Johnsen K, 1999, LANCET, V354, P617; Hanas R, 2013, DIABETIC MED, V30, P885, DOI 10.1111/dme.12204; Hanas R, 2010, DIABETIC MED, V27, P737, DOI 10.1111/j.1464-5491.2010.03033.x; Hardikar PS, 2012, DIABETES CARE, V35, P797, DOI 10.2337/dc11-1321; Hjellestad ID, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-79; Homko Carol J, 2012, J Prim Care Community Health, V3, P235, DOI 10.1177/2150131911435526; Hu YM, 2010, ACTA DIABETOL, V47, P231, DOI 10.1007/s00592-009-0143-2; International Diabetes Federation, 2013, IDF DIAB ATL, V6th; Kharroubi AT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088123; Khoo J, 2012, J DIABETES COMPLICAT, V26, P99, DOI 10.1016/j.jdiacomp.2012.02.007; Kim Hong-Kyu, 2012, Diabetes Metab J, V36, P151, DOI 10.4093/dmj.2012.36.2.151; Kim Jung Min, 2014, Diabetes Metab J, V38, P480, DOI 10.4093/dmj.2014.38.6.480; Kramer CK, 2010, DIABETES CARE, V33, P101, DOI 10.2337/dc09-1366; Lee H, 2013, DIABETES RES CLIN PR, V99, P231, DOI 10.1016/j.diabres.2012.09.030; Li HY, 2012, J DIABETES INVEST, V3, P259, DOI 10.1111/j.2040-1124.2011.00181.x; Lipska KJ, 2010, J CLIN ENDOCR METAB, V95, P5289, DOI 10.1210/jc.2010-1171; Little RR, 2003, CLIN CHEM LAB MED, V41, P1191, DOI 10.1515/CCLM.2003.183; Mannucci E, 2003, ACTA DIABETOL, V40, P181, DOI 10.1007/s00592-003-0109-8; Mo M, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-44; Múnera-Jaramillo María Isabel, 2011, Rev Salud Publica (Bogota), V13, P980; National Glycohemoglobin Standardization Program, INT FED CLIN CHEM IF; Nomura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036309; Pajunen P, 2011, DIABETIC MED, V28, P36, DOI 10.1111/j.1464-5491.2010.03183.x; Peter A, 2011, EXP CLIN ENDOCR DIAB, V119, P234, DOI 10.1055/s-0030-1270440; Piette JD, 2010, REV PANAM SALUD PUBL, V28, P49, DOI 10.1590/S1020-49892010000700008; Pinelli NR, 2011, J CLIN ENDOCR METAB, V96, pE1680, DOI 10.1210/jc.2011-1148; Qiao Q, 2005, DIABETIC MED, V22, P1476, DOI 10.1111/j.1464-5491.2005.01655.x; Sacks DB, 2011, CLIN CHEM, V57, pE1, DOI 10.1373/clinchem.2010.161596; Shaw JE, 1999, DIABETES CARE, V22, P762, DOI 10.2337/diacare.22.5.762; Simon D, 1999, DIABETES CARE, V22, P1361, DOI 10.2337/diacare.22.8.1361; Snijders T. A. A., 2011, MULTILEVEL ANAL INTR; Son Jung Il, 2013, Diabetes Metab J, V37, P343, DOI 10.4093/dmj.2013.37.5.343; Soulimane S, 2012, DIABETES RES CLIN PR, V96, P392, DOI 10.1016/j.diabres.2011.06.003; Tuomilehto J, 2003, DIABETES CARE, V26, P1770; The Diabetes Control and Complications Trial Research Group, 1993, NEW ENGL J MED, V329, P977, DOI [10.1056/NEJM199309303291401, DOI 10.1056/NEJM199309303291401]; Tobias M, 2011, LANCET, V378, P3, DOI 10.1016/S0140-6736(11)60604-1; UK Prospective Diabetes Study (UKPDS) Group, 1998, LANCET, V352, P837, DOI DOI 10.1016/S0140-6736(98)07019-6; van 't Riet E, 2010, DIABETES CARE, V33, P61, DOI 10.2337/dc09-0677; Vlaar EMA, 2013, BMC ENDOCR DISORD, V13, DOI 10.1186/1472-6823-13-8; WHO, 2011, US GLYC HAEM HBA1C D; Wiener K, 1998, DIABETIC MED, V15, P558, DOI 10.1002/(SICI)1096-9136(199807)15:7<558::AID-DIA669>3.0.CO;2-Q; Wild SH, 2005, DIABETIC MED, V22, P490, DOI 10.1111/j.1464-5491.2004.01433.x; World Health Organisation, 2013, GLOB ACT PLAN PREV C; World Health Organization, 2006, DEF DIAGN DIAB MELL; World Health Organization. Definition, 1999, DEF DIAGN CLASS DI 1; Zhang YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037260	103	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	2213-8587			LANCET DIABETES ENDO	Lancet Diabetes Endocrinol.	AUG	2015	3	8					624	637		10.1016/S2213-8587(15)00129-1		14	Endocrinology & Metabolism	Endocrinology & Metabolism	CN6JC	WOS:000358540100018		
J	Sassa, K				Sassa, Kyoji			ISDR-ICL Sendai Partnerships 2015-2025 for global promotion of understanding and reducing landslide disaster risk	LANDSLIDES			English	Editorial Material									Int Consortium Landslides, Kyoto, Japan	Sassa, K (reprint author), Int Consortium Landslides, Kyoto, Japan.	sassa@iclhq.org					Sassa K, 2012, LANDSLIDES, V9, P155, DOI 10.1007/s10346-012-0334-8; Sassa K, 2004, LANDSLIDES, V1, P91, DOI 10.1007/s10346-004-0012-6; Sassa K, 2006, LANDSLIDES, V3, P361, DOI 10.1007/s10346-006-0065-9; Sassa K, 2015, LANDSLIDES, V12, P177, DOI 10.1007/s10346-015-0555-8; Sassa K, 2004, LANDSLIDES, V1, P1, DOI 10.1007/s10346-004-0011-7	5	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1612-510X	1612-5118		LANDSLIDES	Landslides	AUG	2015	12	4					631	640		10.1007/s10346-015-0586-1		10	Engineering, Geological; Geosciences, Multidisciplinary	Engineering; Geology	CO6MM	WOS:000359270800002		
J	Miki, Y; Akimoto, J; Moritake, K; Hironaka, C; Fujiwara, Y				Miki, Yuichi; Akimoto, Jiro; Moritake, Keiko; Hironaka, Chihiro; Fujiwara, Yasuyuki			Photodynamic therapy using talaporfin sodium induces concentration-dependent programmed necroptosis in human glioblastoma T98G cells	LASERS IN MEDICAL SCIENCE			English	Article						Autophagy; Necroptosis; Glioma; Photodynamic therapy; Talaporfin sodium	DEATH PATHWAYS; NECROSIS; CANCER	Photodynamic therapy (PDT) using photosensitizer induces several types of cell death, such as apoptosis, necrosis, and autophagy, depending on the PDT procedure, photosensitizer type, and cell type. We previously demonstrated that PDT using the photosensitizer talaporfin sodium (mono-l-aspartyl chlorine e6, NPe6; NPe6-PDT) induces both mitochondrial apoptotic and necrotic cell death in human glioblastoma T98G cells. However, details regarding the mechanism of necrosis caused by NPe6-PDT are unclear. Here, we investigated whether or not necroptosis, a recently suggested form of programmed necrosis, is involved in the necrotic cell death of NPe6-PDT-treated T98G cells. Leakage of lactate dehydrogenase (LDH) from the cell layer into conditioned medium was significantly increased by NPe6 (25 and 50 mu g/ml)-PDT, indicating that NPe6-PDT induces necrosis in these cells. NPe6 (25 mu g/ml)-PDT treatment also induced conversion of microtubule-associated protein 1 light-chain 3 (LC3)-I into phosphatidylethanolamine-conjugated LC3-II accompanying autophagosome formation, indicators of autophagy; however, of note, NPe6 (50 mu g/ml)-PDT did not induce such autophagic changes. In addition, both necrostatin-1 (a necroptosis inhibitor) and knockdown of necroptotic pathway-related proteins [e.g., receptor interacting serine-threonine kinase (RIP)-1, RIP-3, and mixed lineage kinase domain-like protein (MLKL)] inhibited leakage of LDH caused by NPe6 (25 mu g/ml)-PDT. Taken together, the present findings revealed that NPe6-PDT-induced necrotic cell death is mediated in part by the necroptosis pathway in glioblastoma T98G cells.	[Miki, Yuichi; Moritake, Keiko; Hironaka, Chihiro; Fujiwara, Yasuyuki] Tokyo Univ Pharm & Life Sci, Dept Environm Hlth, Sch Pharm, Hachioji, Tokyo 1920392, Japan; [Akimoto, Jiro] Tokyo Med Univ, Dept Neurosurg, Shinjuku Ku, Tokyo 1600023, Japan	Fujiwara, Y (reprint author), Tokyo Univ Pharm & Life Sci, Dept Environm Hlth, Sch Pharm, 1432-1 Horinouchi, Hachioji, Tokyo 1920392, Japan.	yasuyuki@toyaku.ac.jp					Akimoto J, 2012, PHOTODIAGN PHOTODYN, V9, P91, DOI 10.1016/j.pdpdt.2012.01.001; Leist M, 1997, BIOCHEM BIOPH RES CO, V236, P1, DOI 10.1006/bbrc.1997.6890; Buytaert E, 2007, BBA-REV CANCER, V1776, P86, DOI 10.1016/j.bbcan.2007.07.001; Coupienne I, 2011, PHOTOCH PHOTOBIO SCI, V10, P1868, DOI 10.1039/c1pp05213f; Vandenabeele P, 2010, NAT REV MOL CELL BIO, V11, P700, DOI 10.1038/nrm2970; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Degterev A, 2008, NAT REV MOL CELL BIO, V9, P378, DOI 10.1038/nrm2393; Wang ZG, 2012, CELL, V148, P228, DOI 10.1016/j.cell.2011.11.030; Lockshin RA, 2004, ONCOGENE, V23, P2766, DOI 10.1038/sj.onc.1207514; Agostinis P, 2011, CA-CANCER J CLIN, V61, P250, DOI 10.3322/caac.20114; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Zhao J, 2012, P NATL ACAD SCI USA, V109, P5322, DOI 10.1073/pnas.1200012109; Kessel DH, 2012, AUTOPHAGY, V8, P1333, DOI 10.4161/auto.20792; Firczuk M, 2011, PHOTOCH PHOTOBIO SCI, V10, P653, DOI 10.1039/c0pp00308e; Dolmans DEJGJ, 2003, NAT REV CANCER, V3, P380, DOI 10.1038/nrc1071; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Cai ZY, 2014, NAT CELL BIOL, V16, P55, DOI 10.1038/ncb2883; Iwai-Kanai Eri, 2008, Autophagy, V4, P322; Kaczmarek A, 2013, IMMUNITY, V38, P209, DOI 10.1016/j.immuni.2013.02.003; Miki Y, 2013, BIOL PHARM BULL, V36, P215; Miki Y, 2014, J TOXICOL SCI, V39, P821; Moujalled DM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.18; Ogawa A, 1979, Neurol Med Chir (Tokyo), V19, P367, DOI 10.2176/nmc.19.367	23	0	0	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	0268-8921	1435-604X		LASER MED SCI	Lasers Med. Sci.	AUG	2015	30	6					1739	1745		10.1007/s10103-015-1783-9		7	Engineering, Biomedical; Surgery	Engineering; Surgery	CO4NV	WOS:000359138500014		
J	Amgalanbaatar, A; Hosoda, K; Shimomura, H				Amgalanbaatar, Avarzed; Hosoda, Kouichi; Shimomura, Hirofumi			Phosphatidylethanolamine, but not Phosphatidylglycerol-Cardiolipin, Isolated from Two Species of Helicobacter Binds Cholesterol over Cholesteryl Ester	LIPIDS			English	Article						Helicobacter felis; Helicobacter cinaedi; Phosphatidylethanolamine; Phosphatidylglycerol; Cardiolipin	PYLORI; CINAEDI; FELIS; INFECTION; GLUCOSIDES; RESISTANCE; BACTERIAL; STRAINS	This study demonstrated that the cells of Helicobacter felis and Helicobacter cinaedi spontaneously absorb cholesterol added to the medium. A recent study by our group has revealed that phosphatidylethanolamine (PtdEtn) of Helicobacter pylori contains myristic acid as the most predominant saturated fatty acid and that the PtdEtn of this bacterium binds cholesterol more selectively than cholesteryl ester. We, therefore, isolated the PtdEtn from the two Helicobacter species to analyze the hydrophobic interaction between cholesterol and its glycerophospholipid. PtdEtn of the Helicobacter bacteria interacted more selectively with cholesterol than with cholesteryl ester, and the degree of the selective binding of cholesterol was higher in the PtdEtn than in the phosphatidylglycerol-cardiolipin of the same bacteria. These results suggest the possibility that the cells of H. felis and H. cinaedi may contain abundant PtdEtn with myristic acid. On this basis, we analyzed the PtdEtn molecular species of the Helicobacter bacteria and demonstrated that the PtdEtn containing myristic acid accounts for more than 35 % in the total PtdEtn. These results suggest that the myristoyl PtdEtn takes part in the absorption of cholesterol in H. felis and H. cinaedi.	[Amgalanbaatar, Avarzed; Shimomura, Hirofumi] Jichi Med Univ, Dept Infect & Immun, Div Bacteriol, Shimotsuke, Tochigi 3290498, Japan; [Hosoda, Kouichi] Civil Int Corp, Taito Ku, Tokyo 1100014, Japan	Shimomura, H (reprint author), Jichi Med Univ, Dept Infect & Immun, Div Bacteriol, 3311-1 Yakushiji, Shimotsuke, Tochigi 3290498, Japan.	shimo@jichi.ac.jp			JKA Promotion Funds from Keirin Race	This work was supported in part by JKA Promotion Funds from Keirin Race.	Amgalanbaatar A, 2014, J STEROID BIOCHEM, V140, P17, DOI 10.1016/j.jsbmb.2013.10.023; Wunder C, 2006, NAT MED, V12, P1030, DOI 10.1038/nm1480; Fox JG, 2001, J CLIN MICROBIOL, V39, P1580, DOI 10.1128/JCM.39.4.1580-1585.2001; LEE A, 1988, INFECT IMMUN, V56, P2843; HIRAI Y, 1995, J BACTERIOL, V177, P5327; KIEHLBAUCH JA, 1995, J CLIN MICROBIOL, V33, P2940; McGee DJ, 2011, ANTIMICROB AGENTS CH, V55, P2897, DOI 10.1128/AAC.00016-11; RIETSCHEL ET, 1994, FASEB J, V8, P217; Mohammadi M, 1996, INFECT IMMUN, V64, P238; Shimomura H, 2004, FEMS MICROBIOL LETT, V237, P407, DOI 10.1016/j.femsle.2004.07.004; HAQUE M, 1995, J BACTERIOL, V177, P5334; GEBHART CJ, 1989, J CLIN MICROBIOL, V27, P1692; Trainor EA, 2011, INFECT IMMUN, V79, P88, DOI 10.1128/IAI.00974-09; ENNO A, 1995, AM J PATHOL, V147, P217; Hansen TK, 2001, FEMS IMMUNOL MED MIC, V30, P187, DOI 10.1016/S0928-8244(00)00255-8; INAMOTO Y, 1995, J GASTROENTEROL, V30, P315, DOI 10.1007/BF02347505; Kawamura Y, 2014, J INFECT CHEMOTHER, V20, P517, DOI 10.1016/j.jiac.2014.06.007; Marshall B. J., 1983, LANCET, V321, P1273, DOI DOI 10.1016/S0140-6736(83)92719-8; PASTER BJ, 1991, INT J SYST BACTERIOL, V41, P31; Shimomura H, 2009, FEMS MICROBIOL LETT, V301, P84, DOI 10.1111/j.1574-6968.2009.01807.x; Shimomura H, 2012, J BACTERIOL, V194, P2658, DOI 10.1128/JB.00105-12	21	0	0	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0024-4201	1558-9307		LIPIDS	Lipids	AUG	2015	50	8					799	804		10.1007/s11745-015-4043-7		6	Biochemistry & Molecular Biology; Nutrition & Dietetics	Biochemistry & Molecular Biology; Nutrition & Dietetics	CO1TU	WOS:000358939100008		
J	Motomatsu, J; Kodama, H; Furukawa, T; Tominaga, Y				Motomatsu, Joh; Kodama, Hidekazu; Furukawa, Takeo; Tominaga, Yoichi			Dielectric Relaxation Behavior of a Poly(ethylene carbonate)-Lithium Bis-(trifluoromethanesulfonyl) Imide Electrolyte	MACROMOLECULAR CHEMISTRY AND PHYSICS			English	Article						broadband dielectric spectroscopy; dielectric relaxation; ionic conductivity; lithium batteries; poly(ethylene carbonate); polymer electrolytes	NANOCOMPOSITE POLYMER ELECTROLYTES; ION-CONDUCTION; CARBON-DIOXIDE; LITHIUM BATTERIES; COMPLEXES; POLYETHYLENE; SPECTROSCOPY; MECHANISMS; SPECTRA; SYSTEMS	A new class of polymer electrolytes, consisting of poly(ethylene carbonate) (PEC) and metal salts, is expected to find application in all-solid-state batteries because of its excellent performance as an electrolyte. To study the ion-conductive mechanism in PEC-based electrolytes, broadband dielectric spectroscopy is used to analyze the correlation between dielectric relaxation and ionic conduction in PEC-lithium bis-(trifluoromethanesulfonyl) imide electrolytes over a broad range of salt concentration (0-150 mol%) at 40 degrees C. The PEC system has two relaxation modes, and , associated respectively with the segmental motion and the local motion of PEC chains. The conductivity increases exponentially with increasing salt concentration, while the relaxation frequency (f) decreases with increasing strength (epsilon) at low salt concentrations, whereas in contrast f increases with epsilon being saturated at high salt concentrations above 10 mol%. It is believed that the mobility of PEC segment at high concentration is enhanced by two factors. The first is that intermolecular interactions decrease, given the existence of many ion pairs and aggregated ions around saturated PEC domains where the dissociated ions are highly concentrated. The second is that intramolecular interactions between CO and CH2 are lowered by the ion-dipole interaction.	[Motomatsu, Joh; Tominaga, Yoichi] Tokyo Univ Agr & Technol, Grad Sch Bioapplicat & Syst Engn, Koganei, Tokyo 1848588, Japan; [Kodama, Hidekazu; Furukawa, Takeo] Kobayashi Inst Phys Res, Kokubunji, Tokyo 1850022, Japan	Furukawa, T (reprint author), Kobayashi Inst Phys Res, 3-20-41 Higashi Motomachi, Kokubunji, Tokyo 1850022, Japan.	furukawa@kobayasi-riken.or.jp; ytominag@cc.tuat.ac.jp	Tominaga, Yoichi/D-6400-2012	Tominaga, Yoichi/0000-0001-5098-8537	JSPS KAKENHI, Japan [25288095]	This work was supported by a Grant-in-Aid for Scientific Research (B) of JSPS KAKENHI (No. 25288095), Japan.	Ngai KL, 2004, J CHEM PHYS, V120, P857, DOI 10.1063/1.1630295; Hassoun J, 2009, ADV MATER, V21, P4807, DOI 10.1002/adma.200900470; Tominaga Y, 2014, CHEM COMMUN, V50, P4448, DOI 10.1039/c3cc49588d; Debenedetti PG, 2001, NATURE, V410, P259, DOI 10.1038/35065704; Cole KS, 1941, J CHEM PHYS, V9, P341, DOI 10.1063/1.1750906; Zhang SS, 2000, ELECTROCHIM ACTA, V45, P1229, DOI 10.1016/S0013-4686(99)00385-0; KRIMM S, 1956, J CHEM PHYS, V25, P549, DOI 10.1063/1.1742963; Agapov AL, 2011, MACROMOLECULES, V44, P4410, DOI 10.1021/ma2001096; Tominaga Y, 2010, POLYMER, V51, P4295, DOI 10.1016/j.polymer.2010.07.037; Forsyth M, 2000, ELECTROCHIM ACTA, V45, P1249, DOI 10.1016/S0013-4686(99)00328-X; Money BK, 2012, SOLID STATE IONICS, V225, P346, DOI 10.1016/j.ssi.2012.04.025; Di Noto V, 2011, ELECTROCHIM ACTA, V57, P192, DOI 10.1016/j.electacta.2011.04.095; McOwen DW, 2014, ENERG ENVIRON SCI, V7, P416, DOI 10.1039/c3ee42351d; CHEN XH, 1991, MACROMOLECULES, V24, P5305, DOI 10.1021/ma00019a014; Croce F, 1998, NATURE, V394, P456; ANGELL CA, 1993, NATURE, V362, P137, DOI 10.1038/362137a0; Tarascon JM, 2001, NATURE, V414, P359, DOI 10.1038/35104644; Scrosati B, 2010, J POWER SOURCES, V195, P2419, DOI 10.1016/j.jpowsour.2009.11.048; Sun B, 2014, SOLID STATE IONICS, V262, P738, DOI 10.1016/j.ssi.2013.08.014; FENTON DE, 1973, POLYMER, V14, P589, DOI 10.1016/0032-3861(73)90146-8; Di Noto V., 2012, SOLID STATE PROTON C; Every HA, 1998, ELECTROCHIM ACTA, V43, P1465, DOI 10.1016/S0013-4686(97)10085-8; Furukawa T, 1997, JPN J APPL PHYS 1, V36, P1119, DOI 10.1143/JJAP.36.1119; Furukawa T, 2002, J POLYM SCI POL PHYS, V40, P613, DOI 10.1002/polb.10123.abs; Gray F. M., 1991, SOLID POLYM ELECTROL, P245; Havriliak S, 1966, J POLYMER SCI      C, V14, P99; Kimura F, 1997, J POLYM SCI POL PHYS, V35, P2741, DOI 10.1002/(SICI)1099-0488(19971130)35:16<2741::AID-POLB14>3.0.CO;2-9; SYLLA S, 1992, ELECTROCHIM ACTA, V37, P1699, DOI 10.1016/0013-4686(92)80141-8; Takahashi Y., 2014, P 63 SPSJ ANN M, P1815; TAKEOKA S, 1993, POLYM ADVAN TECHNOL, V4, P53, DOI 10.1002/pat.1993.220040202; Tominaga Y, 2012, POLYM J, V44, P1155, DOI 10.1038/pj.2012.97; Tominaga Y, 2015, J ELECTROCHEM SOC, V162, pA3133, DOI 10.1149/2.0211502jes; Tominaga Y, 2003, MACROMOLECULES, V36, P8766, DOI 10.1021/ma030207n; Yoshida K, 2011, ELECTROCHIM ACTA, V57, P139, DOI 10.1016/j.electacta.2011.06.099	34	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1022-1352	1521-3935		MACROMOL CHEM PHYS	Macromol. Chem. Phys.	AUG	2015	216	15					1660	1665		10.1002/macp.201500125		6	Polymer Science	Polymer Science	CO2XH	WOS:000359019900009		
J	Obata, K; Tamesue, S; Hashimoto, K; Mitsumata, T; Tsubokawa, N; Yamauchi, T				Obata, Kentaro; Tamesue, Shingo; Hashimoto, Kumi; Mitsumata, Tetsu; Tsubokawa, Norio; Yamauchi, Takeshi			Preparation of Porous Poly(pyrrole) Utilizing Agar Particles as Soft Template and Evaluation of Its Actuation Property	MACROMOLECULAR MATERIALS AND ENGINEERING			English	Article						microstructure; morphology; nanoparticles; polypyrroles; templates	CONDUCTING POLYMERS; ARTIFICIAL MUSCLES; POLYPYRROLE; NANOPARTICLES; POLYANILINE; ELASTOMERS; HYDROGELS; DRIVEN	Porous poly(pyrrole) (PPy) films are prepared by utilizing agar particles (APs) of various average diameters as templates. The size of the APs can be regulated by the concentration of agar during preparation, and these APs can be removed easily from PPy films by heating up to 90 degrees C after formation of the films by electropolymerization because agar shows a thermally reversible sol-gel transition. The pores in the surface of PPy films can be controlled by the size of APs utilized as templates. The porous PPy films have higher mechanical strength and exhibit the more dynamic actuating behavior than the flat PPy films. Moreover, spring-like actuating motion is induced by the presence of pores in the surface of helically shaped PPy films.	[Obata, Kentaro; Tamesue, Shingo; Mitsumata, Tetsu; Yamauchi, Takeshi] Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Niigata 9502181, Japan; [Tamesue, Shingo; Hashimoto, Kumi; Mitsumata, Tetsu; Tsubokawa, Norio; Yamauchi, Takeshi] Niigata Univ, Fac Engn, Dept Mat Sci & Technol, Nishi Ku, Niigata 9502181, Japan	Yamauchi, T (reprint author), Niigata Univ, Grad Sch Sci & Technol, Nishi Ku, Igarashi 2-8050, Niigata 9502181, Japan.	yamauchi@gs.niigata-u.ac.jp	Tamesue, Shingo/D-9009-2013		JSPS KAKENHI [2412001]	The authors express their gratitude to Prof. M. Yagi, Niigata University, for his kind help with the SEM observation of the PPy films. This work was supported by JSPS KAKENHI (grant number 2412001).	Park NC, 2002, ROBOT AUTON SYST, V40, P239, DOI 10.1016/S0921-8890(02)00248-8; Naka Y, 2010, POLYM INT, V59, P352, DOI 10.1002/pi.2762; BREDAS JL, 1984, PHYS REV B, V30, P1023, DOI 10.1103/PhysRevB.30.1023; Gerard M, 2002, BIOSENS BIOELECTRON, V17, P345, DOI 10.1016/S0956-5663(01)00312-8; Boral S, 2008, J PHYS CHEM B, V112, P3625, DOI 10.1021/jp7101463; Otero TF, 1998, ADV MATER, V10, P491, DOI 10.1002/(SICI)1521-4095(199804)10:6<491::AID-ADMA491>3.0.CO;2-Q; Smela E, 2003, ADV MATER, V15, P481, DOI 10.1002/adma.200390113; Kang G, 2011, LANGMUIR, V27, P6179, DOI 10.1021/la104194m; O'Brien BM, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3685708; Okuzaki H, 1996, J POLYM SCI POL PHYS, V34, P1747, DOI 10.1002/(SICI)1099-0488(19960730)34:10<1747::AID-POLB5>3.0.CO;2-N; Fukushima T, 2007, CHEM-EUR J, V13, P5048, DOI 10.1002/chem.200700554; Fuhrer R, 2009, SMALL, V5, P383, DOI 10.1002/smll.200801091; Kobatake S, 2007, NATURE, V446, P778, DOI 10.1038/nature05669; Kang ET, 1998, PROG POLYM SCI, V23, P277, DOI 10.1016/S0079-6700(97)00030-0; Gao JB, 2003, CHEM MATER, V15, P2411, DOI 10.1021/cm020329e; Mineta T, 2001, SENSOR ACTUAT A-PHYS, V88, P112, DOI 10.1016/S0924-4247(00)00510-0; Bruns CJ, 2014, ACCOUNTS CHEM RES, V47, P2186, DOI 10.1021/ar500138u; Brochu P, 2010, MACROMOL RAPID COMM, V31, P10, DOI 10.1002/marc.200900425; Khan AA, 1996, J TEXTURE STUD, V27, P143, DOI 10.1111/j.1745-4603.1996.tb00065.x; Ikeda T, 2007, ANGEW CHEM INT EDIT, V46, P506, DOI 10.1002/anie.200602372; Ethirajan A, 2008, BIOMACROMOLECULES, V9, P2383, DOI 10.1021/bm800377w; Fukami K, 2009, PHYS STATUS SOLIDI A, V206, P1259, DOI 10.1002/pssa.200881039; Han GY, 2006, SENSOR ACTUAT B-CHEM, V113, P259, DOI 10.1016/j.snb.2005.02.055; Hepworth DG, 2002, PHILOS T ROY SOC A, V360, P255, DOI 10.1098/rsta.2001.0927; Huang JX, 2003, J AM CHEM SOC, V125, P314, DOI 10.1021/ja028371y; Kellenberger CR, 2012, J MEMBRANE SCI, V387, P76, DOI 10.1016/j.memsci.2011.10.011	26	0	0	WILEY-V C H VERLAG GMBH	WEINHEIM	BOSCHSTRASSE 12, D-69469 WEINHEIM, GERMANY	1438-7492	1439-2054		MACROMOL MATER ENG	Macromol. Mater. Eng.	AUG	2015	300	8					766	771		10.1002/mame.201500047		6	Materials Science, Multidisciplinary; Polymer Science	Materials Science; Polymer Science	CO3VL	WOS:000359089000001		
J	Yamako, G; Chosa, E; Totoribe, K; Watanabe, S; Sakamoto, T				Yamako, Go; Chosa, Etsuo; Totoribe, Koji; Watanabe, Shinji; Sakamoto, Takero			Trade-off between stress shielding and initial stability on an anatomical cementless stem shortening: in-vitro biomechanical study	MEDICAL ENGINEERING & PHYSICS			English	Article						Total hip arthroplasty; Short stem; Anatomical stem; Stress shielding; Initial stability	TOTAL HIP-ARTHROPLASTY; COATED FEMORAL STEMS; STRAIN DISTRIBUTION; CUSTOM-MADE; BONE; FIXATION; REPLACEMENT; INSERTION; IMPLANT; PROSTHESIS	Shortened cementless femoral stems have become popular with the advent of minimally invasive total hip arthroplasty (THA). Successful THA requires initial stem stability and prevention of stress shielding-mediated bone loss, although the effect of stem shortening is controversial. Here we experimentally examined whether stem shortening affects stress shielding and initial stability. Anatomical stems (length, 120 mm) were cut to an 80 mm or 50 mm length. Ten tri-axial strain gauges measured the cortical strain on each stem-implanted femur to evaluate stress shielding. Two transducers measured axial relative displacement and rotation under single-leg stance loading. The 50 mm stem increased the equivalent strains with respect to the original stem in the proximal calcar region (31.0% relative to intact strain), proximal medial region (63.1%), and proximal lateral region (53.9%). In contrast, axial displacement and rotation increased with a decreasing stem length. However, the axial displacement of the 50 mm stem was below a critical value of 150 mu m for bone ingrowth. Our findings indicate that, with regard to a reduction in stem length, there is a tradeoff between stress shielding and initial stability. Shortening the stem up to 50 mm can promote proximal load transfer, but bone loss would be inevitable, even with sufficient initial stability for long-term fixation. (C) 2015 IPEM. Published by Elsevier Ltd. All rights reserved.	[Yamako, Go] Miyazaki Univ, Org Promot Tenure Track, Miyazaki 8892192, Japan; [Chosa, Etsuo; Totoribe, Koji; Watanabe, Shinji; Sakamoto, Takero] Miyazaki Univ, Fac Med, Div Orthoped Surg, Dept Med Sensory & Motor Organs, Miyazaki 8891692, Japan	Yamako, G (reprint author), Miyazaki Univ, Org Promot Tenure Track, 1-1 Gakuen Kibanadai Nishi, Miyazaki 8892192, Japan.	g.yamako@cc.miyazaki-u.ac.jp			MEXT/JSPS [26750148]; Ministry of Education, Culture, Sports, Science; Mizuho Corporation, Tokyo, Japan	This work was supported financially by Grant-in-Aids from MEXT/JSPS (#26750148), and from the Program to Disseminate Tenure Tracking System from the Ministry of Education, Culture, Sports, Science. This study was funded in part by Mizuho Corporation, Tokyo, Japan.	Kim YH, 2001, J BONE JOINT SURG BR, V83B, P295, DOI 10.1302/0301-620X.83B2.10108; Gustke K, 2012, J BONE JOINT SURG BR, V94B, P47, DOI 10.1302/0301-620X.94B11.30677; Kassi JP, 2005, J BIOMECH, V38, P1143, DOI 10.1016/j.jbiomech.2004.05.023; Sluimer JC, 2006, J ARTHROPLASTY, V21, P344, DOI 10.1016/j.arth.2005.06.015; Molli RG, 2012, CLIN ORTHOP RELAT R, V470, P450, DOI 10.1007/s11999-011-2068-7; Tsao A, 2003, BIOMED SCI INSTRUM, V39, P284; Cristofolini L, 1999, J ARTHROPLASTY, V14, P215, DOI 10.1016/S0883-5403(99)90129-8; Khanuja HS, 2011, J BONE JOINT SURG AM, V93A, P500, DOI 10.2106/JBJS.J.00774; Learmonth ID, 2007, LANCET, V370, P1508, DOI 10.1016/S0140-6736(07)60457-7; Gotze C, 2002, CLIN BIOMECH, V17, P267, DOI 10.1016/S0268-0033(02)00012-8; Aamodt A, 2001, J BONE JOINT SURG BR, V83B, P921, DOI 10.1302/0301-620X.83B6.9726; Speirs AD, 2007, CLIN BIOMECH, V22, P431, DOI 10.1016/j.clinbiomech.2006.12.003; SCHNEIDER E, 1989, CLIN ORTHOP RELAT R, P200; Bishop NE, 2010, CLIN BIOMECH, V25, P666, DOI 10.1016/j.clinbiomech.2010.04.013; White CA, 2012, CLIN ORTHOP RELAT R, V470, P410, DOI 10.1007/s11999-011-2160-z; Morrey BF, 2000, J BONE JOINT SURG BR, V82B, P952, DOI 10.1302/0301-620X.82B7.10420; Ostbyhaug PO, 2009, J BONE JOINT SURG BR, V91B, P676, DOI 10.1302/0301-620X.91B5.21749; Santori FS, 2010, J BONE JOINT SURG BR, V92B, P1231, DOI 10.1302/0301-620X.92B9.24605; Buhler DW, 1997, CLIN BIOMECH, V12, P75, DOI 10.1016/S0268-0033(96)00059-9; Kim YH, 2013, J ARTHROPLASTY, V28, P139, DOI 10.1016/j.arth.2012.04.002; Kessler O, 2006, CLIN BIOMECH, V21, P603, DOI 10.1016/j.clinbiomech.2006.01.011; Bieger R, 2012, CLIN BIOMECH, V27, P158, DOI 10.1016/j.clinbiomech.2011.08.004; Morlock M, 2001, J BIOMECH, V34, P873, DOI 10.1016/S0021-9290(01)00035-5; Bieger R, 2013, J ORTHOP RES, V31, P1180, DOI 10.1002/jor.22349; Decking R, 2006, CLIN BIOMECH, V21, P495, DOI 10.1016/j.clinbiomech.2005.12.011; de Witte PB, 2011, J BONE JOINT SURG AM, V93A, P1249, DOI 10.2106/JBJS.I.01792; Ender SA, 2007, ACTA ORTHOP, V78, P616, DOI 10.1080/17453670710014301; Falez F, 2008, J Orthop Traumatol, V9, P49, DOI 10.1007/s10195-008-0105-4; Freeman M A, 1993, Acta Orthop Belg, V59 Suppl 1, P130; Huo MH, 2009, J BONE JOINT SURG AM, V91A, P2522, DOI 10.2106/JBJS.I.00801; Laine HJ, 2000, INT ORTHOP, V24, P184, DOI 10.1007/s002640000150; Morales de Cano JJ, 2014, EUR J ORTHOP SURG TR, V24, P359; Ong KL, 2009, J ARTHROPLASTY, V24, P819, DOI 10.1016/j.arth.2008.09.012; Ostbyhaug PO, 2010, CLIN BIOMECH, V25, P318, DOI 10.1016/j.clinbiomech.2009.12.012; Patel RM, 2012, CLIN ORTHOP RELAT R, V470, P442, DOI 10.1007/s11999-011-2063-z; Pettersen SH, 2009, CLIN BIOMECH, V24, P196, DOI 10.1016/j.clinbiomech.2008.11.003; PILLIAR RM, 1986, CLIN ORTHOP RELAT R, P108; Yamako G, 2014, MED ENG PHYS, V36, P694, DOI 10.1016/j.medengphy.2014.02.018; Yamako G, 2014, MED ENG PHYS	39	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1350-4533	1873-4030		MED ENG PHYS	Med. Eng. Phys.	AUG	2015	37	8					820	825		10.1016/j.medengphy.2015.05.017		6	Engineering, Biomedical	Engineering	CO3BO	WOS:000359031800014		
J	Ebe, K; Sugimoto, S; Utsunomiya, S; Kagamu, H; Aoyama, H; Court, L; Tokuyama, K; Baba, R; Ogihara, Y; Ichikawa, K; Toyama, J				Ebe, Kazuyu; Sugimoto, Satoru; Utsunomiya, Satoru; Kagamu, Hiroshi; Aoyama, Hidefumi; Court, Laurence; Tokuyama, Katsuichi; Baba, Ryuta; Ogihara, Yoshisada; Ichikawa, Kosuke; Toyama, Joji			Development of a video image-based QA system for the positional accuracy of dynamic tumor tracking irradiation in the Vero4DRT system	MEDICAL PHYSICS			English	Article						dynamic tumor tracking irradiation; Vero4DRT; video image-based quality assurance	GUIDED RADIOTHERAPY SYSTEM; X-RAY HEAD; RADIOSURGERY; MOTION	Purpose: To develop and evaluate a new video image-based QA system, including in-house software, that can display a tracking state visually and quantify the positional accuracy of dynamic tumor tracking irradiation in the Vero4DRT system. Methods: Sixteen trajectories in six patients with pulmonary cancer were obtained with the ExacTrac in the Vero4DRT system. Motion data in the cranio-caudal direction (Y direction) were used as the input for a programmable motion table (Quasar). A target phantom was placed on the motion table, which was placed on the 2D ionization chamber array (MatriXX). Then, the 4D modeling procedure was performed on the target phantom during a reproduction of the patient's tumor motion. A substitute target with the patient's tumor motion was irradiated with 6-MV x-rays under the surrogate infrared system. The 2D dose images obtained from the MatriXX (33 frames/s; 40 s) were exported to in-house video-image analyzing software. The absolute differences in the Y direction between the center of the exposed target and the center of the exposed field were calculated. Positional errors were observed. The authors' QA results were compared to 4D modeling function errors and gimbal motion errors obtained from log analyses in the ExacTrac to verify the accuracy of their QA system. The patients' tumor motions were evaluated in the wave forms, and the peak-to-peak distances were also measured to verify their reproducibility. Results: Thirteen of sixteen trajectories (81.3%) were successfully reproduced with Quasar. The peak-to-peak distances ranged from 2.7 to 29.0 mm. Three trajectories (18.7%) were not successfully reproduced due to the limited motions of the Quasar. Thus, 13 of 16 trajectories were summarized. The mean number of video images used for analysis was 1156. The positional errors (absolute mean difference + 2 standard deviation) ranged from 0.54 to 1.55 mm. The error values differed by less than 1 mm from 4D modeling function errors and gimbal motion errors in the ExacTrac log analyses (n = 13). Conclusions: The newly developed video image-based QA system, including in-house software, can analyze more than a thousand images (33 frames/s). Positional errors are approximately equivalent to those in ExacTrac log analyses. This system is useful for the visual illustration of the progress of the tracking state and for the quantification of positional accuracy during dynamic tumor tracking irradiation in the Vero4DRT system. (C) 2015 American Association of Physicists in Medicine.	[Ebe, Kazuyu; Tokuyama, Katsuichi; Baba, Ryuta; Ogihara, Yoshisada; Ichikawa, Kosuke; Toyama, Joji] Joetsu Gen Hosp, Joetsu, Niigata 9438507, Japan; [Sugimoto, Satoru] Juntendo Univ, Grad Sch Med, Bunkyo Ku, Tokyo 1138421, Japan; [Utsunomiya, Satoru; Kagamu, Hiroshi; Aoyama, Hidefumi] Niigata Univ, Grad Sch Med & Dent Sci, Niigata 9518510, Japan; [Court, Laurence] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA	Ebe, K (reprint author), Joetsu Gen Hosp, 616 Daido Fukuda, Joetsu, Niigata 9438507, Japan.	nrr24490@nifty.com					Akimoto M., 2013, MED PHYS, V40; Benedict SH, 2010, MED PHYS, V37, P4078, DOI 10.1118/1.3438081; Wang LT, 2001, COMPUT BIOL MED, V31, P101, DOI 10.1016/S0010-4825(00)00026-3; Kamino Y, 2006, INT J RADIAT ONCOL, V66, P271, DOI 10.1016/j.ijrobp.2006.04.044; Ong C, 2011, INT J RADIAT ONCOL, V79, P305, DOI 10.1016/j.ijrobp.2010.02.059; Hurkmans CW, 2011, INT J RADIAT ONCOL, V80, P918, DOI 10.1016/j.ijrobp.2010.08.017; Depuydt T, 2013, RADIOTHER ONCOL, V106, P236, DOI 10.1016/j.radonc.2012.12.015; Keall PJ, 2006, MED PHYS, V33, P3874, DOI 10.1118/1.2349696; Cheong KH, 2010, MED PHYS, V37, P1146, DOI 10.1118/1.3310806; Depuydt T, 2011, RADIOTHER ONCOL, V98, P365, DOI 10.1016/j.radonc.2011.01.015; Imura M, 2005, INT J RADIAT ONCOL, V63, P1442, DOI 10.1016/j.ijrobp.2005.04.024; Kamino Y, 2007, MED PHYS, V34, P1797, DOI 10.1118/1.2723878; Mukumoto N, 2013, MED PHYS, V40, DOI 10.1118/1.4794506; Taguchi K, 2006, INT J RADIAT ONCOL, V66, pS612, DOI 10.1016/j.ijrobp.2006.07.1139	14	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	AUG	2015	42	8					4745	4754		10.1118/1.4926779		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CO1RN	WOS:000358933000032		
J	Tokurei, S; Morishita, J				Tokurei, Shogo; Morishita, Junji			A method for evaluating image quality of monochrome and color displays based on luminance by use of a commercially available color digital camera	MEDICAL PHYSICS			English	Article						liquid-crystal display; image quality; commercially available color camera; photometric camera	LIQUID-CRYSTAL DISPLAY; MEDICAL DISPLAYS; NOISE; PERFORMANCE; RADIOGRAPHY; PATTERN	Purpose: The aim of this study is to propose a method for the quantitative evaluation of image quality of both monochrome and color liquid-crystal displays (LCDs) using a commercially available color digital camera. Methods: The intensities of the unprocessed red (R), green (G), and blue (B) signals of a camera vary depending on the spectral sensitivity of the image sensor used in the camera. For consistent evaluation of image quality for both monochrome and color LCDs, the unprocessed RGB signals of the camera were converted into gray scale signals that corresponded to the luminance of the LCD. Gray scale signals for the monochrome LCD were evaluated by using only the green channel signals of the camera. For the color LCD, the RGB signals of the camera were converted into gray scale signals by employing weighting factors (WFs) for each RGB channel. A line image displayed on the color LCD was simulated on the monochrome LCD by using a software application for subpixel driving in order to verify the WF-based conversion method. Furthermore, the results obtained by different types of commercially available color cameras and a photometric camera were compared to examine the consistency of the authors' method. Finally, image quality for both the monochrome and color LCDs was assessed by measuring modulation transfer functions (MTFs) and Wiener spectra (WS). Results: The authors' results demonstrated that the proposed method for calibrating the spectral sensitivity of the camera resulted in a consistent and reliable evaluation of the luminance of monochrome and color LCDs. The MTFs and WS showed different characteristics for the two LCD types owing to difference in the subpixel structure. The MTF in the vertical direction of the color LCD was superior to that of the monochrome LCD, although the WS in the vertical direction of the color LCD was inferior to that of the monochrome LCD as a result of luminance fluctuations in RGB subpixels. Conclusions: The authors' method based on the use of a commercially available color camera is useful to evaluate and understand the display performances of both monochrome and color LCDs in radiology departments. (C) 2015 American Association of Physicists in Medicine.	[Tokurei, Shogo] Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan; [Tokurei, Shogo] Yamaguchi Univ, Dept Radiol, Ube, Yamaguchi 7558505, Japan; [Morishita, Junji] Kyushu Univ, Fac Med Sci, Dept Hlth Sci, Higashi Ku, Fukuoka, Fukuoka 8128582, Japan	Tokurei, S (reprint author), Kyushu Univ, Grad Sch Med Sci, Dept Hlth Sci, Higashi Ku, 3-1-1 Maidashi, Fukuoka, Fukuoka 8128582, Japan.	shogo.tokurei@gmail.com; junjim@med.kyushu-u.ac.jp			EIZO Corporation	The authors are grateful to Katsuhiko Ueda (Chief technologist, Yamaguchi University Hospital), Masaki Asahara (Ph.D., Tokushima Bunri University), Noriyuki Hashimoto (M.Sc., EIZO Corporation), Nobukazu Tanaka (Ph.D., Jyunshin Gakuen University), Shohei Kudomi (M.Sc., Yamaguchi University Hospital), Hiroshi Akamine (M.Sc., Kyushu University Hospital), and Kenshi Shiotsuki (Kyushu University) for useful discussions. The authors thank Koichiro Fujimoto (Ogori Daiichi General Hospital) for his technical support of MTF measurements. The authors also acknowledge Hideaki Mizobe (Canon Corporation) for providing a single-lens reflex digital color camera and Tetsuo Nakamaru (Prolinx Corporation) for a scientific-grade photometric camera. This work was supported in part by grant from EIZO Corporation.	Akamine H, 2012, MED PHYS, V39, P5127, DOI 10.1118/1.4737869; Samei E, 2005, MED PHYS, V32, P1205, DOI 10.1118/1.1861159; FUJITA H, 1992, IEEE T MED IMAGING, V11, P34, DOI 10.1109/42.126908; Badano A, 2004, MED PHYS, V31, P715, DOI 10.1118/1.1656529; Dallas WJ, 2007, P SOC PHOTO-OPT INS, V6707, pU7070, DOI 10.1117/12.740250; Deutsches Institut fur Normung, 2001, 6868572001 DIN GERM; Fan JH, 2005, MED PHYS, V32, P578, DOI 10.1118/1.1855031; FUJITA H, 1989, MED PHYS, V16, P52, DOI 10.1118/1.596402; GRAY JE, 1985, RADIOLOGY, V154, P519; Ichikawa Katsuhiro, 2008, Radiol Phys Technol, V1, P201, DOI 10.1007/s12194-008-0029-y; Ichikawa K, 2006, J SOC INF DISPLAY, V14, P831, DOI 10.1889/1.2372416; International Commission on Illumination,, 1994, 6122325 IEC CIE; Kagadis GC, 2013, RADIOGRAPHICS, V33, P275, DOI 10.1148/rg.331125096; National Electrical Manufacturers Association, 2001, 3142001 NEMA PS; Oda N, 1996, INVEST RADIOL, V31, P126, DOI 10.1097/00004424-199603000-00002; Roehrig H, 2012, PROC SPIE, V8318, DOI 10.1117/12.913749; Samei E., 2005, 03 AAPM TASK GROUP 1; Samei E., 2002, SCAR U PREMIER SERIE, P71; Samei E., 2001, Proceedings of the SPIE - The International Society for Optical Engineering, V4319, DOI 10.1117/12.428105; Saunders RS, 2006, MED PHYS, V33, P308, DOI 10.1118/1.2150777; Society of Motion Picture and Television Engineers, 1991, RP133 SMPTE; Vesa, 2001, FLAT PAN DISPL MEAS; Walz-Flannigan A, 2012, MED PHYS, V39, P5446, DOI 10.1118/1.4742851; Yabuuchi H, 2015, ACTA RADIOL, V56, P943, DOI 10.1177/0284185114544244; Yamazaki A, 2014, J SOC INF DISPLAY, V22, P170, DOI 10.1002/jsid.232; Yamazaki A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079243; Yamazaki A, 2013, MED PHYS, V40, DOI 10.1118/1.4773031	27	0	0	AMER ASSOC PHYSICISTS MEDICINE AMER INST PHYSICS	MELVILLE	STE 1 NO 1, 2 HUNTINGTON QUADRANGLE, MELVILLE, NY 11747-4502 USA	0094-2405			MED PHYS	Med. Phys.	AUG	2015	42	8					4773	4782		10.1118/1.4926850		10	Radiology, Nuclear Medicine & Medical Imaging	Radiology, Nuclear Medicine & Medical Imaging	CO1RN	WOS:000358933000035		
J	Liu, CS; Kim, KH; Kim, SJ; Li, JS; Ueda, S; Gao, X; Shibata, H; Kitamura, SY				Liu, Cheng-song; Kim, Kyung-Ho; Kim, Sun-Joong; Li, Jing-She; Ueda, Shigeru; Gao, Xu; Shibata, Hiroyuki; Kitamura, Shin-Ya			Reaction Between MnO-SiO2-FeO Solid Oxide and Solid Steel Deoxidized by Si and Mn During Heat Treatment at 1473 K (1200 degrees C)	METALLURGICAL AND MATERIALS TRANSACTIONS B-PROCESS METALLURGY AND MATERIALS PROCESSING SCIENCE			English	Article							INCLUSIONS; ALLOY	A new method using a confocal scanning laser microscope for melting oxide at 1673 K (1400 degrees C) to produce a diffusion couple, which consists of oxide and an iron-based alloy, has been developed for the investigation of a solid-state reaction between them. It is important to obtain good contact between the Fe-Mn-Si alloy and MnO-SiO2-FeO oxide before the diffusion experiment to observe diffusion of elements between them at 1473 K (1200 degrees C). In this system, the melting point of the oxides is higher than the temperature where the reaction would be observed. The pretreatment involving melting oxide at 1673 K (1400 degrees C) to obtain good contact with the alloy was carried out using a new method. The effect of the pretreatment at 1673 K (1400 degrees C) on the diffusion experiment at 1473 K (1200 degrees C) was minimized by this new method. The effect of diffusion of oxygen on the solid-state reaction between the Fe-Mn-Si alloy and MnO-SiO2-FeO oxide at 1473 K (1200 degrees C) was observed clearly and showed good agreement with Wagner's model of internal oxidation of metal. (C) The Minerals, Metals & Materials Society and ASM International 2015	[Liu, Cheng-song; Li, Jing-She] Univ Sci & Technol Beijing, Sch Met & Ecol Engn, Beijing 100083, Peoples R China; [Kim, Kyung-Ho; Kim, Sun-Joong; Ueda, Shigeru; Gao, Xu; Shibata, Hiroyuki; Kitamura, Shin-Ya] Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan	Kim, KH (reprint author), Tohoku Univ, Inst Multidisciplinary Res Adv Mat, Sendai, Miyagi 9808577, Japan.	naivkim@tagen.tohoku.ac.jp					Shibata H, 2011, ISIJ INT, V51, P1944, DOI 10.2355/isijinternational.51.1944; Kim KH, 2014, ISIJ INT, V54, P2144, DOI 10.2355/isijinternational.54.2144; Shibata H, 2010, IRONMAK STEELMAK, V37, P522, DOI 10.1179/030192310X12700328925903; [Anonymous], 1996, PHYS CHEM MET, P198; BANYA S, 1993, ISIJ INT, V33, P2, DOI 10.2355/isijinternational.33.2; Kim K.-H., 2012, P 5 INT C SCI TECHN; Kim KH, 2014, ISIJ INT, V54, P2678, DOI 10.2355/isijinternational.54.2678; SWISHER JH, 1967, T METALL SOC AIME, V239, P426; WAGNER C, 1959, Z ELEKTROCHEM, V63, P772	9	0	0	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1073-5615	1543-1916		METALL MATER TRANS B	Metall. Mater. Trans. B-Proc. Metall. Mater. Proc. Sci.	AUG	2015	46	4					1875	1884		10.1007/s11663-015-0356-4		10	Materials Science, Multidisciplinary; Metallurgy & Metallurgical Engineering	Materials Science; Metallurgy & Metallurgical Engineering	CO2YB	WOS:000359022000034		
J	Amelin, Y; Koefoed, P; Yin, QZ; Yamashita, K				Amelin, Y.; Koefoed, P.; Yin, Q. -Z.; Yamashita, K.			Sr ISOTOPE SYSTEMATICS OF THE ALLENDE CAIs A63 AND SJ101	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			VOLATILE DEPLETION; IDENTIFICATION		[Amelin, Y.; Koefoed, P.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Yin, Q. -Z.] Univ Calif Davis, Dept Earth & Planet Sci, Davis, CA 95616 USA; [Yamashita, K.] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan		yuri.amelin@anu.edu.au					Amelin Y., 2014, GOLDSCHM C, P5244; Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Hans U, 2013, EARTH PLANET SC LETT, V374, P204, DOI 10.1016/j.epsl.2013.05.029; GRAY CM, 1973, ICARUS, V20, P213, DOI 10.1016/0019-1035(73)90052-3; PODOSEK FA, 1991, GEOCHIM COSMOCHIM AC, V55, P1083, DOI 10.1016/0016-7037(91)90165-2; Moynier F, 2012, ASTROPHYS J, V758, DOI 10.1088/0004-637X/758/1/45; Paton C, 2013, ASTROPHYS J LETT, V763, DOI 10.1088/2041-8205/763/2/L40	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5388.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900010		
J	Bezaeva, NS; Badyukov, DD; Kars, M; Feinberg, JM; Rochette, P; Gattacceca, J; Raitala, J				Bezaeva, N. S.; Badyukov, D. D.; Kars, M.; Feinberg, J. M.; Rochette, P.; Gattacceca, J.; Raitala, J.			MAGNETIC PROPERTIES OF AGGLUTINATE-LIKE PARTICLES FROM PLANAR SHOCK-RECOVERY EXPERIMENTS ON BASALTS	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Bezaeva, N. S.] Ural Fed Univ, Ekaterinburg 620002, Russia; [Bezaeva, N. S.] Kazan Fed Univ, Kazan 420008, Russia; [Badyukov, D. D.] RAS, Vernadsky Inst Geochem & Analyt Chem, Moscow 119991, Russia; [Kars, M.] Kochi Univ, Ctr Adv Marine Core Res, Nankoku, Kochi 7838502, Japan; [Feinberg, J. M.] Univ Minnesota, Inst Rock Magnetism, Minneapolis, MN 55455 USA; [Rochette, P.; Gattacceca, J.] Aix Marseille Univ, CNRS, CEREGE, F-13545 Aix En Provence 4, France; [Raitala, J.] Univ Oulu, Astron, SF-90100 Oulu, Finland		bezaeva@physics.msu.ru					Korotev RL, 2010, GEOCHIM COSMOCHIM AC, V74, P7362, DOI 10.1016/j.gca.2010.09.020; Gattacceca J, 2007, PHYS EARTH PLANET IN, V162, P85, DOI 10.1016/j.pepi.2007.03.006; Bezaeva N.S., GEOPHYS RES LETT, V34; Bezaeva N.S., 2011, 42 LPSC; Yakovlev O.I., 1988, 19 LPSC, P1304	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5009.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900023		
J	Bollard, J; Kawasaki, N; Sakamoto, N; Larsen, K; Wielandt, D; Schiller, M; Connelly, J; Yurimoto, H; Bizzarro, M				Bollard, J.; Kawasaki, N.; Sakamoto, N.; Larsen, K.; Wielandt, D.; Schiller, M.; Connelly, J.; Yurimoto, H.; Bizzarro, M.			EARLY DISK DYNAMICS INFERRED FROM ISOTOPE SYSTEMATICS OF INDIVIDUAL CHONDRULES	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Bollard, J.; Larsen, K.; Wielandt, D.; Schiller, M.; Connelly, J.; Bizzarro, M.] Univ Copenhagen, Starplan, Copenagen, Denmark; [Kawasaki, N.; Sakamoto, N.; Yurimoto, H.] Hokkaido Univ, DNHS, Sapporo, Hokkaido, Japan							Connelly, 2012, SCIENCE, V338, P651; Holst, 2013, PNAS, V110, P8819; Johansen, 2015, SCI ADV, V1; Schiller, 2015, GCA, V149, P88; Schiller, 2015, EPSL, V420, P45; Trinquier, 2009, SCIENCE, V324, P374	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5211.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900029		
J	Chan, QHS; Zolensky, ME; Tsuchiyama, A; Martinez, JE				Chan, Q. H. S.; Zolensky, M. E.; Tsuchiyama, A.; Martinez, J. E.			MAGNETITE SURFACE PROVIDES PREBIOTIC HOMOCHIRAL SELECTIVITY	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			AMINO-ACIDS		[Chan, Q. H. S.; Zolensky, M. E.] NASA, ARES, Johnson Space Ctr, Houston, TX 77058 USA; [Tsuchiyama, A.] Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Martinez, J. E.] Jacobs Engn, Houston, TX 77058 USA		hschan@nasa.gov					Wheeler J, 2001, CONTRIB MINERAL PETR, V141, P109; Ferris JP, 2006, PHILOS T R SOC B, V361, P1777, DOI 10.1098/rstb.2006.1903; Pizzarello S, 2012, METEORIT PLANET SCI, V47, P1291, DOI 10.1111/j.1945-5100.2012.01390.x; Burger A, 2013, J MOL MODEL, V19, P851, DOI 10.1007/s00894-012-1606-x; Chan Q. H. S., 2015, LUN PLAN SCI C, P1150	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5179.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900052		
J	Chang, Y; Kayama, M; Tajika, E; Sekine, Y; Sekine, T; Nishido, H; Kobayashi, T				Chang, Y.; Kayama, M.; Tajika, E.; Sekine, Y.; Sekine, T.; Nishido, H.; Kobayashi, T.			SHOCK-INDUCED EFFECT ON CHATHODO-LUMINESENCE OF EXPERIMENTALLY SHOCKED QUARTZ	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			METAMORPHISM		[Chang, Y.; Sekine, Y.] Univ Tokyo, Earth & Planetary Sci, Tokyo 1138654, Japan; [Kayama, M.] Kobe Univ, Earth & Planetary Sci, Kobe, Hyogo, Japan; [Tajika, E.] Univ Tokyo, Complex Sci & Eng, Tokyo 1138654, Japan; [Sekine, T.] Hiroshima Univ, Earth & Planetary Sci, Hiroshima 730, Japan; [Nishido, H.] Okayama Univ Sci, Res Inst Nat Sci, Okayama, Japan		joh@astrobio.k.u-tokyo.ac.jp					Gucsik A, 2003, METEORIT PLANET SCI, V38, P1187; GRATZ AJ, 1992, PHYS CHEM MINER, V19, P267; Grieve RAF, 1996, METEORIT PLANET SCI, V31, P6; Hamers M. F., 2013, UTRECHT STUDIES EART, V32, P192; Holm S, 2011, METEORIT PLANET SCI, V46, P1888, DOI 10.1111/j.1945-5100.2011.01303.x; Osinski G. R., 2012, IMPACT CRATERING PRO, P330	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5189.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900053		
J	Defouilloy, C; Joswiak, DJ; Brownlee, DE; Nakashima, D; Tenner, TJ; Kita, NT				Defouilloy, C.; Joswiak, D. J.; Brownlee, D. E.; Nakashima, D.; Tenner, T. J.; Kita, N. T.			OXYGEN THREE ISOTOPE RATIOS IN FIVE COMET PARTICLES FROM STARDUST TRACKS 149 AND 172	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Defouilloy, C.; Tenner, T. J.; Kita, N. T.] Univ Wisconsin, WiscSIMS, Dept Geosci, Madison, WI 53706 USA; [Joswiak, D. J.; Brownlee, D. E.] Univ Washington, Dept Astron, Seattle, WA 98195 USA; [Nakashima, D.] Tohoku Univ, Div Earth & Planetary Mat Sci, Sendai, Miyagi 9808578, Japan		defouilloy@wisc.edu					Joswiak DJ, 2012, METEORIT PLANET SCI, V47, P471, DOI 10.1111/j.1945-5100.2012.01337.x; [Anonymous], 2015, GEOCHIMICA COSMOCHIM, V148, P228; Defouilloy, 2015, 46 LUN PLAN SCI C 20; Ebel, 2012, METEORIT PLANET SCI, V47, P585; McKeegan, 2006, SCIENCE, V315, P1724; Nakamura-Messenger, 2011, METEORIT PLANET SCI, V46, P1033; Nakashima D., EARTH PLANET SCI LET, P357; Nakashima D., EARTH PLANET SCI LET, P355	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5131.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900075		
J	Ebihara, M; Shirai, N; Takhashi, H				Ebihara, M.; Shirai, N.; Takhashi, H.			CHEMICAL CHARACTERISTIC OF CK CHONDRITES IN THE LIGHT OF P, REES, TH AND U.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			RARE-EARTH-ELEMENTS; ABUNDANCES; METEORITES; THORIUM; URANIUM		[Ebihara, M.; Shirai, N.; Takhashi, H.] Tokyo Metropolitan Univ, Hachioji, Tokyo, Japan		ebihara-mitsuru@tmu.ac.jp					Greenwood RC, 2010, GEOCHIM COSMOCHIM AC, V74, P1684, DOI 10.1016/j.gca.2009.11.029; Aso K., 2013, ANAL CHIM ACTA, V779, P8; Khan R, 2015, EARTH PLANET SC LETT, V422, P18, DOI 10.1016/j.epsl.2015.04.008; Shinotsuka K, 1997, ANAL CHIM ACTA, V338, P237, DOI 10.1016/S0003-2670(96)00528-4; SHINOTSUKA K, 1995, METEORITICS, V30, P694; Wasson J. T., 2013, GEOCHIMICA COSMOCHIM, P45	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5269.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900090		
J	Fagan, TJ; Aragane, H; Enokido, Y; Brearley, AJ				Fagan, T. J.; Aragane, H.; Enokido, Y.; Brearley, A. J.			METAMORPHISM OF AN EFREMOVKA TYPE B CAI AND COMPARISON WITH OTHER SETTINGS OF ALTERATION	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			AL-RICH INCLUSIONS; CHONDRITES		[Fagan, T. J.; Aragane, H.; Enokido, Y.] Waseda Univ, Tokyo, Japan; [Brearley, A. J.] Univ New Mexico, Albuquerque, NM 87131 USA		fagan@waseda.jp					Bonal L, 2006, GEOCHIM COSMOCHIM AC, V70, P1849, DOI 10.1016/j.gca.2005.12.004; MacPherson GJ, 2014, METEORIT PLANET SCI, V49, P1250, DOI 10.1111/maps.12316; Fagan TJ, 2007, METEORIT PLANET SCI, V42, P1221, DOI 10.1111/j.1945-5100.2007.tb00570.x; Brearley A.J., 2014, LPSC, V45; Enokido Y., 2014, NIPR, V37, P13; Fagan TJ, 2004, METEORIT PLANET SCI, V39, P1257; Fintor K, 2014, METEORIT PLANET SCI, V49, P812, DOI 10.1111/maps.12294; Hoshide T, 2006, J MINER PETROL SCI, V101, P223, DOI 10.2465/jmps.101.223; Krot A. N., 2010, LUNAR PLANET SCI, V41	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5094.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900097		
J	Fagan, TJ; Aoki, R				Fagan, T. J.; Aoki, R.			EVIDENCE FROM CHONDRULE SHAPES AND MODES FOR SHOCK DEFORMATION IN REDUCED CV3 CHONDRITES LEOVILLE AND EFREMOVKA	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			POROSITY		[Fagan, T. J.; Aoki, R.] Waseda Univ, Tokyo, Japan		fagan@waseda.jp					Bonal L, 2006, GEOCHIM COSMOCHIM AC, V70, P1849, DOI 10.1016/j.gca.2005.12.004; MacPherson GJ, 2014, METEORIT PLANET SCI, V49, P1250, DOI 10.1111/maps.12316; Macke RJ, 2011, METEORIT PLANET SCI, V46, P1842, DOI 10.1111/j.1945-5100.2011.01298.x; Krot AN, 1998, METEORIT PLANET SCI, V33, P1065; Ebel D. S., 2009, LUN PLAN SCI C, V40; Krot A. N., ANTARCT METEORITE RE, V17, P154	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5174.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900096		
J	Goodrich, CA; Mikouchi, T; Treiman, AH				Goodrich, C. A.; Mikouchi, T.; Treiman, A. H.			A VOLCANIC (QUENCHED) ANGRITE CLAST IN POLYMICT UREILITE DAG 319.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			LEWIS-CLIFF-87051; ASUKA-881371; METEORITES; OLIVINE		[Goodrich, C. A.] Planetary Sci Inst, Tucson, AZ USA; [Mikouchi, T.] Univ Tokyo, Tokyo 1138654, Japan; [Treiman, A. H.] Lunar & Planetary Inst, Houston, TX 77058 USA		cgoodrich@psi.edu					Downes H, 2008, GEOCHIM COSMOCHIM AC, V72, P4825, DOI 10.1016/j.gca.2008.06.028; Goodrich CA, 2004, CHEM ERDE-GEOCHEM, V64, P283, DOI 10.1016/j.chemer.2004.08.001; Keil K, 2012, CHEM ERDE-GEOCHEM, V72, P191, DOI 10.1016/j.chemer.2012.06.002; Goodrich C. A., 2015, 1214 LPSC, V1214; Ikeda Y., 2000, ANTARCT METEORITE RE, V13, P177; JAQUES AL, 1982, GEOCHIM COSMOCHIM AC, V46, P893, DOI 10.1016/0016-7037(82)90045-X; MCKAY G, 1995, METEORITICS, V30, P543; MIKOUCHI T, 1995, METEORITICS, V30, P549; Mikouchi T., 1996, P NIPR S ANT MET, V9, P174; Prinz M., 1986, LUNAR PLANET SCI, V17, P681	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5048.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900113		
J	Haba, MK; Yamaguchi, A; Hidaka, H				Haba, M. K.; Yamaguchi, A.; Hidaka, H.			FORMATION MECHANISM OF ZIRCONS IN MESOSIDERITES.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			EUCRITE PARENT BODY; U-PB; BASALTIC EUCRITES; VESTA		[Haba, M. K.] Swiss Fed Inst Technol, IGP, CH-8092 Zurich, Switzerland; [Haba, M. K.; Yamaguchi, A.] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan; [Hidaka, H.] Hiroshima Univ, Dept Earth Planet Sys Sci, Higashihiroshima 7398526, Japan		makiko.haba@erdw.ethz.ch					Zhou Q, 2013, GEOCHIM COSMOCHIM AC, V110, P152, DOI 10.1016/j.gca.2013.02.016; Misawa K, 2005, GEOCHIM COSMOCHIM AC, V69, P5847, DOI 10.1016/j.gca.2005.08.009; Haba MK, 2014, EARTH PLANET SC LETT, V387, P10, DOI 10.1016/j.epsl.2013.11.006; Haba M. K., 2013, MINERAL MAG, V77, P1239; HARLOW GE, 1982, GEOCHIM COSMOCHIM AC, V46, P339, DOI 10.1016/0016-7037(82)90225-3; Iizuka T, 2015, EARTH PLANET SC LETT, V409, P182, DOI 10.1016/j.epsl.2014.10.055; Ireland T. R., EARTH PLANETARY SCI, V109, P1	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5207.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900119		
J	Harries, D; Yakame, S; Uesugi, M; Langenhorst, F				Harries, D.; Yakame, S.; Uesugi, M.; Langenhorst, F.			FIB-TEM ANATOMY OF A SUB-MICROMETER IMPACT CRATER ON A HAYABUSA GRAIN	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Harries, D.; Langenhorst, F.] Univ Jena, Inst Geosci, D-07745 Jena, Germany; [Yakame, S.] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1138654, Japan; [Uesugi, M.] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Chofu, Tokyo, Japan		dennis.harries@uni-jena.de					Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Nakamura T., 2013, PNAS, V109, P624; Tsuchiyama A., 2011, SCIENCE, V333, P1121; Uesugi M, 2014, METEORIT PLANET SCI, V49, P1186, DOI 10.1111/maps.12322; Yakame S., 2013, HAY 2013 S	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5095.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900127		
J	Hashiguchi, M; Uesugi, M; Karouji, Y; Yada, T; Nakato, A; Matsumoto, T; Kumagai, K; Okada, T; Abe, M				Hashiguchi, M.; Uesugi, M.; Karouji, Y.; Yada, T.; Nakato, A.; Matsumoto, T.; Kumagai, K.; Okada, T.; Abe, M.			A CONSORTIUM STUDY FOR HAYABUSA-RETURNED SAMPLES: A SILICA-CONTAINING PARTICLE	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Hashiguchi, M.; Uesugi, M.; Karouji, Y.; Yada, T.; Nakato, A.; Matsumoto, T.; Kumagai, K.; Okada, T.; Abe, M.] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Chofu, Tokyo, Japan		hashiguchi@planeta.sci.isas.jaxa.jp					Ebihara, 2011, SCIENCE, V333, P1119; Hezel, 2006, GCA, V70, P1548; Karouji, 2014, 77 ANN M MET SOC, P5240; Nagao, 2011, SCIENCE, V333, P1128; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Noguchi, 2011, SCIENCE, V333, P1121; Tsuchiyama, 2011, SCIENCE, V333, P1125; Uesugi, 2014, 77 ANN MET SOC M, P5226; Yada, 2014, LPS 44, P1759; Yurimoto, 2011, SCIENCE, V333, P1116; Zolensky, 2012, LPS 43, P477	11	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5193.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900133		
J	Hidaka, H; Yoneda, S				Hidaka, H.; Yoneda, S.			SYSTEMATIC ISOTOPIC VARIATIONS OF STRONTIUM, BARIUM AND REE OF SURFICIAL LUNAR SOILS	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Hidaka, H.] Hiroshima Univ, Dept Earth & Planetary Syst Sci, Higashihiroshima 7398526, Japan; [Yoneda, S.] Natl Museum Nat & Sci, Dept Sci & Engn, Tsukuba, Ibaraki 3050005, Japan		hidaka@hiroshima-u.ac.jp					Hidaka, 2014, ASTROPHYSICAL J, V786, P138; Hidaka, 2014, METEORITICS PLANETAR, V49, P5120	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5101.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900140		
J	Kawasaki, N; Sakamoto, N; Yurimoto, H				Kawasaki, N.; Sakamoto, N.; Yurimoto, H.			FORMATION PERIOD FOR A FLUFFY TYPE A CAI FROM VIGARANO.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			MELILITE CRYSTALS; RICH INCLUSIONS; METEORITE		[Kawasaki, N.; Yurimoto, H.] Hokkaido Univ, Nat Hist Sci, Sapporo, Hokkaido 0600810, Japan; [Sakamoto, N.] Hokkaido Univ, Creat Res Inst, Sapporo, Hokkaido 0010021, Japan		kawasaki@ep.sci.hokudai.ac.jp					Park C, 2012, METEORIT PLANET SCI, V47, P2070, DOI 10.1111/maps.12032; Katayama J, 2012, METEORIT PLANET SCI, V47, P2094, DOI 10.1111/maps.12034; Kawasaki N, 2012, METEORIT PLANET SCI, V47, P2084, DOI 10.1111/maps.12033; MACPHERSON GJ, 1984, GEOCHIM COSMOCHIM AC, V48, P29, DOI 10.1016/0016-7037(84)90347-8	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5028.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900161		
J	Kebukawa, Y; Zolensky, ME; Chan, QHS; Fries, M; Steele, A; Kilcoyne, ALD; Rahman, Z; Cody, GD				Kebukawa, Y.; Zolensky, M. E.; Chan, Q. H. S.; Fries, M.; Steele, A.; Kilcoyne, A. L. David; Rahman, Z.; Cody, G. D.			CONSTRAINING THERMAL PROCESSING OF CARBON-RICH AGGREGATES IN XENOLITHIC CLASTS FROM SHARPS (H3.4) METEORITE.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Kebukawa, Y.] Yokohama Natl Univ, Fac Engn, Yokohama, Kanagawa 240, Japan; [Zolensky, M. E.; Chan, Q. H. S.; Fries, M.] NASA, Johnson Space Ctr, Houston, TX USA; [Steele, A.; Cody, G. D.] Carnegie Inst Sci, Geophys Lab, Washington, DC USA; [Kilcoyne, A. L. David] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Adv Light Source, Berkeley, CA 94720 USA; [Rahman, Z.] ESCG Jacobs, Houston, TX USA		kebukawa@ynu.ac.jp					Cody GD, 2008, EARTH PLANET SC LETT, V272, P446, DOI 10.1016/j.epsl.2008.05.008; BREARLEY AJ, 1990, GEOCHIM COSMOCHIM AC, V54, P831, DOI 10.1016/0016-7037(90)90377-W; SCOTT ERD, 1981, NATURE, V291, P544, DOI 10.1038/291544a0; Zolensky M. Z., 2009, 40 LUN PLAN SCI C	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5158.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900162		
J	Kita, NT; Tenner, TJ; Ushikubo, T; Bouvier, A; Wadhwa, M; Bullock, ES; MacPherson, GJ				Kita, N. T.; Tenner, T. J.; Ushikubo, T.; Bouvier, A.; Wadhwa, M.; Bullock, E. S.; MacPherson, G. J.			WHY DO U-PB AGES OF CHONDRULES AND CAIs HAVE MORE SPREAD THAN THEIR (26)AL AGES?	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			SOLAR PROTOPLANETARY DISK		[Kita, N. T.; Tenner, T. J.] Univ Wisconsin, Madison, WI 53706 USA; [Ushikubo, T.] JAMSTEC, Kochi 7838502, Japan; [Bouvier, A.] Univ Western Ontario, London, ON N6A 3K7, Canada; [Wadhwa, M.] Arizona State Univ, Ctr Meteorite Studies, Tempe, AZ 85287 USA; [Bullock, E. S.; MacPherson, G. J.] Smithsonian Inst, Washington, DC 20560 USA		noriko@geology.wisc.edu					Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; Kita NT, 2012, METEORIT PLANET SCI, V47, P1108, DOI 10.1111/j.1945-5100.2011.01264.x; Kita NT, 2013, METEORIT PLANET SCI, V48, P1383, DOI 10.1111/maps.12141; Connelly JN, 2012, SCIENCE, V338, P651, DOI 10.1126/science.1226919; Bouvier A., 2011, WORKSH FORM 1 SOL SO; Bullock E. S., 2015, 46 LUNN PLAN SCI C; Kruijer T. S., 2014, EARTH PLANETARY SCI; Larsen KK, 2011, ASTROPHYS J LETT, V735, DOI 10.1088/2041-8205/735/2/L37; Wadhwa M., 2014, 45 LUNN PLAN SCI C	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5360.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900166		
J	Koop, L; Davis, AM; Kita, NT; Nakashima, D; Tenner, TJ; Krot, AN; Park, C; Nagashima, K; Heck, PR				Koeoep, L.; Davis, A. M.; Kita, N. T.; Nakashima, D.; Tenner, T. J.; Krot, A. N.; Park, C.; Nagashima, K.; Heck, P. R.			(26)AL-DEPLETIONS IN ANOMALOUS AND SOLAR PLAC-LIKE CAIS SUGGEST HIGH DEGREES OF PROCESSING IN THE EARLY SOLAR NEBULA	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			REFRACTORY INCLUSIONS		[Koeoep, L.; Davis, A. M.; Heck, P. R.] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA; [Koeoep, L.; Davis, A. M.; Heck, P. R.] Univ Chicago, Chicago Ctr Cosmochem, Chicago, IL 60637 USA; [Davis, A. M.] Univ Chicago, Enrico Fermi Inst, Chicago, IL 60637 USA; [Koeoep, L.; Davis, A. M.; Heck, P. R.] Field Museum Nat Hist, Robert A Pritzker Ctr Meteorit & Polar Studies, Chicago, IL 60605 USA; [Kita, N. T.; Nakashima, D.; Tenner, T. J.] Univ Wisconsin, Dept Geosci, Madison, WI USA; [Nakashima, D.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Krot, A. N.; Park, C.; Nagashima, K.] Univ Hawaii Manoa, HIGP SOEST, Honolulu, HI 96822 USA; [Park, C.] Korea Polar Res Inst, Inchon, South Korea		koeoep@uchicago.edu					IRELAND TR, 1990, GEOCHIM COSMOCHIM AC, V54, P3219, DOI 10.1016/0016-7037(90)90136-9; Koop L., 2014, METEORITCS PLANETARY, V49, P5384; Krot AN, 2010, ASTROPHYS J, V713, P1159, DOI 10.1088/0004-637X/713/2/1159	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5225.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900173		
J	Krot, AN; Doyle, PM; Nagashima, K; Jogo, K; Wakita, S; Ciesla, FJ; Alexander, CMO; Bonal, L; Fujiya, W				Krot, A. N.; Doyle, P. M.; Nagashima, K.; Jogo, K.; Wakita, S.; Ciesla, F. J.; Alexander, C. M. O'D.; Bonal, L.; Fujiya, W.			CHRONOLOGY OF AQUEOUS ACTIVITY AND SOURCES OF WATER ON THE CHONDRITE PARENT BODIES: TESTING THE GRAND TACK MODEL	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Krot, A. N.; Nagashima, K.] Univ Hawaii, HIGP, Honolulu, HI 96822 USA; [Doyle, P. M.] Univ Cape Town, ZA-7700 Rondebosch, South Africa; [Wakita, S.] NAOJ, Tokyo, Japan; [Ciesla, F. J.] Univ Chicago, Chicago, IL 60637 USA; [Alexander, C. M. O'D.] Carnegie Inst, Baltimore, MD USA; [Fujiya, W.] Ibaraki Univ, Mito, Ibaraki, Japan							Alexander, 2012, SCIENCE, V337, P721; Ciesla, 2006, ICARUS, V181, P178; Connelly, 2012, SCIENCE, V338, P651; Doyle, 2015, NATURE COMM IN PRESS; Fujiya, 2012, NATURE COMMUN, V3, P1; Huss, 2006, MESS, VII, P566; Kita, 2012, MAPS, V43, P1108; Levison, 2009, NATURE, V460, P364; Lodders, 2003, APJ, V591, P1220; Martin, 2012, MNRAS, V425, pL6; Sugiura, 2014, MAPS, V49, P772; Walsh, 2011, NATURE, V475, P206; Zolensky, 2008, REV MINERAL GEOCHEM, V68, P429	13	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5150.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900177		
J	Kuhlman, KR; Poplawsky, JD; Hiroi, T; Baba, K				Kuhlman, K. R.; Poplawsky, J. D.; Hiroi, T.; Baba, K.			ATOM PROBE TOMOGRAPHY AND VISIBLE/NEARINFRARED SPECTRAL ANALYSIS OF SIMULATED SOLAR WIND HYDROGEN IMPLANTED OLIVINE.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Kuhlman, K. R.] Planetary Sci Inst, Tucson, AZ USA; [Poplawsky, J. D.] Oak Ridge Natl Lab, Ctr Nanophase Mat Sci, Oak Ridge, TN USA; [Hiroi, T.] Brown Univ, Dept Earth Environm & Planetary Sci, Providence, RI 02912 USA; [Baba, K.] Ind Technol Ctr, Nagasaki, Japan		kim@psi.edu	Poplawsky, Jonathan/Q-2456-2015	Poplawsky, Jonathan/0000-0002-4272-7043			Marchi S, 2010, ASTROPHYS J LETT, V721, pL172, DOI 10.1088/2041-8205/721/2/L172; Noble SK, 2007, ICARUS, V192, P629, DOI 10.1016/j.icarus.2007.07.021; Pieters CM, 2000, METEORIT PLANET SCI, V35, P1101; Hapke B, 2001, J GEOPHYS RES-PLANET, V106, P10039, DOI 10.1029/2000JE001338; Lucey PG, 2011, ICARUS, V212, P451, DOI 10.1016/j.icarus.2011.01.022; Bradley J. P., P NATL ACAD SCI US, V111, P1732; Burke DJ, 2011, ICARUS, V211, P1082, DOI 10.1016/j.icarus.2010.11.007; Fournelle J., 2009, AGU FALL M; Kuhlman KR, 2015, PLANET SPACE SCI, V115, P110, DOI 10.1016/j.pss.2015.04.003; Miller MK, 2007, MICROSC MICROANAL, V13, P428, DOI 10.1017/S1431927607070845	10	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5034.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900182		
J	Lin, Y; El Goresy, A; Zhang, J; Miyahara, M; Hao, J; Zhang, M; Ohtani, E; Gillet, P				Lin, Y.; El Goresy, A.; Zhang, J.; Miyahara, M.; Hao, J.; Zhang, M.; Ohtani, E.; Gillet, Ph.			H AND C ISOTOPES OF C-GRAINS FROM MARTIAN METEORITE NWA 6162	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			ORGANIC-CARBON		[Lin, Y.; Zhang, J.; Hao, J.; Zhang, M.] Chinese Acad Sci, Key Lab Earth & Planetary Sci, Beijing, Peoples R China; [El Goresy, A.] Univ Bayreuth, Bayer Geoinst, D-95447 Bayreuth, Germany; [Miyahara, M.] Hiroshima Univ, Grad Sch Sci, Hiroshima 7398526, Japan; [Ohtani, E.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Gillet, Ph.] Ecole Polytech Fed Lausanne, CH-1015 Lausanne, Switzerland		LinYT@mail.igcas.ac.cn					Steele A, 2012, SCIENCE, V337, P212, DOI 10.1126/science.1220715; Grady M. M., 2004, INT J ASTROBIOL, V3, P117, DOI DOI 10.1017/S1473550404002071; Lin YT, 2014, METEORIT PLANET SCI, V49, P2201, DOI 10.1111/maps.12389	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5039.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900191		
J	Matsumoto, M; Tomeoka, K; Seto, Y; Miyake, A; Kiriishi, M; Umehara, M; Yamamoto, Y; Nishio-Hamane, D				Matsumoto, M.; Tomeoka, K.; Seto, Y.; Miyake, A.; Kiriishi, M.; Umehara, M.; Yamamoto, Y.; Nishio-Hamane, D.			HYDRATED, UNMETAMORPHOSED CLASTS IN THE NWA 1232 CO3 CARBONACEOUS CHONDRITE.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Matsumoto, M.; Tomeoka, K.; Seto, Y.; Kiriishi, M.; Umehara, M.; Yamamoto, Y.] Kobe Univ, Kobe, Hyogo, Japan; [Miyake, A.] Kyoto Univ, Kyoto 6068501, Japan; [Nishio-Hamane, D.] Univ Tokyo, Tokyo 1138654, Japan		matsu@ruby.kobe-u.ac.jp					BREARLEY AJ, 1993, GEOCHIM COSMOCHIM AC, V57, P1521, DOI 10.1016/0016-7037(93)90011-K; Kiriishi M, 2008, J MINER PETROL SCI, V103, P161, DOI 10.2465/jmps.071018	2	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5058.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900211		
J	Matsumoto, T; Uesugi, M; Karouji, Y; Yada, T; Nakato, A; Hashiguchi, M; Kumagai, K; Okada, T; Abe, M				Matsumoto, T.; Uesugi, M.; Karouji, Y.; Yada, T.; Nakato, A.; Hashiguchi, M.; Kumagai, K.; Okada, T.; Abe, M.			A CONSORTIUM STUDY FOR HAYABUSA RETURNED SAMPLES: AN AGGLUTINATE GRAIN.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Matsumoto, T.; Uesugi, M.; Karouji, Y.; Yada, T.; Nakato, A.; Hashiguchi, M.; Kumagai, K.; Okada, T.; Abe, M.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan		tmatsumoto@planeta.sci.isas.jaxa.jp					Ebihara, 2011, SCIENCE, V333, P1119; Matsumoto, 2015, ICARUS IN PRESS; Nagao, 2011, SCIENCE, V333, P1128; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Noble, 2011, METEORIT PLANET SCI, V32, pA74; Noguchi, 2014, METEORIT PLANET SCI, V49, P188; Tsuchiyama, 2011, SCIENCE, V333, P1125; Yada, 2013, LPS, VXLIV, P1948; Yurimoto, 2011, SCIENCE, V333, P1116	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5194.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900212		
J	Mikouchi, T; Sugiyama, K; Yasuhara, A; Mihira, T				Mikouchi, T.; Sugiyama, K.; Yasuhara, A.; Mihira, T.			TRANSMISSION ELECTRON MICROSCOPY OF SILICO-APATITE IN D'ORBIGNY.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Mikouchi, T.] Univ Tokyo, Dept Earth & Planetary Sci, Tokyo 1130033, Japan; [Sugiyama, K.] Tohoku Univ, Inst Mat Res, Aoba Ku, Sendai, Miyagi 9808577, Japan; [Yasuhara, A.; Mihira, T.] JEOL Ltd, Tokyo 1968558, Japan		mikou-chi@eps.s.u-tokyo.ac.jp					Amelin Y., 2011, 42 LUN PLAN SCI C; Amelin Y, 2008, GEOCHIM COSMOCHIM AC, V72, P221, DOI 10.1016/j.gca.2007.09.034; Mikouchi T., 2010, 41 LUN PLAN SCI C; Mikouchi T., 2011, 42 LUN PLAN SCI C; Mikouchi T., 2010, ANTARCTIC METEORITES, VXXXIII, P53	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5287.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900226		
J	Miura, Y				Miura, Y.			FORMATION OF CARBON-RICH GRAINS IN AIR BY METEORITIC SHOWERES OF THE NIO AND CHELYABINSK.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Miura, Y.] Yamaguchi Univ, Yamaguchi, Yamaguchi 7530074, Japan		yasmiura50@gmail.com					Miura Y, 2015, LPS, VXXXXVI, P1811; Miura Y, 2014, INTERMINERAL ASS, V2014, P689; Miura Y, 2013, LPS, VXXXXIV, P1654	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5259.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900231		
J	Nagao, K; Haba, MK; Lee, JI; Kim, T; Lee, MJ				Nagao, K.; Haba, M. K.; Lee, J. I.; Kim, T.; Lee, M. J.			NOBLE GASES OF THE JINJU (H5) METEORITE FELL ON MARCH 9, 2014, IN KOREA.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			CHONDRITES		[Nagao, K.; Lee, J. I.; Kim, T.; Lee, M. J.] Korea Polar Res Inst, Inchon 406840, South Korea; [Nagao, K.; Haba, M. K.] Univ Tokyo, Tokyo 1130033, Japan; [Haba, M. K.] Swiss Fed Inst Technol, CH-8092 Zurich, Switzerland		na-gao@kopri.re.kr					KALLEMEYN GW, 1989, GEOCHIM COSMOCHIM AC, V53, P2747, DOI 10.1016/0016-7037(89)90146-4; WASSON JT, 1988, PHILOS T R SOC A, V325, P535, DOI 10.1098/rsta.1988.0066; EUGSTER O, 1988, GEOCHIM COSMOCHIM AC, V52, P1649, DOI 10.1016/0016-7037(88)90233-5	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5027.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900239		
J	Nagaoka, H; Hasebe, N; Kusano, H; Naito, M; Shibamura, E; Kuno, H; Kim, KJ; Lopes, JAM; Martinez-Frias, J				Nagaoka, H.; Hasebe, N.; Kusano, H.; Naito, M.; Shibamura, E.; Kuno, H.; Kim, K. J.; Lopes, J. A. M.; Martinez-Frias, J.		JP Team AXS	CURRENT STATUS OF DEVELOPMENT FOR ACTIVE X-RAY FLUORESCENCE SPECTROMETER FOR FUTURE PLANETARY MISSIONS.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Nagaoka, H.; Hasebe, N.; Kusano, H.; Naito, M.; Shibamura, E.; Kuno, H.] Waseda Univ, Tokyo, Japan; [Kim, K. J.] KIGAM, Seoul, South Korea; [Lopes, J. A. M.] Univ Coimbra, P-3000 Coimbra, Portugal; [Martinez-Frias, J.] Fac Ciencias Geol, London, England		nagaoka@asagi.waseda.jp					Fu XH, 2014, RES ASTRON ASTROPHYS, V14, P1595, DOI 10.1088/1674-4527/14/12/008; Kim K.J., 2014, T JSASS AEROSPACE TE, V12, P35; Nagaoka H., 2015, 46 LUN PLAN SCI C; Rieder R, 2003, J GEOPHYS RES-PLANET, V108, DOI 10.1029/2003JE002150	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5182.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900240		
J	Nagaoka, H; Karouji, Y; Fagan, TJ; Ebihara, M; Takeda, H; Hasebe, N				Nagaoka, H.; Karouji, Y.; Fagan, T. J.; Ebihara, M.; Takeda, H.; Hasebe, N.			VARIATIONS IN KREEP-ENRICHMENT OF NWA 773 CLAN OLIVINE GABBROS AND BRECCIAS BASED ON WHOLE-ROCK COMPOSITIONS	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			NORTHWEST AFRICA-773		[Nagaoka, H.; Fagan, T. J.; Hasebe, N.] Waseda Univ, Tokyo, Japan; [Karouji, Y.] JAXA, ISAS, Chofu, Tokyo, Japan; [Ebihara, M.] Tokyo Metropolitan Univ, Tokyo, Japan; [Takeda, H.] Univ Tokyo, Tokyo 1138654, Japan		hiroshi-nagaoka@asagi.waseda.jp					ANDERS E, 1989, GEOCHIM COSMOCHIM AC, V53, P197, DOI 10.1016/0016-7037(89)90286-X; Fagan TJ, 2003, METEORIT PLANET SCI, V38, P529; Fagan TJ, 2014, GEOCHIM COSMOCHIM AC, V133, P97, DOI 10.1016/j.gca.2014.02.025; Jolliff BL, 2003, GEOCHIM COSMOCHIM AC, V67, P4857, DOI 10.1016/j.gca.2003.08.012; Bunch T.E., 2006, LPSC, V37; Nagaoka, 2011, LPSC, V42; Nagaoka H., 2015, EARTH PLANETS SPACE; Zhang AC, 2010, METEORIT PLANET SCI, V45, P1929, DOI 10.1111/j.1945-5100.2010.01131.x	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5185.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900241		
J	Nagashima, K; Krot, AN; Komatsu, M				Nagashima, K.; Krot, A. N.; Komatsu, M.			(26)AL-(26)MG SYSTEMATICS IN CHONDRULES FROM KABA AND YAMATO 980145 CV3 CHONDRITES	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Nagashima, K.; Krot, A. N.] Univ Hawaii Manoa, HIGP SOEST, Honolulu, HI 96822 USA; [Komatsu, M.] Grad Univ Adv Studies, Tokyo, Japan		kazu@higp.hawaii.edu					LaTourrette T, 1998, EARTH PLANET SC LETT, V158, P91, DOI 10.1016/S0012-821X(98)00048-X; Bonal L, 2006, GEOCHIM COSMOCHIM AC, V70, P1849, DOI 10.1016/j.gca.2005.12.004; Jacobsen B, 2008, EARTH PLANET SC LETT, V272, P353, DOI 10.1016/j.epsl.2008.05.003; Kita NT, 2012, METEORIT PLANET SCI, V47, P1108, DOI 10.1111/j.1945-5100.2011.01264.x; Connelly JN, 2012, SCIENCE, V338, P651, DOI 10.1126/science.1226919; Doyle P. M., 2015, NAT COMM IN PRESS; Hutcheon ID, 2009, GEOCHIM COSMOCHIM AC, V73, P5080, DOI 10.1016/j.gca.2009.04.042; Komatsu M., 2014, 5 S POL SCI; Nagashima K, 2014, GEOCHEM J, V48, P561, DOI 10.2343/geochemj.2.0346	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5167.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900242		
J	Nakamura, T; Park, J; Ahn, IS; Shirai, N; Sekimoto, S; Nakato, A; Nakashima, D; Turrin, BD; Lindsay, FN; Herzog, GF; Delaney, JS; Swisher, CC; Nagao, K				Nakamura, T.; Park, J.; Ahn, I. S.; Shirai, N.; Sekimoto, S.; Nakato, A.; Nakashima, D.; Turrin, B. D.; Lindsay, F. N.; Herzog, G. F.; Delaney, J. S.; Swisher, C. C., III; Nagao, K.			DEPLETION OF VOLATILES AND TIMING OF HEATING RECORDED IN THERMALLY METAMORPHOSED HYDROUS CARBONACEOUS CHONDRITES	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Nakamura, T.; Nakashima, D.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Park, J.; Turrin, B. D.; Lindsay, F. N.; Herzog, G. F.; Delaney, J. S.; Swisher, C. C., III] Rutgers State Univ, Piscataway, NJ 08854 USA; [Park, J.] Kingsborough Comm Coll, Brooklyn, NY 11235 USA; [Ahn, I. S.; Nagao, K.] Korea Polar Res Inst, Inchon 406840, South Korea; [Shirai, N.] Tokyo Metropolitan Univ, Tokyo 1920397, Japan; [Sekimoto, S.] Kyoto Univ, Osaka 5900494, Japan; [Nakato, A.] Japan Aerosp Explorat Agcy, Sagamihara, Kanagawa 2525210, Japan		tomo-ki@m.tohoku.ac.jp					Nakamura T, 2005, J MINER PETROL SCI, V100, P260, DOI 10.2465/jmps.100.260; Ivanova MA, 2010, METEORIT PLANET SCI, V45, P1108, DOI 10.1111/j.1945-5100.2010.01064.x; Nakato A., 2013, 44 LUN PLAN SCI C; Tomeoka K., 1990, P NIPR S ANTARCT MET, V3, P40; Turrin B. D., 2014, 45 LUN PLAN SCI C	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5147.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900244		
J	Nakamura, T; Iwata, T; Kitasato, K; Abe, M; Osawa, T; Matsuoka, M; Nakauchi, Y; Arai, T; Komatsu, M; Hiroi, T; Imae, N; Yamaguchi, A; Kojima, H				Nakamura, T.; Iwata, T.; Kitasato, K.; Abe, M.; Osawa, T.; Matsuoka, M.; Nakauchi, Y.; Arai, T.; Komatsu, M.; Hiroi, T.; Imae, N.; Yamaguchi, A.; Kojima, H.			REFLECTANCE SPECTRA MEASUREMENT OF VARIOUS CARBONACEOUS CHONDRITES USING HAYABUSA-2 NEAR INFRARED SPECTROMETER	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Nakamura, T.; Matsuoka, M.] Tohoku Univ, Sendai, Miyagi 9808578, Japan; [Iwata, T.; Abe, M.; Nakauchi, Y.; Arai, T.] Japan Aerosp Explorat Agcy, Sagamihara, Kanagawa 2525210, Japan; [Kitasato, K.] Univ Aizu, Fukushima 9658580, Japan; [Osawa, T.] Japan Atom Energy Agcy, Ibaraki 3191195, Japan; [Komatsu, M.; Imae, N.; Yamaguchi, A.; Kojima, H.] Grad Univ Adv Studies, Hayama, Kanagawa 2400193, Japan; [Hiroi, T.] Brown Univ, Providence, RI 02912 USA; [Imae, N.; Yamaguchi, A.; Kojima, H.] Natl Inst Polar Res, Tokyo 1908518, Japan		tomoki@m.tohoku.ac.jp					Abe M., 2008, LUNAR PLANET SCI, V39, P1594; Vilas F, 2008, ASTRON J, V135, P1101, DOI 10.1088/0004-6256/135/4/1101; Iwata T., 2013, LUNAR PLANET SCI, V44, P1908; Iwata T., 2014, LPSC, V45, P1805; Nakamura T., 2014, ANTARCTIC METEORITES, VXXXVII, P54; Sugita S., 2013, LPSC, V44, P2591	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5206.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900243		
J	Nakato, A; Uesugi, M; Karouji, Y; Yada, T; Hashiguchi, M; Matsumoto, T; Kumagai, K; Okada, T; Abe, M				Nakato, A.; Uesugi, M.; Karouji, Y.; Yada, T.; Hashiguchi, M.; Matsumoto, T.; Kumagai, K.; Okada, T.; Abe, M.			A CONSORTIUM STUDY FOR HAYABUSA-RETURNED SAMPLES: PARTICLES CONTAINING PHASE THAT MIGHT AQUEOUS ALTERATION PRODUCTS	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Nakato, A.; Uesugi, M.; Karouji, Y.; Yada, T.; Hashiguchi, M.; Matsumoto, T.; Kumagai, K.; Okada, T.; Abe, M.] Japan Aerosp Explorat Agcy JAXA, Inst Space & Astronaut Sci, Sagamihara, Kanagawa, Japan		nakato@planeta.sci.isas.jaxa.jp					Abe, 2013, 76 METSOC; Karouji, 2014, 77 METSOC; Schrader, 2015, 46 LPSC; Uesugi, 2014, EARTH PLANETS SPACE, V66, P102; Uesugi, 2014, 76 METSOC; Yada, 2013, 76 METSOC	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5191.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900246		
J	Nyquist, LE; Park, J; Nagao, K; Haba, MK; Mikouchi, T; Kusakabe, M; Shih, CY; Herzog, GF				Nyquist, L. E.; Park, J.; Nagao, K.; Haba, M. K.; Mikouchi, T.; Kusakabe, M.; Shih, C. -Y.; Herzog, G. F.			"NORMAL PLANETARY" Ne-Q IN CHELYABINSK AND MARS	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			NOBLE-GASES; CHONDRITES		[Nyquist, L. E.] XI NASA Johnson Space Ctr, Houston, TX 77058 USA; [Park, J.; Herzog, G. F.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA; [Park, J.] Kingsborough Community Coll, Brooklyn, NY 11235 USA; [Nagao, K.] Korea Polar Res Inst, Inchon 406840, South Korea; [Haba, M. K.] ETH, IGP, CH-8092 Zurich, Switzerland; [Mikouchi, T.] Univ Tokyo, Dept Earth & Planetary Sci, Grad Sch Sci, Tokyo 1130033, Japan; [Kusakabe, M.] Toyama Univ, Dept Environment Biol & Chem, Toyama 9308555, Japan; [Shih, C. -Y.] NASA JSC, Jacobs, Houston, TX 77058 USA		laurence.e.nyquist@nasa.gov					Mohapatra RK, 2009, GEOCHIM COSMOCHIM AC, V73, P1505, DOI 10.1016/j.gca.2008.11.030; Grimberg A, 2008, GEOCHIM COSMOCHIM AC, V72, P626, DOI 10.1016/j.gca.2007.10.017; JAKOSKY BM, 1994, ICARUS, V111, P271, DOI 10.1006/icar.1994.1145; PEPIN RO, 1994, ICARUS, V111, P289, DOI 10.1006/icar.1994.1146; Busemann H, 2000, METEORIT PLANET SCI, V35, P949; ALAERTS L, 1979, GEOCHIM COSMOCHIM AC, V43, P1399, DOI 10.1016/0016-7037(79)90134-0; Ott U., 2002, REV MIN MIN SOC AM, P125; Park J., 2006, 37 LUN PLAN SCI C	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5054.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900254		
J	Park, J; Nyquist, LE; Herzog, GF; Turrin, BD; Lindsay, FN; Delaney, JS; Swisher, CC; Shih, CY; Yamaguchi, A; Shirai, N; Ebihara, M; Nagao, K				Park, J.; Nyquist, L. E.; Herzog, G. F.; Turrin, B. D.; Lindsay, F. N.; Delaney, J. S.; Swisher, C. C., III; Shih, C. -Y.; Yamaguchi, A.; Shirai, N.; Ebihara, M.; Nagao, K.			Ar-40/Ar-39 AGES FOR LUNAR METEORITES MIL 090034, MIL 090036, AND MIL 090070 AND EXCESS Ar-40 IN MIL 090036	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Park, J.; Herzog, G. F.; Lindsay, F. N.; Delaney, J. S.] Rutgers State Univ, Chem & Chem Biol, Piscataway, NJ 08854 USA; [Park, J.] Lunar Planet Inst, Houston, TX 77058 USA; [Park, J.] Kingsborough Comm Coll, Brooklyn, NY 11235 USA; [Nyquist, L. E.] XI NASA JSC, Houston, TX 77058 USA; [Turrin, B. D.; Swisher, C. C., III] Rutgers State Univ, Earth Planet Sci, Piscataway, NJ 08854 USA; [Shih, C. -Y.] ESCG Jacobs Sverdrup, Houston, TX 77258 USA; [Yamaguchi, A.] Natl Inst Polar Res, Tokyo 1908518, Japan; [Shirai, N.; Ebihara, M.] Tokyo Metropolitan Univ, Hachioji, Tokyo 1920372, Japan; [Nagao, K.] Korea Polar Res Inst, Inchon 406840, South Korea		jp975@rci.rutgers.edu					MCCONVILLE P, 1988, GEOCHIM COSMOCHIM AC, V52, P2487, DOI 10.1016/0016-7037(88)90307-9; MANKA RH, 1970, SCIENCE, V169, P278, DOI 10.1126/science.169.3942.278; BOGARD DD, 1985, GEOCHIM COSMOCHIM AC, V49, P941, DOI 10.1016/0016-7037(85)90309-6; Lindsay FN, 2014, GEOCHIM COSMOCHIM AC, V129, P96, DOI 10.1016/j.gca.2013.12.023; Lindsay FN, 2015, EARTH PLANET SC LETT, V413, P208, DOI 10.1016/j.epsl.2014.12.049; McKay D. S., 1986, P 16 LUN PLAN SCI C, pD277; Park J., 2013, 44 LPSC; Turrin BD, 2010, GEOCHEM GEOPHY GEOSY, V11, DOI 10.1029/2009GC003013; Yamaguchi A., 2013, 77 GOLDSCHM C	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5237.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900259		
J	Quirico, E; Bonal, L; Flandinet, L; Beck, P; Alexander, CMO; Yabuta, H; Nakamura, T; Nakato, A; Schmitt-Kopplin, P				Quirico, E.; Bonal, L.; Flandinet, L.; Beck, P.; Alexander, C. M. O'D; Yabuta, H.; Nakamura, T.; Nakato, A.; Schmitt-Kopplin, P.			RATING THERMAL METAMORPHISM IN C2 CHONDRITES WITH INSOLUBLE ORGANIC MATTER	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Quirico, E.; Bonal, L.; Flandinet, L.; Beck, P.] Univ Grenoble 1, CNRS, IPAG, Grenoble, France; [Alexander, C. M. O'D] Carnegie Inst Sci, DTM, Washington, DC USA; [Yabuta, H.] Osaka Univ, Dept Earth & Space Sci, Suita, Osaka 565, Japan; [Nakamura, T.] Tohoku Univ, Dept Earth Sci, Sendai, Miyagi 980, Japan; [Nakato, A.] Univ New Mexico, Dept Earth & Planetary Sci, Albuquerque, NM 87131 USA; [Schmitt-Kopplin, P.] Helmholtz Zentrum Muenchen BGC, Neuherberg, Germany		eric.quirico@obs.ujf-grenoble.fr					Alexander, 2013, GCA, V123, P244; Nakato A, 2008, EARTH PLANETS SPACE, V60, P855; Bonal, GCA, V71, P1605; Cody, 2005, GCA, V69, P1085; Garenne, GCA, V137, P93; Lindgren, 2014, GCA, V148, P159; Orthous-Daunay, 2013, ICARUS, V223, P534	7	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5090.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900268		
J	Sakai, M; Tomeoka, K; Seto, Y; Miyake, A				Sakai, M.; Tomeoka, K.; Seto, Y.; Miyake, A.			PSEUDOMORPHS OF CHONDRULES AND CAIs IN DARK CLASTS IN THE ALLENDE CV3 CHONDRITE.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Sakai, M.; Tomeoka, K.; Seto, Y.] Kobe Univ, Kobe, Hyogo 657, Japan; [Miyake, A.] Kyoto Univ, Kyoto, Japan		m_sakai@stu.kobe-u.ac.jp					KROT AN, 1995, METEORITICS, V30, P748; Buchanan PC, 1997, GEOCHIM COSMOCHIM AC, V61, P1733, DOI 10.1016/S0016-7037(97)00019-7; Kojima T, 1996, GEOCHIM COSMOCHIM AC, V60, P2651, DOI 10.1016/0016-7037(96)00116-0	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5233.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900285		
J	Tachibana, S; Piani, L; Dessimoulie, L; Hama, T; Kimura, Y; Endo, Y; Fujita, K; Nakatsubo, S; Fukushi, H; Mori, S; Chigai, T; Yurimoto, H; Kouchi, A				Tachibana, S.; Piani, L.; Dessimoulie, L.; Hama, T.; Kimura, Y.; Endo, Y.; Fujita, K.; Nakatsubo, S.; Fukushi, H.; Mori, S.; Chigai, T.; Yurimoto, H.; Kouchi, A.			PHOTOCHEMISTRY IN MOLECULAR CLOUDS: STRUCTURE AND PHYSICAL PROPERTIES OF ORGANIC RESIDUES AND ICE AND SUBLIMATION OF VOLATILE MOLECULES.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Tachibana, S.; Piani, L.; Dessimoulie, L.; Endo, Y.; Yurimoto, H.] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 060, Japan; [Hama, T.; Kimura, Y.; Fujita, K.; Nakatsubo, S.; Fukushi, H.; Mori, S.; Chigai, T.; Kouchi, A.] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 060, Japan		tachi@ep.sci.hokudai.ac.jp	HAMA, Tetsuya/A-9766-2012	HAMA, Tetsuya/0000-0002-4991-4044			Hashiguchi M, 2013, GEOCHIM COSMOCHIM AC, V122, P306, DOI 10.1016/j.gca.2013.08.007	1	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5248.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900320		
J	Takenouchi, A; Mikouchi, T				Takenouchi, A.; Mikouchi, T.			OLIVINE DARKENING AND SHOCK TEXTURES IN ALH 77005 LHERZOLITIC SHERGOTTITE.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			MARTIAN METEORITES		[Takenouchi, A.; Mikouchi, T.] Univ Tokyo, Grad Sch Sci, Dept Earth & Planetary Sci, Bunkyo Ku, Tokyo 1130033, Japan		a.takenouchi@eps.s.u-tokyo.ac.jp					Fritz J, 2005, METEORIT PLANET SCI, V40, P1393; Hu S, 2011, CHINESE SCI BULL, V56, P1579, DOI 10.1007/s11434-011-4443-x; Takenouchi A., 2015, 46 LUN PLAN SCI C; Treiman A. H., J GEOPHYS RES, V112; van de Moortele B, 2007, EARTH PLANET SC LETT, V262, P37, DOI 10.1016/j.epsl.2007.07.002; Walton EL, 2007, METEORIT PLANET SCI, V42, P63	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5171.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900322		
J	Tenner, TJ; Nakashima, D; Ushikubo, T; Weisberg, MK; Kita, NT				Tenner, T. J.; Nakashima, D.; Ushikubo, T.; Weisberg, M. K.; Kita, N. T.			SIMS Al-Mg CHRONOLOGY OF CR CHONDRITE CHONDRULES: LINKS WITH Mg# AND O ISOTOPES	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Tenner, T. J.; Kita, N. T.] Univ Wisconsin Madison, Dept Geosci, Madison, WI USA; [Nakashima, D.] Tohoku Univ, Div Earth & Planetary Mat Sci, Sendai, Miyagi 980, Japan; [Ushikubo, T.] JAMSTEC, Inst Core Sample Res, Kochi, Japan; [Weisberg, M. K.] CUNY, Kingsborough Community Coll, New York, NY USA; [Weisberg, M. K.] CUNY, Grad Ctr, New York, NY USA; [Weisberg, M. K.] Amer Museum Nat Hist, New York, NY 10024 USA		tenner@wisc.edu					MacPherson GJ, 2012, EARTH PLANET SC LETT, V331, P43, DOI 10.1016/j.epsl.2012.03.010; Kita NT, 2012, METEORIT PLANET SCI, V47, P1108, DOI 10.1111/j.1945-5100.2011.01264.x; Hutcheon ID, 2009, GEOCHIM COSMOCHIM AC, V73, P5080, DOI 10.1016/j.gca.2009.04.042; Nagashima K, 2014, GEOCHEM J, V48, P561, DOI 10.2343/geochemj.2.0346; Tenner TJ, 2015, GEOCHIM COSMOCHIM AC, V148, P228, DOI 10.1016/j.gca.2014.09.025; Ushikubo T, 2013, GEOCHIM COSMOCHIM AC, V109, P280, DOI 10.1016/j.gca.2013.01.045	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5325.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900324		
J	Tomeoka, K; Ohnishi, I				Tomeoka, Kazushige; Ohnishi, Ichiro			REDISTRIBUTION OF CHONDRULES AND MATRIX GRAINS IN THE MOKOIA CHONDRITE PARENT BODY: A MODEL.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Tomeoka, Kazushige] Kobe Univ, Dept Planetol, Fac Sci, Nada Ku, Kobe, Hyogo 6578501, Japan; [Ohnishi, Ichiro] JEOL Ltd, EM Business Unit, Akishima, Tokyo 1968558, Japan		tomeoka@kobe-u.ac.jp					Tomeoka K, 2014, GEOCHIM COSMOCHIM AC, V137, P18, DOI 10.1016/j.gca.2014.04.004; Tomeoka K, 2010, GEOCHIM COSMOCHIM AC, V74, P4438, DOI 10.1016/j.gca.2010.04.058; WOOD JA, 1963, ICARUS, V2, P152, DOI 10.1016/0019-1035(63)90013-7	3	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5148.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900328		
J	Tsuchiyama, A; Takahashi, R; Miyake, A; Kawamura, K				Tsuchiyama, A.; Takahashi, R.; Miyake, A.; Kawamura, K.			HYDROUS ALTERATION EXPERIMENTS OF Mg AMORPHOUS SILICATE NANOPARTICLES.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			HYDROTHERMAL ALTERATION; MINERALOGY		[Tsuchiyama, A.; Takahashi, R.; Miyake, A.] Kyoto Univ, Grad Schoole Sci, Kyoto 6068501, Japan; [Kawamura, K.] Okayama Univ, Grad Sch Environm & Life Sci, Okayama 7008530, Japan		atsuchi@kueps.kyoto-u.ac.jp					Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; BRADLEY JP, 1994, GEOCHIM COSMOCHIM AC, V58, P2123, DOI 10.1016/0016-7037(94)90290-9; Greshake B., 1997, GEOCHIMICA COSMOCHIM, V61, P437; Jones R. H., 2006, GEOCHIMICA COSMOCHIM, V70, P1040; Nakamura K, 2005, METEORIT PLANET SCI, V40, pA110; Noguchi R, 2008, METEORIT PLANET SCI, V43, pA177; Ohnishi I, 2007, METEORIT PLANET SCI, V42, P49; TOMEOKA K, 1988, GEOCHIM COSMOCHIM AC, V52, P1627, DOI 10.1016/0016-7037(88)90231-1	8	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5165.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900332		
J	Weisberg, MK; Ebel, DS; Kimura, M				Weisberg, M. K.; Ebel, D. S.; Kimura, M.			METAL-RICH NODULES IN EL3 CHONDRITES AND ALMAHATA SITTA EL3 CLAST MS-177.	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Weisberg, M. K.] Kingsborough Coll CUNY, Phys Sci, Brooklyn, NY 11235 USA; [Weisberg, M. K.; Ebel, D. S.] CUNY Grad Ctr, Earth & Envi Sci, New York, NY 10016 USA; [Weisberg, M. K.; Ebel, D. S.] Amer Museum Nat Hist, Earth & Planet Sci, New York, NY 10024 USA; [Kimura, M.] Ibaraki Univ, Fac Sci, Mito, Ibaraki 3108512, Japan; [Kimura, M.] Natl Inst Polar Res, Tokyo 1908518, Japan		mweisberg@kingsborough.edu					El Goresy A., 2012, 75 MET SOC M; Keil K., 2011, METEORIT PLANET SCI, V46, P1487; Lin Y., 2011, 42 LUN PLAN SCI C; Weisberg M. K., 2013, 44 LUN PLAN SCI C; Weisberg M. K., 1997, 28 LUN PLAN SCI C, P1523	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5312.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900355		
J	Yabuta, H; Noguchi, T; Itoh, S; Nakamura, T; Mitsunari, T; Okubo, A; Okazaki, R; Tachibana, S; Terada, K; Ebihara, M; Nagahara, H				Yabuta, H.; Noguchi, T.; Itoh, S.; Nakamura, T.; Mitsunari, T.; Okubo, A.; Okazaki, R.; Tachibana, S.; Terada, K.; Ebihara, M.; Nagahara, H.			VARIATIONS IN ORGANIC FUNCTIONAL GROUPS BETWEEN HYDROUS AND ANHYDROUS ANTARCTIC MICROMETEORITES	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Yabuta, H.; Terada, K.] Osaka Univ, Suita, Osaka 565, Japan; [Noguchi, T.; Okazaki, R.] Kyushu Univ, Fukuoka 812, Japan; [Itoh, S.] Kyoto Univ, Kyoto 6068501, Japan; [Nakamura, T.] Tohoku Univ, Sendai, Miyagi 980, Japan; [Mitsunari, T.] Ibaraki Univ, Mito, Ibaraki, Japan; [Okubo, A.; Nagahara, H.] Univ Tokyo, Tokyo 1138654, Japan; [Tachibana, S.] Hokkaido Univ, Sapporo, Hokkaido 060, Japan; [Ebihara, M.] Tokyo Metropolitan Univ, Tokyo, Japan		hyabuta@ess.sci.osaka-u.ac.jp					Alexander CMO, 2007, GEOCHIM COSMOCHIM AC, V71, P4380, DOI 10.1016/j.gca.2007.06.052; Noguchi T, 2015, EARTH PLANET SC LETT, V410, P1, DOI 10.1016/j.epsl.2014.11.012; Cody, 2005, GCA, V69, P1085; Herd, 2011, SCIENCE, V332, P1304; Yurimoto H., 2003, Applied Surface Science, V203-204, DOI 10.1016/S0169-4332(02)00825-5	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5301.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900367		
J	Yada, T; Abe, M; Uesugi, M; Karouji, Y; Kumagai, K; Nakato, A; Okada, T; Hashiguchi, M; Matsumoto, T; Fujimoto, M				Yada, T.; Abe, M.; Uesugi, M.; Karouji, Y.; Kumagai, K.; Nakato, A.; Okada, T.; Hashiguchi, M.; Matsumoto, T.; Fujimoto, M.			Present status of initial descriptions and distributions of Hayabusa-returned samples	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			ITOKAWA DUST PARTICLES; REGOLITH		[Yada, T.; Abe, M.; Uesugi, M.; Karouji, Y.; Kumagai, K.; Nakato, A.; Okada, T.; Hashiguchi, M.; Matsumoto, T.; Fujimoto, M.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Tokyo, Japan		yada@planeta.sci.isas.jaxa.jp					Abe M., 2011, LPSC, VXXXXII, P1638; Noguchi T, 2011, SCIENCE, V333, P1121, DOI 10.1126/science.1207794; Tsuchiyama A, 2011, SCIENCE, V333, P1125, DOI 10.1126/science.1207807; Ebihara M, 2011, SCIENCE, V333, P1119, DOI 10.1126/science.1207865; Nagao K, 2011, SCIENCE, V333, P1128, DOI 10.1126/science.1207785; Nakamura T, 2011, SCIENCE, V333, P1113, DOI 10.1126/science.1207758; Yada T., 2014, 77 MET SOC M; Yada T, 2014, METEORIT PLANET SCI, V49, P135, DOI 10.1111/maps.12027; Yurimoto Y., 2011, SCIENCE, V333, P1116	9	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5215.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900368		
J	Yamamoto, D; Tachibana, S				Yamamoto, D.; Tachibana, S.			CRYSTRALLIZATION OF AMORPHOUS FORSTERITE PROMOTED BY WATER VAPOR	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			SILICATES; GLASS		[Yamamoto, D.; Tachibana, S.] Hokkaido Univ, Dept Nat Hist Sci, Sapporo, Hokkaido 060, Japan		daiki@ep.sci.hokudai.ac.jp					Kemper F, 2004, ASTROPHYS J, V609, P826, DOI 10.1086/421339; WAGSTAFF FE, 1966, J AM CERAM SOC, V49, P118, DOI 10.1111/j.1151-2916.1966.tb15387.x; Kohara S, 2004, SCIENCE, V303, P1649, DOI 10.1126/science.1095047; Brucate J. R., 2010, PROTOPLANETARY DUST; Henning T, 2010, ANNU REV ASTRON ASTR, V48, P21, DOI 10.1146/annurev-astro-081309-130815	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5247.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900370		
J	Yamashita, S; Nakamura, T; Jogo, K; Matsuoka, M; Okumura, S				Yamashita, S.; Nakamura, T.; Jogo, K.; Matsuoka, M.; Okumura, S.			PROGRESSIVE CHANGES IN MINERALOGY, REFLECTANCE SPECTRA AND WATER CONTENTS OF EXPERIMENTALLY HEATED MURCHISON AT 400, 600, AND 900 degrees C	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			CARBONACEOUS CHONDRITES		[Yamashita, S.; Nakamura, T.; Jogo, K.; Matsuoka, M.; Okumura, S.] Tohoku Univ, Grad Sch Sci, Sendai, Miyagi 9808578, Japan; Korea Polar Res Inst, Inchon 406840, South Korea		sayuri.yamashita.s5@dc.tohoku.ac.jp					HIROI T, 1993, SCIENCE, V261, P1016, DOI 10.1126/science.261.5124.1016; Garenne A, 2014, GEOCHIM COSMOCHIM AC, V137, P93, DOI 10.1016/j.gca.2014.03.034; Ivanova MA, 2010, METEORIT PLANET SCI, V45, P1108, DOI 10.1111/j.1945-5100.2010.01064.x; Nakamura T., 2014, ANTARCTIC METEORITES, VXXXVII, P54; Nakato A., 2012, THESIS TOHOKU U	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5154.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900371		
J	Yano, H; Yamagishi, A; Hashimoto, H; Yokobori, S; Kebukawa, Y; Kawaguchi, Y; Kobayashi, K; Yabuta, H; Tabata, M; Higashide, M				Yano, H.; Yamagishi, A.; Hashimoto, H.; Yokobori, S.; Kebukawa, Y.; Kawaguchi, Y.; Kobayashi, K.; Yabuta, H.; Tabata, M.; Higashide, M.		Tanpopo Project Team	TANPOPO: A NEW MICROMETEOROID CAPTURE AND ASTROBIOLGY EXPOSURE IN LEO: ITS FIRST YEAR OPERATION AND POST-FLIGHT PLAN	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Yano, H.; Hashimoto, H.; Kawaguchi, Y.] JAXA ISAS, Tokyo, Japan; [Yamagishi, A.; Yokobori, S.] Tokyo Univ Pharm & Life Sci, Tokyo, Japan; [Kebukawa, Y.; Kobayashi, K.] Yokohama Natl Univ, Yokohama, Kanagawa, Japan; [Yabuta, H.] Osaka Univ, Suita, Osaka 565, Japan; [Tabata, M.] Chiba Univ, Chiba, Japan; [Higashide, M.] JAXA, Tokyo, Japan							Kobayashi K., 2009, ORIGINS LIFE EVOL B, V39, P4; Tabata M., 2011, BIOL SCI SPACE, V25, P7; Yamagishi A., 2009, T JSASS SPACE TECH J, V7, pTk 49; Yokobori S., 2009, LIFE EVOL BIOSPH, V39, P377	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5395.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900372		
J	Yesiltas, M; Kebukawa, Y				Yesiltas, M.; Kebukawa, Y.			ORGANIC AND MINERAL CORRELATIONS IN TAGISH LAKE VIA HIGH SPATIAL RESOLUTION SYNCHROTRON-BASED FTIR MICROSPECTROSCOPY	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab			CARBONACEOUS CHONDRITE		[Yesiltas, M.] SUNY Stony Brook, Stony Brook, NY USA; [Kebukawa, Y.] Yokohama Natl Univ, Yokohama, Kanagawa, Japan		mehmet.yesiltas@stonybrook.edu					Brown PG, 2000, SCIENCE, V290, P320, DOI 10.1126/science.290.5490.320; Garvie LAJ, 2007, METEORIT PLANET SCI, V42, P2111, DOI 10.1111/j.1945-5100.2007.tb01011.x; Brearley A. J., 2006, METEORITES EARLY SOL, P587; Yesiltas M, 2014, METEORIT PLANET SCI, V49, P2027, DOI 10.1111/maps.12321; Zolensky ME, 2002, METEORIT PLANET SCI, V37, P737	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5070.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900373		
J	Yin, QZ; Amelin, Y; Koefoed, P; Huyskens, MH; Sanborn, ME; Yamashita, K				Yin, Q-Z; Amelin, Y.; Koefoed, P.; Huyskens, M. H.; Sanborn, M. E.; Yamashita, K.			U-Pb DATING OF THE ALLENDE CAI A63 1-C-1	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Yin, Q-Z; Huyskens, M. H.; Sanborn, M. E.] Univ Calif Davis, Earth & Planetary Sci, Davis, CA 95616 USA; [Amelin, Y.; Koefoed, P.] Australian Natl Univ, Res Sch Earth Sci, Canberra, ACT 0200, Australia; [Yamashita, K.] Okayama Univ, Grad Sch Nat Sci & Technol, Okayama 7008530, Japan		qyin@ucdavis.edu					Amelin Y, 2010, EARTH PLANET SC LETT, V300, P343, DOI 10.1016/j.epsl.2010.10.015; Brennecka GA, 2010, SCIENCE, V327, P449, DOI 10.1126/science.1180871; Connelly JN, 2009, CHEM GEOL, V259, P143, DOI 10.1016/j.chemgeo.2008.11.003; Connelly J. N., 2012, SCIENCE, V335, P651; Koefoed P., 2015, 46 LPSC	5	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5088.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900375		
J	Yurimoto, H; Bajo, K; Sakaguchi, I; Suzuki, TT; Itose, S; Matsuya, M; Ishihara, M; Uchino, K				Yurimoto, H.; Bajo, K.; Sakaguchi, I.; Suzuki, T. T.; Itose, S.; Matsuya, M.; Ishihara, M.; Uchino, K.			MICRODISTRIBUTION OF SOLAR WIND HELIUM ON ITOKAWA PARTICLE SURFACES	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Yurimoto, H.; Bajo, K.] Hokkaido Univ, Sapporo, Hokkaido 0600810, Japan; [Sakaguchi, I.; Suzuki, T. T.] NIMS, Tsukuba, Ibaraki 3050044, Japan; [Itose, S.; Matsuya, M.] JEOL Ltd, Akishima, Tokyo 1968558, Japan; [Ishihara, M.] Osaka Univ, Toyonaka, Osaka 5600043, Japan; [Uchino, K.] Kyushu Univ, Kasuga, Fukuoka 8168580, Japan		yuri@ep.sci.hokudai.ac.jp					Ebata S, 2012, SURF INTERFACE ANAL, V44, P635, DOI 10.1002/sia.4857; Noguchi T, 2011, SCIENCE, V333, P1121, DOI 10.1126/science.1207794; Bajo K., 2015, GEOCHEMICAL J; Nagao K, 2011, SCIENCE, V333, P1128, DOI 10.1126/science.1207785	4	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI	5214.pdf						1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900377		
J	Zolensky, ME; Fries, M; Chan, QHS; Kebukawa, Y; Steele, A; Bodnar, RJ				Zolensky, M. E.; Fries, M.; Chan, Q. H-S; Kebukawa, Y.; Steele, A.; Bodnar, R. J.			THE MINERALOGY OF CERES* (*OR SOMETHING AN AWFUL LOT LIKE IT)	METEORITICS & PLANETARY SCIENCE			English	Meeting Abstract	78th Annual Meeting of the Meteoritical-Society	JUL 27-31, 2015	Berkeley, CA	Meteorit Soc, Barringer Crater Co, Natl Aeronaut & Space Adm, Inst Space & Astronaut Sci, Japan Aerosp Explorat Agcy, Japan Polar Res Assoc, Natl Inst Polar Res, NASA Mars Program Off, Agilent Technologies, CAMECA, Lockheed Martin Space Syst Co, Natl Electrostat Corp, TESCAN, Int Meteorite Collectors Assoc, Planetary Studies Fdn, Lunar & Planetary Inst, Univ Calif, Space Sci Lab					[Zolensky, M. E.; Fries, M.; Chan, Q. H-S] NASA, Lyndon B Johnson Space Ctr, Houston, TX 77058 USA; [Kebukawa, Y.] Yokohama Natl Univ, Yokohama, Kanagawa 2408501, Japan; [Steele, A.] Carnegie Geophys Lab, Washington, DC 20015 USA; [Bodnar, R. J.] Virginia Tech, Blacksburg, VA 24061 USA		Michael.e.zolensky@nasa.gov					Fries, 2013, MAPS, V48, pA80; Fries, 2011, MAPS, V46, pA70; Rubin, 2002, MAPS, V37, P125, DOI 10.1111/j.1945-5100.2002.tb00799.x; Zolensky, 2003, 66 METSOC M; Zolensky, 1999, SCIENCE, V285, P1377; Zolensky, 2013, MAPS, V48, pA394	6	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1086-9379	1945-5100		METEORIT PLANET SCI	Meteorit. Planet. Sci.	AUG	2015	50			1	SI							1	Geochemistry & Geophysics	Geochemistry & Geophysics	CN7CR	WOS:000358591900382		
J	Mizushima, S; Ueda, K; Ooiwa, A; Fujii, K				Mizushima, S.; Ueda, K.; Ooiwa, A.; Fujii, K.			Determination of the amount of physical adsorption of water vapour on platinum-iridium surfaces	METROLOGIA			English	Article						redefinition of the kilogram; platinum-iridium surface; water vapour; physical adsorption	MASS STANDARDS; LAYERS; GASES	This paper presents the measurement of the physical adsorption of water vapour on platinum-iridium surfaces using a vacuum mass comparator. This value is of importance for redefining the kilogram, which will be realized under vacuum in the near future. Mirror-polished artefacts, consisting of a reference artefact and a test artefact, were manufactured for this experiment. The surface area difference between the reference and test artefacts was 226.2 cm(2). This surface area difference was approximately 3.2 times the geometric surface area of the prototype of the kilogram made of platinum-iridium (71.7 cm(2)). The measurement results indicate that the amount of physical adsorption at a relative humidity of 50% is 0.0129 mu g cm(-2), with a standard uncertainty of 0.0016 mu g cm(-2). This value is 0.03 to 0.16 times that observed in other studies.	[Mizushima, S.; Ueda, K.; Ooiwa, A.; Fujii, K.] NMIJ, Tsukuba, Ibaraki 3058563, Japan	Mizushima, S (reprint author), NMIJ, 1-1-1 Umezono, Tsukuba, Ibaraki 3058563, Japan.	s.mizushima@aist.go.jp					Brunauer S, 1940, J AM CHEM SOC, V62, P1723, DOI 10.1021/ja01864a025; Mizushima S, 2004, METROLOGIA, V41, P137, DOI 10.1088/0026-1394/41/3/005; Brunauer S, 1938, J AM CHEM SOC, V60, P309, DOI 10.1021/ja01269a023; Davidson S, 2010, METROLOGIA, V47, P487, DOI 10.1088/0026-1394/47/4/015; HAGYMASS.J, 1969, J COLLOID INTERF SCI, V29, P485, DOI 10.1016/0021-9797(69)90132-5; Kobayashi Y., 1990, B NRLM, V39, P582; KOCHSIEK M, 1982, METROLOGIA, V18, P153, DOI 10.1088/0026-1394/18/3/007; Lide DR, 2003, CRC HDB CHEM PHYS; MCCLELLA.AL, 1967, J COLLOID INTERF SCI, V23, P577, DOI 10.1016/0021-9797(67)90204-4; Picard A, 2004, METROLOGIA, V41, P333, DOI 10.1088/0026-1394/41/4/016; Quinn T J, 1986, PLATIN MET REV, V30, P74; Sonntag D, 1990, Z METEOROL, V70, P340	12	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0026-1394	1681-7575		METROLOGIA	Metrologia	AUG	2015	52	4					522	527		10.1088/0026-1394/52/4/522		6	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CO1SF	WOS:000358934800014		
J	Steur, PPM; Nakano, T; Giraudi, D; Pavese, F				Steur, P. P. M.; Nakano, T.; Giraudi, D.; Pavese, F.			In sequence realization of the triple points of both Ne-20 and Ne-22 in a multicell	METROLOGIA			English	Article						neon isotopes; Ne-22 and Ne-20 isotopes; triple point temperature; ITS-90; sealed cells; multicells	ISOTOPIC COMPOSITION; TEMPERATURE SCALE; FIXED-POINTS; PURE NE-20; NEON; ITS-90; DIFFERENCE; DEPENDENCE; CELLS	In an effort to further reduce the uncertainties in the triple point temperatures of Ne-20 and Ne-22, already established in previous publications, at INRIM a cell for each of the two high-purity isotopes was mounted on the same copper block and their triple points were realized subsequently one after the other, allowing a reduction of the total experimental uncertainty on their temperature difference due to a full correlation of some of the uncertainty components arising from this type of realization. The two meltings remain perfectly distinct and do not interfere with each other, being the temperature difference of 0.147 K while the melting ranges are below 0.2 mK. The main difference with respect to single measurements (mounting a single cell at a time), lies in the adiabatic conditions during measurement, which are hardly reproducible when mounting a single cell at a time, leading to one of the dominant uncertainty contributions, 15 mu K (single). In the present work, the uncertainty component due to the adiabatic conditions is reduced by using a measurement in sequence (mounting the two cells at a time), 1 mu K. Thus, an improved reliability in the experimental realization is obtained as reflected in the experimental contributions to the uncertainty budget.	[Steur, P. P. M.; Giraudi, D.; Pavese, F.] Ist Nazl Ric Metrol INRIM, I-1035 Turin, Italy; [Nakano, T.] AIST, NMIJ, Tsukuba, Ibaraki 3058563, Japan	Steur, PPM (reprint author), Ist Nazl Ric Metrol INRIM, Str Cacce 91, I-1035 Turin, Italy.	p.steur@inrim.it; tohru-nakano@aist.go.jp; frpavese@gmail.com					Lee JY, 2006, GEOCHIM COSMOCHIM AC, V70, P4507, DOI 10.1016/j.gca.2006.06.1563; PRESTONTHOMAS H, 1990, METROLOGIA, V27, P3, DOI 10.1088/0026-1394/27/1/002; Wieser ME, 2011, PURE APPL CHEM, V83, P359, DOI 10.1351/PAC-REP-10-09-14; BIPM IEC IFCC ISO IUPAC IUPAP OIML, 1002008 BIPM IEC IFC; Hill KD, 2011, INT J THERMOPHYS, V32, P173, DOI 10.1007/s10765-011-0939-5; Nakano T, 2014, INT J THERMOPHYS, V35, P1032, DOI 10.1007/s10765-014-1697-y; Nakano T, 2013, AIP CONF PROC, V1552, P180, DOI 10.1063/1.4821376; Nakano T, 2014, J CHEM THERMODYN, V75, P33, DOI 10.1016/j.jct.2014.04.013; PAVESE F, 1990, METROLOGIA, V27, P145, DOI 10.1088/0026-1394/27/3/006; Pavese F, 2003, AIP CONF PROC, V684, P173; Pavese F, 2014, INT J THERMOPHYS, V35, P1077, DOI 10.1007/s10765-014-1642-0; Pavese F, 2013, AIP CONF PROC, V1552, P186, DOI 10.1063/1.4821377; Pavese F, 2010, INT J THERMOPHYS, V31, P1633, DOI 10.1007/s10765-010-0817-6; Pavese F, 2009, METROLOGIA, V46, P47, DOI 10.1088/0026-1394/46/1/007; Pavese F, 2010, J CHEM THERMODYN, V42, P1222, DOI 10.1016/j.jct.2010.04.024; Pavese F, 1992, INT MONOGRAPH SERIES, V2nd; Pavese F, 2005, ANAL CHEM, V77, P5076, DOI 10.1021/ac048083f; Pavese F, 2011, J CHEM THERMODYN, V43, P1977, DOI 10.1016/j.jct.2011.07.011; Pavese F, 2013, AIP CONF PROC, V1552, P192, DOI 10.1063/1.4821378; Pavese F, 2008, INT J THERMOPHYS, V29, P57, DOI 10.1007/s10765-007-0329-1; Pavese F, 2010, METROLOGIA, V47, P499, DOI 10.1088/0026-1394/47/5/001; Ramirez R, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3023036; Steur P P M, 2015, METROLOGIA, V52, P104; Steur PPM, 2013, J CHEM THERMODYN, V60, P87, DOI 10.1016/j.jct.2013.01.011	24	0	0	IOP PUBLISHING LTD	BRISTOL	TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND	0026-1394	1681-7575		METROLOGIA	Metrologia	AUG	2015	52	4					L9	L14		10.1088/0026-1394/52/4/L9		6	Instruments & Instrumentation; Physics, Applied	Instruments & Instrumentation; Physics	CO1SF	WOS:000358934800001		
J	Perpelescu, M; Hori, T; Toyoda, A; Misu, S; Monma, N; Ikeo, K; Obuse, C; Fujiyama, A; Fukagawa, T				Perpelescu, Marinela; Hori, Tetsuya; Toyoda, Atsushi; Misu, Sadahiko; Monma, Norikazu; Ikeo, Kazuho; Obuse, Chikashi; Fujiyama, Asao; Fukagawa, Tatsuo			HJURP is involved in the expansion of centromeric chromatin	MOLECULAR BIOLOGY OF THE CELL			English	Article							CENP-A CHROMATIN; FISSION YEAST SCM3; CHROMOSOME SEGREGATION; KINETOCHORE; RECRUITMENT; DEPOSITION; NUCLEOSOMES; M18BP1; DNA; CENH3(CENP-A)	The CENP-A-specific chaperone HJURP mediates CENP-A deposition at centromeres. The N-terminal region of HJURP is responsible for binding to soluble CENP-A. However, it is unclear whether other regions of HJURP have additional functions for centromere formation and maintenance. In this study, we generated chicken DT40 knockout cell lines and gene replacement constructs for HJURP to assess the additional functions of HJURP in vivo. Our analysis revealed that the middle region of HJURP associates with the Mis18 complex protein M18BP1/KNL2 and that the HJURP-M18BP1 association is required for HJURP function. In addition, on the basis of the analysis of artificial centromeres induced by ectopic HJURP localization, we demonstrate that HJURP exhibits a centromere expansion activity that is separable from its CENP-A-binding activity. We also observed centromere expansion surrounding natural centromeres after HJURP overexpression. We propose that this centromere expansion activity reflects the functional properties of HJURP, which uses this activity to contribute to the plastic establishment of a centromeric chromatin structure.	[Perpelescu, Marinela; Hori, Tetsuya; Fukagawa, Tatsuo] Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan; [Perpelescu, Marinela; Hori, Tetsuya; Fukagawa, Tatsuo] Grad Univ Adv Studies SOKENDAI, Mishima, Shizuoka 4118540, Japan; [Hori, Tetsuya; Fukagawa, Tatsuo] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan; [Toyoda, Atsushi; Fujiyama, Asao] Natl Inst Genet, Comparat Genom Lab, Mishima, Shizuoka 4118540, Japan; [Misu, Sadahiko; Monma, Norikazu; Ikeo, Kazuho] Natl Inst Genet, Cell Innovat Project, Mishima, Shizuoka 4118540, Japan; [Obuse, Chikashi] Hokkaido Univ, Grad Sch Life Sci, Sapporo, Hokkaido 0010021, Japan; [Fujiyama, Asao] Natl Inst Informat, Chiyoda Ku, Tokyo 1018430, Japan	Fukagawa, T (reprint author), Natl Inst Genet, Dept Mol Genet, Mishima, Shizuoka 4118540, Japan.	tfukagawa@fbs.osaka-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan	We are very grateful to Mayumi Takahashi, Kaeko Nakaguchi, and Michiko Arii for technical assistance and Iain Cheeseman for useful comments and critical reading of the manuscript. This work was supported by a Grant-in-Aid for Scientific Research (S) from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T.F. M.P. dedicates this work to the memory of her advisor Kinya Yoda, who performed leading biochemical research on human centromeres.	Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.20070166; Maddox PS, 2007, J CELL BIOL, V176, P757, DOI 10.1083/jcb.200701065; Wang JY, 2014, J BIOL CHEM, V289, P8326, DOI 10.1074/jbc.M113.529958; Dunleavy EM, 2009, CELL, V137, P485, DOI 10.1016/j.cell.2009.02.040; Shuaib M, 2010, P NATL ACAD SCI USA, V107, P1349, DOI 10.1073/pnas.0913709107; DIGNAM JD, 1983, METHOD ENZYMOL, V101, P582; Shang WH, 2013, DEV CELL, V24, P635, DOI 10.1016/j.devcel.2013.02.009; Silva MCC, 2012, DEV CELL, V22, P52, DOI 10.1016/j.devcel.2011.10.014; Johnston K, 2010, J CELL BIOL, V189, P937, DOI 10.1083/jcb.200912022; Fujita Y, 2007, DEV CELL, V12, P17, DOI 10.1016/j.devcel.2006.11.002; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Mizuguchi G, 2007, CELL, V129, P1153, DOI 10.1016/j.cell.2007.04.026; Hu H, 2011, GENE DEV, V25, P901, DOI 10.1101/gad.2045111; Dambacher S, 2012, NUCLEUS-AUSTIN, V3, P101, DOI [10.4161/nucl.18955, 10.4161/nucl.3.1.18955]; Tachiwana H, 2015, CELL REP, V11, P22, DOI 10.1016/j.celrep.2015.03.013; Okada M, 2009, MOL BIOL CELL, V20, P3986, DOI 10.1091/mbc.E09-01-0065; Williams JS, 2009, MOL CELL, V33, P287, DOI 10.1016/j.molcel.2009.01.017; Hori T, 2013, J CELL BIOL, V200, P45, DOI 10.1083/jcb.201210106; Moree B, 2011, J CELL BIOL, V194, P855, DOI 10.1083/jcb.201106079; Black B, 2011, CELL, V144, P471, DOI 10.1016/j.cell.2011.02.002; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Perpelescu M, 2009, J CELL BIOL, V185, P397, DOI 10.1083/jcb.200903088; Hori T, 2008, CELL, V135, P1039, DOI 10.1016/j.cell.2008.10.019; Regnier V, 2005, MOL CELL BIOL, V25, P3967, DOI 10.1128/MCB.25.10.3967-3981.2005; Hayashi T, 2004, CELL, V118, P715, DOI 10.1016/j.cell.2004.09.002; Shang WH, 2010, GENOME RES, V20, P1219, DOI 10.1101/gr.106245.110; Fachinetti D, 2013, NAT CELL BIOL, V15, P1056, DOI 10.1038/ncb2805; Sanchez-Pulido L, 2009, CELL, V137, P1173, DOI 10.1016/j.cell.2009.06.010; Foltz DR, 2009, CELL, V137, P472, DOI 10.1016/j.cell.2009.02.039; Hori T, 2014, DEV CELL, V29, P740, DOI 10.1016/j.devcel.2014.05.001; Zasadzinska E, 2013, EMBO J, V32, P2113, DOI 10.1038/emboj.2013.142; McKinley KL, 2014, CELL, V158, P397, DOI 10.1016/j.cell.2014.06.016; Barnhart MC, 2011, J CELL BIOL, V194, P229, DOI 10.1083/jcb.201012017; Shelby RD, 1997, J CELL BIOL, V136, P501, DOI 10.1083/jcb.136.3.501; Muller S, 2014, CELL REP, V8, P190, DOI 10.1016/j.celrep.2014.06.002; Westhorpe FG, 2013, CURR OPIN CELL BIOL, V25, P334, DOI 10.1016/j.ceb.2013.02.001; Fukagawa T, 2014, DEV CELL, V30, P497, DOI 10.1016/j.devcel.2014.08.016	37	1	1	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	AUG 1	2015	26	15					2742	2754		10.1091/mbc.E15-02-0094		13	Cell Biology	Cell Biology	CO2UQ	WOS:000359012500003		
J	Kubo, T; Hirono, M; Aikawa, T; Kamiya, R; Witman, GB				Kubo, Tomohiro; Hirono, Masafumi; Aikawa, Takumi; Kamiya, Ritsu; Witman, George B.			Reduced tubulin polyglutamylation suppresses flagellar shortness in Chlamydomonas	MOLECULAR BIOLOGY OF THE CELL			English	Article							OUTER DYNEIN ARMS; MICROTUBULE-DEPOLYMERIZING KINESIN; INTRAFLAGELLAR TRANSPORT IFT; PLUS END-TRACKING; REGULATORY COMPLEX; AXONEMAL DYNEINS; CILIARY LENGTH; CYTOPLASMIC DYNEIN; GENE ENCODES; HEAVY-CHAIN	Ciliary length control is an incompletely understood process essential for normal ciliary function. The flagella of Chlamydomonas mutants lacking multiple axonemal dyneins are shorter than normal; previously it was shown that this shortness can be suppressed by the mutation suppressor of shortness 1 (ssh1) via an unknown mechanism. To elucidate this mechanism, we carried out genetic analysis of ssh1 and found that it is a new allele of TPG2 (hereafter tpg2-3), which encodes FAP234 functioning in tubulin polyglutamylation in the axoneme. Similar to the polyglutamylation-deficient mutants tpg1 and tpg2-1, tpg2-3 axonemal tubulin has a greatly reduced level of long polyglutamate side chains. We found that tpg1 and tpg2-1 mutations also promote flagellar elongation in short-flagella mutants, consistent with a polyglutamylation-dependent mechanism of suppression. Double mutants of tpg1 or tpg2-1 and fla10-1, a temperature-sensitive mutant of intraflagellar transport, underwent slower flagellar shortening than fla10-1 at restrictive temperatures, indicating that the rate of tubulin disassembly is decreased in the polyglutamylation-deficient flagella. Moreover, alpha-tubulin incorporation into the flagellar tips in temporary dikaryons was retarded in polyglutamylation-deficient flagella. These results show that polyglutamylation deficiency stabilizes axonemal microtubules, decelerating axonemal disassembly at the flagellar tip and shifting the axonemal assembly/disassembly balance toward assembly.	[Kubo, Tomohiro; Witman, George B.] Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA; [Kubo, Tomohiro; Hirono, Masafumi; Aikawa, Takumi; Kamiya, Ritsu] Univ Tokyo, Grad Sch Sci, Dept Biol Sci, Tokyo 1130033, Japan; [Kamiya, Ritsu] Gakushuin Univ, Fac Sci, Dept Life Sci, Tokyo 1718588, Japan	Witman, GB (reprint author), Univ Massachusetts, Sch Med, Dept Cell & Dev Biol, Worcester, MA 01655 USA.	george.witman@umassmed.edu			Japan Society for the Promotion of Science [23657046, 24370079, 23570189]; Uehara Memorial Foundation Research Fellowship for Research Abroad; National Institutes of Health grant [GM30626]; Robert W. Booth Endowment at the University of Massachusetts Medical School	We thank Gianni Piperno (formerly Mount Sinai School of Medicine, New York, NY) and David R. Mitchell (State University of New York, Syracuse, NY) for providing strains. This study was supported by a Japan Society for the Promotion of Science Postdoctoral Fellowship (to T.K.), a Uehara Memorial Foundation Research Fellowship for Research Abroad (to T.K.), grants-in-aid from the Japan Society for Promotion of Science (23657046 and 24370079 to M.H. and 23570189 to R.K.), a National Institutes of Health grant (GM30626 to G.W.), and the Robert W. Booth Endowment at the University of Massachusetts Medical School (to G.W.).	Omran H, 2008, NATURE, V456, P611, DOI 10.1038/nature07471; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Cao MQ, 2009, METHOD CELL BIOL, V94, P333, DOI 10.1016/S0091-679X(08)94017-6; Hou YQ, 2007, J CELL BIOL, V176, P653, DOI 10.1083/jcb.200608041; Heuser T, 2009, J CELL BIOL, V187, P921, DOI 10.1083/jcb.200908067; Okada Y, 2000, P NATL ACAD SCI USA, V97, P640, DOI 10.1073/pnas.97.2.640; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Suryavanshi S, 2010, CURR BIOL, V20, P435, DOI 10.1016/j.cub.2009.12.062; KOZMINSKI KG, 1993, P NATL ACAD SCI USA, V90, P5519, DOI 10.1073/pnas.90.12.5519; Wloga D, 2010, EUKARYOT CELL, V9, P184, DOI 10.1128/EC.00176-09; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Pazour GJ, 2005, J CELL BIOL, V170, P103, DOI 10.1083/jcb.200504008; WITMAN GB, 1978, J CELL BIOL, V76, P729, DOI 10.1083/jcb.76.3.729; HUANG B, 1979, J BIOL CHEM, V254, P3091; Kubo T, 2010, CURR BIOL, V20, P441, DOI 10.1016/j.cub.2009.12.058; Kubo T, 2012, CYTOSKELETON, V69, P1059, DOI 10.1002/cm.21075; Koutoulis A, 1997, J CELL BIOL, V137, P1069, DOI 10.1083/jcb.137.5.1069; Pan JM, 2005, DEV CELL, V9, P431, DOI 10.1016/j.devcel.2005.07.010; TAKADA S, 1994, J CELL BIOL, V126, P737, DOI 10.1083/jcb.126.3.737; Porter ME, 1999, MOL BIOL CELL, V10, P693; Ou Y, 2009, EXP CELL RES, V315, P2802, DOI 10.1016/j.yexcr.2009.06.028; LEDIZET M, 1995, MOL BIOL CELL, V6, P697; KAMIYA R, 1988, J CELL BIOL, V107, P2253, DOI 10.1083/jcb.107.6.2253; Tam LW, 2013, MOL BIOL CELL, V24, P588, DOI 10.1091/mbc.E12-10-0718; Wirschell M, 2008, CELL MOTIL CYTOSKEL, V65, P238, DOI 10.1002/cm.20257; Fowkes ME, 1998, MOL BIOL CELL, V9, P2337; GORMAN DS, 1965, P NATL ACAD SCI USA, V54, P1665, DOI 10.1073/pnas.54.6.1665; Ishikawa H, 2011, NAT REV MOL CELL BIO, V12, P222, DOI 10.1038/nrm3085; Drewes G, 1998, TRENDS BIOCHEM SCI, V23, P307, DOI 10.1016/S0968-0004(98)01245-6; Qin HM, 2004, J CELL BIOL, V164, P255, DOI 10.1083/jcb.200308132; Sirajuddin M, 2014, NAT CELL BIOL, V16, P335, DOI 10.1038/ncb2920; KOZMINSKI KG, 1995, J CELL BIOL, V131, P1517, DOI 10.1083/jcb.131.6.1517; Berman SA, 2003, CURR BIOL, V13, P1145, DOI 10.1016/S0960-9822(03)00415-9; Tam LW, 2007, J CELL BIOL, V176, P819, DOI 10.1083/jcb.200610022; PIPERNO G, 1992, J CELL BIOL, V118, P1455, DOI 10.1083/jcb.118.6.1455; Wilson NF, 2004, EUKARYOT CELL, V3, P1307, DOI 10.1128/EC.3.5.1307-1319.2004; Freshour J, 2007, J BIOL CHEM, V282, P5404, DOI 10.1074/jbc.M607509200; Piperno G, 1996, J CELL BIOL, V133, P371, DOI 10.1083/jcb.133.2.371; Deane JA, 2001, CURR BIOL, V11, P1586, DOI 10.1016/S0960-9822(01)00484-5; Kamiya R, 2002, INT REV CYTOL, V219, P115; Marshall WF, 2001, J CELL BIOL, V155, P405, DOI 10.1083/jcb.200106141; Pathak N, 2007, MOL BIOL CELL, V18, P4353, DOI 10.1091/mbc.E07-06-0537; Pazour GJ, 1999, J CELL BIOL, V144, P473, DOI 10.1083/jcb.144.3.473; Wang L, 2013, J CELL SCI, V126, P1531, DOI 10.1242/jcs.124255; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Hilton LK, 2013, CURR BIOL, V23, P2208, DOI 10.1016/j.cub.2013.09.038; Craige B, 2010, J CELL BIOL, V190, P927, DOI 10.1083/jcb.201006105; Sardar HS, 2010, CURR BIOL, V20, P1648, DOI 10.1016/j.cub.2010.08.001; Pathak N, 2011, J BIOL CHEM, V286, P11685, DOI 10.1074/jbc.M110.209817; Bradley BA, 2005, J CELL SCI, V118, P3317, DOI 10.1242/jcs.02455; O'Hagan R, 2011, CURR BIOL, V21, P1685, DOI 10.1016/j.cub.2011.08.049; BROKAW CJ, 1987, CELL MOTIL CYTOSKEL, V8, P68, DOI 10.1002/cm.970080110; CAVALIER.T, 1974, J CELL SCI, V16, P529; Dentler W, 2005, J CELL BIOL, V170, P649, DOI 10.1083/jcb.200412021; Harris E. H., 2009, CHLAMYDOMONAS SOURCE, V1, P1; JARVIK JW, 1984, J PROTOZOOL, V31, P199, DOI 10.1111/j.1550-7408.1984.tb02949.x; KAMIYA R, 1991, J CELL BIOL, V112, P441, DOI 10.1083/jcb.112.3.441; Kathir P, 2003, EUKARYOT CELL, V2, P362, DOI 10.1128/EC.2.2.362.379.2003; KATO T, 1993, CELL STRUCT FUNCT, V18, P371; Kubo T, 2014, MOL BIOL CELL, V25, P107, DOI 10.1091/mbc.E13-07-0424; Lechtreck KF, 2000, CELL MOTIL CYTOSKEL, V47, P219, DOI 10.1002/1097-0169(200011)47:3<219::AID-CM5>3.0.CO;2-Q; Lechtreck Karl-Ferdinand, 2013, Cilia, V2, P15, DOI 10.1186/2046-2530-2-15; LEFEBVRE PA, 1978, J CELL BIOL, V78, P8, DOI 10.1083/jcb.78.1.8; MITCHELL DR, 1985, J CELL BIOL, V100, P1228, DOI 10.1083/jcb.100.4.1228; Miyoshi K, 2009, BIOCHEM BIOPH RES CO, V388, P757, DOI 10.1016/j.bbrc.2009.08.099; Nakakura T, 2015, MED MOL MORPHOL, V48, P44, DOI 10.1007/s00795-014-0076-x; NAKAMURA S, 1987, CELL STRUCT FUNCT, V12, P369; Pedersen LB, 2003, CURR BIOL, V13, P1969, DOI 10.1016/j.cub.2003.10.058; Piao T, 2009, P NATL ACAD SCI USA, V106, P4713, DOI 10.1073/pnas.0808671106; QUADER H, 1978, EXP CELL RES, V113, P295, DOI 10.1016/0014-4827(78)90369-5; SAGER R, 1954, J GEN PHYSIOL, V37, P729, DOI 10.1085/jgp.37.6.729; SANDERS MA, 1995, METHOD CELL BIOL, V47, P163, DOI 10.1016/S0091-679X(08)60805-5; Shroder JM, 2007, CURR BIOL, V17, P1134; Tanner CA, 2008, MOL BIOL CELL, V19, P3724, DOI 10.1091/mbc.E08-04-0362; Wirschell M, 2009, MOL BIOL CELL, V20, P3044, DOI 10.1091/mbc.E09-04-0276; Wren KN, 2013, CURR BIOL, V23, P2463, DOI 10.1016/j.cub.2013.10.044; Yamamoto R, 2010, J CELL BIOL, V190, P65, DOI 10.1083/jcb.201002081	77	1	1	AMER SOC CELL BIOLOGY	BETHESDA	8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA	1059-1524	1939-4586		MOL BIOL CELL	Mol. Biol. Cell	AUG 1	2015	26	15					2810	2822		10.1091/mbc.E15-03-0182		13	Cell Biology	Cell Biology	CO2UQ	WOS:000359012500008		
J	Numa-Kinjoh, N; Komaru, K; Ishida, Y; Sohda, M; Oda, K				Numa-Kinjoh, Natsuko; Komaru, Keiichi; Ishida, Yoko; Sohda, Miwa; Oda, Kimimitsu			Molecular phenotype of tissue-nonspecific alkaline phosphatase with a proline (108) to leucine substitution associated with dominant odontohypophosphatasia	MOLECULAR GENETICS AND METABOLISM			English	Article						Autosomal dominant; Cell surface localization; Dimerization; Hypophosphatasia; Tissue-nonspecific alkaline phosphatase	SEVERE HYPOPHOSPHATASIA; PERINATAL HYPOPHOSPHATASIA; MISSENSE MUTATIONS; DEGRADATION; PROTEIN; HETEROZYGOSITY; LOCALIZATION; REPLACEMENT; TRANSPORT; BEARING	Hypophosphatasia (HPP) is a genetic disease characterized by defective calcification of hard tissues such as bone and teeth accompanying deficiency of serum alkaline phosphatase (ALP) activity. Its development results from various mutations in the ALPL gene encoding tissue-nonspecific ALP (TNSALP). HPP is known to be transmitted in an autosomal recessive or autosomal dominant manner. A point mutation (c.323C>T) in the ALPL gene leading to a proline to leucine substitution at position 108 of TNSALP was first reported in a patient diagnosed with odonto-HPP (M Herasse et al., J Med Genet 2003;40:605-609), although the effects of this mutation on the TNSALP molecule have not been elucidated. To understand the molecular basis of this dominantly transmitted HPP, we first characterized TNSALP (P108L) by expressing it in COS-1 cells transiently. In contrast to wild-type TNSALP (WT), TNSALP (P108L) showed virtually no ALP activity. When coexpressed with TNSALP (WT), TNSALP (P108L) significantly inhibited the enzyme activity of TNSALP (WT), confirming that this mutant TNSALP exerts a dominant negative effect on TNSALP (WT). Using immunofluorescence and digestion with phosphatidylinositol-specific phospholipase C, we demonstrated that TNSALP (P108L) was anchored to the cell surface via glycosylphosphatidylinositol-like TNSALP (WT) in a Tet-On CHO cell expression system. Consistent with this, TNSALP (P108L) acquired endo-beta-N-acetylglucosaminidase H resistance and sialic acids, as evidenced by glycosidase treatments. Importantly, TNSALP (WT) largely formed a functional dimeric structure, while TNSALP (P108L) was found to be present as a monomer in the cell. This indicates that the molecular structure of TNSALP is affected by a missense mutation at position 108, which is in contact with the active site, such that it no longer assembles into the functional dimeric form. Collectively, these results may explain why TNSALP (P108L) loses its ALP activity, even though it is able to gain access to the cell surface. (C) 2015 Elsevier Inc. All rights reserved.	[Numa-Kinjoh, Natsuko; Ishida, Yoko; Sohda, Miwa; Oda, Kimimitsu] Niigata Univ, Grad Sch Med & Dent Sci, Div Oral Biochem, Niigata, Japan; [Komaru, Keiichi] Kitasato Jr Coll Hlth & Hygien Sci, Minami, Uonuma, Japan	Oda, K (reprint author), 2-5274 Gakkocho dori,Chuo Ku, Niigata 9518514, Japan.	oda@dent.niigata-u.ac.jp			Japan Society for the Promotion of Science [25862004, 24592794]	The authors thank Dr. Jun Cheng and Miyako Okamura for their technical assistance. This work was supported in part by a Grant-in-Aid for Young Scientists (to N.N.-K.) (25862004) and a Grant-in-Aid for Scientific Research (to K.O.) (24592794) from the Japan Society for the Promotion of Science.	Lia-Baldini AS, 2008, HUM GENET, V123, P429, DOI 10.1007/s00439-008-0480-1; Numa N, 2008, FEBS J, V275, P2727, DOI 10.1111/j.1742-4658.2008.06414.x; Shibata H, 1998, J BIOCHEM-TOKYO, V123, P968; Fukushi-Irie M, 2000, BIOCHEM J, V348, P633, DOI 10.1042/0264-6021:3480633; Oda K, 1999, J BIOCHEM-TOKYO, V126, P694; Herasse M, 2003, J MED GENET, V40, P605, DOI 10.1136/jmg.40.8.605; Mornet E, 2001, J BIOL CHEM, V276, P31171, DOI 10.1074/jbc.M102788200; Nasu M, 2006, FEBS J, V273, P5612, DOI 10.1111/j.1742-4658.2006.05550.x; Komaru K, 2005, FEBS J, V272, P1704, DOI 10.1111/j.1742-4658.2005.04597.x; Ishida Y, 2011, BBA-MOL BASIS DIS, V1812, P326, DOI 10.1016/j.bbadis.2010.12.002; Ito M, 2002, BIOCHEM J, V361, P473, DOI 10.1042/0264-6021:3610473; Satou Y, 2012, BBA-MOL BASIS DIS, V1822, P581, DOI 10.1016/j.bbadis.2012.01.007; Brun-Heath I, 2007, EUR J MED GENET, V50, P367, DOI 10.1016/j.ejmg.2007.06.005; Sultana S, 2013, MOL GENET METAB, V109, P282, DOI 10.1016/j.ymgme.2013.04.016; Whyte MP, 2012, NEW ENGL J MED, V366, P904, DOI 10.1056/NEJMoa1106173; Whyte MP, 2010, ANN NY ACAD SCI, V1192, P190, DOI 10.1111/j.1749-6632.2010.05387.x; Ishida Y, 2003, J BIOCHEM, V134, P63, DOI 10.1093/jb/mvg114; Cai GM, 1998, J CLIN ENDOCR METAB, V83, P3936, DOI 10.1210/jc.83.11.3936; Fauvert D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-51; Makita S, 2012, FEBS J, V279, P4327, DOI 10.1111/febs.12022; Milian JL, 2013, CALCIFIED TISSUE INT, V93, P299; Millan J.L., 2006, MAMMALIAN ALKALINE P; Mornet E, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-40; Mornet E., 2013, CLIN REV BONE MINERA, V11, P71; Whyte M.P., 2002, METABOLIC MOL BASES, VIV, P5319; Yang HO, 2013, CELL PHYSIOL BIOCHEM, V32, P635, DOI 10.1159/000354467	26	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	AUG	2015	115	4					180	185		10.1016/j.ymgme.2015.05.006		6	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CO5BD	WOS:000359173700005		
J	Kubaski, F; Tomatsu, S; Patel, P; Shimada, T; Xie, L; Yasuda, E; Mason, R; Mackenzie, WG; Theroux, M; Bober, MB; Oldham, HM; Orii, T; Shaffer, TH				Kubaski, Francyne; Tomatsu, Shunji; Patel, Pravin; Shimada, Tsutomu; Xie, Li; Yasuda, Eriko; Mason, Robert; Mackenzie, William G.; Theroux, Mary; Bober, Michael B.; Oldham, Helen M.; Orii, Tadao; Shaffer, Thomas H.			Non-invasive pulmonary function test on Morquio patients	MOLECULAR GENETICS AND METABOLISM			English	Article						Non-invasive pulmonary function test; Morquio syndrome; Impulse oscillometry system; Pneumotachography; Respiratory inductance plethysmography	RESPIRATORY INDUCTANCE PLETHYSMOGRAPHY; LYSOSOMAL STORAGE DISEASES; MUCOPOLYSACCHARIDOSIS IVA; INDUCTIVE PLETHYSMOGRAPHY; FREQUENCY-DEPENDENCE; IMPULSE OSCILLOMETRY; LUNG-VOLUME; CHILDREN; HEALTHY; RESISTANCE	In clinical practice, respiratory function tests are difficult to perform in Morquio syndrome patients due to their characteristic skeletal dysplasia, small body size and lack of cooperation of young patients, where in some cases, conventional spirometry for pulmonary function is too challenging. To establish feasible clinical pulmonary end-points and determine whether age impacts lung function in Morquio patients non-invasive pulmonary tests and conventional spirometry were evaluated. The non-invasive pulmonary tests: impulse oscillometry system, pneumotachography, and respiratory inductance plethysmography in conjunction with conventional spirometry were evaluated in twenty-two Morquio patients (18 Morquio A and 4 Morquio B) (7 males), ranging from 3 to 40 years of age. Twenty-two patients were compliant with non-invasive tests (100%) with the exception of IOS (81.8%-18 patients). Seventeen patients (77.3%) were compliant with spirometry testing. All subjects had normal vital signs at rest including >95% oxygen saturation, end tidal CO2 (38-44 mm Hg), and age-appropriate heart rate (mean = 98.3, standard deviation = 19) (two patients were deviated). All patients preserved normal values in the impulse oscillometry system, pneumotachography, and respiratory inductance plethysmography, although predicted forced expiratory total (72.8 +/- 6.9 SE%) decreased with age and was below normal; phase angle (35.5 +/- 16.5), %rib cage (41.6 +/- 12.7%), resonant frequency, and forced expiratory volume in 1 s/forced expiratory volume total (110.0 +/- 3.2 SE%) were normal and not significantly impacted by age. The proposed non-invasive pulmonary function tests are able to cover a greater number of patients (young patients and/or wheel-chair bound), thus providing a new diagnostic approach for the assessment of lung function in Morquio syndrome which in many cases may be difficult to evaluate. Morquio patients studied herein demonstrated no clinical or functional signs of restrictive and/or obstructive lung disease. (C) 2015 Elsevier Inc. All rights reserved.	[Kubaski, Francyne; Tomatsu, Shunji; Patel, Pravin; Shimada, Tsutomu; Xie, Li; Yasuda, Eriko; Mason, Robert; Mackenzie, William G.; Theroux, Mary; Bober, Michael B.; Shaffer, Thomas H.] Nemours Alfred I duPont Hosp Children, Wilmington, DE 19803 USA; [Kubaski, Francyne; Mason, Robert] Univ Delaware, Dept Biol Sci, Newark, DE USA; [Tomatsu, Shunji; Orii, Tadao] Gifu Univ, Dept Pediat, Gifu, Japan; [Oldham, Helen M.] Nemours Alfred I duPont Hosp Children, Dept Resp Care, Wilmington, DE 19803 USA; [Shaffer, Thomas H.] Nemours Alfred I duPont Hosp Children, Ctr Pediat Lung Res, Wilmington, DE 19803 USA	Tomatsu, S (reprint author), Nemours Alfred I duPont Hosp Children, Skeletal Dysplasia Ctr, Nemours Biomed Res, 1600 Rockland Rd, Wilmington, DE 19803 USA.	stomatsu@nemours.org; tshaffer@nemours.org		Bober, Michael/0000-0002-6178-1264	National Institute of General Medical Sciences of NIH [P20GM103464]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from Brazil (CNPq)	T.S. and S.T. were supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of NIH under grant number P20GM103464. F.K. was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico from Brazil (CNPq). The content of the article has not been influenced by the sponsors. Editorial assistance to the manuscript was provided by Michelle Stofa at Nemours/Alfred I. duPont Hospital for Children. The views and opinions expressed here do not necessarily reflect those of the funding agencies which had no role in the study design, data collection, data analysis, data interpretation, or writing of the report. All the authors have completed and submitted the ICMJE Form for Disclosure of Potential Conflict of Interest. T.H.S. and S.T. had full access to all of the data in the study and takes responsibility for the integrity of the data and the accuracy of the data analysis.	Dung VC, 2013, MOL GENET METAB, V110, P129, DOI 10.1016/j.ymgme.2013.06.008; Mayer OH, 2003, CHEST, V124, P1812, DOI 10.1378/chest.124.5.1812; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004399900075; Muhlebach MS, 2011, PAEDIATR RESPIR REV, V12, P133, DOI 10.1016/j.prrv.2010.10.005; vanderEnt CK, 1996, AM J RESP CRIT CARE, V153, P1253; Tomatsu S, 2011, CURR PHARM BIOTECHNO, V12, P931, DOI 1389-2010/11 $58.00+.00; Komarow HD, 2011, ANN ALLERG ASTHMA IM, V106, P191, DOI 10.1016/j.anai.2010.11.011; Harmatz P, 2013, MOL GENET METAB, V109, P54, DOI 10.1016/j.ymgme.2013.01.021; WAGAMAN MJ, 1979, J PEDIATR-US, V94, P787, DOI 10.1016/S0022-3476(79)80157-2; Hendriksz CJ, 2013, MOL GENET METAB, V110, P54, DOI 10.1016/j.ymgme.2013.04.002; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; Lin SP, 2014, PEDIATR PULM, V49, P277, DOI 10.1002/ppul.22774; Tomatsu S, 2013, EXPERT OPIN ORPHAN D, V1, P805, DOI 10.1517/21678707.2013.846853; BRISCOE WA, 1958, J CLIN INVEST, V37, P1279, DOI 10.1172/JCI103715; Northover H, 1996, J INHERIT METAB DIS, V19, P357, DOI 10.1007/BF01799267; Berger KI, 2013, J INHERIT METAB DIS, V36, P201, DOI 10.1007/s10545-012-9555-1; Brown K, 1998, EUR RESPIR J, V12, P935, DOI 10.1183/09031936.98.12040935; ALLEN JL, 1991, PEDIATR PULM, V11, P37, DOI 10.1002/ppul.1950110107; Yasuda E, 2013, MOL GENET METAB, V109, P301, DOI 10.1016/j.ymgme.2013.04.009; Nelson J, 1997, HUM GENET, V101, P355, DOI 10.1007/s004390050641; Beydon N, 2007, AM J RESP CRIT CARE, V175, P1304, DOI 10.1164/rccm.200605-642ST; Applegarth DA, 2000, PEDIATRICS, V105, P1969; BERDEL D, 1979, PRAX KLIN PNEUMOL, V33, P35; BERKOWITZ ID, 1990, ANESTHESIOLOGY, V73, P739, DOI 10.1097/00000542-199010000-00021; Brailsford JF, 1929, AM J SURG, V7, P404, DOI 10.1016/S0002-9610(29)90496-7; Chhabra SK, 2008, ANN THORAC MED, V3, P94, DOI 10.4103/1817-1737.39574; Crim C, 2011, RESP MED, V105, P1069, DOI 10.1016/j.rmed.2011.01.010; CUIJPERS CEJ, 1993, RESPIRATION, V60, P149; GRENVIK A, 1966, ACTA ANAESTH SCAND, V10, P147, DOI 10.1111/j.1399-6576.1966.tb00339.x; Harmatz PR, 2015, MOL GENET METAB, V114, P186, DOI 10.1016/j.ymgme.2014.10.015; Hellinckx J, 1998, EUR RESPIR J, V12, P438, DOI 10.1183/09031936.98.12020438; Miller TL, 2004, PEDIATR PULM, V38, P386, DOI 10.1002/ppul.20094; Mineshita M, 2014, RESP PHYSIOL NEUROBI, V202, P1, DOI 10.1016/j.resp.2014.07.008; Möllmann Christian, 2013, JIMD Rep, V11, P65, DOI 10.1007/8904_2013_223; Montano AM, 2007, J INHERIT METAB DIS, V30, P758, DOI 10.1007/s10545-007-0702-z; Montano AM, 2008, AM J MED GENET A, V146A, P1286, DOI 10.1002/ajmg.a.32281; Morquio L, FORME DYSTROPHIE OSS, V321929, P129; Neumann P, 1998, CHEST, V113, P443, DOI 10.1378/chest.113.2.443; Poole KA, 2000, EUR RESPIR J, V16, P1084, DOI 10.1034/j.1399-3003.2000.16f11.x; R Core Team, 2014, R LANG ENV STAT COMP; SEMENZA GL, 1988, MEDICINE, V67, P209; SHAFFER TH, 1976, RESP PHYSIOL, V28, P179, DOI 10.1016/0034-5687(76)90037-2; SHEPHARD R. J., 1955, THORAX, V10, P258, DOI 10.1136/thx.10.3.258; Smith HJ, 2005, EUR RESP MON, V31, P72; STANESCU D, 1979, J APPL PHYSIOL, V47, P268; STOKES DC, 1990, CHEST, V98, P145, DOI 10.1378/chest.98.1.145; Stokes D.C., 1988, CHEST, V93, P365; Tanaka H, 2012, ALLERGOL INT, V61, P385, DOI 10.2332/allergolint.12-RAI-0465; Tomatsu S, 2012, RES REP ENDOCR DISOR, V2, P65; van der Wiel E, 2014, ALLERGY, V69, P1681, DOI 10.1111/all.12510; WOLFSON MR, 1992, J APPL PHYSIOL, V72, P1032	52	0	0	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1096-7192	1096-7206		MOL GENET METAB	Mol. Genet. Metab.	AUG	2015	115	4					186	192		10.1016/j.ymgme.2015.06.007		7	Endocrinology & Metabolism; Genetics & Heredity; Medicine, Research & Experimental	Endocrinology & Metabolism; Genetics & Heredity; Research & Experimental Medicine	CO5BD	WOS:000359173700006		
J	Koike, N; Higashiura, Y; Akasaka, J; Uekuri, C; Ito, F; Kobayashi, H				Koike, Natsuki; Higashiura, Yumi; Akasaka, Juria; Uekuri, Chiharu; Ito, Fuminori; Kobayashi, Hiroshi			Epigenetic dysregulation of endometriosis susceptibility genes (Review)	MOLECULAR MEDICINE REPORTS			English	Review						endometriosis; imprinting; epigenetics; chromatin architecture	ESTROGEN-RECEPTOR-ALPHA; PROGESTERONE RESISTANCE; THERAPEUTIC TARGET; BREAST-CANCER; MESSENGER-RNA; EXPRESSION; HYPERMETHYLATION; IMPLANTATION; PROMOTER; WOMEN	The aim of the present review was to illustrate how dysregulation of hormonal signaling regulates expressional changes of spatially associated genes in endometriosis. From a multi-platform endometriosis dataset, an integrated analysis was performed of epigenomic changes of several biologically relevant genes that have been validated in the literature. Estrogen receptor (ER) may act as a direct epigenetic driver for endometriosis establishment, maintenance and progression. A majority of endometriosis susceptibility genes may be present in functional downstream targets of ER and located near the known imprinting genes. Previous studies have shed light on the overlapping genetic signatures between endometriosis development and the defective decidualization process. The steroid hormone-mediated decidualization signaling pathway was shown to be frequently dysregulated in endometriosis. DNA methylation is associated with various intragenic or intergenic epigenetic modifications of chromatin. Chromatin architecture may be established in temporal and spatial orchestration of the recruitment of genes specifically downregulated in endometriosis. In conclusion, defective chromatin architecture at the ER target locus may have a key role in endometriosis. Endometriosis represents an interesting model to explore the variation of expression of spatially associated genes.	[Koike, Natsuki; Higashiura, Yumi; Akasaka, Juria; Uekuri, Chiharu; Ito, Fuminori; Kobayashi, Hiroshi] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan	Kobayashi, H (reprint author), Nara Med Univ, Dept Obstet & Gynecol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	hirokoba@naramed-u.ac.jp			Ministry of Education, Science, and Culture of Japan [26293361]	The present review was supported by a grant-in-aid for the Scientific Research from the Ministry of Education, Science, and Culture of Japan to H.K (grant no. 26293361).	Burney RO, 2007, ENDOCRINOLOGY, V148, P3814, DOI 10.1210/en.2006-1692; Colon-Diaz M, 2012, REPROD SCI, V19, P483, DOI 10.1177/1933719111432870; Hu Q, 2008, P NATL ACAD SCI USA, V105, P19199, DOI 10.1073/pnas.0810634105; Bulun SE, 2012, SEMIN REPROD MED, V30, P39, DOI 10.1055/s-0031-1299596; Nasu K, 2014, FRONT BIOSCI-LANDMRK, V19, P1202; Kawano Y, 2011, HUM REPROD, V26, P2486, DOI 10.1093/humrep/der203; Lim HJ, 1999, MOL ENDOCRINOL, V13, P1005, DOI 10.1210/me.13.6.1005; Cakmak H, 2011, HUM REPROD UPDATE, V17, P242, DOI 10.1093/humupd/dmq037; Xue Q, 2007, BIOL REPROD, V77, P681, DOI 10.1095/biolreprod.107.061804; Wu Y, 2006, EPIGENETICS-US, V1, P106; Fullwood MJ, 2009, NATURE, V462, P58, DOI 10.1038/nature08497; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Shao RJ, 2014, AM J TRANSL RES, V6, P104; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Kobayashi H, 2014, HUM IMMUNOL, V75, P208, DOI 10.1016/j.humimm.2013.12.012; Guo SW, 2009, MOL HUM REPROD, V15, P587, DOI 10.1093/molehr/gap064; Bulun SE, 2010, SEMIN REPROD MED, V28, P36, DOI 10.1055/s-0029-1242991; Nasu K, 2011, J OBSTET GYNAECOL RE, V37, P683, DOI 10.1111/j.1447-0756.2011.01663.x; Edwards CA, 2007, CURR OPIN CELL BIOL, V19, P281, DOI 10.1016/j.ceb.2007.04.013; Ong CT, 2011, NAT REV GENET, V12, P283, DOI 10.1038/nrg2957; Borghese B, 2010, MOL ENDOCRINOL, V24, P1872, DOI 10.1210/me.2010-0160; Wiegand KC, 2010, NEW ENGL J MED, V363, P1532, DOI 10.1056/NEJMoa1008433; Heger P, 2012, P NATL ACAD SCI USA, V109, P17507, DOI 10.1073/pnas.1111941109; Hsieh YY, 2007, MOL HUM REPROD, V13, P117, DOI 10.1093/molehr/gal099; Liu MH, 2014, MOL CELL ENDOCRINOL, V382, P624, DOI 10.1016/j.mce.2013.09.019; CONNEELY OM, 1987, BIOCHEM BIOPH RES CO, V149, P493, DOI 10.1016/0006-291X(87)90395-0; Wu Y, 2007, FERTIL STERIL, V87, P24, DOI 10.1016/j.fertnstert.2006.05.077; Yang JP, 2011, ADV CANCER RES, V110, P43, DOI 10.1016/B978-0-12-386469-7.00003-7; Dyson MT, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004158; Fambrini M, 2013, ACTA OBSTET GYN SCAN, V92, P1331, DOI 10.1111/aogs.12236; Franco Maurício M, 2014, Biol Reprod, V91, P125, DOI 10.1095/biolreprod.114.122945; Izawa Masao, 2013, Front Biosci (Elite Ed), V5, P900; Kobayashi H, 2014, REPROD SCI, V21, P966, DOI 10.1177/1933719114526473; Kobayashi H, 2014, GYNECOL ENDOCRINOL, V30, P7, DOI 10.3109/09513590.2013.831832; Li XL, 2014, HUM MOL GENET, V23, P6008, DOI 10.1093/hmg/ddu330; Liang XH, 2014, J BIOL CHEM, V289, P23534, DOI 10.1074/jbc.M114.588897; Monteiro JB, 2014, REPROD SCI, V21, P305, DOI 10.1177/1933719113497267; Ross-Innes CS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-593; Tamaresis JS, 2014, ENDOCRINOLOGY, V155, P4986, DOI 10.1210/en.2014-1490; Wang DB, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-12; Wieser F, 2002, FERTIL STERIL, V77, P309, DOI 10.1016/S0015-0282(01)02984-3; Yamagata Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083612; Zhang Y, 2010, J BIOL CHEM, V285, P28604, DOI 10.1074/jbc.M110.149658	43	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	AUG	2015	12	2					1611	1616		10.3892/mmr.2015.3635		6	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CN8GR	WOS:000358678600001		
J	Iwabuchi, M; Narita, M; Uchiyama, T; Iwaya, S; Oiwa, E; Nishizawa, Y; Hashimoto, S; Bonehill, A; Kasahara, N; Takizawa, J; Takahashi, M				Iwabuchi, Minami; Narita, Miwako; Uchiyama, Takayoshi; Iwaya, Shunpei; Oiwa, Eri; Nishizawa, Yoshinori; Hashimoto, Shigeo; Bonehill, Aude; Kasahara, Noriyuki; Takizawa, Jun; Takahashi, Masuhiro			Enhancement of the antigen-specific cytotoxic T lymphocyte-inducing ability in the PMDC11 leukemic plasmacytoid dendritic cell line via lentiviral vector-mediated transduction of the caTLR4 gene	MOLECULAR MEDICINE REPORTS			English	Article						leukemic plasmacytoid dendritic cell line; PMDC11; caTLR4; gene transduction; lentiviral vector; antigen-specific cytotoxic T lymphocytes; adoptive cellular immunotherapy	PRESENTING CELLS; ADOPTIVE THERAPY; IMMUNOTHERAPY; INDUCTION; EXPANSION; RNA; TRANSFECTION; STIMULATION; VACCINATION; DOMINANT	The aim of the present study was to enhance the efficiency of leukemia immunotherapy by increasing the antigen-specific cytotoxic T lymphocyte-inducing ability of leukemia cells. The leukemic plasmacytoid dendritic cell line PMDC05 containing the HLA-A02/24 antigen, which was previously established in our laboratory (Laboratory of Hematology and Oncology, Graduate School of Health Sciences, Niigata University, Niigata, Japan), was used in the present study. It exhibited higher expression levels of CD80 following transduction with lentiviruses encoding the CD80 gene. This CD80-expressing PMDC05 was named PMDC11. In order to establish a more potent antigen-presenting cell for cellular immunotherapy of tumors or severe infections, PMDC11 cells were transduced with a constitutively active (ca) toll-like receptor 4 (TLR4) gene using the Tet-On system (caTLR4-PMDC11). CD8(+) T cells from healthy donors with HLA-A02 were co-cultured with mutant WT1 peptide-pulsed PMDC11, lipopolysaccharide (LPS)-stimulated PMDC11 or caTLR4-PMDC11 cells. Interleukin (IL)-2 (50 IU/ml) and IL-7 (10 ng/ml) were added on day three of culture. Priming with mutant WT1 peptide-pulsed PMDC11, LPS-stimulated PMDC11 or caTLR4-PMDC11 cells was conducted once per week and two thirds of the IL-2/IL-7 containing medium was replenished every 3-4 days. Immediately prior to the priming with these various PMDC11 cells, the cultured cells were analyzed for the secretion of interferon (IFN)-gamma in addition to the percentage and number of CD8(+)/WT1 tetramer(+) T cells using flow cytometry. caTLR4-PMDC11 cells were observed to possess greater antigen-presenting abilities compared with those of PMDC11 or LPS-stimulated PMDC11 cells in a mixed leukocyte culture. CD8 T cells positive for the WT1 tetramer were generated following 3-4 weeks of culture and CD8(+)/WT1 tetramer(+) T cells were markedly increased in caTLR4-PMDC11-primed CD8(+) T cell culture compared with PMDC11 or LPS-stimulated PMDC11-primed CD8(+) T cell culture. These CD8(+) T cells co-cultured with caTLR4-PMDC11 cells were demonstrated to secrete IFN-gamma and to be cytotoxic to WT1-expressing target cells. These data suggested that the antigen-specific cytotoxic T lymphocyte (CTL)-inducing ability of PMDC11 was potentiated via transduction of the caTLR4 gene. The present study also suggested that caTLR4-PMDC11 cells may be applied as potent antigen-presenting cells for generating antigen-specific CTLs in adoptive cellular immunotherapy against tumors and severe viral infections.	[Iwabuchi, Minami; Narita, Miwako; Uchiyama, Takayoshi; Iwaya, Shunpei; Oiwa, Eri; Nishizawa, Yoshinori; Takahashi, Masuhiro] Niigata Univ, Grad Sch Hlth Sci, Lab Hematol & Oncol, Nagaoka, Niigata 9518518, Japan; [Hashimoto, Shigeo] Nagaoka Red Cross Hosp, Div Hematol, Nagaoka, Niigata 9518518, Japan; [Bonehill, Aude] Free Univ Brussels VUB, Sch Med, Dept Physiol & Immunol, Lab Cellular & Mol Therapy, B-1090 Brussels, Belgium; [Kasahara, Noriyuki] Univ Calif Los Angeles, CURE Vector Core & JCCC Vector Shared Resource Fa, Los Angeles, CA 90095 USA; [Takizawa, Jun] Niigata Univ, Fac Med, Dept Internal Med, Div Hematol Endocrinol & Metab, Niigata 9518510, Japan	Takahashi, M (reprint author), Niigata Univ, Grad Sch Hlth Sci, Lab Hematol & Oncol, Chuou Ku, 746-2 Asahimachi Dori, Nagaoka, Niigata 9518518, Japan.	matak@clg.niigata-u.ac.jp	Bonehill, Aude/J-7363-2013	Bonehill, Aude/0000-0002-9372-6876	 [JCCC/P30 CA016042];  [CURE/P30 DK041301]	The results of the present study were presented at the 15th International Congress of Immunology in 2013 (Milan, Italy). The authors would like to thank Dr Renata Stripecke (Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation, Hannover Medical School, Hannover, Germany) for providing the gene transduction protocol. The UCLA Vector Core is supported by JCCC/P30 CA016042 and CURE/P30 DK041301.	Abdel-Wahab Z, 2005, J SURG RES, V124, P264, DOI 10.1006/j.jss.2004.10.002; Narita M, 2010, INT J MED SCI, V7, P72; Sims RB, 2012, VACCINE, V30, P4394, DOI 10.1016/j.vaccine.2011.11.058; Di Domizio J, 2009, BLOOD, V114, P1794, DOI 10.1182/blood-2009-04-216770; Chaperot L, 2006, J IMMUNOL, V176, P248; Maeda T, 2005, INT J HEMATOL, V81, P148, DOI 10.1532/IJH97.04116; Yamanaka R, 2005, CLIN CANCER RES, V11, P4160, DOI 10.1158/1078-0432.CCR-05-0120; Bonehill A, 2008, MOL THER, V16, P1170, DOI 10.1038/mt.2008.77; Steenblock ER, 2009, EXPERT OPIN BIOL TH, V9, P451, DOI [10.1517/14712590902849216 , 10.1517/14712590902849216]; Rudolf D, 2008, CANCER IMMUNOL IMMUN, V57, P175, DOI 10.1007/s00262-007-0360-x; Irvine DJ, 2007, SEMIN IMMUNOL, V19, P245, DOI 10.1016/j.simm.2007.02.011; Cisco RM, 2004, J IMMUNOL, V172, P7162; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Pincha M, 2011, GENE THER, V18, P750, DOI 10.1038/gt.2011.15; Aspord C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010458; Butler MO, 2007, CLIN CANCER RES, V13, P1857, DOI 10.1158/1078-0432.CCR-06-1905; Cai ZL, 1996, P NATL ACAD SCI USA, V93, P14736, DOI 10.1073/pnas.93.25.14736; Hasan AN, 2009, J IMMUNOL, V183, P2837, DOI 10.4049/jimmunol.0804178; Koffernan Eva, 2007, V136, P69; Montagna D, 2012, CYTOTHERAPY, V14, P80, DOI 10.3109/14653249.2011.610303; Narita M, 2008, ACTA HAEMATOL-BASEL, V120, P91, DOI 10.1159/000165510; Narita M, 2009, LEUKEMIA RES, V33, P1224, DOI 10.1016/j.leukres.2009.03.047; Papanicolaou GA, 2003, BLOOD, V102, P2498, DOI 10.1182/blood-2003-02-0345; Sapienza MR, 2014, LEUKEMIA OFFICIAL J; Sasawatari S, 2006, IMMUNOL CELL BIOL, V84, P512, DOI 10.1111/j.1440-1711.2006.01462.x; Stone AEL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003316; Stripecke Renata, 2009, V506, P139, DOI 10.1007/978-1-59745-409-4_11; Takahashi M, 1997, LEUKEMIA RES, V21, P1115, DOI 10.1016/S0145-2126(97)00096-9; Watanabe N, 2010, LEUKEMIA RES, V34, P1517, DOI 10.1016/j.leukres.2010.03.002; Yamahira A, 2012, LEUKEMIA RES, V36, P1541, DOI 10.1016/j.leukres.2012.09.002; Yamahira A, 2011, LEUKEMIA RES, V35, P793, DOI 10.1016/j.leukres.2010.12.003; Yuan J, 2006, CYTOTHERAPY, V8, P498, DOI 10.1080/14653240600868262	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	AUG	2015	12	2					2443	2450		10.3892/mmr.2015.3685		8	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CN8GR	WOS:000358678600115		
J	Ishibashi, T; Ichikawa, M; Sato, B; Shibata, S; Hara, Y; Naritomi, Y; Okazaki, K; Nakashima, Y; Iwamoto, Y; Koyanagi, S; Hara, H; Nagao, T				Ishibashi, Toru; Ichikawa, Miki; Sato, Bunpei; Shibata, Shinji; Hara, Yuichi; Naritomi, Yuji; Okazaki, Ken; Nakashima, Yasuharu; Iwamoto, Yukihide; Koyanagi, Samon; Hara, Hiroshi; Nagao, Tetsuhiko			Improvement of psoriasis-associated arthritis and skin lesions by treatment with molecular hydrogen: A report of three cases	MOLECULAR MEDICINE REPORTS			English	Article						psoriasis; arthritis; molecular hydrogen; 7 ppm; H-2-saline; H-2 gas	RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; TNF-ALPHA; PATHOGENESIS; THERAPY; IL-6; INFLAMMATION; ANTIOXIDANT; MECHANISMS; SEVERITY	Psoriasis, a chronic inflammatory skin disease, is caused by infiltrating lymphocytes and associated cytokines, including tumor necrosis factor (TNF)alpha, interleukin (IL)-6, and IL-17. Effective treatments, including pathogenesis-based biological agents against psoriasis, are currently under development. Although the role of reactive oxygen species (ROS) in the pathogenesis of psoriasis has been investigated, it remains to be fully elucidated; ROS-targeted therapeutic strategies are also lacking at present. Therefore, the objective of the present study was to assess whether H-2, a ROS scavenger, has a therapeutic effect on psoriasis-associated inflammation by reducing hydroxyl radicals or peroxynitrite in the immunogenic psoriasis cascade. Three methods were used to administer H-2: Drop infusion of saline containing 1 ppm H-2 (H-2-saline), inhalation of 3% H-2 gas, and drinking of water containing a high concentration (5-7-ppm) of H-2 (high-H-2 water). Treatment efficacy was estimated using the disease activity score 28 (DAS28) system, based on C-reactive protein levels, and the psoriasis area and severity index (PASI) score, determined at baseline and following each H-2 treatment. Furthermore, levels of TNF alpha, IL-6, and IL-17 were analyzed. The DAS28 and PASI score of the three patients decreased during H2 treatment, regardless of the administration method. The psoriatic skin lesions almost disappeared at the end of the treatment. IL-6 levels decreased during H2 treatment in Case 1 and 2. IL-17, whose concentration was high in Case 1, was reduced following H-2 treatment, and TNFa also decreased in Case 1. In conclusion, H-2 administration reduced inflammation associated with psoriasis in the three cases examined and it may therefore be considered as a treatment strategy for psoriasis-associated skin lesions and arthritis.	[Ishibashi, Toru] Haradoi Hosp, Dept Rheumatol & Orthopaed Surg, Fukuoka 8138588, Japan; [Ichikawa, Miki] Haradoi Hosp, Dept Dermatol, Higashi ku, Fukuoka 8138588, Japan; [Sato, Bunpei] MiZ Co, Fujisawa, Kanagawa 2510871, Japan; [Shibata, Shinji] Haradoi Hosp, Dept Radiol, Fukuoka 8138588, Japan; [Hara, Yuichi; Naritomi, Yuji; Hara, Hiroshi] Haradoi Hosp, Dept Internal Med, Higashi Ku, Fukuoka 8138588, Japan; [Okazaki, Ken; Nakashima, Yasuharu; Iwamoto, Yukihide] Kyushu Univ, Dept Orthopaed Surg, Higashi Ku, Fukuoka 8128582, Japan; [Koyanagi, Samon] Haradoi Hosp, Dept Cardiol, Higashi Ku, Fukuoka 8138588, Japan; [Nagao, Tetsuhiko] Midorino Clin, Higashi Ku, Fukuoka 8130025, Japan	Ishibashi, T (reprint author), Huis Ten Bosch Satellite, Dept Rheumatol & Orthopaed Surg, Hakata ku, H2 Clin Hakata,2-1 Gion, Fukuoka 8120038, Japan.	tishibashi@h2-lab.jp					Lowes MA, 2007, NATURE, V445, P866, DOI 10.1038/nature05663; Hukuda S, 2001, J RHEUMATOL, V28, P554; Lee DH, 2012, INT J MOL SCI, V13, P11783, DOI 10.3390/ijms130911783; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Ishibashi T, 2013, CURR PHARM DESIGN, V19, P6375; Gharib B, 2001, CR ACAD SCI III-VIE, V324, P719, DOI 10.1016/S0764-4469(01)01350-6; Ohno K, 2012, OXID MED CELL LONGEV, DOI 10.1155/2012/353152; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Goodman WA, 2009, J IMMUNOL, V183, P3170, DOI 10.4049/jimmunol.0803721; Arbiser JL, 2011, J INVEST DERMATOL, V131, P1189, DOI 10.1038/jid.2011.45; Ohsawa I, 2007, NAT MED, V13, P688, DOI 10.1038/nm1577; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033; Martin DA, 2013, J INVEST DERMATOL, V133, P17, DOI 10.1038/jid.2012.194; Chaudhari U, 2001, LANCET, V357, P1842, DOI 10.1016/S0140-6736(00)04954-0; Schon MP, 2005, NEW ENGL J MED, V352, P1899, DOI 10.1056/NEJMra041320; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Reich A, 2010, ACTA DERM-VENEREOL, V90, P257, DOI 10.2340/00015555-0851; Mizutani H, 1997, J DERMATOL SCI, V14, P145, DOI 10.1016/S0923-1811(96)00562-2; Zegarska B, 2006, PHARMACOL REP, V58, P13; ABRAINI JH, 1994, J APPL PHYSIOL, V76, P1113; Canavese M, 2010, J DERMATOL SCI, V58, P171, DOI 10.1016/j.jdermsci.2010.03.023; Gabr SA, 2012, ARCH DERMATOL RES, V304, P451, DOI 10.1007/s00403-012-1230-8; Ishibashi Toru, 2012, Med Gas Res, V2, P27, DOI 10.1186/2045-9912-2-27; Levin RW, 1996, SCAND J RHEUMATOL, V25, P277; Mabuchi Tomotaka, 2012, Tokai J Exp Clin Med, V37, P84; Ono Hirohisa, 2012, Med Gas Res, V2, P14, DOI 10.1186/2045-9912-2-14; Ono Hirohisa, 2011, Med Gas Res, V1, P12, DOI 10.1186/2045-9912-1-12; Ono Hirohisa, 2012, Med Gas Res, V2, P21; Raychaudhuri SK, 2009, ANN NY ACAD SCI, V1173, P470, DOI 10.1111/j.1749-6632.2009.04652.x; Seo Tomoki, 2012, Med Gas Res, V2, P1, DOI 10.1186/2045-9912-2-1; Ulmer A, 2008, BRIT J DERMATOL, V158, P867, DOI 10.1111/j.1365-2133.2008.08455.x; vandeKerkhof PCM, 1997, BRIT J DERMATOL, V137, P661; Verhoeven EWM, 2007, BRIT J DERMATOL, V156, P1346, DOI 10.1111/j.1365-2133.2007.07916.x; Zaba LC, J ALLERGY CLIN IMMUN, V124, P1022	34	1	1	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	AUG	2015	12	2					2757	2764		10.3892/mmr.2015.3707		8	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CN8GR	WOS:000358678600156		
J	Wang, T; Lim, JN; Lee, JS; Lee, SB; Hwang, JH; Jung, US; Kim, MJ; Hwang, DY; Lee, SR; Roh, SG; Lee, HG				Wang, Tao; Lim, Ji-Na; Lee, Jae-Sung; Lee, Sang-Bum; Hwang, Jin-Hee; Jung, U-Suk; Kim, Min-Jeong; Hwang, Dae-Youn; Lee, Sang-Rak; Roh, Sang-Gun; Lee, Hong-Gu			Effects of dietary trans-9 octadecenoic acid, trans-11 vaccenic acid and cis-9, trans-11 conjugated linoleic acid in mice	MOLECULAR MEDICINE REPORTS			English	Article						cis-9; trans-11 conjugated linoleic acid; physiological conditions; trans-9 octadecenoic acid; trans-11 vaccenic acid	JCRLA-CP RATS; ELAIDIC ACID; FATTY-ACIDS; HAMSTER; PROFILE; LIPIDS; BLOOD; RICH; CLA	The aim of the present study was to investigate the effects of dietary trans fatty acids in mice. Following the administration of a 0.5/100 g diet of trans-9 octadecenoic acid (EA), trans-11 vaccenic acid (TVA) or cis-9, trans-11 conjugated linoleic acid (CLA) for 4 weeks, the body weights and the weights of the liver, testis and mediastinal adipose tissue (MAT) of the animals gradually decreased (P<0.05). The EA group exhibited the lowest levels of magnesium and triglycerides (P<0.05). CLA increased villus length (P<0.05), while EA and TVA decreased villus length (P<0.05). The TVA group exhibited the lowest levels of low-density lipoprotein and tumor necrosis factor-alpha (P<0.05). Taken together, EA, TVA and CLA affected the physiological conditions of mice differently. The potential effects of three well-known fatty acids, including trans-9 octadecenoic acid (EA), trans-11 vaccenic acid (TVA) and cis-9, trans-11 conjugated linoleic acid (CLA), in animals or humans remain to be elucidated. Therefore, in the present study, 32 animals were randomly divided into four groups and administered a 0.5/100 g diet of EA, TVA or CLA for 4 weeks. The results demonstrated that the body weights and the weights of the liver, testis and mediastinal adipose tissue (MAT) of the animals gradually decreased (P<0.05). Blood was collected individually via the external jugular veins and the EA group exhibited the lowest levels of magnesium and triglycerides (P<0.05). CLA increased villus length (P<0.05), while EA and TVA decreased villus length (P<0.05). The TVA group exhibited the lowest levels of low-density lipoprotein and tumor necrosis factor-alpha (P<0.05). Taken together, EA, TVA and CLA affected the physiological conditions of mice differently and these may further our understanding of the various effects of these fatty acids on animals and humans.	[Wang, Tao] Jilin Agr Univ, Coll Anim Sci & Technol, Dept Anim Nutr & Feed Sci, Changchun 130118, Jilin, Peoples R China; [Wang, Tao] Jilin Agr Univ, Key Lab Anim Nutr & Feed Sci, Changchun 130118, Jilin, Peoples R China; [Lim, Ji-Na; Lee, Jae-Sung; Lee, Sang-Bum; Hwang, Jin-Hee; Jung, U-Suk; Kim, Min-Jeong; Lee, Sang-Rak; Lee, Hong-Gu] Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Sci & Technol, Seoul 143701, South Korea; [Hwang, Dae-Youn] Pusan Natl Univ, Coll Nat Resources & Life Sci, Dept Biomat Sci, Miryang 627706, Gyeongnam, South Korea; [Roh, Sang-Gun] Tohoku Univ, Grad Sch Agr Sci, Lab Anim Physiol, Sendai, Miyagi 9888555, Japan	Lee, HG (reprint author), Konkuk Univ, Coll Anim Biosci & Technol, Dept Anim Sci & Technol, 120 Neungdong Ro, Seoul 143701, South Korea.	hglee66@konkuk.ac.kr			concentrated research professor program for Konkuk University, Seoul, Republic of Korea	This study was supported by a grant from the concentrated research professor program for Konkuk University, Seoul, Republic of Korea.	ABBEY M, 1994, ATHEROSCLEROSIS, V106, P99, DOI 10.1016/0021-9150(94)90086-8; Yang MD, 2003, EXP BIOL MED, V228, P51; Dilzer A, 2012, CRIT REV FOOD SCI, V52, P488, DOI 10.1080/10408398.2010.501409; Meijer GW, 2001, ATHEROSCLEROSIS, V157, P31, DOI 10.1016/S0021-9150(00)00661-4; Blewett HJ, 2009, BRIT J NUTR, V102, P526, DOI 10.1017/S0007114509231722; Wang T, 2013, ASIAN AUSTRAL J ANIM, V26, P189, DOI 10.5713/ajas.2012.12466; Bassett CMC, 2010, J NUTR, V140, P18, DOI 10.3945/jn.109.105163; Lock AL, 2005, J NUTR, V135, P1934; Valeille K, 2005, AM J PHYSIOL-HEART C, V289, pH652, DOI 10.1152/ajpheart.00130.2005; Roy A, 2007, ANIMAL, V1, P467, DOI 10.1017/S175173110770530X; Craig-Schmidt MC, 2006, ATHEROSCLEROSIS SUPP, V7, P1, DOI 10.1016/j.atherosclerosissup.2006.04.001; Anadon A, 2011, J AGR FOOD CHEM, V59, P8036, DOI 10.1021/jf201251g; Bauman D. E., 2000, J ANIM SCI, V77, P1, DOI DOI 10.2134/JAS2000.77E-SUPPL1F; Dupasquier CMC, 2007, ANN NUTR METAB, V1, P266; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fournier N, 2012, BBA-MOL CELL BIOL L, V1821, P303, DOI 10.1016/j.bbalip.2011.10.005; JELINEK DF, 1990, J BIOL CHEM, V265, P8190; Kanwar RK, 2008, CLIN EXP ALLERGY, V38, P208, DOI 10.1111/j.1365-2222.2007.02868.x; Kato Y, 2011, J ANIM SCI, V89, P951, DOI 10.2527/jas.2010-2872; Low JN, 2005, ACTA CRYSTALLOGR E, V61, pO3730, DOI 10.1107/S1600536805033040; PAYNE JM, 1972, P ROY SOC MED, V65, P181; Spurrier Ryan G., 2013, CLIN GASTROENTEROL H, V11, P354; Wang T, 2015, CRIT REV FOOD SCI, V55, P720, DOI 10.1080/10408398.2012.674071; Wang Y, 2008, J NUTR, V138, P2117, DOI 10.3945/jn.108.091009; Zhao LD, 2005, ARCH ANIM NUTR, V59, P429, DOI 10.1080/17450390500353333	25	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	AUG	2015	12	2					3200	3206		10.3892/mmr.2015.3767		7	Oncology; Medicine, Research & Experimental	Oncology; Research & Experimental Medicine	CN8GR	WOS:000358678600219		
J	Tanaka, M; Hong, SM; Akiyama, S; Hu, QQ; Matsui, T				Tanaka, Mitsuru; Hong, Seong-Min; Akiyama, Sayaka; Hu, Qing-Qiang; Matsui, Toshiro			Visualized absorption of anti-atherosclerotic dipeptide, Trp-His, in Sprague-Dawley rats by LC-MS and MALDI-MS imaging analyses	MOLECULAR NUTRITION & FOOD RESEARCH			English	Article						Absorption; Dipeptide; LC-MS; MALDI imaging; PepT1	CACO-2 CELL MONOLAYERS; ACTIVATED PROTEIN-KINASE; TANDEM MASS-SPECTROMETRY; PRO-VAL-PRO; DI-PEPTIDE; HYPERTENSIVE SUBJECTS; TRANSPORT; BLOOD; PERMEABILITY; MILK	ScopeThe basic dipeptide, Trp-His, was found to show an in vivo anti-atherosclerotic effect when orally administered to apo E-deficient mice. In addition, this dipeptide causes vasorelaxation in contracted rat aorta via suppression of intracellular Ca2+ signaling cascades. In this study, we attempted to determine whether Trp-His can be absorbed after single oral administration in Sprague-Dawley (SD) rats. Methods and resultsTrp-His and His-Trp (10 or 50 mg/kg) was orally administered to 8-week-old male SD rats. Both peptides in plasma were assayed by LC-MS/MS in combination with 2,4,6-trinitrobenzene sulfonate derivatization technique. In vitro transport experiments using Caco-2 cell monolayers were performed to evaluate the apparent permeability (P-app). A phytic acid-aided MALDI-MS imaging (MSI) was conducted to visualize the distribution of dipeptides in the rat intestinal membrane. Trp-His was absorbed intact into SD rat blood, showing a maximal level at 1 h after administration at 10 mg/kg dose (C-max, 28.7 8.9 pmol/mL-plasma; area under the curve, 71.3 +/- 18.7 pmolh/mL-plasma). In contrast, His-Trp was surprisingly not detected, although the P-app was compatible to that of Trp-His. MSI analysis provided crucial evidence that Trp-His was visualized in the overall intestinal membrane. The Trp-His peptide was not visualized in the presence of Gly-Sar, which is a model peptide that is transported via the intestinal proton-coupled peptide transporter 1 (PepT1) transporter. The His-Trp molecular ion was not observed at the intestinal membrane. The MSI analysis illustrated that there is no absorption of His-Trp due to its unexpected hydrolysis by brush border proteases. ConclusionTo the best of our knowledge, this is the first study demonstrating that the vasoactive Trp-His is preferably transported across the rat intestinal membrane by PepT1 and is absorbed intact into the circulation. However, no absorption of His-Trp, a reverse sequence of absorbable Trp-His, is observed owing to hydrolysis by intestinal proteases. This suggests that the bioavailability of peptides may be determined in part by their protease resistance in the intestinal membrane.	[Tanaka, Mitsuru; Hong, Seong-Min; Akiyama, Sayaka; Hu, Qing-Qiang; Matsui, Toshiro] Kyushu Univ, Grad Sch, Fac Agr, Fukuoka 8128581, Japan	Matsui, T (reprint author), Kyushu Univ, Grad Sch, Fac Agr, Higashi Ku, 6-10-1 Hakozaki, Fukuoka 8128581, Japan.	tmatsui@agr.kyushu-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [22248014]; Adaptable and Seamless Technology Transfer Program through target-driven RD, JST	We thank Dr. Katsuhiro Osajima, Senmi Ekisu Co. Ltd. for MS analysis of sardine muscle hydrolysate. This study was supported in part by a grant-in-aid from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (No. 22248014) to T.M., and Adaptable and Seamless Technology Transfer Program through target-driven R&D, JST to M.T. and T.M.	Ano R, 2004, BIOORGAN MED CHEM, V12, P249, DOI 10.1016/j.bmc.2003.10.001; Hashimoto C, 2013, ANAL CHEM, V85, P4289, DOI 10.1021/ac400294q; Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4; Hong SM, 2013, ANAL CHEM, V85, P10033, DOI 10.1021/ac402252j; Kawasaki T, 2000, J HUM HYPERTENS, V14, P519, DOI 10.1038/sj.jhh.1001065; Shimizu K, 2010, J AGR FOOD CHEM, V58, P6960, DOI 10.1021/jf100388w; Jappar D, 2010, DRUG METAB DISPOS, V38, P1740, DOI 10.1124/dmd.110.034025; Foltz M, 2007, J NUTR, V137, P953; Hata Y, 1996, AM J CLIN NUTR, V64, P767; Matsui T, 2002, CLIN EXP PHARMACOL P, V29, P204, DOI 10.1046/j.1440-1681.2002.03628.x; Takeda J, 2013, FOOD CHEM, V138, P2140, DOI 10.1016/j.foodchem.2012.12.026; Tanaka M, 2008, LIFE SCI, V82, P869, DOI 10.1016/j.lfs.2008.02.001; Zwarycz B, 2013, POULTRY SCI, V92, P1314, DOI 10.3382/ps.2012-02826; Sun HY, 2009, BIOSCI BIOTECH BIOCH, V73, P293, DOI 10.1271/bbb.80473; Foltz M, 2010, J NUTR, V140, P117, DOI 10.3945/jn.109.116228; Nakashima EMN, 2011, ANAL BIOCHEM, V414, P109, DOI 10.1016/j.ab.2011.02.037; Lei L, 2008, J AGR FOOD CHEM, V56, P3582, DOI 10.1021/jf703640p; Ding L, 2014, J AGR FOOD CHEM, V62, P3177, DOI 10.1021/jf405639w; Nakashima EMN, 2013, BIOSCI BIOTECH BIOCH, V77, P2094, DOI 10.1271/bbb.130448; Fukuda T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088975; Ito K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3502; Kobayashi Y, 2012, FEBS OPEN BIO, V2, P83, DOI 10.1016/j.fob.2012.04.005; KRIPALANI KJ, 1980, CLIN PHARMACOL THER, V27, P636; Kumrungsee T, 2014, BBA-GEN SUBJECTS, V1840, P3073, DOI 10.1016/j.bbagen.2014.07.020; Matsui T, 2010, BRIT J NUTR, V103, P309, DOI 10.1017/S0007114509991814; Shigemura Y, 2012, J AGR FOOD CHEM, V60, P5128, DOI 10.1021/jf300497p; Soga M, 2014, FEBS OPEN BIO, V4, P898, DOI 10.1016/j.fob.2014.10.008	27	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1613-4125	1613-4133		MOL NUTR FOOD RES	Mol. Nutr. Food Res.	AUG	2015	59	8					1541	1549		10.1002/mnfr.201500075		9	Food Science & Technology	Food Science & Technology	CO3KS	WOS:000359056700012		
J	Friedmann, T; Jonlin, EC; King, NMP; Torbett, BE; Wivel, NA; Kaneda, Y; Sadelain, M				Friedmann, Theodore; Jonlin, Erica C.; King, Nancy M. P.; Torbett, Bruce E.; Wivel, Nelson A.; Kaneda, Yasufumi; Sadelain, Michel			ASGCT and JSGT Joint Position Statement on Human Genomic Editing	MOLECULAR THERAPY			English	Editorial Material							DYSTROPHIC EPIDERMOLYSIS-BULLOSA; FIBROBLAST CELL THERAPY; VEHICLE-CONTROLLED TRIAL; BONE-MARROW; VII COLLAGEN; SKIN; TRANSPLANTS		[Friedmann, Theodore] Univ Calif San Diego, Sch Med, Inst Genom Med, Dept Pediat, La Jolla, CA 92093 USA; [Jonlin, Erica C.] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA; [King, Nancy M. P.] Wake Forest Sch Med, Dept Social Sci & Hlth Policy, Winston Salem, NC USA; [Torbett, Bruce E.] Scripps Res Inst, Dept Mol & Expt Med, Mol & Cellular Therapy, La Jolla, CA 92037 USA; [Wivel, Nelson A.] Univ Penn, Philadelphia, PA 19104 USA; [Kaneda, Yasufumi] Osaka Univ, Grad Sch Med, Div Gene Therapy, Suita, Osaka, Japan; [Sadelain, Michel] Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, New York, NY 10021 USA	Sadelain, M (reprint author), Mem Sloan Kettering Canc Ctr, Ctr Cell Engn, Box 182,Room S1021,1275 York Ave, New York, NY 10065 USA.	m-sadelain@ski.mskcc.org					Wagner JE, 2010, NEW ENGL J MED, V363, P629, DOI 10.1056/NEJMoa0910501; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; Tamai K, 2011, P NATL ACAD SCI USA, V108, P6609, DOI 10.1073/pnas.1016753108; Wong T, 2008, J INVEST DERMATOL, V128, P2179, DOI 10.1038/jid.2008.78; Cohnheim J, 1867, VIRCHOWS ARCH, V40, P1; Conget P, 2010, CYTOTHERAPY, V12, P429, DOI 10.3109/14653241003587637; FRIEDENS.AJ, 1966, J EMBRYOL EXP MORPH, V16, P381; FRIEDENS.AJ, 1968, TRANSPLANTATION, V6, P230, DOI 10.1097/00007890-196803000-00009; Iinuma S, 2015, J IMMUNOL, V194, P1996, DOI 10.4049/jimmunol.1400914; Kern JS, 2009, MOL THER, V17, P1605, DOI 10.1038/mt.2009.144; Kuhl T, 2015, MOL THER, V23, P1368, DOI 10.1038/mt.2015.58; Nevala-Plagemann C, 2015, CYTOTHERAPY, V17, P786, DOI 10.1016/j.jcyt.2015.03.006; Petrof G, 2013, BRIT J DERMATOL, V169, P1025, DOI 10.1111/bjd.12599; Petrof G, 2015, J INVEST DERMATOL; Tolar J, 2015, NEW ENGL J MED, V372, P382, DOI 10.1056/NEJMcibr1414709; Venugopal SS, 2013, J AM ACAD DERMATOL, V69, P898, DOI 10.1016/j.jaad.2013.08.014	16	3	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1525-0016	1525-0024		MOL THER	Mol. Ther.	AUG	2015	23	8					1282	1284		10.1038/mt.2015.118		3	Biotechnology & Applied Microbiology; Genetics & Heredity; Medicine, Research & Experimental	Biotechnology & Applied Microbiology; Genetics & Heredity; Research & Experimental Medicine	CO0LV	WOS:000358843900002		
J	Yuki, K; Ikeda, M; Yoshida, S; Ohno, O; Suenaga, K; Yamada, K; Uemura, D; Miyamoto, K				Yuki, Keiji; Ikeda, Mariko; Yoshida, Shosuke; Ohno, Osamu; Suenaga, Kiyotake; Yamada, Kaoru; Uemura, Daisuke; Miyamoto, Kenji			Isolation of Monovalerianester A, an Inhibitor of Fat Accumulation, from Valeriana fauriei	NATURAL PRODUCT COMMUNICATIONS			English	Article						Valeriana fauriei; Monovalerianester A; 3T3-L1 murine adipocytes; Inhibitor; Fat accumulation	ADIPOSE CONVERSION; 3T3-L1 CELLS; (-)-TERNATIN; ACID	The rhizomes and roots of Valeriana fauriei were extracted with 80% aqueous ethanol. This extract was found to exhibit potent inhibitory effects on fat accumulation in 3T3-L1 murine adipocytes. After several steps of chromatographic purification, we succeeded in identifying monovalerianester A as an inhibitor of fat accumulation. Thus, monovalerianester A and the crude extract of the rhizomes and roots of V. fauriei may have therapeutic potential for the treatment of obesity.	[Yuki, Keiji; Ikeda, Mariko; Yoshida, Shosuke; Miyamoto, Kenji] Keio Univ, Dept Biosci & Informat, Yokohama, Kanagawa 2238522, Japan; [Ohno, Osamu; Suenaga, Kiyotake] Keio Univ, Dept Chem, Yokohama, Kanagawa 2238522, Japan; [Yamada, Kaoru; Uemura, Daisuke] Kanagawa Univ, Dept Chem, Hiratsuka, Kanagawa 2561293, Japan	Miyamoto, K (reprint author), Keio Univ, Dept Biosci & Informat, 3-14-1 Hiyoshi, Yokohama, Kanagawa 2238522, Japan.	kmiyamoto@bio.keio.ac.jp	Suenaga, Kiyotake/F-7632-2014				GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Ito M, 2009, PEPTIDES, V30, P1074, DOI 10.1016/j.peptides.2009.02.008; ENDO T, 1977, CHEM PHARM BULL, V25, P2140; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; RUBIN CS, 1978, J BIOL CHEM, V253, P7570; Guo YQ, 2006, CHEM PHARM BULL, V54, P123, DOI 10.1248/cpb.54.123; Konoshima M, 1978, SYOUYAKUGAKU, P234; Mann CC, 2005, SCIENCE, V307, P1716, DOI 10.1126/science.307.5716.1716; Russell T R, 1981, Methods Enzymol, V72, P720; Sashida Y, 1997, SYOUYAKUGAKU, P258; Sekiya K., 1987, PHYTOTHER RES, V1, P58, DOI 10.1002/ptr.2650010203; Shimokawa K, 2006, TETRAHEDRON LETT, V47, P4445, DOI 10.1016/j.tetlet.2006.04.073; Shimokawa K, 2008, J MED CHEM, V51, P5912, DOI 10.1021/jm800741n; Shimokawa K, 2007, BIOORG MED CHEM LETT, V17, P4447, DOI 10.1016/j.bmcl.2007.06.015; Yuki K, 2012, BIOSCI BIOTECH BIOCH, V76, P1233, DOI 10.1271/bbb.110994; Zhou Ying, 2009, Chinese Journal of Natural Medicines, V7, P270, DOI 10.3724/SP.J.1009.2009.00270	16	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	AUG	2015	10	8					1333	1334				2	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CO3XY	WOS:000359095800001		
J	Nakane, R; Iwashina, T				Nakane, Risa; Iwashina, Tsukasa			Flavonol Glycosides from the Leaves of Allium macrostemon	NATURAL PRODUCT COMMUNICATIONS			English	Article						Allium macrostemon; Flavonoids; Flavonols; Kaempferol glycosides; Quercetin glycosides	QUERCETIN; GLUCOSIDES; SAPONINS; ONIONS; BUNGE; CEPA	Twelve flavonoids were isolated from Allium macrostemon leaves. Five compounds were identified as kaempferol 3,7-di-O-glucoside (1), kaempferol 3,4'-di-O-glucoside (2), quercetin 3-O-glucoside (3), kaempferol 3-O-glucoside (4) and isorhamnetin 3-O-glucoside (5) by UV spectra, LC-MS, acid hydrolysis and HPLC comparisons with authentic standards. Other flavonoids were characterized as kaempferol glycosides (6-8, 10 and 11) and quercetin glycosides (9 and 12). Other compounds, such as steroidal saponins, have been already found from the bulbs of A. macrostemon. However, flavonoids were reported for the first time from the leaves.	[Nakane, Risa; Iwashina, Tsukasa] Ibaraki Univ, Grad Sch Agr, Ami, Ibaraki 3000393, Japan; [Iwashina, Tsukasa] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki 3050005, Japan	Nakane, R (reprint author), Ibaraki Univ, Grad Sch Agr, Ami, Ibaraki 3000393, Japan.	nakaners@kahaku.go.jp					Lee S, 2010, J ETHNOPHARMACOL, V131, P386, DOI 10.1016/j.jep.2010.07.015; BILYK A, 1984, J AGR FOOD CHEM, V32, P274, DOI 10.1021/jf00122a024; Terao J, 2008, ASIA PAC J CLIN NUTR, V17, P291; Li F, 2014, J PHARMACEUT BIOMED, V88, P225, DOI 10.1016/j.jpba.2013.09.002; Chen HF, 2009, MOLECULES, V14, P2246, DOI 10.3390/molecules14062246; Cao J, 2010, FOOD SCI TECHNOL RES, V16, P395, DOI 10.3136/fstr.16.395; Xie WD, 2008, EUR J PHARMACOL, V599, P159, DOI 10.1016/j.ejphar.2008.09.042; Wu H, 2009, FOOD CHEM, V115, P592, DOI 10.1016/j.foodchem.2008.12.058; Carotenuto A, 1997, PHYTOCHEMISTRY, V44, P949, DOI 10.1016/S0031-9422(96)00663-2; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Rhodes MJC, 1996, FOOD CHEM, V57, P113, DOI 10.1016/0308-8146(96)00147-1; YOSHIDA T, 1987, CHEM PHARM BULL, V35, P97; Mullen W, 2006, BRIT J NUTR, V96, P107, DOI 10.1079/BJN20061809; Fattorusso E, 2001, PHYTOCHEMISTRY, V57, P565, DOI 10.1016/S0031-9422(01)00039-5; Bonaccorsi P, 2008, FOOD CHEM, V107, P1668, DOI 10.1016/j.foodchem.2007.09.053; BRANDWEI.BJ, 1965, J FOOD SCI, V30, P680, DOI 10.1111/j.1365-2621.1965.tb01824.x; Carotenuto A, 1996, PHYTOCHEMISTRY, V41, P531, DOI 10.1016/0031-9422(95)00574-9; Cheng H, 2008, PHARMAZIE, V62, P544; Iwashina T, 2006, BIOCHEM SYST ECOL, V34, P14, DOI 10.1016/j.bse.2005.05.002; Lachman J, 2003, HORTIC SCI, V30, P142; Mabry T. J., 1970, SYSTEMATIC IDENTIFIC; PENG JP, 1994, CHEM PHARM BULL, V42, P2180; WILLIAMS CA, 1988, PHYTOCHEMISTRY, V27, P2609, DOI 10.1016/0031-9422(88)87033-X; Williamson G., 2000, J NUTR, V130, P2073	24	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	AUG	2015	10	8					1381	1382				2	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CO3XY	WOS:000359095800017		
J	Kasuya, H; Iida, S; Ono, K; Satou, T; Koike, K				Kasuya, Hikaru; Iida, Sayuka; Ono, Kurumi; Satou, Tadaaki; Koike, Kazuo			Intracerebral Distribution of alpha-Pinene and the Anxiolytic-like Effect in Mice Following Inhaled Administration of Essential Oil from Chamaecyparis obtusa	NATURAL PRODUCT COMMUNICATIONS			English	Article						Volatile compound; Inhalation; Nasal cavity; Aromatherapy; Phytotherapy	ORGAN ACCUMULATION; INHALATION; BEHAVIOR	The amdolytic-like and stress reduction effects following inhaled administration of essential oil from Chamaecyparis obtusa (EOCO) have been reported. Volatile components are thought to produce these effects of EOCO by neurological transfer and pharmacological transfer. The regions of the brain in which inhaled compounds are found due to pharmacological transfer of EOCO are not known. This research was undertaken to clarify the relationship between the intracerebral distribution of a-pinene, which is the main component of EOCO, and emotional behavior. a-Pinene was detected as the main component of volatile EOCO. The amount of a-pinene in each region of the brain was measured following inhaled administration of EOCO. The amount of a-pinene was different in each region of the brain. With inhaled administration of 32 mu L/L air EOCO, a high concentration of a-pinene was observed. However, no significant differences in the concentration of a-pinene among brain regions were found. A therapeutic concentration of a-pinene (8 mu L/L air EOCO) in each region of the brain may induce an anxiolytic-like effect, and a high concentration of a-pinene (32 mu L/L air EOCO) in each region of the brain may induce an excitatory-like effect. The increases in the concentration of a-pinene from 8 to 32 mu L/L air EOCO in the striatum and the hippocampus were significantly lower compared with the increases in other brain regions. These results indicate that regions besides the striatum and the hippocampus participated in the increase in locomotor activity due to the high concentration of a-pinene in the brain.	[Kasuya, Hikaru; Iida, Sayuka; Ono, Kurumi; Satou, Tadaaki; Koike, Kazuo] Toho Univ, Fac Pharmaceut Sci, Funabashi, Chiba 2748510, Japan	Satou, T (reprint author), Toho Univ, Fac Pharmaceut Sci, 2-2-1 Miyama, Funabashi, Chiba 2748510, Japan.	satou@phar.toho-u.ac.jp			JSPS KAKENHI [26350873]	We are grateful to Mr Masaki Yoshikawa of Hinoki Seikou and Mr Shinichiro Hayashi of Green Flask Laboratory for providing the EOCO. We are grateful to Dr Takehito Sagawa of S&B Foods Inc. for help with the GC-MS analysis. This work was supported by JSPS KAKENHI Grant Number 26350873.	Adams RP, 2009, IDENTIFICATION ESSEN; Kasuya H, 2013, NAT PROD COMMUN, V8, P515; Satou T, 2011, FLAVOUR FRAG J, V26, P180, DOI 10.1002/ffj.2047; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BRM.41.4.1149; Hensler JG, 2006, NEUROSCI BIOBEHAV R, V30, P203, DOI 10.1016/j.neubiorev.2005.06.007; Shimizu T, 2010, EUR J PHARMACOL, V635, P117, DOI 10.1016/j.ejphar.2010.02.053; Satou T, 2011, FLAVOUR FRAG J, V26, P416, DOI 10.1002/ffj.2075; LISTER RG, 1987, PSYCHOPHARMACOLOGY, V92, P180; Satou T, 2014, PHYTOTHER RES, V28, P1284, DOI 10.1002/ptr.5105; Hsieh YJ, 2008, INT J PHARM, V350, P265, DOI 10.1016/j.ijpharm.2007.09.002; Kasuya H, 2015, PHYTOTHER RES, V29, P43, DOI 10.1002/ptr.5224; Satou T, 2013, PHYTOTHER RES, V27, P306, DOI 10.1002/ptr.4723; Takahara E, 1992, DRUG METABOLISM PHAR, V7, P273	13	0	0	NATURAL PRODUCTS INC	WESTERVILLE	7963 ANDERSON PARK LN, WESTERVILLE, OH 43081 USA	1934-578X	1555-9475		NAT PROD COMMUN	Nat. Prod. Commun.	AUG	2015	10	8					1479	1482				4	Chemistry, Medicinal; Food Science & Technology	Pharmacology & Pharmacy; Food Science & Technology	CO3XY	WOS:000359095800041		
J	Wroblewska, L; Kitada, T; Endo, K; Siciliano, V; Stillo, B; Saito, H; Weiss, R				Wroblewska, Liliana; Kitada, Tasuku; Endo, Kei; Siciliano, Velia; Stillo, Breanna; Saito, Hirohide; Weiss, Ron			Mammalian synthetic circuits with RNA binding proteins for RNA-only delivery	NATURE BIOTECHNOLOGY			English	Article							NONCYTOPATHIC REPLICATION; GENE-EXPRESSION; CELLS; REPLICONS; BIOLOGY; DESIGN; SWITCH; VIRUS	Synthetic regulatory circuits encoded in RNA rather than DNA could provide a means to control cell behavior while avoiding potentially harmful genomic integration in therapeutic applications. We create post-transcriptional circuits using RNA-binding proteins, which can be wired in a plug-and-play fashion to create networks of higher complexity. We show that the circuits function in mammalian cells when encoded in modified mRNA or self-replicating RNA.	[Wroblewska, Liliana; Kitada, Tasuku; Siciliano, Velia; Stillo, Breanna; Weiss, Ron] MIT, Synthet Biol Ctr, Dept Biol Engn, Cambridge, MA 02139 USA; [Endo, Kei; Saito, Hirohide] Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Life Sci Frontiers, Kyoto, Japan; [Saito, Hirohide] Kyoto Univ, Hakubi Ctr Adv Res, Kyoto, Japan	Saito, H (reprint author), Kyoto Univ, Ctr iPS Cell Res & Applicat, Dept Life Sci Frontiers, Kyoto, Japan.	hirohide.saito@cira.kyoto-u.ac.jp; rweiss@mit.edu	Endo, Kei/C-7325-2015; Kitada, Tasuku/B-8121-2009	Endo, Kei/0000-0003-1020-7884; Kitada, Tasuku/0000-0003-2265-3363	Defense Advanced Research Projects Agency [DARPA-BAA-11-23]; US National Institutes of Health [P50-GM098792, 5-R01-CA155320-03]; National Science Foundation GRFP [1122374]; JSPS KAKENHI [23681042, 24104002]; Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency	We thank K. Hayashi and N. Nishimura (Kyoto University) for supporting modified mRNA experiments. We also thank A.C. Goldstrohm and C. Weidmann (University of Michigan Medical School) for sharing Drosophila constructs containing MS2-fused repressors and the corresponding reporter, X. Zhang (MIT) and O. Andries (Ghent University) for assisting in VEE replicon construction, T.E. Wagner, D. Densmore (Boston University) and S. Payne (MIT) for communicating results before publication, W.M. Gelbart, C.M. Knobler, A. Berk, O. Azizgolshani and J.M. Parker (University of California, Los Angeles) for sharing replicon constructs and expertise, as well as A. Graziano (MIT) for supporting pDNA experiments and H. Chung (Harvard University) for designing the intronic mKate construct. This work was supported by Defense Advanced Research Projects Agency DARPA-BAA-11-23, US National Institutes of Health grants no. P50-GM098792, 5-R01-CA155320-03, National Science Foundation GRFP grant no. 1122374 (R.W.) and JSPS KAKENHI grant numbers 23681042, 24104002, and Research Center Network for Realization of Regenerative Medicine from the Japan Science and Technology Agency (H. S.).	Saito H, 2010, NAT CHEM BIOL, V6, P71, DOI [10.1038/nchembio.273, 10.1038/NCHEMBIO.273]; Mortimer I, 1999, GENE THER, V6, P403, DOI 10.1038/sj.gt.3300837; An CI, 2006, RNA, V12, P710, DOI 10.1261/rna.2299306; Azizgolshani O, 2013, VIROLOGY, V441, P12, DOI [10.1016/j.virol.2013.03.001, 10.1016/j.viro1.2013.03.001]; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Frolov I, 1999, J VIROL, V73, P3854; STRAUSS JH, 1994, MICROBIOL REV, V58, P491; Rodrigo G, 2012, P NATL ACAD SCI USA, V109, P15271, DOI 10.1073/pnas.1203831109; Qian L, 2011, SCIENCE, V332, P1196, DOI 10.1126/science.1200520; Tavernier G, 2011, J CONTROL RELEASE, V150, P238, DOI 10.1016/j.jconrel.2010.10.020; Xie Z, 2011, SCIENCE, V333, P1307, DOI 10.1126/science.1205527; Van Etten J, 2012, J BIOL CHEM, V287, P36370, DOI 10.1074/jbc.M112.373522; Khalil AS, 2010, NAT REV GENET, V11, P367, DOI 10.1038/nrg2775; [Anonymous], 2013, MATLAB STAT TOOLB RE; Szymczak AL, 2004, NAT BIOTECHNOL, V22, P589, DOI 10.1038/nbt957; Culler SJ, 2010, SCIENCE, V330, P1251, DOI 10.1126/science.1192128; Gardner TS, 2000, NATURE, V403, P339; Auslander S, 2012, NATURE, V487, P123, DOI 10.1038/nature11149; Aubel D, 2010, BIOESSAYS, V32, P332, DOI 10.1002/bies.200900149; Auslander S, 2014, NAT METHODS, V11, P1154, DOI [10.1038/nmeth.3136, 10.1038/NMETH.3136]; Beal J, 2015, ACS SYNTH BIOL, V4, P48, DOI 10.1021/sb500173f; Green A. A., 2014, NAT BIOTECHNOL, V159, P925; LUSTIG S, 1988, J VIROL, V62, P2329; Petrakova O, 2005, J VIROL, V79, P7597, DOI 10.1128/JVI.79.12.7597-7608.2005; Sahin U, 2014, NAT REV DRUG DISCOV, V13, P759, DOI 10.1038/nrd4278	26	1	1	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1087-0156	1546-1696		NAT BIOTECHNOL	Nat. Biotechnol.	AUG	2015	33	8					839	+		10.1038/nbt.3301		5	Biotechnology & Applied Microbiology	Biotechnology & Applied Microbiology	CO6OB	WOS:000359274900022		
J	Hong, SY; Moreno-Navarrete, JM; Wei, XJ; Kikukawa, Y; Tzameli, I; Prasad, D; Lee, Y; Asara, JM; Fernandez-Real, JM; Maratos-Flier, E; Pissios, P				Hong, Shangyu; Moreno-Navarrete, Jose M.; Wei, Xiaojing; Kikukawa, Yusuke; Tzameli, Iphigenia; Prasad, Deepthi; Lee, Yoonjin; Asara, John M.; Fernandez-Real, Jose Manuel; Maratos-Flier, Eleftheria; Pissios, Pavlos			Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization	NATURE MEDICINE			English	Article							DIET-INDUCED OBESITY; LIPID-METABOLISM; HIGH-FAT; 1-METHYLNICOTINAMIDE MNA; CALORIE RESTRICTION; GENE-EXPRESSION; TRANSGENIC MICE; ADIPOSE-TISSUE; DIABETIC-RATS; NAD(+)	Nicotinamide N-methyltransferase (Nnmt) methylates nicotinamide, a form of vitamin 83, to produce N-1-methylnicotinamide (MNAM). Nnmt has emerged as a metabolic regulator in adipocytes, but its role in the liver, the tissue with the strongest Nnmt expression, is not known. In spite of its overall high expression, here we find that hepatic expression of Nnmt is highly variable and correlates with multiple metabolic parameters in mice and humans. Further, we find that suppression of hepatic Nnmt expression in vivo alters glucose and cholesterol metabolism and that the metabolic effects of Nnmt in the liver are mediated by its product MNAM. Supplementation of high-fat diet with MNAM decreases serum and liver cholesterol and liver triglycerides levels in mice. Mechanistically, increasing Nnmt expression or MNAM levels stabilizes sirtuin 1 protein, an effect that is required for their metabolic benefits. In summary, we describe here a novel regulatory pathway for vitamin B3 that could provide a new opportunity for metabolic disease therapy.	[Hong, Shangyu; Wei, Xiaojing; Tzameli, Iphigenia; Prasad, Deepthi; Maratos-Flier, Eleftheria; Pissios, Pavlos] Beth Israel Deaconess Med Ctr, Div Diabet Endocrinol & Metab, Boston, MA 02215 USA; [Moreno-Navarrete, Jose M.; Fernandez-Real, Jose Manuel] Inst Invest Biomed Girona, Dept Diabet Endocrinol & Nutr, Girona, Spain; [Moreno-Navarrete, Jose M.; Fernandez-Real, Jose Manuel] CIBERobn, Madrid, Spain; [Kikukawa, Yusuke] Takeda Pharmaceut Ltd, Osaka, Japan; [Lee, Yoonjin] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Asara, John M.] Beth Israel Deaconess Med Ctr, Div Signal Transduct, Boston, MA 02215 USA	Pissios, P (reprint author), Beth Israel Deaconess Med Ctr, Div Diabet Endocrinol & Metab, Boston, MA 02215 USA.	ppissios@bidmc.harvard.edu	Moreno-Navarrete, Jose Maria/H-9772-2015		Takeda; US National Institute of Health [DK028082, DK083694]; Boston Area Diabetes Endocrinology Research Center (BADERC) [DK057521]; Instituto de Salud Carlos III [FIS-PI11/00214, FIS-PI12/02631]; Fondo Europeo de Desarrollo Regional (FEDER), Spain	We would like to thank F.F. Liu, D. Adams, A.M. Real and M.J. Lee for technical assistance and J.S. Flier for advice. We thank S.M. Spiegelman and P. Puigserver (Dana-Farber Cancer Center, Boston, MA) for the donation of the Sirt1 and FoxO1 adenoviruses, D.E. Cohen (Brigham and Women's Hospital, Boston, MA) for lipoprotein analysis and R. Ortiz (University Hospital of Girona, Spain) for the pathology evaluation of the human liver biopsies. This work was supported by grants from Takeda, the US National Institute of Health DK028082 (E.M.F.), DK083694 (P.P.), Boston Area Diabetes Endocrinology Research Center (BADERC) grant DK057521 (P.P.), and by grants FIS-PI11/00214 and FIS-PI12/02631 to J.M.F.R. from the Instituto de Salud Carlos III and Fondo Europeo de Desarrollo Regional (FEDER), Spain.	Schmeisser K, 2013, NAT CHEM BIOL, V9, P693, DOI [10.1038/nchembio.1352, 10.1038/NCHEMBIO.1352]; Nemoto S, 2005, J BIOL CHEM, V280, P16456, DOI 10.1074/jbc.M501485200; Chlopicki S, 2007, BRIT J PHARMACOL, V152, P230, DOI 10.1038/sj.bjp.0707383; Bryniarski K, 2008, EUR J PHARMACOL, V578, P332, DOI 10.1016/j.ejphar.2007.09.011; Mato JM, 2008, ANNU REV NUTR, V28, P273, DOI 10.1146/annurev.nutr.28.061807.155438; Kennedy AR, 2007, AM J PHYSIOL-ENDOC M, V292, pE1724, DOI 10.1152/ajpendo.00717.2006; Kraus D, 2014, NATURE, V508, P258, DOI 10.1038/nature13198; KANGLEE YA, 1983, J NUTR, V113, P215; Bordone L, 2007, AGING CELL, V6, P759, DOI 10.1111/j.1474-9726.2007.00335.x; Xu F, 2010, ENDOCRINOLOGY, V151, P2504, DOI 10.1210/en.2009-1013; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; Yoshino J, 2011, CELL METAB, V14, P528, DOI 10.1016/j.cmet.2011.08.014; Rodgers JT, 2007, P NATL ACAD SCI USA, V104, P12861, DOI 10.1073/pnas.0702509104; Bartus M, 2008, PHARMACOL REP, V60, P127; Liu Y, 2008, NATURE, V456, P269, DOI 10.1038/nature07349; Bogan KL, 2008, ANNU REV NUTR, V28, P115, DOI 10.1146/annurev.nutr.28.061807.155443; Kim JE, 2008, NATURE, V451, P583, DOI 10.1038/nature06500; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Banks AS, 2008, CELL METAB, V8, P333, DOI 10.1016/j.cmet.2008.08.014; Canto C, 2012, CELL METAB, V15, P838, DOI 10.1016/j.cmet.2012.04.022; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Ghazalpour A, 2012, MAMM GENOME, V23, P680, DOI 10.1007/s00335-012-9411-5; Schadt EE, 2003, NATURE, V422, P297, DOI 10.1038/nature01482; Purushotham A, 2009, CELL METAB, V9, P327, DOI 10.1016/j.cmet.2009.02.006; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Zhao WH, 2008, NATURE, V451, P587, DOI 10.1038/nature06515; Chalkiadaki A, 2012, NAT REV ENDOCRINOL, V8, P287, DOI 10.1038/nrendo.2011.225; Kemper JK, 2009, CELL METAB, V10, P392, DOI 10.1016/j.cmet.2009.09.009; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Walker AK, 2010, GENE DEV, V24, P1403, DOI 10.1101/gad.1901210; Gao ZG, 2011, J BIOL CHEM, V286, P22227, DOI 10.1074/jbc.M111.228874; Dong SX, 2013, CELL METAB, V18, P380, DOI 10.1016/j.cmet.2013.08.012; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Revollo JR, 2004, J BIOL CHEM, V279, P50754, DOI 10.1074/jbc.M408388200; Li Y, 2011, FASEB J, V25, P1664, DOI 10.1096/fj.10-173492; Ponugoti B, 2010, J BIOL CHEM, V285, P33959, DOI 10.1074/jbc.M110.122978; Qiang L, 2011, CELL METAB, V14, P758, DOI 10.1016/j.cmet.2011.10.007; Ulanovskaya OA, 2013, NAT CHEM BIOL, V9, P300, DOI [10.1038/nchembio.1204, 10.1038/NCHEMBIO.1204]; Li Y, 2011, CELL METAB, V13, P376, DOI 10.1016/j.cmet.2011.03.009; Estep PW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005242; FELSTED RL, 1967, J BIOL CHEM, V242, P1274; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Kannt A, 2015, DIABETOLOGIA, V58, P799, DOI 10.1007/s00125-014-3490-7; Peng LR, 2015, J BIOL CHEM, V290, P8904, DOI 10.1074/jbc.M114.612796; Pfluger R. T., 2008, P NATL ACAD SCI USA, V105, P9793; Sanner M. F., 1999, J MOL GRAPH MODEL, V17, P55; Scheller T, 1996, PHARMACOGENETICS, V6, P43, DOI 10.1097/00008571-199602000-00003; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Wang R.-H., 2011, J CLIN INVEST; Yan L, 1997, BIOCHEM PHARMACOL, V54, P1139	53	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					887	894		10.1038/nm.3882		8	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	WOS:000359181000015		
J	Shiratori-Hayashi, M; Koga, K; Tozaki-Saitoh, H; Kohro, Y; Toyonaga, H; Yamaguchi, C; Hasegawa, A; Nakahara, T; Hachisuka, J; Akira, S; Okano, H; Furue, M; Inoue, K; Tsuda, M				Shiratori-Hayashi, Miho; Koga, Keisuke; Tozaki-Saitoh, Hidetoshi; Kohro, Yuta; Toyonaga, Honami; Yamaguchi, Chiharu; Hasegawa, Ayumi; Nakahara, Takeshi; Hachisuka, Junichi; Akira, Shizuo; Okano, Hideyuki; Furue, Masutaka; Inoue, Kazuhide; Tsuda, Makoto			STAT3-dependent reactive astrogliosis in the spinal dorsal horn underlies chronic itch	NATURE MEDICINE			English	Article							ATOPIC-DERMATITIS; BEHAVIOR; MOUSE; CELLS; MICE; CORD; SENSATION; RESPONSES; CIRCUITS; RECEPTOR	Chronic itch is an intractable symptom of inflammatory skin diseases, such as atopic and contact dermatitis(1-3). Recent studies have revealed neuronal pathways selective for itch(4-8), but the mechanisms by which itch turns into a pathological chronic state are poorly understood. Using mouse models of atopic and contact dermatitis, we demonstrate a long-term reactive state of astrocytes in the dorsal horn of the spinal segments that corresponds to lesioned, itchy skin. We found that reactive astrogliosis depended on the activation of signal transducer and activator of transcription 3 (STAT3). Conditional disruption of astrocytic STAT3 suppressed chronic itch, and pharmacological inhibition of spinal STAT3 ameliorated the fully developed chronic itch. Mice with atopic dermatitis exhibited an increase in scratching elicited by intrathecal administration of the itch-inducer gastrin-releasing peptide (GRP)(4), and this enhancement was normalized by suppressing STAT3-mediated reactive astrogliosis. Moreover, we identified lipocalin-2 (LCN2) as an astrocytic STAT3-dependent upregulated factor that was crucial for chronic itch, and we demonstrated that intrathecal administration of LCN2 to normal mice increased spinal GRP-evoked scratching. Our findings indicate that STAT3-dependent reactive astrocytes act as critical amplifiers of itching through a mechanism involving the enhancement of spinal itch signals by LCN2, thereby providing a previously unrecognized target for treating chronic itch.	[Shiratori-Hayashi, Miho; Koga, Keisuke; Tozaki-Saitoh, Hidetoshi; Toyonaga, Honami; Yamaguchi, Chiharu; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka 812, Japan; [Shiratori-Hayashi, Miho; Koga, Keisuke; Tozaki-Saitoh, Hidetoshi; Kohro, Yuta; Toyonaga, Honami; Yamaguchi, Chiharu; Hasegawa, Ayumi; Inoue, Kazuhide; Tsuda, Makoto] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Mol & Syst Pharmacol, Fukuoka 812, Japan; [Nakahara, Takeshi; Hachisuka, Junichi; Furue, Masutaka] Kyushu Univ, Grad Sch Med, Dept Dermatol, Fukuoka 812, Japan; [Akira, Shizuo] Osaka Univ, WPI Immunol Frontier Res Ctr IFReC, Lab Host Def, Osaka, Japan; [Akira, Shizuo] Osaka Univ, Res Inst Microbial Dis, Osaka, Japan; [Okano, Hideyuki] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan	Tsuda, M (reprint author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Life Innovat, Fukuoka 812, Japan.	tsuda@phar.kyushu-u.ac.jp	Okano, Hideyuki/J-5973-2013; Akira, Shizuo/C-3134-2009		Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program)'; Council for Science and Technology Policy (CSTP); Ministry of Education, Culture, Sports, Science and Technology of Japan; Kyushu University; Japan Science and Technology Agency (JST) through the Core Research for Evolutional Science and Technology (CREST) program	This work was supported by grants from the Japan Society for the Promotion of Science (JSPS) through the 'Funding Program for Next Generation World-Leading Researchers (NEXT Program)' initiated by the Council for Science and Technology Policy (CSTP) (M.T.), from the Ministry of Education, Culture, Sports, Science and Technology of Japan (M.T. and K.I.), from Kyushu University (Progress 100) (M.T.), and from the Japan Science and Technology Agency (JST) through the Core Research for Evolutional Science and Technology (CREST) program (K.I.). We appreciate the technical support from the Research Support Center, Graduate School of Medical Sciences, Kyushu University. We thank S. Akira (Osaka University) and H. Okano (Keio University) air providing critical materials (Lcn2<SUP>-/-</SUP> and Stat3<SUP>flox/flox</SUP> mice). We thank S. Takeuchi, H. Esalci and Y. Eguchi for providing critical advice on behavioral measurements and performing histological experiments. MS-H. is a research fellow of the JSPS.	Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Miller G, 2007, SCIENCE, V318, P188, DOI 10.1126/science.318.5848.188; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Mucha M, 2011, P NATL ACAD SCI USA, V108, P18436, DOI 10.1073/pnas.1107936108; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Bautista DM, 2014, NAT NEUROSCI, V17, P175, DOI 10.1038/nn.3619; Halassa MM, 2010, ANNU REV PHYSIOL, V72, P335, DOI 10.1146/annurev-physiol-021909-135843; Shibata T, 1997, J NEUROSCI, V17, P9212; Yosipovitch G, 2013, NEW ENGL J MED, V368, P1625, DOI 10.1056/NEJMcp1208814; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Lee H, 2005, PFLUG ARCH EUR J PHY, V451, P160, DOI 10.1007/s00424-005-1438-y; Eroglu C, 2010, NATURE, V468, P223, DOI 10.1038/nature09612; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Ikoma A, 2003, ARCH DERMATOL, V139, P1455, DOI 10.1001/archderm.139.11.1455; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Bi FF, 2013, P NATL ACAD SCI USA, V110, P4069, DOI 10.1073/pnas.1218497110; VANDERSTEEN PHM, 1991, J AM ACAD DERMATOL, V24, P253, DOI 10.1016/0190-9622(91)70037-3; Dhand A, 2014, BRAIN, V137, P313, DOI 10.1093/brain/awt158; Berard JL, 2012, GLIA, V60, P1145, DOI 10.1002/glia.22342; Ikoma A, 2013, BIOL PHARM BULL, V36, P1235; Matsuda H, 1997, INT IMMUNOL, V9, P461, DOI 10.1093/intimm/9.3.461; Sandor K, 2009, NEUROSCI LETT, V451, P204, DOI 10.1016/j.neulet.2009.01.016; Seike M, 2005, EXP DERMATOL, V14, P169, DOI 10.1111/j.0906-6705.2005.00247.x; Takano N, 2005, J PHARMACOL SCI, V99, P277, DOI 10.1254/jphs.FP0050564	27	0	0	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	1078-8956	1546-170X		NAT MED	Nat. Med.	AUG	2015	21	8					927	931		10.1038/nm.3912		5	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	CO5DY	WOS:000359181000020		
J	Bongs, K; Holynski, M; Singh, Y				Bongs, Kai; Holynski, Michael; Singh, Yeshpal			Psi in the sky	NATURE PHYSICS			English	Editorial Material							SATELLITE; MISSION; CLOCK		[Bongs, Kai; Holynski, Michael; Singh, Yeshpal] Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England; [Bongs, Kai] Quantum Matter Grp, Tokyo, Japan; [Bongs, Kai] UK Natl Quantum Technol Hub Sensors & Metrol, Stockton On Tees, England	Bongs, K (reprint author), Univ Birmingham, Sch Phys & Astron, Birmingham B15 2TT, W Midlands, England.	k.bongs@bham.ac.uk			EPSRC [EP/M013294/1]; Dstl	K.B., M.H. and Y.S. are members of the UK NQT Hub in Sensors and Metrology and acknowledge funding from EPSRC (within grant EP/M013294/1) and Dstl.	Aguilera DN, 2014, CLASSICAL QUANT GRAV, V31, DOI 10.1088/0264-9381/31/11/115010; Nicholson TL, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7896; Ma XS, 2012, NATURE, V489, P269, DOI 10.1038/nature11472; Rodell M, 2009, NATURE, V460, P999, DOI 10.1038/nature08238; Bongs K, 2015, CR PHYS, V16, P553, DOI 10.1016/j.crhy.2015.03.009; Laurent P, 2015, CR PHYS, V16, P540, DOI 10.1016/j.crhy.2015.05.002; Yin J, 2013, OPT EXPRESS, V21, P20032, DOI 10.1364/OE.21.020032	7	1	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	AUG	2015	11	8					615	617				4	Physics, Multidisciplinary	Physics	CO0OQ	WOS:000358851900006		
J	Martinez-Blanco, J; Nacci, C; Erwin, SC; Kanisawa, K; Locane, E; Thomas, M; von Oppen, F; Brouwer, PW; Folsch, S				Martinez-Blanco, Jesus; Nacci, Christophe; Erwin, Steven C.; Kanisawa, Kiyoshi; Locane, Elina; Thomas, Mark; von Oppen, Felix; Brouwer, Piet W.; Foelsch, Stefan			Gating a single-molecule transistor with individual atoms	NATURE PHYSICS			English	Article							SCANNING TUNNELING MICROSCOPE; FRANCK-CONDON BLOCKADE; QUANTUM DOTS; SEMICONDUCTOR SURFACE; ORGANIC-MOLECULE; JUNCTIONS; BARRIER	Transistors, regardless of their size, rely on electrical gates to control the conductance between source and drain contacts. In atomic-scale transistors, this conductance is sensitive to single electrons hopping via individual orbitals(1,2). Single-electron transport in molecular transistors has been previously studied using top-down approaches to gating, such as lithography and break junctions(1,3-11). But atomically precise control of the gate-which is crucial to transistor action at the smallest size scales-is not possible with these approaches. Here, we used individual charged atoms, manipulated by a scanning tunnelling microscope(12), to create the electrical gates for a single-molecule transistor. This degree of control allowed us to tune the molecule into the regime of sequential single-electron tunnelling, albeit with a conductance gap more than one order of magnitude larger than observed previously(8,11,13,14). This unexpected behaviour arises from the existence of two different orientational conformations of the molecule, depending on its charge state. Our results show that strong coupling between these charge and conformational degrees of freedom leads to new behaviour beyond the established picture of single-electron transport in atomic-scale transistors.	[Martinez-Blanco, Jesus; Nacci, Christophe; Foelsch, Stefan] Paul Drude Inst Festkorperelekt, D-10117 Berlin, Germany; [Erwin, Steven C.] US Navy, Res Lab, Ctr Computat Mat Sci, Washington, DC 20375 USA; [Kanisawa, Kiyoshi] NTT Corp, NTT Basic Res Labs, Atsugi, Kanagawa 2430198, Japan; [Locane, Elina; Thomas, Mark; von Oppen, Felix; Brouwer, Piet W.] Free Univ Berlin, Dahlem Ctr Complex Quantum Syst, D-14195 Berlin, Germany; [Locane, Elina; Thomas, Mark; von Oppen, Felix; Brouwer, Piet W.] Free Univ Berlin, Fachbereich Phys, D-14195 Berlin, Germany	Folsch, S (reprint author), Paul Drude Inst Festkorperelekt, Hausvogteipl 5-7, D-10117 Berlin, Germany.	foelsch@pdi-berlin.de			German Research Foundation [SFB 658]; Office of Naval Research through the Naval Research Laboratory's Basic Research Program	This work was supported by the German Research Foundation (Collaborative Research Network SFB 658) and the Office of Naval Research through the Naval Research Laboratory's Basic Research Program. Some computations were performed at the DoD Major Shared Resource Center at AFRL.	Piva PG, 2005, NATURE, V435, P658, DOI 10.1038/nature03563; Teichmann K, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076103; Nacci C, 2012, ACS NANO, V6, P4190, DOI 10.1021/nn300690n; Schuler B, 2013, PHYS REV LETT, V111, DOI 10.1103/PhysRevLett.111.106103; Nazin GV, 2005, P NATL ACAD SCI USA, V102, P8832, DOI 10.1073/pnas.0501171102; Yang JS, 2011, NANO LETT, V11, P2486, DOI 10.1021/nl2009444; Champagne AR, 2005, NANO LETT, V5, P305, DOI 10.1021/nl0480619; Olsson LO, 1996, PHYS REV LETT, V76, P3626, DOI 10.1103/PhysRevLett.76.3626; Swart I, 2011, NANO LETT, V11, P1580, DOI 10.1021/nl104452x; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Kubatkin S, 2003, NATURE, V425, P698, DOI 10.1038/nature02010; Kouwenhoven LP, 2001, REP PROG PHYS, V64, P701, DOI 10.1088/0034-4885/64/6/201; STROSCIO JA, 1991, SCIENCE, V254, P1319, DOI 10.1126/science.254.5036.1319; Koch J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.206804; STERN F, 1967, PHYS REV, V163, P816, DOI 10.1103/PhysRev.163.816; Park H, 2000, NATURE, V407, P57; Riss A, 2014, ACS NANO, V8, P5395, DOI 10.1021/nn501459v; Folsch S, 2014, NAT NANOTECHNOL, V9, P505, DOI [10.1038/nnano.2014.129, 10.1038/NNANO.2014.129]; Lee DH, 2010, SCIENCE, V330, P1807, DOI 10.1126/science.1197434; Perrin ML, 2013, NAT NANOTECHNOL, V8, P282, DOI [10.1038/nnano.2013.26, 10.1038/NNANO.2013.26]; Leturcq R, 2009, NAT PHYS, V5, P327, DOI 10.1038/NPHYS1234; Liljeroth P, 2007, SCIENCE, V317, P1203, DOI 10.1126/science.1144366; Roch N, 2008, NATURE, V453, P633, DOI 10.1038/nature06930; Song H, 2009, NATURE, V462, P1039, DOI 10.1038/nature08639; Folsch S, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.096104; Burzuri E, 2014, NANO LETT, V14, P3191, DOI 10.1021/nl500524w; Fernandez-Torrente I, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.036801; Paulsson M., 2003, NANOSCIENCE ENG TECH; Ryndyk DA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085409; Yu LH, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.266802	30	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	AUG	2015	11	8					640	+		10.1038/NPHYS3385		6	Physics, Multidisciplinary	Physics	CO0OQ	WOS:000358851900015		
J	Yoshida, Y; Ito, H; Maesato, M; Shimizu, Y; Hayama, H; Hiramatsu, T; Nakamura, Y; Kishida, H; Koretsune, T; Hotta, C; Saito, G				Yoshida, Yukihiro; Ito, Hiroshi; Maesato, Mitsuhiko; Shimizu, Yasuhiro; Hayama, Hiromi; Hiramatsu, Takaaki; Nakamura, Yuto; Kishida, Hideo; Koretsune, Takashi; Hotta, Chisa; Saito, Gunzi			Spin-disordered quantum phases in a quasi-one-dimensional triangular lattice	NATURE PHYSICS			English	Article							PEIERLS TRANSITION; HEISENBERG-ANTIFERROMAGNET; ORGANIC CONDUCTOR; CHAINS; SUPERCONDUCTIVITY; PRESSURE	Large quantum fluctuations drive the spins in solids into magnetically disordered phases that are not simply paramagnetic. This class of system includes the valence bond crystals and quantum spin liquids, in which spin singlets-the basic unit of entangled pairs of spins-form solids and liquids, respectively. In both phases, geometrical frustration is expected to play a role. So far, very few candidate quantum-spin-liquid materials have been found, including an organic Mott insulator, kappa-(ET)(2)Cu-2(CN)(3), which is based on a regular triangular lattice. Here, we report a material, kappa-(ET)(2)B(CN)(4), with different geometry-a highly distorted quasi-one-dimensional triangular lattice. The magnetic susceptibility follows that of the spin-1/2 Heisenberg model on this distorted lattice. The material sustains a magnetically disordered Mott insulating state with enhanced quantum fluctuations over a wide temperature range, and undergoes a transition into a spin-gapped phase at 5 K.	[Yoshida, Yukihiro; Hayama, Hiromi; Hiramatsu, Takaaki; Saito, Gunzi] Meijo Univ, Fac Agr, Tempaku Ku, Nagoya, Aichi 4688502, Japan; [Ito, Hiroshi; Nakamura, Yuto; Kishida, Hideo] Nagoya Univ, Dept Appl Phys, Chikusa Ku, Nagoya, Aichi 4648603, Japan; [Maesato, Mitsuhiko] Kyoto Univ, Grad Sch Sci, Div Chem, Sakyo Ku, Kyoto 6068502, Japan; [Shimizu, Yasuhiro] Nagoya Univ, Grad Sch Sci, Dept Phys, Chikusa Ku, Nagoya, Aichi 4648602, Japan; [Koretsune, Takashi] RIKEN, Ctr Emergent Matter Sci, Wako, Saitama 3510198, Japan; [Hotta, Chisa] Univ Tokyo, Dept Basic Sci, Meguro Ku, Tokyo 1538902, Japan; [Saito, Gunzi] Toyota Phys & Chem Res Inst, Nagakute, Aichi 4801192, Japan	Yoshida, Y (reprint author), Meijo Univ, Fac Agr, Tempaku Ku, Shiogamaguchi 1-501, Nagoya, Aichi 4688502, Japan.	yyoshida@meijo-u.ac.jp			JSPS KAKENHI Grant [23225005, 25800204]	This work was supported by JSPS KAKENHI Grant Number 23225005 and 25800204. We thank H. Kageyama for his comments.	Helton JS, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.107204; CHAKRAVARTY S, 1989, PHYS REV B, V39, P2344, DOI 10.1103/PhysRevB.39.2344; Kohno M, 2007, NAT PHYS, V3, P790, DOI 10.1038/nphys749; Kyung B, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.046402; Coldea R, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137203; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; Okamoto Y, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.137207; Shimizu Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.140407; Shinaoka H, 2012, J PHYS SOC JPN, V81, DOI 10.1143/JPSJ.81.034701; Mendels P, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077204; Zheng WH, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.134422; Jiang HC, 2012, PHYS REV B, V86, DOI 10.1103/PhysRevB.86.024424; Hauke P, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/7/075017; Komatsu T, 1996, J PHYS SOC JPN, V65, P1340, DOI 10.1143/JPSJ.65.1340; Sandvik AW, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.227202; Kagawa F, 2005, NATURE, V436, P534, DOI 10.1038/nature038O6; Yunoki S, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.014408; PYTTE E, 1974, PHYS REV B, V10, P4637, DOI 10.1103/PhysRevB.10.4637; Wen XG, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.165113; Burla MC, 2005, J APPL CRYSTALLOGR, V38, P381, DOI 10.1107/S002188980403225X; Pratt FL, 2011, NATURE, V471, P612, DOI 10.1038/nature09910; Morita H, 2002, J PHYS SOC JPN, V71, P2109, DOI 10.1143/JPSJ.71.2109; Yang HY, 2010, PHYS REV LETT, V105, DOI 10.1103/PhysRevLett.105.267204; BRAY JW, 1975, PHYS REV LETT, V35, P744, DOI 10.1103/PhysRevLett.35.744; [Anonymous], 2009, J PHYS-CONDENS MAT, DOI DOI 10.1088/0953-8984/21/39/395502; ELSTNER N, 1993, PHYS REV LETT, V71, P1629, DOI 10.1103/PhysRevLett.71.1629; MIYAGAWA K, 1995, PHYS REV LETT, V75, P1174, DOI 10.1103/PhysRevLett.75.1174; Shimizu Y, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.107001; VANDERBILT D, 1990, PHYS REV B, V41, P7892, DOI 10.1103/PhysRevB.41.7892; Itou T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.104413; Isono T, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.177201; Ito H, 1996, J PHYS SOC JPN, V65, P2987, DOI 10.1143/JPSJ.65.2987; HUIZINGA S, 1979, PHYS REV B, V19, P4723, DOI 10.1103/PhysRevB.19.4723; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; HASE M, 1993, PHYS REV LETT, V70, P3651, DOI 10.1103/PhysRevLett.70.3651; Marzari N, 1997, PHYS REV B, V56, P12847, DOI 10.1103/PhysRevB.56.12847; BONNER JC, 1964, PHYS REV, V135, pA640, DOI 10.1103/PhysRev.135.A640; Balents L, 2010, NATURE, V464, P199, DOI 10.1038/nature08917; Bulaevskii L. N., 1969, SOV PHYS-SOLID STATE, V11, P921; Dumm M, 2000, PHYS REV B, V61, P511, DOI 10.1103/PhysRevB.61.511; FETTOUHI M, 1995, SYNTHETIC MET, V70, P1131, DOI 10.1016/0379-6779(94)02786-X; Ishiguro T., 1990, ORGANIC SUPERCONDUCT; Koretsune T, 2014, PHYS REV B, V89, DOI 10.1103/PhysRevB.89.045102; Pardini T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.214433; SACHDEV S, 1994, PHYS REV B, V50, P13006, DOI 10.1103/PhysRevB.50.13006; Sheldrick G. M., 1997, SHELXL 97 PROGRAM CR; Starykh OA, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.077205; Tamura M, 2006, J PHYS SOC JPN, V75, DOI 10.1143/JPSJ.75.093701	48	3	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-2473	1745-2481		NAT PHYS	Nat. Phys.	AUG	2015	11	8					679	+		10.1038/NPHYS3359		6	Physics, Multidisciplinary	Physics	CO0OQ	WOS:000358851900023		
J	Suzuki, M; Fujise, Y; Tsuchiya, Y; Tamano, H; Takeda, A				Suzuki, Miki; Fujise, Yuki; Tsuchiya, Yuka; Tamano, Haruna; Takeda, Atsushi			Excess influx of Zn2+ into dentate granule cells affects object recognition memory via attenuated LTP	NEUROCHEMISTRY INTERNATIONAL			English	Article						Zinc; Dentate granule cell; LTP; Cognitive decline	LONG-TERM POTENTIATION; PERMEABLE AMPA CHANNELS; ISCHEMIA-INDUCED DEATH; HIPPOCAMPAL-NEURONS; RECEPTOR ACTIVATION; NERVOUS-SYSTEM; FREE ZINC; DISEASE; COPPER; MOSSY	The influx of extracellular Zn2+ into dentate granule cells is nonessential for dentate gyrus long-term potentiation (LTP) and the physiological significance of extracellular Zn2+ dynamics is unknown in the dentate gyrus. Excess increase in extracellular Zn2+ in the hippocampal CM, which is induced with excitation of zincergic neurons, induces memory deficit via excess influx of Zn2+ into CA1 pyramidal cells. In the present study, it was examined whether extracellular Zn2+ induces object recognition memory deficit via excess influx of Zn2+ into dentate granule cells. KC1 (100 mM, 2 mu l) was locally injected into the dentate gyrus. The increase in intracellular Zn2+ in dentate granule cells induced with high K+ was blocked by co-injection of CaEDTA and CNQX, an extracellular Zn2+ chelator and an AMPA receptor antagonist, respectively, suggesting that high K+ increases the influx of Zn2+ into dentate granule cells via AMPA receptor activation. Dentate gyrus LTP induction was attenuated 1 h after KC1 injection into the dentate gyrus and also attenuated when KC1 was injected 5 min after the induction. Memory deficit was induced when training of object recognition test was performed 1 h after KC1 injection into the dentate gyrus and also induced when KC1 was injected 5 min after the training. High K+-induced impairments of LTP and memory were rescued by co-injection of CaEDTA. These results indicate that excess influx of Zn2+ into dentate granule cells via AMPA receptor activation affects object recognition memory via attenuated LTP induction. Even in the dentate gyrus where is scarcely innervated by zincergic neurons, it is likely that extracellular Zn2+ homeostasis is strictly regulated for cognition. (C) 2015 Elsevier Ltd. All rights reserved.	[Suzuki, Miki; Fujise, Yuki; Tsuchiya, Yuka; Tamano, Haruna; Takeda, Atsushi] Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, Shizuoka 4228526, Japan	Takeda, A (reprint author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Neurophysiol, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	takedaa@u-shizuoka-ken.ac.jp					Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Takeda A, 2007, J NEUROSCI RES, V85, P1310, DOI 10.1002/jnr.21233; Frederickson CJ, 2005, NAT REV NEUROSCI, V6, P449, DOI 10.1038/nrn1671; Neves G, 2008, NAT REV NEUROSCI, V9, P65, DOI 10.1038/nrn2303; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Nakashima AS, 2009, BRAIN RES REV, V59, P347, DOI 10.1016/j.brainresrev.2008.10.003; Takeda A, 2010, NEUROSCIENCE, V171, P443, DOI 10.1016/j.neuroscience.2010.09.017; Sensi SL, 1997, J NEUROSCI, V17, P9554; Takeda A, 2009, NEUROSCIENCE, V158, P585, DOI 10.1016/j.neuroscience.2008.10.009; Takeda A, 2009, BRAIN RES REV, V62, P33, DOI 10.1016/j.brainresrev.2009.09.003; Jia YS, 2002, J PHYSIOL-LONDON, V543, P35, DOI 10.1113/jphysiol.2002.020172; Kwak S, 2006, CURR OPIN NEUROBIOL, V16, P281, DOI 10.1016/j.conb.2006.05.004; Schlief ML, 2005, J NEUROSCI, V25, P239, DOI 10.1523/JNEUROSCI.3699-04.2005; Frederickson CJ, 2006, EXP NEUROL, V198, P285, DOI 10.1016/j.expneurol.2005.08.030; Mathie A, 2006, PHARMACOL THERAPEUT, V111, P567, DOI 10.1016/j.pharmthera.2005.11.004; Hopt A, 2003, J NEUROSCI METH, V128, P159, DOI 10.1016/S0165-0270(03)00173-0; Lengyel I, 2000, J NEUROCHEM, V75, P594, DOI 10.1046/j.1471-4159.2000.0750594.x; Weiss JH, 2000, TRENDS PHARMACOL SCI, V21, P395, DOI 10.1016/S0165-6147(00)01541-8; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Pan EH, 2011, NEURON, V71, P1116, DOI 10.1016/j.neuron.2011.07.019; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; Li Y, 2001, J NEUROSCI, V21, P8015; Sindreu CB, 2003, CEREB CORTEX, V13, P823, DOI 10.1093/cercor/13.8.823; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Colvin RA, 2008, AM J PHYSIOL-CELL PH, V294, pC726, DOI 10.1152/ajpcell.00541.2007; Ueno S, 2002, J CELL BIOL, V158, P215, DOI 10.1083/jcb.200204066; HANSEN AJ, 1981, ACTA PHYSIOL SCAND, V113, P437, DOI 10.1111/j.1748-1716.1981.tb06920.x; HERSHEY CO, 1983, NEUROLOGY, V33, P1350; Hirano T, 2002, J AM CHEM SOC, V124, P6555, DOI 10.1021/ja025567p; Kim JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048543; Takeda A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028615; Takeda A, 2014, HIPPOCAMPUS, V24, P1404, DOI 10.1002/hipo.22322; Tamano H., 2015, HIPPOCAMPUS IN PRESS; Weiss JH, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00042; Wu J, 2006, J NEUROPHYSIOL, V95, P3519, DOI 10.1152/jn.01235.2005	35	2	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	AUG	2015	87						60	65		10.1016/j.neuint.2015.05.006		6	Biochemistry & Molecular Biology; Neurosciences	Biochemistry & Molecular Biology; Neurosciences & Neurology	CO7HO	WOS:000359330400006		
J	Yamasaki, M; Mutombo, PBWB; Iwamoto, M; Nogi, A; Hashimoto, M; Nabika, T; Shiwaku, K				Yamasaki, Masayuki; Mutombo, Paulin Beya wa Bitadi; Iwamoto, Mamiko; Nogi, Akiko; Hashimoto, Michio; Nabika, Toru; Shiwaku, Kuninori			The interaction of Apolipoprotein A5 gene promoter region T-1131C polymorphism (rs12286037) and lifestyle modification on plasma triglyceride levels in Japanese	NUTRITION RESEARCH AND PRACTICE			English	Article						Plasma TG; lifestyle modification; APOA5 T-1131C; energy balance	LIPOPROTEIN-LIPASE; WEIGHT-LOSS; RISK; DIET; INTERVENTION; METABOLISM; GENOTYPE; DISEASE; HUMANS; LOCI	BACKGROUND/OBJECTIVE: Apolipoprotein A5 gene promoter region T-1131C polymorphism (APOA5 T-1131C) is known to be associated with elevated plasma TG levels, although little is known of the influence of the interaction between APOA5 T-1131C and lifestyle modification on TG levels. To investigate this matter, we studied APOA5 T-1131C and plasma TG levels of subjects participating in a three-month lifestyle modification program. SUBJECTS/METHODS: A three-month lifestyle modification program was conducted with 297 participants (Age: 57 8 years) in Izumo City, Japan, from 2001-2007. Changes in energy balance (the difference between energy intake and energy expenditure) and BMI were used to evaluate the participants' responses to the lifestyle modification. RESULTS: Even after adjusting for confounding factors, plasma TG levels were significantly different at baseline among three genotype subgroups: TT, 126 +/- 68 mg/dl; TC, 134 +/- 74 mg/di; and CC, 172 +/- 101 mg/dl. Lifestyle modification resulted in significant reductions in plasma TG levels in the TT, IC, and CC genotype subgroups: -21.9 +/- 61.0 mg/di, -20.9 +/- 51.0 mg/di, and -42.6 +/- 78.5 mg/di, respectively, with no significant differences between them. In a stepwise regression analysis, age, APOA5 T-1131C, body mass index (BMI), homeostasis model assessment-insulin resistance (HOMA-IR), and the 18:1/18:0 ratio showed independent association with plasma TG levels at baseline. In a general linear model analysis, APOA5 T-1131C C-allele carriers showed significantly greater TG reduction with decreased energy balance than wild type carriers after adjustment for age, gender, and baseline plasma TG levels. CONCLUSIONS: The genetic effects of APOA5 T-1131C independently affected plasma TG levels. However, lifestyle modification was effective in significantly reducing plasma TG levels despite the APOA5 T-1131C genotype background.	[Yamasaki, Masayuki; Iwamoto, Mamiko] Shimane Univ, Fac Med, Dept Environm & Prevent Med, Izumo, Shimane 6938501, Japan; [Mutombo, Paulin Beya wa Bitadi] Univ Kinshasa, Fac Med, Sch Publ Hlth, Dept Nutr, Kinshasa, DEM REP CONGO; [Nogi, Akiko] Yamaguchi Prefectural Univ, Fac Nursing & Human Nutr, Dept Human Nutr, Yamaguchi 7538502, Japan; [Hashimoto, Michio] Shimane Univ, Fac Med, Dept Environm Physiol, Izumo, Shimane 6938501, Japan; [Nabika, Toru] Shimane Univ, Fac Med, Dept Funct Pathol, Izumo, Shimane 6938501, Japan; [Shiwaku, Kuninori] Shimane Univ, Matsue, Shimane 6908504, Japan	Yamasaki, M (reprint author), Shimane Univ, Fac Med, Dept Environm & Prevent Med, 89-1 Enya Cho, Izumo, Shimane 6938501, Japan.	myamasak@med.shimane-u.acjp			Japanese Ministry of Education, Culture, Sports, Science and Technology [21790553, 24790586]; Shimane University Medical Education and Research Foundation	This study was supported in part by Grants-in-Aid for Scientific Research from the Japanese Ministry of Education, Culture, Sports, Science and Technology (21790553 and 24790586 to MY) and by Shimane University Medical Education and Research Foundation (MY).	Aberle J, 2005, CLIN GENET, V68, P152, DOI 10.1111/j.1399-0004.2005.00463.x; Sarwar N, 2007, CIRCULATION, V115, P450, DOI 10.1161/CIRCULATIONAHA.106.637793; Seip RL, 1997, AM J PHYSIOL-ENDOC M, V272, pE255; Yuan G, 2007, CAN MED ASSOC J, V176, P1113, DOI 10.1503/cmaj.060963; Zhang XM, 2012, AM J CLIN NUTR, V96, P917, DOI 10.3945/ajcn.112.040907; Maraki M, 2010, CURR OPIN CLIN NUTR, V13, P608, DOI 10.1097/MCO.0b013e32833f1aae; Patel A, 2004, CIRCULATION, V110, P2678, DOI 10.1161/01.CIR.0000145615.33955.83; Wang H, 2009, AM J PHYSIOL-ENDOC M, V297, pE271, DOI 10.1152/ajpendo.90920.2008; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Wong K, 2007, CURR OPIN LIPIDOL, V18, P319, DOI 10.1097/MOL.0b013e328133856c; Kathiresan S, 2008, NAT GENET, V40, P189, DOI 10.1038/ng.75; Pennacchio LA, 2001, SCIENCE, V294, P169, DOI 10.1126/science.1064852; Kolovou GD, 2011, INT J CARDIOL, V147, P349, DOI 10.1016/j.ijcard.2010.08.009; Ordovas JM, 2008, CURR OPIN LIPIDOL, V19, P158, DOI 10.1097/MOL.0b013e3282f6a809; Nabika T, 2002, ATHEROSCLEROSIS, V165, P201, DOI 10.1016/S0021-9150(02)00252-6; Merkel M, 2005, J BIOL CHEM, V280, P21553, DOI 10.1074/jbc.m1142200; Ho JS, 2008, AM J CARDIOL, V102, P689, DOI 10.1016/j.amjcard.2008.05.010; McCormack G, 2004, J Sci Med Sport, V7, P81, DOI 10.1016/S1440-2440(04)80282-2; Ministry of Health Labour and Welfare (JP), 2006, EX PHYS ACT GUID HLT; Miyashita M, 2010, J ATHEROSCLER THROMB, V17, P21; Ordovas JM, 2002, BIOCHEM SOC T, V30, P68, DOI 10.1042/0300-5127:0300068; Parzianello L, 2005, ARCH MED RES, V36, P59, DOI 10.1016/j.arcmed.2004.11.004; Perez-Martinez P, 2008, ATHEROSCLEROSIS SUPP, V9, P49, DOI 10.1016/j.atherosclerosissup.2008.05.005; Resources Council of the Science and Technology Agency of Japan, 2000, STAND TABL FOOD COMP; Shiwaku K, 2004, J LIPID RES, V45, P914, DOI 10.1194/jlr.M300483-JLR200; St George Alexis, 2009, J Gastroenterol Hepatol, V24, P399, DOI 10.1111/j.1440-1746.2008.05694.x; Stone Neil J, 2006, Clin Cornerstone, V8 Suppl 1, pS15, DOI 10.1016/S1098-3597(06)80004-9; Suchanek P, 2008, ANN NUTR METAB, V53, P104, DOI 10.1159/000165358; Tamasawa N, 2003, DIABETES OBES METAB, V5, P345, DOI 10.1046/j.1463-1326.2003.00286.x; VINE Corp. (KR), 2000, INSTR MAN NOND INFR	30	0	0	KOREAN NUTRITION SOC	SEOUL	804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA	1976-1457	2005-6168		NUTR RES PRACT	Nutr. Res. Pract.	AUG	2015	9	4					379	384		10.4162/nrp.2015.9.4.379		6	Nutrition & Dietetics	Nutrition & Dietetics	CO3AM	WOS:000359028600006		
J	Kitaoka, K; Kitade, A; Nagaoka, J; Tsuzaki, K; Harada, K; Aoi, W; Wada, S; Asano, H; Sakane, N; Higashi, A				Kitaoka, Kaori; Kitade, Azusa; Nagaoka, Junko; Tsuzaki, Kokoro; Harada, Kiyomi; Aoi, Wataru; Wada, Sayori; Asano, Hiroaki; Sakane, Naoki; Higashi, Akane			Lifestyle intervention might easily improve blood pressure in hypertensive men with the C genotype of angiotensin II type 2 receptor gene	NUTRITION RESEARCH AND PRACTICE			English	Article						AT2R gene; blood pressure; salt excretion; lifestyle modification; hypertensive men	CARDIOVASCULAR-DISEASE; DIETARY-SODIUM; RISK; JAPANESE; POLYMORPHISMS; INTERMAP; SYSTEM; ADULTS; MICE	BACKGROUND/OBJECTIVES: Recent studies have reported an association of the angiotensin II type 2 receptor (AT2R) 3123Cytosine/Adenine (3123C/A) polymorphism with essential hypertension and cardiovascular diseases. The purpose of the study was to investigate whether the AT2R 3123C/A polymorphism affects blood pressure for free-living hypertensive men during a 5-month intervention period. SUBJECTS/METHODS: The subjects were free-living hypertensive Japanese men aged 40 to 75 years who agreed to intervention in the period from 2004 to 2011. Detection of the AT2R 3123C/A polymorphism was determined by polymerase chain reaction. The dietary intervention was designed to decrease salt level and to increase potassium level through cooking instructions and self-monitoring of the diet. The exercise session consisted of activities such as stretching, resistance training, and walking. Blood pressure, urinary sodium and potassium excretion, dietary and lifestyle data, and non-fasting venous blood sample were collected at baseline and after the intervention period. RESULTS: Thirty nine subjects were eligible for participation and the follow-up rate was 97.4%. The C allele proportion was 57.9%. AT2R 3123C/A polymorphism was X-chromosome-linked, therefore we analyzed the C and A genotypes. At baseline, no significant differences were observed between the genotype groups. After the intervention, there were no significant differences in lifestyle habit between the groups. Nevertheless, the estimated salt excretion (g/day) was significantly decreased only in the C genotype (13.0-10.3, P=0.031). No significant change was observed in systolic blood pressure (SBP) (mmHg) in the A genotype, but a significant decrease was observed in the C genotype (150.0-141.5, P=0.024). CONCLUSTIONS: In the C genotype, it might be easy to improve SBP through lifestyle intervention in free-living hypertensive Japanese men, however generalization could not be achieved by the small sample size.	[Kitaoka, Kaori] Kyoto Koka Womens Univ, Fac Hlth Sci, Dept Hlth & Nutr, Nishikyogo Ku, Kyoto 6150882, Japan; [Kitaoka, Kaori; Kitade, Azusa; Aoi, Wataru; Wada, Sayori; Higashi, Akane] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Div Appl Life Sci, Kyoto 606, Japan; [Nagaoka, Junko] Higashiosaka City Publ Hlth Off, Hlth Promot Div, Osaka, Japan; [Tsuzaki, Kokoro; Sakane, Naoki] Natl Hosp Org Kyoto Med Ctr, Clin Res Inst, Div Prevent Med & Diabet Educ, Kyoto, Japan; [Harada, Kiyomi; Asano, Hiroaki] Kyoto Prefectural Univ Med, Sch Nursing, Kyoto, Japan	Kitaoka, K (reprint author), Kyoto Koka Womens Univ, Fac Hlth Sci, Dept Hlth & Nutr, Nishikyogo Ku, 38 Kadono Cho, Kyoto 6150882, Japan.	k-kitaoka@mail.koka.ac.jp			Health Promotion Foundation, Japan; Osaka Gas Group Welfare Foundation	This study was supported by a grant from the Health Promotion Foundation, Japan (2005) and the Osaka Gas Group Welfare Foundation (2010-2011).	Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; Miura K, 2010, J EPIDEMIOL, V20, pS524, DOI 10.2188/jea.JE20090220; HEIN L, 1995, NATURE, V377, P744, DOI 10.1038/377744a0; KANNEL WB, 1980, CIRCULATION, V61, P1179; ICHIKI T, 1995, NATURE, V377, P748, DOI 10.1038/377748a0; Stamler J, 2003, J HUM HYPERTENS, V17, P591, DOI 10.1038/sj.jhh.1001603; [Anonymous], 1988, J HYPERTENS S, V6, pS584; Kokubo Y, 2008, HYPERTENSION, V52, P652, DOI 10.1161/HYPERTENSIONAHA.108.118273; Kato N, 2002, HYPERTENS RES, V25, P319, DOI 10.1291/hypres.25.319; Ohkubo T, 1998, J HYPERTENS, V16, P971, DOI 10.1097/00004872-199816070-00010; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Appel L. J., 2003, JAMA-J AM MED ASSOC, V289, P2083; Carey RM, 2001, AM J HYPERTENS, V14, p98S, DOI 10.1016/S0895-7061(01)02076-3; Fujii H, 2010, TOHOKU J EXP MED, V220, P307, DOI 10.1620/tjem.220.307; Hamada T, 2011, NUTRITION, V27, P34, DOI 10.1016/j.nut.2009.10.012; Ikeda J, 1995, Nihon Koshu Eisei Zasshi, V42, P829; Iso H, 1996, HYPERTENSION, V27, P968; Jin JJ, 2003, HYPERTENS RES, V26, P547, DOI 10.1291/hypres.26.547; Jones A, 2003, HYPERTENSION, V42, P500, DOI 10.1161/01.HYP.0000088853.27673.D0; Katsuya T, 1997, MOL CELL ENDOCRINOL, V127, P221, DOI 10.1016/S0303-7207(97)04011-2; Kawano Y, 2007, HYPERTENS RES, V30, P887, DOI 10.1291/hypres.30.887; KAWASAKI T, 1993, CLIN EXP PHARMACOL P, V20, P7, DOI 10.1111/j.1440-1681.1993.tb01496.x; Kitaoka K, 2013, CLIN EXP HYPERTENS, V35, P120, DOI 10.3109/10641963.2012.702830; Luft Friedrich C., 1997, American Journal of Clinical Nutrition, V65, p612S; Miura Katsuyuki, 2006, Nihon Koshu Eisei Zasshi, V53, P533; Nakamura Y, 2006, CIRC J, V70, P960, DOI 10.1253/circj.70.960; PARFREY PS, 1981, BRIT MED J, V283, P94; Shay CM, 2012, EUR J NUTR, V51, P917, DOI 10.1007/s00394-011-0268-2; Takahashi V, 2006, J HYPERTENS, V24, P451; Zhang Y, 2003, ACTA PHARMACOL SIN, V24, P1089	30	0	0	KOREAN NUTRITION SOC	SEOUL	804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA	1976-1457	2005-6168		NUTR RES PRACT	Nutr. Res. Pract.	AUG	2015	9	4					385	392		10.4162/nrp.2015.9.4.385		8	Nutrition & Dietetics	Nutrition & Dietetics	CO3AM	WOS:000359028600007		
J	So, KH; Suzuki, Y; Yonekura, S; Suzuki, Y; Lee, CH; Kim, SW; Katoh, K; Roh, SG				So, Kyoung-Ha; Suzuki, Yasuki; Yonekura, Shinichi; Suzuki, Yutaka; Lee, Chan Ho; Kim, Sung Woo; Katoh, Kazuo; Roh, Sang-Gun			Soluble extract of soybean fermented with Aspergillus oryzae GB 107 inhibits fat accumulation in cultured 3T3-L1 adipocytes	NUTRITION RESEARCH AND PRACTICE			English	Article						Fermented soybean; adipocyte; adipogenesis; 3T3-L1; Aspergillus olyzae	IN-VITRO; CHEMERIN ANALOG; LDL OXIDATION; TNF-ALPHA; ADIPOGENESIS; PROTEIN; DIFFERENTIATION; CHOLESTEROL; RECEPTOR; ADIPONECTIN	BACKGROUND/OBJECTIVES: This study was conducted to investigate the effects of fermented soybean (FS) extract on adipocyte differentiation and fat accumulation using cultured 3T3-L1 adipocytes. MATERIALS/METHODS: 3T3-L1 adipocytes were treated with FS and nonfermented soybean (NFS) extract during differentiation for 10 days in vitro. Oil red 0 staining was performed and glycerol-3-phosphate dehydrogenase (GPDH) activity was measured for analysis of fat accumulation. Expressions of adipogenic genes were measured. RESULTS: Soluble extract of soybean fermented with Aspergillus oryzae GB107 contained higher levels of low-molecular-weight protein than conventional soybean protein did. FS extract (50 pg/ml) inhibited adipocyte differentiation and fat accumulation during differentiation of 3T3-L1 preadipocytes for 10 days in vitro. Significantly lower GPDH activity was observed in differentiated adipocytes treated with the FS extract than those treated with NFS extract. Treatment with FS extract resulted in decreased expression levels of leptin, adiponectin, and adipogenin genes, which are associated with adipogenesis. CONCLUSIONS: This report is the first to demonstrate that the water-soluble extract from FS inhibits fat accumulation and lipid storage in 3T3-L1 adipocytes. Thus, the soybean extract fermented with A. oryzae GB107 could be used to control lipid accumulation in adipocytes.	[So, Kyoung-Ha; Suzuki, Yutaka; Katoh, Kazuo; Roh, Sang-Gun] Tohoku Univ, Grad Sch Agr Sci, Physiol Anim Lab, Aoba Ku, Sendai, Miyagi 9818555, Japan; [Suzuki, Yasuki; Yonekura, Shinichi] Shinshu Univ, Fac Agr, Matsumoto, Nagano 3994598, Japan; [Lee, Chan Ho] Genebiotech Co, Seoul 137787, South Korea; [Kim, Sung Woo] N Carolina State Univ, Dept Anim Sci, Raleigh, NC 27695 USA	Roh, SG (reprint author), Tohoku Univ, Grad Sch Agr Sci, Physiol Anim Lab, Aoba Ku, Sendai, Miyagi 9818555, Japan.	sanggun_roh@bios.tohoku.ac.jp			JSPS KAKENHI [25292158, 25292163]	This work was supported in part by JSPS KAKENHI grant number 25292158, 25292163.	Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; LOVATI MR, 1987, J CLIN INVEST, V80, P1498, DOI 10.1172/JCI113232; Roh SG, 2007, BIOCHEM BIOPH RES CO, V362, P1013, DOI 10.1016/j.bbrc.2007.08.104; Roh SG, 2006, ANIM SCI J, V77, P472, DOI 10.1111/j.1740-0929.2006.00374.x; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; SIDHU GS, 1986, BRIT J NUTR, V55, P643, DOI 10.1079/BJN19860070; Suzuki Y, 2012, ASIAN AUSTRAL J ANIM, V25, P1316, DOI 10.5713/ajas.2012.12083; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; WISE LS, 1979, J BIOL CHEM, V254, P273; Suzuki Y, 2012, ANIM SCI J, V83, P263, DOI 10.1111/j.1740-0929.2011.01002.x; Sethi JK, 2000, FEBS LETT, V469, P77, DOI 10.1016/S0014-5793(00)01250-3; Kwon DY, 2010, NUTR RES, V30, P1, DOI 10.1016/j.nutres.2009.11.004; Gregoire FM, 1998, PHYSIOL REV, V78, P783; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Hong KJ, 2004, J MED FOOD, V7, P430, DOI 10.1089/jmf.2004.7.430; Kim HK, 2012, NUTR RES, V32, P770, DOI 10.1016/j.nutres.2012.06.008; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Choi KC, 2003, ASIAN AUSTRAL J ANIM, V16, P1199; de Mejia EG, 2009, PEPTIDES, V30, P2388, DOI 10.1016/j.peptides.2009.08.005; de Mejia EG, 2010, FOOD CHEM, V119, P1571, DOI 10.1016/j.foodchem.2009.09.044; Hong YH, 2005, MOL CELL BIOCHEM, V276, P133, DOI 10.1007/s11010-005-3673-0; Kim SW, 2010, J ANIM SCI, V88, P214, DOI 10.2527/jas.2009-1993; Kwon DY, 2011, NUTRITION, V27, P244, DOI 10.1016/j.nut.2010.02.004; Iwai K, 2002, J AGR FOOD CHEM, V50, P3597, DOI 10.1021/jf0117199; Iwai K, 2002, J AGR FOOD CHEM, V50, P3592, DOI 10.1021/jf011718g; Martinez-Villaluenga C, 2008, J AGR FOOD CHEM, V56, P10533, DOI 10.1021/jf802216b; OAKENFULL DG, 1983, ATHEROSCLEROSIS, V48, P301, DOI 10.1016/0021-9150(83)90048-5; Roh SG, 2014, ANIM SCI J IN PRESS; SUGANO M, 1990, J NUTR, V120, P977	30	0	0	KOREAN NUTRITION SOC	SEOUL	804 KST CTR, 635-4 YEOGSAM-SONG KANGNAM-KU, SEOUL, 135-703, SOUTH KOREA	1976-1457	2005-6168		NUTR RES PRACT	Nutr. Res. Pract.	AUG	2015	9	4					439	444		10.4162/orp.2015.9.4.439		6	Nutrition & Dietetics	Nutrition & Dietetics	CO3AM	WOS:000359028600015		
J	Chen, C; Shiotani, S; Sasa, K				Chen, Chen; Shiotani, Shigeaki; Sasa, Kenji			Effect of ocean currents on ship navigation in the east China sea	OCEAN ENGINEERING			English	Article						Kuroshio Current; POM; Numerical simulations; Ship navigation; Optimal route planning	KUROSHIO; TRANSPORT; MODEL; JAPAN	Weather and ocean states such as ocean winds, ocean waves, and ocean currents can significantly affect ship navigation. To fully understand the current's effect on navigational fuel and time costs, especially in the case of strong western boundary currents such as the Kuroshio Current, an in-depth examination of how the Kuroshio Current quantitatively affects ships is needed. This article presents simulations, based on the Princeton Ocean Model (POM), in the North Pacific Ocean and focuses on the ocean surface current in the East China Sea (ECS). Then, several numerical simulations of ship navigation are conducted by utilizing a ship-maneuvering model known as the Mathematical Maneuvering Group (MMG). The results show that the POM model can generate a high-quality Kuroshio Current distribution that can be applied to conduct numerical simulations of ship navigation. (C) 2015 Elsevier Ltd. All rights reserved.	[Chen, Chen] Kobe Univ, Fac Maritime Sci, Higashinada Ku, Kobe, Hyogo 657, Japan; [Chen, Chen; Sasa, Kenji] Kobe Univ, Fac Maritime Sci, Higashinada Ku, Kobe, Hyogo 657, Japan; [Shiotani, Shigeaki] Org Adv Sci & Technol, Higashinada Ku, Kobe, Hyogo, Japan	Chen, C (reprint author), Kobe Univ, Fac Maritime Sci, Higashinada Ku, Kobe, Hyogo 657, Japan.	cc198895@hotmail.com; shiotani@maritime.kobe-u.ac.jp; sasa@maritime.kobe-u.ac.jp					Amante C., 2009, NGDC24 NOAA NESDIS, P1, DOI DOI 10.7289/V5C8276M; Rusu L, 2011, OCEAN ENG, V38, P63, DOI 10.1016/j.oceaneng.2010.09.012; Oey L, 2013, TERR ATMOS OCEAN SCI, V24, P137, DOI 10.3319/TAO.2012.09.12.01(Oc); Kawabe M, 2005, J OCEANOGR, V61, P529, DOI 10.1007/s10872-005-0060-0; Guo XY, 2003, J PHYS OCEANOGR, V33, P146, DOI 10.1175/1520-0485(2003)033<0146:ATNOMF>2.0.CO;2; Kagimoto T, 1997, J PHYS OCEANOGR, V27, P403, DOI 10.1175/1520-0485(1997)027<0403:STVOTK>2.0.CO;2; Kistler R, 2001, B AM METEOROL SOC, V82, P247, DOI 10.1175/1520-0477(2001)082<0247:TNNYRM>2.3.CO;2; Wakata Y, 2006, J OCEANOGR, V62, P25, DOI 10.1007/s10872-006-0029-7; Hansen DV, 1996, J ATMOS OCEAN TECH, V13, P900, DOI 10.1175/1520-0426(1996)013<0900:QCAIOW>2.0.CO;2; SEKINE Y, 1994, J PHYS OCEANOGR, V24, P261, DOI 10.1175/1520-0485(1994)024<0261:SVIVTO>2.0.CO;2; Chang YC, 2013, J NAVIGATION, V66, P825, DOI 10.1017/S0373463313000441; QIU B, 1990, J GEOPHYS RES-OCEANS, V95, P18191; Blumberg A. F., 1987, COASTAL ESTUARINE SC, V4, P1; Chen H, 1978, THESIS; Ezer T, 1997, J GEOPHYS RES-OCEANS, V102, P15647, DOI 10.1029/97JC00984; Hagiwara H, 1985, J JPN I NAVIG, V72, P87; Hansen D. V., 1989, Journal of Atmospheric and Oceanic Technology, V6, DOI 10.1175/1520-0426(1989)006<0599:TSRFSD>2.0.CO;2; Hanssen G., 1960, J NAVIGATION, V13, P253; Hasegawa K., 1980, J KANSAI SOC NAV ARC, P93; James R.W., 1957, APPL WAVE FORECASTS; Katsuro Kijima, 1990, J SOC NAVAL ARCHIT J, V168, P141; Kose K., 1981, P 3 S SHIP MAN, P28; Lacey P.B., 1995, MAR TECHNOL SOC J; Levitus S., 1994, NOAA ATLAS NESDIS, V4, P117; Levitus S., 1994, SALINITY, V3, P99; Lumpkin R., 2006, LAGRANGIAN ANAL PRED; MELLOR GL, 1994, J ATMOS OCEAN TECH, V11, P1126, DOI 10.1175/1520-0426(1994)011<1126:TPGCOS>2.0.CO;2; Mellor GL., 1998, USERS GUIDE 3 DIMENS; Miller JN, 1983, DOES OCEAN ROUTING R; Niiler P.P., 1995, J PHYS OCEANOGR, V25, P2819; Ogawa T, 1981, P 3 S SHIP MAN, P9; PAPADAKIS NA, 1990, OPER RES, V38, P426, DOI 10.1287/opre.38.3.426; Rusu L, 2011, OCEAN ENG, V38, P1174, DOI 10.1016/j.oceaneng.2011.05.016; Sun X.-P., 1994, OCEANOLOGY CHINA SEA, V1, P49; Ulusoy T., 2004, THESIS; Yoshimura Y., 1989, J KANSAI SOC NAV ARC, V211, P115	36	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	AUG 1	2015	104						283	293		10.1016/j.oceaneng.2015.04.062		11	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	CO4XV	WOS:000359165100023		
J	Sasa, K; Terada, D; Shiotani, S; Wakabayashi, N; Ikebuchi, T; Chen, C; Takayama, A; Uchida, M				Sasa, Kenji; Terada, Daisuke; Shiotani, Shigeaki; Wakabayashi, Nobukazu; Ikebuchi, Takuro; Chen, Chen; Takayama, Atsuyoshi; Uchida, Makoto			Evaluation of ship performance in international maritime transportation using an onboard measurement system - in case of a bulk carrier in international voyages	OCEAN ENGINEERING			English	Article						Maritime transportation; Weather routing; Seakeeping theory; Ocean waves; Onboard measurement	DIRECTIONAL WAVE SPECTRA; VESSEL MOTIONS	The present global society has made the development of a safe and efficient maritime transportation system more imperative than ever before. Of particular impetus is the steep rise in the price of crude oil, which has required shipping companies to minimize the fuel consumption of their ships. Moreover, the emission of carbon dioxide has been restricted by the EEDI (Energy Efficiency Design Index) issued by the IMO (International Maritime Organization). Weather routing services have become more important to shipping companies. However, there are accuracy deficiencies in the numerical models employed by such services for purposes such as weather forecast and the ship speed loss phenomenon. Moreover, the development of weather routing models has been hampered by insufficient accumulation of continuous data on ship motions, and the navigation, engine, and weather parameters. The data used for this study was collected over one year from a 20,000 DWT class bulk carrier on worldwide voyages. Some new relationships regarding ship motions, speed loss, and wave conditions were developed, which were verified by experimental data and numerical simulations of the frequency response of the ship motion and of the weather and ocean. (C) 2015 Elsevier Ltd. All rights reserved.	[Sasa, Kenji; Shiotani, Shigeaki; Wakabayashi, Nobukazu; Chen, Chen; Uchida, Makoto] Kobe Univ, Deptartment Maritime Sci, Kobe, Hyogo 657, Japan; [Terada, Daisuke] Natl Res Inst Fishery Engn, Ibaraki, Japan; [Ikebuchi, Takuro] Imabari Shipbldg Co Ltd, Imabari, Ehime, Japan; [Takayama, Atsuyoshi] Kurume Inst Technol, Deptartment Mech Syst Engn, Fukuoka, Japan	Sasa, K (reprint author), Kobe Univ, Deptartment Maritime Sci, Kobe, Hyogo 657, Japan.				Shoei Kisen Kaisha, Ltd.	This study was conducted with the dedicated support of Shoei Kisen Kaisha, Ltd. and all the crew members of the employed bulk carrier of the company. The authors express their great appreciation to them. The authors also express appreciation for reviewers their many supports to improve this paper so much. The study was conducted as a project of the Special Research Implementation of the Ministry of Education, Culture, Sports, Science and Technology, titled Research on Construction of International Maritime Transportation System due to the Three Principles of Transportation (2008-2011).	Pascoal R, 2009, OCEAN ENG, V36, P477, DOI 10.1016/j.oceaneng.2009.01.013; [Anonymous], 2012, J OCEAN ENG, DOI DOI 10.1016/J.OCEANENG.2012.01.028; Nielsen UD, 2006, MAR STRUCT, V19, P33, DOI 10.1016/j.marstruc.2006.06.001; Tolman HL, 2005, OCEAN MODEL, V9, P305, DOI 10.1016/j.ocemod.2004.09.003; Faltinsen O.M., 1990, SEA LOADS SHIPS OFFS, P328; Faltinsen O.M., 1990, P INT S CFD CAD SHIP, P18; Hirayama K., 2010, TECHNICAL REPORT, V59, P30; International Maritime Organization (IMO), 2009, MEEPC59INF10 IMO; Iseki T, 2002, INT J OFFSHORE POLAR, V12, P25; Kashkoush Mohamed, 2014, Production Engineering - Research and Development, V8, DOI 10.1007/s11740-013-0499-6; Kashiwagi M., 1997, SCHIFFSTECHNIK, V4, P167; Naito S., 1979, J SNAI, V146, P147; Newman J. N., 1977, MARINE HYDRODYNAMICS, P402; Ohkusu M., 1996, ADV MARINE HYDRODYNA, P371; Pascoal R, 2007, J OFFSHORE MECH ARCT, V129, P90, DOI 10.1115/1.2426986; Pascoal R, 2008, APPL OCEAN RES, V30, P46, DOI 10.1016/j.apor.2008.03.003; Shimada Y., 2012, J JPN I NAVIG, P197; Takashima K., 2004, J JAPAN I NAVIGATION, P259; Tolman H., 2002, J ATMOS OCEAN SCI, V8, P67; Tolman H.L., 2002, 213 NOAANWSNCEPOMB, V213, P33; Yokoi T., 2010, P AS NAV C, P33; Yokoi T., 2009, P AS NAV C, P225	22	1	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	AUG 1	2015	104						294	309		10.1016/j.oceaneng.2015.05.015		16	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	CO4XV	WOS:000359165100024		
J	Nishi, Y; Doan, PV				Nishi, Yoshiki; Phan Viet Doan			Distribution of damping device on riser pipe in sheared currents	OCEAN ENGINEERING			English	Article						Riser; Vortex-induced vibration; Damping device; WKB method	VORTEX-INDUCED VIBRATIONS; DYNAMICS; MODEL; LONG; FLOW	This study investigates a method for suppressing the vortex-induced vibration (VIV) of a riser pipe using a mathematical model of beam vibration and numerical computation. The proposed method uses damping devices that partially cover the riser pipe such that the integral measuring the overlap of the drag distribution with the eigenfunction squared is maximized. By considering the isolines of reduced velocity and vertical profiles of magnitude factor of lift force, we specified a mode that would grow most prominently if no damping device is used. We regard this mode as the one that ought to be intensively damped, thereby configuring an added damping distribution function according to the approximate maximization of the overlap integral. We applied this method to a riser pipe in linearly sheared flows and found that the appropriate specification of the damped mode can suppress the VIV to the same degree as the entire coverage, although this effect varies with the strength of the flow velocity shear. It follows that the proposed method is useful for suppressing the VIV with a small number of damping devices attached. (C) 2015 Elsevier Ltd. All rights reserved.	[Nishi, Yoshiki; Phan Viet Doan] Yokohama Natl Univ, Dept Syst Design Ocean Space, Fac Engn, Yokohama, Kanagawa 2408501, Japan	Nishi, Y (reprint author), Yokohama Natl Univ, Dept Syst Design Ocean Space, Fac Engn, 79-5 Tokiwadai, Yokohama, Kanagawa 2408501, Japan.	ynishi@ynu.ac.jp					Sarpkaya T, 2004, J FLUID STRUCT, V19, P389, DOI 10.1016/j.jfluidstructs.2004.02.005; VANDIVER JK, 1993, J FLUID STRUCT, V7, P423, DOI 10.1006/jfls.1993.1028; Cheng Y, 2002, J SOUND VIB, V251, P750, DOI 10.1006/jsvi.2001.3843; BEARMAN PW, 1984, ANNU REV FLUID MECH, V16, P195, DOI 10.1146/annurev.fl.16.010184.001211; Lie H, 2006, J FLUID STRUCT, V22, P557, DOI 10.1016/j.jfluidstructs.2006.01.002; Chatjigeorgiou IK, 2008, MATH COMPUT MODEL, V48, P249, DOI 10.1016/j.mcm.2007.08.012; Facchinetti ML, 2004, J FLUID STRUCT, V19, P123, DOI 10.1016/j.jfluidstructs.2003.12.004; Violette R, 2007, COMPUT STRUCT, V85, P1134, DOI 10.1016/j.compstruc.2006.08.005; Williamson CHK, 2004, ANNU REV FLUID MECH, V36, P413, DOI 10.1146/annurev.fluid.36.050802.122128; Pesce CP, 2006, J OFFSHORE MECH ARCT, V128, P39, DOI 10.1115/1.2151205; Baarholm GS, 2006, J FLUID STRUCT, V22, P109, DOI 10.1016/j.jfluidstructs.2005.07.013; Huang K, 2011, J FLUID STRUCT, V27, P947, DOI 10.1016/j.jfluidstructs.2011.06.010; Srinil N, 2011, APPL OCEAN RES, V33, P41, DOI 10.1016/j.apor.2010.11.004; Bender C. M., 1999, ADV MATH METHODS SCI; BLEVINS R. D., 1977, FLOW INDUCED VIBRATI; Chakrabarti S., 2002, THEORY PRACTICE HYDR; da Silveira LMY, 2007, Proceedings of the 26th International Conference on Offshore Mechanics and Arctic Engineering, Vol 1, P267; Goverdhan R., 2000, J FLUID MECH, V420, P85; Hoffman JD, 1992, NUMERICAL METHODS EN; Iwan W.D., 1974, J APPL MECH, V41, P581; MEIROVITCH L, 1989, DYNAMICS CONTROL STR; Meng D, 2012, APPL OCEAN RES, V34, P52, DOI 10.1016/j.apor.2011.10.002; Pesce C.P., 1999, P 9 INT OFFSH POL EN, P255; Resvanis T. L., 2011, P ASME 2011 30 INT C; Sparks C. P., 2007, FUNDAMENTALS MARINE; Swithenbank S.B., 2007, ASME 2011 26 INT C O; Tamura Y., 1979, P 5 INT C WIND ENG F, P1085; Tan LB, 2015, OCEAN ENG, V94, P19, DOI 10.1016/j.oceaneng.2014.11.007; Tognarelli M. A., 2004, OFFSH TECHN C HOUST; TRIANTAFYLLOU MS, 1991, J SOUND VIB, V148, P343, DOI 10.1016/0022-460X(91)90581-4; TRIANTAFYLLOU MS, 1984, Q J MECH APPL MATH, V37, P421, DOI 10.1093/qjmam/37.3.421; Vandiver JK, 1996, J FLUID STRUCT, V10, P555, DOI 10.1006/jfls.1996.0037; Vandiver J.K., 2006, OFFSH TECHN C; Vandiver J.K., 2003, IUTAM S INT MOD FULL	34	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0029-8018			OCEAN ENG	Ocean Eng.	AUG 1	2015	104						489	499		10.1016/j.oceaneng.2015.05.028		11	Engineering, Marine; Engineering, Civil; Engineering, Ocean; Oceanography	Engineering; Oceanography	CO4XV	WOS:000359165100041		
J	Nakamura, M; Nakaji, T; Muller, O; Hiura, T				Nakamura, Masahiro; Nakaji, Tatsuro; Muller, Onno; Hiura, Tsutom			Different initial responses of the canopy herbivory rate in mature oak trees to experimental soil and branch warming in a soil-freezing area	OIKOS			English	Article							CLIMATE-CHANGE; GLOBAL CHANGE; INSECT HERBIVORES; FOREST ECOSYSTEMS; PLANT-GROWTH; TEMPERATURE; IMPACTS; CONSEQUENCES; METAANALYSIS; COEVOLUTION	Plants and insects comprise more than 50% of known species on earth, and their interactions are of major importance in most natural ecosystems. To understand the mechanisms by which global warming affects plant-insect interactions in the canopy of mature cool-temperate forests with a freeze-thaw cycle, we examined changes in the herbivory rate and leaf traits in oak Quercus crispula. From 2007 to 2009, we experimentally increased the temperature of the surrounding soil and canopy branches of mature oak trees by approximately 5 degrees C using electric heating cables. Soil warming decreased the rate of herbivory in the canopy, whereas branch warming had no effect. The magnitude of the effect of soil warming on canopy herbivory varied. For the first year, the decrease was 32%, but this doubled (63%) in the third year. Branch warming did not affect canopy leaf traits; however, soil warming decreased the leaf nutritional quality by decreasing N and increasing the carbon: nitrogen (CN) ratio for three years. Additionally, soil warming increased total phenolics in the third year. Stepwise multiple regression models showed that among the leaf traits that were changed by soil warming, N explained the variation in herbivory for the first and second years, whereas total phenolics explained it for the third year. Our experimental results demonstrate that soil warming drives the rate of herbivory in the canopy of mature oak trees, and the magnitude of the soil warming effect was gradually enhanced during the initial three years. This suggests the importance of belowground temperature elevation in predicting the effect of global warming on plant-insect interactions in a forest canopy.	[Nakamura, Masahiro; Nakaji, Tatsuro; Muller, Onno; Hiura, Tsutom] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Tomakomai Res Stn, JP-0530035 Tomakomai, Japan; [Nakamura, Masahiro] Hokkaido Univ, Field Sci Ctr Northern Biosphere, Nakagawa Expt Forest, JP-0982501 Nakagawa, Japan	Nakamura, M (reprint author), Hokkaido Univ, Field Sci Ctr Northern Biosphere, Tomakomai Res Stn, JP-0530035 Tomakomai, Japan.	masahiro@fsc.hokudai.ac.jp			Japan Society for the Promotion of Science [26450188, 19657007, 21248017]; Ministry of Environment [D-0909]; Environment Research and Technology Development Fund [S-9-3]	This work was supported by grants from the Japan Society for the Promotion of Science (no. 26450188 to MN, no. 19657007 and 21248017 to TH), the Ministry of Environment (no. D-0909 to TH) and the Environment Research and Technology Development Fund (S-9-3).	Andersen L. C., 2005, OECOLOGIA, V144, P585; Nicotra AB, 2010, TRENDS PLANT SCI, V15, P684, DOI 10.1016/j.tplants.2010.09.008; FEENY P, 1970, ECOLOGY, V51, P565, DOI 10.2307/1934037; Bond BJ, 2000, TRENDS PLANT SCI, V5, P349, DOI 10.1016/S1360-1385(00)01691-5; EHRLICH PR, 1964, EVOLUTION, V18, P586, DOI 10.2307/2406212; Logan JA, 2003, FRONT ECOL ENVIRON, V1, P130, DOI 10.2307/3867985; Zvereva EL, 2006, GLOBAL CHANGE BIOL, V12, P27, DOI 10.1111/j.1365-2486.2005.01086.x; Schimel JP, 1996, SOIL BIOL BIOCHEM, V28, P1061, DOI 10.1016/0038-0717(96)00083-1; Nakamura M, 2010, AGR FOREST METEOROL, V150, P1026, DOI 10.1016/j.agrformet.2010.04.001; Delagrange S, 2004, TREE PHYSIOL, V24, P775; Harrington R, 1999, TRENDS ECOL EVOL, V14, P146, DOI 10.1016/S0169-5347(99)01604-3; Adams JM, 2009, J ECOL, V97, P933, DOI 10.1111/j.1365-2745.2009.01523.x; Hiura T, 2013, BASIC APPL ECOL, V14, P480, DOI 10.1016/j.baae.2013.06.004; Englund G, 2003, ADV ECOL RES, V33, P161, DOI 10.1016/S0065-2504(03)33011-9; Tierney GL, 2001, BIOGEOCHEMISTRY, V56, P175, DOI 10.1023/A:1013072519889; Bidart-Bouzat MG, 2008, J INTEGR PLANT BIOL, V50, P1339, DOI 10.1111/j.1744-7909.2008.00751.x; Shaver GR, 2000, BIOSCIENCE, V50, P871, DOI 10.1641/0006-3568(2000)050[0871:GWATEA]2.0.CO;2; Cornell HV, 2003, AM NAT, V161, P507, DOI 10.1086/368346; Melillo JM, 2002, SCIENCE, V298, P2173, DOI 10.1126/science.1074153; Dury SJ, 1998, GLOB CHANGE BIOL, V4, P55, DOI 10.1046/j.1365-2486.1998.00102.x; Ayres MP, 2000, SCI TOTAL ENVIRON, V262, P263, DOI 10.1016/S0048-9697(00)00528-3; Robinet C, 2010, INTEGR ZOOL, V5, P132, DOI 10.1111/j.1749-4877.2010.00196.x; Groffman PM, 2001, BIOGEOCHEMISTRY, V56, P135, DOI 10.1023/A:1013039830323; Weih M, 2001, NEW PHYTOL, V150, P147, DOI 10.1046/j.1469-8137.2001.00078.x; Moise ERD, 2010, OIKOS, V119, P791, DOI 10.1111/j.1600-0706.2009.18343.x; Bale JS, 2002, GLOBAL CHANGE BIOL, V8, P1, DOI 10.1046/j.1365-2486.2002.00451.x; Andrew NR, 2005, OIKOS, V108, P176, DOI 10.1111/j.0030-1299.2005.13457.x; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; DeLucia EH, 2012, PLANT PHYSIOL, V160, P1677, DOI 10.1104/pp.112.204750; Rustad LE, 2001, OECOLOGIA, V126, P543, DOI 10.1007/s004420000544; Veteli TO, 2002, GLOBAL CHANGE BIOL, V8, P1240, DOI 10.1046/j.1365-2486.2002.00553.x; Basset Y, 2003, STUDYING FOREST CANO, P27; Bronson DR, 2009, GLOBAL CHANGE BIOL, V15, P1534, DOI 10.1111/j.1365-2486.2009.01845.x; Chung H, 2013, J PLANT RES, V126, P447, DOI 10.1007/s10265-013-0565-3; Coley P.D., 1991, PLANT ANIMAL INTERAC, P25; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Hiura T, 2001, ECOL RES, V16, P887, DOI 10.1046/j.1440-1703.2001.00449.x; Intergovernmental Panel on Climate Change, 2007, CLIMATE CHANGE 2007; JULKUNENTIITTO R, 1985, J AGR FOOD CHEM, V33, P213, DOI 10.1021/jf00062a013; Jungqvist G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093957; Kozlov VM, 2008, CLIMATIC CHANGE, V87, P107, DOI [10.1007/s10584-007-9348-y, DOI 10.1007/S10584-007-9348-Y]; Nabeshima E, 2010, FOREST ECOL MANAG, V259, P1055, DOI 10.1016/j.foreco.2009.12.012; Nakamura M, 2010, OIKOS, V119, P1445, DOI 10.1111/j.1600-0706.2010.18255.x; PETERJOHN WT, 1993, OECOLOGIA, V93, P18; Price PW, 1997, INSECT ECOLOGY; Shibata H, 1998, WATER AIR SOIL POLL, V105, P63, DOI 10.1023/A:1005086400473; Strong DR, 1984, INSECTS PLANTS COMMU, P313; Ueda MU, 2013, SOIL BIOL BIOCHEM, V61, P105, DOI 10.1016/j.soilbio.2013.02.016; Ueda MU, 2011, ANN BOT-LONDON, V108, P169, DOI 10.1093/aob/mcr092; YOSHIDA K, 1985, Kontyu, V53, P125	50	0	0	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0030-1299	1600-0706		OIKOS	Oikos	AUG	2015	124	8					1071	1077		10.1111/oik.01940		7	Ecology	Environmental Sciences & Ecology	CO3LJ	WOS:000359058600012		
J	Kobayashi, H; Shigetomi, H; Yoshimoto, C				Kobayashi, Hiroshi; Shigetomi, Hiroshi; Yoshimoto, Chiharu			Checkpoint kinase 1 inhibitors as targeted molecular agents for clear cell carcinoma of the ovary (Review)	ONCOLOGY LETTERS			English	Article						chemoresistance; clear cell carcinoma; cell cycle checkpoint; targeted therapy	OXIDATIVE STRESS; DNA-DAMAGE; CANCER; ENDOMETRIOSIS; MECHANISMS; EXPRESSION; CARCINOGENESIS; IDENTIFICATION; ACCUMULATION; PATHOGENESIS	In clear cell carcinoma of the ovary, chemoresistance frequently results in treatment failure. The present study aimed to review the potential association of transcription factor hepatocyte nuclear factor (HNF)-1 beta with cell cycle checkpoint machinery, as a mechanism for chemoresistance. The English-language literature on the subject was reviewed to identify genomic alterations and aberrant molecular pathways interacting with chemoresistance in clear cell carcinoma. Oxidative stress induced by repeated hemorrhage induces greater susceptibility of endometriotic cells to DNA damage, and subsequent malignant transformation results in endometriosis-associated ovarian cancer. Molecular changes, including those in HNF-1 beta and checkpoint kinase 1 (Chk1), may be a manifestation of essential alterations in cell cycle regulation, detoxification and chemoresistance in clear cell carcinoma. Chk1 is a critical signal transducer in the cell cycle checkpoint machinery. DNA damage, in turn, increases persistent phosphorylation of Chk1 and induction of G2/M phase cell cycle arrest in cells overexpressing HNF-1 beta. HNF-1 beta deletion induces apoptosis, suggesting that enhanced levels of HNF-1 beta may be associated with chemoresistance. Targeted therapy with Chk1 inhibitors may be explored as a potential treatment modality for patients with clear cell carcinoma. This provides a novel direction for combination therapy, including targeting of Chk1, which may overcome drug resistance and improve treatment efficacy.	[Kobayashi, Hiroshi; Shigetomi, Hiroshi; Yoshimoto, Chiharu] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan	Kobayashi, H (reprint author), Nara Med Univ, Dept Obstet & Gynecol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	hirokoba@naramed-u.ac.jp			Ministry of Education, Science and Culture of Japan [26293361]	The present review was supported by a grant-in-aid for Scientific Research from the Ministry of Education, Science and Culture of Japan (no. 26293361) to the Department of Obstetrics and Gynecology, Nara Medical University (to Professor Hiroshi Kobayashi).	ABUGO OO, 1994, J BIOL CHEM, V269, P24845; Akasaka J, 2013, BIOMED REP, V1, P13, DOI DOI 10.3892/BR.2012.19; Cadet J, 1999, MUTAT RES-FUND MOL M, V424, P9, DOI 10.1016/S0027-5107(99)00004-4; Reinhardt HC, 2009, CURR OPIN CELL BIOL, V21, P245, DOI 10.1016/j.ceb.2009.01.018; Sugiyama T, 2000, CANCER, V88, P2584, DOI 10.1002/1097-0142(20000601)88:11<2584::AID-CNCR22>3.0.CO;2-5; Smith J, 2010, ADV CANCER RES, V108, P73, DOI [10.1016/B978-0-12-380888-2.00003-0, 10.1016/S0065.230X(10)08002.4]; Kobayashi H, 2009, ONCOL REP, V22, P233, DOI 10.3892/or_00000429; Wei HC, 1996, CARCINOGENESIS, V17, P73, DOI 10.1093/carcin/17.1.73; Mao TL, 2013, J GYNECOL ONCOL, V24, P376, DOI 10.3802/jgo.2013.24.4.376; Tsuda H, 2005, CLIN CANCER RES, V11, P6880, DOI 10.1158/1078-0432.CCR-05-0751; Ma CX, 2013, BREAST CANCER RES TR, V137, P483, DOI 10.1007/s10549-012-2378-9; Yamaguchi K, 2014, INT J CANCER, V135, P585, DOI 10.1002/ijc.28701; Kajihara H, 2012, INT J GYNECOL PATHOL, V31, P304, DOI 10.1097/PGP.0b013e318243a97b; Xue X, 2013, NUTRIENTS, V5, P2333, DOI 10.3390/nu5072333; Yamada Y, 2011, INT J GYNECOL CANCER, V21, P1200, DOI 10.1097/IGC.0b013e318222cfdd; Iida Y, 2012, INT J ONCOL, V40, P2122, DOI 10.3892/ijo.2012.1406; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Polak G, 2013, EUR J OBSTET GYN R B, V168, P187, DOI 10.1016/j.ejogrb.2012.12.043; Mandai M, 2011, CANCER LETT, V310, P129, DOI 10.1016/j.canlet.2011.06.039; Rolfs F, 2013, CANCER RES, V73, P3460, DOI 10.1158/0008-5472.CAN-12-4369; Kajihara H, 2010, ONCOL REP, V23, P1193, DOI 10.3892/or_00000750; Reed E, 2003, CLIN CANCER RES, V9, P5299; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2; Liu C, 2014, REDOX BIOL, V2, P211, DOI 10.1016/j.redox.2013.12.014; Dai Y, 2010, CLIN CANCER RES, V16, P376, DOI 10.1158/1078-0432.CCR-09-1029; Pectasides D, 2006, ONCOLOGIST, V11, P1089, DOI 10.1634/theoncologist11-10-1089; Takano M, 2006, BRIT J CANCER, V94, P1369, DOI 10.1038/sj.bjc.6603116; Reuter S, 2010, FREE RADICAL BIO MED, V49, P1603, DOI 10.1016/j.freeradbiomed.2010.09.006; Itamochi H, 2002, ONCOLOGY-BASEL, V62, P349, DOI 10.1159/000065067; Bulun SE, 2009, NEW ENGL J MED, V360, P268, DOI 10.1056/NEJMra0804690; Cuff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074562; Dzatic-Smiljkovic O, 2011, CLIN EXP OBSTET GYN, V38, P394; Hecht JL, 2009, CANCER EPIDEM BIOMAR, V18, P1624, DOI 10.1158/1055-9965.EPI-08-1214; Kaufmann SH, 2011, HAEMATOL-HEMATOL J, V96, P1619, DOI 10.3324/haematol.2011.049551; Kobayashi Hiroshi, 2011, Front Biosci (Elite Ed), V3, P529, DOI 10.2741/e267; Mahalingaiah PKS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087371; Mogami T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080359; Shigetomi H, 2014, INT J GYNECOL CANCER, V24, P838, DOI 10.1097/IGC.0000000000000136; Shikama K, 2003, EUR J BIOCHEM, V270, P4041, DOI 10.1046/j.1432-1033.2003.03791.x; Tanase Y, 2012, EXP THER MED, V3, P18, DOI 10.3892/etm.2011.376; Toyokuni S, 2011, J CLIN BIOCHEM NUTR, V48, P46, DOI 10.3164/jcbn.11-001FR; Yang Y, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-14; Yoshida S, 2009, CANCER TREAT REV, V35, P608, DOI 10.1016/j.ctrv.2009.07.002	43	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					571	576		10.3892/ol.2015.3268		6	Oncology	Oncology	CN8FX	WOS:000358676200001		
J	Imai, A; Ichigo, S; Matsunami, K; Takagi, H; Yasuda, K				Imai, Atsushi; Ichigo, Satoshi; Matsunami, Kazutoshi; Takagi, Hiroshi; Yasuda, Keigo			Clinical benefits of metformin in gynecologic oncology (Review)	ONCOLOGY LETTERS			English	Article						endometrial cancer; cervical cancer; ovarian cancer; diabetes mellitus; insulin; metformin	POLYCYSTIC-OVARY-SYNDROME; ENDOMETRIAL CANCER-CELLS; BREAST-CANCER; DIABETES-MELLITUS; INSULIN GLARGINE; INCIDENT CANCER; CYCLE ARREST; IN-VITRO; RISK; GROWTH	Evidence has suggested that diabetes may contribute to the initiation and progression of specific types of cancer. Metformin, a biguanide, has become the preferred first-line therapy for the treatment of type 2 diabetes. Metformin is inexpensive, has a proven safety profile and is able to be safely combined with additional antidiabetic agents. In addition to the well-established antidiabetic effects of metformin, there has also been notable interest in its antitumor properties. The present review discusses the emerging role of metformin as an example of an existing drug, used worldwide in the treatment of diabetes, which has been demonstrated to exert significant in vitro and in vivo anticancer activities and has thus been investigated in clinical trials. In gynecologic oncology, metformin has been suggested to exhibit significant treatment efficacy against endometrial cancer. Three studies have demonstrated the potential therapeutic effects of metformin on the survival outcome of patients with ovarian cancer and in ovarian cancer prevention. However, this evidence was based on observational studies. Metformin has been shown to exert no statistically significant beneficial effect on cervical cancer incidence or mortality. By cancer site, the current limited insights highlight the need for clinical investigations and better-designed studies, along with evaluation of the effects of metformin on cancer at other sites.	[Imai, Atsushi; Ichigo, Satoshi; Matsunami, Kazutoshi; Takagi, Hiroshi] Matsunami Gen Hosp, Dept Obstet & Gynecol, Gifu 5016062, Japan; [Imai, Atsushi] Matsunami Gen Hosp, Inst Endocrine Related Canc, Gifu 5016062, Japan; [Yasuda, Keigo] Matsunami Gen Hosp, Dept Endocrinol & Internal Med, Gifu 5016062, Japan	Imai, A (reprint author), Matsunami Gen Hosp, Inst Endocrine Related Canc, 185-1 Dendai, Gifu 5016062, Japan.	aimai@matsunami-hsp.or.jp					Kalender A, 2010, CELL METAB, V11, P390, DOI 10.1016/j.cmet.2010.03.014; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Noto H, 2013, J DIABETES INVEST, V4, P225, DOI 10.1111/jdi.12068; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Mannucci E, 2010, DIABETES CARE, V33, P1997, DOI 10.2337/dc10-0476; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Hanna RK, 2012, GYNECOL ONCOL, V125, P458, DOI 10.1016/j.ygyno.2012.01.009; Gotlieb WH, 2008, GYNECOL ONCOL, V110, P246, DOI 10.1016/j.ygyno.2008.04.008; Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310; Kubota Toshiro, 2013, Reproductive Medicine and Biology, V12, P71, DOI 10.1007/s12522-013-0145-1; Suissa S, 2014, DIABETES CARE, V37, P1786, DOI 10.2337/dc14-0500; Owen MR, 2000, BIOCHEM J, V348, P607, DOI 10.1042/0264-6021:3480607; DeCensi A, 2010, CANCER PREV RES, V3, P1451, DOI 10.1158/1940-6207.CAPR-10-0157; Currie CJ, 2012, DIABETES CARE, V35, P299, DOI 10.2337/dc11-1313; Lind M, 2012, PRIM CARE DIABETES, V6, P53, DOI 10.1016/j.pcd.2011.10.004; Abe R, 2008, CURR PHARM DESIGN, V14, P940, DOI 10.2174/138161208784139765; Zakikhani M, 2006, CANCER RES, V66, P10269, DOI 10.1158/0008-5472.CAN-06-1500; Nevadunsky NS, 2014, GYNECOL ONCOL, V132, P236, DOI 10.1016/j.ygyno.2013.10.026; Friberg E, 2007, DIABETOLOGIA, V50, P1365, DOI 10.1007/s00125-007-0681-5; Barclay AW, 2008, AM J CLIN NUTR, V87, P627; Home PD, 2010, DIABETOLOGIA, V53, P1838, DOI 10.1007/s00125-010-1804-y; Weinstein D, 2009, DIABETES-METAB RES, V25, P41, DOI 10.1002/dmrr.912; Rattan R, 2011, NEOPLASIA, V13, P483, DOI 10.1593/neo.11148; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Fogarty S, 2010, BBA-PROTEINS PROTEOM, V1804, P581, DOI 10.1016/j.bbapap.2009.09.012; Erices R, 2013, REPROD SCI, V20, P1433, DOI 10.1177/1933719113488441; Alimova IN, 2009, CELL CYCLE, V8, P909, DOI 10.4161/cc.8.6.7933; Zhang ZJ, 2014, DIABETES OBES METAB, V16, P707, DOI 10.1111/dom.12267; Costello MF, 2007, HUM REPROD, V22, P1200, DOI 10.1093/humrep/dem005; Treins C, 2006, BIOCHEM BIOPH RES CO, V342, P1197, DOI 10.1016/j.bbrc.2006.02.088; Xiao XX, 2012, GYNECOL ONCOL, V127, P249, DOI 10.1016/j.ygyno.2012.06.032; Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676; Fader AN, 2009, GYNECOL ONCOL, V114, P121, DOI 10.1016/j.ygyno.2009.03.039; Srokowski TP, 2009, J CLIN ONCOL, V27, P2170, DOI 10.1200/JCO.2008.17.5935; Cantrell LA, 2010, GYNECOL ONCOL, V116, P92, DOI 10.1016/j.ygyno.2009.09.024; Noto H, 2012, J DIABETES INVEST, V3, P24, DOI 10.1111/j.2040-1124.2011.00183.x; Del Barco S, 2011, ONCOTARGET, V2, P896; Ko EM, 2014, GYNECOL ONCOL, V132, P438, DOI 10.1016/j.ygyno.2013.11.021; Baur DM, 2010, METABOLISM, V60, P1363; Becker C, 2013, GYNECOL ONCOL, V129, P565, DOI 10.1016/j.ygyno.2013.03.009; Chodick G, 2010, CANCER CAUSE CONTROL, V21, P879, DOI 10.1007/s10552-010-9515-8; Costello M, 2007, COCHRANE DB SYST REV, V24, DOI DOI 10.1002/14651858.CD005552.PUB2; Dilokthornsakul P, 2013, INT J GYNECOL CANCER, V23, P1544, DOI 10.1097/IGC.0b013e3182a80a21; Dowling RJO, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-33; Engelman JA, 2010, CANCER PREV RES, V3, P1049, DOI 10.1158/1940-6207.CAPR-10-0178; Franciosi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071583; Gunter M, CANC EPIDEMIOL BIOMA, V17, P921; Kim TH, 2014, BIOMED RES INT, DOI 10.1155/2014/132702; Ljung R, 2011, ACTA ONCOL, V50, P685, DOI 10.3109/0284186X.2011.558913; Malek M., 2013, ISRN ENDOCRINOL, V2013; Pulito Claudio, 2013, Metabolites, V3, P1051, DOI 10.3390/metabo3041051; Saeedi R, 2008, AM J PHYSIOL-HEART C, V294, pH2497, DOI 10.1152/ajpheart.00873.2007; Sarfstein R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061537; Sen S, 2014, J DIABETES INVEST, V5, P251, DOI 10.1111/jdi.12208; Shao RJ, 2014, J EXP CLIN CANC RES, V33, DOI 10.1186/1756-9966-33-41; Stevens RJ, 2012, DIABETOLOGIA, V55, P2593, DOI 10.1007/s00125-012-2653-7; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Takahashi A, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-53; Tan B, 2012, J CLIN ENDOCR METAB, V96, P808; Yasmeen A, 2011, GYNECOL ONCOL, V121, P492, DOI 10.1016/j.ygyno.2011.02.021; Zhang Q, 2013, AM J OBSTET GYNECOL, V209, pe1	64	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					577	582		10.3892/ol.2015.3262		6	Oncology	Oncology	CN8FX	WOS:000358676200002		
J	Sasaki, T; Yamashita, Y; Kuniyasu, H				Sasaki, Takamitsu; Yamashita, Yuichi; Kuniyasu, Hiroki			AKT plays a crucial role in gastric cancer (Review)	ONCOLOGY LETTERS			English	Article						Helicobacter pylori; telomerase; hTERT; chronic gastritis	TELOMERASE REVERSE-TRANSCRIPTASE; HELICOBACTOR-PYLORI INFECTION; SHP-2 TYROSINE PHOSPHATASE; CAGA PROTEIN; CELL-CYCLE; STOMACH; PATHWAY; RNA; MUCOSA; PHOSPHORYLATION	The AKT protein is involved in the phosphatidylinositol-3 kinase signaling pathway and is a vital regulator of survival, proliferation and differentiation in various types of cells. Helicobacter pylori infection induces epithelial cell proliferation and oxidative stress in chronic gastritis. These alterations lead to telomere shortening, resulting in the activation of telomerase. AKT, in particular, is activated by H. pylori-induced inflammation. AKT then promotes the expression of human telomerase reverse transcriptase, which encodes a catalytic subunit of telomerase, and induces telomerase activity, an essential component of the process of carcinogenesis. AKT activation is increased in gastric mucosa with carcinogenic properties and is associated with the low survival of patients with gastric cancer. The findings of the present study suggest that AKT is pivotal in gastric carcinogenesis and progression.	[Sasaki, Takamitsu; Yamashita, Yuichi] Fukuoka Univ, Sch Med, Dept Surg Gastroenterol, Fukuoka 8128582, Japan; [Kuniyasu, Hiroki] Nara Med Univ, Dept Mol Pathol, Kashihara, Nara 6348521, Japan	Kuniyasu, H (reprint author), Nara Med Univ, Dept Mol Pathol, 840 Shijo Cho, Kashihara, Nara 6348521, Japan.	cooninh@zb4.so-net.ne.jp					Angrisano T, 2012, MED MICROBIOL IMMUN, V201, P249, DOI 10.1007/s00430-011-0227-9; Sukawa Y, 2012, WORLD J GASTROENTERO, V18, P6577, DOI 10.3748/wjg.v18.i45.6577; Downward J, 2004, SEMIN CELL DEV BIOL, V15, P177, DOI 10.1016/j.semcdb.2004.01.002; Sugano K, 2013, J GASTROEN HEPATOL, V28, P906, DOI 10.1111/jgh.12209; Kim JH, 2005, GENE DEV, V19, P776, DOI 10.1101/gad.1289405; Li H, 1998, J BIOL CHEM, V273, P33436, DOI 10.1074/jbc.273.50.33436; Murata M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/623019; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Hatakeyama M, 2004, NAT REV CANCER, V4, P688, DOI 10.1038/nrc1433; Kuniyasu H, 2003, ONCOLOGY-BASEL, V65, P275, DOI 10.1159/000074481; Avilion AA, 1996, CANCER RES, V56, P645; Blasco MA, 1996, NAT GENET, V12, P200, DOI 10.1038/ng0296-200; You M, 1999, MOL CELL BIOL, V19, P2416; Kuniyasu H, 2000, LANGENBECK ARCH SURG, V385, P69, DOI 10.1007/s004230050248; Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147; Kang SS, 1999, J BIOL CHEM, V274, P13085, DOI 10.1074/jbc.274.19.13085; Radisavljevic Z, 2013, J CELL PHYSIOL, V228, P21, DOI 10.1002/jcp.24115; FENG JL, 1995, SCIENCE, V269, P1236, DOI 10.1126/science.7544491; Ochiai A, 1996, INT J CANCER, V69, P28, DOI 10.1002/(SICI)1097-0215(19960220)69:1<28::AID-IJC6>3.0.CO;2-Y; Populo H, 2012, INT J MOL SCI, V13, P1886, DOI 10.3390/ijms13021886; Autexier C, 2006, ANNU REV BIOCHEM, V75, P493, DOI 10.1146/annurev.biochem.75.103004.142412; Claesson-Welsh L, 2013, J INTERN MED, V273, P114, DOI 10.1111/joim.12019; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; LINGNER J, 1995, SCIENCE, V269, P1533, DOI 10.1126/science.7545310; Xu M, 2012, CELL MOL LIFE SCI, V69, P3601, DOI 10.1007/s00018-012-1129-8; Beales ILP, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-97; Berg Marianne, 2012, Discov Med, V14, P207; Cheung M, 2013, CURR CANC DRUG TARGE; Fidler IJ, 2003, NAT REV CANCER, V3, P453, DOI 10.1038/nrc1098; GUERCI A, 1992, ANAL CELL PATHOL, V4, P381; Ho S B, 1996, Semin Gastrointest Dis, V7, P61; IARC, 1994, IARC SCI; Karamitopoulou Eva, 2012, Front Oncol, V2, P209, DOI 10.3389/fonc.2012.00209; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kuniyasu H, 1997, JPN J CANCER RES, V88, P103; Liu Z, 2012, ONCOGENE, V32, P4203; Ng L, 2013, CELL MOL LIFE SCI, V70, P3631, DOI 10.1007/s00018-013-1266-8; Ochiai A, 1997, MOL PATHOLOGY GASTRO, P43; Sasaki T, 2013, PATHOBIOLOGY, V81, P36, DOI 10.1159/000351721; Sasaki T, 2013, ANTICANCER RES, V33, P3295; Semba S, 1996, CANCER, V77, P1620, DOI 10.1002/(SICI)1097-0142(19960415)77:8+<1620::AID-CNCR6>3.0.CO;2-H; Tahara E, 1994, EUR J GASTR HEPAT S1, V6, P102; Tahara H, 1995, CLIN CANCER RES, V1, P1245; Testino G, 2001, AM J GASTROENTEROL, V96, P2514, DOI 10.1016/S0002-9270(01)02636-3; Tosh D, 2002, NAT REV MOL CELL BIO, V3, P187, DOI 10.1038/nrm761; Tsukamoto T, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0402-4; WEISS H, 1989, SCAND J GASTROENTERO, V24, P643; Yokozaki H, 1997, MOL PATHOLOGY GASTRO, P55	49	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					607	611		10.3892/ol.2015.3260		5	Oncology	Oncology	CN8FX	WOS:000358676200007		
J	Kobayashi, H; Sugimoto, H; Onishi, S; Nakano, K				Kobayashi, Hiroshi; Sugimoto, Hitomi; Onishi, Shunsuke; Nakano, Kazutoshi			Novel biomarker candidates for the diagnosis of ovarian clear cell carcinoma (Review)	ONCOLOGY LETTERS			English	Article						ovarian clear cell carcinoma; biomarker; gene expression profiling; proteomics	BREAST-CANCER; MALIGNANT-TRANSFORMATION; TUMOR PROGRESSION; OXIDATIVE STRESS; POOR-PROGNOSIS; EXPRESSION; ADENOCARCINOMA; MARKER; IDENTIFICATION; GENE	Ovarian clear cell carcinoma can arise from endometriosis; however, it is distinct from other types of epithelial ovarian carcinoma in terms of its clinicopathological and molecular features. Cancer antigen 125 lacks the sensitivity and specificity required for accurate clinical diagnosis of clear cell carcinoma. Therefore, the aim of the current review was to identify novel biomarker candidates for the immunohistochemical and serological diagnosis of clear cell carcinoma. A search of the relevant English language literature published between 1966 and 2014 was conducted using the PubMed MEDLINE online database. High-throughput tissue microarray technology and proteomic screening combined with mass spectrometry may provide additional information regarding diagnostic biomarker candidates for ovarian clear cell carcinoma. The present review summarizes the characteristics of potential genomic alterations that activate cancer signaling pathways and, thus, contribute to carcinogenesis. The major signaling pathways activated in clear cell carcinoma are associated with cell cycle regulation (hepatitis A virus cellular receptor 1 and tumor protein D52), growth factor signaling (insulin-like growth factor binding protein 1; KiSS-1 metastasis-suppressor; erb-b2 receptor tyrosine kinase 2; and fibroblast growth factor receptor 2), anti-apoptosis and survival pathways [sialidase 3 (membrane sialidase)], metabolism (gamma-glutamyltransferase 1), chemoresistance (napsin A aspartic peptidase, glutathione peroxidase 3; and aldehyde dehydrogenase 1 family, member A1), coagulation [coagulation factor III (thromboplastin, tissue factor); and tissue factor pathway inhibitor 2], signaling (lectin, galactoside-binding and soluble, 3), and adhesion and the extracellular matrix [cadherin 1, type 1, E-cadherin (epithelial); versican; and laminin, a 5]. The present review of the relevant literature may provide a basis for additional clinical investigation of the ovarian clear cell carcinoma serum biomarker candidate proteins identified herein.	[Kobayashi, Hiroshi; Sugimoto, Hitomi; Onishi, Shunsuke; Nakano, Kazutoshi] Nara Med Univ, Dept Obstet & Gynecol, Kashihara, Nara 6348522, Japan	Kobayashi, H (reprint author), Nara Med Univ, Dept Obstet & Gynecol, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	hirokoba@naramed-u.ac.jp			Ministry of Education, Science and Culture of Japan	The present review was supported by a grant-in-aid for Scientific Research received from the Ministry of Education, Science and Culture of Japan, and granted to Professor Hiroshi Kobayashi of the Department of Obstetrics and Gynecology, Nara Medical University (Kashihara, Japan).	Akahane T, 2005, INT J GYNECOL PATHOL, V24, P369, DOI 10.1097/01.pgp.0000165173.90339.a2; Alkatout I, 2015, MODERN PATHOL, V28, P69, DOI 10.1038/modpathol.2014.82; Nezhat F, 2002, CANCER, V94, P2935, DOI 10.1002/cncr.10566; Gadducci A, 2014, GYNECOL ENDOCRINOL, V30, P612, DOI 10.3109/09513590.2014.926325; Arakawa N, 2013, J PROTEOME RES, V12, P4340, DOI 10.1021/pr400282j; Saeki H, 2012, ONCOL LETT, V4, P637, DOI 10.3892/ol.2012.796; Yamamoto S, 2008, MODERN PATHOL, V21, P115, DOI 10.1038/modpathol.3800984; Abu Saadeh F, 2013, THROMB RES, V132, P627, DOI 10.1016/j.thromres.2013.09.016; Ho CM, 2010, INT J GYNECOL CANCER, V20, P1490, DOI 10.1111/IGC.0b013e3181e68a4d; Min KW, 2013, INT J GYNECOL PATHOL, V32, P3, DOI 10.1097/PGP.0b013e31825554e9; Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Fujimura M, 2002, JPN J CANCER RES, V93, P1250; Senkel S, 2005, BBA-GENE STRUCT EXPR, V1731, P179, DOI 10.1016/j.bbaexp.2005.10.003; Kusumoto T, 2010, ONCOL REP, V23, P917, DOI 10.3892/or_00000715; Boonjaraspinyo S, 2012, TUMOR BIOL, V33, P1785, DOI 10.1007/s13277-012-0438-8; Suh EJ, 2012, EXP MOL MED, V44, P36, DOI 10.3858/emm.2012.44.1.003; Kuo KT, 2009, AM J PATHOL, V174, P1597, DOI 10.2353/ajpath.2009.081000; Bell JL, 2013, CELL MOL LIFE SCI, V70, P2657, DOI 10.1007/s00018-012-1186-z; Yamamoto S, 2011, MODERN PATHOL, V24, P1146, DOI 10.1038/modpathol.2011.70; Sugita S, 2011, HISTOPATHOLOGY, V58, P729, DOI 10.1111/j.1365-2559.2011.03817.x; Tsuda H, 2005, CLIN CANCER RES, V11, P6880, DOI 10.1158/1078-0432.CCR-05-0751; Nomura H, 2006, ONCOL RES, V16, P289; Wang HM, 2006, MODERN PATHOL, V19, P1149, DOI 10.1038/modpathol.3800637; Ho CM, 2010, EUR J CLIN INVEST, V40, P310, DOI 10.1111/j.1365-2362.2010.02266.x; Balan V, 2013, ONCOTARGET, V4, P542; Yamamoto S, 1997, BRIT J CANCER, V76, P1221, DOI 10.1038/bjc.1997.537; Li WD, 2013, INT J CLIN EXP PATHO, V6, P2535; Kato N, 2007, DIAGN CYTOPATHOL, V35, P193, DOI 10.1002/dc.20623; Lalwani N, 2011, RADIOGRAPHICS, V31, P625, DOI 10.1148/rg.313105066; Liang L, 2014, INT J ONCOL, V45, P659, DOI 10.3892/ijo.2014.2451; Tsuchiya A, 2003, AM J PATHOL, V163, P2503, DOI 10.1016/S0002-9440(10)63605-X; Miao Y, 2009, INT J GYNECOL CANCER, V19, P1545, DOI 10.1111/IGC.0b013e3181a844c8; Yamaguchi K, 2010, ONCOGENE, V29, P1741, DOI 10.1038/onc.2009.470; Jiang LL, 2011, CLIN CANCER RES, V17, P6924, DOI 10.1158/1078-0432.CCR-11-0588; [Anonymous], 2012, INT J GYNECOL PATHOL, V31, P2542; Jacobs IJ, 2004, MOL CELL PROTEOMICS, V3, P355, DOI 10.1074/mcp.R400006-MCP200; Campbell IG, 2004, CANCER RES, V64, P7678, DOI 10.1158/0008-5472.CAN-04-2933; Hirasawa A, 2003, CLIN CANCER RES, V9, P1995; Sundar IK, 2013, ANTIOXID REDOX SIGN, V18, P1956, DOI 10.1089/ars.2012.4863; Haruta S, 2011, ONCOL REP, V26, P1347, DOI 10.3892/or.2011.1456; Arnason T, 2013, CANCER BIOL THER, V14, P672, DOI 10.4161/cbt.25089; Byrne JA, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-497; Canbay E, 2012, WORLD J SURG, V36, P2218, DOI 10.1007/s00268-012-1636-7; Canet B, 2011, HUM PATHOL, V42, P833, DOI 10.1016/j.humpath.2010.08.022; Clayton EF, 2013, ANN DIAGN PATHOL, V17, P192, DOI 10.1016/j.anndiagpath.2012.10.006; Cuff J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074562; Gutgemann I, 2008, MODERN PATHOL, V21, P445, DOI 10.1038/modpathol.3801022; Kaneuchi M, 2004, BIOCHEM BIOPH RES CO, V316, P1156, DOI 10.1016/j.bbrc.2004.02.171; Kato N, 2007, VIRCHOWS ARCH, V450, P273, DOI 10.1007/s00428-006-0354-7; Kuroda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065158; Lee HJ, 2011, MED ONCOL, V28, pS522, DOI 10.1007/s12032-010-9659-0; Li B, 2009, INT J GYNECOL CANCER, V19, P1347, DOI 10.1111/IGC.0b013e3181a83f1d; Lin F, 2008, AM J CLIN PATHOL, V129, P592, DOI [10.1309/Q0FLUXFJ4FTTW1XR, 10.1309/Q0FLUXFJ4FTTVV1XR]; Lin F, 2007, AM J SURG PATHOL, V31, P371, DOI 10.1097/01.pas.0000213353.95508.67; Maeda D, 2009, MODERN PATHOL, V22, P824, DOI 10.1038/modpathol.2009.40; Mahata Pritha, 2006, Genome Inform, V17, P184; Maretzky T, 2009, CANCER RES, V69, P4573, DOI 10.1158/0008-5472.CAN-08-4766; Mehla K, 2014, BBA-REV CANCER, V1845, P126, DOI 10.1016/j.bbcan.2014.01.001; Miyamoto M, 2014, BRIT J CANCER, V110, P2881, DOI 10.1038/bjc.2014.255; Nishimura S, 2010, INT J GYNECOL CANCER, V20, P220, DOI 10.1111/IGC.0b013e3181ca1e16; NOZAWA S, 1990, CANCER RES, V50, P754; Oe S, 2010, INT J GYNECOL PATHOL, V29, P405, DOI 10.1097/PGP.0b013e3181d3261e; Prentice LM, 2007, BMC MED, V15, P5; Quattrocchi L, 2013, J OBSTET GYNAECOL RE, V39, P297, DOI 10.1111/j.1447-0756.2012.01949.x; Samartzis EP, 2013, INT J MOL SCI, V14, P18824, DOI 10.3390/ijms140918824; Shigetomi H, 2014, INT J GYNECOL CANCER, V24, P838, DOI 10.1097/IGC.0000000000000136; Shigetomi H, 2012, GYNECOL ENDOCRINOL, V28, P897, DOI 10.3109/09513590.2012.683071; Shimizu M, 1999, CANCER, V85, P669, DOI 10.1002/(SICI)1097-0142(19990201)85:3<669::AID-CNCR17>3.0.CO;2-F; Skirnisdottir I, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-524; Sonmez H, 1999, CANCER LETT, V136, P75, DOI 10.1016/S0304-3835(98)00295-X; Spowart JE, 2012, J PATHOL, V228, P437, DOI 10.1002/path.4090; Suzuki S, 2011, CANCER SCI, V102, P1622, DOI 10.1111/j.1349-7006.2011.02003.x; Taniguchi F, 2013, INT J GYNECOL CANCER, V23, P791, DOI 10.1097/IGC.0b013e31828f38c4; Tsuda H, 2004, ONCOLOGY-BASEL, V67, P291, DOI 10.1159/000081332; Uekuri C, 2013, ONCOL LETT, V6, P1163, DOI 10.3892/ol.2013.1550; Yoffou PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020705	76	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					612	618		10.3892/ol.2015.3367		7	Oncology	Oncology	CN8FX	WOS:000358676200008		
J	Kita, H; Okamoto, K; Kushima, R; Kawauchi, A; Chano, T				Kita, Hiroko; Okamoto, Keisei; Kushima, Ryoji; Kawauchi, Akihiro; Chano, Tokuhiro			Dimethyl sulfoxide induces chemotherapeutic resistance in the treatment of testicular embryonal carcinomas	ONCOLOGY LETTERS			English	Article						embryonal carcinoma; dimethyl sulfoxide; cisplatin; differentiation; methylation	GERM-CELL TUMORS; GLOBAL DNA METHYLATION; ADJUVANT CHEMOTHERAPY; TESTIS; CISPLATIN; CANCER; DIFFERENTIATION; SURVEILLANCE; REACTIVATION; NONSEMINOMA	Dimethyl sulfoxide (DMSO) is an amphipathic molecule that is used as a solvent in biological studies and as a vehicle for drug therapy. The present study was designed to evaluate the potential effects of DMSO as a solvent in the treatment of testicular embryonal carcinomas (ECs). DMSO was applied to two human EC cell lines (NEC8 and NEC14), with the treated cells evaluated in relation to cisplatin (CDDP) resistance, differentiation (using Vimentin, Fibronectin, TRA-1-60, and SSEA-1 and -3 as markers) and stemness (denoted by expression of SOX2 and OCT3/4). Furthermore, DNA methyltransferase (DNMT-1, -3A and -3L) expression and methylation status were analyzed. DMSO induced resistance to CDDP, aberrant differentiation and reduction of stemness-related markers in each of the EC cell lines. The expression levels of DNMT-3L and -3A were reduced in response to DMSO, while this treatment also affected DNA methylation. The data demonstrated that DMSO perturbed differentiation, reduced stemness and induced resistance to CDDP in human EC cells. Therefore, DMSO could reduce drug efficacy against EC cells and its use should be carefully managed in the clinical application of chemotherapy.	[Kita, Hiroko; Kushima, Ryoji; Chano, Tokuhiro] Shiga Univ Med Sci, Dept Clin Lab Med, Otsu, Shiga 5202192, Japan; [Kita, Hiroko; Okamoto, Keisei; Kawauchi, Akihiro] Shiga Univ Med Sci, Dept Urol, Otsu, Shiga 5202192, Japan	Chano, T (reprint author), Shiga Univ Med Sci, Dept Clin Lab Med, Tsukinowa Cho, Otsu, Shiga 5202192, Japan.	chano@belle.shiga-med.ac.jp			KAKENHI from the Ministry of Education, Culture, Sports, Science and Technology, Japan [25293130]	This study was supported by KAKENHI (Grant-in-Aids for Scientific Research) from the Ministry of Education, Culture, Sports, Science and Technology, Japan (grant no. 25293130).	Amato RJ, 2004, UROLOGY, V63, P144, DOI 10.1016/j.urology.2003.08.045; Yang AS, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh032; Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Looijenga LHJ, 2007, ANN NY ACAD SCI, V1120, P187, DOI 10.1196/annals.1411.000; FREEDMAN LS, 1987, LANCET, V2, P294; Masters JRW, 2003, NAT REV CANCER, V3, P517, DOI 10.1038/nrc1120; Adler S, 2006, TOXICOL IN VITRO, V20, P265, DOI 10.1016/j.tiv.2005.06.043; Ushida H, 2012, MOL CARCINOGEN, V51, P711, DOI 10.1002/mc.20831; ULBRIGHT TM, 1993, AM J SURG PATHOL, V17, P1075, DOI 10.1097/00000478-199311000-00001; Wermann H, 2010, J PATHOL, V221, P433, DOI 10.1002/path.2725; Cullen MH, 1996, J CLIN ONCOL, V14, P1106; Pal R, 2012, ARCH TOXICOL, V86, P651, DOI 10.1007/s00204-011-0782-2; Vergouwe Y, 2003, J CLIN ONCOL, V21, P4092, DOI 10.1200/JCO.2003.01.094; READ G, 1992, J CLIN ONCOL, V10, P1762; Sonneveld DJA, 2001, CANCER, V91, P1304, DOI 10.1002/1097-0142(20010401)91:7<1304::AID-CNCR1133>3.0.CO;2-A; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; Santos NC, 2003, BIOCHEM PHARMACOL, V65, P1035, DOI 10.1016/S0006-2952(03)00002-9; Frevel MAE, 1999, J BIOL CHEM, V274, P29331, DOI 10.1074/jbc.274.41.29331; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990; Dunn TA, 1997, INVEST NEW DRUG, V15, P109, DOI 10.1023/A:1005800520747; Guney S, 2009, MED ONCOL, V26, P136, DOI 10.1007/s12032-008-9095-6; Koul S, 2004, MOL CANCER, V3, DOI 10.1186/1476-4598-3-16; Minami K, 2010, CLIN CANCER RES, V16, P2751, DOI 10.1158/1078-0432.CCR-09-3338; Okamoto K, INT J UROL, V19, P504; Oliver RTD, 2004, UROLOGY, V63, P556, DOI 10.1016/j.urology.2003.10.023; Pectasides D, 2009, CRIT REV ONCOL HEMAT, V70, P114, DOI 10.1016/j.critrevonc.2008.07.018; SKAKKEBA.NE, 1972, LANCET, V2, P516; Ushida H, 2012, J UROLOGY, V187, P1876, DOI 10.1016/j.juro.2011.12.058; Wohrle D, 2001, AM J HUM GENET, V69, P504, DOI 10.1086/322739	29	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					661	666		10.3892/ol.2015.3306		6	Oncology	Oncology	CN8FX	WOS:000358676200016		
J	Suzuki, O; Abe, M; Hashimoto, Y				Suzuki, Osamu; Abe, Masafumi; Hashimoto, Yuko			Caspase-dependent drug-induced apoptosis is regulated by cell surface sialylation in human B-cell lymphoma	ONCOLOGY LETTERS			English	Article						human malignant lymphoma; sialic acid; drug apoptosis	ETOPOSIDE-INDUCED APOPTOSIS; TOPOISOMERASE-II; LECTIN-BINDING; SIALIC ACIDS; BURKITTS-LYMPHOMA; ACTIVATION; ROLES; DEATH; LINES; DNA	The important role of sialic acid in various biological phenomena is well-established. In order to further clarify the role of sialic acid in cell death induced by various stimuli, the present study compared the cell survival of the HBL-2 human diffuse large B-cell lymphoma cell line upon anticancer drug-induced cell death, with or without neununinidase pretreatment: Cell survival was assessed using flow cytometry. Upon treatment with doxorubicin or ctoposide, the HBL-2 cell viability decreased. In etoposide-induced cell death, the HBL-2 cells demonstrated nuclear fragmentation, which was consistent with morphologically apoptotic cells. In addition, a higher decrease in the cell viability of ctoposide-treated HBL-2 cells was observed in cells pretreated with neuraminidase compared with cells that were not pretreated. Furthermore, the caspase-3, caspase-8 and caspase-9 activities in etoposide-induced apoptosis demonstrated a greater increase upon ricuraminidase pretreatment compared with no neuraminidase pretreatment. In conclusion, cell surface sialylation appears to protect lymphoma cells from anticancer drug-induced apoptosis.	[Suzuki, Osamu; Abe, Masafumi; Hashimoto, Yuko] Fukushima Med Univ, Sch Med, Dept Diagnost Pathol, Fukushima 9601295, Japan	Suzuki, O (reprint author), Fukushima Med Univ, Sch Med, Dept Diagnost Pathol, 1 Hikariga Oka, Fukushima 9601295, Japan.	osuzuki@fmu.ac.jp					Abe M, 1996, PATHOL INT, V46, P977, DOI 10.1111/j.1440-1827.1996.tb03577.x; ALTEVOGT P, 1983, CANCER RES, V43, P5138; Scaffidi C, 1998, EMBO J, V17, P1675, DOI 10.1093/emboj/17.6.1675; Karpinich NO, 2002, J BIOL CHEM, V277, P16547, DOI 10.1073/jbc.M110629200; Chandra D, 2004, MOL CELL BIOL, V24, P6592, DOI 10.1128/mcb.24.15.6592-6607.2004; Suzuki O, 1999, PATHOL INT, V49, P874, DOI 10.1046/j.1440-1827.1999.00960.x; Burden DA, 1998, BBA-GENE STRUCT EXPR, V1400, P139, DOI 10.1016/S0167-4781(98)00132-8; Suzuki O, 2005, INT J ONCOL, V26, P1063; MIZUMOTO K, 1994, MOL PHARMACOL, V46, P890; Kelm S, 1997, INT REV CYTOL, V175, P137; Lin CF, 2004, J BIOL CHEM, V279, P40755, DOI 10.1074/jbc.M404726200; Suzuki O, 2003, ONCOL REP, V10, P1759; Suzuki O, 2006, INT J ONCOL, V28, P155; YOGEESWARAN G, 1981, SCIENCE, V212, P1514, DOI 10.1126/science.7233237; Gamen S, 2000, EXP CELL RES, V258, P223, DOI 10.1006/excr.2000.4924; Varki A, 1997, FASEB J, V11, P248; Boesen-de Cock JGR, 1999, J BIOL CHEM, V274, P14255, DOI 10.1074/jbc.274.20.14255; CHEN GL, 1984, J BIOL CHEM, V259, P3560; DENNIS J, 1982, NATURE, V300, P274, DOI 10.1038/300274a0; Halaas JL, 2005, LEUKEMIA LYMPHOMA, V46, P541, DOI 10.1080/10428190400029932; Ma H, 2015, ONCOGENE, V34, P726, DOI 10.1038/onc.2014.7; Suzuki O, 2003, INT J ONCOL, V23, P769; Suzuki O, 2002, INT J ONCOL, V20, P1005; Zinzani PL, 2002, ANN ONCOL, V13, P1364, DOI 10.1093/annonc/mdf208	24	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					687	690		10.3892/ol.2015.3320		4	Oncology	Oncology	CN8FX	WOS:000358676200020		
J	Li, W; Wen, CY; Bai, HY; Wang, XY; Zhang, XL; Huang, LL; Yang, XL; Iwamoto, A; Liu, HL				Li, Wen; Wen, Chuangyu; Bai, Haiyan; Wang, Xiaoyan; Zhang, Xiaoli; Huang, Lanlan; Yang, Xiangling; Iwamoto, Aikichi; Liu, Huanliang			JNK signaling pathway is involved in piperlongumine-mediated apoptosis in human colorectal cancer HCT116 cells	ONCOLOGY LETTERS			English	Article						piperlongumine; colorectal cancer; c-Jun NH2-terminal kinases; apoptosis; phosphorylation; SP600125	N-TERMINAL-KINASE; C-JUN; INHIBITS PROLIFERATION; MAP KINASES; ACTIVATION; DEATH; ERK; PHOSPHORYLATION; INDUCTION; STRESS	Piperlongumine (PPLGM), an alkaloid isolated from the long pepper (Piper longum L.), can selectively trigger cancer cell death in colorectal cancer cells. The present study investigated whether the c-Jun NH2-terminal kinase (JNK) signaling pathway is involved in PPLGM-induced apoptosis in the human colorectal cancer HCT116 cell line. The results demonstrated that PPLGM reduced the cell viability and induced cell apoptosis in a time- and concentration-dependent manner, without a significant effect on cell cycle distribution. Meanwhile, treatment with 10 mu M PPLGM resulted in JNK activation within 1 h, and a marked and sustained increase in c-Jun phosphorylation in the HCT116 cells. In addition, SP600125, a general inhibitor of JNK, inhibited PPIGM-induced apoptosis in the HCTH6 cells by inhibiting PPI,GM-induced c-Jun phosphorylation. Altogether, it can be concluded that the.INK signaling pathway, at least in part, is involved in PPLGM-mediated apoptosis in HCI116 cells.	[Li, Wen; Wen, Chuangyu; Wang, Xiaoyan; Zhang, Xiaoli; Huang, Lanlan; Yang, Xiangling; Liu, Huanliang] Sun Yat Sen Univ, Guangdong Inst Gastroenterol, Guangzhou 510655, Guangdong, Peoples R China; [Li, Wen; Wen, Chuangyu; Wang, Xiaoyan; Zhang, Xiaoli; Huang, Lanlan; Yang, Xiangling; Liu, Huanliang] Sun Yat Sen Univ, Affiliated Hosp 6, Guangzhou 510655, Guangdong, Peoples R China; [Li, Wen; Wen, Chuangyu; Wang, Xiaoyan; Huang, Lanlan; Yang, Xiangling; Liu, Huanliang] Sun Yat Sen Univ, Guangdong Prov Key Lab Colorectal & Pelv Floor Di, Guangzhou 510655, Guangdong, Peoples R China; [Li, Wen; Wen, Chuangyu; Wang, Xiaoyan; Huang, Lanlan; Yang, Xiangling; Liu, Huanliang] Sun Yat Sen Univ, Inst Human Virol, Guangzhou 510080, Guangdong, Peoples R China; [Li, Wen] Guangzhou Med Univ, Guangdong Prov Key Lab Allergy & Immunol, Guangzhou 511436, Guangdong, Peoples R China; [Bai, Haiyan] Sun Yat Sen Univ, Ctr Canc, State Key Lab Oncol South China, Guangzhou 510080, Guangdong, Peoples R China; [Iwamoto, Aikichi] Univ Tokyo, Inst Med Sci, Adv Clin Res Ctr, Tokyo 1088639, Japan	Liu, HL (reprint author), Sun Yat Sen Univ, Guangdong Inst Gastroenterol, 26 Yuancun Er Heng Rd, Guangzhou 510655, Guangdong, Peoples R China.	huanliang.liu@gmail.com		Liu, Huanliang/0000-0002-1006-6666	Sun Yat-sen University '100 Talents Program'; Guangdong Innovative Research Team Program [2009010058]; Science and Information Technology Bureau of Guangzhou, Guangdong [2011J5200009]; Guangdong Provincial Department of Science and Technology, Overseas Excellent Professor Project [2012B050500004]; Japanese Ministry of Education, Culture, Sports, Science and Technology, Program of Japanese Initiative for Global Research Network on Infectious Diseases	The authors would like to thank Dr Xinhui Fu, Dr Zihuan Yang, Dr Jun Hu and Nts. Zhiting Chen for providing technical assistance. This study was supported by Sun Yat-sen University '100 Talents Program', the Guangdong Innovative Research Team Program (grant no. 2009010058), the Science and Information Technology Bureau of Guangzhou, Guangdong (grant no. 2011J5200009), the Guangdong Provincial Department of Science and Technology (grant no. 2012B050500004), Overseas Excellent Professor Project, and the Japanese Ministry of Education, Culture, Sports, Science and Technology, Program of Japanese Initiative for Global Research Network on Infectious Diseases.	Shrivastava S, 2014, APOPTOSIS, V19, P1148, DOI 10.1007/s10495-014-0991-2; Randhawa H, 2013, TOXICOL IN VITRO, V27, P1626, DOI 10.1016/j.tiv.2013.04.006; Adams DJ, 2012, P NATL ACAD SCI USA, V109, P15115, DOI 10.1073/pnas.1212802109; Fuchs SY, 1996, ONCOGENE, V13, P1531; Kong EH, 2008, ONCOL REP, V20, P785, DOI 10.3892/or_00000075; Xu CJ, 2006, CARCINOGENESIS, V27, P437, DOI 10.1093/carcin/bgi251; Kuntzen C, 2005, CANCER RES, V65, P6780, DOI 10.1158/0008-5472.CAN-04-2618; HAM J, 1995, NEURON, V14, P927, DOI 10.1016/0896-6273(95)90331-3; Bezerra DP, 2007, TOXICOL IN VITRO, V21, P1, DOI 10.1016/j.tiv.2006.07.007; Kyriakis JM, 2012, PHYSIOL REV, V92, P689, DOI 10.1152/physrev.00028.2011; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Liu JM, 2013, BIOCHEM BIOPH RES CO, V437, P87, DOI 10.1016/j.bbrc.2013.06.042; Musti AM, 1997, SCIENCE, V275, P400, DOI 10.1126/science.275.5298.400; Hu R, 2003, CARCINOGENESIS, V24, P1361, DOI 10.1093/carcin/bgg092; XIA ZG, 1995, SCIENCE, V270, P1326, DOI 10.1126/science.270.5240.1326; Jarvius M, 2013, BIOCHEM BIOPH RES CO, V431, P117, DOI 10.1016/j.bbrc.2013.01.017; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; BossyWetzel E, 1997, EMBO J, V16, P1695, DOI 10.1093/emboj/16.7.1695; Podar K, 2007, CANCER RES, V67, P1680, DOI 10.1158/0008-5472.CAN-06-1863; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Bezerra DP, 2013, EUR J PHARM SCI, V48, P453, DOI 10.1016/j.ejps.2012.12.003; Raj L, 2011, NATURE, V475, P231, DOI 10.1038/nature10167; CHATTERJ.A, 1967, TETRAHEDRON, V23, P1769, DOI 10.1016/S0040-4020(01)82575-8; Han SS, 2013, LEUKEMIA RES, V37, P146, DOI 10.1016/j.leukres.2012.11.009; Kim TH, 2014, NEURO-ONCOLOGY, V16, P1354, DOI 10.1093/neuonc/nou088; Molton SA, 2003, ONCOGENE, V22, P4690, DOI 10.1038/sj.onc.1206692; Siegel R, 2014, CA-CANCER J CLIN, V2014, P9, DOI DOI 10.3322/CAAC.21208; Song MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065821; Teraishi F, 2005, CANCER RES, V65, P6380, DOI 10.1158/0008-5472.CAN-05-0575; Wang NP, 1999, CIRC RES, V85, P387; Wang Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.292	32	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					709	715		10.3891/ol.2015.3371		7	Oncology	Oncology	CN8FX	WOS:000358676200024		
J	Abdo, W; Hirata, A; Shukry, M; Kamal, T; Abdel-Sattar, E; Mahrous, E; Yanai, T				Abdo, Walied; Hirata, Akihiro; Shukry, Mostafa; Kamal, Tarek; Abdel-Sattar, Essam; Mahrous, Engi; Yanai, Tokuma			Calligonum comosum extract inhibits diethylnitrosamine-induced hepatocarcinogenesis in rats	ONCOLOGY LETTERS			English	Article						Calligonum comosum; diethylnitrosam ne; liver; rat; glutathione S-transferase placental form; oval cell proliferation	GREEN TEA; LIVER; SUPPRESSES; CANCER; CELLS; PROLIFERATION; EGYPT	Calligonum comosum (C. comosum) is an Egyptian desert plant that contains polyphenol antioxidants. The present study examined the chemopreventive effect of an extract of C. comosum in a rat model of hepatocarcinogenesis. Male Wistar rats (n=40) were administered 100.mg/kg diethylnitrosamine (DEN) by intraperitoneal (i.p.) injection once a week for 3 weeks. Subsequently, depending on whether the rats received further administration of 0.8 mg/kg carbon tetrachloride (CCI4).i.p. once a week.for 7 weeks and 100 mg/kg C. comosum extract in their diet for 7 weeks, the rats were divided into four groups as follows: Group I, treatment with DEN alone; group 2, treatment with DEN and C. comosum extract; group 3, treatment with DEN and CC14; and group 4, treatment with DEN, CCI4 and C. comosum extract. The supplementation of C. comosum extract significantly suppressed the elevation in serum liver enzyme levels, including aspartate aminotransferase, alanine transaminase and y-glutamy.1 transferase, and reduced the degree of oval cell proliferation induced by DEN and CCL. In addition, C. comosum extract significantly decreased the number and area of glutathione 5-transferase placental form-positive preneoplastic hepatic foci induced by DEN, with or without CCL treatment. To the best of our knowledge, the present study is the.first to provide definitive evidence of the hepatoprotective and chemopreventive effects of C. comosum.	[Abdo, Walied] Kafrelsheikh Univ, Fac Vet Med, Dept Pathol, Kafr Al Sheikh 33516, Egypt; [Abdo, Walied; Yanai, Tokuma] Gifu Univ, Lab Vet Pathol, Dept Vet Med, Fac Appl Biol Sci, Gifu 5011193, Japan; [Hirata, Akihiro] Gifu Univ, Life Sci Res Ctr, Div Anim Expt, Gifu 5011193, Japan; [Shukry, Mostafa] Kafrelsheikh Univ, Fac Vet Med, Dept Physiol, Kafr Al Sheikh 33516, Egypt; [Kamal, Tarek] Kafrelsheikh Univ, Fac Vet Med, Dept Biochem, Kafr Al Sheikh 33516, Egypt; [Abdel-Sattar, Essam; Mahrous, Engi] Cairo Univ, Dept Pharmacognosy, Fac Pharm, Cairo 11562, Egypt	Abdo, W (reprint author), Kafrelsheikh Univ, Fac Vet Med, Dept Pathol, El Giesh St, Kafr Al Sheikh 33516, Egypt.	waliedsobhy@yahoo.com			Science and Technology fund of Kafrelsheikh University, Egypt [33-2013]	This study was supported, in part, by a grant from the Science and Technology fund of Kafrelsheikh University, Egypt (grant no. 33-2013).	Abdel-Sattar EA, 2014, TOXICOL IND HEALTH, V30, P147, DOI 10.1177/0748233712452601; Ahn HY, 1999, MOL BIOL CELL, V10, P1093; Alshatwi AA, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-167; CHOLBI MR, 1991, EXPERIENTIA, V47, P195, DOI 10.1007/BF01945426; Lee YH, 2012, INT J MOL MED, V30, P69, DOI 10.3892/ijmm.2012.966; SHIMODA R, 1994, CANCER RES, V54, P3171; Farazi PA, 2006, NAT REV CANCER, V6, P674, DOI 10.1038/nrc1934; McClain CJ, 2002, ALCOHOL, V27, P53, DOI 10.1016/S0741-8329(02)00212-4; Anwar WA, 2008, MUTAT RES-REV MUTAT, V659, P176, DOI 10.1016/j.mrrev.2008.01.005; Nuutila AM, 2002, FOOD CHEM, V76, P519, DOI 10.1016/S0308-8146(01)00305-3; Braca A, 2001, J NAT PROD, V64, P892, DOI 10.1021/np0100845; Abdo W, 2013, FOOD CHEM TOXICOL, V55, P578, DOI 10.1016/j.fct.2013.01.035; Stagos D, 2012, FOOD CHEM TOXICOL, V50, P2155, DOI 10.1016/j.fct.2012.04.002; Badria FA, 2007, Z NATURFORSCH C, V62, P656; Demeule Michel, 2002, Current Medicinal Chemistry - Anti-Cancer Agents, V2, P441, DOI 10.2174/1568011023353930; EL-HAWARY Z M, 1990, Archives of Pharmacal Research (Seoul), V13, P113, DOI 10.1007/BF02857846; Ghazanfar SA, 1994, HDB ARABIAN MED PLAN, P173; Grisham J. W., 1997, P233, DOI 10.1016/B978-012563455-7/50009-X; Imai K, 2007, ONCOL REP, V17, P55; Indian National Science Academy New Delhi, GUID CAR US AN SCI R; LAMAISON J L, 1990, Annales Pharmaceutiques Francaises, V48, P103; Liu XM, 2001, FITOTERAPIA, V72, P487, DOI 10.1016/S0367-326X(01)00271-4; Nakamuta M, 2005, INT J MOL MED, V16, P677; Puatanachokchai R, 2006, CANCER LETT, V240, P102, DOI 10.1016/j.canlet.2005.09.006; Sakai H, 2002, CANCER LETT, V188, P33, DOI 10.1016/S0304-3835(02)00009-5; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Zhong ZW, 2012, EXP THER MED, V4, P267, DOI 10.3892/etm.2012.580	27	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					716	722		10.3892/01.2015.3313		7	Oncology	Oncology	CN8FX	WOS:000358676200025		
J	Kawata, S; Yashima, K; Yamamoto, S; Sasaki, S; Takeda, Y; Hayashi, A; Matsumoto, K; Kawaguchi, K; Harada, K; Murawaki, Y				Kawata, Soichiro; Yashima, Kazuo; Yamamoto, Sohei; Sasaki, Shuji; Takeda, Yohei; Hayashi, Akihiro; Matsumoto, Kazuya; Kawaguchi, Koichiro; Harada, Kenichi; Murawaki, Yoshikazu			AID, p53 and MLH1 expression in early gastric neoplasms and the correlation with the background mucosa	ONCOLOGY LETTERS			English	Article						gastric cancer; endoscopic resection; AID; p53; phenotype	INDUCED CYTIDINE DEAMINASE; HELICOBACTER-PYLORI INFECTION; TUMOR-RELATED GENES; NF-KAPPA-B; MICROSATELLITE INSTABILITY; CANCER; CARCINOMA; CLASSIFICATION; INFLAMMATION; HYPERMETHYLATION	A number of tumor-associated genes have been associated with gastric cancer development. The present study evaluated differences in tumor-associated protein expression and phenotype among early gastric neoplasms, and correlated these data with those of the background nmcosa. The expression of activation-induced cytidine deaminase (AID), p53 and MLH1 in 151 early gastric neoplasms 22 gastric adenomas, 92 intramucosal carcinomas (MCs), and 37 submucosal carcinomas (SMCs)] was examined immunohistochemically and compared with that of the corresponding background mucosal condition. The cellular phenotypes of the neoplasms and the corresponding background intestinal metaplasia were also determined. Aberrant AID, p53 and MLH1 expression was detected in 36.4, 0 and 0% of the adenomas, in 35.9, 32.6 and 16.3% of the MCs, and in 56.8, 62.2 and 21.6% of the SMCs, respectively. The frequency of aberrant AID and p53 expression in the SMCs was significantly increased compared with that in the MCs (AID, P<0.05; p53, P<0.01). Aberrant AID expression was significantly associated with p53 overexpression in the SMCs (P<0.01), but not in the adenomas or MCs. In addition, AID expression was associated with the severity of mononuclear cell activity in the non-cancerous inticosa adjacent to the tumor (P<0.05), particularly in the SMC cases. The percentage of MCs (34.8%) and SMCs (24.3%) that were of the gastric phenotype was higher compared with the percentage of adenomas (18.2%). These results indicated that p53 and MLITI expression and a gastric phenotype may be important for carcinogenesis, and that chronic inflammation and AID and p53 expression are associated with subnmcosal progression.	[Kawata, Soichiro; Yashima, Kazuo; Yamamoto, Sohei; Sasaki, Shuji; Takeda, Yohei; Hayashi, Akihiro; Matsumoto, Kazuya; Kawaguchi, Koichiro; Harada, Kenichi; Murawaki, Yoshikazu] Tottori Univ, Fac Med, Div Med & Clin Sci, Yonago, Tottori 6838504, Japan	Yashima, K (reprint author), Tottori Univ, Fac Med, Div Med & Clin Sci, 36-1 Nishicho, Yonago, Tottori 6838504, Japan.	yashima@grape.med.tottori-u.ac.jp					Andachi H, 2002, BRIT J CANCER, V87, P441, DOI 10.1038/sj.bjc.6600501; Fleisher AS, 1999, CANCER RES, V59, P1090; Viala J, 2004, NAT IMMUNOL, V5, P1166, DOI 10.1038/ni1131; Kang DW, 2013, ONCOGENE, V32, P3531, DOI 10.1038/onc.2012.358; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Koseki K, 2000, CANCER, V89, P724, DOI 10.1002/1097-0142(20000815)89:4<724::AID-CNCR2>3.0.CO;2-4; Kozack R, 2000, MUTAT RES-FUND MOL M, V450, P41, DOI 10.1016/S0027-5107(00)00015-4; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Schlemper RJ, 2000, GUT, V47, P251, DOI 10.1136/gut.47.2.251; Endo Y, 2007, ONCOGENE, V26, P5587, DOI 10.1038/sj.onc.1210344; Endo Y, 2008, GASTROENTEROLOGY, V135, P889, DOI 10.1053/j.gastro.2008.06.091; Okazaki I, 2003, J EXP MED, V197, P1173, DOI 10.1084/jem.20030275; Fritz EL, 2010, GENE DEV, V24, P2107, DOI 10.1101/gad.1963010; Matsumoto Y, 2007, NAT MED, V13, P470, DOI 10.1038/nm1566; Dixon MF, 1996, AM J SURG PATHOL, V20, P1161, DOI 10.1097/00000478-199610000-00001; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; NAKAMURA K, 1968, GANN, V59, P251; Chiba T, 2012, GASTROENTEROLOGY, V143, P550, DOI 10.1053/j.gastro.2012.07.009; SIPPONEN P, 1994, EUR J GASTROEN HEPAT, V6, pS79; Tamura G, 2006, WORLD J GASTROENTERO, V12, P192; Baek MJ, 2001, BRIT J CANCER, V85, P1147, DOI 10.1054/bjoc.2001.2051; Nagata N, 2014, J GASTROENTEROL, V49, P427, DOI 10.1007/s00535-013-0808-z; Tsukashita S, 2001, INT J CANCER, V94, P166, DOI 10.1002/ijc.1460; LAUREN P, 1965, ACTA PATHOL MIC SC, V64, P31; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Tajima Y, 2001, ONCOLOGY-BASEL, V61, P212, DOI 10.1159/000055377; CORREA P, 1992, CANCER RES, V52, P6735; Egashira Y, 1999, PATHOL INT, V49, P55, DOI 10.1046/j.1440-1827.1999.00824.x; Goto A, 2011, VIRCHOWS ARCH, V458, P717, DOI 10.1007/s00428-011-1086-x; Hong SH, 2005, J KOREAN MED SCI, V20, P236; Japanese Gastric Cancer Association, 1998, JAP CLASS GASTR CARC; Kim CJ, 2007, TUMOR BIOL, V28, P333, DOI 10.1159/000124239; Komori J, 2008, HEPATOLOGY, V47, P888, DOI 10.1002/hep.22125; Morisawa T, 2008, INT J CANCER, V123, P2735, DOI 10.1002/ijc.23853; Niwa T, 2005, J HISTOCHEM CYTOCHEM, V53, P75, DOI 10.1369/jhc4A6443.2005; Saeki H, 2002, ONCOLOGY, V62, P175; Sugai T, 2010, INT J CANCER, V127, P2500, DOI 10.1002/ijc.25271; Takeda Yohei, 2012, World J Gastrointest Oncol, V4, P131, DOI 10.4251/wjgo.v4.i6.131; Yamazaki K, 2006, WORLD J GASTROENTERO, V12, P3803; Yoshino Takayuki, 1999, Stomach and Intestine (Tokyo), V34, P513; Yuasa H, 2002, J TOXICOL PATHOL, V15, P85, DOI 10.1293/tox.15.85	41	0	0	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1792-1074	1792-1082		ONCOL LETT	Oncol. Lett.	AUG	2015	10	2					737	743		10.3892/ol.2015.3342		7	Oncology	Oncology	CN8FX	WOS:000358676200028		
